Citrus Sinensis ID: 001782
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1013 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.957 | 0.960 | 0.439 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.942 | 0.926 | 0.435 | 0.0 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.945 | 0.934 | 0.434 | 0.0 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.876 | 0.757 | 0.329 | 1e-126 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.856 | 0.728 | 0.333 | 1e-122 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.862 | 0.699 | 0.336 | 1e-121 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.937 | 0.937 | 0.308 | 1e-118 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.866 | 0.701 | 0.326 | 1e-118 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.914 | 0.823 | 0.310 | 1e-118 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.900 | 0.909 | 0.333 | 1e-117 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 791 bits (2044), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/1010 (43%), Positives = 634/1010 (62%), Gaps = 40/1010 (3%)
Query: 20 FLLHSHSCFALHSNETDRLALLAIKSQL-QDPLGVTSSWNNSMNLCQWTGVTCGHRHQRV 78
LL +H ++ETDR ALL KSQ+ +D V SSWN+S LC W GVTCG +++RV
Sbjct: 13 MLLETHG----FTDETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRV 68
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
T L+L + G++SP +GNLSFL ++ N F G IP E+G+L RLE L + N G
Sbjct: 69 THLELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRG 128
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISN 198
IP L CS L+N N L G +P ++G S L L+L N + G+L S+GN++
Sbjct: 129 PIPLGLYNCSRLLNLRLDSNRLGGSVPSELG-SLTNLVQLNLYGNNMRGKLPTSLGNLTL 187
Query: 199 LQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLE 258
L+ L++ N L G +P + QL ++ L + N FSG+FP +++N+SSL+ + + N
Sbjct: 188 LEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFS 247
Query: 259 GSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLP 318
G L ++G LPNL + ++ N +TGS+P +LSN S L L + N+ +G + F +P
Sbjct: 248 GRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVP 306
Query: 319 NLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILF 378
NL L N+LG+ + DL+F+ LTNC++LE LG+ N GG LP+SIANLS+ ++
Sbjct: 307 NLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTL 366
Query: 379 SMGLNQIY------VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIP 432
+G I + NL+NL L+ N L+GP+P ++G+L NL+ L L N L G IP
Sbjct: 367 DLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIP 426
Query: 433 ESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL 492
+GN+T+L +LDL N G VP+SLGNC +L+ L + +NKL G +P +I+ I L +
Sbjct: 427 AFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQL-LR 485
Query: 493 LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSI 552
LD+SGN L GS+P ++G L+NL L L +N+ S ++P +L C T+E L++EGN G I
Sbjct: 486 LDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDI 545
Query: 553 PLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRF 612
P LK L +KE+DLS N+LSG IPE+ + S LEYLNLS+N+LEG+VP +G+F N T
Sbjct: 546 P-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTV 604
Query: 613 YFTGNKRLCGGLDELHLPVCHSAGP---RKTRIALLKVVVPVTVILTII----VACLIVL 665
GN LCGG+ L C S P +K L KVV+ V+V +T++ +A + ++
Sbjct: 605 SIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLI 664
Query: 666 YTRRRKHKHKSSSML--LMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGEN 723
+ R+RK ++++ +E +SY DL ATN FSSSNM+G GSFG VY+ L
Sbjct: 665 WLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTE 724
Query: 724 EMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYM 783
+ VAVKV+N+++RGA KSF+AECE+L++IRHRNL+K++T CSSIDF+ +F+A++YE+M
Sbjct: 725 KKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFM 784
Query: 784 ECGSLEDWLHQSNDQLEV----GNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPS 839
GSL+ WLH + E+ +++RLN+ IDVA ++YLH HCH PI H DLKPS
Sbjct: 785 PNGSLDMWLHPEEVE-EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPS 843
Query: 840 NVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATG 899
NVLLD D+ AHV DFGLAR L + SS+ G++GT+GY APEYG+GG S G
Sbjct: 844 NVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSA-GVRGTIGYAAPEYGVGGQPSING 902
Query: 900 DVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNC 959
DVYSFGILLLEMFT +RPT+ +F TL+ + K ALPE++++IVD +L + R
Sbjct: 903 DVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDE-SILHIGLRVG-- 959
Query: 960 GSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIFL 1009
+ ECL + +G+ C ESP R+ + VV +L S R+ F
Sbjct: 960 -------FPVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFF 1002
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 753 bits (1945), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/1010 (43%), Positives = 611/1010 (60%), Gaps = 55/1010 (5%)
Query: 29 ALHSNETDRLALLAIKSQLQD--PLGVTSSWNNSMNLCQWTGVTCGHRHQRVTVLDLSNR 86
A SNETD ALL KSQ+ + V +SWN+S C W GVTCG R +RV L+L
Sbjct: 24 ARFSNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGF 83
Query: 87 SIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSR 146
+ G++SP +GNLSFLR +N A+N F IP ++GRLFRL+ L ++ N G+IPS+LS
Sbjct: 84 KLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSN 143
Query: 147 CSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGE 206
CS L N+L +P ++G S KL L L N L G S+GN+++LQ L
Sbjct: 144 CSRLSTVDLSSNHLGHGVPSELG-SLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAY 202
Query: 207 NRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIG 266
N++ G +PD + +L + + I+ N+FSG FP +++NISSLES+SL N G+L + G
Sbjct: 203 NQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFG 262
Query: 267 FSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFS 326
+ LPNL L + N +TG++P +L+N S+L D S N+ SG + + F +L NL+ L
Sbjct: 263 YLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIR 322
Query: 327 KNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIY 386
N+LG + L+FI + NC++LE L + N GG LP SIANLS+T+ +G N I
Sbjct: 323 NNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLIS 382
Query: 387 ------VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTI 440
+ NLV+L LE N L+G +P + G+L NLQV+DL+ N + G IP GN+T
Sbjct: 383 GTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTR 442
Query: 441 LNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLL 500
L L L N G +P SLG C+ L+ L + N+L G +P +IL I +L+ +DLS N L
Sbjct: 443 LQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAY-IDLSNNFL 501
Query: 501 TGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLK 560
TG P EVG L+ LV LG S N+ S ++P ++ C ++E+L+M+GNS G+IP + L
Sbjct: 502 TGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP-DISRLV 560
Query: 561 SIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRL 620
S+K +D S NNLSG+IP +L +L L LNLS N EG VP GVF N T GN +
Sbjct: 561 SLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNI 620
Query: 621 CGGLDELHLPVC-HSAGPRKTR-IALLKVVVP------VTVILTIIVACLIVLYTRRRKH 672
CGG+ E+ L C A PRK + +++ K VV +++L IIVA L R++K+
Sbjct: 621 CGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKN 680
Query: 673 K------HKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMA 726
S+++ + ++ VSY +L AT+ FSS+N+IG G+FG V++G LG
Sbjct: 681 NASDGNPSDSTTLGMFHEK---VSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKL 737
Query: 727 VAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECG 786
VAVKV+NL + GATKSF+AECE + IRHRNL+K+ITVCSS+D E DF+A+VYE+M G
Sbjct: 738 VAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKG 797
Query: 787 SLEDWLHQSNDQLEVGN----FNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVL 842
SL+ WL Q D V + ++LN+ IDVA A+EYLH HCH P+ H D+KPSN+L
Sbjct: 798 SLDMWL-QLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNIL 856
Query: 843 LDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVY 902
LD D+ AHV DFGLA+ L + L SS G++GT+GY APEYGMGG S GDVY
Sbjct: 857 LDDDLTAHVSDFGLAQLLYKYDRESFLNQ-FSSAGVRGTIGYAAPEYGMGGQPSIQGDVY 915
Query: 903 SFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSH 962
SFGILLLEMF+ ++PTD F LH + K L S C S
Sbjct: 916 SFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL--------------------SGCTSS 955
Query: 963 RTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIFLSNR 1012
A I+E L ++++G+ CS E P +R++ + V +L S R F S++
Sbjct: 956 GGSNA-IDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFFSSK 1004
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 741 bits (1913), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/1011 (43%), Positives = 622/1011 (61%), Gaps = 53/1011 (5%)
Query: 32 SNETDRLALLAIKSQLQDPLGVT-SSWNNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEG 90
+ ETD+ ALL KSQ+ + V SWN+S+ LC WTGV CG +H+RVT +DL + G
Sbjct: 36 TEETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTG 95
Query: 91 ILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNL 150
++SP+VGNLSFLR +N A+N F G IP E+G LFRL+ L ++NN F G IP LS CS+L
Sbjct: 96 VVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSL 155
Query: 151 INFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLS 210
N+L +P + G + R+NL G+ S+GN+++LQ+L N++
Sbjct: 156 STLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNL-TGKFPASLGNLTSLQMLDFIYNQIE 214
Query: 211 GRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLP 270
G +P + +L+ + + I+ N F+G+FP I+N+SSL +S+ GN G+L + G LP
Sbjct: 215 GEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLP 274
Query: 271 NLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNL 330
NL+ L + N++TG++P +LSN S+LR LD NH +G++ + F RL NL L + N+L
Sbjct: 275 NLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSL 334
Query: 331 GTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIY---- 386
G + GDLDF+ LTNCS+L+ L + N GG LP+ IANLS+ + S+G N I
Sbjct: 335 GNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIP 394
Query: 387 --VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSL 444
+ NLV+L L N LTG +P ++GEL L+ + L+ N L G IP SLGN++ L L
Sbjct: 395 HGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYL 454
Query: 445 DLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSI 504
L N G +PSSLG+C L+ L++ NKL G++P +++ + +L ++L++S NLL G +
Sbjct: 455 YLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSL-VVLNVSFNLLVGPL 513
Query: 505 PAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKE 564
++G LK L+ L +S N+ S +IP +L+ C +LE+L ++GNS G IP ++ L ++
Sbjct: 514 RQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIRGLTGLRF 572
Query: 565 LDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGL 624
LDLS+NNLSG IPE++ N S L+ LNLS N+ +G VP GVF N + GN LCGG+
Sbjct: 573 LDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGI 632
Query: 625 DELHLPVCHSAGPRKTRIALLKVVVPVTVILTIIVACL------------------IVLY 666
L L C PR+ V I+TI V+ + + +
Sbjct: 633 PSLQLQPCSVELPRRHS--------SVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVK 684
Query: 667 TRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMA 726
+ R + S ++ + +SY +L K T FSSSN+IG G+FG V++G LG A
Sbjct: 685 SVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKA 744
Query: 727 VAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECG 786
VA+KV+NL +RGA KSF+AECEAL IRHRNL+K++T+CSS DFE DF+A+VYE+M G
Sbjct: 745 VAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNG 804
Query: 787 SLEDWLHQSNDQLEVGN----FNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVL 842
+L+ WLH + E GN + RLN+ IDVA A+ YLH +CH PI H D+KPSN+L
Sbjct: 805 NLDMWLHPDEIE-ETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNIL 863
Query: 843 LDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVY 902
LD D+ AHV DFGLA+ L T SS G++GT+GY APEYGMGG S GDVY
Sbjct: 864 LDKDLTAHVSDFGLAQLLLKFDRDT-FHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVY 922
Query: 903 SFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEK-VMEIVDPLLLLDLEARASNCGS 961
SFGI+LLE+FT +RPT+ +F DGLTLH F K AL ++ ++I D +L A+ N
Sbjct: 923 SFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFN--- 979
Query: 962 HRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIFLSNR 1012
+ ECL + R+GV CS ESP RI M + ++KL S R+ F +
Sbjct: 980 -------MVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFRDE 1023
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 452 bits (1163), Expect = e-126, Method: Compositional matrix adjust.
Identities = 324/984 (32%), Positives = 507/984 (51%), Gaps = 96/984 (9%)
Query: 88 IEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRC 147
+ G + +G L+ L ++ + N +G+IP + G L L++L+L N G IP+ + C
Sbjct: 204 LTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNC 263
Query: 148 SNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGEN 207
S+L+ N L G+IP ++G + ++L+ L + N L + S+ ++ L L + EN
Sbjct: 264 SSLVQLELYDNQLTGKIPAELG-NLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSEN 322
Query: 208 RLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGF 267
L G + + +G L SL L++ N F+G FP SI N+ +L +++ N + G LP ++G
Sbjct: 323 HLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL 382
Query: 268 SLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSK 327
L NL NLS N TG +P S+SN + L+LLD S N +G++ F R+ NL +S +
Sbjct: 383 -LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGR 440
Query: 328 NNLGTGAIGDLDFIAHLTNCSKLEALGL-DTNIFG-----------------------GV 363
N+ TG I D F NCS LE L + D N+ G G
Sbjct: 441 NHF-TGEIPDDIF-----NCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGP 494
Query: 364 LPLSIANLSSTIILF-----SMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQ 418
+P I NL IL+ G + NL L G + N L GPIP + +++ L
Sbjct: 495 IPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLS 554
Query: 419 VLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGA 478
VLDL +N G IP L L L L NK G +P+SL + L +S+N LTG
Sbjct: 555 VLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGT 614
Query: 479 LPPQILG-IVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACT- 536
+P ++L + + + L+ S NLLTG+IP E+G L+ + ++ LS N FS IP SL AC
Sbjct: 615 IPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKN 674
Query: 537 --TLEY----------------------LYMEGNSLTGSIPLALKTLKSIKELDLSRNNL 572
TL++ L + NS +G IP + + + LDLS NNL
Sbjct: 675 VFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNL 734
Query: 573 SGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGLDELH---L 629
+G+IPE L NLS L++L L+ N+L+G VP GVF N GN LCG L +
Sbjct: 735 TGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTI 794
Query: 630 PVCHSAGPRKTRIALL----KVVVPVTVILTIIVACLIVLYTRRRKHKHKSSSMLLMEQQ 685
S ++TR+ L+ + + ++L +I+ C + S L +
Sbjct: 795 KQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALK 854
Query: 686 FPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT--KSF 743
+L +AT+ F+S+N+IG S VY+G L E+ +AVKV+NLK+ A K F
Sbjct: 855 LKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAESDKWF 913
Query: 744 VAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGN 803
E + L ++HRNL+KI+ +E KA+V +ME G+LED +H S +G
Sbjct: 914 YTEAKTLSQLKHRNLVKILGFA----WESGKTKALVLPFMENGNLEDTIHGS--AAPIG- 966
Query: 804 FNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863
+++++++L + +A I+YLH PIVH DLKP+N+LLD D VAHV DFG AR L
Sbjct: 967 -SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFR 1025
Query: 864 SPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPT--DNM 921
+ T +S++ +GT+GY+APE+ ++ DV+SFGI+++E+ T++RPT ++
Sbjct: 1026 EDGS---TTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDE 1082
Query: 922 FNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGV 981
+ +TL + + ++ +V +LD+E S K EE + +++ +
Sbjct: 1083 DSQDMTLRQLVEKSIGNGRKGMVR---VLDMELGDSIVS------LKQEEAIEDFLKLCL 1133
Query: 982 LCSMESPSERIQMTDVVAKLCSAR 1005
C+ P +R M +++ L R
Sbjct: 1134 FCTSSRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-122, Method: Compositional matrix adjust.
Identities = 322/966 (33%), Positives = 486/966 (50%), Gaps = 98/966 (10%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
+ + L LS S+ G L + + L F + N SG +P +G+ L++L+LANN
Sbjct: 282 KSLKSLMLSFNSLSGPLPLELSEIPLLTF-SAERNQLSGSLPSWMGKWKVLDSLLLANNR 340
Query: 136 FSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGN 195
FSG+IP + C L + N L G IP ++ S LE + L NLL+G +
Sbjct: 341 FSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSG-SLEAIDLSGNLLSGTIEEVFDG 399
Query: 196 ISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGN 255
S+L L + N+++G +P+ L +L L L + N F+G P S++ ++L + N
Sbjct: 400 CSSLGELLLTNNQINGSIPEDLWKL-PLMALDLDSNNFTGEIPKSLWKSTNLMEFTASYN 458
Query: 256 RLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFN 315
RLEG LP IG + +L+ L + N TG +P + ++L +L+ + N F G++ ++
Sbjct: 459 RLEGYLPAEIG-NAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVELG 517
Query: 316 RLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTI 375
+L L NNL G I D +T ++L+ L L N G +P
Sbjct: 518 DCTSLTTLDLGSNNL-QGQIPD-----KITALAQLQCLVLSYNNLSGSIPSKP------- 564
Query: 376 ILFSMGLNQIYVKNLVNLNG---FGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIP 432
S +QI + +L L F L YN+L+GPIP +GE L + L +N+L G IP
Sbjct: 565 ---SAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIP 621
Query: 433 ESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL 492
SL LT L LDL N L G +P +GN L L+++NN+L G +P + G++ +
Sbjct: 622 ASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIP-ESFGLLGSLVK 680
Query: 493 LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSI 552
L+L+ N L G +PA +GNLK L + LS N S E+ LS L LY+E N TG I
Sbjct: 681 LNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEI 740
Query: 553 PLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRF 612
P L L ++ LD+S N LSG+IP + L LE+LNL+ N+L GEVP GV + ++
Sbjct: 741 PSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKA 800
Query: 613 YFTGNKRLCG---GLDELHLPVCHSAGPR-KTRIALLKVVVPVTVILTIIVACLIVL-YT 667
+GNK LCG G D C G + ++ + +++ T+I+ + V L T
Sbjct: 801 LLSGNKELCGRVVGSD------CKIEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMT 854
Query: 668 RRRKHKHKSSSM-----------------------------LLMEQQFPMVSYADLSKAT 698
+R K + M + EQ V D+ +AT
Sbjct: 855 KRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEAT 914
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
+ FS N+IG G FG VY+ L E VAVK ++ + + F+AE E L ++H NL
Sbjct: 915 DHFSKKNIIGDGGFGTVYKACL-PGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNL 973
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
+ ++ CS F E K +VYEYM GSL+ WL LEV +++ +RL + + A
Sbjct: 974 VSLLGYCS---FSEE--KLLVYEYMVNGSLDHWLRNQTGMLEVLDWS--KRLKIAVGAAR 1026
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+ +LHH P I+H D+K SN+LLD D V DFGLAR + C ST I
Sbjct: 1027 GLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHV-------STVI 1079
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMF--NDGLTLHEFAKMAL 936
GT GY+ PEYG + GDVYSFG++LLE+ T + PT F ++G L +A +
Sbjct: 1080 AGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKI 1139
Query: 937 PE-KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMT 995
+ K ++++DPLL+ ++ + +++I +LC E+P++R M
Sbjct: 1140 NQGKAVDVIDPLLV----------------SVALKNSQLRLLQIAMLCLAETPAKRPNML 1183
Query: 996 DVVAKL 1001
DV+ L
Sbjct: 1184 DVLKAL 1189
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1122), Expect = e-121, Method: Compositional matrix adjust.
Identities = 329/977 (33%), Positives = 473/977 (48%), Gaps = 103/977 (10%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEI-GRLFRLETLILANNSF 136
+ LDLS ++ G + N+S L + ANN SG +P I LE L+L+
Sbjct: 289 LQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQL 348
Query: 137 SGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNI 196
SG+IP LS+C +L N+L G IP + + ++L L L +N L G L+PSI N+
Sbjct: 349 SGEIPVELSKCQSLKQLDLSNNSLAGSIPEAL-FELVELTDLYLHNNTLEGTLSPSISNL 407
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNR 256
+NLQ L + N L G+LP + LR L L + EN FSG P I N +SL+ I + GN
Sbjct: 408 TNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNH 467
Query: 257 LEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNR 316
EG +P +IG L L L +RQN G LP SL N L +LD + N SG + F
Sbjct: 468 FEGEIPPSIG-RLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGF 526
Query: 317 LPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVL-PLSIANLSSTI 375
L L +L N+L G + D L + L + L N G + PL SS+
Sbjct: 527 LKGLEQLMLYNNSL-QGNLPD-----SLISLRNLTRINLSHNRLNGTIHPLCG---SSSY 577
Query: 376 ILFSMGLN------QIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDG 429
+ F + N + + N NL+ L NQLTG IP +G++R L +LD+ N L G
Sbjct: 578 LSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTG 637
Query: 430 HIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTL 489
IP L L +DL N L G +P LG L L +S+N+ +LP ++ L
Sbjct: 638 TIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKL 697
Query: 490 SILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLT 549
++L L GN L GSIP E+GNL L L L +N+FS +P ++ + L L + NSLT
Sbjct: 698 -LVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLT 756
Query: 550 GSIPLALKTLKSIKE-LDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPR------ 602
G IP+ + L+ ++ LDLS NN +G IP + LS LE L+LS+N L GEVP
Sbjct: 757 GEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMK 816
Query: 603 ----------------RGVFSNKTRFYFTGNKRLCGGLDELHLPVCH-------SAGPRK 639
+ FS F GN LCG L C+ G
Sbjct: 817 SLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGS----PLSRCNRVRSNNKQQGLSA 872
Query: 640 TRIALLKVVVPVTVILTIIVACLIVLYTRR---RKHKHKSSS-----MLLMEQQFPM--- 688
+ ++ + +T I +I+ + R +K H S++ P+
Sbjct: 873 RSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRN 932
Query: 689 ------VSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKS 742
+ + D+ +AT++ S MIG G G VY+ L E K++ + KS
Sbjct: 933 GASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKS 992
Query: 743 FVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVG 802
F E + L IRHR+L+K++ CSS + ++YEYM+ GS+ DWLH+ LE
Sbjct: 993 FSREVKTLGRIRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKK 1049
Query: 803 N--FNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860
+ RL + + +A +EYLHH C PPIVH D+K SNVLLD +M AH+GDFGLA+ L
Sbjct: 1050 KKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVL 1109
Query: 861 PP-CSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTD 919
C T S+T + GY+APEY + DVYS GI+L+E+ T + PTD
Sbjct: 1110 TENCDTNT-----DSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTD 1164
Query: 920 NMFNDGLTLHEFAKMALP---EKVMEIVDPLL--LLDLEARASNCGSHRTEIAKIEECLV 974
++F + + + + L +++DP L LL E E+
Sbjct: 1165 SVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFE----------------EDAAC 1208
Query: 975 AIVRIGVLCSMESPSER 991
++ I + C+ SP ER
Sbjct: 1209 QVLEIALQCTKTSPQER 1225
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1098), Expect = e-118, Method: Compositional matrix adjust.
Identities = 317/1029 (30%), Positives = 519/1029 (50%), Gaps = 79/1029 (7%)
Query: 13 LVWCFSLFLLHSHSCFALHSNETDRLALLAIKSQLQDPLGVTSSW--NNSMNLCQWTGVT 70
+++ + ++ + S A N + LL++KS L DPL W +++ + C WTGV
Sbjct: 7 VLFLYYCYIGSTSSVLASIDNVNELSVLLSVKSTLVDPLNFLKDWKLSDTSDHCNWTGVR 66
Query: 71 CGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLI 130
C + + V LDL+ ++ G +S + LS L N + NGF +P I L +++
Sbjct: 67 C-NSNGNVEKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFESLLPKSIPPL---KSID 122
Query: 131 LANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLA 190
++ NSFSG + + L++ +A GNNL G + D+G + + LE L LR N G L
Sbjct: 123 ISQNSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLG-NLVSLEVLDLRGNFFQGSLP 181
Query: 191 PSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESI 250
S N+ L+ L + N L+G LP LGQL SL + N F G P NI+SL+ +
Sbjct: 182 SSFKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYL 241
Query: 251 SLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQV 310
L +L G +P +G L +LE L + +NN+TG++P + + + L++LDFS N +G++
Sbjct: 242 DLAIGKLSGEIPSELG-KLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEI 300
Query: 311 KIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIAN 370
++ +L NL L+ +N L +G+I +++ ++L+ L L N G LP +
Sbjct: 301 PMEITKLKNLQLLNLMRNKL-SGSIP-----PAISSLAQLQVLELWNNTLSGELPSDLGK 354
Query: 371 LSSTIILFSMGLNQIYVK------NLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHH 424
+S + + N + N NL L N TG IP + ++L + + +
Sbjct: 355 -NSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQN 413
Query: 425 NNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQIL 484
N L+G IP G L L L+L N+L G +P + + +L + S N++ +LP IL
Sbjct: 414 NLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTIL 473
Query: 485 GIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYME 544
I L L ++ N ++G +P + + +L L LS N + IP S+++C L L +
Sbjct: 474 SIHNLQAFL-VADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLR 532
Query: 545 GNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRG 604
N+LTG IP + T+ ++ LDLS N+L+G +PE + LE LN+SYN L G VP G
Sbjct: 533 NNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPING 592
Query: 605 VFSNKTRFYFTGNKRLCGGLDELHLPVC---------HSAGPRKTRIALLKVVVPVTVIL 655
GN LCGG+ LP C HS+ K +A + + + L
Sbjct: 593 FLKTINPDDLRGNSGLCGGV----LPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLAL 648
Query: 656 TIIVACLIVLYTRRRKHKH-KSSSMLLMEQQFPMVSYADLSKATND----FSSSNMIGQG 710
I+ LY + + + E + ++++ L +D SNMIG G
Sbjct: 649 GILTIVTRTLYKKWYSNGFCGDETASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMG 708
Query: 711 SFGFVYRGNLGENEMAVAVKVMNLK----QRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+ G VY+ + + +AVK + + G T FV E L +RHRN+++++
Sbjct: 709 ATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFL- 767
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNV--IQRLNLVIDVAFAIEYLH 824
+ + + IVYE+M G+L D +H N G V + R N+ + VA + YLH
Sbjct: 768 ---YNDKNM-MIVYEFMLNGNLGDAIHGKN---AAGRLLVDWVSRYNIALGVAHGLAYLH 820
Query: 825 HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGY 884
H CHPP++H D+K +N+LLD ++ A + DFGLAR + A ET S + G+ GY
Sbjct: 821 HDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM-----ARKKETVSM---VAGSYGY 872
Query: 885 VAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVM--E 942
+APEYG + D+YS+G++LLE+ T RRP + F + + + E+ + + + + E
Sbjct: 873 IAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEE 932
Query: 943 IVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002
+DP N G+ R ++E ++ +++I +LC+ + P +R M DV++ L
Sbjct: 933 ALDP-----------NVGNCRY----VQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLG 977
Query: 1003 SARKIFLSN 1011
A+ SN
Sbjct: 978 EAKPRRKSN 986
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 426 bits (1096), Expect = e-118, Method: Compositional matrix adjust.
Identities = 316/969 (32%), Positives = 472/969 (48%), Gaps = 91/969 (9%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEI-GRLFRLETLILANNSF 136
+ LDLS+ ++ G++ ++ L F+ A N SG +P I L+ L L+
Sbjct: 290 LQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQL 349
Query: 137 SGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNI 196
SG+IP+ +S C +L N L GQIP + + ++L L L +N L G L+ SI N+
Sbjct: 350 SGEIPAEISNCQSLKLLDLSNNTLTGQIPDSL-FQLVELTNLYLNNNSLEGTLSSSISNL 408
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNR 256
+NLQ ++ N L G++P +G L L + + EN FSG P I N + L+ I GNR
Sbjct: 409 TNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNR 468
Query: 257 LEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNR 316
L G +P +IG L +L L +R+N G++P SL N + ++D + N SG + F
Sbjct: 469 LSGEIPSSIG-RLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGF 527
Query: 317 LPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANL--SST 374
L L L NN G + D L N L + +N F G SI+ L SS+
Sbjct: 528 LTAL-ELFMIYNNSLQGNLPD-----SLINLKNLTRINFSSNKFNG----SISPLCGSSS 577
Query: 375 IILFSMGLN------QIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLD 428
+ F + N + + NL+ L NQ TG IP G++ L +LD+ N+L
Sbjct: 578 YLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLS 637
Query: 429 GHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVT 488
G IP LG L +DL N L G +P+ LG L L +S+NK G+LP +I +
Sbjct: 638 GIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTN 697
Query: 489 LSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSL 548
+ L L GN L GSIP E+GNL+ L L L EN+ S +P ++ + L L + N+L
Sbjct: 698 ILTLF-LDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNAL 756
Query: 549 TGSIPLALKTLKSIKE-LDLSRNNLSGQIPEFLENLSFLE-------------------- 587
TG IP+ + L+ ++ LDLS NN +G+IP + L LE
Sbjct: 757 TGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDM 816
Query: 588 ----YLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGLDELHLPVCHSAGPRKTRIA 643
YLNLSYN+LEG++ ++ FS F GN LCG L C+ AG + R
Sbjct: 817 KSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCGS----PLSHCNRAGSKNQRSL 870
Query: 644 LLKVVVPVTVILTIIVACLIVLYT-----------RRRKHKHKSSSMLLMEQQFPMVS-- 690
K VV ++ I ++ L+VL ++ + + + S Q P+ S
Sbjct: 871 SPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNG 930
Query: 691 -------YADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSF 743
+ D+ +AT+ + MIG G G VY+ L E K++ + KSF
Sbjct: 931 GAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSF 990
Query: 744 VAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGN 803
E + L IRHR+L+K++ CSS + ++YEYM GS+ DWLH + + +
Sbjct: 991 NREVKTLGTIRHRHLVKLMGYCSS---KADGLNLLIYEYMANGSVWDWLHANENTKKKEV 1047
Query: 804 FNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863
RL + + +A +EYLH+ C PPIVH D+K SNVLLD ++ AH+GDFGLA+ L
Sbjct: 1048 LGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKIL--- 1104
Query: 864 SPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFN 923
S+T G+ GY+APEY + DVYS GI+L+E+ T + PT+ MF+
Sbjct: 1105 -TGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFD 1163
Query: 924 DGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSH-RTEIAKIEECLVAIVRIGVL 982
+ + + + L EAR S ++ + EE ++ I +
Sbjct: 1164 EETDMVRWVETVLDTPPGS----------EAREKLIDSELKSLLPCEEEAAYQVLEIALQ 1213
Query: 983 CSMESPSER 991
C+ P ER
Sbjct: 1214 CTKSYPQER 1222
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 425 bits (1093), Expect = e-118, Method: Compositional matrix adjust.
Identities = 345/1112 (31%), Positives = 527/1112 (47%), Gaps = 186/1112 (16%)
Query: 35 TDRLALLAIKSQ-LQDPLGVTSSWNN-SMNLCQWTGVTCGHRHQR-------VTVLDLSN 85
+D LL +K++ QD L +WN C W GV C + VT LDLS+
Sbjct: 35 SDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLSS 94
Query: 86 RSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLS 145
++ GI+SP +G L L ++N A N +G+IP EIG +LE + L NN F G IP ++
Sbjct: 95 MNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEIN 154
Query: 146 RCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNIS-------- 197
+ S L +F+ N L G +P +IG + LE L N L G L S+GN++
Sbjct: 155 KLSQLRSFNICNNKLSGPLPEEIGDLY-NLEELVAYTNNLTGPLPRSLGNLNKLTTFRAG 213
Query: 198 ----------------NLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSI 241
NL++L + +N +SG LP +G L L + + +N FSG P I
Sbjct: 214 QNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDI 273
Query: 242 FNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDF 301
N++SLE+++L GN L G +P IG ++ +L+ L + QN G++P L S + +DF
Sbjct: 274 GNLTSLETLALYGNSLVGPIPSEIG-NMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDF 332
Query: 302 SLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAI----------GDLDF-IAHLT----- 345
S N SG++ ++ +++ L L +N L TG I LD I LT
Sbjct: 333 SENLLSGEIPVELSKISELRLLYLFQNKL-TGIIPNELSKLRNLAKLDLSINSLTGPIPP 391
Query: 346 ---NCSKLEALGLDTNIFGGVLP--------LSIANLS---------------STIILFS 379
N + + L L N GV+P L + + S S +IL +
Sbjct: 392 GFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLN 451
Query: 380 MGLNQIY---------VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGH 430
+G N+I+ K+L+ L G N+LTG P + +L NL ++L N G
Sbjct: 452 LGSNRIFGNIPPGVLRCKSLLQLRVVG---NRLTGQFPTELCKLVNLSAIELDQNRFSGP 508
Query: 431 IPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLS 490
+P +G L L L N+ ++P+ + NL+ +VS+N LTG +P +I L
Sbjct: 509 LPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQ 568
Query: 491 ILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTG 550
LDLS N GS+P E+G+L L L LSENRFS IP ++ T L L M GN +G
Sbjct: 569 -RLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSG 627
Query: 551 SIPLALKTLKSIK-------------------------ELDLSRNNLSGQIPEFLENLSF 585
SIP L L S++ L L+ N+LSG+IP ENLS
Sbjct: 628 SIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSS 687
Query: 586 LEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGLDELHLPVC---HSAGP----- 637
L N SYN+L G++P +F N T F GNK LCGG HL C HS+ P
Sbjct: 688 LLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGG----HLRSCDPSHSSWPHISSL 743
Query: 638 -----RKTRIALLKVVVPVTVILTIIVACLIVL---------YTRRRKHKHKSSSMLLME 683
R+ RI ++ V + L +I + L Y ++ + S + +
Sbjct: 744 KAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVP 803
Query: 684 QQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN-------LKQ 736
++ + D+ +AT F S ++G+G+ G VY+ + + +AVK +
Sbjct: 804 KE--RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGK-TIAVKKLESNREGNNNNS 860
Query: 737 RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSN 796
SF AE L IRHRN++++ + C + + ++YEYM GSL + LH
Sbjct: 861 NNTDNSFRAEILTLGKIRHRNIVRLYSFCYH---QGSNSNLLLYEYMSRGSLGELLHGGK 917
Query: 797 DQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856
+ + R + + A + YLHH C P I+H D+K +N+L+D + AHVGDFGL
Sbjct: 918 SH----SMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGL 973
Query: 857 ARFLPPCSPATILETP--SSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914
A+ +++ P S + + G+ GY+APEY ++ D+YSFG++LLE+ T
Sbjct: 974 AK---------VIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTG 1024
Query: 915 RRPTDNMFNDGLTLHEFAKMALPEKVM--EIVDPLLLLDLEARASNCGSHRTEIAKIEEC 972
+ P + G L + + + + + EI+DP L + E I
Sbjct: 1025 KAPVQPLEQGG-DLATWTRNHIRDHSLTSEILDPYLT-------------KVEDDVILNH 1070
Query: 973 LVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004
++ + +I VLC+ SPS+R M +VV L +
Sbjct: 1071 MITVTKIAVLCTKSSPSDRPTMREVVLMLIES 1102
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 424 bits (1090), Expect = e-117, Method: Compositional matrix adjust.
Identities = 334/1001 (33%), Positives = 492/1001 (49%), Gaps = 89/1001 (8%)
Query: 39 ALLAIKSQL----QDPLGVTSSWNNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEGILSP 94
ALL++K+ L D SSW S + C W GVTC + VT LDLS ++ G LSP
Sbjct: 28 ALLSLKTSLTGAGDDKNSPLSSWKVSTSFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSP 87
Query: 95 YVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFH 154
V +L L+ ++ A N SG IP EI L L L L+NN F+G P +S S L+N
Sbjct: 88 DVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEIS--SGLVNLR 145
Query: 155 A---RGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSG 211
NNL G +P + + +L L L N AG++ PS G+ ++ L++ N L G
Sbjct: 146 VLDVYNNNLTGDLPVSV-TNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVG 204
Query: 212 RLPDSLGQLRSLYYLSISE-NAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLP 270
++P +G L +L L I NAF P I N+S L L G +P IG L
Sbjct: 205 KIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIG-KLQ 263
Query: 271 NLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNL 330
L+ L ++ N ++G L L S+L+ +D S N F+G++ F L NL L+ +N L
Sbjct: 264 KLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKL 323
Query: 331 GTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLP--------LSIANLSSTIILFSMGL 382
G I + FI L +LE L L N F G +P L++ +LSS + ++
Sbjct: 324 -HGEIPE--FIGDLP---ELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPP 377
Query: 383 NQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILN 442
N L L G N L G IP ++G+ +L + + N L+G IP+ L L L
Sbjct: 378 NMCSGNKLETLITLG---NFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLT 434
Query: 443 SLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTG 502
++L N L G +P + G NL +S+SNN+L+G LPP I + LL L GN G
Sbjct: 435 QVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLL-LDGNKFQG 493
Query: 503 SIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSI 562
IP+EVG L+ L ++ S N FS I +S C L ++ + N L+G IP + +K +
Sbjct: 494 PIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKIL 553
Query: 563 KELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCG 622
L+LSRN+L G IP + ++ L L+ SYN+L G VP G FS F GN LCG
Sbjct: 554 NYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCG 613
Query: 623 GLDELHLPVC-----------HSAGPRKTRIALLKVVVPVTVILTIIVACLIVLYTRRRK 671
+L C HS GP + LL V+ + + V +I + R
Sbjct: 614 P----YLGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAII----KARS 665
Query: 672 HKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKV 731
K S S F + + + N+IG+G G VY+G + ++ VAVK
Sbjct: 666 LKKASESRAWRLTAFQRLDFT-CDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDL-VAVKR 723
Query: 732 MNLKQRGATKS--FVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLE 789
+ RG++ F AE + L IRHR++++++ CS+ E + +VYEYM GSL
Sbjct: 724 LAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN---HETNL--LVYEYMPNGSLG 778
Query: 790 DWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVA 849
+ LH G+ + R + ++ A + YLHH C P IVH D+K +N+LLD + A
Sbjct: 779 EVLHGKKG----GHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEA 834
Query: 850 HVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLL 909
HV DFGLA+FL + + + I G+ GY+APEY + DVYSFG++LL
Sbjct: 835 HVADFGLAKFLQDSGTSECM------SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLL 888
Query: 910 EMFTRRRPTDNMFNDGLTLHEFAKMAL---PEKVMEIVDPLLLLDLEARASNCGSHRTEI 966
E+ T R+P F DG+ + ++ + + V++++DP R S+ H
Sbjct: 889 ELVTGRKPVGE-FGDGVDIVQWVRKMTDSNKDSVLKVLDP--------RLSSIPIHE--- 936
Query: 967 AKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007
+ + + +LC E ER M +VV L K+
Sbjct: 937 ------VTHVFYVAMLCVEEQAVERPTMREVVQILTEIPKL 971
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1013 | ||||||
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.958 | 0.933 | 0.512 | 0.0 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.972 | 0.517 | 0.507 | 0.0 | |
| 224081190 | 1011 | predicted protein [Populus trichocarpa] | 0.979 | 0.981 | 0.487 | 0.0 | |
| 255577438 | 1028 | receptor-kinase, putative [Ricinus commu | 0.976 | 0.962 | 0.488 | 0.0 | |
| 224115346 | 1017 | predicted protein [Populus trichocarpa] | 0.970 | 0.966 | 0.488 | 0.0 | |
| 224090977 | 1034 | predicted protein [Populus trichocarpa] | 0.980 | 0.960 | 0.484 | 0.0 | |
| 224141953 | 1026 | predicted protein [Populus trichocarpa] | 0.962 | 0.950 | 0.481 | 0.0 | |
| 224119022 | 1021 | predicted protein [Populus trichocarpa] | 0.969 | 0.961 | 0.483 | 0.0 | |
| 224113117 | 1006 | predicted protein [Populus trichocarpa] | 0.962 | 0.969 | 0.496 | 0.0 | |
| 224127492 | 1022 | predicted protein [Populus trichocarpa] | 0.979 | 0.970 | 0.473 | 0.0 |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 966 bits (2498), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/1007 (51%), Positives = 685/1007 (68%), Gaps = 36/1007 (3%)
Query: 31 HSNETDRLALLAIKSQL-QDPLGVTSSWNNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIE 89
H NETDRLALLAIK+Q+ QDPLG+T+SWN+S++ C WTGVTCGHRHQRV L+L++ +
Sbjct: 35 HRNETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLNSLHLV 94
Query: 90 GILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSN 149
G LSP +GNL+FL +N N F G+IP E+GRL RL L L NNSFSG+IP+NLSRCSN
Sbjct: 95 GSLSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSN 154
Query: 150 LINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRL 209
L+ F NNL+G+IP +G S+ K+ + L N L G + S+GN+++++ LS N L
Sbjct: 155 LVYFRLGFNNLIGRIPSWLG-SYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHL 213
Query: 210 SGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSL 269
G +P +LGQL++L ++ + N FSG+ PSS++N+SSLE SL N+L GSLP ++ F+L
Sbjct: 214 EGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTL 273
Query: 270 PNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNN 329
PNL+ L++ N++TGSLP SLSNASNL D ++++F+G+V IDF +PNL+ L + N
Sbjct: 274 PNLQVLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNP 333
Query: 330 LGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIY--- 386
LG G DL F+ L C L+ L L + FGGVLP SIANLS+ ++ + NQ+
Sbjct: 334 LGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTI 393
Query: 387 ---VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNS 443
+ NLVNL L N TG IP IG L+ L +DL N L GHIP SLGN+T L S
Sbjct: 394 PPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYS 453
Query: 444 LDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGS 503
L L N L G +PSS GN L L +S N L G +P +++ +V+L+I L+L+ N LTG
Sbjct: 454 LHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGL 513
Query: 504 IPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIK 563
+P+EV LKNL L +SEN+ S EIP L +C TLE+L+MEGN GSIP + +L+ +
Sbjct: 514 LPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLL 573
Query: 564 ELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCGG 623
+LDLSRNNLSGQIPEFL+ LS L LNLS+N+ EG++P +GVF+N T GN +LCGG
Sbjct: 574 DLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGG 632
Query: 624 LDELHLPVCHSAGPR--------KTRIALLKVVVPVTVILTIIVACLIVLYTRRRKHKHK 675
+ ELHLP C P+ K I LL + + +I++++V + R
Sbjct: 633 IPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVINRLRRVKREPSQTSA 692
Query: 676 SSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK 735
SS L++ VSY L KAT FSS+N+IG G FG VY+G LG++E VAVKV+ L
Sbjct: 693 SSKDLILN-----VSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLH 747
Query: 736 QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLH-- 793
QRGA KSF AECEALRNIRHRNL+K++T CSS+D++ DFKA+VYE+M GSLE+WLH
Sbjct: 748 QRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPV 807
Query: 794 ----QSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVA 849
+ ND L + ++ QRLN+ IDVA A++YLHHHCH PIVH DLKPSN+LLD+DM A
Sbjct: 808 PTPDEINDVLRI--LSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTA 865
Query: 850 HVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLL 909
HVGDFGLARF+P + + + SSS G+KGT+GY APEYGMG +SA GD YS+GILLL
Sbjct: 866 HVGDFGLARFIPEAAGRS-HPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLL 924
Query: 910 EMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIA-- 967
EMFT +RPT++MF+D L LH F KMALPE++ +I+DP L + + +A
Sbjct: 925 EMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHM 984
Query: 968 ---KIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIFLSN 1011
K+ ECL++I+RIGV CS+ESP ER+ +T+ + +L RKI L N
Sbjct: 985 KREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILLGN 1031
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 964 bits (2493), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/1025 (50%), Positives = 692/1025 (67%), Gaps = 40/1025 (3%)
Query: 17 FSLFLLHS----HSCFALHSNETDRLALLAIKSQL-QDPLGVTSSWNNSMNLCQWTGVTC 71
+++ LHS S L+ NETDRLALLAIK+Q+ QDPLG+T+SWN+S++ C WTGVTC
Sbjct: 48 YTIIFLHSPSPTTSSTILYGNETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTC 107
Query: 72 GHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLIL 131
GHRHQRV L+LS+ + G LSP +GNL+FL +N N F G+IP E+GRL RL L L
Sbjct: 108 GHRHQRVNTLNLSSLHLVGSLSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNL 167
Query: 132 ANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAP 191
NNSFSG+IP+NLSRCSNL+ F NNL+G+IP +G S+ K+ + L N L G +
Sbjct: 168 TNNSFSGEIPANLSRCSNLVYFRLGFNNLIGRIPSWLG-SYPKVVRMQLHYNNLTGPVPD 226
Query: 192 SIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESIS 251
S+GN+++++ LS N L G +P +LGQL++L ++ + N FSG+ PSS++N+SSLE S
Sbjct: 227 SLGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFS 286
Query: 252 LLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVK 311
L N+L GSLP ++ F+LPNL+ L++ N++TG LP SLSNASNL D ++++F+G+V
Sbjct: 287 LPYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGPLPSSLSNASNLLEFDITMSNFTGKVS 346
Query: 312 IDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANL 371
IDF +PNL+ L + N LG G DL F+ L C L+ L L + FGGVLP SIANL
Sbjct: 347 IDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANL 406
Query: 372 SSTIILFSMGLNQIY------VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHN 425
S+ ++ + NQ+ + NLVNL L N TG IP IG L+ L +DL N
Sbjct: 407 STQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRN 466
Query: 426 NLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILG 485
L GHIP SLGN+T L SL L N L G +PSS GN L L +S N L G +P +++
Sbjct: 467 QLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMD 526
Query: 486 IVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEG 545
+V+L+I L+L+ N LTG +P+EV LKNL L +SEN+ S EIP L +C TLE+L+MEG
Sbjct: 527 LVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEG 586
Query: 546 NSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGV 605
N GSIP + +L+ + +LDLSRNNLSGQIPEFL+ LS L LNLS+N+ EG++P +GV
Sbjct: 587 NFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGV 645
Query: 606 FSNKTRFYFTGNKRLCGGLDELHLPVCHSAGPR--------KTRIALLKVVVPVTVILTI 657
F+N T GN +LCGG+ ELHLP C P+ K I LL + + +I+++
Sbjct: 646 FNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSL 705
Query: 658 IVACLIVLYTRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYR 717
+V + R SS L++ VSY L KAT FSS+N+IG G FG VY+
Sbjct: 706 LVINRLRRVKREPSQTSASSKDLILN-----VSYDGLFKATGGFSSANLIGTGGFGSVYK 760
Query: 718 GNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777
G LG++E VAVKV+ L QRGA KSF AECEALRNIRHRNL+K++T CSS+D++ DFKA
Sbjct: 761 GXLGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKA 820
Query: 778 IVYEYMECGSLEDWLH------QSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPI 831
+VYE+M GSLE+WLH + ND L + ++ QRLN+ IDVA A++YLHHHCH PI
Sbjct: 821 LVYEFMPNGSLENWLHPVPTPDEINDVLRI--LSLPQRLNIAIDVASALDYLHHHCHKPI 878
Query: 832 VHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM 891
VH DLKPSN+LLD+DM AHVGDFGLARF+P + + + SSS G+KGT+GY APEYGM
Sbjct: 879 VHCDLKPSNILLDNDMTAHVGDFGLARFIPEAAGRS-HPSQSSSIGLKGTIGYAAPEYGM 937
Query: 892 GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLD 951
G +SA GD YS+GILLLEMFT +RPT++MF+D L LH F KMALPE++ +I+DP L
Sbjct: 938 GTKVSALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSS 997
Query: 952 LEARASNCGSHRTEIA-----KIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006
+ + +A K+ ECL++I+RIGV CS+ESP ER+ +T+ + +L RK
Sbjct: 998 EAKEEETTAADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRK 1057
Query: 1007 IFLSN 1011
I L N
Sbjct: 1058 ILLGN 1062
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 923 bits (2385), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/1018 (48%), Positives = 679/1018 (66%), Gaps = 26/1018 (2%)
Query: 5 VSISYLATLVWCFSLFLLHSHS-CFALHS-NETDRLALLAIKSQLQDPLGVTSSWNNSMN 62
+ +S +++ ++C L L+ S F+LH NETDRL+LLA K+Q+ DPL SSWN S +
Sbjct: 1 MELSGMSSCIFCPLLLLIIQLSFSFSLHEGNETDRLSLLAFKAQITDPLDALSSWNASTH 60
Query: 63 LCQWTGVTCGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGR 122
C+W+GV CGHRHQR+ L+L + + G LSP++GNLSFLR +N N FS +IP E+GR
Sbjct: 61 FCKWSGVICGHRHQRIVELNLQSSQLTGNLSPHIGNLSFLRVLNLEGNYFSRDIPQELGR 120
Query: 123 LFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRD 182
LFRL+ L+L NN+FSG+IP N+S CSNL+ H NNL G+IP +G S KL L+
Sbjct: 121 LFRLQRLVLGNNTFSGEIPVNISSCSNLLVLHLGSNNLTGKIPAQLG-SLSKLGAFVLQG 179
Query: 183 NLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF 242
N L G + S GN+S++Q +N L G +P+SLG L+ L Y +++EN SG PSSI
Sbjct: 180 NNLVGDIPSSFGNLSSVQNFFWTKNYLRGGIPESLGNLKRLKYFAVAENDLSGTIPSSIC 239
Query: 243 NISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFS 302
NISSL +SL N+L GSLP ++G +LPNL L + N+ G +P +LSNAS + L+D S
Sbjct: 240 NISSLAYVSLGQNQLHGSLPPDLGLNLPNLAYLVINFNHLNGPIPATLSNASKIFLVDLS 299
Query: 303 LNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGG 362
N+ +G++ D LP+L +L N+LG G DL F+ L N + LE+LG++ N FGG
Sbjct: 300 YNNLTGKIP-DLASLPDLQKLLVHHNDLGNGEEDDLSFLYTLANSTNLESLGINDNNFGG 358
Query: 363 VLPLSIANLSSTIILFSMGLNQIY------VKNLVNLNGFGLEYNQLTGPIPHAIGELRN 416
VLP ++N S+ + + G NQI+ + NL++L+ LE NQL G IP +IG+L+N
Sbjct: 359 VLPEIVSNFSTNLKGITFGRNQIHGSIPTEIGNLISLDTLSLETNQLHGIIPSSIGKLQN 418
Query: 417 LQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLT 476
L L L+ N + G IP SLGN+T L + N L+G +P+SLGN L++L +S N L+
Sbjct: 419 LAALYLNENKISGSIPSSLGNITSLVEVSFAQNNLQGTIPASLGNWHKLLILDLSQNNLS 478
Query: 477 GALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACT 536
G +P ++LGI +LS+LL L N LTGS+P+EVG L NL L +S+NR S EIP SL +C
Sbjct: 479 GPIPKEVLGISSLSVLLYLHDNQLTGSLPSEVGQLVNLGFLRVSKNRLSGEIPKSLDSCK 538
Query: 537 TLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHL 596
+LE L + GN G +P L +L++++ L LS NNLSGQIP+FL++ LE L+LSYN
Sbjct: 539 SLEGLDLGGNFFEGPVP-DLSSLRALQMLLLSYNNLSGQIPQFLKDFKLLETLDLSYNDF 597
Query: 597 EGEVPRRGVFSNKTRFYFTGNKRLCGGLDELHLPVCHS---AGPRKTRIALLKVVVPVTV 653
EGEVP +GVF N +R GNK+LCGG+ +L LP C S A P+ +L + +P
Sbjct: 598 EGEVPEQGVFENTSRISVQGNKKLCGGIPQLDLPKCTSNEPARPKSHTKLILIIAIPCGF 657
Query: 654 ILTIIVACLIVLYTRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFG 713
+ +++ ++ Y+R+ K + S E F ++Y DL +AT+ FSSSN++G G+FG
Sbjct: 658 LGIVLMTSFLLFYSRKTKDEPASGPS--WESSFQRLTYQDLLQATDGFSSSNLVGAGAFG 715
Query: 714 FVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773
VYRG L + VAVKV+NL ++GA+KSF+AEC AL NIRHRNL+K+IT CSS DF+
Sbjct: 716 SVYRGTLTSDGAVVAVKVLNLLRKGASKSFMAECAALINIRHRNLVKVITACSSNDFQGN 775
Query: 774 DFKAIVYEYMECGSLEDWLHQ---SNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPP 830
DFKA+VYE+M GSLE+WLH S+ E N +++QRLN+ IDVA A++YLH+HC P
Sbjct: 776 DFKALVYEFMVNGSLEEWLHPVHISDVTPETRNLDLVQRLNIAIDVASALDYLHNHCQVP 835
Query: 831 IVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYG 890
+VH DLKPSNVLL DM A VGDFGLARFLP S + SSS G+KGT+GY APEYG
Sbjct: 836 VVHCDLKPSNVLLGDDMTACVGDFGLARFLPEAS-NQLPADESSSVGLKGTIGYAAPEYG 894
Query: 891 MGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLL 950
MG ++S GDVYS+GILLLEMFT RRPTD MF DG LH +AKM LP+ V+E VDP L
Sbjct: 895 MGSEVSTYGDVYSYGILLLEMFTGRRPTDGMFKDGHNLHNYAKMVLPDNVLEFVDPTL-- 952
Query: 951 DLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIF 1008
R +H + K+ EC+V+I+++G+ CS E P ER+ + +VV +L R++
Sbjct: 953 ----REHEEMNHNDDSHKVMECMVSIIKVGLACSAELPGERMGIANVVVELHRIREML 1006
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 909 bits (2349), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/1020 (48%), Positives = 684/1020 (67%), Gaps = 31/1020 (3%)
Query: 13 LVWCFSLFLLH-SHSCFALHSNETDRLALLAIKSQL-QDPLGVTSSWNNSMNLCQWTGVT 70
L+W L ++ S S + NETDRL+LLA K+ + DPL + SSWN S++ C+W+G+T
Sbjct: 11 LLWVLFLKMIQLSCSSLSGRGNETDRLSLLAFKAHITDDPLHILSSWNESLHFCKWSGIT 70
Query: 71 CGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLI 130
CG RHQRV +DL + + G L+ ++GNLSFLR +N NN S IP EIGRLFRL TLI
Sbjct: 71 CGSRHQRVIEIDLESSRLSGSLTAFIGNLSFLRVLNLQNNSLSHYIPQEIGRLFRLRTLI 130
Query: 131 LANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLA 190
L NSFSG+IP N+S CSNL+ NNL G++P ++ S KL+ N L G+++
Sbjct: 131 LRRNSFSGEIPVNISYCSNLLTLRLGRNNLTGKLPAEL-KSLSKLQMFEFEINYLTGEIS 189
Query: 191 PSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESI 250
PS N+S+L+++ N G +P+S+GQL+SL S+ + FSG+ P SIFN+SSL +
Sbjct: 190 PSFSNLSSLEIIYGTRNNFHGEIPNSIGQLKSLQTFSLGGSNFSGVIPPSIFNLSSLTIL 249
Query: 251 SLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQV 310
S+ N+L G+LP ++G SLP LE L + N ++GS+P ++SNASNL LD S N+F+G+V
Sbjct: 250 SVPINQLHGNLPPDLGQSLPKLEVLRLYANKFSGSIPPTISNASNLVALDVSQNNFTGKV 309
Query: 311 KIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIAN 370
RL NL + KNNLG G DL F+ L N + LE L + N GGVLP ++N
Sbjct: 310 P-SLARLHNLSYIGIHKNNLGNGEDDDLSFLYTLANNTNLEILAITENNLGGVLPEMLSN 368
Query: 371 LSSTIILFSMGLNQIY------VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHH 424
S+ ++ + G N+I + NL+ L G E N+LTG IP ++G+L+NL L L+
Sbjct: 369 FSTKLVHMAFGRNKIRGRIPSEIDNLIRLEALGFERNELTGSIPSSLGKLKNLIKLYLND 428
Query: 425 NNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQIL 484
NN+ G IP SLGN+T L+++ L N L G +PSSLGNCQ ++L+ +S N L+G +P +++
Sbjct: 429 NNISGSIPSSLGNITSLSTISLKVNNLEGSIPSSLGNCQQMLLMDLSRNNLSGTIPKELI 488
Query: 485 GIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYME 544
I +LSI LDLS N TGS+P EVG L NL L +S+N+ S EIP SL +CT LE LY++
Sbjct: 489 SIPSLSISLDLSENQFTGSLPMEVGGLVNLGYLDVSKNKLSGEIPKSLGSCTRLETLYLQ 548
Query: 545 GNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRG 604
GN+ G+IP++L +L+ I +L+LS NNL+GQIP F LE L+LSYN EGEVP G
Sbjct: 549 GNAFQGTIPVSLSSLRGINDLNLSHNNLTGQIPNFFAEFKSLEKLDLSYNDFEGEVPAEG 608
Query: 605 VFSNKTRFYFTGNKRLCGGLDELHLPVC---HSAGPR---KTRIALLKVVVPVTVILTII 658
VF N + F +GNK LCGG+ E++LP C S P+ K R+ ++ V +L ++
Sbjct: 609 VFKNASAFSISGNKNLCGGIPEINLPRCTLNKSMKPKTSHKLRLIIVVACCGVVGVL-LL 667
Query: 659 VACLIVLYTRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRG 718
+ L+ + RK+K S S L + F VSY +L KAT+ FSS+N+IG GSFG VY+G
Sbjct: 668 TSALLFCCLKMRKNKEASGSSL--DIFFQKVSYQNLLKATDGFSSANLIGAGSFGSVYKG 725
Query: 719 NLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778
L +E +AVKV+NL+ +GA++SF+ EC+AL N+RHRNL+K++T CSS DFEE DFKA+
Sbjct: 726 ILAPDETIIAVKVLNLQHKGASRSFMTECQALANVRHRNLVKVLTACSSSDFEENDFKAL 785
Query: 779 VYEYMECGSLEDWLH--QSNDQLEVGN-FNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGD 835
VYEYM GSLE+WLH Q+ DQ + ++I+RL++ IDVA A++YLH+ C P+VH D
Sbjct: 786 VYEYMVNGSLEEWLHPTQNPDQDQPPRILSLIERLSISIDVASALDYLHNQCQVPVVHCD 845
Query: 836 LKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDM 895
LKPSN+LLD DM AHVGDFGLARFL A +PSSS GI+GTVGY APEYGMG D+
Sbjct: 846 LKPSNILLDSDMTAHVGDFGLARFL---IAAPHHSSPSSSIGIRGTVGYAAPEYGMGSDV 902
Query: 896 SATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLE-- 953
S GDVY++GILLLE+FT ++PTD MF DGL LH AKMA+P+++ DP LL+ +
Sbjct: 903 STYGDVYTYGILLLELFTGKKPTDAMFKDGLNLHILAKMAMPDRLALAADPFLLITEDEG 962
Query: 954 -ARASNCGSHR-TEIA--KIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIFL 1009
+ ++ SHR T IA K+ CL +I++IGV CS ESP +R+ ++DV +L R I L
Sbjct: 963 TSASATSASHRITCIARDKVLGCLNSILKIGVDCSAESPRDRMDISDVANELVRIRNILL 1022
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115346|ref|XP_002317009.1| predicted protein [Populus trichocarpa] gi|222860074|gb|EEE97621.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 906 bits (2341), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/1019 (48%), Positives = 678/1019 (66%), Gaps = 36/1019 (3%)
Query: 10 LATLVWCFSLFLLHSHSCFALHSNETDRLALLAIKSQL-QDPLGVTSSWNNSMNLCQWTG 68
L+ + F+ F + S S SN TDRLALL KS++ DP + SWN+S++ CQW G
Sbjct: 14 LSATLLNFTPFRISSVSATTF-SNFTDRLALLDFKSKIIHDPQNIFGSWNDSLHFCQWQG 72
Query: 69 VTCGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLET 128
V CG RH+RVTVL L + + G +SP +GNLSFL ++ +NN G+IP +GRLFRL+
Sbjct: 73 VRCGRRHERVTVLKLESSGLVGSISPALGNLSFLWGLDLSNNTLQGKIPDGLGRLFRLQI 132
Query: 129 LILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQ 188
L+L NNSF G+IP NLS CS L NNLVG+IP ++ S KLE L + N L+G
Sbjct: 133 LVLNNNSFVGEIPGNLSHCSKLDYLGLASNNLVGKIPAEL-VSLSKLEKLVIHKNNLSGA 191
Query: 189 LAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLE 248
+ P IGN+++L +S N GR+PD+LGQL++L L + N SG P I+N+S+L
Sbjct: 192 IPPFIGNLTSLNSISAAANNFQGRIPDTLGQLKNLESLGLGTNFLSGTIPLPIYNLSTLS 251
Query: 249 SISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSG 308
+SL N+L+G LP +IG SLPNL+ + +R N ++GS+P S+SN+SNL++L+ N FSG
Sbjct: 252 ILSLSENQLQGYLPSDIGVSLPNLQYIQIRANQFSGSIPLSISNSSNLQVLEAGDNSFSG 311
Query: 309 QVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSI 368
++ ++F L +L +S S N +G+G G+L F+ L NC+ L A+ + N F G+LP S+
Sbjct: 312 KLSVNFGGLKHLAVVSLSFNKMGSGEPGELSFLDSLINCTSLYAIDIVGNHFEGMLPNSL 371
Query: 369 ANLSSTIILFSMGLNQIY------VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDL 422
NLS+ + +G NQ++ + NL+NLN GLE+NQL+GPIP IG+LR LQ L
Sbjct: 372 GNLSTGLTFLGLGQNQLFGGIHSGIGNLINLNTLGLEFNQLSGPIPLDIGKLRMLQRFSL 431
Query: 423 HHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQ 482
+N L GHIP S+GNLT+L DL N+L+G +PSS+GNCQ L+LL +S N L+G P +
Sbjct: 432 SYNRLSGHIPSSIGNLTLLLEFDLQGNQLQGTIPSSIGNCQKLLLLHLSRNNLSGNAPKE 491
Query: 483 ILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLY 542
+ I +LS+ LDLS N GS+P+E+G+LK+L +L +S N FS EIP +L++CT+LEYLY
Sbjct: 492 LFAISSLSVSLDLSQNYFNGSLPSEIGSLKSLAKLNVSYNEFSGEIPSTLASCTSLEYLY 551
Query: 543 MEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPR 602
M+ N GSIP + TL+ I++LDLS NNLSGQIP+FL+ + L LNLS+N EGEVP
Sbjct: 552 MQHNFFQGSIPSSFSTLRGIQKLDLSHNNLSGQIPKFLDTFALLT-LNLSFNDFEGEVPT 610
Query: 603 RGVFSNKTRFYFTGNKRLCGGLDELHLPVCHSAGPRKTRIALLKVVVPVTV--ILTIIVA 660
+G F N T GNK+LCGG+ EL LP C+ +K +I L +++ L + V
Sbjct: 611 KGAFGNATAISVDGNKKLCGGISELKLPKCNFKKSKKWKIPLWLILLLTIACGFLGVAVV 670
Query: 661 CLIVLYTRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNL 720
++LY RRK K +SS + L E P VSY L KATN FSS N+IG+G FG VYRG L
Sbjct: 671 SFVLLYLSRRKRKEQSSELSLKE-PLPKVSYEMLLKATNGFSSDNLIGEGGFGSVYRGIL 729
Query: 721 GENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVY 780
+++ VA+KV+NL+ RGA+KSFVAECEALRN+RHRNL+KIIT CSS+DF+ +FKA+VY
Sbjct: 730 DQDDTVVAIKVLNLQTRGASKSFVAECEALRNVRHRNLLKIITSCSSVDFQGNEFKALVY 789
Query: 781 EYMECGS---LEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLK 837
E+M GS LE WL+ N L+ ++QRLN++IDVA A+EYLHH +VH DLK
Sbjct: 790 EFMPNGSLEILEKWLYSHNYFLD-----LLQRLNIMIDVASALEYLHHGNATLVVHCDLK 844
Query: 838 PSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSA 897
PSN+LLD +MVAHV DFG+A+ L T T TVGY+APEYG+G +S
Sbjct: 845 PSNILLDENMVAHVSDFGIAKLLGEGHSIT-------QTMTLATVGYMAPEYGLGSQVSI 897
Query: 898 TGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARA- 956
GD+YS+GI LLEM TR+RPTDNMF L LH FA+MALPE+V+ IVDP LL +A
Sbjct: 898 YGDIYSYGIPLLEMITRKRPTDNMFEGTLNLHGFARMALPEQVLNIVDPSLLSSGNVKAG 957
Query: 957 -------SNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIF 1008
N S EI + EC+ ++++IG+ CS E P +R+++ + +LCS RKI
Sbjct: 958 RMSNTSLENPTSSSGEIGTLVECVTSLIQIGLSCSRELPRDRLEINHAITELCSIRKIL 1016
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224090977|ref|XP_002309132.1| predicted protein [Populus trichocarpa] gi|222855108|gb|EEE92655.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 904 bits (2336), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/1041 (48%), Positives = 686/1041 (65%), Gaps = 48/1041 (4%)
Query: 4 SVSISYLATLVWCFSLFLLH----SHSCFALHSNETDRLALLAIKSQLQ-DPLGVTSSWN 58
S S+ L CF + LH + + L NETD LALLAIK+Q++ DPLG+ SSWN
Sbjct: 2 SCSLFLKVILQSCFVVIFLHAPSFTQAATTLSGNETDHLALLAIKAQIKLDPLGLMSSWN 61
Query: 59 NSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPG 118
+S++ C W G+ CG+ HQRV L+LS+ + G LSP +GN+SFLR I+ N F GEIP
Sbjct: 62 DSLHFCNWGGIICGNLHQRVITLNLSHYGLVGSLSPQIGNMSFLRGISLEQNYFHGEIPQ 121
Query: 119 EIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFL 178
EIGRL RL+ + +NNSFSG+IP+NLS CS+L+ N L GQIP +G S KLE +
Sbjct: 122 EIGRLDRLKYINFSNNSFSGEIPANLSGCSSLLMLRLGFNKLTGQIPYQLG-SLQKLERV 180
Query: 179 SLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFP 238
L N L G + S+GNIS+++ LS+ N G +PD+LG+L++L +L + N SGM P
Sbjct: 181 QLHYNNLNGSVPDSLGNISSVRSLSLSVNNFEGSIPDALGRLKTLNFLGLGLNNLSGMIP 240
Query: 239 SSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRL 298
+IFN+SSL +L N+L G+LP ++G +LPNL+ L++ N ++G LP S+SNASNL
Sbjct: 241 PTIFNLSSLIVFTLPYNQLHGTLPSDLGLTLPNLQVLNIGHNFFSGPLPVSISNASNLLE 300
Query: 299 LDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTN 358
LD ++F+ +V IDF LPNL+ L+ S N LG G DL FI LT C L L L +
Sbjct: 301 LDIDTSNFT-KVTIDFGGLPNLWSLALSSNPLGKGEADDLSFIDSLTKCRNLRLLDLSNS 359
Query: 359 IFGGVLPLSIANLSSTIILFSMGLNQI------YVKNLVNLNGFGLEYNQLTGPIPHAIG 412
FGGV+P SI NLS+ + L + NQ+ ++NL+NL +E N L+G IP +G
Sbjct: 360 HFGGVIPDSIGNLSTQLFLLKLRGNQLSGSIPTVIENLLNLAELTVEKNYLSGSIPSVLG 419
Query: 413 ELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSN 472
L+ LQ LDL N L G IP SLGN+T L L N++ G +PSS GN + L L +S
Sbjct: 420 NLKMLQRLDLSENKLSGLIPSSLGNITQLFEFHLQKNQIMGSIPSSFGNLKYLQNLDLSQ 479
Query: 473 NKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSL 532
N L+G +P +++G+ +L+I L+L+ N LTG +P E NL NL L +SEN+ +IP SL
Sbjct: 480 NLLSGTIPKEVMGLSSLTISLNLAQNQLTGPLPPEAQNLMNLGYLDVSENKLYGQIPSSL 539
Query: 533 SACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLS 592
+C TLE L+M+GN G+IP + +L+ ++++DLSRNNLSGQIP+FL+ L+ + LNLS
Sbjct: 540 GSCVTLEKLHMQGNFFEGAIPPSFSSLRGLRDMDLSRNNLSGQIPQFLKRLALIS-LNLS 598
Query: 593 YNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGLDELHLPVC----HSAGPRKTRIALLKVV 648
+NH EGEVPR G F N T +GNKRLCGG+ +L LP C G R+ L+ +
Sbjct: 599 FNHFEGEVPREGAFLNATAISLSGNKRLCGGIPQLKLPRCVVNRSKNGKTSRRVKLMIAI 658
Query: 649 VPVTVILTIIVACLIVLYTRRRKHKHKSSSMLLMEQQFPM-VSYADLSKATNDFSSSNMI 707
+ ++L +++ L++ R++ + +S L +Q+ + VSY +L KAT FSS+N+I
Sbjct: 659 LTPLLVLVFVMSILVINRLRKKNRQSSLASSLSSKQELLLKVSYRNLHKATAGFSSANLI 718
Query: 708 GQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSS 767
G GSFG VYRG L NE VAVKV+ ++QR KSF+AECE L+NIRHRNL+KI+T CSS
Sbjct: 719 GAGSFGSVYRGILDPNETVVAVKVLFMRQRKTLKSFMAECEILKNIRHRNLVKILTACSS 778
Query: 768 IDFEEVDFKAIVYEYMECGSLEDWLHQS------NDQLEVGNFNVIQRLNLVIDVAFAIE 821
+DF+ DFKA+VYE+M G+LE WLH N+ L++ +F+ QRLN+ IDVA A+
Sbjct: 779 VDFQGNDFKALVYEFMPNGTLESWLHSFPRTNGINEDLKILSFH--QRLNIAIDVAAALN 836
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC-SPATILETPSSSTGIKG 880
YLH+ CH P+VH DLKPSNVLLD+DM AHVGDFGLARF+ +P+ SSS G+KG
Sbjct: 837 YLHYQCHKPVVHCDLKPSNVLLDNDMTAHVGDFGLARFIEEAINPSH--RNESSSVGLKG 894
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940
TVGY APEYGMG S GDVYS+GILLLEMFT +RPTD+MF+DGL LH F K ALP+++
Sbjct: 895 TVGYAAPEYGMGSKPSMNGDVYSYGILLLEMFTGKRPTDDMFHDGLDLHNFVKTALPDQI 954
Query: 941 MEIVDPLLL----------LDLEARASNCGSHRTEIAK--IEECLVAIVRIGVLCSMESP 988
E+VDPL + LE R R +I K ++E L+AI+RIG+ CS+ES
Sbjct: 955 SEVVDPLFVTGGEGDEEETGHLENRT------RGQIKKDQMQESLIAILRIGIACSVESI 1008
Query: 989 SERIQMTDVVAKLCSARKIFL 1009
+ER + DV+ +L + R+ FL
Sbjct: 1009 NERKNVKDVLTELQNVRRFFL 1029
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141953|ref|XP_002324325.1| predicted protein [Populus trichocarpa] gi|222865759|gb|EEF02890.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 898 bits (2321), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/1012 (48%), Positives = 674/1012 (66%), Gaps = 37/1012 (3%)
Query: 18 SLFLLHSHSCFALHS----NETDRLALLAIKSQLQDPLGVT-SSWNNSMNLCQWTGVTCG 72
S FLL + S S NETD ALLA K+++QDP T SSWN+S++ C W G+TCG
Sbjct: 11 SSFLLTAASTITAPSSFGGNETDYEALLAFKAKIQDPHSNTLSSWNDSLDFCNWPGITCG 70
Query: 73 HRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILA 132
RH RV +++L ++ + G LSPYVGN+SFLR I ANN GEIP E+GRL RL L+L
Sbjct: 71 RRHGRVRIINLVDQKLAGTLSPYVGNISFLREIRLANNTIHGEIPPEVGRLLRLRVLMLT 130
Query: 133 NNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPS 192
NNS GKIP+NLS CS+L + N L G+IP ++G+ KL LS R N L G++ S
Sbjct: 131 NNSIEGKIPANLSGCSSLAELYIDRNKLGGEIPTELGF-LSKLTILSFRQNNLLGKIPHS 189
Query: 193 IGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISL 252
IGN+++L+ LS+ N L G +PDSLG+L+ L L + EN SG P S++N+S + + L
Sbjct: 190 IGNLTSLESLSLKRNVLEGTIPDSLGRLKRLTSLLLGENKLSGFIPPSLYNLSLITTFYL 249
Query: 253 LGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKI 312
GN GSLP N+G S P+L+ L++ QN ++G +P SL+NAS L+++ F+ N +G++
Sbjct: 250 GGNGFRGSLPSNLGLSFPHLQWLALWQNQFSGPIPGSLTNASELQIVSFTYNSLTGKIPD 309
Query: 313 DFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLS 372
F +L +L L F NNLGTG ++ F+A LTNCS L+ + ++ N G LP+++ NLS
Sbjct: 310 IFGKLHHLSGLHFGSNNLGTGGDDEMAFLASLTNCSMLKVVSINNNRLEGSLPITVGNLS 369
Query: 373 STIILFSMGLNQIY------VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNN 426
+ ++ F + N I + NLVNL ++ N TG IP + G LR L+ L N
Sbjct: 370 TYMVYFGLSGNHIVGRIPSGIGNLVNLTFLYMDRNHFTGEIPTSFGNLRKLEQFSLFSNR 429
Query: 427 LDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGI 486
L G IP SLGNL++L+ L L NKL+ +P+SLG C+NL+ L +S L G++P Q+ G
Sbjct: 430 LSGKIPSSLGNLSLLSVLYLDDNKLKDTIPASLGGCKNLVSLGLSRKNLNGSIPEQLFGT 489
Query: 487 VTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGN 546
++ L+LS N TGS+P+ +G+LK L +L +S N S EIP S CT+LE L+ME N
Sbjct: 490 SSVLFSLNLSHNQFTGSLPSTIGSLKGLSELDVSWNMLSGEIPTSFGGCTSLEVLHMEDN 549
Query: 547 SLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVF 606
GSIP + +L+ I+ LDLS NNLSGQ+P FL + F+ LNLSYN+ EGEVPR+GVF
Sbjct: 550 FFQGSIPSSFSSLRGIQFLDLSCNNLSGQLPNFLVTIPFIS-LNLSYNNFEGEVPRKGVF 608
Query: 607 SNKTRFYFTGNKRLCGGLDELHLPVCHSAGPRKTRIA----LLKVVVPVTVILTIIVACL 662
+N++ GN +LCGG+ ELHLP C + P+KT+++ LL + +P ++ I V+
Sbjct: 609 TNESAVSVVGNDKLCGGILELHLPECPNKEPKKTKMSHLQYLLAITIPCALVGAITVSSF 668
Query: 663 IVLYTRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGE 722
+ + ++++ +H S + L+++ FP +SY L KAT+ FS++N+IG GSF VY+G + E
Sbjct: 669 LFCWFKKKRKEHSSDT--LLKESFPQISYERLFKATDGFSTTNLIGVGSFSSVYKGRIDE 726
Query: 723 NEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEY 782
+ VA+KV+NL++RGA+KSF ECEALRNIRHRNL+KIIT CSSIDF+ +FKA+VYEY
Sbjct: 727 DGTLVAIKVLNLQRRGASKSFKDECEALRNIRHRNLVKIITSCSSIDFQGNNFKALVYEY 786
Query: 783 MECGSLEDWLHQS----NDQL--EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDL 836
M GSLE WLH + +DQ +V N+++R+N+ IDVA A++YLHHHCH PI+H D+
Sbjct: 787 MPKGSLEKWLHPTQETHDDQQINQVQRPNLLERINIAIDVAAALDYLHHHCHSPIIHCDV 846
Query: 837 KPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMS 896
KPSN+LLD DM+ H+GDFGLAR S ++ SSS GIKGT GY APEYG G ++S
Sbjct: 847 KPSNILLDKDMIGHLGDFGLARIFQEFSEPSL---ESSSAGIKGTTGYAAPEYGQGREVS 903
Query: 897 ATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARA 956
GDVYS+GILLLEM T +RP D+ F GL LH FAKMALP+ V+EI DP+LL +
Sbjct: 904 IDGDVYSYGILLLEMMTGKRPIDDTFEKGLNLHMFAKMALPDHVIEITDPVLLSE----- 958
Query: 957 SNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIF 1008
H A +EECL ++V+IGV CSM+SP +R+ M+ VV +L R F
Sbjct: 959 ----RHLENAASMEECLTSLVKIGVACSMDSPRDRMDMSRVVRELLMVRDTF 1006
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2317), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/1026 (48%), Positives = 683/1026 (66%), Gaps = 44/1026 (4%)
Query: 14 VWCFSLFL----LHSHSCFALHSNETDRLALLAIKSQL-QDPLGVTSSWNNSMNLCQWTG 68
+CF F+ L S +C + ++NETD LAL+ K+++ DPLG+ SSWN++++ CQW G
Sbjct: 5 AFCFRSFVFLLSLISVTC-SDYTNETDLLALIQFKNKIVDDPLGIMSSWNSTIHFCQWHG 63
Query: 69 VTCGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLET 128
V+CG RHQRV VL L + + G +SP++GNLSFLR ++ NN F EIP ++GRL L+
Sbjct: 64 VSCGRRHQRVRVLALQSLKLSGTISPHIGNLSFLRELHLQNNSFFHEIPPQVGRLRSLQI 123
Query: 129 LILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQ 188
L NNS SG+IP ++S CSNLI+ NNL G+IP ++G S LKL+ L+L N L G
Sbjct: 124 FSLHNNSISGQIPPSISDCSNLISIKIEFNNLTGEIPMELG-SLLKLKNLTLEVNGLTGT 182
Query: 189 LAPSIGNISNLQVLSIGENR-LSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSL 247
+ PS+GN+S+L++L + +N+ L G +P +LG+L++L L++ +N SG+ P SIFN+SSL
Sbjct: 183 IPPSLGNLSSLEILRLEKNKILFGNVPSTLGKLKNLRILNLMDNRLSGVIPPSIFNLSSL 242
Query: 248 ESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFS 307
++ + N G+LP +IG SLPNLE S+ N +TGS+P S+SNASN+ LL SLN+ +
Sbjct: 243 TALDIGFNLFHGNLPSDIGISLPNLEFFSIASNQFTGSIPVSISNASNIELLQVSLNNLT 302
Query: 308 GQVKIDFNRLPNLFRLSFS---KNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVL 364
G+V L L RL+F N+LG+G DL F++ LTN + LE L + N FGG L
Sbjct: 303 GEVPT----LEKLHRLNFFTLFSNHLGSGQANDLSFLSSLTNATTLEYLSIKRNNFGGEL 358
Query: 365 PLSIANLSSTIILFSMGLNQIY------VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQ 418
P I+NLS+ + + S+ N I ++ LVNL F + N+++G IP +IGEL+NL+
Sbjct: 359 PKQISNLSTMLGVISLPENNILGSIPAGIEKLVNLKVFDVGNNKISGIIPSSIGELQNLE 418
Query: 419 VLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGA 478
L L +NNL G IP S+GNLT L +L LG N L G +PSSLGNC+ L++L++ N L+G
Sbjct: 419 GLVLDYNNLSGRIPSSVGNLTKLMALYLGDNSLEGSIPSSLGNCKKLLVLTLCGNNLSGD 478
Query: 479 LPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTL 538
+PP + GI +L + + S N +GS+P E+G L NL L +S N S EIP SL C +L
Sbjct: 479 IPPGLFGIFSL-LYICFSKNHFSGSLPIEIGKLINLEFLDVSGNMLSGEIPSSLGGCISL 537
Query: 539 EYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEG 598
E LYM N GSIP AL +L+ + + + S NNLSG+IPEF + + LE L+LSYN+ EG
Sbjct: 538 EDLYMNSNFFHGSIPSALSSLRGVLQFNFSHNNLSGKIPEFFQGFNSLEMLDLSYNNFEG 597
Query: 599 EVPRRGVFSNKTRFYFTGNKRLCGGLDELHLPVCHSAGPRKTRIALLKVVVPVTVILTI- 657
+P G+F N T GN +LCGG EL LP C P++ ++ L + +TV+L +
Sbjct: 598 MIPDEGIFKNSTAVSVIGNSQLCGGNTELGLPRCKVHQPKRLKLKLKIAIFAITVLLALA 657
Query: 658 -IVACLIVLYTRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVY 716
+V CL + +RR++ + K SSM + VSY L KATN FSSSN++G GSFG VY
Sbjct: 658 LVVTCLFLCSSRRKRREIKLSSM---RNELLEVSYQILLKATNGFSSSNLVGIGSFGSVY 714
Query: 717 RGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776
+G L +N M +AVKV+NL ++GA++SF+AECEALRNIRHRNL+K++T CSSID+ DFK
Sbjct: 715 KGMLDQNGMVIAVKVLNLMRQGASRSFIAECEALRNIRHRNLVKVLTACSSIDYHGNDFK 774
Query: 777 AIVYEYMECGSLEDWLH-QSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGD 835
AIVYE+M GSLEDWLH N++QRLN+ IDVA A+EYLHHHC PI H D
Sbjct: 775 AIVYEFMANGSLEDWLHPTGTGGGTTLTLNLLQRLNIAIDVACALEYLHHHCEMPIAHCD 834
Query: 836 LKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP---SSSTGIKGTVGYVAPEYGMG 892
LKPSNVLLD ++ HVGDFGLA+FL S L+ P S+S G++GT+GY PEYG+G
Sbjct: 835 LKPSNVLLDDELTGHVGDFGLAKFLSGAS----LDYPTNESTSIGVRGTIGYAPPEYGVG 890
Query: 893 GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDL 952
G++SA GD YS+GILLLEMFT +RPTD MF +G LH F K A+PE+V +I DP LL +
Sbjct: 891 GEVSAYGDTYSYGILLLEMFTGKRPTDEMFREGSNLHNFVKRAVPEQVKQITDPTLLQEE 950
Query: 953 EARASNCGSHRTEIAKIE-----ECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007
+ + EI+ + ECL +I+RIG+ CS+E P ER++++D VA+L S R
Sbjct: 951 PTGDDD----KHEISSMRNSRPLECLNSILRIGISCSVEFPRERMKISDAVAQLHSVRNE 1006
Query: 1008 FLSNRG 1013
S G
Sbjct: 1007 LQSTGG 1012
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113117|ref|XP_002316396.1| predicted protein [Populus trichocarpa] gi|222865436|gb|EEF02567.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 893 bits (2308), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/992 (49%), Positives = 665/992 (67%), Gaps = 17/992 (1%)
Query: 35 TDRLALLAIKSQL-QDPLGVTSSWNNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEGILS 93
TDRL+LLA K+Q+ DPLG SSWN S++ C+W+G CG RHQRV LDL + + G LS
Sbjct: 15 TDRLSLLAFKAQITDDPLGALSSWNESLHFCEWSGAKCGRRHQRVVELDLHSCKLAGSLS 74
Query: 94 PYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINF 153
P++GNLSFLR ++ +NN FS IP E+GRL RL+ L L NN+FSG+IP+N+S CSNL
Sbjct: 75 PHIGNLSFLRILDLSNNSFSQNIPQELGRLLRLQQLNLENNTFSGEIPANISNCSNLQLI 134
Query: 154 HARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRL 213
+GNNL+G+IP ++G S L L+ L N L G++ S N+S+++++ +G+N L G +
Sbjct: 135 DLKGNNLIGKIPAELG-SLLNLQACLLVTNHLVGEIPLSFENLSSVEIIGVGDNHLQGSI 193
Query: 214 PDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLE 273
P +G+L+ L LS+ N SG P SI+N+SSL S+ N+ GSLP ++G LP+LE
Sbjct: 194 PYGIGKLKRLRKLSVPLNNLSGTIPPSIYNLSSLTLFSVAINQFHGSLPSDLGQKLPSLE 253
Query: 274 NLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTG 333
L N + G +P ++SNAS L ++DF N F+G+V F LPNL L N LG G
Sbjct: 254 VLVFYANRFNGPIPVTISNASTLSVIDFGNNSFTGKVP-PFANLPNLQYLGIDSNELGNG 312
Query: 334 AIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIY------V 387
GDL F+ L N + LE LG+ N GG+ P I+N SS SMG NQ+ +
Sbjct: 313 EEGDLSFLQSLANYTNLEELGMSDNNLGGMFPEIISNFSSQFTTLSMGRNQVRGSIPVDI 372
Query: 388 KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLG 447
NL++L+ LE NQLTG IP +IG+L+NL L L N + G+IP SLGN+T L L L
Sbjct: 373 GNLISLDTLMLETNQLTGVIPTSIGKLKNLHGLTLVENKISGNIPSSLGNVTSLVELYLS 432
Query: 448 FNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAE 507
N L+G +PSSL NCQNLM L ++ N L+G L Q++G+ +LS+ LDLS N L G +P+E
Sbjct: 433 ANNLQGGIPSSLANCQNLMSLKLAQNNLSGPLTKQVIGMASLSVSLDLSHNQLIGPLPSE 492
Query: 508 VGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDL 567
VG L NL L +S NR S EIP SL +C LEYL++EGN L GSIP L +L++++ L+L
Sbjct: 493 VGRLVNLGYLDVSHNRLSGEIPGSLGSCIMLEYLHLEGNFLQGSIPELLSSLRALQYLNL 552
Query: 568 SRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGLDEL 627
S NNL+GQIP FL + L+ L+LS+NHLEGE+P + VF N + GN +LCGG+ +L
Sbjct: 553 SYNNLTGQIPRFLADFQLLQRLDLSFNHLEGEMPTQRVFGNVSAVSVLGNDKLCGGISQL 612
Query: 628 HLPVCHSAGPRKTRIAL-LKVVVPVTVILTIIVACLIVLYTRR-RKHKHKSSSMLLMEQQ 685
+L C S RK + + LK+V+ + I + + L RK K++ +S E
Sbjct: 613 NLSRCTSNELRKPKFSTKLKLVISIPCGFIIALLLISSLLIHSWRKTKNEPASGASWEVS 672
Query: 686 FPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA 745
F V+Y +L +AT FSSSN IG GSFG VY+ L + M VAVKV NL ++GA+KS++A
Sbjct: 673 FRRVTYEELYQATGGFSSSNFIGGGSFGSVYKAILAPDGMIVAVKVFNLLRKGASKSYMA 732
Query: 746 ECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL---HQSNDQLEVG 802
EC AL NIRHRNL+KI+T CSS+DF DFKA+VYE+M GSLE+WL H S+++ E G
Sbjct: 733 ECAALINIRHRNLVKILTACSSLDFRGNDFKALVYEFMVNGSLEEWLHPVHTSDEEREQG 792
Query: 803 NFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPP 862
N N+IQRLN+ IDVA A++YLH+HC +VH DLKPSNVLLD DM AHVGDFGLARF P
Sbjct: 793 NLNLIQRLNVAIDVASALDYLHYHCQMAVVHCDLKPSNVLLDGDMTAHVGDFGLARFRPE 852
Query: 863 CSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMF 922
S + +SS G+KGTVGY APEYG+G ++S GDVYS+GILLLE+ T + PTD F
Sbjct: 853 AS-VQLSSNQNSSIGLKGTVGYAAPEYGIGNEVSTYGDVYSYGILLLEILTGKTPTDGSF 911
Query: 923 NDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNC--GSHRTEIAKIEECLVAIVRIG 980
+GL LH++ KMALP++V+E+VDP+LL ++E ++N G R K+ ECLV+I+ +G
Sbjct: 912 KEGLNLHKYVKMALPDRVVEVVDPILLREIEQTSANASDGMKRIGNDKVLECLVSIMEVG 971
Query: 981 VLCSMESPSERIQMTDVVAKLCSARKIFLSNR 1012
V CS++ P ER +++VVA+L R I L R
Sbjct: 972 VSCSVDLPRERTNISNVVAELHRIRGILLGTR 1003
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 892 bits (2306), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 482/1018 (47%), Positives = 668/1018 (65%), Gaps = 26/1018 (2%)
Query: 13 LVW--CFSLFLLHSHSCFALHSNETDRLALLAIKSQLQ-DPLGVTSSWNNSMNLCQWTGV 69
++W ++LL S S NETD+L+LL K+Q+ DPLG SSWN S CQW+GV
Sbjct: 10 ILWPIFLQIYLLVSFSFSIYGGNETDKLSLLTFKAQITGDPLGKLSSWNESSQFCQWSGV 69
Query: 70 TCGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETL 129
TCG RHQRV LDL + + G LSP++GNLSFLR +N ANN S IP E+GRLFRLE L
Sbjct: 70 TCGRRHQRVVELDLHSYQLVGSLSPHIGNLSFLRILNLANNSLSLYIPQELGRLFRLEEL 129
Query: 130 ILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQL 189
+L NN+F G IP+N+SRC+NL NL G++P ++G KL+ L++ N G++
Sbjct: 130 VLRNNTFDGGIPANISRCANLRILDFSRGNLTGKLPAELGL-LSKLQVLTIELNNFVGEI 188
Query: 190 APSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLES 249
S GN+S + + N L G +P+ GQL+ L LS+ N SGM P SIFN+SSL
Sbjct: 189 PYSFGNLSAINAIYGSINNLEGSIPNVFGQLKRLKILSLGANNLSGMIPPSIFNLSSLTL 248
Query: 250 ISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQ 309
+S N+L GSLP +G +LPNL+ ++ N + G +P + SNASNL N+F+G+
Sbjct: 249 LSFPVNQLYGSLPHTLGLTLPNLQVFNIHTNQFGGLIPATFSNASNLLSFQIGSNNFNGK 308
Query: 310 VKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTN-CSKLEALGLDTNIFGGVLPLSI 368
V + +L L NNLG G DL+F+ L N + LEAL N FGGVLP +
Sbjct: 309 VP-PLSSSHDLQVLGVGDNNLGKGENNDLNFVYPLANNMTSLEALDTSDNNFGGVLPEIV 367
Query: 369 ANLSSTIILFSMGLNQI------YVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDL 422
+N S+ ++ + NQI + NL+NL GLE NQLTG IP ++G+L+ L L L
Sbjct: 368 SNFSTKLMKMTFARNQIRGSIPTQIGNLINLEALGLETNQLTGMIPSSMGKLQKLSDLFL 427
Query: 423 HHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQ 482
+ N + G IP S+GN+T L +++ N L G +P SLGN Q L+ L++S N L+G +P +
Sbjct: 428 NGNKISGMIPSSMGNMTSLGRVNMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGPIPKE 487
Query: 483 ILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLY 542
++ I +LS+ L LS N LTGS+P E+ L NL L +S+NRFS EIP SL +C +LE L+
Sbjct: 488 LVSIPSLSMYLVLSENELTGSLPIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLH 547
Query: 543 MEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPR 602
+E N L G IP+ L +L++I+EL+LS NNL+GQIPEFLE+ LE LNLS+N EGEVP
Sbjct: 548 LEENFLQGPIPITLSSLRAIQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPV 607
Query: 603 RGVFSNKTRFYFTGNKRLCGGLDELHLPVCHSAGP--RKTRIALLKVVVPVTVIL-TIIV 659
+G F N + GNK+LCGG+ +L+L C S+ P K+ L+ ++ V L I++
Sbjct: 608 QGAFQNTSAISIFGNKKLCGGIPQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGFLGVILI 667
Query: 660 ACLIVLYTRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGN 719
++ Y R+K ++S +E FP V+Y DL AT+ FSS+N+IG+GSFG V++G
Sbjct: 668 ISFLLFYCFRKKKDKPAASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGI 727
Query: 720 LGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIV 779
LG +++ VAVKV+NL ++GA+KSF+AECEAL++IRHRNL+K++T CSSIDF+ DFKA+V
Sbjct: 728 LGPDKIVVAVKVLNLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALV 787
Query: 780 YEYMECGSLEDWLH--QSNDQLE-VGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDL 836
YE+M G+LE+WLH Q++D+ +++ RLN+ I +A A+ YLHH C PI+H DL
Sbjct: 788 YEFMVNGNLEEWLHPVQTSDEANGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDL 847
Query: 837 KPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMS 896
KPSN+LLD +M AHVGDFGLARF S T SS G+KGT+GY APEYG+GG +S
Sbjct: 848 KPSNILLDTNMTAHVGDFGLARFHSEASNQT------SSVGLKGTIGYAAPEYGIGGKVS 901
Query: 897 ATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEA-- 954
GDVYS+GILLLEMFT +RP D MF DGL LH +AKMALP++++E+VDPLL+ ++ +
Sbjct: 902 TYGDVYSYGILLLEMFTGKRPVDGMFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVN 961
Query: 955 RASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIFLSNR 1012
+ G + +I CL+ I+++GV CS+E P ER+ + DVV +L + L R
Sbjct: 962 SSDEMGMYHIGPHEISACLMTIIKMGVACSVELPRERMDIGDVVTELNRIKDTLLGTR 1019
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1013 | ||||||
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.967 | 0.969 | 0.422 | 2.4e-209 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.959 | 0.962 | 0.423 | 1.1e-208 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.954 | 0.958 | 0.418 | 2.1e-203 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.972 | 0.960 | 0.425 | 4.1e-200 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.946 | 0.935 | 0.407 | 1.4e-188 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.751 | 0.738 | 0.422 | 1.2e-164 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.740 | 0.922 | 0.397 | 1.5e-136 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.882 | 0.891 | 0.338 | 2.1e-126 | |
| TAIR|locus:2204350 | 980 | CLV1 "AT1G75820" [Arabidopsis | 0.865 | 0.894 | 0.303 | 1.7e-120 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.882 | 0.762 | 0.328 | 1.3e-118 |
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2024 (717.5 bits), Expect = 2.4e-209, P = 2.4e-209
Identities = 430/1018 (42%), Positives = 616/1018 (60%)
Query: 19 LFLLHSHSCFAL-----HSNETDRLALLAIKSQLQD-PLGVTSSWNNSMNLCQWTGVTCG 72
LFLL S S L ++ETDR ALL KSQ+ + V SSWNNS LC W VTCG
Sbjct: 3 LFLLLSFSAHLLLGADGFTDETDRQALLEFKSQVSEGKRDVLSSWNNSFPLCNWKWVTCG 62
Query: 73 HRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILA 132
+H+RVT L+L + GI+SP +GN+SFL ++ ++N F G IP E+G LFRLE L +A
Sbjct: 63 RKHKRVTHLNLGGLQLGGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMA 122
Query: 133 NNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPS 192
NS G IP+ LS CS L+N N L +P ++G S KL L L N L G+L S
Sbjct: 123 FNSLEGGIPATLSNCSRLLNLDLYSNPLRQGVPSELG-SLTKLVILDLGRNNLKGKLPRS 181
Query: 193 IGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISL 252
+GN+++L+ L +N + G +PD L +L + L +S N F G+FP +I+N+S+LE + L
Sbjct: 182 LGNLTSLKSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFL 241
Query: 253 LGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKI 312
G+ GSL + G LPN+ L++ +N+ G++P +LSN S L+ + N +G +
Sbjct: 242 FGSGFSGSLKPDFGNLLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYP 301
Query: 313 DFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLS 372
+F ++P+L L S+N LG+ GDL+FI LTNC+ L+ L + GG LP SIAN+S
Sbjct: 302 NFGKVPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMS 361
Query: 373 STIILFSMGLNQIY------VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNN 426
+ +I ++ N + + NL+ L L N LTGP+P ++G+L L +L L+ N
Sbjct: 362 TELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNR 421
Query: 427 LDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGI 486
+ G IP +GNLT L L L N G VP SLG C +++ L + NKL G +P +I+ I
Sbjct: 422 MSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQI 481
Query: 487 VXXXXXXXXXXXXXXXXIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGN 546
+P ++G+L+NLV+L L N+FS +P +L C +E L+++GN
Sbjct: 482 PTLVNLSMEGNSLSGS-LPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGN 540
Query: 547 SLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVF 606
S G+IP ++ L ++ +DLS N+LSG IPE+ N S LEYLNLS N+ G+VP +G F
Sbjct: 541 SFDGAIP-NIRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNF 599
Query: 607 SNKTRFYFTGNKRLCGGLDELHLPVCHSAGPR-KTRIAXXXXXXXXXXXXXXXXACLIVL 665
N T + GNK LCGG+ +L L C + P +T+ + L+V+
Sbjct: 600 QNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVI 659
Query: 666 YTR-----RRKHKHKSSSMLL---MEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYR 717
+ R++ K++ ++ L+ +E +SY DL ATN FSSSNM+G GSFG V++
Sbjct: 660 ASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFK 719
Query: 718 GNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777
L VAVKV+N+++RGA KSF+AECE+L++ RHRNL+K++T C+S DF+ +F+A
Sbjct: 720 ALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRA 779
Query: 778 IVYEYMECGSLEDWLHQSN-DQLE--VGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHG 834
++YEY+ GS++ WLH +++ +++RLN+VIDVA ++YLH HCH PI H
Sbjct: 780 LIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHC 839
Query: 835 DLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD 894
DLKPSNVLL+ D+ AHV DFGLAR L + L SS+ G++GT+GY APEYGMGG
Sbjct: 840 DLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSA-GVRGTIGYAAPEYGMGGQ 898
Query: 895 MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEA 954
S GDVYSFG+LLLEMFT +RPTD +F LTLH + K+ALPEKV EI D +L +
Sbjct: 899 PSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAIL-HIGL 957
Query: 955 RASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIFLSNR 1012
R RT ECL ++ +G+ C E P+ R+ ++V +L S R+ F R
Sbjct: 958 RVG----FRTA-----ECLTLVLEVGLRCCEEYPTNRLATSEVAKELISIRERFFKTR 1006
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2018 (715.4 bits), Expect = 1.1e-208, P = 1.1e-208
Identities = 428/1010 (42%), Positives = 614/1010 (60%)
Query: 18 SLFLLHSHSCFALHSNETDRLALLAIKSQL-QDPLGVTSSWNNSMNLCQWTGVTCGHRHQ 76
+L LL +H ++ETDR ALL KSQ+ +D V SSWN+S LC W GVTCG +++
Sbjct: 11 ALMLLETHG----FTDETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNK 66
Query: 77 RVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSF 136
RVT L+L + G++SP +GNLSFL ++ N F G IP E+G+L RLE L + N
Sbjct: 67 RVTHLELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYL 126
Query: 137 SGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNI 196
G IP L CS L+N N L G +P ++G S L L+L N + G+L S+GN+
Sbjct: 127 RGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELG-SLTNLVQLNLYGNNMRGKLPTSLGNL 185
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNR 256
+ L+ L++ N L G +P + QL ++ L + N FSG+FP +++N+SSL+ + + N
Sbjct: 186 TLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNH 245
Query: 257 LEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNR 316
G L ++G LPNL + ++ N +TGS+P +LSN S L L + N+ +G + F
Sbjct: 246 FSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGN 304
Query: 317 LPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTII 376
+PNL L N+LG+ + DL+F+ LTNC++LE LG+ N GG LP+SIANLS+ ++
Sbjct: 305 VPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLV 364
Query: 377 LFSMGLNQI-----Y-VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGH 430
+G I Y + NL+NL L+ N L+GP+P ++G+L NL+ L L N L G
Sbjct: 365 TLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGG 424
Query: 431 IPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVXXX 490
IP +GN+T+L +LDL N G VP+SLGNC +L+ L + +NKL G +P +I+ I
Sbjct: 425 IPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKI-QQL 483
Query: 491 XXXXXXXXXXXXXIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTG 550
+P ++G L+NL L L +N+ S ++P +L C T+E L++EGN G
Sbjct: 484 LRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYG 543
Query: 551 SIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKT 610
IP LK L +KE+DLS N+LSG IPE+ + S LEYLNLS+N+LEG+VP +G+F N T
Sbjct: 544 DIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENAT 602
Query: 611 RFYFTGNKRLCGGLDELHLPVCHSAGP--------RKTRIAXXXXXXXXXXXXXXXXACL 662
GN LCGG+ L C S P R ++ +
Sbjct: 603 TVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVT 662
Query: 663 IVLYTRRRKHKHKSS-SMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLG 721
++ +R+K+K ++ + +E +SY DL ATN FSSSNM+G GSFG VY+ L
Sbjct: 663 LIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLL 722
Query: 722 ENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781
+ VAVKV+N+++RGA KSF+AECE+L++IRHRNL+K++T CSSIDF+ +F+A++YE
Sbjct: 723 TEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYE 782
Query: 782 YMECGSLEDWLHQSN-DQLEVGN--FNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKP 838
+M GSL+ WLH +++ + +++RLN+ IDVA ++YLH HCH PI H DLKP
Sbjct: 783 FMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKP 842
Query: 839 SNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSAT 898
SNVLLD D+ AHV DFGLAR L + SS+ G++GT+GY APEYG+GG S
Sbjct: 843 SNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSA-GVRGTIGYAAPEYGVGGQPSIN 901
Query: 899 GDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASN 958
GDVYSFGILLLEMFT +RPT+ +F TL+ + K ALPE++++IVD +L + R
Sbjct: 902 GDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESIL-HIGLRVG- 959
Query: 959 CGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIF 1008
+ ECL + +G+ C ESP R+ + VV +L S R+ F
Sbjct: 960 --------FPVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERF 1001
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1968 (697.8 bits), Expect = 2.1e-203, P = 2.1e-203
Identities = 418/998 (41%), Positives = 596/998 (59%)
Query: 32 SNETDRLALLAIKSQLQDPL-GVTSSWNNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEG 90
++E+DR ALL IKSQ+ + S+WNNS LC W V CG +H+RVT LDL + G
Sbjct: 21 TDESDRQALLEIKSQVSESKRDALSAWNNSFPLCSWKWVRCGRKHKRVTRLDLGGLQLGG 80
Query: 91 ILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNL 150
++SP +GNLSFL +++ +NN F G IP E+G LFRL+ L + N G+IP++LS CS L
Sbjct: 81 VISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRL 140
Query: 151 INFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLS 210
+ NNL +P ++G S KL +L L N L G+ I N+++L VL++G N L
Sbjct: 141 LYLDLFSNNLGDGVPSELG-SLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLE 199
Query: 211 GRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLP 270
G +PD + L + L+++ N FSG+FP + +N+SSLE++ LLGN G+L + G LP
Sbjct: 200 GEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLP 259
Query: 271 NLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNL 330
N+ LS+ N TG++P +L+N S L + N +G + +F +L NL L + N+L
Sbjct: 260 NIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSL 319
Query: 331 GTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIY---- 386
G+ + GDL F+ LTNCS L L + N GG LP SI N+S+ + + ++ N IY
Sbjct: 320 GSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIP 379
Query: 387 --VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSL 444
+ NL+ L L N LTGP+P ++G L L L L N G IP +GNLT L L
Sbjct: 380 HDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKL 439
Query: 445 DLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVXXXXXXXXXXXXXXXXI 504
L N G VP SLG+C +++ L + NKL G +P +I+ I +
Sbjct: 440 YLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGS-L 498
Query: 505 PAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKE 564
P ++G L+NLV+L L N S +P +L C ++E +Y++ N G+IP +K L +K
Sbjct: 499 PNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIP-DIKGLMGVKN 557
Query: 565 LDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGL 624
+DLS NNLSG I E+ EN S LEYLNLS N+ EG VP G+F N T GNK LCG +
Sbjct: 558 VDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSI 617
Query: 625 DELHLPVCHS-AGPRKTRIAXXXXXXXXXXXXXXXXACLIVLYT----RRRKHKHK--SS 677
EL L C + A P +TR L+ + + ++RK+ K +S
Sbjct: 618 KELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNS 677
Query: 678 SMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR 737
+ +E +SY DL AT+ FSSSN++G GSFG V++ L VAVKV+N+++R
Sbjct: 678 APFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRR 737
Query: 738 GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSN- 796
GA KSF+AECE+L++IRHRNL+K++T C+SIDF+ +F+A++YE+M GSL+ WLH
Sbjct: 738 GAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEV 797
Query: 797 DQLEVGN--FNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854
+++ + +++RLN+ IDVA ++YLH HCH PI H DLKPSN+LLD D+ AHV DF
Sbjct: 798 EEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDF 857
Query: 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914
GLAR L + SS+ G++GT+GY APEYGMGG S GDVYSFG+L+LEMFT
Sbjct: 858 GLARLLLKFDQESFFNQLSSA-GVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTG 916
Query: 915 RRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLV 974
+RPT+ +F TL+ + K ALPE+V++I D +L + G R +E CL
Sbjct: 917 KRPTNELFGGNFTLNSYTKAALPERVLDIADKSIL--------HSGL-RVGFPVLE-CLK 966
Query: 975 AIVRIGVLCSMESPSERIQMTDVVAKLCSARKIFLSNR 1012
I+ +G+ C ESP R+ ++ +L S R+ F R
Sbjct: 967 GILDVGLRCCEESPLNRLATSEAAKELISIRERFFKTR 1004
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1937 (686.9 bits), Expect = 4.1e-200, P = 4.1e-200
Identities = 428/1006 (42%), Positives = 603/1006 (59%)
Query: 10 LATLVWCFSLFLLHSHSCFALHSNETDRLALLAIKSQLQDPLGVT-SSWNNSMN--LCQW 66
L V FS LL S D LALL+ KS L G + +SWN S + C W
Sbjct: 6 LLLFVLLFSALLLCPSSSDDDGDAAGDELALLSFKSSLLYQGGQSLASWNTSGHGQHCTW 65
Query: 67 TGVTCGHRHQR----VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGR 122
GV CG R +R V L L + ++ GI+SP +GNLSFLR ++ +N SGEIP E+ R
Sbjct: 66 VGVVCGRRRRRHPHRVVKLLLRSSNLSGIISPSLGNLSFLRELDLGDNYLSGEIPPELSR 125
Query: 123 LFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRD 182
L RL+ L L++NS G IP+ + C+ L + N L G IP +IG S L L L
Sbjct: 126 LSRLQLLELSDNSIQGSIPAAIGACTKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYK 185
Query: 183 NLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF 242
N L+G++ ++GN+++LQ + NRLSG +P SLGQL SL +++ +N SGM P+SI+
Sbjct: 186 NGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIW 245
Query: 243 NISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFS 302
N+SSL + S+ N+L G +P N +L LE + + N + G +P S++NAS+L ++
Sbjct: 246 NLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIY 305
Query: 303 LNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGG 362
N FSG + F RL NL L +N T D FI+ LTNCSKL+ L L N GG
Sbjct: 306 GNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGG 365
Query: 363 VLPLSIANLSSTIILFSMGLNQIY------VKNLVNLNGFGLEYNQLTGPIPHAIGELRN 416
VLP S +NLS+++ ++ LN+I + NL+ L L N G +P ++G L+N
Sbjct: 366 VLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKN 425
Query: 417 LQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLT 476
L +L + NNL G IP ++GNLT LN L LG NK G +P +L N NL+ L +S N L+
Sbjct: 426 LGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLS 485
Query: 477 GALPPQILGIVXXXXXXXXXXXXXXXXIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACT 536
G +P ++ I IP E+G+LKNLV+ NR S +IP +L C
Sbjct: 486 GPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQ 545
Query: 537 TLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHL 596
L YLY++ N L+GSIP AL LK ++ LDLS NNLSGQIP L +++ L LNLS+N
Sbjct: 546 LLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSF 605
Query: 597 EGEVPRRGVFSNKTRFYFTGNKRLCGGLDELHLPVCHSAGPRKTRIAXXXXXXXXXXXXX 656
GEVP G F+ + GN +LCGG+ +LHLP C +
Sbjct: 606 VGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVSLAAALA 665
Query: 657 XXXACLIVLYTRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVY 716
+ L +L T ++ K + S M+ P+VSY+ L KAT+ F+ +N++G GSFG VY
Sbjct: 666 ILSS-LYLLITWHKRTKKGAPSRTSMKGH-PLVSYSQLVKATDGFAPTNLLGSGSFGSVY 723
Query: 717 RGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776
+G L + VAVKV+ L+ A KSF AECEALRN+RHRNL+KI+T+CSSID DFK
Sbjct: 724 KGKLNIQDH-VAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFK 782
Query: 777 AIVYEYMECGSLEDWLH-QSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGD 835
AIVY++M GSLEDW+H ++NDQ + + N+ +R+ +++DVA A++YLH H P+VH D
Sbjct: 783 AIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCD 842
Query: 836 LKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDM 895
+K SNVLLD DMVAHVGDFGLAR L ++++ +SS G GT+GY APEYG+G
Sbjct: 843 IKSSNVLLDSDMVAHVGDFGLARIL--VDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIA 900
Query: 896 SATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEAR 955
S GD+YS+GIL+LE+ T +RPTD+ F L L ++ ++ L +V ++VD L+LD E
Sbjct: 901 STHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENW 960
Query: 956 ASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001
++ ++ + +I EC+V ++R+G+ CS E PS R D++ +L
Sbjct: 961 LNS--TNNSPCRRITECIVWLLRLGLSCSQELPSSRTPTGDIIDEL 1004
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1828 (648.5 bits), Expect = 1.4e-188, P = 1.4e-188
Identities = 408/1002 (40%), Positives = 587/1002 (58%)
Query: 32 SNETDRLALLAIKSQLQDPLGVT-SSWNNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEG 90
+ ETD+ ALL KSQ+ + V SWN+S+ LC WTGV CG +H+RVT +DL + G
Sbjct: 36 TEETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTG 95
Query: 91 ILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNL 150
++SP+VGNLSFLR +N A+N F G IP E+G LFRL+ L ++NN F G IP LS CS+L
Sbjct: 96 VVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSL 155
Query: 151 INFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLS 210
N+L +P + G S KL LSL N L G+ S+GN+++LQ+L N++
Sbjct: 156 STLDLSSNHLEQGVPLEFG-SLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIE 214
Query: 211 GRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLP 270
G +P + +L+ + + I+ N F+G+FP I+N+SSL +S+ GN G+L + G LP
Sbjct: 215 GEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLP 274
Query: 271 NLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNL 330
NL+ L + N++TG++P +LSN S+LR LD NH +G++ + F RL NL L + N+L
Sbjct: 275 NLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSL 334
Query: 331 GTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIY---- 386
G + GDLDF+ LTNCS+L+ L + N GG LP+ IANLS+ + S+G N I
Sbjct: 335 GNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIP 394
Query: 387 --VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSL 444
+ NLV+L L N LTG +P ++GEL L+ + L+ N L G IP SLGN++ L L
Sbjct: 395 HGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYL 454
Query: 445 DLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVXXXXXXXXXXXXXXXXI 504
L N G +PSSLG+C L+ L++ NKL G++P +++ + +
Sbjct: 455 YLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGP-L 513
Query: 505 PAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKE 564
++G LK L+ L +S N+ S +IP +L+ C +LE+L ++GNS G IP ++ L ++
Sbjct: 514 RQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIRGLTGLRF 572
Query: 565 LDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGL 624
LDLS+NNLSG IPE++ N S L+ LNLS N+ +G VP GVF N + GN LCGG+
Sbjct: 573 LDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGI 632
Query: 625 DELHLPVCHSAGPRK-TRIAXXXXXXXXXXXXXXXXACLIVLY---------TRRRKHKH 674
L L C PR+ + + CL V+Y + R +
Sbjct: 633 PSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNE 692
Query: 675 KSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNL 734
S ++ + +SY +L K T FSSSN+IG G+FG V++G LG AVA+KV+NL
Sbjct: 693 NDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL 752
Query: 735 KQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQ 794
+RGA KSF+AECEAL IRHRNL+K++T+CSS DFE DF+A+VYE+M G+L+ WLH
Sbjct: 753 CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP 812
Query: 795 SNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854
+ E GN + L +++A + + H H + ++ + ++ D
Sbjct: 813 DEIE-ETGNPSRTLGLFARLNIAIDVASALVYLHT-YCHNPIAHCDIKPSNILL----DK 866
Query: 855 GLARFLPPCSPATIL-----ET---PSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGI 906
L + A +L +T SS G++GT+GY APEYGMGG S GDVYSFGI
Sbjct: 867 DLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGI 926
Query: 907 LLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEI 966
+LLE+FT +RPT+ +F DGLTLH F K AL ++ LD+ G++
Sbjct: 927 VLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQA--------LDITDETILRGAYAQHF 978
Query: 967 AKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIF 1008
+E CL + R+GV CS ESP RI M + ++KL S R+ F
Sbjct: 979 NMVE-CLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESF 1019
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1545 (548.9 bits), Expect = 1.2e-164, Sum P(2) = 1.2e-164
Identities = 331/783 (42%), Positives = 460/783 (58%)
Query: 29 ALHSNETDRLALLAIKSQLQD--PLGVTSSWNNSMNLCQWTGVTCGHRHQRVTVLDLSNR 86
A SNETD ALL KSQ+ + V +SWN+S C W GVTCG R +RV L+L
Sbjct: 24 ARFSNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGF 83
Query: 87 SIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSR 146
+ G++SP +GNLSFLR +N A+N F IP ++GRLFRL+ L ++ N G+IPS+LS
Sbjct: 84 KLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSN 143
Query: 147 CSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGE 206
CS L N+L +P ++G S KL L L N L G S+GN+++LQ L
Sbjct: 144 CSRLSTVDLSSNHLGHGVPSELG-SLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAY 202
Query: 207 NRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIG 266
N++ G +PD + +L + + I+ N+FSG FP +++NISSLES+SL N G+L + G
Sbjct: 203 NQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFG 262
Query: 267 FSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFS 326
+ LPNL L + N +TG++P +L+N S+L D S N+ SG + + F +L NL+ L
Sbjct: 263 YLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIR 322
Query: 327 KNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIY 386
N+LG + L+FI + NC++LE L + N GG LP SIANLS+T+ +G N I
Sbjct: 323 NNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLIS 382
Query: 387 ------VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTI 440
+ NLV+L LE N L+G +P + G+L NLQV+DL+ N + G IP GN+T
Sbjct: 383 GTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTR 442
Query: 441 LNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVXXXXXXXXXXXXX 500
L L L N G +P SLG C+ L+ L + N+L G +P +IL I
Sbjct: 443 LQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLT 502
Query: 501 XXXIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLK 560
P EVG L+ LV LG S N+ S ++P ++ C ++E+L+M+GNS G+IP + L
Sbjct: 503 GH-FPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP-DISRLV 560
Query: 561 SIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRL 620
S+K +D S NNLSG+IP +L +L L LNLS N EG VP GVF N T GN +
Sbjct: 561 SLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNI 620
Query: 621 CGGLDELHLPVCH-SAGPRKTRIAXXXXXXXXXXXXXXXXACLIVL------YTRRRKHK 673
CGG+ E+ L C A PRK + LI++ + +R+K
Sbjct: 621 CGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKN 680
Query: 674 HKS----SSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAV 729
+ S S + VSY +L AT+ FSS+N+IG G+FG V++G LG VAV
Sbjct: 681 NASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAV 740
Query: 730 KVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLE 789
KV+NL + GATKSF+AECE + IRHRNL+K+ITVCSS+D E DF+A+VYE+M GSL+
Sbjct: 741 KVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLD 800
Query: 790 DWL 792
WL
Sbjct: 801 MWL 803
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1337 (475.7 bits), Expect = 1.5e-136, P = 1.5e-136
Identities = 315/792 (39%), Positives = 441/792 (55%)
Query: 36 DRLALLAIKSQLQDPLGVTSSWNNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEGILSPY 95
D LALL+ KS L + +L W T GH Q T + + + G P+
Sbjct: 34 DELALLSFKSSLL--------YQGGQSLASWN--TSGHG-QHCTWVGV----VCGRRHPH 78
Query: 96 -VGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFH 154
V L LR N A G I +G L L TL L++N SGKIP LSR S L
Sbjct: 79 RVVKLR-LRSSNLA-----GIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLV 132
Query: 155 ARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLP 214
N+L G+IP +G + L L L +N L+G + S+G ++ L L++ EN LSG +P
Sbjct: 133 LNFNSLSGEIPAALG-NLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIP 191
Query: 215 DSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLEN 274
S GQLR L +LS++ N SG P I+NISSL ++ N+L G+LP N +LP+L+
Sbjct: 192 SSFGQLRRLSFLSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQE 251
Query: 275 LSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGA 334
+ + N + G +P S+ NASN+ + LN FSG V + R+ NL RL +
Sbjct: 252 VYMYYNQFHGRIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEE 311
Query: 335 IGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIY------VK 388
D F+ LTNCS L+ + L FGGVLP S++NLSS+++ S+ N+I +
Sbjct: 312 TNDWKFMTALTNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIG 371
Query: 389 NLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGF 448
NLVNL L N LTG +P + +L+NL+ L + +N L G +P ++GNLT L ++++ F
Sbjct: 372 NLVNLQYLSLANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQF 431
Query: 449 NKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVXXXXXXXXXXXXXXXXIPAEV 508
N G +PS+LGN L +++ +N G +P +I I IP E+
Sbjct: 432 NAFGGTIPSTLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEI 491
Query: 509 GNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLS 568
G LKN+V+ N+ S E P ++ C L++L+++ N L GSIP+AL LK + LDLS
Sbjct: 492 GKLKNIVEFHADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLS 551
Query: 569 RNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGLDELH 628
NNLSGQIP L ++ L LNLS+N GEVP GVF+N + Y GN +CGG+ ELH
Sbjct: 552 GNNLSGQIPMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELH 611
Query: 629 LPVCHSAGPRKTR----IAXXXXXXXXXXXXXXXXACLIVLYTRRRKHKHKSSSMLLMEQ 684
LP C +K + + L+ + RR+K ++SM Q
Sbjct: 612 LPTCSLKSRKKKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTSM----Q 667
Query: 685 QFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNL----GENEMAVAVKVMNLKQRGAT 740
PM++Y L KAT+ FSSS+++G GSFG VY+G GE VAV+V+ L+ A
Sbjct: 668 GHPMITYKQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKAL 727
Query: 741 KSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLH-QSNDQL 799
KSF AECE LRN RHRNL+KI+T+CSSID DFKAIVY++M GSLEDWLH ++NDQ
Sbjct: 728 KSFTAECETLRNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQA 787
Query: 800 EVGNFNVIQRLN 811
E + + QR++
Sbjct: 788 EQRHLTLHQRVS 799
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1128 (402.1 bits), Expect = 2.1e-126, Sum P(2) = 2.1e-126
Identities = 324/958 (33%), Positives = 469/958 (48%)
Query: 19 LFLLHSHSCFALHSNETDRLALLAIKSQL----QDPLGVTSSWNNSMNLCQWTGVTCGHR 74
LFLLH F ++ ALL++K+ L D SSW S + C W GVTC
Sbjct: 8 LFLLHISHTFTASRPISEFRALLSLKTSLTGAGDDKNSPLSSWKVSTSFCTWIGVTCDVS 67
Query: 75 HQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANN 134
+ VT LDLS ++ G LSP V +L L+ ++ A N SG IP EI L L L L+NN
Sbjct: 68 RRHVTSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNN 127
Query: 135 SFSGKIPSNLSRCSNLINFHAR---GNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAP 191
F+G P +S S L+N NNL G +P + + +L L L N AG++ P
Sbjct: 128 VFNGSFPDEIS--SGLVNLRVLDVYNNNLTGDLPVSVT-NLTQLRHLHLGGNYFAGKIPP 184
Query: 192 SIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISE-NAFSGMFPSSIFNISSLESI 250
S G+ ++ L++ N L G++P +G L +L L I NAF P I N+S L
Sbjct: 185 SYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRF 244
Query: 251 SLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQV 310
L G +P IG L L+ L ++ N ++G L L S+L+ +D S N F+G++
Sbjct: 245 DGANCGLTGEIPPEIG-KLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEI 303
Query: 311 KIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLP----- 365
F L NL L+ +N L G I + FI L +LE L L N F G +P
Sbjct: 304 PASFAELKNLTLLNLFRNKLH-GEIPE--FIGDLP---ELEVLQLWENNFTGSIPQKLGE 357
Query: 366 ---LSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDL 422
L++ +LSS + ++ N L L G N L G IP ++G+ +L + +
Sbjct: 358 NGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLG---NFLFGSIPDSLGKCESLTRIRM 414
Query: 423 HHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQ 482
N L+G IP+ L L L ++L N L G +P + G NL +S+SNN+L+G LPP
Sbjct: 415 GENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPA 474
Query: 483 ILGIVXXXXXXXXXXXXXXXXIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLY 542
I G IP+EVG L+ L ++ S N FS I +S C L ++
Sbjct: 475 I-GNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVD 533
Query: 543 MEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPR 602
+ N L+G IP + +K + L+LSRN+L G IP + ++ L L+ SYN+L G VP
Sbjct: 534 LSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPG 593
Query: 603 RGVFSNKTRFYFTGNKRLCGG-LDELHLPVC------HSAGPRKTRIAXXXXXXXXXXXX 655
G FS F GN LCG L V HS GP ++
Sbjct: 594 TGQFSYFNYTSFLGNPDLCGPYLGPCKDGVAKGGHQSHSKGP----LSASMKLLLVLGLL 649
Query: 656 XXXXACLIVLYTRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFV 715
A +V + R K S S F + + + N+IG+G G V
Sbjct: 650 VCSIAFAVVAIIKARSLKKASESRAWRLTAFQRLDFT-CDDVLDSLKEDNIIGKGGAGIV 708
Query: 716 YRGNLGENEMAVAVKVMNLKQRGATKS--FVAECEALRNIRHRNLIKIITVCSSIDFEEV 773
Y+G + ++ VAVK + RG++ F AE + L IRHR++++++ CS+ E
Sbjct: 709 YKGVMPNGDL-VAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN---HET 764
Query: 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVH 833
+ +VYEYM GSL + LH G+ + R + ++ A + YLHH C P IVH
Sbjct: 765 NL--LVYEYMPNGSLGEVLHGKKG----GHLHWDTRYKIALEAAKGLCYLHHDCSPLIVH 818
Query: 834 GDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG 893
D+K +N+LLD + AHV DFGLA+FL T + I G+ GY+APEY
Sbjct: 819 RDVKSNNILLDSNFEAHVADFGLAKFLQDSG------TSECMSAIAGSYGYIAPEYAYTL 872
Query: 894 DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA-KMALPEK--VMEIVDPLL 948
+ DVYSFG++LLE+ T R+P F DG+ + ++ KM K V++++DP L
Sbjct: 873 KVDEKSDVYSFGVVLLELVTGRKPVGE-FGDGVDIVQWVRKMTDSNKDSVLKVLDPRL 929
|
|
| TAIR|locus:2204350 CLV1 "AT1G75820" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 960 (343.0 bits), Expect = 1.7e-120, Sum P(2) = 1.7e-120
Identities = 282/929 (30%), Positives = 451/929 (48%)
Query: 5 VSISYLATLVWCFSLFLLHSHSCFALHSNETDRLALLAIKSQLQDPLGV-TSSWNNSMNL 63
+++ L T + L+L S CFA TD LL +KS + P G W +S +
Sbjct: 1 MAMRLLKTHLLFLHLYLFFS-PCFAY----TDMEVLLNLKSSMIGPKGHGLHDWIHSSSP 55
Query: 64 ---CQWTGVTCGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEI 120
C ++GV+C RV L++S + G +SP +G L+ L + A N F+GE+P E+
Sbjct: 56 DAHCSFSGVSCDD-DARVISLNVSFTPLFGTISPEIGMLTHLVNLTLAANNFTGELPLEM 114
Query: 121 GRLFRLETLILANN-SFSGKIPSNLSRCS-NLINFHARGNNLVGQIPPDIGYSWLKLEFL 178
L L+ L ++NN + +G P + + +L NN G++PP++ KL++L
Sbjct: 115 KSLTSLKVLNISNNGNLTGTFPGEILKAMVDLEVLDTYNNNFNGKLPPEMS-ELKKLKYL 173
Query: 179 SLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISE-NAFSGMF 237
S N +G++ S G+I +L+ L + LSG+ P L +L++L + I N+++G
Sbjct: 174 SFGGNFFSGEIPESYGDIQSLEYLGLNGAGLSGKSPAFLSRLKNLREMYIGYYNSYTGGV 233
Query: 238 PSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLR 297
P ++ LE + + L G +P ++ +L +L L + NN TG +P LS +L+
Sbjct: 234 PPEFGGLTKLEILDMASCTLTGEIPTSLS-NLKHLHTLFLHINNLTGHIPPELSGLVSLK 292
Query: 298 LLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDT 357
LD S+N +G++ F L N+ ++ +NNL G I + I L KLE +
Sbjct: 293 SLDLSINQLTGEIPQSFINLGNITLINLFRNNL-YGQIPEA--IGELP---KLEVFEVWE 346
Query: 358 NIFGGVLPLSIANLSSTIIL--FSMGLNQIYVKNLVN---LNGFGLEYNQLTGPIPHAIG 412
N F LP ++ + I L L + K+L L L N GPIP +G
Sbjct: 347 NNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCRGEKLEMLILSNNFFFGPIPEELG 406
Query: 413 ELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSN 472
+ ++L + + N L+G +P L NL ++ ++L N G +P ++ L + +SN
Sbjct: 407 KCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDNFFSGELPVTMSG-DVLDQIYLSN 465
Query: 473 NKLTGALPPQILGIVXXXXXXXXXXXXXXXXIPAEVGNLKNLVQLGLSENRFSNEIPVSL 532
N +G +PP I G IP E+ LK+L ++ S N + IP S+
Sbjct: 466 NWFSGEIPPAI-GNFPNLQTLFLDRNRFRGNIPREIFELKHLSRINTSANNITGGIPDSI 524
Query: 533 SACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLS 592
S C+TL + + N + G IP + +K++ L++S N L+G IP + N++ L L+LS
Sbjct: 525 SRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLTGSIPTGIGNMTSLTTLDLS 584
Query: 593 YNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGLDELHLPVCHSAGPRKTRIAXXXXXXXXX 652
+N L G VP G F F GN LC + P A
Sbjct: 585 FNDLSGRVPLGGQFLVFNETSFAGNTYLCLP-HRVSCPTRPGQTSDHNHTALFSPSRIVI 643
Query: 653 XXXXXXXACLIVLYTRRRKHKHKSSSMLLME-QQFPMVSYADLSKATNDFSSSNMIGQGS 711
+++ R+ +K K+ L + F + + N+IG+G
Sbjct: 644 TVIAAITGLILISVAIRQMNKKKNQKSLAWKLTAFQKLDFKS-EDVLECLKEENIIGKGG 702
Query: 712 FGFVYRGNLGENEMAVAVKVMNLKQRGATKS---FVAECEALRNIRHRNLIKIITVCSSI 768
G VYRG++ N + VA+K L RG +S F AE + L IRHR++++++ ++
Sbjct: 703 AGIVYRGSM-PNNVDVAIK--RLVGRGTGRSDHGFTAEIQTLGRIRHRHIVRLLGYVAN- 758
Query: 769 DFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCH 828
D ++YEYM GSL + LH S G+ R + ++ A + YLHH C
Sbjct: 759 ----KDTNLLLYEYMPNGSLGELLHGSKG----GHLQWETRHRVAVEAAKGLCYLHHDCS 810
Query: 829 PPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPE 888
P I+H D+K +N+LLD D AHV DFGLA+FL + + E SS I G+ GY+APE
Sbjct: 811 PLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAAS---ECMSS---IAGSYGYIAPE 864
Query: 889 YGMGGDMSATGDVYSFGILLLEMFTRRRP 917
Y + DVYSFG++LLE+ ++P
Sbjct: 865 YAYTLKVDEKSDVYSFGVVLLELIAGKKP 893
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1168 (416.2 bits), Expect = 1.3e-118, P = 1.3e-118
Identities = 310/944 (32%), Positives = 487/944 (51%)
Query: 81 LDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKI 140
L L+ +EG + +GN S L + +N +G+IP E+G L +L+ L + N + I
Sbjct: 245 LVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSI 304
Query: 141 PSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQ 200
PS+L R + L + N+LVG I +IG+ LE L+L N G+ SI N+ NL
Sbjct: 305 PSSLFRLTQLTHLGLSENHLVGPISEEIGFLE-SLEVLTLHSNNFTGEFPQSITNLRNLT 363
Query: 201 VLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGS 260
VL++G N +SG LP LG L +L LS +N +G PSSI N + L+ + L N++ G
Sbjct: 364 VLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGE 423
Query: 261 LPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNL 320
+P GF NL +S+ +N++TG +P + N SNL L + N+ +G +K +L L
Sbjct: 424 IPR--GFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKL 481
Query: 321 FRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLS--STIILF 378
L S N+L TG I + N L L L +N F G +P ++NL+ + ++
Sbjct: 482 RILQVSYNSL-TGPIP-----REIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMY 535
Query: 379 SMGLNQIYVKNLVN---LNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESL 435
S L + + + L+ L N+ +G IP +L +L L L N +G IP SL
Sbjct: 536 SNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASL 595
Query: 436 GNLTILNSLDLGFNKLRGHVPSSL-GNCQNLML-LSVSNNKLTGALPPQILGIVXXXXXX 493
+L++LN+ D+ N L G +P L + +N+ L L+ SNN LTG +P + LG +
Sbjct: 596 KSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKE-LGKLEMVQEI 654
Query: 494 XXXXXXXXXXIPAEVGNLKNLVQLGLSENRFSNEIPVSL-SACTTLEYLYMEGNSLTGSI 552
IP + KN+ L S+N S IP + + L + NS +G I
Sbjct: 655 DLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEI 714
Query: 553 PLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRF 612
P + + + LDLS NNL+G+IPE L NLS L++L L+ N+L+G VP GVF N
Sbjct: 715 PQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINAS 774
Query: 613 YFTGNKRLCGGLDELH---LPVCHSAGPRKTRIAXXXXXXXXXXXXXXXXACLIVLYTRR 669
GN LCG L + S ++TR+ ++ ++
Sbjct: 775 DLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKK 834
Query: 670 RKHKHKSSSMLL--MEQQFPMVSYA--DLSKATNDFSSSNMIGQGSFGFVYRGNLGENEM 725
K SS L ++ + + +L +AT+ F+S+N+IG S VY+G L E+
Sbjct: 835 EKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGT 893
Query: 726 AVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYM 783
+AVKV+NLK+ A K F E + L ++HRNL+KI+ +E KA+V +M
Sbjct: 894 VIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPFM 949
Query: 784 ECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL 843
E G+LED +H S +G+ ++++++L + +A I+YLH PIVH DLKP+N+LL
Sbjct: 950 ENGNLEDTIHGS--AAPIGS--LLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILL 1005
Query: 844 DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYS 903
D D VAHV DFG AR L + T +S++ +GT+GY+APE+ ++ DV+S
Sbjct: 1006 DSDRVAHVSDFGTARILGFREDGS---TTASTSAFEGTIGYLAPEFAYMRKVTTKADVFS 1062
Query: 904 FGILLLEMFTRRRPTDNMFNDG--LTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGS 961
FGI+++E+ T++RPT D +TL + + ++ +V +LD+E G
Sbjct: 1063 FGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVR---VLDMEL-----GD 1114
Query: 962 HRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005
+ K EE + +++ + C+ P +R M +++ L R
Sbjct: 1115 SIVSL-KQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4396 | 0.9575 | 0.9603 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1013 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-127 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 4e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.003 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.003 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.003 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.003 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 410 bits (1056), Expect = e-127
Identities = 313/1023 (30%), Positives = 495/1023 (48%), Gaps = 121/1023 (11%)
Query: 19 LFLLHSHSCFALHSNETDRLALLAIKSQLQDPLGVTSSWNNSMNLCQWTGVTCGHRHQRV 78
FL + S LH+ E + LL+ KS + DPL S+WN+S ++C W G+TC + RV
Sbjct: 17 FFLFLNFSM--LHAEELE--LLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNN-SSRV 71
Query: 79 TVLDLSNRSIEGILS------PYV-------GNLSF------------LRFINFANNGFS 113
+DLS ++I G +S PY+ LS LR++N +NN F+
Sbjct: 72 VSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFT 131
Query: 114 GEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWL 173
G IP G + LETL L+NN SG+IP+++ S+L GN LVG+IP + +
Sbjct: 132 GSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT-NLT 188
Query: 174 KLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAF 233
LEFL+L N L GQ+ +G + +L+ + +G N LSG +P +G L SL +L + N
Sbjct: 189 SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248
Query: 234 SGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNA 293
+G PSS+ N+ +L+ + L N+L G +P +I FSL L +L + N+ +G +P +
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI-FSLQKLISLDLSDNSLSGEIPELVIQL 307
Query: 294 SNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEAL 353
NL +L N+F+G++ + LP L L N +L +LT L
Sbjct: 308 QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT------VL 361
Query: 354 GLDTNIFGGVLPLSIANLSS--TIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAI 411
L TN G +P + + + +ILFS N L G IP ++
Sbjct: 362 DLSTNNLTGEIPEGLCSSGNLFKLILFS---------------------NSLEGEIPKSL 400
Query: 412 GELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVS 471
G R+L+ + L N+ G +P L ++ LD+ N L+G + S + +L +LS++
Sbjct: 401 GACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLA 460
Query: 472 NNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVS 531
NK G LP G L L DLS N +G++P ++G+L L+QL LSEN+ S EIP
Sbjct: 461 RNKFFGGLP-DSFGSKRLENL-DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDE 518
Query: 532 LSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNL 591
LS+C L L + N L+G IP + + + +LDLS+N LSG+IP+ L N+ L +N+
Sbjct: 519 LSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578
Query: 592 SYNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGLDELHLPVCHSAGPRKTRIALLKVVVPV 651
S+NHL G +P G F GN LCGG LP C RKT + +
Sbjct: 579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV--RKTPSWWFYITCTL 636
Query: 652 TVILTIIVACLIVLYTRRRKH---KHKSSSMLLMEQQFPMVSYADLSKATNDFSSS---- 704
L + + ++ R R + K + E QF S S ND SS
Sbjct: 637 GAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQF-FDSKVSKSITINDILSSLKEE 695
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITV 764
N+I +G G Y+G +N M VK +N S +A+ + ++H N++K+I +
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGL 751
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
C S E+ + +++EY+E +L + L N + +R + I +A A+ +LH
Sbjct: 752 CRS---EKGAY--LIHEYIEGKNLSEVLR---------NLSWERRRKIAIGIAKALRFLH 797
Query: 825 HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGY 884
C P +V G+L P +++D H+ R P T + SS Y
Sbjct: 798 CRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-------AY 844
Query: 885 VAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEI- 943
VAPE D++ D+Y FG++L+E+ T + P D F ++ E+A+ + +++
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW 904
Query: 944 VDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003
+DP + + ++ EI V ++ + + C+ P+ R DV+ L S
Sbjct: 905 IDPSI-------RGDVSVNQNEI-------VEVMNLALHCTATDPTARPCANDVLKTLES 950
Query: 1004 ARK 1006
A +
Sbjct: 951 ASR 953
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 4e-42
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 24/208 (11%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATK-SFVAECEALRNIRHRNLIKIITVC 765
+G+G FG VY + VA+K++ + + + E E L+ + H N++K+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV- 59
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
FE+ + +V EY E GSL+D L ++ G + + L +++ + +EYLH
Sbjct: 60 ----FEDENHLYLVMEYCEGGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHS 110
Query: 826 HCHPPIVHGDLKPSNVLLDHD-MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGY 884
+ I+H DLKP N+LLD D + DFGL++ L S I GT Y
Sbjct: 111 N---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLT--------SDKSLLKTIVGTPAY 159
Query: 885 VAPEYGMG-GDMSATGDVYSFGILLLEM 911
+APE +G G S D++S G++L E+
Sbjct: 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 74/234 (31%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNL-KQRGATKSFVAECEALRNIRHRNLIKIITVC 765
+G+GSFG VY + VA+KV+ K + + + E + L+ ++H N++++ V
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV- 65
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
FE+ D +V EY E G L D L + G + + + + A+EYLH
Sbjct: 66 ----FEDEDKLYLVMEYCEGGDLFDLLKKR------GRLSEDEARFYLRQILSALEYLHS 115
Query: 826 HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYV 885
IVH DLKP N+LLD D + DFGLAR L P T GT Y+
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDP---------GEKLTTFVGTPEYM 163
Query: 886 APEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEK 939
APE +G D++S G++L E+ T + P F L E K K
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPK 213
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 71/215 (33%), Positives = 112/215 (52%), Gaps = 27/215 (12%)
Query: 707 IGQGSFGFVYRG-NLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIIT 763
+G GSFG VY+ + G ++ VAVK++ + ++ E LR + H N++++I
Sbjct: 7 LGSGSFGTVYKAKHKGTGKI-VAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
FE+ D +V EY E G L D+L + G + + + + + +EYL
Sbjct: 66 A-----FEDKDHLYLVMEYCEGGDLFDYLSRG------GPLSEDEAKKIALQILRGLEYL 114
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
H + I+H DLKP N+LLD + V + DFGLA+ L L++ SS T GT
Sbjct: 115 HSN---GIIHRDLKPENILLDENGVVKIADFGLAKKL--------LKSSSSLTTFVGTPW 163
Query: 884 YVAPEYGMGGDM-SATGDVYSFGILLLEMFTRRRP 917
Y+APE +GG+ DV+S G++L E+ T + P
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 71/244 (29%), Positives = 115/244 (47%), Gaps = 24/244 (9%)
Query: 705 NMIGQGSFGFVYRGNL---GENEMAVAVKVMNL-KQRGATKSFVAECEALRNIRHRNLIK 760
+G+G+FG VY+G L VAVK + K F+ E ++ + H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVI---QRLNLVIDVA 817
++ VC + E + +V EYME G L D+L +S + + L+ I +A
Sbjct: 61 LLGVC--TEEEPL---YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+EYL VH DL N L+ D+V + DFGL+R + + TG
Sbjct: 116 KGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD------DDYYRKKTG 166
Query: 878 IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFNDGL--TLHEFAKM 934
K + ++APE G ++ DV+SFG+LL E+FT P + N+ + L + ++
Sbjct: 167 GKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL 226
Query: 935 ALPE 938
PE
Sbjct: 227 PKPE 230
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 31/217 (14%)
Query: 706 MIGQGSFGFVYRG----NLGENEMAVAVKVMNL-KQRGATKSFVAECEALRNIRHRNLIK 760
+G+G+FG VY+G G+ ++ VAVK + + F+ E +R + H N++K
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
++ VC+ EE + IV EYME G L +L ++ +L ++ L+ + +A +
Sbjct: 66 LLGVCTE---EEPLY--IVMEYMEGGDLLSYLRKNRPKL-----SLSDLLSFALQIARGM 115
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
EYL +H DL N L+ ++V + DFGL+R L + G K
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD------DYYRKRGG-KL 165
Query: 881 TVGYVAPE---YGMGGDMSATGDVYSFGILLLEMFTR 914
+ ++APE G S DV+SFG+LL E+FT
Sbjct: 166 PIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 199
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 707 IGQGSFGFVYRGNL----GENEMAVAVKVMNLK-QRGATKSFVAECEALRNIRHRNLIKI 761
+G+G+FG VY+G L E VAVK + + F+ E ++ + H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
+ VC+ + IV EYM G L D+L + ++L + L + + +A +E
Sbjct: 67 LGVCT----QGEPLY-IVTEYMPGGDLLDFLRKHGEKL-----TLKDLLQMALQIAKGME 116
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
YL VH DL N L+ ++V + DFGL+R + G K
Sbjct: 117 YLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR------KRGGGKLP 167
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914
+ ++APE G ++ DV+SFG+LL E+FT
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 706 MIGQGSFGFVYRG----NLGENEMAVAVKVMNL-KQRGATKSFVAECEALRNIRHRNLIK 760
+G+G+FG VY+G E+ VAVK + + F+ E +R + H N++K
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
++ VC+ E + IV EYM G L D+L ++ + ++ L+ + +A +
Sbjct: 66 LLGVCT-----EEEPLMIVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIARGM 116
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
EYL +H DL N L+ ++V + DFGL+R L K
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-----YYKVKGG--KL 166
Query: 881 TVGYVAPE---YGMGGDMSATGDVYSFGILLLEMFTR 914
+ ++APE G S DV+SFG+LL E+FT
Sbjct: 167 PIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 200
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 24/228 (10%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRN 757
+++ ++G+GSFG VY + +AVK + L ++ E L +++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFN--VIQRLNLVID 815
+++ EE + I EY+ GSL L + G VI++
Sbjct: 61 IVRYYGSERD---EEKNTLNIFLEYVSGGSLSSLLKK------FGKLPEPVIRKY--TRQ 109
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+ + YLH + IVH D+K +N+L+D D V + DFG A+ L I ET +
Sbjct: 110 ILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRL-----GDI-ETGEGT 160
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFN 923
++GT ++APE G + D++S G ++EM T + P + N
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 700 DFSSSNMIGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
F IG+G FG VY+ + + VA+KV+ L+ + + + E + L+ +H N+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKE-VAIKVIKLESKEKKEKIINEIQILKKCKHPNI 59
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
+K S + +E+ IV E+ GSL+D L +N L + + ++
Sbjct: 60 VKYY--GSYLKKDEL---WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCK-----ELLK 109
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+EYLH + I+H D+K +N+LL D + DFGL+ A + +T + +T +
Sbjct: 110 GLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLS--------AQLSDTKARNT-M 157
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT ++APE G D++S GI +E+ + P
Sbjct: 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 74/215 (34%), Positives = 103/215 (47%), Gaps = 21/215 (9%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLI 759
+F+ +G G FG V+ G L +N + VA+K++ + F E +AL+ +RH++LI
Sbjct: 7 EFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
+ VCS E V I+ E ME GSL +L Q V +++ VA
Sbjct: 66 SLFAVCSV--GEPV---YIITELMEKGSLLAFLRSPEGQ----VLPVASLIDMACQVAEG 116
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+ YL +H DL N+L+ D+V V DFGLAR I E S+ K
Sbjct: 117 MAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARL--------IKEDVYLSSDKK 165
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914
+ APE G S DV+SFGILL EMFT
Sbjct: 166 IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 81/238 (34%), Positives = 113/238 (47%), Gaps = 33/238 (13%)
Query: 704 SNMIGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGATKSFVA---ECEALRNIRHRNLI 759
N IG G+FG VY NL E+ +AVK + + Q K+ E + L ++H NL+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGEL-MAVKEIRI-QDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
K V + E+V I EY G+LE+ L E +VI+ L +
Sbjct: 63 KYYGV--EVHREKV---YIFMEYCSGGTLEELLEHGRILDE----HVIRVYTLQLLEG-- 111
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+ YLH H IVH D+KP+N+ LDH+ V +GDFG A L + T + S
Sbjct: 112 LAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK--NNTTTMGEEVQSL--A 164
Query: 880 GTVGYVAPEYGMGGDMSATG---DVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934
GT Y+APE GG G D++S G ++LEM T +RP + N EF M
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN------EFQIM 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 69/215 (32%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
+ IG+G FG V G+ + VAVK + A +F+AE + +RH NL
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNL 62
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
++++ V + IV EYM GSL D+L + + Q+L +DV
Sbjct: 63 VQLLGVV----LQGNPL-YIVTEYMAKGSLVDYLRSRGRAV----ITLAQQLGFALDVCE 113
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+EYL VH DL NVL+ D+VA V DFGLA+ E
Sbjct: 114 GMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-----------EASQGQDSG 159
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
K V + APE S DV+SFGILL E+++
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 73/253 (28%), Positives = 113/253 (44%), Gaps = 29/253 (11%)
Query: 704 SNMIGQGSFGFVYRG---NLGENEMA-VAVKVMNLKQRGATKS-FVAECEALRNIRHRNL 758
+G+G FG V LG+N VAVK +N +S F E E LR + H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
+K VC + ++ EY+ GSL D+L + DQ+ N+ + L +
Sbjct: 69 VKYKGVCEKPGGRSL---RLIMEYLPSGSLRDYLQRHRDQI-----NLKRLLLFSSQICK 120
Query: 819 AIEYLH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
++YL +H DL N+L++ + + + DFGLA+ LP ++ P S
Sbjct: 121 GMDYLGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES-- 174
Query: 878 IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937
+ + APE S+ DV+SFG+ L E+FT P+ + EF +M
Sbjct: 175 ---PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS------PPAEFLRMIGI 225
Query: 938 EKVMEIVDPLLLL 950
+ IV LL L
Sbjct: 226 AQGQMIVTRLLEL 238
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 77/279 (27%), Positives = 119/279 (42%), Gaps = 37/279 (13%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEAL-RNIR 754
+DF +IG+GSF V E A+K+++ L + K E E L R
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
H +IK+ + D E + F V EY G L ++ + G+ +
Sbjct: 61 HPGIIKLY--YTFQDEENLYF---VLEYAPNGELLQYIRK------YGSLDEKCTRFYAA 109
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPAT---ILET 871
++ A+EYLH I+H DLKP N+LLD DM + DFG A+ L P S T
Sbjct: 110 EILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 872 PSSSTGIK---------GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMF 922
S K GT YV+PE + D+++ G ++ +M T + P
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS- 225
Query: 923 NDGLTLHEFAKMAL------PEKVMEIVDPLLLLDLEAR 955
N+ LT + K+ P ++++ LL+LD + R
Sbjct: 226 NEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDR 264
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 106 bits (264), Expect = 2e-24
Identities = 72/219 (32%), Positives = 114/219 (52%), Gaps = 24/219 (10%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIRH-RNLIKII 762
+G+GSFG VY L + VA+KV+ K + + F+ E + L ++ H N++K+
Sbjct: 8 LGEGSFGEVY---LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
F++ +V EY++ GSLED L + + G + + L ++ + A+EY
Sbjct: 65 DF-----FQDEGSLYLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEY 116
Query: 823 LHHHCHPPIVHGDLKPSNVLLDHD-MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
LH I+H D+KP N+LLD D V + DFGLA+ LP + + S+ GT
Sbjct: 117 LHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST--SVGT 171
Query: 882 VGYVAPEYGMG---GDMSATGDVYSFGILLLEMFTRRRP 917
GY+APE +G S++ D++S GI L E+ T P
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 74/219 (33%), Positives = 105/219 (47%), Gaps = 24/219 (10%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT-KSFVAECEALRNIRHRNLIKIITVC 765
+G G FG V+ G L N VAVK LK K F+AE + ++ +RH LI++ VC
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
+ EE + IV E M+ GSL ++L + Q +++ VA + YL
Sbjct: 71 T---LEEPIY--IVTELMKYGSLLEYLQGG----AGRALKLPQLIDMAAQVASGMAYLEA 121
Query: 826 HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYV 885
+ +H DL NVL+ + + V DFGLAR + I E + G K + +
Sbjct: 122 QNY---IHRDLAARNVLVGENNICKVADFGLARVIK----EDIYE---AREGAKFPIKWT 171
Query: 886 APEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
APE + S DV+SFGILL E+ T R P M N
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 70/222 (31%), Positives = 106/222 (47%), Gaps = 30/222 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA--TKSFVAECEALRNIRHRNLIKIITV 764
+G G FG V+ G VAVK LK G ++F+ E + ++ +RH L+++ V
Sbjct: 14 LGAGQFGEVWMG-TWNGTTKVAVKT--LKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
CS E + IV EYM GSL D+L E + Q +++ +A + YL
Sbjct: 70 CS-----EEEPIYIVTEYMSKGSLLDFLKSG----EGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 825 HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP--SSSTGIKGTV 882
+ +H DL N+L+ ++V + DFGLAR ++E ++ G K +
Sbjct: 121 SRNY---IHRDLAARNILVGENLVCKIADFGLAR---------LIEDDEYTAREGAKFPI 168
Query: 883 GYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRR-PTDNMFN 923
+ APE G + DV+SFGILL E+ T R P M N
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 27/220 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIITV 764
+G G FG V+ G ++ VA+K++ GA F+ E + + + H NL+++ V
Sbjct: 12 LGSGQFGVVHLGKW-RGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
C+ + IV EYM G L ++L + G L++ DV A+EYL
Sbjct: 68 CT-----KQRPIFIVTEYMANGCLLNYLRERK-----GKLGTEWLLDMCSDVCEAMEYLE 117
Query: 825 HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGY 884
+ +H DL N L+ D V V DFGLAR++ + + +SS G K V +
Sbjct: 118 SNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV-------LDDQYTSSQGTKFPVKW 167
Query: 885 VAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
PE S+ DV+SFG+L+ E+F+ + P + N
Sbjct: 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 68/227 (29%), Positives = 112/227 (49%), Gaps = 30/227 (13%)
Query: 705 NMIGQGSFGFVYRGNL---GENEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRN 757
+IG G FG V RG L G+ E+ VA+K LK G++ F+ E + H N
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT--LKA-GSSDKQRLDFLTEASIMGQFDHPN 66
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
+I++ V + I+ EYME GSL+ +L +++ + F V Q + ++ +A
Sbjct: 67 IIRLEGVVTK-----SRPVMIITEYMENGSLDKFLRENDGK-----FTVGQLVGMLRGIA 116
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
++YL + VH DL N+L++ ++V V DFGL+R L ++ G
Sbjct: 117 SGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY------TTKG 167
Query: 878 IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
K + + APE ++ DV+SFGI++ E+ + RP +M N
Sbjct: 168 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA--TKSFVAECEALRNIRHRNLIKII 762
IG+GSFG VY + +K ++L + + E + L+ + H N+IK
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
FEE IV EY + G L + + + E F Q L+ + + A++Y
Sbjct: 66 E-----SFEEKGKLCIVMEYADGGDLSQKIKKQ--KKEGKPFPEEQILDWFVQLCLALKY 118
Query: 823 LH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
LH I+H D+KP N+ L + + +GDFG+++ L T + + GT
Sbjct: 119 LHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL--------SSTVDLAKTVVGT 166
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
Y++PE + D++S G +L E+ T + P
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 72/223 (32%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKV--MNLKQRGATKSFVAECEALRNIRHRNLIKIITV 764
IG+G+FG VY+G L N VAVK L K F+ E E L+ H N++K+I V
Sbjct: 3 IGKGNFGDVYKGVLKGN-TEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
C + + + IV E + GSL +L + ++L V + L + +D A +EYL
Sbjct: 61 C--VQKQPI---YIVMELVPGGSLLTFLRKKKNRLTVK-----KLLQMSLDAAAGMEYLE 110
Query: 825 HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG---IKGT 881
+H DL N L+ + V + DFG++R + T S IK T
Sbjct: 111 SKN---CIHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWT 162
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
APE G ++ DV+S+GILL E F+ P M N
Sbjct: 163 ----APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN 201
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 7e-23
Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLI 759
D + + +G G +G VY G + + VAVK + + + F+ E ++ I+H NL+
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
+++ VC+ E F I+ E+M G+L D+L + N Q N + L + ++ A
Sbjct: 66 QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE----VNAVVLLYMATQISSA 116
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+EYL +H DL N L+ + + V DFGL+R + +T ++ G K
Sbjct: 117 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAHAGAK 166
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ + APE S DV++FG+LL E+ T
Sbjct: 167 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 8e-23
Identities = 77/264 (29%), Positives = 127/264 (48%), Gaps = 43/264 (16%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNL---GENEMAVAVKVMNL----KQRGATKSFVAECEALR 751
+ + +IG G FG V+RG L G E+AVA+K + KQR + F++E +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMG 61
Query: 752 NIRHRNLIKIITVCSSIDFEEVDFK--AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQR 809
H N+I++ V + FK I+ EYME G+L+ +L + G F+ Q
Sbjct: 62 QFSHHNIIRLEGVVTK-------FKPAMIITEYMENGALDKYLRDHD-----GEFSSYQL 109
Query: 810 LNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATIL 869
+ ++ +A ++YL + VH DL N+L++ ++ V DFGL+R L T
Sbjct: 110 VGMLRGIAAGMKYLSDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY- 165
Query: 870 ETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNM------- 921
+++G K + + APE ++ DV+SFGI++ E+ + RP +M
Sbjct: 166 ----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMK 221
Query: 922 -FNDGLTLHEFAKMALPEKVMEIV 944
NDG L A M P V +++
Sbjct: 222 AINDGFRLP--APMDCPSAVYQLM 243
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIITV 764
IG G FG V+ G + VA+K + + GA + F+ E + + + H L+++ V
Sbjct: 12 IGSGQFGLVWLGYW-LEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
C E +V+E+ME G L D+L G F+ L + +DV + YL
Sbjct: 68 C----TERSPI-CLVFEFMEHGCLSDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLE 117
Query: 825 HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGY 884
++H DL N L+ + V V DFG+ RF+ + + +SSTG K V +
Sbjct: 118 SSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV-------LDDQYTSSTGTKFPVKW 167
Query: 885 VAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+PE S+ DV+SFG+L+ E+F+ + P +N N
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN 207
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 76/231 (32%), Positives = 117/231 (50%), Gaps = 37/231 (16%)
Query: 706 MIGQGSFGFVYRGNL---GENEMAVAVKVMNL----KQRGATKSFVAECEALRNIRHRNL 758
+IG G FG V RG L G+ E+ VA+K + KQR + F++E + H N+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHPNI 67
Query: 759 IK---IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
I ++T + I+ E+ME G+L+ +L Q ND G F VIQ + ++
Sbjct: 68 IHLEGVVTKSRPV--------MIITEFMENGALDSFLRQ-ND----GQFTVIQLVGMLRG 114
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP--PCSPATILETPS 873
+A ++YL + VH DL N+L++ ++V V DFGL+RFL P T +
Sbjct: 115 IAAGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP-----TYT 166
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLE-MFTRRRPTDNMFN 923
SS G K + + APE ++ DV+S+GI++ E M RP +M N
Sbjct: 167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 71/217 (32%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 707 IGQGSFGFVYRGN-LGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVC 765
IG+G FG V +G G+ VAVK N+K ++F+ E + + H+NL++++ V
Sbjct: 14 IGEGEFGAVLQGEYTGQK---VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
IV E M G+L ++L L +VIQ L +DVA +EYL
Sbjct: 69 LHNGLY------IVMELMSKGNLVNFLRTRGRAL----VSVIQLLQFSLDVAEGMEYLES 118
Query: 826 HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYV 885
+VH DL N+L+ D VA V DFGLAR + L V +
Sbjct: 119 K---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-----------PVKWT 164
Query: 886 APEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNM 921
APE S+ DV+S+G+LL E+F+ R P M
Sbjct: 165 APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 76/221 (34%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 700 DFSSSNMIGQGSFGFV----YRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRH 755
+ IG+G FG V YRGN VAVK +K ++F+AE + +RH
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYRGN------KVAVKC--IKNDATAQAFLAEASVMTQLRH 58
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
NL++++ V EE IV EYM GSL D+L + G+ L +D
Sbjct: 59 SNLVQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD----CLLKFSLD 110
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
V A+EYL + VH DL NVL+ D VA V DFGL + E S+
Sbjct: 111 VCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQ 156
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRR 916
K V + APE S DV+SFGILL E+++ R
Sbjct: 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 9e-22
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT-KSFVAECEALRNIRHRNLIKIITVC 765
+GQGS G VY+ A+K +++ K + E + LR+ ++K C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
++E + +IV EYM+ GSL D L +VG + + ++YLH
Sbjct: 65 YGAFYKEGEI-SIVLEYMDGGSLADLLK------KVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 826 HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYV 885
H I+H D+KPSN+L++ + DFG+++ L L+ ++ GTV Y+
Sbjct: 118 KRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL-----ENTLDQCNTFV---GTVTYM 167
Query: 886 APEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
+PE G S D++S G+ LLE + P
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 67/229 (29%), Positives = 103/229 (44%), Gaps = 44/229 (19%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNL 758
+G+G+FG V+ G ++ VAVK LK+ A K F E E L N +H N+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKT--LKETASNDARKDFEREAELLTNFQHENI 70
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL--------EVGNFNVIQRL 810
+K VC+ E D +V+EYME G L +L +G + Q L
Sbjct: 71 VKFYGVCT-----EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 811 NLVIDVAFAIEYL--HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATI 868
+ + +A + YL H VH DL N L+ +D+V +GDFG++R +
Sbjct: 126 QIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT----- 175
Query: 869 LETPSSSTGIKGT----VGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ G + ++ PE M + DV+SFG++L E+FT
Sbjct: 176 -----DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 69/222 (31%), Positives = 108/222 (48%), Gaps = 31/222 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+GQG FG V+ G VA+K + + ++F+ E + ++ +RH L+++ V S
Sbjct: 14 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID----VAFAIEY 822
EE + IV EYM GSL D+L G RL ++D +A + Y
Sbjct: 72 ----EEPIY--IVTEYMSKGSLLDFLK--------GEMGKYLRLPQLVDMAAQIASGMAY 117
Query: 823 LHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTV 882
+ + VH DL+ +N+L+ ++V V DFGLAR + ++ G K +
Sbjct: 118 VERMNY---VHRDLRAANILVGENLVCKVADFGLARLIED-------NEYTARQGAKFPI 167
Query: 883 GYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRR-PTDNMFN 923
+ APE + G + DV+SFGILL E+ T+ R P M N
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 700 DFSSSNMIGQGSFGFVYRG-NLGENEMAVAVKVMNL--KQRGATKSFVAECEALRNIRHR 756
++ ++IG+G+FG VY+G NL + VA+K ++L + A KS + E + L+N++H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDF-VAIKQISLEKIKEEALKSIMQEIDLLKNLKHP 59
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
N++K I E D I+ EY E GSL + + G F V V
Sbjct: 60 NIVKYIGS-----IETSDSLYIILEYAENGSLRQIIKKF------GPFPESLVAVYVYQV 108
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
+ YLH ++H D+K +N+L D V + DFG+A L +
Sbjct: 109 LQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN--------DVSKDDA 157
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
+ GT ++APE S D++S G ++E+ T P
Sbjct: 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 3e-21
Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 29/216 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRNLIKIIT 763
+G+GSFG V + A+KV+ + +R + + E L I H ++K
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFN--VIQRLNLVIDVAFAIE 821
+ E++ V EY G L L + G F+ + ++ A+E
Sbjct: 59 HYAFQTEEKLYL---VLEYAPGGELFSHLSK------EGRFSEERARFY--AAEIVLALE 107
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
YLH I++ DLKP N+LLD D + DFGLA+ + S + GT
Sbjct: 108 YLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAK--------ELSSEGSRTNTFCGT 156
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
Y+APE +G D +S G+LL EM T + P
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 72/229 (31%), Positives = 112/229 (48%), Gaps = 35/229 (15%)
Query: 706 MIGQGSFGFVYRGNL---GENEMAVAVKVMNL----KQRGATKSFVAECEALRNIRHRNL 758
+IG G FG V G L G+ E+ VA+K + KQR + F++E + H N+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR---RDFLSEASIMGQFDHPNI 67
Query: 759 IK---IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
I ++T + IV EYME GSL+ +L + + G F VIQ + ++
Sbjct: 68 IHLEGVVTKSKPV--------MIVTEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRG 114
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+A ++YL + VH DL N+L++ ++V V DFGL+R L P E ++
Sbjct: 115 IASGMKYLSDMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLED-DP----EAAYTT 166
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLE-MFTRRRPTDNMFN 923
G K + + APE ++ DV+S+GI++ E M RP M N
Sbjct: 167 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 28/221 (12%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ----RGATKSFVAECEALRNIRHR 756
F +IG+G+FG V + + A+K MN KQ +G+ ++ + E L+ + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN-KQKCVEKGSVRNVLNERRILQELNHP 60
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
L+ + S F++ + +V + + G L L Q F+ Q + ++
Sbjct: 61 FLVN---LWYS--FQDEENMYLVVDLLLGGDLRYHLSQK------VKFSEEQVKFWICEI 109
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
A+EYLH I+H D+KP N+LLD H+ DF +A + P + +T
Sbjct: 110 VLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---------DTLTT 157
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT GY+APE S D +S G+ E +RP
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G G FG V+ G N VAVK + + +SF+ E + ++ +RH L+++ V S
Sbjct: 14 LGNGQFGEVWMGTWNGN-TKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
EE + IV EYM GSL D+L + + +++ VA + Y+
Sbjct: 72 ----EEPIY--IVTEYMSKGSLLDFLKDGEGR----ALKLPNLVDMAAQVAAGMAYIERM 121
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVA 886
+ +H DL+ +N+L+ +V + DFGLAR + ++ G K + + A
Sbjct: 122 NY---IHRDLRSANILVGDGLVCKIADFGLARLIED-------NEYTARQGAKFPIKWTA 171
Query: 887 PEYGMGGDMSATGDVYSFGILLLEMFTRRR-PTDNMFN 923
PE + G + DV+SFGILL E+ T+ R P M N
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 36/223 (16%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMN----LKQRGATKSFVAECEALRNIRHRN 757
+GQGSFG VY G GE E VA+K +N +++R F+ E ++ +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER---IEFLNEASVMKEFNCHH 70
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL--HQSNDQLEVGNFNVIQR---LNL 812
+++++ V S +V E M G L+ +L + + + +
Sbjct: 71 VVRLLGVVS-----TGQPTLVVMELMAKGDLKSYLRSRRPEAE-NNPGLGPPTLQKFIQM 124
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP 872
++A + YL VH DL N ++ D+ +GDFG+ R I ET
Sbjct: 125 AAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIYETD 173
Query: 873 SSSTGIKGT--VGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
G KG V ++APE G + DV+SFG++L EM T
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 61/214 (28%), Positives = 91/214 (42%), Gaps = 28/214 (13%)
Query: 707 IGQGSFGFVYRGNL---GENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIK 760
+G G+FG V +G E+ VAVK LKQ K F+ E + + H +++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKT--LKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+I VC +V E G L +L + V L VA +
Sbjct: 61 LIGVCKGEPL------MLVMELAPLGPLLKYLKKR------REIPVSDLKELAHQVAMGM 108
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
YL H VH DL NVLL + A + DFG++R L S + ++T +
Sbjct: 109 AYLES-KH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS-----DYYRATTAGRW 160
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914
+ + APE G S+ DV+S+G+ L E F+
Sbjct: 161 PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 8e-20
Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 27/224 (12%)
Query: 689 VSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNL-KQRGATKSFVAEC 747
VS D + + IG+G+ G VY+ VA+K M L KQ + + E
Sbjct: 12 VSEGDPRELYKNLE---KIGEGASGEVYKATDRATGKEVAIKKMRLRKQN--KELIINEI 66
Query: 748 EALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVI 807
+++ +H N++ S + + +V EYM+ GSL D + Q+ ++ +
Sbjct: 67 LIMKDCKHPNIVDYY---DSYLVGDELW--VVMEYMDGGSLTDIITQNFVRMNEPQIAYV 121
Query: 808 QRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPAT 867
R +V +EYLH ++H D+K N+LL D + DFG A A
Sbjct: 122 CR-----EVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFA--------AQ 165
Query: 868 ILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
+ + S + GT ++APE D D++S GI+ +EM
Sbjct: 166 LTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 707 IGQGSFGFVYRG-NLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIIT 763
+G+G++G VY+ + E+ VA+K + L G + + E L+ ++H N++K++
Sbjct: 7 LGEGTYGVVYKARDKKTGEI-VALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 764 VCSSIDFEEVDFK-AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF---- 818
V + K +V+EY + L+ +L + L NL+ + +
Sbjct: 66 VIHTER------KLYLVFEYCDM-DLKKYLDKRPGPLS---------PNLIKSIMYQLLR 109
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+ Y H H I+H DLKP N+L++ D V + DFGLAR P + + +
Sbjct: 110 GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAF--GIP-----LRTYTHEV 159
Query: 879 KGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
T+ Y APE +G +T D++S G + EM T +
Sbjct: 160 V-TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 23/224 (10%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G G FG V G + VA+K M + + F+ E + + + H L+++ VC+
Sbjct: 12 LGTGQFGVVKYGKW-RGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
+ + IV EYM G L ++L + + + Q L + DV + YL
Sbjct: 70 K---QRPIY--IVTEYMSNGCLLNYLREHGKRFQP-----SQLLEMCKDVCEGMAYLESK 119
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVA 886
+H DL N L+D V DFGL+R++ + + +SS G K V +
Sbjct: 120 ---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-------LDDEYTSSVGSKFPVRWSP 169
Query: 887 PEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFNDGLTLH 929
PE + S+ DV++FG+L+ E+++ + P + N
Sbjct: 170 PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+GQG FG V+ G VA+K + ++F+ E + ++ +RH L+ + V S
Sbjct: 14 LGQGCFGEVWMGTW-NGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
EE + IV E+M GSL D+L + + + + Q +++ +A + Y+
Sbjct: 72 ----EEPIY--IVTEFMGKGSLLDFLKEGDGK----YLKLPQLVDMAAQIADGMAYIERM 121
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVA 886
+ +H DL+ +N+L+ ++V + DFGLAR + ++ G K + + A
Sbjct: 122 NY---IHRDLRAANILVGDNLVCKIADFGLARLIED-------NEYTARQGAKFPIKWTA 171
Query: 887 PEYGMGGDMSATGDVYSFGILLLEMFTRRR-PTDNMFN 923
PE + G + DV+SFGILL E+ T+ R P M N
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 64/226 (28%), Positives = 92/226 (40%), Gaps = 48/226 (21%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN------LKQRGATKSFVAECEALRN 752
+DF +G GSFG V + A+K+++ LKQ + E L++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN---EKRILQS 57
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNL 812
IRH L+ + F++ +V EY+ G L L +S G F
Sbjct: 58 IRHPFLVNLYGS-----FQDDSNLYLVMEYVPGGELFSHLRKS------GRFPEPVARFY 106
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPP-----CSPAT 867
V A+EYLH IV+ DLKP N+LLD D + DFG A+ + C
Sbjct: 107 AAQVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC---- 159
Query: 868 ILETPSSSTGIKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEM 911
GT Y+APE G + D ++ GIL+ EM
Sbjct: 160 ------------GTPEYLAPEIILSKGYGKAV--DWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 50/226 (22%)
Query: 707 IGQGSFGFVYRG-NLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIIT 763
IG+G++G VY+ N E+ VA+K + ++ G + + E + L+ +RH N++++
Sbjct: 7 IGEGTYGQVYKARNKKTGEL-VALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVI--QRLNLVIDVAFAIE 821
+ +S + +V+EYM+ L L + Q L ++
Sbjct: 66 IVTS---KGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLE-------GLQ 114
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL-----PPCSPATILETPSSST 876
YLH + I+H D+K SN+L+++D V + DFGLAR + I
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-------- 163
Query: 877 GIKGTVGYVAPE-------YGMGGDMSATGDVYSFGILLLEMFTRR 915
T+ Y PE YG DM +S G +L E+F +
Sbjct: 164 ----TLWYRPPELLLGATRYGPEVDM------WSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 25/219 (11%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKS-FVAECEALRNIRHRNLIKIITVC 765
+G G FG V+ G VA+K +LKQ + F+AE ++ ++H L+++ V
Sbjct: 14 LGAGQFGEVWMG-YYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
+ E + I+ EYME GSL D+L E + + +++ +A + ++
Sbjct: 71 TQ---EPI---YIITEYMENGSLVDFLKTP----EGIKLTINKLIDMAAQIAEGMAFIER 120
Query: 826 HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYV 885
+ +H DL+ +N+L+ + + DFGLAR + ++ G K + +
Sbjct: 121 KNY---IHRDLRAANILVSETLCCKIADFGLARLIED-------NEYTAREGAKFPIKWT 170
Query: 886 APEYGMGGDMSATGDVYSFGILLLEMFTRRR-PTDNMFN 923
APE G + DV+SFGILL E+ T R P M N
Sbjct: 171 APEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 706 MIGQGSFGFVYRGN---LGEN-EMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIK 760
++G G+FG VY+G GE ++ VA+KV+ + A K + E + ++ H ++++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
++ +C S +V ++ + M G L D++ D + LN + +A +
Sbjct: 74 LLGICLS---SQV---QLITQLMPLGCLLDYVRNHKDNI-----GSQYLLNWCVQIAKGM 122
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
YL +VH DL NVL+ + DFGLA+ L E + G K
Sbjct: 123 SYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD------EKEYHAEGGKV 173
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDN 920
+ ++A E + + DV+S+G+ + E+ T +P +
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 56/217 (25%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIIT 763
++G+G+FG V+ ++ V +K + ++Q + + EC+ L+ + H N+I+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
+F E IV EY G+L +++ + + L + L+ + + A+ ++
Sbjct: 67 -----NFLEDKALMIVMEYAPGGTLAEYIQKRCNSL----LDEDTILHFFVQILLALHHV 117
Query: 824 HHHCHPPIVHGDLKPSNVLLD-HDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTV 882
H I+H DLK N+LLD H MV +GDFG+++ IL + S + + GT
Sbjct: 118 HTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISK---------ILSSKSKAYTVVGTP 165
Query: 883 GYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTD 919
Y++PE G + D+++ G +L E+ + +R +
Sbjct: 166 CYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 29/227 (12%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT-KSFVAECEALRNIRHRN 757
+D+ +IG G+ VY N VA+K ++L++ + E +A+ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSN--DQLEVGNFNVIQRLNLVID 815
++K S F D +V Y+ GSL D + S L+ + + +
Sbjct: 61 VVK--YYTS---FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK-----E 110
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL--PPCSPATILETPS 873
V +EYLH + +H D+K N+LL D + DFG++ L + +T
Sbjct: 111 VLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT-- 165
Query: 874 SSTGIKGTVGYVAPEY---GMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT ++APE G D A D++SFGI +E+ T P
Sbjct: 166 ----FVGTPCWMAPEVMEQVHGYDFKA--DIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 6e-17
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATK---SFVA--ECEALRNIRHRNLIKI 761
+G+G++ VY+ E VA+K + L +R K +F A E + L+ ++H N+I +
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFN--VIQRLNLVIDVAFA 819
+ V F +V+E+ME LE + + L + ++ L
Sbjct: 68 LDV-----FGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLR-------G 114
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+EYLH + I+H DLKP+N+L+ D V + DFGLAR SP + + +
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG--SPNRKM----THQVV- 164
Query: 880 GTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
T Y APE G G D++S G + E+ R
Sbjct: 165 -TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIITV 764
+G G FG V+ G ++ VA+K +N GA + F+ E + + + H L+++ V
Sbjct: 12 LGSGQFGVVHLGKW-RAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
C+ + IV E+ME G L ++L Q G + L++ DV +EYL
Sbjct: 68 CT-----QQKPLYIVTEFMENGCLLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLE 117
Query: 825 HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGY 884
+ +H DL N L+ V V DFG+ R++ + + +SS+G K V +
Sbjct: 118 RN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-------LDDEYTSSSGAKFPVKW 167
Query: 885 VAPEYGMGGDMSATGDVYSFGILLLEMFT 913
PE S+ DV+SFG+L+ E+FT
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 62/211 (29%), Positives = 90/211 (42%), Gaps = 22/211 (10%)
Query: 707 IGQGSFGFVYRG---NLGENEMAVAVKVM-NLKQRGATKSFVAECEALRNIRHRNLIKII 762
+G GSFG V RG G + VAVK + + K F+ E + ++ H NLI++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
V + +V E GSL D L + +G+F + + + +A + Y
Sbjct: 63 GVVLT------HPLMMVTELAPLGSLLDRLRKD----ALGHFLISTLCDYAVQIANGMRY 112
Query: 823 LHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTV 882
L +H DL N+LL D +GDFGL R LP + +K
Sbjct: 113 LESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE-----DHYVMEEHLKVPF 164
Query: 883 GYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ APE S DV+ FG+ L EMFT
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 707 IGQGSFGFVYRG---NL--GENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKI 761
+G+G+FG V+ NL +++M VAVK + A + F E E L ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLH----------QSNDQLEVGNFNVIQRLN 811
VC+ E +V+EYM G L +L D G + Q L
Sbjct: 73 YGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDV-APGQLTLGQMLA 126
Query: 812 LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILET 871
+ +A + YL H VH DL N L+ +V +GDFG++R I T
Sbjct: 127 IASQIASGMVYLAS-LH--FVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYST 175
Query: 872 PSSSTGIKGT--VGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
G + + ++ PE + + D++SFG++L E+FT
Sbjct: 176 DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 40/232 (17%)
Query: 706 MIGQGSFGFVYRG-NLGENEMAVAVKVMNL----------KQRGATKSFVAECEALRNIR 754
+IG+G++G VY N+ EM +AVK + L +Q+ K+ +E E L+++
Sbjct: 8 LIGKGTYGRVYLALNVTTGEM-MAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 755 HRNLIKIITVCSSIDFEEV-DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLV 813
H N+++ + FE ++ +I EY+ GS+ L G F
Sbjct: 67 HLNIVQYL------GFETTEEYLSIFLEYVPGGSIGSCLRTY------GRFEEQLVRFFT 114
Query: 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS 873
V + YLH I+H DLK N+L+D D + + DFG+++ I +
Sbjct: 115 EQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK-----KSDDIYDN-D 165
Query: 874 SSTGIKGTVGYVAPE----YGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921
+ ++G+V ++APE Y G SA D++S G ++LEMF RRP +
Sbjct: 166 QNMSMQGSVFWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 41/229 (17%)
Query: 705 NMIGQGSFGFVYRGNL------GENEMAVAVKVMNLKQRGAT----KSFVAECEALRNIR 754
N +G G+FG VY G G + VAVK + ++GAT K F+ E + N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGN-FNVIQRLNLV 813
H N++K++ VC + + I+ E ME G L +L + + + + L++
Sbjct: 58 HPNIVKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLL-----DHDMVAHVGDFGLARFLPPCSPATI 868
+DVA YL H +H DL N L+ D D V +GDFGLAR +
Sbjct: 113 LDVAKGCVYL-EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-------- 161
Query: 869 LETPSSSTGIKG----TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
S +G V ++APE + G + DV+SFG+L+ E+ T
Sbjct: 162 --YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 30/223 (13%)
Query: 707 IGQGSFGFVYRGNL---GENEMAVAVKVMNLKQRGATK---SFVAECEALRNIRHRNLIK 760
+G+G+FG VY+G L E A +V + LK+ K F E E + +++H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWL--HQSNDQLEVGNFNVIQR--------L 810
++ VC+ +E +++EY+ G L ++L + + + + + + L
Sbjct: 73 LLGVCT----KEQPT-CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
++ I +A +EYL H H VH DL N L+ + + DFGL+R + A
Sbjct: 128 HIAIQIAAGMEYLSSH-H--FVHRDLAARNCLVGEGLTVKISDFGLSRDI---YSADYYR 181
Query: 871 TPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
S S V ++ PE + G + D++SFG++L E+F+
Sbjct: 182 VQSKSL---LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENE---MAVAVKVMNLK--QRGATKSFVAECEALRNIRH 755
++G+G FG V G L +++ + VAVK M L + F++E +++ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 756 RNLIKIITVC-SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
N++K+I VC + +++ ++ +M+ G L +L S + L ++
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
D+A +EYL + +H DL N +L DM V DFGL++ I
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYY 169
Query: 875 STG--IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914
G K V ++A E ++ DV++FG+ + E+ TR
Sbjct: 170 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 28/212 (13%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVM--NLKQRGATKSFVAECEALRNIRHRNLIKIIT 763
++G+G+FG V++G L +++ VAVK +L Q K F++E L+ H N++K+I
Sbjct: 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIG 59
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
VC+ + IV E + G +L + D+L+ Q + +D A + YL
Sbjct: 60 VCT-----QRQPIYIVMELVPGGDFLSFLRKKKDELKTK-----QLVKFALDAAAGMAYL 109
Query: 824 H-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT- 881
+C +H DL N L+ + V + DFG++R + SS+G+K
Sbjct: 110 ESKNC----IHRDLAARNCLVGENNVLKISDFGMSR--------QEDDGIYSSSGLKQIP 157
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ + APE G S+ DV+S+GILL E F+
Sbjct: 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 5e-16
Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 46/226 (20%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIITV 764
IG G++G V VA+K ++ K + E + LR++RH N+I ++ +
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 765 C---SSIDFEEVDFKAIVYEYMECGSLEDWLHQ---SNDQLEVGNFNVI--QRLNLVIDV 816
S DF +V IV E ME D LH+ S L + Q L
Sbjct: 68 LRPPSPEDFNDV---YIVTELME----TD-LHKVIKSPQPLTDDHIQYFLYQILR----- 114
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
++YLH + ++H DLKPSN+L++ + + DFGLAR ++
Sbjct: 115 --GLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLAR---------GVDPDEDEK 160
Query: 877 GIKGTVGYV------APE-YGMGGDMSATGDVYSFGILLLEMFTRR 915
G YV APE + D++S G + E+ TR+
Sbjct: 161 GFL--TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 42/248 (16%)
Query: 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVK------VMNLKQRGATKSFVAECEALR 751
+F IG+G F VY+ + VA+K +M+ K R + + E + L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR---QDCLKEIDLLK 57
Query: 752 NIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLN 811
+ H N+IK + S I+ E++ IV E + G L + Q +
Sbjct: 58 QLDHPNVIKYLA--SFIENNELN---IVLELADAGDLSRMIKHFKKQKRL--IPERTIWK 110
Query: 812 LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILET 871
+ + A+E++H I+H D+KP+NV + V +GD GL RF
Sbjct: 111 YFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF----------- 156
Query: 872 PSSST----GIKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDG 925
SS T + GT Y++PE + G + + D++S G LL EM + P + D
Sbjct: 157 -SSKTTAAHSLVGTPYYMSPERIHENGYNFKS--DIWSLGCLLYEMAALQSP---FYGDK 210
Query: 926 LTLHEFAK 933
+ L+ K
Sbjct: 211 MNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 33/224 (14%)
Query: 707 IGQGSFGFVYRG---NLG--ENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKI 761
+G+G+FG V+ NL +++M VAVK + A K F E E L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWL--HQSNDQLEV--------GNFNVIQRLN 811
VC + D +V+EYM+ G L +L H + + V G + Q L+
Sbjct: 73 YGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 812 LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILET 871
+ +A + YL VH DL N L+ +++ +GDFG++R + T
Sbjct: 128 IASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR--------DVYST 176
Query: 872 PSSSTGIKGT--VGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
G + ++ PE M + DV+SFG++L E+FT
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 8e-16
Identities = 64/214 (29%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 707 IGQGSFGFV--YR---GNLGENEMAVAVKVMNLK-QRGATKSFVAECEALRNIRHRNLIK 760
+G+G FG V Y N G EM VAVK + + + T + E L+ + H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEM-VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
CS + + ++ EY+ GSL D+L + N+ Q L + +
Sbjct: 71 YKGCCSEQGGKGL---QLIMEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQICEGM 120
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
YLH + +H DL NVLLD+D + +GDFGLA+ +P E
Sbjct: 121 AYLHSQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVP-----EGHEYYRVREDGDS 172
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914
V + A E S DV+SFG+ L E+ T
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-15
Identities = 54/177 (30%), Positives = 79/177 (44%), Gaps = 28/177 (15%)
Query: 493 LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSI 552
L L L G IP ++ L++L + LS N IP SL + T+LE L + NS GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 553 PLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRF 612
P +L L S++ L+L+ N+LSG++P L G F
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL-----------------GGRLLHR-----ASF 520
Query: 613 YFTGNKRLCGGLDELHLPVCHSAGPRKTRIALLKVVVPVTVILTIIVACLIVLYTRR 669
FT N LCG +P + GP + A + + V+V +V C + + RR
Sbjct: 521 NFTDNAGLCG------IPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAMCWWKRR 571
|
Length = 623 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKV--MNLKQRGATKSFVAECEALRNIRHRN 757
+F N IG+G++G VYR + VA+K M+ ++ G S + E L N+RH N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYME--CGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
++++ V + + F +V EY E SL D + F+ Q L++
Sbjct: 68 IVELKEVVVGKHLDSI-F--LVMEYCEQDLASLLDNMPTP--------FSESQVKCLMLQ 116
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR-FLPPCSPATILETPSS 874
+ ++YLH + I+H DLK SN+LL + DFGLAR + P P TP
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM----TPKV 169
Query: 875 STGIKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFT 913
T+ Y APE +G T D+++ G +L E+
Sbjct: 170 V-----TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 60/241 (24%), Positives = 93/241 (38%), Gaps = 69/241 (28%)
Query: 707 IGQGSFGFVY---RGNLGENEMAVAVKV-----MNLKQRGATKSFVAECEALRNIRHRNL 758
IG+GSFG V R + G+ + K M K++ + V+E LR ++H N+
Sbjct: 8 IGKGSFGTVRKVRRKSDGK---ILVWKEIDYGNMTEKEK---QQLVSEVNILRELKHPNI 61
Query: 759 IKIITVCSSIDFEEVDFKA----IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRL---- 810
++ +D IV EY E G L +IQ+
Sbjct: 62 VRYYD-------RIIDRSNQTLYIVMEYCEGGDLA---------------QLIQKCKKER 99
Query: 811 -----NLVIDVAFAIEYLHHHCH------PPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859
+ + + + CH ++H DLKP+N+ LD + +GDFGLA+
Sbjct: 100 KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK- 158
Query: 860 LPPCSPATILETPSSSTGIKGTVG---YVAPEYGMGGDMSATGDVYSFGILLLEMFTRRR 916
IL SS K VG Y++PE D++S G L+ E+
Sbjct: 159 --------ILGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208
Query: 917 P 917
P
Sbjct: 209 P 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 34/215 (15%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVM------NLKQRGATKSFVAECEALRNIRHRNLIK 760
IG+G+FG V+ G L + VAVK +LK + F+ E L+ H N+++
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+I VC+ + IV E ++ G +L +L+V + +V + A +
Sbjct: 58 LIGVCT-----QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKEL-----IQMVENAAAGM 107
Query: 821 EYLH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
EYL HC +H DL N L+ V + DFG++R +S+ G+K
Sbjct: 108 EYLESKHC----IHRDLAARNCLVTEKNVLKISDFGMSR-------EEEDGVYASTGGMK 156
Query: 880 GT-VGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
V + APE G S+ DV+SFGILL E F+
Sbjct: 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 704 SNMIGQGSFGFVYRG-NLGENEMAVAVK--VMNLKQRGATKSFVAECEALRNIR---HRN 757
IG+G++G VY+ +L VA+K + L + G S + E L+ + H N
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRF-VALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
+++++ VC + +V+E+++ L + +L+ +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQD-----LATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+++LH H IVH DLKP N+L+ D + DFGLAR I + T
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---------IYSFEMALTS 165
Query: 878 IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
+ T+ Y APE + + D++S G + E+F RRRP
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G G FG V+ G N VAVK + + ++F+ E ++ ++H L+++ V +
Sbjct: 14 LGAGQFGEVWMG-YYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
EE + I+ EYM GSL D+L E G + + ++ +A + Y+
Sbjct: 72 K---EEPIY--IITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVA 886
+ +H DL+ +NVL+ ++ + DFGLAR + ++ G K + + A
Sbjct: 123 NY---IHRDLRAANVLVSESLMCKIADFGLARVIED-------NEYTAREGAKFPIKWTA 172
Query: 887 PEYGMGGDMSATGDVYSFGILLLEMFT 913
PE G + DV+SFGILL E+ T
Sbjct: 173 PEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 36/286 (12%)
Query: 681 LMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT 740
++E+ +VS D K F IGQG+ G VY VA+K MNL+Q+
Sbjct: 4 ILEKLRTIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK 60
Query: 741 KSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLE 800
+ + E +R +H N++ + S + +E+ +V EY+ GSL D + ++ ++
Sbjct: 61 ELIINEILVMRENKHPNIVNYLD--SYLVGDEL---WVVMEYLAGGSLTDVVTET--CMD 113
Query: 801 VGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860
G + R + A+E+LH + ++H D+K N+LL D + DFG
Sbjct: 114 EGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC--- 162
Query: 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920
A I S + + GT ++APE D++S GI+ +EM P N
Sbjct: 163 -----AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
Query: 921 MFNDGLTLHEFA-----KMALPEKVMEI----VDPLLLLDLEARAS 957
N L+ A ++ PEK+ I ++ L +D+E R S
Sbjct: 218 E-NPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITV 764
IG+G+ G V++ E VA+K + L++ G + E +AL+ +H ++K++ V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
F +V EYM L + L L R+ L + Y+H
Sbjct: 68 -----FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK-----GVAYMH 116
Query: 825 HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGY 884
+ I+H DLKP+N+L+ D V + DFGLAR E P + T Y
Sbjct: 117 AN---GIMHRDLKPANLLISADGVLKIADFGLARLFSE-------EEPRLYSHQVATRWY 166
Query: 885 VAPE-------YGMGGDMSATGDVYSFGILL 908
APE Y G D+ A G + F LL
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCI--FAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-15
Identities = 37/88 (42%), Positives = 59/88 (67%)
Query: 393 LNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR 452
++G GL+ L G IP+ I +LR+LQ ++L N++ G+IP SLG++T L LDL +N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 453 GHVPSSLGNCQNLMLLSVSNNKLTGALP 480
G +P SLG +L +L+++ N L+G +P
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 60/226 (26%), Positives = 94/226 (41%), Gaps = 35/226 (15%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA-TKSFVAECEALRNIRHRN 757
+D +G G+ G V + +AVK + L+ A K + E + L
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI--D 815
++ + D +I EYM+ GSL+ L + V R+ I
Sbjct: 61 IVGFYGAF----YNNGDI-SICMEYMDGGSLDKILKE-----------VQGRIPERILGK 104
Query: 816 VAFAI----EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILET 871
+A A+ YLH I+H D+KPSN+L++ + DFG++ L
Sbjct: 105 IAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQL----------V 152
Query: 872 PSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
S + GT Y+APE G D S D++S G+ L+E+ T R P
Sbjct: 153 NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 700 DFSSSN---MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHR 756
++ + ++G+G++G VY ++ +A+K + + + E ++HR
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQS----NDQLEVGNFNVIQRLNL 812
N+++ + S E F I E + GSL L D + F Q L
Sbjct: 66 NIVQYLGSDS-----ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE- 119
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD-HDMVAHVGDFGLARFLPPCSPATILET 871
++YLH + IVH D+K NVL++ + V + DFG ++ L +P T ET
Sbjct: 120 ------GLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT--ET 168
Query: 872 PSSSTGIKGTVGYVAPE---YGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT+ Y+APE G G A D++S G ++EM T + P
Sbjct: 169 ------FTGTLQYMAPEVIDKGPRG-YGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 59/223 (26%), Positives = 92/223 (41%), Gaps = 47/223 (21%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR------HRNLIK 760
IG+G++G VY+ VA+K + L+ S ALR I+ H N+IK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFE----SEGIPKTALREIKLLKELNHPNIIK 62
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
++ V F +V+E+M+ D +I+ + +
Sbjct: 63 LLDV-----FRHKGDLYLVFEFMD----TDLYK------------LIKDRQRGLPESLIK 101
Query: 821 EYLHH------HCHPP-IVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS 873
YL+ CH I+H DLKP N+L++ + V + DFGLAR T
Sbjct: 102 SYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF---GSPVRPYTHY 158
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
T Y APE +G +T D++S G + E+ +RR
Sbjct: 159 VV-----TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 25/219 (11%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G G FG V+ ++ VAVK M + ++F+AE ++ ++H L+K+ V +
Sbjct: 14 LGAGQFGEVWMATYNKH-TKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRL-NLVIDVAFAIEYLHH 825
E + I+ E+M GSL D+L + G+ + +L + +A + ++
Sbjct: 72 K---EPI---YIITEFMAKGSLLDFLKS-----DEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 826 HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYV 885
+ +H DL+ +N+L+ +V + DFGLAR + ++ G K + +
Sbjct: 121 RNY---IHRDLRAANILVSASLVCKIADFGLARVIED-------NEYTAREGAKFPIKWT 170
Query: 886 APEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
APE G + DV+SFGILL+E+ T R P M N
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 707 IGQGSFGFVY---RGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRNLIK 760
I +G++G V+ + + G+ A+KV+ + ++ + E + L + ++K
Sbjct: 1 ISKGAYGRVFLAKKKSTGD---IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+ S F+ +V EY+ G L L VG+ + + ++ A+
Sbjct: 58 L--YYS---FQGKKNLYLVMEYLPGGDLASLLEN------VGSLDEDVARIYIAEIVLAL 106
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
EYLH + I+H DLKP N+L+D + + DFGL++ + + I G
Sbjct: 107 EYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
T Y+APE +G S T D +S G +L E
Sbjct: 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 53/223 (23%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGE----NEMAVAVKVMNLKQRGATKS----FVAECEALRN 752
+ S+++ +G+FG ++ G L + E V VK + + A++ + E L
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV---KDHASEIQVTLLLQESCLLYG 64
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQR--L 810
+ H+N++ I+ VC E+ + ++Y YM G+L+ +L Q + + +
Sbjct: 65 LSHQNILPILHVC----IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
++ I +A + YLH ++H D+ N ++D ++ + D L+R L P ++
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFP------MD 171
Query: 871 TPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
V ++A E + + S+ DV+SFG+LL E+ T
Sbjct: 172 YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 705 NMIGQGSFGFVY----RGNLGEN-EMAVAVKVMNLKQRGATKS-FVAECEALRNIRHRNL 758
+G G+FG VY RG G+ E+ VAVK + +S F+ E + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRL-NLVIDVA 817
+++I V FE + + I+ E M G L+ +L ++ + E + ++ L DVA
Sbjct: 72 VRLIGVS----FERLP-RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDH---DMVAHVGDFGLARFLPPCSPATILETPSS 874
+YL + +H D+ N LL VA + DFG+AR I
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--------DIYRASYY 175
Query: 875 STGIKGT--VGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
G + + ++ PE + G ++ DV+SFG+LL E+F+
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 25/225 (11%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNL---------KQRGATKSFVAECEALRNIRHR 756
+IG GSFG VY G + +AVK + L ++R + E L+ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
N+++ + SS+D + ++ I EY+ GS+ L+ G F N V +
Sbjct: 67 NIVQYLG--SSLDADHLN---IFLEYVPGGSVAALLNN------YGAFEETLVRNFVRQI 115
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
+ YLH+ I+H D+K +N+L+D+ + DFG+++ L S +T S
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS- 171
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921
++G+V ++APE + D++S G L++EM T + P +
Sbjct: 172 -LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 706 MIGQGSFGFV-------YRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
+G+G+FG V + N GE VAVK + + F E E L++++H N+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGE---VVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
+K VC S + +V EY+ GSL D+L + ++L+ + L +
Sbjct: 68 VKYKGVCYSAGRRNL---RLVMEYLPYGSLRDYLQKHRERLDH-----RKLLLYASQICK 119
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+EYL + VH DL N+L++ + +GDFGL + LP + P S
Sbjct: 120 GMEYLGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES--- 173
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ + APE S DV+SFG++L E+FT
Sbjct: 174 --PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 706 MIGQGSFGFVYRGNL---GEN-EMAVAVKVMNLKQRGATKSFVAECE---ALRNIRHRNL 758
++G G FG V++G G++ ++ VA+K ++ R ++F + A+ ++ H +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRL-NLVIDVA 817
++++ +C + +V + GSL D + Q D L+ QRL N + +A
Sbjct: 72 VRLLGICPGASLQ------LVTQLSPLGSLLDHVRQHRDSLDP------QRLLNWCVQIA 119
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+ YL H +VH +L N+LL D + + DFG+A L P
Sbjct: 120 KGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE------ 170
Query: 878 IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
K + ++A E + G + DV+S+G+ + EM +
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 26/224 (11%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAEC--EA--LRNIRH 755
DF N IG+GSFG V++ ++ A+K ++L + E EA L +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL--SKMNRREREEAIDEARVLAKLDS 58
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
+I+ F + IV EY E G L L + + Q I
Sbjct: 59 SYIIRYYE-----SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPED----QVWRFFIQ 109
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+ + +LH I+H D+K N+ LD +GD G+A+ L S T +
Sbjct: 110 ILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNF-----A 158
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTD 919
I GT Y++PE + DV++ G++L E T + P D
Sbjct: 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-----RGATKSFVAECEALRNIRHRNLIK 760
++GQG+FG VY + +AVK + + + E + L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
C D + +I EYM GS++D L E V ++ I +
Sbjct: 69 YYG-CLRDD----ETLSIFMEYMPGGSVKDQLKAYGALTE----TVTRKYTRQI--LEGV 117
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK- 879
EYLH + IVH D+K +N+L D +GDFG ++ L TI SS TG+K
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL-----QTIC---SSGTGMKS 166
Query: 880 --GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT +++PE G DV+S G ++EM T + P
Sbjct: 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 32/248 (12%)
Query: 707 IGQGSFGFVY---RGNLGENEMAVA-VKVMNLKQRGATK-------SFVAECEALR-NIR 754
+G G+FG VY + N G+N +A+ + V N + V+E ++ +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
H N+++ F E D IV + +E L + H ++ + + F + N+ +
Sbjct: 68 HPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTEERIWNIFV 120
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
+ A+ YLH IVH DL P+N++L D + DFGLA+ P S
Sbjct: 121 QMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP---------ESK 169
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP--TDNMFNDGLTLHEFA 932
T + GT+ Y PE DV++FG +L +M T + P + NM + + E
Sbjct: 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229
Query: 933 KMALPEKV 940
LPE +
Sbjct: 230 YEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 57/214 (26%), Positives = 84/214 (39%), Gaps = 24/214 (11%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRNLIKIIT 763
+G+G FG V + A K ++ LK+R + + E + L + R
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
V + FE D +V M G L+ ++ + F + + + +E+L
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEP----GFPEARAIFYAAQIICGLEHL 111
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
H IV+ DLKP NVLLD + D GLA L G GT G
Sbjct: 112 HQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---------IKGRAGTPG 159
Query: 884 YVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
Y+APE G + D ++ G L EM R P
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 28/221 (12%)
Query: 705 NMIGQGSFGFVYRGNLGEN---EMAVAVKVMN-LKQRGATKSFVAECEALRNIRHRNLIK 760
+IG+G FG VY G L ++ ++ AVK +N + + F+ E +++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
++ +C +V YM+ G L +++ E N V + + VA +
Sbjct: 61 LLGIC----LPSEGSPLVVLPYMKHGDLRNFIRS-----ETHNPTVKDLIGFGLQVAKGM 111
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE----TPSSST 876
EYL VH DL N +LD V DFGLAR I + + + T
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHT 160
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
G K V ++A E + DV+SFG+LL E+ TR P
Sbjct: 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 24/231 (10%)
Query: 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVK-VMNLKQR-GATKSFVAECEALRNIR 754
D+ +G+G+FG VY+ + VA+K ++ ++ G + + E + L+ ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVY---EYME---CGSLEDWLHQSNDQLEVGNFNVIQ 808
H N++ +I + + + VY YM+ G LE N + Q
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE------NPSV---KLTESQ 116
Query: 809 RLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL---PPCSP 865
++ + I YLH + I+H D+K +N+L+D+ + + DFGLAR PP
Sbjct: 117 IKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 866 ATILETPSSSTGIKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
T + T Y PE +G T D++ G + EMFTRR
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 60/237 (25%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVK---VMNLKQRGATKSFVAECEALRNIRHR 756
+F IG+G F VYR + + VA+K + +L A + E + L+ + H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
N+IK S I+ E++ IV E + G L + Q + + + + +
Sbjct: 63 NVIKYYA--SFIEDNELN---IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY--FVQL 115
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
A+E++H ++H D+KP+NV + V +GD GL RF +++
Sbjct: 116 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS--------SKTTAAH 164
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933
+ GT Y++PE + D++S G LL EM + P + D + L+ K
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 28/215 (13%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT----KSFVAECEALRNIRHRNLIKI 761
++G+G++G V + VA+K K+ K+ + E + LR +RH N++ +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
F +V+EY+E LE L S L + ++ + + AI
Sbjct: 66 KEA-----FRRKGRLYLVFEYVERTLLEL-LEASPGGLPP---DAVRSY--IWQLLQAIA 114
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
Y H H I+H D+KP N+L+ V + DFG AR L PA+ L T T
Sbjct: 115 YCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARAL-RARPASPL------TDYVAT 164
Query: 882 VGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
Y APE +G DV++ G ++ E+
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 706 MIGQGSFGFVYRGNL---GENEMAVAVKVM----NLKQRGATKSFVAECEALRNIRHRNL 758
++G G FG + RG L + E+ VA+ + + KQR + F+AE L H N+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR---RGFLAEALTLGQFDHSNI 68
Query: 759 IK---IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
++ +IT +++ IV EYM G+L+ +L + QL G Q + ++
Sbjct: 69 VRLEGVITRGNTM--------MIVTEYMSNGALDSFLRKHEGQLVAG-----QLMGMLPG 115
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+A ++YL + VH L VL++ D+V + F E ++
Sbjct: 116 LASGMKYLSEMGY---VHKGLAAHKVLVNSDLVCKISGFRRL-------QEDKSEAIYTT 165
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLE-MFTRRRPTDNMFN 923
K V + APE S+ DV+SFGI++ E M RP +M
Sbjct: 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSF-VA----ECEALRNIRHRNLIK 760
+IG+G++G VYRG VA+K++NL T V+ E L +R
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQSQPPN 63
Query: 761 IITVCSS-IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
I S + + I+ EY E GS+ + + +VI R LV A
Sbjct: 64 ITKYYGSYLKGPRL---WIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLV-----A 113
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
++Y+H ++H D+K +N+L+ + + DFG+A A + + S +
Sbjct: 114 LKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVA--------ALLNQNSSKRSTFV 162
Query: 880 GTVGYVAPEYGMGGDM-SATGDVYSFGILLLEMFTRRRP 917
GT ++APE G D++S GI + EM T P
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 49/224 (21%)
Query: 707 IGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-------HRNL 758
+G G+FG VY N E+ VA+K M K++ + EC LR ++ H N+
Sbjct: 7 LGDGTFGSVYLARNKETGEL-VAIKKM--KKKFYSWE---ECMNLREVKSLRKLNEHPNI 60
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
+K+ V + +E+ F V+EYME L+Q + F+ +++ +
Sbjct: 61 VKLKEVF--RENDELYF---VFEYMEGN-----LYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+ ++H H H DLKP N+L+ V + DFGLAR + P T + S
Sbjct: 111 GLAHIHKHGF---FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT--DYVS----- 160
Query: 879 KGTVGYVAPE-------YGMGGDMSATGDVYSFGILLLEMFTRR 915
T Y APE Y S+ D+++ G ++ E++T R
Sbjct: 161 --TRWYRAPEILLRSTSY------SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-13
Identities = 76/233 (32%), Positives = 108/233 (46%), Gaps = 34/233 (14%)
Query: 372 SSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGEL-RNLQVLDLHHNNLDGH 430
S + L + N + L NL L+ N +T IP IG L NL+ LDL N +
Sbjct: 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ES 154
Query: 431 IPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLS 490
+P L NL L +LDL FN L +P L N NL L +S NK++ LPP+I + L
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE 212
Query: 491 ILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTG 550
L DLS N + + + + NLKNL L LS N+ +
Sbjct: 213 EL-DLSNNSII-ELLSSLSNLKNLSGLELSNNKLED------------------------ 246
Query: 551 SIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRR 603
+P ++ L +++ LDLS N +S L +L+ L L+LS N L +P
Sbjct: 247 -LPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLI 296
|
Length = 394 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 707 IGQGSFGFVYRG---NL--GENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKI 761
+G+G+FG V+ NL ++++ VAVK + A K F E E L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQ---LEVGN----FNVIQRLNLVI 814
VC E D +V+EYM+ G L +L + GN Q L++
Sbjct: 73 YGVCV-----EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
+A + YL VH DL N L+ +++ +GDFG++R + T
Sbjct: 128 QIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR--------DVYSTDYY 176
Query: 875 STGIKGT--VGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
G + ++ PE M + DV+S G++L E+FT
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMN----LKQRGATKSFVAECEALRNIRHRN 757
+GQGSFG VY GN GE E VAVK +N L++R F+ E ++ +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHH 70
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
+++++ V S + +V E M G L+ +L + E L +I +A
Sbjct: 71 VVRLLGVVS-----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125
Query: 818 FAIE----YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS 873
I YL+ VH DL N ++ HD +GDFG+ R I ET
Sbjct: 126 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDY 174
Query: 874 SSTGIKG--TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
G KG V ++APE G + + D++SFG++L E+ +
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 63/237 (26%), Positives = 89/237 (37%), Gaps = 52/237 (21%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSF---VAECEALRNIRHRN 757
F+ IG GSFG VY VA+K M+ + + + + + E L+ +RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 758 LIKIITVCSSIDFEEVDFKA---------IVYEYMEC-GSLEDWLHQSNDQLEVGNFNVI 807
I ++K +V EY C GS D L L+ I
Sbjct: 77 TI--------------EYKGCYLREHTAWLVMEY--CLGSASDILEVHKKPLQEVEIAAI 120
Query: 808 QRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPAT 867
+ YLH H +H D+K N+LL + DFG A SPA
Sbjct: 121 -----CHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASL---VSPA- 168
Query: 868 ILETPSSSTGIKGTVGYVAPEYGMG---GDMSATGDVYSFGILLLEMFTRRRPTDNM 921
GT ++APE + G DV+S GI +E+ R+ P NM
Sbjct: 169 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 65/227 (28%), Positives = 102/227 (44%), Gaps = 35/227 (15%)
Query: 706 MIGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGATKS---FVAECEALRNI-RHR 756
+G+G+FG V + VAVK+ LK K V+E E ++ I +H+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNV----IQRLNL 812
N+I ++ VC+ +E +V EY G+L D+L E + + + L
Sbjct: 77 NIINLLGVCT----QEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 813 VIDVAFA------IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPA 866
V+FA +E+L +H DL NVL+ D V + DFGLAR +
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI--- 185
Query: 867 TILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ +T + V ++APE + DV+SFG+LL E+FT
Sbjct: 186 ---DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-13
Identities = 41/111 (36%), Positives = 61/111 (54%), Gaps = 19/111 (17%)
Query: 350 LEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPH 409
++ LGLD G +P I+ L ++L ++N L N + G IP
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKL----------------RHLQSIN---LSGNSIRGNIPP 460
Query: 410 AIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLG 460
++G + +L+VLDL +N+ +G IPESLG LT L L+L N L G VP++LG
Sbjct: 461 SLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 21/223 (9%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVK--VMNLKQRGATKSFVAECEALRNIRHR 756
+ + IGQG+FG V++ + + VA+K +M ++ G + + E + L+ ++H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYME-CG-SLEDWLHQSNDQLEVGNFNVI--QRLNL 812
N++ +I +C + +K Y E C L L N + + + LN
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN- 130
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP 872
+ Y+H + I+H D+K +N+L+ D + + DFGLAR S + P
Sbjct: 131 ------GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR---AFSLSKN-SKP 177
Query: 873 SSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTR 914
+ T T+ Y PE +G D D++ G ++ EM+TR
Sbjct: 178 NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 707 IGQGSFGFVY------RG-NLGENEMAVAVKVMNLKQRGA-TKSFVAECEALRNIRHRNL 758
+G+G FG V G N GE VAVK + + G E E LRN+ H N+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGE---QVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 759 IKIITVCSSIDFEEVDFK-AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
+K +C+ E+ ++ E++ GSL+++L ++ +++ N+ Q+L + +
Sbjct: 69 VKYKGICT----EDGGNGIKLIMEFLPSGSLKEYLPRNKNKI-----NLKQQLKYAVQIC 119
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
++YL + VH DL NVL++ + +GDFGL + + T E +
Sbjct: 120 KGMDYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDKEYYTVKDD 171
Query: 878 IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ V + APE + DV+SFG+ L E+ T
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 23/219 (10%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
F +G+GS+G VY+ E VA+KV+ ++ + + E L+
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPY- 59
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
I+ S F+ D IV EY GS+ D + +N L I
Sbjct: 60 --IVKYYGSY-FKNTDL-WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILY-----QTLK 110
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+EYLH + +H D+K N+LL+ + A + DFG++ + +T + +
Sbjct: 111 GLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS--------GQLTDTMAKRNTV 159
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT ++APE + D++S GI +EM + P
Sbjct: 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 42/227 (18%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNL--KQRGATKSFVAECEALRNIRHRNL 758
F IG+G++G VY+ VA+K + L + G + + E L+ + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 759 IKIITVCSS-------IDFEEVDFKAIVYEYMECGSLEDW-LHQSNDQLEVGNFNVIQRL 810
+K++ V + +F D K ++M+ L L L F ++Q
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQDLK----KFMDASPLSGIPLPLIKSYL----FQLLQ-- 111
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR-FLPPCSPATIL 869
+ + H H ++H DLKP N+L++ + + DFGLAR F P
Sbjct: 112 --------GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV------ 154
Query: 870 ETPSSSTGIKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
+ T T+ Y APE +G +T D++S G + EM TRR
Sbjct: 155 ---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-13
Identities = 80/273 (29%), Positives = 119/273 (43%), Gaps = 15/273 (5%)
Query: 326 SKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQI 385
S + L I LD +L N L +L L+ N + L++ L N
Sbjct: 71 SLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT 129
Query: 386 YVKNLVNLNGFGLEYNQLTGP----IPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTIL 441
+ L+ L L+ L+ +P + L NL+ LDL N+L +P+ L NL+ L
Sbjct: 130 DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188
Query: 442 NSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLT 501
N+LDL NK+ +P + L L +SNN + L + L+LS N L
Sbjct: 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIEL--LSSLSNLKNLSGLELSNNKLE 245
Query: 502 GSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKS 561
+P +GNL NL L LS N+ S+ SL + T L L + GNSL+ ++PL L
Sbjct: 246 -DLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALPLIALLLLL 302
Query: 562 IKELDLSRNNLSGQIPEFLENLSFLEYLNLSYN 594
++ L L L+ S L N+ N
Sbjct: 303 LELLLNLLLTL---KALELKLNSILLNNNILSN 332
|
Length = 394 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 700 DFSSSNMIGQGSFGFVYRG---NLGENEMAVAVKVMNLKQRGA-TKSFVAECEALRNIRH 755
D + IG+G FG VY+G + ++AVAVK + + F+ E +R H
Sbjct: 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI- 814
+++K+I V + IV E G L +L + L++ L L
Sbjct: 67 PHIVKLIGVI------TENPVWIVMELAPLGELRSYLQVNKYSLDLA------SLILYSY 114
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
++ A+ YL VH D+ NVL+ +GDFGL+R+L S +
Sbjct: 115 QLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK------A 165
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914
S G K + ++APE ++ DV+ FG+ + E+
Sbjct: 166 SKG-KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 66/269 (24%), Positives = 101/269 (37%), Gaps = 53/269 (19%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
I +G+FG VY A+KV+ K K+ V +A R I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLK-KSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 767 SIDFEEVDFKAIVYEYM---ECGSL--------EDWLHQSNDQLEVGNFNVIQRLNLVID 815
F+ D+ +V EY+ +C SL EDW Q + +
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQ-----------------YIAE 105
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
V +E LH I+H D+KP N+L+D + DFGL+R LE
Sbjct: 106 VVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR--------NGLENKK-- 152
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPT---------DNMFNDGL 926
GT Y+APE +G D +S G ++ E P DN+ + +
Sbjct: 153 --FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI 210
Query: 927 TLHEFAKMALPEKVMEIVDPLLLLDLEAR 955
E K + +++++ LL +D R
Sbjct: 211 NWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 7e-13
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 37/221 (16%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVK--VMNLKQRGATKSFVAECEALRNIRHRNLIKI- 761
N I +G++G VYR + VA+K M ++ G + + E L ++H N++ +
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 762 -ITVCSSID--FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEV--GNFNVIQRLNLVIDV 816
+ V S++D + +V EY+E H +E F + L++ +
Sbjct: 71 EVVVGSNLDKIY-------MVMEYVE--------HDLKSLMETMKQPFLQSEVKCLMLQL 115
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR-FLPPCSPATILETPSSS 875
+ +LH + I+H DLK SN+LL++ + + DFGLAR + P P T L
Sbjct: 116 LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV---- 168
Query: 876 TGIKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
T+ Y APE +G +T D++S G + E+ T++
Sbjct: 169 -----TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-13
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 40/223 (17%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA-ECEALRNIRHRNLIKIIT 763
N IG G+ G VY+ A+KV+ + + E E LR++ H N++K
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--- 136
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF----A 819
C + F+ ++ E+M+ GSLE D+ + DVA
Sbjct: 137 -CHDM-FDHNGEIQVLLEFMDGGSLEG--THIADEQFLA------------DVARQILSG 180
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
I YLH IVH D+KPSN+L++ + DFG++R L A ++ +SS
Sbjct: 181 IAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL-----AQTMDPCNSSV--- 229
Query: 880 GTVGYVAPE-----YGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT+ Y++PE G GD++S G+ +LE + R P
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIRHRNLIKIIT 763
+G G FG V + A+K + + + G + +E E L H ++K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
+ D + + + EY G L L + G F+ + V A EYL
Sbjct: 59 YRTFKDKKYIYM---LMEYCLGGELWTILR------DRGLFDEYTARFYIACVVLAFEYL 109
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
H+ I++ DLKP N+LLD + + DFG A+ L++ + GT
Sbjct: 110 HNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAK---------KLKSGQKTWTFCGTPE 157
Query: 884 YVAPE--YGMGGDMSATGDVYSFGILLLEMFTRRRP 917
YVAPE G D S D +S GILL E+ T R P
Sbjct: 158 YVAPEIILNKGYDFSV--DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 43/229 (18%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIRHRN 757
D++ IG+G++G VY+G + VA+K + L+ + G + + E L+ ++H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
++ + V +E +++E++ L+ +L D L G + +D
Sbjct: 61 IVCLQDVL----MQESRL-YLIFEFLSM-DLKKYL----DSLPKGQY---------MDAE 101
Query: 818 FAIEYLHH------HCHPP-IVHGDLKPSNVLLDHDMVAHVGDFGLAR-FLPPCSPAT-- 867
YL+ CH ++H DLKP N+L+D+ V + DFGLAR F P T
Sbjct: 102 LVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHE 161
Query: 868 ILETPSSSTGIKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
++ T+ Y APE +G +T D++S G + EM T++
Sbjct: 162 VV-----------TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 21/221 (9%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVK---VMNLKQRGATKSFVAECEALRNIRHR 756
+F IG+G F VYR + VA+K + + A + V E + L+ + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
N+IK + S I+ E++ IV E + G L + Q + + + + +
Sbjct: 63 NVIKYLD--SFIEDNELN---IVLELADAGDLSQMIKYFKKQKRLIPERTVWKY--FVQL 115
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
A+E++H ++H D+KP+NV + V +GD GL RF S T +++
Sbjct: 116 CSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKT-----TAAH 164
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
+ GT Y++PE + D++S G LL EM + P
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT-KSFVAECEA----LRNIRHRNLIK 760
++G GSFG VY G ++ AVK ++L G T + V + E L ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 761 II-TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
+ T D I E + GSL L + G+F +
Sbjct: 67 YLGTEREE------DNLYIFLELVPGGSLAKLLK------KYGSFPEPVIRLYTRQILLG 114
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+EYLH VH D+K +N+L+D + V + DFG+A+ + S + K
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK---------QVVEFSFAKSFK 162
Query: 880 GTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRP 917
G+ ++APE G D++S G +LEM T + P
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 32/82 (39%), Positives = 53/82 (64%), Gaps = 1/82 (1%)
Query: 160 LVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQ 219
L G IP DI L+ ++L N + G + PS+G+I++L+VL + N +G +P+SLGQ
Sbjct: 430 LRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 220 LRSLYYLSISENAFSGMFPSSI 241
L SL L+++ N+ SG P+++
Sbjct: 489 LTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIR---HRNLIKI 761
IG G++G VY+ + VA+K + ++ + G S V E L+ + H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
+ VC++ + +V+E+++ L +L D++ +L+ ++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVD-QDLRTYL----DKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
+LH +C IVH DLKP N+L+ + DFGLAR I + T + T
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR---------IYSCQMALTPVVVT 170
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
+ Y APE + + D++S G + EMF RR+P
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 64/231 (27%), Positives = 97/231 (41%), Gaps = 36/231 (15%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN------LKQRGATKSFVAECEALRNI 753
D +G G+FG V+ +E A+KVM LKQ + E L+ +
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKEV 58
Query: 754 RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLV 813
H +I++ + D F ++ EY+ G L +L S G F+ L
Sbjct: 59 SHPFIIRLF--WTEHD---QRFLYMLMEYVPGGELFSYLRNS------GRFSNSTGLFYA 107
Query: 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS 873
++ A+EYLH IV+ DLKP N+LLD + + DFG A+ +
Sbjct: 108 SEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK-----------KLRD 153
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP--TDNMF 922
+ + GT Y+APE + D ++ GIL+ EM P DN F
Sbjct: 154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF 204
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 54/232 (23%), Positives = 98/232 (42%), Gaps = 39/232 (16%)
Query: 701 FSSSNM-----IGQGSFGFVYRGNLGEN-----EMAVAVKVMN-LKQRGATKSFVAECEA 749
F SN+ +G+G FG V+ E V VK + K F E +
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 750 LRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQS---NDQLEVGNFNV 806
R + H+N+++++ +C E + ++ EY + G L+ +L + +++L+ +
Sbjct: 62 FRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 807 IQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPA 866
Q++ L +A +++L + VH DL N L+ V L++
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK-------- 165
Query: 867 TILETPSSSTGIK-----GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+S K + ++APE D S DV+SFG+L+ E+FT
Sbjct: 166 ----DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 31/228 (13%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGE--NEMAVAVKVMN-LKQRGATKSFVAECEALRNI-RH 755
D ++IG+G+FG V R + + +M A+K++ + F E E L + H
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQS----------NDQLEVGNFN 805
N+I ++ C E + I EY G+L D+L +S +
Sbjct: 63 PNIINLLGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117
Query: 806 VIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSP 865
Q L DVA ++YL +H DL NVL+ ++ + + DFGL+R
Sbjct: 118 SQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK 174
Query: 866 ATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
T+ P V ++A E + DV+SFG+LL E+ +
Sbjct: 175 KTMGRLP---------VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 30/226 (13%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNL--KQRGATKSFVAECEALRNIRHRNL 758
F IG+G++G VY+ + VA+K + L ++ G + + E + LR + HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 759 IKIITVCSSIDFEEVDFKA------IVYEYMECGSLEDWLHQSNDQLEVG--NFNVIQRL 810
+ + + + + +DFK +V+EYM+ H LE G +F+
Sbjct: 69 VNLKEIVTD-KQDALDFKKDKGAFYLVFEYMD--------HDLMGLLESGLVHFSEDHIK 119
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
+ + + + Y H +H D+K SN+LL++ + DFGLAR E
Sbjct: 120 SFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLY-------NSE 169
Query: 871 TPSSSTGIKGTVGYVAPEYGMGGDM-SATGDVYSFGILLLEMFTRR 915
T T+ Y PE +G + DV+S G +L E+FT++
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 63/234 (26%), Positives = 105/234 (44%), Gaps = 35/234 (14%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMN----LKQRGATKSFVAECEALRNIRHRN 757
+GQGSFG VY G E E VA+K +N +++R F+ E ++ +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRER---IEFLNEASVMKEFNCHH 70
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI--- 814
+++++ V S + ++ E M G L+ +L ++E L +I
Sbjct: 71 VVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125
Query: 815 -DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS 873
++A + YL+ + VH DL N ++ D +GDFG+ R I ET
Sbjct: 126 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYETDY 174
Query: 874 SSTGIKG--TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFND 924
G KG V +++PE G + DV+SFG++L E+ T +P M N+
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVM--NLKQRGATKSFVAECEALRNIRHRNLIKIIT 763
++G+GS+G V + E VA+K + + K + E L+ +RH NL+ +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
V F +V+E+++ L+D N + + +++ + + IE+
Sbjct: 68 V-----FRRKKRLYLVFEFVDHTVLDDLEKYPNGL----DESRVRKY--LFQILRGIEFC 116
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
H H I+H D+KP N+L+ V + DFG AR L +P + T T
Sbjct: 117 HSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVY------TDYVATRW 165
Query: 884 YVAPEYGMGGDMS--ATGDVYSFGILLLEMFT 913
Y APE + GD D+++ G L+ EM T
Sbjct: 166 YRAPEL-LVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 76/286 (26%), Positives = 128/286 (44%), Gaps = 36/286 (12%)
Query: 681 LMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT 740
++E+ +VS D K F IGQG+ G VY VA++ MNL+Q+
Sbjct: 5 ILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 741 KSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLE 800
+ + E +R ++ N++ + S + +E+ +V EY+ GSL D + ++ ++
Sbjct: 62 ELIINEILVMRENKNPNIVNYLD--SYLVGDEL---WVVMEYLAGGSLTDVVTETC--MD 114
Query: 801 VGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860
G + R L A+E+LH + ++H D+K N+LL D + DFG
Sbjct: 115 EGQIAAVCRECLQ-----ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC--- 163
Query: 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920
A I S + + GT ++APE D++S GI+ +EM P N
Sbjct: 164 -----AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
Query: 921 MFNDGLTLHEFA-----KMALPEKVMEI----VDPLLLLDLEARAS 957
N L+ A ++ PEK+ I ++ L +D+E R S
Sbjct: 219 E-NPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 46/223 (20%)
Query: 707 IGQGSFGFVYRG-NLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIIT 763
IG+G++G VY+ + E+ VA+K + L+ G + + E L+ + H N+++++
Sbjct: 7 IGEGTYGVVYKARDKLTGEI-VALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 764 VCSS-------IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
V S +F ++D K +YM+ D + ++ + Q L
Sbjct: 66 VVHSENKLYLVFEFLDLDLK----KYMDSSP-----LTGLDPPLIKSY-LYQLLQ----- 110
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR-FLPPCSPAT--ILETPS 873
I Y H H ++H DLKP N+L+D + + DFGLAR F P T ++
Sbjct: 111 --GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV---- 161
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
T+ Y APE +G +T D++S G + EM RR
Sbjct: 162 -------TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 35/227 (15%)
Query: 707 IGQGSFGFVYRG-----NLGENEMAVAVKVMNLKQRGATKSF---VAECEALRNI-RHRN 757
+G+G FG V R + + V V V LK K ++E E ++ I +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQR-------- 809
+I ++ VC+ +E IV EY G+L ++L F++ +
Sbjct: 80 IINLLGVCT----QEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 810 --LNLVIDVAFAIEYLH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPA 866
++ VA +EYL C +H DL NVL+ D V + DFGLAR +
Sbjct: 135 DLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGV-----H 185
Query: 867 TILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
I +S G + V ++APE + DV+SFGIL+ E+FT
Sbjct: 186 DIDYYKKTSNG-RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 27/220 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNL-KQRGATKSFVAECEALRNIRHRNLIKIITVC 765
+G+G++ VY+G VA+K ++L + G + + E ++ ++H N++++ V
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV- 66
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
I E + +V+EYM+ L+ ++ + G + + + I + H
Sbjct: 67 --IHTE--NKLMLVFEYMD-KDLKKYMDTHGVR---GALDPNTVKSFTYQLLKGIAFCHE 118
Query: 826 HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR-FLPPCSPATILETPSSSTGIKGTVGY 884
+ ++H DLKP N+L++ + DFGLAR F P + T S+ T+ Y
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN------TFSNEV---VTLWY 166
Query: 885 VAPEYGMGGDMSATG-DVYSFGILLLEMFTRR---RPTDN 920
AP+ +G +T D++S G ++ EM T R T+N
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-11
Identities = 44/138 (31%), Positives = 67/138 (48%), Gaps = 9/138 (6%)
Query: 39 ALLAIKSQLQDPLGVTSSWNNSMNLCQ---WTGVTCG----HRHQRVTVLDLSNRSIEGI 91
AL +KS L PL WN + Q W+G C + L L N+ + G
Sbjct: 376 ALQTLKSSLGLPLRF--GWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGF 433
Query: 92 LSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLI 151
+ + L L+ IN + N G IP +G + LE L L+ NSF+G IP +L + ++L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 152 NFHARGNNLVGQIPPDIG 169
+ GN+L G++P +G
Sbjct: 494 ILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-11
Identities = 72/222 (32%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTI-LNSLDLGFNKLRGHVP 456
L N+L I + EL NL LDL +NN+ IP +G L L LDL NK+ +P
Sbjct: 100 LNLNRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLP 156
Query: 457 SSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQ 516
S L N NL L +S N L+ +P + NL NL
Sbjct: 157 SPLRNLPNLKNLDLSFNDLS--------------------------DLPKLLSNLSNLNN 190
Query: 517 LGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQI 576
L LS N+ S+ +P + + LE L + NS+ + +L LK++ L+LS NN +
Sbjct: 191 LDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS-NNKLEDL 247
Query: 577 PEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNK 618
PE + NLS LE L+LS N + + G +N +GN
Sbjct: 248 PESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNS 288
|
Length = 394 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 26/219 (11%)
Query: 707 IGQGSFGFVYRGNLGENE--MAVAVKVMNLK--QRGATKSFVAECEALRNIRHRNLIKII 762
+G+G FG V G L +++ + VAVK M + R + F++E ++ H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 763 TVC-SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGN---FNVIQRL-NLVIDVA 817
VC +++ E ++ +M+ G L +L S +G+ + Q L + D+A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS----RLGDCPQYLPTQMLVKFMTDIA 122
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+EYL +H DL N +L+ +M V DFGL++ I G
Sbjct: 123 SGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSK--------KIYNGDYYRQG 171
Query: 878 --IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914
K V ++A E + DV+SFG+ + E+ TR
Sbjct: 172 RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 1e-11
Identities = 81/293 (27%), Positives = 122/293 (41%), Gaps = 99/293 (33%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA---ECEALRNIR--------- 754
+G+G++G V++ + VA+K K F A +A R R
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQELG 64
Query: 755 -HRNLIKIITVCSSIDFEEVDFKA-------IVYEYMECGSLEDWLHQSNDQLEVGNFNV 806
H N++K++ V KA +V+EYME D LH V
Sbjct: 65 DHPNIVKLLNV----------IKAENDKDIYLVFEYME----TD-LH-----------AV 98
Query: 807 IQRLNLVIDV---------AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857
I R N++ DV A++Y+H ++H DLKPSN+LL+ D + DFGLA
Sbjct: 99 I-RANILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA 154
Query: 858 RFLPPCSPATILETPSSS--TGIKGTVGYVAPE-------YGMGGDMSATGDVYSFGILL 908
R S + + E P + T T Y APE Y G DM +S G +L
Sbjct: 155 R-----SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDM------WSVGCIL 203
Query: 909 LEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGS 961
EM +P +F TL++ EK++E++ P D+E+ S +
Sbjct: 204 GEML-LGKP---LFPGTSTLNQL------EKIIEVIGPPSAEDIESIKSPFAA 246
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 58/235 (24%), Positives = 89/235 (37%), Gaps = 62/235 (26%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
F+ IG+GSFG VY+ VA+KV++L+ EA I ++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE------------EAEDEIE--DI 46
Query: 759 IKIITVCSSIDFEEV---------DFK-AIVYEYMECGSLEDWLHQSNDQLEVGNFN--- 805
+ I S + K I+ EY GS D L + G +
Sbjct: 47 QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-------KPGKLDETY 99
Query: 806 --VIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863
I R +V +EYLH +H D+K +N+LL + + DFG++ L
Sbjct: 100 IAFILR-----EVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQL--- 148
Query: 864 SPATILETPSSSTGIK-----GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ST K GT ++APE D++S GI +E+
Sbjct: 149 ----------TSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 38/231 (16%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLI 759
+ IG+GS G V VAVK M+L+++ + E +R+ +H N++
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
++ + S + +E+ +V E++E G+L D + + E Q + + V A
Sbjct: 80 EMYS--SYLVGDEL---WVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLAVLKA 127
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+ +LH ++H D+K ++LL D + DFG C+ + E P + +
Sbjct: 128 LSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGF------CAQVSK-EVPRRKS-LV 176
Query: 880 GTVGYVAPE------YGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFND 924
GT ++APE YG D++S GI+++EM P FN+
Sbjct: 177 GTPYWMAPEVISRLPYG------TEVDIWSLGIMVIEMVDGEPP---YFNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 24/208 (11%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG G++G VY+ VA+KV+ L+ + E L+ RH N++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG--- 67
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
+ D IV EY GSL+D + L + R L + YLH
Sbjct: 68 --SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK-----GLAYLHET 120
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVA 886
+H D+K +N+LL D + DFG++ A + T + GT ++A
Sbjct: 121 ---GKIHRDIKGANILLTEDGDVKLADFGVS--------AQLTATIAKRKSFIGTPYWMA 169
Query: 887 PEYG---MGGDMSATGDVYSFGILLLEM 911
PE G D+++ GI +E+
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 1/95 (1%)
Query: 440 ILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNL 499
++ L L LRG +P+ + ++L +++S N + G +PP + I +L +L DLS N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL-DLSYNS 477
Query: 500 LTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSA 534
GSIP +G L +L L L+ N S +P +L
Sbjct: 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 28/223 (12%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNL-----KQRGATKSFVAECEALRNIR 754
DF +G+GS+G VY+ + A+K ++L K+R V E L ++
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDA---VNEIRILASVN 57
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
H N+I + +D ++ IV EY G L + + + ++ I R+ I
Sbjct: 58 HPNIISYKE--AFLDGNKL---CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI--FI 110
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
+ ++ LH I+H DLK +N+LL + + +GD G+ + +L+ +
Sbjct: 111 QLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGI---------SKVLKKNMA 158
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T I GT Y+APE G S D++S G LL EM T P
Sbjct: 159 KTQI-GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G G+FG VY+ E + A K++ ++ + F+ E + L +H N++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY- 71
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
F E I+ E+ + G+L+ + + L + R + A+ +LH H
Sbjct: 72 ---FYENKL-WILIEFCDGGALDSIMLELERGLTEPQIRYVCR-----QMLEALNFLHSH 122
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVA 886
++H DLK N+LL D + DFG+ S T I GT ++A
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGV-------SAKNKSTLQKRDTFI-GTPYWMA 171
Query: 887 PEYGMGGDMSAT-----GDVYSFGILLLEMFTRRRPTDNM 921
PE D++S GI L+E+ P +
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 69/258 (26%), Positives = 114/258 (44%), Gaps = 27/258 (10%)
Query: 681 LMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT 740
++E+ +VS D K F IGQG+ G VY VA+K MNL+Q+
Sbjct: 4 ILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK 60
Query: 741 KSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLE 800
+ + E +R ++ N++ + S + +E+ +V EY+ GSL D + ++ ++
Sbjct: 61 ELIINEILVMRENKNPNIVNYLD--SYLVGDEL---WVVMEYLAGGSLTDVVTETC--MD 113
Query: 801 VGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860
G + R L A+++LH + ++H D+K N+LL D + DFG
Sbjct: 114 EGQIAAVCRECLQ-----ALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC--- 162
Query: 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920
A I S + + GT ++APE D++S GI+ +EM P N
Sbjct: 163 -----AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
Query: 921 MFNDGLTLHEFAKMALPE 938
N L+ A PE
Sbjct: 218 E-NPLRALYLIATNGTPE 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 707 IGQGSFGFVYRG--NLGENEMAVAVKVM-NLKQRGATKSFVAECEALRNIRHRNLIKIIT 763
+G G+FG V +G + + ++ VA+KV+ N ++ + E E + + + ++++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
VC E + +V E G L +L D++ V N + L+ V+ ++YL
Sbjct: 63 VC------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNV-----VELMHQVSMGMKYL 111
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
VH DL NVLL + A + DFGL++ L + + K +
Sbjct: 112 EGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKAL-----GADDSYYKARSAGKWPLK 163
Query: 884 YVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ APE S+ DV+S+GI + E F+
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 42/231 (18%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIK 760
F+ IG+GSFG V++G + VA+K+++L++ AE E + +I+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDE-IEDIQQE---- 52
Query: 761 IITVCSSIDFEEVD------FKA----IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRL 810
ITV S D V K I+ EY+ GS + D L G F+ Q
Sbjct: 53 -ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS-------ALDLLRAGPFDEFQIA 104
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
++ ++ ++YLH +H D+K +NVLL + DFG+A + +
Sbjct: 105 TMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA--------GQLTD 153
Query: 871 TPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921
T GT ++APE + D++S GI +E+ P +M
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 55/217 (25%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 707 IGQGSFGFVYRG-NLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIR---HRNLIK 760
IG+G++G V++ +L VA+K + ++ + G S + E LR++ H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+ VC+ + +V+E+++ L +L + + +++ + +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEP----GVPTETIKDMMFQLLRGL 123
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
++LH H +VH DLKP N+L+ + DFGLAR I + T +
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR---------IYSFQMALTSVVV 171
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T+ Y APE + + D++S G + EMF RR+P
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 706 MIGQGSFGFVYRGNL---GEN-EMAVAVKVMNLKQRG--ATKSFVAECEALRNIRHRNLI 759
++G G+FG VY+G GE ++ VA+K++N + G A F+ E + ++ H +L+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
+++ VC S + +V + M G L D++H+ D N LN + +A
Sbjct: 73 RLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKG 121
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+ YL +VH DL NVL+ + DFGLAR L E ++ G K
Sbjct: 122 MMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD------EKEYNADGGK 172
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ ++A E + DV+S+G+ + E+ T
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 707 IGQGSFGFVYRG--NLGENEMAVAVKVM-NLKQRGATK-SFVAECEALRNIRHRNLIKII 762
+G G+FG V +G + ++E VAVK++ N A K + E ++ + + ++++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
+C E + +V E E G L +L ++ V N+ + LV V+ ++Y
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNK---HVTEKNITE---LVHQVSMGMKY 110
Query: 823 LHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTV 882
L VH DL NVLL A + DFGL++ L A + + G K V
Sbjct: 111 LEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL----GADENYYKAKTHG-KWPV 162
Query: 883 GYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ APE S+ DV+SFG+L+ E F+
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 40/228 (17%)
Query: 690 SYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK-QRGATKSFVAECE 748
SY +L K +G+GS+ VY+G N VA+KV+++K + G + + E
Sbjct: 6 SYLNLEK----------LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREAS 55
Query: 749 ALRNIRHRNLI---KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFN 805
L+ ++H N++ II ++ F V+EYM L ++ Q L N
Sbjct: 56 LLKGLKHANIVLLHDIIHTKETLTF--------VFEYMHT-DLAQYMIQHPGGLHPYNVR 106
Query: 806 VIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSP 865
+ + + + Y+H I+H DLKP N+L+ + + DFGLAR +
Sbjct: 107 L-----FMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR-----AK 153
Query: 866 ATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMF 912
+ +T SS T+ Y P+ +G D S+ D++ G + +EM
Sbjct: 154 SIPSQTYSSEV---VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEA--LRNIRHRNLIK 760
++G+G+FG VY + +AVK + Q + + ECE L+N+RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
D EE +I EYM GS++D L E NV +R I +
Sbjct: 69 YYGCLR--DPEEKKL-SIFVEYMPGGSIKDQLKAYGALTE----NVTRRYTRQI--LQGV 119
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
YLH + IVH D+K +N+L D +GDFG ++ I S TGIK
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK--------RIQTICMSGTGIKS 168
Query: 881 TVG---YVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
G +++PE G DV+S ++EM T + P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 707 IGQGSFG--FVYRGNLGENEMAVAVKVMNLKQRGATKSFVA--ECEALRNIRHRNLIKII 762
+G+G+FG +YR E++ V K +NL + + A E L ++H N+I
Sbjct: 8 LGKGAFGEATLYRRT--EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
F + + I EY G+L D + + QL F L + + A+ Y
Sbjct: 66 N-----HFMDDNTLLIEMEYANGGTLYDKIVRQKGQL----FEEEMVLWYLFQIVSAVSY 116
Query: 823 LHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTV 882
+H I+H D+K N+ L + +GDFG+++ L E + T + GT
Sbjct: 117 IHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-------EYSMAET-VVGTP 165
Query: 883 GYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRR 916
Y++PE G + D+++ G +L E+ T +R
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 33/219 (15%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEA-------LRNIRHRNLI 759
IG+GSFG +Y + +K ++L TK V E EA L ++H N
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDL-----TKMPVKEKEASKKEVILLAKMKHPN-- 60
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
I+T +S F+E IV EY + G L +++ L F+ Q L+ + ++
Sbjct: 61 -IVTFFAS--FQENGRLFIVMEYCDGGDLMKRINRQRGVL----FSEDQILSWFVQISLG 113
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHD-MVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
++++H I+H D+K N+ L + MVA +GDFG+AR + ++ +
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR--------QLNDSMELAYTC 162
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT Y++PE + D++S G +L E+ T + P
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 65/236 (27%), Positives = 100/236 (42%), Gaps = 27/236 (11%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G G+FG VY+ E A KV+ K + ++ E E L H ++K++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA-- 77
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
F I+ E+ G+++ + + + L VI R L A++YLH
Sbjct: 78 ---FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE-----ALQYLHSM 129
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVA 886
I+H DLK NVLL D + DFG++ A ++T GT ++A
Sbjct: 130 ---KIIHRDLKAGNVLLTLDGDIKLADFGVS--------AKNVKTLQRRDSFIGTPYWMA 178
Query: 887 PEYGMGGDMSAT-----GDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937
PE M M T D++S GI L+EM + P + N L + AK P
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEM-AQIEPPHHELNPMRVLLKIAKSEPP 233
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 59/223 (26%), Positives = 91/223 (40%), Gaps = 37/223 (16%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT-KSFVAECEALRNIRHRNLIKIIT 763
+ +G+G+ G V + L M A+K + K + E E ++ + ++K
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 764 VC-----SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
SSI I EY E GSL+ + + V+ + +A
Sbjct: 67 AFLDESSSSI--------GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK------IAE 112
Query: 819 AI----EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
++ YLH I+H D+KPSN+LL + DFG+ S + +
Sbjct: 113 SVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV-------SGELVNSLAGT 162
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
TG T Y+APE G S T DV+S G+ LLE+ R P
Sbjct: 163 FTG---TSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 38/230 (16%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSF---VAECEALRNIRHRN 757
FS IG GSFG VY N VA+K M+ + + + + + E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
+I + + E+ +E L ++D LEV +Q + +
Sbjct: 77 ---------TIQYRGCYLR----EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTH 122
Query: 818 FAIE---YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
A++ YLH H ++H D+K N+LL + +GDFG A + P
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------------ 167
Query: 875 STGIKGTVGYVAPEYGMG---GDMSATGDVYSFGILLLEMFTRRRPTDNM 921
+ GT ++APE + G DV+S GI +E+ R+ P NM
Sbjct: 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 8e-11
Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN--LKQRGATKSFVAECEALRNIRHRNLIKIITV 764
IG+G++G V E VA+K + R K + E + LR++ H N+I I +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQ--------SNDQLEVGNFNVIQRLNLVIDV 816
E + IVYE M+ LHQ S+D + + + Q L
Sbjct: 73 MPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQ---YFLYQLLR----- 119
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
++Y+H ++H DLKPSN+LL+ + + DFGLAR T E T
Sbjct: 120 --GLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGDFMT 166
Query: 877 GIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRR 915
T Y APE + + + DV+S G + E+ R+
Sbjct: 167 EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKS---FVAECEA--LRNIRHRNLIK 760
++GQG+FG VY + +AVK + S ECE L+N+ H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
D E +I E+M GS++D L E NV ++ I +
Sbjct: 69 YYGCLR--DPMERTL-SIFMEHMPGGSIKDQLKSYGALTE----NVTRKYTRQI--LEGV 119
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
YLH + IVH D+K +N+L D +GDFG ++ L TI + + + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL-----QTICLSGTGMKSVTG 171
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T +++PE G D++S G ++EM T + P
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEA--LRNIRHRNLIKIITV 764
+G+GS+G V + +K +NL+ + AE EA L ++H N I+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN---IVAY 64
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
S + E+ IV + E G L L + +L N Q + + +A A++YLH
Sbjct: 65 RESWEGEDGLL-YIVMGFCEGGDLYHKLKEQKGKLLPEN----QVVEWFVQIAMALQYLH 119
Query: 825 HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGY 884
H I+H DLK NV L + VGD G+AR L + +ST I GT Y
Sbjct: 120 EK-H--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-------QCDMASTLI-GTPYY 168
Query: 885 VAPEYGMGGDMSATGDVYSFGILLLEMFTRR 915
++PE + DV++ G + EM T +
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 21/214 (9%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRNLIKIIT 763
+G+G FG V + A K +N LK+R + + E L + R ++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-- 58
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
+ F+ +V M G L H N E F + + +E+L
Sbjct: 59 ---AYAFQTKTDLCLVMTIMNGGDLR--YHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
H I++ DLKP NVLLD+D + D GLA + + S + G GT G
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLA--------VELKDGQSKTKGYAGTPG 162
Query: 884 YVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
++APE G + + D ++ G+ L EM R P
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-10
Identities = 35/90 (38%), Positives = 56/90 (62%), Gaps = 1/90 (1%)
Query: 420 LDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGAL 479
L L + L G IP + L L S++L N +RG++P SLG+ +L +L +S N G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 480 PPQILGIVTLSILLDLSGNLLTGSIPAEVG 509
P+ LG +T +L+L+GN L+G +PA +G
Sbjct: 483 -PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 34/90 (37%), Positives = 55/90 (61%), Gaps = 1/90 (1%)
Query: 129 LILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQ 188
L L N G IP+++S+ +L + + GN++ G IPP +G S LE L L N G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVLDLSYNSFNGS 481
Query: 189 LAPSIGNISNLQVLSIGENRLSGRLPDSLG 218
+ S+G +++L++L++ N LSGR+P +LG
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 31/229 (13%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGEN--EMAVAVKVM-NLKQRGATKSFVAECEALRNI-R 754
ND ++IG+G+FG V + + ++ M A+K M + + F E E L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQS-----NDQLEVGN-----F 804
H N+I ++ C E + + EY G+L D+L +S + + N
Sbjct: 67 HPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 805 NVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCS 864
+ Q L+ DVA ++YL +H DL N+L+ + VA + DFGL+R
Sbjct: 122 SSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 178
Query: 865 PATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
T+ P V ++A E + DV+S+G+LL E+ +
Sbjct: 179 KKTMGRLP---------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITV 764
IG+G++G VY+ +A+K + L+Q G + + E L+ ++H N++++ V
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRL--NLVIDVAFAIEY 822
S E+ + +V+EY++ L+ + S D F RL + + I Y
Sbjct: 70 VHS---EKRLY--LVFEYLDL-DLKKHMDSSPD------FAKNPRLIKTYLYQILRGIAY 117
Query: 823 LHHHCHPPIVHGDLKPSNVLLDHDMVA-HVGDFGLAR-FLPPCSPATILETPSSSTGIKG 880
H H ++H DLKP N+L+D A + DFGLAR F P + T
Sbjct: 118 CHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV---------RTFTHEVV 165
Query: 881 TVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
T+ Y APE +G +T D++S G + EM ++
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 43/219 (19%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG+G+FG VY+ + A+KV+ + K VA+ E I RN I V +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERN----ILVRT 50
Query: 767 SID-----------FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
+D F+ +V +YM G L + H + G F+ + + +
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKE----GRFSEDRAKFYIAE 104
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+ A+E+LH + IV+ DLKP N+LLD + DFGL S A + + +++
Sbjct: 105 LVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGL-------SKANLTDNKTTN 154
Query: 876 TGIKGTVGYVAPEYGMGGDMSATG---DVYSFGILLLEM 911
T GT Y+APE + D D +S G+L+ EM
Sbjct: 155 T-FCGTTEYLAPEVLL--DEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 64/246 (26%), Positives = 103/246 (41%), Gaps = 39/246 (15%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSF---VAECEALRNIRHRN 757
F+ IG GSFG VY VA+K M+ + + + + + E + L+ I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
SI+++ + E+ +E L ++D LEV +Q + +
Sbjct: 87 ---------SIEYKGCYLR----EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITH 132
Query: 818 FAIE---YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
A++ YLH H ++H D+K N+LL + DFG A P
Sbjct: 133 GALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP------------ 177
Query: 875 STGIKGTVGYVAPEYGMG---GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEF 931
+ GT ++APE + G DV+S GI +E+ R+ P NM N L+
Sbjct: 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHI 236
Query: 932 AKMALP 937
A+ P
Sbjct: 237 AQNESP 242
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 31/89 (34%), Positives = 51/89 (57%)
Query: 178 LSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMF 237
L L + L G + I + +LQ +++ N + G +P SLG + SL L +S N+F+G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 238 PSSIFNISSLESISLLGNRLEGSLPVNIG 266
P S+ ++SL ++L GN L G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 64/245 (26%), Positives = 113/245 (46%), Gaps = 29/245 (11%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG+GS G V + + VAVK M+L+++ + E +R+ +H N++++ S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--S 85
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
+ +E+ +V E++E G+L D + + N Q + + V A+ LH
Sbjct: 86 YLVGDEL---WVVMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVA 886
++H D+K ++LL HD + DFG C+ + E P + + GT ++A
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGF------CAQVS-KEVPRRKS-LVGTPYWMA 184
Query: 887 PEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFND-GLTLHEFAKMALPEKV--MEI 943
PE D++S GI+++EM P FN+ L + + LP K+ +
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPKLKNLHK 241
Query: 944 VDPLL 948
V P L
Sbjct: 242 VSPSL 246
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 31/223 (13%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT---KSFVAECEALRNI-RHRNLIK 760
++IG+G+FG V + + ++ + + + +K+ + + F E E L + H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSN----------DQLEVGNFNVIQRL 810
++ C E + + EY G+L D+L +S + Q L
Sbjct: 61 LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
+ DVA ++YL +H DL N+L+ + VA + DFGL+R T+
Sbjct: 116 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 172
Query: 871 TPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
P V ++A E + DV+S+G+LL E+ +
Sbjct: 173 LP---------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 706 MIGQGSFGFV---YRGNLGENEMAVAVKVMNLKQRGATKSFVAECEA--LRNIRHRNLIK 760
++GQG+FG V Y + G A V+ + + ECE L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
D E I EYM GS++D L E +V ++ + +
Sbjct: 69 YYGCLR--DRAEKTL-TIFMEYMPGGSVKDQLKAYGALTE----SVTRKYTR--QILEGM 119
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
YLH + IVH D+K +N+L D +GDFG ++ L TI + + + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL-----QTICMSGTGIRSVTG 171
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T +++PE G DV+S G ++EM T + P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLK-QRGATKSFVAECEALRNIRHRNLIKIITVC 765
+G+G++ V++G E VA+K + L+ + GA + + E L+N++H N I+T+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN---IVTLH 69
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
I E +V+EY++ L+ +L + + + N + + + + Y H
Sbjct: 70 DIIHTERC--LTLVFEYLD-SDLKQYLDNCGNLMSMHNVKI-----FMFQLLRGLSYCHK 121
Query: 826 HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYV 885
I+H DLKP N+L++ + DFGLAR A + T + S + T+ Y
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLAR-------AKSVPTKTYSNEVV-TLWYR 170
Query: 886 APEYGMGG-DMSATGDVYSFGILLLEMFTRR 915
P+ +G + S D++ G +L EM T R
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 60/231 (25%), Positives = 110/231 (47%), Gaps = 46/231 (19%)
Query: 707 IGQGSFGFVYRGNL----GENEMAVAVKVM----NLKQRGATKSFVAECEALRNIRHRNL 758
+G+ +FG +Y+G+L ++ VA+K + N +Q G F E + + H N+
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG---EFQQEASLMAELHHPNI 69
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL-----HQ----SNDQ-------LEVG 802
+ ++ V + + +++EY+ G L ++L H S+D+ L+ G
Sbjct: 70 VCLLGVVT-----QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 803 NFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPP 862
+F L++ I +A +EYL H VH DL N+L+ + + D GL+R +
Sbjct: 125 DF-----LHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 863 CSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ P S I+ ++ PE M G S+ D++SFG++L E+F+
Sbjct: 177 ADYYRV--QPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 37/228 (16%)
Query: 707 IGQGSFGFVYRGN-LGENE------MAVAVKVMNLKQRGATKSF---VAECEALRNI-RH 755
+G+G FG V +G ++ VAVK+ LK K ++E E ++ I +H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM--LKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSN----------DQLEVGNFN 805
+N+I ++ C+ ++ IV EY G+L ++L Q+ +
Sbjct: 84 KNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138
Query: 806 VIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSP 865
++ VA +EYL +H DL NVL+ D V + DFGLAR +
Sbjct: 139 FKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH--- 192
Query: 866 ATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
++ +T + V ++APE + DV+SFG+LL E+FT
Sbjct: 193 ---IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 36/226 (15%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGATKS-FVAECEALRNIRHRNLI- 759
+G+ FG VY+G+L GE AVA+K + K G + F E ++H N++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 760 ------------KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVI 807
I + CS D E F + + + GS +D LE +F
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHE--FLVMRSPHSDVGSTDD-DKTVKSTLEPADF--- 126
Query: 808 QRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPAT 867
+++V +A +E+L H H +VH DL NVL+ + + D GL R +
Sbjct: 127 --VHIVTQIAAGMEFLSSH-H--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 868 ILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
++ +S I+ +++PE M G S D++S+G++L E+F+
Sbjct: 182 LMG--NSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 42/221 (19%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIK 760
F+ IG+GSFG V++G + VA+K+++L++ AE E + +I+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDE-IEDIQQE---- 52
Query: 761 IITVCSSIDFEEV---------DFKA-IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRL 810
ITV S D V D K I+ EY+ GS + D LE G + Q
Sbjct: 53 -ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIA 104
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
++ ++ ++YLH +H D+K +NVLL + DFG+A + +
Sbjct: 105 TILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--------GQLTD 153
Query: 871 TPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
T GT ++APE + D++S GI +E+
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 28/210 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEAL-RNIRHRNLIKII 762
IG+GSFG V + AVKV+ K ++ K +AE L +N++H L+ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEV-GNFNVIQRLNLVIDVAFAIE 821
F+ D V +Y+ G L L + E F ++A A+
Sbjct: 62 ----HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-------YAAEIASALG 110
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
YLH I++ DLKP N+LLD + DFGL C +E +++ GT
Sbjct: 111 YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGL------CKEG--IEHSKTTSTFCGT 159
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
Y+APE T D + G +L EM
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 72/287 (25%), Positives = 130/287 (45%), Gaps = 38/287 (13%)
Query: 681 LMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT 740
+ME+ +VS D K ++ IGQG+ G V+ VA+K +NL+++
Sbjct: 4 IMEKLRTIVSIGDPKK---KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK 60
Query: 741 KSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQS-NDQL 799
+ + E ++ +++ N++ + S + +E+ +V EY+ GSL D + ++ D+
Sbjct: 61 ELIINEILVMKELKNPNIVNFLD--SFLVGDEL---FVVMEYLAGGSLTDVVTETCMDEA 115
Query: 800 EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859
++ + + A+E+LH + ++H D+K NVLL D + DFG
Sbjct: 116 QIAA--------VCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFC-- 162
Query: 860 LPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTD 919
A I S + + GT ++APE D++S GI+ +EM P
Sbjct: 163 ------AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
Query: 920 NMFNDGLTLHEFA-----KMALPEKVMEI----VDPLLLLDLEARAS 957
N N L+ A ++ PEK+ I ++ L +D+E R S
Sbjct: 217 NE-NPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 40/232 (17%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNL----KQRGATKSFVAEC----------EAL 750
+G+G++G V + VA+K + + + V C + +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 751 RNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVI--Q 808
I+H N++ ++ V + E DF +V + M L+ + +L I Q
Sbjct: 75 NEIKHENIMGLVDV-----YVEGDFINLVMDIMA-SDLKK-VVDRKIRLTESQVKCILLQ 127
Query: 809 RLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR---FLPPCSP 865
LN + LH +H DL P+N+ ++ + + DFGLAR + P
Sbjct: 128 ILN-------GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 866 ATILETPSSS---TGIKGTVGYVAPEYGMGGD-MSATGDVYSFGILLLEMFT 913
+ ET T T+ Y APE MG + D++S G + E+ T
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 22/229 (9%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEAL--RNIRHRN 757
DF+ ++G+GSFG V + A+K+ LK+ + EC + R + ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
+T S F+ VD V EY+ G L + Q VG F Q + +++
Sbjct: 59 KPPFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPQAVFYAAEIS 111
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+ +LH I++ DLK NV+LD + + DFG+ + +++ ++ T
Sbjct: 112 VGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMVDGVTTRT- 160
Query: 878 IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGL 926
GT Y+APE + D +++G+LL EM + P D D L
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 706 MIGQGSFGFVYRGNL---GEN-EMAVAVKVM--NLKQRGATKSFVAECEALRNIRHRNLI 759
++G G+FG VY+G GEN ++ VA+KV+ N + A K + E + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAGVGSPYVC 72
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
+++ +C + + +V + M G L D++ ++ D++ + LN + +A
Sbjct: 73 RLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL-----LNWCVQIAKG 121
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+ YL +VH DL NVL+ + DFGLAR L I ET + G K
Sbjct: 122 MSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL------DIDETEYHADGGK 172
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ ++A E + + DV+S+G+ + E+ T
Sbjct: 173 VPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 707 IGQGSFG---FVYRGNLGENEM--AVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKI 761
IG+GSFG V G+ + + + M+ K+R ++ E L N++H N I
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPN---I 61
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
+ S FEE IV +Y E G L ++ L F Q L+ + + A++
Sbjct: 62 VQYQES--FEENGNLYIVMDYCEGGDLYKKINAQRGVL----FPEDQILDWFVQICLALK 115
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
++H I+H D+K N+ L D +GDFG+AR L + +E + T I GT
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NSTVEL--ARTCI-GT 164
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
Y++PE + D+++ G +L EM T
Sbjct: 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 43/231 (18%)
Query: 699 NDFSSSNMIGQGSFGFVYRGN---LGENE--MAVAVKVMNLKQRGATK-SFVAECEALRN 752
N+ S +G G+FG V L +++ M VAVK++ + + + ++E + + +
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 753 I-RHRNLIKIITVCSSIDFEEVDFKA----IVYEYMECGSLEDWLHQSNDQLEVGNFNVI 807
+ H N++ ++ C+ ++ EY G L ++L + + +
Sbjct: 95 LGNHENIVNLLGACT---------IGGPILVITEYCCYGDLLNFLRRKRESF----LTLE 141
Query: 808 QRLNLVIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPA 866
L+ VA + +L +C +H DL NVLL H + + DFGLAR
Sbjct: 142 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLAR-------- 189
Query: 867 TILETPSSSTGIKGT----VGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
I+ S+ +KG V ++APE + DV+S+GILL E+F+
Sbjct: 190 DIMN--DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 38/224 (16%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSF---VAECEALRNIRHRNLIKIIT 763
IG GSFG VY VAVK M+ + + + + E + L+ ++H N
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN------ 82
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE-- 821
+I+++ K E+ +E L ++D LEV +Q + + A++
Sbjct: 83 ---TIEYKGCYLK----EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGL 134
Query: 822 -YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
YLH H ++H D+K N+LL + DFG A P + G
Sbjct: 135 AYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------------ANSFVG 179
Query: 881 TVGYVAPEYGMG---GDMSATGDVYSFGILLLEMFTRRRPTDNM 921
T ++APE + G DV+S GI +E+ R+ P NM
Sbjct: 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 8e-10
Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 50/234 (21%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN------LKQRGATKSFVAECEALRNI 753
+ + + IG+G++G V + VA+K ++ QR + E + LR
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-----LREIKILRRF 60
Query: 754 RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQ-------SNDQLEVGNFNV 806
+H N+I I+ + FE + IV E ME L++ SND ++ + +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQ---YFL 112
Query: 807 IQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPA 866
Q L ++Y+H ++H DLKPSN+LL+ + + DFGLAR P
Sbjct: 113 YQILR-------GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
Query: 867 TILETPSSSTGIKGTVGYVAPEYGMGGDMSATG-----DVYSFGILLLEMFTRR 915
T T +T Y APE M +++ G D++S G +L EM + R
Sbjct: 163 TGFLTEYVATR-----WYRAPEI-M---LNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG+GS G V + VAVK+M+L+++ + E +R+ +H+N++++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK--S 86
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQ---SNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
+ EE+ ++ E+++ G+L D + Q + +Q+ +V+Q A+ YL
Sbjct: 87 YLVGEEL---WVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQ----------ALCYL 133
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
H ++H D+K ++LL D + DFG A I + + GT
Sbjct: 134 HSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC--------AQISKDVPKRKSLVGTPY 182
Query: 884 YVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
++APE D++S GI+++EM P
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 35/227 (15%)
Query: 707 IGQGSFGFVYRGN-LG----ENEMAVAVKVMNLKQRGATKSF---VAECEALRNI-RHRN 757
+G+G FG V +G + V V V LK K V+E E ++ I +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQ--------SNDQLEVGNFNVIQR 809
+I ++ C+ ++ +V EY G+L ++L S D ++ + +
Sbjct: 80 IINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 810 --LNLVIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPA 866
++ VA +EYL C +H DL NVL+ D V + DFGLAR
Sbjct: 135 DLVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLAR------DV 184
Query: 867 TILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
++ +T + V ++APE + DV+SFG+LL E+FT
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 15/220 (6%)
Query: 701 FSSSNMIGQGSFGFVYRGNLG-ENEMAVAVKVMNLKQRGATKSFVAEC--EA--LRNIRH 755
F+ M+G+G FG V L E+ V V LK + S + E EA ++ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 756 RNLIKIITVC-SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
N+IK+I V S + ++ +M+ G L +L S E + + +I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
D+A +EYL +H DL N +L+ +M V DFGL++ + +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKI---YSGDYYRQGCA 174
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914
S K V ++A E + DV++FG+ + E+ TR
Sbjct: 175 S---KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 31/238 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G G+FG VY+ E + A KV++ K + ++ E + L + H N++K++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 70
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
F + I+ E+ G+++ + + L V+ + L A+ YLH +
Sbjct: 71 ---FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE-----ALNYLHEN 122
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVA 886
I+H DLK N+L D + DFG++ A T GT ++A
Sbjct: 123 ---KIIHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMA 171
Query: 887 PEYGMGG-------DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937
PE M D A DV+S GI L+EM + P + N L + AK P
Sbjct: 172 PEVVMCETSKDRPYDYKA--DVWSLGITLIEM-AQIEPPHHELNPMRVLLKIAKSEPP 226
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 51/162 (31%), Positives = 71/162 (43%), Gaps = 33/162 (20%)
Query: 812 LVIDVAFAIEYLHHHCHPP-IVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
L I V A+ HH H ++H D+K +N+LL + + +GDFG ++
Sbjct: 148 LFIQVLLAV----HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA--------A 195
Query: 871 TPSSSTG--IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 928
T S G GT YVAPE S D++S G+LL E+ T +RP DG +
Sbjct: 196 TVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-----DGENM 250
Query: 929 HEFAKMAL------------PEKVMEIVDPLLLLDLEARASN 958
E L PE + EIV LL D + R S+
Sbjct: 251 EEVMHKTLAGRYDPLPPSISPE-MQEIVTALLSSDPKRRPSS 291
|
Length = 496 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 62/235 (26%), Positives = 94/235 (40%), Gaps = 43/235 (18%)
Query: 688 MVSYADLSK-ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVK------VMNLKQRGAT 740
M + D S +DF +G GSFG V A+K ++ +KQ
Sbjct: 6 MFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ---V 62
Query: 741 KSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQS----N 796
+ E L + H ++ ++ CS D V F + E++ G L L ++ N
Sbjct: 63 QHVAQEKSILMELSHPFIVNMM--CSFQDENRVYF---LLEFVVGGELFTHLRKAGRFPN 117
Query: 797 DQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856
D V F ++ A EYLH I++ DLKP N+LLD+ V DFG
Sbjct: 118 D---VAKF-------YHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGF 164
Query: 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
A+ + P + + GT Y+APE D ++ G+LL E
Sbjct: 165 AK-----------KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208
|
Length = 329 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 700 DFSSSNMIGQGSFGFVYRGNL---GEN-EMAVAVKVM-NLKQRGATKSFVAECEALRNIR 754
+F ++G G+FG VY+G GE ++ VA+K + A K + E + ++
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
+ ++ +++ +C + + ++ + M G L D++ + D N LN +
Sbjct: 68 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCV 116
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
+A + YL +VH DL NVL+ + DFGLA+ L E
Sbjct: 117 QIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL------GADEKEYH 167
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ G K + ++A E + + DV+S+G+ + E+ T
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-09
Identities = 62/246 (25%), Positives = 99/246 (40%), Gaps = 58/246 (23%)
Query: 706 MIGQGSFGFVY----------------RGNLGENEMAVAVKVMNLKQRGATKSFVAECEA 749
+IG+G G VY R +L EN + LK+R F+ E +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPL--------LKKR-----FLREAKI 55
Query: 750 LRNIRHRNLIKIITVCSSID--------FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEV 801
++ H ++ + ++CS D E K+++ + SL L + + V
Sbjct: 56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE---KTSV 112
Query: 802 GNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP 861
G F L++ + IEY+H ++H DLKP N+LL + D+G A F
Sbjct: 113 GAF-----LSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKK 164
Query: 862 P------CSPATILETPSSSTGIK----GTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
SS I GT Y+APE +G S + D+Y+ G++L +M
Sbjct: 165 LEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224
Query: 912 FTRRRP 917
T P
Sbjct: 225 LTLSFP 230
|
Length = 932 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECE-------ALRNIRHRNL 758
++G+GSFG V L + AVKV LK+ + EC AL +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
++ + C F+ D V EY+ G L + +S G F+ + ++
Sbjct: 59 TQLHS-C----FQTKDRLFFVMEYVNGGDLMFHIQRS------GRFDEPRARFYAAEIVL 107
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+++LH I++ DLK NVLLD + + DFG+ + IL ++ST
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK-------EGILGGVTTST-F 156
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTD 919
GT Y+APE D ++ G+LL EM + P +
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 27/169 (15%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G GS G V+ + + VAVK + L + K + E + +R + H N++K+ V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 767 SI---------DFEEVDFKAIVYEYMECGSLEDWLHQ---SNDQLEVGNFNVIQRLNLVI 814
E++ IV EYME L + L Q S + + + +++ L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGL---- 127
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLD-HDMVAHVGDFGLARFLPP 862
+Y+H ++H DLKP+NV ++ D+V +GDFGLAR + P
Sbjct: 128 ------KYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG+GS G V VAVK M+L+++ + E +R+ H N++ + S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN--S 87
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
+ +E+ +V E++E G+L D + + N Q + + V A+ YLH+
Sbjct: 88 YLVGDEL---WVVMEFLEGGALTDIVTHT-------RMNEEQIATVCLSVLRALSYLHNQ 137
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVA 886
++H D+K ++LL D + DFG C+ + E P + + GT ++A
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGF------CAQVS-KEVPKRKS-LVGTPYWMA 186
Query: 887 PEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920
PE D++S GI+++EM P N
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-09
Identities = 55/241 (22%), Positives = 94/241 (39%), Gaps = 44/241 (18%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
+DF +IG+G+FG V+ + A+KV+ + +R AE + L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSND-QLEVGNFNVIQRLNLVI 814
++K+ S F++ + +V EYM G L + L + + E F +
Sbjct: 61 PWIVKLY--YS---FQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARF-------YIA 108
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLA--------------- 857
++ A++ +H +H D+KP N+L+D D H+ DFGL
Sbjct: 109 ELVLALDSVHKLGF---IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLND 163
Query: 858 RFLPPCSPATILETPSSSTGIK------GTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
++ GT Y+APE G D +S G++L EM
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223
Query: 912 F 912
Sbjct: 224 L 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLK-QRGATKSFVAECEALRNIRHRNLIKIITVC 765
+G+G++ VY+G + VA+K + L+ + GA + + E L++++H N I+T+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN---IVTLH 70
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
I E+ +V+EY++ L+ +L + + + N + + + + Y H
Sbjct: 71 DIIHTEKS--LTLVFEYLD-KDLKQYLDDCGNSINMHNVKL-----FLFQLLRGLNYCHR 122
Query: 826 HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYV 885
++H DLKP N+L++ + DFGLAR A + T + S + T+ Y
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLAR-------AKSIPTKTYSNEVV-TLWYR 171
Query: 886 APEYGMGG-DMSATGDVYSFGILLLEMFTRR 915
P+ +G D S D++ G + EM T R
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 35/227 (15%)
Query: 707 IGQGSFGFVYRGN-LG----ENEMAVAVKVMNLKQRGATKSF---VAECEALRNI-RHRN 757
+G+G FG V LG + + AV V V LK K V+E E ++ I +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQ--------SNDQLEVGNFNVIQR 809
+I ++ C+ ++ IV EY G+L ++L S D V + + +
Sbjct: 83 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 810 --LNLVIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPA 866
++ VA +EYL C +H DL NVL+ + V + DFGLAR
Sbjct: 138 DLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR------DV 187
Query: 867 TILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
++ +T + V ++APE + DV+SFG+L+ E+FT
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 49/239 (20%)
Query: 694 LSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI 753
L T F +IG+G++G VY+ + VA+K+M++ + + E LR
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKY 59
Query: 754 -RHRNLIKIITVCSSIDFEEVDFKA----------IVYEYMECGSLEDW---LHQSNDQL 799
H N+ F K +V E GS+ D L + +L
Sbjct: 60 SNHPNI---------ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL 110
Query: 800 EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG--DFGLA 857
+ I R + + YLH + ++H D+K N+LL + A V DFG++
Sbjct: 111 KEEWIAYILR-----ETLRGLAYLHEN---KVIHRDIKGQNILLTKN--AEVKLVDFGVS 160
Query: 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPE-----YGMGGDMSATGDVYSFGILLLEM 911
L +T+ +T I GT ++APE A DV+S GI +E+
Sbjct: 161 AQL----DSTLGRR---NTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-09
Identities = 65/225 (28%), Positives = 96/225 (42%), Gaps = 44/225 (19%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVK-------VMNLKQRGATKSFVAECEALRNIRHRNLI 759
IG G++G V + VA+K V L +R + E + LR+ +H N+I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT-----LRELKILRHFKHDNII 67
Query: 760 KIITVCSSIDFEEVDFKAI--VYEYMECGSLEDWLHQ---SNDQLEVGNFN--VIQRLNL 812
I + DFK + V + ME LH S+ L + + Q L
Sbjct: 68 AIRDILRP---PGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEEHIRYFLYQLLR- 118
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP 872
++Y+H ++H DLKPSN+L++ D +GDFG+AR L S T E
Sbjct: 119 ------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL--SSSPT--EHK 165
Query: 873 SSSTGIKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEMFTRR 915
T T Y APE + +A D++S G + EM RR
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAI-DMWSVGCIFAEMLGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-09
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 46/223 (20%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIITV 764
+G G++G V + VA+K ++ + A K E L+++ H N+I ++ V
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 765 ----CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLN------LVI 814
S DF++V +V M ++ N Q+L+ LV
Sbjct: 83 FTPASSLEDFQDV---YLVTHLM--------------GADLNNIVKCQKLSDDHIQFLVY 125
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
+ ++Y+H I+H DLKPSN+ ++ D + DFGLAR T
Sbjct: 126 QILRGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLAR-----------HTDDE 171
Query: 875 STGIKGTVGYVAPEYGMGGDM--SATGDVYSFGILLLEMFTRR 915
TG T Y APE M M + T D++S G ++ E+ T +
Sbjct: 172 MTGYVATRWYRAPEI-MLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 4e-09
Identities = 24/41 (58%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 33 NETDRLALLAIKSQLQ-DPLGVTSSWNNSM-NLCQWTGVTC 71
DR ALLA KS L DP G SSWN S + C WTGVTC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 32/229 (13%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
+DF +IG+G+FG V + E A+K++N + +R T F E RN+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE----RNVLV 56
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL--EVGNFNVIQRLNLV 813
+ IT F++ ++ +V +Y G L L + D+L ++ F + + + L
Sbjct: 57 NGDCQWITTLHYA-FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMV-LA 114
Query: 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS 873
I +I LH+ VH D+KP NVLLD + + DFG C T
Sbjct: 115 IH---SIHQLHY------VHRDIKPDNVLLDMNGHIRLADFG------SCLKMNQDGTVQ 159
Query: 874 SSTGIKGTVGYVAPEY--GMGGDMSATG---DVYSFGILLLEMFTRRRP 917
SS + GT Y++PE M M G D +S G+ + EM P
Sbjct: 160 SSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-09
Identities = 38/114 (33%), Positives = 62/114 (54%), Gaps = 3/114 (2%)
Query: 226 LSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGS 285
L + G P+ I + L+SI+L GN + G++P ++G S+ +LE L + N++ GS
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVLDLSYNSFNGS 481
Query: 286 LPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFS-KNNLGTGAIGDL 338
+P SL ++LR+L+ + N SG+V L R SF+ +N G I L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRL-LHRASFNFTDNAGLCGIPGL 534
|
Length = 623 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVC 765
+G+GS+ VY+G VA+K + L+ GA + + E L++++H N I+T+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN---IVTLH 69
Query: 766 SSIDFEEVDFKAIVYEYME---------CGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
I ++ +V+EY++ CG L N +L + F +++ L
Sbjct: 70 DIIHTKKT--LTLVFEYLDTDLKQYMDDCGGG---LSMHNVRLFL--FQLLRGL------ 116
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
Y H ++H DLKP N+L+ + DFGLAR A + + + S
Sbjct: 117 ----AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR-------AKSVPSKTYSN 162
Query: 877 GIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRR 915
+ T+ Y P+ +G + S + D++ G + EM T R
Sbjct: 163 EVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 40/231 (17%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGAT---KSFVAECEALRNIRHRNL 758
IGQG+FG V++ E VAVK+ LK+ + F E + H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL-HQSNDQLEVGN-------------- 803
+K++ VC+ +++EYM G L ++L H+S +
Sbjct: 71 VKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 804 -FNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPP 862
+ ++L + VA + YL VH DL N L+ +MV + DFGL+R +
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI-- 180
Query: 863 CSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ S + I + ++ PE + DV+++G++L E+F+
Sbjct: 181 --YSADYYKASENDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 35/218 (16%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLK-QRGATKSFVAECEALRNIRHRNLIKIITVC 765
+G+G+ F + L VAVK++ + A F+ E + + +++ N+I+++ VC
Sbjct: 33 LGEGAPEFDGQPVL------VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVC 86
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVI------QRLNLVIDVAFA 819
S D ++ EYME G L +L Q + + N I L + + +A
Sbjct: 87 VS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASG 141
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
++YL VH DL N L+ + + DFG++R L I+
Sbjct: 142 MKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL----------YSGDYYRIQ 188
Query: 880 G----TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
G + ++A E + G + DV++FG+ L EMFT
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 24/220 (10%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRN 757
F ++G+G FG V + A K + +K+R + E + L + R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
++ + + +E D +V M G L+ ++ + F + + ++
Sbjct: 62 VVSL-----AYAYETKDALCLVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEIC 112
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+E LH IV+ DLKP N+LLD + D GLA +P TI G
Sbjct: 113 CGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTI-------KG 160
Query: 878 IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GTVGY+APE + + D ++ G LL EM + P
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 6e-09
Identities = 94/357 (26%), Positives = 142/357 (39%), Gaps = 27/357 (7%)
Query: 84 SNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSN 143
+ + +L + L L ++ + S + + L L +L L N + SN
Sbjct: 54 LSSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNR----LRSN 108
Query: 144 LSRCSNLINFHA--RGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQV 201
+S L N + NN + IPP IG L+ L L DN + L + N+ NL+
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKN 167
Query: 202 LSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSL 261
L + N LS LP L L +L L +S N S P I +S+LE + L N + L
Sbjct: 168 LDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-EL 224
Query: 262 PVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLN---HFSGQVKIDFNRLP 318
++ +L NL L + NN LP S+ N SNL LD S N S +
Sbjct: 225 LSSL-SNLKNLSGLEL-SNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGSLT----- 277
Query: 319 NLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILF 378
NL L S N+L L IA L +L L T + SI L++ I+
Sbjct: 278 NLRELDLSGNSL----SNALPLIALLLLLLELLLNLLLTLKALELKLNSI-LLNNNILSN 332
Query: 379 SMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESL 435
+ + L +LN N L ++N + + + H+ + L
Sbjct: 333 GETSSPEALSILESLNNLWTLDNAL-DESNLNRYIVKNPNAIGSLLDLVKKHVNQLL 388
|
Length = 394 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 54/227 (23%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNL---KQRGATKSFVA---ECEALRNIRHRNL 758
++G+G++G VY G + ++ +AVK + L A K + E + L++++H N+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQL-IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
++ + C + + +I E++ GS+ L++ G +
Sbjct: 65 VQYLGTCL-----DDNTISIFMEFVPGGSISSILNR------FGPLPEPVFCKYTKQILD 113
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP----PCSPATILETPSS 874
+ YLH++C +VH D+K +NV+L + + + DFG AR L + + +L++
Sbjct: 114 GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS--- 167
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921
+ GT ++APE D++S G + EM T + P +M
Sbjct: 168 ---MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 55/233 (23%), Positives = 95/233 (40%), Gaps = 51/233 (21%)
Query: 707 IGQGSFGFVYRGNLGENEMA--VAVKVM---NLKQRGATKSFVAECEALRNIRHRNLIKI 761
IG+G++G VY+ + A+K + G ++S E LR ++H N++ +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 762 ITVCSS---------IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNV----IQ 808
+ V D+ E D I+ H+ ++ + V Q
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIK-----------FHRQAKRVSIPPSMVKSLLWQ 116
Query: 809 RLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL----DHDMVAHVGDFGLAR-FLPPC 863
LN + YLH + ++H DLKP+N+L+ V +GD GLAR F P
Sbjct: 117 ILN-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP- 165
Query: 864 SPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRR 915
L+ + + T+ Y APE +G + D+++ G + E+ T
Sbjct: 166 -----LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 40/127 (31%), Positives = 65/127 (51%), Gaps = 16/127 (12%)
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
++A A+++LH I++ DLKP N+LLD + + DFGL++ ++
Sbjct: 106 ELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK--------ESIDHEKK 154
Query: 875 STGIKGTVGYVAPEY--GMGGDMSATGDVYSFGILLLEMFTRRRPTDNM-FNDGLTLHEF 931
+ GTV Y+APE G SA D +SFG+L+ EM T P + +T+
Sbjct: 155 AYSFCGTVEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
Query: 932 AKMALPE 938
AK+ +P+
Sbjct: 213 AKLGMPQ 219
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 33/220 (15%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG--ATKSFVAECEALRNIRHR 756
N F ++G+G++G V + E + VA+K + ++ + E + LR ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSN----DQLEVGNFNVIQRLNL 812
N++++ F +V+EY+E LE N +++ + +I+ +
Sbjct: 61 NIVELKEA-----FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAI-- 113
Query: 813 VIDVAFAIEYLHHHCHP-PIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILET 871
H CH IVH D+KP N+L+ H+ V + DFG AR L S A E
Sbjct: 114 ------------HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY 161
Query: 872 PSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
+ T Y +PE +G D++S G +L E+
Sbjct: 162 VA-------TRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 74/280 (26%), Positives = 119/280 (42%), Gaps = 47/280 (16%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIIT-- 763
+IG+G FG VY + A+K ++ K+R K E AL R ++ +++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLD-KKRIKMKQ--GETLALN---ERIMLSLVSTG 54
Query: 764 -----VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
VC + F D + + M G L L Q G F+ + ++
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH------GVFSEKEMRFYATEIIL 108
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+E++H+ +V+ DLKP+N+LLD + D GLA C + + P +S
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSK--KKPHASV-- 156
Query: 879 KGTVGYVAPEY---GMGGDMSATGDVYSFGILLLEM------FTRRRPTDNMFNDGLTLH 929
GT GY+APE G D SA D +S G +L ++ F + + D D +TL
Sbjct: 157 -GTHGYMAPEVLQKGTAYDSSA--DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 213
Query: 930 ---EFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEI 966
E PE + +++ LL D+ R G E+
Sbjct: 214 VNVELPDSFSPE-LKSLLEGLLQRDVSKRLGCLGRGAQEV 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 39/221 (17%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITV 764
IG+G++G V++ E VA+K + L G S + E L+ ++H+N++++ V
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 765 CSSIDFEEVDFK-AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
S D K +V+EY + L+ + N ++ +++ +F + L
Sbjct: 68 LHS------DKKLTLVFEYCD-QDLKKYFDSCNGDIDP---EIVK--------SFMFQLL 109
Query: 824 H--HHCHPP-IVHGDLKPSNVLLDHDMVAHVGDFGLAR-FLPP--CSPATILETPSSSTG 877
CH ++H DLKP N+L++ + + DFGLAR F P C A ++
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-------- 161
Query: 878 IKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRRRP 917
T+ Y P+ G + +T D++S G + E+ RP
Sbjct: 162 ---TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 37/222 (16%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIIT-- 763
+IG+G FG VY + A+K ++ K+R K E AL R ++ +++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLD-KKRIKMKQ--GETLALN---ERIMLSLVSTG 54
Query: 764 -----VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
VC S F D + + + M G L L Q G F+ + ++
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH------GVFSEAEMRFYAAEIIL 108
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+E++H+ +V+ DLKP+N+LLD + D GLA C + + P +S
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSK--KKPHASV-- 156
Query: 879 KGTVGYVAPEY---GMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT GY+APE G+ D SA D +S G +L ++ P
Sbjct: 157 -GTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 80/285 (28%), Positives = 117/285 (41%), Gaps = 61/285 (21%)
Query: 238 PSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLR 297
S + +++L S+ L N + +P IG NL+ L + N SLP L N
Sbjct: 109 ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRN----- 161
Query: 298 LLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDT 357
LPNL L S N+L D L+N S L L L
Sbjct: 162 -------------------LPNLKNLDLSFNDL-------SDLPKLLSNLSNLNNLDLSG 195
Query: 358 NIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNL 417
N I++L I + L L L N + + ++ L+NL
Sbjct: 196 NK--------ISDLPPEI------------ELLSALEELDLSNNSII-ELLSSLSNLKNL 234
Query: 418 QVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTG 477
L+L +N L +PES+GNL+ L +LDL N++ SSLG+ NL L +S N L+
Sbjct: 235 SGLELSNNKL-EDLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSN 291
Query: 478 ALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSEN 522
ALP L ++ L +LL+L L E+ L+ + N
Sbjct: 292 ALPLIALLLLLLELLLNLLLTL----KALELKLNSILLNNNILSN 332
|
Length = 394 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 64/238 (26%), Positives = 104/238 (43%), Gaps = 33/238 (13%)
Query: 682 MEQQFPMVSYADLS-KATNDFSSSNMIGQGSFGFV---YRGNLGENEMAVAVKVMN--LK 735
+ QF V AD + + IG G+ G V + LG N VAVK ++ +
Sbjct: 3 EDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGIN---VAVKKLSRPFQ 59
Query: 736 QRGATKSFVAECEALRNIRHRNLIKIITVCS-SIDFEEVDFKAIVYEYMECGSLEDWLHQ 794
+ K E L+ + H+N+I ++ V + EE +V E M+ +L +H
Sbjct: 60 NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM 118
Query: 795 SNDQLEVGNFNVIQRLN-LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853
D +R++ L+ + I++LH I+H DLKPSN+++ D + D
Sbjct: 119 ELDH---------ERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 166
Query: 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
FGLAR + + TP T Y APE +G D++S G ++ E+
Sbjct: 167 FGLAR----TACTNFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKS---FVAECEALRNIRHRNLIKIIT 763
IG G FG V G + V V L+ + + F+ E + R+++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLH-QSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
C+ EV +V E+ G L+ +L +L + +QR+ ++A + +
Sbjct: 63 QCT-----EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLH 115
Query: 823 LHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTV 882
LH + +H DL N LL D+ +GD+GL+ + +
Sbjct: 116 LHKNNF---IHSDLALRNCLLTADLTVKIGDYGLSH----NKYKEDYYVTPDQLWVP--L 166
Query: 883 GYVAPE-----YG--MGGDMSATGDVYSFGILLLEMF 912
++APE +G + D + +V+S G+ + E+F
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 35/200 (17%)
Query: 731 VMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV---DFKAIVYEYMECGS 787
V+ QRG T E LR I H ++I++ + F + +K +Y Y+
Sbjct: 121 VIKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYL---- 173
Query: 788 LEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM 847
+ + + + I+R V AI+YLH + I+H D+K N+ ++H
Sbjct: 174 ------AAKRNIAICDILAIER-----SVLRAIQYLHEN---RIIHRDIKAENIFINHPG 219
Query: 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGIL 907
+GDFG A C P I + G GT+ APE D++S GI+
Sbjct: 220 DVCLGDFGAA-----CFPVDI--NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIV 272
Query: 908 LLEMFTRRRPTDNMFN-DGL 926
L EM T D++F DGL
Sbjct: 273 LFEMATCH---DSLFEKDGL 289
|
Length = 391 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 42/231 (18%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIK 760
F+ IG+GSFG VY+G + VA+K+++L++ AE E + +I+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AEDE-IEDIQQE---- 52
Query: 761 IITVCSSIDFEEVD------FKA----IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRL 810
ITV S D + K I+ EY+ GS D L LE I R
Sbjct: 53 -ITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILR- 108
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
++ ++YLH +H D+K +NVLL + DFG+A + +
Sbjct: 109 ----EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA--------GQLTD 153
Query: 871 TPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921
T GT ++APE D++S GI +E+ P ++
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 49/219 (22%), Positives = 92/219 (42%), Gaps = 29/219 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKS------FVAECEALRNIRHRNLIK 760
IG G FG V LGE ++ + +K+ A+ + F+ E + R + H N+++
Sbjct: 3 IGNGWFGKVL---LGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+ C E +V E+ G L+++L +SN + + +VA +
Sbjct: 60 CLGQCI-----ESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGL 113
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA--RFLPPCSPATILETPSS-STG 877
+LH +H DL N L D+ +GD+GLA ++ P T +
Sbjct: 114 LWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY-----PEDYYITKDCHAVP 165
Query: 878 IKGTVGYVAPEYG---MGGDMSATGDVYSFGILLLEMFT 913
++ + G + D + +++S G+ + E+FT
Sbjct: 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 58/241 (24%), Positives = 102/241 (42%), Gaps = 32/241 (13%)
Query: 706 MIGQGSFGFVY----RGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKI 761
+IG G FG VY + N AVA K+ NL+ ++ V E NI + I +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVA-KIENLEN----ETIVMETLVYNNIYDIDKIAL 73
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGS-----------LEDWLHQSNDQL--EVGNFNVIQ 808
+ID + +Y CGS L + L ++ ++ + N
Sbjct: 74 WKNIHNIDHLGIP------KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKL 127
Query: 809 RLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATI 868
N++ D+ +EY+H H I HGD+KP N+++D + ++ D+G+A I
Sbjct: 128 IKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHF-IIHGKHI 183
Query: 869 LETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 928
+ +GT+ Y + G ++ GD+ S G +L+ + P ++G +
Sbjct: 184 EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243
Query: 929 H 929
H
Sbjct: 244 H 244
|
Length = 294 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-08
Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLI 759
+F I +G+FG VY G N AVKV+ K K+ V + +A R+ +
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVK-KADMINKNMVHQVQAERDALALSKS 63
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
I V + + +V EY+ G ++ LH G F+ + + +VA A
Sbjct: 64 PFI-VHLYYSLQSANNVYLVMEYLIGGDVKSLLHI------YGYFDEEMAVKYISEVALA 116
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858
++YLH H I+H DLKP N+L+ ++ + DFGL++
Sbjct: 117 LDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 13/153 (8%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATK---SFVAECEALRNIRHRNLIKIIT 763
IG G FG V + + V V LK ++K F+ + + R ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
C E + + +V+EY E G L+ +L Q ++QR + ++A + ++
Sbjct: 63 QC----VEAIPY-LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR--MACEIAAGVTHM 115
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856
H H +H DL N L D+ VGD+G+
Sbjct: 116 HKH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 707 IGQGSFGFVYRGNLGE-------NEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLI 759
+GQG+F +++G E ++ V +KV++ R ++SF + + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
VC D E + +V EY++ GSL+ +L ++ + + N+ +L + +A+A
Sbjct: 63 LNYGVCVCGD-ESI----MVQEYVKFGSLDTYLKKNKNLI-----NISWKLEVAKQLAWA 112
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+ +L + HG++ NVLL + G+ + P T+L +
Sbjct: 113 LHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL----PKEILL 165
Query: 880 GTVGYVAPE-YGMGGDMSATGDVYSFGILLLEMFT 913
+ +V PE ++S D +SFG L E+F+
Sbjct: 166 ERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 35/108 (32%), Positives = 57/108 (52%), Gaps = 19/108 (17%)
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
A+EYLH ++H D+KPSNVL++ + + DFG++ +L S + I
Sbjct: 115 ALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL----------VDSVAKTI 162
Query: 879 K-GTVGYVAPEYGMGGDMSATG-----DVYSFGILLLEMFTRRRPTDN 920
G Y+APE + +++ G DV+S GI ++E+ T R P D+
Sbjct: 163 DAGCKPYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-08
Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 36/231 (15%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
+DF +IG+G+FG V + A+K++N + +R T F E + L N
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL--EVGNFNVIQRLNLV 813
R + + F++ + +V +Y G L L + D+L ++ F + + L
Sbjct: 61 RWITNL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-YLAEMVLA 114
Query: 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILET 871
ID ++ L + VH D+KP NVLL D H+ DFG C T
Sbjct: 115 ID---SVHQLGY------VHRDIKPDNVLL--DKNGHIRLADFG------SCLRLLADGT 157
Query: 872 PSSSTGIKGTVGYVAPEY--GMGGDMSATG---DVYSFGILLLEMFTRRRP 917
S+ + GT Y++PE M G D +S G+ + EM P
Sbjct: 158 VQSNVAV-GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 25/221 (11%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNL-KQRGATKSFVAECEALRNIRHRNL 758
++ ++G+GSFG ++ A+K + L K A + E L ++H N
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN- 59
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
I+ S FE IV EY + G L + +L F L + +
Sbjct: 60 --IVAFKES--FEADGHLYIVMEYCDGGDLMQKIKLQRGKL----FPEDTILQWFVQMCL 111
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL--PPCSPATILETPSSST 876
++++H ++H D+K N+ L + +GDFG AR L P T + TP
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY--- 165
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
YV PE + D++S G +L E+ T + P
Sbjct: 166 -------YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 63/241 (26%), Positives = 90/241 (37%), Gaps = 48/241 (19%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIRHRNLIKIIT 763
+G+G G V+ L A+KV++ K +R K + E E L + H L +
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSND---QLEVGNFNVIQRLNLVIDVAFAI 820
F+ + +V +Y G L L + EV F +V A+
Sbjct: 69 -----SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF-------YAAEVLLAL 116
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATI---------- 868
EYLH IV+ DLKP N+LL H+ DF L+ P +
Sbjct: 117 EYLHLL---GIVYRDLKPENILLHES--GHIMLSDFDLS-KQSDVEPPPVSKALRKGSRR 170
Query: 869 -------LETPSSSTGIK-----GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRR 916
ET S + GT Y+APE G + D ++ GILL EM
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 917 P 917
P
Sbjct: 231 P 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 57/222 (25%), Positives = 90/222 (40%), Gaps = 28/222 (12%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRN 757
F ++G+G FG V + A K + +K+R + E + L + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGN--FNVIQRLNLVID 815
++ + + +E D +V M G L+ H N +GN F + L +
Sbjct: 62 VVNL-----AYAYETKDALCLVLTIMNGGDLK--FHIYN----MGNPGFEEERALFYAAE 110
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+ +E LH V+ DLKP N+LLD + D GLA +P S
Sbjct: 111 ILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIP---------EGESI 158
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
G GTVGY+APE + + D + G L+ EM + P
Sbjct: 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 35/222 (15%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMN--LKQRGATKSFVAECEALRNIRHRNLIKIIT 763
+IG+GS+G V VA+K +N + + E + LR +RH ++++I
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 764 VC---SSIDFEEVDFKAIVYEYMECGSLEDWLHQ---SNDQL--EVGNFNVIQRLNLVID 815
+ S +F+++ +V+E ME LHQ +ND L E F + Q L
Sbjct: 67 IMLPPSRREFKDI---YVVFELMESD-----LHQVIKANDDLTPEHHQFFLYQLLR---- 114
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
A++Y+H + H DLKP N+L + D + DFGLAR +P I T +
Sbjct: 115 ---ALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 876 TGIKGTVGYVAPEY--GMGGDMSATGDVYSFGILLLEMFTRR 915
T Y APE + D++S G + E+ T +
Sbjct: 169 TR-----WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 66/236 (27%), Positives = 98/236 (41%), Gaps = 35/236 (14%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEAL-RNIRHRNLIKI 761
+IG+GSFG V E AVKV+ K ++ K ++E L +N++H L+ +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
F+ D V +Y+ G L L + LE + ++A A+
Sbjct: 62 -----HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASALG 110
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
YLH IV+ DLKP N+LLD + DFGL + +E +++ GT
Sbjct: 111 YLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK--------ENIEHNGTTSTFCGT 159
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP---------TDNMFNDGLTL 928
Y+APE T D + G +L EM P DN+ N L L
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL 215
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRN------IRHRNLI 759
M+G+GSFG V+ L A+K LK+ EC + H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
+ C+ E + F V EY+ G L + + F++ + ++
Sbjct: 60 HLY--CTFQTKENLFF---VMEYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICG 108
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+++LH IV+ DLK N+LLD D + DFG+ C + + + +
Sbjct: 109 LQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGM------CKENMLGDAKTCT--FC 157
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT Y+APE +G + + D +SFG+LL EM + P
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 4e-08
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 27/225 (12%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA----ECEALRNIRHRNLIKI 761
++G+G+FG V + A+K++ K+ K VA E L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILK-KEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
F+ D V EY+ G L + H S +++ F+ + ++ A++
Sbjct: 61 -----KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERV----FSEDRTRFYGAEIVSALD 109
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
YLH IV+ DLK N++LD D + DFGL + + A ++T GT
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKT------FCGT 158
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGL 926
Y+APE D D + G+++ EM R P N ++ L
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 28/212 (13%)
Query: 707 IGQGSFGFVY----RGNLGENEMAV--AVKVMNLKQRGATKSFVAECEALRNIRHRNLIK 760
+G+GSFG VY + + E + V + V L ++ E + L + H ++K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKLDHPAIVK 66
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
F E D I+ EY E L+ L + + + Q I + +
Sbjct: 67 FHA-----SFLERDAFCIITEYCEGRDLDCKLEELKHTGKT--LSENQVCEWFIQLLLGV 119
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL-PPCSPATILETPSSSTGIK 879
Y+H I+H DLK N+ L ++++ +GDFG++R L C AT
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTF---------T 166
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
GT Y++PE + D++S G +L EM
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-08
Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 26/200 (13%)
Query: 726 AVAVKVM------NLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIV 779
VA+K++ QR + A C L H N++ ++ + V
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLY---HPNIVALLDSGEAPP----GLLFAV 57
Query: 780 YEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPS 839
+EY+ +L + L + D G + L++ V A+ H+ IVH DLKP
Sbjct: 58 FEYVPGRTLREVL--AAD----GALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQ 108
Query: 840 NVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMS 896
N+++ A V DFG+ LP A + T + +T + GT Y APE G ++
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVA-TLTRTTEVLGTPTYCAPEQLRGEPVT 167
Query: 897 ATGDVYSFGILLLEMFTRRR 916
D+Y++G++ LE T +R
Sbjct: 168 PNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 23/225 (10%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
DF +++G+G FG V A+KVM A ++ V+ E R+I +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQET-VSFFEEERDILSISN 59
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
I F++ D +V EY G L L++ DQ + + + L ++
Sbjct: 60 SPWIPQLQYA-FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD----EDMAQFYLA-ELVL 113
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
AI +H + VH D+KP NVL+D + DFG A L + + S
Sbjct: 114 AIHSVHQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVN-----SKLP 163
Query: 879 KGTVGYVAPEY--GMGGDMSATGDV----YSFGILLLEMFTRRRP 917
GT Y+APE M GD T V +S G++ EM R P
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-08
Identities = 45/181 (24%), Positives = 81/181 (44%), Gaps = 26/181 (14%)
Query: 731 VMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLED 790
V+ + Q+G T + E L+N+ H ++I++ S +V + L
Sbjct: 95 VLKIGQKGTT---LIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLPHYSS-DLYT 145
Query: 791 WLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAH 850
+L + + L + +I++ + + YLH I+H D+K N+ ++
Sbjct: 146 YLTKRSRPLPIDQALIIEK-----QILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVC 197
Query: 851 VGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLE 910
+GD G A+F P +PA + G+ GTV APE ++ D++S GI+L E
Sbjct: 198 IGDLGAAQF-PVVAPAFL--------GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFE 248
Query: 911 M 911
M
Sbjct: 249 M 249
|
Length = 357 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 20/164 (12%)
Query: 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSN 840
E+M+CGSL D +++ + V I + V + YL++ I+H D+KPSN
Sbjct: 83 EFMDCGSL-DRIYKKGGPIPVEILGKI-----AVAVVEGLTYLYNVHR--IMHRDIKPSN 134
Query: 841 VLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGD 900
+L++ + DFG++ L S + GT Y++PE GG + D
Sbjct: 135 ILVNSRGQIKLCDFGVSGEL----------INSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 901 VYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIV 944
V+S GI ++E+ + P F++ + M + + + +IV
Sbjct: 185 VWSLGISIIELALGKFPFA--FSNIDDDGQDDPMGILDLLQQIV 226
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 42/221 (19%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN--LKQRGATKSFVAECEALRNIRHRNLIKIITV 764
+G G++G V + + VAVK ++ + K E L++++H N+I ++ V
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 765 CS-SIDFEEVDFKAIVYEYM--------ECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
+ + EE + +V M +C L D D ++ L+
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD------DHVQF----------LIYQ 128
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+ ++Y+H I+H DLKPSN+ ++ D + DFGLAR T
Sbjct: 129 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------HTDDEM 174
Query: 876 TGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRR 915
TG T Y APE + + T D++S G ++ E+ T R
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVC 765
++G+GSFG V L A+K LK+ + EC + R ++ +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVE----RRVLALAWEH 55
Query: 766 SSI-----DFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+ F+ + V EY+ G L + S G F+ + ++ +
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS------GRFDEARARFYAAEIICGL 109
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
++LH I++ DLK NVLLD D + DFG+ C E +S+ G
Sbjct: 110 QFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGM------CKENMNGEGKAST--FCG 158
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T Y+APE G + + D +SFG+LL EM + P
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 28/225 (12%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHR 756
DF+ ++G+GSFG V + A+K++ + Q + + E L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
+ + C F+ +D V EY+ G L + Q VG F + ++
Sbjct: 61 PFLTQLHSC----FQTMDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPHAVFYAAEI 110
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR--FLPPCSPATILETPSS 874
A + +LH I++ DLK NV+LD + + DFG+ + + T TP
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD- 166
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTD 919
Y+APE + D ++FG+LL EM + P D
Sbjct: 167 ---------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 9/217 (4%)
Query: 407 IPHAIGELRNLQVLDLHHNNLDGHI-PESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNL 465
P + E + L L+ ++ + P SL L L+ L +L N L
Sbjct: 37 FPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGS-ENLLNLLPL 95
Query: 466 MLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLK-NLVQLGLSENRF 524
L ++ N+L + L +T LDL N +T IP +G LK NL +L LS+N+
Sbjct: 96 PSLDLNLNRLRSNISE--LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI 152
Query: 525 SNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLS 584
+P L L+ L + N L+ +P L L ++ LDLS N +S +P +E LS
Sbjct: 153 E-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLS 209
Query: 585 FLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLC 621
LE L+LS N + + N + + NK
Sbjct: 210 ALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED 246
|
Length = 394 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 706 MIGQGSFGFVYRGNL-GENEMAVAVKVMNLKQRGATKSFVAECEALRN----IRHRNLIK 760
++G+GSFG V L G+ E AVK LK+ EC + + N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEY-FAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFL 58
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
C+ F+ + V E++ G D + D+ G F++ + ++ +
Sbjct: 59 THLYCT---FQTKEHLFFVMEFLNGG---DLMFHIQDK---GRFDLYRATFYAAEIVCGL 109
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
++LH I++ DLK NV+LD D + DFG+ C + +S+ G
Sbjct: 110 QFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGM------CKENVFGDNRAST--FCG 158
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T Y+APE G + + D +SFG+LL EM + P
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 50/221 (22%)
Query: 707 IGQGSFGFV---YRGNLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKI 761
IG G+ G V Y G+N VA+K ++ + T K E ++ + H+N+I +
Sbjct: 24 IGSGAQGIVCAAYDTVTGQN---VAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 762 ITVC----SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQ------RLN 811
+ V S +F++V +V E M+ L Q VIQ R++
Sbjct: 81 LNVFTPQKSLEEFQDV---YLVMELMDAN-----LCQ-----------VIQMDLDHERMS 121
Query: 812 -LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
L+ + I++LH I+H DLKPSN+++ D + DFGLAR + + +
Sbjct: 122 YLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMM 174
Query: 871 TPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
TP T Y APE +G D++S G ++ EM
Sbjct: 175 TPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 65/278 (23%), Positives = 110/278 (39%), Gaps = 57/278 (20%)
Query: 707 IGQGSFGFVYRGNLGE-----NEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRN 757
+G+G FG V + VAVK++ + A+ S ++E L+ + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSN------------------DQL 799
+IK+ CS + ++ EY + GSL +L +S D
Sbjct: 65 VIKLYGACSQ---DGPLL--LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 800 EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859
+ + ++ ++ ++YL +VH DL NVL+ + DFGL+R
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR- 175
Query: 860 LPPCSPATILETPSSSTGIKG--TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRR- 916
+ E S KG V ++A E + DV+SFG+LL E+ T
Sbjct: 176 -------DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228
Query: 917 -----PTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLL 949
+ +FN T + +M PE E + L+L
Sbjct: 229 PYPGIAPERLFNLLKTGY---RMERPENCSEEMYNLML 263
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 22/229 (9%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEAL--RNIRHRN 757
DF+ ++G+GSFG V + A+K+ LK+ + EC + R +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSG 58
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
+T S F+ +D V EY+ G L + Q VG F + ++A
Sbjct: 59 KPPFLTQLHSC-FQTMDRLYFVMEYVNGGDLMYQIQQ------VGRFKEPHAVFYAAEIA 111
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+ +LH I++ DLK NV+LD + + DFG+ + + + ++ T
Sbjct: 112 IGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-------ENMWDGVTTKT- 160
Query: 878 IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGL 926
GT Y+APE + D ++FG+LL EM + P + D L
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLK-QRGATKSFVAECEALRNIRHRNLIKIITVC 765
+G+G++ V++G E VA+K + L+ + GA + + E L++++H N++ +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH--- 70
Query: 766 SSIDFEEVDFK-AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
D D +V+EY L+ L Q D + GN + + + + + I
Sbjct: 71 ---DIVHTDKSLTLVFEY-----LDKDLKQYMD--DCGNIMSMHNVKIFL---YQILRGL 117
Query: 825 HHCHP-PIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
+CH ++H DLKP N+L++ + DFGLAR A + T + S + T+
Sbjct: 118 AYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR-------AKSVPTKTYSNEVV-TLW 169
Query: 884 YVAPEYGMG-GDMSATGDVYSFGILLLEMFTRR 915
Y P+ +G + S D++ G + EM + R
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 60/226 (26%), Positives = 87/226 (38%), Gaps = 57/226 (25%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECE--------ALRNIR---- 754
IG+GS+G V++ E VA+K FV E E ALR IR
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIK-----------KFV-ESEDDPVIKKIALREIRMLKQ 56
Query: 755 --HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLE--VGNFNVIQRL 810
H NL+ +I V F +V+EY + H ++LE
Sbjct: 57 LKHPNLVNLIEV-----FRRKRKLHLVFEYCD--------HTVLNELEKNPRGVPEHLIK 103
Query: 811 NLVIDVAFAIEYLH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATIL 869
++ A+ + H H+C +H D+KP N+L+ + DFG AR L
Sbjct: 104 KIIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTG------- 152
Query: 870 ETPSSSTGIKGTVGYVAPEYGMGGDMS--ATGDVYSFGILLLEMFT 913
T T Y APE + GD DV++ G + E+ T
Sbjct: 153 -PGDDYTDYVATRWYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-07
Identities = 25/92 (27%), Positives = 46/92 (50%), Gaps = 19/92 (20%)
Query: 349 KLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIP 408
L+++ L N G +P S+ +++S +L L YN G IP
Sbjct: 443 HLQSINLSGNSIRGNIPPSLGSITSLEVL-------------------DLSYNSFNGSIP 483
Query: 409 HAIGELRNLQVLDLHHNNLDGHIPESLGNLTI 440
++G+L +L++L+L+ N+L G +P +LG +
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 11/105 (10%)
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
+++ A+ YLH I++ DLK NVLLD + + D+G+ C L +
Sbjct: 104 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM------CKEG--LRPGDT 152
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTD 919
++ GT Y+APE G D + D ++ G+L+ EM R P D
Sbjct: 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 48/226 (21%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVM-NLKQR-GATKSFVAECEALRNIRHRNLIKIITV 764
IG G+FG V+ + VA+K M N+ Q + K E + L +H N++ + +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 765 CSSID---FEEVDFKAIVYEYMECGSLEDWLHQ--------SNDQLEVGNFNVIQRLNLV 813
FEE+ +V E M+ LH+ S+D ++V + +++ L
Sbjct: 68 LQPPHIDPFEEI---YVVTELMQSD-----LHKIIVSPQPLSSDHVKVFLYQILRGL--- 116
Query: 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS 873
+YLH I+H D+KP N+L++ + V + DFGLAR +E P
Sbjct: 117 -------KYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR----------VEEPD 156
Query: 874 SSTGIKGTV---GYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
S + V Y APE MG + D++S G + E+ RR
Sbjct: 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 33/219 (15%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA----ECEALRNIRHRNLIKI 761
++G+G+FG V A+K++ K+ K VA E L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
F+ D V EY G L + H S +++ F + ++ A+E
Sbjct: 61 -----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAEIVSALE 109
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK-- 879
YLH +V+ D+K N++LD D + DFGL + E S +K
Sbjct: 110 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATMKTF 155
Query: 880 -GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT Y+APE D D + G+++ EM R P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 50/229 (21%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG+G++G VY+ VA+K K R ALR I +L+++++
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALK----KTRLEMDEEGIPPTALREI---SLLQMLSESI 61
Query: 767 SI----DFEEVDFKA------IVYEYMECGSLEDWLHQSNDQLEVGNFN-----VIQRL- 810
I D E V+ K +V+EY++ L+ ++ D G I+
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFM----DSNGRGPGRPLPAKTIKSFM 116
Query: 811 -NLVIDVAFAIEYLHHHCHP-PIVHGDLKPSNVLLDHD-MVAHVGDFGLAR-FLPPCSPA 866
L+ VA HCH ++H DLKP N+L+D + + D GL R F P
Sbjct: 117 YQLLKGVA--------HCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV--- 165
Query: 867 TILETPSSSTGIKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTR 914
S T T+ Y APE +G +T D++S G + EM +
Sbjct: 166 ------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEAL-RNIRHRNLIKI 761
+IG+GSFG V + AVKV+ K ++ +AE L +N++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
F+ + V +Y+ G L + H ++ F + +VA AI
Sbjct: 62 -----HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERC----FLEPRARFYAAEVASAIG 110
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
YLH I++ DLKP N+LLD + DFGL C +E +++ GT
Sbjct: 111 YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGL------CKEG--VEPEETTSTFCGT 159
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMF 912
Y+APE T D + G +L EM
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN--LKQRGATKSFVAECEALRNIRHRNLIKIITV 764
+G G++G V VA+K + + K E L++++H N+I ++ V
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 765 CSSIDFEEVDFKA--IVYEYM--ECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+ D F +V +M + G L S D+++ F V Q L +
Sbjct: 83 FTP-DLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQ---FLVYQMLK-------GL 131
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
+Y+H I+H DLKP N+ ++ D + DFGLAR +T S TG
Sbjct: 132 KYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----------QTDSEMTGYVV 177
Query: 881 TVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRR 915
T Y APE + + T D++S G ++ EM T +
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 59/232 (25%), Positives = 89/232 (38%), Gaps = 57/232 (24%)
Query: 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVK-VMN-LKQRGATKSFVAECEALRNIRH 755
TN + +G G+FG V VA+K +M K E + L+++RH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYM--------ECGSLEDWLHQSNDQLEVGNFNVI 807
N+I + + S E++ F V E + LE Q + +
Sbjct: 69 ENIISLSDIFIS-PLEDIYF---VTELLGTDLHRLLTSRPLEKQFIQ---------YFLY 115
Query: 808 QRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPAT 867
Q L ++Y+H +VH DLKPSN+L++ + + DFGLAR P
Sbjct: 116 QILR-------GLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDP----- 160
Query: 868 ILETPSSSTGIKGTVGYVAPE-------YGMGGDMSATGDVYSFGILLLEMF 912
TG T Y APE Y + D++S G + EM
Sbjct: 161 ------QMTGYVSTRYYRAPEIMLTWQKYDV------EVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATK-SFVAECEALRNIRHRNLIKIITVC 765
+G+GS+ VY+G N VA+KV+ L++ T + + E L+ ++H N++ + +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
+ + +V+EY+ L ++ + L N + + + + Y+H
Sbjct: 73 HT-----KETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKL-----FLFQLLRGLSYIHQ 121
Query: 826 HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYV 885
I+H DLKP N+L+ + DFGLAR A + + + S + T+ Y
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLAR-------AKSVPSHTYSNEVV-TLWYR 170
Query: 886 APEYGMGG-DMSATGDVYSFGILLLEM 911
P+ +G + S D++ G + +EM
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 59/237 (24%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 693 DLSKAT--NDFSSSNMIGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGATKSFVAECEA 749
DLS+ DF IG G++G VY+ N+ E+A A+KV+ L+ E
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELA-AIKVIKLEPGEDFAVVQQEIIM 59
Query: 750 LRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQR 809
+++ +H N++ + D I E+ GSL+D H + G + Q
Sbjct: 60 MKDCKHSNIVAYFG-----SYLRRDKLWICMEFCGGGSLQDIYHVT------GPLSESQI 108
Query: 810 LNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATIL 869
+ + + YLH +H D+K +N+LL + + DFG++ A I
Sbjct: 109 AYVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS--------AQIT 157
Query: 870 ETPSSSTGIKGTVGYVAPEYGM---GGDMSATGDVYSFGILLLEMFTRRRPTDNMFN 923
T + GT ++APE G + D+++ GI +E+ + P MF+
Sbjct: 158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP---MFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEAL-RNIRHRNLIKI 761
+IG+GSFG V + AVKV+ K R K +AE L +N++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
F+ + V +++ G L + H ++ +F + ++A A+
Sbjct: 62 -----HYSFQTTEKLYFVLDFVNGGEL--FFHLQRER----SFPEPRARFYAAEIASALG 110
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
YLH IV+ DLKP N+LLD + DFGL C + ++T GT
Sbjct: 111 YLHS---INIVYRDLKPENILLDSQGHVVLTDFGL------CKEG--IAQSDTTTTFCGT 159
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMF 912
Y+APE T D + G +L EM
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN--LKQRGATKSFVAECEALRNIRHRNLIKIITV 764
IG G+ G V E VA+K ++ + + K E ++ + H+N+I ++ V
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 765 CS-SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLN-LVIDVAFAIEY 822
+ EE IV E M+ + Q+E+ + +R++ L+ + I++
Sbjct: 92 FTPQKSLEEFQDVYIVMELMDANLCQVI------QMELDH----ERMSYLLYQMLCGIKH 141
Query: 823 LHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTV 882
LH I+H DLKPSN+++ D + DFGLAR + + + TP T
Sbjct: 142 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVVTRY---- 190
Query: 883 GYVAPEYGMGGDMSATGDVYSFGILLLEM 911
Y APE +G D++S G ++ EM
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 62/245 (25%), Positives = 106/245 (43%), Gaps = 34/245 (13%)
Query: 699 NDFSSSNMIGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRN 757
+D+ +G G++G VY+ NL E+A AVK++ L+ E ++ +H N
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELA-AVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
++ S + E++ I EY GSL+D H + G + +Q + +
Sbjct: 68 IVAYFG--SYLSREKL---WICMEYCGGGSLQDIYHVT------GPLSELQIAYVCRETL 116
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+ YLH +H D+K +N+LL + + DFG+A A I T +
Sbjct: 117 QGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA--------AKITATIAKRKS 165
Query: 878 IKGTVGYVAPEYGM---GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934
GT ++APE G + D+++ GI +E+ + P MF+ LH +
Sbjct: 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP---MFD----LHPMRAL 218
Query: 935 ALPEK 939
L K
Sbjct: 219 FLMSK 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 5e-07
Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHR 756
DF +IG+G+FG V L + A+K++N + +R T F E + L N ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL--EVGNFNVIQRLNLVI 814
+ + F++ + +V +Y G L L + D+L ++ F + + + + I
Sbjct: 62 WITTL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-IAI 115
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE--TP 872
D ++ LH+ VH D+KP N+L+D + + DFG S ++E T
Sbjct: 116 D---SVHQLHY------VHRDIKPDNILMDMNGHIRLADFG--------SCLKLMEDGTV 158
Query: 873 SSSTGIKGTVGYVAPEYGMG-----GDMSATGDVYSFGILLLEMFTRRRP 917
SS + GT Y++PE G D +S G+ + EM P
Sbjct: 159 QSSVAV-GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 50/224 (22%), Positives = 93/224 (41%), Gaps = 29/224 (12%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT------KSFVAECEALRNIRHRNLI 759
+G G+F Y+ + +AVK + + ++ ++ E + + H ++I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
+ E+ F + E+M GS+ L + G F +N +
Sbjct: 67 R----MLGATCEDSHFN-LFVEWMAGGSVSHLLS------KYGAFKEAVIINYTEQLLRG 115
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLD---HDMVAHVGDFGLARFLPPCSPATILETPSSST 876
+ YLH + I+H D+K +N+L+D + + DFG A L A
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLA----AKGTGAGEFQG 166
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920
+ GT+ ++APE G + DV+S G +++EM T + P +
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 36/130 (27%), Positives = 61/130 (46%), Gaps = 12/130 (9%)
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
++ A+ +LH I++ DLK NVLLD D + D+G+ C L +
Sbjct: 104 EICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGM------CKEG--LGPGDT 152
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMF-NDGLTLHEFAK 933
++ GT Y+APE G + + D ++ G+L+ EM R P D + N + ++
Sbjct: 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212
Query: 934 MALPEKVMEI 943
+ EK + I
Sbjct: 213 QVILEKPIRI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 32/223 (14%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEAL-RNI-----RHRNLI 759
++G+GSFG V L + A+KV LK+ + +C + I +H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
+ F+ D V EY+ G L + +S F+ + +V A
Sbjct: 60 AL---HCC--FQTKDRLFFVMEYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLA 108
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+ +LH H +++ DLK N+LLD + + DFG+ + IL +++T
Sbjct: 109 LMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-------EGILNGVTTTT-FC 157
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP--TDN 920
GT Y+APE + + D ++ G+L+ EM + P DN
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 36/204 (17%)
Query: 727 VAVKVMNLK-QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMEC 785
VAVK++ + A F+ E + L ++ N+I+++ VC D ++ EYME
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITEYMEN 103
Query: 786 GSLEDWL--HQSNDQLEVGNFNVIQR-----------LNLVIDVAFAIEYLHHHCHPPIV 832
G L +L H +D+ E GN V L++ + +A ++YL V
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV 160
Query: 833 HGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG----TVGYVAPE 888
H DL N L+ ++ + DFG++R L I+G + ++A E
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNL----------YAGDYYRIQGRAVLPIRWMAWE 210
Query: 889 YGMGGDMSATGDVYSFGILLLEMF 912
+ G + DV++FG+ L E+
Sbjct: 211 CILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 8e-07
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 707 IGQGSFGFV---YRGNLGENEMAVAVKVMN--LKQRGATKSFVAECEALRNIRHRNLIKI 761
IG G+ G V Y L N VA+K ++ + + K E ++ + H+N+I +
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 762 ITVCS-SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLN-LVIDVAFA 819
+ V + EE +V E M+ + Q+E+ + +R++ L+ +
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVI------QMELDH----ERMSYLLYQMLCG 131
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
I++LH I+H DLKPSN+++ D + DFGLAR + + + TP T
Sbjct: 132 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVVTRY- 183
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
Y APE +G D++S G ++ EM
Sbjct: 184 ----YRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 39/222 (17%)
Query: 700 DFSSSNMIGQGSFGFVYRGNL-GENEMAVAVKVMN----LKQRGATKSFVAECEALRNIR 754
DF+ +G GSFG V E+ VA+K +KQ+ F +E + L I
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYIN 89
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQS----NDQLEVGNFNVIQRL 810
H + + F++ + +V E++ G +L ++ ND VG F Q
Sbjct: 90 HPFCVNLYG-----SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND---VGCFYAAQ-- 139
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
+ EYL IV+ DLKP N+LLD D + DFG A+ +++
Sbjct: 140 -----IVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAK---------VVD 182
Query: 871 TPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMF 912
T + + + GT Y+APE + D ++ GI + E+
Sbjct: 183 TRTYT--LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-07
Identities = 50/179 (27%), Positives = 71/179 (39%), Gaps = 35/179 (19%)
Query: 746 ECEALRNIRHRNLIKII-------TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQ 798
E + L+ I HR +I +I TVC + + D V + LE +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV-DRSGPLPLEQAI------ 188
Query: 799 LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858
IQR L A+ YLH I+H D+K N+ LD A +GDFG A
Sbjct: 189 -------TIQRRLLE-----ALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAA- 232
Query: 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
C +TP G GT+ +PE A D++S G++L EM +
Sbjct: 233 ----CKLDAHPDTP-QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
+++ A+ +LH I++ DLK NVLLD + + D+G+ + I ++
Sbjct: 104 EISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-------EGIRPGDTT 153
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTD 919
ST GT Y+APE G D + D ++ G+L+ EM R P D
Sbjct: 154 ST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 707 IGQGSFGFVYRGNLG------------ENEMAVAVKVMNLKQRGATKSFVAECEALRNIR 754
+G+G+ +Y G L E E+ V +KV++ R + +F +R +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVG-NFNVIQRLNLV 813
H++++ + VC D E + +V E++E G L+ ++H+ +D L F V ++L
Sbjct: 63 HKHIVLLYGVCVR-DVENI----MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQL--- 114
Query: 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG-LARFLPPCSPATILETP 872
A A+ YL +VHG++ N+LL + + G+ G + P P T+L
Sbjct: 115 ---ASALSYLEDK---DLVHGNVCTKNILLAREGID--GECGPFIKLSDPGIPITVLSRQ 166
Query: 873 SSSTGIKGTVGYVAPE-YGMGGDMSATGDVYSFGILLLEM 911
I ++APE ++S D +SFG L E+
Sbjct: 167 ECVERIP----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG+GSFG V + + + A+K + K ++S V A R + + I V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHTLAERTVLAQVNCPFI-VPL 58
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
F+ + +V ++ G L L + G F++ + ++ A+E LH
Sbjct: 59 KFSFQSPEKLYLVLAFINGGELFHHLQRE------GRFDLSRARFYTAELLCALENLHKF 112
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVA 886
+++ DLKP N+LLD+ + DFGL + + + ++T GT Y+A
Sbjct: 113 ---NVIYRDLKPENILLDYQGHIALCDFGLCKL-------NMKDDDKTNT-FCGTPEYLA 161
Query: 887 PEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
PE +G + D ++ G+LL EM T P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-07
Identities = 66/252 (26%), Positives = 110/252 (43%), Gaps = 45/252 (17%)
Query: 683 EQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVK-VMNLKQRGATK 741
E F +V D+ +T F +++G+G+FG V + + AVK V N+ + T+
Sbjct: 113 EGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY--TR 170
Query: 742 SFVAECEALRNIRHRN------LIKIITVCSSIDFEEVDFKAIVY-EYMECGSLEDWLHQ 794
E + + +R + L+KI + E IV +Y C L DW+
Sbjct: 171 DAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----ETGHMCIVMPKYGPC--LLDWI-- 222
Query: 795 SNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH-----DMVA 849
++ G F+ ++ A++Y H H ++H DLKP N+L++ D V
Sbjct: 223 ----MKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVT 276
Query: 850 HVGDFGLARFLPP-------CSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDV 901
+ R LPP C + S T I T Y +PE +G G M +T D+
Sbjct: 277 N-------RALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYST-DM 328
Query: 902 YSFGILLLEMFT 913
+S G ++ E++T
Sbjct: 329 WSMGCIIYELYT 340
|
Length = 467 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 62/255 (24%), Positives = 104/255 (40%), Gaps = 52/255 (20%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN--LKQRGATKSFVAECEALRNIRHRNLIKIITV 764
+G G++G V VAVK ++ + + E L++++H N+I ++ V
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 765 ----CSSIDFEEV---------DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLN 811
S +F EV D IV +C L D + ++ F + Q L
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIV----KCQKLSD------EHVQ---FLIYQLLR 129
Query: 812 LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILET 871
++Y+H I+H DLKPSNV ++ D + DFGLAR +
Sbjct: 130 -------GLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR-----------QA 168
Query: 872 PSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRR--PTDNMFNDGLTL 928
TG T Y APE + + T D++S G ++ E+ + P ++ + +
Sbjct: 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
Query: 929 HEFAKMALPEKVMEI 943
E PE + +I
Sbjct: 229 MEVVGTPSPEVLKKI 243
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 26/225 (11%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA----ECEALRNIRHRNLIKI 761
++G+G+FG V A+K++ K+ K VA E L+N RH L +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
F+ D V EY G L + H S +++ F+ + ++ A++
Sbjct: 61 -----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAEIVSALD 109
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
YLH +V+ DLK N++LD D + DFGL C ++ ++ GT
Sbjct: 110 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGL------CKEG--IKDGATMKTFCGT 159
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGL 926
Y+APE D D + G+++ EM R P N ++ L
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 28/203 (13%)
Query: 721 GENEMAVAVKVMNLK-QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIV 779
G + VAVK++ + A F+ E + + ++ N+I+++ VC D ++
Sbjct: 43 GNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMI 97
Query: 780 YEYMECGSLEDWL--HQSNDQLEVGNFNVIQRLNLV---IDVAFAIEYLHHHCHPPIVHG 834
EYME G L +L H+ + E + I L+ +A ++YL VH
Sbjct: 98 TEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHR 154
Query: 835 DLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG----TVGYVAPEYG 890
DL N L+ + + DFG++R L I+G + +++ E
Sbjct: 155 DLATRNCLVGKNYTIKIADFGMSRNL----------YSGDYYRIQGRAVLPIRWMSWESI 204
Query: 891 MGGDMSATGDVYSFGILLLEMFT 913
+ G + DV++FG+ L E+ T
Sbjct: 205 LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRNLIKII 762
++G+GSFG V L E+ AVKV+ + Q + + E L R+ + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
C F+ D V E++ G L + +S F+ + ++ A+ +
Sbjct: 62 YCC----FQTPDRLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMF 111
Query: 823 LHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTV 882
LH I++ DLK NVLLDH+ + DFG+ + I ++ST GT
Sbjct: 112 LHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-------EGIFNGKTTST-FCGTP 160
Query: 883 GYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
Y+APE + D ++ G+LL EM P
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 62/241 (25%), Positives = 94/241 (39%), Gaps = 33/241 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRNLIKIIT 763
+G+G FG V + A K ++ LK++ K + E E L + N I+
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV---NSPFIVN 57
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQR---LNLVIDVAFAI 820
+ + FE +V M G L+ + +NV +R + VI + I
Sbjct: 58 LAYA--FESKTHLCLVMSLMNGGDLKYHI-----------YNVGERGLEMERVIHYSAQI 104
Query: 821 EYLHHHCHP-PIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
H H IV+ D+KP NVLLD + D GLA L T
Sbjct: 105 TCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---------ITQRA 155
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEK 939
GT GY+APE S D ++ G + EM R P + + + E + L ++
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD-HKEKVAKEELKRRTLEDE 214
Query: 940 V 940
V
Sbjct: 215 V 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 57/224 (25%), Positives = 91/224 (40%), Gaps = 32/224 (14%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRN 757
F ++G+G FG V + A K + +K+R + E L + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGN--FNVIQRLNLVID 815
++ + + +E D +V M G L+ H N +GN F+ + + +
Sbjct: 62 VVSL-----AYAYETKDALCLVLTIMNGGDLK--FHIYN----MGNPGFDEQRAIFYAAE 110
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+ +E L IV+ DLKP N+LLD + D GLA ++ P
Sbjct: 111 LCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA-----------VQIPEGE 156
Query: 876 T--GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T G GTVGY+APE + + D + G L+ EM + P
Sbjct: 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 57/226 (25%), Positives = 106/226 (46%), Gaps = 36/226 (15%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
+DF + +G G+ G V++ + + + +A K+++L+ + A+RN R L
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK----------PAIRNQIIREL 54
Query: 759 IKIITVCSS---IDFEEVDFK----AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLN 811
+++ C+S + F + +I E+M+ GSL+ L ++ E ++ +++
Sbjct: 55 -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVS 109
Query: 812 LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILET 871
I V + YL I+H D+KPSN+L++ + DFG++ L
Sbjct: 110 --IAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----------I 155
Query: 872 PSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
S + GT Y++PE G S D++S G+ L+EM R P
Sbjct: 156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 11/103 (10%)
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
+++ A+E+LH I++ DLKP N+LLD + DFGL + +I E +
Sbjct: 108 EISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK-------ESIHEGTVT 157
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T GT+ Y+APE M D +S G L+ +M T P
Sbjct: 158 HT-FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 52/230 (22%)
Query: 707 IGQGSFGFVYRGNLGEN----------EMAVAVKVMNLKQRGATKSFVAECEALRNIRHR 756
+GQG+F +Y+G L E++V +KV+ R + +F + + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDS-LAFFETASLMSQLSHK 61
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
+L+K+ VC D +V EY++ G L+ +LH E N ++ +L++ +
Sbjct: 62 HLVKLYGVCVR------DENIMVEEYVKFGPLDVFLH-----REKNNVSLHWKLDVAKQL 110
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
A A+ YL +VHG++ N+L+ GL P S
Sbjct: 111 ASALHYLEDK---KLVHGNVCGKNILVARY--------GLNEGYVPFIKL-------SDP 152
Query: 877 GIKGTVG----------YVAPEYGMGGDMSAT--GDVYSFGILLLEMFTR 914
GI TV ++APE G S T D +SFG LLE+ +
Sbjct: 153 GIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 54/226 (23%), Positives = 103/226 (45%), Gaps = 36/226 (15%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
+DF + +G G+ G V + + + +A K+++L+ + A+RN R L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK----------PAIRNQIIREL 54
Query: 759 IKIITVCSS---IDFEEVDFK----AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLN 811
+++ C+S + F + +I E+M+ GSL+ L ++ E ++ +++
Sbjct: 55 -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE----EILGKVS 109
Query: 812 LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILET 871
+ + A H I+H D+KPSN+L++ + DFG++ L
Sbjct: 110 IAVLRGLAYLREKHQ----IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----------I 155
Query: 872 PSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
S + GT Y++PE G S D++S G+ L+E+ R P
Sbjct: 156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 47/214 (21%), Positives = 89/214 (41%), Gaps = 36/214 (16%)
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
+ N IK+ +++ ++ +Y++ G L D L + G + + ++
Sbjct: 68 NPNFIKLYYSVTTLKGH-----VLIMDYIKDGDLFDLLKKE------GKLSEAEVKKIIR 116
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMV-AHVGDFGLARFLPPCSPATILETPS 873
+ A+ LH H I+H D+K NVL D ++ D+GL + I+ TPS
Sbjct: 117 QLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK---------IIGTPS 164
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933
GT+ Y +PE G + + D ++ G+L E+ T + P ++ L L K
Sbjct: 165 C---YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221
Query: 934 M---------ALPEKVMEIVDPLLLLDLEARASN 958
+ + + V +L ++ R +N
Sbjct: 222 RQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTN 255
|
Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 42/216 (19%)
Query: 727 VAVKVMNLK---QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYM 783
VAVKV L+ A + F+ E + L + N+ +++ VC+ ++ EYM
Sbjct: 49 VAVKV--LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV-----DPPLCMIMEYM 101
Query: 784 ECGSLEDWL--HQSNDQLEVGNFNVIQRLNLV---IDVAFAIEYLHHHCHPPIVHGDLKP 838
E G L +L H + N + L+ +A + YL VH DL
Sbjct: 102 ENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT 158
Query: 839 SNVLLDHDMVAHVGDFGLARFLPPC--------SPATILETPSSSTGIKGTVGYVAPEYG 890
N L+ + + DFG++R L +P I ++A E
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR--------------WMAWESV 204
Query: 891 MGGDMSATGDVYSFGILLLEMFT--RRRPTDNMFND 924
+ G + DV++FG+ L E+ T R +P +++ +
Sbjct: 205 LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 35/108 (32%), Positives = 52/108 (48%), Gaps = 19/108 (17%)
Query: 832 VHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT----VGYVAP 887
+H D+ NVLL VA + DFGLAR I+ S+ +KG V ++AP
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLAR--------DIMN--DSNYVVKGNARLPVKWMAP 283
Query: 888 EYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFNDGLTLHEFAKM 934
E + DV+S+GILL E+F+ + P + + +F KM
Sbjct: 284 ESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN----SKFYKM 327
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 707 IGQGSFGFV----YRGNLGENEMAVAVKVMNLKQRG-ATKSFVAECEALRNIR-HRNLIK 760
+GQG++G V E +A+ K+ N+ + K + E + LR+ R H+N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIK-KITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 761 IITVCSSIDFEEVDFKAI--VYEYMECGSLEDWLHQ---SNDQLEVGNFNVIQRLNLVID 815
+ D + V +Y Y E +E LHQ S L +F + +
Sbjct: 67 LY------DMDIVFPGNFNELYLYEEL--MEADLHQIIRSGQPLTDAHFQ-----SFIYQ 113
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+ ++Y+H ++H DLKP N+L++ D + DFGLAR S E
Sbjct: 114 ILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR---GFSENPG-ENAGFM 166
Query: 876 TGIKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
T T Y APE + DV+S G +L E+ R+
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 19/195 (9%)
Query: 724 EMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYM 783
E VA VM +R A + +E L H ++K DF+ D ++ EY
Sbjct: 94 EKVVAKFVMLNDERQAAYA-RSELHCLAACDHFGIVKHFD-----DFKSDDKLLLIMEYG 147
Query: 784 ECGSLEDWLHQS-NDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVL 842
G L + Q + L + V L + A++ +H ++H DLK +N+
Sbjct: 148 SGGDLNKQIKQRLKEHLPFQEYEVGL---LFYQIVLALDEVHSRK---MMHRDLKSANIF 201
Query: 843 LDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVY 902
L + +GDFG ++ S + L+ SS GT Y+APE S D++
Sbjct: 202 LMPTGIIKLGDFGFSK---QYSDSVSLDVASS---FCGTPYYLAPELWERKRYSKKADMW 255
Query: 903 SFGILLLEMFTRRRP 917
S G++L E+ T RP
Sbjct: 256 SLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 38/224 (16%)
Query: 707 IGQGSFGFVYRGNL--GENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITV 764
+G+G++G VY+ G++E A+K ++ G + S E LR ++H N+I + V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALK--QIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLH--------QSNDQ-LEVGNFNVIQRLNLVID 815
S +V ++++Y E D H ++N + +++ V L ++D
Sbjct: 67 FLSHSDRKV---WLLFDYAE----HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLL----DHDMVAHVGDFGLAR-FLPPCSPATILE 870
I YLH + ++H DLKP+N+L+ + D G AR F P P L+
Sbjct: 120 ---GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 871 TPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFT 913
+ T Y APE +G + D+++ G + E+ T
Sbjct: 174 P------VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 35/105 (33%), Positives = 48/105 (45%), Gaps = 16/105 (15%)
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
++ +E LH IV+ DLKP N+LLD + D GLA +E P
Sbjct: 110 EITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA-----------VEIPEG 155
Query: 875 ST--GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T G GTVGY+APE + + D + G L+ EM + P
Sbjct: 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 25/215 (11%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRNLIKII 762
++G+G+FG V A+K++ + + + E L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
F+ D V EY G L + H S +++ F+ + ++ A+ Y
Sbjct: 61 ----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAEIVSALGY 110
Query: 823 LHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTV 882
LH +V+ DLK N++LD D + DFGL + I + + T GT
Sbjct: 111 LHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKT-FCGTP 159
Query: 883 GYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
Y+APE D D + G+++ EM R P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 7e-06
Identities = 57/252 (22%), Positives = 96/252 (38%), Gaps = 59/252 (23%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI---RH 755
+DF S +IG+G+FG V + A+K + K K VA A R+I
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEAD 59
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSL------EDWLHQSNDQLEVGNFNVIQR 809
+ + S F++ ++ ++ EY+ G + +D + + +
Sbjct: 60 NPWV-VKLYYS---FQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA------- 108
Query: 810 LNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL------------A 857
+ AI+ +H + +H D+KP N+LLD + DFGL
Sbjct: 109 -----ETILAIDSIHKLGY---IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160
Query: 858 RFLPPCSPATILETPSSSTGIKG---------------TVG---YVAPEYGMGGDMSATG 899
R L P+ L+ S K TVG Y+APE + +
Sbjct: 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC 220
Query: 900 DVYSFGILLLEM 911
D +S G+++ EM
Sbjct: 221 DWWSLGVIMYEM 232
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT-KSFVAECEALRNIRHRNLIKIITVC 765
+G+G++G VY+ + +A+K + L+ + + E + L H+ + I
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI--- 61
Query: 766 SSIDFEEVDF-KAIVY---EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
+DF F + VY EYM+ GSL D L+ E +V++R+ +
Sbjct: 62 --VDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
H+ I+H D+KP+NVL++ + + DFG+ + L + T I G
Sbjct: 119 KEEHN----IIHRDVKPTNVLVNGNGQVKLCDFGV---------SGNLVASLAKTNI-GC 164
Query: 882 VGYVAPEYGMGGDMSATG------DVYSFGILLLEMFTRRRP 917
Y+APE G + DV+S G+ +LEM R P
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-06
Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 15/106 (14%)
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR-FLPPCSPATILETPS 873
++ A+E+LH IV+ D+K N+LLD + + DFGL++ FL E
Sbjct: 113 EIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS--------EEKE 161
Query: 874 SSTGIKGTVGYVAPEY--GMGGDMSATGDVYSFGILLLEMFTRRRP 917
+ GT+ Y+APE G GG A D +S GIL+ E+ T P
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAV-DWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 9e-06
Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 34/221 (15%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
DF +GQG +G V+ + VA+K M L + + + E + L +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLE-VGNFNVIQRLNLVI 814
L+K++ F++ ++ + EY+ G L+ E F + +
Sbjct: 61 EWLVKLL-----YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE--- 112
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
A++ LH +H DLKP N L+D + DFGL+ I+ +S
Sbjct: 113 ----AVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLS--------KGIVTYANS 157
Query: 875 STGIKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEMFT 913
+ G+ Y+APE G G D T D +S G +L E
Sbjct: 158 ---VVGSPDYMAPEVLRGKGYDF--TVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 24/145 (16%)
Query: 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI-DVAFAIEYLHHHCHPPIVHGDL 836
++ +Y+ G L L+Q +F + + I ++ A+++LH I++ D+
Sbjct: 82 LILDYVNGGELFTHLYQR------EHFT-ESEVRVYIAEIVLALDHLHQL---GIIYRDI 131
Query: 837 KPSNVLLDHDMVAHVGDFGLAR-FLPPCSPATILETPSSSTGIKGTVGYVAPEY---GMG 892
K N+LLD + + DFGL++ FL E + GT+ Y+APE G G
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLA--------EEEERAYSFCGTIEYMAPEVIRGGSG 183
Query: 893 GDMSATGDVYSFGILLLEMFTRRRP 917
G A D +S G+L E+ T P
Sbjct: 184 GHDKAV-DWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-06
Identities = 36/116 (31%), Positives = 53/116 (45%), Gaps = 25/116 (21%)
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC--SPATILETPSSST 876
AI+Y+H I+H D+K NVL++ +GDFG A F +P
Sbjct: 272 AIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF--------HY 320
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLE-------MFT-----RRRPTDN 920
GI GTV APE G + + D++S G+++ E +F+ RRP D
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDA 376
|
Length = 461 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-05
Identities = 25/59 (42%), Positives = 32/59 (54%)
Query: 538 LEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHL 596
L+ L + N LT A K L ++K LDLS NNL+ PE L L L+LS N+L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 60/222 (27%), Positives = 91/222 (40%), Gaps = 24/222 (10%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRH--R 756
DF + +I G++G VY E A+K +N KQ ++ + + R+I
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN-KQNLILRNQIQQVFVERDILTFAE 59
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
N + CS FE +V EY+E G L +G V +
Sbjct: 60 NPFVVSMFCS---FETKRHLCMVMEYVEGGDCATLLKN------IGALPVDMARMYFAET 110
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
A+EYLH++ IVH DLKP N+L+ + DFGL++ + S T L
Sbjct: 111 VLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSK-IGLMSLTTNLYEGHIEK 166
Query: 877 GIK--------GTVGYVAPEYGMGGDMSATGDVYSFGILLLE 910
+ GT Y+APE + D ++ GI+L E
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-05
Identities = 20/60 (33%), Positives = 26/60 (43%)
Query: 416 NLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKL 475
NL+ LDL +N L + L L LDL N L P + +L L +S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 30/95 (31%), Positives = 43/95 (45%), Gaps = 15/95 (15%)
Query: 831 IVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS-SSTGIKGTVGYVAPEY 889
++H D+KPSN+LLD + DFG++ L S + T G Y+APE
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRL----------VDSKAKTRSAGCAAYMAPER 185
Query: 890 ----GMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920
DV+S GI L+E+ T + P N
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 707 IGQGSFGFVYRGNL--GENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITV 764
+G+G++G VY+ G+++ A+K ++ G + S E LR ++H N+I + V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALK--QIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 765 CSS---------IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
S D+ E D I+ + + ++ QL G +L+
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKA-----NKKPVQLPRGMVK-----SLLYQ 116
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLL----DHDMVAHVGDFGLAR-FLPPCSPATILE 870
+ I YLH + ++H DLKP+N+L+ + D G AR F P P L+
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 871 TPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFT 913
+ T Y APE +G + D+++ G + E+ T
Sbjct: 174 P------VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN--LKQRGATKSFVAECEALRNIRHRNL 758
++S +G G++G V VA+K ++ + K E L++++H N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 759 IKIITV-CSSIDFEEVDFKAIVYEYMECGSLED--WLHQSNDQLEVGNFNVIQRLNLVID 815
I ++ V S++ +E +V YM+ L+ S D+++ + V Q L
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQ---YLVYQMLC---- 128
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
++Y+H I+H DLKP N+ ++ D + DFGLAR +
Sbjct: 129 ---GLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----------HADAEM 171
Query: 876 TGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFT 913
TG T Y APE + + T D++S G ++ EM T
Sbjct: 172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 31/228 (13%)
Query: 700 DFSSSNMIGQGSFG--FVYRGNLGENE-----MAVAVKVMNLKQRGATKSFVAECEALRN 752
+F ++G G++G F+ R G + M V K +++ T+ E + L +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNL 812
IR + V F+ ++ +Y+ G L L Q E Q + +
Sbjct: 61 IRQSPFL----VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE-------QEVQI 109
Query: 813 VI-DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILET 871
++ A+E+LH I++ D+K N+LLD + + DFGL++ +
Sbjct: 110 YSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF-------HEDE 159
Query: 872 PSSSTGIKGTVGYVAPEYGMGGDM--SATGDVYSFGILLLEMFTRRRP 917
+ GT+ Y+AP+ GGD D +S G+L+ E+ T P
Sbjct: 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 18/140 (12%)
Query: 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLK 837
I E+M+ GSL+ L ++ E N++ +++ I V + YL I+H D+K
Sbjct: 76 ICMEHMDGGSLDQVLKKAGRIPE----NILGKIS--IAVLRGLTYLREKHK--IMHRDVK 127
Query: 838 PSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSA 897
PSN+L++ + DFG++ L S + GT Y++PE G +
Sbjct: 128 PSNILVNSRGEIKLCDFGVSGQL----------IDSMANSFVGTRSYMSPERLQGTHYTV 177
Query: 898 TGDVYSFGILLLEMFTRRRP 917
D++S G+ L+EM R P
Sbjct: 178 QSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 28/87 (32%), Positives = 41/87 (47%), Gaps = 10/87 (11%)
Query: 831 IVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYG 890
I+H D+KPSN+L++ + DFG++ L S + GT Y+APE
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----------VNSIAKTYVGTNAYMAPERI 165
Query: 891 MGGDMSATGDVYSFGILLLEMFTRRRP 917
G DV+S GI +E+ R P
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 12/202 (5%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
LDLS + L + NLS L ++ + N S ++P EI L LE L L+NNS
Sbjct: 166 KNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII- 222
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISN 198
++ S+LS NL N L P+ + LE L L +N ++ S+G+++N
Sbjct: 223 ELLSSLSNLKNLSGLELSNNKLED--LPESIGNLSNLETLDLSNNQISS--ISSLGSLTN 278
Query: 199 LQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLE 258
L+ L + N LS LP L L + ++S+ + + + E
Sbjct: 279 LRELDLSGNSLSNALPLIALLL----LLLELLLNLLLTLKALELKLNSILLNNNILSNGE 334
Query: 259 GSLPVNIGFSLPNLENLSVRQN 280
S P + L +L NL N
Sbjct: 335 TSSPEAL-SILESLNNLWTLDN 355
|
Length = 394 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 41/140 (29%), Positives = 62/140 (44%), Gaps = 27/140 (19%)
Query: 810 LNLVIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATI 868
L+ VA + +L +C +H DL N+LL H + + DFGLAR +
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI-------- 264
Query: 869 LETPSSSTGIKGT----VGYVAPEYGMGGDMSATGDVYSFGILLLEMFT------RRRPT 918
S+ +KG V ++APE + DV+S+GILL E+F+ P
Sbjct: 265 --RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322
Query: 919 DNMFNDGLTLHEFAKMALPE 938
D+ F + E +M PE
Sbjct: 323 DSKFYK--MIKEGYRMLSPE 340
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 5e-05
Identities = 39/124 (31%), Positives = 57/124 (45%), Gaps = 21/124 (16%)
Query: 795 SNDQLEVGNFNVIQRLNLVIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853
S+D E + L+ VA +E+L +C VH DL NVLL + + D
Sbjct: 227 SDDGSE--GLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICD 280
Query: 854 FGLARFLPPCSPATILETPSSSTGIKGT----VGYVAPEYGMGGDMSATGDVYSFGILLL 909
FGLAR + S+ KG+ V ++APE + DV+S+GILL
Sbjct: 281 FGLARDI----------MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330
Query: 910 EMFT 913
E+F+
Sbjct: 331 EIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 31/176 (17%)
Query: 746 ECEALRNIRHRNLIKIITVCSSIDF-----EEVDFKAIVYEYMECGSLEDWLHQSNDQLE 800
E AL + H N++KI + S ++ DF +Y +M + DW + L+
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAF-DW--KDRPLLK 267
Query: 801 VGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860
Q ++ + A+EY+H ++H D+K N+ L+ D +GDFG
Sbjct: 268 -------QTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFG----- 312
Query: 861 PPCSPATILETPSSST--GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914
A E + G GTV +PE G D++S G++LL+M +
Sbjct: 313 ----TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364
|
Length = 501 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 9e-05
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 50/222 (22%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFV---AECEALRNIR-HRNLIKII 762
IG+G+F V + + A+K M K+ + V E +ALR + H N++++I
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 763 TV-------CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
V ++ FE +D +YE ++ G + + V ++ + Q L
Sbjct: 65 EVLFDRKTGRLALVFELMDMN--LYELIK-GR-----KRPLPEKRVKSY-MYQLLK---- 111
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+++++H + I H D+KP N+L+ D++ + DFG R I P +
Sbjct: 112 ---SLDHMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCR--------GIYSKPPYT 156
Query: 876 TGIKGTVGYVAPE-------YGMGGDMSATGDVYSFGILLLE 910
I T Y APE YG D+ A G V+ F IL L
Sbjct: 157 EYI-STRWYRAPECLLTDGYYGPKMDIWAVGCVF-FEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 57/245 (23%), Positives = 84/245 (34%), Gaps = 58/245 (23%)
Query: 413 ELRNLQVLDLHHNNLDGH----IPESLGNLTILNSLDLGFNKLRGH------VPSSLGNC 462
+L LQVL L N L + +L L L L N+ + L
Sbjct: 21 KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80
Query: 463 QNLMLLSVSNNKLTGALP---PQILGIVTLSIL--------------------------- 492
L L +S+N L +L +L L
Sbjct: 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140
Query: 493 -LDLSGNLLTGSIPAEVGNL----KNLVQLGLSENRFSNE----IPVSLSACTTLEYLYM 543
L L N L G+ + ++L +L L+ N + + L A LE L +
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL 200
Query: 544 EGNSLT--GSIPLA--LKTLKSIKELDLSRNNLSGQI-----PEFLENLSFLEYLNLSYN 594
N LT G+ LA L +LKS++ L+L NNL+ L L L+LS N
Sbjct: 201 NNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260
Query: 595 HLEGE 599
+ +
Sbjct: 261 DITDD 265
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 33/233 (14%)
Query: 694 LSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEAL 750
L D+ +IG+G+FG V ++ A+K+++ + +R + F E + +
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 751 RNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRL 810
++++ C+ F++ + +V EYM G L + + N++V ++
Sbjct: 98 AFANSPWVVQLF--CA---FQDDKYLYMVMEYMPGGDLVNLM---------SNYDVPEKW 143
Query: 811 N--LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATI 868
+V A++ +H ++H D+KP N+LLD + DFG C
Sbjct: 144 AKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFG------TCMKMDE 194
Query: 869 LETPSSSTGIKGTVGYVAPEY--GMGGD--MSATGDVYSFGILLLEMFTRRRP 917
T + GT Y++PE GGD D +S G+ L EM P
Sbjct: 195 TGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 36/119 (30%), Positives = 53/119 (44%), Gaps = 24/119 (20%)
Query: 748 EALRNIRHRNLIKIIT------VCSSIDFE-EVDFKAIVYEYMECGSLEDWLHQSNDQLE 800
E LR R R +I+ V I ++ + D IV EY+E L+D L ++
Sbjct: 39 EKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----- 93
Query: 801 VGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859
R +L+ +V + LH IVHGDL SN++L + + DFGL F
Sbjct: 94 --------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGRI-YFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 62/239 (25%), Positives = 101/239 (42%), Gaps = 52/239 (21%)
Query: 701 FSSSNM-----IGQGSFGFVYRGNLGENEMAVAVK-----VMNLKQRGATKSFVAECEAL 750
F++ ++ IG+G+FG V + + +AVK V +Q K + + + +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ----KRLLMDLDVV 56
Query: 751 RNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL-----EVGNFN 805
+R + I+ ++ F E D I E M+ S D+ EV
Sbjct: 57 --MRSSDCPYIVKFYGAL-FREGD-CWICMELMDI---------SLDKFYKYVYEVLKSV 103
Query: 806 VIQRLNLVIDVAF--AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863
+ + + I VA A+ YL I+H D+KPSN+LLD + + DFG++
Sbjct: 104 IPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQ---- 157
Query: 864 SPATILETPSSSTGIKGTVGYVAPE-----YGMGGDMSATGDVYSFGILLLEMFTRRRP 917
L + T G Y+APE G D+ + DV+S GI L E+ T + P
Sbjct: 158 -----LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRS--DVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 55/229 (24%), Positives = 96/229 (41%), Gaps = 25/229 (10%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLI 759
F ++G G++G VY+G + A+KVM++ + E L+ HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 66
Query: 760 KIITVCSSIDFEEVDFKA-IVYEYMECGSLEDWLHQSN-DQLEVGNFNVIQRLNLVIDVA 817
+ +D + +V E+ GS+ D + + + L+ I R ++
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EIL 121
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+ +LH H ++H D+K NVLL + + DFG++ A + T
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS--------AQLDRTVGRRNT 170
Query: 878 IKGTVGYVAPEY-GMGGDMSAT----GDVYSFGILLLEMFTRRRPTDNM 921
GT ++APE + AT D++S GI +EM P +M
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 50/196 (25%), Positives = 84/196 (42%), Gaps = 21/196 (10%)
Query: 718 GNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777
GN E+ V +KV++ R +F + + H +L + VC E +
Sbjct: 38 GNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVR-GSENI---- 92
Query: 778 IVYEYMECGSLEDWLHQSNDQLEVG-NFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDL 836
+V E++E G L+ L + ++ V V Q+L A A+ YL +VHG++
Sbjct: 93 MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQL------ASALSYLEDK---NLVHGNV 143
Query: 837 KPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPE-YGMGGDM 895
N+LL +A G + F+ P S ++ + ++APE G +
Sbjct: 144 CAKNILLARLGLAE----GTSPFIKLSDPGVSFTALSREERVE-RIPWIAPECVPGGNSL 198
Query: 896 SATGDVYSFGILLLEM 911
S D +SFG LLE+
Sbjct: 199 STAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-04
Identities = 57/254 (22%), Positives = 101/254 (39%), Gaps = 33/254 (12%)
Query: 673 KHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVM 732
K+K+ L + + DL D+ +IG+G+FG V A+K++
Sbjct: 17 KNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL 76
Query: 733 N---LKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLE 789
+ + +R + F E + + ++++ F++ + +V EYM G L
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLV 131
Query: 790 DWLHQSNDQLEVGNFNVIQRLN--LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM 847
+ + N++V ++ +V A++ +H +H D+KP N+LLD
Sbjct: 132 NLM---------SNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG 179
Query: 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEY--GMGGD--MSATGDVYS 903
+ DFG C T + GT Y++PE GGD D +S
Sbjct: 180 HLKLADFG------TCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 232
Query: 904 FGILLLEMFTRRRP 917
G+ L EM P
Sbjct: 233 VGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 19/103 (18%)
Query: 816 VAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
VA +E+L C +H DL N+LL + V + DFGLAR I + P
Sbjct: 183 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLAR--------DIYKDPDY 230
Query: 875 STGIKGT----VGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
KG+ + ++APE + DV+SFG+LL E+F+
Sbjct: 231 VR--KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 15/101 (14%)
Query: 816 VAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS- 873
VA +E+L C +H DL N+LL + V + DFGLAR I + P
Sbjct: 182 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLAR--------DIYKDPDY 229
Query: 874 -SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ + ++APE + DV+SFG+LL E+F+
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 25/229 (10%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLI 759
F ++G G++G VY+G + A+KVM++ + + E L+ HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIA 76
Query: 760 KII-TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSN-DQLEVGNFNVIQRLNLVIDVA 817
D +V E+ GS+ D + + + L+ I R ++
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR-----EIL 131
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+ +LH H ++H D+K NVLL + + DFG++ A + T
Sbjct: 132 RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS--------AQLDRTVGRRNT 180
Query: 878 IKGTVGYVAPEY-GMGGDMSAT----GDVYSFGILLLEMFTRRRPTDNM 921
GT ++APE + AT D++S GI +EM P +M
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 30/103 (29%), Positives = 43/103 (41%), Gaps = 13/103 (12%)
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
V ++YLH + IV+ DLK N+LLD + + DFGL C
Sbjct: 110 VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL------CKEGM---GFGDR 157
Query: 876 TG-IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T GT ++APE + D + G+L+ EM P
Sbjct: 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 20/60 (33%), Positives = 30/60 (50%)
Query: 271 NLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNL 330
NL++L + N T + NL++LD S N+ + F+ LP+L L S NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 816 VAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
VA +E+L +C VH DL NVL+ + + DFGLAR + + + S+
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI--MRDSNYISKGST 301
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+K ++APE + DV+SFGILL E+FT
Sbjct: 302 FLPLK----WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 60/251 (23%), Positives = 97/251 (38%), Gaps = 48/251 (19%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
+DF S +IG+G+FG V + A+K++ K K VA A R+I L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDI----L 55
Query: 759 IK-----IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLV 813
++ ++ + S F++ ++ E++ G + L + + E I L
Sbjct: 56 VEADGAWVVKMFYS--FQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLA 113
Query: 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL------------- 860
ID + ++H D+KP N+LLD + DFGL L
Sbjct: 114 IDAIHQLGFIHR---------DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164
Query: 861 --PPC--SPATILETPSSSTGIK----------GTVGYVAPEYGMGGDMSATGDVYSFGI 906
PP S + + T K GT Y+APE M + D +S G+
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 907 LLLEMFTRRRP 917
++ EM P
Sbjct: 225 IMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.002
Identities = 25/54 (46%), Positives = 28/54 (51%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKL 451
L N+LT A L NL+VLDL NNL PE+ L L SLDL N L
Sbjct: 7 LSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 15/101 (14%)
Query: 816 VAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS- 873
VA +E+L C +H DL N+LL + V + DFGLAR I + P
Sbjct: 188 VAKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLAR--------DIYKDPDY 235
Query: 874 -SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ + ++APE + DV+SFG+LL E+F+
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 56/250 (22%), Positives = 92/250 (36%), Gaps = 48/250 (19%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-HRNL 758
DF S +IG+G+FG V + A+K++ K+ + E E + +IR R++
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-------KADMLEKEQVGHIRAERDI 54
Query: 759 I----KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
+ + V F++ ++ E++ G + L + + E I L I
Sbjct: 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAI 114
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILET--- 871
D + ++H D+KP N+LLD + DFGL L
Sbjct: 115 DSIHQLGFIHR---------DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165
Query: 872 --PSSST----------------------GIKGTVGYVAPEYGMGGDMSATGDVYSFGIL 907
PS T GT Y+APE M + D +S G++
Sbjct: 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 908 LLEMFTRRRP 917
+ EM P
Sbjct: 226 MYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 19/60 (31%), Positives = 30/60 (50%)
Query: 198 NLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRL 257
NL+ L + NRL+ + L +L L +S N + + P + + SL S+ L GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 60/258 (23%), Positives = 106/258 (41%), Gaps = 57/258 (22%)
Query: 674 HKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN 733
+SSML +E L T+ + IG+G++G VY+ ++ AVK+++
Sbjct: 6 PYNSSMLGLE---------SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD 56
Query: 734 LKQRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL 792
+ AE L+++ H N++K F + Y+ + + WL
Sbjct: 57 -PISDVDEEIEAEYNILQSLPNHPNVVK--------------FYGMFYKADKLVGGQLWL 101
Query: 793 ------HQSNDQLEVGNFNVIQRLN------LVIDVAFAIEYLHHHCHPPIVHGDLKPSN 840
S +L G QRL+ ++ +++LH++ I+H D+K +N
Sbjct: 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNN 158
Query: 841 VLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPE-------YGMGG 893
+LL + + DFG++ A + T GT ++APE Y
Sbjct: 159 ILLTTEGGVKLVDFGVS--------AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSY 210
Query: 894 DMSATGDVYSFGILLLEM 911
D A DV+S GI +E+
Sbjct: 211 D--ARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.003
Identities = 25/82 (30%), Positives = 40/82 (48%), Gaps = 14/82 (17%)
Query: 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLK 837
IV EY+E L+D ++ + + L L ++ + LH I+HGDL
Sbjct: 76 IVMEYIEGEPLKDLINSNGMEE----------LELSREIGRLVGKLHSA---GIIHGDLT 122
Query: 838 PSNVLLDHDMVAHVGDFGLARF 859
SN++L + ++ DFGLA F
Sbjct: 123 TSNMILSGGKI-YLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.003
Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 35/230 (15%)
Query: 692 ADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECE 748
L DF +IG+G+FG V ++ A+K+++ + +R + F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE-- 93
Query: 749 ALRNIR-HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVI 807
R+I H N I+ + + F++ + +V EYM G L + + N+++
Sbjct: 94 --RDIMAHANSEWIVQLHYA--FQDDKYLYMVMEYMPGGDLVNLM---------SNYDIP 140
Query: 808 QRLN--LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSP 865
++ +V A++ +H +H D+KP N+LLD + DFG C
Sbjct: 141 EKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG------TCMK 191
Query: 866 ATILETPSSSTGIKGTVGYVAPEY----GMGGDMSATGDVYSFGILLLEM 911
T + GT Y++PE G G D +S G+ L EM
Sbjct: 192 MDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.003
Identities = 78/295 (26%), Positives = 127/295 (43%), Gaps = 58/295 (19%)
Query: 96 VGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSN-----------L 144
V +L+ LR I+ + EIP ++ LETL L++ S ++PS+ +
Sbjct: 630 VHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688
Query: 145 SRCSNL------INFHARGN-NLVG----QIPPDIG--YSWLKLEFLSLRDNLLAGQLAP 191
SRC NL IN + NL G + PDI SWL L+ ++ + P
Sbjct: 689 SRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEE-------FP 741
Query: 192 SIGNISNLQVLSIGENRLSGRLPDSLGQLR---------SLYYLSISENAFSGMFPSSIF 242
S + NL L + E + S +L + + Q SL L +S+ PSSI
Sbjct: 742 SNLRLENLDELILCEMK-SEKLWERV-QPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQ 799
Query: 243 NISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRL---- 298
N+ LE + + +LP G +L +LE+L + + + P +N S+L L
Sbjct: 800 NLHKLEHLEIENCINLETLPT--GINLESLESLDLSGCSRLRTFPDISTNISDLNLSRTG 857
Query: 299 ---LDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKL 350
+ + + FS +D N NL R+S + + L + +DF ++C L
Sbjct: 858 IEEVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKH--LETVDF----SDCGAL 906
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.004
Identities = 56/257 (21%), Positives = 107/257 (41%), Gaps = 49/257 (19%)
Query: 691 YADLSKATNDFSSSNMIGQGSFGFVY---RGNLGENEMAVAVKVMNLKQRGATKSFVAEC 747
Y D N++ IG G FG V+ E A+ LK+R ++ V E
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQ-LVIEV 63
Query: 748 EALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVI 807
+R ++H+N+++ I + +++ I+ E+ + G L N Q F I
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKL---YILMEFCDAGDL-----SRNIQKCYKMFGKI 115
Query: 808 QRLNLVIDVAFAIEYLHHHCH--------PPIVHGDLKPSNVLLDHDM------------ 847
+ + ++D+ + + +CH ++H DLKP N+ L +
Sbjct: 116 EE-HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 848 -----VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMS--ATGD 900
+A +GDFGL++ + +E+ + S GT Y +PE + S D
Sbjct: 175 LNGRPIAKIGDFGLSKNIG-------IESMAHSC--VGTPYYWSPELLLHETKSYDDKSD 225
Query: 901 VYSFGILLLEMFTRRRP 917
+++ G ++ E+ + + P
Sbjct: 226 MWALGCIIYELCSGKTP 242
|
Length = 1021 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1013 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.23 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.18 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.16 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.15 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.15 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.13 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.01 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.01 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.0 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.98 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.98 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.97 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.95 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.95 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.94 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.77 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.77 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.74 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.73 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.73 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.51 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.48 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.44 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-113 Score=1097.39 Aligned_cols=917 Identities=31% Similarity=0.508 Sum_probs=758.0
Q ss_pred CHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCceeEEEEeCCCCCeeEEEeeccccccccCccccCCCCCCCeeeeccCCc
Q 001782 33 NETDRLALLAIKSQLQDPLGVTSSWNNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGF 112 (1013)
Q Consensus 33 ~~~~~~aLl~~k~~~~~~~~~~~sw~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~l~~n~l 112 (1013)
.+.|+.||++||+++.||.+.+.+|+.+.+||.|.||+|++ .++|+.|||++++++|.+++.+..+++|++|+|++|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCcc
Confidence 56899999999999999988889998888999999999985 46999999999999999999999999999999999999
Q ss_pred cccCCcccC-CcccceEEeccCCccccCCCCccccCCCCceeccccccccCCCCCccccccccccceecccccccccCCC
Q 001782 113 SGEIPGEIG-RLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAP 191 (1013)
Q Consensus 113 ~~~ip~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~ 191 (1013)
+|.+|.++. .+++|++|+|++|+++|.+|. +.+++|++|++++|.+++.+|..+. .+++|++|+|++|.+.+.+|.
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~ 182 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIG-SFSSLKVLDLGGNVLVGKIPN 182 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHh-cCCCCCEEECccCcccccCCh
Confidence 999998865 999999999999999998886 5689999999999999999998765 789999999999999999999
Q ss_pred CccCCCCcceeeecccccCCCCCCccccccccceeecccccccCCCcchhccCCccceeeccCCccCCCCCCCcCCCCCC
Q 001782 192 SIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPN 271 (1013)
Q Consensus 192 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~ 271 (1013)
.++++++|++|+|++|++.+.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..+. .+++
T Consensus 183 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~ 261 (968)
T PLN00113 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKN 261 (968)
T ss_pred hhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh-CCCC
Confidence 999999999999999999999999999999999999999999999999999999999999999999988998876 7999
Q ss_pred CcEEEeeeccccccCCCCCCCCCCCceEEcccCcccccccccccCCCCccccccccCcCCCCCCCChhhhhhcccccccc
Q 001782 272 LENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLE 351 (1013)
Q Consensus 272 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~ 351 (1013)
|++|++++|++++.+|..+.++++|++|++++|.+.+..|..+..+++|+.|++++|.+... .+..+..+++|+
T Consensus 262 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~------~~~~~~~l~~L~ 335 (968)
T PLN00113 262 LQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK------IPVALTSLPRLQ 335 (968)
T ss_pred CCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCc------CChhHhcCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999988652 234567788999
Q ss_pred cccccccccCCccchhhhcchhhHHHHh--cc---chhHHhhcccccceeecccccccCCcccccCCCCCCCEEEccCCc
Q 001782 352 ALGLDTNIFGGVLPLSIANLSSTIILFS--MG---LNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNN 426 (1013)
Q Consensus 352 ~L~l~~n~~~~~~p~~~~~l~~~~~~~~--~~---~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 426 (1013)
.|+++.|.+.+.+|..++.+.++..+.- .. .....+..+.+|+.|++++|.+.+.+|..++.+++|+.|++++|+
T Consensus 336 ~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~ 415 (968)
T PLN00113 336 VLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS 415 (968)
T ss_pred EEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCE
Confidence 9999999999999988877655433311 11 112345677889999999999999999999999999999999999
Q ss_pred cCccCCccccccCccCEEEcCCCcccCCCCcccccCcccceeecccccccccCCchhhcccchhhhhccCCCeecccCCc
Q 001782 427 LDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPA 506 (1013)
Q Consensus 427 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~Ls~N~l~~~~~~ 506 (1013)
+++.+|..|..+++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+. .+.|+.|++++|++++.+|.
T Consensus 416 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~--~~~L~~L~ls~n~l~~~~~~ 493 (968)
T PLN00113 416 FSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG--SKRLENLDLSRNQFSGAVPR 493 (968)
T ss_pred eeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc--cccceEEECcCCccCCccCh
Confidence 9999999999999999999999999999999999999999999999999988887653 57899999999999999999
Q ss_pred cccCcCCCcEEEccCCCCCCCCccccccccccccccccccccccccCccccccCCCCeEecccccccccccccccccccc
Q 001782 507 EVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFL 586 (1013)
Q Consensus 507 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 586 (1013)
.+.++++|+.|+|++|++++.+|..+..+++|++|+|++|.+++.+|..+..+++|+.|||++|++++.+|..+.++++|
T Consensus 494 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 573 (968)
T PLN00113 494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESL 573 (968)
T ss_pred hhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCccCCCCCCCCCccCCCcceeeeCCcCCCCCCCCCCCCcccCCCCCcceeEEEEeehhhHHHHHHHHHHHHHHh
Q 001782 587 EYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGLDELHLPVCHSAGPRKTRIALLKVVVPVTVILTIIVACLIVLY 666 (1013)
Q Consensus 587 ~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~vi~~~~v~~~~~~~ 666 (1013)
+.|++++|+++|.+|..+.+..+....+.||+.+||+......++|..... ...+ ...+++.+++++.++++++++++
T Consensus 574 ~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 651 (968)
T PLN00113 574 VQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK-TPSW-WFYITCTLGAFLVLALVAFGFVF 651 (968)
T ss_pred CEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc-ccee-eeehhHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999765444567754222 1122 22222222222222222222233
Q ss_pred hhhccc-ccccchh--hhhhhc-C--CCcchhhhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccch
Q 001782 667 TRRRKH-KHKSSSM--LLMEQQ-F--PMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT 740 (1013)
Q Consensus 667 ~rrr~~-~~~~~~~--~~~~~~-~--~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~ 740 (1013)
+|+|+. +.+.... ...+.. + ..............|...++||+|+||.||+|++..++..||||+++....
T Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--- 728 (968)
T PLN00113 652 IRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--- 728 (968)
T ss_pred HHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---
Confidence 332221 1111100 000000 0 000111222334567888999999999999999988999999998863322
Q ss_pred hHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHH
Q 001782 741 KSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820 (1013)
Q Consensus 741 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L 820 (1013)
....|++++++++||||++++|+|.. ++..++||||+++|+|.++++ .++|.++.+|+.|+|+|+
T Consensus 729 -~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey~~~g~L~~~l~---------~l~~~~~~~i~~~ia~~L 793 (968)
T PLN00113 729 -IPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAYLIHEYIEGKNLSEVLR---------NLSWERRRKIAIGIAKAL 793 (968)
T ss_pred -ccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCEEEEeCCCCCcHHHHHh---------cCCHHHHHHHHHHHHHHH
Confidence 22356889999999999999999753 366899999999999999995 368899999999999999
Q ss_pred HHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccc
Q 001782 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGD 900 (1013)
Q Consensus 821 ~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 900 (1013)
+|||..+.++|+||||||+||+++.++.+++. ||.+..... .....+|+.|+|||++.+..++.++|
T Consensus 794 ~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~sD 860 (968)
T PLN00113 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------------DTKCFISSAYVAPETRETKDITEKSD 860 (968)
T ss_pred HHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------------CCCccccccccCcccccCCCCCcccc
Confidence 99996655699999999999999999888875 665442211 12236789999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCCh-hHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHH
Q 001782 901 VYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPE-KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRI 979 (1013)
Q Consensus 901 IwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l 979 (1013)
||||||++|||++|+.||+...........+.+..... ....++++.+.... ....++..++.++
T Consensus 861 v~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~l 926 (968)
T PLN00113 861 IYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV--------------SVNQNEIVEVMNL 926 (968)
T ss_pred hhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC--------------CccHHHHHHHHHH
Confidence 99999999999999999975444444445554433322 22333332221110 1112345578899
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHHhhhhhh
Q 001782 980 GVLCSMESPSERIQMTDVVAKLCSARKIFL 1009 (1013)
Q Consensus 980 ~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 1009 (1013)
+.+||+.||++|||++||+++|+++.+...
T Consensus 927 ~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 927 ALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred HHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 999999999999999999999999877543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-59 Score=597.01 Aligned_cols=513 Identities=34% Similarity=0.495 Sum_probs=468.5
Q ss_pred CCCCeeeeccCCccccCCcccCCcccceEEeccCCccccCCCCccc-cCCCCceeccccccccCCCCCccccccccccce
Q 001782 100 SFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLS-RCSNLINFHARGNNLVGQIPPDIGYSWLKLEFL 178 (1013)
Q Consensus 100 ~~L~~L~l~~n~l~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L 178 (1013)
.+++.|+|++|+++|.+|.+|..+++|++|+|++|+++|.+|..+. .+++|++|++++|+++|.+|.. .+++|++|
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~---~l~~L~~L 145 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG---SIPNLETL 145 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCcc---ccCCCCEE
Confidence 4689999999999999999999999999999999999999998876 9999999999999999999974 57899999
Q ss_pred ecccccccccCCCCccCCCCcceeeecccccCCCCCCccccccccceeecccccccCCCcchhccCCccceeeccCCccC
Q 001782 179 SLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLE 258 (1013)
Q Consensus 179 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 258 (1013)
+|++|.+++.+|..++++++|++|+|++|.+.+.+|..|+++++|++|+|++|++++.+|..++++++|++|+|++|+++
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcCCCCCCCcEEEeeeccccccCCCCCCCCCCCceEEcccCcccccccccccCCCCccccccccCcCCCCCCCCh
Q 001782 259 GSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDL 338 (1013)
Q Consensus 259 ~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 338 (1013)
+.+|..+. .+++|++|++++|++++.+|..++++++|++|++++|++.+..|..+..+++|+.|++++|.+...
T Consensus 226 ~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~----- 299 (968)
T PLN00113 226 GEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE----- 299 (968)
T ss_pred CcCChhHh-cCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccC-----
Confidence 99998887 799999999999999999999999999999999999999999999999999999999999998642
Q ss_pred hhhhhcccccccccccccccccCCccchhhhcchhhHHHHh--ccc---hhHHhhcccccceeecccccccCCcccccCC
Q 001782 339 DFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFS--MGL---NQIYVKNLVNLNGFGLEYNQLTGPIPHAIGE 413 (1013)
Q Consensus 339 ~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~~~~~~~--~~~---~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 413 (1013)
++..+.++++|+.|+++.|.+.+..|..+..++++..+.- ..+ ....+..+++|+.|+|++|++++.+|..+..
T Consensus 300 -~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~ 378 (968)
T PLN00113 300 -IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378 (968)
T ss_pred -CChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhC
Confidence 3455678899999999999999999988877665443321 111 1235677889999999999999999999999
Q ss_pred CCCCCEEEccCCccCccCCccccccCccCEEEcCCCcccCCCCcccccCcccceeecccccccccCCchhhcccchhhhh
Q 001782 414 LRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILL 493 (1013)
Q Consensus 414 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L 493 (1013)
+++|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..|.++++|+.|++++|++++.+|..+.. ++.|+.|
T Consensus 379 ~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L 457 (968)
T PLN00113 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWD-MPSLQML 457 (968)
T ss_pred cCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhcc-CCCCcEE
Confidence 999999999999999999999999999999999999999999999999999999999999999888877665 8889999
Q ss_pred ccCCCeecccCCccccCcCCCcEEEccCCCCCCCCccccccccccccccccccccccccCccccccCCCCeEeccccccc
Q 001782 494 DLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLS 573 (1013)
Q Consensus 494 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 573 (1013)
+|++|++.+.+|..+ ..++|+.|+|++|++++.+|..+..+++|++|+|++|++++.+|..+..+++|++|+|++|.++
T Consensus 458 ~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 536 (968)
T PLN00113 458 SLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536 (968)
T ss_pred ECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccc
Confidence 999999999888766 4589999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccceeecCCccCCCCCCCC-CccCCCcceeeeCCcCCCCCC
Q 001782 574 GQIPEFLENLSFLEYLNLSYNHLEGEVPRR-GVFSNKTRFYFTGNKRLCGGL 624 (1013)
Q Consensus 574 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~N~~~c~~~ 624 (1013)
+.+|..|.++++|+.|+|++|++++.+|.. ..+..+..+.+.+|+..+.-|
T Consensus 537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 999999999999999999999999988874 567788999999999766433
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=401.21 Aligned_cols=291 Identities=40% Similarity=0.658 Sum_probs=239.1
Q ss_pred cCCCcchhhhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEE
Q 001782 685 QFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITV 764 (1013)
Q Consensus 685 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 764 (1013)
....|++.++..+|++|....+||+|+||.||+|.... +..||||++........++|.+|++++.+++|||+++++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 56779999999999999999999999999999999974 48899998875443214569999999999999999999999
Q ss_pred eecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEec
Q 001782 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD 844 (1013)
Q Consensus 765 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 844 (1013)
|.+. ++..++|+|||++|+|.+++...... .++|.++++||.++|+||+|||+.+.+.||||||||+|||+|
T Consensus 140 C~e~----~~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 140 CLEG----GEHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred EecC----CceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 9643 12689999999999999999886431 789999999999999999999999888999999999999999
Q ss_pred CCCceEEccccccccCCCCCCCccccCCCCCccc-ccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcC-
Q 001782 845 HDMVAHVGDFGLARFLPPCSPATILETPSSSTGI-KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMF- 922 (1013)
Q Consensus 845 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~- 922 (1013)
+++++||+|||+|+..+... ...... .||.+|+|||+...+..+.|+||||||+++.|+++|+.|.+...
T Consensus 212 ~~~~aKlsDFGLa~~~~~~~--------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~ 283 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEGD--------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP 283 (361)
T ss_pred CCCCEEccCccCcccCCccc--------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC
Confidence 99999999999996543210 001111 79999999999999999999999999999999999999887643
Q ss_pred CCCccHHHHHHhhCCh-hHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 923 NDGLTLHEFAKMALPE-KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 923 ~~~~~~~~~~~~~~~~-~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
........|....... .+.+++|+.+..+.. . ..++..++.+++.+|++.+|++||+|.||+++|
T Consensus 284 ~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~-------------~-~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 284 RGELSLVEWAKPLLEEGKLREIVDPRLKEGEY-------------P-DEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred cccccHHHHHHHHHHCcchhheeCCCccCCCC-------------C-hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 2333466666555443 577888876642110 0 014466789999999999999999999999999
Q ss_pred HHhhh
Q 001782 1002 CSARK 1006 (1013)
Q Consensus 1002 ~~~~~ 1006 (1013)
+.+..
T Consensus 350 ~~~~~ 354 (361)
T KOG1187|consen 350 EGILS 354 (361)
T ss_pred Hhhcc
Confidence 76654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=373.66 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=211.1
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc-eEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD-FKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~ 777 (1013)
+.+..+.||+|..|+||+++++.+++.+|+|++....+ ...+++.+|+++++..+||+||.+||+|.. .. ...
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~-----~~~~is 154 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS-----NGEEIS 154 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe-----CCceEE
Confidence 44556899999999999999999999999999964433 345789999999999999999999999753 24 699
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH-HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||++|+|++++... +++++....+|+.++++||.|||+ + +||||||||+|||+...|.|||||||.
T Consensus 155 I~mEYMDgGSLd~~~k~~------g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRV------GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred eehhhcCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccc
Confidence 999999999999999876 679999999999999999999996 6 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
++.+... ....++||..|||||.+.+..|+.++||||||++++|+++|+.||......
T Consensus 226 S~~lvnS----------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~------------ 283 (364)
T KOG0581|consen 226 SGILVNS----------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP------------ 283 (364)
T ss_pred cHHhhhh----------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC------------
Confidence 9865322 346788999999999999999999999999999999999999999763111
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
+....+++.......|..-|. ..+.+++..++..|++.||.+|||+.|+++.
T Consensus 284 ~~~~~~Ll~~Iv~~ppP~lP~------------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 284 YLDIFELLCAIVDEPPPRLPE------------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCHHHHHHHHhcCCCCCCCc------------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 123344444444333322111 1356778999999999999999999999763
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=377.55 Aligned_cols=267 Identities=28% Similarity=0.467 Sum_probs=212.8
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec--cccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
..++|...+.||+|+||+||+|+++.++..||||.+... .....+.+..|+++|+.++|||||++++++ +.++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence 356899999999999999999999999999999999765 344456789999999999999999999995 4557
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC------Cc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD------MV 848 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~ 848 (1013)
+.|+|||||.||+|.+|++.. +.+++..++.++.|+|.|+++||++ +||||||||+|||++.. -.
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~------~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~ 153 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRR------GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPV 153 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCce
Confidence 999999999999999999987 5799999999999999999999999 99999999999999865 46
Q ss_pred eEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccH
Q 001782 849 AHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 928 (1013)
Q Consensus 849 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~ 928 (1013)
+||+|||+|+.+.+.. .....+|++.|||||++...+|+.|+|+||+|+++|++++|+.||+.....+...
T Consensus 154 LKIADFGfAR~L~~~~---------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 154 LKIADFGFARFLQPGS---------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred EEecccchhhhCCchh---------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 8999999999875432 2456789999999999999999999999999999999999999998532221111
Q ss_pred --------HHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 929 --------HEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 929 --------~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
........+....+++-+.+..++.+|... ...+...++..+|.+|+.+.++-..
T Consensus 225 ~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~-----------------~~~~~~~~l~~~p~~~~~~~~~~~~ 287 (429)
T KOG0595|consen 225 YIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISF-----------------EDFFDHPFLAANPQDRADAFELESR 287 (429)
T ss_pred HHhccccccCchhhhccCchhhhhhHHHhcCccccCch-----------------HHhhhhhhcccCcccccCccccccc
Confidence 000111122233455555555555444321 2345567788888888877766544
Q ss_pred HHH
Q 001782 1001 LCS 1003 (1013)
Q Consensus 1001 L~~ 1003 (1013)
...
T Consensus 288 ~~~ 290 (429)
T KOG0595|consen 288 TDQ 290 (429)
T ss_pred ccc
Confidence 443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=388.28 Aligned_cols=263 Identities=31% Similarity=0.473 Sum_probs=211.7
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccc--hhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA--TKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
...+.+.+|+|+||+||+|.+++. ..||||++....... .++|.+|+.+|.+++|||||+++|+|... ....+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~----~~~~~ 116 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP----PGSLC 116 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----CCceE
Confidence 445556799999999999999733 239999997544322 45899999999999999999999998643 12689
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eeecCCCCCceEecCCC-ceEEcccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPP-IVHGDLKPSNVLLDHDM-VAHVGDFG 855 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DFG 855 (1013)
+||||+++|+|.+++.... ...+++..+++|+.|||+||.|||++ + ||||||||+|||++.++ ++||+|||
T Consensus 117 iVtEy~~~GsL~~~l~~~~----~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKR----KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred EEEEeCCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCc
Confidence 9999999999999998741 15899999999999999999999999 7 99999999999999998 99999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccC--CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM--GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
+++...... .......||+.|||||++. ...|+.|+||||||+++|||+||+.||...... .....
T Consensus 190 lsr~~~~~~--------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~~~~--- 257 (362)
T KOG0192|consen 190 LSREKVISK--------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QVASA--- 257 (362)
T ss_pred cceeecccc--------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HHHHH---
Confidence 998653211 2233468999999999999 569999999999999999999999999875331 11111
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhhhhhcc
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIFLSN 1011 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 1011 (1013)
++.. ..||... ..++..+..++.+||+.||.+||++.|++..|+.+...+...
T Consensus 258 ---------v~~~------~~Rp~~p----------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 258 ---------VVVG------GLRPPIP----------KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred ---------HHhc------CCCCCCC----------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 1100 0111111 125677899999999999999999999999999998876643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=388.42 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=211.6
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec---cccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
.+|...+.||+|||+.||++++..+|..||+|++... .....+.+.+|+++.+.++|||||+++++ |++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 6899999999999999999999889999999999742 34456778999999999999999999999 567799
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.|+|.|.|+.++|.++++.. +.+++.+++.+..||+.|+.|||++ +|+|||||..|++++++.++||+|||
T Consensus 93 VYivLELC~~~sL~el~Krr------k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRR------KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred eEEEEEecCCccHHHHHHhc------CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence 99999999999999999965 6899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
+|..+.. ...+....+|||.|.|||++....++..+||||+|||+|.|+.|++||+..
T Consensus 164 LAt~le~--------~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-------------- 221 (592)
T KOG0575|consen 164 LATQLEY--------DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-------------- 221 (592)
T ss_pred eeeeecC--------cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------------
Confidence 9987643 223466789999999999999999999999999999999999999999752
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.+.+..++....++ ..| ........++|.++|++||.+|||+++|+.
T Consensus 222 ---~vkety~~Ik~~~Y-~~P-------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 222 ---TVKETYNKIKLNEY-SMP-------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---hHHHHHHHHHhcCc-ccc-------------cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12222222221111 011 122344678999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=371.09 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=206.8
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-------cchhHHHHHHHHHhcCCCCccceEEEEeecCC
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-------GATKSFVAECEALRNIRHRNLIKIITVCSSID 769 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 769 (1013)
..+.|.+.+.||+|+||.|-+|..+.+++.||||+++.... .......+|+++|++++||+||+++++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~----- 244 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF----- 244 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----
Confidence 35678899999999999999999999999999999973321 122346799999999999999999999
Q ss_pred ccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC---
Q 001782 770 FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD--- 846 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--- 846 (1013)
++.++..|+||||++||+|.+.+-.+ +.+.+.....++.|++.|+.|||++ ||+||||||+|||+..+
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv~n------k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVVAN------KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAED 315 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHHhc------cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcc
Confidence 45668889999999999999999876 5677888899999999999999999 99999999999999765
Q ss_pred CceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCC---CcccchHHHHHHHHHHHhCCCCCCCcCC
Q 001782 847 MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDM---SATGDVYSFGILLLEMFTRRRPTDNMFN 923 (1013)
Q Consensus 847 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DIwSlG~il~ell~G~~pf~~~~~ 923 (1013)
..+||+|||+|+..+. .......+||+.|.|||++.+..+ ..++||||+||++|-+++|.+||.....
T Consensus 316 ~llKItDFGlAK~~g~---------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~ 386 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGE---------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT 386 (475)
T ss_pred eEEEecccchhhcccc---------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence 7899999999997642 233667899999999999987643 3478999999999999999999987533
Q ss_pred CCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 924 DGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
+.....++. ....... ...+.+..++..+++.+||..||++|||+.|+++.
T Consensus 387 ~~sl~eQI~------------~G~y~f~--------------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 387 DPSLKEQIL------------KGRYAFG--------------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred CccHHHHHh------------cCccccc--------------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 321111111 1111111 12334556678899999999999999999999763
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=389.74 Aligned_cols=482 Identities=29% Similarity=0.432 Sum_probs=383.4
Q ss_pred eeEEEeeccccccccCccccCCCCCCCeeeeccCCccccCCcccCCcccceEEeccCCccccCCCCccccCCCCceeccc
Q 001782 77 RVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHAR 156 (1013)
Q Consensus 77 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~l~~n~l~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~ 156 (1013)
....+++++|.++ .+.+.+.+|..|..|++++|+++ ++|+++|.+..+..|+.++|+++ .+|++++.+.+|++|+.+
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 4677889999887 46678889999999999999999 89999999999999999999999 899999999999999999
Q ss_pred cccccCCCCCccccccccccceecccccccccCCCCccCCCCcceeeecccccCCCCCCccccccccceeecccccccCC
Q 001782 157 GNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGM 236 (1013)
Q Consensus 157 ~n~l~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 236 (1013)
.|.+. ++|++++ .+..|+.|+..+|+++ ..|+.++++.+|..|++.+|++.. .|...-.++.|++||+-.|-++ .
T Consensus 123 ~n~~~-el~~~i~-~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-t 197 (565)
T KOG0472|consen 123 SNELK-ELPDSIG-RLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-T 197 (565)
T ss_pred cccee-ecCchHH-HHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-c
Confidence 99998 8888887 6778999999999998 778889999999999999999984 5544555999999999999887 7
Q ss_pred CcchhccCCccceeeccCCccCCCCCCCcCCCCCCCcEEEeeeccccccCCCCC-CCCCCCceEEcccCccccccccccc
Q 001782 237 FPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSL-SNASNLRLLDFSLNHFSGQVKIDFN 315 (1013)
Q Consensus 237 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~ 315 (1013)
+|..++.+.+|+-|+|.+|+|. .+| .+. +...|++|+++.|+|. .+|.+. .++.+|.+|||..|+++ ..|+..+
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~-gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c 272 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIR-FLP-EFP-GCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC 272 (565)
T ss_pred CChhhcchhhhHHHHhhhcccc-cCC-CCC-ccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHH
Confidence 8999999999999999999998 888 444 5788999999999998 666654 58999999999999998 5677888
Q ss_pred CCCCccccccccCcCCCCCCCChhhhhhcccccccccccccccccCCccchhhhcchhhHHHHhccchhHHhhcccccce
Q 001782 316 RLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNG 395 (1013)
Q Consensus 316 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~ 395 (1013)
.+.+|.+||+|+|.|+.. +..++++ .|+.|.+.+|.+..+--+-+. ..+..++ .++.+ ..+.
T Consensus 273 lLrsL~rLDlSNN~is~L-------p~sLgnl-hL~~L~leGNPlrTiRr~ii~-~gT~~vL-------KyLrs--~~~~ 334 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDISSL-------PYSLGNL-HLKFLALEGNPLRTIRREIIS-KGTQEVL-------KYLRS--KIKD 334 (565)
T ss_pred HhhhhhhhcccCCccccC-------Ccccccc-eeeehhhcCCchHHHHHHHHc-ccHHHHH-------HHHHH--hhcc
Confidence 999999999999998874 3467788 889999999877533211111 1111000 01111 0000
Q ss_pred eeccccc---------ccCCcccccCCCCCCCEEEccCCccCccCCccccccCc---cCEEEcCCCcccCCCCcccccCc
Q 001782 396 FGLEYNQ---------LTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTI---LNSLDLGFNKLRGHVPSSLGNCQ 463 (1013)
Q Consensus 396 L~L~~n~---------l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~ 463 (1013)
=.++.-. ..+.. .....+.+.+.|+++.-+++ .+|+....... +...+++.|++. ++|..+..+.
T Consensus 335 dglS~se~~~e~~~t~~~~~~-~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lk 411 (565)
T KOG0472|consen 335 DGLSQSEGGTETAMTLPSESF-PDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELK 411 (565)
T ss_pred CCCCCCcccccccCCCCCCcc-cchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHH
Confidence 0111110 11111 12334567889999999999 55655444333 888999999998 7898888887
Q ss_pred cc-ceeecccccccccCCchhhcccchhhhhccCCCeecccCCccccCcCCCcEEEccCCCCCCCCcccccccccccccc
Q 001782 464 NL-MLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLY 542 (1013)
Q Consensus 464 ~L-~~L~L~~N~l~~~~p~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 542 (1013)
.+ +.+.+++|.++ .+|..+.. ++.++.|+|++|-+. .+|.+++.+..|+.||+|.|+|. .+|..+..+..|+.+-
T Consensus 412 elvT~l~lsnn~is-fv~~~l~~-l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtll 487 (565)
T KOG0472|consen 412 ELVTDLVLSNNKIS-FVPLELSQ-LQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLL 487 (565)
T ss_pred HHHHHHHhhcCccc-cchHHHHh-hhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHH
Confidence 65 45566666665 66665555 888999999999988 68999999999999999999998 8898888888888888
Q ss_pred ccccccccccCccccccCCCCeEeccccccccccccccccccccceeecCCccCC
Q 001782 543 MEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLE 597 (1013)
Q Consensus 543 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 597 (1013)
.++|++..+.|+.+.++.+|..|||.+|.|. .+|..+++|++|++|++++|++.
T Consensus 488 as~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 488 ASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 8889999777777999999999999999998 78889999999999999999998
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=353.15 Aligned_cols=265 Identities=23% Similarity=0.355 Sum_probs=210.5
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
...+|++.++||+|.||+||++....++..||.|.+.... ..+.+....|+.+|++++|||||+++++-. .++..
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~e 93 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNE 93 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccch
Confidence 3457889999999999999999999999999999987443 234566899999999999999999998532 23344
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCceEecCCCceEEcc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHP-PIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
..++|||+|+.|+|.++++..+.+ .+.+++..+|+++.|++.||.++|+..+. -|+||||||.||+++.+|.+||+|
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence 489999999999999999876543 35799999999999999999999994332 288999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||+++++.... ......+|||.||+||.+.+.+|+.++||||+||++|||+.-++||...
T Consensus 172 fGL~r~l~s~~--------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------------ 231 (375)
T KOG0591|consen 172 FGLGRFLSSKT--------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------------ 231 (375)
T ss_pred chhHhHhcchh--------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------------
Confidence 99999875322 2245688999999999999999999999999999999999999999763
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
...++-.+.-..|... .+ .+-....+..++..|+..||+.||+...++..+..
T Consensus 232 -----n~~~L~~KI~qgd~~~-----------~p-~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 232 -----NLLSLCKKIEQGDYPP-----------LP-DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----cHHHHHHHHHcCCCCC-----------Cc-HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1111111111111100 00 02234568889999999999999997666655544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=379.14 Aligned_cols=263 Identities=31% Similarity=0.486 Sum_probs=213.8
Q ss_pred hhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 695 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
......+...+.||+|.||.||.|.+.. ...||+|.++... ...+.|.+|+++|++++|++||+++|+|... +
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~ 274 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----E 274 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecC-----C
Confidence 3344456677899999999999999974 3479999998553 3347788999999999999999999998632 4
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..+||||||+.|+|.+|++.... ..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+||
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~----~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDF 347 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREG----GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDF 347 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCC----CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccc
Confidence 68999999999999999998322 5789999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~ 933 (1013)
|+|+...++. ... .....-+..|.|||.+..+.++.|+|||||||++|||+| |+.||..+.+.
T Consensus 348 GLAr~~~d~~-Y~~------~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------- 411 (468)
T KOG0197|consen 348 GLARLIGDDE-YTA------SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------- 411 (468)
T ss_pred ccccccCCCc-eee------cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---------
Confidence 9999443221 111 223334689999999999999999999999999999999 99998775322
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIF 1008 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1008 (1013)
++.+.+++. .+++.+..||..+.++|..||+.+|++|||++.+...++++....
T Consensus 412 -----ev~~~le~G----------------yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 412 -----EVLELLERG----------------YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred -----HHHHHHhcc----------------CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 112222211 122233567889999999999999999999999999998876543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=345.43 Aligned_cols=278 Identities=19% Similarity=0.266 Sum_probs=209.4
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
+.|+...++|+|+||+||+++++.+|+.||||++....+ ...+-..+|++++++++|||+|.++++| ......
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 468888999999999999999999999999999974433 2234578999999999999999999995 455889
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++|+|||+ .++.+-++... ..++...+.+++.|++.|+.|+|++ ++|||||||+|||++.+|.+||||||+
T Consensus 77 hLVFE~~d-hTvL~eLe~~p-----~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 77 HLVFEYCD-HTVLHELERYP-----NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred EEEeeecc-hHHHHHHHhcc-----CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence 99999999 56666666543 4789999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH-Hh
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA-KM 934 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~-~~ 934 (1013)
|+.+.. .....+.++.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+.|.+..+-+..+.... -.
T Consensus 148 AR~L~~--------pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG 219 (396)
T KOG0593|consen 148 ARTLSA--------PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG 219 (396)
T ss_pred hHhhcC--------CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence 997752 1223556788999999999888 6899999999999999999999999987543322221111 11
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
...+....++..--.+. .-|.+..+...+-..+......-+.+++..|++.||++|++.+|++.
T Consensus 220 ~L~prhq~iF~~N~~F~-Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 220 NLIPRHQSIFSSNPFFH-GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ccCHHHHHHhccCCcee-eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 22333333322100000 00111111111111122233446889999999999999999999874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=353.03 Aligned_cols=238 Identities=29% Similarity=0.426 Sum_probs=204.7
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec---cccchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
..++|++.++||+|+||.||.++.+.+++.+|+|+++.. ...+.+....|..++.+++||.||+++-. |+++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccC
Confidence 356899999999999999999999999999999999743 23445678899999999999999999987 6777
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
+..|+|+||+.||.|...+++. +.+++..+..++..|+.||.|||++ ||||||+||+|||+|++|+++|+|
T Consensus 98 ~kLylVld~~~GGeLf~hL~~e------g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtD 168 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQRE------GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTD 168 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhc------CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEec
Confidence 9999999999999999999876 6899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||+++..- ........++||+.|||||++.+..|+.++|.||+|+++|||++|.+||...... .....+.+
T Consensus 169 FgL~k~~~--------~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-~~~~~I~~ 239 (357)
T KOG0598|consen 169 FGLCKEDL--------KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-KMYDKILK 239 (357)
T ss_pred cccchhcc--------cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-HHHHHHhc
Confidence 99998432 2233455689999999999999999999999999999999999999999864222 22222222
Q ss_pred hh-------CChhHHHhhhhhhccchhhhhc
Q 001782 934 MA-------LPEKVMEIVDPLLLLDLEARAS 957 (1013)
Q Consensus 934 ~~-------~~~~~~~~i~~~l~~~~~~R~~ 957 (1013)
.. .+.+.++++.+++..+|.+|..
T Consensus 240 ~k~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 240 GKLPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CcCCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 22 4566888889999999988875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=368.27 Aligned_cols=260 Identities=28% Similarity=0.423 Sum_probs=211.8
Q ss_pred hhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec---cccchhHHHHHHHHHhcC-CCCccceEEEEeecCCc
Q 001782 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDF 770 (1013)
Q Consensus 695 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 770 (1013)
++...+|..++.||+|+|++|++|+...+++.||||++... .....+.+..|-++|.++ .||.|++++.. |
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence 44567899999999999999999999999999999998632 334456678899999999 89999999987 5
Q ss_pred cccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceE
Q 001782 771 EEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAH 850 (1013)
Q Consensus 771 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 850 (1013)
+++...|+|+||+++|+|.++|++. +.+++..++.++.||+.|++|||++ |||||||||+|||+|+||++|
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~------Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKY------GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHh------CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence 6778999999999999999999987 7899999999999999999999999 999999999999999999999
Q ss_pred EccccccccCCCCCCCcc---cc--CCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCC
Q 001782 851 VGDFGLARFLPPCSPATI---LE--TPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDG 925 (1013)
Q Consensus 851 l~DFG~a~~~~~~~~~~~---~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~ 925 (1013)
|+|||.|+.+++...... .. .......++||..|.+||++..+..++++|||+|||++|+|+.|.+||... ++-
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~-Ney 293 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA-NEY 293 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc-cHH
Confidence 999999999876543311 11 111235689999999999999999999999999999999999999999763 111
Q ss_pred ccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 926 LTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..+.+ +++ .+++ ..+..++...+|+.+.+..||.+|+|+.||.+
T Consensus 294 liFqk------------I~~----l~y~--------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 294 LIFQK------------IQA----LDYE--------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHH------------HHH----hccc--------------CCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 11111 111 1110 00112244667888888899999999987765
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=374.35 Aligned_cols=408 Identities=23% Similarity=0.265 Sum_probs=307.2
Q ss_pred cCCcccCCcccceEEeccCCccccCCCCccccCCCCceeccccccccCCCCCccccccccccceecccccccccCCCCcc
Q 001782 115 EIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIG 194 (1013)
Q Consensus 115 ~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 194 (1013)
..|+...... ..||.+++.+.. ++.-.+.|.+|. .-+.|++++|.+..+.+..|-
T Consensus 45 ~cpa~c~c~~--~lldcs~~~lea----------------~~~~~l~g~lp~-------~t~~LdlsnNkl~~id~~~f~ 99 (873)
T KOG4194|consen 45 ECPATCPCNT--RLLDCSDRELEA----------------IDKSRLKGFLPS-------QTQTLDLSNNKLSHIDFEFFY 99 (873)
T ss_pred cCCCcCCCCc--eeeecCcccccc----------------ccccccCCcCcc-------ceeeeeccccccccCcHHHHh
Confidence 4555544433 347777776651 112234455554 346799999999999899999
Q ss_pred CCCCcceeeecccccCCCCCCccccccccceeecccccccCCCcchhccCCccceeeccCCccCCCCCCCcCCCCCCCcE
Q 001782 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLEN 274 (1013)
Q Consensus 195 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~ 274 (1013)
++++|+++++.+|.++ .||...+...+|+.|+|.+|.|+..-.+.+..++.|+.||||.|.|+ .+|..-+..-.++++
T Consensus 100 nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~ 177 (873)
T KOG4194|consen 100 NLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKK 177 (873)
T ss_pred cCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceE
Confidence 9999999999999999 89987777778999999999999888889999999999999999999 899887766689999
Q ss_pred EEeeeccccccCCCCCCCCCCCceEEcccCcccccccccccCCCCccccccccCcCCCCCCCChhhhhhccccccccccc
Q 001782 275 LSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALG 354 (1013)
Q Consensus 275 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~ 354 (1013)
|+|++|+|+..-...|.++.+|..|.|++|+++...+..|.+++.|+.|+|.+|.|+...
T Consensus 178 L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive-------------------- 237 (873)
T KOG4194|consen 178 LNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE-------------------- 237 (873)
T ss_pred EeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh--------------------
Confidence 999999999888899999999999999999999999999999999999999999987632
Q ss_pred ccccccCCccchhhhcchhhHHHHhccchhHHhhcccccceeecccccccCCcccccCCCCCCCEEEccCCccCccCCcc
Q 001782 355 LDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPES 434 (1013)
Q Consensus 355 l~~n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 434 (1013)
...|+++++|+.|.|..|.|...-..+|..+.++++|+|+.|+++..-..+
T Consensus 238 -----------------------------~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~ 288 (873)
T KOG4194|consen 238 -----------------------------GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGW 288 (873)
T ss_pred -----------------------------hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccc
Confidence 123555666666666666666666666777777777777777777666666
Q ss_pred ccccCccCEEEcCCCcccCCCCcccccCcccceeecccccccccCCchhhcccchhhhhccCCCeecccCCccccCcCCC
Q 001782 435 LGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNL 514 (1013)
Q Consensus 435 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L 514 (1013)
+.+++.|+.|+||+|.|...-+++....++|++|+|++|+|+ .++++-+..+..|+.|+|++|.++..--..|..+.+|
T Consensus 289 lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL 367 (873)
T KOG4194|consen 289 LFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSL 367 (873)
T ss_pred ccccchhhhhccchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhh
Confidence 777777777777777777666666666677777777777777 5555555557777777777777765555566677777
Q ss_pred cEEEccCCCCCCCCcc---ccccccccccccccccccccccCccccccCCCCeEeccccccccccccccccccccceeec
Q 001782 515 VQLGLSENRFSNEIPV---SLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNL 591 (1013)
Q Consensus 515 ~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 591 (1013)
+.|||++|.|+..+-+ .|.++++|+.|.|.+|+|..+.-.+|.+++.|++|||.+|.|..+.|+.|..+ .|+.|-+
T Consensus 368 ~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~ 446 (873)
T KOG4194|consen 368 HKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVM 446 (873)
T ss_pred hhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhh
Confidence 7777777777655432 36667777777777777775444567777777777777777777777777776 6777666
Q ss_pred CCccCCCCC
Q 001782 592 SYNHLEGEV 600 (1013)
Q Consensus 592 ~~N~l~~~~ 600 (1013)
..-.+-|.+
T Consensus 447 nSssflCDC 455 (873)
T KOG4194|consen 447 NSSSFLCDC 455 (873)
T ss_pred cccceEEec
Confidence 655554443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=385.21 Aligned_cols=266 Identities=26% Similarity=0.477 Sum_probs=219.5
Q ss_pred hccCCCCCceeeccceEEEEEEEC-----CCCeEEEEEEEeecccc-chhHHHHHHHHHhcCCCCccceEEEEeecCCcc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLG-----ENEMAVAVKVMNLKQRG-ATKSFVAECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 771 (1013)
+.+....+.||+|+||.||+|+.. +....||||.++..... ..++|++|++.+..++|||||+++|+|..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~---- 560 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE---- 560 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc----
Confidence 345566789999999999999874 34578999999866665 67889999999999999999999999964
Q ss_pred ccceEEEEEeeccCCCHHHHhhccccccc--------cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEe
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLE--------VGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL 843 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll 843 (1013)
++..++|+|||+.|+|.+|++....... ..+++..+.+.||.|||.||+||-++ .+|||||..+|+||
T Consensus 561 -~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 561 -GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLV 636 (774)
T ss_pred -CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhcee
Confidence 4789999999999999999987643321 23488999999999999999999999 99999999999999
Q ss_pred cCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcC
Q 001782 844 DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMF 922 (1013)
Q Consensus 844 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~ 922 (1013)
.++..|||+|||+++.....+.+.. .....-+++|||||.+..++++.++|||||||++||+++ |+.||....
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~------~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKV------RGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcc------cCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 9999999999999996654433332 223345789999999999999999999999999999998 999998754
Q ss_pred CCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 923 NDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
+++ +.+.+... ..++.++.||.++++||..||+.+|++||+++||-..|+
T Consensus 711 n~E--------------VIe~i~~g----------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~ 760 (774)
T KOG1026|consen 711 NQE--------------VIECIRAG----------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ 760 (774)
T ss_pred hHH--------------HHHHHHcC----------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence 331 11111110 113344678999999999999999999999999999999
Q ss_pred Hhhhh
Q 001782 1003 SARKI 1007 (1013)
Q Consensus 1003 ~~~~~ 1007 (1013)
+..+.
T Consensus 761 ~~~~~ 765 (774)
T KOG1026|consen 761 AWAQA 765 (774)
T ss_pred HHHhc
Confidence 87654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=362.86 Aligned_cols=274 Identities=21% Similarity=0.303 Sum_probs=209.9
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchh-HHHHHHHHHhcCC-CCccceEEEEeecCCccccce
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATK-SFVAECEALRNIR-HRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 775 (1013)
-++|.+.++||.|.||.||+|+...++..||||.++.+-....+ .=.+|+..++++. ||||+++.+++. +.+..
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~----d~~~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR----DNDRI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh----ccCce
Confidence 46899999999999999999999999999999999744333222 2368999999998 999999999963 33348
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++|||||+ .+|+++++.++ +.+++.+++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||
T Consensus 85 L~fVfE~Md-~NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccc
Confidence 999999999 89999999873 5899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
+|+.+.. ....+.++.|.+|+|||++.. +-|+.+.||||+|||++|+.+-++.|.+...-+. +-++...
T Consensus 156 LARev~S---------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~KIc~V 225 (538)
T KOG0661|consen 156 LAREVRS---------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IYKICEV 225 (538)
T ss_pred ccccccc---------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HHHHHHH
Confidence 9996543 223556789999999998655 6789999999999999999999999987533222 2222111
Q ss_pred hCChh------HHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 935 ALPEK------VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 935 ~~~~~------~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
...+. ...+.. .+.... +.+...... .-...+..+..+++.+|+++||.+||||+|+++.
T Consensus 226 LGtP~~~~~~eg~~La~-~mnf~~----P~~~~~~l~-~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 226 LGTPDKDSWPEGYNLAS-AMNFRF----PQVKPSPLK-DLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hCCCccccchhHHHHHH-HhccCC----CcCCCCChH-HhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111 111111 111111 111111100 1112256778999999999999999999999863
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=371.67 Aligned_cols=480 Identities=26% Similarity=0.344 Sum_probs=398.0
Q ss_pred CCCCCCCeeeeccCCccccCCcccCCcccceEEeccCCccccCCCCccccCCCCceeccccccccCCCCCcccccccccc
Q 001782 97 GNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLE 176 (1013)
Q Consensus 97 ~~l~~L~~L~l~~n~l~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~ 176 (1013)
.+-..|+.|++++|.+. .+-+.+.+|..|++|++.+|+++ ..|++++.+.+++.|+.++|+++ .+|..+. ++..|.
T Consensus 42 W~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~-s~~~l~ 117 (565)
T KOG0472|consen 42 WEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIG-SLISLV 117 (565)
T ss_pred hhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHh-hhhhhh
Confidence 44567889999999999 77778999999999999999999 89999999999999999999999 8999887 788999
Q ss_pred ceecccccccccCCCCccCCCCcceeeecccccCCCCCCccccccccceeecccccccCCCcchhccCCccceeeccCCc
Q 001782 177 FLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNR 256 (1013)
Q Consensus 177 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~ 256 (1013)
.|+.++|.+. .++++++.+..|+.|+..+|+++ ..|..++++.+|..|++.+|+++...|..+. +++|++||...|.
T Consensus 118 ~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~ 194 (565)
T KOG0472|consen 118 KLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNL 194 (565)
T ss_pred hhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhh
Confidence 9999999998 67888999999999999999999 7999999999999999999999955555444 9999999999999
Q ss_pred cCCCCCCCcCCCCCCCcEEEeeeccccccCCCCCCCCCCCceEEcccCcccccccccccCCCCccccccccCcCCCCCCC
Q 001782 257 LEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIG 336 (1013)
Q Consensus 257 l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 336 (1013)
++ .+|..++ .+.+|..|+|..|+|. .+| .|.+++.|++|+++.|+|..........++++..|||.+|++++.+
T Consensus 195 L~-tlP~~lg-~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~P-- 268 (565)
T KOG0472|consen 195 LE-TLPPELG-GLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVP-- 268 (565)
T ss_pred hh-cCChhhc-chhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCc--
Confidence 98 9999998 7999999999999998 677 8999999999999999999877777789999999999999998743
Q ss_pred ChhhhhhcccccccccccccccccCCccchhhhcchhhHHHHhccchhHHhhcccccceeecccccccCCcccccCCCC-
Q 001782 337 DLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELR- 415 (1013)
Q Consensus 337 ~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~- 415 (1013)
..+.-+.+|+.|++++|.+++. |.+++++ +|+.|.+.+|.+..+-.+-+..-+
T Consensus 269 -----de~clLrsL~rLDlSNN~is~L-p~sLgnl--------------------hL~~L~leGNPlrTiRr~ii~~gT~ 322 (565)
T KOG0472|consen 269 -----DEICLLRSLERLDLSNNDISSL-PYSLGNL--------------------HLKFLALEGNPLRTIRREIISKGTQ 322 (565)
T ss_pred -----hHHHHhhhhhhhcccCCccccC-Ccccccc--------------------eeeehhhcCCchHHHHHHHHcccHH
Confidence 3445566777777777777654 3344433 466666777776532222221110
Q ss_pred -CCCEEE-------ccCCcc----Ccc-CCc---cccccCccCEEEcCCCcccCCCCcccccCcc---cceeeccccccc
Q 001782 416 -NLQVLD-------LHHNNL----DGH-IPE---SLGNLTILNSLDLGFNKLRGHVPSSLGNCQN---LMLLSVSNNKLT 476 (1013)
Q Consensus 416 -~L~~L~-------L~~N~l----~~~-~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~ 476 (1013)
-|++|. ++.-+= .+. .+. ....+.+.+.|+++.=+++ .+|.....-.+ .+..+++.|++.
T Consensus 323 ~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~ 401 (565)
T KOG0472|consen 323 EVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC 401 (565)
T ss_pred HHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh
Confidence 011111 111100 000 111 1223567899999999999 67776655544 789999999999
Q ss_pred ccCCchhhcccchhhhhccCCCeecccCCccccCcCCCcEEEccCCCCCCCCccccccccccccccccccccccccCccc
Q 001782 477 GALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLAL 556 (1013)
Q Consensus 477 ~~~p~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 556 (1013)
++|..+.......+.+++++|.+. .+|..++.+++|..|+|++|.+. .+|.+++.+..|+.|++|.|++. .+|..+
T Consensus 402 -elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~ 477 (565)
T KOG0472|consen 402 -ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECL 477 (565)
T ss_pred -hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHH
Confidence 999998886666777888888887 78999999999999999999997 89999999999999999999999 899999
Q ss_pred cccCCCCeEeccccccccccccccccccccceeecCCccCCCCCCCCCccCCCcceeeeCCcCC
Q 001782 557 KTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRL 620 (1013)
Q Consensus 557 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~~ 620 (1013)
..+..|+.+-.++|++....|..+.+|.+|..|||.+|.+...+|..+...+++.+.+.|||.-
T Consensus 478 y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 478 YELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 9999999999999999977777799999999999999999999999999999999999999863
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=325.88 Aligned_cols=277 Identities=22% Similarity=0.284 Sum_probs=211.6
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc--chhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG--ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.+|...+++|+|.||.||+|++.++++.||||.++..... -.....+|++.|+.++|+||+.++++ +...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence 4788889999999999999999999999999999855332 23567899999999999999999999 4566889
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
.+|+|||+ .+|+..++... ..++..++..++.++++|++|+|++ .|+||||||.|+|++++|.+||+|||+
T Consensus 77 ~lVfEfm~-tdLe~vIkd~~-----i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 77 SLVFEFMP-TDLEVVIKDKN-----IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred EEEEEecc-ccHHHHhcccc-----cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence 99999999 89999998764 4788999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
|+.+...... ....+-|.+|+|||.+.|. .|+..+||||.||++.||+-|.+-|.+. .+.+++..+.+..
T Consensus 148 Ar~f~~p~~~--------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-sDidQL~~If~~L 218 (318)
T KOG0659|consen 148 ARFFGSPNRI--------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-SDIDQLSKIFRAL 218 (318)
T ss_pred hhccCCCCcc--------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-chHHHHHHHHHHc
Confidence 9988654332 2233679999999998885 6999999999999999999998777663 3333344333332
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
..+...+|-+-.--.|+.+-........ ......+.....+++..|+.+||.+|+|+.|++++
T Consensus 219 GTP~~~~WP~~~~lpdY~~~~~~P~~~~--~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 219 GTPTPDQWPEMTSLPDYVKIQQFPKPPL--NNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCCcccCccccccccHHHHhcCCCCcc--ccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 2221111111111111111000000000 00122344556899999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=354.52 Aligned_cols=281 Identities=24% Similarity=0.322 Sum_probs=216.3
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
.+.|+..++||+|.||.||+|++..+++.||+|.++.+. .+......+||.+|++++||||+++.+..... ....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 456777899999999999999999999999999998665 33445678999999999999999999997643 3478
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.|+|+|||+ .+|..++.... -.|++.++..++.|++.||+|+|.+ ||+|||||.+|||||.+|.+||+|||
T Consensus 193 iYlVFeYMd-hDL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 193 IYLVFEYMD-HDLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred EEEEEeccc-chhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccc
Confidence 999999999 89999887642 4799999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
+|+++...... ..+..+-|.+|+|||.+.|. .|+.++|+||.|||+.||++|++.|+.. .+-.++..+.+.
T Consensus 264 LAr~y~~~~~~-------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~-tEveQl~kIfkl 335 (560)
T KOG0600|consen 264 LARFYTPSGSA-------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR-TEVEQLHKIFKL 335 (560)
T ss_pred ceeeccCCCCc-------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc-cHHHHHHHHHHH
Confidence 99988654432 25567789999999998885 7999999999999999999999999874 233344444443
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..++.-..|-...+-.--..++... ..+.-.+.....+...++++..+|..||.+|.||.++++
T Consensus 336 cGSP~e~~W~~~kLP~~~~~kp~~~-y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 336 CGSPTEDYWPVSKLPHATIFKPQQP-YKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred hCCCChhccccccCCcccccCCCCc-ccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 3322211111100100000011100 001111223445566788999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=363.89 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=215.1
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
....|...++||+|+.|.||.|+...+++.||||++........+-+.+|+.+|+..+|+|||.+++.+ ...+..
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sy-----lv~deL 345 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSY-----LVGDEL 345 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHh-----ccccee
Confidence 355788889999999999999999999999999999988777778899999999999999999999985 344889
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
|+|||||+||+|.+.+... .+++.++..|+.+++.||+|||.+ ||+|||||.+|||++.+|.+||+|||+
T Consensus 346 WVVMEym~ggsLTDvVt~~-------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGF 415 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT-------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGF 415 (550)
T ss_pred EEEEeecCCCchhhhhhcc-------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeee
Confidence 9999999999999999875 689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+..+... .......+||+.|||||++....|++++||||||++++||+.|++||-.. ..++...
T Consensus 416 caqi~~~--------~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE----~PlrAly---- 479 (550)
T KOG0578|consen 416 CAQISEE--------QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPLRALY---- 479 (550)
T ss_pred eeccccc--------cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC----ChHHHHH----
Confidence 9866532 22466789999999999999999999999999999999999999999651 1111110
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
++ .....+++...+.....+.+++.+||..||.+||+|.|+++
T Consensus 480 ------LI--------------a~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 480 ------LI--------------ATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ------HH--------------hhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 00 01122233334455677899999999999999999999986
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.08 Aligned_cols=266 Identities=22% Similarity=0.297 Sum_probs=212.3
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
....|++.++||.|..++||+|+....+..||||++..+.- ...+.+.+|+..|+.++||||++++..| ..+..
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF-----vv~~~ 98 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF-----VVDSE 98 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE-----Eecce
Confidence 35689999999999999999999999999999999985543 3357899999999999999999999885 45588
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.|+||+||.+|++.++++.... ..+++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.|||+|||
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~----~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFg 171 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYP----DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFG 171 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHcc----ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCce
Confidence 9999999999999999998754 4699999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG--GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
.+..+..... +...+....+||+.|||||++.. ..|+.|+||||||++..|+.+|..||.....-.....
T Consensus 172 vsa~l~~~G~----R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~---- 243 (516)
T KOG0582|consen 172 VSASLFDSGD----RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL---- 243 (516)
T ss_pred eeeeecccCc----eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH----
Confidence 8876544221 11112266789999999999654 4699999999999999999999999987532211111
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.+..+|. .........++.......+.+++..|++.||++||||+++++
T Consensus 244 -------------tLqn~pp----~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 244 -------------TLQNDPP----TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -------------HhcCCCC----CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111 000111112222334457889999999999999999999975
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=364.84 Aligned_cols=268 Identities=28% Similarity=0.425 Sum_probs=213.9
Q ss_pred hhhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCC
Q 001782 692 ADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSID 769 (1013)
Q Consensus 692 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 769 (1013)
.++....+++.+.+.||+|.||+||+|++.++ ||||++..+.. +..+.|++|+.++++-+|.||+-++|+|...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p- 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP- 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-
Confidence 55556667788899999999999999999755 99999985543 3457899999999999999999999997533
Q ss_pred ccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCce
Q 001782 770 FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVA 849 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 849 (1013)
. ..+|+.+|+|-+|+.+++..+ ..++..+.+.||.|||+|+.|||.+ +|||||+|..||++.+++.|
T Consensus 461 ----~-~AIiTqwCeGsSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kV 527 (678)
T KOG0193|consen 461 ----P-LAIITQWCEGSSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKV 527 (678)
T ss_pred ----c-eeeeehhccCchhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcE
Confidence 3 389999999999999999875 3789999999999999999999999 99999999999999999999
Q ss_pred EEccccccccCCCCCCCccccCCCCCcccccccccccccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCc
Q 001782 850 HVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG---DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGL 926 (1013)
Q Consensus 850 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~ 926 (1013)
||+|||++..-... ..........|...|||||++..+ +|++++||||||+|+|||++|..||.....+..
T Consensus 528 kIgDFGLatvk~~w------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI 601 (678)
T KOG0193|consen 528 KIGDFGLATVKTRW------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI 601 (678)
T ss_pred EEecccceeeeeee------ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe
Confidence 99999999754322 112223345678899999998653 689999999999999999999999983211111
Q ss_pred cHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhh
Q 001782 927 TLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 927 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1006 (1013)
.+..- +..+..|+ ......|++++.+|+..||..++++||.+.+|+.+|+++..
T Consensus 602 ifmVG-------------rG~l~pd~-------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 602 IFMVG-------------RGYLMPDL-------------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred EEEec-------------ccccCccc-------------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11000 00000111 11224667889999999999999999999999999998876
Q ss_pred hh
Q 001782 1007 IF 1008 (1013)
Q Consensus 1007 ~~ 1008 (1013)
+.
T Consensus 656 ~~ 657 (678)
T KOG0193|consen 656 SL 657 (678)
T ss_pred cc
Confidence 43
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=349.32 Aligned_cols=262 Identities=26% Similarity=0.369 Sum_probs=205.3
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
..+|...+.||+|+||+||++.+..++...|||.+........+.+.+|+.+|++++|||||+++|..... +...++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~---~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR---ENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc---cCeeeE
Confidence 34678889999999999999999988999999999866443356789999999999999999999973322 113789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC-CCceEEccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH-DMVAHVGDFGL 856 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~ 856 (1013)
+.|||+++|+|.+++.... +.+++..+.++..||++||+|||++ |||||||||+|||++. ++.+||+|||.
T Consensus 93 i~mEy~~~GsL~~~~~~~g-----~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYG-----GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred eeeeccCCCcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcc
Confidence 9999999999999999873 2689999999999999999999999 9999999999999999 79999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
++..... ...........||+.|||||++..+ ...+++||||+||++.||+||+.||... .. .........
T Consensus 165 a~~~~~~-----~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~--~~~~~~~ig 236 (313)
T KOG0198|consen 165 AKKLESK-----GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FE--EAEALLLIG 236 (313)
T ss_pred ccccccc-----cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cc--hHHHHHHHh
Confidence 9865430 1122334567899999999999954 3446999999999999999999999763 00 000000000
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
... ..| .+ +...+....+++.+|+..||++||||+|+++.--.
T Consensus 237 --------~~~---~~P------------~i--p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 237 --------RED---SLP------------EI--PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred --------ccC---CCC------------CC--CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 000 000 00 11234567889999999999999999999986543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=362.20 Aligned_cols=366 Identities=24% Similarity=0.261 Sum_probs=248.2
Q ss_pred eEEeccCCccccCCCCccccCCCCceeccccccccCCCCCccccccccccceecccccccccCCCCccCCCCcceeeecc
Q 001782 127 ETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGE 206 (1013)
Q Consensus 127 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 206 (1013)
++||+|+|+++..-+..|.++++|+++.+..|.++ .||.... ...+|+.|+|.+|.|+..-.+.+..++.|+.||||.
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~-~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGH-ESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccc-cccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 45666666666555555666666666666666555 4443221 112233333333333333334444455555555555
Q ss_pred cccCCCCCCccccccccceeecccccccCCCcchhccCCccceeeccCCccCCCCCCCcCCCCCCCcEEEeeeccccccC
Q 001782 207 NRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSL 286 (1013)
Q Consensus 207 n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~ 286 (1013)
|.|+..--.+|..-.++++|+|++|.|+..-...|.++.+|.+|.|++|+++ .+|..
T Consensus 159 N~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~r---------------------- 215 (873)
T KOG4194|consen 159 NLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-TLPQR---------------------- 215 (873)
T ss_pred chhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc-ccCHH----------------------
Confidence 5555322234444445555555555555444444555555555555555554 44444
Q ss_pred CCCCCCCCCCceEEcccCcccccccccccCCCCccccccccCcCCCCCCCChhhhhhcccccccccccccccccCCccch
Q 001782 287 PHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPL 366 (1013)
Q Consensus 287 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~ 366 (1013)
.|.++++|+.|+|.+|+|.-..-..|.++++|+.|.|.+|+|...
T Consensus 216 --~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL--------------------------------- 260 (873)
T KOG4194|consen 216 --SFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKL--------------------------------- 260 (873)
T ss_pred --HhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccc---------------------------------
Confidence 444555555555555555544344566666666666666665432
Q ss_pred hhhcchhhHHHHhccchhHHhhcccccceeecccccccCCcccccCCCCCCCEEEccCCccCccCCccccccCccCEEEc
Q 001782 367 SIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDL 446 (1013)
Q Consensus 367 ~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 446 (1013)
++..|-.+.++++|+|+.|+++..-..++.++++|+.|+||+|.|..+.++.+...++|++|+|
T Consensus 261 ----------------~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdL 324 (873)
T KOG4194|consen 261 ----------------DDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDL 324 (873)
T ss_pred ----------------cCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEec
Confidence 2223445667777777778887777788888999999999999999888888888899999999
Q ss_pred CCCcccCCCCcccccCcccceeecccccccccCCchhhcccchhhhhccCCCeecccCCc---cccCcCCCcEEEccCCC
Q 001782 447 GFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPA---EVGNLKNLVQLGLSENR 523 (1013)
Q Consensus 447 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~ 523 (1013)
++|+|+...+..|..+..|++|+|++|+++ .+.+..+..+++|+.|||++|.+++.+-+ .|.++++|+.|+|.+|+
T Consensus 325 s~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq 403 (873)
T KOG4194|consen 325 SSNRITRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ 403 (873)
T ss_pred cccccccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence 999999877888889999999999999998 67777777789999999999998876643 57789999999999999
Q ss_pred CCCCCccccccccccccccccccccccccCccccccCCCCeEecccc
Q 001782 524 FSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRN 570 (1013)
Q Consensus 524 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 570 (1013)
|+.+.-.+|.++.+|++|+|.+|.|..+-|++|..+ .|++|.+..-
T Consensus 404 lk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs 449 (873)
T KOG4194|consen 404 LKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSS 449 (873)
T ss_pred eeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhccc
Confidence 996556789999999999999999999999999998 8999987653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=354.16 Aligned_cols=246 Identities=27% Similarity=0.403 Sum_probs=207.1
Q ss_pred CCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEe
Q 001782 702 SSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 702 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
...+-||.|+.|.||+|+.+ ++.||||.++. .-..+|+-|++++||||+.+.|+|... ..+|||||
T Consensus 127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiME 192 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIME 192 (904)
T ss_pred hhhhhhccCcccceeeeecc--CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCC-----ceeEEeee
Confidence 34578999999999999996 66899998752 223688899999999999999999754 78999999
Q ss_pred eccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCC
Q 001782 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP 861 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 861 (1013)
||..|-|.++++.. ..+.......|..+||.|+.|||.+ .|||||||.-||||..+..|||+|||-++...
T Consensus 193 fCa~GqL~~VLka~------~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAG------RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred ccccccHHHHHhcc------CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 99999999999987 5688889999999999999999999 99999999999999999999999999988543
Q ss_pred CCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHH
Q 001782 862 PCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVM 941 (1013)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 941 (1013)
. ......+.||..|||||++...+.+.|+||||||||+|||+||..||.+.......+..
T Consensus 264 ~---------~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----------- 323 (904)
T KOG4721|consen 264 D---------KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----------- 323 (904)
T ss_pred h---------hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec-----------
Confidence 2 23466789999999999999999999999999999999999999999875333221111
Q ss_pred HhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 001782 942 EIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIF 1008 (1013)
Q Consensus 942 ~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1008 (1013)
+.....++.+..|++.+.-++++||+..|..||++.+++..|+-+...+
T Consensus 324 ------------------GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 324 ------------------GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred ------------------cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 0111123344678899999999999999999999999999988665443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=351.42 Aligned_cols=237 Identities=31% Similarity=0.453 Sum_probs=198.7
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
++|.+.+.||+|.||.||+|+.+.+.+.||+|.+....+ .+.+.+.+|+++++.++||||+.++++ ++...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence 578899999999999999999999999999999974433 334668999999999999999999998 5677999
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
|+|+||+. |+|..++... +.++++.+..|+.|++.||.|||+. +|.|||+||+|||++.++.+|+||||+
T Consensus 77 ~vVte~a~-g~L~~il~~d------~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 77 WVVTEYAV-GDLFTILEQD------GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred EEEehhhh-hhHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence 99999999 5999999876 6899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH-Hh-
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA-KM- 934 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~-~~- 934 (1013)
|+.+.. .........||+.|||||...+++|+..+|+||+||++||+++|++||....- ..+.+.+ ..
T Consensus 147 Ar~m~~--------~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si--~~Lv~~I~~d~ 216 (808)
T KOG0597|consen 147 ARAMST--------NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI--TQLVKSILKDP 216 (808)
T ss_pred hhhccc--------CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH--HHHHHHHhcCC
Confidence 997643 22335677899999999999999999999999999999999999999965211 1111111 10
Q ss_pred -----hCChhHHHhhhhhhccchhhhhccCC
Q 001782 935 -----ALPEKVMEIVDPLLLLDLEARASNCG 960 (1013)
Q Consensus 935 -----~~~~~~~~~i~~~l~~~~~~R~~~~~ 960 (1013)
..+..+..+++..+.+||..|.++..
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~ 247 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTD 247 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcccHHH
Confidence 12334666777777777777776654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=321.20 Aligned_cols=237 Identities=26% Similarity=0.365 Sum_probs=206.2
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
.++|+..+.||.|+||.|.+++.+.++..+|+|+++...- ...+...+|..+++.+.||+++++++.+ .+..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence 4578899999999999999999999999999999975433 2335578899999999999999999884 4668
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..++||||++||.|..++++. +++++..++.+|.||+.|++|||+. +|++||+||+|||+|.+|.+||+||
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~------~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKS------GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred eEEEEEeccCCccHHHHHHhc------CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence 999999999999999999987 6899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
|+|+.+. ......+|||.|+|||++...++..++|.|||||++|||+.|.+||..... ...+..+...
T Consensus 189 GFAK~v~-----------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~ 256 (355)
T KOG0616|consen 189 GFAKRVS-----------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEG 256 (355)
T ss_pred cceEEec-----------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhC
Confidence 9998653 225678999999999999999999999999999999999999999987433 3333443332
Q ss_pred ------hCChhHHHhhhhhhccchhhhhccCC
Q 001782 935 ------ALPEKVMEIVDPLLLLDLEARASNCG 960 (1013)
Q Consensus 935 ------~~~~~~~~~i~~~l~~~~~~R~~~~~ 960 (1013)
.++.++++++++.+..|-..|.....
T Consensus 257 ~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlk 288 (355)
T KOG0616|consen 257 KVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLK 288 (355)
T ss_pred cccCCcccCHHHHHHHHHHHhhhhHhhhcCcC
Confidence 24567899999999999999966554
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=331.73 Aligned_cols=285 Identities=21% Similarity=0.271 Sum_probs=217.1
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEe--eccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN--LKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
...+|...+.||+|+||.|+.|.+..+++.||||.+. .......++..+|+++++.++|+||+.+.+++.......-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456777899999999999999999999999999987 45555667889999999999999999999998775556678
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..|+|+|+|+ .+|.+.++.+ ..++...+..+..|+++|+.|+|+. +|+|||+||+|++++.+...||+||
T Consensus 100 DvYiV~elMe-tDL~~iik~~------~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQ------QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcC------ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence 8999999997 8999999987 4589999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
|+|+..... ......+..+.|.+|+|||.+.. ..|+.+.||||.|||+.||++|++.|.+...-. ++.....
T Consensus 170 GLAR~~~~~------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~-Ql~lI~~ 242 (359)
T KOG0660|consen 170 GLARYLDKF------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH-QLQLILE 242 (359)
T ss_pred cceeecccc------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH-HHHHHHH
Confidence 999976543 22334567888999999998654 579999999999999999999999998743221 1222111
Q ss_pred hh--CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 934 MA--LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 934 ~~--~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.. .+++....+...-...+-.... .....+.............+++.+|+..||.+|+|++|+++
T Consensus 243 ~lGtP~~e~l~~i~s~~ar~yi~slp-~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 243 LLGTPSEEDLQKIRSEKARPYIKSLP-QIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred hcCCCCHHHHHHhccHHHHHHHHhCC-CCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11 1111111111100111100000 00111112222344456789999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=358.33 Aligned_cols=268 Identities=23% Similarity=0.349 Sum_probs=205.6
Q ss_pred hhccCCCCCceeeccceEEEEEEEC-----CCCeEEEEEEEeeccc-cchhHHHHHHHHHhcC-CCCccceEEEEeecCC
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLG-----ENEMAVAVKVMNLKQR-GATKSFVAECEALRNI-RHRNLIKIITVCSSID 769 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 769 (1013)
..++|++.++||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.+++.+ +||||++++++|.
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--- 81 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT--- 81 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec---
Confidence 3568999999999999999999852 3456799999874322 2345688999999999 8999999999874
Q ss_pred ccccceEEEEEeeccCCCHHHHhhcccccc--------------------------------------------------
Q 001782 770 FEEVDFKAIVYEYMECGSLEDWLHQSNDQL-------------------------------------------------- 799 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------- 799 (1013)
......++||||+++|+|.+++.......
T Consensus 82 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 82 -KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred -CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 23456899999999999999997642110
Q ss_pred ------ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCCCCCccccCCC
Q 001782 800 ------EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS 873 (1013)
Q Consensus 800 ------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 873 (1013)
....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++........ .
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~------~ 231 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------V 231 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcch------h
Confidence 013478889999999999999999999 9999999999999999999999999999865322111 1
Q ss_pred CCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccch
Q 001782 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDL 952 (1013)
Q Consensus 874 ~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~ 952 (1013)
......++..|+|||++.+..++.++|||||||++|||++ |..||........ ....+. ....
T Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-------------~~~~~~---~~~~ 295 (338)
T cd05102 232 RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-------------FCQRLK---DGTR 295 (338)
T ss_pred cccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-------------HHHHHh---cCCC
Confidence 1223446788999999999999999999999999999997 9999976322110 000000 0000
Q ss_pred hhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhh
Q 001782 953 EARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 953 ~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1006 (1013)
.+. ...++..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 296 -~~~------------~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 296 -MRA------------PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred -CCC------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 000 01223467899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.55 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=204.3
Q ss_pred hhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec----cc-cchhHHHHHHHHHhcCC-CCccceEEEEeecCC
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK----QR-GATKSFVAECEALRNIR-HRNLIKIITVCSSID 769 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 769 (1013)
...++|.+.+.||+|+||.|+.|.+..++..||+|++... .. ...+.+.+|+.++++++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~--- 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA--- 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe---
Confidence 4467999999999999999999999999999999977643 11 23456778999999998 999999999954
Q ss_pred ccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC-Cc
Q 001782 770 FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD-MV 848 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~ 848 (1013)
.....++||||+.+|+|.+++... +++.+.++.+++.|++.|++|+|++ ||+||||||+||+++.+ ++
T Consensus 91 --t~~~~~ivmEy~~gGdL~~~i~~~------g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 91 --TPTKIYIVMEYCSGGDLFDYIVNK------GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred --cCCeEEEEEEecCCccHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCC
Confidence 446699999999999999999985 6789999999999999999999999 99999999999999999 99
Q ss_pred eEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCC-CC-cccchHHHHHHHHHHHhCCCCCCCcCCCCc
Q 001782 849 AHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD-MS-ATGDVYSFGILLLEMFTRRRPTDNMFNDGL 926 (1013)
Q Consensus 849 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DIwSlG~il~ell~G~~pf~~~~~~~~ 926 (1013)
+||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++....
T Consensus 160 ~Kl~DFG~s~~~~--------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-- 229 (370)
T KOG0583|consen 160 LKLSDFGLSAISP--------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-- 229 (370)
T ss_pred EEEeccccccccC--------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH--
Confidence 9999999998653 1223356789999999999999977 76 6899999999999999999999862110
Q ss_pred cHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHH-HHHHHHHhhhcccCCCCCCCCHHHHH
Q 001782 927 TLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEEC-LVAIVRIGVLCSMESPSERIQMTDVV 998 (1013)
Q Consensus 927 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl 998 (1013)
... .. +.+.--.-| ... ...+..++.+|+..||.+|+|+.||+
T Consensus 230 ---~l~--------~k-i~~~~~~~p-----------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 230 ---NLY--------RK-IRKGEFKIP-----------------SYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---HHH--------HH-HhcCCccCC-----------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 000 00 110000000 011 34578899999999999999999998
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=344.43 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=207.7
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
...|+..+.||+|.||.||+|.+..+++.||+|++..+.. ...+++++|+.++..++++||.++|+.+. .+...
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl-----~g~~L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL-----KGTKL 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee-----ecccH
Confidence 3467788999999999999999999999999999986544 44678999999999999999999999854 45789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
+++||||.||++.+.++.. ..+++.++.-|.+++..|+.|+|.+ +.+|||||+.||++..+|.+|++|||.
T Consensus 87 wiiMey~~gGsv~~lL~~~------~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgV 157 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSG------NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGV 157 (467)
T ss_pred HHHHHHhcCcchhhhhccC------CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecce
Confidence 9999999999999999876 3447888888999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+..+.. ...+...++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+........
T Consensus 158 a~ql~~--------~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv---------- 219 (467)
T KOG0201|consen 158 AGQLTN--------TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV---------- 219 (467)
T ss_pred eeeeec--------hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----------
Confidence 976543 22334678999999999999998999999999999999999999999987533110
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+-.-|..-|... + ..+.+.+.+++..|++.||+.||+|.++++
T Consensus 220 -----------lflIpk~~PP~L-------~--~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 220 -----------LFLIPKSAPPRL-------D--GDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred -----------EEeccCCCCCcc-------c--cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 000111111111 1 133456888999999999999999999986
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=332.47 Aligned_cols=280 Identities=23% Similarity=0.306 Sum_probs=208.1
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
.-.|+..+++|.|+||.||+|...++++.||||..-.+.+ .-.+|+++|++++|||||++.-++......+.-+..
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 3467778999999999999999999999999998864433 224799999999999999999988765333345677
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC-CceEEccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD-MVAHVGDFGL 856 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~ 856 (1013)
+|||||+ .+|.++++.... ....++...+.-+..||.+|++|||+. +|+||||||+|+|||.+ |.+||||||.
T Consensus 99 lVleymP-~tL~~~~r~~~~--~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 99 LVLEYMP-ETLYRVIRHYTR--ANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHhch-HHHHHHHHHHhh--cCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence 9999999 899999986311 124688889999999999999999999 99999999999999976 8999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
|+.+..+.+ ......|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.+. ....++.++.+..
T Consensus 173 AK~L~~~ep---------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~l 242 (364)
T KOG0658|consen 173 AKVLVKGEP---------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVL 242 (364)
T ss_pred ceeeccCCC---------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHh
Confidence 997754332 3456788999999998885 7999999999999999999999999873 3334445544443
Q ss_pred CChhHHHhhhhhhccchhhh-hccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEAR-ASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..+...++ ..|-...-+.+ |........+ -.....+.+..+++.+++.++|.+|.++.|++.
T Consensus 243 G~Pt~e~I-~~mn~~y~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 243 GTPTREDI-KSMNPNYTEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CCCCHHHH-hhcCcccccccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 22222221 11110000000 0000000000 011234566789999999999999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=321.86 Aligned_cols=277 Identities=24% Similarity=0.309 Sum_probs=209.6
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc--chhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG--ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
.+.|+...+|++|.||.||+|+++.+++.||+|.++.+... -.-...+|+.++.+.+|||||.+-.+... .+-+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG---~~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG---SNMDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec---cccce
Confidence 45788899999999999999999999999999999855432 12346899999999999999999998753 34466
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.|+|||||+ .+|..+++..+ .++...++.-+..|+++|++|||.+ .|+|||+||+|+|+...|.+||+|||
T Consensus 152 iy~VMe~~E-hDLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 152 IYIVMEYVE-HDLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred eeeeHHHHH-hhHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccc
Confidence 999999999 89999998874 4799999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
+|+.++.. ....+..+-|.+|+|||.+.+. .|+.+.|+||+|||+.||+++++.|.....-+. +..+...
T Consensus 223 LAR~ygsp--------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If~l 293 (419)
T KOG0663|consen 223 LAREYGSP--------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIFKL 293 (419)
T ss_pred hhhhhcCC--------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHHHH
Confidence 99977532 2335677889999999998885 589999999999999999999999987533322 2222221
Q ss_pred -hCChhHHHhhhhhhccch----hhhhcc-CCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 -ALPEKVMEIVDPLLLLDL----EARASN-CGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 -~~~~~~~~~i~~~l~~~~----~~R~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..|.+. +-+....-| ..++.. ....+..+.... ..+.-.+++...+.+||.+|.||+|.++
T Consensus 294 lGtPte~---iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 294 LGTPSEA---IWPGYSELPAVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hCCCccc---cCCCccccchhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhc
Confidence 112110 000000000 000000 001111111111 2345678999999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=316.19 Aligned_cols=280 Identities=18% Similarity=0.231 Sum_probs=219.5
Q ss_pred hhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
...+||++.+.+|+|||+.||.++...++..+|+|++.....+..+..++|++..++++||||+++++++....-+....
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 34579999999999999999999998899999999998877777888999999999999999999999876543445567
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.|++++|...|+|.+.++..+.. ...+++.++++|+.+|++||++||+. .+.++||||||.||++.+++.+++.|||
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~k--g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIK--GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhc--CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 89999999999999999876542 24799999999999999999999998 2359999999999999999999999999
Q ss_pred ccccCCCCCCCccc-cCCCCCcccccccccccccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHH
Q 001782 856 LARFLPPCSPATIL-ETPSSSTGIKGTVGYVAPEYGMG---GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~ 931 (1013)
.++..+-....... ..-........|..|+|||.+.- ...+.++|||||||++|+|+.|..||+.....+..+.-.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 99865432211100 00011233457899999998754 357889999999999999999999998654433322111
Q ss_pred HHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhh
Q 001782 932 AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1005 (1013)
+ ...-+.. | . ....++.+.+++..|++.||.+||++.|++..++.+.
T Consensus 255 v-----------~n~q~s~-P-------~--------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 255 V-----------QNAQISI-P-------N--------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred e-----------ecccccc-C-------C--------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1 0000000 0 0 0113456889999999999999999999999998764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=360.06 Aligned_cols=259 Identities=27% Similarity=0.470 Sum_probs=214.9
Q ss_pred CCCCCceeeccceEEEEEEECCCC---eEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENE---MAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
..+.++||.|.||.|++|+.+..+ ..||||.++.... ....+|..|+.||.+++||||+++.|+.+ .....
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT-----ks~Pv 705 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT-----KSKPV 705 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe-----cCcee
Confidence 457789999999999999996544 6799999985543 34567999999999999999999999964 44788
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++|+|||++|+|+.|++.+. +.+++.+...+.++||.||.||.+. ++|||||.++||||+.+..+|++|||+
T Consensus 706 MIiTEyMENGsLDsFLR~~D-----GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQND-----GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcC-----CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccc
Confidence 99999999999999999875 4689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhh
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
++++.++.+.... ..+-.-+.+|.|||.+...+++.++||||||++|||.++ |..||.++.+.+.
T Consensus 778 SRvledd~~~~yt-----t~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV--------- 843 (996)
T KOG0196|consen 778 SRVLEDDPEAAYT-----TLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--------- 843 (996)
T ss_pred eeecccCCCcccc-----ccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH---------
Confidence 9977654422211 111223579999999999999999999999999999887 9999987644321
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 1007 (1013)
...+.... +++.+.+|+..+.+||..||+.|-.+||.+.||+..|.++.+.
T Consensus 844 -----IkaIe~gy----------------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 844 -----IKAIEQGY----------------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred -----HHHHHhcc----------------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 11111111 1233457899999999999999999999999999999987643
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=364.61 Aligned_cols=273 Identities=21% Similarity=0.254 Sum_probs=214.9
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCC-CCccceEEEEe-ecCCccc-c
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-HRNLIKIITVC-SSIDFEE-V 773 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~-~~~~~~~-~ 773 (1013)
...++++.++|.+|||+.||.|++...+..||+|++-..+....+...+|+++|++++ |+|||.+++.. ....... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3457888999999999999999999887999999998777777788999999999996 99999999943 2221222 3
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
-++.+.||||+||.|-+++..+.. .++++.++++|+.|+++|+++||.. +++|||||||-+|||++.++..||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq----~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ----TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh----ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 678899999999999999987644 4699999999999999999999997 56799999999999999999999999
Q ss_pred ccccccCCCCC-CCccccCCCCCcccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHH
Q 001782 854 FGLARFLPPCS-PATILETPSSSTGIKGTVGYVAPEYGM---GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 929 (1013)
Q Consensus 854 FG~a~~~~~~~-~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~ 929 (1013)
||.|...-... .......-........|+.|+|||++. +.++++|+|||||||++|-|+....||+....-
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----- 264 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----- 264 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----
Confidence 99987432211 110000111122345799999999854 568999999999999999999999999863111
Q ss_pred HHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 001782 930 EFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007 (1013)
Q Consensus 930 ~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 1007 (1013)
.++.......+ .......+.+||+.||++||.+||++.+|++.+.+++..
T Consensus 265 ------------aIlng~Y~~P~----------------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 ------------AILNGNYSFPP----------------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ------------eEEeccccCCC----------------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 11111111111 113356689999999999999999999999999998754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=376.10 Aligned_cols=269 Identities=26% Similarity=0.422 Sum_probs=216.9
Q ss_pred hccCCCCCceeeccceEEEEEEECCC-----CeEEEEEEEeec-cccchhHHHHHHHHHhcCCCCccceEEEEeecCCcc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGEN-----EMAVAVKVMNLK-QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 771 (1013)
....+..+.||+|+||.||.|..... ...||||.++.. +..+..+|.+|..+|+.++||||++++|+|..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~---- 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD---- 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC----
Confidence 34456678999999999999988533 234899988744 34556789999999999999999999999854
Q ss_pred ccceEEEEEeeccCCCHHHHhhcccccc-ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceE
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQL-EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAH 850 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 850 (1013)
....++++|||++|+|..|+++.+... ....+...+.+.++.|||+|+.||+++ ++|||||.++|+|+++...||
T Consensus 767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred -CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEE
Confidence 477899999999999999999874422 234689999999999999999999999 999999999999999999999
Q ss_pred EccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHH
Q 001782 851 VGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLH 929 (1013)
Q Consensus 851 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~ 929 (1013)
|+|||+|+.+...+.... .....-+..|||||.+..+.++.|+|||||||++||+++ |..||.+..+.+...
T Consensus 843 IaDFGlArDiy~~~yyr~------~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~- 915 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRK------HGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL- 915 (1025)
T ss_pred EcccchhHhhhhchheec------cCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH-
Confidence 999999995433222211 111244679999999999999999999999999999999 999998753221100
Q ss_pred HHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhhhhh
Q 001782 930 EFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIFL 1009 (1013)
Q Consensus 930 ~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 1009 (1013)
.+... .+++++..|+..++++|.+||+.+|++||++..+++++..+.+...
T Consensus 916 ------------~~~~g-----------------gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 916 ------------DVLEG-----------------GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred ------------HHHhC-----------------CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 01110 1334456789999999999999999999999999999999876654
Q ss_pred c
Q 001782 1010 S 1010 (1013)
Q Consensus 1010 ~ 1010 (1013)
.
T Consensus 967 ~ 967 (1025)
T KOG1095|consen 967 G 967 (1025)
T ss_pred c
Confidence 3
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=346.01 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=206.6
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
.+-|+.++.||+|+.|.|-.|++..+|+.+|||++..... .....+.+|+-+|+.+.||||+++|++ +++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCc
Confidence 4578899999999999999999999999999999975422 223568899999999999999999999 67779
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
++|+|.||+++|-|.+++-.. +++++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++||+||
T Consensus 86 ~lylvlEyv~gGELFdylv~k------G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRK------GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred eEEEEEEecCCchhHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecc
Confidence 999999999999999999887 7899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCC-cccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMS-ATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
|+|..-.++ .-....+|.+.|.|||++.|.+|. .++||||.|||+|.+++|+.||++. .++
T Consensus 157 GMAsLe~~g---------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir---- 218 (786)
T KOG0588|consen 157 GMASLEVPG---------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIR---- 218 (786)
T ss_pred ceeecccCC---------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHH----
Confidence 999854332 224567899999999999999884 6899999999999999999999842 111
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.++.+..... ++.+...+.+.++|+++|+..||.+|.|++||++.
T Consensus 219 --------~LLlKV~~G~--------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 219 --------VLLLKVQRGV--------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --------HHHHHHHcCc--------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1111111110 11112334567888889999999999999998764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=327.31 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=207.5
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc---chhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG---ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
..+|++.+.||+|.||.|-+|.....|+.||||.++.+.-. +.-.+.+|+++|..++||||+.++.+ |++.+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCc
Confidence 45899999999999999999999889999999999754433 33457899999999999999999999 67778
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
...+||||..+|.|++|+.+. +.+++.++.++++||+.|+.|.|.+ ++||||+|.+|||+|.++++||+||
T Consensus 127 KIvivMEYaS~GeLYDYiSer------~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADF 197 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISER------GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADF 197 (668)
T ss_pred eEEEEEEecCCccHHHHHHHh------ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeecc
Confidence 999999999999999999987 6899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDM-SATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
|++.++.. ......++|++-|.+||++.+.+| ++.+|-||+|+++|.++.|..||+....
T Consensus 198 GLSNly~~---------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---------- 258 (668)
T KOG0611|consen 198 GLSNLYAD---------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---------- 258 (668)
T ss_pred chhhhhcc---------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----------
Confidence 99987643 233567899999999999999988 5689999999999999999999987421
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
..++++.-...+.+ + +. +....-+|++|+..+|++|.|+.+|....
T Consensus 259 -------k~lvrQIs~GaYrE---------P--~~----PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 259 -------KRLVRQISRGAYRE---------P--ET----PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------HHHHHHhhcccccC---------C--CC----CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11222111111100 0 00 22245688899999999999999988654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=328.86 Aligned_cols=282 Identities=25% Similarity=0.347 Sum_probs=211.5
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhc--CCCCccceEEEEeecCCccccceE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRN--IRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
...+..+.||+|+||.||+|+.. ++.||||++.... .+.|.+|.++++. ++|+||++++++-...+.. ...+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence 34556789999999999999995 5899999997443 4678888888876 4899999999985443222 5589
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeeecCCCCCceEecCCCceE
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHC------HPPIVHGDLKPSNVLLDHDMVAH 850 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~k 850 (1013)
++|+||.+.|+|.+|+..+ .++|.+..+|+..+++||+|||+.. +|+|+|||||++||||..|+++.
T Consensus 284 wLVt~fh~kGsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred eEEeeeccCCcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 9999999999999999986 7899999999999999999999654 57899999999999999999999
Q ss_pred EccccccccCCCCCCCccccCCCCCcccccccccccccccCCCC------CCcccchHHHHHHHHHHHhCCCCCCC--cC
Q 001782 851 VGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD------MSATGDVYSFGILLLEMFTRRRPTDN--MF 922 (1013)
Q Consensus 851 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DIwSlG~il~ell~G~~pf~~--~~ 922 (1013)
|+|||+|..+.++.+.. .....+||.+|||||++.+.. .-.+.||||+|.|+|||+++-.-++. ..
T Consensus 357 IaDFGLAl~~~p~~~~~------d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp 430 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQG------DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP 430 (534)
T ss_pred eeccceeEEecCCCCCc------chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence 99999999887654332 234578999999999988752 22368999999999999997654431 11
Q ss_pred CCCccHHHHHHhh-CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 923 NDGLTLHEFAKMA-LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 923 ~~~~~~~~~~~~~-~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
+-...+...+... --++.++.+- ....||......+.- ..+..+.+.+..||+.||+.|-|+.=|.+++
T Consensus 431 ~Yqlpfe~evG~hPt~e~mq~~VV-----~kK~RP~~p~~W~~h-----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 431 EYQLPFEAEVGNHPTLEEMQELVV-----RKKQRPKIPDAWRKH-----AGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred cccCchhHHhcCCCCHHHHHHHHH-----hhccCCCChhhhhcC-----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 1112222111111 1122222221 112344333322221 3356688899999999999999999999999
Q ss_pred HHhhhhhh
Q 001782 1002 CSARKIFL 1009 (1013)
Q Consensus 1002 ~~~~~~~~ 1009 (1013)
.++.....
T Consensus 501 ~~l~~~~~ 508 (534)
T KOG3653|consen 501 AELMMLWE 508 (534)
T ss_pred HHHhccCC
Confidence 99876554
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=332.09 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=203.3
Q ss_pred hhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--------------cchhHHHHHHHHHhcCCCCccce
Q 001782 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--------------GATKSFVAECEALRNIRHRNLIK 760 (1013)
Q Consensus 695 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~ 760 (1013)
.+..++|++.+.||+|.||.|-+|++..+++.||||++..... ...+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 4557899999999999999999999999999999999963211 12357899999999999999999
Q ss_pred EEEEeecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 001782 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSN 840 (1013)
Q Consensus 761 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~N 840 (1013)
++++..+ ...+..|+|+|||..|.+...=... ..+++.++++++.+++.||+|||.+ |||||||||+|
T Consensus 173 LiEvLDD---P~s~~~YlVley~s~G~v~w~p~d~------~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsN 240 (576)
T KOG0585|consen 173 LIEVLDD---PESDKLYLVLEYCSKGEVKWCPPDK------PELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSN 240 (576)
T ss_pred EEEeecC---cccCceEEEEEeccCCccccCCCCc------ccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhh
Confidence 9999653 3557899999999988775432221 2389999999999999999999999 99999999999
Q ss_pred eEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCC----CCcccchHHHHHHHHHHHhCCC
Q 001782 841 VLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD----MSATGDVYSFGILLLEMFTRRR 916 (1013)
Q Consensus 841 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DIwSlG~il~ell~G~~ 916 (1013)
+|++++|++||+|||.+.......... .........||+.|+|||...++. .+.+.||||+||++|.|+.|+.
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~---~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEG---SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccc---cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 999999999999999998764432221 122234578999999999987743 3567899999999999999999
Q ss_pred CCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 001782 917 PTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTD 996 (1013)
Q Consensus 917 pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 996 (1013)
||.+.. ..+..++... +|- .++...+..+.+.+++.++|..||.+|.+..+
T Consensus 318 PF~~~~-----------------~~~l~~KIvn-~pL-----------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ 368 (576)
T KOG0585|consen 318 PFFDDF-----------------ELELFDKIVN-DPL-----------EFPENPEINEDLKDLIKRLLEKDPEQRITLPD 368 (576)
T ss_pred Ccccch-----------------HHHHHHHHhc-Ccc-----------cCCCcccccHHHHHHHHHHhhcChhheeehhh
Confidence 997521 1111111110 000 01111133456788999999999999999999
Q ss_pred HHHHH
Q 001782 997 VVAKL 1001 (1013)
Q Consensus 997 vl~~L 1001 (1013)
|....
T Consensus 369 ik~Hp 373 (576)
T KOG0585|consen 369 IKLHP 373 (576)
T ss_pred heecc
Confidence 86543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=334.74 Aligned_cols=212 Identities=23% Similarity=0.369 Sum_probs=182.1
Q ss_pred hhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccc
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 772 (1013)
...++|++.++||+|+||.||+|+-+.+|..+|+|+++... ....+.+..|..+|....+|.||+++-. |++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecC
Confidence 35678999999999999999999999999999999998543 3445678899999999999999999988 577
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
.++.|+||||++||++..++... +.+++..+..++.+++.|++.+|+. |+|||||||+|+|||..|++||+
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~------~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLS 283 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRK------DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLS 283 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhc------CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeec
Confidence 79999999999999999999887 6899999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCc----------------cccCC-----------------------CCCcccccccccccccccCCC
Q 001782 853 DFGLARFLPPCSPAT----------------ILETP-----------------------SSSTGIKGTVGYVAPEYGMGG 893 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~----------------~~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~ 893 (1013)
|||++.-+....... ..+.. ......+|||.|||||++.+.
T Consensus 284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k 363 (550)
T KOG0605|consen 284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK 363 (550)
T ss_pred cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence 999985332100000 00000 012345699999999999999
Q ss_pred CCCcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 894 DMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 894 ~~~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
.|+..+|.||+|||+|||+.|.+||...
T Consensus 364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~ 391 (550)
T KOG0605|consen 364 GYGKECDWWSLGCIMYEMLVGYPPFCSE 391 (550)
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999999864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=323.88 Aligned_cols=286 Identities=21% Similarity=0.317 Sum_probs=210.2
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCc-cceEEEEeecCC-cccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRN-LIKIITVCSSID-FEEV 773 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~-~~~~ 773 (1013)
...|...++||+|+||+||+|+...+|+.||+|.++.... .......+|+.+++.++|+| |+++++++.... +...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456777889999999999999999999999999986544 34566789999999999999 999999986432 1223
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++|+||++ .+|.++++...... ..++...+..++.||+.||+|+|++ +|+||||||+||+|+++|.+||+|
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence 47889999999 89999998864311 3567789999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
||+|+.+... .......++|.+|+|||++.+. .|+...||||+||++.||++++..|.+..+.+. ...+.
T Consensus 164 FGlAra~~ip--------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q-l~~If 234 (323)
T KOG0594|consen 164 FGLARAFSIP--------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ-LFRIF 234 (323)
T ss_pred cchHHHhcCC--------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH-HHHHH
Confidence 9999855321 1224567789999999999887 789999999999999999999999987544222 22222
Q ss_pred Hh-hCChh-HHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 933 KM-ALPEK-VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 933 ~~-~~~~~-~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
+. ..|.+ ...-+...-..++ ........+.-............+++.+|++++|++|.|++.++++
T Consensus 235 ~~lGtP~e~~Wp~v~~~~~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 235 RLLGTPNEKDWPGVSSLPDYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHcCCCCccCCCCccccccccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 21 11111 0000000000000 0000000011111111112457889999999999999999999886
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=333.61 Aligned_cols=251 Identities=19% Similarity=0.288 Sum_probs=199.4
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeeccccc---hhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEe
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA---TKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
..||+|+++.||+|++ +++.||||+++...... .+.+.+|+.++++++||||+++++++... .......++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEEE
Confidence 6799999999999998 57899999997543322 46678999999999999999999997541 123457899999
Q ss_pred eccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCC
Q 001782 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP 861 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 861 (1013)
|+++|+|.+++... ..+++..+.+++.|++.|++|||+.. +++||||||+||++++++.+||+|||+++.+.
T Consensus 103 y~~~g~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 103 YCTRGYLREVLDKE------KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred eCCCCcHHHHHhhC------CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 99999999999865 46889999999999999999999832 78899999999999999999999999987543
Q ss_pred CCCCCccccCCCCCcccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChh
Q 001782 862 PCSPATILETPSSSTGIKGTVGYVAPEYGMG--GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEK 939 (1013)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~ 939 (1013)
.. .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...
T Consensus 175 ~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-----~~~------- 231 (283)
T PHA02988 175 SP-----------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-----EIY------- 231 (283)
T ss_pred cc-----------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-----HHH-------
Confidence 21 123457899999999876 68999999999999999999999999753211 100
Q ss_pred HHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhh
Q 001782 940 VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 940 ~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1006 (1013)
..++. ..+ ++.. ...++..+.+++.+||+.||++|||++|+++.|+.++.
T Consensus 232 -~~i~~----~~~--~~~~----------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 232 -DLIIN----KNN--SLKL----------PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -HHHHh----cCC--CCCC----------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 00100 000 0000 01235568899999999999999999999999998764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=338.18 Aligned_cols=275 Identities=21% Similarity=0.294 Sum_probs=203.5
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++++++ ...+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 47999999999999999999999999999999987432 22345688999999999999999999985 345789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||++++.+..+.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMP------NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred EEEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence 9999999987666554332 4689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh--
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM-- 934 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~-- 934 (1013)
+........ .......|++.|+|||++.+..++.++||||+||++|||++|+.||......+ ........
T Consensus 147 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~ 218 (287)
T cd07848 147 ARNLSEGSN-------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLG 218 (287)
T ss_pred ccccccccc-------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhC
Confidence 986532211 11234568999999999999899999999999999999999999997632211 11111111
Q ss_pred hCChhHHHhhhhhhccchhhh----hccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEAR----ASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..+....... ..++..+ +................+..+.+++.+|++.||++|||++|+++
T Consensus 219 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 219 PLPAEQMKLF----YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CCCHHHHHhh----hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111111 0111100 00000000011111224567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=344.19 Aligned_cols=266 Identities=26% Similarity=0.399 Sum_probs=209.1
Q ss_pred hhhhhccCCCCCceeeccceEEEEEEECCCC----eEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEee
Q 001782 694 LSKATNDFSSSNMIGQGSFGFVYRGNLGENE----MAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCS 766 (1013)
Q Consensus 694 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 766 (1013)
++..-++....++||+|+||.||+|+....+ ..||||..+... .....++.+|+++|+.++||||+++||++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3334455666799999999999999985432 238999988532 445678999999999999999999999975
Q ss_pred cCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC
Q 001782 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD 846 (1013)
Q Consensus 767 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 846 (1013)
. ....++|||+|.||+|.++++... ..++..++.+++.+.|.||+|||++ +++||||.++|+|++.+
T Consensus 232 ~-----~~Pl~ivmEl~~gGsL~~~L~k~~-----~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~ 298 (474)
T KOG0194|consen 232 L-----EEPLMLVMELCNGGSLDDYLKKNK-----KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKK 298 (474)
T ss_pred C-----CCccEEEEEecCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCC
Confidence 3 377899999999999999999874 2589999999999999999999999 99999999999999999
Q ss_pred CceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCC
Q 001782 847 MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDG 925 (1013)
Q Consensus 847 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~ 925 (1013)
+.+||+|||+++.-.. ... ......-+..|+|||.+..+.++.++|||||||++||+++ |..||......
T Consensus 299 ~~vKISDFGLs~~~~~---~~~-----~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~- 369 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGSQ---YVM-----KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY- 369 (474)
T ss_pred CeEEeCccccccCCcc---eee-----ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-
Confidence 9999999999874321 110 0112235689999999999999999999999999999999 89999875322
Q ss_pred ccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhh
Q 001782 926 LTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1005 (1013)
.+...+ ...++... .....+..+..++.+||..+|++||++.++.+.++.+.
T Consensus 370 -------------~v~~kI---~~~~~r~~------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 370 -------------EVKAKI---VKNGYRMP------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred -------------HHHHHH---HhcCccCC------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 111111 00000000 00133566788888999999999999999999999987
Q ss_pred hhhh
Q 001782 1006 KIFL 1009 (1013)
Q Consensus 1006 ~~~~ 1009 (1013)
+...
T Consensus 422 ~~~~ 425 (474)
T KOG0194|consen 422 KKKE 425 (474)
T ss_pred hccc
Confidence 7654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.96 Aligned_cols=266 Identities=23% Similarity=0.374 Sum_probs=212.5
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc-chhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG-ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
+.....+.++||+|-||.|.+++.. ....||||.++..+.. ...+|.+|+++|.+++||||++++|+|.. ++.
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-----DeP 609 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-----DDP 609 (807)
T ss_pred chhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-----CCc
Confidence 3456678899999999999999986 3689999999866543 45789999999999999999999999964 377
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++|+|||++|+|.+|+..+... ........+|+.|||.|++||.+. ++||||+.++|+|+|+++++||+|||
T Consensus 610 icmI~EYmEnGDLnqFl~aheap----t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfg 682 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELP----TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFG 682 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCc----ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcc
Confidence 89999999999999999887432 244556778999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh--CCCCCCCcCCCCccHHHHHH
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT--RRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~--G~~pf~~~~~~~~~~~~~~~ 933 (1013)
+++-+..++.... ....+-+.+|||||.+.-++++.++|||+||+++||+++ ...||....+++.
T Consensus 683 msR~lysg~yy~v------qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v------- 749 (807)
T KOG1094|consen 683 MSRNLYSGDYYRV------QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV------- 749 (807)
T ss_pred cccccccCCceee------ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-------
Confidence 9996544443332 345567899999999999999999999999999999876 8889876533211
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
-+...++.+.--....-.|| .-|+.++++++.+||+.|.++||+++++...|++.
T Consensus 750 ---ven~~~~~~~~~~~~~l~~P-------------~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 750 ---VENAGEFFRDQGRQVVLSRP-------------PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---HHhhhhhcCCCCcceeccCC-------------CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11122222111111111222 34567899999999999999999999999988764
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.99 Aligned_cols=262 Identities=26% Similarity=0.414 Sum_probs=217.7
Q ss_pred hhhhhccCCCCCceeeccceEEEEEEEC----CCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecC
Q 001782 694 LSKATNDFSSSNMIGQGSFGFVYRGNLG----ENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSI 768 (1013)
Q Consensus 694 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 768 (1013)
++...+.....++||+|-||.||+|.+. +....||||..+.+. .+..+.|..|..+|+.++||||++++|+|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 3334455566789999999999999873 334679999987543 3456789999999999999999999999853
Q ss_pred CccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCc
Q 001782 769 DFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMV 848 (1013)
Q Consensus 769 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 848 (1013)
...|+|||.++.|.|..|++..++ .++......++.||+.||+|||+. .+|||||.++||||.....
T Consensus 463 -----~P~WivmEL~~~GELr~yLq~nk~-----sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~C 529 (974)
T KOG4257|consen 463 -----QPMWIVMELAPLGELREYLQQNKD-----SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQC 529 (974)
T ss_pred -----cceeEEEecccchhHHHHHHhccc-----cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcce
Confidence 568999999999999999998764 688889999999999999999999 9999999999999999999
Q ss_pred eEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCcc
Q 001782 849 AHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLT 927 (1013)
Q Consensus 849 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~ 927 (1013)
+|++|||+++.+.++..... ....-+..|||||.+...+++.++|||.|||++||++. |..||+...+.+..
T Consensus 530 VKLaDFGLSR~~ed~~yYka-------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI 602 (974)
T KOG4257|consen 530 VKLADFGLSRYLEDDAYYKA-------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI 602 (974)
T ss_pred eeecccchhhhccccchhhc-------cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE
Confidence 99999999998876544332 23335689999999999999999999999999999997 99999986555332
Q ss_pred HHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhh
Q 001782 928 LHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 928 ~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1006 (1013)
.. ..-.+| ++.+..|++.++.++.+||++||.+||.+.|+.+.|+++.+
T Consensus 603 ~~--------------------iEnGeR----------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 GH--------------------IENGER----------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EE--------------------ecCCCC----------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11 111122 22335788899999999999999999999999999999876
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=345.36 Aligned_cols=275 Identities=21% Similarity=0.254 Sum_probs=203.4
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.++||+|+||.||+|++..++..||||++.... .....++.+|++++++++||||+++++++...........+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999999899999999986322 22345688999999999999999999987654444445689
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||++ ++|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~-~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 81 VVFELME-SDLHQVIKAN------DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEEecCC-CCHHHHHHhc------ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence 9999997 7899988765 4689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG--GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
+......... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..........
T Consensus 151 ~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-~~~~~~~~~~ 224 (338)
T cd07859 151 RVAFNDTPTA-----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLITDLL 224 (338)
T ss_pred cccccccCcc-----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHh
Confidence 7543221111 11234578999999999876 67899999999999999999999999753211 0111111000
Q ss_pred --CChh---------HHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 936 --LPEK---------VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 936 --~~~~---------~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.+.. ..+.+..+....+ .............+.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSSMRKKQP----------VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHhhcccCC----------CchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0011 1111111100000 00001111234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.48 Aligned_cols=239 Identities=25% Similarity=0.395 Sum_probs=198.3
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec---cccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 772 (1013)
..++|...++||+|.||.|++|..+.+++.+|||+++.. .+++.+..+.|.+++... +||.+++++.. |+.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence 356899999999999999999999999999999999844 455677889999998887 59999999998 667
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
.++.|+||||+.||++..+.+. +.+++..+..++..|+.||+|||++ ||||||||.+|||+|.+|++||+
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~-------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHT-------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEec-------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEec
Confidence 7999999999999995444433 4799999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
|||+++.. +........++||+.|||||++.+..|+.++|.|||||++|||+.|..||... +++.....+.
T Consensus 511 DFGlcKe~--------m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd-dEee~FdsI~ 581 (694)
T KOG0694|consen 511 DFGLCKEG--------MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD-DEEEVFDSIV 581 (694)
T ss_pred cccccccc--------CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHh
Confidence 99999842 22344577899999999999999999999999999999999999999999863 2222333332
Q ss_pred Hhh------CChhHHHhhhhhhccchhhhhccC
Q 001782 933 KMA------LPEKVMEIVDPLLLLDLEARASNC 959 (1013)
Q Consensus 933 ~~~------~~~~~~~~i~~~l~~~~~~R~~~~ 959 (1013)
... .+.++..++++++..+|++|....
T Consensus 582 ~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~ 614 (694)
T KOG0694|consen 582 NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSG 614 (694)
T ss_pred cCCCCCCCcccHHHHHHHHHHhccCcccccCCC
Confidence 221 234556666666666666666553
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=301.80 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=211.1
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
..++|++.+.||+|.||.||.|+.++++-.||+|++...+ ....+++.+|+++-..++||||+++|+++ .+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ecc
Confidence 3568999999999999999999999999999999997443 23456789999999999999999999994 566
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...|+++||..+|.+...+...+. .++++.....+..|+|.|+.|+|.. +|+||||||+|+|++.++..||+|
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~----~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRM----KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhccc----ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccC
Confidence 889999999999999999986543 5789999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||.+..- ...+....+||..|.|||+..+..++..+|+|++|++.||++.|.+||.... .+..+.++..
T Consensus 168 fGwsV~~----------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k 236 (281)
T KOG0580|consen 168 FGWSVHA----------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRK 236 (281)
T ss_pred CCceeec----------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHH
Confidence 9998532 2344667899999999999999999999999999999999999999998743 2222222221
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.. ..+| ........+++.+|+..+|.+|.+..||++.
T Consensus 237 ~~-------------~~~p-----------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 VD-------------LKFP-----------------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cc-------------ccCC-----------------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11 1111 1223456789999999999999999999875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=334.93 Aligned_cols=279 Identities=21% Similarity=0.311 Sum_probs=201.8
Q ss_pred ccCCCCCceeeccceEEEEEEECC-CCeEEEEEEEeeccc--cchhHHHHHHHHHhcC---CCCccceEEEEeecCCccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGE-NEMAVAVKVMNLKQR--GATKSFVAECEALRNI---RHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~ 772 (1013)
++|++.+.||+|+||.||+|++.. +++.||+|+++.... .....+.+|+.+++.+ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 468899999874432 2234566787777765 6999999999986544445
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
....++||||++ ++|.+++..... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence 667899999998 799999876532 4589999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......
T Consensus 153 Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~ 222 (290)
T cd07862 153 DFGLARIYSFQ---------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKIL 222 (290)
T ss_pred cccceEeccCC---------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHH
Confidence 99999754321 1233456899999999999889999999999999999999999999764221 1111111
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHH-HHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAK-IEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.....+...++.. ... .+.... .......... .......+.+++.+|++.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~-~~~-~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 223 DVIGLPGEEDWPR-DVA-LPRQAF--HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHhCCCChhhchh-hhc-ccchhc--cCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1110000000000 000 000000 0000000111 1123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=334.85 Aligned_cols=277 Identities=21% Similarity=0.305 Sum_probs=200.3
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.++|++.++||+|+||.||+|++..++..||+|+++.... .....+.+|+.++++++||||+++++++ ..+...
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence 3579999999999999999999999999999999874432 2345678999999999999999999985 345678
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||++ ++|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 79 TLVFEYLD-SDLKQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred EEEEeCCC-cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcc
Confidence 99999998 59999887542 3578899999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
++..... ........+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .........
T Consensus 150 ~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~ 220 (288)
T cd07871 150 ARAKSVP--------TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLL 220 (288)
T ss_pred eeeccCC--------CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 8753221 111234567899999998865 568999999999999999999999997532211 111111110
Q ss_pred CChhHHHhhhhhhccchhhhhccCCC--CchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGS--HRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.....+....... ..+-+...... ................+++.+|++.||++|||++|+++
T Consensus 221 -~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 221 -GTPTEETWPGITS-NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred -CCCChHHhhcccc-chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 00000000000 00000011122345789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=337.73 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=210.8
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce-
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF- 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~- 775 (1013)
++|..++++|+|+||.++.++++.+++.||+|.+..... ...+...+|+.++++++|||||.+.+.+ .+++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~-----~~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSF-----EEDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccch-----hcCCce
Confidence 578999999999999999999999999999999985543 2334678999999999999999999984 44444
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.+|||+||+||++.+.+.+++. ..++++++.+|+.|++.|+.|||++ .|+|||||+.||+++.++.|||+|||
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchh
Confidence 9999999999999999998863 5799999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
+|+.+.+.. .......||+.||.||.+.+.+|..|+|||||||++|||++-+++|....-...
T Consensus 152 laK~l~~~~--------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L--------- 214 (426)
T KOG0589|consen 152 LAKILNPED--------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL--------- 214 (426)
T ss_pred hhhhcCCch--------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---------
Confidence 999876533 124567899999999999999999999999999999999999999976321111
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
...+........| .....++..++..|++.+|..||++.+++.+
T Consensus 215 ----i~ki~~~~~~Plp-----------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 ----ILKINRGLYSPLP-----------------SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----HHHHhhccCCCCC-----------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1111111111111 2234568889999999999999999999987
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=337.95 Aligned_cols=246 Identities=26% Similarity=0.328 Sum_probs=198.9
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 478999999999999999999998999999999874321 2345688999999999999999999874 45578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++++|.+++... +.+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNS------GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence 99999999999999999765 4688999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
+++.... ......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 147 ~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~---- 206 (291)
T cd05612 147 FAKKLRD-----------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GI---- 206 (291)
T ss_pred cchhccC-----------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH----
Confidence 9875421 122346899999999999999999999999999999999999999753110 00
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCC-----HHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ-----MTDVVAK 1000 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 1000 (1013)
...+....... | ......+.+++.+|++.||.+||+ ++|+++.
T Consensus 207 ----~~~i~~~~~~~-~-----------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 207 ----YEKILAGKLEF-P-----------------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----HHHHHhCCcCC-C-----------------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 01111100000 0 011345678999999999999995 8887654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=336.97 Aligned_cols=277 Identities=20% Similarity=0.311 Sum_probs=200.5
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.++|++.++||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence 4689999999999999999999998999999999874432 22346788999999999999999999954 45789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||++ +++.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred EEEEECCC-cCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence 99999997 78888876542 4688899999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
++..... ........+++.|+|||++.+ ..++.++||||+||++|||++|..||....+............
T Consensus 150 ~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 221 (303)
T cd07869 150 ARAKSVP--------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL 221 (303)
T ss_pred ceeccCC--------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence 8743211 111234567899999999865 4578899999999999999999999986432222222111111
Q ss_pred CChhHHHh--hhhhhccchhhhhccCCCCchhHHHH---HHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 936 LPEKVMEI--VDPLLLLDLEARASNCGSHRTEIAKI---EECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 936 ~~~~~~~~--i~~~l~~~~~~R~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.......+ ....-...++ +.... ........ ......+.+++.+|++.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 222 GTPNEDTWPGVHSLPHFKPE-RFTLY--SPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CCCChhhccchhhccccccc-ccccc--CCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000 0000000000 00000 00000000 011245778999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=334.40 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=198.6
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+|++++++++|++|+++++++ .+.+..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 3677899999999999999999899999999987432 22234578899999999999999999985 345789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+++|+|.+++..... ..+++.++..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999988865422 3689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+....... ......||..|+|||++.+..++.++||||+||++|||++|+.||........ ...
T Consensus 149 ~~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~------ 212 (285)
T cd05631 149 AVQIPEGE---------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REE------ 212 (285)
T ss_pred cEEcCCCC---------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHH------
Confidence 97643211 12345689999999999999999999999999999999999999976322110 000
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCC-----HHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ-----MTDVVA 999 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 999 (1013)
+.......... .....+..+.+++.+||+.||++||+ ++|+++
T Consensus 213 -------~~~~~~~~~~~-------------~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 213 -------VDRRVKEDQEE-------------YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -------HHHHhhccccc-------------CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00000000000 00112345788999999999999997 788776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=339.76 Aligned_cols=200 Identities=24% Similarity=0.358 Sum_probs=175.5
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.++|++.+.||+|+||.||+|++..++..||+|++..... ...+.+.+|++++++++||||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence 4689999999999999999999999999999999975432 23457899999999999999999999964 44678
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+++++|.+++... ..+++..+..++.|++.|+.|||+.. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred EEEeecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 9999999999999999765 46889999999999999999999852 699999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
+...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 151 ~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 151 SGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccccccc----------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 8754321 12345689999999999999999999999999999999999999965
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=344.58 Aligned_cols=273 Identities=21% Similarity=0.264 Sum_probs=203.5
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
..+|++.+.||+|+||.||+|.+..+++.||+|... ...+.+|++++++++||||+++++++. .....+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeE
Confidence 457999999999999999999999999999999753 245678999999999999999999853 457789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+|+|++. ++|.+++... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|
T Consensus 160 lv~e~~~-~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAK------RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred EEEecCC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 9999997 7898888764 4688999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCC------CccHHHH
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFND------GLTLHEF 931 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~------~~~~~~~ 931 (1013)
+...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......
T Consensus 230 ~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i 302 (391)
T PHA03212 230 CFPVDIN-------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI 302 (391)
T ss_pred ccccccc-------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHH
Confidence 7532211 11233467999999999999999999999999999999999999887542211 1111111
Q ss_pred HHhh------CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 932 AKMA------LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 932 ~~~~------~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.... .+......++.... ....+.......++......+.+..+.+++.+|++.||++|||++|+++
T Consensus 303 ~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 303 IRRSGTHPNEFPIDAQANLDEIYI-GLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHhcCChhhcCcchhHHHHHHHH-HHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 1111 01011111110000 0001111111112222333445667899999999999999999999985
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=341.91 Aligned_cols=242 Identities=22% Similarity=0.295 Sum_probs=194.3
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEe
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999997432 22345678899999999999999999985 45578999999
Q ss_pred eccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCC
Q 001782 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP 861 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 861 (1013)
|+++++|.+++... +.+++.++..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 76 YANGGELFFHLSRE------RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 99999999999765 4689999999999999999999999 99999999999999999999999999987432
Q ss_pred CCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHH
Q 001782 862 PCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVM 941 (1013)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 941 (1013)
. .........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..
T Consensus 147 ~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~~---------- 203 (323)
T cd05571 147 S--------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KL---------- 203 (323)
T ss_pred c--------CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----HH----------
Confidence 1 111233457999999999999999999999999999999999999999652110 00
Q ss_pred HhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHH
Q 001782 942 EIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVA 999 (1013)
Q Consensus 942 ~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 999 (1013)
.......++ .. .......+.+++.+||+.||++|| ++.|+++
T Consensus 204 --~~~~~~~~~----~~----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 204 --FELILMEEI----RF----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --HHHHHcCCC----CC----------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 000000000 00 011234577899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=319.56 Aligned_cols=274 Identities=25% Similarity=0.377 Sum_probs=210.4
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcC--CCCccceEEEEeecCCccccce
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI--RHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
..+.++.+.||+|.||+||+|+++ |+.||||++...+ .+.+.+|.++++.+ +|+||+.+++.-... -..-..
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~TQ 283 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWTQ 283 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccC-CCceEE
Confidence 456778899999999999999997 6679999996433 36678888888864 999999999874321 122246
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeeecCCCCCceEecCCCceE
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH-----HCHPPIVHGDLKPSNVLLDHDMVAH 850 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~k 850 (1013)
.|+|++|.+.|||.||+... .++....++++..+|.||+|||. +.+|.|.|||||+.||||..++.+.
T Consensus 284 LwLvTdYHe~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEeeecccCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 89999999999999999885 68899999999999999999995 3468999999999999999999999
Q ss_pred EccccccccCCCCCCCccccCCCCCcccccccccccccccCCCC------CCcccchHHHHHHHHHHHhC----------
Q 001782 851 VGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD------MSATGDVYSFGILLLEMFTR---------- 914 (1013)
Q Consensus 851 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DIwSlG~il~ell~G---------- 914 (1013)
|+|+|+|-....... .-.......+||.+|||||++.... .-..+||||||.|+||+..+
T Consensus 357 IADLGLAv~h~~~t~----~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTD----TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred EeeceeeEEecccCC----cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 999999987655431 1223356788999999999987642 23469999999999999864
Q ss_pred CCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCH
Q 001782 915 RRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQM 994 (1013)
Q Consensus 915 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 994 (1013)
+.||.+..+.+..+.++.+...-+.. ||+..... +..++...+.++|+.||..+|..|-||
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~--------------RP~ipnrW-----~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKL--------------RPNIPNRW-----KSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeeccc--------------CCCCCccc-----ccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 35666655555444443332221111 22211111 113456788999999999999999999
Q ss_pred HHHHHHHHHhhhh
Q 001782 995 TDVVAKLCSARKI 1007 (1013)
Q Consensus 995 ~evl~~L~~~~~~ 1007 (1013)
-.+-+.|.++.+.
T Consensus 494 LriKKtl~~l~~~ 506 (513)
T KOG2052|consen 494 LRIKKTLAKLSNS 506 (513)
T ss_pred HHHHHHHHHHhcC
Confidence 9999999988753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=345.47 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=203.6
Q ss_pred hhccCCCCCceeeccceEEEEEEE-----CCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcC-CCCccceEEEEeecCC
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQ-RGATKSFVAECEALRNI-RHRNLIKIITVCSSID 769 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 769 (1013)
..++|++.++||+|+||.||+|++ ..++..||+|+++... ....+.+.+|+.+++.+ +||||++++++|.
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~--- 109 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT--- 109 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec---
Confidence 355899999999999999999975 3456789999987433 23345688999999999 8999999999964
Q ss_pred ccccceEEEEEeeccCCCHHHHhhccccc---------------------------------------------------
Q 001782 770 FEEVDFKAIVYEYMECGSLEDWLHQSNDQ--------------------------------------------------- 798 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------- 798 (1013)
.....++||||+++|+|.+++......
T Consensus 110 --~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 110 --VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred --cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 446789999999999999999754210
Q ss_pred ------------------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 799 ------------------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 799 ------------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
.....+++.++.+++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceec
Confidence 0112578899999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCChh
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALPEK 939 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~~~ 939 (1013)
....... ......++..|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 265 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-------------~ 325 (375)
T cd05104 265 RNDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-------------K 325 (375)
T ss_pred cCccccc------ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-------------H
Confidence 4322111 1122345678999999999999999999999999999998 888986532211 1
Q ss_pred HHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 940 VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 940 ~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
....+.... ++... ...+.++.+++.+||+.||++|||+.||++.|++.
T Consensus 326 ~~~~~~~~~------~~~~~----------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 326 FYKMIKEGY------RMLSP----------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHhCc------cCCCC----------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111111100 00000 01134678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=341.56 Aligned_cols=254 Identities=20% Similarity=0.272 Sum_probs=202.6
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.++||+|+||.||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++++++. ..+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence 47899999999999999999999889999999997432 223456889999999999999999999853 4578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++++|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNL------GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence 99999999999999999765 4688999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||......+ .....
T Consensus 147 ~a~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i---- 210 (333)
T cd05600 147 LSKGIVT-----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENL---- 210 (333)
T ss_pred CCccccc-----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHH----
Confidence 9975432 2334578999999999999999999999999999999999999997532110 00000
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.... ..+ .++..... .......+.+++.+|+..+|.+||++.|+++.
T Consensus 211 -----~~~~-~~~-----~~~~~~~~-------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 211 -----KYWK-ETL-----QRPVYDDP-------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -----Hhcc-ccc-----cCCCCCcc-------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000 000 00000000 01234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=342.34 Aligned_cols=246 Identities=23% Similarity=0.298 Sum_probs=198.4
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++ ..++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence 467899999999999999999999999999999997432 22345688999999999999999999985 4457
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..++||||+.+++|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKA------GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeec
Confidence 899999999999999999865 4688999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+
T Consensus 163 g~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~--- 224 (329)
T PTZ00263 163 GFAKKVPDR-----------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FRIY--- 224 (329)
T ss_pred cCceEcCCC-----------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----HHHH---
Confidence 999754321 2235689999999999999999999999999999999999999965211 0000
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCC-----HHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ-----MTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 999 (1013)
..+... .+ ... ......+.+++.+||+.||.+||+ +++++.
T Consensus 225 ------~~i~~~----~~----~~p----------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 225 ------EKILAG----RL----KFP----------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ------HHHhcC----Cc----CCC----------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 001000 00 000 001234678999999999999986 577664
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=344.89 Aligned_cols=267 Identities=23% Similarity=0.372 Sum_probs=204.2
Q ss_pred hhhccCCCCCceeeccceEEEEEEECC-----CCeEEEEEEEeeccc-cchhHHHHHHHHHhcC-CCCccceEEEEeecC
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLGE-----NEMAVAVKVMNLKQR-GATKSFVAECEALRNI-RHRNLIKIITVCSSI 768 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 768 (1013)
...++|++.+.||+|+||.||+|++.. ++..||+|+++.... ...+.+.+|+++++.+ +||||++++++|.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~-- 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT-- 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec--
Confidence 345689999999999999999998643 335799999974432 2345688999999999 8999999999964
Q ss_pred CccccceEEEEEeeccCCCHHHHhhccccc--------------------------------------------------
Q 001782 769 DFEEVDFKAIVYEYMECGSLEDWLHQSNDQ-------------------------------------------------- 798 (1013)
Q Consensus 769 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------- 798 (1013)
.....++||||+++|+|.+++......
T Consensus 113 ---~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 113 ---HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred ---CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 446789999999999999998653210
Q ss_pred --------------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCCC
Q 001782 799 --------------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCS 864 (1013)
Q Consensus 799 --------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 864 (1013)
....++++.++++++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.+....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~ 266 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCc
Confidence 0113578899999999999999999999 99999999999999999999999999997653221
Q ss_pred CCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCChhHHHh
Q 001782 865 PATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALPEKVMEI 943 (1013)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1013)
... ......++..|+|||++.+..++.++|||||||++|||++ |+.||........ ....
T Consensus 267 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-------------~~~~ 327 (374)
T cd05106 267 NYV------VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-------------FYKM 327 (374)
T ss_pred cee------eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-------------HHHH
Confidence 110 1122345678999999999999999999999999999997 9999975322110 1111
Q ss_pred hhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhh
Q 001782 944 VDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 944 i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1005 (1013)
+...... ..+ ...+..+.+++.+||+.||++|||+.||++.|+++.
T Consensus 328 ~~~~~~~---~~~-------------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 328 VKRGYQM---SRP-------------DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHcccCc---cCC-------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1100000 000 011346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=333.23 Aligned_cols=269 Identities=22% Similarity=0.363 Sum_probs=201.0
Q ss_pred hccCCCCCceeeccceEEEEEEECC----------------CCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccce
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGE----------------NEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIK 760 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 760 (1013)
.++|++.++||+|+||.||+|.+.. ++..||+|++..... ....++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999998632 345799999875432 23457899999999999999999
Q ss_pred EEEEeecCCccccceEEEEEeeccCCCHHHHhhccccc-------------cccCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 001782 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQ-------------LEVGNFNVIQRLNLVIDVAFAIEYLHHHC 827 (1013)
Q Consensus 761 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~ 827 (1013)
+++++. ..+..++||||+++++|.+++...... .....+++.++++++.||+.|++|||+.
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~- 157 (304)
T cd05096 84 LLGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL- 157 (304)
T ss_pred EEEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence 999964 336789999999999999998654211 1113478889999999999999999999
Q ss_pred CCCeeecCCCCCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHH
Q 001782 828 HPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGIL 907 (1013)
Q Consensus 828 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~i 907 (1013)
+|+||||||+||+++.++.+||+|||+++.+....... ......++..|+|||++.++.++.++|||||||+
T Consensus 158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 229 (304)
T cd05096 158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR------IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVT 229 (304)
T ss_pred --CccccCcchhheEEcCCccEEECCCccceecccCceeE------ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHH
Confidence 99999999999999999999999999997653322111 1223446789999999998899999999999999
Q ss_pred HHHHHh--CCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhccc
Q 001782 908 LLEMFT--RRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSM 985 (1013)
Q Consensus 908 l~ell~--G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 985 (1013)
+|||++ +..||....... .... ..+............++ ..++..+.+++.+||+
T Consensus 230 l~el~~~~~~~p~~~~~~~~-~~~~---------~~~~~~~~~~~~~~~~~-------------~~~~~~~~~li~~cl~ 286 (304)
T cd05096 230 LWEILMLCKEQPYGELTDEQ-VIEN---------AGEFFRDQGRQVYLFRP-------------PPCPQGLYELMLQCWS 286 (304)
T ss_pred HHHHHHccCCCCCCcCCHHH-HHHH---------HHHHhhhccccccccCC-------------CCCCHHHHHHHHHHcc
Confidence 999987 567776532110 0000 00100000000000000 1234568899999999
Q ss_pred CCCCCCCCHHHHHHHHHH
Q 001782 986 ESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 986 ~dP~~RPs~~evl~~L~~ 1003 (1013)
.||++|||+.||.+.|++
T Consensus 287 ~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 287 RDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCchhCcCHHHHHHHHhC
Confidence 999999999999988763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=330.14 Aligned_cols=264 Identities=25% Similarity=0.431 Sum_probs=219.4
Q ss_pred hhhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCcc
Q 001782 692 ADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 692 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 771 (1013)
+.++-...+....++||-|-||.||.|.|++....||||.++.+ ....++|.+|+.+|+.++|||+|+++|+|+..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E--- 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--- 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccC---
Confidence 34444556778889999999999999999999999999999743 44578899999999999999999999999643
Q ss_pred ccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEE
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV 851 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 851 (1013)
...|||+|||.+|+|.+|+++... ..++....+.++.||+.|++||..+ ++||||+.++|+||.++..+|+
T Consensus 336 --pPFYIiTEfM~yGNLLdYLRecnr----~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKv 406 (1157)
T KOG4278|consen 336 --PPFYIITEFMCYGNLLDYLRECNR----SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKV 406 (1157)
T ss_pred --CCeEEEEecccCccHHHHHHHhch----hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEe
Confidence 678999999999999999998754 4677778899999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHH
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHE 930 (1013)
Q Consensus 852 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~ 930 (1013)
+|||+++++..+.... .....-++.|.|||-+....++.|+|||+|||++|||.| |-.||.... +.+
T Consensus 407 ADFGLsRlMtgDTYTA-------HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----lSq 474 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTYTA-------HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQ 474 (1157)
T ss_pred eccchhhhhcCCceec-------ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----HHH
Confidence 9999999886543221 222334688999999999999999999999999999998 888987631 111
Q ss_pred HHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhh
Q 001782 931 FAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 931 ~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1005 (1013)
+.+++.+. + +.+.++.|+++++++|++||++.|.+||+++|+-+.++.+-
T Consensus 475 ---------VY~LLEkg----y------------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 475 ---------VYGLLEKG----Y------------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ---------HHHHHhcc----c------------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 12222221 1 12234678899999999999999999999999999998764
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=345.07 Aligned_cols=364 Identities=27% Similarity=0.431 Sum_probs=216.0
Q ss_pred CCCCCeeeeccCCcc-ccCCcccCCcccceEEeccCCccccCCCCccccCCCCceeccccccccCCCCCccccccccccc
Q 001782 99 LSFLRFINFANNGFS-GEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEF 177 (1013)
Q Consensus 99 l~~L~~L~l~~n~l~-~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~ 177 (1013)
|+..+-.|+++|.|+ +..|.....+++++.|.|...++. .+|++++.|.+|++|.+++|++.
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~---------------- 68 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI---------------- 68 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH----------------
Confidence 444555566666666 346666666777777777776666 67777777776666666666665
Q ss_pred eecccccccccCCCCccCCCCcceeeecccccC-CCCCCccccccccceeecccccccCCCcchhccCCccceeeccCCc
Q 001782 178 LSLRDNLLAGQLAPSIGNISNLQVLSIGENRLS-GRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNR 256 (1013)
Q Consensus 178 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~ 256 (1013)
.+...++.|+.|+.+.+.+|++. .-+|..+-.|..|+.||||+|+++ ..|..+..-+++-.|+||+|+
T Consensus 69 ----------~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~ 137 (1255)
T KOG0444|consen 69 ----------SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNN 137 (1255)
T ss_pred ----------hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCc
Confidence 22234555666666777777664 236777777888888888888887 677777777888888888888
Q ss_pred cCCCCCCCcCCCCCCCcEEEeeeccccccCCCCCCCCCCCceEEcccCcccccccccccCCCCccccccccCcCCCCCCC
Q 001782 257 LEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIG 336 (1013)
Q Consensus 257 l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 336 (1013)
|. .||..++.+++.|-+|||++|++. .+|+....+..|++|+|++|.+...--..+..+++|+.|.+++.+=+
T Consensus 138 Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT----- 210 (1255)
T KOG0444|consen 138 IE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT----- 210 (1255)
T ss_pred cc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch-----
Confidence 87 888888877888888888888887 67777777888888888888765332222222333333333322100
Q ss_pred ChhhhhhcccccccccccccccccCCccchhhhcchhhHHHHhccchhHHhhcccccceeecccccccCCcccccCCCCC
Q 001782 337 DLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRN 416 (1013)
Q Consensus 337 ~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 416 (1013)
...+|.++..+.+
T Consensus 211 -------------------------------------------------------------------l~N~Ptsld~l~N 223 (1255)
T KOG0444|consen 211 -------------------------------------------------------------------LDNIPTSLDDLHN 223 (1255)
T ss_pred -------------------------------------------------------------------hhcCCCchhhhhh
Confidence 0134555555555
Q ss_pred CCEEEccCCccCccCCccccccCccCEEEcCCCcccCCCCcccccCcccceeecccccccccCCchhhcccchhhhhccC
Q 001782 417 LQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLS 496 (1013)
Q Consensus 417 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~Ls 496 (1013)
|..+|||.|++. ..|+.+.++.+|+.|+||+|+|+ .+.-......+|+.|+||.|+++ .+|..++. ++.|+.|.+.
T Consensus 224 L~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcK-L~kL~kLy~n 299 (1255)
T KOG0444|consen 224 LRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCK-LTKLTKLYAN 299 (1255)
T ss_pred hhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhh-hHHHHHHHhc
Confidence 666666666665 55555555555666666666555 33333444445555555555555 44444443 4444444444
Q ss_pred CCeec-ccCCccccCcCCCcEEEccCCCCCCCCccccccccccccccccccccccccCccccccCCCCeEecccc
Q 001782 497 GNLLT-GSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRN 570 (1013)
Q Consensus 497 ~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 570 (1013)
+|+++ .-+|..++.+.+|+.+..++|.+. ..|+.++.|.+|+.|.|+.|++. .+|+.+.-|+.|+.|||..|
T Consensus 300 ~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreN 372 (1255)
T KOG0444|consen 300 NNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLREN 372 (1255)
T ss_pred cCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCC
Confidence 44433 014445555555555555555554 45555555555555555555554 44555555555555555444
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=336.09 Aligned_cols=197 Identities=24% Similarity=0.328 Sum_probs=173.7
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCC-C-----CccceEEEEeecCCcccc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-H-----RNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~ 773 (1013)
+|.+.++||+|+||.|.+|.+.++++.||||+++... ....+...|+.+|..++ | -|+|++++++ ...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----ccc
Confidence 8999999999999999999999999999999998443 23456678999999996 4 4899999994 556
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC--CceEE
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD--MVAHV 851 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl 851 (1013)
++.|+|+|.++ .+|+++++.++- .+++...++.|+.||+.||.+||+. +|||+||||+|||+.+. ..+||
T Consensus 261 ~HlciVfELL~-~NLYellK~n~f----~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 261 NHLCIVFELLS-TNLYELLKNNKF----RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred cceeeeehhhh-hhHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence 99999999998 899999998854 5799999999999999999999999 99999999999999754 48999
Q ss_pred ccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 852 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
+|||.|+...+. ....+.+..|+|||++.|.+|+.+.||||||||+.||++|.+.|.+.
T Consensus 333 IDFGSSc~~~q~-----------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 333 IDFGSSCFESQR-----------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred EecccccccCCc-----------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 999999865432 22566789999999999999999999999999999999998888764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=335.40 Aligned_cols=242 Identities=24% Similarity=0.289 Sum_probs=192.1
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEe
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
+.||+|+||.||+|++..++..||+|++.... ......+.+|+++++.++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 46999999999999999899999999997432 22345677899999999999999999985 34578999999
Q ss_pred eccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCC
Q 001782 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP 861 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 861 (1013)
|+++|+|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 76 YANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 99999999988765 4689999999999999999999999 99999999999999999999999999987432
Q ss_pred CCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHH
Q 001782 862 PCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVM 941 (1013)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 941 (1013)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 147 ~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~------------ 205 (323)
T cd05595 147 SD--------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFE------------ 205 (323)
T ss_pred CC--------CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHH------------
Confidence 11 11123456899999999999999999999999999999999999999653111 0000
Q ss_pred HhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHH
Q 001782 942 EIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVA 999 (1013)
Q Consensus 942 ~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 999 (1013)
.+.. ..+ +. ....+..+.+++.+||+.||++|| ++.++++
T Consensus 206 ~~~~----~~~--~~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 206 LILM----EEI--RF------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHhc----CCC--CC------------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 0000 000 00 011234567888899999999998 7877765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=325.21 Aligned_cols=257 Identities=24% Similarity=0.386 Sum_probs=201.7
Q ss_pred hccCCCCCceeeccceEEEEEEEC---CCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLG---ENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
..+|++.+.||+|+||.||+|.+. ..+..||+|+++.... ...+.+.+|+.++++++||||+++++++. ..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence 457899999999999999999874 4567899999875432 23456889999999999999999999964 44
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
+..++||||+++|+|.+++.... ..+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+|++|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~d 150 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISG 150 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECC
Confidence 77899999999999999997642 3689999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~ 932 (1013)
||.+....... ........++..|+|||.+.+..++.++|||||||++||+++ |+.||......
T Consensus 151 fg~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------- 215 (266)
T cd05064 151 FRRLQEDKSEA-------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------- 215 (266)
T ss_pred Ccccccccccc-------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------
Confidence 99876432111 001112345678999999999999999999999999999875 99999753211
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
...+.+.... ++. ....++..+.+++.+||+.+|.+||++.|+.+.|+.+
T Consensus 216 ------~~~~~~~~~~------~~~----------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 216 ------DVIKAVEDGF------RLP----------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------HHHHHHHCCC------CCC----------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0011111000 000 0122455688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=333.50 Aligned_cols=200 Identities=25% Similarity=0.387 Sum_probs=174.7
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.++|++.++||+|+||.||+|.+..++..+|+|++..... ...+.+.+|++++++++||||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence 4689999999999999999999998999999999875432 23456889999999999999999999964 44789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+++++|.+++... +.+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred EEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 9999999999999999765 46788999999999999999999742 799999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
+..+... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 151 ~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 151 SGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred chhhhhh----------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 8754221 12234689999999999998999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=335.85 Aligned_cols=240 Identities=23% Similarity=0.316 Sum_probs=191.1
Q ss_pred eeeccceEEEEEEECCCCeEEEEEEEeec---cccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeec
Q 001782 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYM 783 (1013)
Q Consensus 707 lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 783 (1013)
||+|+||.||+|++..+++.||+|++... .......+.+|++++++++||||+++++++. ..+..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence 69999999999999989999999998743 2233456788999999999999999999853 457899999999
Q ss_pred cCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCC
Q 001782 784 ECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863 (1013)
Q Consensus 784 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 863 (1013)
++|+|.+++... +.+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 76 NGGELFHHLQRE------GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 999999999765 4689999999999999999999999 9999999999999999999999999998753211
Q ss_pred CCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHh
Q 001782 864 SPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEI 943 (1013)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1013)
........||+.|+|||++.+..++.++||||+||++|||++|+.||..... .... ..+
T Consensus 147 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~--------~~~ 205 (312)
T cd05585 147 --------DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMY--------RKI 205 (312)
T ss_pred --------CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHH--------HHH
Confidence 1123345789999999999999999999999999999999999999975211 1110 111
Q ss_pred hhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCC---HHHHHH
Q 001782 944 VDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ---MTDVVA 999 (1013)
Q Consensus 944 i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~ 999 (1013)
.. ..+ .- .......+.+++.+||+.||++||+ +.|++.
T Consensus 206 ~~----~~~-~~-------------~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 206 LQ----EPL-RF-------------PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred Hc----CCC-CC-------------CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 10 000 00 0112345778999999999999985 555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=336.00 Aligned_cols=243 Identities=23% Similarity=0.313 Sum_probs=193.9
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEe
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
++||+|+||.||+|++..+++.||+|++.... ......+.+|+++++.++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999997432 23345678899999999999999999885 45578999999
Q ss_pred eccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCC
Q 001782 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP 861 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 861 (1013)
|+++|+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 y~~~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 76 YVNGGELFFHLSRE------RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 99999999988765 4689999999999999999999999 99999999999999999999999999987432
Q ss_pred CCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHH
Q 001782 862 PCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVM 941 (1013)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 941 (1013)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 147 ~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~--------- 204 (328)
T cd05593 147 TD--------AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLF--------- 204 (328)
T ss_pred Cc--------ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHH---------
Confidence 11 1112345689999999999999999999999999999999999999965311 1100
Q ss_pred HhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHHH
Q 001782 942 EIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVAK 1000 (1013)
Q Consensus 942 ~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 1000 (1013)
......++. -+ ......+.+++.+|++.||++|| ++.|+++.
T Consensus 205 ---~~~~~~~~~-~p-------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 205 ---ELILMEDIK-FP-------------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ---HHhccCCcc-CC-------------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 000000000 00 01234567889999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=312.54 Aligned_cols=247 Identities=28% Similarity=0.374 Sum_probs=197.8
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
.+.|+..+.||+|.-|+||+++..+++..+|+|++.... +....+...|.+||+.++||.++.+|+. ++.+.
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccc
Confidence 446777899999999999999999999999999997443 3345678889999999999999999998 56679
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
+.|+|||||+||+|....+++.. +.+++..++.++..++-||+|||-. |||+|||||+||||.++|++.|+||
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~----~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDF 223 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPG----KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDF 223 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCC----CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeec
Confidence 99999999999999999988754 6899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCC------------------------------C-c-----------------cccCCCCCccccccccccc
Q 001782 855 GLARFLPPCSP------------------------------A-T-----------------ILETPSSSTGIKGTVGYVA 886 (1013)
Q Consensus 855 G~a~~~~~~~~------------------------------~-~-----------------~~~~~~~~~~~~gt~~y~a 886 (1013)
.++........ . . ......+...++||-.|.|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 98764321000 0 0 0112234557889999999
Q ss_pred ccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh--------CChhHHHhhhhhhccchhhhhc
Q 001782 887 PEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA--------LPEKVMEIVDPLLLLDLEARAS 957 (1013)
Q Consensus 887 PE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~i~~~l~~~~~~R~~ 957 (1013)
||++.+...+.++|.|+|||++|||+.|..||....+.+ .+..+.... ++..++++|++.+.+||..|..
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence 999999999999999999999999999999998754332 233222211 1233455555555555555544
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=337.57 Aligned_cols=248 Identities=21% Similarity=0.300 Sum_probs=197.5
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCC-eEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENE-MAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 772 (1013)
..++|++.++||+|+||.||+|++..++ ..||+|++.... ....+.+.+|+++++.++||||+++++++. +
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----D 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----e
Confidence 3457999999999999999999876554 689999986432 233456889999999999999999999964 4
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
+...++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~ 173 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRN------KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMT 173 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEe
Confidence 57899999999999999999865 4689999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
|||+++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...
T Consensus 174 DFG~a~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~---- 237 (340)
T PTZ00426 174 DFGFAKVVDT-----------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIY---- 237 (340)
T ss_pred cCCCCeecCC-----------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHH----
Confidence 9999975432 123456899999999999988999999999999999999999999753110 000
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHHH
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVAK 1000 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 1000 (1013)
..+....... | ......+.+++.+|++.||++|+ +++|+++.
T Consensus 238 --------~~i~~~~~~~-p-----------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 238 --------QKILEGIIYF-P-----------------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --------HHHhcCCCCC-C-----------------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0111100000 0 01123467888899999999995 78887653
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=334.69 Aligned_cols=268 Identities=23% Similarity=0.348 Sum_probs=205.6
Q ss_pred hhccCCCCCceeeccceEEEEEEECC-----CCeEEEEEEEeeccc-cchhHHHHHHHHHhcC-CCCccceEEEEeecCC
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGE-----NEMAVAVKVMNLKQR-GATKSFVAECEALRNI-RHRNLIKIITVCSSID 769 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 769 (1013)
..++|++.+.||+|+||.||+|.+.. +++.||+|+++.... ...+.+.+|+.+++++ +||||++++++|.
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~--- 81 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT--- 81 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe---
Confidence 34589999999999999999997533 357899999874322 2335678899999999 7999999999874
Q ss_pred ccccceEEEEEeeccCCCHHHHhhccccc---------------------------------------------------
Q 001782 770 FEEVDFKAIVYEYMECGSLEDWLHQSNDQ--------------------------------------------------- 798 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------- 798 (1013)
..+...+++|||+++++|.+++......
T Consensus 82 -~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 82 -KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred -cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 3346788999999999999998653210
Q ss_pred ----cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCCCCCccccCCCC
Q 001782 799 ----LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874 (1013)
Q Consensus 799 ----~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 874 (1013)
.....+++.++..++.||+.|++|||++ +|+||||||+||++++++.+||+|||+++.+...... ..
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~------~~ 231 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------VR 231 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch------hh
Confidence 0013689999999999999999999999 9999999999999999999999999999865432211 11
Q ss_pred CcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchh
Q 001782 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLE 953 (1013)
Q Consensus 875 ~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~ 953 (1013)
.....++..|+|||++.+..++.++|||||||++|||++ |..||......+. ....+....
T Consensus 232 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-------------~~~~~~~~~----- 293 (337)
T cd05054 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-------------FCRRLKEGT----- 293 (337)
T ss_pred ccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-------------HHHHHhccC-----
Confidence 223456778999999999999999999999999999998 9999875321110 111110000
Q ss_pred hhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhh
Q 001782 954 ARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 954 ~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1006 (1013)
++.. .......+.+++.+||+.+|++||++.||++.|+.+.+
T Consensus 294 -~~~~----------~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 294 -RMRA----------PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred -CCCC----------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000 01223467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=326.70 Aligned_cols=262 Identities=25% Similarity=0.490 Sum_probs=205.3
Q ss_pred hccCCCCCceeeccceEEEEEEECCCC-----eEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCcc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENE-----MAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 771 (1013)
.++|++.+.||+|+||.||+|.....+ ..||+|.+..... ....++.+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~----- 78 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT----- 78 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----
Confidence 357899999999999999999886544 6799999864332 23456889999999999999999999864
Q ss_pred ccceEEEEEeeccCCCHHHHhhccccccc----------cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCce
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLE----------VGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNV 841 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NI 841 (1013)
.....+++|||+++++|.+++.......+ ...+++.+++.++.|++.|++|||++ +++||||||+||
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Ni 155 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNC 155 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceE
Confidence 34678999999999999999976532111 14588999999999999999999999 999999999999
Q ss_pred EecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 001782 842 LLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDN 920 (1013)
Q Consensus 842 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~ 920 (1013)
++++++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 156 l~~~~~~~~L~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05048 156 LVGEGLTVKISDFGLSRDIYSADYY------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229 (283)
T ss_pred EEcCCCcEEECCCcceeeccccccc------cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999754322111 11233456789999999998899999999999999999998 9999875
Q ss_pred cCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 921 MFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.... +..+.+... .+ + .....++..+.+++.+||+.||++||++.||++.
T Consensus 230 ~~~~--------------~~~~~i~~~---~~---~----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 230 FSNQ--------------EVIEMIRSR---QL---L----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCHH--------------HHHHHHHcC---Cc---C----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3211 111111100 00 0 0012345678999999999999999999999999
Q ss_pred HHH
Q 001782 1001 LCS 1003 (1013)
Q Consensus 1001 L~~ 1003 (1013)
|++
T Consensus 280 l~~ 282 (283)
T cd05048 280 LRS 282 (283)
T ss_pred Hhc
Confidence 975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=313.77 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=210.7
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
+-|.++++||+|+||.||+|.++++|..||||.+..+. +.+++.+|+.+|++.+.|+||++||.+. .....|+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYF-----K~sDLWI 105 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYF-----KHSDLWI 105 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhc-----cCCceEe
Confidence 34677899999999999999999999999999987554 3578999999999999999999999853 3467999
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
|||||..|+..+.++.++ +++.+.++..+....++||+|||.. .-+|||||+.|||+.-+|.+|++|||.|.
T Consensus 106 VMEYCGAGSiSDI~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAG 177 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARR-----KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAG 177 (502)
T ss_pred ehhhcCCCcHHHHHHHhc-----CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccc
Confidence 999999999999998764 5899999999999999999999999 89999999999999999999999999997
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCCh
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPE 938 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~ 938 (1013)
.+. +...+.....||+.|||||++..-.|+.++||||+|++..||..|++||.+...-...+.
T Consensus 178 QLT--------DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM--------- 240 (502)
T KOG0574|consen 178 QLT--------DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM--------- 240 (502)
T ss_pred hhh--------hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe---------
Confidence 554 334446678899999999999999999999999999999999999999987532211000
Q ss_pred hHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 939 KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 939 ~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
-|.. ..+.+.++++....+.+++++|+-..|++|.||-++++.
T Consensus 241 ------------IPT~-------PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 241 ------------IPTK-------PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ------------ccCC-------CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 0000 012223456667788999999999999999999888653
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=339.75 Aligned_cols=269 Identities=26% Similarity=0.384 Sum_probs=207.3
Q ss_pred hhhhccCCCCCceeeccceEEEEEEECCC-----CeEEEEEEEeeccc-cchhHHHHHHHHHhcCC-CCccceEEEEeec
Q 001782 695 SKATNDFSSSNMIGQGSFGFVYRGNLGEN-----EMAVAVKVMNLKQR-GATKSFVAECEALRNIR-HRNLIKIITVCSS 767 (1013)
Q Consensus 695 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 767 (1013)
....++|++.++||+|+||.||+|++... +..||||++..... ...+.+.+|+++++++. ||||++++++|.
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~- 111 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT- 111 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc-
Confidence 34467899999999999999999987432 35699999974433 23457899999999996 999999999964
Q ss_pred CCccccceEEEEEeeccCCCHHHHhhcccccc------------------------------------------------
Q 001782 768 IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL------------------------------------------------ 799 (1013)
Q Consensus 768 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------------ 799 (1013)
.....++||||+++|+|.+++.......
T Consensus 112 ----~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 112 ----KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred ----cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 4467899999999999999987542100
Q ss_pred ------------------------------------------ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 001782 800 ------------------------------------------EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLK 837 (1013)
Q Consensus 800 ------------------------------------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk 837 (1013)
....+++.++..++.|++.|++|||+. +|+|||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dik 264 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLA 264 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCC
Confidence 012478889999999999999999999 99999999
Q ss_pred CCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCC
Q 001782 838 PSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRR 916 (1013)
Q Consensus 838 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~ 916 (1013)
|+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 265 p~Nill~~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~ 338 (400)
T cd05105 265 ARNVLLAQGKIVKICDFGLARDIMHDSNY------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGT 338 (400)
T ss_pred hHhEEEeCCCEEEEEeCCcceeccccccc------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999865332111 11223456788999999999999999999999999999997 999
Q ss_pred CCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 001782 917 PTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTD 996 (1013)
Q Consensus 917 pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 996 (1013)
||......... ...+.... ++. ....++..+.+++.+||+.||++||++.+
T Consensus 339 P~~~~~~~~~~-------------~~~~~~~~------~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~ 389 (400)
T cd05105 339 PYPGMIVDSTF-------------YNKIKSGY------RMA----------KPDHATQEVYDIMVKCWNSEPEKRPSFLH 389 (400)
T ss_pred CCcccchhHHH-------------HHHHhcCC------CCC----------CCccCCHHHHHHHHHHCccCHhHCcCHHH
Confidence 98754221110 01110000 000 01123456889999999999999999999
Q ss_pred HHHHHHHhhh
Q 001782 997 VVAKLCSARK 1006 (1013)
Q Consensus 997 vl~~L~~~~~ 1006 (1013)
|.+.|+.+.+
T Consensus 390 l~~~l~~l~~ 399 (400)
T cd05105 390 LSDIVESLLP 399 (400)
T ss_pred HHHHHHHHcC
Confidence 9999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=348.35 Aligned_cols=267 Identities=23% Similarity=0.313 Sum_probs=206.9
Q ss_pred hhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCc
Q 001782 693 DLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDF 770 (1013)
Q Consensus 693 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 770 (1013)
+.....++|++.+.||+|+||+||+|++..+++.||||++..... .....+.+|+..+..++|+|++++.+.+...+.
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 334456799999999999999999999998999999999875432 234567889999999999999998877543211
Q ss_pred ---cccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC
Q 001782 771 ---EEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM 847 (1013)
Q Consensus 771 ---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 847 (1013)
......++||||+++|+|.+++..... ....+++.++..++.|++.||+|+|+. +|+||||||+||+++.++
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNG 180 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCC
Confidence 111246899999999999999975432 124689999999999999999999999 999999999999999999
Q ss_pred ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCcc
Q 001782 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLT 927 (1013)
Q Consensus 848 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~ 927 (1013)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 181 ~vkL~DFGls~~~~~~~~~------~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~----- 249 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSD------DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN----- 249 (496)
T ss_pred CEEEEecccCeeccccccc------cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----
Confidence 9999999999865432111 11334679999999999999999999999999999999999999996521
Q ss_pred HHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 928 LHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 928 ~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
... ++...+...+... ....+..+.+++.+||+.||++||++.++++.
T Consensus 250 ~~~------------~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 250 MEE------------VMHKTLAGRYDPL-------------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHH------------HHHHHhcCCCCCC-------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 1111111100000 01224567889999999999999999999763
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=326.79 Aligned_cols=270 Identities=24% Similarity=0.351 Sum_probs=204.3
Q ss_pred ccC-CCCCceeeccceEEEEEEE----CCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccc
Q 001782 699 NDF-SSSNMIGQGSFGFVYRGNL----GENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 699 ~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 772 (1013)
++| ++.+.||+|+||+||++.. ..++..||+|++..... ...+.+.+|++++++++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CC
Confidence 345 8899999999999988653 34678899999875432 234678899999999999999999998753 23
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
....++||||+++++|.+++... .+++.+++.++.|++.|++|||++ +|+||||||+||++++++.+||+
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~ 149 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIG 149 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEe
Confidence 45689999999999999999753 589999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
|||+++.+........ ......++..|+|||++.+..++.++||||||+++|||++|..||...... .....
T Consensus 150 dfg~~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~ 221 (283)
T cd05080 150 DFGLAKAVPEGHEYYR-----VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMI 221 (283)
T ss_pred ecccccccCCcchhhc-----cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhh
Confidence 9999986543221110 012234567799999999889999999999999999999999998653211 11111
Q ss_pred HhhC----ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhh
Q 001782 933 KMAL----PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 933 ~~~~----~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1005 (1013)
.... .....+.++... ++. ....++..+.+++.+||+.+|++|||+++|++.|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~------~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 222 GPKQGQMTVVRLIELLERGM------RLP----------CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cccccccchhhhhhhhhcCC------CCC----------CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1100 001111111110 000 01123467889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=340.85 Aligned_cols=209 Identities=23% Similarity=0.361 Sum_probs=176.4
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.++||+|+||+||+|++..+++.||||++.... ......+.+|+++++.++||||+++++++ ..+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 47899999999999999999999999999999997432 22345678899999999999999999985 45578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++|+|.+++... +.+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKK------DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred EEEEECCCCCcHHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence 99999999999999999765 4689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccC------------------------------CCCCcccccccccccccccCCCCCCcccchHHHH
Q 001782 856 LARFLPPCSPATILET------------------------------PSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFG 905 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG 905 (1013)
++..+........... .......+||+.|+|||++.+..++.++||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 9876532211100000 0011234699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCc
Q 001782 906 ILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 906 ~il~ell~G~~pf~~~ 921 (1013)
|++|||++|..||...
T Consensus 227 ~il~el~~G~~Pf~~~ 242 (364)
T cd05599 227 VIMYEMLVGYPPFCSD 242 (364)
T ss_pred hHHHHhhcCCCCCCCC
Confidence 9999999999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=323.87 Aligned_cols=267 Identities=24% Similarity=0.425 Sum_probs=208.3
Q ss_pred hccCCCCCceeeccceEEEEEEE-----CCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 772 (1013)
.++|.+.+.||+|+||.||++.. ..++..||+|.+........+.+.+|++++++++||||+++++++. .
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence 45788999999999999999985 2345679999987554445567999999999999999999999964 4
Q ss_pred cceEEEEEeeccCCCHHHHhhccccc-------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQ-------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH 845 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 845 (1013)
....++||||+++++|.+++...... .....+++.+++.++.|++.||+|||++ |++||||||+||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~ 155 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGE 155 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 47789999999999999999754311 1123589999999999999999999999 9999999999999999
Q ss_pred CCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCC
Q 001782 846 DMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFND 924 (1013)
Q Consensus 846 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~ 924 (1013)
++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~ 229 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229 (288)
T ss_pred CCcEEeccCCccccccCCcee------ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999755322111 11223445788999999998899999999999999999998 89998653211
Q ss_pred CccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 925 GLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
. .+.......+...+ ...+..+.+++.+||+.||.+|||+.||.+.|+++
T Consensus 230 ~-----------------~~~~i~~~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 230 E-----------------VIECITQGRVLQRP-------------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred H-----------------HHHHHHcCCcCCCC-------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 0 00000000000000 01234578999999999999999999999999998
Q ss_pred hhhh
Q 001782 1005 RKIF 1008 (1013)
Q Consensus 1005 ~~~~ 1008 (1013)
.+..
T Consensus 280 ~~~~ 283 (288)
T cd05093 280 AKAS 283 (288)
T ss_pred HHhc
Confidence 8653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=339.82 Aligned_cols=208 Identities=24% Similarity=0.336 Sum_probs=174.9
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++. +.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence 5888999999999999999999999999999997432 223456889999999999999999999964 45789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRM------EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred EEEEecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 9999999999999999765 4688999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccc---------------------------------------cCCCCCcccccccccccccccCCCCCCc
Q 001782 857 ARFLPPCSPATIL---------------------------------------ETPSSSTGIKGTVGYVAPEYGMGGDMSA 897 (1013)
Q Consensus 857 a~~~~~~~~~~~~---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 897 (1013)
++.+......... ..........||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 8643211100000 0000112457999999999999989999
Q ss_pred ccchHHHHHHHHHHHhCCCCCCCc
Q 001782 898 TGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 898 ~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
++|||||||++|||++|+.||...
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~ 251 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAP 251 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCC
Confidence 999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.33 Aligned_cols=279 Identities=22% Similarity=0.286 Sum_probs=201.6
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcC---CCCccceEEEEeecCCccccc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNI---RHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 774 (1013)
+|++.+.||+|+||+||+|++..+++.||+|.++.... .....+.+|+++++++ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58889999999999999999999999999999874322 2234566788777765 699999999997654444556
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..++||||+. ++|.+++..... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 7899999998 689998876532 3589999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
|+++..... .......||..|+|||++.+..++.++||||+||++|||++|++||...... .........
T Consensus 153 g~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~ 222 (288)
T cd07863 153 GLARIYSCQ---------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDL 222 (288)
T ss_pred CccccccCc---------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHH
Confidence 999765321 1123456789999999999999999999999999999999999998653211 111111111
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
........+-.. .. .+...... ...+.......+....+.+++.+|++.||++|||+.|++.
T Consensus 223 ~~~~~~~~~~~~-~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 223 IGLPPEDDWPRD-VT-LPRGAFSP-RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCCCChhhCccc-cc-ccccccCC-CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 100000000000 00 00000000 0000000111233456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.37 Aligned_cols=257 Identities=26% Similarity=0.461 Sum_probs=204.6
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
..+|++.++||+|+||.||+|.+..+++.||+|++... ....+.+.+|++++++++||||+++++++. .+...+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY 78 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcE
Confidence 34688889999999999999999888999999998643 333567889999999999999999999864 346789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++..... ..+++..++.++.|++.|++|||++ +++||||||+||++++++.+||+|||.+
T Consensus 79 lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~ 151 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 151 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccc
Confidence 99999999999999976432 4689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .
T Consensus 152 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~------ 213 (263)
T cd05052 152 RLMTGDTYT-------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----Q------ 213 (263)
T ss_pred cccccceee-------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----H------
Confidence 865432110 1112234678999999999999999999999999999998 99998653111 1
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
....+..... + .. ...++..+.+++.+||+.||++||++.|++++|+.+
T Consensus 214 ---~~~~~~~~~~--~-~~-------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 214 ---VYELLEKGYR--M-ER-------------PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---HHHHHHCCCC--C-CC-------------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0011110000 0 00 012345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=348.02 Aligned_cols=255 Identities=20% Similarity=0.269 Sum_probs=201.4
Q ss_pred ccCCCCCceeeccceEEEEEEECCC-CeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGEN-EMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
..|.+.+.||+|+||.||+|....+ +..||+|.+..........+.+|+++++.++||||+++++++. ..+..+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEE
Confidence 3589999999999999999998777 7889999876554444556788999999999999999999964 457899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++|+|.+++..... ....+++.++..++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||++
T Consensus 142 lv~E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla 216 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFS 216 (478)
T ss_pred EEEECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence 99999999999998865321 124688999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
+.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 217 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------------- 276 (478)
T PTZ00267 217 KQYSDSVS------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------------- 276 (478)
T ss_pred eecCCccc------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------------
Confidence 86543211 1113345699999999999999999999999999999999999999964211
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.+++...+......- ....+..+.+++.+||+.||++||++++++.
T Consensus 277 ---~~~~~~~~~~~~~~~-------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 277 ---REIMQQVLYGKYDPF-------------PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---HHHHHHHHhCCCCCC-------------CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111111111110000 0112345788999999999999999999865
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=343.63 Aligned_cols=281 Identities=19% Similarity=0.243 Sum_probs=198.2
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCc---ccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDF---EEV 773 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~ 773 (1013)
...+|++.++||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++....+ ...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3468999999999999999999999899999999885322 234579999999999999999988654322 223
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC-ceEEc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM-VAHVG 852 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~ 852 (1013)
...++||||++ +++.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++ .+||+
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence 45779999999 678777754311 124689999999999999999999999 999999999999999665 79999
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHH
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~ 931 (1013)
|||+|+.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|.+||...... ......
T Consensus 214 DFGla~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i 283 (440)
T PTZ00036 214 DFGSAKNLLAGQ---------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRI 283 (440)
T ss_pred ccccchhccCCC---------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHH
Confidence 999998653211 12345689999999998764 6899999999999999999999999763221 111121
Q ss_pred HHhhCChhHHHhhhhhhccchh-hhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 932 AKMALPEKVMEIVDPLLLLDLE-ARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~-~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
......+....+ ..+ ..+.. .+.................+..+.+++.+||+.||.+|||+.|+++
T Consensus 284 ~~~~~~p~~~~~-~~~-~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 284 IQVLGTPTEDQL-KEM-NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhCCCCHHHH-HHh-chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 111111110000 000 00000 0000000000000001123456889999999999999999999984
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=331.29 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=202.6
Q ss_pred ceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeeccC
Q 001782 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMEC 785 (1013)
Q Consensus 706 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 785 (1013)
+||+|.||+||.|++..+...+|||-+........+-+..|+..-++++|.|||+++|.| .++++.-+.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 799999999999999999999999999877776777899999999999999999999985 455788899999999
Q ss_pred CCHHHHhhccccccccCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEec-CCCceEEccccccccCCC
Q 001782 786 GSLEDWLHQSNDQLEVGNF--NVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD-HDMVAHVGDFGLARFLPP 862 (1013)
Q Consensus 786 gsL~~~l~~~~~~~~~~~l--~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~~~ 862 (1013)
|+|.++++.. ++++ .+.+.-.+..||++||.|||+. .|||||||-+||||. -.|.+||+|||-++.+..
T Consensus 657 GSLSsLLrsk-----WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg 728 (1226)
T KOG4279|consen 657 GSLSSLLRSK-----WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG 728 (1226)
T ss_pred CcHHHHHHhc-----cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence 9999999876 3566 7888889999999999999999 999999999999995 578999999999987643
Q ss_pred CCCCccccCCCCCcccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhH
Q 001782 863 CSPATILETPSSSTGIKGTVGYVAPEYGMGG--DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940 (1013)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1013)
- ......+.||..|||||++..+ .|+.++|||||||++.||.||++||....... ..+.+
T Consensus 729 i--------nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAMFk------- 790 (1226)
T KOG4279|consen 729 I--------NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAMFK------- 790 (1226)
T ss_pred C--------CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---Hhhhh-------
Confidence 2 2234567899999999999887 48889999999999999999999997642211 00000
Q ss_pred HHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 941 MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 941 ~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
-.|....| +.+++...+...++.+|+.+||.+||+|.++++
T Consensus 791 ----VGmyKvHP--------------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 791 ----VGMYKVHP--------------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ----hcceecCC--------------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 01111111 122455667788999999999999999999875
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.47 Aligned_cols=262 Identities=29% Similarity=0.493 Sum_probs=204.8
Q ss_pred hccCCCCCceeeccceEEEEEEECC-----CCeEEEEEEEeecccc-chhHHHHHHHHHhcCCCCccceEEEEeecCCcc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGE-----NEMAVAVKVMNLKQRG-ATKSFVAECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 771 (1013)
.++|.+.+.||+|+||.||+|++.. +++.||+|++...... ..+.+.+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT----- 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-----
Confidence 4578899999999999999998743 3578999998754433 3567999999999999999999999964
Q ss_pred ccceEEEEEeeccCCCHHHHhhcccc--------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEe
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSND--------QLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL 843 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll 843 (1013)
.....++||||+++++|.++++.... ......+++.++..++.|++.|++|||++ +++||||||+||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili 155 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV 155 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence 34789999999999999999976532 11224588999999999999999999999 99999999999999
Q ss_pred cCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcC
Q 001782 844 DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMF 922 (1013)
Q Consensus 844 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~ 922 (1013)
+.++.+||+|||.++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYYR------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred cCCCeEEECCcccceecccCccee------cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999987543222111 1223345788999999999999999999999999999998 999986532
Q ss_pred CCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 923 NDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
.. ...+.+. ...+... ....+..+.+++.+||+.||++||++.||++.|+
T Consensus 230 ~~--------------~~~~~~~---~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 230 NE--------------EVIECIT---QGRLLQR-------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH--------------HHHHHHH---cCCcCCC-------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11 0011111 0000000 0122456789999999999999999999999986
Q ss_pred H
Q 001782 1003 S 1003 (1013)
Q Consensus 1003 ~ 1003 (1013)
+
T Consensus 280 ~ 280 (280)
T cd05049 280 K 280 (280)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=300.03 Aligned_cols=201 Identities=24% Similarity=0.409 Sum_probs=174.9
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec--cccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
..+.|++.+.||+|.|+.||++....+|+.+|+|++... .....+.+.+|+.+-+.++||||+++.+. +....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccc
Confidence 356888999999999999999999999999999998633 22356789999999999999999999987 45668
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC---CCceEE
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH---DMVAHV 851 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 851 (1013)
+.|+|+|+|+|++|..-+-.+ ..+++..+-....||++|+.|.|.+ +|||||+||+|+++.. .--+|+
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL 154 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKL 154 (355)
T ss_pred eeEEEEecccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceee
Confidence 899999999999987555433 3578888999999999999999999 9999999999999953 346999
Q ss_pred ccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 852 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
+|||+|..+.. .....+..|||.|||||++...+|+..+|||+.||++|-++.|.+||.+
T Consensus 155 ~~FGvAi~l~~---------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 155 ADFGLAIEVND---------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred cccceEEEeCC---------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 99999987652 2235578899999999999999999999999999999999999999976
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=358.52 Aligned_cols=482 Identities=28% Similarity=0.333 Sum_probs=367.3
Q ss_pred EeeccccccccCccccCCCCCCCeeeeccCCccccCCc-ccCCcccceEEeccCCccccCCCCccccCCCCceecccccc
Q 001782 81 LDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPG-EIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNN 159 (1013)
Q Consensus 81 l~l~~~~l~~~~~~~l~~l~~L~~L~l~~n~l~~~ip~-~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~ 159 (1013)
+|++...++ .||..+..-..|+.|+++.|.+- ..|- .+.+.-+|+.|||++|+++ ..|..+..++.|+.|.++.|.
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 566666666 56666666666888888888777 4333 2344555999999999888 888888888888888888888
Q ss_pred ccCCCCCccccccccccceecccccccccCCCCccCCCCcceeeecccccCCCCCCccccccccceeecccccccCCCcc
Q 001782 160 LVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPS 239 (1013)
Q Consensus 160 l~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~ 239 (1013)
+. .+|.... +..+|++|.|.+|.+. ..|.++..+.+|++|+++.|++. .+|..+..++.++.+..++|......
T Consensus 80 i~-~vp~s~~-~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~l-- 153 (1081)
T KOG0618|consen 80 IR-SVPSSCS-NMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRL-- 153 (1081)
T ss_pred Hh-hCchhhh-hhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhh--
Confidence 88 7775554 6677888888888877 77888888888888888888887 78888888888888888888222122
Q ss_pred hhccCCccceeeccCCccCCCCCCCcCCCCCCCcEEEeeeccccccCCCCCCCCCCCceEEcccCcccccccccccCCCC
Q 001782 240 SIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPN 319 (1013)
Q Consensus 240 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 319 (1013)
+... ++.++|..|.+.+.++..+. .+.+ .|+|++|.+. -..+.++.+|+.|..+.|+++... -..++
T Consensus 154 --g~~~-ik~~~l~~n~l~~~~~~~i~-~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~ 220 (1081)
T KOG0618|consen 154 --GQTS-IKKLDLRLNVLGGSFLIDIY-NLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPS 220 (1081)
T ss_pred --cccc-chhhhhhhhhcccchhcchh-hhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcc
Confidence 2222 78888888888888887765 3444 5888888876 234667788888888888887443 24578
Q ss_pred ccccccccCcCCCCCCCChhhhhhcccccccccccccccccCCccchhhhcchhhHHHHhccchhHHhhcccccceeecc
Q 001782 320 LFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLE 399 (1013)
Q Consensus 320 L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~ 399 (1013)
|+.|+.++|.+++.. ....-.+|+.++++.|.+++.. .++ ..+.+|+.+...
T Consensus 221 l~~L~a~~n~l~~~~--------~~p~p~nl~~~dis~n~l~~lp-~wi-------------------~~~~nle~l~~n 272 (1081)
T KOG0618|consen 221 LTALYADHNPLTTLD--------VHPVPLNLQYLDISHNNLSNLP-EWI-------------------GACANLEALNAN 272 (1081)
T ss_pred hheeeeccCcceeec--------cccccccceeeecchhhhhcch-HHH-------------------HhcccceEeccc
Confidence 888888888887422 2223457888888888887653 443 456778888888
Q ss_pred cccccCCcccccCCCCCCCEEEccCCccCccCCccccccCccCEEEcCCCcccCCCCccccc-Cc-ccceeecccccccc
Q 001782 400 YNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGN-CQ-NLMLLSVSNNKLTG 477 (1013)
Q Consensus 400 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~-~L~~L~L~~N~l~~ 477 (1013)
+|+++ .+|..+...++|+.|++.+|.++ -+|.....++.|++|+|..|+|. .+|+.+-. .. .|..|+.+.|++.
T Consensus 273 ~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~- 348 (1081)
T KOG0618|consen 273 HNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS- 348 (1081)
T ss_pred chhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-
Confidence 88885 78888888888999999999888 67777888889999999999988 56654332 22 3677888888887
Q ss_pred cCCchhhcccchhhhhccCCCeecccCCccccCcCCCcEEEccCCCCCCCCccccccccccccccccccccccccCcccc
Q 001782 478 ALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALK 557 (1013)
Q Consensus 478 ~~p~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 557 (1013)
..|..-....+.|+.|.+.+|.|+...-..+.+..+|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|.++.
T Consensus 349 ~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva 427 (1081)
T KOG0618|consen 349 TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVA 427 (1081)
T ss_pred ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHH
Confidence 555444444677888999999999887778888899999999999997444445788999999999999998 7889999
Q ss_pred ccCCCCeEeccccccccccccccccccccceeecCCccCCCC-CCCCCccCCCcceeeeCCcC
Q 001782 558 TLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGE-VPRRGVFSNKTRFYFTGNKR 619 (1013)
Q Consensus 558 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~~~~~~~~~~~N~~ 619 (1013)
.+..|++|...+|+|. ..| .+.+++.|+.+|+|.|+|+-. +|.....+++..+.+.||+|
T Consensus 428 ~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 428 NLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999999999999998 677 788899999999999998753 34333347888888999987
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.29 Aligned_cols=208 Identities=23% Similarity=0.340 Sum_probs=176.4
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+|+.++++++||+|+++++.+ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 47899999999999999999999899999999997432 22335678899999999999999999985 45578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++|+|.+++... +.+++.++..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG 146 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG 146 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence 99999999999999999865 5789999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCcccc---------------------------CCCCCcccccccccccccccCCCCCCcccchHHHHHHH
Q 001782 856 LARFLPPCSPATILE---------------------------TPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILL 908 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il 908 (1013)
+++.+.......... ........+||+.|+|||++.+..++.++|||||||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 997654221100000 00011245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCC
Q 001782 909 LEMFTRRRPTDN 920 (1013)
Q Consensus 909 ~ell~G~~pf~~ 920 (1013)
|||++|+.||..
T Consensus 227 ~ell~G~~Pf~~ 238 (363)
T cd05628 227 YEMLIGYPPFCS 238 (363)
T ss_pred HHHHhCCCCCCC
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=338.86 Aligned_cols=258 Identities=22% Similarity=0.329 Sum_probs=203.5
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+|+++++.++||||+++++++ .+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 47899999999999999999999899999999997432 23446688999999999999999999885 45578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++++|.+++... ..+++.++..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg 146 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG 146 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence 99999999999999999865 4689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCcc---------------------ccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhC
Q 001782 856 LARFLPPCSPATI---------------------LETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914 (1013)
Q Consensus 856 ~a~~~~~~~~~~~---------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G 914 (1013)
++........... ...........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 9986543320000 0001123345689999999999999999999999999999999999
Q ss_pred CCCCCCcCCCCccHHHHHHhhCChhHHHhhh--hhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC
Q 001782 915 RRPTDNMFNDGLTLHEFAKMALPEKVMEIVD--PLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI 992 (1013)
Q Consensus 915 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~--~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 992 (1013)
+.||...... .. ...+.. .... .+.. ...+..+.+++.+|+. ||.+||
T Consensus 227 ~~Pf~~~~~~----~~---------~~~i~~~~~~~~-----~p~~-----------~~~~~~~~~li~~ll~-dp~~R~ 276 (350)
T cd05573 227 FPPFYSDTLQ----ET---------YNKIINWKESLR-----FPPD-----------PPVSPEAIDLICRLLC-DPEDRL 276 (350)
T ss_pred CCCCCCCCHH----HH---------HHHHhccCCccc-----CCCC-----------CCCCHHHHHHHHHHcc-ChhhcC
Confidence 9999753211 00 011111 0000 0000 0124557889999997 999999
Q ss_pred C-HHHHHHH
Q 001782 993 Q-MTDVVAK 1000 (1013)
Q Consensus 993 s-~~evl~~ 1000 (1013)
+ ++|+++.
T Consensus 277 ~s~~~ll~h 285 (350)
T cd05573 277 GSFEEIKSH 285 (350)
T ss_pred CCHHHHhcC
Confidence 9 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=297.37 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=207.7
Q ss_pred hhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc----c----hhHHHHHHHHHhcC-CCCccceEEEEe
Q 001782 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG----A----TKSFVAECEALRNI-RHRNLIKIITVC 765 (1013)
Q Consensus 695 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~----~~~~~~E~~~l~~l-~h~niv~~~~~~ 765 (1013)
+.....|...+.+|.|..++|.++..+.++..+|+|++...... . .+.-.+|+.+++++ .||+|+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34556788899999999999999999999999999999744321 1 23346799999998 699999999994
Q ss_pred ecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC
Q 001782 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH 845 (1013)
Q Consensus 766 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 845 (1013)
+.+...++|+|.|+.|.|.|++... ..+++.+..+|+.|+.+|++|||.+ .|||||+||+|||+|+
T Consensus 93 -----es~sF~FlVFdl~prGELFDyLts~------VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILldd 158 (411)
T KOG0599|consen 93 -----ESDAFVFLVFDLMPRGELFDYLTSK------VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDD 158 (411)
T ss_pred -----cCcchhhhhhhhcccchHHHHhhhh------eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecc
Confidence 5668899999999999999999886 5799999999999999999999999 9999999999999999
Q ss_pred CCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCC------CCCCcccchHHHHHHHHHHHhCCCCCC
Q 001782 846 DMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG------GDMSATGDVYSFGILLLEMFTRRRPTD 919 (1013)
Q Consensus 846 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DIwSlG~il~ell~G~~pf~ 919 (1013)
+.++||+|||+|+.+.++ .+....+|||+|.|||.+.. ..|+..+|+||.||++|.++.|.+||.
T Consensus 159 n~~i~isDFGFa~~l~~G---------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPG---------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred ccceEEeccceeeccCCc---------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 999999999999977543 33566899999999998764 357889999999999999999999996
Q ss_pred CcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 920 NMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
...+ .-+++-.+...+ .-..+++.+......+++.+|++.||.+|.|++|+++
T Consensus 230 HRkQ-----------------mlMLR~ImeGky----------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 230 HRKQ-----------------MLMLRMIMEGKY----------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHH-----------------HHHHHHHHhccc----------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 5210 001111111111 1222344455666788999999999999999999986
Q ss_pred H
Q 001782 1000 K 1000 (1013)
Q Consensus 1000 ~ 1000 (1013)
.
T Consensus 283 H 283 (411)
T KOG0599|consen 283 H 283 (411)
T ss_pred C
Confidence 3
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.60 Aligned_cols=262 Identities=23% Similarity=0.346 Sum_probs=206.1
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.++||+|+||.||+|++..+++.||+|.+.... ......+.+|+++++.++||||+++++++. ..+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 57999999999999999999998899999999886422 223356889999999999999999999854 3467
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++++|.+++...... ...+++.++..++.|++.|++|||++ +++|+||||+||+++.++.++|+|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g 151 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence 89999999999999988653221 13578899999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
.+..+..... ......|++.|+|||++.+..++.++||||+|+++|||++|+.||....... ..+.
T Consensus 152 ~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~~~--- 217 (267)
T cd08228 152 LGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---FSLC--- 217 (267)
T ss_pred cceeccchhH--------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH---HHHH---
Confidence 9886542211 1223458889999999988889999999999999999999999986432111 1110
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhh
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1005 (1013)
..+.. ..+ +. . .....+..+.+++.+||+.+|++||++.||++.++.++
T Consensus 218 ------~~~~~---~~~---~~-------~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 218 ------QKIEQ---CDY---PP-------L--PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ------HHHhc---CCC---CC-------C--ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00000 000 00 0 01123456889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=319.13 Aligned_cols=265 Identities=25% Similarity=0.409 Sum_probs=203.4
Q ss_pred CCCCCceeeccceEEEEEEECCC---CeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCc-cccc
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGEN---EMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDF-EEVD 774 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 774 (1013)
|++.+.||+|+||.||+|....+ +..||+|+++.... .....+.+|++.++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 57889999999999999987543 47899999874432 234578999999999999999999998754322 2334
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..+++|||+++++|.+++...........+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 5799999999999999986653322234689999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~ 933 (1013)
|.++.+....... ......++..|+|||++.+..++.++|||||||++|||++ |..||...... +.
T Consensus 158 g~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-----~~-- 224 (273)
T cd05035 158 GLSKKIYSGDYYR------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-----EI-- 224 (273)
T ss_pred cceeecccccccc------ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-----HH--
Confidence 9998654322110 1112234678999999988899999999999999999999 88888653211 00
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
...... ..... ....++..+.+++.+||+.||++||++.|+++.|+++
T Consensus 225 ------~~~~~~----~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 225 ------YDYLRH----GNRLK-------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ------HHHHHc----CCCCC-------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000000 00000 0012345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=323.43 Aligned_cols=267 Identities=26% Similarity=0.448 Sum_probs=208.7
Q ss_pred hccCCCCCceeeccceEEEEEEEC-----CCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLG-----ENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 772 (1013)
.++|.+.+.||+|+||.||+|++. .++..|++|.+........+.+.+|++++++++||||+++++++. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 78 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----D 78 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----c
Confidence 356888899999999999999863 245678999987555444567899999999999999999999964 4
Q ss_pred cceEEEEEeeccCCCHHHHhhccccc----------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceE
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQ----------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVL 842 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIl 842 (1013)
....++||||+++++|.+++...... .....+++.+++.++.||+.|++|||++ +++||||||+||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 155 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCL 155 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEE
Confidence 46789999999999999999764321 1123589999999999999999999999 9999999999999
Q ss_pred ecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCc
Q 001782 843 LDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNM 921 (1013)
Q Consensus 843 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~ 921 (1013)
++.++.+||+|||++......... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 156 ~~~~~~~~l~dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 156 VGANLLVKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred EccCCcEEECCCCcccccCCCcee------ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999754332111 11233456789999999999999999999999999999998 99998653
Q ss_pred CCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 922 FNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
... . .++.........++ ..++..+.+++.+||+.||++|||+.+|+++|
T Consensus 230 ~~~-----~------------~~~~~~~~~~~~~~-------------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 230 SNT-----E------------VIECITQGRVLERP-------------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred CHH-----H------------HHHHHhCCCCCCCC-------------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 211 0 00100000000000 11245688999999999999999999999999
Q ss_pred HHhhhhh
Q 001782 1002 CSARKIF 1008 (1013)
Q Consensus 1002 ~~~~~~~ 1008 (1013)
+++.+..
T Consensus 280 ~~~~~~~ 286 (291)
T cd05094 280 HALGKAT 286 (291)
T ss_pred HHHHhhc
Confidence 9997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=322.48 Aligned_cols=258 Identities=31% Similarity=0.481 Sum_probs=207.7
Q ss_pred hhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
....+|++.++||+|+||.||+|.+.. +..||+|++..........+.+|+.+++.++||||+++++++. ....
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 76 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEP 76 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCC
Confidence 455689999999999999999999986 7889999987665545677899999999999999999999864 4467
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++++|.+++..... ..+++.++..++.|++.|++|||++ +++||||||+||++++++.+||+|||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g 149 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFG 149 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEcccc
Confidence 8999999999999999986532 4689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
.+........ ......++..|+|||+..+..++.++||||||+++|+|++ |+.||......
T Consensus 150 ~~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---------- 211 (261)
T cd05148 150 LARLIKEDVY--------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---------- 211 (261)
T ss_pred chhhcCCccc--------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----------
Confidence 9976532111 1123345778999999988899999999999999999998 89998653210
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
...+.+... .++.. ...++..+.+++.+||+.||.+|||++++++.|+.+
T Consensus 212 ----~~~~~~~~~------~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 212 ----EVYDQITAG------YRMPC----------PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----HHHHHHHhC------CcCCC----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 000101000 00000 012345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=334.02 Aligned_cols=282 Identities=22% Similarity=0.239 Sum_probs=202.3
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec--cccchhHHHHHHHHHhcCCCCccceEEEEeecCC-cccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIRHRNLIKIITVCSSID-FEEV 773 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 773 (1013)
..++|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.+++.++||||+++++++.... ....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999999989999999998633 2233456789999999999999999999875332 1233
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++||||++ +++.+.+.. .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 46799999998 567666642 478889999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||+++.... ........||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ..+.....
T Consensus 167 fg~a~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~ 236 (359)
T cd07876 167 FGLARTACT---------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIE 236 (359)
T ss_pred CCCcccccc---------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 999974321 11123456899999999999999999999999999999999999999764221 11111111
Q ss_pred hhCC--hhHHHhhhhhhccchhhhhccCCCCch----------hHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 934 MALP--EKVMEIVDPLLLLDLEARASNCGSHRT----------EIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 934 ~~~~--~~~~~~i~~~l~~~~~~R~~~~~~~~~----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.... ......+......-...++........ ...........+.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 237 QLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred hcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1110 001000000000000001100000000 000001123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.85 Aligned_cols=259 Identities=23% Similarity=0.404 Sum_probs=202.7
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCe----EEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEM----AVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
.+|++.+.||+|+||.||+|++..++. .||+|+++... ....+++.+|+.+++.++||||++++|+|..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence 479999999999999999999855544 48999986432 2345678899999999999999999999742
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++|+||+.+|+|.+++.... ..+++..+++++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D 152 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD 152 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence 34679999999999999998653 3578899999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~ 932 (1013)
||+++.+....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 153 fG~a~~~~~~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-----~-- 219 (316)
T cd05108 153 FGLAKLLGADEKEY------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----E-- 219 (316)
T ss_pred ccccccccCCCcce------eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----H--
Confidence 99998664322111 1122334678999999999999999999999999999998 99998653111 1
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 1007 (1013)
....+... .++... ..+...+.+++.+||+.+|.+||++.+++..+..+.+.
T Consensus 220 -------~~~~~~~~------~~~~~~----------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 220 -------ISSILEKG------ERLPQP----------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred -------HHHHHhCC------CCCCCC----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 11111100 000000 11234578899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=318.63 Aligned_cols=265 Identities=24% Similarity=0.392 Sum_probs=201.0
Q ss_pred CCCCCceeeccceEEEEEEECCCCe--EEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCc-cccce
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEM--AVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDF-EEVDF 775 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 775 (1013)
|.+.++||+|+||.||+|++..++. .||+|.++... ....+.+.+|+++++.++||||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999876654 68999886432 3335678899999999999999999998754311 12245
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.+++|||+++|+|.+++...+.......+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 789999999999999885432221224589999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
+++.+...... .......+++.|+|||+..+..++.++|||||||++|||++ |+.||...... ..
T Consensus 158 ~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~--- 223 (272)
T cd05075 158 LSKKIYNGDYY------RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-----EI--- 223 (272)
T ss_pred cccccCcccce------ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----HH---
Confidence 99865432211 01122345678999999999999999999999999999999 88898653111 00
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
.+.+.. .. ++.. ...++..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 224 ------~~~~~~---~~---~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 224 ------YDYLRQ---GN---RLKQ----------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ------HHHHHc---CC---CCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000000 00 0000 011234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=331.73 Aligned_cols=197 Identities=25% Similarity=0.394 Sum_probs=168.3
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHH---hcCCCCccceEEEEeecCCccccc
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEAL---RNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++ +.++||||+++++++ ...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 677899999999999999999899999999997432 22345566776665 456799999999985 4457
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..|+||||+++++|..++.. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence 89999999999999988864 3689999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
|+++.... .........|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 146 g~~~~~~~--------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~ 203 (324)
T cd05589 146 GLCKEGMG--------FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203 (324)
T ss_pred cCCccCCC--------CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence 99864321 11123346789999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=321.43 Aligned_cols=251 Identities=33% Similarity=0.557 Sum_probs=190.9
Q ss_pred CCCceeeccceEEEEEEEC----CCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 703 SSNMIGQGSFGFVYRGNLG----ENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 703 ~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+.+.||.|.||.||+|.+. ..+..|+||++..... ...+.+.+|++.+++++||||++++|+|. ..+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence 3478999999999999997 4467899999964333 23578999999999999999999999985 335589
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++|+|.+++..... ..+++.++..|+.||+.||+|||++ +++||||+++||++++++.+||+|||++
T Consensus 78 lv~e~~~~g~L~~~L~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~ 150 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNK----EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLS 150 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCT----TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred cccccccccccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 99999999999999998622 4789999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
......... ...........|+|||.+.+..++.++||||||+++|||++ |+.||...... .
T Consensus 151 ~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-----~------ 213 (259)
T PF07714_consen 151 RPISEKSKY------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-----E------ 213 (259)
T ss_dssp EETTTSSSE------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-----H------
T ss_pred ccccccccc------ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----c------
Confidence 865221111 11233446789999999998889999999999999999999 78888653111 1
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
..+.+....... ....++..+.+++.+||+.||++|||+.|++++|
T Consensus 214 ---~~~~~~~~~~~~----------------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 214 ---IIEKLKQGQRLP----------------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---HHHHHHTTEETT----------------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ccccccccccce----------------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 001111000000 0012345688999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=352.11 Aligned_cols=272 Identities=23% Similarity=0.304 Sum_probs=206.1
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.++||+|+||.||+|.+..+++.||+|++..... ...+++.+|++++++++||||+++++++. +.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 589999999999999999999998999999999874322 22457899999999999999999999864 4478
Q ss_pred EEEEEeeccCCCHHHHhhccccc-----cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceE
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQ-----LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAH 850 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 850 (1013)
.++||||+++++|.+++...... ......++.+++.++.||+.||+|||++ ||+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 89999999999999998753211 0113466788899999999999999999 999999999999999999999
Q ss_pred EccccccccCCCCCCCcc----------ccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 851 VGDFGLARFLPPCSPATI----------LETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 851 l~DFG~a~~~~~~~~~~~----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
|+|||+++.......... ...........||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999986622111000 0011112345799999999999999999999999999999999999999965
Q ss_pred cCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-CHHHHHH
Q 001782 921 MFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-QMTDVVA 999 (1013)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~ 999 (1013)
......... ....+|... ....+.+..+.+++.+|++.||++|| +++++.+
T Consensus 234 ~~~~ki~~~-----------------~~i~~P~~~-----------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 234 KKGRKISYR-----------------DVILSPIEV-----------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred cchhhhhhh-----------------hhccChhhc-----------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 211100000 000011000 00113345678899999999999996 6677777
Q ss_pred HHHHhhh
Q 001782 1000 KLCSARK 1006 (1013)
Q Consensus 1000 ~L~~~~~ 1006 (1013)
.|+...+
T Consensus 286 ~Le~~lq 292 (932)
T PRK13184 286 DLEPHLQ 292 (932)
T ss_pred HHHHHHh
Confidence 7777644
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.39 Aligned_cols=257 Identities=19% Similarity=0.245 Sum_probs=200.1
Q ss_pred hhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCcc
Q 001782 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 695 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 771 (1013)
....++|++.++||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++ .
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~ 113 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----Q 113 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence 345678999999999999999999999999999999996422 22334578899999999999999999985 4
Q ss_pred ccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEE
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV 851 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 851 (1013)
++...++||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL 183 (370)
T cd05596 114 DDKYLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKL 183 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEE
Confidence 557899999999999999998653 578889999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCCCCcccccccccccccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCcc
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG----DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLT 927 (1013)
Q Consensus 852 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~ 927 (1013)
+|||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 184 ~DfG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--- 253 (370)
T cd05596 184 ADFGTCMKMDANGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--- 253 (370)
T ss_pred EeccceeeccCCCc-------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---
Confidence 99999975532111 112345799999999998653 4788999999999999999999999753110
Q ss_pred HHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCC--CCCHHHHHHH
Q 001782 928 LHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSE--RIQMTDVVAK 1000 (1013)
Q Consensus 928 ~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 1000 (1013)
.. ...+.... .. .. .+.....+..+.+++.+|++.+|++ ||++.|+++.
T Consensus 254 -~~---------~~~i~~~~----~~--~~--------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 254 -GT---------YSKIMDHK----NS--LT--------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -HH---------HHHHHcCC----Cc--CC--------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 11111100 00 00 0000012345778999999999988 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=316.00 Aligned_cols=252 Identities=28% Similarity=0.437 Sum_probs=197.8
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
++|++.+.||+|+||.||+|++. ++..+|+|.+... ....+.+.+|++++++++||||+++++++. .....++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEE
Confidence 56888999999999999999886 4567999987633 233467889999999999999999999864 4467899
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
||||+++|+|.+++.... ..+++..++.++.|++.|++|||++ +++||||||+||++++++.+||+|||.++
T Consensus 77 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence 999999999999987542 3578999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCC
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ..
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-----~~------ 210 (256)
T cd05114 149 YVLDDEY-------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-----EV------ 210 (256)
T ss_pred ccCCCce-------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-----HH------
Confidence 5432111 01122345678999999988899999999999999999999 89998653110 00
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
...+... ....++. ..+..+.+++.+||+.+|++||+++|+++.|.
T Consensus 211 --~~~i~~~----~~~~~~~-------------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 211 --VEMISRG----FRLYRPK-------------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --HHHHHCC----CCCCCCC-------------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111100 0000000 11345789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.99 Aligned_cols=239 Identities=25% Similarity=0.339 Sum_probs=187.5
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
++||+|+||.||+|++..+++.||+|+++... ....+.+..|..++... +||||+++++++ ..++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999899999999997432 22334556677777654 899999999985 3457899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~gg~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 76 EYLNGGDLMFHIQSS------GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred cCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 999999999998765 4689999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhH
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1013)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~--------- 204 (316)
T cd05592 147 MNGE--------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----EL--------- 204 (316)
T ss_pred CCCC--------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HH---------
Confidence 2211 1233456899999999999999999999999999999999999999753211 00
Q ss_pred HHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 001782 941 MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTD 996 (1013)
Q Consensus 941 ~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 996 (1013)
....... ++... ......+.+++.+||+.||++||++.+
T Consensus 205 ---~~~i~~~----~~~~~----------~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 205 ---FDSILND----RPHFP----------RWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred ---HHHHHcC----CCCCC----------CCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 0000000 00000 012344678899999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=325.65 Aligned_cols=276 Identities=18% Similarity=0.297 Sum_probs=200.4
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
++|.+.++||+|+||.||+|++..++..||+|+++.... .....+.+|++++++++||||+++++++. .++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence 579999999999999999999998999999999874432 23346788999999999999999999964 447789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||++ +++.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 81 LVFEYLD-KDLKQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred EEEeCCC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence 9999998 58888886542 3578899999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+...... .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ..........
T Consensus 152 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~ 222 (309)
T cd07872 152 RAKSVPT--------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLG 222 (309)
T ss_pred eecCCCc--------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC
Confidence 7532211 11223457899999998765 468899999999999999999999997642221 1111111110
Q ss_pred -C-hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 -P-EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 -~-~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+ ......+...........+... ..............+.+++.+|++.||.+|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 223 TPTEETWPGISSNDEFKNYNFPKYK--PQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CCCHHHHhhhcchhhhhhhhcCccC--CCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 0000000000000000000000 00001111223456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=329.31 Aligned_cols=242 Identities=24% Similarity=0.318 Sum_probs=190.2
Q ss_pred CceeeccceEEEEEEEC---CCCeEEEEEEEeecc----ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 705 NMIGQGSFGFVYRGNLG---ENEMAVAVKVMNLKQ----RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
++||+|+||.||+|+.. .+++.||+|+++... ......+.+|+++++.++||||+++++++. .++..+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence 68999999999999873 467899999987432 222345788999999999999999999853 457899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 77 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (323)
T cd05584 77 LILEYLSGGELFMHLERE------GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLC 147 (323)
T ss_pred EEEeCCCCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence 999999999999999765 4678889999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 148 ~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~------ 208 (323)
T cd05584 148 KESIHE--------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KT------ 208 (323)
T ss_pred eecccC--------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HH------
Confidence 743211 11123456899999999999989999999999999999999999999753110 00
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVA 999 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 999 (1013)
...+........ ......+.+++.+|++.||++|| ++.++++
T Consensus 209 --~~~~~~~~~~~~------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 209 --IDKILKGKLNLP------------------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --HHHHHcCCCCCC------------------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111111100000 01234567888999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=318.95 Aligned_cols=259 Identities=22% Similarity=0.372 Sum_probs=200.8
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCe----EEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEM----AVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
++|++.+.||+|+||+||+|.+..++. .|++|.+..... ....++..|+..+++++||||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence 578889999999999999999876665 467777653322 22356778888999999999999999863 2
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++++||+++|+|.+++.... +.+++..+..++.||+.|++|||++ +++||||||+||++++++.+||+|
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~D 152 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD 152 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcC
Confidence 34678999999999999997643 3689999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~ 932 (1013)
||.++...+.... .......++..|+|||++.++.++.++|||||||++||+++ |..||......
T Consensus 153 fg~~~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------- 218 (279)
T cd05111 153 FGVADLLYPDDKK------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------- 218 (279)
T ss_pred CccceeccCCCcc------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 9999865432211 11223456788999999998999999999999999999998 99998653111
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 1007 (1013)
...+++... .++... ..++..+.+++.+||+.||++|||+.|+++.|..+.+.
T Consensus 219 ------~~~~~~~~~------~~~~~~----------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 219 ------EVPDLLEKG------ERLAQP----------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ------HHHHHHHCC------CcCCCC----------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 111111110 011000 01233467889999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=324.16 Aligned_cols=276 Identities=25% Similarity=0.376 Sum_probs=205.4
Q ss_pred hccCCCCCceeeccceEEEEEEE----CCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNL----GENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
..+|++.+.||+|+||.||+|.. ..++..||+|.+........+.+.+|++++++++||||+++++++.. .+.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCC
Confidence 34788999999999999999984 45678899999875555455678999999999999999999998753 234
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+||++++++.+||+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~d 151 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGD 151 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECC
Confidence 56899999999999999997542 3588999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||+++.......... ......++..|+|||++.+..++.++|||||||++|||++|..|+...... ......
T Consensus 152 fg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~ 223 (284)
T cd05081 152 FGLTKVLPQDKEYYK-----VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMG 223 (284)
T ss_pred CcccccccCCCccee-----ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcc
Confidence 999986643221110 011123445699999999889999999999999999999988776432110 000000
Q ss_pred hhCC--hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhh
Q 001782 934 MALP--EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 934 ~~~~--~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1005 (1013)
.... .....+.+ .+... .++. ....++..+.+++.+||+.+|++|||+.||+++|++++
T Consensus 224 ~~~~~~~~~~~~~~-~~~~~--~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 224 NDKQGQMIVYHLIE-LLKNN--GRLP----------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cccccccchHHHHH-HHhcC--CcCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 0000 00001100 00000 0000 01123456889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=329.34 Aligned_cols=194 Identities=27% Similarity=0.369 Sum_probs=167.5
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeec---cccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
++||+|+||+||+|++..+++.||+|++... .....+.+..|.++++.. +||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 4699999999999999989999999998743 223345677888888876 699999999985 4457899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 Ey~~~g~L~~~i~~~------~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 76 EFVNGGDLMFHIQKS------RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred cCCCCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 999999999998765 4689999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
... ........||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (320)
T cd05590 147 IFN--------GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198 (320)
T ss_pred CcC--------CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 211 1123345789999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=334.12 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=192.7
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.++|+..++||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++.++|+||+++++++ ...+..
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 147 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEI 147 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeE
Confidence 4567788999999999999999998999999999864432 2345688999999999999999999985 455788
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+++++|.+.. ..++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 148 ~lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 148 QVLLEFMDGGSLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred EEEEecCCCCcccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccccc
Confidence 9999999999986432 345678889999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHH
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-----GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~ 931 (1013)
++.+.... .......||..|+|||++.. ...+.++|||||||++|||++|+.||...... .+...
T Consensus 215 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~ 284 (353)
T PLN00034 215 SRILAQTM--------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASL 284 (353)
T ss_pred ceeccccc--------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHH
Confidence 97653211 11234568999999998743 23456899999999999999999999732111 11111
Q ss_pred HHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 932 AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
+.......+.. ....+...+.+++.+||+.||++|||+.|+++.
T Consensus 285 ------------~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 285 ------------MCAICMSQPPE-------------APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------------HHHHhccCCCC-------------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 001234568899999999999999999999874
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=332.31 Aligned_cols=243 Identities=23% Similarity=0.297 Sum_probs=192.3
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEe
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
+.||+|+||.||+|++..+++.||+|++.... ......+.+|+++++.++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999997432 22345678899999999999999999985 44578999999
Q ss_pred eccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH-HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
|+++|+|.+++... ..+++.++..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 76 YANGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred CCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 99999999988765 468999999999999999999997 7 9999999999999999999999999998743
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhH
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1013)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~--------- 204 (325)
T cd05594 147 IKD--------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KL--------- 204 (325)
T ss_pred CCC--------CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HH---------
Confidence 211 11123456999999999999999999999999999999999999999653111 00
Q ss_pred HHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHHH
Q 001782 941 MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVAK 1000 (1013)
Q Consensus 941 ~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 1000 (1013)
.+.+. ...+ +. .......+.+++.+|++.||++|+ ++.++++.
T Consensus 205 ~~~i~---~~~~--~~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 205 FELIL---MEEI--RF------------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHh---cCCC--CC------------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 00000 0000 00 001234567888999999999996 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=336.63 Aligned_cols=279 Identities=22% Similarity=0.265 Sum_probs=202.0
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.++||+|+||.||+|.+..+++.||+|++.... ....+++.+|+++++.++||||+++++++...........+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999998899999999986332 22345788999999999999999999997644322234789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+. ++|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred EEeeccc-cCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence 9999998 6888887654 4689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+....... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||...... ...........
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g 222 (372)
T cd07853 151 RVEEPDES-------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLG 222 (372)
T ss_pred eecccCcc-------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcC
Confidence 75432211 112334678999999998874 4789999999999999999999999764221 11111111111
Q ss_pred ChhHHHhh------hhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 937 PEKVMEIV------DPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 937 ~~~~~~~i------~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.+...++. ...+...+...+. .........+....+.+++.+|++.||++|||+.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 223 TPSLEAMRSACEGARAHILRGPHKPPS----LPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCCHHHHHHhhHHHHHHHHhCCCCCCc----hHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 11111100 0000000100000 000000001224567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=322.67 Aligned_cols=253 Identities=25% Similarity=0.335 Sum_probs=199.1
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.|++.++||+|+||+||++.+..+++.||+|++.... ......+.+|+.++++++||||+++++.+ ..++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 4788899999999999999998889999999986432 12234577899999999999999999985 344789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+++|+|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999998865422 4689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||...... .....
T Consensus 149 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~------ 212 (285)
T cd05605 149 AVEIPEGE---------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREE------ 212 (285)
T ss_pred ceecCCCC---------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHH------
Confidence 87543211 122346899999999999889999999999999999999999999753211 00000
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVAK 1000 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 1000 (1013)
....+.. .+ +. .....+..+.+++.+||+.||++|| +++++++.
T Consensus 213 ---~~~~~~~----~~---~~----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 213 ---VERRVKE----DQ---EE----------YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---HHHHhhh----cc---cc----------cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0010100 00 00 0012345678899999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=339.09 Aligned_cols=209 Identities=24% Similarity=0.328 Sum_probs=175.0
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++.+ .+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 37899999999999999999999999999999986332 22345688999999999999999999985 45578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++|+|.+++... +.+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRL------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999765 4688899999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCcc-----------------------------------ccCCCCCcccccccccccccccCCCCCCcccc
Q 001782 856 LARFLPPCSPATI-----------------------------------LETPSSSTGIKGTVGYVAPEYGMGGDMSATGD 900 (1013)
Q Consensus 856 ~a~~~~~~~~~~~-----------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 900 (1013)
+|..+........ ...........||+.|+|||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 9853321000000 00001112457999999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCCCc
Q 001782 901 VYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 901 IwSlG~il~ell~G~~pf~~~ 921 (1013)
||||||++|||++|+.||...
T Consensus 227 iwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred eeeccceeeehhhCCCCCCCC
Confidence 999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.99 Aligned_cols=255 Identities=19% Similarity=0.299 Sum_probs=201.1
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
.++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++||||+++++++. .++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEE
Confidence 458999999999999999999998899999999997655445567889999999999999999999864 346789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++... ..+++.++..++.|++.|++|||+. +|+|||+||+||+++.++.+||+|||++
T Consensus 83 iv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVT------GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred EEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccc
Confidence 999999999999998754 4688999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM---GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
..+.... .......|+..|+|||.+. ...++.++||||+||++|||++|+.||.........
T Consensus 154 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~------- 218 (267)
T cd06646 154 AKITATI--------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------- 218 (267)
T ss_pred eeecccc--------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-------
Confidence 8653211 1123356889999999874 345788999999999999999999998643211000
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
..+..... .+ . ........+..+.+++.+||+.+|++||+++++++.
T Consensus 219 ------~~~~~~~~--~~----~-------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 219 ------FLMSKSNF--QP----P-------KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred ------eeeecCCC--CC----C-------CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 00000000 00 0 000001223567899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=329.74 Aligned_cols=199 Identities=26% Similarity=0.367 Sum_probs=170.3
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCC-ccceEEEEeecCCccccce
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHR-NLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 775 (1013)
+|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+..|.++++.++|+ +|+++++++ ...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 5888999999999999999999899999999997432 23445678899999999765 577787774 34578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQV------GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence 99999999999999999765 4688999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
++...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 147 ~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (324)
T cd05587 147 MCKENIFG--------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203 (324)
T ss_pred cceecCCC--------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 98642211 1112345689999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=337.78 Aligned_cols=208 Identities=22% Similarity=0.331 Sum_probs=174.4
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.++||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 47899999999999999999999999999999986432 22345688899999999999999999985 45578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.|+||||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG 146 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKY------DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG 146 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999765 4688999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCcc----cc----C-------------------------------CCCCcccccccccccccccCCCCCC
Q 001782 856 LARFLPPCSPATI----LE----T-------------------------------PSSSTGIKGTVGYVAPEYGMGGDMS 896 (1013)
Q Consensus 856 ~a~~~~~~~~~~~----~~----~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 896 (1013)
+++.+........ .. . ........||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 9974322110000 00 0 0000124699999999999999999
Q ss_pred cccchHHHHHHHHHHHhCCCCCCC
Q 001782 897 ATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 897 ~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
.++|||||||++|||++|..||..
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCC
Confidence 999999999999999999999965
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=334.19 Aligned_cols=282 Identities=22% Similarity=0.229 Sum_probs=205.8
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCC-cccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSID-FEEV 773 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 773 (1013)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999999899999999986432 233456789999999999999999999875432 2334
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++||||++ +++.+++.. .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence 56899999998 578777743 467889999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...... ..+.....
T Consensus 170 fG~a~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~ 239 (364)
T cd07875 170 FGLARTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIE 239 (364)
T ss_pred CCCccccCCC---------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 9999754321 1123456899999999999999999999999999999999999999764221 11112111
Q ss_pred hhC--ChhHHHhhhhhhccchhhhhccCCCCch----------hHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 934 MAL--PEKVMEIVDPLLLLDLEARASNCGSHRT----------EIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 934 ~~~--~~~~~~~i~~~l~~~~~~R~~~~~~~~~----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
... .+.....+.+........|+........ ...........+.+++.+|++.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 111 1111111221111111222221110000 000001123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=319.76 Aligned_cols=263 Identities=24% Similarity=0.417 Sum_probs=201.5
Q ss_pred hhccCCCCCceeeccceEEEEEEECC-----CCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGE-----NEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDF 770 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 770 (1013)
..++|++.+.||+|+||.||+|.+.+ ++..||+|++..... ....++.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~---- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 46789999999999999999998742 356799998863322 23456889999999999999999999863
Q ss_pred cccceEEEEEeeccCCCHHHHhhccccccc----cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC
Q 001782 771 EEVDFKAIVYEYMECGSLEDWLHQSNDQLE----VGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD 846 (1013)
Q Consensus 771 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 846 (1013)
.....++||||+++++|.+++...+.... ...+++.++..++.|++.|++|||+. +++||||||+||+++++
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155 (277)
T ss_pred -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence 44678999999999999999976432211 13467889999999999999999999 99999999999999999
Q ss_pred CceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCC
Q 001782 847 MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDG 925 (1013)
Q Consensus 847 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~ 925 (1013)
+.+||+|||+++......... ......++..|+|||++.++.++.++|||||||++|||++ |..||......
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~- 228 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE- 228 (277)
T ss_pred CCEEECCCCCccccCCcceee------cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 999999999987553221111 1122345788999999998899999999999999999999 78888653111
Q ss_pred ccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 926 LTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
.... ........ + . ...++..+.+++.+|++.||++|||+.|+++.|++
T Consensus 229 ----~~~~--------~~~~~~~~-~---~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 229 ----QVLR--------FVMEGGLL-D---K-------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----HHHH--------HHHcCCcC-C---C-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1100 00000000 0 0 01234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=327.30 Aligned_cols=194 Identities=24% Similarity=0.346 Sum_probs=168.1
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
++||+|+||.||+|++..+++.||+|+++... ....+.+..|..+++.+ +||||+++++++ ......++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46999999999999999999999999997432 22345578899999988 799999999985 3457899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 76 EFVSGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 999999999988765 4789999999999999999999999 9999999999999999999999999998642
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
.. .........||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 147 ~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 147 IR--------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cc--------CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 11 11123345789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=318.07 Aligned_cols=258 Identities=29% Similarity=0.470 Sum_probs=203.6
Q ss_pred hccCCCCCceeeccceEEEEEEECCC---CeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGEN---EMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
.++|++.+.||+|+||.||+|.+... ...||+|+++.... ....++.+|+.++++++||||+++++++. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cC
Confidence 45799999999999999999998543 46799999874432 23457889999999999999999999853 44
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
+..++||||+++++|.+++.... +.+++.++++++.|++.|++|||++ +|+||||||+||++++++.+||+|
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~d 149 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSD 149 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECc
Confidence 67899999999999999997642 3689999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~ 932 (1013)
||+++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 150 fg~~~~~~~~~~~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------- 215 (266)
T cd05033 150 FGLSRRLEDSEATY------TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------- 215 (266)
T ss_pred cchhhcccccccce------eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--------
Confidence 99998764211110 1112335678999999999999999999999999999998 99998653211
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
...+.+...... + ....++..+.+++.+|++.+|++||++.||++.|+++
T Consensus 216 ------~~~~~~~~~~~~-~---------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 216 ------DVIKAVEDGYRL-P---------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------HHHHHHHcCCCC-C---------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011111100000 0 0012345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.60 Aligned_cols=196 Identities=31% Similarity=0.444 Sum_probs=173.2
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.|.-.+.||.|+||.||.|++..+.+.||||.+..... +...++.+|+..+++++|||++.+-|+|. .+...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-----re~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-----REHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----ccchH
Confidence 45556789999999999999999999999999975433 33467899999999999999999999853 34668
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
|+|||||- |+-.|++.-.+ +++.+.++..|+.+.+.||+|||++ +.||||||+.|||+++.|.||++|||.
T Consensus 102 WLVMEYCl-GSAsDlleVhk-----KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 102 WLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred HHHHHHHh-ccHHHHHHHHh-----ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccc
Confidence 99999998 89999988764 5789999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM---GGDMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
|..+.+ ...++|||.|||||++. .+.|+-++||||+|++..|+..+++|+..+
T Consensus 173 Asi~~P------------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM 228 (948)
T KOG0577|consen 173 ASIMAP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 228 (948)
T ss_pred hhhcCc------------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc
Confidence 986644 45678999999999875 468999999999999999999999998764
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.75 Aligned_cols=238 Identities=26% Similarity=0.320 Sum_probs=186.2
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHH-HHhcCCCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECE-ALRNIRHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
+.||+|+||+||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999997432 122334555554 56788999999999985 3457899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++|+|.+++... ..+++.++..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 76 DYVNGGELFFHLQRE------RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred cCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999999999998765 4688999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhH
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1013)
.. .........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 147 ~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~----------- 202 (323)
T cd05575 147 IE--------HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----A----------- 202 (323)
T ss_pred cc--------CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----H-----------
Confidence 21 11123345789999999999999999999999999999999999999975311 1
Q ss_pred HHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHH
Q 001782 941 MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMT 995 (1013)
Q Consensus 941 ~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 995 (1013)
+..+.........++ ..+..+.+++.+|++.||++||++.
T Consensus 203 -~~~~~i~~~~~~~~~--------------~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 203 -EMYDNILNKPLRLKP--------------NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -HHHHHHHcCCCCCCC--------------CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111111111110000 1134567888899999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=345.37 Aligned_cols=280 Identities=21% Similarity=0.273 Sum_probs=197.8
Q ss_pred hhhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCC------CccceEEEEe
Q 001782 692 ADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRH------RNLIKIITVC 765 (1013)
Q Consensus 692 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~ 765 (1013)
.++....++|++.++||+|+||+||+|++..+++.||||+++... ...+....|+++++.++| ++++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344456789999999999999999999999899999999996432 223445667777777654 4588888886
Q ss_pred ecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCceEec
Q 001782 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH-HCHPPIVHGDLKPSNVLLD 844 (1013)
Q Consensus 766 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlkp~NIll~ 844 (1013)
. .+..+.|+|||++. ++|.+++... +.+++.++..|+.||+.||+|||+ . |||||||||+|||++
T Consensus 201 ~----~~~~~~~iv~~~~g-~~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~ 266 (467)
T PTZ00284 201 Q----NETGHMCIVMPKYG-PCLLDWIMKH------GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILME 266 (467)
T ss_pred E----cCCceEEEEEeccC-CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEe
Confidence 4 23467899999984 8899888765 468999999999999999999997 6 999999999999998
Q ss_pred CCC----------------ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHH
Q 001782 845 HDM----------------VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILL 908 (1013)
Q Consensus 845 ~~~----------------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il 908 (1013)
.++ .+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 335 (467)
T PTZ00284 267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335 (467)
T ss_pred cCCcccccccccccCCCCceEEECCCCccccCc-----------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHH
Confidence 765 49999999875321 113346789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCcCCCCccHHHHHHh--hCChhH---------HHhhhhhhccchhhhhccCC-CCc-hhHHHHHHHHHH
Q 001782 909 LEMFTRRRPTDNMFNDGLTLHEFAKM--ALPEKV---------MEIVDPLLLLDLEARASNCG-SHR-TEIAKIEECLVA 975 (1013)
Q Consensus 909 ~ell~G~~pf~~~~~~~~~~~~~~~~--~~~~~~---------~~~i~~~l~~~~~~R~~~~~-~~~-~~~~~~~~~~~~ 975 (1013)
|||++|+.||...... .....+... ..+..+ .++.+......+...+.... ... ..... .-....
T Consensus 336 ~elltG~~pf~~~~~~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 413 (467)
T PTZ00284 336 YELYTGKLLYDTHDNL-EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVRE-VIRDDL 413 (467)
T ss_pred HHHHhCCCCCCCCChH-HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhh-hhchHH
Confidence 9999999999763221 111111111 112111 11111110000000000000 000 00000 011346
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHH
Q 001782 976 IVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 976 l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+.+++.+||+.||++|||++|+++
T Consensus 414 ~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 414 LCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHHHHHhCCcChhhCCCHHHHhc
Confidence 789999999999999999999986
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.54 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=201.7
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
.++|++.++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcE
Confidence 468999999999999999999976 55679999876432 23567899999999999999999999853 456789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
++|||+++++|.+++..... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 78 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred EEEecCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccc
Confidence 99999999999999976432 4688899999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
........ .......++..|+|||++.++.++.++|||||||++|+|++ |+.||......
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~------------ 211 (261)
T cd05072 151 RVIEDNEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS------------ 211 (261)
T ss_pred eecCCCce-------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH------------
Confidence 86532111 01122345678999999998899999999999999999998 99998653111
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
.....+.... ++. .....+..+.+++.+|++.+|++||+++++.+.|++
T Consensus 212 --~~~~~~~~~~------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 212 --DVMSALQRGY------RMP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --HHHHHHHcCC------CCC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0001011000 000 001123457889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=333.10 Aligned_cols=282 Identities=21% Similarity=0.242 Sum_probs=202.8
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCC-cccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSID-FEEV 773 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 773 (1013)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.... ....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4579999999999999999999998889999999986432 223456788999999999999999999875432 2234
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++||||++ +++.+++.. .+++.++..++.|++.||+|||++ ||+||||||+||+++.++.+||+|
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEee
Confidence 56899999998 577776643 478889999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||....... .......
T Consensus 163 fg~~~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~ 232 (355)
T cd07874 163 FGLARTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIE 232 (355)
T ss_pred CcccccCCCc---------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 9999754321 11234568999999999999999999999999999999999999997532111 1111111
Q ss_pred hhC--ChhHHHhhhhhhccchhhhhccCCC----------CchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 934 MAL--PEKVMEIVDPLLLLDLEARASNCGS----------HRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 934 ~~~--~~~~~~~i~~~l~~~~~~R~~~~~~----------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
... .......+.+........++..... ..............+.+++.+|++.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 110 0000000000000000011100000 000000011123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.48 Aligned_cols=242 Identities=24% Similarity=0.321 Sum_probs=191.3
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
++||+|+||.||+|++..+++.||+|++.... ....+.+..|.++++.+ +||+|+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 46999999999999999899999999997432 23345577888888866 799999999985 3457899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 76 E~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 76 EYVNGGDLMFQIQRS------RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 999999999998765 4688999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhH
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1013)
... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~---------- 203 (321)
T cd05591 147 ILN--------GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----D---------- 203 (321)
T ss_pred ccC--------CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----H----------
Confidence 211 11133456899999999999999999999999999999999999999753211 0
Q ss_pred HHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-------CHHHHHH
Q 001782 941 MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-------QMTDVVA 999 (1013)
Q Consensus 941 ~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~evl~ 999 (1013)
.+......++. -+ ......+.+++.+|++.||++|| ++.++++
T Consensus 204 --~~~~i~~~~~~-~p-------------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 204 --LFESILHDDVL-YP-------------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred --HHHHHHcCCCC-CC-------------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 00111100000 00 01134567889999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=333.37 Aligned_cols=206 Identities=22% Similarity=0.338 Sum_probs=175.6
Q ss_pred hhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCC
Q 001782 693 DLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSID 769 (1013)
Q Consensus 693 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 769 (1013)
.+....++|++.++||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~---- 112 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF---- 112 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 34445678999999999999999999999999999999986322 22335578999999999999999999985
Q ss_pred ccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCce
Q 001782 770 FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVA 849 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 849 (1013)
..+...++||||+++|+|.+++... .+++.++..++.||+.||+|||++ +|+||||||+||++++++.+
T Consensus 113 -~~~~~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~ 181 (370)
T cd05621 113 -QDDKYLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHL 181 (370)
T ss_pred -EcCCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCE
Confidence 4557899999999999999999653 578889999999999999999999 99999999999999999999
Q ss_pred EEccccccccCCCCCCCccccCCCCCcccccccccccccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 850 HVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG----DMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 850 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
||+|||+|........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 182 kL~DFG~a~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 182 KLADFGTCMKMDETGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred EEEecccceecccCCc-------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 9999999986532111 112345799999999998754 378899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=336.70 Aligned_cols=208 Identities=23% Similarity=0.335 Sum_probs=174.2
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
+|++.++||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++. +++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence 6888999999999999999999999999999987432 223456889999999999999999999954 45789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+++|+|.+++... +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRM------GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred EEEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence 9999999999999999765 4688899999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCcc---------------------------------------ccCCCCCcccccccccccccccCCCCCCc
Q 001782 857 ARFLPPCSPATI---------------------------------------LETPSSSTGIKGTVGYVAPEYGMGGDMSA 897 (1013)
Q Consensus 857 a~~~~~~~~~~~---------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 897 (1013)
++.+........ ...........||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 864321100000 00000112357999999999999999999
Q ss_pred ccchHHHHHHHHHHHhCCCCCCCc
Q 001782 898 TGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 898 ~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
++||||+||++|||++|+.||...
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCC
Confidence 999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=325.87 Aligned_cols=241 Identities=24% Similarity=0.339 Sum_probs=188.8
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..+++.. +||||+++++++. +.+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 46999999999999999899999999997432 22345566788888764 8999999999853 457899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ey~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 76 EYLNGGDLMFHIQSC------HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999999999999764 4688999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhH
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1013)
... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~-------- 205 (316)
T cd05619 147 MLG--------DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-----ELF-------- 205 (316)
T ss_pred CCC--------CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-----HHH--------
Confidence 211 11123456899999999999999999999999999999999999999753111 000
Q ss_pred HHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHH-HHH
Q 001782 941 MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMT-DVV 998 (1013)
Q Consensus 941 ~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 998 (1013)
+.+. ...+ ... ......+.+++.+|++.||++||++. ++.
T Consensus 206 -~~i~---~~~~----~~~----------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 206 -QSIR---MDNP----CYP----------RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -HHHH---hCCC----CCC----------ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 0000 0000 000 01123467888999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=327.41 Aligned_cols=194 Identities=25% Similarity=0.355 Sum_probs=167.3
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++.++ +||||+++++++ ......++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997432 22335577888888776 799999999985 3457899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++++|..++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 76 EYVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 999999999988765 4689999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 147 LRP--------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cCC--------CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 211 1112345789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=329.81 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=193.7
Q ss_pred cCCCCCceeeccceEEEEEEEC---CCCeEEEEEEEeecc----ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCcc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLG---ENEMAVAVKVMNLKQ----RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 771 (1013)
+|++.++||+|+||.||+|+.. .+++.||+|++.... ....+.+..|+.+++.+ +||+|+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4888999999999999999874 467899999987422 22335678899999999 599999999884 4
Q ss_pred ccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEE
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV 851 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 851 (1013)
..+..++||||+++|+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl 146 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQR------DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL 146 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence 557889999999999999999765 4689999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHH
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHE 930 (1013)
Q Consensus 852 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~ 930 (1013)
+|||+++.+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...
T Consensus 147 ~DfG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~ 218 (332)
T cd05614 147 TDFGLSKEFLSEEK-------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSE 218 (332)
T ss_pred eeCcCCccccccCC-------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHH
Confidence 99999975432211 112345789999999998865 478899999999999999999999964322111 111
Q ss_pred HHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHH
Q 001782 931 FAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVA 999 (1013)
Q Consensus 931 ~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 999 (1013)
+.......++.- . ...+..+.+++.+|++.||++|| +++++++
T Consensus 219 ------------~~~~~~~~~~~~----~----------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 219 ------------VSRRILKCDPPF----P----------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ------------HHHHHhcCCCCC----C----------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111111111100 0 01234567888899999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=317.51 Aligned_cols=248 Identities=23% Similarity=0.279 Sum_probs=192.5
Q ss_pred eeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeec
Q 001782 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYM 783 (1013)
Q Consensus 707 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 783 (1013)
||+|+||.||+++...+++.||+|++.... ....+.+..|++++++++||||+++++++ ..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999999899999999986322 12234456799999999999999999985 4457899999999
Q ss_pred cCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCC
Q 001782 784 ECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863 (1013)
Q Consensus 784 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 863 (1013)
++++|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 76 ~g~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 76 NGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCCHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 99999988865432 3588999999999999999999999 9999999999999999999999999998755321
Q ss_pred CCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHh
Q 001782 864 SPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEI 943 (1013)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1013)
. ......|+..|+|||++.+..++.++||||+||++|||++|+.||........ .. ++
T Consensus 149 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~------------~~ 206 (277)
T cd05607 149 K---------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KE------------EL 206 (277)
T ss_pred c---------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HH------------HH
Confidence 1 12234688999999999998999999999999999999999999975321110 00 11
Q ss_pred hhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 944 VDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 944 i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
........... .......++.+++.+||+.||++||+++|+++..
T Consensus 207 ~~~~~~~~~~~-------------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 207 KRRTLEDEVKF-------------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHhhcccccc-------------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 11111000000 0011234578999999999999999998776433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=325.55 Aligned_cols=241 Identities=23% Similarity=0.312 Sum_probs=189.2
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
++||+|+||.||+|++..+++.||+|+++... ....+....|..++... +||+|+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997432 22345567788888754 899999999985 4557899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 76 EFLNGGDLMFHIQDK------GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999999999998764 4688999999999999999999999 9999999999999999999999999998642
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhH
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1013)
... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... . .
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-----~---------~ 204 (316)
T cd05620 147 VFG--------DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-----E---------L 204 (316)
T ss_pred ccC--------CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----H---------H
Confidence 211 11233467899999999999999999999999999999999999999653110 0 0
Q ss_pred HHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHH-HHH
Q 001782 941 MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMT-DVV 998 (1013)
Q Consensus 941 ~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 998 (1013)
.+.+. ...+ ... ......+.+++.+|++.||++||++. ++.
T Consensus 205 ~~~~~---~~~~----~~~----------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 205 FESIR---VDTP----HYP----------RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHH---hCCC----CCC----------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 01000 0000 000 01124567889999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=327.33 Aligned_cols=200 Identities=25% Similarity=0.355 Sum_probs=170.8
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccce
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
+|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+..|..++..+ +|++|+++++++ ...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 5788999999999999999999899999999997432 22234567788888777 588999998885 34578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++|+|.+++... +.+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQV------GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence 99999999999999998765 4688999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 147 ~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 147 MCKENMWD--------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred CceecCCC--------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 98743211 11123456899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.40 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=207.1
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++|++++++++++. ..+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 57999999999999999999999899999999886322 223567899999999999999999999864 3477
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++++|.+++..... ....+++.+++.++.|++.|++|||+. |++||||+|+||+++.++.++|+|||
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence 8999999999999999875322 124588999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
++....... .......++..|+|||++.+..++.++|||||||++|+|++|+.||..... ....
T Consensus 152 ~~~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~----- 215 (267)
T cd08224 152 LGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYS----- 215 (267)
T ss_pred eeeeccCCC--------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHH-----
Confidence 987543211 112234578899999999988899999999999999999999999864321 1111
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhh
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1005 (1013)
+.+....... + ..+ ....+..+.+++.+||+.+|++|||+.+|+++++++.
T Consensus 216 -------~~~~~~~~~~---~--------~~~-~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 216 -------LCKKIEKCDY---P--------PLP-ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -------HHhhhhcCCC---C--------CCC-hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1110000000 0 000 0123456789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=326.04 Aligned_cols=242 Identities=24% Similarity=0.310 Sum_probs=192.3
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
+.||+|+||+||+|++..+++.||+|+++... ......+..|.++++.+ +||||+++++++. ..+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 46999999999999999899999999997432 23345677898998887 6999999999853 457899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++++|.+++... +.+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 76 EYVNGGDLMFHIQRS------GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred cCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 999999999998765 4689999999999999999999999 9999999999999999999999999998642
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhH
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1013)
... ........|++.|+|||++.+..++.++||||+||++|||++|+.||..... ....
T Consensus 147 ~~~--------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~-------- 205 (318)
T cd05570 147 ILG--------GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELF-------- 205 (318)
T ss_pred CcC--------CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHH--------
Confidence 111 1112345689999999999999999999999999999999999999975321 0100
Q ss_pred HHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCH-----HHHHH
Q 001782 941 MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQM-----TDVVA 999 (1013)
Q Consensus 941 ~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~ 999 (1013)
..+. ...+ .. ....+..+.+++.+||+.||++||++ .++++
T Consensus 206 ~~i~----~~~~----~~----------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 206 QSIL----EDEV----RY----------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHH----cCCC----CC----------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0000 0000 00 01123457889999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=328.05 Aligned_cols=267 Identities=21% Similarity=0.341 Sum_probs=203.2
Q ss_pred hccCCCCCceeeccceEEEEEEEC-----CCCeEEEEEEEeeccc-cchhHHHHHHHHHhcC-CCCccceEEEEeecCCc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLG-----ENEMAVAVKVMNLKQR-GATKSFVAECEALRNI-RHRNLIKIITVCSSIDF 770 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 770 (1013)
.++|++.+.||+|+||.||+|.+. .+++.||||+++.... .....+.+|+.++.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---- 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT---- 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee----
Confidence 468999999999999999999853 4568899999974432 2345688999999999 6899999999874
Q ss_pred cccceEEEEEeeccCCCHHHHhhcccccc---------------------------------------------------
Q 001782 771 EEVDFKAIVYEYMECGSLEDWLHQSNDQL--------------------------------------------------- 799 (1013)
Q Consensus 771 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 799 (1013)
..+...++||||+++|+|.+++.......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 23456789999999999999987532100
Q ss_pred ----------ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCCCCCccc
Q 001782 800 ----------EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATIL 869 (1013)
Q Consensus 800 ----------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 869 (1013)
....+++.++..++.|++.|++|||++ +|+||||||+||++++++.+||+|||++.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 235 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--- 235 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcch---
Confidence 012478889999999999999999999 9999999999999999999999999999765322111
Q ss_pred cCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhh
Q 001782 870 ETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLL 948 (1013)
Q Consensus 870 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 948 (1013)
.......++..|+|||++.+..++.++||||||+++|||++ |..||....... .....+...
T Consensus 236 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------------~~~~~~~~~- 298 (343)
T cd05103 236 ---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------------EFCRRLKEG- 298 (343)
T ss_pred ---hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-------------HHHHHHhcc-
Confidence 11222345678999999988899999999999999999997 999986532111 000100000
Q ss_pred ccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhh
Q 001782 949 LLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 949 ~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1006 (1013)
.++... ......+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 299 -----~~~~~~----------~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 299 -----TRMRAP----------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -----CCCCCC----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 000000 0112357889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=337.45 Aligned_cols=368 Identities=26% Similarity=0.386 Sum_probs=278.5
Q ss_pred CeeEEEeeccccccc-cCccccCCCCCCCeeeeccCCccccCCcccCCcccceEEeccCCccccCCCCccccCCCCceec
Q 001782 76 QRVTVLDLSNRSIEG-ILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFH 154 (1013)
Q Consensus 76 ~~v~~l~l~~~~l~~-~~~~~l~~l~~L~~L~l~~n~l~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 154 (1013)
.-|..+|+++|.++| ..|..+..+++++.|-|...++. .+|.+++.|.+|++|.+++|++. .+-.+++.|+.|+.++
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 468999999999994 78999999999999999999999 99999999999999999999999 7888999999999999
Q ss_pred cccccccC-CCCCccccccccccceecccccccccCCCCccCCCCcceeeecccccCCCCCC-ccccccccceeeccccc
Q 001782 155 ARGNNLVG-QIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPD-SLGQLRSLYYLSISENA 232 (1013)
Q Consensus 155 l~~n~l~~-~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~Ls~n~ 232 (1013)
+++|++.. .||+++| .+..|+.|+|+.|+++ ..|..+.+-+++-+|+||+|+|. .||. -|-+|+.|-+||||+|+
T Consensus 85 ~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~Nr 161 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNR 161 (1255)
T ss_pred hhccccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccch
Confidence 99999874 5777776 5666666666666666 45666666666666666666666 3443 34456666666666666
Q ss_pred ccCCCcchhccCCccceeeccCCccCCCCCCCcCCCCCCCcEEEeeeccccccCCCCCCCCCCCceEEcccCccc-cccc
Q 001782 233 FSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFS-GQVK 311 (1013)
Q Consensus 233 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~ 311 (1013)
+. .+|+.+..+..|++|+|++|.+. ..--..+-.|++|++|.+++.+=+ ..+|
T Consensus 162 Le-~LPPQ~RRL~~LqtL~Ls~NPL~-------------------------hfQLrQLPsmtsL~vLhms~TqRTl~N~P 215 (1255)
T KOG0444|consen 162 LE-MLPPQIRRLSMLQTLKLSNNPLN-------------------------HFQLRQLPSMTSLSVLHMSNTQRTLDNIP 215 (1255)
T ss_pred hh-hcCHHHHHHhhhhhhhcCCChhh-------------------------HHHHhcCccchhhhhhhcccccchhhcCC
Confidence 66 55666666666666666666553 111112223555666666554322 1123
Q ss_pred ccccCCCCccccccccCcCCCCCCCChhhhhhcccccccccccccccccCCccchhhhcchhhHHHHhccchhHHhhccc
Q 001782 312 IDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLV 391 (1013)
Q Consensus 312 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~l~ 391 (1013)
..+..+ .
T Consensus 216 tsld~l-------------------------------------------------------------------------~ 222 (1255)
T KOG0444|consen 216 TSLDDL-------------------------------------------------------------------------H 222 (1255)
T ss_pred Cchhhh-------------------------------------------------------------------------h
Confidence 222222 2
Q ss_pred ccceeecccccccCCcccccCCCCCCCEEEccCCccCccCCccccccCccCEEEcCCCcccCCCCcccccCcccceeecc
Q 001782 392 NLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVS 471 (1013)
Q Consensus 392 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 471 (1013)
||..++|+.|.+. ..|+.+.++.+|+.|+||+|+|+ .+.-..+...+|++|+||+|+++ .+|.+++.+++|+.|++.
T Consensus 223 NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n 299 (1255)
T KOG0444|consen 223 NLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYAN 299 (1255)
T ss_pred hhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhc
Confidence 3444444445554 67778888888888999999888 45556667788999999999998 789999999999999999
Q ss_pred cccccc-cCCchhhcccchhhhhccCCCeecccCCccccCcCCCcEEEccCCCCCCCCcccccccccccccccccccccc
Q 001782 472 NNKLTG-ALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTG 550 (1013)
Q Consensus 472 ~N~l~~-~~p~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 550 (1013)
+|+++- -+|.++.. +..|+.+..++|++. .+|+.++.+.+|+.|.|+.|++. ..|+.+.-++.|+.|+|..|.--
T Consensus 300 ~NkL~FeGiPSGIGK-L~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL- 375 (1255)
T KOG0444|consen 300 NNKLTFEGIPSGIGK-LIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL- 375 (1255)
T ss_pred cCcccccCCccchhh-hhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc-
Confidence 998873 46777766 888999999999998 78999999999999999999998 78999999999999999999655
Q ss_pred ccCc
Q 001782 551 SIPL 554 (1013)
Q Consensus 551 ~~p~ 554 (1013)
+.|.
T Consensus 376 VMPP 379 (1255)
T KOG0444|consen 376 VMPP 379 (1255)
T ss_pred cCCC
Confidence 3443
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=318.86 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=192.6
Q ss_pred eeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeec
Q 001782 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYM 783 (1013)
Q Consensus 707 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 783 (1013)
||+|+||+||++.+..+++.||+|++..... ...+.+..|++++++++||+|+++.+++ ......++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 6999999999999998999999999864322 2234577899999999999999999885 3457799999999
Q ss_pred cCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCC
Q 001782 784 ECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863 (1013)
Q Consensus 784 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 863 (1013)
++|+|.+++..... ....+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.+..+...
T Consensus 76 ~~g~L~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 76 NGGDLRYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 99999988754321 124689999999999999999999999 9999999999999999999999999999755322
Q ss_pred CCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHh
Q 001782 864 SPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEI 943 (1013)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1013)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. +.
T Consensus 151 ~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~------------~~ 209 (280)
T cd05608 151 Q--------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NK------------EL 209 (280)
T ss_pred C--------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HH------------HH
Confidence 1 112345689999999999999999999999999999999999999975321110 00 00
Q ss_pred hhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHH
Q 001782 944 VDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVA 999 (1013)
Q Consensus 944 i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 999 (1013)
......... ......+..+.+++.+|++.||++|| +++|+++
T Consensus 210 ~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 210 KQRILNDSV--------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHhhcccCC--------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 000000000 00012345678899999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=328.99 Aligned_cols=242 Identities=27% Similarity=0.299 Sum_probs=188.0
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHH-HHhcCCCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECE-ALRNIRHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
+.||+|+||+||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 46999999999999999999999999997432 222344555655 46778999999999985 4457899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++|+|..++... ..+++.++..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 76 DFVNGGELFFHLQRE------RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred cCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 999999999988765 4689999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhH
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1013)
.. .........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 147 ~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---------------- 202 (325)
T cd05604 147 IA--------QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---------------- 202 (325)
T ss_pred CC--------CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH----------------
Confidence 21 111233457899999999999999999999999999999999999999753111
Q ss_pred HHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 941 MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 941 ~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+..+..+......++ .....+.+++.+|++.+|.+||++.+.++
T Consensus 203 -~~~~~~~~~~~~~~~--------------~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 203 -EMYDNILHKPLVLRP--------------GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred -HHHHHHHcCCccCCC--------------CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 111111111110010 11234678889999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=317.58 Aligned_cols=261 Identities=23% Similarity=0.381 Sum_probs=203.6
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCe----EEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEM----AVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 772 (1013)
..+|++.++||+|+||+||+|++..++. .||+|++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 4578899999999999999999865654 489999864332 234568899999999999999999998742
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
...++++||+++|+|.+++.... ..+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+||+
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~ 151 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKIT 151 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEEC
Confidence 34679999999999999997642 3689999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHH
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~ 931 (1013)
|||+++.+....... ......++..|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 152 dfG~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------- 218 (279)
T cd05109 152 DFGLARLLDIDETEY------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR------- 218 (279)
T ss_pred CCCceeeccccccee------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence 999998664321110 1112234678999999998999999999999999999998 89998653211
Q ss_pred HHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhhhh
Q 001782 932 AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIF 1008 (1013)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1008 (1013)
.....+........ ...++..+.+++.+||+.||++||++.|+++.|..+.+..
T Consensus 219 -------~~~~~~~~~~~~~~----------------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 219 -------EIPDLLEKGERLPQ----------------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -------HHHHHHHCCCcCCC----------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 11111111100000 0122456788999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=319.80 Aligned_cols=263 Identities=22% Similarity=0.383 Sum_probs=202.9
Q ss_pred cCCCCCceeeccceEEEEEEECC-----CCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGE-----NEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
+|++.+.||+|+||.||+|.+.. ....|++|.+..... ...+++.+|+.+++.++||||+++++.+. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 47889999999999999998743 235688888864332 23457889999999999999999999864 34
Q ss_pred ceEEEEEeeccCCCHHHHhhccccc------------------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQ------------------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGD 835 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~D 835 (1013)
+..+++|||+.+++|.+++...... .....+++.+++.++.|++.|++|||++ +++|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 6689999999999999998754211 1123588999999999999999999999 999999
Q ss_pred CCCCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-C
Q 001782 836 LKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-R 914 (1013)
Q Consensus 836 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G 914 (1013)
|||+||++++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g 226 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSY------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 226 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccch------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence 9999999999999999999999755322211 01222345678999999988899999999999999999998 9
Q ss_pred CCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCH
Q 001782 915 RRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQM 994 (1013)
Q Consensus 915 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 994 (1013)
..||.... ++...+.+......+. + ..++..+.+++.+|++.+|++||++
T Consensus 227 ~~p~~~~~--------------~~~~~~~~~~~~~~~~---~-------------~~~~~~~~~~i~~cl~~~P~~Rp~~ 276 (290)
T cd05045 227 GNPYPGIA--------------PERLFNLLKTGYRMER---P-------------ENCSEEMYNLMLTCWKQEPDKRPTF 276 (290)
T ss_pred CCCCCCCC--------------HHHHHHHHhCCCCCCC---C-------------CCCCHHHHHHHHHHccCCcccCCCH
Confidence 99986531 1111122211111100 0 1223467889999999999999999
Q ss_pred HHHHHHHHHhhh
Q 001782 995 TDVVAKLCSARK 1006 (1013)
Q Consensus 995 ~evl~~L~~~~~ 1006 (1013)
+|+++.|+++..
T Consensus 277 ~~i~~~l~~~~~ 288 (290)
T cd05045 277 ADISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHHHh
Confidence 999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=320.54 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=203.4
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
...+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++.+. .+...
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~ 92 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDEL 92 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEE
Confidence 3468999999999999999999998899999999998665555677899999999999999999999864 34689
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+++++|.+++... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~ 162 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162 (296)
T ss_pred EEeecccCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECcccc
Confidence 9999999999999998643 578889999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+....... .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ...
T Consensus 163 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~---- 226 (296)
T cd06654 163 CAQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALY---- 226 (296)
T ss_pred chhccccc--------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHH----
Confidence 87543221 11223468899999999998889999999999999999999999996532110 000
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
... ....+ . ..........+.+++.+||..||++||++.|+++.
T Consensus 227 -----~~~---~~~~~----~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 227 -----LIA---TNGTP----E--------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -----HHh---cCCCC----C--------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 000 00000 0 00001223457889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=320.34 Aligned_cols=267 Identities=26% Similarity=0.405 Sum_probs=205.9
Q ss_pred hhhhccCCCCCceeeccceEEEEEEECCC-----CeEEEEEEEeeccc-cchhHHHHHHHHHhcC-CCCccceEEEEeec
Q 001782 695 SKATNDFSSSNMIGQGSFGFVYRGNLGEN-----EMAVAVKVMNLKQR-GATKSFVAECEALRNI-RHRNLIKIITVCSS 767 (1013)
Q Consensus 695 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 767 (1013)
....++|++.+.||+|+||.||+|..... ...||+|++..... ....++.+|+++++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~- 86 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT- 86 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc-
Confidence 34567899999999999999999988543 37899999874322 2345688999999999 7999999999864
Q ss_pred CCccccceEEEEEeeccCCCHHHHhhccccc----------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 001782 768 IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQ----------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLK 837 (1013)
Q Consensus 768 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk 837 (1013)
.....+++|||+++++|.++++..... .....+++.+++.++.|++.|++|||+. +|+|||||
T Consensus 87 ----~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlk 159 (293)
T cd05053 87 ----QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLA 159 (293)
T ss_pred ----CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccc
Confidence 346789999999999999999754210 1234689999999999999999999999 99999999
Q ss_pred CCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCC
Q 001782 838 PSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRR 916 (1013)
Q Consensus 838 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~ 916 (1013)
|+||+++.++.+||+|||.++.+....... ......++..|+|||++.+..++.++|||||||++||+++ |..
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 233 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYR------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233 (293)
T ss_pred eeeEEEcCCCeEEeCcccccccccccccee------ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCC
Confidence 999999999999999999998654322111 1122335678999999988899999999999999999997 999
Q ss_pred CCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 001782 917 PTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTD 996 (1013)
Q Consensus 917 pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 996 (1013)
||...... . ..+.+.... ++. ....++..+.+++.+|++.||++|||+.|
T Consensus 234 p~~~~~~~-----~---------~~~~~~~~~------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e 283 (293)
T cd05053 234 PYPGIPVE-----E---------LFKLLKEGY------RME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQ 283 (293)
T ss_pred CCCCCCHH-----H---------HHHHHHcCC------cCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence 98653111 0 111111000 000 00122456789999999999999999999
Q ss_pred HHHHHHHhh
Q 001782 997 VVAKLCSAR 1005 (1013)
Q Consensus 997 vl~~L~~~~ 1005 (1013)
+++.|+++.
T Consensus 284 il~~l~~~~ 292 (293)
T cd05053 284 LVEDLDRML 292 (293)
T ss_pred HHHHHHHhh
Confidence 999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=313.42 Aligned_cols=249 Identities=29% Similarity=0.427 Sum_probs=195.1
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeec
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYM 783 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 783 (1013)
+.||+|+||.||+|++..+++.||+|.+..... .....+.+|++++++++||||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence 469999999999999988899999998763322 23456899999999999999999999964 346789999999
Q ss_pred cCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCC
Q 001782 784 ECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863 (1013)
Q Consensus 784 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 863 (1013)
++++|.+++.... ..+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+......
T Consensus 76 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 76 QGGDFLTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred cCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccc
Confidence 9999999997542 3578999999999999999999999 9999999999999999999999999998754321
Q ss_pred CCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCChhHHH
Q 001782 864 SPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALPEKVME 942 (1013)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1013)
... ........+..|+|||.+.++.++.++|||||||++|||++ |..||...... ....
T Consensus 148 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------------~~~~ 207 (252)
T cd05084 148 VYA------STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------------QTRE 207 (252)
T ss_pred ccc------ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------------HHHH
Confidence 110 00111223567999999999999999999999999999998 88888643111 1111
Q ss_pred hhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 943 IVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 943 ~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
.+.... ++. ....++..+.+++.+|++.+|++|||+.||+++|+
T Consensus 208 ~~~~~~------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 208 AIEQGV------RLP----------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHcCC------CCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111100 000 00122456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=328.08 Aligned_cols=242 Identities=26% Similarity=0.308 Sum_probs=186.6
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHH-HHhcCCCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECE-ALRNIRHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
+.||+|+||+||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 46999999999999999899999999997432 122233444444 56788999999999985 4457899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++++|.+++... ..+++.++..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 76 DYINGGELFYHLQRE------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred eCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 999999999999765 4678889999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhH
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1013)
.. .........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .. .
T Consensus 147 ~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~--------~ 205 (325)
T cd05602 147 IE--------HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EM--------Y 205 (325)
T ss_pred cc--------CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----HH--------H
Confidence 21 111233457999999999999999999999999999999999999999753211 00 0
Q ss_pred HHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 941 MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 941 ~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..+........ ...+..+.+++.+|++.||.+||++.+.+.
T Consensus 206 ~~i~~~~~~~~------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 206 DNILNKPLQLK------------------PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred HHHHhCCcCCC------------------CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 01111000000 012345677888899999999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=314.91 Aligned_cols=257 Identities=30% Similarity=0.448 Sum_probs=202.8
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
..++|++.+.||+|++|.||+|.+. +++.||+|.++... ...+.+.+|++++++++||||+++++++. ..+..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPI 76 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCe
Confidence 3567999999999999999999976 45679999986433 23567899999999999999999999854 44678
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+++++|.+++..... ..+++.++..++.|++.|+.|||+. +++||||||+||++++++.+||+|||+
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~ 149 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAG----RALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGL 149 (261)
T ss_pred eeeeecccCCcHHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcce
Confidence 999999999999999976531 4689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhh
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
++........ .......+..|+|||+..+..++.++||||||+++|||++ |+.||......
T Consensus 150 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----------- 211 (261)
T cd05068 150 ARVIKEDIYE-------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----------- 211 (261)
T ss_pred EEEccCCccc-------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----------
Confidence 9866421110 1112233568999999998899999999999999999999 99998653111
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
.....+..... +. .....+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 212 ---~~~~~~~~~~~------~~----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 212 ---EVLQQVDQGYR------MP----------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---HHHHHHHcCCC------CC----------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 00011110000 00 0012245688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=313.79 Aligned_cols=255 Identities=29% Similarity=0.468 Sum_probs=201.3
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
.++|++.++||+|+||.||+|++..+ ..||+|+++... ...+.+.+|++++++++||||+++++++. ....+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcE
Confidence 46799999999999999999998755 459999987432 23467899999999999999999998742 24578
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++..... ..+++..+..++.|++.||+|+|+. +++||||||+||++++++.+||+|||.+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred EEEEcCCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCce
Confidence 99999999999999976422 3578999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+.+...... ......++..|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 150 ~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------------ 210 (262)
T cd05071 150 RLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------------ 210 (262)
T ss_pred eeccccccc-------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------------
Confidence 765432211 1123346778999999988899999999999999999999 88888653211
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
...+.+.... +.. ...+++..+.+++.+|++.||++||+++++++.|++.
T Consensus 211 --~~~~~~~~~~------~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 211 --EVLDQVERGY------RMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --HHHHHHhcCC------CCC----------CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0000000000 000 0113355688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=316.97 Aligned_cols=260 Identities=21% Similarity=0.309 Sum_probs=202.9
Q ss_pred hhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcC-CCCccceEEEEeecCCcc-c
Q 001782 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFE-E 772 (1013)
Q Consensus 695 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~-~ 772 (1013)
+.+.+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +||||+++++++...... .
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 346778999999999999999999999899999999987543 3346788999999998 699999999998643222 1
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
....++||||+++++|.+++..... ..+++..+..++.|++.|++|||++ +|+|+||||+||++++++.+||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence 3568999999999999999986432 4688999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCcc
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM-----GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLT 927 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~ 927 (1013)
|||++....... .......|+..|+|||++. +..++.++||||+||++|||++|+.||......
T Consensus 154 Dfg~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~--- 222 (272)
T cd06637 154 DFGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--- 222 (272)
T ss_pred cCCCceeccccc--------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---
Confidence 999987543211 1233456889999999986 345788999999999999999999998643111
Q ss_pred HHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 928 LHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 928 ~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..... ... .+..+. ....++..+.+++.+||..||.+|||+.|+++
T Consensus 223 -~~~~~---------~~~-----~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 223 -RALFL---------IPR-----NPAPRL-----------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -HHHHH---------Hhc-----CCCCCC-----------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000 000 000000 00112345789999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=316.57 Aligned_cols=262 Identities=26% Similarity=0.396 Sum_probs=202.0
Q ss_pred hhccCCCCCceeeccceEEEEEEECC-----CCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGE-----NEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDF 770 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 770 (1013)
..++|++.+.||+|+||.||+|.+.. .+..||+|.+..... .....+.+|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 79 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF---- 79 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc----
Confidence 35679999999999999999999976 678899998864432 23456889999999999999999999864
Q ss_pred cccceEEEEEeeccCCCHHHHhhcccccc-ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC--
Q 001782 771 EEVDFKAIVYEYMECGSLEDWLHQSNDQL-EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM-- 847 (1013)
Q Consensus 771 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 847 (1013)
+....++||||+++++|.+++...+... ....+++.++++++.||+.|++|||++ +++||||||+||+++.++
T Consensus 80 -~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~ 155 (277)
T cd05036 80 -ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPG 155 (277)
T ss_pred -cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCC
Confidence 3356789999999999999998764211 113589999999999999999999999 999999999999998754
Q ss_pred -ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCC
Q 001782 848 -VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDG 925 (1013)
Q Consensus 848 -~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~ 925 (1013)
.+||+|||+++........ ........+..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~- 228 (277)
T cd05036 156 RVAKIADFGMARDIYRASYY------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ- 228 (277)
T ss_pred cceEeccCccccccCCccce------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 6999999999865321110 01112234578999999999999999999999999999997 99998753211
Q ss_pred ccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 926 LTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
...+.+.... ++.. ...++..+.+++.+|++.+|++||++.||++.|+
T Consensus 229 -------------~~~~~~~~~~------~~~~----------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 -------------EVMEFVTGGG------RLDP----------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -------------HHHHHHHcCC------cCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111111000 0000 0122456789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=330.82 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=198.0
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.+.||+|+||+||+|++..+++.||+|+++.... ...+.+.+|+.+++.++||+|+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 478899999999999999999999999999999974322 2345688999999999999999999985 34578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence 999999999999999998652 3689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccC------CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHH
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM------GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 929 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~ 929 (1013)
++..+...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .
T Consensus 148 ~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~ 216 (330)
T cd05601 148 SAARLTANKMV-------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----K 216 (330)
T ss_pred CCeECCCCCce-------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH----H
Confidence 99865432111 122346899999999986 456788999999999999999999999653111 0
Q ss_pred HHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 930 EFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 930 ~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
. ...+......... +.....+..+.+++..|++ +|++||+++++++
T Consensus 217 ~---------~~~i~~~~~~~~~--------------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 217 T---------YNNIMNFQRFLKF--------------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred H---------HHHHHcCCCccCC--------------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 1111100000000 0000123456788889997 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=317.95 Aligned_cols=254 Identities=20% Similarity=0.300 Sum_probs=200.4
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
.++|++.++||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++. ..+..+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEE
Confidence 457888999999999999999999899999999997655444566889999999999999999999853 457889
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++... +.+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.+
T Consensus 83 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVT------GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVS 153 (267)
T ss_pred EEEeccCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceee
Confidence 999999999999998765 4689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM---GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
...... ........|+..|+|||++. ...++.++||||+||++|+|++|..||.......... .....
T Consensus 154 ~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~-~~~~~ 224 (267)
T cd06645 154 AQITAT--------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMTKS 224 (267)
T ss_pred eEccCc--------ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH-hhhcc
Confidence 754321 11123456899999999874 4568889999999999999999999986532111000 00000
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.. .+ . ........+..+.+++.+|++.+|++||+++++++
T Consensus 225 ~~--------------~~----~-------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 225 NF--------------QP----P-------KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CC--------------CC----C-------cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 00 0 00000012345778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=316.17 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=206.2
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.+.||+|+||.||+|++..++..||||.+.... ....+++.+|+.+++.++||||+++++++. .++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 47889999999999999999998899999999886432 223357889999999999999999999864 4478
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.+++|||+++++|.+++..... ....+++.+++.++.|++.|++|||++ +++|+||||+||+++.++.++|+|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg 151 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence 8999999999999999875321 124689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
++........ ......++..|+|||++.+..++.++||||||+++|+|++|..||...... ...
T Consensus 152 ~~~~~~~~~~--------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----- 215 (267)
T cd08229 152 LGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYS----- 215 (267)
T ss_pred hhhccccCCc--------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHH-----
Confidence 9876532211 122346889999999998888999999999999999999999998643111 001
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhh
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1005 (1013)
..+......+... .....+..+.+++.+||+.||.+|||+.+|++.++++.
T Consensus 216 -------~~~~~~~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 216 -------LCKKIEQCDYPPL------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -------HhhhhhcCCCCCC------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0000000000000 00123456889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=330.71 Aligned_cols=208 Identities=22% Similarity=0.322 Sum_probs=177.5
Q ss_pred hhhhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeec
Q 001782 691 YADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSS 767 (1013)
Q Consensus 691 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 767 (1013)
..++....++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-- 112 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-- 112 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence 4555666789999999999999999999999999999999986322 22334578899999999999999999985
Q ss_pred CCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC
Q 001782 768 IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM 847 (1013)
Q Consensus 768 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 847 (1013)
..+...++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 113 ---~~~~~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 113 ---QDDRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG 179 (371)
T ss_pred ---EcCCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCC
Confidence 4557899999999999999998653 578889999999999999999999 999999999999999999
Q ss_pred ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG----DMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 848 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
.+||+|||+++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 180 ~ikL~DfG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 180 HLKLADFGTCMKMNKEGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CEEEEeCCceeEcCcCCc-------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 999999999986532111 112345799999999998754 378899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.10 Aligned_cols=263 Identities=26% Similarity=0.394 Sum_probs=202.0
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCe--EEEEEEEeec-cccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEM--AVAVKVMNLK-QRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 774 (1013)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. .....+.+.+|+++++++ +||||+++++++. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence 578999999999999999999876654 4688887632 223345788999999999 7999999999863 446
Q ss_pred eEEEEEeeccCCCHHHHhhccccc----------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEec
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQ----------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD 844 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 844 (1013)
..++||||+++++|.+++...... .....+++.+++.++.|++.|++|||++ +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 789999999999999999764311 0113588999999999999999999999 999999999999999
Q ss_pred CCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCC
Q 001782 845 HDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFN 923 (1013)
Q Consensus 845 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~ 923 (1013)
+++.+||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||.....
T Consensus 154 ~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 154 ENLASKIADFGLSRGEEVY---------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred CCCeEEECCcCCCccccce---------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999998632110 00111223567999999998899999999999999999997 9999965321
Q ss_pred CCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 924 DGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
. .. .+.+.... ++. ....++..+.+++.+||+.+|.+||+++++++.|..
T Consensus 225 ~-----~~---------~~~~~~~~------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 274 (297)
T cd05089 225 A-----EL---------YEKLPQGY------RME----------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274 (297)
T ss_pred H-----HH---------HHHHhcCC------CCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 00 00000000 000 001234567899999999999999999999999998
Q ss_pred hhhhh
Q 001782 1004 ARKIF 1008 (1013)
Q Consensus 1004 ~~~~~ 1008 (1013)
+.+..
T Consensus 275 ~~~~~ 279 (297)
T cd05089 275 MLEAR 279 (297)
T ss_pred HHHhh
Confidence 87654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.07 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=197.9
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
++|++.+.||+|+||.||.|++.+ +..||+|.+.... ...+.+.+|+.++++++||||+++++++. .....++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEE
Confidence 578889999999999999998864 4569999886432 23467899999999999999999999964 3356899
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
||||+.+++|.+++.... ..+++.+++.++.||+.|++|||+. +++|+||||+||+++.++.+||+|||.++
T Consensus 77 v~e~~~~~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~ 148 (256)
T cd05113 77 VTEYMSNGCLLNYLREHG-----KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence 999999999999997642 3689999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCC
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
....... .......++..|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------------- 208 (256)
T cd05113 149 YVLDDEY-------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------------- 208 (256)
T ss_pred ecCCCce-------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------------
Confidence 5532111 01122345678999999988889999999999999999998 99998653211
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
...+.+ .... |+... ...+..+.+++.+||+.+|.+||++.++++.++
T Consensus 209 -~~~~~~---~~~~---~~~~~----------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 209 -ETVEKV---SQGL---RLYRP----------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -HHHHHH---hcCC---CCCCC----------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000100 0000 00000 012356789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.66 Aligned_cols=251 Identities=30% Similarity=0.417 Sum_probs=199.1
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
..+|++.+.||+|+||.||+|... +..||+|..... ...+.+.+|+.++++++|++++++++++. ..+...+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY 76 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceE
Confidence 357899999999999999999875 667999988533 23467899999999999999999999753 3446789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++..... ..+++..++.++.|++.|++|||++ +++||||||+||++++++.+||+|||++
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred EEEECCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccc
Confidence 99999999999999976532 3578999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+..... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ....
T Consensus 150 ~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~----- 208 (256)
T cd05082 150 KEASST-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDV----- 208 (256)
T ss_pred eecccc-----------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHH-----
Confidence 743221 112234578999999998899999999999999999997 999986421 1111
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
...+.... +.. ....++..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 209 ----~~~~~~~~---~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 209 ----VPRVEKGY---KMD-------------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----HHHHhcCC---CCC-------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 01011000 000 0012345678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.69 Aligned_cols=262 Identities=25% Similarity=0.430 Sum_probs=202.8
Q ss_pred hccCCCCCceeeccceEEEEEEEC-----CCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLG-----ENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 772 (1013)
..+|+..++||+|+||.||+|... .++..+|+|.+........+.+.+|++++++++||||+++++++. .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 78 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----E 78 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----c
Confidence 357888999999999999999752 346789999887555555677999999999999999999999864 3
Q ss_pred cceEEEEEeeccCCCHHHHhhccccc---------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEe
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQ---------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL 843 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll 843 (1013)
....+++|||+++++|.+++...... .....+++.+++.++.|++.|++|||+. +++||||||+||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~ 155 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLV 155 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEE
Confidence 46789999999999999999765321 1113578999999999999999999999 99999999999999
Q ss_pred cCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcC
Q 001782 844 DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMF 922 (1013)
Q Consensus 844 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~ 922 (1013)
++++.+||+|||+++.+...... .......+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDYY------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred cCCCCEEECCCCceeEcCCCcee------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence 99999999999998755322110 11223345688999999999999999999999999999998 899986532
Q ss_pred CCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 923 NDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
... . ..... ...+...+ ..++..+.+++.+||+.||.+||+++||.+.|+
T Consensus 230 ~~~----~---------~~~~~----~~~~~~~~-------------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 230 NTE----A---------IECIT----QGRELERP-------------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHH----H---------HHHHH----cCccCCCC-------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 110 0 00000 00000000 123456789999999999999999999999886
Q ss_pred H
Q 001782 1003 S 1003 (1013)
Q Consensus 1003 ~ 1003 (1013)
.
T Consensus 280 ~ 280 (280)
T cd05092 280 A 280 (280)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.77 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=197.1
Q ss_pred CceeeccceEEEEEEECCCC---eEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENE---MAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
++||+|+||.||+|++...+ ..||+|.+..... ...+++.+|++++++++||||+++++++. ....++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 47999999999999875544 7899999874433 24467899999999999999999999853 24579999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++++|.+++... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++..
T Consensus 75 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 75 ELAPLGPLLKYLKKR------REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred EeCCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence 999999999999865 3688999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCChh
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALPEK 939 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~~~ 939 (1013)
....... .......++..|+|||...+..++.++|||||||++|||++ |..||..... .....
T Consensus 146 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~--------- 209 (257)
T cd05060 146 GAGSDYY-----RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIA--------- 209 (257)
T ss_pred ecCCccc-----ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHH---------
Confidence 4322111 01112234568999999999999999999999999999998 9999865321 11111
Q ss_pred HHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhh
Q 001782 940 VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 940 ~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1005 (1013)
.+... .+... ...++..+.+++.+|+..+|++||++.++++.|+++.
T Consensus 210 ---~~~~~---~~~~~-------------~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 210 ---MLESG---ERLPR-------------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---HHHcC---CcCCC-------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11100 00000 0122456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.13 Aligned_cols=251 Identities=20% Similarity=0.313 Sum_probs=200.8
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
+|++.++||+|+||.||++++..+++.||+|.++... ....+.+.+|+.+++.++||||+++++.+ ......++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 5788999999999999999999899999999986432 33456788999999999999999999985 44578999
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
||||+++++|.+++..... ..+++..++.++.|++.|+.|||++ +++|+||||+||++++++.++++|||.+.
T Consensus 76 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEeeCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence 9999999999999875432 4578999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCCh
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPE 938 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~ 938 (1013)
....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ....
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~------ 209 (255)
T cd08219 149 LLTSPGA--------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLI------ 209 (255)
T ss_pred eeccccc--------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHH------
Confidence 5532111 12235688899999999998999999999999999999999999975211 1000
Q ss_pred hHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 939 KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 939 ~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
..+. ...... . ....+..+.+++.+||+.||++||++.|++.+
T Consensus 210 --~~~~----~~~~~~-----------~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 210 --LKVC----QGSYKP-----------L--PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --HHHh----cCCCCC-----------C--CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0000 000000 0 01123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.47 Aligned_cols=261 Identities=25% Similarity=0.388 Sum_probs=203.3
Q ss_pred hhccCCCCCceeeccceEEEEEEE-----CCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcC-CCCccceEEEEeecCC
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQ-RGATKSFVAECEALRNI-RHRNLIKIITVCSSID 769 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 769 (1013)
..++|.+.+.||+|+||.||+|.+ ...+..||+|+++... ....+.+.+|+++++++ +||||+++++++.
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 109 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT--- 109 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe---
Confidence 346899999999999999999985 3345689999887443 23345788999999999 7999999999864
Q ss_pred ccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCce
Q 001782 770 FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVA 849 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 849 (1013)
..+..++||||+.+++|.+++..... ..+++.++..++.|++.|++|||++ +++|+||||+||+++.++.+
T Consensus 110 --~~~~~~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~ 180 (302)
T cd05055 110 --IGGPILVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIV 180 (302)
T ss_pred --cCCceEEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeE
Confidence 34678999999999999999976432 2489999999999999999999999 99999999999999999999
Q ss_pred EEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccH
Q 001782 850 HVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTL 928 (1013)
Q Consensus 850 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~ 928 (1013)
|++|||+++......... ......++..|+|||++.+..++.++||||+||++|||++ |..||.......
T Consensus 181 ~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--- 251 (302)
T cd05055 181 KICDFGLARDIMNDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--- 251 (302)
T ss_pred EECCCcccccccCCCcee------ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---
Confidence 999999997553321110 1122346788999999999999999999999999999998 999987532111
Q ss_pred HHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 929 HEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 929 ~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
...+.+..... +.. . ...+..+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 252 ----------~~~~~~~~~~~------~~~-~---------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 ----------KFYKLIKEGYR------MAQ-P---------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----------HHHHHHHcCCc------CCC-C---------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111111100 000 0 01134578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=327.02 Aligned_cols=279 Identities=19% Similarity=0.249 Sum_probs=200.4
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCC-cccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSID-FEEV 773 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 773 (1013)
..++|++.+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++.... ....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 45789999999999999999999998999999999864322 23356778999999999999999999865321 1233
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++++|++ +++|.+++.. ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence 5678999988 5899888764 3689999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
||+++.... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... .....+.
T Consensus 162 fg~~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~ 229 (343)
T cd07878 162 FGLARQADD-----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIM 229 (343)
T ss_pred CccceecCC-----------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHH
Confidence 999975432 1234568999999999877 56889999999999999999999999753211 1111111
Q ss_pred HhhC--ChhHHHhhhhhhccchhhhhccCCCCchhHH-HHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 933 KMAL--PEKVMEIVDPLLLLDLEARASNCGSHRTEIA-KIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 933 ~~~~--~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.... +......+............... ...... ........+.+++.+|++.||.+|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 230 EVVGTPSPEVLKKISSEHARKYIQSLPHM--PQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhCCCCHHHHHhcchhhHHHHhhccccc--cchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1110 11110000000000000000000 000000 011123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.58 Aligned_cols=278 Identities=20% Similarity=0.281 Sum_probs=201.0
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.++|++.++||+|+||.||+|++..+++.||+|.+..... .....+.+|+.++++++||||+++++++. .+...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence 3579999999999999999999998999999999874432 23456788999999999999999999954 45789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCG-----NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred EEEEeccc-cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcc
Confidence 99999998 69999887642 3578999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
+....... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||...... ....... ..
T Consensus 151 ~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~-~~ 220 (301)
T cd07873 151 ARAKSIPT--------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIF-RI 220 (301)
T ss_pred hhccCCCC--------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-HH
Confidence 87532211 112234568899999987654 5788999999999999999999999754221 1111111 11
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhH-HHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEI-AKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
............+......+........... .........+.+++.+|++.||.+|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 221 LGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1100001111111110000000000000000 011123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.35 Aligned_cols=261 Identities=25% Similarity=0.425 Sum_probs=200.4
Q ss_pred ccCCCCCceeeccceEEEEEEE----CCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNL----GENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
.+|++.+.||+|+||.||+|.+ ...+..||+|.+..... .....+.+|++++++++||||+++++++. .+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence 5788889999999999999985 33567899999874332 23356889999999999999999999854 44
Q ss_pred ceEEEEEeeccCCCHHHHhhccccc-----------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceE
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQ-----------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVL 842 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIl 842 (1013)
...++||||+++++|.+++...... .....+++.++..++.|++.|++|||++ +++||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 6789999999999999998643210 0113578899999999999999999999 9999999999999
Q ss_pred ecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCc
Q 001782 843 LDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNM 921 (1013)
Q Consensus 843 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~ 921 (1013)
+++++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYY------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred EcCCCcEEeccccccccccCCcce------ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999865332211 11223345778999999988899999999999999999998 99898653
Q ss_pred CCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 922 FNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
... ...+.+..... +.. ...++..+.+++.+|++.||++||++.+|.++|
T Consensus 231 ~~~--------------~~~~~~~~~~~------~~~----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 231 SNQ--------------EVIEMVRKRQL------LPC----------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred CHH--------------HHHHHHHcCCc------CCC----------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 110 11111110000 000 012245678899999999999999999999988
Q ss_pred HH
Q 001782 1002 CS 1003 (1013)
Q Consensus 1002 ~~ 1003 (1013)
..
T Consensus 281 ~~ 282 (283)
T cd05090 281 RS 282 (283)
T ss_pred hc
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=330.91 Aligned_cols=257 Identities=24% Similarity=0.427 Sum_probs=209.8
Q ss_pred cCCCCCceeeccceEEEEEEECCCC----eEEEEEEEeec-cccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENE----MAVAVKVMNLK-QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
..+..++||+|+||+||+|.+...+ .+||+|++... ......++..|+.+|.+++|||+++++|+|...
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------ 770 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------ 770 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------
Confidence 3455689999999999999985443 56899988633 334567899999999999999999999998643
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
...+|++|++.|+|.+|++..++ .+.....+.|..|||+||.|||++ ++|||||.++||||.+...+||.||
T Consensus 771 ~~qlvtq~mP~G~LlDyvr~hr~-----~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdf 842 (1177)
T KOG1025|consen 771 TLQLVTQLMPLGCLLDYVREHRD-----NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDF 842 (1177)
T ss_pred hHHHHHHhcccchHHHHHHHhhc-----cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEec
Confidence 37799999999999999998754 678889999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~ 933 (1013)
|+|+...++..... .....-.+.|||-|.+....|+.++|||||||++||++| |..||+....+
T Consensus 843 gla~ll~~d~~ey~------~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--------- 907 (1177)
T KOG1025|consen 843 GLAKLLAPDEKEYS------APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--------- 907 (1177)
T ss_pred chhhccCccccccc------ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH---------
Confidence 99998876543322 222234688999999999999999999999999999999 99999864221
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhh
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1006 (1013)
++.+++++- + +++++.-|...++.++.+||..|+..||+++|+.+++.+..+
T Consensus 908 -----eI~dlle~g------e----------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 908 -----EIPDLLEKG------E----------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -----HhhHHHhcc------c----------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 122222211 1 122334567788999999999999999999999999988764
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.10 Aligned_cols=194 Identities=24% Similarity=0.350 Sum_probs=168.0
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++.++ +||+|+++++++ ......++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997432 22345678899999888 699999999985 4457899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++|+|.+++... +.+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 76 EYVNGGDLMFHMQRQ------RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 999999999988765 4689999999999999999999999 9999999999999999999999999998742
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 147 LGP--------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred cCC--------CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 211 1112345789999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=309.12 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=195.0
Q ss_pred ceeeccceEEEEEEE--CCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEe
Q 001782 706 MIGQGSFGFVYRGNL--GENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 706 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
.||+|+||.||+|.+ ..++..||+|+++.... ...+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 689999999999965 45678899999864432 23457889999999999999999999863 245689999
Q ss_pred eccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCC
Q 001782 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP 861 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 861 (1013)
|+++++|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 76 ~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 76 LAELGPLNKFLQKN------KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146 (257)
T ss_pred cCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence 99999999999764 4688999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCChhH
Q 001782 862 PCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALPEKV 940 (1013)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1013)
...... .......++..|+|||.+....++.++|||||||++|||++ |+.||...... ..
T Consensus 147 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------------~~ 207 (257)
T cd05116 147 ADENYY-----KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------------EV 207 (257)
T ss_pred CCCCee-----eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------------HH
Confidence 322110 01122334678999999988889999999999999999998 99999753111 01
Q ss_pred HHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 941 MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 941 ~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
.+.+.... ++... ..++..+.+++.+||+.||++||++++|.+.|+..
T Consensus 208 ~~~i~~~~------~~~~~----------~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 208 TQMIESGE------RMECP----------QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHCCC------CCCCC----------CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11111110 00000 12345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=308.54 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=206.0
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc--chhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG--ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
..+-|...+.||+|.|+.|-+|++--+|..||||++....-. ....+.+|++.|+.++|||||++|++ .+...
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccc
Confidence 345788899999999999999999999999999999855433 34568899999999999999999999 56678
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEec-CCCceEEcc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD-HDMVAHVGD 853 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~D 853 (1013)
..|+|.|.-++|+|.+||-+.. ..+.+.-+.+++.||+.|+.|.|+. .+||||+||+||.+- .-|-||+.|
T Consensus 91 KlyLiLELGD~GDl~DyImKHe-----~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTD 162 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHE-----EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTD 162 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhh-----ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeee
Confidence 8999999999999999998874 4789999999999999999999999 999999999998775 568999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCc-ccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSA-TGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
||++..+.++. .....+|+..|.|||++.+..|+. ++||||+|||+|-+++|+.||+...+. ..+
T Consensus 163 FGFSNkf~PG~---------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-ETL---- 228 (864)
T KOG4717|consen 163 FGFSNKFQPGK---------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-ETL---- 228 (864)
T ss_pred ccccccCCCcc---------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-hhh----
Confidence 99998765432 355678999999999999999875 689999999999999999999864222 111
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.-+++-.. .- +.-...++.++|..|+..||++|.+.+||+.
T Consensus 229 --------TmImDCKY-tv-----------------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 229 --------TMIMDCKY-TV-----------------PSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --------hhhhcccc-cC-----------------chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 11111111 00 1123455788999999999999999999874
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=313.59 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=199.4
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchh--HHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATK--SFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
|++++.||+|+||+||+|++..+++.||+|++......... ...+|+.++++++||||+++++++. .....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence 66789999999999999999999999999999865443222 3456999999999999999999964 3578899
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
||||+++++|.+++... ..+++.+++.++.|+++||++||++ +++|+||||+||++++++.++|+|||.+.
T Consensus 76 v~~~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKN------KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEETTEBHHHHHHHH------SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred ccccccccccccccccc------ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 99999988999999843 5789999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGM-GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
... ..........++..|+|||++. +..++.++||||+|+++|+|++|..||......
T Consensus 147 ~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~------------- 205 (260)
T PF00069_consen 147 KLS--------ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD------------- 205 (260)
T ss_dssp EST--------STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-------------
T ss_pred ccc--------ccccccccccccccccccccccccccccccccccccccccccccccccccccccch-------------
Confidence 541 1112244567899999999998 788999999999999999999999999764100
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+....+.+........... ........+.+++.+|++.||++||++.|+++
T Consensus 206 -~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 206 -DQLEIIEKILKRPLPSSSQ----------QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -HHHHHHHHHHHTHHHHHTT----------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -hhhhhhhhccccccccccc----------ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011111111100000000 00011257899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=314.70 Aligned_cols=268 Identities=23% Similarity=0.384 Sum_probs=208.1
Q ss_pred hhccCCCCCceeeccceEEEEEEECC----CCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCcc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGE----NEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 771 (1013)
..++|++.+.||+|+||.||+|.+.. ++..|++|++.... ....+.+.+|+.++++++||||+++++++. .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~ 79 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI----E 79 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----c
Confidence 35689999999999999999999865 36789999886332 223456889999999999999999999874 3
Q ss_pred ccceEEEEEeeccCCCHHHHhhccccc--cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCce
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQ--LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVA 849 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 849 (1013)
.+...++++||+++++|.+++...... .....+++.+++.++.|++.|++|||++ +++||||||+||++++++.+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcE
Confidence 346789999999999999999764321 1124689999999999999999999999 99999999999999999999
Q ss_pred EEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccH
Q 001782 850 HVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTL 928 (1013)
Q Consensus 850 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~ 928 (1013)
||+|||+++.+.+...... .....++..|+|||++.+..++.++|||||||++||+++ |+.||..... ...
T Consensus 157 kl~d~g~~~~~~~~~~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~ 228 (280)
T cd05043 157 KITDNALSRDLFPMDYHCL------GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEM 228 (280)
T ss_pred EECCCCCcccccCCceEEe------CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHH
Confidence 9999999986543221111 112345778999999998899999999999999999999 9999865311 011
Q ss_pred HHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 001782 929 HEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007 (1013)
Q Consensus 929 ~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 1007 (1013)
...+.... ++.. ...++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 229 ------------~~~~~~~~------~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 229 ------------AAYLKDGY------RLAQ----------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ------------HHHHHcCC------CCCC----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11111100 0000 012245678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=348.39 Aligned_cols=263 Identities=19% Similarity=0.308 Sum_probs=201.7
Q ss_pred hhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCc
Q 001782 693 DLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDF 770 (1013)
Q Consensus 693 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 770 (1013)
+.....++|++.++||+|+||+||+|++..++..||+|++.... ......+..|+.++++++||||+++++++..
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d--- 83 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN--- 83 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---
Confidence 34455679999999999999999999999999999999987432 2234668899999999999999999998642
Q ss_pred cccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeeecCCCCCceEecCC
Q 001782 771 EEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCH----PPIVHGDLKPSNVLLDHD 846 (1013)
Q Consensus 771 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~----~~ivH~Dlkp~NIll~~~ 846 (1013)
......|+||||+++++|.+++...... ...+++..++.|+.||+.||+|||+... .+||||||||+|||++.+
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 2346789999999999999999764221 1468999999999999999999998520 159999999999999642
Q ss_pred -----------------CceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCC--CCCCcccchHHHHHH
Q 001782 847 -----------------MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG--GDMSATGDVYSFGIL 907 (1013)
Q Consensus 847 -----------------~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwSlG~i 907 (1013)
+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~I 232 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCccccccccc---------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHH
Confidence 358999999997553211 1234578999999999864 458899999999999
Q ss_pred HHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCC
Q 001782 908 LLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMES 987 (1013)
Q Consensus 908 l~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 987 (1013)
+|||++|+.||..... ..... ..+. ..| ... ....+..+.+++..||+.+
T Consensus 233 LYELLTGk~PF~~~~~----~~qli---------~~lk----~~p----~lp---------i~~~S~eL~dLI~~~L~~d 282 (1021)
T PTZ00266 233 IYELCSGKTPFHKANN----FSQLI---------SELK----RGP----DLP---------IKGKSKELNILIKNLLNLS 282 (1021)
T ss_pred HHHHHHCCCCCCcCCc----HHHHH---------HHHh----cCC----CCC---------cCCCCHHHHHHHHHHhcCC
Confidence 9999999999965311 11110 0000 000 000 0012345788999999999
Q ss_pred CCCCCCHHHHHH
Q 001782 988 PSERIQMTDVVA 999 (1013)
Q Consensus 988 P~~RPs~~evl~ 999 (1013)
|.+||++.|++.
T Consensus 283 PeeRPSa~QlL~ 294 (1021)
T PTZ00266 283 AKERPSALQCLG 294 (1021)
T ss_pred hhHCcCHHHHhc
Confidence 999999999984
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=309.74 Aligned_cols=251 Identities=23% Similarity=0.371 Sum_probs=202.1
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec--cccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.+.||+|++|.||+|.+..+++.|++|.+... .....+.+.+|++++++++|||++++++++. .....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 477889999999999999999989999999998743 2334567889999999999999999999853 447899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++..... ..+++.+++.++.|++.|+.|||+. +++|+||||+||++++++.+||+|||++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 99999999999999986522 4688999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
+.+.... .......|++.|+|||+..+..++.++|||||||++|||++|+.||...... ..
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~------ 209 (256)
T cd08529 149 KLLSDNT--------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----AL------ 209 (256)
T ss_pred eeccCcc--------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HH------
Confidence 8654321 1122345788999999999999999999999999999999999999753210 00
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
...... ... + ... ...+..+.+++.+||+.+|++||++.|+++.
T Consensus 210 --~~~~~~----~~~---~--------~~~--~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 210 --ILKIIR----GVF---P--------PVS--QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --HHHHHc----CCC---C--------CCc--cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 000000 000 0 000 1234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=318.49 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=192.7
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec--cccchhHHHHHHHHHhcCC-CCccceEEEEeecCCccccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 774 (1013)
...|++.++||+||.+.||++...+. +.||+|.+... +.....-|.+|+..|.+++ |.+|+++++| .-.++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY-----Ev~d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY-----EVTDG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee-----eccCc
Confidence 45799999999999999999998644 45666655422 2233467999999999995 9999999999 34568
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
+.|+||||-+ .+|..+++.... .++.-.++.+..|++.|+.++|++ ||||.||||.|+|+- .|.+||+||
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~~~-----~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDF 503 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKKKS-----IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDF 503 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeee
Confidence 9999999877 899999998743 233238889999999999999999 999999999999994 568999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCC-----------CCCcccchHHHHHHHHHHHhCCCCCCCcCC
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-----------DMSATGDVYSFGILLLEMFTRRRPTDNMFN 923 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DIwSlG~il~ell~G~~pf~~~~~ 923 (1013)
|+|..+.++...- .....+||+.||+||.+... ..++++||||+|||+|+|+.|+.||+...+
T Consensus 504 GIA~aI~~DTTsI------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n 577 (677)
T KOG0596|consen 504 GIANAIQPDTTSI------VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN 577 (677)
T ss_pred chhcccCccccce------eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH
Confidence 9999776543322 24567899999999987653 256789999999999999999999976321
Q ss_pred CCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 924 DGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.. .++..+.++--...+ +.++. ..++.++|+.||..||++|||+.|+++
T Consensus 578 ~~------------aKl~aI~~P~~~Ief-----------p~~~~----~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 578 QI------------AKLHAITDPNHEIEF-----------PDIPE----NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HH------------HHHHhhcCCCccccc-----------cCCCC----chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 10 112222221110000 01111 123789999999999999999999985
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.51 Aligned_cols=248 Identities=23% Similarity=0.406 Sum_probs=202.8
Q ss_pred CCCCceeeccceEEEEEEECCCCeEEEEEEEee----ccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 702 SSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNL----KQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 702 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+...+||+|+|-+||+|.+..+|..||--.++. ......++|..|+.+|+.++||||+++|+.+.+. ......
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~---~n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT---DNKTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC---CCceee
Confidence 456789999999999999999998887543331 2233457899999999999999999999996543 235678
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC-CceEEccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD-MVAHVGDFGL 856 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~ 856 (1013)
+|+|.+..|+|..|.++. +.++...+..|++||++||.|||++ .|+|+|||||.+||+|..+ |.|||+|+|+
T Consensus 120 ~iTEL~TSGtLr~Y~kk~------~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKH------RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred eeeecccCCcHHHHHHHh------ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence 999999999999999988 5788899999999999999999998 5689999999999999865 8999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
|..... .......|||.|||||+.. ..|+..+||||||+++.||+|+.+||..-.+....+++......
T Consensus 193 Atl~r~----------s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 193 ATLLRK----------SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK 261 (632)
T ss_pred HHHhhc----------cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC
Confidence 986532 2234478999999999976 78999999999999999999999999876555555555444444
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
|..+..+- | +.+.++|.+|+.. .++|||+.|++.
T Consensus 262 P~sl~kV~------d----------------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 262 PAALSKVK------D----------------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHhhccC------C----------------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 43333322 2 2357889999999 999999999985
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.86 Aligned_cols=270 Identities=19% Similarity=0.254 Sum_probs=208.9
Q ss_pred cchhhhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcC-CCCccceEEEEeec
Q 001782 689 VSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVCSS 767 (1013)
Q Consensus 689 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 767 (1013)
+.++++..+.++|++.+.||+|+||.||+|++..+++.||+|+..... .....+.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 455677788899999999999999999999999899999999876432 2235688899999999 69999999999865
Q ss_pred CCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC
Q 001782 768 IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM 847 (1013)
Q Consensus 768 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 847 (1013)
.....++..++||||+++++|.+++..... ....+++..+..++.|++.|+.|||+. +++||||||+||++++++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLK--RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhc--cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 544566789999999999999998864321 114688899999999999999999999 999999999999999999
Q ss_pred ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCCcC
Q 001782 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-----GDMSATGDVYSFGILLLEMFTRRRPTDNMF 922 (1013)
Q Consensus 848 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DIwSlG~il~ell~G~~pf~~~~ 922 (1013)
.+||+|||+++...... .......|+..|+|||++.. ..++.++||||+||++|||++|+.||....
T Consensus 162 ~~kl~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 162 GVKLVDFGVSAQLTSTR--------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred CEEEccCCceeecccCC--------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 99999999987553211 11223468899999998753 457889999999999999999999986532
Q ss_pred CCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 923 NDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.. .... .... . .++... ........+.+++.+||+.||++|||+.||++.
T Consensus 234 ~~----~~~~---------~~~~----~---~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 234 PM----RALF---------KIPR----N---PPPTLH--------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hh----HHHh---------hccc----c---CCCccc--------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11 0000 0000 0 000000 001123457889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.46 Aligned_cols=263 Identities=26% Similarity=0.390 Sum_probs=200.5
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCe--EEEEEEEeecc-ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCcccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEM--AVAVKVMNLKQ-RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 773 (1013)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+.... ....+.+.+|++++.++ +||||+++++++. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CC
Confidence 4578899999999999999999876664 45777665322 22345788999999999 8999999999963 44
Q ss_pred ceEEEEEeeccCCCHHHHhhcccccc----------ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEe
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQL----------EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL 843 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll 843 (1013)
+..++||||+++++|.+++....... ....+++.+++.++.|++.|++|||++ |++||||||+||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence 67899999999999999997653210 123588999999999999999999999 99999999999999
Q ss_pred cCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcC
Q 001782 844 DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMF 922 (1013)
Q Consensus 844 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~ 922 (1013)
++++.+||+|||+++.... ........++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 158 GENYVAKIADFGLSRGQEV---------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred cCCCcEEeCccccCcccch---------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 9999999999999863211 001111234678999999988889999999999999999998 999986432
Q ss_pred CCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 923 NDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
.. .. .+.+.... ++.. ....+..+.+++.+||+.+|++||++.++++.+.
T Consensus 229 ~~-----~~---------~~~~~~~~------~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 229 CA-----EL---------YEKLPQGY------RLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred hH-----HH---------HHHHhcCC------cCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11 10 00000000 0000 0112345788999999999999999999999998
Q ss_pred Hhhhh
Q 001782 1003 SARKI 1007 (1013)
Q Consensus 1003 ~~~~~ 1007 (1013)
.+.+.
T Consensus 279 ~~~~~ 283 (303)
T cd05088 279 RMLEE 283 (303)
T ss_pred HHHHh
Confidence 87544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=318.90 Aligned_cols=268 Identities=25% Similarity=0.380 Sum_probs=205.5
Q ss_pred hccCCCCCceeeccceEEEEEEECC-------CCeEEEEEEEeecc-ccchhHHHHHHHHHhcC-CCCccceEEEEeecC
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGE-------NEMAVAVKVMNLKQ-RGATKSFVAECEALRNI-RHRNLIKIITVCSSI 768 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 768 (1013)
.++|.+.+.||+|+||.||+|++.. +...||+|++.... .....++.+|+++++++ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-- 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence 4689999999999999999998743 23469999987542 22345688899999999 7999999999964
Q ss_pred CccccceEEEEEeeccCCCHHHHhhccccc----------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 001782 769 DFEEVDFKAIVYEYMECGSLEDWLHQSNDQ----------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKP 838 (1013)
Q Consensus 769 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp 838 (1013)
.....++||||+++++|.+++...+.. .....+++.++++++.|++.|++|||++ +++||||||
T Consensus 95 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 95 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 346789999999999999999865321 1123588999999999999999999999 999999999
Q ss_pred CceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCC
Q 001782 839 SNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRP 917 (1013)
Q Consensus 839 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~p 917 (1013)
+||+++.++.+||+|||.++........ .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p 242 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYY------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchh------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999998755321110 01112234578999999998899999999999999999998 8888
Q ss_pred CCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 001782 918 TDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDV 997 (1013)
Q Consensus 918 f~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 997 (1013)
|.... ... ..+.+.... ++. ....++..+.+++.+|++.+|++|||+.||
T Consensus 243 ~~~~~-----~~~---------~~~~~~~~~------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 292 (307)
T cd05098 243 YPGVP-----VEE---------LFKLLKEGH------RMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292 (307)
T ss_pred CCcCC-----HHH---------HHHHHHcCC------CCC----------CCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 85421 111 111111000 000 001234567889999999999999999999
Q ss_pred HHHHHHhhhhhh
Q 001782 998 VAKLCSARKIFL 1009 (1013)
Q Consensus 998 l~~L~~~~~~~~ 1009 (1013)
++.|+++.+...
T Consensus 293 l~~l~~~~~~~~ 304 (307)
T cd05098 293 VEDLDRILALTS 304 (307)
T ss_pred HHHHHHHHHHhh
Confidence 999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=319.04 Aligned_cols=264 Identities=22% Similarity=0.331 Sum_probs=202.2
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
++|++.++||+|+||.||+|++..++..||+|.+..... ....++.+|++++++++||||+++++++. .++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence 468999999999999999999998999999999874422 23356889999999999999999999964 457899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH-HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
+||||+++++|.+++... +.+++..+..++.|++.||+|||+ . +++||||||+||+++.++.+||+|||+
T Consensus 76 lv~ey~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKA------GRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGV 146 (308)
T ss_pred EEeeccCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCC
Confidence 999999999999999765 468899999999999999999997 5 899999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ..........
T Consensus 147 ~~~~~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~ 214 (308)
T cd06615 147 SGQLIDS----------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPV 214 (308)
T ss_pred ccccccc----------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCcc
Confidence 8754221 123456889999999998888999999999999999999999998643211 1111111000
Q ss_pred Ch---------------------hHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHH
Q 001782 937 PE---------------------KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMT 995 (1013)
Q Consensus 937 ~~---------------------~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 995 (1013)
.. ...+..+...... ++ ..+. ......+.+++.+|++.+|++|||+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--------~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~ 282 (308)
T cd06615 215 SEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEP---PP--------KLPS-GAFSDEFQDFVDKCLKKNPKERADLK 282 (308)
T ss_pred ccccccCCcccccCCCCCccchhhHHHHHHHHhcCC---Cc--------cCcC-cccCHHHHHHHHHHccCChhhCcCHH
Confidence 00 0000000000000 00 0000 01345688999999999999999999
Q ss_pred HHHHH
Q 001782 996 DVVAK 1000 (1013)
Q Consensus 996 evl~~ 1000 (1013)
||++.
T Consensus 283 ~ll~~ 287 (308)
T cd06615 283 ELTKH 287 (308)
T ss_pred HHhcC
Confidence 99876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.44 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=201.0
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-----cchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-----GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
++|++.+.||+|++|.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++ ...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 478999999999999999999988899999999874322 1234688899999999999999999995 344
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
+..++|+||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAY------GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 6899999999999999999765 4678899999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||.++........ ........++..|+|||++.+..++.++||||+|+++|||++|+.||...... .....
T Consensus 148 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~ 218 (263)
T cd06625 148 FGASKRLQTICSS-----GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFK 218 (263)
T ss_pred cccceeccccccc-----cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHHH
Confidence 9998755321110 11112345788999999999989999999999999999999999998653111 11000
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
..... .++. ........+.+++.+||..+|.+|||+.|+++.
T Consensus 219 ---------~~~~~------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 219 ---------IATQP------TNPQ----------LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---------HhccC------CCCC----------CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00000 0000 001234457889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=317.36 Aligned_cols=268 Identities=24% Similarity=0.391 Sum_probs=205.9
Q ss_pred hhhccCCCCCceeeccceEEEEEEEC-------CCCeEEEEEEEeecc-ccchhHHHHHHHHHhcC-CCCccceEEEEee
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLG-------ENEMAVAVKVMNLKQ-RGATKSFVAECEALRNI-RHRNLIKIITVCS 766 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 766 (1013)
...++|++.+.||+|+||.||+|++. ..+..||+|...... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34568999999999999999999752 234579999886432 23346789999999999 8999999999964
Q ss_pred cCCccccceEEEEEeeccCCCHHHHhhccccc----------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 001782 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQ----------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDL 836 (1013)
Q Consensus 767 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dl 836 (1013)
.....++||||+++++|.+++...... .....+++.++..++.||+.|++|||++ |++||||
T Consensus 92 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dl 163 (304)
T cd05101 92 -----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDL 163 (304)
T ss_pred -----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccc
Confidence 346789999999999999999865321 1123578899999999999999999999 9999999
Q ss_pred CCCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CC
Q 001782 837 KPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RR 915 (1013)
Q Consensus 837 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~ 915 (1013)
||+||++++++.+||+|||.++.+...... .......++..|+|||++.+..++.++||||||+++|||++ |.
T Consensus 164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~ 237 (304)
T cd05101 164 AARNVLVTENNVMKIADFGLARDVNNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 237 (304)
T ss_pred ccceEEEcCCCcEEECCCccceeccccccc------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999865432211 11222345678999999998889999999999999999998 78
Q ss_pred CCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHH
Q 001782 916 RPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMT 995 (1013)
Q Consensus 916 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 995 (1013)
.||.... .... .+.+.. .. +.. ....++..+.+++.+||+.+|++|||+.
T Consensus 238 ~p~~~~~-----~~~~---------~~~~~~---~~---~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~ 287 (304)
T cd05101 238 SPYPGIP-----VEEL---------FKLLKE---GH---RMD----------KPANCTNELYMMMRDCWHAIPSHRPTFK 287 (304)
T ss_pred CCcccCC-----HHHH---------HHHHHc---CC---cCC----------CCCCCCHHHHHHHHHHcccChhhCCCHH
Confidence 8875421 1111 111100 00 000 0012345688899999999999999999
Q ss_pred HHHHHHHHhhhh
Q 001782 996 DVVAKLCSARKI 1007 (1013)
Q Consensus 996 evl~~L~~~~~~ 1007 (1013)
|+++.|+.+...
T Consensus 288 e~l~~l~~~~~~ 299 (304)
T cd05101 288 QLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHHHHh
Confidence 999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=309.34 Aligned_cols=254 Identities=29% Similarity=0.489 Sum_probs=199.9
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
.++|++.++||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.++++++||+++++++++. ....+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~ 76 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIY 76 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcE
Confidence 458999999999999999999876 556799999874333 3467899999999999999999999852 24578
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
++|||+++++|.+++..... ..+++.+++.++.|++.|++|||+. +++||||||+||++++++.+||+|||.+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceee
Confidence 99999999999999976422 4689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
..+...... ......++..|+|||+..+..++.++||||||+++|||++ |..||......
T Consensus 150 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------------ 210 (260)
T cd05070 150 RLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------------ 210 (260)
T ss_pred eeccCcccc-------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------------
Confidence 765322110 1122335678999999988899999999999999999999 88998653111
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
+..+.+... . ++. .....+..+.+++.+|++.+|++|||++++.+.|++
T Consensus 211 --~~~~~~~~~---~---~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 211 --EVLEQVERG---Y---RMP----------CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --HHHHHHHcC---C---CCC----------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011111100 0 000 001224568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=322.77 Aligned_cols=200 Identities=26% Similarity=0.364 Sum_probs=170.2
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCC-CCccceEEEEeecCCccccce
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 775 (1013)
+|+..+.||+|+||+||+|++..+++.||+|++.... ....+.+..|.++++.+. |++|+++++++ ...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 4677899999999999999999999999999987432 233456778889988885 57777888874 44578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++|+|.+++... +.+++.++..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQV------GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence 99999999999999999765 4689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
+++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 147 ~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 147 MCKEHMVD--------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred cccccCCC--------CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 98743211 11123456899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=313.49 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=196.8
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
++|++.++||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++. ..+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEEE
Confidence 36888999999999999999998899999999986442 223456889999999999999999999964 346788
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||++
T Consensus 76 lv~e~~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 76 ICTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred EEEecCCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 999999999986542 467788999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||........... +
T Consensus 143 ~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-------~ 205 (279)
T cd06619 143 TQLVNS----------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-------P 205 (279)
T ss_pred eecccc----------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-------h
Confidence 754321 12345689999999999999999999999999999999999999976322211100 0
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.. ........++...+ .......+.+++.+|++.+|++||+++|+++.
T Consensus 206 ~~---~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 206 LQ---LLQCIVDEDPPVLP------------VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HH---HHHHHhccCCCCCC------------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 00000000100000 00113457889999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=328.35 Aligned_cols=268 Identities=24% Similarity=0.350 Sum_probs=205.0
Q ss_pred hhhhccCCCCCceeeccceEEEEEEEC-----CCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCC-CCccceEEEEeec
Q 001782 695 SKATNDFSSSNMIGQGSFGFVYRGNLG-----ENEMAVAVKVMNLKQR-GATKSFVAECEALRNIR-HRNLIKIITVCSS 767 (1013)
Q Consensus 695 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 767 (1013)
....++|.+.++||+|+||.||+|++. ..++.||+|+++.... ...+.+.+|++++.++. ||||++++++|.
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~- 111 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT- 111 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc-
Confidence 334567889999999999999999964 3456899999974432 22356889999999997 999999999974
Q ss_pred CCccccceEEEEEeeccCCCHHHHhhccccc-------------------------------------------------
Q 001782 768 IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQ------------------------------------------------- 798 (1013)
Q Consensus 768 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------- 798 (1013)
.....++||||+++|+|.++++..+..
T Consensus 112 ----~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 112 ----KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred ----cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 336789999999999999999764320
Q ss_pred -------------------------------------------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 001782 799 -------------------------------------------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGD 835 (1013)
Q Consensus 799 -------------------------------------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~D 835 (1013)
.....+++.+++.++.|++.||+|||+. +++|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrd 264 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRD 264 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCccc
Confidence 0112467888999999999999999999 999999
Q ss_pred CCCCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-C
Q 001782 836 LKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-R 914 (1013)
Q Consensus 836 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G 914 (1013)
|||+||++++++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |
T Consensus 265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g 338 (401)
T cd05107 265 LAARNVLICEGKLVKICDFGLARDIMRDSNY------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLG 338 (401)
T ss_pred CCcceEEEeCCCEEEEEecCcceeccccccc------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcC
Confidence 9999999999999999999999864322111 11223456789999999998899999999999999999998 8
Q ss_pred CCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCH
Q 001782 915 RRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQM 994 (1013)
Q Consensus 915 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 994 (1013)
..||......+. ..+.+.... |+.. +..++..+.+++.+||..+|.+||++
T Consensus 339 ~~P~~~~~~~~~-------------~~~~~~~~~------~~~~----------p~~~~~~l~~li~~cl~~~P~~RPs~ 389 (401)
T cd05107 339 GTPYPELPMNEQ-------------FYNAIKRGY------RMAK----------PAHASDEIYEIMQKCWEEKFEIRPDF 389 (401)
T ss_pred CCCCCCCCchHH-------------HHHHHHcCC------CCCC----------CCCCCHHHHHHHHHHcCCChhHCcCH
Confidence 999865321110 111111100 0000 01123567899999999999999999
Q ss_pred HHHHHHHHHhh
Q 001782 995 TDVVAKLCSAR 1005 (1013)
Q Consensus 995 ~evl~~L~~~~ 1005 (1013)
+||++.|+.+.
T Consensus 390 ~ell~~L~~~~ 400 (401)
T cd05107 390 SQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHHHh
Confidence 99999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=319.20 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=203.1
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
...+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+++++.++|||++++++++. ..+..
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~ 91 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDEL 91 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceE
Confidence 3457999999999999999999998899999999997655555677899999999999999999999864 45789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++|+||+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+
T Consensus 92 ~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~ 161 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTET-------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGF 161 (296)
T ss_pred EEEEEecCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCcc
Confidence 9999999999999998653 578999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+........ ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ....
T Consensus 162 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~----~~~~---- 225 (296)
T cd06655 162 CAQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----RALY---- 225 (296)
T ss_pred chhcccccc--------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH----
Confidence 875433211 122346889999999999888999999999999999999999999653211 0000
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.+.. ...+ ........+..+.+++.+||..||.+||++.+++.
T Consensus 226 -----~~~~---~~~~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 226 -----LIAT---NGTP------------ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -----HHHh---cCCc------------ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000 0000 00001123345778999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.63 Aligned_cols=262 Identities=25% Similarity=0.399 Sum_probs=203.0
Q ss_pred hccCCCCCceeeccceEEEEEEECCC-----CeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCcc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGEN-----EMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 771 (1013)
.++|++.+.||+|+||.||+|.+... +..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~----- 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----- 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence 46899999999999999999998643 37899999864332 23456889999999999999999999964
Q ss_pred ccceEEEEEeeccCCCHHHHhhcccccc----ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQL----EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM 847 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 847 (1013)
.....++||||+++++|.+++....... ....+++..++.++.|++.|+.|||+. +++||||||+||+++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 4477899999999999999997643221 123578899999999999999999999 999999999999999999
Q ss_pred ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCc
Q 001782 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGL 926 (1013)
Q Consensus 848 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~ 926 (1013)
.+||+|||+++.+...... .......++..|+|||++.++.++.++|||||||++||+++ |..||......
T Consensus 157 ~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-- 228 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-- 228 (277)
T ss_pred CEEECCcccchhhccCccc------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--
Confidence 9999999998765432211 11223446789999999988899999999999999999998 99998642111
Q ss_pred cHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 927 TLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 927 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
. ..+.+. .......+ ..++..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 229 ---~---------~~~~~~---~~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 229 ---E---------VLKFVI---DGGHLDLP-------------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---H---------HHHHHh---cCCCCCCC-------------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 0 111111 00000000 1124568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=331.08 Aligned_cols=275 Identities=20% Similarity=0.244 Sum_probs=198.7
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|++++++++||||+++++++. ..+..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEE
Confidence 457999999999999999999999999999999643 234678999999999999999999864 347789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+|||++. ++|.+++.... ..+++.+++.|+.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 237 lv~e~~~-~~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla 307 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARL-----RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA 307 (461)
T ss_pred EEEEccC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCc
Confidence 9999996 79998886542 3689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCC------ccHHHH
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDG------LTLHEF 931 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~------~~~~~~ 931 (1013)
+........ .......||..|+|||++.+..++.++|||||||++|||++|..|+....... ......
T Consensus 308 ~~~~~~~~~------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~ 381 (461)
T PHA03211 308 CFARGSWST------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRI 381 (461)
T ss_pred eeccccccc------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHH
Confidence 865332111 11234569999999999999999999999999999999999887654322110 011111
Q ss_pred HHhh------CChhH-HHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 932 AKMA------LPEKV-MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 932 ~~~~------~~~~~-~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
+... ++... ..+...... ...+....................+.+++.+||+.||++|||+.|+++.
T Consensus 382 i~~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 382 IRQAQVHVDEFPQHAGSRLVSQYRH--RAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHhhccccccCCCCcchHHHHHHHh--hhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1110 00000 000000000 0000000000111111112223457889999999999999999999864
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.82 Aligned_cols=250 Identities=25% Similarity=0.410 Sum_probs=194.5
Q ss_pred ceeeccceEEEEEEEC--CCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEee
Q 001782 706 MIGQGSFGFVYRGNLG--ENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEY 782 (1013)
Q Consensus 706 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 782 (1013)
.||+|+||.||+|.+. ..+..||+|+...... ...+.+.+|+.++++++||||+++++++. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence 3899999999999874 4456799999875433 23456899999999999999999999863 2467999999
Q ss_pred ccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCC
Q 001782 783 MECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPP 862 (1013)
Q Consensus 783 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~ 862 (1013)
+++++|.+++.... ..+++.++++++.|++.|++|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 76 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 76 ASGGPLNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred CCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence 99999999987542 4689999999999999999999999 999999999999999999999999999975543
Q ss_pred CCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCChhHH
Q 001782 863 CSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALPEKVM 941 (1013)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 941 (1013)
...... ......++..|+|||++.+..++.++|||||||++||+++ |..||...... +..
T Consensus 148 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------------~~~ 208 (257)
T cd05115 148 DDSYYK-----ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------------EVM 208 (257)
T ss_pred Ccccee-----ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------------HHH
Confidence 221110 1112234578999999988889999999999999999996 99999753211 111
Q ss_pred HhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 942 EIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 942 ~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
..+.+....+ . ...++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 209 ~~~~~~~~~~------~----------~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 209 SFIEQGKRLD------C----------PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHCCCCCC------C----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1111110000 0 012345678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=318.69 Aligned_cols=204 Identities=22% Similarity=0.325 Sum_probs=164.3
Q ss_pred CCceeeccceEEEEEEEC--CCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEe
Q 001782 704 SNMIGQGSFGFVYRGNLG--ENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
.++||+|+||+||+|++. .+++.||+|++.... ....+.+|++++++++||||+++++++.. ..+...++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence 468999999999999975 456889999986432 23567899999999999999999998643 23467899999
Q ss_pred eccCCCHHHHhhcccccc---ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEe----cCCCceEEccc
Q 001782 782 YMECGSLEDWLHQSNDQL---EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL----DHDMVAHVGDF 854 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DF 854 (1013)
|+. ++|.+++....... ....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 998 68888876432211 113589999999999999999999999 99999999999999 45679999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
|+++.+..... .........||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 157 G~a~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCCc-----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99986543211 11123356789999999998774 5889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.73 Aligned_cols=261 Identities=23% Similarity=0.388 Sum_probs=200.3
Q ss_pred ccCCCCCceeeccceEEEEEEECC-----CCeEEEEEEEeecccc-chhHHHHHHHHHhcCCCCccceEEEEeecCCccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGE-----NEMAVAVKVMNLKQRG-ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 772 (1013)
.+|++.+.||+|+||.||+|.+.. .++.||+|+++..... ..+.+.+|+.+++.++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----K 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence 467888999999999999998753 3578999999744332 2356889999999999999999999964 3
Q ss_pred cceEEEEEeeccCCCHHHHhhccccc----------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceE
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQ----------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVL 842 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIl 842 (1013)
....++++||+.+++|.+++...... .....+++..+.+++.|++.|++|+|++ +|+||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil 156 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL 156 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence 46689999999999999998642110 0123588899999999999999999999 9999999999999
Q ss_pred ecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCc
Q 001782 843 LDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNM 921 (1013)
Q Consensus 843 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~ 921 (1013)
+++++.+||+|||+++........ .......+++.|+|||++.++.++.++|||||||++|||++ |..||...
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYY------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred ecCCCceEecccccccccccchhe------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999998865332111 11223446789999999988899999999999999999998 88888653
Q ss_pred CCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 922 FNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
... . ..+.+. ..... . ....++..+.+++.+||+.+|++||+++||++.|
T Consensus 231 ~~~-----~---------~~~~i~---~~~~~---~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 231 SNQ-----D---------VIEMIR---NRQVL---P----------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred CHH-----H---------HHHHHH---cCCcC---C----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 111 1 111110 00000 0 0013345678999999999999999999999998
Q ss_pred HH
Q 001782 1002 CS 1003 (1013)
Q Consensus 1002 ~~ 1003 (1013)
+.
T Consensus 281 ~~ 282 (283)
T cd05091 281 RT 282 (283)
T ss_pred hC
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.60 Aligned_cols=251 Identities=29% Similarity=0.471 Sum_probs=197.0
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
.+|++.+.||+|+||.||+|++. ++..+|+|++.... .....+.+|++++++++||||+++++++. .....++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEE
Confidence 46889999999999999999986 45679999886332 23456889999999999999999999853 4467899
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
||||+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 77 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 77 VTEYMANGCLLNYLRERK-----GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred EEecCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccce
Confidence 999999999999997642 3688999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCC
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
....... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------------ 209 (256)
T cd05059 149 YVLDDQY-------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE------------ 209 (256)
T ss_pred ecccccc-------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH------------
Confidence 5432110 01112234568999999999999999999999999999999 899986531110
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
..+.+.... ...++ ..++..+.+++.+||..+|++|||+.|+++.|
T Consensus 210 --~~~~~~~~~---~~~~~-------------~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 210 --VVESVSAGY---RLYRP-------------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --HHHHHHcCC---cCCCC-------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000000000 00000 11345688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=317.63 Aligned_cols=268 Identities=24% Similarity=0.394 Sum_probs=204.9
Q ss_pred hhccCCCCCceeeccceEEEEEEEC-------CCCeEEEEEEEeeccc-cchhHHHHHHHHHhcC-CCCccceEEEEeec
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLG-------ENEMAVAVKVMNLKQR-GATKSFVAECEALRNI-RHRNLIKIITVCSS 767 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 767 (1013)
..++|.+.++||+|+||.||+|+.. .....||+|.+..... .....+.+|+++++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 88 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT- 88 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc-
Confidence 3468999999999999999999863 2345799998874322 2345688999999999 6999999999864
Q ss_pred CCccccceEEEEEeeccCCCHHHHhhccccc----------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 001782 768 IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQ----------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLK 837 (1013)
Q Consensus 768 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk 837 (1013)
.....++||||+++|+|.+++...... .....+++.++.+++.|++.|++|||++ |++|||||
T Consensus 89 ----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlk 161 (314)
T cd05099 89 ----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLA 161 (314)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence 346789999999999999999764321 1124589999999999999999999999 99999999
Q ss_pred CCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCC
Q 001782 838 PSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRR 916 (1013)
Q Consensus 838 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~ 916 (1013)
|+||+++.++.+||+|||.++......... ......++..|+|||++.++.++.++|||||||++|||++ |..
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~ 235 (314)
T cd05099 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYK------KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS 235 (314)
T ss_pred ceeEEEcCCCcEEEcccccccccccccccc------ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCC
Confidence 999999999999999999998654321111 0111234567999999998899999999999999999999 888
Q ss_pred CCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 001782 917 PTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTD 996 (1013)
Q Consensus 917 pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 996 (1013)
||..... . +..+.+.... ++. ....++..+.+++.+|++.+|++|||+.|
T Consensus 236 p~~~~~~-----~---------~~~~~~~~~~------~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 285 (314)
T cd05099 236 PYPGIPV-----E---------ELFKLLREGH------RMD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQ 285 (314)
T ss_pred CCCCCCH-----H---------HHHHHHHcCC------CCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 9865311 0 1111111000 000 00122446788999999999999999999
Q ss_pred HHHHHHHhhhhh
Q 001782 997 VVAKLCSARKIF 1008 (1013)
Q Consensus 997 vl~~L~~~~~~~ 1008 (1013)
+++.|+++....
T Consensus 286 ll~~l~~~~~~~ 297 (314)
T cd05099 286 LVEALDKVLAAV 297 (314)
T ss_pred HHHHHHHHHHHh
Confidence 999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=318.68 Aligned_cols=269 Identities=22% Similarity=0.362 Sum_probs=201.2
Q ss_pred hccCCCCCceeeccceEEEEEEECC----------------CCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccce
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGE----------------NEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIK 760 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 760 (1013)
.++|++.++||+|+||.||+|++.. +...||+|++..... ....++.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4579999999999999999986532 345689999874432 23467899999999999999999
Q ss_pred EEEEeecCCccccceEEEEEeeccCCCHHHHhhccccc-----cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 001782 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQ-----LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGD 835 (1013)
Q Consensus 761 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~D 835 (1013)
+++++. ..+..++||||+++++|.+++...... .....+++.++..++.|++.|++|||+. +++|||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~d 155 (296)
T cd05095 84 LLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRD 155 (296)
T ss_pred EEEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence 999964 346689999999999999999764321 1123578889999999999999999999 999999
Q ss_pred CCCCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh--
Q 001782 836 LKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-- 913 (1013)
Q Consensus 836 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-- 913 (1013)
|||+||+++.++.+||+|||+++.+...... .......++..|+|||+..++.++.++|||||||++|||++
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~ 229 (296)
T cd05095 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229 (296)
T ss_pred CChheEEEcCCCCEEeccCcccccccCCcce------eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhC
Confidence 9999999999999999999999765332111 11122344678999999888899999999999999999998
Q ss_pred CCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCC
Q 001782 914 RRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ 993 (1013)
Q Consensus 914 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 993 (1013)
|..||....... ... ...+.......... .+....++..+.+++.+||+.||++||+
T Consensus 230 ~~~p~~~~~~~~-----~~~-----~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~ 286 (296)
T cd05095 230 KEQPYSQLSDEQ-----VIE-----NTGEFFRDQGRQVY-------------LPKPALCPDSLYKLMLSCWRRNAKERPS 286 (296)
T ss_pred CCCCccccChHH-----HHH-----HHHHHHhhcccccc-------------CCCCCCCCHHHHHHHHHHcCCCcccCCC
Confidence 778886532111 100 00010000000000 0000123456889999999999999999
Q ss_pred HHHHHHHHHH
Q 001782 994 MTDVVAKLCS 1003 (1013)
Q Consensus 994 ~~evl~~L~~ 1003 (1013)
+.||.+.|++
T Consensus 287 ~~~i~~~l~~ 296 (296)
T cd05095 287 FQEIHATLLE 296 (296)
T ss_pred HHHHHHHHhC
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=315.25 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=198.1
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.|+..++||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++|++++++++.+. ..+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEE
Confidence 36778899999999999999999999999999864322 12345778999999999999999999853 44789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+++++|.+++..... ..+++.++..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||+
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999865432 3689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+....... ......|+..|+|||++.+..++.++||||+||++|+|++|+.||........ ...
T Consensus 149 ~~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~------ 212 (285)
T cd05630 149 AVHVPEGQ---------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REE------ 212 (285)
T ss_pred eeecCCCc---------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHH------
Confidence 87543211 12234689999999999999999999999999999999999999976322110 000
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCC-----HHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ-----MTDVVA 999 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 999 (1013)
........ +.. ........+.+++.+||+.||++||| +.|+++
T Consensus 213 ---~~~~~~~~----~~~-------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 213 ---VERLVKEV----QEE-------------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---HHhhhhhh----hhh-------------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00110000 000 00112345788999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=323.50 Aligned_cols=194 Identities=29% Similarity=0.363 Sum_probs=164.1
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHH-HHhcCCCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECE-ALRNIRHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
++||+|+||.||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++ .+.+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999999899999999987432 122334555554 57889999999999885 4457899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++++|.+++... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 76 DYVNGGELFFHLQRE------RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred cCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 999999999888754 4688899999999999999999999 9999999999999999999999999998742
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 147 VEP--------EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred CCC--------CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 111 1123345689999999999998999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.09 Aligned_cols=268 Identities=21% Similarity=0.352 Sum_probs=202.1
Q ss_pred hccCCCCCceeeccceEEEEEEECCCC----------------eEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccce
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENE----------------MAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIK 760 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 760 (1013)
.++|++.+.||+|+||.||+|++...+ ..||+|++..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 468999999999999999999876433 5689999874432 33567889999999999999999
Q ss_pred EEEEeecCCccccceEEEEEeeccCCCHHHHhhcccccc-----ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 001782 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL-----EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGD 835 (1013)
Q Consensus 761 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~D 835 (1013)
+++++. .+...+++|||+++++|.+++....... ....+++..++.++.|++.|++|||++ +++|||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 999964 3377899999999999999997653211 113689999999999999999999999 999999
Q ss_pred CCCCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh--
Q 001782 836 LKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-- 913 (1013)
Q Consensus 836 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-- 913 (1013)
|||+||+++.++.++|+|||.++........ .......++..|+|||++.++.++.++|||||||++|||++
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 229 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYY------RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcce------eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence 9999999999999999999998754322111 11223456788999999988899999999999999999998
Q ss_pred CCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCC
Q 001782 914 RRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ 993 (1013)
Q Consensus 914 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 993 (1013)
|..||....... .+... .+..... . .+ ...+....++..+.+++.+|++.||.+|||
T Consensus 230 ~~~p~~~~~~~~-~~~~~---------~~~~~~~---~--~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt 286 (296)
T cd05051 230 REQPYEHLTDQQ-VIENA---------GHFFRDD---G--RQ--------IYLPRPPNCPKDIYELMLECWRRDEEDRPT 286 (296)
T ss_pred CCCCCCCcChHH-HHHHH---------Hhccccc---c--cc--------ccCCCccCCCHHHHHHHHHHhccChhcCCC
Confidence 677775432110 00000 0000000 0 00 000001122356899999999999999999
Q ss_pred HHHHHHHHH
Q 001782 994 MTDVVAKLC 1002 (1013)
Q Consensus 994 ~~evl~~L~ 1002 (1013)
+.||++.|+
T Consensus 287 ~~el~~~L~ 295 (296)
T cd05051 287 FREIHLFLQ 295 (296)
T ss_pred HHHHHHHhc
Confidence 999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=325.71 Aligned_cols=239 Identities=23% Similarity=0.293 Sum_probs=189.0
Q ss_pred CceeeccceEEEEEEE---CCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEE
Q 001782 705 NMIGQGSFGFVYRGNL---GENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIV 779 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 779 (1013)
+.||+|+||.||++++ ..+++.||+|++..... .....+.+|++++++++||||+++++++. .++..++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence 6799999999999986 35688999999974322 22345778999999999999999999853 45789999
Q ss_pred EeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccccc
Q 001782 780 YEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859 (1013)
Q Consensus 780 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 859 (1013)
|||+++++|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 77 ~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 77 LDFLRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred EcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 9999999999998764 4689999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChh
Q 001782 860 LPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEK 939 (1013)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~ 939 (1013)
.... ........|++.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 148 ~~~~--------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~-------- 206 (318)
T cd05582 148 SIDH--------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ET-------- 206 (318)
T ss_pred cCCC--------CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HH--------
Confidence 4321 11223457899999999999888999999999999999999999999753110 00
Q ss_pred HHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 001782 940 VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTD 996 (1013)
Q Consensus 940 ~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 996 (1013)
...+....... | ...+..+.+++.+||+.||++||++.+
T Consensus 207 ~~~i~~~~~~~-p-----------------~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 207 MTMILKAKLGM-P-----------------QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHcCCCCC-C-----------------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00111000000 0 112345678999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=329.46 Aligned_cols=209 Identities=22% Similarity=0.341 Sum_probs=176.4
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.++..++||+|+++++.+ .+.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 46888999999999999999999999999999997432 23345678899999999999999999985 45578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++|+|.+++... +.+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKK------DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred EEEEEeCCCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999765 4689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccc---------------------------cCCCCCcccccccccccccccCCCCCCcccchHHHHHHH
Q 001782 856 LARFLPPCSPATIL---------------------------ETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILL 908 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il 908 (1013)
++..+......... .........+||+.|+|||++.+..++.++|||||||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 98755322110000 000012245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCc
Q 001782 909 LEMFTRRRPTDNM 921 (1013)
Q Consensus 909 ~ell~G~~pf~~~ 921 (1013)
|||++|+.||...
T Consensus 227 yel~tG~~Pf~~~ 239 (360)
T cd05627 227 YEMLIGYPPFCSE 239 (360)
T ss_pred eecccCCCCCCCC
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=314.82 Aligned_cols=275 Identities=22% Similarity=0.309 Sum_probs=199.0
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.+.||+|++|.||+|++..++..||+|++..... ...+.+.+|+.++++++||||+++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 57888999999999999999998999999999874432 23456889999999999999999999964 457889
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||++ ++|.+++..... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred EEEecCC-CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccce
Confidence 9999998 789988875432 14689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
....... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||........... ......
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~-~~~~~~ 219 (285)
T cd07861 149 RAFGIPV--------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR-IFRILG 219 (285)
T ss_pred eecCCCc--------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHhC
Confidence 7543211 112234568899999987654 578899999999999999999999975322111111 000000
Q ss_pred C--hhHHHhhhhhhccchhhhhccCCCCch-hHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 P--EKVMEIVDPLLLLDLEARASNCGSHRT-EIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 ~--~~~~~~i~~~l~~~~~~R~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
. +........ ..++ +......... ..........++.+++.+|+..||++|||+.||++
T Consensus 220 ~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 220 TPTEDVWPGVTS--LPDY--KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CCChhhhhcchh--hHHH--HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 000000000 0000 0000000000 00011123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.74 Aligned_cols=270 Identities=20% Similarity=0.257 Sum_probs=208.8
Q ss_pred CcchhhhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcC-CCCccceEEEEee
Q 001782 688 MVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVCS 766 (1013)
Q Consensus 688 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 766 (1013)
.+++.++..+.++|++.+.||+|+||.||+|....+++.+|+|++.... .....+.+|+.+++++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3566777888999999999999999999999999899999999986432 2345678899999998 7999999999986
Q ss_pred cCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC
Q 001782 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD 846 (1013)
Q Consensus 767 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 846 (1013)
..+.......++||||+++++|.++++.... ....+++..++.++.|++.|++|||+. +++||||||+||+++.+
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~ 164 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE 164 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence 5433344678999999999999998864321 124688999999999999999999999 99999999999999999
Q ss_pred CceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCC-----CCCcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 847 MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-----DMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 847 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
+.+||+|||.+........ ......|+..|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 165 ~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRL--------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred CCEEEeecccchhcccccc--------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 9999999999875532111 12234578999999987643 3688999999999999999999998753
Q ss_pred CCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 922 FNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
... ... .++.. ..+ .+ ....++....+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~----~~~---------~~~~~----~~~-~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 237 HPV----KTL---------FKIPR----NPP-PT----------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cHH----HHH---------HHHhc----CCC-CC----------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 211 000 00000 000 00 0001122345789999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.14 Aligned_cols=274 Identities=22% Similarity=0.365 Sum_probs=203.7
Q ss_pred ccCCCCCceeeccceEEEEEEE----CCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNL----GENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
.-|++.+.||+|+||.||+|+. ..++..||+|.++... ....+.+.+|++++++++|||++++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 3578899999999999999985 3467889999987443 2334678999999999999999999998743 224
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++||||+++++|.+++.... ..+++.++..++.|++.|++|||++ |++||||||+||+++.++.+||+|
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECC
Confidence 66899999999999999997542 3579999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||+++.+....... .......++..|+|||++.+..++.++|||||||++|||+++..|+...... ......
T Consensus 153 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~ 224 (284)
T cd05079 153 FGLTKAIETDKEYY-----TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIG 224 (284)
T ss_pred CccccccccCccce-----eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhcc
Confidence 99998654322110 1122345678899999998889999999999999999999988765431110 000000
Q ss_pred hhCCh-hHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 934 MALPE-KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 934 ~~~~~-~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
....+ .....+...... .+.. ....++..+.+++.+|++.+|++|||+.++++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~---~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 225 PTHGQMTVTRLVRVLEEG---KRLP----------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccccccHHHHHHHHHcC---ccCC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 001111000000 0000 0112345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.47 Aligned_cols=252 Identities=22% Similarity=0.278 Sum_probs=203.3
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
...+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++. .+...
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 91 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDEL 91 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEE
Confidence 3478999999999999999999998899999999997655555677889999999999999999999964 45788
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+++++|.+++... .+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.
T Consensus 92 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~ 161 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 161 (297)
T ss_pred EEeecccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCcc
Confidence 9999999999999998653 578889999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+....+... ......+++.|+|||.+.+..++.++|||||||++|++++|..||..........
T Consensus 162 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-------- 225 (297)
T cd06656 162 CAQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------- 225 (297)
T ss_pred ceEccCCcc--------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--------
Confidence 875433211 1223467889999999999889999999999999999999999996532111000
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.......+ . .......+..+.+++.+||+.+|++||+++++++
T Consensus 226 --------~~~~~~~~----~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 226 --------LIATNGTP----E--------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --------eeccCCCC----C--------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 0 0001122345678999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.70 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=204.1
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
.++|++.++||+|+||.||+|.+..+++.+|+|++........+.+.+|++++++++||||+++++++ ......+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEE
Confidence 46889999999999999999999888899999999866555667899999999999999999999985 3457899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
++|||+++++|.+++.... ..+++.++..++.|++.|++|||++ +++||||+|+||+++.++.+||+|||.+
T Consensus 77 l~~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 148 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-----GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVS 148 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccc
Confidence 9999999999999987642 3688999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG---DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
....... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||..........
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~------ 214 (262)
T cd06613 149 AQLTATI--------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF------ 214 (262)
T ss_pred hhhhhhh--------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------
Confidence 7543211 112335678899999998776 88999999999999999999999997532111000
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
....... .+ + ........+..+.+++.+||..+|.+|||+.+|+.
T Consensus 215 -------~~~~~~~--~~---~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 215 -------LISKSNF--PP---P--------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -------HHHhccC--CC---c--------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 00 0 00011223456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=315.75 Aligned_cols=265 Identities=24% Similarity=0.397 Sum_probs=201.9
Q ss_pred hhccCCCCCceeeccceEEEEEEEC-----CCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLG-----ENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDF 770 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 770 (1013)
..++|++.++||+|+||.||+|... ..+..||+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS---- 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 4678999999999999999999764 2356799998763322 22345788999999999999999999854
Q ss_pred cccceEEEEEeeccCCCHHHHhhcccccc----ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC
Q 001782 771 EEVDFKAIVYEYMECGSLEDWLHQSNDQL----EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD 846 (1013)
Q Consensus 771 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 846 (1013)
.....++||||+++|+|.+++....... .....++..+..++.|++.|++|||++ +|+||||||+||+++++
T Consensus 80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~ 155 (288)
T cd05061 80 -KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 155 (288)
T ss_pred -CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence 3467899999999999999997643211 113456778899999999999999999 99999999999999999
Q ss_pred CceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCC
Q 001782 847 MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDG 925 (1013)
Q Consensus 847 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~ 925 (1013)
+.+||+|||+++......... ......++..|+|||.+.++.++.++|||||||++|||++ |..||......
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~- 228 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE- 228 (288)
T ss_pred CcEEECcCCcccccccccccc------ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 999999999988553322111 1122345678999999999999999999999999999998 78888653111
Q ss_pred ccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhh
Q 001782 926 LTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1005 (1013)
.... .+.+...... ...++..+.+++.+|++.||++|||+.|+++.+++..
T Consensus 229 ----~~~~--------~~~~~~~~~~-----------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 229 ----QVLK--------FVMDGGYLDQ-----------------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ----HHHH--------HHHcCCCCCC-----------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1100 0000000000 0122456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=313.21 Aligned_cols=277 Identities=21% Similarity=0.292 Sum_probs=201.4
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++|||++++++++. .....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence 478999999999999999999998899999999864332 22356789999999999999999999853 45788
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||++++++..+.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 76 ~~v~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNP------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred EEEEeccCccHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence 9999999988888877543 4689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh-
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM- 934 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~- 934 (1013)
+........ ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. .......
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~ 217 (286)
T cd07847 147 ARILTGPGD--------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTL 217 (286)
T ss_pred ceecCCCcc--------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHh
Confidence 986543211 1223457889999999876 4578899999999999999999999975432211 1111100
Q ss_pred -hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 -ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 -~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
...+...+..+..-.... ...................+..+.+++.+||+.+|++||++.|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 218 GDLIPRHQQIFSTNQFFKG-LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCCChHHhhhccccccccc-ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000111111000000000 0000000000001111223567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=322.09 Aligned_cols=252 Identities=22% Similarity=0.325 Sum_probs=207.4
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
+-|.++..||.|+||.||+|..+.++...|.|++......+.+++.-|++||..++||+|+++++.|+ .++..|+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkLwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKLWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCceEE
Confidence 45677889999999999999999888888999999888888899999999999999999999999853 4578999
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
+.|||.||-.+.++-.-. ..+.+.++..++.|++.||.|||++ .|||||+|+.|||++-+|.++|+|||.+.
T Consensus 107 liEFC~GGAVDaimlEL~-----r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELG-----RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred EEeecCCchHhHHHHHhc-----cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccc
Confidence 999999999999887653 4789999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGM-----GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
... ........+.|||+|||||+.. ..+|++++||||||+++.||..+.+|-.....
T Consensus 179 Kn~--------~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---------- 240 (1187)
T KOG0579|consen 179 KNK--------STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---------- 240 (1187)
T ss_pred cch--------hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----------
Confidence 432 2223355788999999999854 46899999999999999999999999654311
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..++-+.-..+| +.+-++......+.+++.+|+..||..||+++++++
T Consensus 241 -------MRVllKiaKSeP-----------PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 241 -------MRVLLKIAKSEP-----------PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -------HHHHHHHhhcCC-----------CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 111111111111 111222344567889999999999999999999975
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.24 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=208.0
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc---chhHHHHHHHHHhcCC-CCccceEEEEeecCCccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG---ATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 772 (1013)
....|++.+.||+|.||.||+++.+.+|+.+|+|++...... ..+.+.+|+.+|+++. ||||+.+++++ +.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----ED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ec
Confidence 456899999999999999999999999999999999754432 3457899999999998 99999999995 55
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC----Cc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD----MV 848 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~ 848 (1013)
....++|||++.||.|.+.+... .+++.++..++.|++.|++|+|+. ||+|||+||+|+|+... +.
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCc
Confidence 57999999999999999999875 289999999999999999999999 99999999999999643 47
Q ss_pred eEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccH
Q 001782 849 AHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 928 (1013)
Q Consensus 849 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~ 928 (1013)
+|++|||+|....+ .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||..........
T Consensus 178 ik~~DFGla~~~~~---------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~ 248 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKP---------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL 248 (382)
T ss_pred EEEeeCCCceEccC---------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH
Confidence 99999999987643 233567889999999999999999999999999999999999999998643221111
Q ss_pred HHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 929 HEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 929 ~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.+... ++ ....+.+........++++.|+..||.+|+|+.++++.
T Consensus 249 -------------~i~~~----~~----------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 -------------AILRG----DF----------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -------------HHHcC----CC----------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111 11 00111122335567889999999999999999999874
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=321.99 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=207.6
Q ss_pred cCCCCCceeeccceEEEEEEECC---CCeEEEEEEEeecccc-chhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGE---NEMAVAVKVMNLKQRG-ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
+....++||+|.||.||+|.|.. +-..||||.++..... ...+|.+|+.+|.+++|||++++||+..+ ..
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QP 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------ch
Confidence 44556899999999999999943 3356899999866544 56789999999999999999999999632 45
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
..+|||.++.|+|.+.++.... ..+.......++.|||.||.||.++ +.||||+.++|+++.....|||+|||
T Consensus 185 ~mMV~ELaplGSLldrLrka~~----~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKK----AILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccc----cceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccc
Confidence 6799999999999999998432 5788889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
+.+-++.....+.+.. ...-...|+|||.+....++.++|||+|||++|||++ |..||.....
T Consensus 258 LmRaLg~ned~Yvm~p-----~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------- 321 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAP-----QRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------- 321 (1039)
T ss_pred ceeccCCCCcceEecC-----CCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------
Confidence 9998876655443322 2334678999999999999999999999999999998 8899976311
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
..+.+.+| .. .+++..+.|++.+++++++||...|.+|||+..+.+.+-
T Consensus 322 ---~qIL~~iD------~~----------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 322 ---IQILKNID------AG----------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ---HHHHHhcc------cc----------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 01111111 11 122334578899999999999999999999999985543
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=309.96 Aligned_cols=254 Identities=25% Similarity=0.397 Sum_probs=200.2
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccc---------hhHHHHHHHHHhcCCCCccceEEEEeecCCc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA---------TKSFVAECEALRNIRHRNLIKIITVCSSIDF 770 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 770 (1013)
+|.+.+.||+|++|.||+|.+..+++.||+|.+....... .+.+.+|++++++++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL---- 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence 5788899999999999999998888999999886433221 245788999999999999999999853
Q ss_pred cccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceE
Q 001782 771 EEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAH 850 (1013)
Q Consensus 771 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 850 (1013)
.....++||||+++++|.+++... +.+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 77 -DADHLNIFLEYVPGGSVAALLNNY------GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred -eCCccEEEEEecCCCCHHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence 447889999999999999999765 4678889999999999999999999 999999999999999999999
Q ss_pred EccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHH
Q 001782 851 VGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHE 930 (1013)
Q Consensus 851 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~ 930 (1013)
|+|||.++......... ..........|+..|+|||.+.+..++.++||||+||++|+|++|+.||..... ...
T Consensus 147 l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~ 220 (267)
T cd06628 147 ISDFGISKKLEANSLST--KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQA 220 (267)
T ss_pred ecccCCCcccccccccC--CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HHH
Confidence 99999998664321111 011112335588999999999998999999999999999999999999975311 011
Q ss_pred HHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 931 FAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 931 ~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
. ...... .++.. ....+..+.+++.+||+.||.+||++.||++
T Consensus 221 ~---------~~~~~~-------~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 I---------FKIGEN-------ASPEI----------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred H---------HHHhcc-------CCCcC----------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 000000 00000 0122456788999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.93 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=196.8
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.|+..+.||+|+||+||+|.+..+++.||+|++..... .....+.+|++++++++|++|+++.+++ ..++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence 36677899999999999999999999999999864321 2234577899999999999999999885 345789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+++++|.+++..... ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~ 148 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EEEEEeccCccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCc
Confidence 999999999999988865422 3689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+....... ......|+..|+|||++.+..++.++||||+||++|||++|..||........ .....
T Consensus 149 ~~~~~~~~---------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~---- 214 (285)
T cd05632 149 AVKIPEGE---------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVD---- 214 (285)
T ss_pred ceecCCCC---------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH----
Confidence 87543211 12234689999999999988999999999999999999999999975321100 00000
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCC-----HHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ-----MTDVVAK 1000 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 1000 (1013)
.......+. .....+..+.+++..|++.||++||+ +.+++..
T Consensus 215 --------~~~~~~~~~--------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 215 --------RRVLETEEV--------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --------Hhhhccccc--------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 000000000 00112345678999999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.91 Aligned_cols=275 Identities=20% Similarity=0.309 Sum_probs=198.3
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|++++++++||||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 58888999999999999999999999999999874322 2235678899999999999999999984 4557899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+|+||++ ++|.+++.... ..+++..++.++.||++||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 76 lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred EEEecCC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence 9999998 68888876532 4689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+...... .......++..|+|||++.+. .++.++|||||||++|||++|+.|+..................
T Consensus 147 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
T cd07839 147 RAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 218 (284)
T ss_pred hccCCCC--------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC
Confidence 7543211 112234578899999998765 4789999999999999999999987543222211211111111
Q ss_pred ChhHHH--hhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 PEKVME--IVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 ~~~~~~--~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
...... .+... .+....+. ......-.+........+.+++.+||+.||.+|||++|+++
T Consensus 219 ~~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 219 TPTEESWPGVSKL--PDYKPYPM-YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCChHHhHHhhhc--ccccccCC-CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 100000 00000 00000000 00000000111123456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=315.35 Aligned_cols=268 Identities=22% Similarity=0.346 Sum_probs=199.3
Q ss_pred hccCCCCCceeeccceEEEEEEECCC--------------CeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGEN--------------EMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKII 762 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~ 762 (1013)
.++|++.++||+|+||.||+|++.+. ...||+|+++.... .....+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 46899999999999999999987543 23589999874422 2345688999999999999999999
Q ss_pred EEeecCCccccceEEEEEeeccCCCHHHHhhccccc------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 001782 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQ------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDL 836 (1013)
Q Consensus 763 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dl 836 (1013)
+++. .....++||||+++++|.+++...... .....+++.+++.++.|++.|++|||++ +++||||
T Consensus 84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl 155 (295)
T cd05097 84 GVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDL 155 (295)
T ss_pred EEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 9964 446789999999999999999653211 1112478899999999999999999999 9999999
Q ss_pred CCCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh--C
Q 001782 837 KPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT--R 914 (1013)
Q Consensus 837 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~--G 914 (1013)
||+||+++.++.+||+|||++......... .......++..|+|||+..++.++.++|||||||++|||++ |
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~ 229 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcce------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCC
Confidence 999999999999999999998754322111 11223345788999999998899999999999999999998 6
Q ss_pred CCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCH
Q 001782 915 RRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQM 994 (1013)
Q Consensus 915 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 994 (1013)
..||....... ..... .+..+......+... ....+..+.+++.+|++.||++|||+
T Consensus 230 ~~p~~~~~~~~-~~~~~---------~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~RPs~ 286 (295)
T cd05097 230 EQPYSLLSDEQ-VIENT---------GEFFRNQGRQIYLSQ-------------TPLCPSPVFKLMMRCWSRDIKDRPTF 286 (295)
T ss_pred CCCCcccChHH-HHHHH---------HHhhhhccccccCCC-------------CCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 66776432110 00000 000000000000000 00123568999999999999999999
Q ss_pred HHHHHHHH
Q 001782 995 TDVVAKLC 1002 (1013)
Q Consensus 995 ~evl~~L~ 1002 (1013)
++|++.|+
T Consensus 287 ~~i~~~l~ 294 (295)
T cd05097 287 NKIHHFLR 294 (295)
T ss_pred HHHHHHHh
Confidence 99999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.95 Aligned_cols=259 Identities=28% Similarity=0.493 Sum_probs=201.7
Q ss_pred hccCCCCCceeeccceEEEEEEECCCC---eEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENE---MAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
.++|+..+.||+|+||.||+|++..++ ..||+|.++... ....+.+.+|++++++++|||++++.+++. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cC
Confidence 357888899999999999999986544 379999886442 233467889999999999999999999964 44
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
+..++||||+++++|.+++.... +.+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d 150 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSD 150 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECC
Confidence 67899999999999999997542 4689999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~ 932 (1013)
||++........... .......+..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 151 fg~~~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-------- 217 (268)
T cd05063 151 FGLSRVLEDDPEGTY-----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-------- 217 (268)
T ss_pred Cccceecccccccce-----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------
Confidence 999876543221110 0111223567999999998889999999999999999997 99998643110
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
+....+.... +... ...++..+.+++.+||+.+|++||++.+|++.|.++
T Consensus 218 ------~~~~~i~~~~------~~~~----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 218 ------EVMKAINDGF------RLPA----------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------HHHHHHhcCC------CCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111111000 0000 012345678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.41 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=197.9
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIV 779 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 779 (1013)
-|++.+.||+|+||.||+|.+..++..+++|.+........+.+.+|+++++.++||||+++++++. .+...++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEE
Confidence 4678899999999999999999899999999987555445567889999999999999999999864 34788999
Q ss_pred EeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccccc
Q 001782 780 YEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859 (1013)
Q Consensus 780 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 859 (1013)
|||+++++|..++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 81 ~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 81 IEFCAGGAVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred EEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccc
Confidence 99999999999876532 4689999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCCCccccCCCCCcccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 860 LPPCSPATILETPSSSTGIKGTVGYVAPEYGM-----GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
.... ........++..|+|||++. +..++.++||||+||++|||++|+.||...... ....
T Consensus 153 ~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~-- 218 (282)
T cd06643 153 NTRT--------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----RVLL-- 218 (282)
T ss_pred cccc--------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH----HHHH--
Confidence 4321 11123456889999999874 345788999999999999999999998653211 0000
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.... ..+ +. .......+..+.+++.+||+.||.+||++.++++
T Consensus 219 -------~~~~----~~~---~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 219 -------KIAK----SEP---PT--------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -------HHhh----cCC---CC--------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000 00 0000112346789999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=328.37 Aligned_cols=274 Identities=20% Similarity=0.235 Sum_probs=200.0
Q ss_pred hccCCCCCceeeccceEEEEEEEC--CCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLG--ENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
..+|.+.+.||+|+||.||+|... ..++.||+|.+... +...+|++++++++||||+++++++ .....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCE
Confidence 357999999999999999999764 34678999987532 3456899999999999999999985 34578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++|||++. ++|.+++... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG 230 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRS------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG 230 (392)
T ss_pred EEEEehhcC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence 999999997 7898888543 5789999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCC--ccHHHHHH
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDG--LTLHEFAK 933 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~--~~~~~~~~ 933 (1013)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.....
T Consensus 231 ~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~ 304 (392)
T PHA03207 231 AACKLDAHPD------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304 (392)
T ss_pred cccccCcccc------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH
Confidence 9976543211 111234679999999999999999999999999999999999999997643221 11111111
Q ss_pred hh------CChh-HHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 934 MA------LPEK-VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 934 ~~------~~~~-~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.. ++.. ...+....-......|+.... +...........+.+++.+|+..||++|||+.|++..
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 305 CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTI---PPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HhccCccccCCccchhHHHHHHhhcccccCCccc---cchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 10 0100 001111111111111111100 0000001123457789999999999999999999864
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=314.08 Aligned_cols=263 Identities=21% Similarity=0.308 Sum_probs=206.3
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.++|++.++||+|+||+||+|++..+++.||+|++..... ...+.+.+|+++++.++||||+++++++. .....
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEE
Confidence 3578899999999999999999998899999999875432 33467899999999999999999999964 34789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+++++|.+++... +.+++..+..++.|++.|+.|||+.. +++||||||+||+++.++.++|+|||+
T Consensus 79 ~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKG------GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred EEEEecCCCCCHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCc
Confidence 9999999999999998764 46899999999999999999999732 899999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+...... ......|+..|+|||++.+..++.++|||||||++|++++|+.||........ ....
T Consensus 151 ~~~~~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~------~~~~ 214 (284)
T cd06620 151 SGELINS----------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD------GQDD 214 (284)
T ss_pred ccchhhh----------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh------hhhh
Confidence 8643211 12235689999999999888999999999999999999999999986432211 0011
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
+....+.+.......+.. .. ..+.+..+.+++.+|++.||++|||+.|+++..
T Consensus 215 ~~~~~~~~~~~~~~~~~~---~~---------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 215 PMGILDLLQQIVQEPPPR---LP---------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhHHHHHHHHHhhccCCC---CC---------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111222222222111100 00 012345688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.44 Aligned_cols=254 Identities=20% Similarity=0.341 Sum_probs=202.0
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
.++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|++++++++||||+++++++. .+...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence 467999999999999999999998889999999998665555677899999999999999999999964 457889
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++.... ..+++.+++.++.|++.|+.|||+. +|+|+||||+||+++.++.++|+|||.+
T Consensus 79 lv~e~~~~~~L~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-----RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccc
Confidence 9999999999999987642 3689999999999999999999999 9999999999999999999999999988
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM-----GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
....... .......+++.|+|||++. ...++.++||||||+++|||++|+.||...... ...
T Consensus 151 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----~~~- 217 (280)
T cd06611 151 AKNKSTL--------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----RVL- 217 (280)
T ss_pred hhhcccc--------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----HHH-
Confidence 7543211 1123456889999999874 345778999999999999999999999753211 000
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.. .....+ +. .......+..+.+++.+||+.+|.+||++.+|++.
T Consensus 218 --------~~----~~~~~~---~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 218 --------LK----ILKSEP---PT--------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --------HH----HhcCCC---CC--------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00 000000 00 00011223457889999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=309.23 Aligned_cols=257 Identities=24% Similarity=0.369 Sum_probs=199.7
Q ss_pred hhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 694 LSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 694 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
++.+++.+.....||+|+||.||+|++..++..||+|.+........+.+.+|++++++++|+||+++++++. .+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 77 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----EN 77 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cC
Confidence 4455666767789999999999999998889999999987655555677899999999999999999999964 44
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC-CCceE
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNF--NVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH-DMVAH 850 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l--~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~k 850 (1013)
+..++|+||+++++|.+++.... ..+ ++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+|
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~ 149 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKW-----GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVK 149 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhc-----ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEE
Confidence 78899999999999999997642 234 7788899999999999999999 9999999999999986 67999
Q ss_pred EccccccccCCCCCCCccccCCCCCcccccccccccccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCCcCCCCccH
Q 001782 851 VGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD--MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 928 (1013)
Q Consensus 851 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~ 928 (1013)
|+|||.+........ ......++..|+|||++.+.. ++.++||||+|+++|+|++|+.||..........
T Consensus 150 l~dfg~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~ 221 (268)
T cd06624 150 ISDFGTSKRLAGINP--------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221 (268)
T ss_pred EecchhheecccCCC--------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH
Confidence 999999875532111 122345789999999987654 7889999999999999999999986532111000
Q ss_pred HHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 929 HEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 929 ~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+. .......+ . ........+.+++.+||+.+|.+|||+.|+++
T Consensus 222 --~~------------~~~~~~~~------------~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 222 --FK------------VGMFKIHP------------E--IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --hh------------hhhhccCC------------C--CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00 00000000 0 00122345788999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=321.45 Aligned_cols=281 Identities=17% Similarity=0.162 Sum_probs=197.5
Q ss_pred CCCceeec--cceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 703 SSNMIGQG--SFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 703 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
+.++||+| +|++||++++..+++.||+|+++.... ...+.+.+|+++++.++||||+++++++. .++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 46789999 789999999999999999999975432 23356788999999999999999999964 4477899
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
||||+++++|.+++..... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.++++||+.+.
T Consensus 77 v~e~~~~~~l~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFM----DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEeccCCCcHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 9999999999999976432 3589999999999999999999999 99999999999999999999999998754
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCC--CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG--GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
.......... ..........++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... .......
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~ 227 (327)
T cd08227 150 SMINHGQRLR-VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTV 227 (327)
T ss_pred cccccccccc-ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH-HHhcCCc
Confidence 3321111000 00111223456788999999876 458899999999999999999999997643221111 1111111
Q ss_pred Chh-------HHHhhhh--------hhccch---hhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 001782 937 PEK-------VMEIVDP--------LLLLDL---EARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVV 998 (1013)
Q Consensus 937 ~~~-------~~~~i~~--------~l~~~~---~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 998 (1013)
+.. ..+.... ...... ..++... .....+........+.+++.+||+.||++|||++|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell 305 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNG--ESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL 305 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCcccc--CCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence 100 0000000 000000 0000000 0000111223456788999999999999999999998
Q ss_pred H
Q 001782 999 A 999 (1013)
Q Consensus 999 ~ 999 (1013)
+
T Consensus 306 ~ 306 (327)
T cd08227 306 N 306 (327)
T ss_pred c
Confidence 6
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=311.95 Aligned_cols=260 Identities=28% Similarity=0.466 Sum_probs=201.2
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCe---EEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEM---AVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
.+|++.+.||+|+||.||+|++..++. .||+|++.... ....+++..|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence 468889999999999999999876553 69999986432 23356799999999999999999999985 3456
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..++||||+++++|.+++.... +.+++.+++.++.|++.|++|||++ |++||||||+||+++.++.+|++||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~df 150 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF 150 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCC
Confidence 7899999999999999997642 3688999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~ 933 (1013)
|.+........... .........+..|+|||++.+..++.++||||+||++||+++ |..||......
T Consensus 151 g~~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------- 218 (269)
T cd05065 151 GLSRFLEDDTSDPT---YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------- 218 (269)
T ss_pred ccccccccCccccc---cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---------
Confidence 99876543221110 000111112457999999999999999999999999999886 99998653211
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
+..+.+.... +.. ...+++..+.+++.+||+.+|.+||++.+|+..|+++
T Consensus 219 -----~~~~~i~~~~------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 219 -----DVINAIEQDY------RLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----HHHHHHHcCC------cCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111111000 000 0112345678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=308.03 Aligned_cols=251 Identities=31% Similarity=0.475 Sum_probs=201.9
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
.++|++.+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++. .....+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeE
Confidence 457899999999999999999885 67899999975543 4577899999999999999999999964 357789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++..... ..+++.++..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccc
Confidence 99999999999999986532 3689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+...... .....+..|+|||++.++.++.++||||||+++||+++ |..||...... .
T Consensus 150 ~~~~~~~-----------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~------ 207 (256)
T cd05039 150 KEASQGQ-----------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----D------ 207 (256)
T ss_pred ccccccc-----------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----H------
Confidence 8552211 12234568999999998899999999999999999997 99998653111 0
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
..+.+.. ++ ++.. ....+..+.+++.+|+..+|++|||+.|++++|+.+
T Consensus 208 ---~~~~~~~----~~--~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 208 ---VVPHVEK----GY--RMEA----------PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---HHHHHhc----CC--CCCC----------ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1111100 00 0000 012245678999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=307.04 Aligned_cols=254 Identities=28% Similarity=0.479 Sum_probs=199.2
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
.++|.+.+.||+|++|.||+|.+..+ ..||+|.+.... ...+.+.+|++++++++||+++++++++. ....+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 76 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIY 76 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcE
Confidence 35789999999999999999998754 459999876432 23467889999999999999999998852 24578
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||||+||++++++.+||+|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~ 149 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLA 149 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccc
Confidence 99999999999999976422 3578999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
........ .......++..|+|||+..+..++.++||||||+++|||++ |..||......
T Consensus 150 ~~~~~~~~-------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------------ 210 (260)
T cd05069 150 RLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR------------ 210 (260)
T ss_pred eEccCCcc-------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 76532211 01122345678999999988899999999999999999999 89998753211
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
...+.+.... ++. .....+..+.+++.+||+.||++||++++|++.|++
T Consensus 211 --~~~~~~~~~~------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 211 --EVLEQVERGY------RMP----------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --HHHHHHHcCC------CCC----------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0001000000 000 001234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=314.74 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=199.6
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
.+.|++.++||+|+||.||+|++..+++.||+|++........+.+.+|+++++.++||||+++++.+. .+...+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEE
Confidence 357999999999999999999999889999999997665555677889999999999999999999864 346899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|..++.... ..+++.++..++.|++.|++|||++ +++||||||+||+++.++.+||+|||.+
T Consensus 86 lv~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~ 157 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVS 157 (292)
T ss_pred EEEecCCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccc
Confidence 9999999999998876542 3689999999999999999999999 9999999999999999999999999988
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM-----GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
...... ........++..|+|||++. ...++.++|||||||++|||++|+.||...... ..
T Consensus 158 ~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~-- 223 (292)
T cd06644 158 AKNVKT--------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RV-- 223 (292)
T ss_pred eecccc--------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----HH--
Confidence 643211 11123345788999999975 345788999999999999999999998653110 00
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
...... ..+ + ...........+.+++.+||+.+|++||+++|+++
T Consensus 224 -------~~~~~~----~~~---~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 224 -------LLKIAK----SEP---P--------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -------HHHHhc----CCC---c--------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 000 0 00001122345788999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=314.67 Aligned_cols=263 Identities=25% Similarity=0.423 Sum_probs=201.9
Q ss_pred hhccCCCCCceeeccceEEEEEEECC-----CCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGE-----NEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDF 770 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 770 (1013)
..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+++.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~---- 78 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA---- 78 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc----
Confidence 35689999999999999999998743 567899999874432 23456889999999999999999999864
Q ss_pred cccceEEEEEeeccCCCHHHHhhccccc----------------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 001782 771 EEVDFKAIVYEYMECGSLEDWLHQSNDQ----------------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHG 834 (1013)
Q Consensus 771 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~ 834 (1013)
.+...++||||+++++|.+++...... .....+++.+++.++.|++.||+|||++ +++||
T Consensus 79 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~ 154 (288)
T cd05050 79 -VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHR 154 (288)
T ss_pred -CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceecc
Confidence 346789999999999999999754221 1113578899999999999999999999 99999
Q ss_pred CCCCCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-
Q 001782 835 DLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT- 913 (1013)
Q Consensus 835 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~- 913 (1013)
||||+||++++++.+||+|||.++.+....... .......+..|+|||.+.+..++.++|||||||++|||++
T Consensus 155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~ 228 (288)
T cd05050 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYK------ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 228 (288)
T ss_pred cccHhheEecCCCceEECccccceecccCcccc------ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhC
Confidence 999999999999999999999987543322111 1122234678999999998899999999999999999997
Q ss_pred CCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCC
Q 001782 914 RRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ 993 (1013)
Q Consensus 914 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 993 (1013)
|..||...... +.. ..+.+... +.. ...++..+.+++.+|++.||.+|||
T Consensus 229 ~~~p~~~~~~~-----~~~--------~~~~~~~~-------~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt 278 (288)
T cd05050 229 GMQPYYGMAHE-----EVI--------YYVRDGNV-------LSC----------PDNCPLELYNLMRLCWSKLPSDRPS 278 (288)
T ss_pred CCCCCCCCCHH-----HHH--------HHHhcCCC-------CCC----------CCCCCHHHHHHHHHHcccCcccCCC
Confidence 88888643111 100 00000000 000 0122456889999999999999999
Q ss_pred HHHHHHHHHH
Q 001782 994 MTDVVAKLCS 1003 (1013)
Q Consensus 994 ~~evl~~L~~ 1003 (1013)
+.|+++.|+.
T Consensus 279 ~~el~~~l~~ 288 (288)
T cd05050 279 FASINRILQR 288 (288)
T ss_pred HHHHHHHhhC
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=320.81 Aligned_cols=202 Identities=26% Similarity=0.356 Sum_probs=172.4
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec---cccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.+.||+|+||+||+|++..+++.||+|++... .....+.+.+|+.+++.++|++|+++++++ ..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 4789999999999999999999989999999999742 222345688999999999999999999985 45578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++|+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence 999999999999999997632 3688999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-----GDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
++..+..... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||..
T Consensus 148 ~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 148 SCLRLLADGT-------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ceeecCCCCC-------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 9875432111 11223468999999999863 4578899999999999999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=308.23 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=193.3
Q ss_pred CceeeccceEEEEEEECC---CCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGE---NEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
+.||+|+||.||+|.+.. ....||+|.+.... ....+.+.+|+.+++.++||||+++++++. ..+...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL----PSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEee----cCCCCcEEEE
Confidence 468999999999998643 34679999875322 233467889999999999999999999864 2335678999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+.+++|.+++.... ...++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.+
T Consensus 77 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 77 PYMKHGDLRNFIRSET-----HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred ecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccc
Confidence 9999999999997642 2467788899999999999999999 9999999999999999999999999999755
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhC-CCCCCCcCCCCccHHHHHHhhCChh
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFNDGLTLHEFAKMALPEK 939 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G-~~pf~~~~~~~~~~~~~~~~~~~~~ 939 (1013)
....... ........++..|+|||++.+..++.++|||||||++|||++| .+||..... ..
T Consensus 149 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~--------- 210 (262)
T cd05058 149 YDKEYYS----VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----FD--------- 210 (262)
T ss_pred cCCccee----ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HH---------
Confidence 3221111 0111233457789999999888999999999999999999995 555543210 00
Q ss_pred HHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhh
Q 001782 940 VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 940 ~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1006 (1013)
.........+ +.. ....+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 211 ---~~~~~~~~~~---~~~----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 211 ---ITVYLLQGRR---LLQ----------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---HHHHHhcCCC---CCC----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0000000000 000 01123468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=312.93 Aligned_cols=266 Identities=20% Similarity=0.291 Sum_probs=206.8
Q ss_pred cchhhhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcC-CCCccceEEEEeec
Q 001782 689 VSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVCSS 767 (1013)
Q Consensus 689 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 767 (1013)
.++.++..+.+.|++.+.||+|+||.||+|++..+++.||+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 355666677889999999999999999999999899999999986443 2345688899999998 69999999998753
Q ss_pred CCc-cccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC
Q 001782 768 IDF-EEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD 846 (1013)
Q Consensus 768 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 846 (1013)
... ......+++|||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +++|+||||+||+++++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 211 235678999999999999999976532 3578888999999999999999999 99999999999999999
Q ss_pred CceEEccccccccCCCCCCCccccCCCCCcccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 847 MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM-----GGDMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 847 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
+.++|+|||++...... ........|+..|+|||++. +..++.++|||||||++|||++|..||...
T Consensus 158 ~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 158 AEVKLVDFGVSAQLDRT--------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred CCEEEeeCcchhhhhcc--------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 99999999998754321 11123456889999999876 346788999999999999999999999653
Q ss_pred CCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 922 FNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
... ... ...... ..+ . ......+..+.+++.+||+.||.+||++.|+++
T Consensus 230 ~~~----~~~---------~~~~~~---~~~----~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 230 HPM----RAL---------FLIPRN---PPP----K---------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CHH----hhh---------hhHhhC---CCC----C---------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 211 000 000000 000 0 000123456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=309.09 Aligned_cols=255 Identities=26% Similarity=0.463 Sum_probs=201.4
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
..++|++.++||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++. .+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~ 75 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPI 75 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCc
Confidence 3468999999999999999999876 56789999987433 33467899999999999999999998742 2468
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
+++|||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~ 148 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGL 148 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcc
Confidence 999999999999999876432 4688999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhh
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
+........ .......++..|+|||++.+..++.++||||||+++||+++ |+.||......
T Consensus 149 ~~~~~~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------- 210 (260)
T cd05067 149 ARLIEDNEY-------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP----------- 210 (260)
T ss_pred eeecCCCCc-------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-----------
Confidence 876542111 01123345678999999998899999999999999999999 99999753211
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
...+.+.... ++.. ....+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 211 ---~~~~~~~~~~------~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 211 ---EVIQNLERGY------RMPR----------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---HHHHHHHcCC------CCCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0011010000 0000 01123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=308.14 Aligned_cols=259 Identities=29% Similarity=0.475 Sum_probs=201.5
Q ss_pred hccCCCCCceeeccceEEEEEEECCC---CeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGEN---EMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
.++|++.+.||+|+||.||+|++..+ +..||+|.++... ....+.+.+|+.++++++||||+++++++. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 35788999999999999999988533 3479999886432 223457899999999999999999999863 44
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
+..++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~d 149 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSD 149 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCC
Confidence 67899999999999999997642 3579999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~ 932 (1013)
||.+..+....... .......++..|+|||++.+..++.++|||||||++||+++ |..||......+
T Consensus 150 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~------- 217 (267)
T cd05066 150 FGLSRVLEDDPEAA-----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD------- 217 (267)
T ss_pred CCccccccccccee-----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------
Confidence 99998664322111 01112233568999999998899999999999999999886 999986532110
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
....+.... ++.. ...++..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 218 -------~~~~~~~~~------~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 218 -------VIKAIEEGY------RLPA----------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------HHHHHhCCC------cCCC----------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000000000 0000 012245678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=311.08 Aligned_cols=258 Identities=25% Similarity=0.396 Sum_probs=202.4
Q ss_pred hccCCCCCceeeccceEEEEEEECCC---CeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGEN---EMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
..+|.+.++||+|+||.||+|.+... ...||+|...... ....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------ 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------
Confidence 45688899999999999999987543 4568999887544 2345678999999999999999999998642
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d 150 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGD 150 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEcc
Confidence 44689999999999999997642 3589999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~ 932 (1013)
||+++........ ......++..|+|||.+....++.++||||||+++||+++ |..||......+. ...
T Consensus 151 ~g~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~-- 220 (270)
T cd05056 151 FGLSRYLEDESYY-------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-IGR-- 220 (270)
T ss_pred Cceeeecccccce-------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHH--
Confidence 9998765332110 0112234568999999988889999999999999999996 9999975422110 000
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhh
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1006 (1013)
+.. . .++.. ...++..+.+++.+|+..+|++|||+.|+++.|+++.+
T Consensus 221 -----------~~~---~---~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 221 -----------IEN---G---ERLPM----------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -----------HHc---C---CcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000 0 00000 01234568889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=318.05 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=203.7
Q ss_pred hccCCCCCceeeccceEEEEEEECC-------CCeEEEEEEEeecc-ccchhHHHHHHHHHhcC-CCCccceEEEEeecC
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGE-------NEMAVAVKVMNLKQ-RGATKSFVAECEALRNI-RHRNLIKIITVCSSI 768 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 768 (1013)
..+|++.+.||+|+||.||+|++.. ....||+|++.... ....+++.+|+++++++ +||||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--
Confidence 3579999999999999999998642 23468999887432 22346788999999999 7999999999964
Q ss_pred CccccceEEEEEeeccCCCHHHHhhccccc----------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 001782 769 DFEEVDFKAIVYEYMECGSLEDWLHQSNDQ----------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKP 838 (1013)
Q Consensus 769 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp 838 (1013)
.....+++|||+++|+|.+++...... .....+++.++..++.|++.|++|||++ +++||||||
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 162 (334)
T cd05100 89 ---QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA 162 (334)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccccc
Confidence 346789999999999999999764321 1224588899999999999999999999 999999999
Q ss_pred CceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCC
Q 001782 839 SNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRP 917 (1013)
Q Consensus 839 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~p 917 (1013)
+||++++++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 236 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236 (334)
T ss_pred ceEEEcCCCcEEECCcccceeccccccc------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999765322111 01122334578999999999999999999999999999998 8888
Q ss_pred CCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 001782 918 TDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDV 997 (1013)
Q Consensus 918 f~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 997 (1013)
|..... ... ...+... ..... ...++..+.+++.+|++.+|.+||++.|+
T Consensus 237 ~~~~~~-----~~~---------~~~~~~~---~~~~~-------------~~~~~~~l~~li~~cl~~~p~~Rps~~el 286 (334)
T cd05100 237 YPGIPV-----EEL---------FKLLKEG---HRMDK-------------PANCTHELYMIMRECWHAVPSQRPTFKQL 286 (334)
T ss_pred CCCCCH-----HHH---------HHHHHcC---CCCCC-------------CCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 865311 111 1111000 00000 01224568899999999999999999999
Q ss_pred HHHHHHhhhh
Q 001782 998 VAKLCSARKI 1007 (1013)
Q Consensus 998 l~~L~~~~~~ 1007 (1013)
++.|+.+...
T Consensus 287 l~~l~~~~~~ 296 (334)
T cd05100 287 VEDLDRVLTV 296 (334)
T ss_pred HHHHHHHhhh
Confidence 9999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.71 Aligned_cols=260 Identities=22% Similarity=0.398 Sum_probs=203.2
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCe----EEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEM----AVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 772 (1013)
..+|++.+.||+|+||.||+|.+..++. .||+|....... .....+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS----- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 3578899999999999999999865543 689998764432 234578899999999999999999999742
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
...++||||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~ 151 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHK-----DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKIT 151 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEEC
Confidence 56889999999999999997653 3589999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHH
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~ 931 (1013)
|||.++......... ......++..|+|||.+....++.++||||||+++||+++ |+.||......
T Consensus 152 dfg~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------- 218 (279)
T cd05057 152 DFGLAKLLDVDEKEY------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------- 218 (279)
T ss_pred CCcccccccCcccce------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-------
Confidence 999998664322111 1112224578999999988899999999999999999998 99998753111
Q ss_pred HHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 001782 932 AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007 (1013)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 1007 (1013)
+....+... .+...+ ..+...+.+++.+||..+|.+||++.++++.+.++.+.
T Consensus 219 -------~~~~~~~~~---~~~~~~-------------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 219 -------EIPDLLEKG---ERLPQP-------------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred -------HHHHHHhCC---CCCCCC-------------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 111111100 000000 01223567899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=312.75 Aligned_cols=275 Identities=21% Similarity=0.339 Sum_probs=197.9
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.++|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+|++++++++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeE
Confidence 3689999999999999999999988899999999874432 22345778999999999999999999953 45789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||++ ++|.+++.... ..+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 79 ~lv~e~~~-~~L~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 79 TLVFEYLD-TDLKQYMDDCG-----GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred EEEEecCC-CCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccc
Confidence 99999998 59999887642 3678999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
++...... .......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.................
T Consensus 150 ~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~ 221 (291)
T cd07844 150 ARAKSVPS--------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL 221 (291)
T ss_pred ccccCCCC--------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhc
Confidence 86432110 11122346789999999876 4588999999999999999999999975432111111111111
Q ss_pred CC---hhHHHhhhhhhccchhhhhccCCC--CchhHHHHHHH--HHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 936 LP---EKVMEIVDPLLLLDLEARASNCGS--HRTEIAKIEEC--LVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 936 ~~---~~~~~~i~~~l~~~~~~R~~~~~~--~~~~~~~~~~~--~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.. ........ .+..+...... ........... ...+.+++.+|++.+|++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 222 GTPTEETWPGVSS-----NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CCCChhhhhhhhh-----ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00000000 00000000000 00000000011 145678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=307.37 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=194.0
Q ss_pred CceeeccceEEEEEEECCCCe--EEEEEEEeecc-ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEM--AVAVKVMNLKQ-RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
+.||+|+||.||+|++.+++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++. .....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence 468999999999999977664 46888876322 23345788999999999 7999999999964 346789999
Q ss_pred eeccCCCHHHHhhccccc----------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceE
Q 001782 781 EYMECGSLEDWLHQSNDQ----------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAH 850 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 850 (1013)
||+++++|.+++...+.. .....+++.+++.++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 999999999999765321 1123578999999999999999999999 999999999999999999999
Q ss_pred EccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHH
Q 001782 851 VGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLH 929 (1013)
Q Consensus 851 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~ 929 (1013)
++|||++...... ........+..|+|||++....++.++|||||||++|||++ |..||......
T Consensus 153 l~dfgl~~~~~~~---------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----- 218 (270)
T cd05047 153 IADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----- 218 (270)
T ss_pred ECCCCCccccchh---------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----
Confidence 9999998632110 00111233567999999988899999999999999999997 99998653111
Q ss_pred HHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhh
Q 001782 930 EFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 930 ~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1005 (1013)
.. .+.+.... ++.. ...++..+.+++.+|++.+|.+|||+.|+++.|..+.
T Consensus 219 ~~---------~~~~~~~~------~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 EL---------YEKLPQGY------RLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HH---------HHHHhCCC------CCCC----------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 00000000 0000 0112345789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=322.34 Aligned_cols=192 Identities=22% Similarity=0.339 Sum_probs=164.7
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
..+|++.+.||+|+||.||+|++..++..||+|+... .....|+.++++++||||+++++++. .....+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 133 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLV-----SGAITC 133 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEE-----eCCeeE
Confidence 4579999999999999999999998899999997532 22356999999999999999999864 446789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+. ++|.+++.... ..+++.+++.|+.||+.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 134 lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 204 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA 204 (357)
T ss_pred EEEEccC-CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccc
Confidence 9999997 78988886542 4689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPT 918 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf 918 (1013)
+.... ........||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 205 ~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 205 QFPVV---------APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccc---------CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 74321 11123456899999999999999999999999999999999865554
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.00 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=202.6
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
.++|++.++||+|+||.||+|.+..++..||+|.+..... .+++.+|++++++++||||+++++++. .....+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEE
Confidence 3689999999999999999999998889999999875433 578999999999999999999999864 447899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+++||+++++|.+++.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||.+
T Consensus 75 l~~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~ 146 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS 146 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccc
Confidence 9999999999999997542 4689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
........ ......++..|+|||++.+..++.++||||||+++|+|++|+.||........ .
T Consensus 147 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~------ 208 (256)
T cd06612 147 GQLTDTMA--------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----I------ 208 (256)
T ss_pred hhcccCcc--------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----h------
Confidence 86543211 12234578899999999998999999999999999999999999875321100 0
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..+.... .............+.+++.+|++.||++|||+.||++
T Consensus 209 ----~~~~~~~--------------~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 209 ----FMIPNKP--------------PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ----hhhccCC--------------CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0000000 0000011123356788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=313.25 Aligned_cols=276 Identities=25% Similarity=0.390 Sum_probs=207.1
Q ss_pred ccCCCCCceeeccceEEEEEEEC----CCCeEEEEEEEeecccc-chhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLG----ENEMAVAVKVMNLKQRG-ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
.+|++.+.||+|+||.||+|+.. +++..||+|++...... ..+.+.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 46788899999999999999864 34788999999755443 45679999999999999999999998743 235
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++||||+++++|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR-----DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc-----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence 67899999999999999997653 2589999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||.+........... ......++..|+|||...+..++.++||||||+++|||++|+.|+......... +..
T Consensus 153 fg~~~~~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~ 224 (284)
T cd05038 153 FGLAKVLPEDKDYYY-----VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIG 224 (284)
T ss_pred cccccccccCCccee-----ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccc
Confidence 999986643221110 111233556799999998889999999999999999999999998653221110 000
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhh
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1005 (1013)
..........+...+... .+.+ ....++.++.+++.+||+.+|++|||+.||+++|+.++
T Consensus 225 ~~~~~~~~~~~~~~~~~~--~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 225 IAQGQMIVTRLLELLKEG--ERLP----------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred cccccccHHHHHHHHHcC--CcCC----------CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 000000000000011000 0000 01233467889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.19 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=200.2
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.+.||+|++|.||+|++..+++.||+|.+..... ...+.+.+|++++++++|||++++++.+. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 48899999999999999999988899999999874332 33456889999999999999999998742 2335689
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
++|||+++++|.+++..... ..+++.+++.++.|++.|+++||+. +++||||||+||+++.++.++|+|||++
T Consensus 77 lv~e~~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred EEecccCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence 99999999999999986432 4689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
...... ........+++.|+|||+..+..++.++||||+||++|+|++|+.||..... ....
T Consensus 150 ~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~----- 211 (257)
T cd08223 150 RVLENQ--------CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLV----- 211 (257)
T ss_pred EEeccc--------CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHH-----
Confidence 755321 1112345688999999999999999999999999999999999999864211 1100
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.......+. .. ....+..+.+++.+|++.+|++||++.|+++.
T Consensus 212 ---~~~~~~~~~-~~----------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 212 ---YRIIEGKLP-PM----------------PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---HHHHhcCCC-CC----------------ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 011110000 00 01223467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=310.52 Aligned_cols=262 Identities=21% Similarity=0.306 Sum_probs=204.5
Q ss_pred hhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcC-CCCccceEEEEeecCCc-ccc
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDF-EEV 773 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~ 773 (1013)
.+.++|++.+.||+|++|.||+|.+..+++.|++|++..... ..+.+.+|+++++++ +||||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 457899999999999999999999988889999999875433 346789999999999 69999999999865432 345
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++||||+++++|.+++..... ....+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRK--KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 678999999999999999876431 114789999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-----GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 928 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~ 928 (1013)
||.+....... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||......
T Consensus 157 ~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---- 224 (275)
T cd06608 157 FGVSAQLDSTL--------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---- 224 (275)
T ss_pred Cccceecccch--------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH----
Confidence 99987543211 11234568899999998754 34678999999999999999999999643111
Q ss_pred HHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 929 HEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 929 ~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
... ..+.. .+.. ...........+.+++.+||..||++|||+.|+++
T Consensus 225 ~~~---------~~~~~-----~~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 225 RAL---------FKIPR-----NPPP----------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHH---------HHhhc-----cCCC----------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 00000 0000 00011223456789999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.04 Aligned_cols=254 Identities=21% Similarity=0.327 Sum_probs=195.7
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-----cchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-----GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
.+|+..+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 478999999999999999999988899999999864321 223468889999999999999999998642 234
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...+++|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAY------GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 6788999999999999999765 4578899999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||+++........ ........++..|+|||++.+..++.++||||+||++|||++|+.||...... ...
T Consensus 150 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----~~~-- 218 (266)
T cd06651 150 FGASKRLQTICMS-----GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AAI-- 218 (266)
T ss_pred CCCcccccccccc-----CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----HHH--
Confidence 9998755321110 11122345789999999999988999999999999999999999999753111 100
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
....... ..| ..+ ......+.+++ +||..+|++||+++||++
T Consensus 219 -------~~~~~~~--~~~------------~~~--~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 219 -------FKIATQP--TNP------------QLP--SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -------HHHhcCC--CCC------------CCc--hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0000000 000 000 11123445565 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=307.45 Aligned_cols=256 Identities=28% Similarity=0.466 Sum_probs=202.1
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
..++|++.++||+|+||.||+|.+. +++.||+|.+.... ...+++.+|+.++++++||||+++++++. .....
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPI 76 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCce
Confidence 4578999999999999999999986 45779999987433 33567899999999999999999999853 44678
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+++++|.+++..... ..+++.++..++.|++.|++|||++ +++|+||||+||++++++.+|++|||.
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~ 149 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGL 149 (261)
T ss_pred EEEEeccCCCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECcccc
Confidence 999999999999999976532 4689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhh
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
+........ .......++..|+|||.+.+..++.++||||+|+++||+++ |+.||...... ...
T Consensus 150 ~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~------- 214 (261)
T cd05034 150 ARLIEDDEY-------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVL------- 214 (261)
T ss_pred ceeccchhh-------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHH-------
Confidence 876542110 01112234578999999998899999999999999999998 99998643111 000
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
..+....-...+ ...+..+.+++.+|++.+|++||+++|+.+.|+.
T Consensus 215 -----~~~~~~~~~~~~-----------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 215 -----EQVERGYRMPRP-----------------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----HHHHcCCCCCCC-----------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 010000000000 1123467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=288.52 Aligned_cols=258 Identities=23% Similarity=0.284 Sum_probs=207.1
Q ss_pred hhccCCCC-CceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccc
Q 001782 697 ATNDFSSS-NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 697 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 774 (1013)
.+++|++. ++||-|-.|.|..+..+.+++.+|+|++... ....+|++.--.. .|||||.+++++... +....
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence 35567664 6899999999999999999999999998633 3456788764444 699999999998655 66778
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC---CCceEE
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH---DMVAHV 851 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 851 (1013)
...+|||.|+||.|...++.+++ ..+++.++..|+.||+.|+.|||+. +|.||||||+|+|... +..+||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~----~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGD----QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred eeEeeeecccchHHHHHHHHccc----ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence 88999999999999999998865 5799999999999999999999999 9999999999999975 457999
Q ss_pred ccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHH
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 852 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~ 931 (1013)
+|||+|+.-. ........+-|+.|.|||++...+|+...|+||+||++|-|++|.+||......
T Consensus 206 tDfGFAK~t~---------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~------- 269 (400)
T KOG0604|consen 206 TDFGFAKETQ---------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL------- 269 (400)
T ss_pred cccccccccC---------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-------
Confidence 9999998432 123355677899999999999999999999999999999999999999764221
Q ss_pred HHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 932 AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.+++..+.-|.. +...-.-+++....+...++++.+++.+|.+|-|+.|+++
T Consensus 270 ---aispgMk~rI~~-------------gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 270 ---AISPGMKRRIRT-------------GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ---cCChhHHhHhhc-------------cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 122222222221 1111223455666777889999999999999999999875
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=309.15 Aligned_cols=240 Identities=22% Similarity=0.341 Sum_probs=184.6
Q ss_pred ceeeccceEEEEEEECC------------------------CCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceE
Q 001782 706 MIGQGSFGFVYRGNLGE------------------------NEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKI 761 (1013)
Q Consensus 706 ~lg~G~~g~V~~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 761 (1013)
.||+|+||.||+|.... ....||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 124588998875544445678889999999999999999
Q ss_pred EEEeecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCce
Q 001782 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNV 841 (1013)
Q Consensus 762 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NI 841 (1013)
+++|.. ....++||||+++++|..++.... +.+++..+..++.|+++||+|||++ +|+||||||+||
T Consensus 82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Ni 148 (274)
T cd05076 82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKEK-----GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNI 148 (274)
T ss_pred EEEEEe-----CCceEEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccE
Confidence 999753 367899999999999999987532 4688999999999999999999999 999999999999
Q ss_pred EecCCC-------ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHH-
Q 001782 842 LLDHDM-------VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMF- 912 (1013)
Q Consensus 842 ll~~~~-------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell- 912 (1013)
+++..+ .+|++|||.+..... .....++..|+|||.+.+ ..++.++|||||||++||++
T Consensus 149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~ 216 (274)
T cd05076 149 LLARLGLAEGTSPFIKLSDPGVSFTALS------------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF 216 (274)
T ss_pred EEeccCcccCccceeeecCCcccccccc------------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 997643 489999998763321 112346788999998865 56899999999999999995
Q ss_pred hCCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC
Q 001782 913 TRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI 992 (1013)
Q Consensus 913 ~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 992 (1013)
+|+.||....... .......... .| . .....+.+++.+||+.+|++||
T Consensus 217 ~g~~p~~~~~~~~--------------~~~~~~~~~~-~~-------~----------~~~~~~~~li~~cl~~~p~~Rp 264 (274)
T cd05076 217 DGEVPLKERTPSE--------------KERFYEKKHR-LP-------E----------PSCKELATLISQCLTYEPTQRP 264 (274)
T ss_pred CCCCCccccChHH--------------HHHHHHhccC-CC-------C----------CCChHHHHHHHHHcccChhhCc
Confidence 6999986532111 0111110000 00 0 0123478899999999999999
Q ss_pred CHHHHHHHHH
Q 001782 993 QMTDVVAKLC 1002 (1013)
Q Consensus 993 s~~evl~~L~ 1002 (1013)
|+.+|++.|+
T Consensus 265 s~~~il~~L~ 274 (274)
T cd05076 265 SFRTILRDLT 274 (274)
T ss_pred CHHHHHHhhC
Confidence 9999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=312.37 Aligned_cols=204 Identities=23% Similarity=0.334 Sum_probs=163.5
Q ss_pred CCceeeccceEEEEEEECC--CCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEe
Q 001782 704 SNMIGQGSFGFVYRGNLGE--NEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
..+||+|+||+||+|+... ++..||+|.+.... ....+.+|++++++++||||+++++++.. ..+...++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence 3689999999999999753 56789999886432 23567899999999999999999998753 24467899999
Q ss_pred eccCCCHHHHhhccccc---cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEe----cCCCceEEccc
Q 001782 782 YMECGSLEDWLHQSNDQ---LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL----DHDMVAHVGDF 854 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DF 854 (1013)
|++ ++|.+++...... .....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 988 6888887543211 1123588999999999999999999999 99999999999999 56679999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
|+++....... .........||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 157 G~a~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 157 GFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cceeccCCCcc-----cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 99986543211 11123345689999999998764 5789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.02 Aligned_cols=254 Identities=32% Similarity=0.521 Sum_probs=201.0
Q ss_pred CceeeccceEEEEEEECCC---CeEEEEEEEeeccccc-hhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGEN---EMAVAVKVMNLKQRGA-TKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
++||+|+||.||+|.+... +..||+|++....... .+.+.+|++.++.++|+|++++++++. .....++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 4799999999999999865 8899999997554332 577899999999999999999999964 357899999
Q ss_pred eeccCCCHHHHhhccccc---cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 781 EYMECGSLEDWLHQSNDQ---LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
||+++++|.+++...... .....+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence 999999999999875210 0124689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
........ ........++..|+|||.+....++.++||||+|+++|||++ |..||..... ..
T Consensus 153 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~------ 215 (262)
T cd00192 153 RDVYDDDY------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EE------ 215 (262)
T ss_pred cccccccc------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HH------
Confidence 86643221 111334557889999999988899999999999999999999 6999876411 00
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
..+.+.. . .+.. ....++..+.+++.+|++.+|++|||+.|+++.|+
T Consensus 216 ---~~~~~~~---~---~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 216 ---VLEYLRK---G---YRLP----------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---HHHHHHc---C---CCCC----------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111100 0 0000 01122456889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.83 Aligned_cols=240 Identities=20% Similarity=0.375 Sum_probs=185.8
Q ss_pred CceeeccceEEEEEEECC------------CCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccc
Q 001782 705 NMIGQGSFGFVYRGNLGE------------NEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 772 (1013)
+.||+|+||.||+|+... ....|++|++..........+.+|+.+++.++||||+++++++. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence 468999999999998642 23468999887655555567889999999999999999999964 3
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCc----
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMV---- 848 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---- 848 (1013)
....++||||+++++|..++.... ..+++.++++++.||+.|++|||++ +|+||||||+||+++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~ 147 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC 147 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCC
Confidence 356789999999999999887542 3589999999999999999999999 9999999999999987664
Q ss_pred ---eEEccccccccCCCCCCCccccCCCCCcccccccccccccccC-CCCCCcccchHHHHHHHHHHH-hCCCCCCCcCC
Q 001782 849 ---AHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM-GGDMSATGDVYSFGILLLEMF-TRRRPTDNMFN 923 (1013)
Q Consensus 849 ---~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DIwSlG~il~ell-~G~~pf~~~~~ 923 (1013)
+|++|||.+..... .....++..|+|||++. +..++.++|||||||++|||+ .|..||.....
T Consensus 148 ~~~~~l~d~g~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 148 GPFIKLSDPGIPITVLS------------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred CceeEeCCCCCCccccC------------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 89999999864321 12345788999999886 467899999999999999998 58888764211
Q ss_pred CCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 924 DGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
. . ........... . ......+.+++.+||+.||.+||++.+|++.+
T Consensus 216 ~-----~---------~~~~~~~~~~~-----------~-------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 216 A-----E---------KERFYEGQCML-----------V-------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred h-----H---------HHHHHhcCccC-----------C-------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 0 00000000000 0 00124578899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.21 Aligned_cols=251 Identities=28% Similarity=0.454 Sum_probs=197.4
Q ss_pred CceeeccceEEEEEEECC-CC--eEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGE-NE--MAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
++||+|++|.||+|.+.. .+ ..||+|.+..... ...+.+.+|+.++++++||||+++++++. . ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence 468999999999999854 23 3699999975544 45677999999999999999999999853 2 6789999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++++|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++.+
T Consensus 75 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred EecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccc
Confidence 99999999999987532 3689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCChh
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALPEK 939 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~~~ 939 (1013)
........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 148 ~~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~------ 211 (257)
T cd05040 148 PQNEDHYV-----MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILK------ 211 (257)
T ss_pred ccccccee-----cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH------
Confidence 43221111 1123456789999999998899999999999999999998 99998643111 0000
Q ss_pred HHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 940 VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 940 ~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
. +.. .. .+.. .....+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 212 --~-~~~----~~-~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 212 --K-IDK----EG-ERLE----------RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --H-HHh----cC-CcCC----------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 000 00 0000 00123456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=307.21 Aligned_cols=257 Identities=22% Similarity=0.369 Sum_probs=187.6
Q ss_pred CceeeccceEEEEEEECC--CCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEe
Q 001782 705 NMIGQGSFGFVYRGNLGE--NEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
+.||+|+||.||+|.+.. ++..+|+|.++.... .....+.+|+.++++++||||+++++++. +....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence 468999999999998643 456799998864432 23356888999999999999999999864 3466899999
Q ss_pred eccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCC
Q 001782 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP 861 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 861 (1013)
|+++|+|.+++...... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++...
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999999764321 113567778889999999999999999 99999999999999999999999999987432
Q ss_pred CCCCCccccCCCCCcccccccccccccccCCC-------CCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHH
Q 001782 862 PCSPATILETPSSSTGIKGTVGYVAPEYGMGG-------DMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~ 933 (1013)
.... ........++..|+|||++.+. .++.++||||||+++|||++ |+.||........ . ..
T Consensus 152 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~-~~-- 221 (269)
T cd05087 152 KEDY------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-L-TY-- 221 (269)
T ss_pred Ccce------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-H-HH--
Confidence 2111 0112234578899999987642 35789999999999999996 9999975322110 0 00
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
......... .+|.. .......+.+++..|+ .+|++|||++||++.|+
T Consensus 222 -~~~~~~~~~------~~~~~--------------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 222 -TVREQQLKL------PKPRL--------------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -HhhcccCCC------CCCcc--------------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000000000 00000 0011234677888998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.61 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=202.6
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|+..+.||+|+||.||.++...+++.|++|.+.... ....+++.+|++++++++|+||+++++++. +....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 5888999999999999999999999999999987442 334467889999999999999999999964 457899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
++|||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKG----QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred EEEEecCCCcHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence 99999999999999986532 4689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
........ ......+++.|+|||+..+..++.++||||||+++|||++|..||...... .
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~------- 208 (256)
T cd08221 149 KILGSEYS--------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----N------- 208 (256)
T ss_pred EEcccccc--------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----H-------
Confidence 76533221 123456889999999998888999999999999999999999998642110 0
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
....+.. ..+.. .....+..+.+++.+||+.+|.+||++.|+++.
T Consensus 209 -~~~~~~~----~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 209 -LVVKIVQ----GNYTP-------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -HHHHHHc----CCCCC-------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0111110 00000 001224557889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.48 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=201.3
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCe----EEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEM----AVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 772 (1013)
.++|+..+.||+|+||.||+|.+..++. .||+|++..... ....++.+|+.+++.++||||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS----- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence 3578888999999999999999866654 578888764332 223468899999999999999999998742
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
...++++||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~ 151 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHK-----DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKIT 151 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEc
Confidence 23579999999999999987642 3578999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHH
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~ 931 (1013)
|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 152 Dfg~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~------- 218 (303)
T cd05110 152 DFGLARLLEGDEKE------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR------- 218 (303)
T ss_pred cccccccccCcccc------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------
Confidence 99999865432111 11222345678999999998999999999999999999997 99998653110
Q ss_pred HHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 001782 932 AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007 (1013)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 1007 (1013)
...+++.... ++... ..++..+.+++.+||..+|++||+++|+++.++++.+.
T Consensus 219 -------~~~~~~~~~~------~~~~~----------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 219 -------EIPDLLEKGE------RLPQP----------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -------HHHHHHHCCC------CCCCC----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111111100 00000 01234578899999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.45 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=201.4
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
..|+..++||+|+||.||+|.+..++..||+|++.... ......+.+|+++++++.||||+++++++. +....+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEE
Confidence 46888899999999999999998889999999987443 233467889999999999999999999964 457899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++... .+++.++..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++
T Consensus 79 lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence 999999999999998653 578889999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
....... .......++..|+|||++.+..++.++|+|||||++|||++|..||........
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------- 209 (277)
T cd06640 149 GQLTDTQ--------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV----------- 209 (277)
T ss_pred eeccCCc--------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----------
Confidence 7553221 112234578899999999988899999999999999999999999875321100
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
...+.. ..+ + . .....+..+.+++.+||+.+|++||++.+++..
T Consensus 210 ---~~~~~~---~~~---~--------~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 210 ---LFLIPK---NNP---P--------T--LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---hhhhhc---CCC---C--------C--CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 000000 000 0 0 112345668899999999999999999999766
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=318.43 Aligned_cols=202 Identities=25% Similarity=0.349 Sum_probs=171.7
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.++||+|+||+||++++..+++.||+|++.... ......+.+|+.++..++|++|+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 47899999999999999999999899999999986321 22334578899999999999999999985 34578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++|+|.+++.... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999997642 3688999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM-----GGDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
++........ .......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 148 SCLKLMEDGT-------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred hheecccCCc-------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 9875432111 1122356899999999986 34688899999999999999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=320.34 Aligned_cols=192 Identities=27% Similarity=0.365 Sum_probs=161.1
Q ss_pred eeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcC---CCCccceEEEEeecCCccccceEEEEE
Q 001782 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNI---RHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 707 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
||+|+||+||+|++..+++.||+|++..... ........|..++... +||+|+++++++ ......++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 6999999999999998999999999864321 2223455666776655 699999999985 4557899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++|+|.+++... +.+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 76 DYMSGGELFWHLQKE------GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred cCCCCChHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 999999999998764 5689999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
... ........||..|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 147 LTD--------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred CCC--------CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 211 1112345689999999998764 488999999999999999999999965
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=318.93 Aligned_cols=202 Identities=26% Similarity=0.362 Sum_probs=172.9
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.+.||+|+||+||++++..+++.||+|++.... ......+.+|+.++..++|++|+++++++ ...+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47899999999999999999999999999999986422 22334578899999999999999999985 45578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence 999999999999999997642 3688999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-----GDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
++........ .......||+.|+|||++.+ +.++.++||||+||++|||++|+.||..
T Consensus 148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 148 SCLKMNQDGT-------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ceeeccCCCc-------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 9976532211 11223568999999999876 4678899999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=312.91 Aligned_cols=277 Identities=23% Similarity=0.324 Sum_probs=200.9
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
++|++.++||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+++++.++||||+++++++ ..+...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 468899999999999999999988899999998763322 2345688999999999999999999985 455789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||++++++.++.... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYP------NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred EEEEecCCccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeee
Confidence 9999999998888877643 3589999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH--
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK-- 933 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~-- 933 (1013)
+....... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... ........
T Consensus 147 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~ 217 (286)
T cd07846 147 ARTLAAPG--------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCL 217 (286)
T ss_pred eeeccCCc--------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHh
Confidence 87543221 11223457899999999875 35788999999999999999999998643211 11111110
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
....+............+.. +.................+..+.+++.+||+.+|++||++.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAGM-RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CCCchhhHHHhccchHhhcc-ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00111111111100000000 000000000011111234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=317.20 Aligned_cols=282 Identities=22% Similarity=0.278 Sum_probs=206.0
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.++|++.++||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999999899999999986432 2234567889999999999999999998776555555678
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++|+||++ +++.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 84 ~lv~e~~~-~~l~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 84 YIVQELME-TDLYKLIKT-------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEehhcc-cCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 99999998 688887754 3689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
+......... ........|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...... .....+....
T Consensus 153 ~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~ 226 (336)
T cd07849 153 ARIADPEHDH-----TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVL 226 (336)
T ss_pred eeeccccccc-----cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHc
Confidence 9765432111 111234568899999998654 56889999999999999999999999653211 1111111100
Q ss_pred ---CChhHHHhhhhhhccchhhhhccCC-CCchhHH-HHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 936 ---LPEKVMEIVDPLLLLDLEARASNCG-SHRTEIA-KIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 936 ---~~~~~~~~i~~~l~~~~~~R~~~~~-~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.++....+.... ......... ....... ........+.+++.+||+.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 227 GTPSQEDLNCIISLR----ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCCHHHHHHhhchh----hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111121111111 000000000 0000001 111234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.00 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=197.9
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc------cchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR------GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
+|++.+.||+|+||+||+|... +++.+|+|.+..... ...+.+.+|++++++++|+||+++++++. +.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence 5888999999999999999875 678899999874321 12345889999999999999999999964 34
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 145 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRF------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID 145 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence 7899999999999999999765 4678999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||.+.......... ..........|+..|+|||++.+..++.++|||||||++|+|++|+.||....... ...
T Consensus 146 fg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~- 218 (265)
T cd06631 146 FGCARRLAWVGLHG--THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----AMF- 218 (265)
T ss_pred chhhHhhhhccccc--cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH----HHH-
Confidence 99987653211110 11111234568999999999998889999999999999999999999997531110 000
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..... ....+ .. .......+.+++++||+.+|.+||++.|+++
T Consensus 219 --------~~~~~-~~~~~----~~----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 219 --------YIGAH-RGLMP----RL----------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --------Hhhhc-cCCCC----CC----------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00000 00 0112345788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.01 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=201.0
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
++|++.+.||.|++|.||+|++..+++.||+|++.... ......+.+|+++++.++||||+++++++. ++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence 47889999999999999999999899999999987543 334467889999999999999999999854 447899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+|+||+++++|.+++... .+++.+++.++.|++.|+.|||++ +++||||+|+||++++++.++|+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 999999999999998753 678999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
+...... .......++..|+|||++.+..++.++|||||||++|+|++|+.||...... .
T Consensus 146 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~------- 205 (274)
T cd06609 146 GQLTSTM--------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----R------- 205 (274)
T ss_pred eeecccc--------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----H-------
Confidence 8664321 1123456788999999999988999999999999999999999999653211 0
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
....+... .+ +.... ...+..+.+++.+|+..+|++|||++++++
T Consensus 206 --~~~~~~~~---~~---~~~~~---------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 206 --VLFLIPKN---NP---PSLEG---------NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --HHHHhhhc---CC---CCCcc---------cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00000000 00 00000 002345788999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.71 Aligned_cols=241 Identities=23% Similarity=0.396 Sum_probs=186.4
Q ss_pred CceeeccceEEEEEEECCCCe-------EEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEM-------AVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+.||+|+||.||+|.+...+. .||+|.+........+.+.+|+.+++.++||||+++++++. .+...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCCcE
Confidence 469999999999998865433 48888886554444567889999999999999999999964 336688
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCc--------e
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMV--------A 849 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~ 849 (1013)
+||||+++|+|.+++.... ..+++..++.++.||+.|++|||++ +|+||||||+||+++.++. +
T Consensus 76 lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~ 147 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK-----NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFI 147 (258)
T ss_pred EEEecCCCCcHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceE
Confidence 9999999999999998653 2578999999999999999999999 9999999999999987765 6
Q ss_pred EEccccccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCC-CCCCCcCCCCcc
Q 001782 850 HVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRR-RPTDNMFNDGLT 927 (1013)
Q Consensus 850 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~-~pf~~~~~~~~~ 927 (1013)
|++|||.+..... .....++..|+|||++.+. .++.++|||||||++|||++|. .||......
T Consensus 148 ~l~d~g~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--- 212 (258)
T cd05078 148 KLSDPGISITVLP------------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--- 212 (258)
T ss_pred EecccccccccCC------------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH---
Confidence 9999998864321 1224577899999998874 5789999999999999999985 555432110
Q ss_pred HHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 928 LHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 928 ~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
........ +..... ....++.+++.+||+.||++|||++++++.|+
T Consensus 213 -----------~~~~~~~~--------~~~~~~----------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 213 -----------KKLQFYED--------RHQLPA----------PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----------HHHHHHHc--------cccCCC----------CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000000 000000 11235789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.99 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=201.1
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.++||+|+||.||++++..+++.||+|.+.... ....+++.+|++++++++||||+++++++ ...+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 5888999999999999999999899999999987432 22345789999999999999999999985 4557899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++..... ..+++.++..++.|++.|++|||++ +++|+||+|+||+++.++.++++|||.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 99999999999999876432 3578899999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
........ ......|++.|+|||+..+..++.++|||||||++|+|++|+.||.....
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------------- 206 (256)
T cd08218 149 RVLNSTVE--------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------------- 206 (256)
T ss_pred eecCcchh--------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------------
Confidence 75532111 12234578899999999988999999999999999999999999864211
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.+.+.......... ........+.+++.+||+.+|.+||++.||++.
T Consensus 207 ---~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 207 ---KNLVLKIIRGSYPP-------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---HHHHHHHhcCCCCC-------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111111110000 001234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.73 Aligned_cols=265 Identities=23% Similarity=0.381 Sum_probs=199.5
Q ss_pred CCCCCceeeccceEEEEEEEC---CCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCcc-ccc
Q 001782 701 FSSSNMIGQGSFGFVYRGNLG---ENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFE-EVD 774 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 774 (1013)
|++.++||+|+||.||+|.+. .+++.||+|++.... ....+++.+|++++++++||||+++++++...... ...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999864 357889999987442 22345688999999999999999999987543111 112
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..++++||+.+|+|.+++...........+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 4578999999999998876432211223578899999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~ 933 (1013)
|.++........ .......++..|++||.+.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 158 g~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~-- 227 (273)
T cd05074 158 GLSKKIYSGDYY------RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNY-- 227 (273)
T ss_pred cccccccCCcce------ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHH--
Confidence 999865322110 01122345678999999998899999999999999999999 88888653211 00000
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
+... .. ... ....+..+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 228 ---------~~~~----~~---~~~----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 228 ---------LIKG----NR---LKQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------HHcC----Cc---CCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 00 000 011235688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=345.64 Aligned_cols=257 Identities=28% Similarity=0.378 Sum_probs=205.5
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
.+-+|+...+||.|.||.||-|.+..+|...|+|-++... ....+.+.+|+.++..++|||+|+++|+ ..+.+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----EvHRe 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EVHRE 1307 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----eecHH
Confidence 3457888899999999999999999999999999887433 3344668899999999999999999998 45667
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..+|.||||++|+|.+.++.. +-.++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++||
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~g------ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHG------RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhc------chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecc
Confidence 889999999999999999876 3356666777889999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG---DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~ 931 (1013)
|.|..+.... ...+.......||+.|||||++.+. ....++||||+|||+.||+||+.||...++.-......
T Consensus 1379 Gsa~ki~~~~----~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V 1454 (1509)
T KOG4645|consen 1379 GSAVKIKNNA----QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV 1454 (1509)
T ss_pred cceeEecCch----hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH
Confidence 9998775431 1223445678899999999999875 35678999999999999999999998764432211111
Q ss_pred HHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 932 AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.....|+ ++ +....+-.+++..|+..||++|.++.|+++.
T Consensus 1455 ~~gh~Pq---------------------------~P--~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AAGHKPQ---------------------------IP--ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hccCCCC---------------------------Cc--hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111111 11 1123445678889999999999999988764
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=304.28 Aligned_cols=254 Identities=20% Similarity=0.283 Sum_probs=196.5
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-----cchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-----GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
.+|++.++||+|+||.||.|.+..++..||+|.+..... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 478899999999999999999998999999998863321 1235688899999999999999999985421 23
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...+++|||+++++|.+++... ..+++..+.+++.|++.||+|||++ +++|+||||+||+++.++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY------GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence 5678999999999999998765 3578889999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||.++....... .........|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 150 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~- 219 (265)
T cd06652 150 FGASKRLQTICL-----SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIF- 219 (265)
T ss_pred Cccccccccccc-----cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHH-
Confidence 999875532111 011123346889999999998888999999999999999999999998642111 1000
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+.. ..+ .++ .. .......+.+++.+|+. +|++||+++|+++
T Consensus 220 --------~~~-----~~~-~~~--------~~--~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 220 --------KIA-----TQP-TNP--------VL--PPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --------HHh-----cCC-CCC--------CC--chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 000 000 000 00 11223456778888884 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.44 Aligned_cols=255 Identities=26% Similarity=0.454 Sum_probs=200.1
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
..++|++.++||+|+||.||+|.+. .+..||+|.+... ....+.+.+|++++++++|+||+++++++. . ...
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~ 75 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPI 75 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCe
Confidence 3568999999999999999999875 4556999988643 223467889999999999999999999853 2 567
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
+++|||+++++|.+++..... ..+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~ 148 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGL 148 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCc----cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcc
Confidence 999999999999999976432 4678889999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhh
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
+........ .......++..|+|||++..+.++.++|||||||++|++++ |+.||......
T Consensus 149 ~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----------- 210 (260)
T cd05073 149 ARVIEDNEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----------- 210 (260)
T ss_pred eeeccCCCc-------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-----------
Confidence 875532111 01122345678999999998899999999999999999998 99998653111
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
...+.+...... . .....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 211 ---~~~~~~~~~~~~---~-------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 211 ---EVIRALERGYRM---P-------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---HHHHHHhCCCCC---C-------------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001111100000 0 001224568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.34 Aligned_cols=260 Identities=24% Similarity=0.315 Sum_probs=202.3
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc---chhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG---ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.+.||+|+||+||+|.+..+++.||+|.+...... ..+.+..|+++++.++||||+++++.+ .....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 3688899999999999999999988999999999754322 345688999999999999999999985 34578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+.+++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecc
Confidence 8999999999999999875432 4689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccc---------------------cCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhC
Q 001782 856 LARFLPPCSPATIL---------------------ETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G 914 (1013)
++............ ..........|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 98765432211100 000112245688999999999998999999999999999999999
Q ss_pred CCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCC-
Q 001782 915 RRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ- 993 (1013)
Q Consensus 915 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs- 993 (1013)
+.||...... . ...++... ++ .. +.....+..+.+++.+|+..||++|||
T Consensus 229 ~~pf~~~~~~-~------------~~~~~~~~----~~----~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~ 279 (316)
T cd05574 229 TTPFKGSNRD-E------------TFSNILKK----EV----TF--------PGSPPVSSSARDLIRKLLVKDPSKRLGS 279 (316)
T ss_pred CCCCCCCchH-H------------HHHHHhcC----Cc----cC--------CCccccCHHHHHHHHHHccCCHhHCCCc
Confidence 9999753211 0 01111110 00 00 000113456889999999999999999
Q ss_pred ---HHHHHH
Q 001782 994 ---MTDVVA 999 (1013)
Q Consensus 994 ---~~evl~ 999 (1013)
++|++.
T Consensus 280 ~~~~~~ll~ 288 (316)
T cd05574 280 KRGAAEIKQ 288 (316)
T ss_pred hhhHHHHHc
Confidence 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=284.52 Aligned_cols=253 Identities=21% Similarity=0.260 Sum_probs=197.3
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec-cccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccce
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK-QRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
.++.+...-||.|.-|+||+++.+.++...|||.+... ..++.+++...++++..- .+|+||+.+|++. .+..
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi-----~n~d 165 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI-----TNTD 165 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe-----eCch
Confidence 34556678899999999999999999999999999744 334456777788876665 4899999999964 4466
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
+++.||.|. .-.+.+++..+ +++++.-+-++...+..||.||.+++ +|+|||+||+|||+|+.|++|+||||
T Consensus 166 V~IcMelMs-~C~ekLlkrik-----~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 166 VFICMELMS-TCAEKLLKRIK-----GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred HHHHHHHHH-HHHHHHHHHhc-----CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccc
Confidence 789999987 56677776553 46888888999999999999999986 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG---DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
++.++-+. .......|.+.|||||.+.-. .|+.++||||||++++|+.||+.||..-..+-..+..+
T Consensus 238 IsGrlvdS---------kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv- 307 (391)
T KOG0983|consen 238 ISGRLVDS---------KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV- 307 (391)
T ss_pred ccceeecc---------cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH-
Confidence 99866432 224456689999999998754 68889999999999999999999998743332222222
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+...|. . ++.-......+.+++..|++.|+.+||...++++
T Consensus 308 ---------------ln~ePP---~--------L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 308 ---------------LNEEPP---L--------LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ---------------HhcCCC---C--------CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 221110 0 0000113456788899999999999999999875
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.99 Aligned_cols=278 Identities=23% Similarity=0.339 Sum_probs=198.2
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+++++.++|+||+++++++. .+..
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCe
Confidence 45789999999999999999999988899999999875432 22346788999999999999999999853 4468
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+. +++.+++.... ..+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg 148 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHP-----GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG 148 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccc
Confidence 899999997 78877765432 3577888999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
+++...... .......++..|+|||++.+. .++.++|||||||++|||++|..||.........+......
T Consensus 149 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~ 220 (291)
T cd07870 149 LARAKSIPS--------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220 (291)
T ss_pred cccccCCCC--------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHH
Confidence 987532211 112234568899999998764 57889999999999999999999997643221111111110
Q ss_pred h-CChh-HHHhhhhhhccchhhhhccCCCCchhHHHH---HHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 A-LPEK-VMEIVDPLLLLDLEARASNCGSHRTEIAKI---EECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~-~~~~-~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
. .+.. ....+...-...+. ....+. ....... ......+.+++.+|+..||++|||+.|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 221 LGVPTEDTWPGVSKLPNYKPE-WFLPCK--PQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cCCCChhhhhhhhhcccccch-hccccC--CcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 0100 00000000000000 000000 0000000 011356788999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=318.29 Aligned_cols=288 Identities=24% Similarity=0.263 Sum_probs=208.2
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCC-ccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSID-FEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~ 777 (1013)
.|...+.||+|+||.||+|+++.+|+.||||.++... ....++..+|++++++++|||||+++++-.... .--.....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 4566789999999999999999999999999998543 344577899999999999999999999732211 01135678
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEec--CCC--ceEEcc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD--HDM--VAHVGD 853 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~D 853 (1013)
+|||||.+|||+..+++.... .++++.+.+.+..+++.||.|||++ |||||||||.||++- ++| ..||+|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~---~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENA---YGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred EEEeecCCCcHHHHhcCcccc---cCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence 999999999999999876443 6899999999999999999999999 999999999999994 333 689999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccC-CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM-GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
||.|+.++++. .....+||..|.+||... .+.|+..+|.|||||++||.+||..||..............
T Consensus 168 fG~Arel~d~s---------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~ 238 (732)
T KOG4250|consen 168 FGAARELDDNS---------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW 238 (732)
T ss_pred ccccccCCCCC---------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence 99999775433 366789999999999998 48889999999999999999999999987533321111111
Q ss_pred Hh--hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC--CHHHHHHHHHHhhh
Q 001782 933 KM--ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI--QMTDVVAKLCSARK 1006 (1013)
Q Consensus 933 ~~--~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP--s~~evl~~L~~~~~ 1006 (1013)
.. ..+..+.-...+.. -+| ..+.......-.........+..++..++..+|++|. ...+....+..|..
T Consensus 239 ~~~tkkp~~v~i~~~~~e-Ngp---v~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 239 HIITKKPSGVAIGAQEEE-NGP---VEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred hhhccCCCceeEeeeccc-CCc---eeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 11 11111111000000 001 0011111111111122334456677778888889988 77777777777654
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=306.72 Aligned_cols=275 Identities=21% Similarity=0.290 Sum_probs=202.0
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.+.||+|+||.||+|++..++..||+|++.... ....+.+.+|+.++++++||||+++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence 5888999999999999999998889999999987544 233467899999999999999999999954 457889
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+ +++|.+++.... ..+++.+++.++.||+.|++|||+. +++|+||||+||+++.++.++|+|||.+
T Consensus 76 ~v~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred EEeccc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 999999 899999987643 4689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
........ .......++..|+|||++.+. .++.++||||+||++|||++|.+||...... ...........
T Consensus 147 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~ 218 (286)
T cd07832 147 RLFSEEEP-------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLG 218 (286)
T ss_pred ccccCCCC-------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcC
Confidence 86543211 112345688999999998654 4688999999999999999998887653211 11111111100
Q ss_pred Ch---hHHHhhhhhhccchhhhhccCCCCchhH-HHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 937 PE---KVMEIVDPLLLLDLEARASNCGSHRTEI-AKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 937 ~~---~~~~~i~~~l~~~~~~R~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.. ...+.. .+ .+. ............. ....+....+.+++.+|++.+|.+|||++++++.
T Consensus 219 ~~~~~~~~~~~-~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 219 TPNEETWPGLT-SL--PDY-NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CCChHHHhhcc-Cc--chh-hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000 00 000 0000000000000 0112234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=301.76 Aligned_cols=253 Identities=28% Similarity=0.498 Sum_probs=197.6
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
..+|++.+.||+|+||.||+|.+. .+..+|+|++.... .....+.+|++++++++||+++++++++. .....+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPIC 75 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceE
Confidence 357888899999999999999886 46679999886332 23467899999999999999999999853 446789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 147 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMT 147 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcce
Confidence 9999999999999987642 3578999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+....... .......++..|+|||+..++.++.++||||||+++|||++ |..||...... ...
T Consensus 148 ~~~~~~~~-------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~---- 211 (256)
T cd05112 148 RFVLDDQY-------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVV---- 211 (256)
T ss_pred eecccCcc-------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHH----
Confidence 75432110 01122335678999999998899999999999999999998 99998653211 100
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
+.+...... .++. ..+..+.+++.+||+.+|++|||+.|++++|.
T Consensus 212 -----~~~~~~~~~---~~~~-------------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 212 -----ETINAGFRL---YKPR-------------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----HHHhCCCCC---CCCC-------------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 000000000 0000 11346888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.56 Aligned_cols=255 Identities=19% Similarity=0.280 Sum_probs=198.2
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
++|++.+.||+|+||.||+|++..++..||+|.+.... ......+.+|++++++++||||+++++.+. ..+..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEE
Confidence 47889999999999999999999899999999887432 223457889999999999999999999853 457899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++..... ...+++..+..++.|++.|+.|||+.. +|+||||||+||+++.++.+||+|||.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred EEEeecCCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999999999999876421 146899999999999999999999632 8999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCC------CCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHH
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD------MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~ 931 (1013)
..+... ......++..|+|||++.+.. ++.++||||+||++|+|++|+.||.......
T Consensus 151 ~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------ 214 (286)
T cd06622 151 GNLVAS----------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN------ 214 (286)
T ss_pred ccccCC----------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh------
Confidence 754221 122345788999999986543 4789999999999999999999996531110
Q ss_pred HHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 932 AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
....+.......+... .......+.+++.+|++.+|++||++.+++..
T Consensus 215 --------~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 215 --------IFAQLSAIVDGDPPTL-------------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --------HHHHHHHHhhcCCCCC-------------CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0000011111111000 01234567889999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=317.31 Aligned_cols=282 Identities=22% Similarity=0.244 Sum_probs=205.7
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec--cccchhHHHHHHHHHhcCCCCccceEEEEeecCC-cccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIRHRNLIKIITVCSSID-FEEV 773 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 773 (1013)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.++++++||||+++++++.... ..+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 357899999999999999999999989999999998632 2223456778999999999999999999875321 2334
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++||||+. ++|.+++.. .++..++..++.|++.||+|||++ ||+||||||+||+++.++.+||+|
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 56899999998 688887753 378889999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||.++...... ......++..|+|||++.+..++.++||||+||++|+|++|+.||...... ..+.....
T Consensus 162 fg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~ 231 (353)
T cd07850 162 FGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIE 231 (353)
T ss_pred CccceeCCCCC---------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence 99998653211 123346788999999999999999999999999999999999999753211 11111111
Q ss_pred hh--CChhHHHhhhhhhccchhhhhccCCCCchh----------HH-HHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 934 MA--LPEKVMEIVDPLLLLDLEARASNCGSHRTE----------IA-KIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 934 ~~--~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~----------~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.. .+++..+.+..........|+......... .. .....+..+.+++.+|++.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 111222222222211112222111000000 00 011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.64 Aligned_cols=255 Identities=30% Similarity=0.465 Sum_probs=195.8
Q ss_pred CceeeccceEEEEEEECCCC------eEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 705 NMIGQGSFGFVYRGNLGENE------MAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+.||+|+||.||+|++.... +.||+|.+.... ......+.+|+.+++.++||||+++++++. .....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 46899999999999985433 679999876432 234567889999999999999999999864 346789
Q ss_pred EEEeeccCCCHHHHhhcccccc-ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC-----ceEE
Q 001782 778 IVYEYMECGSLEDWLHQSNDQL-EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM-----VAHV 851 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl 851 (1013)
+||||+++++|.+++....... ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .+|+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence 9999999999999997643221 224578999999999999999999999 999999999999999877 8999
Q ss_pred ccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHH
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHE 930 (1013)
Q Consensus 852 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~ 930 (1013)
+|||+++........ .......++..|+|||++.++.++.++|||||||++|||++ |+.||...... .
T Consensus 153 ~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-----~ 221 (269)
T cd05044 153 GDFGLARDIYKSDYY------RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-----E 221 (269)
T ss_pred CCccccccccccccc------ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-----H
Confidence 999998755322111 11123345788999999999999999999999999999998 99998643110 0
Q ss_pred HHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 931 FAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 931 ~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
....+.. ..++. .....+..+.+++.+||..+|.+||++.+|++.|++
T Consensus 222 ---------~~~~~~~------~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 222 ---------VLQHVTA------GGRLQ----------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------HHHHHhc------CCccC----------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0000000 00000 011234567899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.20 Aligned_cols=247 Identities=32% Similarity=0.472 Sum_probs=196.3
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
++|++.+.||+|+||.||++.. +++.||+|+..... ..+.+.+|+.++++++|||++++++++.. +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence 5789999999999999999975 56789999986432 34678899999999999999999998632 34689
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
||||+++++|.+++..... ..+++.+++.++.|++.|+.|||+. |++||||||+||+++.++.+||+|||.+.
T Consensus 76 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred EEECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence 9999999999999976532 3578999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCC
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
..... ......+..|+|||++.++.++.++|||||||++|||++ |+.||...... .
T Consensus 149 ~~~~~-----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~------- 205 (254)
T cd05083 149 VGSMG-----------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----E------- 205 (254)
T ss_pred ecccc-----------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----H-------
Confidence 43211 112234578999999998899999999999999999997 99998653211 1
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
..+.+.+....++ ....+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 206 --~~~~~~~~~~~~~----------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 206 --VKECVEKGYRMEP----------------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --HHHHHhCCCCCCC----------------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111111100000 01234567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=311.36 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=198.7
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
+.|.....||+|+||.||++.+..++..||||.+........+.+.+|+.+++.++||||+++++.+. .++..++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~l 96 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWV 96 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEE
Confidence 44555678999999999999998889999999987555555567899999999999999999999853 4578899
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
||||+++++|.+++.. +.+++.++..++.||+.|++|||++ +|+||||||+||++++++.+||+|||++.
T Consensus 97 v~e~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 97 VMEFLEGGALTDIVTH-------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred EEeCCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence 9999999999998854 3578899999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCCh
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPE 938 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~ 938 (1013)
...... .......|+..|+|||+..+..++.++||||||+++|||++|+.||...... ...
T Consensus 167 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~------- 227 (292)
T cd06658 167 QVSKEV--------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----QAM------- 227 (292)
T ss_pred hccccc--------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHH-------
Confidence 543211 1123356889999999998888999999999999999999999998642110 000
Q ss_pred hHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 939 KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 939 ~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.. +........ .........+.+++.+|+..||.+|||++|+++.
T Consensus 228 --~~-~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 228 --RR-IRDNLPPRV--------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --HH-HHhcCCCcc--------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 000000000 0001123457788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=309.29 Aligned_cols=249 Identities=21% Similarity=0.317 Sum_probs=199.1
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+.|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|++++++++||||+++++++ ......+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceE
Confidence 35667789999999999999998889999999987433 23345788999999999999999999985 3457899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++.. ..+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.+|++|||++
T Consensus 79 lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 79 IIMEYLGGGSALDLLKP-------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEEEccCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccccc
Confidence 99999999999999864 3678899999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
..+.... .......++..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------- 209 (277)
T cd06642 149 GQLTDTQ--------IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV----------- 209 (277)
T ss_pred ccccCcc--------hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-----------
Confidence 7553211 112234578899999999998999999999999999999999999865321100
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
...+... .++.. ....+..+.+++.+|++.+|.+||++.||++.
T Consensus 210 ---~~~~~~~------~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 210 ---LFLIPKN------SPPTL----------EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---HhhhhcC------CCCCC----------CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0000000 00000 01234567899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.70 Aligned_cols=257 Identities=21% Similarity=0.312 Sum_probs=185.4
Q ss_pred CceeeccceEEEEEEECC--CCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEe
Q 001782 705 NMIGQGSFGFVYRGNLGE--NEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
+.||+|+||.||+|.... ....+|+|.+..... .....+.+|+++++.++||||+++++.+. .....++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence 368999999999997532 345788887754332 23456789999999999999999999864 4467899999
Q ss_pred eccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCC
Q 001782 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP 861 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 861 (1013)
|+++|+|.+++....... ....++..+..++.||+.|++|||++ +|+||||||+||++++++.+||+|||++....
T Consensus 76 ~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred eCCCCcHHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence 999999999998754211 12456788899999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCccccCCCCCcccccccccccccccCC-------CCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHH
Q 001782 862 PCSPATILETPSSSTGIKGTVGYVAPEYGMG-------GDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~ 933 (1013)
..... .......++..|+|||+... ..++.++|||||||++|||++ |..||......+ ....
T Consensus 152 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~--- 221 (269)
T cd05042 152 PEDYY------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQ--- 221 (269)
T ss_pred cchhe------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHH---
Confidence 21110 01123345778999998643 356889999999999999999 788886532110 0000
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
.+.. .....+. +. .....+..+.+++..|| .||++|||++||++.|+
T Consensus 222 ---------~~~~----~~~~~~~------~~--~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 222 ---------VVRE----QDIKLPK------PQ--LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ---------Hhhc----cCccCCC------Cc--ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0000 0000000 00 00122345667788888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=304.82 Aligned_cols=256 Identities=21% Similarity=0.334 Sum_probs=200.2
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc------cchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR------GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
+|+..+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++||||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 47888999999999999999988999999999874331 1245788999999999999999999995 455
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC-ceEEc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM-VAHVG 852 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~ 852 (1013)
+..++||||+++++|.+++... +.+++..+..++.|++.|++|||++ +++|+||+|+||+++.++ .+||+
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~ 146 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKY------GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA 146 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 7889999999999999999765 4688999999999999999999999 999999999999998776 69999
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
|||.+..+..... ..........++..|+|||++.+..++.++||||+|+++|+|++|..||........ .....
T Consensus 147 dfg~~~~~~~~~~----~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~ 221 (268)
T cd06630 147 DFGAAARLAAKGT----GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIF 221 (268)
T ss_pred ccccccccccccc----cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHH
Confidence 9999986643211 111112345688999999999888899999999999999999999999964321110 00000
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+..... ..+ . ........+.+++.+|++.+|++||++.|++.
T Consensus 222 ---------~~~~~~--~~~------------~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 222 ---------KIASAT--TAP------------S--IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---------HHhccC--CCC------------C--CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000000 000 0 00123456788999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=308.80 Aligned_cols=276 Identities=21% Similarity=0.247 Sum_probs=199.8
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc-----chhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG-----ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+..|++++++++|+||+++++++. +..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence 478889999999999999999888999999999754322 2345678999999999999999999964 357
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..++||||+ +++|.+++.... ..+++.+++.++.||++||+|||++ +++||||||+||+++.++.+||+||
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence 889999999 799999997652 2689999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
|+++...... .......++..|+|||.+.+ ..++.++|||||||++|||++|..||...... ........
T Consensus 147 g~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~ 217 (298)
T cd07841 147 GLARSFGSPN--------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFE 217 (298)
T ss_pred eeeeeccCCC--------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHH
Confidence 9998654321 11223356788999998865 46788999999999999999998777653211 11111111
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.........+.. .... +..+....................+.+++.+||+.||++|||++||++.
T Consensus 218 ~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 218 ALGTPTEENWPG-VTSL-PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HcCCCchhhhhh-cccc-cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 100000000000 0000 0000000000000011112335678899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=288.24 Aligned_cols=203 Identities=24% Similarity=0.360 Sum_probs=174.8
Q ss_pred CCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCC-CCccceEEEEeecCCccccceEEEEEee
Q 001782 704 SNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEVDFKAIVYEY 782 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~ 782 (1013)
.+.||+|+|+.|--+....++..||||++.........++.+|++++...+ |+||++++++ |+++...|+|||-
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief-----FEdd~~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF-----FEDDTRFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----hcccceEEEEEec
Confidence 368999999999999999999999999998776677788999999999994 9999999999 6778999999999
Q ss_pred ccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC---ceEEcccccccc
Q 001782 783 MECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM---VAHVGDFGLARF 859 (1013)
Q Consensus 783 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~ 859 (1013)
|.||+|...|.++ ..+++.++.++..+|+.||.|||.+ ||.|||+||+|||-.... -+|||||.++.-
T Consensus 158 m~GGplLshI~~~------~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 158 MRGGPLLSHIQKR------KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred ccCchHHHHHHHh------hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccc
Confidence 9999999999887 5799999999999999999999999 999999999999997654 589999988764
Q ss_pred CCCCCCCccccCCCCCcccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 860 LPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-----GDMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
+.....-.. .........+|+..|||||+..- ..|+.++|.||||||+|-|+.|.+||...
T Consensus 229 ~k~~~~~sp-astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 229 IKLNNDCSP-ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred cccCCCCCC-CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 433222221 22334556789999999997532 35888999999999999999999999864
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=343.08 Aligned_cols=465 Identities=26% Similarity=0.328 Sum_probs=394.8
Q ss_pred eeeeccCCccccCCcccCCcccceEEeccCCccccCCCCccccCCCCceeccccccccCCCCCccccccccccceecccc
Q 001782 104 FINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDN 183 (1013)
Q Consensus 104 ~L~l~~n~l~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~L~~n 183 (1013)
.+|+++.++. .||..+-.-..++.|+++.|.+-...-+.+.+.-+|+.||+++|.+. ..|..+. .+.+|+.|.++.|
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it-~l~~L~~ln~s~n 78 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQIT-LLSHLRQLNLSRN 78 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhh-hHHHHhhcccchh
Confidence 3677788888 89988877777999999999987322344455667999999999997 8888775 7889999999999
Q ss_pred cccccCCCCccCCCCcceeeecccccCCCCCCccccccccceeecccccccCCCcchhccCCccceeeccCCccCCCCCC
Q 001782 184 LLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPV 263 (1013)
Q Consensus 184 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 263 (1013)
.|. ..|.+.+++.+|++|.|.+|++. ..|.++..+++|++|++|.|++. .+|..+..++.++.+..++|.....++.
T Consensus 79 ~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~ 155 (1081)
T KOG0618|consen 79 YIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ 155 (1081)
T ss_pred hHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc
Confidence 998 67789999999999999999998 89999999999999999999998 8999999999999999999933323332
Q ss_pred CcCCCCCCCcEEEeeeccccccCCCCCCCCCCCceEEcccCcccccccccccCCCCccccccccCcCCCCCCCChhhhhh
Q 001782 264 NIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAH 343 (1013)
Q Consensus 264 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 343 (1013)
..++.++|..|.+.+.++..+.+++. .|||+.|.+. ...+..+.+|+.|....|++......
T Consensus 156 ------~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~~------- 217 (1081)
T KOG0618|consen 156 ------TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEIS------- 217 (1081)
T ss_pred ------ccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEEec-------
Confidence 23888999999999999998888877 8999999987 34577889999999999998764432
Q ss_pred cccccccccccccccccCCccchhhhcchhhHHHHhccchhHHhhcccccceeecccccccCCcccccCCCCCCCEEEcc
Q 001782 344 LTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLH 423 (1013)
Q Consensus 344 l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 423 (1013)
-++|+.|..+.|.+....+. ....+|++++++.|+++ .+|+|++.+.+|+.|+..
T Consensus 218 ---g~~l~~L~a~~n~l~~~~~~---------------------p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n 272 (1081)
T KOG0618|consen 218 ---GPSLTALYADHNPLTTLDVH---------------------PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNAN 272 (1081)
T ss_pred ---CcchheeeeccCcceeeccc---------------------cccccceeeecchhhhh-cchHHHHhcccceEeccc
Confidence 35788888888877632211 12357999999999999 566999999999999999
Q ss_pred CCccCccCCccccccCccCEEEcCCCcccCCCCcccccCcccceeecccccccccCCchhhcccch-hhhhccCCCeecc
Q 001782 424 HNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTL-SILLDLSGNLLTG 502 (1013)
Q Consensus 424 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~-l~~L~Ls~N~l~~ 502 (1013)
+|+|+ .+|..+...++|+.|.+..|.+. -+|.....++.|+.|+|..|+|. .+|+.++..+.. +..|+.+.|++..
T Consensus 273 ~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~ 349 (1081)
T KOG0618|consen 273 HNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLST 349 (1081)
T ss_pred chhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccc
Confidence 99997 88999999999999999999999 78888888999999999999998 888877765555 8889999999984
Q ss_pred cCCccccCcCCCcEEEccCCCCCCCCccccccccccccccccccccccccCccccccCCCCeEecccccccccccccccc
Q 001782 503 SIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLEN 582 (1013)
Q Consensus 503 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 582 (1013)
...-.=.....|+.|++.+|+|++..-+.+.+.++|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|..+.+
T Consensus 350 lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~ 428 (1081)
T KOG0618|consen 350 LPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVAN 428 (1081)
T ss_pred cccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHh
Confidence 33222234678999999999999988888999999999999999999544456899999999999999999 79999999
Q ss_pred ccccceeecCCccCCCCCCCCCccCCCcceeeeCCcCCCC
Q 001782 583 LSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCG 622 (1013)
Q Consensus 583 l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~ 622 (1013)
+..|++|...+|++...+ +..+++.+..+.++.|...-.
T Consensus 429 ~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 429 LGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred hhhhHHHhhcCCceeech-hhhhcCcceEEecccchhhhh
Confidence 999999999999999765 778889999999998875433
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.82 Aligned_cols=260 Identities=22% Similarity=0.389 Sum_probs=200.6
Q ss_pred ccCCCCCceeeccceEEEEEEECC-----CCeEEEEEEEeecccc-chhHHHHHHHHHhcCCCCccceEEEEeecCCccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGE-----NEMAVAVKVMNLKQRG-ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 772 (1013)
++|++.+.||+|+||.||+|+... +.+.|++|.+...... ..+.+.+|++++++++||||+++++++. +
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR-----E 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----C
Confidence 578899999999999999999753 3467999988644333 3467899999999999999999999864 3
Q ss_pred cceEEEEEeeccCCCHHHHhhcccccc---ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCce
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQL---EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVA 849 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 849 (1013)
....++||||+++++|.+++....... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence 467899999999999999998654211 012589999999999999999999999 99999999999999999999
Q ss_pred EEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccH
Q 001782 850 HVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTL 928 (1013)
Q Consensus 850 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~ 928 (1013)
+++|||+++...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .
T Consensus 157 ~l~~~~~~~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~ 227 (275)
T cd05046 157 KVSLLSLSKDVYNSE-------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--V 227 (275)
T ss_pred EEcccccccccCccc-------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--H
Confidence 999999986432111 111223456788999999988889999999999999999998 888886432110 0
Q ss_pred HHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 929 HEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 929 ~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
... ........ .....++..+.+++.+||+.+|.+||++.|+++.|+
T Consensus 228 ~~~-----------~~~~~~~~----------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 228 LNR-----------LQAGKLEL----------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHH-----------HHcCCcCC----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000 00000000 000123456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=307.52 Aligned_cols=269 Identities=20% Similarity=0.261 Sum_probs=191.5
Q ss_pred hccCCCCCceeeccceEEEEEEECCC---CeEEEEEEEeeccccch-----------hHHHHHHHHHhcCCCCccceEEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGEN---EMAVAVKVMNLKQRGAT-----------KSFVAECEALRNIRHRNLIKIIT 763 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 763 (1013)
.++|++.++||+|+||.||+|.+..+ +..+|+|+......... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999999776 66777776543322111 11223334456678999999999
Q ss_pred EeecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEe
Q 001782 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL 843 (1013)
Q Consensus 764 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll 843 (1013)
++... .......++++|++. .++.+.+... ...++..+..|+.|++.|++|||+. +|+||||||+||++
T Consensus 91 ~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill 159 (294)
T PHA02882 91 CGSFK-RCRMYYRFILLEKLV-ENTKEIFKRI------KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV 159 (294)
T ss_pred eeeEe-cCCceEEEEEEehhc-cCHHHHHHhh------ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 76432 112235578888876 5677766543 2357788999999999999999999 99999999999999
Q ss_pred cCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCC
Q 001782 844 DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFN 923 (1013)
Q Consensus 844 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~ 923 (1013)
+.++.+||+|||+|+.+........ ..........||+.|+|||+..+..++.++|||||||++|||++|+.||.....
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIE-YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccc-cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999986643221110 011112335699999999999999999999999999999999999999986422
Q ss_pred CCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 924 DGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
......... .+++.+..... .....++..+.+++..|++.+|++||+++++.+.+
T Consensus 239 ~~~~~~~~~--------~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 239 NGNLIHAAK--------CDFIKRLHEGK---------------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred chHHHHHhH--------HHHHHHhhhhh---------------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 211111100 01111110000 01122356688999999999999999999999875
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=303.05 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=202.1
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ....+++..|++++++++||||+++++++.. ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 5888899999999999999999899999999987432 2234568889999999999999999997642 2346789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH-----HHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
++|||+++++|.+++..... ....+++.+++.++.|++.|++||| +. +++|+||+|+||+++.++.+||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred EEehhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEe
Confidence 99999999999999976422 1247899999999999999999999 77 99999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
|||++........ ......+++.|+|||++.+..++.++||||||+++|+|++|+.||..... ....
T Consensus 153 d~g~~~~~~~~~~--------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~ 219 (265)
T cd08217 153 DFGLAKILGHDSS--------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----LQLA 219 (265)
T ss_pred cccccccccCCcc--------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----HHHH
Confidence 9999986543211 12234688999999999998899999999999999999999999975321 1110
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
+.+... .+.. .....+..+.+++.+|++.+|++||++.||++.
T Consensus 220 ---------~~~~~~---~~~~-------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 220 ---------SKIKEG---KFRR-------------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---------HHHhcC---CCCC-------------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111100 0000 001224567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=301.94 Aligned_cols=255 Identities=27% Similarity=0.388 Sum_probs=201.0
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc--chhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG--ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.+.||+|+||.||+|.+..+++.||+|+++..... ..+.+.+|++++++++|+||+++++++ ...+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 588899999999999999999888999999999755442 456789999999999999999999985 3457889
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+|+||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+
T Consensus 76 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 76 IFMEYCSGGTLEELLEHG------RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred EEEecCCCCcHHHHHhhc------CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 999999999999999764 3578889999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCC---CCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD---MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
........... .......++..|+|||++.+.. ++.++||||||+++||+++|+.||....... ......
T Consensus 147 ~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~~~~ 219 (264)
T cd06626 147 VKLKNNTTTMG----EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIMFHV 219 (264)
T ss_pred cccCCCCCccc----ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHHHHH
Confidence 86643322110 0012346788999999988766 8899999999999999999999997532110 000000
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
. ... ++ ..+........+.+++.+||+.+|.+||++.|++.
T Consensus 220 ~------------~~~----~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 220 G------------AGH----KP--------PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred h------------cCC----CC--------CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 000 00 00011122445678999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=306.66 Aligned_cols=275 Identities=23% Similarity=0.332 Sum_probs=199.2
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|+..+.||+|++|.||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++ .+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 47889999999999999999998999999999874432 2235688999999999999999999985 4557899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+. ++|.+++..... ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred EEeeccc-cCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence 9999997 689998876432 4689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh-
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD-MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA- 935 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~- 935 (1013)
........ ......++..|+|||++.+.. ++.++|||||||++|||++|+.||....... .........
T Consensus 148 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~ 218 (284)
T cd07860 148 RAFGVPVR--------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLG 218 (284)
T ss_pred hhcccCcc--------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhC
Confidence 75532111 122334678999999877654 6889999999999999999999997532111 111111111
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHH-HHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAK-IEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.+.. . +.+.....+..+............. .......+.+++.+|++.||++|||++|+++
T Consensus 219 ~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 219 TPDE--V-VWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred CCCh--h-hhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 1100 0 0000000011111100000111111 1122345788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=300.57 Aligned_cols=249 Identities=29% Similarity=0.439 Sum_probs=195.3
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecccc-chhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeec
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG-ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYM 783 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 783 (1013)
++||+|+||.||+|.+.. ++.||+|.+...... ..+.+.+|++++++++||||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence 479999999999999986 889999988754333 4467899999999999999999999864 446789999999
Q ss_pred cCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCC
Q 001782 784 ECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863 (1013)
Q Consensus 784 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 863 (1013)
++++|.+++.... ..+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||.+......
T Consensus 75 ~~~~l~~~l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 75 PGGSLLTFLRKKK-----NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred CCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 9999999997642 3578899999999999999999999 9999999999999999999999999998754321
Q ss_pred CCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCChhHHH
Q 001782 864 SPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALPEKVME 942 (1013)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1013)
.. ........++..|+|||++.++.++.++|||||||++|||++ |..||...... ...+
T Consensus 147 ~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------------~~~~ 206 (251)
T cd05041 147 IY------TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------------QTRE 206 (251)
T ss_pred cc------eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------------HHHH
Confidence 10 000112234567999999998899999999999999999999 88888653211 0111
Q ss_pred hhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 943 IVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 943 ~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
.+.... ++.. ....+..+.+++.+|+..+|++|||+.|+++.|++
T Consensus 207 ~~~~~~------~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 207 RIESGY------RMPA----------PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHhcCC------CCCC----------CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 111000 0000 01234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=301.43 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=198.2
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-----cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-----GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
+|+..+.||+|+||.||+|.+..++..|++|.+..... ...+.+.+|+++++.++||||+++++++. .+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 57888999999999999999988899999999875432 23457889999999999999999999853 447
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..+++|||+++++|.+++... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.+||+||
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKY------GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 889999999999999999765 4578999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCC-CCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD-MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
|.+....... ......++..|+|||.+.... ++.++|+|||||++|+|++|+.||...... ....
T Consensus 147 ~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~----~~~~- 212 (258)
T cd06632 147 GMAKQVVEFS---------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----AAVF- 212 (258)
T ss_pred ccceeccccc---------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH----HHHH-
Confidence 9987543211 123456889999999987776 899999999999999999999999753211 0000
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.... .. .++.. .......+.+++.+||+.+|.+||++.+++.
T Consensus 213 --------~~~~---~~---~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 213 --------KIGR---SK---ELPPI----------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --------HHHh---cc---cCCCc----------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0000 00 00000 0112345678999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.37 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=202.8
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
.++|.+.+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++. ..+..+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEE
Confidence 478999999999999999999998888999999987555555577899999999999999999999864 346789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+|+||+++++|.+++... .+++.++..++.|++.|++|||++ +++||||||+||+++.++.+||+|||++
T Consensus 93 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred EEEecCCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcce
Confidence 999999999999999753 578889999999999999999999 9999999999999999999999999988
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
....+... ......+++.|+|||.+.+..++.++||||||+++|++++|+.||............
T Consensus 163 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------- 227 (293)
T cd06647 163 AQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------- 227 (293)
T ss_pred eccccccc--------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------
Confidence 75533211 123346888999999998888999999999999999999999999753221100000
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
. ..+ .+. .......+..+.+++.+||+.+|.+||++.+++..
T Consensus 228 ----------~-~~~--~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 228 ----------A-TNG--TPE--------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ----------h-cCC--CCC--------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 000 00111223457889999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=304.50 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=197.3
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc----------chhHHHHHHHHHhcCCCCccceEEEEeecCC
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG----------ATKSFVAECEALRNIRHRNLIKIITVCSSID 769 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 769 (1013)
+|.+.+.||+|+||.||+|....+++.||+|.++..... ..+.+.+|+.+++.++|||++++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 578889999999999999999888999999988632110 1245788999999999999999999863
Q ss_pred ccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCce
Q 001782 770 FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVA 849 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 849 (1013)
..+..++||||+++++|.++++.. +.+++..+..++.|++.|+.|||++ +++||||+|+||+++.++.+
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC 147 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence 447889999999999999999765 4688999999999999999999999 99999999999999999999
Q ss_pred EEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCCcCCCCcc
Q 001782 850 HVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD--MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLT 927 (1013)
Q Consensus 850 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~ 927 (1013)
|++|||.++....... ........|+..|+|||++.... ++.++|+||||+++||+++|..||......
T Consensus 148 ~l~d~~~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--- 218 (272)
T cd06629 148 KISDFGISKKSDDIYD------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--- 218 (272)
T ss_pred EEeecccccccccccc------ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---
Confidence 9999999875432111 11123456889999999987654 788999999999999999999998642111
Q ss_pred HHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 928 LHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 928 ~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.... +..... .++..... ...+.+..+.+++.+|++.+|++||+++||++
T Consensus 219 -~~~~---------~~~~~~------~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 219 -AAMF---------KLGNKR------SAPPIPPD------VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -HHHH---------Hhhccc------cCCcCCcc------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1100 000000 00000000 00123456888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.21 Aligned_cols=249 Identities=24% Similarity=0.423 Sum_probs=199.0
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|+..+.||+|+||.||+|.+..+++.+|+|.+.... ....+.+.+|++++++++|||++++++.+ ..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 5888999999999999999998899999999987442 23356788999999999999999999984 3457899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC-CceEEccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD-MVAHVGDFGL 856 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~ 856 (1013)
+||||+++++|.+++..... ..+++.++.+++.|++.|++|||++ +++||||+|+||+++.+ +.+|++|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred EEEecCCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 99999999999999976532 3589999999999999999999999 99999999999999865 4689999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..
T Consensus 149 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~----- 209 (256)
T cd08220 149 SKILSSKS---------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----AL----- 209 (256)
T ss_pred ceecCCCc---------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HH-----
Confidence 98653211 122346788999999999888999999999999999999999998653211 00
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.......... . .....+..+.+++.+||+.+|++|||+.|+++
T Consensus 210 ---~~~~~~~~~~-------~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 210 ---VLKIMSGTFA-------P----------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---HHHHHhcCCC-------C----------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0011000000 0 00112456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=309.28 Aligned_cols=263 Identities=22% Similarity=0.271 Sum_probs=200.2
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+++++.++||||+++++.+. .+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence 368899999999999999999999999999999874432 23456789999999999999999999853 4578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++++|.+++... +.+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNI------GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred EEEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence 89999999999999999765 4689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccc-------cCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccH
Q 001782 856 LARFLPPCSPATIL-------ETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 928 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~ 928 (1013)
+++........... ..........++..|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---- 222 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---- 222 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 98742111100000 0001112345788999999998889999999999999999999999999642111
Q ss_pred HHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHH
Q 001782 929 HEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 929 ~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1003 (1013)
.... ...... ...|.. ....+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 223 -~~~~--------~~~~~~-~~~~~~--------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 223 -ELFG--------QVISDD-IEWPEG--------------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -HHHH--------HHHhcc-cCCCCc--------------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1000 000000 000000 00124557899999999999999997666665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=333.41 Aligned_cols=267 Identities=25% Similarity=0.349 Sum_probs=196.7
Q ss_pred hhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCC-----
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSID----- 769 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 769 (1013)
+...+|+..+.||+||||.||+++++-+|+.||||++.... ......+.+|+..+++++|||||+++..+.+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567888899999999999999999999999999997553 333466889999999999999999976532111
Q ss_pred --------------------------------------------------------c-----------------------
Q 001782 770 --------------------------------------------------------F----------------------- 770 (1013)
Q Consensus 770 --------------------------------------------------------~----------------------- 770 (1013)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred -----------------------c-------ccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHH
Q 001782 771 -----------------------E-------EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820 (1013)
Q Consensus 771 -----------------------~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L 820 (1013)
. ..-..||=||||+..+++++++.+... -.....++++++|++||
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEGL 710 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHHH
Confidence 0 002357889999988888888876321 14678899999999999
Q ss_pred HHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCC------CC----CCCccccCCCCCccccccccccccccc
Q 001782 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP------PC----SPATILETPSSSTGIKGTVGYVAPEYG 890 (1013)
Q Consensus 821 ~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~------~~----~~~~~~~~~~~~~~~~gt~~y~aPE~~ 890 (1013)
+|+|++ |||||||||.||++|+++.|||+|||+|.... .. ............+..+||.-|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999 99999999999999999999999999998721 00 001111122245678999999999998
Q ss_pred CCCC---CCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHH
Q 001782 891 MGGD---MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIA 967 (1013)
Q Consensus 891 ~~~~---~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~ 967 (1013)
.+.. |+.|+|+||+|+|++||+. ||.........+.......+|.+ ..+.
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~----------------------- 840 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFF----------------------- 840 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccc-----------------------
Confidence 8754 9999999999999999996 56543222111111111112221 1111
Q ss_pred HHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 968 KIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 968 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
......-.++++++++.||.+||||.|++.
T Consensus 841 --~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 841 --DPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred --cccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 111233468899999999999999999975
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=302.91 Aligned_cols=264 Identities=24% Similarity=0.281 Sum_probs=201.6
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
++|...++||.|++|.||+|.+..+++.||+|.+..... ....++.+|++++++++||||+++++++.. ......+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence 367888999999999999999988999999999874432 334678999999999999999999998753 2345789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++..... ....+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 78 lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred EEEEecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccc
Confidence 99999999999998765322 124688999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
....... .....++..|+|||.+.+..++.++||||+||++|+|++|+.||...........+
T Consensus 153 ~~~~~~~----------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------- 215 (287)
T cd06621 153 GELVNSL----------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE------- 215 (287)
T ss_pred ccccccc----------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHH-------
Confidence 7543211 12345788999999999999999999999999999999999999764221011011
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
....+... ..+. .... .......+..+.+++.+||+.+|.+|||+.||++
T Consensus 216 --~~~~~~~~--~~~~----~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 216 --LLSYIVNM--PNPE----LKDE----PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred --HHHHHhcC--Cchh----hccC----CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 01110000 0000 0000 0000112356789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=299.89 Aligned_cols=247 Identities=28% Similarity=0.434 Sum_probs=192.4
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeec
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYM 783 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 783 (1013)
++||+|+||.||+|... ++..||+|++..... .....+.+|++++++++||||+++++++. .....++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence 47999999999999865 678899999864432 22346889999999999999999999964 336789999999
Q ss_pred cCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCC
Q 001782 784 ECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863 (1013)
Q Consensus 784 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 863 (1013)
++++|.+++.... ..+++.+++.++.|++.|+.|+|++ +++||||||+||+++.++.+|++|||++......
T Consensus 75 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 75 PGGDFLSFLRKKK-----DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred CCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 9999999987542 3578999999999999999999999 9999999999999999999999999998753321
Q ss_pred CCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhhCChhHHH
Q 001782 864 SPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALPEKVME 942 (1013)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1013)
.. .......++..|+|||++.++.++.++||||||+++|++++ |..||...... . ...
T Consensus 147 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~---------~~~ 205 (250)
T cd05085 147 IY-------SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----Q---------ARE 205 (250)
T ss_pred cc-------ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----H---------HHH
Confidence 11 01112234678999999998899999999999999999998 99998653111 0 000
Q ss_pred hhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 943 IVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 943 ~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
.+... .|+.. ...++..+.+++.+|++.+|++||++.|++++|.
T Consensus 206 ~~~~~------~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 206 QVEKG------YRMSC----------PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHcC------CCCCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 00000 00000 0112456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.16 Aligned_cols=289 Identities=20% Similarity=0.262 Sum_probs=206.7
Q ss_pred hccCCCCCceeeccceEEEEEEECCCC----eEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCcc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENE----MAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 771 (1013)
...|+.++.||+|.||.||+|....+. +.+|+|.++.+.+ .......+|+..++.++||||+.+..++. .
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl----~ 98 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL----S 98 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh----c
Confidence 457899999999999999999664432 3689999975433 33456889999999999999999999863 3
Q ss_pred ccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC----C
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD----M 847 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~ 847 (1013)
.+...++++||.+ .+|.+.|+..+.... +.++...+..|..||+.|++|||++ =|+|||+||.||||..+ |
T Consensus 99 ~d~~v~l~fdYAE-hDL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG 173 (438)
T KOG0666|consen 99 HDKKVWLLFDYAE-HDLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERG 173 (438)
T ss_pred cCceEEEEehhhh-hhHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccC
Confidence 3688999999999 899999988765443 5899999999999999999999999 79999999999999877 8
Q ss_pred ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCc
Q 001782 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGL 926 (1013)
Q Consensus 848 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~ 926 (1013)
.|||+|||+|+.+...- ..-......+-|.+|+|||.+.+. .||++.||||.||++.||++-++.|.+...+..
T Consensus 174 ~VKIaDlGlaR~~~~pl-----kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~ 248 (438)
T KOG0666|consen 174 RVKIADLGLARLFNNPL-----KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIK 248 (438)
T ss_pred eeEeecccHHHHhhccc-----cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcc
Confidence 99999999999774321 112234567789999999998886 589999999999999999999998876422211
Q ss_pred --------cHHHHHHhh-CChh-----HHHhhhh-hhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCC
Q 001782 927 --------TLHEFAKMA-LPEK-----VMEIVDP-LLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSER 991 (1013)
Q Consensus 927 --------~~~~~~~~~-~~~~-----~~~~i~~-~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 991 (1013)
++..+.... .|.+ +...-+- .+..+...+.........-........+..++++.+++.+||.+|
T Consensus 249 ~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kR 328 (438)
T KOG0666|consen 249 TKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKR 328 (438)
T ss_pred cCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhh
Confidence 111111111 0100 0000000 000011111111000111111112122346889999999999999
Q ss_pred CCHHHHHHH
Q 001782 992 IQMTDVVAK 1000 (1013)
Q Consensus 992 Ps~~evl~~ 1000 (1013)
.|++++++.
T Consensus 329 Ita~qAleh 337 (438)
T KOG0666|consen 329 ITAEQALEH 337 (438)
T ss_pred ccHHHHhcc
Confidence 999998864
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=302.25 Aligned_cols=238 Identities=24% Similarity=0.440 Sum_probs=187.9
Q ss_pred CceeeccceEEEEEEECCCC----------eEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 705 NMIGQGSFGFVYRGNLGENE----------MAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 47999999999999997665 45788887644433 5778999999999999999999998642 4
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC-------
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM------- 847 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~------- 847 (1013)
..++||||+++++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~ 145 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREK-----NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP 145 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCce
Confidence 5689999999999999998753 2688999999999999999999999 999999999999999887
Q ss_pred ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCC--CCCcccchHHHHHHHHHHHh-CCCCCCCcCCC
Q 001782 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG--DMSATGDVYSFGILLLEMFT-RRRPTDNMFND 924 (1013)
Q Consensus 848 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~ 924 (1013)
.+||+|||++..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||......
T Consensus 146 ~~kl~Dfg~a~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~ 213 (259)
T cd05037 146 FIKLSDPGIPITVLS------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213 (259)
T ss_pred eEEeCCCCccccccc------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence 799999999875432 1223466789999998876 78999999999999999999 57777653211
Q ss_pred CccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 925 GLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
....... .. . ..+ . + ....+.+++.+||..+|.+|||+.||++.|
T Consensus 214 --~~~~~~~-----------~~----~--~~~-~-----~-------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 214 --EKERFYQ-----------DQ----H--RLP-M-----P-------DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --hHHHHHh-----------cC----C--CCC-C-----C-------CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000000 00 0 000 0 0 014578999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.65 Aligned_cols=275 Identities=23% Similarity=0.319 Sum_probs=201.6
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
++|++.++||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++|+||+++++++. .++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence 47889999999999999999999889999999987432 233467899999999999999999999964 35789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||++++.+..+.... ..+++.++..++.|++.|++|||+. +++|||++|+||++++++.+||+|||.
T Consensus 76 ~iv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 76 YLVFEYVERTLLELLEASP------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred EEEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeec
Confidence 9999999977776665543 4589999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH--
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK-- 933 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~-- 933 (1013)
+........ .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+ .......
T Consensus 147 ~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~ 218 (288)
T cd07833 147 ARALRARPA-------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCL 218 (288)
T ss_pred ccccCCCcc-------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 886543221 112345678899999999888 78999999999999999999999997532111 0000000
Q ss_pred hhCChhHHHhhhhhhccchhhhh---ccCCCC-chhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARA---SNCGSH-RTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~---~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
...++....... .++..+. ...... ..+.......+..+.+++++||..+|++||+++++++
T Consensus 219 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 219 GPLPPSHQELFS----SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCCCHHHhhhcc----cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 001111110000 0000000 000000 0000001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=309.42 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=198.2
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIV 779 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 779 (1013)
.|.....||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++|||++++++++. .++..++|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv 96 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVL 96 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEE
Confidence 3444568999999999999998889999999997655555567889999999999999999999853 45788999
Q ss_pred EeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccccc
Q 001782 780 YEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859 (1013)
Q Consensus 780 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 859 (1013)
|||+++++|.+++.. ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 97 ~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~ 166 (297)
T cd06659 97 MEFLQGGALTDIVSQ-------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ 166 (297)
T ss_pred EecCCCCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence 999999999998754 3578999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChh
Q 001782 860 LPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEK 939 (1013)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~ 939 (1013)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 167 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~------- 227 (297)
T cd06659 167 ISKDV--------PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAMK------- 227 (297)
T ss_pred ccccc--------ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH-------
Confidence 43211 1123356889999999999889999999999999999999999999642111 0000
Q ss_pred HHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 940 VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 940 ~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.+... +... .......+..+.+++.+|++.+|.+||+++|+++.
T Consensus 228 ---~~~~~----~~~~----------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 228 ---RLRDS----PPPK----------LKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ---HHhcc----CCCC----------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 0000 00001123457789999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=304.47 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=202.5
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
++|+..+.||+|+||.||+|.+..+++.||+|++..... ...+++.+|++++++++||||+++++++. .....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEE
Confidence 368888999999999999999998999999999875432 34467889999999999999999999864 347899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH-HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
+++||+++++|.+++.... ..+++..+.+++.|++.|++|||+ . +++|+||||+||++++++.+||+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred EEEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999998653 368889999999999999999999 8 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+....... .....++..|+|||++.+..++.++||||+|+++|+|++|+.||.........
T Consensus 148 ~~~~~~~~----------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--------- 208 (265)
T cd06605 148 SGQLVNSL----------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG--------- 208 (265)
T ss_pred chhhHHHH----------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc---------
Confidence 87542211 11156788999999999999999999999999999999999999764321111
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..+.++......+.. ... ......+.+++.+||..||++|||+.|++.
T Consensus 209 ---~~~~~~~~~~~~~~~-----------~~~-~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 209 ---IFELLQYIVNEPPPR-----------LPS-GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ---HHHHHHHHhcCCCCC-----------CCh-hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111111111111100 000 013456889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=305.42 Aligned_cols=254 Identities=21% Similarity=0.294 Sum_probs=193.3
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHH-HhcCCCCccceEEEEeecCCccccceE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEA-LRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
++|++.+.||+|+||.||+|++..+++.||+|+++.... ....++..|+.. ++..+||||+++++++. .+...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence 478899999999999999999999999999999875432 223455566665 56678999999999964 34678
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||++ ++|.+++...... ...+++.+++.++.|++.|++|||++. +++||||||+||+++.++.+||+|||.
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~ 150 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI 150 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999998 7898888654221 146899999999999999999999853 899999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCC----CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG----GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
+...... .......++..|+|||++.+ ..++.++|+||+||++|||++|+.||...... ...
T Consensus 151 ~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~-- 216 (283)
T cd06617 151 SGYLVDS---------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQQ-- 216 (283)
T ss_pred ccccccc---------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HHH--
Confidence 8754321 11223457889999998865 45688999999999999999999998643211 111
Q ss_pred HhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
....+.......+. ...+..+.+++.+||..+|++||++.++++
T Consensus 217 -------~~~~~~~~~~~~~~----------------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 217 -------LKQVVEEPSPQLPA----------------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -------HHHHHhcCCCCCCc----------------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111100000000 112456789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=305.43 Aligned_cols=245 Identities=25% Similarity=0.309 Sum_probs=197.6
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++ .+...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence 47889999999999999999999899999999986432 22345688999999999999999999985 44578
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKS------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred EEEEEecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence 99999999999999999775 4689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...
T Consensus 147 ~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~---- 206 (290)
T cd05580 147 FAKRVKGR-----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQI---- 206 (290)
T ss_pred CccccCCC-----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHH----
Confidence 98754321 2234688999999999888899999999999999999999999975321 000
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVA 999 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 999 (1013)
...... ..+ ... ......+.+++.+||..||.+|| +++|+++
T Consensus 207 ----~~~~~~----~~~----~~~----------~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 207 ----YEKILE----GKV----RFP----------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----HHHHhc----CCc----cCC----------ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 001100 000 000 01134567899999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=301.08 Aligned_cols=261 Identities=25% Similarity=0.331 Sum_probs=203.9
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
++|++.+.||.|+||+||+|....++..||+|++.... ....+.+.+|+++++.++|+|++++++.+. .++..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEE
Confidence 47899999999999999999998889999999986433 224567899999999999999999999853 457889
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.++++.... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||++
T Consensus 76 iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred EEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 99999999999999976432 13689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
..+....... ........|+..|+|||++... .++.++|+|||||++|||++|+.||....... ....
T Consensus 150 ~~~~~~~~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~------ 218 (267)
T cd06610 150 ASLADGGDRT----RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLML------ 218 (267)
T ss_pred HHhccCcccc----ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHH------
Confidence 8665432211 0112345688999999998877 78999999999999999999999997532211 0111
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
... ..+.. . .........+..+.+++.+|++.||++||++.|+++
T Consensus 219 ------~~~----~~~~~----~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 219 ------TLQ----NDPPS----L----ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ------Hhc----CCCCC----c----CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 00000 0 000001233456789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=306.46 Aligned_cols=281 Identities=25% Similarity=0.308 Sum_probs=200.6
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc--chhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG--ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
.++|++.++||+|+||.||+|.+..+++.||+|+++..... ....+.+|+.++++++|+||+++++++.. ...+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence 46899999999999999999999989999999998754322 22346789999999999999999998642 22356
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||++ ++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence 899999998 68988887642 4689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
.+....... .......++..|+|||++.+ ..++.++||||+||++|||++|+.||...... .........
T Consensus 154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~~ 224 (309)
T cd07845 154 LARTYGLPA--------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQL 224 (309)
T ss_pred eeeecCCcc--------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh
Confidence 998654321 11223345788999999866 45789999999999999999999999753211 111111111
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhH-HHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEI-AKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
...................+........... .........+.+++.+|++.||++|||+.|+++.
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 225 -LGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred -cCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000000000000000000000000 0111234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=297.10 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=205.8
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec---cccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
.+.|+.-++||+||||.||-++.+.+|+.+|.|.+..+ .+.......+|..++++++.+.||.+--+ ++..+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCC
Confidence 45678889999999999999999999999999988633 23344557889999999999999887666 56679
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..|+|+..|.||+|.-.|..... ..+++..++.++.+|+.||++||+. +||+||+||+|||+|+.|+++|+|.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~----~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGN----PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCC----CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeecc
Confidence 99999999999999998887644 5899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCcc--HHHH-
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLT--LHEF- 931 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~--~~~~- 931 (1013)
|+|..+....+ ....+||.+|||||++.+..|+...|.||+||++|||+.|+.||......... ....
T Consensus 332 GLAvei~~g~~---------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~ 402 (591)
T KOG0986|consen 332 GLAVEIPEGKP---------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT 402 (591)
T ss_pred ceEEecCCCCc---------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH
Confidence 99987654332 34458999999999999999999999999999999999999999864322111 1111
Q ss_pred ------HHhhCChhHHHhhhhhhccchhhhhccCCCCchh
Q 001782 932 ------AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTE 965 (1013)
Q Consensus 932 ------~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~ 965 (1013)
....+++++..+....+..||.+|....+....+
T Consensus 403 ~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~e 442 (591)
T KOG0986|consen 403 LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQE 442 (591)
T ss_pred hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcch
Confidence 1123567788899999999999998877554443
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=305.92 Aligned_cols=279 Identities=23% Similarity=0.299 Sum_probs=199.8
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
.++|++.+.||+|+||.||+|++..+++.||+|.++.... .....+.+|+.++++++||||+++++++... +...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCc
Confidence 3578999999999999999999998899999999974432 2234567899999999999999999986432 2378
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||++ ++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 81 ~~lv~e~~~-~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 81 IYMVMEYVE-HDLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred EEEEehhcC-cCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecC
Confidence 999999998 69999887642 2589999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
.+....... .......++..|+|||++.+. .++.++||||+|+++|||++|+.||....... ........
T Consensus 152 ~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~ 222 (293)
T cd07843 152 LAREYGSPL--------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKL 222 (293)
T ss_pred ceeeccCCc--------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence 988654321 112234578899999988764 46889999999999999999999997532211 11111111
Q ss_pred hC-Ch-hHHHhhhhhhccc--hhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 AL-PE-KVMEIVDPLLLLD--LEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~-~~-~~~~~i~~~l~~~--~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.. +. ........+.... ...+... .......+. ......+.+++.+|++.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 223 LGTPTEKIWPGFSELPGAKKKTFTKYPY-NQLRKKFPA-LSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hCCCchHHHHHhhccchhcccccccccc-hhhhccccc-cCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 00 0000000000000 0000000 000000000 002456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=304.03 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=198.0
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIV 779 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 779 (1013)
.|...++||+|++|.||+|.+..+++.|++|++........+.+.+|+.+++.++||||+++++++. ..+..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence 4555689999999999999998889999999987554444566889999999999999999999854 44778999
Q ss_pred EeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccccc
Q 001782 780 YEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859 (1013)
Q Consensus 780 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 859 (1013)
+||+++++|.+++... .+++.++..++.|++.|++|||++ +++||||+|+||+++.++.++|+|||.+..
T Consensus 95 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 95 MEFLEGGALTDIVTHT-------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred EeccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 9999999999998762 578899999999999999999999 999999999999999999999999998864
Q ss_pred CCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChh
Q 001782 860 LPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEK 939 (1013)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~ 939 (1013)
..... .......|+..|+|||...+..++.++||||+||++|||++|+.||..... ....
T Consensus 165 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~~-------- 224 (285)
T cd06648 165 VSKEV--------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQAM-------- 224 (285)
T ss_pred hccCC--------cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHHH--------
Confidence 43211 112234588999999999888899999999999999999999999864211 0000
Q ss_pred HHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 940 VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 940 ~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..+... .+ +. .......+..+.+++.+||+.+|++||++.|+++
T Consensus 225 --~~~~~~---~~---~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 225 --KRIRDN---LP---PK--------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --HHHHhc---CC---CC--------CcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 000000 00 00 0000112356889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.11 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=204.5
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|++++++++|||++++++++. .....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence 368889999999999999999998899999999875543 34567899999999999999999999954 447899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH-HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
+||||+++++|.+++... ..+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.
T Consensus 76 lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred EEEEecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence 999999999999999865 468999999999999999999999 9 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~-------- 208 (264)
T cd06623 147 SKVLENTLD--------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SF-------- 208 (264)
T ss_pred ceecccCCC--------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CH--------
Confidence 876532211 112345789999999999999999999999999999999999999764320 11
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHH-HHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEE-CLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.+.......... +.. ... .+..+.+++.+|++.+|++||++.|+++.
T Consensus 209 ----~~~~~~~~~~~~---~~~----------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 209 ----FELMQAICDGPP---PSL----------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----HHHHHHHhcCCC---CCC----------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111111110000 000 001 34568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.40 Aligned_cols=252 Identities=32% Similarity=0.554 Sum_probs=198.6
Q ss_pred CCCCCceeeccceEEEEEEECCCC----eEEEEEEEeecccc-chhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENE----MAVAVKVMNLKQRG-ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
+++.+.||.|+||.||+|++...+ ..||+|++...... ..+.+..|+++++.++|+||+++++++. ..+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCe
Confidence 457789999999999999997665 88999999754433 4567899999999999999999999864 3478
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.+++|||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRP----KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhh----ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence 9999999999999999987532 1289999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
.+.......... .....++..|+|||.+.+..++.++||||+|+++|+|++ |..||..... ..
T Consensus 149 ~~~~~~~~~~~~-------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~~---- 212 (258)
T smart00219 149 LSRDLYDDDYYK-------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----EE---- 212 (258)
T ss_pred Cceecccccccc-------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----HH----
Confidence 998654331111 112236789999999988889999999999999999998 7888764211 00
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
..+.+.... ++.. ....+..+.+++.+|+..||++|||+.|+++.|
T Consensus 213 -----~~~~~~~~~------~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 213 -----VLEYLKKGY------RLPK----------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----HHHHHhcCC------CCCC----------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 001010000 0000 011345688899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=311.50 Aligned_cols=285 Identities=21% Similarity=0.265 Sum_probs=205.1
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 368999999999999999999999999999999987432 233456788999999999999999998865432 34567
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+. ++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD------QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred EEEEEehhh-hhHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence 899999997 6899988754 4689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
++......... .........|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... ........
T Consensus 153 ~~~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~ 227 (334)
T cd07855 153 MARGLSSSPTE----HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSV 227 (334)
T ss_pred cceeecccCcC----CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHH
Confidence 99765332111 1111234568899999998765 468899999999999999999999997532211 11111110
Q ss_pred hCChhHHHhhhhhhccchh---hhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLE---ARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~---~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
......++++........ +......... -.......+..+.+++.+|++.+|.+||++++++..
T Consensus 228 -~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 228 -LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVP-WSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred -hCCChhHhhhhhchhhHHHHHhhcccCCCCC-HHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000001111100000000 0000000000 000112335678999999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=307.37 Aligned_cols=286 Identities=22% Similarity=0.331 Sum_probs=200.2
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCc---c
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDF---E 771 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~ 771 (1013)
..++|++.++||+|+||.||+|++..+++.||+|.+..... .....+.+|++++++++||||+++++++..... .
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 35689999999999999999999999999999999864332 223356789999999999999999999865321 1
Q ss_pred ccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEE
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV 851 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 851 (1013)
.....++||||+. +++.+++.... ..+++.+++.++.|++.|++|||++ +++|+||||+||+++.++.+||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL 160 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEE
Confidence 2346799999998 68888876542 3689999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHH
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHE 930 (1013)
Q Consensus 852 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~ 930 (1013)
+|||.+..+....... ........++..|+|||++.+. .++.++||||||+++|||++|..||...... .....
T Consensus 161 ~dfg~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~ 235 (310)
T cd07865 161 ADFGLARAFSLSKNSK----PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTL 235 (310)
T ss_pred CcCCCcccccCCcccC----CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence 9999998654322110 1112345678899999987765 4788999999999999999999998753211 11111
Q ss_pred HHH--hhCChhHHHhhhhhhccchhhhhccCCCCchhHHH---HHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 931 FAK--MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAK---IEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 931 ~~~--~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
... ...+++...-... .+................. .......+.+++.+|+..||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 236 ISQLCGSITPEVWPGVDK---LELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHhCCCChhhcccccc---hhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 110 0111110000000 0000000000000000000 0001245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=284.51 Aligned_cols=241 Identities=25% Similarity=0.325 Sum_probs=201.3
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec---cccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
-++|...++||+|.||.|.+++.+.+++.+|+|+++.+ ...+...-..|-++++..+||.+..+--. ++..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence 35788889999999999999999999999999999743 23344455779999999999998877544 66779
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..|+||||+.||.|.-.+.+. ..+++...+.+...|+.||.|||++ +||+||+|.+|.|+|.||++||+||
T Consensus 242 rlCFVMeyanGGeLf~HLsre------r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRE------RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred eEEEEEEEccCceEeeehhhh------hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeec
Confidence 999999999999999888765 5789999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH--
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA-- 932 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~-- 932 (1013)
|+++.- .........++|||.|.|||++....|+.++|.|.+||++|||++|+.||.....+. .+..+.
T Consensus 313 GLCKE~--------I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-LFeLIl~e 383 (516)
T KOG0690|consen 313 GLCKEE--------IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-LFELILME 383 (516)
T ss_pred ccchhc--------ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-HHHHHHhh
Confidence 999732 233445678999999999999999999999999999999999999999998643321 111111
Q ss_pred ----HhhCChhHHHhhhhhhccchhhhhccCCC
Q 001782 933 ----KMALPEKVMEIVDPLLLLDLEARASNCGS 961 (1013)
Q Consensus 933 ----~~~~~~~~~~~i~~~l~~~~~~R~~~~~~ 961 (1013)
....++++..++...+.+||.+|......
T Consensus 384 d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpd 416 (516)
T KOG0690|consen 384 DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPD 416 (516)
T ss_pred hccCCccCCHHHHHHHHHHhhcChHhhcCCCch
Confidence 12346678888888999999988765543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=297.44 Aligned_cols=256 Identities=21% Similarity=0.338 Sum_probs=183.2
Q ss_pred CceeeccceEEEEEEECCC--CeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEe
Q 001782 705 NMIGQGSFGFVYRGNLGEN--EMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
+.||+|+||.||+|+.... ...+++|.+.... ....+.+.+|+.+++.++||||+++++.+. .....++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence 3699999999999976433 2346677665433 234567899999999999999999999964 3467899999
Q ss_pred eccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCC
Q 001782 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP 861 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 861 (1013)
|+++|+|.+++...... ....++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150 (268)
T ss_pred cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccC
Confidence 99999999999764321 13467778889999999999999999 99999999999999999999999999986321
Q ss_pred CCCCCccccCCCCCcccccccccccccccCC-------CCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHH
Q 001782 862 PCSPATILETPSSSTGIKGTVGYVAPEYGMG-------GDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~ 933 (1013)
... .........++..|+|||++.. ..++.++|||||||++|||++ |..||...... .......
T Consensus 151 ~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~- 222 (268)
T cd05086 151 KED------YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVI- 222 (268)
T ss_pred cch------hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH-
Confidence 111 0111234567889999998753 245789999999999999997 56677542111 0000000
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
.+....+. ++.... .....+.+++..|| .+|++||+++||++.|.
T Consensus 223 ---~~~~~~~~----------~~~~~~----------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 223 ---KDQQVKLF----------KPQLEL----------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ---hhcccccC----------CCccCC----------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 00000000 011100 11234677888899 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=311.57 Aligned_cols=282 Identities=22% Similarity=0.270 Sum_probs=204.8
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec--cccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
.++|.+.+.||+|+||+||+|++..+++.||||.+... .......+.+|+.+++.++||||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45899999999999999999999989999999998643 2233456788999999999999999999876443333456
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+. ++|.+++... +.+++.++..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS------QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence 899999997 7899888764 4689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
++....... .......++..|+|||++.. ..++.++|||||||++|+|++|+.||...... .........
T Consensus 154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~ 224 (337)
T cd07858 154 LARTTSEKG--------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITEL 224 (337)
T ss_pred cccccCCCc--------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHH
Confidence 997553211 11233457889999998765 46889999999999999999999999753211 111111110
Q ss_pred ---hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 935 ---ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 935 ---~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
..++....+.+... ....++....... ........++..+.+++.+|++.+|++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 225 LGSPSEEDLGFIRNEKA-RRYIRSLPYTPRQ-SFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hCCCChHHhhhcCchhh-hHHHHhcCccccc-CHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00111100000000 0000000000000 0001112345678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=301.21 Aligned_cols=275 Identities=21% Similarity=0.323 Sum_probs=201.0
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
+|++.++||+|++|.||+|++..++..||+|++..... ...+.+.+|++++++++||||+++++++. ..+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence 58889999999999999999998999999999975433 23456788999999999999999999964 3467899
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
||||++ ++|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||.+.
T Consensus 76 v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 76 VFEYMD-KDLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred EEecCC-ccHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 999999 589998876432 13689999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC-
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL- 936 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~- 936 (1013)
...... .......++..|+|||++.+. .++.++||||+||++|+|++|+.||...... ...........
T Consensus 149 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~ 219 (284)
T cd07836 149 AFGIPV--------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGT 219 (284)
T ss_pred hhcCCc--------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCC
Confidence 543211 112234568899999987664 5688999999999999999999999764322 11111111110
Q ss_pred C--hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 P--EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 ~--~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+ .....+. .. ........... ...........+..+.+++.+|++.||.+||+++|+++
T Consensus 220 ~~~~~~~~~~-~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 220 PTESTWPGIS-QL--PEYKPTFPRYP-PQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CChhhHHHHh-cC--chhcccccCCC-hHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 0111110 00 00000000000 00001111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=304.52 Aligned_cols=283 Identities=19% Similarity=0.279 Sum_probs=201.7
Q ss_pred cCCCCCceeeccceEEEEEEECC--CCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGE--NEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
+|++.++||+|+||.||+|.+.. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence 47888999999999999999987 78999999997532 3334667889999999999999999999753 2336
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC----CCceE
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH----DMVAH 850 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~k 850 (1013)
..++||||++ +++.+++...... ....+++..++.++.|++.|++|||+. +|+||||||+||+++. ++.+|
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 78 SVYLLFDYAE-HDLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred eEEEEEeCCC-cCHHHHHHhhccC-CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEE
Confidence 7999999998 5777777543221 113688999999999999999999999 9999999999999999 89999
Q ss_pred EccccccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHH
Q 001782 851 VGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 929 (1013)
Q Consensus 851 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~ 929 (1013)
|+|||++......... ........++..|+|||++.+. .++.++|||||||++|+|++|+.||...........
T Consensus 153 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 227 (316)
T cd07842 153 IGDLGLARLFNAPLKP-----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN 227 (316)
T ss_pred ECCCccccccCCCccc-----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccc
Confidence 9999999865432211 1122345678999999987764 578999999999999999999999976433220000
Q ss_pred HHHHhhCChhHHHhhhhhhccchhhh--------------hccCCCCc-hhHHH----HHHHHHHHHHHhhhcccCCCCC
Q 001782 930 EFAKMALPEKVMEIVDPLLLLDLEAR--------------ASNCGSHR-TEIAK----IEECLVAIVRIGVLCSMESPSE 990 (1013)
Q Consensus 930 ~~~~~~~~~~~~~~i~~~l~~~~~~R--------------~~~~~~~~-~~~~~----~~~~~~~l~~l~~~cl~~dP~~ 990 (1013)
.+.. ....+++..+-..++..+ ........ ..... .......+.+++.+|++.||++
T Consensus 228 ~~~~----~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 303 (316)
T cd07842 228 PFQR----DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTK 303 (316)
T ss_pred hhHH----HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCccc
Confidence 0000 011111111100000000 00000000 01111 0123456889999999999999
Q ss_pred CCCHHHHHH
Q 001782 991 RIQMTDVVA 999 (1013)
Q Consensus 991 RPs~~evl~ 999 (1013)
|||+.|+++
T Consensus 304 Rps~~eil~ 312 (316)
T cd07842 304 RITAEEALE 312 (316)
T ss_pred CcCHHHHhc
Confidence 999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=302.86 Aligned_cols=285 Identities=19% Similarity=0.219 Sum_probs=199.8
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCC-CCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 775 (1013)
++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+|+.+++++. ||||+++++++...+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468899999999999999999998999999999864432 23356888999999995 699999999876443323345
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC-CCceEEccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH-DMVAHVGDF 854 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DF 854 (1013)
.++||||++ +++.+++...... ....+++.+++.++.||+.||+|||++ +|+||||||+||+++. ++.+||+||
T Consensus 81 ~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLD-SDLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccC-cCHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 899999999 5899988764321 124689999999999999999999999 9999999999999998 889999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
|+++.+.... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||........ ......
T Consensus 156 g~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~ 226 (295)
T cd07837 156 GLGRAFSIPV--------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFK 226 (295)
T ss_pred ccceecCCCc--------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHH
Confidence 9987543211 11122346788999998765 4578999999999999999999999975321111 111110
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
....+....+.......+....+.... .............+.+++.+|++.||.+||++.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQWKP--QDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcccc--hhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000000000000000000000 0000111234566889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=309.39 Aligned_cols=280 Identities=21% Similarity=0.295 Sum_probs=203.0
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec--cccchhHHHHHHHHHhcC-CCCccceEEEEeecCCcccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 773 (1013)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++++ +||||+++++++.. .+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 456899999999999999999999888999999988532 222345677899999999 99999999998642 234
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++||||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence 56899999998 6999888653 578889999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
||.+.......... .........|+..|+|||++.+ ..++.++||||||+++|+|++|+.||........ .....
T Consensus 151 ~g~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~ 226 (337)
T cd07852 151 FGLARSLSELEENP---ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKII 226 (337)
T ss_pred ccchhccccccccc---cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH
Confidence 99998664322110 1112334568999999998765 4578899999999999999999999975322211 11111
Q ss_pred Hhh--CChh-HHHh----hhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 933 KMA--LPEK-VMEI----VDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 933 ~~~--~~~~-~~~~----i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
... .+.. ...+ .+.++...+. .............+..+.+++.+||+.||++|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 227 EVIGPPSAEDIESIKSPFAATMLDSLPS------RPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHhCCCCHHHHHHHHhhhHHHhhhhccc------ccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 110 0100 1100 0001100000 00000011112245678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=300.97 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=196.7
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCC---CCccceEEEEeecCCccccce
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIR---HRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 775 (1013)
.|++.+.||+|+||.||+|.+..+++.||+|++.... ....+++.+|+.++++++ |||++++++++. .+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 4788899999999999999998899999999987442 334467889999999986 999999999864 4477
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++||||+++++|.++++.. .+++..++.++.|++.|+.|||+. +++||||+|+||++++++.++|+|||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence 89999999999999998653 678999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
.+..+.... .......|+..|+|||++.++ .++.++|||||||++|+|++|..||...... ...
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~-- 211 (277)
T cd06917 147 VAALLNQNS--------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAM-- 211 (277)
T ss_pred ceeecCCCc--------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhh--
Confidence 997654322 112334688999999988654 4688999999999999999999999753111 000
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..+... .+ +.... ...+..+.+++.+||+.||++||++.|+++
T Consensus 212 -------~~~~~~---~~---~~~~~---------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 212 -------MLIPKS---KP---PRLED---------NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred -------hccccC---CC---CCCCc---------ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 000000 00 00000 012356788999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=299.65 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=197.9
Q ss_pred cCCCCCceeeccceEEEEEEECC-CCeEEEEEEEeecc----------ccchhHHHHHHHHHhc-CCCCccceEEEEeec
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGE-NEMAVAVKVMNLKQ----------RGATKSFVAECEALRN-IRHRNLIKIITVCSS 767 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 767 (1013)
.|++.+.||+|+||.||+|.+.. .++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 47889999999999999999987 67889999886322 1123456778887765 79999999999863
Q ss_pred CCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCceEecCC
Q 001782 768 IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH-HCHPPIVHGDLKPSNVLLDHD 846 (1013)
Q Consensus 768 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~ 846 (1013)
.++..++||||+++++|.+++...... ...+++..++.++.|++.|+.|||+ . +++|+||+|+||+++.+
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~ 150 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGED 150 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCC
Confidence 457899999999999999988653211 1468999999999999999999996 5 89999999999999999
Q ss_pred CceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCc
Q 001782 847 MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGL 926 (1013)
Q Consensus 847 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~ 926 (1013)
+.+||+|||.+....... ......|+..|+|||+..+..++.++||||||+++|||++|+.||.....
T Consensus 151 ~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--- 218 (269)
T cd08528 151 DKVTITDFGLAKQKQPES---------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--- 218 (269)
T ss_pred CcEEEecccceeeccccc---------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---
Confidence 999999999997643221 23345688999999999988899999999999999999999999864211
Q ss_pred cHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 927 TLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 927 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
... ...+........+. ...+..+.+++.+||+.||++||++.||.++++
T Consensus 219 --~~~--------~~~~~~~~~~~~~~----------------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 219 --LSL--------ATKIVEAVYEPLPE----------------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --HHH--------HHHHhhccCCcCCc----------------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000 00111100000000 012346788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=298.89 Aligned_cols=274 Identities=18% Similarity=0.223 Sum_probs=194.9
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCC-CCccceEEEEeecCCccccceEEE
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
|++.++||+|+||.||+|++..+++.||+|+++... ........+|+.+++++. |||++++++++... ..+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 677899999999999999999899999999987432 222234457888898885 99999999997532 2367899
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
||||++ +++.+++.... ..+++.+++.++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.++
T Consensus 78 v~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 78 VFELMD-MNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred EEecCC-ccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence 999998 68888887542 3689999999999999999999999 9999999999999999 999999999997
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
...... ......++..|+|||++.. +.++.++||||+||++|||++|..||......+ ..... .....
T Consensus 148 ~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~-~~~~~ 216 (282)
T cd07831 148 GIYSKP---------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKI-HDVLG 216 (282)
T ss_pred ccccCC---------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHH-HHHcC
Confidence 653211 1123457889999997644 557889999999999999999999996532111 11111 11111
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchh-HHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTE-IAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
....++. .................... .......+..+.+++.+||+.+|++||+++|+++
T Consensus 217 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 217 TPDAEVL-KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CCCHHHH-HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1111110 00000000000000000000 0111234678899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=304.28 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=195.7
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
..+|+..++||+|+||+||+|++..+++.||+|++..... ...+++.+|+++++.++||||+++++++. ..+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCC
Confidence 4579999999999999999999988899999999864332 22356889999999999999999999974 346
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..++||||+. |++.+++.... ..+++.++..++.|++.|+.|||+. +++||||+|+||++++++.+||+||
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~df 159 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHK-----KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADF 159 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeec
Confidence 7899999998 68877776432 3689999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM---GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~ 931 (1013)
|++..... .....++..|+|||++. ...++.++||||||+++|||++|+.||....... .
T Consensus 160 g~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~----~- 222 (307)
T cd06607 160 GSASLVSP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----A- 222 (307)
T ss_pred CcceecCC------------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH----H-
Confidence 99875432 12345788999999874 4568889999999999999999999986531110 0
Q ss_pred HHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 932 AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
...... .+ .+.. ....++..+.+++.+||+.+|++||++.+|+..
T Consensus 223 --------~~~~~~----~~---~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 223 --------LYHIAQ----ND---SPTL---------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --------HHHHhc----CC---CCCC---------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 00 0000 011234568899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=305.64 Aligned_cols=202 Identities=27% Similarity=0.418 Sum_probs=180.3
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccc--hhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA--TKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
-...|.+.+.||+|.|+.|.+|++..++..||||+++...-.. ...+.+|+++|+.++||||++++.+. +...
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETEA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eecc
Confidence 4568999999999999999999999999999999998554432 24488999999999999999999994 5568
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..|+||||+.+|.+.+|+... +++.+.++..++.|+.+|++|+|++ .|||||||++||+++.+.++||+||
T Consensus 129 ~lylV~eya~~ge~~~yl~~~------gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDf 199 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKH------GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADF 199 (596)
T ss_pred eeEEEEEeccCchhHHHHHhc------ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecc
Confidence 899999999999999999987 5677789999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDM-SATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
|++.++.. .......+|++.|.|||++.+..| ++++|+||+|+++|.|+.|..||+..
T Consensus 200 gfS~~~~~---------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 200 GFSTFFDY---------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred ccceeecc---------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 99987653 233567899999999999998876 56899999999999999999999863
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=299.75 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=199.7
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
+|++.++||+|+||.||+|++..++..||+|++.... ....+.+.+|++++++++||||+++++.+ .++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 4788999999999999999999889999999997432 23456789999999999999999999884 456789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++|+||+.+++|.+++... ..+++.++..++.|+++|+.|||+. +++|+||+|+||++++++.++|+|||.
T Consensus 76 ~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 9999999999999999765 4688999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+....... ......|+..|+|||++.+..++.++|+||+|+++|+|++|..||...... ....+
T Consensus 147 ~~~~~~~~---------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~----- 210 (258)
T cd05578 147 ATKVTPDT---------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQI----- 210 (258)
T ss_pred ccccCCCc---------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHH-----
Confidence 87553221 123355788999999999888999999999999999999999999764321 01111
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCH--HHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQM--TDVV 998 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~evl 998 (1013)
....... ++. .+...+..+.+++.+||+.||.+||++ +|++
T Consensus 211 ----~~~~~~~-------~~~----------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 211 ----RAKQETA-------DVL----------YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ----HHHhccc-------ccc----------CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0000000 000 001223567899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=301.36 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=204.1
Q ss_pred hhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
...+.|++.+.||+|++|.||+|.+..++..|++|++..... ..+.+.+|++++++++|+|++++++++. ....
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL-----VGDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE-----ECCE
Confidence 456789999999999999999999988899999999975544 4567889999999999999999999864 3478
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.++|+||+++++|.+++.... ..+++.++..++.|++.|++|||+. |++|+||+|+||+++.++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccc
Confidence 999999999999999998752 2689999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
.+....... .......++..|+|||++.+..++.++||||||+++|+|++|+.||...... ...
T Consensus 162 ~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----~~~---- 225 (286)
T cd06614 162 FAAQLTKEK--------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----RAL---- 225 (286)
T ss_pred hhhhhccch--------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----HHH----
Confidence 986543211 1122345788999999999888999999999999999999999998642111 000
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..+... .+ .........+..+.+++.+|++.+|.+||++.++++
T Consensus 226 -----~~~~~~----~~-----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 226 -----FLITTK----GI-----------PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -----HHHHhc----CC-----------CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 000000 00 000011123456889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.68 Aligned_cols=282 Identities=18% Similarity=0.242 Sum_probs=194.8
Q ss_pred Cceeec--cceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQG--SFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
..||+| +||+||+|++..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++. .++..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence 456666 999999999998999999999874432 23467889999999999999999999964 457789999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+.++++.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++||+.+...
T Consensus 79 e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 79 PFMAYGSANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred ecccCCCHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 99999999999887532 3588999999999999999999999 9999999999999999999999999865433
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC--
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGG--DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL-- 936 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~-- 936 (1013)
........ ..........++..|+|||++.+. .++.++||||+||++|||++|+.||..................
T Consensus 152 ~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd08226 152 VRNGQKAK-VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP 230 (328)
T ss_pred hccCcccc-ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC
Confidence 21111000 000001122356779999998764 4788999999999999999999999764322111111100000
Q ss_pred ------ChhHHHhhhhhhccc-----hhhhhc---cCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 ------PEKVMEIVDPLLLLD-----LEARAS---NCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 ------~~~~~~~i~~~l~~~-----~~~R~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+.............+ ...+.. .........+....+...+.+++++||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000000000000 000000 000000111223345678899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=301.04 Aligned_cols=274 Identities=22% Similarity=0.316 Sum_probs=198.3
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
|++.+.||.|++|.||+|.+..++..||+|++..... ...+.+.+|+++++.++|||++++++++. ++...++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 6788999999999999999988999999999875432 22356889999999999999999999964 4478999
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
+|||++ ++|.+++..... ..+++..++.++.|++.||+|||++ +++||||+|+||+++.++.+||+|||.+.
T Consensus 76 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred EEeccC-cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 999996 799999876532 3689999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh-C
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA-L 936 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-~ 936 (1013)
...... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||........ ........ .
T Consensus 148 ~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~ 218 (283)
T cd07835 148 AFGVPV--------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGT 218 (283)
T ss_pred ccCCCc--------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCC
Confidence 543211 111223468899999987664 578899999999999999999999975322111 11111110 0
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchh-HHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTE-IAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+... ... .....+..+.......... .......+..+.+++.+|++.||++|||++|+++
T Consensus 219 ~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 219 PDED--VWP-GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CChH--Hhh-hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1000 000 0000000000000000000 0111122356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=298.86 Aligned_cols=243 Identities=22% Similarity=0.289 Sum_probs=184.9
Q ss_pred ceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhc---CCCCccceEEEEeecCCccccceEEEE
Q 001782 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRN---IRHRNLIKIITVCSSIDFEEVDFKAIV 779 (1013)
Q Consensus 706 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~~~~~~lv 779 (1013)
+||+|+||.||+|.+..+++.||+|.+..... .....+.+|..+++. .+||+|+.+++++. .++..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 48999999999999998899999999864322 112234455544443 47999999998853 44678999
Q ss_pred EeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccccc
Q 001782 780 YEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859 (1013)
Q Consensus 780 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 859 (1013)
|||+++++|.+++... +.+++.++..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 76 ~e~~~~~~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 76 LDLMNGGDLHYHLSQH------GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred EecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 9999999999998765 4689999999999999999999999 999999999999999999999999999874
Q ss_pred CCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCCh
Q 001782 860 LPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPE 938 (1013)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~ 938 (1013)
.... ......|+..|+|||...+ ..++.++||||+||++|||++|..||........ ...
T Consensus 147 ~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~------- 207 (279)
T cd05633 147 FSKK----------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEI------- 207 (279)
T ss_pred cccc----------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHH-------
Confidence 4321 1123468999999999864 5688999999999999999999999975422111 000
Q ss_pred hHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHHH
Q 001782 939 KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVAK 1000 (1013)
Q Consensus 939 ~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 1000 (1013)
.... ....+ . .....+..+.+++.+|++.||++|| |++|+++.
T Consensus 208 --~~~~---~~~~~----~----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 208 --DRMT---LTVNV----E----------LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --HHHh---hcCCc----C----------CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0000 00000 0 0012345678899999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=295.35 Aligned_cols=251 Identities=20% Similarity=0.291 Sum_probs=193.6
Q ss_pred hhhhhhhhccCCCCCce--eeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcC-CCCccceEEEEeec
Q 001782 691 YADLSKATNDFSSSNMI--GQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVCSS 767 (1013)
Q Consensus 691 ~~~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 767 (1013)
..+.....++|++.+.+ |+|+||.||++....++..+|+|++....... .|+.....+ +||||+++++.+.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~- 79 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVT- 79 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEe-
Confidence 34455556788888877 99999999999999999999999986432211 122222222 6999999999964
Q ss_pred CCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC
Q 001782 768 IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM 847 (1013)
Q Consensus 768 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 847 (1013)
..+..++||||+++++|.+++... ..+++.++..++.|+++|++|||+. +++||||||+||+++.++
T Consensus 80 ----~~~~~~iv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~ 146 (267)
T PHA03390 80 ----TLKGHVLIMDYIKDGDLFDLLKKE------GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAK 146 (267)
T ss_pred ----cCCeeEEEEEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCC
Confidence 346899999999999999999765 3789999999999999999999999 999999999999999998
Q ss_pred -ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCc
Q 001782 848 -VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGL 926 (1013)
Q Consensus 848 -~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~ 926 (1013)
.++|+|||.++.... .....++..|+|||++.+..++.++||||+|+++|||++|+.||........
T Consensus 147 ~~~~l~dfg~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T PHA03390 147 DRIYLCDYGLCKIIGT------------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214 (267)
T ss_pred CeEEEecCccceecCC------------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh
Confidence 999999999875432 1223578999999999998999999999999999999999999975432221
Q ss_pred cHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCC-HHHHHH
Q 001782 927 TLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ-MTDVVA 999 (1013)
Q Consensus 927 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~ 999 (1013)
....+.... . .. . .........+.+++.+|++.+|.+||+ ++|+++
T Consensus 215 ~~~~~~~~~---------~----~~----~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 215 DLESLLKRQ---------Q----KK----L----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hHHHHHHhh---------c----cc----C----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111111000 0 00 0 001123456789999999999999996 588874
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=293.54 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=197.8
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-----ccchhHHHHHHHHHhcCCCCccceEEEEeecCCcccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-----RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 773 (1013)
.+|++.+.||+|+||.||+|++..++..||+|++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 47899999999999999999999899999999875321 12345788999999999999999999986432 23
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...+++|||+++++|.+++... ..+++..+.+++.|++.|++|||+. +++|+||||+||+++.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAY------GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence 5688999999999999998764 4578899999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||.++....... .........++..|+|||++.+..++.++|||||||++|++++|+.||...... ...
T Consensus 150 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-- 218 (264)
T cd06653 150 FGASKRIQTICM-----SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----AAI-- 218 (264)
T ss_pred cccccccccccc-----cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----HHH--
Confidence 999986532111 111123356889999999999888999999999999999999999999653111 110
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.... ... .++.. +....+.+.+++.+|+. +|.+||++.+++.
T Consensus 219 -------~~~~---~~~---~~~~~----------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 219 -------FKIA---TQP---TKPML----------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -------HHHH---cCC---CCCCC----------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0000 000 00000 01223557889999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=299.09 Aligned_cols=278 Identities=21% Similarity=0.291 Sum_probs=200.9
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|++++++++|||++++++++... .....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 677899999999999999999889999999998653 33345688999999999999999999997432 1378999
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
||||++ ++|.+++.... ..+++.+++.++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+.
T Consensus 78 v~e~~~-~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred Eecccc-ccHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence 999998 58988886542 3689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ............
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~ 220 (287)
T cd07840 149 PYTKRNS-------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGS 220 (287)
T ss_pred eccCCCc-------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence 6543221 11223456788999998765 45789999999999999999999999753211 111111111110
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhH-HHHHH-HHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEI-AKIEE-CLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~-~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.....+. ..................... ..... ++..+.+++.+|++.+|.+||+++++++
T Consensus 221 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 221 PTDENWP-GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred Cchhhcc-ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000 000000000000000001111 11112 2667899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=297.95 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=198.7
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+-|++.+.||+|+||.||+|.+..++..||+|+..... ....+.+.+|+.++++++||||+++++++. .+...+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 78 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLW 78 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEE
Confidence 35778899999999999999998889999999986432 233456889999999999999999999953 457889
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 79 lv~e~~~~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA 148 (277)
T ss_pred EEEEeCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccc
Confidence 99999999999999864 3578999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
..+.... .......++..|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~------ 209 (277)
T cd06641 149 GQLTDTQ--------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KV------ 209 (277)
T ss_pred eecccch--------hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HH------
Confidence 7553211 1122345788999999998888999999999999999999999998653111 00
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
...+... .++.. ....+..+.+++.+|++.+|.+||++.++++.
T Consensus 210 ---~~~~~~~------~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 210 ---LFLIPKN------NPPTL----------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---HHHHhcC------CCCCC----------CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000 00000 01224557889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=297.84 Aligned_cols=278 Identities=22% Similarity=0.293 Sum_probs=200.3
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcC---CCCccceEEEEeecCCccccce
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNI---RHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
|++.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|+.+++++ +|||++++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778999999999999999988899999999974322 2234566788777666 5999999999986553333445
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
.+++|||+. ++|.+++..... ..+++.+++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence 899999998 589998876532 3589999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
.+..+.... ......++..|+|||++.+..++.++|||||||++|||++|..||..... ......+....
T Consensus 153 ~~~~~~~~~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~ 222 (287)
T cd07838 153 LARIYSFEM---------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVI 222 (287)
T ss_pred cceeccCCc---------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHc
Confidence 987653221 12233578899999999999999999999999999999999999875322 11122222111
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.......+..... .+..... ............+....+.+++.+||+.||++||++.|++.
T Consensus 223 ~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 223 GLPSEEEWPRNVS--LPRSSFP-SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCChHhcCCCcc--cchhhcc-cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 1100000000000 0000000 00000011112234567789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=308.57 Aligned_cols=284 Identities=22% Similarity=0.296 Sum_probs=199.7
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCC--------
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSID-------- 769 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 769 (1013)
..+|++.+.||.|+||.||+|.+..+++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999999999999999987665555677889999999999999999998764321
Q ss_pred -ccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEec-CCC
Q 001782 770 -FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD-HDM 847 (1013)
Q Consensus 770 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~ 847 (1013)
..+....++||||++ ++|.+++.. ..+++..++.++.||+.|++|||+. |++||||||+||+++ +++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 112246789999998 689888764 3588999999999999999999999 999999999999997 456
Q ss_pred ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCc
Q 001782 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGL 926 (1013)
Q Consensus 848 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~ 926 (1013)
.+|++|||.++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 153 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~ 227 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSH-----KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ 227 (342)
T ss_pred eEEECCcccceecCCcccc-----ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 7899999999765321111 111223457889999998654 4678899999999999999999999975322111
Q ss_pred cHHHHHHhhCChhHHHhhhhhhccchhhhh-ccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 927 TLHEFAKMALPEKVMEIVDPLLLLDLEARA-SNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 927 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
....... .+....+.........+..-. .......+...........+.+++.+|++.||.+|||+.|++.
T Consensus 228 -~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 228 -MQLILES-VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred -HHHHHHh-cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 1111110 000000000000000000000 0000000000111123456789999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=279.08 Aligned_cols=211 Identities=24% Similarity=0.422 Sum_probs=175.8
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec--cccchhHHHHHHHHHhcCCCCccceEEEEeecCCc---cc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDF---EE 772 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 772 (1013)
.+.|....+||+|.||.||+|+.+.+++.||+|++-.+ .........+|++++..++|+|++.+++.|....- .+
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 34667778999999999999999999999999876432 23334567899999999999999999999876432 23
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
....|+||++|+ .+|..++.... .+++..++.+++.++..||.|+|.. .|+|||+||.|||++.+|.+||+
T Consensus 96 r~t~ylVf~~ce-hDLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEee
Confidence 345899999999 89999887653 4789999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
|||+|+.+...... .....+..+-|.+|++||.+.+. .|+++.|||+.||++.||++|.+-++..
T Consensus 167 DFGlar~fs~~~n~----~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 167 DFGLARAFSTSKNV----VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred ccccccceeccccc----CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 99999865432221 12234556679999999998875 6999999999999999999999988763
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=304.11 Aligned_cols=289 Identities=21% Similarity=0.271 Sum_probs=201.6
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc--chhHHHHHHHHHhcCCCCccceEEEEeecCCc---cc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG--ATKSFVAECEALRNIRHRNLIKIITVCSSIDF---EE 772 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 772 (1013)
.++|++.++||+|+||.||+|++..+++.||+|++...... ....+.+|++++++++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999999989999999998644322 23457889999999999999999988653321 23
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
....++||||++ +++.+.+.... ..+++.++..++.|+++||+|||++ +++||||||+||++++++.+||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence 456799999998 57777766432 4689999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCcccc---CCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccH
Q 001782 853 DFGLARFLPPCSPATILE---TPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 928 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~ 928 (1013)
|||+++............ .........+++.|+|||++.+. .++.++|||||||++|||++|+.||...... ...
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~ 236 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQL 236 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence 999998654332211100 11122345678899999987654 5789999999999999999999999753221 111
Q ss_pred HHHHHhhC-C-hhHHHhhhhhhccchhhhhccCCCCchh-HHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 929 HEFAKMAL-P-EKVMEIVDPLLLLDLEARASNCGSHRTE-IAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 929 ~~~~~~~~-~-~~~~~~i~~~l~~~~~~R~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
........ + +......+. +......+ ........ ..........+.+++.+|++.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRS-LPGCEGVH--SFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHhCCCChhhchhhhh-cccccccc--cCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111100 0 000000000 00000000 00000000 0111223356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=325.02 Aligned_cols=283 Identities=19% Similarity=0.212 Sum_probs=189.5
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCC-eEEEEEEEe-----------------eccccchhHHHHHHHHHhcCCCCcc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENE-MAVAVKVMN-----------------LKQRGATKSFVAECEALRNIRHRNL 758 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~-----------------~~~~~~~~~~~~E~~~l~~l~h~ni 758 (1013)
..++|++.++||+|+||+||+|..+... ..++.|.+. .........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3568999999999999999998764322 122222110 0111223457899999999999999
Q ss_pred ceEEEEeecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 001782 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKP 838 (1013)
Q Consensus 759 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp 838 (1013)
+++++++. ..+..++|+|++. +++.+++........ ......++..|+.|++.||+|||++ +||||||||
T Consensus 226 v~l~~~~~-----~~~~~~lv~e~~~-~~l~~~l~~~~~~~~-~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP 295 (501)
T PHA03210 226 LKIEEILR-----SEANTYMITQKYD-FDLYSFMYDEAFDWK-DRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL 295 (501)
T ss_pred CcEeEEEE-----ECCeeEEEEeccc-cCHHHHHhhcccccc-ccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 99999964 4467899999987 678877754322111 2344667889999999999999999 999999999
Q ss_pred CceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCC-
Q 001782 839 SNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP- 917 (1013)
Q Consensus 839 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~p- 917 (1013)
+|||++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKERE-------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCcccc-------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999986543211 112346799999999999999999999999999999999998754
Q ss_pred CCCcCCC-CccHHHHHHh------hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCC
Q 001782 918 TDNMFND-GLTLHEFAKM------ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSE 990 (1013)
Q Consensus 918 f~~~~~~-~~~~~~~~~~------~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 990 (1013)
|...... ...+...... .+++...++.+..........+. .....-.....+..+.+++.+|++.||++
T Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~kmL~~DP~~ 444 (501)
T PHA03210 369 IGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGH----SVPPLIRNLGLPADFEYPLVKMLTFDWHL 444 (501)
T ss_pred ccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCcc----chhhHHHhcCCChHHHHHHHHHhccCccc
Confidence 4322111 1111111111 11111111111100000000000 00000011112345678899999999999
Q ss_pred CCCHHHHHHH
Q 001782 991 RIQMTDVVAK 1000 (1013)
Q Consensus 991 RPs~~evl~~ 1000 (1013)
|||+.|+++.
T Consensus 445 Rpsa~elL~h 454 (501)
T PHA03210 445 RPGAAELLAL 454 (501)
T ss_pred CcCHHHHhhC
Confidence 9999999863
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=307.23 Aligned_cols=282 Identities=21% Similarity=0.252 Sum_probs=205.8
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.++||+|++|.||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++++++...........+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999998889999999987433 33456789999999999999999999987544323335789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||++ ++|.+++... ..+++..++.++.|++.|++|||++ ||+||||||+||+++.++.++|+|||.+
T Consensus 81 lv~e~~~-~~l~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 81 IVTELME-TDLHKVIKSP------QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred EEecchh-hhHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 9999998 6899988764 4789999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
......... ........++..|+|||++.+. .++.++||||+|+++|+|++|+.||....... ..........
T Consensus 151 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~ 224 (330)
T cd07834 151 RGVDPDEDE-----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVEVLG 224 (330)
T ss_pred Eeecccccc-----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHhcC
Confidence 865432210 1112344678899999999887 78999999999999999999999997643211 1111111100
Q ss_pred --ChhHHHhhhhhhccchhhhhccCC-CC-chhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 937 --PEKVMEIVDPLLLLDLEARASNCG-SH-RTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 937 --~~~~~~~i~~~l~~~~~~R~~~~~-~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
++.......... ......... .. ..........+..+.+++.+||+.+|.+||++.+++..
T Consensus 225 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 225 TPSEEDLKFITSEK---ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred CCChhHhhhccccc---hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000000 000000000 00 00000112245678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=300.51 Aligned_cols=284 Identities=21% Similarity=0.312 Sum_probs=201.7
Q ss_pred hhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCC----
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSID---- 769 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 769 (1013)
...++|++.++||+|+||.||+|.+..+++.||+|+++.... .....+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 356789999999999999999999998899999999975432 23356778999999999999999999875432
Q ss_pred -ccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCc
Q 001782 770 -FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMV 848 (1013)
Q Consensus 770 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 848 (1013)
..+....++|+||+++ ++.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence 1123478999999984 7777776542 3689999999999999999999999 9999999999999999999
Q ss_pred eEEccccccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCcc
Q 001782 849 AHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLT 927 (1013)
Q Consensus 849 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~ 927 (1013)
+||+|||.+........ .......++..|+|||++.+ ..++.++||||+||++|||++|+.||..... ...
T Consensus 155 ~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~ 226 (302)
T cd07864 155 IKLADFGLARLYNSEES-------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQ 226 (302)
T ss_pred EEeCcccccccccCCcc-------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHH
Confidence 99999999986543221 01122345788999998765 3578899999999999999999999975311 111
Q ss_pred HHHHHHhhC---ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 928 LHEFAKMAL---PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 928 ~~~~~~~~~---~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
......... +....++...........+... .+.-.......+..+.+++.+||+.||.+||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 227 LELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQY---RRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHHhCCCChhhccccccccccccccccccc---ccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111100 0000000000000000000000 00000111223567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=301.64 Aligned_cols=248 Identities=22% Similarity=0.318 Sum_probs=196.1
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEE
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
|....+||+|+||.||+|....++..||+|++..........+.+|+.+++.++|+|++++++++. ..+..++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEE
Confidence 333468999999999999999899999999986544445567889999999999999999999854 457899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++++|.+++.. ..+++..+..++.|++.|++|||+. |++||||+|+||++++++.++|+|||.+...
T Consensus 97 e~~~~~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 97 EFLEGGALTDIVTH-------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred ecCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceec
Confidence 99999999998754 3578899999999999999999999 9999999999999999999999999988754
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhH
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1013)
.... .......|+..|+|||++.+..++.++||||+|+++|+|++|..||...... ...
T Consensus 167 ~~~~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~----------- 225 (292)
T cd06657 167 SKEV--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAM----------- 225 (292)
T ss_pred cccc--------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH-----------
Confidence 3211 1123346789999999998888999999999999999999999998642110 000
Q ss_pred HHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 941 MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 941 ~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..+...+.. ........+..+.+++.+||+.+|.+||++.++++
T Consensus 226 -~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 226 -KMIRDNLPP--------------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred -HHHHhhCCc--------------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 001000000 00001122345678899999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=292.14 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=202.0
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIV 779 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 779 (1013)
+|+..+.||+|++|.||+|.+..+++.|++|++........+.+.+|++++++++||+++++++++. .....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence 4788899999999999999998889999999997655445678999999999999999999999854 34778999
Q ss_pred EeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccccc
Q 001782 780 YEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859 (1013)
Q Consensus 780 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 859 (1013)
+||+++++|.+++.... ..+++.++..++.|++.|+++||+. +++||||+|+||++++++.++|+|||.+..
T Consensus 76 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred EecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 99999999999987653 3689999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChh
Q 001782 860 LPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEK 939 (1013)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~ 939 (1013)
...... .....++..|+|||++.+..++.++||||||+++|+|++|+.||....... ..
T Consensus 148 ~~~~~~---------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~-------- 206 (253)
T cd05122 148 LSDTKA---------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK----AL-------- 206 (253)
T ss_pred cccccc---------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH----HH--------
Confidence 543211 234567889999999998889999999999999999999999987532110 00
Q ss_pred HHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 940 VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 940 ~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..... .... ........+..+.+++.+|++.||++|||+.|+++
T Consensus 207 --~~~~~---~~~~-----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 207 --FKIAT---NGPP-----------GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --HHHHh---cCCC-----------CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000 0000 00000112356788999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=305.29 Aligned_cols=282 Identities=22% Similarity=0.262 Sum_probs=199.5
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCC-ccccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSID-FEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 774 (1013)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++++++||||+++++++.... .....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999998889999999986432 222356789999999999999999999875432 12234
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..++|+||+. .++.++.. ..+++.++..++.|++.|++|||++ +++||||||+||+++.++.+||+||
T Consensus 94 ~~~lv~e~~~-~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred eEEEEecccc-cCHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence 5799999997 57776652 2578899999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
|+++.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .......
T Consensus 162 g~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~ 229 (342)
T cd07879 162 GLARHADA-----------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK 229 (342)
T ss_pred CCCcCCCC-----------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 99875321 1223467889999999876 468899999999999999999999997532111 1111111
Q ss_pred h-hC-ChhHHHhhhhhhccchhhhhccCCCCchhHH-HHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH--HHHhh
Q 001782 934 M-AL-PEKVMEIVDPLLLLDLEARASNCGSHRTEIA-KIEECLVAIVRIGVLCSMESPSERIQMTDVVAK--LCSAR 1005 (1013)
Q Consensus 934 ~-~~-~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 1005 (1013)
. .. ++...+.+............... .+.... ........+.+++.+||+.||.+||+++|++.. ++..+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 230 VTGVPGPEFVQKLEDKAAKSYIKSLPKY--PRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred hcCCCCHHHHHHhcccchHHHHhhcCCc--ccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0 00 11111111100000000000000 000000 011234567899999999999999999999854 55443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=298.84 Aligned_cols=277 Identities=23% Similarity=0.307 Sum_probs=196.0
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
++|++.+.||+|++|+||+|++..+++.||+|.+..... ...+.+.+|++++++++||||+++++++. .....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 578999999999999999999998999999999864322 23356889999999999999999999964 45789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC-CCceEEcccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH-DMVAHVGDFG 855 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG 855 (1013)
++||||++ +++.+++..... ..+++..+..++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence 99999997 688888765422 3467888899999999999999999 9999999999999985 5679999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
++....... .......+++.|+|||++.+. .++.++||||+||++|+|++|+.||......+.. ......
T Consensus 149 ~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~-~~~~~~ 219 (294)
T PLN00009 149 LARAFGIPV--------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL-FKIFRI 219 (294)
T ss_pred cccccCCCc--------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHH
Confidence 997543211 112234578899999988664 5788999999999999999999999753221111 111000
Q ss_pred hCChhHHHhhhhhh-ccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 ALPEKVMEIVDPLL-LLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l-~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
. ............ ..+.......... .............+.+++.+|++.+|++||++.++++
T Consensus 220 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 220 L-GTPNEETWPGVTSLPDYKSAFPKWPP-KDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred h-CCCChhhccccccchhhhhhcccCCC-CCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000000000000 0000000000000 0000011122445788999999999999999999986
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=301.46 Aligned_cols=259 Identities=22% Similarity=0.267 Sum_probs=192.9
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCC-CCccceEEEEeecCCccccceE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
++|+..+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.++.++. ||||+++++++. .+...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcE
Confidence 356667899999999999999999999999999874332 33456889999999996 999999999864 34678
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
+++|||+. +++.++....... ....+++..+..++.|++.|++|||+.. +++||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~e~~~-~~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~ 154 (288)
T cd06616 79 WICMELMD-ISLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGI 154 (288)
T ss_pred EEEEeccc-CCHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecch
Confidence 89999987 5665544321100 1146899999999999999999999732 899999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCC---CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG---DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
++.+.... ......|+..|+|||++.+. .++.++||||+||++|||++|+.||..... ....
T Consensus 155 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~--- 219 (288)
T cd06616 155 SGQLVDSI---------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQ--- 219 (288)
T ss_pred hHHhccCC---------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHH---
Confidence 87543211 12234578899999998876 688999999999999999999999865310 0000
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
..+. ....+...+ . ......+..+.+++.+||+.||++|||++||++.
T Consensus 220 ------~~~~----~~~~~~~~~---~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 220 ------LTQV----VKGDPPILS---N------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ------Hhhh----cCCCCCcCC---C------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0010 000000000 0 0001234568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=302.25 Aligned_cols=280 Identities=21% Similarity=0.257 Sum_probs=201.8
Q ss_pred hhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCc
Q 001782 693 DLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDF 770 (1013)
Q Consensus 693 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 770 (1013)
++....++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++.+++..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--- 80 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS--- 80 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec---
Confidence 34456789999999999999999999999999999999875322 2234668899999999999999999998632
Q ss_pred cccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceE
Q 001782 771 EEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAH 850 (1013)
Q Consensus 771 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 850 (1013)
.....++||||+. ++|.++++.. .+++..+..++.|++.|++|||+. +|+||||+|+||++++++.+|
T Consensus 81 -~~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~ 148 (328)
T cd07856 81 -PLEDIYFVTELLG-TDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLK 148 (328)
T ss_pred -CCCcEEEEeehhc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEE
Confidence 2356889999985 7898888643 578888899999999999999999 999999999999999999999
Q ss_pred EccccccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHH
Q 001782 851 VGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 929 (1013)
Q Consensus 851 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~ 929 (1013)
|+|||.+..... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ....
T Consensus 149 l~dfg~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~ 216 (328)
T cd07856 149 ICDFGLARIQDP-----------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFS 216 (328)
T ss_pred eCccccccccCC-----------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence 999999874321 1223457889999998766 56899999999999999999999999653211 0111
Q ss_pred HHHHhhCChhHHHhhhhhhccchhhhhccCCC--CchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 930 EFAKMALPEKVMEIVDPLLLLDLEARASNCGS--HRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 930 ~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.... .......++.......+..+....... ..+...........+.+++.+|++.+|++||+++|++..
T Consensus 217 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 217 IITD-LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHH-HhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111 000001111111111110000000000 000001111234678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=301.53 Aligned_cols=276 Identities=18% Similarity=0.203 Sum_probs=190.2
Q ss_pred cceEEEEEEECCCCeEEEEEEEeec--cccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeeccCCCH
Q 001782 711 SFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSL 788 (1013)
Q Consensus 711 ~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL 788 (1013)
++|.||.++...+++.||+|++... .....+.+.+|++++++++||||+++++++ ...+..+++|||+++++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEEEeccCCCCH
Confidence 4455666666668999999999754 233456799999999999999999999985 345778999999999999
Q ss_pred HHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCCCCCcc
Q 001782 789 EDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATI 868 (1013)
Q Consensus 789 ~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 868 (1013)
.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+..+........
T Consensus 87 ~~~l~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 87 EDLLKTHFP----EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999986532 3588999999999999999999999 999999999999999999999999998875533221110
Q ss_pred ccCCCCCcccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHhhhh
Q 001782 869 LETPSSSTGIKGTVGYVAPEYGMGG--DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDP 946 (1013)
Q Consensus 869 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 946 (1013)
..........++..|+|||++.+. .++.++|||||||++|||++|+.||............ .....+........+
T Consensus 160 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 -VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYP 237 (314)
T ss_pred -ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchh
Confidence 111112344577899999998763 5888999999999999999999999764222111111 110010000000000
Q ss_pred hhccchhhh----hccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 947 LLLLDLEAR----ASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 947 ~l~~~~~~R----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
......... ....................+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000000 000000001111112334568899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=291.08 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=202.7
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+++++.++|||++++.+.+. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 57888999999999999999998899999999975533 34567889999999999999999999854 347889
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+|+||+++++|.+++..... ....+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 76 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred EEEEecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccce
Confidence 99999999999999987532 125789999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
....... .......|++.|+|||...+..++.++||||+|+++|+|++|+.||..... ....
T Consensus 151 ~~~~~~~--------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~----- 212 (258)
T cd08215 151 KVLSSTV--------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELA----- 212 (258)
T ss_pred eecccCc--------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHH-----
Confidence 7654321 112334688899999999888899999999999999999999999865321 1110
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
...... .+..-+ ...+..+.+++.+||..+|++|||+.|+++
T Consensus 213 ---~~~~~~----~~~~~~-------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 213 ---LKILKG----QYPPIP-------------SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---HHHhcC----CCCCCC-------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 011110 000000 022356788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=295.27 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=198.5
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+++++.++|+||+++++.+ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 5788899999999999999999899999999987532 12345688999999999999999999985 3457899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC-ceEEccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM-VAHVGDFGL 856 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~ 856 (1013)
+|+||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||||+||++++++ .+|++|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence 99999999999999976432 3578999999999999999999999 999999999999999885 569999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+........ ......|++.|+|||+..+..++.++|+||||+++|||++|..||..... .....
T Consensus 149 ~~~~~~~~~--------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~--- 212 (257)
T cd08225 149 ARQLNDSME--------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVL--- 212 (257)
T ss_pred chhccCCcc--------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHH---
Confidence 876532211 12234588999999999888899999999999999999999999864311 11111
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.......... . ...+..+.+++.+|+..+|++|||+.|+++.
T Consensus 213 -----~~~~~~~~~~-------~----------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 213 -----KICQGYFAPI-------S----------PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----HHhcccCCCC-------C----------CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1110000000 0 0123457889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=300.68 Aligned_cols=247 Identities=25% Similarity=0.350 Sum_probs=194.0
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.|...+.||+|+||.||+|++..++..||+|++..... .....+.+|++++++++|||++++++++. .+...
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeE
Confidence 47788999999999999999988899999999864322 22356888999999999999999999964 34678
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+. |++.+++.... ..+++.++..++.|++.|+.|||++ +|+||||+|+||+++.++.+||+|||+
T Consensus 101 ~lv~e~~~-g~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 101 WLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred EEEEeCCC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence 99999998 68887775432 4689999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM---GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
+..... .....|+..|+|||++. .+.++.++|||||||++|||++|+.||...... ..
T Consensus 172 ~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~--- 232 (317)
T cd06635 172 ASIASP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SA--- 232 (317)
T ss_pred ccccCC------------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH----HH---
Confidence 864322 12345788999999974 456889999999999999999999998653111 00
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
...+..... + .. .....+..+.+++.+|++.+|.+||++.++++..
T Consensus 233 ------~~~~~~~~~---~----~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 233 ------LYHIAQNES---P----TL---------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred ------HHHHHhccC---C----CC---------CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 001110000 0 00 0012234578899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=291.86 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=202.9
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|+..+.||+|++|.||+|.+..+++.|++|++..... ...+.+.+|++++++++||||+++++.+... .....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence 47788999999999999999998899999999875542 3456789999999999999999999986422 136789
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+|+||+++++|.+++... ..+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+
T Consensus 78 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred EEEEecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence 999999999999999865 3789999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
......... .......++..|+|||...+...+.++||||||+++|+|++|..||..... .....
T Consensus 149 ~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~------ 213 (260)
T cd06606 149 KRLGDIETG------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAAL------ 213 (260)
T ss_pred Eeccccccc------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHH------
Confidence 866432211 012345688999999999888899999999999999999999999976431 00000
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..... ....+. .....+..+.+++.+|+..+|++||++.|++.
T Consensus 214 ---~~~~~------~~~~~~----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 214 ---YKIGS------SGEPPE----------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---Hhccc------cCCCcC----------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 00000 000000 00122456889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.45 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=195.2
Q ss_pred eeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeec
Q 001782 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYM 783 (1013)
Q Consensus 707 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 783 (1013)
||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++||||+++++.+ ..+...+++|||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999998899999999864433 3446788999999999999999999874 4557899999999
Q ss_pred cCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCC
Q 001782 784 ECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863 (1013)
Q Consensus 784 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 863 (1013)
++++|.+++... +.+++.++..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 76 ~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 76 PGGDLASLLENV------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 999999999865 4689999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHh
Q 001782 864 SPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEI 943 (1013)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1013)
................++..|+|||......++.++||||||+++|++++|..||...... +.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----------------~~ 209 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----------------EI 209 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----------------HH
Confidence 1111001111233456788999999998888999999999999999999999999653211 00
Q ss_pred hhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 944 VDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 944 i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
......... ..+ .....+..+.+++.+|++.+|++|||+.++.+.|+
T Consensus 210 ~~~~~~~~~-~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 210 FQNILNGKI-EWP-----------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHhcCCc-CCC-----------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 111100000 000 00012456789999999999999999966555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=288.42 Aligned_cols=276 Identities=24% Similarity=0.310 Sum_probs=205.9
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCC-C-C----ccceEEEEeecCCcc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-H-R----NLIKIITVCSSIDFE 771 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~~~~~~~~~~~ 771 (1013)
.++|.+...+|+|.||.|-.+.+.+++..||+|+++... ...+..+-|+++++++. + | -++++.++ ++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence 789999999999999999999999999999999997432 23355678999999993 2 2 35666666 56
Q ss_pred ccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC------
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH------ 845 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~------ 845 (1013)
..++.|+|+|.+. .|+.+++..+.. .+++...+..++.|++++++|||+. +++|.|+||+||++..
T Consensus 162 yrghiCivfellG-~S~~dFlk~N~y----~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 162 YRGHICIVFELLG-LSTFDFLKENNY----IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred ccCceEEEEeccC-hhHHHHhccCCc----cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence 7799999999986 799999998755 5899999999999999999999999 9999999999999932
Q ss_pred --------------CCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHH
Q 001782 846 --------------DMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911 (1013)
Q Consensus 846 --------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~el 911 (1013)
...+|++|||.|.+-.+. ....+.|..|+|||++.+-.++.++||||+|||++|+
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccC-----------cceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 235899999999853221 2456789999999999999999999999999999999
Q ss_pred HhCCCCCCCcCCCC-ccHHHHHHhhCChhHH------Hhhhhhhccchhhhhcc---------CCCCchhHHHHHHHHHH
Q 001782 912 FTRRRPTDNMFNDG-LTLHEFAKMALPEKVM------EIVDPLLLLDLEARASN---------CGSHRTEIAKIEECLVA 975 (1013)
Q Consensus 912 l~G~~pf~~~~~~~-~~~~~~~~~~~~~~~~------~~i~~~l~~~~~~R~~~---------~~~~~~~~~~~~~~~~~ 975 (1013)
++|...|+...+.+ ....+.+-...|..+. ...... ..|+.+-.+. |............+...
T Consensus 303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~ 381 (415)
T KOG0671|consen 303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ 381 (415)
T ss_pred eccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence 99999998754221 1112222222332211 111111 1221111110 11111111122455677
Q ss_pred HHHHhhhcccCCCCCCCCHHHHHH
Q 001782 976 IVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 976 l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+.+|+++|+..||.+|+|+.|++.
T Consensus 382 LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 382 LFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHHHccCccccccHHHHhc
Confidence 999999999999999999999975
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=295.37 Aligned_cols=245 Identities=24% Similarity=0.300 Sum_probs=190.9
Q ss_pred eeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeec
Q 001782 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYM 783 (1013)
Q Consensus 707 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 783 (1013)
||+|+||+||+|.+..+++.||+|++.... ......+.+|++++++++||||+++++++ ...+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 689999999999999899999999986432 22334567899999999999999999985 3457889999999
Q ss_pred cCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCC
Q 001782 784 ECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863 (1013)
Q Consensus 784 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 863 (1013)
++++|.+++..... ..+++.++..++.|++.|+.|||+. +++||||+|+||++++++.+||+|||.+......
T Consensus 76 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 76 NGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred CCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 99999999976532 3689999999999999999999999 9999999999999999999999999998754321
Q ss_pred CCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHh
Q 001782 864 SPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEI 943 (1013)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1013)
.......++..|+|||++.+..++.++||||+||++|+|++|+.||....... ..... ..
T Consensus 149 ---------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~---------~~- 208 (277)
T cd05577 149 ---------KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEEL---------KR- 208 (277)
T ss_pred ---------CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHH---------Hh-
Confidence 11223457889999999988889999999999999999999999997532211 00000 00
Q ss_pred hhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHH
Q 001782 944 VDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVA 999 (1013)
Q Consensus 944 i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 999 (1013)
.... .+.. ........+.+++.+||+.||.+|| ++.+++.
T Consensus 209 --~~~~-~~~~-------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 209 --RTLE-MAVE-------------YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --cccc-cccc-------------CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0000 0000 0011244578899999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=294.43 Aligned_cols=243 Identities=27% Similarity=0.356 Sum_probs=193.0
Q ss_pred eeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeec
Q 001782 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYM 783 (1013)
Q Consensus 707 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 783 (1013)
||.|++|.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++. ++...++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 689999999999999889999999987432 233467899999999999999999999853 457899999999
Q ss_pred cCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCC
Q 001782 784 ECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863 (1013)
Q Consensus 784 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 863 (1013)
++++|.+++... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+......
T Consensus 76 ~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 76 LGGELWTILRDR------GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred CCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 999999999765 3588999999999999999999999 9999999999999999999999999999865332
Q ss_pred CCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHh
Q 001782 864 SPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEI 943 (1013)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1013)
. ......++..|+|||++.+..++.++|+||+|+++|+|++|..||.....+. ... ...+
T Consensus 147 ~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~--------~~~~ 206 (262)
T cd05572 147 Q---------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEI--------YNDI 206 (262)
T ss_pred c---------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHH--------HHHH
Confidence 1 1223467889999999988889999999999999999999999997642210 000 0111
Q ss_pred hhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCC-----HHHHHH
Q 001782 944 VDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ-----MTDVVA 999 (1013)
Q Consensus 944 i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 999 (1013)
.+.. .++.. ....+..+.+++.+||+.+|++||+ ++|+++
T Consensus 207 ~~~~------~~~~~----------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 207 LKGN------GKLEF----------PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred hccC------CCCCC----------CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1000 00000 0111456889999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=302.11 Aligned_cols=283 Identities=19% Similarity=0.230 Sum_probs=198.5
Q ss_pred cCCCCCceeeccceEEEEEEECCC--CeEEEEEEEeecc--ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGEN--EMAVAVKVMNLKQ--RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 774 (1013)
+|++.+.||+|+||.||+|++..+ +..||+|++.... ....+.+.+|+++++++ +||||+++++.+... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 478889999999999999999877 8899999986322 22345678899999999 599999999975432 12335
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..++++||++ ++|.+++... ..+++.+++.++.|++.||+|||++ |++||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSG------QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence 6789999987 7899988754 4689999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
|.++.+...... .........|+..|+|||+..+ ..++.++||||+||++|+|++|+.||...... ........
T Consensus 150 g~a~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~ 224 (332)
T cd07857 150 GLARGFSENPGE----NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQ 224 (332)
T ss_pred CCceeccccccc----ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHH
Confidence 999865432211 1112334578999999998765 46899999999999999999999998753211 11111111
Q ss_pred hhCChhHHHhhhhhhccchhhhhc-cCCCCchhHHH-HHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARAS-NCGSHRTEIAK-IEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~-~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.... ...+.+............. ........... .......+.+++.+|++.||++|||+.|+++
T Consensus 225 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 225 VLGT-PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhCC-CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1100 0001111000000000000 00000000000 0112456889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=302.95 Aligned_cols=278 Identities=21% Similarity=0.252 Sum_probs=200.8
Q ss_pred hhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCc-cc
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDF-EE 772 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 772 (1013)
...++|++.+.||+|+||.||+|.+..++..||||++.... ....+.+.+|++++++++||||+++++++..... ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34678999999999999999999999899999999985332 2223567899999999999999999998753211 12
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
....++||||+ +++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 23568999999 5899988864 3688999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHH
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~ 931 (1013)
|||++..... ......+++.|+|||++.+ ..++.++||||+||++|++++|+.||...... ......
T Consensus 161 dfg~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~ 228 (343)
T cd07880 161 DFGLARQTDS-----------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEI 228 (343)
T ss_pred eccccccccc-----------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence 9999875421 1223457889999999876 45888999999999999999999999753211 111111
Q ss_pred HHhh--CChhHHHhhhhhhccchhhhhccC-CCCchhHH-HHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 932 AKMA--LPEKVMEIVDPLLLLDLEARASNC-GSHRTEIA-KIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 932 ~~~~--~~~~~~~~i~~~l~~~~~~R~~~~-~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.... .+..+.+.+.. .+........ ........ ........+.+++.+|++.||++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 229 MKVTGTPSKEFVQKLQS---EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhcCCCCHHHHHhhcc---hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111 11111111110 0000000000 00001111 11234456889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=303.23 Aligned_cols=285 Identities=20% Similarity=0.240 Sum_probs=202.4
Q ss_pred hhhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCC
Q 001782 692 ADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSID 769 (1013)
Q Consensus 692 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 769 (1013)
.++....++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 455567789999999999999999999998899999999986432 222456788999999999999999999875432
Q ss_pred -ccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCc
Q 001782 770 -FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMV 848 (1013)
Q Consensus 770 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 848 (1013)
+......+++++++ +++|.++++. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 12334578888887 5899888864 3588999999999999999999999 9999999999999999999
Q ss_pred eEEccccccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCcc
Q 001782 849 AHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLT 927 (1013)
Q Consensus 849 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~ 927 (1013)
+||+|||+++.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..
T Consensus 159 ~kl~dfg~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~ 226 (345)
T cd07877 159 LKILDFGLARHTDD-----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQ 226 (345)
T ss_pred EEEecccccccccc-----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 99999999874321 1233467889999998766 46888999999999999999999999653211 11
Q ss_pred HHHHHHhh--CChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 928 LHEFAKMA--LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 928 ~~~~~~~~--~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
........ .++.....+.................. ............+.+++.+|++.||.+||++.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM-NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCc-chhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 11111111 011111000000000000000000000 0000001124467899999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=290.06 Aligned_cols=248 Identities=28% Similarity=0.432 Sum_probs=200.7
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.+.||+|++|.||+|++..+++.|++|.+..... ...+.+.+|++++++++||+++++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 57889999999999999999988899999999975543 34567899999999999999999999864 347889
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
++|||+++++|.+++... ..+++..+..++.|++.|+.|||+. |++||||+|+||+++.++.+||+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 76 IILEYAENGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred EEEecCCCCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence 999999999999999765 4689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
........ ......++..|+|||...+..++.++||||+|+++|+|++|+.||..... ......
T Consensus 147 ~~~~~~~~--------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~---- 210 (254)
T cd06627 147 TKLNDVSK--------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFR---- 210 (254)
T ss_pred eecCCCcc--------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHH----
Confidence 86543221 12334678899999998888889999999999999999999999865321 010000
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
... ..++.. ....+..+.+++.+|+..+|++||++.|++.
T Consensus 211 -----~~~-------~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 211 -----IVQ-------DDHPPL----------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -----Hhc-------cCCCCC----------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 000 000000 0112346788999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=294.02 Aligned_cols=272 Identities=23% Similarity=0.304 Sum_probs=201.5
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc--chhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG--ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
|++.+.||+|++|.||+|.+..+++.+++|.+...... ....+.+|++++++++||+|+++++++. .+...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence 67789999999999999999889999999998744332 3467889999999999999999999853 4478999
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
||||++ +++.+++.... ..+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||.+.
T Consensus 76 v~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 76 VFEFMD-TDLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred EEeccC-CCHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 999998 58888887642 3689999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC-
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL- 936 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~- 936 (1013)
...... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+ ..........
T Consensus 147 ~~~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~ 217 (283)
T cd05118 147 SFGSPV--------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGT 217 (283)
T ss_pred ecCCCc--------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCC
Confidence 654322 112234578899999998876 78999999999999999999999996532211 1111111100
Q ss_pred --ChhHHHhhhhhhccchhhhhccCCCCchh-HHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 --PEKVMEIVDPLLLLDLEARASNCGSHRTE-IAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 --~~~~~~~i~~~l~~~~~~R~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+.....+.. +.... ........... .......+..+.+++.+||+.||.+||++.|++.
T Consensus 218 ~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 218 PDPEVWPKFTS-LARNY---KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CchHhcccchh-hhhhh---hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000111100 00000 00000000011 1122345678899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=294.54 Aligned_cols=275 Identities=23% Similarity=0.273 Sum_probs=196.4
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCC-CCccceEEEEeecCCccccceEEE
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
|++.+.||+|++|+||+|+...+++.||+|.+..... .......+|+..+++++ |||++++++++. .++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence 6788999999999999999988899999999864322 22234567999999998 999999999853 4578999
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
||||+ +++|.+++..... ..+++.++..++.|++.|++|||++ +++|+||+|+||++++++.++|+|||.+.
T Consensus 76 v~e~~-~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred EEecC-CCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence 99999 6899998876531 3689999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
...... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+ ..........+
T Consensus 148 ~~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~ 217 (283)
T cd07830 148 EIRSRP---------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGT 217 (283)
T ss_pred eccCCC---------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCC
Confidence 543211 1223457889999998754 467899999999999999999999986542211 11111110000
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhH-HHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEI-AKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.....+.... ......+........... .........+.+++++||+.||++|||++|++.
T Consensus 218 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 218 PTKQDWPEGY-KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CChhhhhhHh-hhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000 000000000000000000 111112456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=291.21 Aligned_cols=244 Identities=23% Similarity=0.292 Sum_probs=187.0
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHH-hcCCCCccceEEEEeecCCccccceEEEEE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEAL-RNIRHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
+.||+|+||.||+|.+..+++.||+|++..... .....+..|..++ ...+|||++++++++. ..+..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 579999999999999988899999999864322 1122344555544 4458999999999963 457899999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++..
T Consensus 77 e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 77 EYLNGGDCASLIKTL------GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred eccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 999999999999765 4688999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhH
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1013)
.. .....++..|+|||...+..++.++||||+|+++|||++|..||...... ..
T Consensus 148 ~~------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~--------- 201 (260)
T cd05611 148 LE------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-----AV--------- 201 (260)
T ss_pred cc------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-----HH---------
Confidence 21 22345788999999998888899999999999999999999999653111 00
Q ss_pred HHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 941 MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 941 ~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
.......... ... .....++..+.+++.+||+.+|++||++.++.+.+
T Consensus 202 ---~~~~~~~~~~----~~~------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 202 ---FDNILSRRIN----WPE------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ---HHHHHhcccC----CCC------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0000000000 000 00112345688999999999999999876665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=301.13 Aligned_cols=284 Identities=18% Similarity=0.217 Sum_probs=198.0
Q ss_pred hccCCC-CCceeeccceEEEEEEECCCCeEEEEEEEeeccccc--------------hhHHHHHHHHHhcCCCCccceEE
Q 001782 698 TNDFSS-SNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA--------------TKSFVAECEALRNIRHRNLIKII 762 (1013)
Q Consensus 698 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~ 762 (1013)
.++|.. .+.||+|+||+||+|.+..+++.||+|++....... ...+.+|+++++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356754 577999999999999999889999999986432211 12477899999999999999999
Q ss_pred EEeecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceE
Q 001782 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVL 842 (1013)
Q Consensus 763 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIl 842 (1013)
+++. .++..++||||++ ++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+
T Consensus 87 ~~~~-----~~~~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nil 151 (335)
T PTZ00024 87 DVYV-----EGDFINLVMDIMA-SDLKKVVDRK------IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIF 151 (335)
T ss_pred EEEe-----cCCcEEEEEeccc-cCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeE
Confidence 9964 4478999999998 7999998754 4689999999999999999999999 9999999999999
Q ss_pred ecCCCceEEccccccccCCCCCCCcc------ccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCC
Q 001782 843 LDHDMVAHVGDFGLARFLPPCSPATI------LETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRR 915 (1013)
Q Consensus 843 l~~~~~~kl~DFG~a~~~~~~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~ 915 (1013)
++.++.+||+|||.+........... ...........++..|+|||++.+. .++.++||||+||++|||++|+
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 231 (335)
T PTZ00024 152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231 (335)
T ss_pred ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999986542111000 0011112234568899999998764 4688999999999999999999
Q ss_pred CCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHH
Q 001782 916 RPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMT 995 (1013)
Q Consensus 916 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 995 (1013)
.||......+ ................+-... ..+...+...............+...+.+++.+|++.+|++|||++
T Consensus 232 ~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 308 (335)
T PTZ00024 232 PLFPGENEID-QLGRIFELLGTPNEDNWPQAK--KLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308 (335)
T ss_pred CCCCCCCHHH-HHHHHHHHhCCCchhhCcchh--hcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence 9997542211 111111100000000000000 0000000000000000011112345678999999999999999999
Q ss_pred HHHH
Q 001782 996 DVVA 999 (1013)
Q Consensus 996 evl~ 999 (1013)
|++.
T Consensus 309 ~~l~ 312 (335)
T PTZ00024 309 EALK 312 (335)
T ss_pred HHhc
Confidence 9986
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=290.86 Aligned_cols=242 Identities=21% Similarity=0.298 Sum_probs=184.3
Q ss_pred ceeeccceEEEEEEECCCCeEEEEEEEeecccc---chhHHHHHHHH---HhcCCCCccceEEEEeecCCccccceEEEE
Q 001782 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG---ATKSFVAECEA---LRNIRHRNLIKIITVCSSIDFEEVDFKAIV 779 (1013)
Q Consensus 706 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 779 (1013)
.||+|+||.||+|++..+++.||+|.+...... ....+..|..+ ++...||+|+++++++ ...+..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 489999999999999888999999998743221 11223444443 4445799999999885 445789999
Q ss_pred EeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccccc
Q 001782 780 YEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859 (1013)
Q Consensus 780 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 859 (1013)
|||+.+++|.+++... +.+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 76 ~e~~~g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 76 LDLMNGGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred EecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 9999999999988754 4689999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCCh
Q 001782 860 LPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPE 938 (1013)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~ 938 (1013)
.... ......|+..|+|||++.++ .++.++||||+||++|||++|+.||........ ..
T Consensus 147 ~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~-------- 206 (278)
T cd05606 147 FSKK----------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE-------- 206 (278)
T ss_pred cCcc----------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HH--------
Confidence 4221 11234689999999998754 689999999999999999999999976422111 00
Q ss_pred hHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHH
Q 001782 939 KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVA 999 (1013)
Q Consensus 939 ~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 999 (1013)
..... ....+ ... ...+..+.+++.+|+..+|.+|| ++.|+++
T Consensus 207 -~~~~~---~~~~~----~~~----------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 207 -IDRMT---LTMAV----ELP----------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -HHHHh---hccCC----CCC----------CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 00000 00000 000 01235678899999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=250.25 Aligned_cols=275 Identities=20% Similarity=0.293 Sum_probs=199.2
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|...++||+|.||+||+|+..++.+.||+|.++.+.. .......+|+-+++.++|.||++++++ ...+....
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCceeE
Confidence 46667899999999999999999999999999985543 334668899999999999999999998 44568899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+|+|||+ .+|..|..... +.++.+.+..++.|+++|+.|.|++ ++.|||+||+|.++..+|..|++|||+|
T Consensus 78 lvfe~cd-qdlkkyfdsln-----g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 78 LVFEFCD-QDLKKYFDSLN-----GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred EeHHHhh-HHHHHHHHhcC-----CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence 9999999 78999887753 5789999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCC-CCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHHHHHHhh
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD-MSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~~~~~~~ 935 (1013)
+.++..- ......+-|.+|++|.++.+.. |+...|+||.||++.|+.. |++.|..... +.++..+.+..
T Consensus 149 rafgipv--------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~l 219 (292)
T KOG0662|consen 149 RAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLL 219 (292)
T ss_pred hhcCCce--------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHh
Confidence 8765321 1122345689999999998864 8889999999999999997 6666665322 23333333322
Q ss_pred CChhHHHhhhhhhccchhhhhccCCCCchhHHH-HHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAK-IEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..+.-..+-.-....|+..-|... +. ....+ .......=.+++.+.+.-+|.+|.++++.++
T Consensus 220 g~p~ed~wps~t~lpdyk~yp~yp-at-tswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 220 GTPTEDQWPSMTKLPDYKPYPIYP-AT-TSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCccccCCccccCCCCcccCCcc-cc-chHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111111110000001111101000 00 00001 1111112345677788889999999998875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=277.69 Aligned_cols=275 Identities=22% Similarity=0.330 Sum_probs=218.6
Q ss_pred hhhhhhhhccCCCCCceeeccceEEEEEEECCCC-----eEEEEEEEeeccc-cchhHHHHHHHHHhcCCCCccceEEEE
Q 001782 691 YADLSKATNDFSSSNMIGQGSFGFVYRGNLGENE-----MAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITV 764 (1013)
Q Consensus 691 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~ 764 (1013)
.+++.....|++....+.+|.||.||.|.+++.+ +.|.+|.++.... -....+..|...+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3445555677888889999999999999886543 3456666653322 233567888888999999999999999
Q ss_pred eecCCccccceEEEEEeeccCCCHHHHhhccccc--cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceE
Q 001782 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQ--LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVL 842 (1013)
Q Consensus 765 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIl 842 (1013)
+. ++....++++.++.-|+|..|+...+.. .....++..+...++.|++.|++|||++ +|||.||.++|.+
T Consensus 356 ~i----e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCv 428 (563)
T KOG1024|consen 356 SI----EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCV 428 (563)
T ss_pred Ee----eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcce
Confidence 84 5667888999999999999999844322 1224677888999999999999999999 9999999999999
Q ss_pred ecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-CCCCCCCc
Q 001782 843 LDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNM 921 (1013)
Q Consensus 843 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G~~pf~~~ 921 (1013)
+|+..++||+|=.+++.+-+.+.....+.+ ..+..||+||.+....|+.++||||||+++|||+| |+.||...
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnE------nRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI 502 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNE------NRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI 502 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCCC------CCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence 999999999999999998887776664443 34679999999999999999999999999999999 99998764
Q ss_pred CCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 922 FNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
+.. +....+.+. .++.++-.||++++.+|.-||+.+|++||+++|++.-|
T Consensus 503 DPf--------------Em~~ylkdG----------------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 503 DPF--------------EMEHYLKDG----------------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred CHH--------------HHHHHHhcc----------------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 211 122222111 12334457899999999999999999999999999999
Q ss_pred HHhhhhh
Q 001782 1002 CSARKIF 1008 (1013)
Q Consensus 1002 ~~~~~~~ 1008 (1013)
.+.-..+
T Consensus 553 seF~~ql 559 (563)
T KOG1024|consen 553 SEFHTQL 559 (563)
T ss_pred HHHHHHH
Confidence 8875443
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=296.47 Aligned_cols=254 Identities=24% Similarity=0.303 Sum_probs=193.2
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 774 (1013)
..++|++.+.||+|+||.||+|++..+++.||||+++.... .....+..|+.++.+. .||||+++++++. ...
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~ 87 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDS 87 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCC
Confidence 35678999999999999999999998899999999974432 2334566777777666 4999999999964 346
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH-HCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
..++||||+. +++.++..... ..+++.++..++.|++.|++|||+ . +|+||||+|+||++++++.+||+|
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~d 158 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQ-----GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCD 158 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECc
Confidence 7999999987 67877776532 368899999999999999999997 5 899999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCC----CCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD----MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 929 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~ 929 (1013)
||.+..+.... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||.........
T Consensus 159 fg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-- 227 (296)
T cd06618 159 FGISGRLVDSK---------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-- 227 (296)
T ss_pred cccchhccCCC---------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHH--
Confidence 99987553211 112234778999999987654 788999999999999999999999652111000
Q ss_pred HHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 930 EFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 930 ~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
....+.. .. +.... ...++..+.+++.+||+.||++||++.++++.
T Consensus 228 ----------~~~~~~~----~~---~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 228 ----------LTKILQE----EP---PSLPP--------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----------HHHHhcC----CC---CCCCC--------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111110 00 00000 00123467899999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=296.71 Aligned_cols=250 Identities=26% Similarity=0.349 Sum_probs=194.6
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
...|+..+.||+|+||.||+|++..++..||+|.+.... ....+++.+|+++++.++|+|++++++++. ...
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REH 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCC
Confidence 445778899999999999999998889999999986432 223356788999999999999999999964 346
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..++||||+. |++.+++.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+||+||
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~df 159 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF 159 (308)
T ss_pred eeEEEEEccC-CCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCc
Confidence 7899999997 68888776432 3578999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM---GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~ 931 (1013)
|++..... .....++..|+|||++. ...++.++|||||||++|+|++|..||........ .
T Consensus 160 g~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~--- 223 (308)
T cd06634 160 GSASIMAP------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-L--- 223 (308)
T ss_pred ccceeecC------------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-H---
Confidence 99875432 12345788999999874 35678899999999999999999999865311100 0
Q ss_pred HHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 001782 932 AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1002 (1013)
....... .+ .. ........+.+++.+||+.+|.+||++.++++.-.
T Consensus 224 ---------~~~~~~~---~~----~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 224 ---------YHIAQNE---SP----AL---------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ---------HHHhhcC---CC----Cc---------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0000000 00 00 00122455788999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=289.27 Aligned_cols=250 Identities=24% Similarity=0.306 Sum_probs=200.5
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+|++.++||+|+||.||++++..+++.+|+|.+.... ......+.+|++++++++||||+++.+++ ......+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence 5788999999999999999999899999999987432 23345678899999999999999999885 3447899
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||+++++|.+++..... ....+++.+++.++.|++.|++|||+. +++|+||+|+||++++++.+|++|||++
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKK--KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred EEehhcCCCCHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccch
Confidence 99999999999999876322 124688999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCC
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~ 937 (1013)
...... ......++..|+|||.+.+..++.++|+||+|+++|||++|+.||...... ..
T Consensus 151 ~~~~~~----------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~------ 209 (256)
T cd08530 151 KVLKKN----------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DL------ 209 (256)
T ss_pred hhhccC----------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH------
Confidence 865432 112245788999999999999999999999999999999999999653211 00
Q ss_pred hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 938 ~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
...+. .... ... .......+.+++.+|++.+|++||++.|+++
T Consensus 210 ---~~~~~---~~~~-----------~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 210 ---RYKVQ---RGKY-----------PPI--PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---HHHHh---cCCC-----------CCC--chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0000 000 0123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=294.23 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=202.2
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec---cccchhHHHHHHHHHhcCC-CCccceEEEEeecCCccccc
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 774 (1013)
++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|++++++++ ||||+++++++ ...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 4789999999999999999999989999999998642 2233456889999999998 99999999884 4557
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..++||||+++++|.+++... +.+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++++||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKY------GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence 899999999999999999865 4789999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCcc------------ccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcC
Q 001782 855 GLARFLPPCSPATI------------LETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMF 922 (1013)
Q Consensus 855 G~a~~~~~~~~~~~------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~ 922 (1013)
|.+........... ...........++..|+|||+..+..++.++||||+|+++|++++|+.||....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 99986654322100 001122345567899999999988889999999999999999999999997532
Q ss_pred CCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCH----HHHH
Q 001782 923 NDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQM----TDVV 998 (1013)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~evl 998 (1013)
. ... ......... ..+ ...+..+.+++.+|++.+|.+||++ +|++
T Consensus 227 ~----~~~---------~~~~~~~~~-~~~-----------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 227 E----YLT---------FQKILKLEY-SFP-----------------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred H----HHH---------HHHHHhcCC-CCC-----------------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 1 000 001100000 000 1114457899999999999999999 7765
Q ss_pred H
Q 001782 999 A 999 (1013)
Q Consensus 999 ~ 999 (1013)
.
T Consensus 276 ~ 276 (280)
T cd05581 276 A 276 (280)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=303.92 Aligned_cols=267 Identities=20% Similarity=0.306 Sum_probs=220.5
Q ss_pred cchhhhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcC-CCCccceEEEEeec
Q 001782 689 VSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVCSS 767 (1013)
Q Consensus 689 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 767 (1013)
..++.+...++.|++.++||+|.+|.||+++...+++.+|+|+.....+ ..+++..|+++++.. .|||++.++|++.-
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 4455666678899999999999999999999999999999999875544 346678899999988 69999999999987
Q ss_pred CCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC
Q 001782 768 IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM 847 (1013)
Q Consensus 768 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 847 (1013)
.+...++..|+|||||.+||..|+++.... .++.|..+..|++.++.|+.+||.. .++|||||-.|||++.++
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g----~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~ 160 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKG----NRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENA 160 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcc----cchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccC
Confidence 777788999999999999999999998753 6899999999999999999999999 999999999999999999
Q ss_pred ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCC-----CCCcccchHHHHHHHHHHHhCCCCCCCcC
Q 001782 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-----DMSATGDVYSFGILLLEMFTRRRPTDNMF 922 (1013)
Q Consensus 848 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DIwSlG~il~ell~G~~pf~~~~ 922 (1013)
.||++|||.+..++ .+.......+||+.|||||++... .|+.++|+||+|++..||..|.+|+.++.
T Consensus 161 ~VKLvDFGvSaQld--------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH 232 (953)
T KOG0587|consen 161 EVKLVDFGVSAQLD--------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH 232 (953)
T ss_pred cEEEeeeeeeeeee--------cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence 99999999998654 334446678899999999998754 47778999999999999999999998753
Q ss_pred CCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 923 NDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
... .++ ... ....+.+..++....++.++|..|+..|-.+||++.++++
T Consensus 233 Pmr----------------aLF----~Ip--------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 233 PMR----------------ALF----LIP--------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhh----------------hhc----cCC--------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 221 000 000 0111222334555677889999999999999999988864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=283.83 Aligned_cols=137 Identities=24% Similarity=0.375 Sum_probs=121.9
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCC--------CCccceEEEEeecCC
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR--------HRNLIKIITVCSSID 769 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~ 769 (1013)
.++|.+.++||.|.|++||+|.+..+.+.||+|+.+. .....+....||++|++++ ..+||++++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs- 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS- 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec-
Confidence 3699999999999999999999999999999999973 3344567789999999983 24799999998765
Q ss_pred ccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEe
Q 001782 770 FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL 843 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll 843 (1013)
..++.++|+|+|++. .+|..+|..... +.++...+.+|+.||+.||.|||+.| ||||.||||+|||+
T Consensus 155 GpNG~HVCMVfEvLG-dnLLklI~~s~Y----rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLG-DNLLKLIKYSNY----RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhhh-hHHHHHHHHhCC----CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 678899999999997 799999988755 58999999999999999999999998 99999999999999
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=294.11 Aligned_cols=246 Identities=26% Similarity=0.353 Sum_probs=192.0
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.|...++||+|+||+||+|++..+++.||+|++..... ...+.+.+|+++++.++|||++++++++. +....
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 96 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTA 96 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEE
Confidence 36667889999999999999988999999999874332 22346788999999999999999999964 44778
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||+. +++.+++.... ..+++.++..++.|++.|++|||+. |++||||+|+||+++.++.+||+|||+
T Consensus 97 ~lv~e~~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~ 167 (313)
T cd06633 97 WLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS 167 (313)
T ss_pred EEEEecCC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCC
Confidence 99999997 68888876542 3688999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM---GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
+..... .....|+..|+|||++. .+.++.++|||||||++|||++|..||....... ..
T Consensus 168 ~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~----~~-- 229 (313)
T cd06633 168 ASKSSP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----AL-- 229 (313)
T ss_pred CcccCC------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HH--
Confidence 863211 22346888999999974 4568889999999999999999999986532110 00
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
...... ..+ ... ....+..+.+++.+|++.+|.+||++.+++..
T Consensus 230 -------~~~~~~---~~~----~~~---------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 230 -------YHIAQN---DSP----TLQ---------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -------HHHHhc---CCC----CCC---------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 000 000 01122457789999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=290.71 Aligned_cols=273 Identities=23% Similarity=0.327 Sum_probs=199.5
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
|+..+.||+|++|.||+|+...+++.||+|++.... ....+.+..|++++++++|+|++++++++. .....++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 567789999999999999999889999999998553 333466788999999999999999999853 4478999
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
||||++ ++|.+++.... ..+++.++..++.|++.|++|||++ +|+||||+|+||++++++.+||+|||.++
T Consensus 76 v~e~~~-~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred EecCcC-cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence 999998 69999998652 3689999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhC-
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL- 936 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~- 936 (1013)
....... ......++..|+|||++.+. .++.++|||||||++|||++|+.||...... ...........
T Consensus 147 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~ 217 (282)
T cd07829 147 AFGIPLR--------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGT 217 (282)
T ss_pred ccCCCcc--------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCC
Confidence 6532211 12233457789999998776 7899999999999999999999999653211 11111111100
Q ss_pred C-hhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 937 P-EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 937 ~-~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+ +.....+...-. ......... ..............+.+++.+|+..||++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 218 PTEESWPGVTKLPD--YKPTFPKFP-PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred CcHHHHHhhccccc--ccccccccC-ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 000000000000 000000000 00000111122457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-33 Score=288.51 Aligned_cols=212 Identities=26% Similarity=0.418 Sum_probs=179.6
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-------cchhHHHHHHHHHhcCCCCccceEEEEeecCCc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-------GATKSFVAECEALRNIRHRNLIKIITVCSSIDF 770 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 770 (1013)
.++|-..+.||+|||+.||+|.+....+.||+|+-..... ...+...+|.+|-+.+.||.||++|+++.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs---- 537 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS---- 537 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee----
Confidence 4578889999999999999999998899999998753321 11244688999999999999999999974
Q ss_pred cccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC---C
Q 001782 771 EEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD---M 847 (1013)
Q Consensus 771 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~ 847 (1013)
-+.+..|-|+|||+|-+|+-|++.. +.+++.++..|+.||+.||.||.+. +++|||-|+||.|||+... |
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQh------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQH------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhh------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence 3457789999999999999999987 5789999999999999999999997 5689999999999999654 6
Q ss_pred ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCC----CCCcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG----DMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 848 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
.+||+|||+++.++++..... ....-.....||.+|.+||.+--+ .++.++||||.||++|..+.|+.||...
T Consensus 611 eIKITDFGLSKIMdddSy~~v-dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSV-DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred eeEeeecchhhhccCCccCcc-cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 899999999999887655433 233345567799999999986543 4788999999999999999999999874
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=292.20 Aligned_cols=257 Identities=20% Similarity=0.255 Sum_probs=196.5
Q ss_pred cCCCCCceeeccceEEEEEEEC---CCCeEEEEEEEeecc----ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCcc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLG---ENEMAVAVKVMNLKQ----RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 771 (1013)
+|++.+.||+|+||.||+|++. .++..||+|+++... ....+.+.+|+++++++ +||+|+++++.+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4778899999999999999864 356889999987332 22335678999999999 599999999884 4
Q ss_pred ccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEE
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV 851 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 851 (1013)
.+...++||||+++++|.+++... ..+++.++..++.|+++||+|||+. +++||||+|+||+++.++.++|
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l 146 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQR------EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL 146 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhc------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence 557889999999999999998754 4688999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCCCCcccccccccccccccCCCC--CCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHH
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD--MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 929 (1013)
Q Consensus 852 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~ 929 (1013)
+|||+++....... .......|+..|+|||...+.. .+.++||||||+++|||++|..||...... ....
T Consensus 147 ~dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~ 218 (288)
T cd05583 147 TDFGLSKEFLAEEE-------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQS 218 (288)
T ss_pred EECccccccccccc-------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHH
Confidence 99999876532211 1122345789999999987765 788999999999999999999998642111 0011
Q ss_pred HHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHh
Q 001782 930 EFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 930 ~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1004 (1013)
++........+.. .......+.+++.+||+.||++|||+.++.+.|+..
T Consensus 219 ------------~~~~~~~~~~~~~--------------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 219 ------------EISRRILKSKPPF--------------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ------------HHHHHHHccCCCC--------------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1111111111100 011234577899999999999999998887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=315.46 Aligned_cols=269 Identities=25% Similarity=0.402 Sum_probs=209.5
Q ss_pred hhhhccCCCCCceeeccceEEEEEEECC-------CCeEEEEEEEeeccc-cchhHHHHHHHHHhcC-CCCccceEEEEe
Q 001782 695 SKATNDFSSSNMIGQGSFGFVYRGNLGE-------NEMAVAVKVMNLKQR-GATKSFVAECEALRNI-RHRNLIKIITVC 765 (1013)
Q Consensus 695 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 765 (1013)
+...++..+.+.+|+|.||.||+|.... ....||||..+.... .+.+.+..|+++|+.+ +||||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3344555677899999999999997531 156799999874433 3557799999999999 599999999998
Q ss_pred ecCCccccceEEEEEeeccCCCHHHHhhccc--ccccc--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 001782 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSN--DQLEV--------GNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGD 835 (1013)
Q Consensus 766 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~--------~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~D 835 (1013)
.. .+..++|+||+..|+|.+|++..+ ...+. ..++..+.+.++.|||.|++||++. ++||||
T Consensus 372 t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRD 443 (609)
T KOG0200|consen 372 TQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRD 443 (609)
T ss_pred cc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchh
Confidence 64 478999999999999999999886 11111 1388999999999999999999999 999999
Q ss_pred CCCCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh-C
Q 001782 836 LKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-R 914 (1013)
Q Consensus 836 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~-G 914 (1013)
+.++|||+.++..+||+|||+|+........... .....-+..|||||.+....|+.++||||||+++|||++ |
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-----~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG 518 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTK-----SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLG 518 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCCCceEec-----CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCC
Confidence 9999999999999999999999865443322110 011013567999999999999999999999999999999 9
Q ss_pred CCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCH
Q 001782 915 RRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQM 994 (1013)
Q Consensus 915 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 994 (1013)
..||.+.... +++.+.+++.. +.++++.|..+++++|+.||+.+|++||++
T Consensus 519 ~~PYp~~~~~-------------~~l~~~l~~G~----------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F 569 (609)
T KOG0200|consen 519 GTPYPGIPPT-------------EELLEFLKEGN----------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTF 569 (609)
T ss_pred CCCCCCCCcH-------------HHHHHHHhcCC----------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence 9999763111 11112221111 112234556788999999999999999999
Q ss_pred HHHHHHHHHhh
Q 001782 995 TDVVAKLCSAR 1005 (1013)
Q Consensus 995 ~evl~~L~~~~ 1005 (1013)
.|+.+.++...
T Consensus 570 ~~~~~~~~~~l 580 (609)
T KOG0200|consen 570 SECVEFFEKHL 580 (609)
T ss_pred HHHHHHHHHHH
Confidence 99999999854
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-33 Score=276.40 Aligned_cols=254 Identities=23% Similarity=0.244 Sum_probs=192.6
Q ss_pred CCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhc-CCCCccceEEEEeecCCccccceEEEEEe
Q 001782 704 SNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRN-IRHRNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
...||.|+||+|++-.++.+|+..|||.++.... .+.+++..|.+...+ -+.|+||++||++.. ++..|+.||
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdcWiCME 143 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDCWICME 143 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCceeeeHH
Confidence 4679999999999999999999999999986554 456778888886544 479999999999743 366799999
Q ss_pred eccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCC
Q 001782 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP 861 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 861 (1013)
.|+ .|++.+-+.... .....+++.-.-+|....+.||.||.+.. .|||||+||+|||++..|.+||||||++..+.
T Consensus 144 LMd-~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHh-hhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 998 777665433211 12247888888999999999999999876 89999999999999999999999999987543
Q ss_pred CCCCCccccCCCCCcccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChh
Q 001782 862 PCSPATILETPSSSTGIKGTVGYVAPEYGMGG--DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEK 939 (1013)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~ 939 (1013)
. ....+...|...|||||.+... .|+.++||||||+++||+.||..||..+...-
T Consensus 220 ~---------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf-------------- 276 (361)
T KOG1006|consen 220 D---------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF-------------- 276 (361)
T ss_pred H---------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH--------------
Confidence 2 1223445688999999998754 48889999999999999999999998653211
Q ss_pred HHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 940 VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 940 ~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+-+......||..-.+.. +..+....+.+++..|+..|-.+||...++.+
T Consensus 277 --eql~~Vv~gdpp~l~~~~--------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 277 --EQLCQVVIGDPPILLFDK--------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred --HHHHHHHcCCCCeecCcc--------cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111222222221100000 00123456788999999999999999998765
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=300.57 Aligned_cols=279 Identities=20% Similarity=0.247 Sum_probs=199.2
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCc-ccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDF-EEV 773 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 773 (1013)
..++|++.+.||+|++|.||+|++..+++.||+|++.... ....+.+.+|+.++++++|||++++.+++..... ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999999899999999986432 2233567789999999999999999887543211 222
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
...++|+||+. ++|.+++.. ..+++.++..++.|++.|++|||+. ||+||||||+||+++.++.+||+|
T Consensus 93 ~~~~lv~e~~~-~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 93 QDVYLVTHLMG-ADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred ccEEEEEecCC-CCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence 35899999985 799999875 3689999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~ 932 (1013)
||++...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||...... .......
T Consensus 162 fg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~ 229 (343)
T cd07851 162 FGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIM 229 (343)
T ss_pred cccccccccc-----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence 9998754321 223457889999998765 36788999999999999999999999753221 1111111
Q ss_pred HhhCChhHHHhhhhhhccchhhhhc-cCCCCchhHH-HHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARAS-NCGSHRTEIA-KIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~R~~-~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
.. .+....++..+........-.. .....+.... ........+.+++.+|++.||++|||+.||++
T Consensus 230 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 230 NL-VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred Hh-cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 10 0000001111000000000000 0000000111 11123567889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=290.18 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=192.4
Q ss_pred cCCCCCceeeccceEEEEEEEC---CCCeEEEEEEEeecc----ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCcc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLG---ENEMAVAVKVMNLKQ----RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 771 (1013)
.|++.+.||+|+||.||.|++. .++..||+|++.... ....+.+.+|+.+++++ +|++|+++++++ +
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4788899999999999999884 367899999987432 12335678899999999 599999999885 3
Q ss_pred ccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEE
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV 851 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 851 (1013)
.+...++||||+++++|.+++... ..+++.++..++.|++.||+|||+. +++||||+|+||+++.++.+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 146 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQR------ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 146 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence 457889999999999999999765 4678899999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCCCCccccCCCCCcccccccccccccccCCC--CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHH
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG--DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 929 (1013)
Q Consensus 852 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~ 929 (1013)
+|||++........ .......|+..|+|||++.+. .++.++||||||+++|+|++|+.||...... ....
T Consensus 147 ~dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~ 218 (290)
T cd05613 147 TDFGLSKEFHEDEV-------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQA 218 (290)
T ss_pred eeCccceecccccc-------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHH
Confidence 99999875432111 112235688999999998753 4678999999999999999999998642111 1111
Q ss_pred HHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCC-----CHHHHHH
Q 001782 930 EFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVA 999 (1013)
Q Consensus 930 ~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 999 (1013)
++.+......+. . .......+.+++.+|++.||++|| ++.++++
T Consensus 219 ------------~~~~~~~~~~~~----~----------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 219 ------------EISRRILKSEPP----Y----------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------------HHHHHhhccCCC----C----------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 111111111110 0 011234577899999999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=286.36 Aligned_cols=237 Identities=26% Similarity=0.409 Sum_probs=191.7
Q ss_pred CCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEe
Q 001782 704 SNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
.++||+|-||+||-|+++.+|+.||||++.... ......+.+|+.|++.++||.||.+.-. ++..+..++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence 489999999999999999999999999997432 2234678999999999999999999887 456688999999
Q ss_pred eccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC---CceEEccccccc
Q 001782 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD---MVAHVGDFGLAR 858 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~a~ 858 (1013)
-+. |+..++|-.... +++++.....+..||+.||.|||.+ +|||+|+||+|||+... -.+||||||+|+
T Consensus 644 Kl~-GDMLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 644 KLH-GDMLEMILSSEK----GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred hhc-chHHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence 998 677777765532 7899999999999999999999999 99999999999999654 389999999999
Q ss_pred cCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHH--HH----
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHE--FA---- 932 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~--~~---- 932 (1013)
.+++. ......+||+.|.|||++..+.|...-|+||.||++|--+.|..||....+..+++.. +.
T Consensus 716 iIgEk---------sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~ 786 (888)
T KOG4236|consen 716 IIGEK---------SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPN 786 (888)
T ss_pred ecchh---------hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCC
Confidence 87642 2245678999999999999999999999999999999999999999753222222111 11
Q ss_pred -HhhCChhHHHhhhhhhccchhhhhccCCCC
Q 001782 933 -KMALPEKVMEIVDPLLLLDLEARASNCGSH 962 (1013)
Q Consensus 933 -~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~ 962 (1013)
+..++..+.++|...+.....+|++.....
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 122345567777777777777777654433
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=319.85 Aligned_cols=148 Identities=30% Similarity=0.486 Sum_probs=131.6
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
.++|++.++||+|+||.||+|++..+++.||||+++.... .....+..|+.+++.++||||+++++++ ....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 3689999999999999999999998999999999974322 2235688999999999999999999885 3457
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..|+||||+.+++|.+++... +.+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~------~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIY------GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeC
Confidence 899999999999999999765 4678899999999999999999999 9999999999999999999999999
Q ss_pred ccccc
Q 001782 855 GLARF 859 (1013)
Q Consensus 855 G~a~~ 859 (1013)
|+++.
T Consensus 149 Gls~~ 153 (669)
T cd05610 149 GLSKV 153 (669)
T ss_pred CCCcc
Confidence 99863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=316.47 Aligned_cols=209 Identities=25% Similarity=0.367 Sum_probs=184.4
Q ss_pred hhhhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEee---ccccchhHHHHHHHHHhcCCCCccceEEEEeec
Q 001782 691 YADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNL---KQRGATKSFVAECEALRNIRHRNLIKIITVCSS 767 (1013)
Q Consensus 691 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 767 (1013)
..+++-..++|.+.++||+|+||.|..++.+.+++.||+|++.. -.+....-|..|.++|..-+.+-|+++.-+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA--- 143 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA--- 143 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH---
Confidence 45566667899999999999999999999999999999999974 234455679999999999899999988766
Q ss_pred CCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC
Q 001782 768 IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM 847 (1013)
Q Consensus 768 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 847 (1013)
|.++.+.|+|||||+||+|-.++... .++++..++.++..|+.||..+|+. |+|||||||+|||+|..|
T Consensus 144 --FQD~~~LYlVMdY~pGGDlltLlSk~------~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 144 --FQDERYLYLVMDYMPGGDLLTLLSKF------DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred --hcCccceEEEEecccCchHHHHHhhc------CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccC
Confidence 67889999999999999999999887 4699999999999999999999999 999999999999999999
Q ss_pred ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCC-----CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-----GDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 848 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
++||+|||.+..+..+... .....+|||.|.+||++.. +.|++.+|.||+||++|||+.|..||..
T Consensus 213 HikLADFGsClkm~~dG~V-------~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 213 HIKLADFGSCLKMDADGTV-------RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred cEeeccchhHHhcCCCCcE-------EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 9999999999877643322 2455789999999998753 5789999999999999999999999975
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=280.08 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=201.8
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec---cccchhHHHHHHHHHhcC-CCCccceEEEEeecCCcccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 773 (1013)
..+|....+||+|+||.|.+|+.+++.+.+|||+++.+ +..+.+--+.|-++|..- +-|.++++..+ ++.-
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhh
Confidence 34788899999999999999999999999999999743 233344456777788776 46788888776 4555
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
+..|+||||+.||+|--.+++. +.+.+..+..+|..||-||-+||++ ||++||+|.+|||+|.+|++||+|
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~------GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQV------GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred hheeeEEEEecCchhhhHHHHh------cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeee
Confidence 8899999999999999888876 6788889999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
||+++.- .........++||+.|+|||++...+|+.++|.||+||++|||+.|++||+....+ ..+..+..
T Consensus 494 FGmcKEn--------i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-elF~aI~e 564 (683)
T KOG0696|consen 494 FGMCKEN--------IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQAIME 564 (683)
T ss_pred ccccccc--------ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHH
Confidence 9998732 11223356789999999999999999999999999999999999999999875333 33333333
Q ss_pred hh------CChhHHHhhhhhhccchhhhhccCCCCchh
Q 001782 934 MA------LPEKVMEIVDPLLLLDLEARASNCGSHRTE 965 (1013)
Q Consensus 934 ~~------~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~ 965 (1013)
.. .+.++.++....+...|..|.......+..
T Consensus 565 hnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~d 602 (683)
T KOG0696|consen 565 HNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERD 602 (683)
T ss_pred ccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccc
Confidence 32 345688889999999999998876655443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=284.98 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=193.0
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-----ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-----RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 774 (1013)
+|.+.++||+|+||.||+|++...+..+++|+.+... ......+..|+.+++.++||||+++++++ .+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence 5889999999999999999998776667777765321 12234567899999999999999999885 3446
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..++||||+++++|.+++..... ....+++.+++.++.|++.|+.|||+. +++|+||+|+||+++. +.+||+||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~ 149 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKH--TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF 149 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence 78999999999999999875322 124689999999999999999999999 9999999999999975 56999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
|.+....... .......|+..|+|||...+..++.++|+||||+++|+|++|..||.... .....
T Consensus 150 g~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~~~~--- 214 (260)
T cd08222 150 GVSRLLMGSC--------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVV--- 214 (260)
T ss_pred CceeecCCCc--------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHH---
Confidence 9987653211 11223457889999999988889999999999999999999999986421 00000
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
....... .+. . ....+..+.+++.+|++.+|++||++.|+++
T Consensus 215 ----------~~~~~~~---~~~--------~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 215 ----------LRIVEGP---TPS--------L--PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----------HHHHcCC---CCC--------C--cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0000000 000 0 0133456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=292.22 Aligned_cols=241 Identities=23% Similarity=0.227 Sum_probs=192.7
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccce
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
.++.|.....+|.|+|+.|-.+.+..+++..++|++.... .+-.+|+.++... +||||+++.+.+ .++.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeeccee-----cCCce
Confidence 3567888888999999999999999999999999997442 2334677666666 699999999995 56689
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEe-cCCCceEEccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL-DHDMVAHVGDF 854 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DF 854 (1013)
.|+|||.+.++-+.+.+...+ ....++..|+.+|+.|+.|||++ ||||||+||+|||+ +..++++|+||
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyF 460 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP-------EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYF 460 (612)
T ss_pred eeeeehhccccHHHHHHHhcc-------hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEe
Confidence 999999999998888877652 23378889999999999999999 99999999999999 58899999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
|.++...+. ....+-|..|.|||+.....|++++|+||||+++|+|++|+.||.....+......
T Consensus 461 G~a~~~~~~-----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~---- 525 (612)
T KOG0603|consen 461 GFWSELERS-----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR---- 525 (612)
T ss_pred chhhhCchh-----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh----
Confidence 999865432 23345688999999999999999999999999999999999999875333111000
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
....+.. +.......+++.+|++.||.+||++.|+..
T Consensus 526 i~~~~~s----------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 526 IQMPKFS----------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred hcCCccc----------------------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 0000000 223455678889999999999999999865
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=278.79 Aligned_cols=237 Identities=28% Similarity=0.346 Sum_probs=190.3
Q ss_pred eeeccceEEEEEEECCCCeEEEEEEEeeccc---cchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeec
Q 001782 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYM 783 (1013)
Q Consensus 707 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 783 (1013)
||+|+||.||++.+..+++.||+|++..... ...+.+..|++++++++||||+++++.+ +.+...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6899999999999988899999999874432 2345788999999999999999999884 4568899999999
Q ss_pred cCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCC
Q 001782 784 ECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863 (1013)
Q Consensus 784 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~ 863 (1013)
++++|.+++... ..+++.++..++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 76 PGGELFSHLSKE------GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 999999999865 3689999999999999999999999 9999999999999999999999999998755322
Q ss_pred CCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHh
Q 001782 864 SPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEI 943 (1013)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1013)
. .......++..|+|||...+...+.++|+||||+++|++++|..||..... ... ...+
T Consensus 147 ~--------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~--------~~~~ 205 (250)
T cd05123 147 G--------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEI--------YEKI 205 (250)
T ss_pred C--------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHH--------HHHH
Confidence 1 123345678899999999888899999999999999999999999965321 010 0011
Q ss_pred hhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 001782 944 VDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTD 996 (1013)
Q Consensus 944 i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 996 (1013)
.... .... ...+..+.+++.+|+..||++||++.+
T Consensus 206 ~~~~--------~~~~----------~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 206 LKDP--------LRFP----------EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred hcCC--------CCCC----------CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1000 0000 011355788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=250.71 Aligned_cols=218 Identities=22% Similarity=0.312 Sum_probs=176.0
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc-ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 774 (1013)
..++......||+|+||.|-+-++..+|+..|+|.++..- ....++..+|+++..+. .+|.+|+++|.. -...
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~reg 118 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FREG 118 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh-----hccc
Confidence 3445556788999999999999999999999999997443 23456678888876655 799999999974 3457
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..++.||.|+ .||+.+-++.-. ..+.+++.-.-+||..+..||.|||++. .++|||+||+|||++.+|++|+|||
T Consensus 119 dvwIcME~M~-tSldkfy~~v~~--~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 119 DVWICMELMD-TSLDKFYRKVLK--KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred cEEEeHHHhh-hhHHHHHHHHHh--cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence 7899999998 888877655322 1257899999999999999999999986 8999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCC----CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG----GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHE 930 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~ 930 (1013)
|++..+.+.. ..+-..|...|||||.+.. ..|+.++||||||+++.||.+++.||+.+...-.++.+
T Consensus 194 GIsG~L~dSi---------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 194 GISGYLVDSI---------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred ccceeehhhh---------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 9997653221 1222457889999998764 36889999999999999999999999987665555554
Q ss_pred HHH
Q 001782 931 FAK 933 (1013)
Q Consensus 931 ~~~ 933 (1013)
.+.
T Consensus 265 vVe 267 (282)
T KOG0984|consen 265 VVE 267 (282)
T ss_pred Hhc
Confidence 443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=275.14 Aligned_cols=222 Identities=19% Similarity=0.141 Sum_probs=175.1
Q ss_pred ccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeeccCCCHH
Q 001782 710 GSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLE 789 (1013)
Q Consensus 710 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 789 (1013)
|.+|.||+|++..+++.||+|++.... ...+|...+....||||+++++++ ...+..++||||+++++|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHH
Confidence 889999999999999999999986442 233455555566799999999985 3457899999999999999
Q ss_pred HHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCCCCCccc
Q 001782 790 DWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATIL 869 (1013)
Q Consensus 790 ~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 869 (1013)
+++... ..+++..+..++.|++.|++|+|+. +++||||||+||+++.++.++++|||.+......
T Consensus 74 ~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------ 138 (237)
T cd05576 74 SHISKF------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------ 138 (237)
T ss_pred HHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc------
Confidence 998765 3589999999999999999999999 9999999999999999999999999987654321
Q ss_pred cCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhc
Q 001782 870 ETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLL 949 (1013)
Q Consensus 870 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 949 (1013)
.....++..|+|||+..+..++.++||||+|+++|||++|+.|+...... .... ..
T Consensus 139 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~~~~----~~ 194 (237)
T cd05576 139 -----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------INTH----TT 194 (237)
T ss_pred -----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------cccc----cc
Confidence 12234567899999998888999999999999999999999887532100 0000 00
Q ss_pred cchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 001782 950 LDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTD 996 (1013)
Q Consensus 950 ~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 996 (1013)
.+ . .......+.+++.+|++.||++||++.+
T Consensus 195 ~~--------------~--~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 195 LN--------------I--PEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred cC--------------C--cccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 00 0 0012345788999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=298.23 Aligned_cols=279 Identities=19% Similarity=0.184 Sum_probs=173.6
Q ss_pred hhccCCCCCceeeccceEEEEEEECCC----CeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeec-CCcc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGEN----EMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSS-IDFE 771 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 771 (1013)
..++|++.++||+|+||.||+|++..+ +..||+|++..... .+....| .++...+.++..++..+.. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999888 88999998753221 1111121 1122222222222221111 1013
Q ss_pred ccceEEEEEeeccCCCHHHHhhcccccc--------------ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQL--------------EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLK 837 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk 837 (1013)
.+...++||||+++++|.+++....... .........+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 5577899999999999999987542110 001122345678999999999999999 99999999
Q ss_pred CCceEecC-CCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCC----------------------C
Q 001782 838 PSNVLLDH-DMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG----------------------D 894 (1013)
Q Consensus 838 p~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~ 894 (1013)
|+|||++. ++.+||+|||+|+.+.... ........+++.|+|||.+... .
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 99999986 5799999999998553221 1123446789999999965432 2
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHH
Q 001782 895 MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLV 974 (1013)
Q Consensus 895 ~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~ 974 (1013)
++.++||||+||++|||+++..|++.. ...+....... ..+...+.... . + +. ........+.......
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~~---~~~~~~~l~~~-~~~~~~~~~~~-~--~--~~--~~~~~~~~~~~d~~~~ 424 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRN-DYDLVAWRKLV-E--P--RA--SPDLRRGFEVLDLDGG 424 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCchH---HHHHHHHHHhc-CCcHHHHHHhh-c--c--cc--chhhhhhhhhccccch
Confidence 344679999999999999977665421 00111111100 00111110000 0 0 00 0000000111111223
Q ss_pred HHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 975 AIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 975 ~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
...+++.+|++.||++|||+.|+++.
T Consensus 425 ~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 425 AGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhCC
Confidence 45689999999999999999999873
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-31 Score=282.58 Aligned_cols=199 Identities=26% Similarity=0.393 Sum_probs=176.2
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec---cccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
+++++..||-||||.|=+++.......+|+|+++.. .....+.+..|-.+|...+.|.||++|.. +.+..+.
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~kyv 495 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKYV 495 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchhh
Confidence 445567899999999999998766656888887633 23334567889999999999999999987 5667899
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
|+.||-|-||.++..++.. +.++...+..++.-+++|++|||++ +||+||+||+|.++|.+|-+||.|||+
T Consensus 496 YmLmEaClGGElWTiLrdR------g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDR------GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGF 566 (732)
T ss_pred hhhHHhhcCchhhhhhhhc------CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhh
Confidence 9999999999999999987 6789999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
|+.+. ...+...++||+.|.|||++.....+.++|.||+|+++||+++|.+||...
T Consensus 567 AKki~---------~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 567 AKKIG---------SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred HHHhc---------cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99764 344567899999999999999999999999999999999999999999874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=258.90 Aligned_cols=242 Identities=22% Similarity=0.326 Sum_probs=198.0
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec---cccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 772 (1013)
..++|...++||+|+|+.|..++..++.+.+|+|+++.+ .++..+-.+.|-.+..+. +||.+|.+..+ ++.
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqt 322 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQT 322 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hcc
Confidence 356899999999999999999999999999999999743 334445567788888776 69999998887 566
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
+...++|.||+.||+|--.++++ ..++++.+..+...|.-||.|||++ ||++||+|.+|||+|..|++|++
T Consensus 323 esrlffvieyv~ggdlmfhmqrq------rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghiklt 393 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLT 393 (593)
T ss_pred cceEEEEEEEecCcceeeehhhh------hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeec
Confidence 78899999999999998777766 5799999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCc--CCCCccHHH
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM--FNDGLTLHE 930 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~--~~~~~~~~~ 930 (1013)
|+|+++.-- ........++||+.|.|||++.+..|...+|.|++|++++||+.|+.||+-. .+.+..-..
T Consensus 394 dygmcke~l--------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nted 465 (593)
T KOG0695|consen 394 DYGMCKEGL--------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTED 465 (593)
T ss_pred ccchhhcCC--------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhH
Confidence 999987421 2334466789999999999999999999999999999999999999999753 222222222
Q ss_pred HH-----Hh--hC----ChhHHHhhhhhhccchhhhhccCC
Q 001782 931 FA-----KM--AL----PEKVMEIVDPLLLLDLEARASNCG 960 (1013)
Q Consensus 931 ~~-----~~--~~----~~~~~~~i~~~l~~~~~~R~~~~~ 960 (1013)
+. .. .+ +-.+..+++..+.+||.+|.....
T Consensus 466 ylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~ 506 (593)
T KOG0695|consen 466 YLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRP 506 (593)
T ss_pred HHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCc
Confidence 21 11 12 234667778888888888876543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=246.81 Aligned_cols=276 Identities=20% Similarity=0.298 Sum_probs=205.6
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCC-CCccceEEEEeecCCccccce
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 775 (1013)
..++|++.+++|+|.|++||.|....+.++++||++++.. .+.+.+|+.+++.+. ||||+.++++..++ ....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccC
Confidence 3568999999999999999999998889999999998553 367899999999996 99999999997543 3355
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC-CceEEccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD-MVAHVGDF 854 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DF 854 (1013)
..+|+||+.+.+...+-. .++..++..++.+++.||.|+|+. ||.|||+||.||++|.. ...+|+|+
T Consensus 110 paLiFE~v~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred chhHhhhhccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeec
Confidence 679999999877766553 466678899999999999999999 99999999999999865 57999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCC-CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
|+|.++-+...... .+.+..|.-||.+-. ..|+.+-|+|||||++..|+..+.||..-.....++..+++
T Consensus 178 GLAEFYHp~~eYnV---------RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak 248 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNV---------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK 248 (338)
T ss_pred chHhhcCCCceeee---------eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence 99998866544332 345678889998765 45888999999999999999999999776555555555555
Q ss_pred hhCChhHHHhhhh-hhccchhhhhccCCCCchhHHH------HHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 934 MALPEKVMEIVDP-LLLLDLEARASNCGSHRTEIAK------IEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 934 ~~~~~~~~~~i~~-~l~~~~~~R~~~~~~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
....+++...+.+ .+..||+-.--...-.+..... ..-..++..+++.+.+.+|-.+||||.|.++
T Consensus 249 VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 249 VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 4444443333322 1112221100000000000000 0111245678899999999999999999875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-31 Score=256.78 Aligned_cols=205 Identities=24% Similarity=0.350 Sum_probs=171.7
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec--cccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
+.+..+.||.|+||.||.+.+..+++.||+|.+... .-...+++.+|++++..++|.||+..+++........-.+.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 455678999999999999999999999999988622 223457788999999999999999999886544334445678
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+++|.|. .+|...+-.. ..++...+.-+..||++||.|||+. +|.||||||.|.+|..+...||||||+|
T Consensus 134 V~TELmQ-SDLHKIIVSP------Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSP------QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHH-hhhhheeccC------CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccc
Confidence 8999988 7888877654 4688888999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCc
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~ 921 (1013)
+..+.+... ..+..+-|..|+|||++.+. .|+.+.||||.||++.|++.++..|+..
T Consensus 204 Rvee~d~~~-------hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 204 RTWDQRDRL-------NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred cccchhhhh-------hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 976543322 23445568999999999986 5899999999999999999999988763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=264.42 Aligned_cols=239 Identities=28% Similarity=0.388 Sum_probs=191.2
Q ss_pred cceEEEEEEECCCCeEEEEEEEeeccccc-hhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeeccCCCHH
Q 001782 711 SFGFVYRGNLGENEMAVAVKVMNLKQRGA-TKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLE 789 (1013)
Q Consensus 711 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 789 (1013)
+||.||+|++.++++.||+|++....... .+.+.+|++.+++++|++++++++++. .....++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence 58999999999889999999997655444 678999999999999999999999864 337789999999989999
Q ss_pred HHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCCCCCccc
Q 001782 790 DWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATIL 869 (1013)
Q Consensus 790 ~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 869 (1013)
+++... ..+++.+++.++.+++.+++|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 76 ~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----- 141 (244)
T smart00220 76 DLLKKR------GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----- 141 (244)
T ss_pred HHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----
Confidence 999765 2378999999999999999999999 99999999999999999999999999998654321
Q ss_pred cCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhc
Q 001782 870 ETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLL 949 (1013)
Q Consensus 870 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 949 (1013)
......++..|+|||...+..++.++||||+|+++|++++|..||....... . ..+.+. .
T Consensus 142 ----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~----~---------~~~~~~---~ 201 (244)
T smart00220 142 ----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL----E---------LFKKIG---K 201 (244)
T ss_pred ----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH----H---------HHHHHh---c
Confidence 2334567889999999988889999999999999999999999986531110 0 011110 0
Q ss_pred cchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 950 LDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 950 ~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..+... ......+..+.+++.+|+..+|++||++.++++
T Consensus 202 ~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 202 PKPPFP-----------PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cCCCCc-----------cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 000000 000003456888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=286.74 Aligned_cols=246 Identities=26% Similarity=0.356 Sum_probs=186.0
Q ss_pred CCCCceeeccceE-EEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccceEEEE
Q 001782 702 SSSNMIGQGSFGF-VYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFKAIV 779 (1013)
Q Consensus 702 ~~~~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv 779 (1013)
.-.+++|.|+.|+ ||+|... ++.||||.+-.+. .+...+|+..++.- +||||+++++. ..+..+.|++
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIa 581 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIA 581 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEE
Confidence 3346789999985 7999984 7799999885332 24567999999988 59999999987 5667899999
Q ss_pred EeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC---C--CceEEccc
Q 001782 780 YEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH---D--MVAHVGDF 854 (1013)
Q Consensus 780 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DF 854 (1013)
.|.|. .+|+++++...... ........+.+..|++.||++||+. +||||||||.||||+. + .+++|+||
T Consensus 582 lELC~-~sL~dlie~~~~d~--~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDf 655 (903)
T KOG1027|consen 582 LELCA-CSLQDLIESSGLDV--EMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDF 655 (903)
T ss_pred ehHhh-hhHHHHHhccccch--hhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccc
Confidence 99999 89999999852111 1112245678899999999999998 9999999999999976 3 47999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhC-CCCCCCcCCCCccHHHHHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G-~~pf~~~~~~~~~~~~~~~ 933 (1013)
|+++.+..+...- .......||.+|+|||++....-+.++||||+||++|+.++| .+||.+....+..+..
T Consensus 656 glsKkl~~~~sS~-----~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--- 727 (903)
T KOG1027|consen 656 GLSKKLAGGKSSF-----SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--- 727 (903)
T ss_pred ccccccCCCcchh-----hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc---
Confidence 9999887654321 124567799999999999999889999999999999999995 9999864221111000
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVV 998 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 998 (1013)
.. ..+. .+....++ ...++|.+|+++||..||+|.+|+
T Consensus 728 ~~-----~~L~--------------------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 728 GN-----YTLV--------------------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred Cc-----ccee--------------------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 00 0000 00000111 467899999999999999999996
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=281.00 Aligned_cols=276 Identities=17% Similarity=0.187 Sum_probs=183.2
Q ss_pred hhhccCCCCCceeeccceEEEEEEEC----------------CCCeEEEEEEEeeccccchh--------------HHHH
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLG----------------ENEMAVAVKVMNLKQRGATK--------------SFVA 745 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~--------------~~~~ 745 (1013)
...++|++.++||+|+||+||+|.+. ..++.||||.+........+ ....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34679999999999999999999752 23567999998754332222 2345
Q ss_pred HHHHHhcCCCCc-----cceEEEEeecCC---ccccceEEEEEeeccCCCHHHHhhccccc------------------c
Q 001782 746 ECEALRNIRHRN-----LIKIITVCSSID---FEEVDFKAIVYEYMECGSLEDWLHQSNDQ------------------L 799 (1013)
Q Consensus 746 E~~~l~~l~h~n-----iv~~~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~ 799 (1013)
|+.++.+++|.+ +++++++|.... ....+..++||||+++++|.++++..... .
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 677777776654 467777765321 11235689999999999999998753210 0
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccc
Q 001782 800 EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879 (1013)
Q Consensus 800 ~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 879 (1013)
....+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||++..+..... .......
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-------~~~~~g~ 371 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-------FNPLYGM 371 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-------cCccccC
Confidence 112456788999999999999999999 999999999999999999999999999975432111 0111233
Q ss_pred cccccccccccCCCCC----------------------CcccchHHHHHHHHHHHhCCC-CCCCcCCCCccHHHHHHhhC
Q 001782 880 GTVGYVAPEYGMGGDM----------------------SATGDVYSFGILLLEMFTRRR-PTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 880 gt~~y~aPE~~~~~~~----------------------~~~~DIwSlG~il~ell~G~~-pf~~~~~~~~~~~~~~~~~~ 936 (1013)
+++.|+|||.+..... ..+.||||+||++|+|++|.. ||.....-..... ..
T Consensus 372 ~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~-----~~ 446 (507)
T PLN03224 372 LDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELR-----QY 446 (507)
T ss_pred CCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHh-----hc
Confidence 4789999998754321 124799999999999999875 6653211100000 00
Q ss_pred ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCC---CCCCCHHHHHH
Q 001782 937 PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESP---SERIQMTDVVA 999 (1013)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~evl~ 999 (1013)
......+.. . ... ...............+++.+++..+| .+|+|++|+++
T Consensus 447 ~~~~~~~r~-~----~~~--------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 447 DNDLNRWRM-Y----KGQ--------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cchHHHHHh-h----ccc--------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111111100 0 000 00111122334567888889998765 78999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=266.82 Aligned_cols=215 Identities=24% Similarity=0.324 Sum_probs=177.3
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
.-|..++.||-|+||+|.++....+...||+|.++..+ +......+.|.+||..-+.+-||++|-. |.+.+.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence 44677889999999999999998888899999987432 2334557889999999999999999977 567799
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
+|+||+|++||++-.++-+. +-|.+.-++.++..++.|+++.|.. |+|||||||+|||||.+|++||+|||
T Consensus 704 LYFVMdYIPGGDmMSLLIrm------gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRM------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred eEEEEeccCCccHHHHHHHh------ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecc
Confidence 99999999999999988776 5788889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCC--C------CCc---ccc-----------------------CCCCCcccccccccccccccCCCCCCcccch
Q 001782 856 LARFLPPC--S------PAT---ILE-----------------------TPSSSTGIKGTVGYVAPEYGMGGDMSATGDV 901 (1013)
Q Consensus 856 ~a~~~~~~--~------~~~---~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DI 901 (1013)
++.-+.-. . ... .++ ........+||+.|+|||++....|+..+|.
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw 854 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW 854 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence 97532110 0 000 000 0001224569999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCcCCCCcc
Q 001782 902 YSFGILLLEMFTRRRPTDNMFNDGLT 927 (1013)
Q Consensus 902 wSlG~il~ell~G~~pf~~~~~~~~~ 927 (1013)
||.|||+|||+.|++||......+.+
T Consensus 855 ws~gvil~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 855 WSVGVILYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred hHhhHHHHHHhhCCCCccCCCCCcce
Confidence 99999999999999999875554443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-29 Score=268.41 Aligned_cols=200 Identities=26% Similarity=0.393 Sum_probs=174.0
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--------ccchhHHHHHHHHHhcCC---CCccceEEEEe
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--------RGATKSFVAECEALRNIR---HRNLIKIITVC 765 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~ 765 (1013)
...+|...+.+|+|+||.||.|.++++...|+||.+..++ +...-....|+.||..++ |+||++++++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf- 637 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF- 637 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe-
Confidence 3457999999999999999999999999999999986432 112234678999999997 9999999999
Q ss_pred ecCCccccceEEEEEeecc-CCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEec
Q 001782 766 SSIDFEEVDFKAIVYEYME-CGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD 844 (1013)
Q Consensus 766 ~~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 844 (1013)
|++++++|++||... +-+|.++|+.. ..+++.++..|+.||+.|+++||+. ||||||||-+||.++
T Consensus 638 ----FEddd~yyl~te~hg~gIDLFd~IE~k------p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd 704 (772)
T KOG1152|consen 638 ----FEDDDYYYLETEVHGEGIDLFDFIEFK------PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVD 704 (772)
T ss_pred ----eecCCeeEEEecCCCCCcchhhhhhcc------CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEe
Confidence 678899999999764 56899999987 5799999999999999999999999 999999999999999
Q ss_pred CCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCC-CcccchHHHHHHHHHHHhCCCCCCC
Q 001782 845 HDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDM-SATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 845 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
.+|-+||+|||.|.+... .....++||..|.|||++.+.+| +..-|||++|+++|.++....||..
T Consensus 705 ~~g~~klidfgsaa~~ks----------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 705 SNGFVKLIDFGSAAYTKS----------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cCCeEEEeeccchhhhcC----------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999999975432 22455789999999999999887 4568999999999999999999854
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=266.47 Aligned_cols=277 Identities=18% Similarity=0.264 Sum_probs=205.8
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCC------CCccceEEEEeecCCc
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR------HRNLIKIITVCSSIDF 770 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~ 770 (1013)
...+|.+....|+|-|++|.+|.+...+..||||++..... ..+.=..|+++|+++. --|+++++.. |
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~-----F 503 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRH-----F 503 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----h
Confidence 45689999999999999999999998899999999984422 2344568999999995 2467777776 5
Q ss_pred cccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC-Cce
Q 001782 771 EEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD-MVA 849 (1013)
Q Consensus 771 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~ 849 (1013)
...+++|+|+|.+. .+|.++++..... ..+....+..++.|+..||..|... ||+|.||||+||||.+. ...
T Consensus 504 ~hknHLClVFE~Ls-lNLRevLKKyG~n---vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLS-LNLREVLKKYGRN---VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred hhcceeEEEehhhh-chHHHHHHHhCcc---cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence 56799999999998 8999999987553 4788889999999999999999998 99999999999999876 478
Q ss_pred EEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCcc-H
Q 001782 850 HVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLT-L 928 (1013)
Q Consensus 850 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~-~ 928 (1013)
||||||.|...... ..+++.-+..|.|||++.|-+|+...|+||.||++||+.||+..|.+..+..+. +
T Consensus 577 KLCDfGSA~~~~en----------eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 577 KLCDFGSASFASEN----------EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred eeccCccccccccc----------cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 99999999865432 234455677899999999999999999999999999999999999875443221 1
Q ss_pred HHHHHhhCChhHH---Hhhhh------------------------hhccchh----hhhccCCCCchhHHHHHHHHHHHH
Q 001782 929 HEFAKMALPEKVM---EIVDP------------------------LLLLDLE----ARASNCGSHRTEIAKIEECLVAIV 977 (1013)
Q Consensus 929 ~~~~~~~~~~~~~---~~i~~------------------------~l~~~~~----~R~~~~~~~~~~~~~~~~~~~~l~ 977 (1013)
.--....+|..+. .++++ +....|. .+.-.+... .........++.
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~---~deq~~~~~~~r 723 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRL---PDEQPKIVQQLR 723 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCC---CchhHHHHHHHH
Confidence 1111112222110 11111 1111111 111111000 111123456788
Q ss_pred HHhhhcccCCCCCCCCHHHHHH
Q 001782 978 RIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 978 ~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+|+.+|+..||++|.|..++++
T Consensus 724 dLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 724 DLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHHhccChhhcCCHHHHhc
Confidence 9999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=240.68 Aligned_cols=255 Identities=18% Similarity=0.236 Sum_probs=189.9
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcC-CCCccceEEEEeecCCccccceE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.+.|.+.+.+|+|.||.+-+++++++...+|+|.+... ....++|.+|...--.+ .|.||+.-|++. ++..+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceE
Confidence 35799999999999999999999999999999998633 33457788888765555 589999988875 5666899
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEec--CCCceEEccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD--HDMVAHVGDF 854 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DF 854 (1013)
++++||++.|+|..-+... .+.+....+++.|++.|+.|||++ ++||||||.+||||- +..++|+|||
T Consensus 98 vF~qE~aP~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred EEeeccCccchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeec
Confidence 9999999999999888764 678888999999999999999999 999999999999994 3358999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCC-----CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHH
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-----DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 929 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~ 929 (1013)
|.++..+.. .....-+..|.|||..... ...+.+|||.||+++|.+++|..||+.....+..+.
T Consensus 168 G~t~k~g~t-----------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~ 236 (378)
T KOG1345|consen 168 GLTRKVGTT-----------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW 236 (378)
T ss_pred ccccccCce-----------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH
Confidence 998744311 1222345779999975442 357789999999999999999999987555555544
Q ss_pred HHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 930 EFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 930 ~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
+|..... +....-| .......+.+.++.++-+.++|++|--..++.++.
T Consensus 237 ~~~~w~~---------rk~~~~P--------------~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 237 EWEQWLK---------RKNPALP--------------KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred HHHHHhc---------ccCccCc--------------hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 4432211 0000000 01112233456677777788888875544444443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=244.39 Aligned_cols=275 Identities=20% Similarity=0.237 Sum_probs=203.0
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec--cccchhHHHHHHHHHhcCCCCccceEEEEeecCCc-cccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDF-EEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 774 (1013)
..+|.-.+.+|.|.- .|..|.+.-.+++||+|..... .....++..+|...+..+.|+||++++.+++.... ++..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357888899999998 8888989888999999987522 22345678899999999999999999999865322 3345
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
..|+|||+|. .+|.+.+.. .++-+....|..|++.|++|||+. ||+|||+||+||++..++.+||.||
T Consensus 95 e~y~v~e~m~-~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~df 162 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM--------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDF 162 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccc
Confidence 6899999999 899998873 356678899999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
|+|+..+.. -..+..+.|..|+|||++.+..+...+||||.||++.||++|+..|.+ ...+.+|.+.
T Consensus 163 g~ar~e~~~---------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g----~d~idQ~~ki 229 (369)
T KOG0665|consen 163 GLARTEDTD---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG----KDHIDQWNKI 229 (369)
T ss_pred hhhcccCcc---------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC----chHHHHHHHH
Confidence 999854321 135677889999999999998899999999999999999999999874 2233333222
Q ss_pred h----CC-hh--------HHHhhh---hhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 001782 935 A----LP-EK--------VMEIVD---PLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVV 998 (1013)
Q Consensus 935 ~----~~-~~--------~~~~i~---~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 998 (1013)
. -+ +. .+..+. +-......++... ..+....+...-......+++.+|+..||++|.++++++
T Consensus 230 ~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD-~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 230 IEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPD-SLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCc-ccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 1 01 11 111111 0000111111110 111111111112234567899999999999999999998
Q ss_pred H
Q 001782 999 A 999 (1013)
Q Consensus 999 ~ 999 (1013)
.
T Consensus 309 ~ 309 (369)
T KOG0665|consen 309 R 309 (369)
T ss_pred c
Confidence 5
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-29 Score=270.59 Aligned_cols=202 Identities=26% Similarity=0.401 Sum_probs=179.7
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
..++|+..+++|.|.||.||+|++..+++..|+|+++.......+-+++|+-+++..+||||+.++|-+ ...+..
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dkl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDKL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcCc
Confidence 456899999999999999999999999999999999988777778889999999999999999999984 455789
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
|++||||.+|+|++.-+-. +.+++.++..+++...+|++|||+. |-+|||||-.||++++.|.+|++|||.
T Consensus 88 wicMEycgggslQdiy~~T------gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgv 158 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVT------GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGV 158 (829)
T ss_pred EEEEEecCCCcccceeeec------ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCc
Confidence 9999999999999987765 6899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccC---CCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM---GGDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
+..+. ....+...+.||+.|||||+.. .+.|...+|||+.|+...|+-.-++|-.+
T Consensus 159 saqit--------ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd 217 (829)
T KOG0576|consen 159 SAQIT--------ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD 217 (829)
T ss_pred hhhhh--------hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc
Confidence 87543 3344566789999999999743 46789999999999999999988777543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=246.45 Aligned_cols=287 Identities=26% Similarity=0.324 Sum_probs=209.4
Q ss_pred hhhhhccCCCCCceeeccceEEEEEEECC---CCeEEEEEEEeeccccchhHHHHHHHHHhcC-CCCccceEEEEeecCC
Q 001782 694 LSKATNDFSSSNMIGQGSFGFVYRGNLGE---NEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVCSSID 769 (1013)
Q Consensus 694 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 769 (1013)
+....+.|..+++||+|.|++||+|.+.. .++.||+|.+...+. ..++.+|+++|..+ .+.||+++.++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~----- 103 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGC----- 103 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhh-----
Confidence 44556789999999999999999999976 788999999875543 46789999999999 58999999998
Q ss_pred ccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC-CCc
Q 001782 770 FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH-DMV 848 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~ 848 (1013)
+..++..++|+||++.....++... ++..++..+++.+..||+++|.. |||||||||+|++.+. .+.
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~r 171 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYRS---------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQR 171 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHhc---------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCC
Confidence 5677899999999998888888754 56789999999999999999999 9999999999999975 467
Q ss_pred eEEccccccccCCCCCCC-------------------------------c-----cccCCCCCcccccccccccccccCC
Q 001782 849 AHVGDFGLARFLPPCSPA-------------------------------T-----ILETPSSSTGIKGTVGYVAPEYGMG 892 (1013)
Q Consensus 849 ~kl~DFG~a~~~~~~~~~-------------------------------~-----~~~~~~~~~~~~gt~~y~aPE~~~~ 892 (1013)
-.|+|||+|...+..... . ............||++|+|||++..
T Consensus 172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence 889999999832211100 0 0011112334569999999999876
Q ss_pred -CCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHH---hhhh--hhc-----cchhhhhcc---
Q 001782 893 -GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVME---IVDP--LLL-----LDLEARASN--- 958 (1013)
Q Consensus 893 -~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~i~~--~l~-----~~~~~R~~~--- 958 (1013)
..-++++||||.|+++..+++++.||....++...+.+.+....+..++. ...+ .+. ..++.|...
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~ 331 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL 331 (418)
T ss_pred ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence 45788999999999999999999999887666665555544433332221 1111 001 111111110
Q ss_pred ----CCCCc---hhHHHHHHH-HHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 959 ----CGSHR---TEIAKIEEC-LVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 959 ----~~~~~---~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
+...+ .......++ +..+++++.+|+..||.+|.||+|+++
T Consensus 332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00000 011122222 237899999999999999999999875
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-28 Score=254.03 Aligned_cols=398 Identities=21% Similarity=0.226 Sum_probs=276.1
Q ss_pred CCCCccccccccccceecccccccccCCCCccCCCCcceeeecccccCCCCCCccccccccceeeccc-ccccCCCcchh
Q 001782 163 QIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISE-NAFSGMFPSSI 241 (1013)
Q Consensus 163 ~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~~ 241 (1013)
+||.+++ ..-.+++|..|+|+.+.+..|+.+++|+.||||+|.|+.+-|++|.++.+|..|-+.+ |+|+......|
T Consensus 60 eVP~~LP---~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F 136 (498)
T KOG4237|consen 60 EVPANLP---PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAF 136 (498)
T ss_pred cCcccCC---CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHh
Confidence 5666555 3467788888888888888899999999999999999988899999998887777766 88886666788
Q ss_pred ccCCccceeeccCCccCCCCCCCcCCCCCCCcEEEeeeccccccCCCCCCCCCCCceEEcccCccc------------cc
Q 001782 242 FNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFS------------GQ 309 (1013)
Q Consensus 242 ~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~------------~~ 309 (1013)
++|.+|+.|.+.-|++. .++...+..+++|..|.+..|.+..+--.+|..+.+++.+.+..|.+- ..
T Consensus 137 ~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~ 215 (498)
T KOG4237|consen 137 GGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAM 215 (498)
T ss_pred hhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhh
Confidence 88999999999999998 777777778889999999999888443448888899999998888732 22
Q ss_pred ccccccCCCCccccccccCcCCCCCCCChhhhhhcccccccccccccccccCCccchhhhcchhhHHHHhccchhHHhhc
Q 001782 310 VKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKN 389 (1013)
Q Consensus 310 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~ 389 (1013)
.+..++.........+..+++..+....+ ... +..+.+--.+..... ...+...|+.
T Consensus 216 ~~ietsgarc~~p~rl~~~Ri~q~~a~kf--~c~---~esl~s~~~~~d~~d------------------~~cP~~cf~~ 272 (498)
T KOG4237|consen 216 NPIETSGARCVSPYRLYYKRINQEDARKF--LCS---LESLPSRLSSEDFPD------------------SICPAKCFKK 272 (498)
T ss_pred chhhcccceecchHHHHHHHhcccchhhh--hhh---HHhHHHhhccccCcC------------------CcChHHHHhh
Confidence 23334444444444444444443322211 111 001100000011111 1123456899
Q ss_pred ccccceeecccccccCCcccccCCCCCCCEEEccCCccCccCCccccccCccCEEEcCCCcccCCCCcccccCcccceee
Q 001782 390 LVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLS 469 (1013)
Q Consensus 390 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 469 (1013)
+++|+.|+|++|+|+++-+.+|.++..++.|.|..|+|..+....|.++..|++|+|++|+|+..-|.+|..+..|.+|+
T Consensus 273 L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~ 352 (498)
T KOG4237|consen 273 LPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLN 352 (498)
T ss_pred cccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeee
Confidence 99999999999999999999999999999999999999988888899999999999999999999999999999999999
Q ss_pred cccccccccCCc-hhhc--------------ccchhhhhccCCCeec---ccCCccccC---------cCCCc-EEEccC
Q 001782 470 VSNNKLTGALPP-QILG--------------IVTLSILLDLSGNLLT---GSIPAEVGN---------LKNLV-QLGLSE 521 (1013)
Q Consensus 470 L~~N~l~~~~p~-~~~~--------------~~~~l~~L~Ls~N~l~---~~~~~~~~~---------l~~L~-~L~Ls~ 521 (1013)
|-.|.+...--- ++.. ....++.+.++.+.+. ..-|++.+. .+-+. ...-|+
T Consensus 353 l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSn 432 (498)
T KOG4237|consen 353 LLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSN 432 (498)
T ss_pred hccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcc
Confidence 999987521111 1111 0122333344433322 111222111 11121 222333
Q ss_pred CCCCCCCccccccccccccccccccccccccCccccccCCCCeEeccccccccccccccccccccceeecCCc
Q 001782 522 NRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYN 594 (1013)
Q Consensus 522 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 594 (1013)
+.++ .+|..+. ..-.+|++.+|.++ .+|.. .+.+| .+|+|+|+++..-...|.++++|.+|-||+|
T Consensus 433 k~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 433 KLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred cchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 3333 3443332 23467899999998 67776 66778 8999999998777778889999999888876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=234.53 Aligned_cols=211 Identities=29% Similarity=0.528 Sum_probs=181.0
Q ss_pred eeeccceEEEEEEECCCCeEEEEEEEeecccc-chhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeeccC
Q 001782 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG-ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMEC 785 (1013)
Q Consensus 707 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 785 (1013)
||+|++|.||++....+++.+++|++...... ..+.+.+|++.++.++|++++++++++. .....++++||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence 68999999999999888999999999755432 3467899999999999999999999964 33788999999999
Q ss_pred CCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC-CCceEEccccccccCCCCC
Q 001782 786 GSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH-DMVAHVGDFGLARFLPPCS 864 (1013)
Q Consensus 786 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~~ 864 (1013)
++|.+++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 76 ~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 76 GSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 99999987642 2578999999999999999999999 9999999999999999 8999999999997654321
Q ss_pred CCccccCCCCCcccccccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHh
Q 001782 865 PATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEI 943 (1013)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1013)
. ......+...|++||..... .++.++|+|++|++++++
T Consensus 148 ~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------- 187 (215)
T cd00180 148 S--------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------- 187 (215)
T ss_pred c--------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------
Confidence 1 12334577899999998877 888999999999999999
Q ss_pred hhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 944 VDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 944 i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 135678889999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=235.08 Aligned_cols=200 Identities=32% Similarity=0.497 Sum_probs=172.2
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc-chhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEE
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG-ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIV 779 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 779 (1013)
|++.+.||+|++|.||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++. .....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence 56778999999999999999988899999999865544 5678899999999999999999999864 33678999
Q ss_pred EeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccccc
Q 001782 780 YEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859 (1013)
Q Consensus 780 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 859 (1013)
+||+++++|.+++..... .+++..+..++.+++.++.+||+. +++|+|++|+||+++.++.++|+|||.+..
T Consensus 76 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-----KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred EeccCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 999999999999987521 178899999999999999999999 999999999999999999999999999886
Q ss_pred CCCCCCCccccCCCCCccccccccccccccc-CCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001782 860 LPPCSPATILETPSSSTGIKGTVGYVAPEYG-MGGDMSATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
..... ........++..|++||.. ....++.++|||+||+++|||++|+.||..
T Consensus 148 ~~~~~-------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 148 IHRDL-------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ecCcc-------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 54322 0022345677899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-27 Score=242.31 Aligned_cols=271 Identities=23% Similarity=0.258 Sum_probs=157.6
Q ss_pred CeeeeccCCccccCCcccCCcccceEEeccCCccccCCCCccccCCCCceecccc-ccccCCCCCccccccccccceecc
Q 001782 103 RFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARG-NNLVGQIPPDIGYSWLKLEFLSLR 181 (1013)
Q Consensus 103 ~~L~l~~n~l~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~-n~l~~~ip~~~~~~l~~L~~L~L~ 181 (1013)
..++|..|+|+..-|.+|+.+++|+.||||+|+|+..-|..|.+|.+|..|.+-+ |+|+ ++|.+.|.+|..|+.|.+.
T Consensus 70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcC
Confidence 4455666666644444666666666666666666655566666666666655555 5555 6666666666666666666
Q ss_pred cccccccCCCCccCCCCcceeeecccccCCCCCC-ccccccccceeeccccc------------ccCCCcchhccCCccc
Q 001782 182 DNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPD-SLGQLRSLYYLSISENA------------FSGMFPSSIFNISSLE 248 (1013)
Q Consensus 182 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~Ls~n~------------l~~~~p~~~~~l~~L~ 248 (1013)
.|++.-+....|..|++|..|.+.+|.+. .++. +|..+.+++.+.+..|. +....|..++......
T Consensus 149 an~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 149 ANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred hhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 66666666666666777777777777666 3443 66666667776666665 2233445555555555
Q ss_pred eeeccCCccCCCCCCCcCCCCCCCcEE---EeeeccccccCC-CCCCCCCCCceEEcccCcccccccccccCCCCccccc
Q 001782 249 SISLLGNRLEGSLPVNIGFSLPNLENL---SVRQNNYTGSLP-HSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLS 324 (1013)
Q Consensus 249 ~L~L~~N~l~~~~p~~~~~~l~~L~~L---~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 324 (1013)
...|.++++. .+++.-+ .-.++.+ ..+.+..-++-| ..|..+++|+.|+|++|+++.+.+..|.....++.|.
T Consensus 228 p~rl~~~Ri~-q~~a~kf--~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~ 304 (498)
T KOG4237|consen 228 PYRLYYKRIN-QEDARKF--LCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELY 304 (498)
T ss_pred hHHHHHHHhc-ccchhhh--hhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhh
Confidence 5556666555 3433322 1112211 111222222333 2356666666666666666666666666666666666
Q ss_pred cccCcCCCCCCCChhhhhhcccccccccccccccccCCccchhhhcchhhHHHHhccchhHHhhcccccceeeccccccc
Q 001782 325 FSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLT 404 (1013)
Q Consensus 325 L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 404 (1013)
|.+|+|..+ ...-|.++..|+.|+|.+|+|+
T Consensus 305 L~~N~l~~v-------------------------------------------------~~~~f~~ls~L~tL~L~~N~it 335 (498)
T KOG4237|consen 305 LTRNKLEFV-------------------------------------------------SSGMFQGLSGLKTLSLYDNQIT 335 (498)
T ss_pred cCcchHHHH-------------------------------------------------HHHhhhccccceeeeecCCeeE
Confidence 666655431 1223455555666666666666
Q ss_pred CCcccccCCCCCCCEEEccCCcc
Q 001782 405 GPIPHAIGELRNLQVLDLHHNNL 427 (1013)
Q Consensus 405 ~~~p~~~~~l~~L~~L~L~~N~l 427 (1013)
...|.+|..+..|.+|+|-.|.+
T Consensus 336 ~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 336 TVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred EEecccccccceeeeeehccCcc
Confidence 66666666666666666666544
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=268.65 Aligned_cols=343 Identities=23% Similarity=0.294 Sum_probs=184.8
Q ss_pred ccCCCCCCCeeeeccCC------ccccCCcccCCcc-cceEEeccCCccccCCCCccccCCCCceeccccccccCCCCCc
Q 001782 95 YVGNLSFLRFINFANNG------FSGEIPGEIGRLF-RLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPD 167 (1013)
Q Consensus 95 ~l~~l~~L~~L~l~~n~------l~~~ip~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ip~~ 167 (1013)
.+.++.+|++|.+..+. +...+|..|..++ +|+.|.+.+|.+. .+|..+ ...+|++|++++
T Consensus 553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~---------- 620 (1153)
T PLN03210 553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQG---------- 620 (1153)
T ss_pred HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcC----------
Confidence 35566666666665432 2233455554442 3555555555554 445444 234444444444
Q ss_pred cccccccccceecccccccccCCCCccCCCCcceeeecccccCCCCCCccccccccceeecccccccCCCcchhccCCcc
Q 001782 168 IGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSL 247 (1013)
Q Consensus 168 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 247 (1013)
|.+. .++..+..+++|+.|+|++|...+.+|+ ++.+++|+.|+|++|.....+|..+.++++|
T Consensus 621 ---------------s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L 683 (1153)
T PLN03210 621 ---------------SKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKL 683 (1153)
T ss_pred ---------------cccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCC
Confidence 4444 3444556677777777776654445664 6667777777777766555677777777777
Q ss_pred ceeeccCCccCCCCCCCcCCCCCCCcEEEeeeccccccCCCCCCCCCCCceEEcccCcccccccccccCCCCcccccccc
Q 001782 248 ESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSK 327 (1013)
Q Consensus 248 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 327 (1013)
+.|++++|...+.+|..+ .+++|+.|++++|...+.+|.. .++|+.|++++|.+... |..+ .+++|++|++.+
T Consensus 684 ~~L~L~~c~~L~~Lp~~i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~l-P~~~-~l~~L~~L~l~~ 756 (1153)
T PLN03210 684 EDLDMSRCENLEILPTGI--NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEF-PSNL-RLENLDELILCE 756 (1153)
T ss_pred CEEeCCCCCCcCccCCcC--CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccc-cccc-cccccccccccc
Confidence 777777764444666654 4677777777776554445542 34667777777766532 2222 345555555543
Q ss_pred CcCCCCCCCChhhhhhcccccccccccccccccCCccchhhhcchhhHHHHhccchhHHhhcccccceeecccccccCCc
Q 001782 328 NNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPI 407 (1013)
Q Consensus 328 N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 407 (1013)
+..... . +.+....
T Consensus 757 ~~~~~l---------------------------~---------------------------------------~~~~~l~ 770 (1153)
T PLN03210 757 MKSEKL---------------------------W---------------------------------------ERVQPLT 770 (1153)
T ss_pred cchhhc---------------------------c---------------------------------------ccccccc
Confidence 321100 0 0000011
Q ss_pred ccccCCCCCCCEEEccCCccCccCCccccccCccCEEEcCCCcccCCCCcccccCcccceeecccccccccCCchhhccc
Q 001782 408 PHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIV 487 (1013)
Q Consensus 408 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~ 487 (1013)
|..+...++|+.|+|++|...+.+|..++++++|+.|+|++|..-+.+|..+ ++++|+.|++++|.....+|.
T Consensus 771 ~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~------ 843 (1153)
T PLN03210 771 PLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD------ 843 (1153)
T ss_pred hhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc------
Confidence 1112223456666666665555666666666666666666654333555544 456666666666543222221
Q ss_pred chhhhhccCCCeecccCCccccCcCCCcEEEccCCCCCCCCccccccccccccccccc-cccccccCccccccCCCCeEe
Q 001782 488 TLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEG-NSLTGSIPLALKTLKSIKELD 566 (1013)
Q Consensus 488 ~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ 566 (1013)
. .++|+.|+|++|.++ .+|.++..+++|+.|+|++ |+++ .+|..+..+++|+.|+
T Consensus 844 -------------------~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~ 899 (1153)
T PLN03210 844 -------------------I---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVD 899 (1153)
T ss_pred -------------------c---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeee
Confidence 1 134555555555554 4555555555555555555 3343 3455555556666666
Q ss_pred cccc
Q 001782 567 LSRN 570 (1013)
Q Consensus 567 Ls~N 570 (1013)
+++|
T Consensus 900 l~~C 903 (1153)
T PLN03210 900 FSDC 903 (1153)
T ss_pred cCCC
Confidence 6555
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=266.08 Aligned_cols=127 Identities=24% Similarity=0.283 Sum_probs=94.2
Q ss_pred cCccCEEEcCCCcccCCCCcccccCcccceeecccccccccCCchhhcccchhhhhccCCCeecccCCccccCcCCCcEE
Q 001782 438 LTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQL 517 (1013)
Q Consensus 438 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L 517 (1013)
.++|+.|+|++|...+.+|..++++++|+.|++++|..- +.+|..+ ++++|+.|
T Consensus 777 ~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L-------------------------~~LP~~~-~L~sL~~L 830 (1153)
T PLN03210 777 SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINL-------------------------ETLPTGI-NLESLESL 830 (1153)
T ss_pred cccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCc-------------------------CeeCCCC-CccccCEE
Confidence 345666666666555556666666666666666554322 2344444 57889999
Q ss_pred EccCCCCCCCCccccccccccccccccccccccccCccccccCCCCeEeccc-cccccccccccccccccceeecCCcc
Q 001782 518 GLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSR-NNLSGQIPEFLENLSFLEYLNLSYNH 595 (1013)
Q Consensus 518 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~ 595 (1013)
+|++|.....+|.. .++|++|+|++|.++ .+|..+..+++|+.|+|++ |+|. .+|..+..+++|+.++++++.
T Consensus 831 ~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 831 DLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 99987655556653 368999999999999 7899999999999999999 5666 588888999999999999885
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=210.80 Aligned_cols=172 Identities=20% Similarity=0.239 Sum_probs=129.7
Q ss_pred CCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCCCC
Q 001782 786 GSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSP 865 (1013)
Q Consensus 786 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 865 (1013)
|+|.++++... ..+++.+++.|+.|++.||+|||++ + ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~-- 62 (176)
T smart00750 1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE-- 62 (176)
T ss_pred CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc--
Confidence 68999998642 4699999999999999999999999 6 999999999999999 9998754321
Q ss_pred CccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHhhh
Q 001782 866 ATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVD 945 (1013)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~ 945 (1013)
...||+.|||||++.+..++.++|||||||++|||++|+.||...... ......++.
T Consensus 63 -----------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~------------~~~~~~~~~ 119 (176)
T smart00750 63 -----------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL------------SAILEILLN 119 (176)
T ss_pred -----------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh------------cHHHHHHHH
Confidence 125789999999999999999999999999999999999998653211 111222222
Q ss_pred hhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhhh
Q 001782 946 PLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007 (1013)
Q Consensus 946 ~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 1007 (1013)
.+....+..|+. ..... ....+.+++.+||+.+|++||++.|+++.+..+...
T Consensus 120 ~~~~~~~~~~~~--------~~~~~-~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 120 GMPADDPRDRSN--------LESVS-AARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HhccCCcccccc--------HHHHH-hhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 222222211110 01111 113588999999999999999999999998877544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=246.91 Aligned_cols=264 Identities=33% Similarity=0.383 Sum_probs=131.7
Q ss_pred CcceeeecccccCCCCCCccccccccceeecccccccCCCcchhccCCccceeeccCCccCCCCCCCcCCCCCCCcEEEe
Q 001782 198 NLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSV 277 (1013)
Q Consensus 198 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L 277 (1013)
.-..|+|++|.|+ .+|..+. ++|+.|++++|+++ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l----p~sL~~L~L 269 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL----PPGLLELSI 269 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc----ccccceeec
Confidence 4556677777776 5666554 35667777777666 34432 456666666666666 45531 245666666
Q ss_pred eeccccccCCCCCCCCCCCceEEcccCcccccccccccCCCCccccccccCcCCCCCCCChhhhhhcccccccccccccc
Q 001782 278 RQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDT 357 (1013)
Q Consensus 278 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~ 357 (1013)
++|.++ .+|..+ ++|+.|++++|+++.... .+++|+.|++++|
T Consensus 270 s~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N----------------------------- 312 (788)
T PRK15387 270 FSNPLT-HLPALP---SGLCKLWIFGNQLTSLPV----LPPGLQELSVSDN----------------------------- 312 (788)
T ss_pred cCCchh-hhhhch---hhcCEEECcCCccccccc----cccccceeECCCC-----------------------------
Confidence 666655 333322 345555555555543211 1223333333333
Q ss_pred cccCCccchhhhcchhhHHHHhccchhHHhhcccccceeecccccccCCcccccCCCCCCCEEEccCCccCccCCccccc
Q 001782 358 NIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGN 437 (1013)
Q Consensus 358 n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 437 (1013)
+|++ +|.. ..+|+.|++++|+|++ +|..
T Consensus 313 --------------------------------------------~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~l--- 340 (788)
T PRK15387 313 --------------------------------------------QLAS-LPAL---PSELCKLWAYNNQLTS-LPTL--- 340 (788)
T ss_pred --------------------------------------------cccc-CCCC---cccccccccccCcccc-cccc---
Confidence 3332 1111 1234444555555542 3321
Q ss_pred cCccCEEEcCCCcccCCCCcccccCcccceeecccccccccCCchhhcccchhhhhccCCCeecccCCccccCcCCCcEE
Q 001782 438 LTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQL 517 (1013)
Q Consensus 438 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L 517 (1013)
..+|+.|+|++|+|+ .+|... .+|+.|++++|+|+ .+|.. ...|+.|++++|+|++ +|.. .++|+.|
T Consensus 341 p~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~-~LP~l----~~~L~~LdLs~N~Lt~-LP~l---~s~L~~L 407 (788)
T PRK15387 341 PSGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPAL----PSGLKELIVSGNRLTS-LPVL---PSELKEL 407 (788)
T ss_pred ccccceEecCCCccC-CCCCCC---cccceehhhccccc-cCccc----ccccceEEecCCcccC-CCCc---ccCCCEE
Confidence 134555555555555 234321 24455555555555 34421 1234445555555552 3322 1345666
Q ss_pred EccCCCCCCCCccccccccccccccccccccccccCccccccCCCCeEecccccccccccccc
Q 001782 518 GLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFL 580 (1013)
Q Consensus 518 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 580 (1013)
++++|+|+ .+|..+ .+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++.+|..+
T Consensus 408 dLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 408 MVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred EccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 66666665 344322 34555666666665 455556666666666666666665555444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=244.44 Aligned_cols=115 Identities=30% Similarity=0.438 Sum_probs=59.2
Q ss_pred ccceEEeccCCccccCCCCccccCCCCceeccccccccCCCCCccccccccccceecccccccccCCCCccCCCCcceee
Q 001782 124 FRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLS 203 (1013)
Q Consensus 124 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 203 (1013)
..-..|+|++|.|+ .+|..+. ++|+.|++++|+++ .+|.. +++|++|+
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l----------------------------p~~Lk~Ld 248 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL----------------------------PPELRTLE 248 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC----------------------------CCCCcEEE
Confidence 34556777777777 6776665 36667777776666 34431 13444445
Q ss_pred ecccccCCCCCCccccccccceeecccccccCCCcchhccCCccceeeccCCccCCCCCCCcCCCCCCCcEEEeeecccc
Q 001782 204 IGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYT 283 (1013)
Q Consensus 204 L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~L~~N~l~ 283 (1013)
|++|+|+ .+|.. .++|+.|+|++|.++ .+|.. .++|+.|+|++|+++ .+|. .+++|++|+|++|+++
T Consensus 249 Ls~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~----~p~~L~~LdLS~N~L~ 315 (788)
T PRK15387 249 VSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPAL---PSGLCKLWIFGNQLT-SLPV----LPPGLQELSVSDNQLA 315 (788)
T ss_pred ecCCccC-cccCc---ccccceeeccCCchh-hhhhc---hhhcCEEECcCCccc-cccc----cccccceeECCCCccc
Confidence 5555444 23332 234455555555554 23332 134445555555555 4443 1244555555555555
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-24 Score=265.04 Aligned_cols=207 Identities=18% Similarity=0.227 Sum_probs=138.8
Q ss_pred cCCC-CccceEEEEeecCC--ccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 001782 752 NIRH-RNLIKIITVCSSID--FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCH 828 (1013)
Q Consensus 752 ~l~h-~niv~~~~~~~~~~--~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~ 828 (1013)
.++| +||.++++++.... ..+.+..+.++||++ ++|.++++... ..+++.+++.++.||++||+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~-- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQ-- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 3455 57888888753221 123345778899886 79999997532 4689999999999999999999999
Q ss_pred CCeeecCCCCCceEecCCC-------------------ceEEccccccccCCCCCCCcc--c------cCCCCCcccccc
Q 001782 829 PPIVHGDLKPSNVLLDHDM-------------------VAHVGDFGLARFLPPCSPATI--L------ETPSSSTGIKGT 881 (1013)
Q Consensus 829 ~~ivH~Dlkp~NIll~~~~-------------------~~kl~DFG~a~~~~~~~~~~~--~------~~~~~~~~~~gt 881 (1013)
||+||||||+|||++..+ .+|++|||+++.......... . ..........||
T Consensus 100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 999999999999996544 455556665543211000000 0 000011224689
Q ss_pred cccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCC
Q 001782 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGS 961 (1013)
Q Consensus 882 ~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~ 961 (1013)
+.|||||++.+..++.++|||||||++|||++|..|+.... ........... .+.
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~--------------~~~-------- 233 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVL--------------PPQ-------- 233 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhc--------------Chh--------
Confidence 99999999999999999999999999999999888764310 00000000000 000
Q ss_pred CchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 962 HRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 962 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
..........++.+||+.+|.+||++.||++
T Consensus 234 -------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 234 -------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred -------hhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 0001123456778899999999999999975
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=227.50 Aligned_cols=175 Identities=21% Similarity=0.161 Sum_probs=133.7
Q ss_pred hhhhccCCCCCceeeccceEEEEEEECC-CCeEEEEEEEeecc-----ccchhHHHHHHHHHhcCCCCccceEEEEeecC
Q 001782 695 SKATNDFSSSNMIGQGSFGFVYRGNLGE-NEMAVAVKVMNLKQ-----RGATKSFVAECEALRNIRHRNLIKIITVCSSI 768 (1013)
Q Consensus 695 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 768 (1013)
....++|.+.+.||+|+||+||+|.+.. +++.||||+..... ....+.+.+|++++++++|+++++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3445789999999999999999999875 67778999875321 12245689999999999999998533321
Q ss_pred CccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCceEecCCC
Q 001782 769 DFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDL-KPSNVLLDHDM 847 (1013)
Q Consensus 769 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~ 847 (1013)
+..++||||++|++|... ... . ...++.|+++||+|+|++ ||+|||| ||+||+++.++
T Consensus 91 -----~~~~LVmE~~~G~~L~~~-~~~---------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~ 149 (365)
T PRK09188 91 -----GKDGLVRGWTEGVPLHLA-RPH---------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDG 149 (365)
T ss_pred -----CCcEEEEEccCCCCHHHh-Ccc---------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCC
Confidence 347999999999999632 110 1 146788999999999999 9999999 99999999999
Q ss_pred ceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCC
Q 001782 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG 893 (1013)
Q Consensus 848 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 893 (1013)
.+||+|||+|+.+...................+++.|+|||++...
T Consensus 150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999999999977654322221112223467788999999987654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-22 Score=202.16 Aligned_cols=208 Identities=21% Similarity=0.344 Sum_probs=178.4
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCC-CCccceEEEEeecCCccccceEE
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
-.|+++++||+|.||.++.|+..-++++||||.-...+ +..++..|.+..+.+. .++|..++-+ ..++.+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhh
Confidence 37999999999999999999999899999999764333 3467889999999984 7899988877 56778889
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC-----ceEEc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM-----VAHVG 852 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~ 852 (1013)
+|+|.+. .+|+|+.+-.. ..++..++..||.|+..-++|+|++ .+|+|||||+|+||...+ .+.++
T Consensus 101 LVidLLG-PSLEDLFD~Cg-----R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 101 LVIDLLG-PSLEDLFDLCG-----RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred hhhhhhC-cCHHHHHHHhc-----CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEE
Confidence 9999886 89999998774 4799999999999999999999999 999999999999997543 68899
Q ss_pred cccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCC
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFN 923 (1013)
Q Consensus 853 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~ 923 (1013)
|||+|+.+.+......... .......||.+||+-....+.+-+.+.|+-|+|-++++.+-|..||+....
T Consensus 172 DFGmAK~YrDp~TkqHIPY-rE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPY-REHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred eccchhhhcCccccccCcc-ccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 9999998866554433222 234567899999999999999999999999999999999999999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-22 Score=218.95 Aligned_cols=269 Identities=22% Similarity=0.257 Sum_probs=198.1
Q ss_pred cCCCCCceeeccceEEEEEEECCCC-eEEEEEEEeeccccchhHHHHHHHHHhcCCC----CccceEEEEeecCCccccc
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENE-MAVAVKVMNLKQRGATKSFVAECEALRNIRH----RNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 774 (1013)
+|.+.++||+|+||.||.|.+..++ ..+|+|+...........+..|..++..+.. +++..+++... ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 8999999999999999999997664 6789998875544333378889999998862 68888888731 3567
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC-----Cce
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD-----MVA 849 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~ 849 (1013)
+.++||+.+. .+|.++..... .+.++..++.+|+.|++.+|+++|+. |++||||||+|+++... ..+
T Consensus 95 ~~~iVM~l~G-~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 95 FNFIVMSLLG-PSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred eeEEEEeccC-ccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence 8899999876 89999886654 26899999999999999999999999 99999999999999865 468
Q ss_pred EEccccccccCC--CCCCCccccCCCC-CcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCc
Q 001782 850 HVGDFGLARFLP--PCSPATILETPSS-STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGL 926 (1013)
Q Consensus 850 kl~DFG~a~~~~--~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~ 926 (1013)
.+.|||+|+.+. ...... ...... .....||..|+++.+..+...+++.|+||++.++.|+..|..||........
T Consensus 167 ~llDfGlar~~~~~~~~~~~-~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~ 245 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGN-LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL 245 (322)
T ss_pred EEEecCCCccccccCCCCcc-cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence 999999998332 222111 011111 3457799999999999999999999999999999999999999976432211
Q ss_pred cHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhhh
Q 001782 927 TLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 927 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1006 (1013)
...+. .......... .....+..+.++...+-..+..++|....+...++....
T Consensus 246 -~~~~~---------~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 246 -KSKFE---------KDPRKLLTDR----------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred -HHHHH---------HHhhhhcccc----------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 11110 0000000000 000112334455555555889999999999998877754
Q ss_pred h
Q 001782 1007 I 1007 (1013)
Q Consensus 1007 ~ 1007 (1013)
.
T Consensus 300 ~ 300 (322)
T KOG1164|consen 300 S 300 (322)
T ss_pred h
Confidence 4
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=240.79 Aligned_cols=99 Identities=29% Similarity=0.425 Sum_probs=59.9
Q ss_pred CCCEEEccCCccCccCCccccccCccCEEEcCCCcccCCCCcccccCcccceeecccccccccCCchhhcccchhhhhcc
Q 001782 416 NLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDL 495 (1013)
Q Consensus 416 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~L 495 (1013)
+|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|+.+. ..|+.|++
T Consensus 326 sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~---~sL~~LdL 395 (754)
T PRK15370 326 GLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP---AALQIMQA 395 (754)
T ss_pred cceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH---HHHHHHhh
Confidence 45566666666653 444332 46677777777766 4555443 46777777777777 5565542 35666777
Q ss_pred CCCeecccCCccc----cCcCCCcEEEccCCCCC
Q 001782 496 SGNLLTGSIPAEV----GNLKNLVQLGLSENRFS 525 (1013)
Q Consensus 496 s~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~ 525 (1013)
++|+|+ .+|..+ ..++++..|+|.+|.++
T Consensus 396 s~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 396 SRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred ccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 777776 344433 33466677777777765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-22 Score=191.40 Aligned_cols=208 Identities=24% Similarity=0.326 Sum_probs=173.8
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCC-CccceEEEEeecCCccccceE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRH-RNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.+.|.++++||.|+||.+|.|....+|..||||+-..... ...+..|.++.+.+++ ..|..+..+ ..+..+.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHY-----GTEKDYN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhh-----ccccccc
Confidence 4689999999999999999999999999999998754433 4678889999999964 566666665 4456788
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC---CceEEcc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD---MVAHVGD 853 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~D 853 (1013)
.+||+... .+|.++..-.. ..++..+++-++-|++.-++|+|.+ +++||||||+|+|..-+ ..+.++|
T Consensus 87 vlVMdLLG-PsLEdLfnfC~-----R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 87 VLVMDLLG-PSLEDLFNFCS-----RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred eeeeeccC-ccHHHHHHHHh-----hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence 99999886 89999988764 4799999999999999999999999 99999999999999754 3688999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcC
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMF 922 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~ 922 (1013)
||+|+.+-+........ ........||.+|.+-....+...+.+.|+-|+|.++.+.--|..||+...
T Consensus 158 FGLaKky~d~~t~~HIp-yre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIP-YREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccchhhhccccccccCc-cccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 99999876544333221 223456789999999988888888999999999999999999999999853
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-23 Score=203.65 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=186.7
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEE
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
.....+|.+...|+.|+|++++++ +++|++.... ....++|..|.-.++.+.||||.+++|.|..+ ....+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~ 264 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVI 264 (448)
T ss_pred hhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceE
Confidence 344568999999999999998665 6777776332 22346799999999999999999999998654 77899
Q ss_pred EEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc--cccc
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG--DFGL 856 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--DFG~ 856 (1013)
+..||+.|+|+..++.... -..+..++.+++.++|+|++|||+.. +-|-.--+.+..|++|++.+++|+ |-.+
T Consensus 265 isq~mp~gslynvlhe~t~----vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTS----VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred eeeeccchHHHHHHhcCcc----EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheeccccee
Confidence 9999999999999998744 35677899999999999999999973 234444688999999999988773 4333
Q ss_pred cccCCCCCCCccccCCCCCcccccccccccccccCCCCCC---cccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMS---ATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~ 933 (1013)
+.. ..+..-.+.||+||.++..+-+ .++|+|||++++||+.|+..||.+...-+-.......
T Consensus 340 sfq---------------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale 404 (448)
T KOG0195|consen 340 SFQ---------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE 404 (448)
T ss_pred eee---------------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc
Confidence 221 1223346899999998877543 4699999999999999999999876443322211110
Q ss_pred hhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHHhh
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1005 (1013)
. -|+... ......+.+++.-|+..||.+||.+..|+-.|+.+.
T Consensus 405 g-------------------lrv~ip----------pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 G-------------------LRVHIP----------PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred c-------------------ccccCC----------CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 0 011100 122345678888999999999999999998888754
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=232.51 Aligned_cols=204 Identities=30% Similarity=0.466 Sum_probs=164.6
Q ss_pred CCCCeeeeccCCccccCCcccCCcccceEEeccCCccccCCCCccccCCCCceeccccccccCCCCCcccccccccccee
Q 001782 100 SFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLS 179 (1013)
Q Consensus 100 ~~L~~L~l~~n~l~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~ 179 (1013)
.+...|++++++++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|++|++++|+++ .+|..++ ..|+.|+
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~ 247 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP---DTIQEME 247 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh---ccccEEE
Confidence 45788999999999 7887764 58999999999999 6887765 58999999999998 7887654 4789999
Q ss_pred cccccccccCCCCccCCCCcceeeecccccCCCCCCccccccccceeecccccccCCCcchhccCCccceeeccCCccCC
Q 001782 180 LRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEG 259 (1013)
Q Consensus 180 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 259 (1013)
|++|.++ .+|..+. ++|+.|++++|+|+ .+|+.+. ++|+.|+|++|++++ +|..+. ++|+.|++++|+++
T Consensus 248 Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt- 317 (754)
T PRK15370 248 LSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLT- 317 (754)
T ss_pred CcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccc-
Confidence 9999998 5666654 58999999999998 6888765 589999999999994 665543 57999999999999
Q ss_pred CCCCCcCCCCCCCcEEEeeeccccccCCCCCCCCCCCceEEcccCcccccccccccCCCCccccccccCcCCC
Q 001782 260 SLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGT 332 (1013)
Q Consensus 260 ~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 332 (1013)
.+|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+|+. +|..+ .++|+.|++++|+++.
T Consensus 318 ~LP~~l~---~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~l--p~~L~~LdLs~N~Lt~ 381 (754)
T PRK15370 318 ALPETLP---PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETL--PPTITTLDVSRNALTN 381 (754)
T ss_pred cCCcccc---ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhh--cCCcCEEECCCCcCCC
Confidence 6887653 689999999999985 676664 689999999999985 34333 2567777777776653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-21 Score=230.01 Aligned_cols=257 Identities=19% Similarity=0.247 Sum_probs=187.4
Q ss_pred CCCCceeeccceEEEEEEECCCCeEEEEEEEeec--ccc----chhHHHHHHHHHhcCCCCccceEEEEeecCCccccce
Q 001782 702 SSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRG----ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 702 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
...+++|.|++|.|+.+.........+.|.+... ... ....+..|+.+-..++|||++..+..+... ..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-----DG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-----cc
Confidence 3567899999998888877655555555544311 111 112256677777888999997776664322 22
Q ss_pred EEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccc
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 855 (1013)
..-+||||++ +|..++... +.+...++..++.|+..|++|+|+. ||.|||+|++|+++..+|.+||+|||
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~------~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg 465 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSN------GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG 465 (601)
T ss_pred chhhhhcccH-HHHHHHhcc------cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence 2333999998 999999875 4688889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcc-cchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHh
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSAT-GDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 934 (1013)
.+..+.-.... ........+|+..|+|||++.+..|.+. .||||.|++++.|.+|+.||......+..+.. .
T Consensus 466 ~~~vf~~~~e~----~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---~ 538 (601)
T KOG0590|consen 466 AASVFRYPWEK----NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---N 538 (601)
T ss_pred cceeeccCcch----hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---h
Confidence 98765432221 1133567889999999999999999885 89999999999999999999875444333200 0
Q ss_pred hCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 999 (1013)
...... .............+.....++.+|++.||.+|.|+++|++
T Consensus 539 ~~~~~~-------------------~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 539 NYSDQR-------------------NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccc-------------------ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000000 0001111222445566788999999999999999999976
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.6e-19 Score=199.27 Aligned_cols=264 Identities=29% Similarity=0.422 Sum_probs=194.2
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc---chhHHHHHHHHHhcCCCC-ccceEEEEeecCCccccceE
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG---ATKSFVAECEALRNIRHR-NLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 776 (1013)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++. .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence 677889999999999999997 67899998754333 356789999999999988 7999999862 33447
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC-ceEEcccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM-VAHVGDFG 855 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG 855 (1013)
+++++++.++++.+++...... ..+.......+..|++.++.|+|+. +++|||+||+||+++..+ .++++|||
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence 9999999999999777765221 2688899999999999999999999 999999999999999988 79999999
Q ss_pred ccccCCCCCCCccccCCCCCcccccccccccccccCC---CCCCcccchHHHHHHHHHHHhCCCCCCCcCCC--CccHHH
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG---GDMSATGDVYSFGILLLEMFTRRRPTDNMFND--GLTLHE 930 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~--~~~~~~ 930 (1013)
.++.+.......... .......|+..|+|||.+.+ ..+....|+||+|++++++++|..||...... ......
T Consensus 148 ~~~~~~~~~~~~~~~--~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~ 225 (384)
T COG0515 148 LAKLLPDPGSTSSIP--ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225 (384)
T ss_pred cceecCCCCcccccc--ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH
Confidence 998554322111000 12456789999999999988 57888999999999999999999997653221 001111
Q ss_pred HHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 931 FAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 931 ~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
........ ...... ..... ......+.+++..|+..+|..|.++.+....
T Consensus 226 ~~~~~~~~--------~~~~~~----------~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 226 IILELPTP--------SLASPL----------SPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHhcCCc--------cccccc----------Ccccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11000000 000000 00000 1223456778888999999999998887764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-20 Score=190.02 Aligned_cols=206 Identities=22% Similarity=0.244 Sum_probs=141.0
Q ss_pred CCCccceEEEEeecCC----------------------ccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHH
Q 001782 754 RHRNLIKIITVCSSID----------------------FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLN 811 (1013)
Q Consensus 754 ~h~niv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~ 811 (1013)
+|||||++.+++.+.- ..++...|+||..++ .+|.+|+..+ ..+.....-
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-------~~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-------HRSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-------CCchHHHHH
Confidence 5999999998864311 133456789999988 8999999876 456667888
Q ss_pred HHHHHHHHHHHHhhcCCCCeeecCCCCCceEec--CCC--ceEEccccccccCCCCCCCccccCCCCCcccccccccccc
Q 001782 812 LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD--HDM--VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAP 887 (1013)
Q Consensus 812 i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 887 (1013)
+..|+++|+.|||.+ ||.|||+|++|||+. +|+ ...|+|||++-- ++....+ ...........|...-|||
T Consensus 346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA-d~~hGlq-lpy~S~~Vd~GGNa~lmAP 420 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA-DDNHGLQ-LPYESDEVDLGGNAKLMAP 420 (598)
T ss_pred HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeee-ccccccc-cccccccccCCCcceecch
Confidence 999999999999999 999999999999994 444 567899998742 1111111 1223334556688889999
Q ss_pred cccCCCC------CCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCC
Q 001782 888 EYGMGGD------MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGS 961 (1013)
Q Consensus 888 E~~~~~~------~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~ 961 (1013)
|+....+ -..|+|.|+.|.+.||++....||..........+.+.....|
T Consensus 421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP------------------------ 476 (598)
T KOG4158|consen 421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP------------------------ 476 (598)
T ss_pred hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC------------------------
Confidence 9876532 2348999999999999999999997621111111111111111
Q ss_pred CchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 001782 962 HRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 962 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1001 (1013)
.-++.++..+.+++...++.||++|++..-....|
T Consensus 477 -----alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 477 -----ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred -----CCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 01123455566777777777888887765544443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.2e-20 Score=188.57 Aligned_cols=176 Identities=14% Similarity=0.141 Sum_probs=133.2
Q ss_pred hhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhH---------HHHHHHHHhcCCCCccceEEEEeec
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKS---------FVAECEALRNIRHRNLIKIITVCSS 767 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~~~~~~~~ 767 (1013)
..++|++.+++|.|+||.||.+.. ++..+|+|+++.......+. +.+|+..+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 367999999999999999999766 35579999997543332222 6789999999999999999988543
Q ss_pred CCc---cccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEec
Q 001782 768 IDF---EEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD 844 (1013)
Q Consensus 768 ~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 844 (1013)
... ......++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||+||+||+++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 211 12346899999999999988732 222 2456999999999999 999999999999999
Q ss_pred CCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHH
Q 001782 845 HDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMF 912 (1013)
Q Consensus 845 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell 912 (1013)
.++ ++++|||.......+... ..+.....+..++|||+||+++....
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~--------------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK--------------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH--------------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999987643211100 11334445667999999999876544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=183.43 Aligned_cols=139 Identities=16% Similarity=0.116 Sum_probs=107.8
Q ss_pred CCceeeccceEEEEEEECCCCeEEEEEEEeecccc--c-------hhH-----------------HHHHHHHHhcCCCCc
Q 001782 704 SNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG--A-------TKS-----------------FVAECEALRNIRHRN 757 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~n 757 (1013)
.+.||+|+||.||+|.+. +|++||||+++..... . ..+ ...|++.++++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 478999999999999997 8999999999754221 0 111 234999999998777
Q ss_pred cceEEEEeecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeecCC
Q 001782 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL-HHHCHPPIVHGDL 836 (1013)
Q Consensus 758 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~L-H~~~~~~ivH~Dl 836 (1013)
+.....+.. ...++||||++++++....... ..++..++..++.|++.+++++ |+. ||+||||
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~------~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl 144 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKD------APLSESKARELYLQVIQIMRILYQDC---RLVHADL 144 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 643332211 2237999999987766543222 4688899999999999999999 688 9999999
Q ss_pred CCCceEecCCCceEEccccccccC
Q 001782 837 KPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 837 kp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
||+||+++ ++.++|+|||+|...
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccC
Confidence 99999998 578999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.9e-20 Score=190.90 Aligned_cols=243 Identities=21% Similarity=0.264 Sum_probs=151.2
Q ss_pred ccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc---chhHHHHHHHHHhcCC----------CCccceEEEEe
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG---ATKSFVAECEALRNIR----------HRNLIKIITVC 765 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~----------h~niv~~~~~~ 765 (1013)
..+...+.||.|+++.||.+++.++++++|+|++...... ..+++++|.-....+. |-.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 3455678999999999999999999999999999755432 3355666665444432 22222223322
Q ss_pred ecC---Cc----cccc-----eEEEEEeeccCCCHHHHhhccccccc-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 001782 766 SSI---DF----EEVD-----FKAIVYEYMECGSLEDWLHQSNDQLE-VGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIV 832 (1013)
Q Consensus 766 ~~~---~~----~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iv 832 (1013)
... .+ .+.. ..+++|+-+. ++|.+++..-..... ........+..+..|+++.+++||+. |+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence 210 00 0111 3467888886 899888764211100 12344555677779999999999999 999
Q ss_pred ecCCCCCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCC--------CCCCcccchHHH
Q 001782 833 HGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG--------GDMSATGDVYSF 904 (1013)
Q Consensus 833 H~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DIwSl 904 (1013)
|+||+|+|++++.+|.++|+||+.....+.. ......+..|.|||.... -.++.+.|.|++
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L 236 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL 236 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEE-----------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCce-----------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence 9999999999999999999999987644321 111234578999997543 247889999999
Q ss_pred HHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcc
Q 001782 905 GILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCS 984 (1013)
Q Consensus 905 G~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 984 (1013)
|+++|.|++|..||+.......... .+ ..| .+.++.+.+++..++
T Consensus 237 G~~ly~lWC~~lPf~~~~~~~~~~~-------------~f------------~~C----------~~~Pe~v~~LI~~lL 281 (288)
T PF14531_consen 237 GITLYSLWCGRLPFGLSSPEADPEW-------------DF------------SRC----------RDMPEPVQFLIRGLL 281 (288)
T ss_dssp HHHHHHHHHSS-STCCCGGGSTSGG-------------GG------------TTS----------S---HHHHHHHHHHT
T ss_pred HHHHHHHHHccCCCCCCCccccccc-------------cc------------hhc----------CCcCHHHHHHHHHHc
Confidence 9999999999999986422211100 00 011 133566788899999
Q ss_pred cCCCCCC
Q 001782 985 MESPSER 991 (1013)
Q Consensus 985 ~~dP~~R 991 (1013)
+++|.+|
T Consensus 282 ~~~~~~R 288 (288)
T PF14531_consen 282 QRNPEDR 288 (288)
T ss_dssp -SSGGGS
T ss_pred cCCcccC
Confidence 9999887
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.2e-20 Score=213.41 Aligned_cols=250 Identities=21% Similarity=0.280 Sum_probs=177.6
Q ss_pred cCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHH--HhcCCCCccceEEEEeecCCccccceE
Q 001782 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEA--LRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
+|...+.+|++.|=.|.+|++++ |. |+||++-...+ -..+.+.++++- ...++|||++++..+ ...+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~-----~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV-----LVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH-----HHhhHHH
Confidence 67788999999999999999974 43 89999864442 222334333332 455689999998776 4455677
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
|+|-+|.. .+|.|.+..+ .-+...+.+.|+.|++.|+...|.. ||+|||||.+||||+.-.-+.|+||..
T Consensus 97 ylvRqyvk-hnLyDRlSTR------PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 97 YLVRQYVK-HNLYDRLSTR------PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred HHHHHHHh-hhhhhhhccc------hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccc
Confidence 88888888 7999999875 4677888999999999999999999 999999999999999998999999976
Q ss_pred cc--cCCCCCCCccccCCCCCcccccccccccccccCCC----------C-CCcccchHHHHHHHHHHHh-CCCCCCCcC
Q 001782 857 AR--FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG----------D-MSATGDVYSFGILLLEMFT-RRRPTDNMF 922 (1013)
Q Consensus 857 a~--~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DIwSlG~il~ell~-G~~pf~~~~ 922 (1013)
-+ +++++.+.++.- .......-..|.|||.+-.. . .+++.||||+||++.|+++ |++||.-
T Consensus 167 FKPtYLPeDNPadf~f---FFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-- 241 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTF---FFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-- 241 (1431)
T ss_pred cCCccCCCCCcccceE---EEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--
Confidence 54 223333222111 11112233579999976441 2 5778999999999999998 7888853
Q ss_pred CCCccHHHHHHhhC--ChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 001782 923 NDGLTLHEFAKMAL--PEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 923 ~~~~~~~~~~~~~~--~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1000 (1013)
.+...... .......+ +++++ ..+..++..|++.||++|-+|++.++.
T Consensus 242 ------SQL~aYr~~~~~~~e~~L----------------------e~Ied--~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 242 ------SQLLAYRSGNADDPEQLL----------------------EKIED--VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ------HHHHhHhccCccCHHHHH----------------------HhCcC--ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11111110 11111111 11111 246788999999999999999999887
Q ss_pred H
Q 001782 1001 L 1001 (1013)
Q Consensus 1001 L 1001 (1013)
-
T Consensus 292 y 292 (1431)
T KOG1240|consen 292 Y 292 (1431)
T ss_pred h
Confidence 3
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.7e-19 Score=177.78 Aligned_cols=139 Identities=19% Similarity=0.158 Sum_probs=110.1
Q ss_pred CCceeeccceEEEEEEECCCCeEEEEEEEeeccccc--------------------------hhHHHHHHHHHhcCCCCc
Q 001782 704 SNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA--------------------------TKSFVAECEALRNIRHRN 757 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n 757 (1013)
.+.||+|++|.||+|.+. +|+.||||+++...... ...+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999998542110 112357899999999988
Q ss_pred cceEEEEeecCCccccceEEEEEeeccCCCHHHH-hhccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecC
Q 001782 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDW-LHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH-HCHPPIVHGD 835 (1013)
Q Consensus 758 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~D 835 (1013)
+.....+.. ...++||||++++++... +.. ..++..++..++.|++.++.++|+ . ||+|||
T Consensus 81 i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrD 143 (190)
T cd05145 81 VPVPEPILL-------KKNVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGD 143 (190)
T ss_pred CCCceEEEe-------cCCEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence 754444321 124899999998755433 322 356788999999999999999999 8 999999
Q ss_pred CCCCceEecCCCceEEccccccccCC
Q 001782 836 LKPSNVLLDHDMVAHVGDFGLARFLP 861 (1013)
Q Consensus 836 lkp~NIll~~~~~~kl~DFG~a~~~~ 861 (1013)
|||+||+++ ++.++|+|||++....
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecC
Confidence 999999998 8899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.4e-19 Score=173.73 Aligned_cols=192 Identities=17% Similarity=0.087 Sum_probs=138.3
Q ss_pred CCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc----chhHHHHHHHHHhcCC-CCccceEEEEeecCCccccceE
Q 001782 702 SSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG----ATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 702 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
.+...|++|+||+||.+.. .+.+++.+.+...... ....+.+|+++|+++. |+++++++++ ...
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence 4668899999999998776 5667887776533321 1225789999999995 5889999886 346
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCceEecCCCceEEcccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDL-KPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFG 855 (1013)
+++|||+.|.+|.+.... ....++.|++.+++++|++ ||+|||| ||+||+++.++.++|+|||
T Consensus 74 ~lvmeyI~G~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG 137 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR-------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ 137 (218)
T ss_pred EEEEeeecCccHHhhhhh-------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence 899999998888654321 1135778999999999999 9999999 7999999999999999999
Q ss_pred ccccCCCCCCC-ccccCCC----CCcccccccccccccccCCC-CCC-cccchHHHHHHHHHHHhCCCCCCC
Q 001782 856 LARFLPPCSPA-TILETPS----SSTGIKGTVGYVAPEYGMGG-DMS-ATGDVYSFGILLLEMFTRRRPTDN 920 (1013)
Q Consensus 856 ~a~~~~~~~~~-~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~-~~~DIwSlG~il~ell~G~~pf~~ 920 (1013)
+|....+.... ....... .......++.|++|+...-- ..+ .+.+.++-|+-+|.++||+.|...
T Consensus 138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 99855432210 0000000 01112256777777753321 233 567889999999999999988654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-20 Score=171.44 Aligned_cols=177 Identities=27% Similarity=0.436 Sum_probs=124.9
Q ss_pred CCCCCCEEEccCCccCccCCccccccCccCEEEcCCCcccCCCCcccccCcccceeecccccccccCCchhhcccchhhh
Q 001782 413 ELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL 492 (1013)
Q Consensus 413 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~ 492 (1013)
++..++.|.|++|+++ .+|..+..+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++.
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~---------------- 92 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN---------------- 92 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh----------------
Confidence 3445555555555555 44445555555555555555555 45555555555555555555544
Q ss_pred hccCCCeecccCCccccCcCCCcEEEccCCCCCC-CCccccccccccccccccccccccccCccccccCCCCeEeccccc
Q 001782 493 LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSN-EIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNN 571 (1013)
Q Consensus 493 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 571 (1013)
..|..|+.++.|+.|||..|.+.. ..|..|..++.|+-|+|++|.+. .+|..++++++|+.|.+.+|.
T Consensus 93 ----------~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 93 ----------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred ----------cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCc
Confidence 566777777777777777777753 46778888888888888888888 788888888999999998888
Q ss_pred cccccccccccccccceeecCCccCCCCCCCCCccC---CCcceeeeCCcC
Q 001782 572 LSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFS---NKTRFYFTGNKR 619 (1013)
Q Consensus 572 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~---~~~~~~~~~N~~ 619 (1013)
+- ..|..++.++.|++|.+.+|+++-.+|+.+.+. +.....+..|||
T Consensus 162 ll-~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPw 211 (264)
T KOG0617|consen 162 LL-SLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPW 211 (264)
T ss_pred hh-hCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCC
Confidence 87 688888889999999999999988888765543 233455678887
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.2e-20 Score=168.88 Aligned_cols=164 Identities=34% Similarity=0.566 Sum_probs=144.6
Q ss_pred cccccceeecccccccCCcccccCCCCCCCEEEccCCccCccCCccccccCccCEEEcCCCcccCCCCcccccCccccee
Q 001782 389 NLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLL 468 (1013)
Q Consensus 389 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 468 (1013)
++.+++.|.|++|+++ .+|..+..+.+|+.|++++|+++ .+|..++.+++|+.|+++-|++. ..|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4567888999999999 77888999999999999999999 78999999999999999999998 899999999999999
Q ss_pred ecccccccc-cCCchhhcccchhhhhccCCCeecccCCccccCcCCCcEEEccCCCCCCCCccccccccccccccccccc
Q 001782 469 SVSNNKLTG-ALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNS 547 (1013)
Q Consensus 469 ~L~~N~l~~-~~p~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 547 (1013)
||++|++.. .+|..+|. +..|+.|+|+.|.+. .+|..++++++|+.|.+..|.+- ..|.+++.+++|++|++.+|+
T Consensus 108 dltynnl~e~~lpgnff~-m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFY-MTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hccccccccccCCcchhH-HHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 999999974 56777776 788888899999988 78888889999999999988887 788888888888888888888
Q ss_pred cccccCcccccc
Q 001782 548 LTGSIPLALKTL 559 (1013)
Q Consensus 548 l~~~~p~~~~~l 559 (1013)
++ .+|..++++
T Consensus 185 l~-vlppel~~l 195 (264)
T KOG0617|consen 185 LT-VLPPELANL 195 (264)
T ss_pred ee-ecChhhhhh
Confidence 88 667666553
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-18 Score=206.99 Aligned_cols=201 Identities=20% Similarity=0.244 Sum_probs=158.8
Q ss_pred hhhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCC---CCccceEEEEeecCC
Q 001782 693 DLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR---HRNLIKIITVCSSID 769 (1013)
Q Consensus 693 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 769 (1013)
+.+.....|.|.+.||+|+||.||+|.... ++.||+|+-+.... -+|.--.+++.+++ -+.|+.+..++
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~---- 763 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAH---- 763 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHH----
Confidence 334445688999999999999999999986 99999999765543 23333444555555 23344444332
Q ss_pred ccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC----
Q 001782 770 FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH---- 845 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---- 845 (1013)
...+.-++|+||.+.|+|.+++... +.+++.-++.++.|+++.+++||.. +||||||||+|+++..
T Consensus 764 -~~~~~S~lv~ey~~~Gtlld~~N~~------~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 764 -VFQNASVLVSEYSPYGTLLDLINTN------KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred -ccCCcceeeeeccccccHHHhhccC------CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCC
Confidence 2335678999999999999999954 6789999999999999999999999 9999999999999942
Q ss_pred ---CCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 001782 846 ---DMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917 (1013)
Q Consensus 846 ---~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~p 917 (1013)
...++|+|||.+-.+..- .........++|-.+-.+|+..|.++++++|.|.++.+++-|+.|++.
T Consensus 834 ~~~~~~l~lIDfG~siDm~lf------p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLF------PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred CCcccceEEEecccceeeeEc------CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 346899999998755321 122235567789999999999999999999999999999999999764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.8e-18 Score=187.87 Aligned_cols=217 Identities=29% Similarity=0.434 Sum_probs=164.1
Q ss_pred HhcCCCCccceEEEEeecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 001782 750 LRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHP 829 (1013)
Q Consensus 750 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~ 829 (1013)
|+.+.|.|+.+++|.+... ...+.|.+||..|+|.+.+.... ..+++.....+.++|+.|++|+|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~s--- 67 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHNS--- 67 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhcC---
Confidence 4567899999999998543 78899999999999999998742 4788999999999999999999998
Q ss_pred Ce-eecCCCCCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCC-------CCcccch
Q 001782 830 PI-VHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD-------MSATGDV 901 (1013)
Q Consensus 830 ~i-vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DI 901 (1013)
.| .|+.+++.|.++|..+.+|++|||+........ .........-..-|.|||.+.+.. .+.++||
T Consensus 68 ~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~------~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi 141 (484)
T KOG1023|consen 68 PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETA------EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDI 141 (484)
T ss_pred cceeeeeeccccceeeeeEEEEechhhhcccccccc------cccccchhHHHHhccCHHHhcccccccccccccccCCe
Confidence 55 999999999999999999999999988664310 011112222456799999987641 4667999
Q ss_pred HHHHHHHHHHHhCCCCCCCcCCCCccHHHHHHhhCChhHHHhhhhhhc-cchhhhhccCCCCchhHHHHHHHHHHHHHHh
Q 001782 902 YSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLL-LDLEARASNCGSHRTEIAKIEECLVAIVRIG 980 (1013)
Q Consensus 902 wSlG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~ 980 (1013)
||||++++|+++.+.||+........ .+++.+... .. ...++.+....+..+.+..++
T Consensus 142 Ys~~ii~~ei~~r~~~~~~~~~~~~~-------------~eii~~~~~~~~--------~~~rP~i~~~~e~~~~l~~l~ 200 (484)
T KOG1023|consen 142 YSFGIIMYEILFRSGPFDLRNLVEDP-------------DEIILRVKKGGS--------NPFRPSIELLNELPPELLLLV 200 (484)
T ss_pred ehHHHHHHHHHhccCccccccccCCh-------------HHHHHHHHhcCC--------CCcCcchhhhhhcchHHHHHH
Confidence 99999999999999999874333221 111111111 11 112333333334555789999
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHhhh
Q 001782 981 VLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 981 ~~cl~~dP~~RPs~~evl~~L~~~~~ 1006 (1013)
.+||..+|.+||++++|-..++.+..
T Consensus 201 ~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 201 ARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred HHhcccChhhCccHHHHHhhhhhhcc
Confidence 99999999999999999988887754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=168.46 Aligned_cols=141 Identities=16% Similarity=0.206 Sum_probs=107.5
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcC-----CCCccceEEEEeecCCccccce
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-----RHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~ 775 (1013)
+.-.+.||+|+||.||. +..+... +||++........+.+.+|+.+++.+ .||||++++|++.+.. ..+..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~-g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC-GTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC-CCeEE
Confidence 34457899999999995 5555554 69998765444567799999999999 5799999999975431 11122
Q ss_pred EEEEEee--ccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeeecCCCCCceEecCC----Cc
Q 001782 776 KAIVYEY--MECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI-EYLHHHCHPPIVHGDLKPSNVLLDHD----MV 848 (1013)
Q Consensus 776 ~~lv~e~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L-~~LH~~~~~~ivH~Dlkp~NIll~~~----~~ 848 (1013)
..+|+|| +.+++|.+++... .+++. ..++.|++.++ +|||++ +|+||||||+||+++.. +.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCc
Confidence 4478999 5579999999653 34444 35678888777 999999 99999999999999743 48
Q ss_pred eEEcccccc
Q 001782 849 AHVGDFGLA 857 (1013)
Q Consensus 849 ~kl~DFG~a 857 (1013)
++|+||+-+
T Consensus 148 ~~LiDg~G~ 156 (210)
T PRK10345 148 PVVCDNIGE 156 (210)
T ss_pred EEEEECCCC
Confidence 999995433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-17 Score=171.69 Aligned_cols=142 Identities=19% Similarity=0.130 Sum_probs=112.1
Q ss_pred cCCCCCceeeccceEEEEEE-ECCCCeEEEEEEEeecccc------------------------chhHHHHHHHHHhcCC
Q 001782 700 DFSSSNMIGQGSFGFVYRGN-LGENEMAVAVKVMNLKQRG------------------------ATKSFVAECEALRNIR 754 (1013)
Q Consensus 700 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 754 (1013)
-|++.+.||+|+||.||+|. +..+++.||+|+++..... ....+..|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57889999999999999998 6668999999999743210 0123568999999997
Q ss_pred C--CccceEEEEeecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-e
Q 001782 755 H--RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPP-I 831 (1013)
Q Consensus 755 h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~-i 831 (1013)
+ ..+.+++++ ...++||||+++.++..+.... ......++..++.|++.++++||++ | +
T Consensus 109 ~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---g~i 170 (237)
T smart00090 109 EAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKD------VEPEEEEEFELYDDILEEMRKLYKE---GEL 170 (237)
T ss_pred hcCCCCCeeeEe---------cCceEEEEEecCCccccccccc------CCcchHHHHHHHHHHHHHHHHHHhc---CCE
Confidence 5 334455543 2347999999988887654322 2455667789999999999999999 9 9
Q ss_pred eecCCCCCceEecCCCceEEccccccccC
Q 001782 832 VHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 832 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
+||||||+||+++ ++.++|+|||.+...
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999999 889999999998743
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=4e-19 Score=198.02 Aligned_cols=280 Identities=24% Similarity=0.272 Sum_probs=141.8
Q ss_pred EEEeeeccccc-cCCCCCCCCCCCceEEcccCccccc----ccccccCCCCccccccccCcCCCCCCCChhhhhhccccc
Q 001782 274 NLSVRQNNYTG-SLPHSLSNASNLRLLDFSLNHFSGQ----VKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCS 348 (1013)
Q Consensus 274 ~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~ 348 (1013)
.|+|..+.+++ ..+..+..+.+|+.|+++++.++.. ++..+...+++++|+++++.+.....+......
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~------ 75 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQ------ 75 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHH------
Confidence 45666666662 3334445566677777777776432 222344455556666655544310000001111
Q ss_pred ccccccccccccCCccchhhhcchhhHHHHhccchhHHhhcccccceeecccccccCCcccccCCCCC---CCEEEccCC
Q 001782 349 KLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRN---LQVLDLHHN 425 (1013)
Q Consensus 349 ~L~~L~l~~n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~---L~~L~L~~N 425 (1013)
.+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|
T Consensus 76 -------------------------------------~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~ 118 (319)
T cd00116 76 -------------------------------------GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNN 118 (319)
T ss_pred -------------------------------------HHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCC
Confidence 2333455555566555555444444444433 666666666
Q ss_pred ccCc----cCCcccccc-CccCEEEcCCCcccCC----CCcccccCcccceeecccccccccCCchhhcc---cchhhhh
Q 001782 426 NLDG----HIPESLGNL-TILNSLDLGFNKLRGH----VPSSLGNCQNLMLLSVSNNKLTGALPPQILGI---VTLSILL 493 (1013)
Q Consensus 426 ~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~---~~~l~~L 493 (1013)
++++ .+...+..+ ++|+.|++++|.+++. ++..+..+++|+.|++++|.+++.....+... .+.|+.|
T Consensus 119 ~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L 198 (319)
T cd00116 119 GLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVL 198 (319)
T ss_pred ccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEE
Confidence 6652 222233444 5666666666666532 22334445566666666666653211111111 2245555
Q ss_pred ccCCCeeccc----CCccccCcCCCcEEEccCCCCCCCCcccccc-----cccccccccccccccc----ccCccccccC
Q 001782 494 DLSGNLLTGS----IPAEVGNLKNLVQLGLSENRFSNEIPVSLSA-----CTTLEYLYMEGNSLTG----SIPLALKTLK 560 (1013)
Q Consensus 494 ~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~ 560 (1013)
++++|.+++. ++..+..+++|++|++++|.+++.....+.. .++|++|++++|.++. .+...+..++
T Consensus 199 ~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~ 278 (319)
T cd00116 199 DLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKE 278 (319)
T ss_pred eccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCC
Confidence 5555555422 2233445666777777777766433333221 2567777777776651 2233444556
Q ss_pred CCCeEeccccccccc----cccccccc-cccceeecCCccC
Q 001782 561 SIKELDLSRNNLSGQ----IPEFLENL-SFLEYLNLSYNHL 596 (1013)
Q Consensus 561 ~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~l~~N~l 596 (1013)
+|+++++++|.++.. ....+... +.|+.+++.+|++
T Consensus 279 ~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 279 SLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred CccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 677777777777643 33333333 5666666666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-18 Score=192.76 Aligned_cols=221 Identities=24% Similarity=0.292 Sum_probs=171.7
Q ss_pred ceeeccceEEEEEEE---CCCCeEEEEEEEeecccc--chhHHHHHHHHHhcCC-CCccceEEEEeecCCccccceEEEE
Q 001782 706 MIGQGSFGFVYRGNL---GENEMAVAVKVMNLKQRG--ATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEVDFKAIV 779 (1013)
Q Consensus 706 ~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 779 (1013)
++|+|.||.|+.++- ...+..+|+|+.+..... .......|..++...+ ||.++++.-. ++.+...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence 379999999987654 334677899888643221 1124566888888886 9999998877 4566888999
Q ss_pred EeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccccc
Q 001782 780 YEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859 (1013)
Q Consensus 780 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 859 (1013)
++|..+|.+...+... ..+++.....+...++-|++++|+. +++|||+|++||+++.+|++|+.|||.++.
T Consensus 76 ld~~rgg~lft~l~~~------~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKE------VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred hhhcccchhhhccccC------CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence 9999999998888765 4678888888999999999999999 999999999999999999999999999985
Q ss_pred CCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHHHHH--hhC-
Q 001782 860 LPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK--MAL- 936 (1013)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~~~~--~~~- 936 (1013)
.-. . ...+||..|||||++. ....++|.||||++++||++|..||.. .....+.+ ...
T Consensus 147 ~v~--------~----~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~~p 207 (612)
T KOG0603|consen 147 AVK--------E----KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELEMP 207 (612)
T ss_pred hHh--------h----hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccCCc
Confidence 421 1 1128999999999988 677899999999999999999999986 12222222 112
Q ss_pred ---ChhHHHhhhhhhccchhhhhccC
Q 001782 937 ---PEKVMEIVDPLLLLDLEARASNC 959 (1013)
Q Consensus 937 ---~~~~~~~i~~~l~~~~~~R~~~~ 959 (1013)
...++.+++.+...+|..|....
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~~ 233 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGAG 233 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhccC
Confidence 23466777777777877776554
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-19 Score=197.73 Aligned_cols=288 Identities=24% Similarity=0.300 Sum_probs=146.9
Q ss_pred eeeecccccC-CCCCCccccccccceeecccccccCC----CcchhccCCccceeeccCCccCCCCCCCcCCCCCCCcEE
Q 001782 201 VLSIGENRLS-GRLPDSLGQLRSLYYLSISENAFSGM----FPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENL 275 (1013)
Q Consensus 201 ~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L 275 (1013)
.|+|..+.++ ...+..|..+.+|+.|+++++.++.. ++..+...++|++|+++++.+.+ .+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~---------- 70 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGL---------- 70 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHH----------
Confidence 4666667666 34445556666677777777776432 33444555566666666665541 11110
Q ss_pred EeeeccccccCCCCCCCCCCCceEEcccCcccccccccccCCCC---ccccccccCcCCCCCCCChhhhhhccccccccc
Q 001782 276 SVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPN---LFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEA 352 (1013)
Q Consensus 276 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~ 352 (1013)
..++..+.++++|+.|++++|.+.+..+..+..+.+ |+.|++++|+++..... .+..
T Consensus 71 --------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~--~l~~---------- 130 (319)
T cd00116 71 --------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR--LLAK---------- 130 (319)
T ss_pred --------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH--HHHH----------
Confidence 122334445556666666666665433333333333 55555555544321000 0001
Q ss_pred ccccccccCCccchhhhcchhhHHHHhccchhHHhhcc-cccceeecccccccC----CcccccCCCCCCCEEEccCCcc
Q 001782 353 LGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNL-VNLNGFGLEYNQLTG----PIPHAIGELRNLQVLDLHHNNL 427 (1013)
Q Consensus 353 L~l~~n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~l-~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l 427 (1013)
.+..+ ++|+.|++++|.+++ .++..+..+++|++|++++|.+
T Consensus 131 ---------------------------------~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l 177 (319)
T cd00116 131 ---------------------------------GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGI 177 (319)
T ss_pred ---------------------------------HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCC
Confidence 11222 445555555555552 1233455556677777777776
Q ss_pred Ccc----CCccccccCccCEEEcCCCcccCC----CCcccccCcccceeecccccccccCCchhhcccchhhhhccCCCe
Q 001782 428 DGH----IPESLGNLTILNSLDLGFNKLRGH----VPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNL 499 (1013)
Q Consensus 428 ~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~Ls~N~ 499 (1013)
++. ++..+..+++|+.|+|++|.+++. ++..+..+++|++|++++|.+++.....+...+
T Consensus 178 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~------------ 245 (319)
T cd00116 178 GDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASAL------------ 245 (319)
T ss_pred chHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHH------------
Confidence 632 223344455777777777776532 233455566777777777776642222221110
Q ss_pred ecccCCccccCcCCCcEEEccCCCCCC----CCccccccccccccccccccccccc----cCcccccc-CCCCeEecccc
Q 001782 500 LTGSIPAEVGNLKNLVQLGLSENRFSN----EIPVSLSACTTLEYLYMEGNSLTGS----IPLALKTL-KSIKELDLSRN 570 (1013)
Q Consensus 500 l~~~~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~Ls~N 570 (1013)
+ ...+.|+.|++++|.++. .++..+..+++|+++++++|.++.. ....+... +.|++|++.+|
T Consensus 246 -----~---~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (319)
T cd00116 246 -----L---SPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDD 317 (319)
T ss_pred -----h---ccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCC
Confidence 0 023456666666666652 1233344455666666666666633 23333333 56677777666
Q ss_pred cc
Q 001782 571 NL 572 (1013)
Q Consensus 571 ~l 572 (1013)
.+
T Consensus 318 ~~ 319 (319)
T cd00116 318 SF 319 (319)
T ss_pred CC
Confidence 53
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.4e-18 Score=185.77 Aligned_cols=129 Identities=31% Similarity=0.501 Sum_probs=110.8
Q ss_pred ceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcc
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 853 (1013)
.+.++.|++|+-.+|.+|+...+.. ...++.....++.|++.|++| + +.+|+|+||.||++..+..+||.|
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~---e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTG---EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcc---cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhh
Confidence 4688999999999999999865442 466788899999999999999 6 999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHh
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913 (1013)
Q Consensus 854 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~ 913 (1013)
||+......+. .............||..||+||++.+..|+.++||||||++++|++.
T Consensus 400 Fgl~ts~~~~~--~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 400 FGLVTSQDKDE--TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhheeecccCC--cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99987665443 11222334567789999999999999999999999999999999998
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.1e-17 Score=194.69 Aligned_cols=149 Identities=31% Similarity=0.539 Sum_probs=125.9
Q ss_pred CCHHHHHHHHHHHHhcCCCCCCCCCCCCCCCCc----eeEEEEeCC--CC--CeeEEEeeccccccccCccccCCCCCCC
Q 001782 32 SNETDRLALLAIKSQLQDPLGVTSSWNNSMNLC----QWTGVTCGH--RH--QRVTVLDLSNRSIEGILSPYVGNLSFLR 103 (1013)
Q Consensus 32 ~~~~~~~aLl~~k~~~~~~~~~~~sw~~~~~~c----~w~gv~C~~--~~--~~v~~l~l~~~~l~~~~~~~l~~l~~L~ 103 (1013)
+.+.|..||++||+++.++.. .+|+++ .|| .|.||+|+. .. .+|+.|+|+++++.|.+|+.++.|++|+
T Consensus 369 t~~~~~~aL~~~k~~~~~~~~--~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~ 445 (623)
T PLN03150 369 TLLEEVSALQTLKSSLGLPLR--FGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQ 445 (623)
T ss_pred cCchHHHHHHHHHHhcCCccc--CCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCC
Confidence 466799999999999977643 489743 342 799999953 22 3699999999999999999999999999
Q ss_pred eeeeccCCccccCCcccCCcccceEEeccCCccccCCCCccccCCCCceeccccccccCCCCCccccccccccceecccc
Q 001782 104 FINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDN 183 (1013)
Q Consensus 104 ~L~l~~n~l~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~~L~L~~n 183 (1013)
.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+++|++|++|+|++|+++|.+|..+.....++..+++.+|
T Consensus 446 ~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N 525 (623)
T PLN03150 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525 (623)
T ss_pred EEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCC
Confidence 99999999999999999999999999999999999999999999999999999999999999876533333444444444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.9e-16 Score=158.38 Aligned_cols=142 Identities=25% Similarity=0.187 Sum_probs=110.7
Q ss_pred hhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc----------------------chhHHHHHHHHHh
Q 001782 694 LSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG----------------------ATKSFVAECEALR 751 (1013)
Q Consensus 694 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 751 (1013)
+......|.+.+.||+|+||.||+|... +++.||||+++..... .......|+.++.
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3333445888899999999999999885 7889999997643210 0123567888898
Q ss_pred cCCCC--ccceEEEEeecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 001782 752 NIRHR--NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHP 829 (1013)
Q Consensus 752 ~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~ 829 (1013)
.+.|+ .+...++. ...++||||+++++|.+.... .....++.+++.++.++|+.
T Consensus 89 ~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~--- 144 (198)
T cd05144 89 ALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKH--- 144 (198)
T ss_pred HHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHC---
Confidence 88777 44555443 335899999999998765431 23467889999999999999
Q ss_pred CeeecCCCCCceEecCCCceEEccccccccC
Q 001782 830 PIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 830 ~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
|++||||||+||++++++.++|+|||.+...
T Consensus 145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999999999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.5e-16 Score=182.80 Aligned_cols=210 Identities=26% Similarity=0.371 Sum_probs=143.1
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
..+|..++.|..|+||.||.++++.+.+.+|+|+=+ +. .+++ ||..+-+ ..+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----------lilR-----nilt~a~-----------npf 133 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----------LILR-----NILTFAG-----------NPF 133 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----------hhhh-----ccccccC-----------Ccc
Confidence 458889999999999999999999999999995432 11 0111 1222111 112
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
.| |+-.+.++.. +.++.. ++.+++|+|+. ||+|||+||+|.+|+.-|++|++|||++
T Consensus 134 vv------gDc~tllk~~------g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 134 VV------GDCATLLKNI------GPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLS 190 (1205)
T ss_pred ee------chhhhhcccC------CCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhh
Confidence 22 3333333332 233322 27899999999 9999999999999999999999999998
Q ss_pred ccCCCCCCC-----cc--ccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccHHH
Q 001782 858 RFLPPCSPA-----TI--LETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHE 930 (1013)
Q Consensus 858 ~~~~~~~~~-----~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~~~ 930 (1013)
+........ ++ ....-.....+||+.|+|||++....|+..+|.|++|+++||.+.|..||.....++ .+..
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lfg~ 269 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQ 269 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HHhh
Confidence 753211100 00 111122456689999999999999999999999999999999999999998742221 1222
Q ss_pred HHH---------hhCChhHHHhhhhhhccchhhhhccC
Q 001782 931 FAK---------MALPEKVMEIVDPLLLLDLEARASNC 959 (1013)
Q Consensus 931 ~~~---------~~~~~~~~~~i~~~l~~~~~~R~~~~ 959 (1013)
++. ...+.++++++++++...|..|....
T Consensus 270 visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 270 VISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 221 12345677777777777776665544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2e-15 Score=157.11 Aligned_cols=133 Identities=24% Similarity=0.333 Sum_probs=109.0
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecccc--------chhHHHHHHHHHhcCCCCccceEEEEeecCCccccceE
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG--------ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 776 (1013)
+.||+|++|.||+|.+ .+..|++|+....... ...++.+|++++..+.|+++.....++. .....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCC
Confidence 6799999999999988 4667899986533211 1235778999999999988876666543 23567
Q ss_pred EEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccc
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~ 856 (1013)
++||||++|++|.+++... .. ++..++.+++.++.++|+. +++|||++|+||+++ ++.++++|||.
T Consensus 75 ~lv~e~~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred EEEEEEeCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence 8999999999999998643 11 7889999999999999999 999999999999999 78999999998
Q ss_pred cc
Q 001782 857 AR 858 (1013)
Q Consensus 857 a~ 858 (1013)
+.
T Consensus 141 a~ 142 (211)
T PRK14879 141 AE 142 (211)
T ss_pred cc
Confidence 86
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.9e-15 Score=177.37 Aligned_cols=141 Identities=26% Similarity=0.316 Sum_probs=110.7
Q ss_pred hhhhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeec--cc------cchhHHHHHHHHHhcCCCCccceEEEEe
Q 001782 694 LSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QR------GATKSFVAECEALRNIRHRNLIKIITVC 765 (1013)
Q Consensus 694 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~ 765 (1013)
.......|...+.||+|+||+||+|.+.... +++|+.... .. ...+++.+|+++++.++|++++....++
T Consensus 328 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~ 405 (535)
T PRK09605 328 EEEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYD 405 (535)
T ss_pred ccccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEE
Confidence 3344456677899999999999999886443 444433211 11 1134688999999999999998877664
Q ss_pred ecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC
Q 001782 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH 845 (1013)
Q Consensus 766 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 845 (1013)
.. ....++||||+++++|.+++. ....++.|++.++.+||+. +++|||+||+||++ .
T Consensus 406 ~~-----~~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~ 462 (535)
T PRK09605 406 VD-----PEEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-R 462 (535)
T ss_pred Ee-----CCCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-E
Confidence 32 245689999999999998875 2467899999999999999 99999999999999 6
Q ss_pred CCceEEcccccccc
Q 001782 846 DMVAHVGDFGLARF 859 (1013)
Q Consensus 846 ~~~~kl~DFG~a~~ 859 (1013)
++.++|+|||+++.
T Consensus 463 ~~~~~liDFGla~~ 476 (535)
T PRK09605 463 DDRLYLIDFGLGKY 476 (535)
T ss_pred CCcEEEEeCccccc
Confidence 78999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.6e-15 Score=152.74 Aligned_cols=130 Identities=27% Similarity=0.414 Sum_probs=102.2
Q ss_pred ceeeccceEEEEEEECCCCeEEEEEEEeecccc--------chhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEE
Q 001782 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG--------ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 706 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 777 (1013)
.||+|+||.||+|.+ ++..|++|+....... ..+++.+|+++++.+.|+++.....++. .....+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence 489999999999996 4677999986532211 1245778999999998876544333322 224568
Q ss_pred EEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
+||||++|++|.+++.... . .++.|++.++.++|+. +++|||++|+||+++ ++.++++|||.+
T Consensus 74 lv~e~~~g~~l~~~~~~~~------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred EEEEEECCccHHHHHhhcH------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 9999999999998875431 0 7899999999999999 999999999999999 889999999998
Q ss_pred cc
Q 001782 858 RF 859 (1013)
Q Consensus 858 ~~ 859 (1013)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 64
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=2e-14 Score=146.45 Aligned_cols=135 Identities=23% Similarity=0.234 Sum_probs=98.1
Q ss_pred CCceeeccceEEEEEEECCCCeEEEEEEEeeccccc--hhH----------------------HHHHHHHHhcCCCC--c
Q 001782 704 SNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA--TKS----------------------FVAECEALRNIRHR--N 757 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~--n 757 (1013)
.+.||+|+||+||+|.+. +++.||||++....... ... ...|.+.+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999987 78899999987432211 111 13456666665433 3
Q ss_pred cceEEEEeecCCccccceEEEEEeeccCCCHHH-HhhccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecC
Q 001782 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLED-WLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH-HCHPPIVHGD 835 (1013)
Q Consensus 758 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~D 835 (1013)
+.+.+++ ...++||||++++++.. .+... ... .++..++.+++.++.++|. . +|+|||
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~-------~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D 140 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV-------RLL-EDPEELYDQILELMRKLYREA---GLVHGD 140 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhh-------hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence 4555543 23589999999854321 11111 001 5678899999999999999 8 999999
Q ss_pred CCCCceEecCCCceEEccccccccC
Q 001782 836 LKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 836 lkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
|||+||+++ ++.++++|||.+...
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CChhhEEEE-CCcEEEEECcccccc
Confidence 999999999 899999999998744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.3e-14 Score=173.46 Aligned_cols=118 Identities=38% Similarity=0.604 Sum_probs=101.8
Q ss_pred CCcEEEccCCCCCCCCccccccccccccccccccccccccCccccccCCCCeEeccccccccccccccccccccceeecC
Q 001782 513 NLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLS 592 (1013)
Q Consensus 513 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 592 (1013)
.++.|+|++|.++|.+|..+..+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccCCCCCCCC--CccCCCcceeeeCCcCCCCCCCCCCCCccc
Q 001782 593 YNHLEGEVPRR--GVFSNKTRFYFTGNKRLCGGLDELHLPVCH 633 (1013)
Q Consensus 593 ~N~l~~~~p~~--~~~~~~~~~~~~~N~~~c~~~~~~~~~~~~ 633 (1013)
+|+++|.+|.. ..+.....+.+.+|+.+|+.+. ...|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC---CCCCc
Confidence 99999998864 2233456788999999998654 25675
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.8e-14 Score=138.99 Aligned_cols=135 Identities=19% Similarity=0.273 Sum_probs=110.8
Q ss_pred CCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCC--CccceEEEEeecCCccccceEEEEE
Q 001782 703 SSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRH--RNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 703 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~ 780 (1013)
+.+.||+|.++.||++...+ ..+++|+...... ...+.+|+.+++.++| ..+++++++. ...+..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEE
Confidence 45789999999999999854 6799998864433 4578899999999976 5888988874 3336789999
Q ss_pred eeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccccc
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~ 859 (1013)
||++++.+..+ +......++.+++.+++++|.....+++|+|++|+||++++++.+++.|||.++.
T Consensus 73 e~~~g~~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99997766544 3346677899999999999996444799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.6e-13 Score=143.87 Aligned_cols=139 Identities=17% Similarity=0.139 Sum_probs=105.5
Q ss_pred CCcee-eccceEEEEEEECCCCeEEEEEEEeecc-------------ccchhHHHHHHHHHhcCCCCcc--ceEEEEeec
Q 001782 704 SNMIG-QGSFGFVYRGNLGENEMAVAVKVMNLKQ-------------RGATKSFVAECEALRNIRHRNL--IKIITVCSS 767 (1013)
Q Consensus 704 ~~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~ 767 (1013)
...|| .||.|+||.++.. +..+++|.+.... .....++.+|++++.+++|+++ +..+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35687 8999999999885 5678999885311 1223567889999999988774 677776432
Q ss_pred CCccccceEEEEEeeccC-CCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC
Q 001782 768 IDFEEVDFKAIVYEYMEC-GSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD 846 (1013)
Q Consensus 768 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 846 (1013)
. .......++|||++++ .+|.+++... .++.. .+.|++.++.+||+. ||+||||||+|||++.+
T Consensus 114 ~-~~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 114 R-HGLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPD 178 (239)
T ss_pred e-cCcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCC
Confidence 2 1111234699999997 6899888642 34433 357899999999999 99999999999999999
Q ss_pred CceEEcccccccc
Q 001782 847 MVAHVGDFGLARF 859 (1013)
Q Consensus 847 ~~~kl~DFG~a~~ 859 (1013)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 9999999998863
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.6e-16 Score=167.06 Aligned_cols=180 Identities=31% Similarity=0.451 Sum_probs=154.8
Q ss_pred CCCCCCCEEEccCCccCccCCccccccCccCEEEcCCCcccCCCCcccccCcccceeecccccccccCCchhhcccchhh
Q 001782 412 GELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSI 491 (1013)
Q Consensus 412 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~ 491 (1013)
..+..-...||+.|++. .+|..+..+..|+.+.|+.|.|. .+|..++++..|++|||+.|+++ .+|..++. + -|+
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~-l-pLk 146 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCD-L-PLK 146 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhc-C-cce
Confidence 45666778899999998 78888888889999999999998 78999999999999999999998 78887765 3 356
Q ss_pred hhccCCCeecccCCccccCcCCCcEEEccCCCCCCCCccccccccccccccccccccccccCccccccCCCCeEeccccc
Q 001782 492 LLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNN 571 (1013)
Q Consensus 492 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 571 (1013)
.|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. ..|..+..| .|..||+|.|+
T Consensus 147 vli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNk 222 (722)
T KOG0532|consen 147 VLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNK 222 (722)
T ss_pred eEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCc
Confidence 7788999998 78888998889999999999998 78888999999999999999998 678888865 58899999999
Q ss_pred cccccccccccccccceeecCCccCCCCCC
Q 001782 572 LSGQIPEFLENLSFLEYLNLSYNHLEGEVP 601 (1013)
Q Consensus 572 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 601 (1013)
++ .+|-.|.+|..|++|-|.+|+|+..+-
T Consensus 223 is-~iPv~fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 223 IS-YLPVDFRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred ee-ecchhhhhhhhheeeeeccCCCCCChH
Confidence 98 799999999999999999999986543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2e-15 Score=177.29 Aligned_cols=257 Identities=22% Similarity=0.252 Sum_probs=186.7
Q ss_pred hccCCCCCceeeccceEEEEEEECC-CCeEEEEEEEeecc--ccchhHHHHHHHHHhcCC-CCccceEEEEeecCCcccc
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGE-NEMAVAVKVMNLKQ--RGATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 773 (1013)
...|.+.+.||+|+|+.|-.+.... ....+|+|.+.... .........|..+-+.+. |+|++++++. ..+.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCC
Confidence 4578888899999999999887743 34566777665432 222344556777777776 9999999998 4566
Q ss_pred ceEEEEEeeccCCCHHHHh-hccccccccCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeeecCCCCCceEecCCC-ceE
Q 001782 774 DFKAIVYEYMECGSLEDWL-HQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH-HHCHPPIVHGDLKPSNVLLDHDM-VAH 850 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~k 850 (1013)
+..+++++|.+++++.+-+ .... ...+...+-.++.|+..++.|+| +. +++|+|+||+|.+++..+ ..|
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~-----~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~ 165 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDS-----TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALK 165 (601)
T ss_pred cccccccCcccccccccccccCCc-----cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCccc
Confidence 8899999999999999888 3331 14566677889999999999999 87 999999999999999999 999
Q ss_pred EccccccccCCCCCCCccccCCCCCccccc-ccccccccccCCC-CCCcccchHHHHHHHHHHHhCCCCCCCcCCCCccH
Q 001782 851 VGDFGLARFLPPCSPATILETPSSSTGIKG-TVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 928 (1013)
Q Consensus 851 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DIwSlG~il~ell~G~~pf~~~~~~~~~~ 928 (1013)
++|||+|..+..-. .........+| ++.|+|||...+. -..+..|+||.|+++..+++|..||.........+
T Consensus 166 ~~df~~At~~~~~~-----g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~ 240 (601)
T KOG0590|consen 166 IADFGLATAYRNKN-----GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY 240 (601)
T ss_pred CCCchhhccccccC-----CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc
Confidence 99999998765411 11222445567 9999999998884 45678999999999999999999998754443322
Q ss_pred HHHHHhhCChhHHHhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 001782 929 HEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVV 998 (1013)
Q Consensus 929 ~~~~~~~~~~~~~~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 998 (1013)
..|..... .....+ .........++..+++..+|..|.+.+++.
T Consensus 241 ~~~~~~~~----------~~~~~~----------------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 241 SSWKSNKG----------RFTQLP----------------WNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred eeeccccc----------ccccCc----------------cccCChhhhhcccccccCCchhcccccccc
Confidence 22221110 000000 111223456677788888888888887764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.5e-15 Score=161.13 Aligned_cols=195 Identities=30% Similarity=0.474 Sum_probs=170.9
Q ss_pred ccccceeecccccccCCcccccCCCCCCCEEEccCCccCccCCccccccCccCEEEcCCCcccCCCCcccccCcccceee
Q 001782 390 LVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLS 469 (1013)
Q Consensus 390 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 469 (1013)
+..-...+|+.|++. .+|..+..+..|+.+.|..|.+. .+|..+.++..|+.|||+.|+++ .+|..++.|+ |+.|-
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 344556789999998 78999999999999999999998 89999999999999999999999 8999999886 99999
Q ss_pred cccccccccCCchhhcccchhhhhccCCCeecccCCccccCcCCCcEEEccCCCCCCCCccccccccccccccccccccc
Q 001782 470 VSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLT 549 (1013)
Q Consensus 470 L~~N~l~~~~p~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 549 (1013)
+++|+++ .+|+.+. ....|..||.+.|++. .+|..++++.+|+.|.+..|++. .+|+++..| .|..||+|.|+++
T Consensus 150 ~sNNkl~-~lp~~ig-~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIG-LLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EecCccc-cCCcccc-cchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 9999999 8999988 5888999999999999 68999999999999999999998 678888855 5999999999999
Q ss_pred cccCccccccCCCCeEecccccccccccccccc---ccccceeecCCcc
Q 001782 550 GSIPLALKTLKSIKELDLSRNNLSGQIPEFLEN---LSFLEYLNLSYNH 595 (1013)
Q Consensus 550 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---l~~L~~L~l~~N~ 595 (1013)
.+|..|.+|+.|++|-|.+|.|. ..|..+.- ..=.++|+..-++
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 89999999999999999999998 56665542 3334667776664
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.8e-13 Score=152.72 Aligned_cols=199 Identities=37% Similarity=0.492 Sum_probs=160.4
Q ss_pred eeecccccccCCcccccCCCCCCCEEEccCCccCccCCccccccC-ccCEEEcCCCcccCCCCcccccCcccceeecccc
Q 001782 395 GFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLT-ILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNN 473 (1013)
Q Consensus 395 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 473 (1013)
.+.++.|.+.. ....+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 46667777642 2334555678999999999998 5676677774 8999999999998 67777889999999999999
Q ss_pred cccccCCchhhcccchhhhhccCCCeecccCCccccCcCCCcEEEccCCCCCCCCccccccccccccccccccccccccC
Q 001782 474 KLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIP 553 (1013)
Q Consensus 474 ~l~~~~p~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 553 (1013)
+++ .+|..... .+.|+.|++++|+++ .+|........|++|++++|++. .++..+..+.++..|.+.+|++. ..+
T Consensus 174 ~l~-~l~~~~~~-~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 174 DLS-DLPKLLSN-LSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred hhh-hhhhhhhh-hhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc
Confidence 998 66665433 788888999999998 57776666677999999999755 57778889999999999999988 457
Q ss_pred ccccccCCCCeEeccccccccccccccccccccceeecCCccCCCCCCCC
Q 001782 554 LALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRR 603 (1013)
Q Consensus 554 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 603 (1013)
..++.+++|+.|++++|+++. ++. +..+.+++.|++++|.+...+|..
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred chhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhh
Confidence 888889999999999999984 444 888999999999999998877754
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.4e-13 Score=150.99 Aligned_cols=103 Identities=33% Similarity=0.525 Sum_probs=50.0
Q ss_pred CCcceeeecccccCCCCCCcccccc-ccceeecccccccCCCcchhccCCccceeeccCCccCCCCCCCcCCCCCCCcEE
Q 001782 197 SNLQVLSIGENRLSGRLPDSLGQLR-SLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENL 275 (1013)
Q Consensus 197 ~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L 275 (1013)
+.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|.... .+++|+.|
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~-~~~~L~~L 191 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLS-NLSNLNNL 191 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhh-hhhhhhhe
Confidence 44555555555555 4555454443 5555555555555 34444555555555555555555 4444332 24445555
Q ss_pred EeeeccccccCCCCCCCCCCCceEEcccC
Q 001782 276 SVRQNNYTGSLPHSLSNASNLRLLDFSLN 304 (1013)
Q Consensus 276 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 304 (1013)
++++|+++ .+|........|++|.+++|
T Consensus 192 ~ls~N~i~-~l~~~~~~~~~L~~l~~~~N 219 (394)
T COG4886 192 DLSGNKIS-DLPPEIELLSALEELDLSNN 219 (394)
T ss_pred eccCCccc-cCchhhhhhhhhhhhhhcCC
Confidence 55555544 33333323333444444444
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=6.2e-12 Score=143.64 Aligned_cols=142 Identities=19% Similarity=0.225 Sum_probs=100.4
Q ss_pred CCceeeccceEEEEEEECCCCeEEEEEEEeeccccc----------------------------------------hhHH
Q 001782 704 SNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA----------------------------------------TKSF 743 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~ 743 (1013)
.+.||.|++|+||+|+.. +|+.||||+.++..... .-++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 368999999999999986 68899999986432100 0024
Q ss_pred HHHHHHHhcCC----CCccceEEEEeecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHH-
Q 001782 744 VAECEALRNIR----HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF- 818 (1013)
Q Consensus 744 ~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~- 818 (1013)
.+|++.+.++. |..-+.+-.++. +.....++||||++|+++.++...... .. ...+++.+++.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~----~~~~~~vLvmE~i~G~~L~~~~~~~~~-----~~---~~~~ia~~~~~~ 268 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYW----DRTSERVLTMEWIDGIPLSDIAALDEA-----GL---DRKALAENLARS 268 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEeh----hhcCCceEEEEeECCcccccHHHHHhc-----CC---CHHHHHHHHHHH
Confidence 55666555552 333333333332 222456899999999999987654211 12 23456666666
Q ss_pred HHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCC
Q 001782 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP 861 (1013)
Q Consensus 819 ~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~ 861 (1013)
.+..+|.. |++|+|++|.||++++++.++++|||++..++
T Consensus 269 ~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 269 FLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 47888998 99999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.1e-12 Score=130.44 Aligned_cols=162 Identities=24% Similarity=0.412 Sum_probs=124.7
Q ss_pred HHhcCCCCccceEEEEeecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 001782 749 ALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCH 828 (1013)
Q Consensus 749 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~ 828 (1013)
-+-.+.|.|++++..|+.+...++.....+++|||..|++..++++.+.. ...+......+|+-||..||.|||+. .
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~--~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN--QKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh--hhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 34455699999999998887777788889999999999999999876442 25678888899999999999999995 6
Q ss_pred CCeeecCCCCCceEecCCCceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHH
Q 001782 829 PPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILL 908 (1013)
Q Consensus 829 ~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il 908 (1013)
|.|+|+++..+-|++..+|-+|+.--.-...... .............+-++|.|||+-.....+.++|||+||+..
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s----~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPS----VNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchh----hhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 7899999999999999999999842211111000 000011112334467899999987777788899999999999
Q ss_pred HHHHhCCCC
Q 001782 909 LEMFTRRRP 917 (1013)
Q Consensus 909 ~ell~G~~p 917 (1013)
.||..+..-
T Consensus 273 lemailEiq 281 (458)
T KOG1266|consen 273 LEMAILEIQ 281 (458)
T ss_pred HHHHHheec
Confidence 999988764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.4e-12 Score=142.49 Aligned_cols=203 Identities=25% Similarity=0.296 Sum_probs=159.1
Q ss_pred ccCCCCCceee--ccceEEEEEEE--CCCCeEEEEEEEeecc--ccchhHHHHHHHHHhcC-CCCccceEEEEeecCCcc
Q 001782 699 NDFSSSNMIGQ--GSFGFVYRGNL--GENEMAVAVKVMNLKQ--RGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 699 ~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 771 (1013)
..+.+.+.+|. |.+|.||.+.. ..+...+|+|.-+..- .....+-.+|+...+++ .|++.++.+.. ++
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WE 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----cc
Confidence 35667788999 99999999998 8888899999854222 22233445677766666 48999885555 67
Q ss_pred ccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeeecCCCCCceEecCC-
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF----AIEYLHHHCHPPIVHGDLKPSNVLLDHD- 846 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~- 846 (1013)
..+..++-+|++. .++.++..... ..++....+.+..+... |+.++|+. +++|-|+||.||+...+
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~-----~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPC-----NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDW 259 (524)
T ss_pred cCCcceeeecccc-chhHHhhhccc-----ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccc
Confidence 7788999999998 78888877653 24777888899999999 99999999 99999999999999999
Q ss_pred CceEEccccccccCCCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 001782 847 MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTD 919 (1013)
Q Consensus 847 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~pf~ 919 (1013)
...+++|||+...+........ ........|...|++||.. .+.++...|||++|.++.+..+|..+..
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~---~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSV---FKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred ceeecCCcceeEEccCCccccc---eeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhccccc
Confidence 8999999999987765443222 1112333677889999984 4678899999999999999999877654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-11 Score=142.74 Aligned_cols=151 Identities=19% Similarity=0.199 Sum_probs=98.7
Q ss_pred hccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecccc----------------------------------chh--
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG----------------------------------ATK-- 741 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------------~~~-- 741 (1013)
..+|+. +.||.|++|+||+|+.+.+|+.||||+.++.... ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 446776 8999999999999999877999999999744110 001
Q ss_pred ----HHHHHHHHHhcCC----CCccceEEEEeecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHH
Q 001782 742 ----SFVAECEALRNIR----HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLV 813 (1013)
Q Consensus 742 ----~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~ 813 (1013)
++.+|+..+.+++ +...+.+-.++ ++.....++||||++|+.+.++-.-.....+...+....+..++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~----~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVY----WDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceee----cccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence 2444555554442 33334433333 12235678999999999998753221111001123333333344
Q ss_pred HHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC----ceEEccccccccCCCC
Q 001782 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM----VAHVGDFGLARFLPPC 863 (1013)
Q Consensus 814 ~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~a~~~~~~ 863 (1013)
.|+ +.. |++|+|+||.||+++.++ .++++|||++..+++.
T Consensus 274 ~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 274 TQV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 443 456 999999999999999888 9999999999877543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.6e-10 Score=130.15 Aligned_cols=173 Identities=18% Similarity=0.254 Sum_probs=131.2
Q ss_pred EE-EEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeeccCCCHHHHhh
Q 001782 715 VY-RGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLH 793 (1013)
Q Consensus 715 V~-~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 793 (1013)
+| .|..+.++.+|.|++.+...........+-++.++.++||+|+++++. ++..+..|+|+|.+. .|..+++
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk 99 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLK 99 (690)
T ss_pred cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHH
Confidence 45 466677888999998875555444557788889999999999999997 456678999999985 6777776
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCCCCCccccCCC
Q 001782 794 QSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS 873 (1013)
Q Consensus 794 ~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 873 (1013)
+. ....+...+.||+.||.|||+.+ +++|++|.-+.|+|++.|..||++|.++........
T Consensus 100 ~l---------~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-------- 160 (690)
T KOG1243|consen 100 EL---------GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-------- 160 (690)
T ss_pred Hh---------HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--------
Confidence 54 35577788999999999999775 999999999999999999999999998764332111
Q ss_pred CCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCC
Q 001782 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRR 915 (1013)
Q Consensus 874 ~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~ 915 (1013)
......--..|..|+.+.... -..|.|.|||++||++.|.
T Consensus 161 ~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 161 PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 011112223456666433222 3569999999999999993
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.5e-10 Score=115.59 Aligned_cols=137 Identities=18% Similarity=0.186 Sum_probs=100.5
Q ss_pred CCceeeccceEEEEEEECC------CCeEEEEEEEeecc------------c----------cchhHH----HHHHHHHh
Q 001782 704 SNMIGQGSFGFVYRGNLGE------NEMAVAVKVMNLKQ------------R----------GATKSF----VAECEALR 751 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~ 751 (1013)
...||.|--+.||.|.... .+..+|||+.+... + ...+.+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998753 35789999986321 0 001123 38999999
Q ss_pred cCC--CCccceEEEEeecCCccccceEEEEEeeccCCCHHH-HhhccccccccCCCCHHHHHHHHHHHHHHHHHH-hhcC
Q 001782 752 NIR--HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLED-WLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL-HHHC 827 (1013)
Q Consensus 752 ~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~L-H~~~ 827 (1013)
++. .-++..++++ ...++||||+.+..+.. .++. ..++..+...+..+++.++..+ |+.
T Consensus 82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~H~~- 144 (197)
T cd05146 82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLYKEC- 144 (197)
T ss_pred HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHHHhC-
Confidence 984 3567777765 45689999998654321 2221 1344556778889999999999 888
Q ss_pred CCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 828 HPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 828 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
|+||||+++.||+++ ++.+.++|||.+...
T Consensus 145 --glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 145 --NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred --CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999999999997 467999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.2e-10 Score=117.24 Aligned_cols=281 Identities=14% Similarity=0.090 Sum_probs=173.3
Q ss_pred CCCCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcC-CCCccceEEEEeec--CCccccceEEE
Q 001782 702 SSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVCSS--IDFEEVDFKAI 778 (1013)
Q Consensus 702 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~~~~~~l 778 (1013)
...+.||+|+.+.+|-.-.-.+ .+.|+++........ +.+..|... .||-+-.-+.+-.. ..........+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchhhc---hhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 3567899999999997644322 467888744332222 222333333 56644331221100 00122233667
Q ss_pred EEeeccCCC-HHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEcccccc
Q 001782 779 VYEYMECGS-LEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 779 v~e~~~~gs-L~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a 857 (1013)
.|+.+.+.- ...+.........-....|...++.++.+|.+.+.||++ |.+-||+.++|+||++++.+.+.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 888877542 223322211111113578999999999999999999999 9999999999999999999999875432
Q ss_pred ccCCCCCCCccccCCCCCcccccccccccccccC-----CCCCCcccchHHHHHHHHHHHhC-CCCCCCcCCCCccHHHH
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGM-----GGDMSATGDVYSFGILLLEMFTR-RRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DIwSlG~il~ell~G-~~pf~~~~~~~~~~~~~ 931 (1013)
. +..........+|...|.+||... +..-+...|.|.+|+++++++.| ++||........
T Consensus 165 q---------i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~----- 230 (637)
T COG4248 165 Q---------INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD----- 230 (637)
T ss_pred e---------eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC-----
Confidence 2 222333355677899999999754 33456789999999999999986 999987532211
Q ss_pred HHhhCChhHH-HhhhhhhccchhhhhccCCCCchhHHHHHHHHHHHHHHhhhcccC--CCCCCCCHHHHHHHHHHhhhhh
Q 001782 932 AKMALPEKVM-EIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSME--SPSERIQMTDVVAKLCSARKIF 1008 (1013)
Q Consensus 932 ~~~~~~~~~~-~~i~~~l~~~~~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~evl~~L~~~~~~~ 1008 (1013)
-+...+ ++.......-++.|+..... +.....+-.+..+..+..+|+.. .|.-|||++..+..|.++.+++
T Consensus 231 ----ap~p~E~~Ia~g~f~ya~~~~~g~~p~--P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 231 ----APNPLETDIAHGRFAYASDQRRGLKPP--PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred ----CCCcchhhhhcceeeechhccCCCCCC--CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 111112 22222222222222211110 01111233455677778888865 3568999999999999999888
Q ss_pred hcc
Q 001782 1009 LSN 1011 (1013)
Q Consensus 1009 ~~~ 1011 (1013)
.+|
T Consensus 305 ~~C 307 (637)
T COG4248 305 KKC 307 (637)
T ss_pred hhh
Confidence 766
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.4e-12 Score=126.71 Aligned_cols=179 Identities=27% Similarity=0.263 Sum_probs=125.4
Q ss_pred CCCCEEEccCCccCccCCccccccCccCEEEcCCC-cccCCCCcccccCcccceeecccccccccCCchhhcccchhhhh
Q 001782 415 RNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFN-KLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILL 493 (1013)
Q Consensus 415 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L 493 (1013)
+.|+++...+..++. .| .+-..+.+..+.-+.- -.+|..-..+...+.|+++|||+|.|+ .+..+.. ..+.++.|
T Consensus 237 ptl~t~~v~~s~~~~-~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvK-L~Pkir~L 312 (490)
T KOG1259|consen 237 PTLQTICVHNTTIQD-VP-SLLPETILADPSGSEPSTSNGSALVSADTWQELTELDLSGNLIT-QIDESVK-LAPKLRRL 312 (490)
T ss_pred chhheeeeecccccc-cc-cccchhhhcCccCCCCCccCCceEEecchHhhhhhccccccchh-hhhhhhh-hccceeEE
Confidence 567777776665542 11 1222222222221111 112333333344467889999999988 5655543 37888889
Q ss_pred ccCCCeecccCCccccCcCCCcEEEccCCCCCCCCccccccccccccccccccccccccCccccccCCCCeEeccccccc
Q 001782 494 DLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLS 573 (1013)
Q Consensus 494 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 573 (1013)
++|+|.++. + +.+..+++|+.||||+|.++ .+-.+-..+.+.+.|.|+.|.|.. -+.++.+-+|..||+++|+|.
T Consensus 313 ~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 313 ILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred eccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchh
Confidence 999999883 2 34888899999999999998 566666778899999999999873 356788889999999999998
Q ss_pred ccc-ccccccccccceeecCCccCCCCCCC
Q 001782 574 GQI-PEFLENLSFLEYLNLSYNHLEGEVPR 602 (1013)
Q Consensus 574 ~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~ 602 (1013)
... -..++++|-|+++.|.+|++.+.+.-
T Consensus 388 ~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY 417 (490)
T KOG1259|consen 388 ELDEVNHIGNLPCLETLRLTGNPLAGSVDY 417 (490)
T ss_pred hHHHhcccccccHHHHHhhcCCCccccchH
Confidence 432 25688999999999999999987653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.5e-10 Score=115.76 Aligned_cols=130 Identities=18% Similarity=0.154 Sum_probs=95.4
Q ss_pred CCceeeccceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCcc-ceEEEEeecCCccccceEEEEEee
Q 001782 704 SNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL-IKIITVCSSIDFEEVDFKAIVYEY 782 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 782 (1013)
.+.++.|.++.||+++.. +..|++|+...... ....+.+|+++++.+.+.++ .+++.+.. ...++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEEEe
Confidence 367899999999999875 67899998764432 22356789999998865443 45554421 234799999
Q ss_pred ccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCceEecCCCceEEccccccc
Q 001782 783 MECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHC--HPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 783 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~ 858 (1013)
++|.++.+. . .....++.+++++++.||+.. +.+++|||++|.||+++ ++.++++|||.+.
T Consensus 73 i~G~~l~~~-~-------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 73 IEGSELLTE-D-------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cCCCccccc-c-------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 998877543 0 011345678999999999982 12359999999999999 6689999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.2e-12 Score=132.35 Aligned_cols=208 Identities=22% Similarity=0.209 Sum_probs=124.8
Q ss_pred hcccccceeecccccccCCcc--cccCCCCCCCEEEccCCccCcc--CCccccccCccCEEEcCCCcccCCCCcc-cccC
Q 001782 388 KNLVNLNGFGLEYNQLTGPIP--HAIGELRNLQVLDLHHNNLDGH--IPESLGNLTILNSLDLGFNKLRGHVPSS-LGNC 462 (1013)
Q Consensus 388 ~~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l 462 (1013)
+++.+|+.+.|.+..+. ..+ .....+++++.|||++|-+... +..-...+++|+.|+|+.|++.-...+. -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 35667778888877776 223 3556678888888888877632 2223446788888888888876322221 1245
Q ss_pred cccceeecccccccccCCchhhcccchhhhhccCCCeecccCCccccCcCCCcEEEccCCCCCCCCc-cccccccccccc
Q 001782 463 QNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIP-VSLSACTTLEYL 541 (1013)
Q Consensus 463 ~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L 541 (1013)
++|+.|.|++|.|+..--..+....+.+..|+|+.|...++-......+..|+.|||++|++....- ...+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 6788888888888744334444456777777887775333333444556677777777777763221 345667777777
Q ss_pred cccccccccc-cCcc-----ccccCCCCeEeccccccccccc--cccccccccceeecCCccCC
Q 001782 542 YMEGNSLTGS-IPLA-----LKTLKSIKELDLSRNNLSGQIP--EFLENLSFLEYLNLSYNHLE 597 (1013)
Q Consensus 542 ~L~~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~ 597 (1013)
+++.+.+... .|+. ...+++|+.|+++.|++.. .+ ..+..+++|+.|.+..|.|+
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~-w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRD-WRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCcccc-ccccchhhccchhhhhhccccccc
Confidence 7777776642 2222 3445666666666666642 21 12333444455555555544
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6e-12 Score=133.35 Aligned_cols=209 Identities=22% Similarity=0.220 Sum_probs=110.4
Q ss_pred CcccceEEeccCCccccCCC--CccccCCCCceeccccccccCCCC-CccccccccccceecccccccccCCCC-ccCCC
Q 001782 122 RLFRLETLILANNSFSGKIP--SNLSRCSNLINFHARGNNLVGQIP-PDIGYSWLKLEFLSLRDNLLAGQLAPS-IGNIS 197 (1013)
Q Consensus 122 ~l~~L~~L~L~~n~l~~~~p--~~l~~l~~L~~L~l~~n~l~~~ip-~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~ 197 (1013)
++++|+...|.+.... ..+ .....|++++.|||+.|-+..--| ..+..++++|+.|+|+.|.+.-..... -..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 3444444444444433 112 133344444444444444332111 112234445555555555443211111 12456
Q ss_pred CcceeeecccccCCC-CCCccccccccceeecccccccCCCcchhccCCccceeeccCCccCCCCCC--CcCCCCCCCcE
Q 001782 198 NLQVLSIGENRLSGR-LPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPV--NIGFSLPNLEN 274 (1013)
Q Consensus 198 ~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~~l~~L~~ 274 (1013)
+|+.|.|+.|.++.. +...+...++|+.|+|..|..-+.-......+..|++|||++|.+. ..+. -.+ .++.|..
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~-~l~~L~~ 275 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVG-TLPGLNQ 275 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccc-cccchhh
Confidence 677777777777621 2222344667777777777433233444455667777777777765 4442 222 4677777
Q ss_pred EEeeecccccc-CCCC-----CCCCCCCceEEcccCcccccc-cccccCCCCccccccccCcCCCC
Q 001782 275 LSVRQNNYTGS-LPHS-----LSNASNLRLLDFSLNHFSGQV-KIDFNRLPNLFRLSFSKNNLGTG 333 (1013)
Q Consensus 275 L~L~~N~l~~~-~~~~-----~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~ 333 (1013)
|+++.|.++.. .|+. ....++|++|+++.|++.... -..+..+++|+.|.+..|.+...
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 77777776643 2332 345677888888888875322 22355677778888778877653
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=5e-11 Score=136.73 Aligned_cols=107 Identities=38% Similarity=0.428 Sum_probs=47.8
Q ss_pred CCCCCEEEccCCccCccCC-ccccccCccCEEEcCCCcccCCCCcccccCcccceeecccccccccCCchhhcccchhhh
Q 001782 414 LRNLQVLDLHHNNLDGHIP-ESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL 492 (1013)
Q Consensus 414 l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~ 492 (1013)
+..|+.+++++|+++...+ . ...+.+++.+++++|.+.. ...+..+..+..+++..|+++-.-+..... ...|+.
T Consensus 161 l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~-~~~L~~ 236 (414)
T KOG0531|consen 161 LKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEGLNELV-MLHLRE 236 (414)
T ss_pred chhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceeccCcccch-hHHHHH
Confidence 4455555555555553222 1 3445555556666665542 233334444444455555555211111000 002445
Q ss_pred hccCCCeecccCCccccCcCCCcEEEccCCCCC
Q 001782 493 LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFS 525 (1013)
Q Consensus 493 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 525 (1013)
+++++|.+. .++..+..+.++..|++++|++.
T Consensus 237 l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 237 LYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred HhcccCccc-cccccccccccccccchhhcccc
Confidence 555555554 22234444455555555555544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=1e-10 Score=114.25 Aligned_cols=129 Identities=28% Similarity=0.349 Sum_probs=37.6
Q ss_pred ccCCCCCCCeeeeccCCccccCCcccC-CcccceEEeccCCccccCCCCccccCCCCceeccccccccCCCCCccccccc
Q 001782 95 YVGNLSFLRFINFANNGFSGEIPGEIG-RLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWL 173 (1013)
Q Consensus 95 ~l~~l~~L~~L~l~~n~l~~~ip~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ip~~~~~~l~ 173 (1013)
.+.+...+++|+|++|.|+ .|. .++ .+.+|+.|||++|.++ .++ .+..+++|++|++++|+++ .++..+.
T Consensus 14 ~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~---- 84 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLD---- 84 (175)
T ss_dssp ------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHH----
T ss_pred ccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchH----
Confidence 3455566777888888777 443 455 4677788888888777 343 4666667777777766666 3332221
Q ss_pred cccceecccccccccCCCCccCCCCcceeeecccccCCC-CCCccccccccceeecccccccCCC---cchhccCCccce
Q 001782 174 KLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGR-LPDSLGQLRSLYYLSISENAFSGMF---PSSIFNISSLES 249 (1013)
Q Consensus 174 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~n~l~~~~---p~~~~~l~~L~~ 249 (1013)
..+++|++|++++|+|... .-..+..+++|+.|+|.+|.++... ...+..+++|+.
T Consensus 85 --------------------~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~ 144 (175)
T PF14580_consen 85 --------------------KNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKV 144 (175)
T ss_dssp --------------------HH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SE
T ss_pred --------------------HhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhhe
Confidence 2345555555555555421 1133455666666666666665321 123556777776
Q ss_pred eec
Q 001782 250 ISL 252 (1013)
Q Consensus 250 L~L 252 (1013)
||-
T Consensus 145 LD~ 147 (175)
T PF14580_consen 145 LDG 147 (175)
T ss_dssp ETT
T ss_pred eCC
Confidence 663
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.3e-10 Score=129.99 Aligned_cols=198 Identities=22% Similarity=0.213 Sum_probs=146.5
Q ss_pred hhhhccCCCCCceeeccceEEEEEEEC-CCCeEEEEEEEeeccccchhH--HHHHHHHHhcC-CCCccceEEEEeecCCc
Q 001782 695 SKATNDFSSSNMIGQGSFGFVYRGNLG-ENEMAVAVKVMNLKQRGATKS--FVAECEALRNI-RHRNLIKIITVCSSIDF 770 (1013)
Q Consensus 695 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 770 (1013)
.....+|..+..||.|.|+.|+....+ .++..|++|...........+ -..|+.+...+ .|.++++++.. |
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W 335 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----W 335 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----c
Confidence 345678899999999999999998765 678889998775333322222 24566666655 47777776655 3
Q ss_pred cccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCC-Cce
Q 001782 771 EEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD-MVA 849 (1013)
Q Consensus 771 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~ 849 (1013)
...+..++=-||+++++....+... ..+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~~~------~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~ 406 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSVTS------QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFS 406 (524)
T ss_pred cccccccCchhhhcCcchhhhhHHH------HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhh
Confidence 3445666889999999887766332 3577888999999999999999999 99999999999999886 788
Q ss_pred EEccccccccCCCCCCCccccCCCCCcccccccccc--cccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 001782 850 HVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYV--APEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917 (1013)
Q Consensus 850 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DIwSlG~il~ell~G~~p 917 (1013)
++.|||.+..+.-. ........+++ +|+......+..++|+||||..+.|..+|...
T Consensus 407 ~~~~~~~~t~~~~~-----------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 407 KLGDFGCWTRLAFS-----------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred hcccccccccccee-----------cccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 99999998632111 11112233344 55555667788899999999999999998754
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.8e-12 Score=130.12 Aligned_cols=141 Identities=21% Similarity=0.302 Sum_probs=75.5
Q ss_pred CCCceEEcccCcccccc----cccccCCCCccccccccCcCCCCCCCChhhhhhcccccccccccccccccCCccchhhh
Q 001782 294 SNLRLLDFSLNHFSGQV----KIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIA 369 (1013)
Q Consensus 294 ~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p~~~~ 369 (1013)
++|+++...+|++.... ...|...+.|+.+.++.|.|....+ ......+..|+.|+.|++..|.|+......
T Consensus 157 ~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~--~al~eal~~~~~LevLdl~DNtft~egs~~-- 232 (382)
T KOG1909|consen 157 PKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGV--TALAEALEHCPHLEVLDLRDNTFTLEGSVA-- 232 (382)
T ss_pred cceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchh--HHHHHHHHhCCcceeeecccchhhhHHHHH--
Confidence 45555666666554322 2335555667777777776654333 234455566666666666666665332211
Q ss_pred cchhhHHHHhccchhHHhhcccccceeecccccccCCcccccCCCCCCCEEEccCCccCccCCcccc-----ccCccCEE
Q 001782 370 NLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLG-----NLTILNSL 444 (1013)
Q Consensus 370 ~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L 444 (1013)
+...+..+++|+.|++++|.++......|. ..+.|++|
T Consensus 233 -------------------------------------LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl 275 (382)
T KOG1909|consen 233 -------------------------------------LAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVL 275 (382)
T ss_pred -------------------------------------HHHHhcccchheeecccccccccccHHHHHHHHhccCCCCcee
Confidence 122334445555555555555533222221 24566777
Q ss_pred EcCCCcccC----CCCcccccCcccceeecccccc
Q 001782 445 DLGFNKLRG----HVPSSLGNCQNLMLLSVSNNKL 475 (1013)
Q Consensus 445 ~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l 475 (1013)
.|.+|.|+. .+...+...+.|..|+|++|++
T Consensus 276 ~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 276 ELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 777776662 1223344466777777777777
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.2e-11 Score=125.88 Aligned_cols=116 Identities=20% Similarity=0.232 Sum_probs=70.5
Q ss_pred cccccccccccccccCCccchhhhcchhhHHHHhccchhHHhhcccccceeecccccccC----CcccccCCCCCCCEEE
Q 001782 346 NCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTG----PIPHAIGELRNLQVLD 421 (1013)
Q Consensus 346 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~ 421 (1013)
+-++|+.+...+|++.......+ ...|+..+.|+.+.+++|.|.. .+...|..+++|+.||
T Consensus 155 ~~~~Lrv~i~~rNrlen~ga~~~---------------A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLd 219 (382)
T KOG1909|consen 155 SKPKLRVFICGRNRLENGGATAL---------------AEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLD 219 (382)
T ss_pred CCcceEEEEeeccccccccHHHH---------------HHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeee
Confidence 34566666666666653322211 1235556677777777777652 2234567778888888
Q ss_pred ccCCccCc----cCCccccccCccCEEEcCCCcccCCCCcccc-----cCcccceeeccccccc
Q 001782 422 LHHNNLDG----HIPESLGNLTILNSLDLGFNKLRGHVPSSLG-----NCQNLMLLSVSNNKLT 476 (1013)
Q Consensus 422 L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~ 476 (1013)
|.+|-++. .+...+..+++|+.|++++|.+...-..+|. ..++|++|.|.+|.++
T Consensus 220 l~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 220 LRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred cccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 88887763 2344566677788888888877643322221 2456777777777766
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.2e-10 Score=110.90 Aligned_cols=107 Identities=27% Similarity=0.315 Sum_probs=24.3
Q ss_pred CCCCCEEEccCCccCccCCcccc-ccCccCEEEcCCCcccCCCCcccccCcccceeecccccccccCCchhhcccchhhh
Q 001782 414 LRNLQVLDLHHNNLDGHIPESLG-NLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL 492 (1013)
Q Consensus 414 l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~ 492 (1013)
...++.|+|++|+|+. + +.++ .+.+|+.|+|++|.|+. ++ .+..++.|+.|++++|+|+ .+++.+...++.|+.
T Consensus 18 ~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 18 PVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--E
T ss_pred cccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCE
Confidence 3356666666666662 2 2344 35666666666666663 22 3555666666666666666 333222222333444
Q ss_pred hccCCCeecccC-CccccCcCCCcEEEccCCCCC
Q 001782 493 LDLSGNLLTGSI-PAEVGNLKNLVQLGLSENRFS 525 (1013)
Q Consensus 493 L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~ 525 (1013)
|+|++|+|...- -..+..+++|+.|+|.+|.++
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 444444433210 122334444455555554443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.98 E-value=9.6e-11 Score=117.86 Aligned_cols=134 Identities=23% Similarity=0.274 Sum_probs=87.5
Q ss_pred CccCCCCcceeeecccccCCCCCCccccccccceeecccccccCCCcchhccCCccceeeccCCccCCCCCCCcCCCCCC
Q 001782 192 SIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPN 271 (1013)
Q Consensus 192 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~ 271 (1013)
.+-....|++||||+|.|+ .+.++..-++.++.|++|+|.|.. + ..+..+++|+.||||+|.++ .+. ++...+-+
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~-Gwh~KLGN 353 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECV-GWHLKLGN 353 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhh-hhHhhhcC
Confidence 3334456777777777776 566666667777777777777762 2 23677777777777777776 332 22224667
Q ss_pred CcEEEeeeccccccCCCCCCCCCCCceEEcccCcccccc-cccccCCCCccccccccCcCCC
Q 001782 272 LENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQV-KIDFNRLPNLFRLSFSKNNLGT 332 (1013)
Q Consensus 272 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~ 332 (1013)
.+.|.|+.|.|.. -..+..+-+|..||+++|+|.... -..++++|.|+.|.|.+|++..
T Consensus 354 IKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 354 IKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred EeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 7777777777652 234566667778888888776432 2346777777777777777654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1e-10 Score=134.13 Aligned_cols=251 Identities=25% Similarity=0.305 Sum_probs=178.9
Q ss_pred CCCCCCCeeeeccCCccccCCcccCCcccceEEeccCCccccCCCCccccCCCCceeccccccccCCCCCcccccccccc
Q 001782 97 GNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLE 176 (1013)
Q Consensus 97 ~~l~~L~~L~l~~n~l~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~ 176 (1013)
..+..++.+++..|.++ .+-..++.+++|+.|++.+|+|. .+...+..+++|++|++++|.|+..-+-. .++.|+
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~l~---~l~~L~ 143 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEGLS---TLTLLK 143 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccchh---hccchh
Confidence 45677777888888888 44456788899999999999998 56655888999999999999988443332 455688
Q ss_pred ceecccccccccCCCCccCCCCcceeeecccccCCCCCCc-cccccccceeecccccccCCCcchhccCCccceeeccCC
Q 001782 177 FLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDS-LGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGN 255 (1013)
Q Consensus 177 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N 255 (1013)
.|++++|.|+.. ..+..+.+|+.+++++|++.. +... ...+.+|+.+++++|.+. ....+..+..+..+++..|
T Consensus 144 ~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 144 ELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVD-IENDELSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDN 218 (414)
T ss_pred hheeccCcchhc--cCCccchhhhcccCCcchhhh-hhhhhhhhccchHHHhccCCchh--cccchHHHHHHHHhhcccc
Confidence 999999988754 456668899999999999984 4332 577889999999999887 3444555666777788899
Q ss_pred ccCCCCCCCcCCCCCC--CcEEEeeeccccccCCCCCCCCCCCceEEcccCcccccccccccCCCCccccccccCcCCCC
Q 001782 256 RLEGSLPVNIGFSLPN--LENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTG 333 (1013)
Q Consensus 256 ~l~~~~p~~~~~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 333 (1013)
+++ .+- .+. .+.. |+.+++++|.+. ..+..+..+.++..|++.+|++.... .+...+.+..+...+|.+...
T Consensus 219 ~i~-~~~-~l~-~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 292 (414)
T KOG0531|consen 219 KIS-KLE-GLN-ELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALS 292 (414)
T ss_pred cce-ecc-Ccc-cchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcchhcch
Confidence 887 222 111 2333 889999999988 44466778889999999999887543 355667777788888876632
Q ss_pred CCCChhhhhhcccccccccccccccccCCccc
Q 001782 334 AIGDLDFIAHLTNCSKLEALGLDTNIFGGVLP 365 (1013)
Q Consensus 334 ~~~~~~~~~~l~~l~~L~~L~l~~n~~~~~~p 365 (1013)
... ...........++...+..|......+
T Consensus 293 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 293 EAI--SQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hhh--hccccccccccccccccccCccccccc
Confidence 111 011114455677777777776665443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.9e-09 Score=98.83 Aligned_cols=140 Identities=26% Similarity=0.311 Sum_probs=101.2
Q ss_pred CCCceeeccceEEEEEEECCCCeEEEEEEEeeccc--------cchhHHHHHHHHHhcCCCCcc--ceEEEEeecCCccc
Q 001782 703 SSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--------GATKSFVAECEALRNIRHRNL--IKIITVCSSIDFEE 772 (1013)
Q Consensus 703 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~ 772 (1013)
....+-+|+-+.|+++.+. |+.++||.-..+.. -..++-.+|++.+.++.--.| .+++.+ +
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~-------D 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI-------D 81 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE-------e
Confidence 5678999999999999985 66677775432221 123567889999988753222 233322 2
Q ss_pred cceEEEEEeeccC-CCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCC---c
Q 001782 773 VDFKAIVYEYMEC-GSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM---V 848 (1013)
Q Consensus 773 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~ 848 (1013)
...-.++|||++| .++.+++..... ..........++.+|-+.+.-||.. +|+|||+..+||++..++ .
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~----~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~ 154 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTME----DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQIT 154 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHcc----CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCc
Confidence 2445799999995 388898877533 1222233368899999999999999 999999999999997665 4
Q ss_pred eEEccccccc
Q 001782 849 AHVGDFGLAR 858 (1013)
Q Consensus 849 ~kl~DFG~a~ 858 (1013)
+.++|||++.
T Consensus 155 ~~lIdfgls~ 164 (229)
T KOG3087|consen 155 PILIDFGLSS 164 (229)
T ss_pred eEEEeecchh
Confidence 5899999985
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.1e-10 Score=82.51 Aligned_cols=39 Identities=59% Similarity=1.053 Sum_probs=31.1
Q ss_pred HHHHHHHHHHHHhcC-CCCCCCCCCCCC--CCCceeEEEEeC
Q 001782 34 ETDRLALLAIKSQLQ-DPLGVTSSWNNS--MNLCQWTGVTCG 72 (1013)
Q Consensus 34 ~~~~~aLl~~k~~~~-~~~~~~~sw~~~--~~~c~w~gv~C~ 72 (1013)
++|++||++||+++. ||.+.+++|+.+ .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999997 678899999876 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.5e-09 Score=99.43 Aligned_cols=128 Identities=30% Similarity=0.375 Sum_probs=95.2
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecccc--------chhHHHHHHHHHhcCCC--CccceEEEEeecCCccccc
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG--------ATKSFVAECEALRNIRH--RNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~ 774 (1013)
..+++|+-+.+|.+.+. +.++++|.-..+... ..++-.+|+.++.+++- -++..++++ ++.
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD 72 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence 46889999999999774 444667654332211 12345789999988853 344455554 335
Q ss_pred eEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccc
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 854 (1013)
...++|||++|..|.+++... ...++..+-.-+.-||.. ||||||+.++||++..+. +.++||
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf 135 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF 135 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence 667999999999999898764 134566777778889999 999999999999997765 899999
Q ss_pred cccc
Q 001782 855 GLAR 858 (1013)
Q Consensus 855 G~a~ 858 (1013)
|++.
T Consensus 136 GLg~ 139 (204)
T COG3642 136 GLGE 139 (204)
T ss_pred Cccc
Confidence 9986
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.3e-09 Score=108.22 Aligned_cols=145 Identities=21% Similarity=0.267 Sum_probs=108.0
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeeccc-cchhHHHHHHHHHhcCCC--CccceEEEEeecCCccccceEEEEEe
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRH--RNLIKIITVCSSIDFEEVDFKAIVYE 781 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e 781 (1013)
+.++.|.++.||+++..+ ++.+++|+...... .....+..|+++++.+.+ ..+.+++.+..... ..+..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence 578999999999998853 57899998764332 134578899999999975 44677777743221 1235689999
Q ss_pred eccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 001782 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHC---------------------------------- 827 (1013)
Q Consensus 782 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~---------------------------------- 827 (1013)
|++|.++.+.+.. ..++..+...++.++++++.+||+..
T Consensus 81 ~i~G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 81 RVDGRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred EeCCEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 9998888775532 13566677788888888888888521
Q ss_pred -------------------CCCeeecCCCCCceEecC--CCceEEcccccccc
Q 001782 828 -------------------HPPIVHGDLKPSNVLLDH--DMVAHVGDFGLARF 859 (1013)
Q Consensus 828 -------------------~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~ 859 (1013)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5.7e-10 Score=130.86 Aligned_cols=249 Identities=20% Similarity=0.251 Sum_probs=165.6
Q ss_pred hhhccCCCCCceeeccceEEEEEEECCCCeEEEEEEEeecc---ccchhHHHHHHHHHhcCCCCccceEEEEeecCCccc
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 772 (1013)
...+.+.+.+-+.+|.++.++.++-...+...++|+..... ....+....+-.+.-...+|-++...-- +..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCC
Confidence 34567788889999999999999887777555555543111 1111222222222222234444433221 345
Q ss_pred cceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEc
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 852 (1013)
....+++++|..+++|...++.. +..+.+-.......+..+.+|||.. .+.|+|++|.|.+...++..+++
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~------~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~ 946 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNS------GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLT 946 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcC------CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccC
Confidence 57788999999999999988876 3445555566667788999999998 89999999999999999999999
Q ss_pred cccccccCCCC---CCC------------------ccccC--CCCCcccccccccccccccCCCCCCcccchHHHHHHHH
Q 001782 853 DFGLARFLPPC---SPA------------------TILET--PSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLL 909 (1013)
Q Consensus 853 DFG~a~~~~~~---~~~------------------~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ 909 (1013)
|||.....+-. ... ..... ........||+.|.+||...+......+|.|+.|++++
T Consensus 947 ~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~ 1026 (1205)
T KOG0606|consen 947 DFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLF 1026 (1205)
T ss_pred ccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhh
Confidence 99844332111 000 00001 12245667999999999999999999999999999999
Q ss_pred HHHhCCCCCCCcCCCCccHHHHHHhh---------CChhHHHhhhhhhccchhhhhccC
Q 001782 910 EMFTRRRPTDNMFNDGLTLHEFAKMA---------LPEKVMEIVDPLLLLDLEARASNC 959 (1013)
Q Consensus 910 ell~G~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~~i~~~l~~~~~~R~~~~ 959 (1013)
|.++|..||....... .+....... .++.+++.+.+.+..++.+|....
T Consensus 1027 e~l~g~pp~na~tpq~-~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1027 EVLTGIPPFNAETPQQ-IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhcCCCCCCCcchhh-hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999997643221 112111111 233456666666667776666544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.87 E-value=3e-08 Score=108.18 Aligned_cols=178 Identities=16% Similarity=0.155 Sum_probs=134.4
Q ss_pred cceEEEEEEECCCCeEEEEEEEeeccccchhHHHHHHHHHhcCCCCccceEEEEeecCCccccceEEEEEeeccC-CCHH
Q 001782 711 SFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMEC-GSLE 789 (1013)
Q Consensus 711 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~ 789 (1013)
-..+.|++....+|..|++|+++..+......-..-+++++++.|+|||++.+++....+ .+...++|++|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHH
Confidence 346889999999999999999965544333334556889999999999999999775433 44678999999984 5676
Q ss_pred HHhhccccc---------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccC
Q 001782 790 DWLHQSNDQ---------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 790 ~~l~~~~~~---------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~ 860 (1013)
++--..... ......++...|.++.|+..||.++|+. |..-+-+.+.+|+++.+.+++|+.-|+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 654332211 1234578899999999999999999999 9999999999999999999999888876654
Q ss_pred CCCCCCccccCCCCCcccccccccccccccCCCCCCcccchHHHHHHHHHHHhCCCC
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell~G~~p 917 (1013)
.++.. |-+. --.+-|.=.||.++..+.||..-
T Consensus 444 ~~d~~----------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPT----------------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCC----------------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 32210 0011 11257899999999999999654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.8e-08 Score=100.40 Aligned_cols=124 Identities=25% Similarity=0.240 Sum_probs=82.6
Q ss_pred EEEEEEECCCCeEEEEEEEeeccc-------------c-------------chhHHHHHHHHHhcCCCC--ccceEEEEe
Q 001782 714 FVYRGNLGENEMAVAVKVMNLKQR-------------G-------------ATKSFVAECEALRNIRHR--NLIKIITVC 765 (1013)
Q Consensus 714 ~V~~~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~h~--niv~~~~~~ 765 (1013)
.||.|... ++..+|+|+.+.... . ......+|++.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 48999885 677999999863210 0 012367899999999754 57777776
Q ss_pred ecCCccccceEEEEEeecc--CCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeeecCCCCCceE
Q 001782 766 SSIDFEEVDFKAIVYEYME--CGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY-LHHHCHPPIVHGDLKPSNVL 842 (1013)
Q Consensus 766 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~-LH~~~~~~ivH~Dlkp~NIl 842 (1013)
...++||||++ |..+..+.... ++..+...++.+++..+.. +|.. |++|||+.+.||+
T Consensus 79 --------~~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIl 139 (188)
T PF01163_consen 79 --------NRNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNIL 139 (188)
T ss_dssp --------ETTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEE
T ss_pred --------eCCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEE
Confidence 34579999999 65665544332 1123456677888886655 5688 9999999999999
Q ss_pred ecCCCceEEcccccccc
Q 001782 843 LDHDMVAHVGDFGLARF 859 (1013)
Q Consensus 843 l~~~~~~kl~DFG~a~~ 859 (1013)
++++ .+.|+|||.+..
T Consensus 140 v~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 140 VDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp EETT-CEEE--GTTEEE
T ss_pred eecc-eEEEEecCccee
Confidence 9888 999999998763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.3e-07 Score=100.39 Aligned_cols=145 Identities=17% Similarity=0.066 Sum_probs=100.4
Q ss_pred CceeeccceEEEEEEECCCCeEEEEEEEeecccc-----------chhHHHHHHHHHhcCC--CCccceEEEEeecCCcc
Q 001782 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG-----------ATKSFVAECEALRNIR--HRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~ 771 (1013)
+.+-+.....|+++.. .|+.|.||........ ....+.+|...+.++. .-.++..+++.......
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 4444444455777766 4678999977432211 1124778999888874 22334445553222111
Q ss_pred ccceEEEEEeeccCC-CHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecC-----
Q 001782 772 EVDFKAIVYEYMECG-SLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH----- 845 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----- 845 (1013)
.....++|||++++. +|.+++..... ...+...+..++.+++..+.-||.. ||+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence 134578999999975 89999864211 2456677889999999999999999 9999999999999975
Q ss_pred --CCceEEccccccc
Q 001782 846 --DMVAHVGDFGLAR 858 (1013)
Q Consensus 846 --~~~~kl~DFG~a~ 858 (1013)
++.+.++||+.++
T Consensus 179 ~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 179 EEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCceEEEEECCccc
Confidence 4689999999875
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.6e-09 Score=84.98 Aligned_cols=60 Identities=42% Similarity=0.574 Sum_probs=34.4
Q ss_pred ccccccccccccccccCccccccCCCCeEeccccccccccccccccccccceeecCCccC
Q 001782 537 TLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHL 596 (1013)
Q Consensus 537 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 596 (1013)
+|++|++++|+|+...+..|..+++|++|++++|+|+...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544445555566666666666666555555556666666666666553
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.3e-09 Score=127.78 Aligned_cols=126 Identities=26% Similarity=0.415 Sum_probs=58.0
Q ss_pred CCCCeeeeccCCccccCCcccCCcccceEEeccCCc--cccCCC-CccccCCCCceeccccccccCCCCCcccccccccc
Q 001782 100 SFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS--FSGKIP-SNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLE 176 (1013)
Q Consensus 100 ~~L~~L~l~~n~l~~~ip~~~~~l~~L~~L~L~~n~--l~~~~p-~~l~~l~~L~~L~l~~n~l~~~ip~~~~~~l~~L~ 176 (1013)
...+...+.+|.+. .++.+...- +|++|-+..|. +. .++ +.|..++.|+.|||++|.--+.+|..++ .+.+|+
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~~~-~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~-~Li~Lr 598 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSENP-KLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIG-ELVHLR 598 (889)
T ss_pred hheeEEEEeccchh-hccCCCCCC-ccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHh-hhhhhh
Confidence 44555555555554 333333222 45555555554 22 222 2244455555555555444444444443 344444
Q ss_pred ceecccccccccCCCCccCCCCcceeeecccccCCCCCCccccccccceeeccc
Q 001782 177 FLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISE 230 (1013)
Q Consensus 177 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~ 230 (1013)
+|+|+...++ .+|..+++|..|.+|++..+.-...+|.....|++|++|.+-.
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~ 651 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPR 651 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeec
Confidence 4444444444 4444555555555555554443333444444455555555443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.5e-10 Score=127.76 Aligned_cols=202 Identities=31% Similarity=0.314 Sum_probs=135.1
Q ss_pred hcccccceeecccccccCCc-ccccCCCCCCCEEEccCCccCccCCcccccc-CccCEEEcCCCccc----------CCC
Q 001782 388 KNLVNLNGFGLEYNQLTGPI-PHAIGELRNLQVLDLHHNNLDGHIPESLGNL-TILNSLDLGFNKLR----------GHV 455 (1013)
Q Consensus 388 ~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~----------~~~ 455 (1013)
.-+++++.+.+-.-.=.+.. |-.+..+.+|++|.|.++.|.. ..++..+ ..|++|.- .|.++ |.+
T Consensus 81 d~lqkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~ 157 (1096)
T KOG1859|consen 81 DFLQKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDI 157 (1096)
T ss_pred HHHhhheeeeecccCCCCCCCCceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhcccc
Confidence 33455555555443333333 5567788899999999998873 2222222 24444422 23332 122
Q ss_pred CcccccCcccceeecccccccccCCchhhcccchhhhhccCCCeecccCCccccCcCCCcEEEccCCCCCCCCcc-cccc
Q 001782 456 PSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPV-SLSA 534 (1013)
Q Consensus 456 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~ 534 (1013)
..++. ...|...+.++|.++ .+...+ ..++.++.|||++|+++.. +.+..+++|++|||+.|++. .+|. ...+
T Consensus 158 ~ns~~-Wn~L~~a~fsyN~L~-~mD~SL-qll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~g 231 (1096)
T KOG1859|consen 158 SNSPV-WNKLATASFSYNRLV-LMDESL-QLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVG 231 (1096)
T ss_pred ccchh-hhhHhhhhcchhhHH-hHHHHH-HHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhh
Confidence 22221 136888899999988 555444 3478888999999999853 37788899999999999998 4443 3444
Q ss_pred ccccccccccccccccccCccccccCCCCeEeccccccccccc-cccccccccceeecCCccCCCCCC
Q 001782 535 CTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIP-EFLENLSFLEYLNLSYNHLEGEVP 601 (1013)
Q Consensus 535 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p 601 (1013)
+. |..|.+++|.++.. ..+.+|.+|+.|||++|-|++.-- ..++.|..|+.|+|.+|++.+.+-
T Consensus 232 c~-L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 232 CK-LQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred hh-heeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 54 99999999988743 357888999999999998876322 235677888999999999987543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.5e-10 Score=125.08 Aligned_cols=179 Identities=26% Similarity=0.281 Sum_probs=128.3
Q ss_pred CccccccCccCEEEcCCCcccCCCCcccccC-cccceeeccccccc----------ccCCchhhcccchhhhhccCCCee
Q 001782 432 PESLGNLTILNSLDLGFNKLRGHVPSSLGNC-QNLMLLSVSNNKLT----------GALPPQILGIVTLSILLDLSGNLL 500 (1013)
Q Consensus 432 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~----------~~~p~~~~~~~~~l~~L~Ls~N~l 500 (1013)
|-.+..+..|++|.|.++.|.. ...+..+ .+|+.|. -+|.++ |.+..++ ....|...+.++|.+
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LI-C~~Sl~Al~~v~ascggd~~ns~--~Wn~L~~a~fsyN~L 176 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLI-CHNSLDALRHVFASCGGDISNSP--VWNKLATASFSYNRL 176 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhh-hhccHHHHHHHHHHhccccccch--hhhhHhhhhcchhhH
Confidence 5567778899999999999873 2222222 2455543 223332 1221111 134566778899999
Q ss_pred cccCCccccCcCCCcEEEccCCCCCCCCccccccccccccccccccccccccCc-cccccCCCCeEeccccccccccccc
Q 001782 501 TGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPL-ALKTLKSIKELDLSRNNLSGQIPEF 579 (1013)
Q Consensus 501 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~ 579 (1013)
+ .+...+.-++.|+.|||++|+++... .+..|++|++|||++|.|. .+|. .-..+. |+.|.+++|.++.. ..
T Consensus 177 ~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~g 249 (1096)
T KOG1859|consen 177 V-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RG 249 (1096)
T ss_pred H-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hh
Confidence 8 67778888899999999999998543 7888999999999999998 4443 334444 99999999999842 35
Q ss_pred cccccccceeecCCccCCCCC--CCCCccCCCcceeeeCCcCCCC
Q 001782 580 LENLSFLEYLNLSYNHLEGEV--PRRGVFSNKTRFYFTGNKRLCG 622 (1013)
Q Consensus 580 ~~~l~~L~~L~l~~N~l~~~~--p~~~~~~~~~~~~~~~N~~~c~ 622 (1013)
+.+|.+|+.||+++|-|.+.- ...+.+..+..+++.|||..|.
T Consensus 250 ie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 250 IENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred HHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 788999999999999988643 2346677888899999998775
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=5.2e-09 Score=84.02 Aligned_cols=61 Identities=41% Similarity=0.505 Sum_probs=47.7
Q ss_pred CCCcEEEccCCCCCCCCccccccccccccccccccccccccCccccccCCCCeEecccccc
Q 001782 512 KNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNL 572 (1013)
Q Consensus 512 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 572 (1013)
++|++|++++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4677888888888765556778888888888888888877777888888888888888875
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.6e-09 Score=126.00 Aligned_cols=105 Identities=26% Similarity=0.321 Sum_probs=55.1
Q ss_pred Ccceeeecccc--cCCCCCCccccccccceeecccccccCCCcchhccCCccceeeccCCccCCCCCCCcCCCCCCCcEE
Q 001782 198 NLQVLSIGENR--LSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENL 275 (1013)
Q Consensus 198 ~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L 275 (1013)
.|+.|-+..|. +....++.|..++.|+.|||++|.=-+.+|..+++|-+|++|+|++..++ .+|.++. .+..|.+|
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~-~Lk~L~~L 623 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLG-NLKKLIYL 623 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHH-HHHhhhee
Confidence 45555555554 33222233455555555555555444455555555555555555555555 5555554 45555555
Q ss_pred EeeeccccccCCCCCCCCCCCceEEcccC
Q 001782 276 SVRQNNYTGSLPHSLSNASNLRLLDFSLN 304 (1013)
Q Consensus 276 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 304 (1013)
++..+.-...+|.....+++|++|.+-.-
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred ccccccccccccchhhhcccccEEEeecc
Confidence 55555443344444445555655555443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.8e-08 Score=99.22 Aligned_cols=134 Identities=26% Similarity=0.208 Sum_probs=98.4
Q ss_pred CCCCCceeeccceEEEEEEECCCCeEEEEEEEeeccc----------------------cchhHHHHHHHHHhcCCCC--
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR----------------------GATKSFVAECEALRNIRHR-- 756 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~-- 756 (1013)
+.+..+||.|--|.||.|.+. .+.++|||.-+.... .......+|.++|+++.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999997 677899997542110 0123468899999999644
Q ss_pred ccceEEEEeecCCccccceEEEEEeeccCCCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 001782 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDL 836 (1013)
Q Consensus 757 niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dl 836 (1013)
.|.+.+++ +..++||||++|--|...- ++.+..-.++..|+.-+..+-.. ||||||+
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~~---GiVHGDl 228 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYRR---GIVHGDL 228 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHHc---CccccCC
Confidence 77887776 6678999999975554432 12223344555555555555566 9999999
Q ss_pred CCCceEecCCCceEEccccccc
Q 001782 837 KPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 837 kp~NIll~~~~~~kl~DFG~a~ 858 (1013)
.+-||+++++|.+.++||--+.
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred chheEEEecCCCEEEEeCcccc
Confidence 9999999999999999996543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.7e-06 Score=86.51 Aligned_cols=142 Identities=18% Similarity=0.146 Sum_probs=104.3
Q ss_pred eeeccceEEEEEEECCCCeEEEEEEEeecc------ccchhHHHHHHHHHhcCC--CCccceEEEEeecCCccccceEEE
Q 001782 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQ------RGATKSFVAECEALRNIR--HRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 707 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~l 778 (1013)
-|+||-+.|+.....+ ..+-+|.-...- ......|.+|...++++. .-.+.+++ ++...........++
T Consensus 26 ~~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 3668999999988753 357788764111 234578999999999984 22355555 332221223455789
Q ss_pred EEeeccC-CCHHHHhhccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCc--eEEcccc
Q 001782 779 VYEYMEC-GSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMV--AHVGDFG 855 (1013)
Q Consensus 779 v~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFG 855 (1013)
|+|-+++ .+|.+++..... .+.+..++..+..+++..++-||+. |+.|+|+.+.||+++.++. ++++||.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEEeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 9997764 588888865422 3567788889999999999999999 9999999999999986666 9999998
Q ss_pred ccc
Q 001782 856 LAR 858 (1013)
Q Consensus 856 ~a~ 858 (1013)
-++
T Consensus 176 k~r 178 (216)
T PRK09902 176 KSR 178 (216)
T ss_pred ccc
Confidence 765
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=9.5e-09 Score=92.07 Aligned_cols=87 Identities=25% Similarity=0.308 Sum_probs=50.6
Q ss_pred CCcEEEccCCCCCCCCccccccccccccccccccccccccCccccccCCCCeEeccccccccccccccccccccceeecC
Q 001782 513 NLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLS 592 (1013)
Q Consensus 513 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 592 (1013)
.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|..||..+|.+. .+|..+-.-+.....++.
T Consensus 78 t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lg 154 (177)
T KOG4579|consen 78 TATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLG 154 (177)
T ss_pred hhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhc
Confidence 4555556666665 55555666666666666666665 55566666666666666666665 344333322333444556
Q ss_pred CccCCCCCCC
Q 001782 593 YNHLEGEVPR 602 (1013)
Q Consensus 593 ~N~l~~~~p~ 602 (1013)
++++.+..+.
T Consensus 155 nepl~~~~~~ 164 (177)
T KOG4579|consen 155 NEPLGDETKK 164 (177)
T ss_pred CCcccccCcc
Confidence 7777766664
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=7.9e-09 Score=92.59 Aligned_cols=104 Identities=25% Similarity=0.375 Sum_probs=66.7
Q ss_pred hhhccCCCeecccCCcc---ccCcCCCcEEEccCCCCCCCCccccc-cccccccccccccccccccCccccccCCCCeEe
Q 001782 491 ILLDLSGNLLTGSIPAE---VGNLKNLVQLGLSENRFSNEIPVSLS-ACTTLEYLYMEGNSLTGSIPLALKTLKSIKELD 566 (1013)
Q Consensus 491 ~~L~Ls~N~l~~~~~~~---~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 566 (1013)
..+||+++++- .+++. +.....|+..+|++|.|+ ..|+.|. ..+.++.|+|++|+|+ .+|..+..++.|+.|+
T Consensus 30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 34455555543 23332 233445666677777777 4454443 3456777777777777 6677777777777777
Q ss_pred ccccccccccccccccccccceeecCCccCCC
Q 001782 567 LSRNNLSGQIPEFLENLSFLEYLNLSYNHLEG 598 (1013)
Q Consensus 567 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 598 (1013)
++.|.|. ..|+.+..|.+|-.|+..+|.+..
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~e 137 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARAE 137 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCcccc
Confidence 7777777 566666667777777777776653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.6e-06 Score=89.18 Aligned_cols=110 Identities=26% Similarity=0.259 Sum_probs=85.3
Q ss_pred hhHHHHHHHHHhcCC--CCccceEEEEeecCCccccceEEEEEeeccCC-CHHHHhhccccccccCCCCHHHHHHHHHHH
Q 001782 740 TKSFVAECEALRNIR--HRNLIKIITVCSSIDFEEVDFKAIVYEYMECG-SLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816 (1013)
Q Consensus 740 ~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi 816 (1013)
..+..+|...+.++. .=.+.+.+++........ ...++|+|++++. +|.+++.... ..+......++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l 127 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRAL 127 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHH
Confidence 356788888888774 334566666654432222 4568999999974 7999988642 25566778899999
Q ss_pred HHHHHHHhhcCCCCeeecCCCCCceEecCCC---ceEEcccccccc
Q 001782 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM---VAHVGDFGLARF 859 (1013)
Q Consensus 817 a~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~ 859 (1013)
+..++-||+. ||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 128 ~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 128 ARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999 999999999999999887 899999997763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=6.4e-08 Score=109.98 Aligned_cols=140 Identities=21% Similarity=0.338 Sum_probs=95.1
Q ss_pred HHHHHHHHHHhhcCCCCeeecCCCCCceEecCCCceEEccccccccCCCCCCCcccc-CCCCCcccccccccccccccCC
Q 001782 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE-TPSSSTGIKGTVGYVAPEYGMG 892 (1013)
Q Consensus 814 ~qia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~ 892 (1013)
.+++.|+.|+|.. +++||+.|.|++|.++..+..||+.|+++.-..+........ ......-..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999998 499999999999999999999999999886554422211111 1111122234578999999999
Q ss_pred CCCCcccchHHHHHHHHHHHh-CCCCCCCcCCCCccHH----------HHHHhhCChhHHHhhhhhhccchhhhh
Q 001782 893 GDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLH----------EFAKMALPEKVMEIVDPLLLLDLEARA 956 (1013)
Q Consensus 893 ~~~~~~~DIwSlG~il~ell~-G~~pf~~~~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~~~~~R~ 956 (1013)
...+.++|+||+|+++|.+.. |+.-+... ....... ......+|++..+-+.+++..+...||
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~-~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp 257 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAAN-GGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP 257 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhcc-CCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCc
Confidence 888999999999999999995 54444331 1111000 001123566667777777777776666
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1013 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-45 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-41 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-39 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-25 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 9e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-07 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 5e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-06 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-06 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 3e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 4e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-06 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 4e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 4e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-05 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 4e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-05 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 5e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-05 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 7e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-04 | ||
| 3a79_B | 562 | Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len | 1e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-04 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-04 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 2e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-04 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-04 | ||
| 3t6q_A | 606 | Crystal Structure Of Mouse Rp105MD-1 Complex Length | 7e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 7e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-04 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 7e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-04 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 485 bits (1250), Expect = e-158
Identities = 162/573 (28%), Positives = 256/573 (44%), Gaps = 30/573 (5%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
LD+S+ + + P++G+ S L+ ++ + N SG+ I L+ L +++N F G
Sbjct: 203 EFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISN 198
IP +L N G+IP + + L L L N G + P G+ S
Sbjct: 262 PIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 199 LQVLSIGENRLSGRLP-DSLGQLRSLYYLSISENAFSGMFPSSIFNIS-SLESISLLGNR 256
L+ L++ N SG LP D+L ++R L L +S N FSG P S+ N+S SL ++ L N
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 257 LEGSLPVNIG-FSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFN 315
G + N+ L+ L ++ N +TG +P +LSN S L L S N+ SG +
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 316 RLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTI 375
L L L N L G I L LE L LD N G +P ++N ++
Sbjct: 440 SLSKLRDLKLWLNML-EGEI-----PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLN 493
Query: 376 ILFSMGLNQIY------VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDG 429
+ S+ N++ + L NL L N +G IP +G+ R+L LDL+ N +G
Sbjct: 494 WI-SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 430 HIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNN--KLTGALPPQILGIV 487
IP ++ S + N + G + N + N + G Q+ +
Sbjct: 553 TIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608
Query: 488 TLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNS 547
T + +++ + G N +++ L +S N S IP + + L L + N
Sbjct: 609 TRNPC-NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 548 LTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFS 607
++GSIP + L+ + LDLS N L G+IP+ + L+ L ++LS N+L G +P G F
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 608 NKTRFYFTGNKRLCGGLDELHLPVCHSAGPRKT 640
F N LCG LP C +
Sbjct: 728 TFPPAKFLNNPGLCG----YPLPRCDPSNADGY 756
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 455 bits (1172), Expect = e-146
Identities = 165/584 (28%), Positives = 265/584 (45%), Gaps = 47/584 (8%)
Query: 31 HSNETDRLALLAIKSQLQDPLGVTSSWNNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEG 90
S + L++ K L D + W+++ N C + GVTC R +VT +DLS++ +
Sbjct: 8 QSLYREIHQLISFKDVLPDK-NLLPDWSSNKNPCTFDGVTC--RDDKVTSIDLSSKPLNV 64
Query: 91 I---LSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPS--NLS 145
+S + +L+ L + +N+ +G + L +L L+ NS SG + + +L
Sbjct: 65 GFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLG 123
Query: 146 RCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSI---GNISNLQVL 202
CS L + N L G LE L L N ++G L+ L
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183
Query: 203 SIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLP 262
+I N++SG + + + +L +L +S N FS P + + S+L+ + + GN+L G
Sbjct: 184 AISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFS 240
Query: 263 VNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKID-FNRLPNLF 321
I + L+ L++ N + G +P +L+ L + N F+G++ L
Sbjct: 241 RAIS-TCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLT 297
Query: 322 RLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMG 381
L S N+ GA+ +CS LE+L L +N F G LP+
Sbjct: 298 GLDLSGNHF-YGAV-----PPFFGSCSLLESLALSSNNFSGELPMDT------------- 338
Query: 382 LNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELR-NLQVLDLHHNNLDGHIPESLGN--L 438
+ + L L +N+ +G +P ++ L +L LDL NN G I +L
Sbjct: 339 -----LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393
Query: 439 TILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGN 498
L L L N G +P +L NC L+ L +S N L+G +P + + L L L N
Sbjct: 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD-LKLWLN 452
Query: 499 LLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKT 558
+L G IP E+ +K L L L N + EIP LS CT L ++ + N LTG IP +
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 559 LKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPR 602
L+++ L LS N+ SG IP L + L +L+L+ N G +P
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-33
Identities = 48/191 (25%), Positives = 79/191 (41%), Gaps = 10/191 (5%)
Query: 434 SLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILL 493
+T ++ N V SSL + L L +SN+ + G++ L
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG--FKCSASLTSL 105
Query: 494 DLSGNLLTGSIPA--EVGNLKNLVQLGLSENRFSNEIPVSLSA-CTTLEYLYMEGNSLTG 550
DLS N L+G + +G+ L L +S N VS +LE L + NS++G
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165
Query: 551 SIPLALKT---LKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFS 607
+ + +K L +S N +SG + + LE+L++S N+ +P G S
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCS 223
Query: 608 NKTRFYFTGNK 618
+GNK
Sbjct: 224 ALQHLDISGNK 234
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-20
Identities = 40/179 (22%), Positives = 62/179 (34%), Gaps = 52/179 (29%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
++++R G SP N + F++ + N SG IP EIG + L L L +N S
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNIS 197
G IP +G++
Sbjct: 670 GSIPD-------------------------------------------------EVGDLR 680
Query: 198 NLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSS-IFNISSLESISLLGN 255
L +L + N+L GR+P ++ L L + +S N SG P F + L N
Sbjct: 681 GLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQF--ETFPPAKFLNN 737
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 8e-14
Identities = 30/90 (33%), Positives = 46/90 (51%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
+ LD+S + G + +G++ +L +N +N SG IP E+G L L L L++N
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 136 FSGKIPSNLSRCSNLINFHARGNNLVGQIP 165
G+IP +S + L NNL G IP
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = 7e-94
Identities = 92/307 (29%), Positives = 138/307 (44%), Gaps = 18/307 (5%)
Query: 338 LDFIAHLTNCSKL----EALGLDTNIFGGVLPLSIANLSS--TIILFSMGLN---QI--Y 386
L L N + L + GVL + + L + L I
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS 71
Query: 387 VKNLVNLNGFGL-EYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLD 445
+ NL LN + N L GPIP AI +L L L + H N+ G IP+ L + L +LD
Sbjct: 72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131
Query: 446 LGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIP 505
+N L G +P S+ + NL+ ++ N+++GA+P L + +S N LTG IP
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
Query: 506 AEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKEL 565
NL NL + LS N + V + + +++ NSL + + K++ L
Sbjct: 192 PTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGL 249
Query: 566 DLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGLD 625
DL N + G +P+ L L FL LN+S+N+L GE+P+ G + NK LCG
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS-- 307
Query: 626 ELHLPVC 632
LP C
Sbjct: 308 --PLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 1e-68
Identities = 87/348 (25%), Positives = 135/348 (38%), Gaps = 70/348 (20%)
Query: 33 NETDRLALLAIKSQLQDPLGVTSSWNNSMNLCQ--WTGVTCGHRHQ--RVTVLDLSNRSI 88
N D+ ALL IK L +P SSW + + C W GV C Q RV LDLS ++
Sbjct: 4 NPQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 89 EGILS---------------------------PYVGNLSFLRFINFANNGFSGEIPGEIG 121
P + L+ L ++ + SG IP +
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 122 RLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLR 181
++ L TL + N+ SG +P ++S NL+ GN + G IP
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP---------------- 166
Query: 182 DNLLAGQLAPSIGNISNL-QVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSS 240
S G+ S L ++I NRL+G++P + L +L ++ +S N G
Sbjct: 167 ---------DSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVL 216
Query: 241 IFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLD 300
+ + + I L N L L +G NL L +R N G+LP L+ L L+
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLG-KVGL-SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274
Query: 301 FSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCS 348
S N+ G++ N L +++ N G + L C+
Sbjct: 275 VSFNNLCGEIPQGGN-LQRFDVSAYANNKCLCG--------SPLPACT 313
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = 2e-93
Identities = 94/606 (15%), Positives = 179/606 (29%), Gaps = 99/606 (16%)
Query: 36 DRLALLAIKSQLQDP--------LGVTSSWNNSMNLCQWT---GVTCGHRHQRVTVLDLS 84
D LAL I L ++WN + L W GV+ + RVT L L
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN-SNGRVTGLSLE 89
Query: 85 NRSIEGILSPYVGNLSFLRFINFANNGFSG----EIPGEIGRLFRLETLILANNSFSGKI 140
G + +G L+ L + ++G P I E +
Sbjct: 90 GFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTF 149
Query: 141 PSNLSR--CSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISN 198
R S+LI + I + LK + N + ++ ++ ++
Sbjct: 150 VDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT-LKDTQIGQLSNNITF-VSKAVMRLTK 207
Query: 199 LQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLE 258
L+ +G + + + Y + N+ L + +
Sbjct: 208 LRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLKDLTDVEVYNCPNL 262
Query: 259 GSLPVNIGFSLPNLENLSVRQNNYT--------GSLPHSLSNASNLRLLDFSLNHF-SGQ 309
LP + +LP ++ ++V N ++++ N+ +
Sbjct: 263 TKLPTFLK-ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321
Query: 310 VKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIA 369
V+ ++ L L N L G + + KL +L L N +P +
Sbjct: 322 VETSLQKMKKLGMLECLYNQL-EG------KLPAFGSEIKLASLNLAYNQITE-IPANFC 373
Query: 370 NLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTG-PIPHAIGELRNLQVLDLHHNNLD 428
+ +N+L P + + +D +N +
Sbjct: 374 G------------------FTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIG 415
Query: 429 G-------HIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPP 481
+ + ++S++L N++ L +++ N LT +P
Sbjct: 416 SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPK 474
Query: 482 QILGIVTLSI-------LLDLSGNLLTGSIPAE--VGNLKNLVQLGLSENRFSNEIPVSL 532
L + +DL N LT + + L LV + LS N FS + P
Sbjct: 475 NSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFS-KFPTQP 532
Query: 533 SACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLS 592
+TL+ + D N + PE + L L +
Sbjct: 533 LNSSTLKGFGIRNQ------------------RDAQGNRTLREWPEGITLCPSLTQLQIG 574
Query: 593 YNHLEG 598
N +
Sbjct: 575 SNDIRK 580
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 6e-74
Identities = 88/533 (16%), Positives = 169/533 (31%), Gaps = 54/533 (10%)
Query: 91 ILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNL 150
+ Y+ + L+ I A NG + G + + + + +L+ +
Sbjct: 24 RTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRV 83
Query: 151 INFHARGNNLVGQIPPDIGYSWL-KLEFLSLRDNLLAGQ----LAPSIGNISNLQVLSIG 205
G G++P IG L +LE L+L + I + +
Sbjct: 84 TGLSLEGFGASGRVPDAIGQ--LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 206 ENRLSGRLPDSLG--QLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPV 263
D L I+ + S I L N + +
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSK 200
Query: 264 NIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRL 323
+ L L + + + N + ++ L +L +
Sbjct: 201 AVM-RLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDV 254
Query: 324 SFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLN 383
+ L L +++ + + N S L
Sbjct: 255 EVYNCPN----LTKLP--TFLKALPEMQLINVACN-----------RGISGEQLKDDWQA 297
Query: 384 QIYVKNLVNLNGFGLEYNQL-TGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILN 442
+ + YN L T P+ ++ +++ L +L+ +N L+G +P G+ L
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLA 356
Query: 443 SLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL--LDLSGNLL 500
SL+L +N++ + G + + LS ++NKL P I ++S++ +D S N +
Sbjct: 357 SLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY--IPNIFDAKSVSVMSAIDFSYNEI 414
Query: 501 TG-------SIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTG--- 550
+ N+ + LS N+ S S + L + + GN LT
Sbjct: 415 GSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPK 474
Query: 551 ----SIPLALKTLKSIKELDLSRNNLSGQIPEF-LENLSFLEYLNLSYNHLEG 598
K + +DL N L+ +F L +L ++LSYN
Sbjct: 475 NSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-66
Identities = 86/474 (18%), Positives = 161/474 (33%), Gaps = 60/474 (12%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
T + + +I + S V L+ LR N+ F E E E
Sbjct: 186 TQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYK 239
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLK-LEFLSLRDNLL--------AGQL 189
+L + + ++P + L ++ +++ N Q
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA--LPEMQLINVACNRGISGEQLKDDWQA 297
Query: 190 APSIGNISNLQVLSIGENRL-SGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLE 248
+Q++ IG N L + + SL +++ L L N G + + L
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLA 356
Query: 249 SISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLS--NASNLRLLDFSLNHF 306
S++L N++ +P N +ENLS N +P+ + S + +DFS N
Sbjct: 357 SLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEI 414
Query: 307 SGQVKIDFNRLP-------NLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNI 359
+F+ L N+ ++ S N + + +L + S L ++ L N+
Sbjct: 415 GSVDGKNFDPLDPTPFKGINVSSINLSNNQI-SKFPKEL-----FSTGSPLSSINLMGNM 468
Query: 360 FGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTG-PIPHAIGELRNLQ 418
+ S+ + + KN L L +N+LT L L
Sbjct: 469 LTEIPKNSLKDENENF------------KNTYLLTSIDLRFNKLTKLSDDFRATTLPYLV 516
Query: 419 VLDLHHNNLDGHIPESLGNLT------ILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSN 472
+DL +N+ P N + I N D N+ P + C +L L + +
Sbjct: 517 GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575
Query: 473 NKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSN 526
N + + +I +S+L D+ N + V L ++ +
Sbjct: 576 NDIRK-VNEKIT--PNISVL-DIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQD 625
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 9e-39
Identities = 35/226 (15%), Positives = 74/226 (32%), Gaps = 16/226 (7%)
Query: 389 NLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDG----HIPESLGNLTILNSL 444
+ L+ LE +G +P AIG+L L+VL L + P+ +
Sbjct: 82 RVTGLS---LEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 445 DLGFNKLRGHVPSSLGNCQ--NLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTG 502
+ +L+ ++++ ++ I + N +T
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS-RITLKDTQIGQLSNNIT- 196
Query: 503 SIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSI 562
+ V L L Q + + F E EY + L LK +
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDL 251
Query: 563 KELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
++++ ++P FL+ L ++ +N++ N + +
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 4e-90
Identities = 112/560 (20%), Positives = 188/560 (33%), Gaps = 54/560 (9%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
LDLS + + S + L+ ++ + G L L TLIL N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAG-QLAPSIGNI 196
S S+L A NL IG L+ L++ NL+ +L N+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIG-HLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSL----YYLSISENAFSGMFPSSIFNISSLESISL 252
+NL+ L + N++ L L + L +S N + F L ++L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTL 207
Query: 253 LGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSL------PHSLSNASNLRLLDFSLNH- 305
N ++ L LE + + +L NL + +F L +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 306 --FSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGV 363
+ + FN L N+ S + + + + L L FG
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIER--------VKDFSYNFGWQHLELVNCKFGQF 319
Query: 364 LPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLH 423
L + +L L + G + +L +L+ LDL
Sbjct: 320 PTLKLKSLKR------------------------LTFTSNKGGNAFSEVDLPSLEFLDLS 355
Query: 424 HNNLD--GHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPP 481
N L G +S T L LDL FN + + S+ + L L ++ L
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF 414
Query: 482 QILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEI-PVSLSACTTLEY 540
+ + I LD+S + L +L L ++ N F P + L +
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474
Query: 541 LYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEV 600
L + L P A +L S++ L++S NN + L+ L+ L+ S NH+
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534
Query: 601 PR--RGVFSNKTRFYFTGNK 618
+ + S+ T N
Sbjct: 535 KQELQHFPSSLAFLNLTQND 554
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 7e-70
Identities = 98/552 (17%), Positives = 176/552 (31%), Gaps = 44/552 (7%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
VLDLS I+ I +LS L + N G L L+ L+ + +
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISN 198
+ L + N + P+ + LE L L N + + +
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 199 LQV----LSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF-NISSLESISLL 253
+ + L + N ++ P + ++R L+ L++ N S + ++ LE L+
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 254 GNRLEGS--LPVNIGFSLPNLENLSVRQNNYT------GSLPHSLSNASNLRLLDFSLNH 305
L +L L NL++ + + + +N+
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 306 FSGQVKIDFNRLPNLFRLSFSKNNLGT------GAIGDLDF-------IAHLTNCSKLEA 352
DF+ L G ++ L F + LE
Sbjct: 294 IERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEF 351
Query: 353 LGLDTN--IFGGVLPLSIANLSSTIILFSMGLNQIYV-----KNLVNLNGFGLEYNQLTG 405
L L N F G S +S L + N + L L +++ L
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYL-DLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 406 PIPH-AIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHV-PSSLGNCQ 463
LRNL LD+ H + L+ L L + N + + P +
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 464 NLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENR 523
NL L +S +L L P ++ +L++S N L +L L S N
Sbjct: 471 NLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 524 FSNEIPVSLSAC-TTLEYLYMEGNSLTGSIPLA--LKTLKSIKELDLSRNNLSGQIPEFL 580
L ++L +L + N + L+ +K ++L + + P
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
Query: 581 ENLSFLEYLNLS 592
+ + L LN++
Sbjct: 590 QGMPVLS-LNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-63
Identities = 93/486 (19%), Positives = 161/486 (33%), Gaps = 40/486 (8%)
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISN 198
KIP NL + N N L S+ +L+ L L + + ++S+
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFF-SFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 199 LQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLE 258
L L + N + + L SL L E + + I ++ +L+ +++ N ++
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 259 GSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRL----LDFSLNHFSGQVKIDF 314
+L NLE+L + N L + L LD SLN + F
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 315 NRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTN--------------IF 360
+ L +L+ N + + + LE L
Sbjct: 198 KEI-RLHKLTLRNNFDSLNVMKTC-----IQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251
Query: 361 GGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVL 420
G+ L+I + + + L N++ F L + + Q L
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHL 309
Query: 421 DLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLT--GA 478
+L + L +L L F +G S + +L L +S N L+ G
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 479 LPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVS-LSACTT 537
G +L LDLS N + + + L+ L L + S +
Sbjct: 365 CSQSDFGTTSLKY-LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 538 LEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQI-PEFLENLSFLEYLNLSYNHL 596
L YL + + L S++ L ++ N+ P+ L L +L+LS L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 597 EGEVPR 602
E P
Sbjct: 483 EQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-23
Identities = 26/128 (20%), Positives = 46/128 (35%), Gaps = 4/128 (3%)
Query: 471 SNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPV 530
+P + LDLS N L + L L LS
Sbjct: 15 MELNFY-KIPDNLPFSTKN---LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 531 SLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLN 590
+ + + L L + GN + A L S+++L NL+ + +L L+ LN
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 591 LSYNHLEG 598
+++N ++
Sbjct: 131 VAHNLIQS 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-09
Identities = 26/155 (16%), Positives = 50/155 (32%), Gaps = 25/155 (16%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
+ +T LDLS +E + +LS L+ +N ++N F L L+ L + N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 136 FSGKIPSNLSRC-SNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIG 194
L S+L + N+ + +
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFAC----TCEHQSF-------------------LQ 566
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSIS 229
I + + L + R+ P + + L+I+
Sbjct: 567 WIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 5e-86
Identities = 122/551 (22%), Positives = 203/551 (36%), Gaps = 39/551 (7%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
+TVL+L++ + + + S L ++ N S P +L L+ L L +N S
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNIS 197
+ C+NL H N++ I + L L L N L+ + +
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145
Query: 198 NLQVLSIGENRLSGRLPDSLG--QLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGN 255
NLQ L + N++ + L SL L +S N P I L + L
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 256 RLEGSLPVNIGF--SLPNLENLSVRQNNYTGSLPHSLSN--ASNLRLLDFSLNHFSGQVK 311
+L SL + + ++ NLS+ + + + + +NL +LD S N+ +
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 312 IDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANL 371
F LP L NN+ F L + L L + +S+A+L
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQH------LFSHSLHGLFNVRYLNLKRSFT--KQSISLASL 317
Query: 372 SSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHN--NLDG 429
I FS L L +E N + G + L NL+ L L ++ +L
Sbjct: 318 PK-IDDFSFQ-------WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369
Query: 430 HIPESLGNLTI--LNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIV 487
E+ +L L+ L+L NK+ + +L +L + N++ L Q +
Sbjct: 370 LTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGL 429
Query: 488 TLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFS--NEIPVSLSACTTLEYLYMEG 545
+ LS N + +L +L L + P L L +
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 546 NSLTGSIPLALKTLKSIKELDLSRNNLS--------GQIPEFLENLSFLEYLNLSYNHLE 597
N++ L+ L+ ++ LDL NNL+ G FL+ LS L LNL N +
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549
Query: 598 GEVPRRGVFSN 608
VF +
Sbjct: 550 EIPV--EVFKD 558
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 1e-80
Identities = 113/558 (20%), Positives = 197/558 (35%), Gaps = 52/558 (9%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
T L L + SI+ I + L ++ ++NG S G +L L+ L+L+NN
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 139 KIPSNLS--RCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIG-- 194
L S+L N + P + +L L L + L L +
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFH-AIGRLFGLFLNNVQLGPSLTEKLCLE 218
Query: 195 -NISNLQVLSIGENRLSGRLPDSLGQLR--SLYYLSISENAFSGMFPSSIFNISSLESIS 251
++++ LS+ ++LS + L+ +L L +S N + + S + LE
Sbjct: 219 LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFF 278
Query: 252 LLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSL---------PHSLSNASNLRLLDFS 302
L N ++ ++ L N+ L+++++ S+ S L L+
Sbjct: 279 LEYNNIQHLFSHSLH-GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNME 337
Query: 303 LNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGG 362
N G F L NL LS S + + + F L + S L L L N
Sbjct: 338 DNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF-VSLAH-SPLHILNLTKNKISK 395
Query: 363 VLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIP-HAIGELRNLQVLD 421
+ + + L +L L+ L N++ + L N+ +
Sbjct: 396 IESDAFSWLG----------------HLEVLD---LGLNEIGQELTGQEWRGLENIFEIY 436
Query: 422 LHHNNLDGHIPESLGNLTILNSLDLGFNKLRG--HVPSSLGNCQNLMLLSVSNNKLTGAL 479
L +N S + L L L L+ PS +NL +L +SNN + +
Sbjct: 437 LSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN-I 495
Query: 480 PPQILGIVTLSILLDLSGNLLT--------GSIPAEVGNLKNLVQLGLSENRFSNEIPVS 531
+L + +LDL N L G + L +L L L N F
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
Query: 532 LSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPE-FLENLSFLEYLN 590
L+ + + N+L S+K L+L +N ++ + F L L+
Sbjct: 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELD 615
Query: 591 LSYNHLEGEVPRRGVFSN 608
+ +N + F N
Sbjct: 616 MRFNPFDCTCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 2e-74
Identities = 98/546 (17%), Positives = 176/546 (32%), Gaps = 76/546 (13%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
V D S+ + + + + +N +N R +L +L + N+ S
Sbjct: 7 EVADCSHLKLTQVPD---DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISN 198
P + L+ L+L+ N L+ + +N
Sbjct: 64 LEPELCQKLPM-------------------------LKVLNLQHNELSQLSDKTFAFCTN 98
Query: 199 LQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLE 258
L L + N + + + ++L L +S N S + + +L+ + L N+++
Sbjct: 99 LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158
Query: 259 GSLPVNIG-FSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDF--- 314
+ F+ +L+ L + N P L L + +
Sbjct: 159 ALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLE 218
Query: 315 NRLPNLFRLSFSKNNLGT---GAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANL 371
++ LS S + L T L + L L L N V S A L
Sbjct: 219 LANTSIRNLSLSNSQLSTTSNTTFLGL-------KWTNLTMLDLSYNNLNVVGNDSFAWL 271
Query: 372 SSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHN------ 425
L LEYN + H++ L N++ L+L +
Sbjct: 272 P----------------QLEYFF---LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI 312
Query: 426 ---NLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLT-GALPP 481
+L S L L L++ N + G + NL LS+SN+ + L
Sbjct: 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTN 372
Query: 482 QILGIVTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVS-LSACTTL 538
+ + S L L+L+ N ++ L +L L L N E+ +
Sbjct: 373 ETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENI 432
Query: 539 EYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSG--QIPEFLENLSFLEYLNLSYNHL 596
+Y+ N + + S++ L L R L P + L L L+LS N++
Sbjct: 433 FEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492
Query: 597 EGEVPR 602
Sbjct: 493 ANINDD 498
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 6e-61
Identities = 109/546 (19%), Positives = 183/546 (33%), Gaps = 60/546 (10%)
Query: 76 QRVTVLDLSNRSIEGILSP--YVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILAN 133
+ + L LSN I+ + S + S L+ + ++N PG + RL L L N
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204
Query: 134 NSFSGKIPSNLS---RCSNLINFHARGNNLVGQIPPDI-GYSWLKLEFLSLRDNLLAGQL 189
+ L +++ N + L G W L L L N L
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264
Query: 190 APSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYL---------SISENAFSGMFPSS 240
S + L+ + N + SL L ++ YL SIS + + S
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
Query: 241 IFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLS----NASNL 296
+ LE +++ N + G + N+ L NL+ LS+ + + + + S L
Sbjct: 325 FQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL 383
Query: 297 RLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLD 356
+L+ + N S F+ L +L L N + + ++ + + L
Sbjct: 384 HILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI-GQELTGQEW----RGLENIFEIYLS 438
Query: 357 TNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTG--PIPHAIGEL 414
N + + S A + +L L L L P L
Sbjct: 439 YNKYLQLTRNSFALVP----------------SLQRLM---LRRVALKNVDSSPSPFQPL 479
Query: 415 RNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKL--------RGHVPSSLGNCQNLM 466
RNL +LDL +NN+ + L L L LDL N L G L +L
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 467 LLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSN 526
+L++ +N +P ++ + ++DL N L + N +L L L +N ++
Sbjct: 540 ILNLESNGFDE-IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS 598
Query: 527 EIPVSLS-ACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQI----PEFLE 581
A L L M N + + I E + LS P
Sbjct: 599 VEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYH 658
Query: 582 NLSFLE 587
Sbjct: 659 GFPVRL 664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 8e-61
Identities = 85/427 (19%), Positives = 143/427 (33%), Gaps = 38/427 (8%)
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNR 256
+N+ VL++ N+L + + L L + N S + P + L+ ++L N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 257 LEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNR 316
L L NL L + N+ + NL LD S N S +
Sbjct: 85 LSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 317 LPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTII 376
L NL L S N + +LD S L+ L L +N P +
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIF----ANSSLKKLELSSNQIKEFSPGCFHAIGRLFG 199
Query: 377 LFSMGLNQI---------YVKNLVNLNGFGLEYNQLTGPIPHAIGELR--NLQVLDLHHN 425
LF + Q+ ++ L +QL+ L+ NL +LDL +N
Sbjct: 200 LF-LNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
Query: 426 NLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILG 485
NL+ +S L L L +N ++ SL N+ L++ +
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK--------- 309
Query: 486 IVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEG 545
+S L LK L L + +N + L+YL +
Sbjct: 310 -------QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362
Query: 546 NSLTGSIP----LALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVP 601
+ + + L+L++N +S + L LE L+L N + E+
Sbjct: 363 SFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422
Query: 602 RRGVFSN 608
+
Sbjct: 423 -GQEWRG 428
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 7e-52
Identities = 85/417 (20%), Positives = 141/417 (33%), Gaps = 42/417 (10%)
Query: 72 GHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLIL 131
G + +T+LDLS ++ + + L L + N + LF + L L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 132 ANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAP 191
+ I + +F + LE L++ DN + G +
Sbjct: 304 KRSFTKQSISLA--SLPKIDDFSFQWLK--------------CLEHLNMEDNDIPGIKSN 347
Query: 192 SIGNISNLQVLSIGENRLSGRLPDSLG----QLRSLYYLSISENAFSGMFPSSIFNISSL 247
+ NL+ LS+ + S R + L+ L++++N S + + + L
Sbjct: 348 MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL 407
Query: 248 ESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFS 307
E + L N + L L N+ + + N Y +S + +L+ L
Sbjct: 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467
Query: 308 GQVKID--FNRLPNLFRLSFSKNNLGTGAIGDLDFIAH-LTNCSKLEALGLDTNIFGGVL 364
F L NL L S NN+ L KLE L L N
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIAN-------INDDMLEGLEKLEILDLQHN------ 514
Query: 365 PLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHH 424
NL+ + G ++K L +L+ LE N +L L+++DL
Sbjct: 515 -----NLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569
Query: 425 NNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLG-NCQNLMLLSVSNNKLTGALP 480
NNL+ N L SL+L N + G +NL L + N
Sbjct: 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-45
Identities = 72/321 (22%), Positives = 118/321 (36%), Gaps = 38/321 (11%)
Query: 295 NLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALG 354
+ + D S + ++ + N+ L+ + N L + +F T S+L +L
Sbjct: 5 SHEVADCSHLKLT---QVPDDLPTNITVLNLTHNQLRR--LPAANF----TRYSQLTSLD 55
Query: 355 LDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGEL 414
+ N + P L L LN L++N+L+
Sbjct: 56 VGFNTISKLEPELCQKL----------------PMLKVLN---LQHNELSQLSDKTFAFC 96
Query: 415 RNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNK 474
NL L L N++ L +LDL N L + +NL L +SNNK
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 475 LTGALPPQILGIVTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSL 532
+ L + L I S L L+LS N + P + L L L+ + + L
Sbjct: 157 IQA-LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 533 S---ACTTLEYLYMEGNSLTGSIPLALKTLK--SIKELDLSRNNLSGQIPEFLENLSFLE 587
A T++ L + + L+ + LK ++ LDLS NNL+ + L LE
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275
Query: 588 YLNLSYNHLEGEVPRRGVFSN 608
Y L YN+++
Sbjct: 276 YFFLEYNNIQHLFS--HSLHG 294
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 8e-83
Identities = 97/317 (30%), Positives = 164/317 (51%), Gaps = 36/317 (11%)
Query: 690 SYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECE 748
S +L A+++FS+ N++G+G FG VY+G L + VAVK + ++ G F E E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 749 ALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQ 808
+ HRNL+++ C + +VY YM GS+ L + + ++ +
Sbjct: 80 MISMAVHRNLLRLRGFCM-----TPTERLLVYPYMANGSVASCLRERPESQPPLDWP--K 132
Query: 809 RLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATI 868
R + + A + YLH HC P I+H D+K +N+LLD + A VGDFGLA+ +
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY------ 186
Query: 869 LETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMF---NDG 925
+ +T ++GT+G++APEY G S DV+ +G++LLE+ T +R D +D
Sbjct: 187 -KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 926 LTLHEFAKMALPE-KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCS 984
+ L ++ K L E K+ +VD L + + +E + ++++ +LC+
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYK----------------DEEVEQLIQVALLCT 289
Query: 985 MESPSERIQMTDVVAKL 1001
SP ER +M++VV L
Sbjct: 290 QSSPMERPKMSEVVRML 306
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 1e-81
Identities = 103/623 (16%), Positives = 196/623 (31%), Gaps = 83/623 (13%)
Query: 33 NETDRLALLAIKSQLQ-----------DPLGVTSSWNNSMNLCQW---TGVTCGHRHQRV 78
D AL AI L + + +WN + L W GV + + RV
Sbjct: 267 YIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRV 325
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
T L L+ +G + +G L+ L+ ++F + + + +
Sbjct: 326 TGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRM 385
Query: 139 KIPSNLS------RCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPS 192
S+L+ N + I D S LK + N + ++ +
Sbjct: 386 HYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRIS-LKDTQIGNLTNRITF-ISKA 443
Query: 193 IGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISL 252
I ++ LQ++ + + + + Y EN S N+ L + L
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN-----EELSWSNLKDLTDVEL 498
Query: 253 LGNRLEGSLPVNIGFSLPNLENLSVRQNNYTG---------SLPHSLSNASNLRLLDFSL 303
LP + LP L++L++ N L +++
Sbjct: 499 YNCPNMTQLPDFLY-DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 304 NHFSG-QVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGG 362
N+ ++ L L N + + KL L LD N
Sbjct: 558 NNLEEFPASASLQKMVKLGLLDCVHNKVRH--------LEAFGTNVKLTDLKLDYNQIEE 609
Query: 363 VLPLSIANLSSTIILFSMGLNQIYV-------KNLVNLNGFGLEYNQLTGPIPHA----- 410
+P + + N++ K++ + YN++ +
Sbjct: 610 -IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 411 IGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR-------GHVPSSLGNCQ 463
+ N + L +N + E + ++++ L N + + N
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTY 728
Query: 464 NLMLLSVSNNKLTGALPPQILGIVTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLSE 521
L + + NKLT L TL L +D+S N + S P + N L G+
Sbjct: 729 LLTTIDLRFNKLTS-LSDDF-RATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRH 785
Query: 522 ------NRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNL-SG 574
NR + P ++ C +L L + N + + L + LD++ N S
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISI 842
Query: 575 QIPEFLENLSFLEYLNLSYNHLE 597
+ + Y+ L Y+ +
Sbjct: 843 DVTSVCPYIEAGMYV-LLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-52
Identities = 63/433 (14%), Positives = 126/433 (29%), Gaps = 71/433 (16%)
Query: 183 NLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF 242
++ Q + N + LS+ GR+PD++GQL L LS ++ +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 243 NISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFS 302
+ + +R+ L + Q+ + + +
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDSRISLK 426
Query: 303 LNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGG 362
N + + +KL+ + + F
Sbjct: 427 DTQIGN-----------------LTNRITF-------ISKAIQRLTKLQIIYFANSPFTY 462
Query: 363 VLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDL 422
++ +Y + + L++L ++L
Sbjct: 463 DNIAVDWEDAN------------------------SDYAKQYENEELSWSNLKDLTDVEL 498
Query: 423 HHNNLDGHIPESLGNLTILNSLDLGFNKLRG---------HVPSSLGNCQNLMLLSVSNN 473
++ +P+ L +L L SL++ N+ + + + + N
Sbjct: 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYN 558
Query: 474 KLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLS 533
L L + LLD N + + G L L L N+ EIP
Sbjct: 559 NLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFC 615
Query: 534 ACTT-LEYLYMEGNSLTGSIP--LALKTLKSIKELDLSRNNLSGQIPEFLENLSF----- 585
A T +E L N L IP K++ + +D S N + + ++
Sbjct: 616 AFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674
Query: 586 LEYLNLSYNHLEG 598
+ LSYN ++
Sbjct: 675 ASTVTLSYNEIQK 687
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-31
Identities = 34/241 (14%), Positives = 70/241 (29%), Gaps = 33/241 (13%)
Query: 396 FGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHV 455
F E + + + L L G +P+++G LT L L G +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 456 PSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTG------------- 502
+ +++ L L DL + +
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423
Query: 503 ---------------SIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNS 547
I + L L + + + F+ + E +
Sbjct: 424 SLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAK 478
Query: 548 LTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFS 607
+ L+ LK + +++L Q+P+FL +L L+ LN++ N + ++
Sbjct: 479 QYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT 538
Query: 608 N 608
Sbjct: 539 R 539
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 7e-76
Identities = 112/558 (20%), Positives = 198/558 (35%), Gaps = 45/558 (8%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
L+ S + I + L L F++ RL+TL+L N
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNIS 197
+ LS L + + I ++ LE L L N ++ P
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 198 NLQVLSIGENRLSGRLPDSLGQLRSL--YYLSISENAFSGMFPSSIFNISSLESISLLGN 255
L+VL N + + + L+ L+++ N +G F+ + +S++ G
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGT 212
Query: 256 RLEGSLPVNIGFS-LPNLENLSVRQNNYTGSLPHSLSNASNLRL--LDFSLNHFSGQVKI 312
+ + + S + +L + + P + + ++ ++F
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272
Query: 313 DFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLS 372
F+ L L + +L + L S L+ L L N F + +S +N
Sbjct: 273 TFHCFSGLQELDLTATHLSE-------LPSGLVGLSTLKKLVLSANKFENLCQISASNF- 324
Query: 373 STIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPI-PHAIGELRNLQVLDLHHNNLD--G 429
+L +L+ ++ N + + L NL+ LDL H++++
Sbjct: 325 ---------------PSLTHLS---IKGNTKRLELGTGCLENLENLRELDLSHDDIETSD 366
Query: 430 HIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTL 489
L NL+ L SL+L +N+ + C L LL ++ +L + L
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426
Query: 490 SILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPV---SLSACTTLEYLYMEGN 546
+L+LS +LL S L L L L N F SL LE L +
Sbjct: 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC 486
Query: 547 SLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVF 606
L+ A +LK + +DLS N L+ E L +L + YLNL+ NH+ +P +
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP--SLL 543
Query: 607 SNKT---RFYFTGNKRLC 621
+ N C
Sbjct: 544 PILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 4e-67
Identities = 98/519 (18%), Positives = 179/519 (34%), Gaps = 26/519 (5%)
Query: 109 NNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDI 168
N G + EIPG + E L + N + SR NL + I D
Sbjct: 21 NLGLN-EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-IHEDT 76
Query: 169 GYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSI 228
S +L+ L L N L ++ L+ L + +S L ++L L +
Sbjct: 77 FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136
Query: 229 SENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVR-QNNYTGSLP 287
N S + F L+ + N + L SL NLS+ N +
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIAGIE 195
Query: 288 HSLSNASNLRLLDFSLNHFSGQV--KIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLT 345
+++ + L+F + + + + +L+ +F + + + + ++
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS 255
Query: 346 NCSKLEALGLDTNIFGGVLPLSIANLSS--TIILFSMGLNQI--YVKNLVNLNGFGLEYN 401
+E++ L + F + + S + L + L+++ + L L L N
Sbjct: 256 ----VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSAN 311
Query: 402 QLTGPIPHAIGELRNLQVLDLHHNNLDGHI-PESLGNLTILNSLDLGFNKLR--GHVPSS 458
+ + +L L + N + L NL L LDL + +
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 459 LGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQL 517
L N +L L++S N+ L + LLDL+ L NL L L
Sbjct: 372 LRNLSHLQSLNLSYNEPLS-LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 518 GLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLK---SIKELDLSRNNLSG 574
LS + L++L ++GN +L+ ++ L LS +LS
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 575 QIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFY 613
+L + +++LS+N L S+ Y
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSI--EALSHLKGIY 527
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 8e-56
Identities = 94/488 (19%), Positives = 167/488 (34%), Gaps = 40/488 (8%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
L I I + N L + +N S + +L+ L NN+
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
Query: 139 KIPSNLSRCSNL--INFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGN- 195
++S ++ + GN++ I P S + L+ + + N
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNS 225
Query: 196 -ISNLQVLSIGENRLSGRLPDSLGQLR--SLYYLSISENAFSGMFPSSIFNISSLESISL 252
I +L + + + P L S+ +++ ++ F + ++ S L+ + L
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDL 285
Query: 253 LGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKI 312
L LP + L L+ L + N + S SN +L L N ++
Sbjct: 286 TATHLS-ELPSGL-VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343
Query: 313 D-FNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANL 371
L NL L S +++ T +L N S L++L L N + +
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQL----RNLSHLQSLNLSYNEPLSLKTEAFKEC 399
Query: 372 SSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTG-PIPHAIGELRNLQVLDLHHNNLDGH 430
L L+ L + +L L L+VL+L H+ LD
Sbjct: 400 P----------------QLELLD---LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440
Query: 431 IPESLGNLTILNSLDLGFNKLRG---HVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIV 487
+ L L L+L N +SL L +L +S L+ + +
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS-IDQHAFTSL 499
Query: 488 TLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNS 547
+ +DLS N LT S + +LK + L L+ N S +P L + + + N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNP 558
Query: 548 LTGSIPLA 555
L +
Sbjct: 559 LDCTCSNI 566
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-50
Identities = 100/529 (18%), Positives = 175/529 (33%), Gaps = 82/529 (15%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLE--TLILAN 133
+ + L L + I I P L+ ++F NN ++ L + +L L
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188
Query: 134 NSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSI 193
N +G I + + + G + I + S
Sbjct: 189 NDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS---------------------- 225
Query: 194 GNISNLQVLSIGENRLSGRLPDSLGQLR--SLYYLSISENAFSGMFPSSIFNISSLESIS 251
I +L + + + P L S+ +++ ++ F + ++ S L+ +
Sbjct: 226 -TIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD 284
Query: 252 LLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVK 311
L L LP + L L+ L + N + S SN +L L N ++
Sbjct: 285 LTATHLS-ELPSGL-VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342
Query: 312 ID-FNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIAN 370
L NL L S +++ T +L N S L++L L N + +
Sbjct: 343 TGCLENLENLRELDLSHDDIETSDCCNLQL----RNLSHLQSLNLSYNEPLSLKTEAFKE 398
Query: 371 LSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTG-PIPHAIGELRNLQVLDLHHNNLDG 429
L L+ L + +L L L+VL+L H+ LD
Sbjct: 399 CP----------------QLELLD---LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 430 HIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTL 489
+ L L L+L N + Q L L +
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI------------------- 480
Query: 490 SILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLT 549
L LS L+ +LK + + LS NR ++ +LS + YL + N ++
Sbjct: 481 ---LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHIS 536
Query: 550 GSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEG 598
+P L L + ++L +N L N+ FLE+ + LE
Sbjct: 537 IILPSLLPILSQQRTINLRQNPLDCTC----SNIYFLEWYKENMQKLED 581
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-35
Identities = 76/427 (17%), Positives = 135/427 (31%), Gaps = 40/427 (9%)
Query: 58 NNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEGILSPYVGNLSF--LRFINFANNGFSGE 115
+ NL Q + + + E I L + IN + F
Sbjct: 210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNI 269
Query: 116 IPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKL 175
L+ L L S ++PS L S L N + ++ L
Sbjct: 270 SSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF-ENLCQISASNFPSL 327
Query: 176 EFLSLRDNLLAGQLAP-SIGNISNLQVLSIGENRL--SGRLPDSLGQLRSLYYLSISENA 232
LS++ N +L + N+ NL+ L + + + S L L L L++S N
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 233 FSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSN 292
+ + LE + L RL+ + +L L+ L++ + S
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447
Query: 293 ASNLRLLDFSLNHFSGQVKID---FNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSK 349
L+ L+ NHF L L L S +L + I F T+
Sbjct: 448 LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS--IDQHAF----TSLKM 501
Query: 350 LEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPH 409
+ + L N ++++L + L N ++ +P
Sbjct: 502 MNHVDLSHNRLTSSSIEALSHLKGIYLN--------------------LASNHISIILPS 541
Query: 410 AIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLS 469
+ L + ++L N LD + N+ L KL + N L +
Sbjct: 542 LLPILSQQRTINLRQNPLDC----TCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVR 597
Query: 470 VSNNKLT 476
+S+ L+
Sbjct: 598 LSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-34
Identities = 54/328 (16%), Positives = 95/328 (28%), Gaps = 58/328 (17%)
Query: 275 LSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGA 334
+ +P +L ++ L+FS N F+RL NL L ++ +
Sbjct: 17 YNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQI---- 69
Query: 335 IGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLN 394
+ + F + L+
Sbjct: 70 ------------------YWIHEDTFQ---------------------------SQHRLD 84
Query: 395 GFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGH 454
L N L A+ + L+ L + L N L SL LG N +
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 455 VPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL-LDLSGNLLTGSIPAEVGNLKN 513
+ L +L NN + + + + L L+L+GN + I +
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAV 203
Query: 514 LVQLGLSENRFSNEIPVSLSACT--TLEYLYMEGNSLTGSIPLALKTLK--SIKELDLSR 569
L + I L T +L E P + L S++ ++L +
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 570 NNLSGQIPEFLENLSFLEYLNLSYNHLE 597
+ S L+ L+L+ HL
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS 291
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 43/212 (20%), Positives = 73/212 (34%), Gaps = 6/212 (2%)
Query: 418 QVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTG 477
+ + + L+ IP +L N L+ FN L ++ NL L ++ ++
Sbjct: 15 KTYNCENLGLN-EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 478 ALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTT 537
+ L L+ N L + K L L + S+ + L T
Sbjct: 72 -IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130
Query: 538 LEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLE--YLNLSYNH 595
LE LY+ N ++ + +K LD N + E + +L LNL+ N
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190
Query: 596 LEGEVPRRGVFSNKTRFYFTGNKRLCGGLDEL 627
+ G P + F G + L L
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGL 222
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 6e-75
Identities = 96/314 (30%), Positives = 147/314 (46%), Gaps = 35/314 (11%)
Query: 690 SYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEA 749
DL +ATN+F +IG G FG VY+G L + VA+K + + F E E
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 750 LRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQR 809
L RH +L+ +I C +E + ++Y+YME G+L+ L+ S+ ++ QR
Sbjct: 89 LSFCRHPHLVSLIGFC-----DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE--QR 141
Query: 810 LNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATIL 869
L + I A + YLH I+H D+K N+LLD + V + DFG+++ +
Sbjct: 142 LEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL- 197
Query: 870 ETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDG-LTL 928
ST +KGT+GY+ PEY + G ++ DVYSFG++L E+ R + L
Sbjct: 198 -----STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 929 HEFAKMALPE-KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMES 987
E+A + ++ +IVDP L +I E L V C S
Sbjct: 253 AEWAVESHNNGQLEQIVDPNL--------------ADKIRP--ESLRKFGDTAVKCLALS 296
Query: 988 PSERIQMTDVVAKL 1001
+R M DV+ KL
Sbjct: 297 SEDRPSMGDVLWKL 310
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 9e-71
Identities = 101/536 (18%), Positives = 187/536 (34%), Gaps = 29/536 (5%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
+DLS ++ + S N S L++++ + L L LIL N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAG-QLAPSIGNI 196
P + S ++L N A L + + L+ L++ N + +L N+
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLAS-LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLR----SLYYLSISENAFSGMFPSSIFNISSLESISL 252
+NL + + N + + L LR L +S N F L ++L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTL 211
Query: 253 LGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSL------PHSLSNASNLRLLDFSLNH- 305
GN ++ +L L + + P + ++ + +F L +
Sbjct: 212 RGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271
Query: 306 -FSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVL 364
+ F+ L N+ +S + ++ + + K ++L +
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIKY--------LEDVPKHFKWQSLSIIRCQLKQFP 323
Query: 365 PLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGEL--RNLQVLDL 422
L + L S + + G L +L+ L N L+ + +L +L+ LDL
Sbjct: 324 TLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383
Query: 423 HHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVP-SSLGNCQNLMLLSVSNNKLTGALPP 481
N + + L L LD + L+ S+ + + L+ L +S
Sbjct: 384 SFNGA-IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442
Query: 482 QILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLSENRFSNEIPVSLSACTTLEY 540
LG+ +L+ L ++GN + + V N NL L LS+ + L+
Sbjct: 443 IFLGLTSLNTL-KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501
Query: 541 LYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHL 596
L M N+L L S+ LD S N + L + NL+ N +
Sbjct: 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-67
Identities = 97/556 (17%), Positives = 182/556 (32%), Gaps = 29/556 (5%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
++ + + S + I+ + N L+ L L+
Sbjct: 14 ITYQCMDQKLSKVPD---DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISN 198
+L N GN + P LE L + LA + IG +
Sbjct: 71 IEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129
Query: 199 LQVLSIGENRLSG-RLPDSLGQLRSLYYLSISENAFSGMFPSSIFNIS----SLESISLL 253
L+ L++ N + +LP L +L ++ +S N + + + + S+ +
Sbjct: 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189
Query: 254 GNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLP-HSLSNASNLRLLDFSLNHFSGQVKI 312
N ++ + F L L++R N + ++ L N + L + L F + +
Sbjct: 190 LNPID-FIQDQA-FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247
Query: 313 D------FNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPL 366
+ L ++ F + + F + + A+ L + +
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF----HCLANVSAMSLAGVSIKYLEDV 303
Query: 367 SIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNN 426
++ + L Q +L L L N+ + I L +L LDL N
Sbjct: 304 PKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNA 361
Query: 427 LDGHIPESLGNLTI--LNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQIL 484
L S +L L LDL FN + ++ + L L ++ L
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420
Query: 485 GIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVS-LSACTTLEYLYM 543
+ + LD+S L +L L ++ N F + + + T L +L +
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480
Query: 544 EGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPR- 602
L TL ++ L++S NNL L L L+ S+N +E
Sbjct: 481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
Query: 603 RGVFSNKTRFYFTGNK 618
+ + F T N
Sbjct: 541 QHFPKSLAFFNLTNNS 556
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-57
Identities = 95/548 (17%), Positives = 161/548 (29%), Gaps = 55/548 (10%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
LDLS IE I L L + N PG L LE L+ +
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLL----AGQLAPSIG 194
+ + L + N + P + L + L N + L
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF-NISSLESISLL 253
N L + N + + D Q L+ L++ N S + N++ L L+
Sbjct: 179 NPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 254 GNRLEG-----SLPVNIGFSLPNL--ENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHF 306
+ +I L ++ + + N +N+ + +
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
Query: 307 SGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHL-------------TNCSKLEAL 353
+ LS + L DL F+ L L L
Sbjct: 298 KYLEDVPK--HFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYL 355
Query: 354 GLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGE 413
L N S ++L + +L +L+ L +N +
Sbjct: 356 DLSRNALSFSGCCSYSDLGTN--------------SLRHLD---LSFNGAII-MSANFMG 397
Query: 414 LRNLQVLDLHHNNLDGHIPES-LGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSN 472
L LQ LD H+ L S +L L LD+ + + +L L ++
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAG 457
Query: 473 NKLTGALPPQILGIVTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPV 530
N + + L LDLS L L L L +S N
Sbjct: 458 NSFKDNTLSNVFA--NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515
Query: 531 SLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLN 590
+ +L L N + S + KS+ +L+ N+++ I E+ FL+++
Sbjct: 516 HYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVAC-IC---EHQKFLQWVK 571
Query: 591 LSYNHLEG 598
L
Sbjct: 572 EQKQFLVN 579
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-54
Identities = 104/493 (21%), Positives = 176/493 (35%), Gaps = 45/493 (9%)
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNIS 197
G + + N+ + L ++P DI S + + L N L + S N S
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPSS---TKNIDLSFNPLKILKSYSFSNFS 56
Query: 198 NLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRL 257
LQ L + + + L L L ++ N P S ++SLE++ + +L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 258 EGSLPVNIGFSLPNLENLSVRQNNYTG-SLPHSLSNASNLRLLDFSLNHFSGQVKIDFNR 316
SL L L+ L+V N LP SN +NL +D S N+ D
Sbjct: 117 A-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175
Query: 317 LPNL----FRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTN-IFGGVLPLSIANL 371
L L S N + I D F KL L L N ++ + NL
Sbjct: 176 LRENPQVNLSLDMSLNPIDF--IQDQAF-----QGIKLHELTLRGNFNSSNIMKTCLQNL 228
Query: 372 SSTIIL-----FSMGLNQIYV------KNLVNLNG--FGLEYNQLTGPIPHAIGELRNLQ 418
+ + + + + L ++ F L Y L N+
Sbjct: 229 AGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVS 288
Query: 419 VLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGA 478
+ L ++ E + SL + +L+ L ++L L + NK +
Sbjct: 289 AMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTL---TMNKGS-- 341
Query: 479 LPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLK--NLVQLGLSENRFSNEIPVSLSACT 536
+ + + + +LS L DLS N L+ S +L +L L LS N + +
Sbjct: 342 ISFKKVALPSLSYL-DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLE 399
Query: 537 TLEYLYMEGNSLTGSIPL-ALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNH 595
L++L + ++L A +L+ + LD+S N L+ L L ++ N
Sbjct: 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNS 459
Query: 596 LEGEVPRRGVFSN 608
+ VF+N
Sbjct: 460 FKDNTL-SNVFAN 471
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-28
Identities = 57/400 (14%), Positives = 117/400 (29%), Gaps = 62/400 (15%)
Query: 77 RVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSF 136
+ L+ + L+ + ++ A ++ + F+ ++L +
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL 319
Query: 137 SGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNI 196
+L L+ L+L N ++ +
Sbjct: 320 KQFPTLDLPF----------------------------LKSLTLTMNKG--SISFKKVAL 349
Query: 197 SNLQVLSIGENRLSGRLPDSLGQL--RSLYYLSISENAFSGMFPSSIFNISSLESISLLG 254
+L L + N LS S L SL +L +S N M ++ + L+ +
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFMGLEELQHLDFQH 408
Query: 255 NRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKID- 313
+ L+ + SL L L + N ++L L + N F +
Sbjct: 409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468
Query: 314 FNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSS 373
F NL L SK L + +L+ L + N + L S
Sbjct: 469 FANTTNLTFLDLSKCQL-EQISWGV-----FDTLHRLQLLNMSHNNLLFLDSSHYNQLYS 522
Query: 374 TIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPE 433
L L+ +N++ ++L +L +N++ I E
Sbjct: 523 ----------------LSTLD---CSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICE 562
Query: 434 SLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNN 473
L + + ++ ++L +N+
Sbjct: 563 HQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNNS 602
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 7e-06
Identities = 19/85 (22%), Positives = 32/85 (37%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
+T LDLS +E I L L+ +N ++N +L+ L TL + N
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 136 FSGKIPSNLSRCSNLINFHARGNNL 160
+L F+ N++
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSV 557
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 6e-66
Identities = 80/326 (24%), Positives = 134/326 (41%), Gaps = 54/326 (16%)
Query: 690 SYADLSKATNDFSS------SNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKS- 742
S+ +L TN+F N +G+G FG VY+G + VAVK L +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKK--LAAMVDITTE 71
Query: 743 -----FVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSND 797
F E + + +H NL++++ S + D +VY YM GSL D L +
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 798 QLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857
+ R + A I +LH + +H D+K +N+LLD A + DFGLA
Sbjct: 127 TP---PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
R + + ++ I GT Y+APE + G+++ D+YSFG++LLE+ T
Sbjct: 181 RASEKFAQTVM------TSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPA 233
Query: 918 TDNMFNDGLTLHEFAKMALPEK--VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVA 975
D L + + E+ + + +D + + T +
Sbjct: 234 VDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKMN----------DADSTSVEA------- 275
Query: 976 IVRIGVLCSMESPSERIQMTDVVAKL 1001
+ + C E ++R + V L
Sbjct: 276 MYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 4e-59
Identities = 70/328 (21%), Positives = 121/328 (36%), Gaps = 45/328 (13%)
Query: 690 SYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECE- 748
+L + + +G FG V++ L VAVK+ +S+ E E
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFP---IQDKQSWQNEYEV 69
Query: 749 -ALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVI 807
+L ++H N+++ I +VD ++ + E GSL D+L + +
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKANV-------VSWN 121
Query: 808 QRLNLVIDVAFAIEYLHHH-------CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860
+ ++ +A + YLH P I H D+K NVLL +++ A + DFGLA
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-----DMSATGDVYSFGILLLEMFTRR 915
+ + G GT Y+APE G D D+Y+ G++L E+ +R
Sbjct: 182 EAGK------SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 916 RPTDNMFNDGLTLHEFAKMALP--EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECL 973
D ++ + E P E + E+V R H +
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVH-KKKRPVLR-DYWQKH--------AGM 285
Query: 974 VAIVRIGVLCSMESPSERIQMTDVVAKL 1001
+ C R+ V ++
Sbjct: 286 AMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 1e-57
Identities = 101/532 (18%), Positives = 183/532 (34%), Gaps = 44/532 (8%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
LDLS + + S + L+ ++ + G L L TLIL N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNIS 197
+ L+ L + LA IG++
Sbjct: 90 -------------------------SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124
Query: 198 NLQVLSIGENRL-SGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLE----SISL 252
L+ L++ N + S +LP+ L +L +L +S N ++ + + + + S+ L
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 253 LGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPH-SLSNASNLRLLDFSLNHFSGQVK 311
N + + F L L++R N + ++ + + L + L F +
Sbjct: 185 SLNPMN-FIQPGA-FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 312 I---DFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSI 368
+ D + L L L+ + L D I + + + L + V S
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302
Query: 369 ANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLD 428
+ L + Q L +L N+ + +L +L+ LDL N L
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLS 360
Query: 429 --GHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGI 486
G +S T L LDL FN + + S+ + L L ++ L +
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 487 VTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLSENRFSNEI-PVSLSACTTLEYLYME 544
+ I LD+S + L +L L ++ N F P + L +L +
Sbjct: 420 LRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 545 GNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHL 596
L P A +L S++ L+++ N L + L+ L+ + L N
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-43
Identities = 96/470 (20%), Positives = 161/470 (34%), Gaps = 33/470 (7%)
Query: 156 RGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPD 215
N +IP ++ +S + L L N L + S + LQVL + +
Sbjct: 15 MELNFY-KIPDNLPFS---TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 216 SLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENL 275
+ L L L ++ N + + +SSL+ + + L SL L L+ L
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKEL 129
Query: 276 SVRQNNYT-GSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNL----FRLSFSKNNL 330
+V N LP SN +NL LD S N D L + L S N +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 331 GTGAIGDLDFI--AHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVK 388
G I LT + ++L + G+ L + L L +
Sbjct: 190 NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 389 NLVNLNGFGLEYNQLTG------PIPHAIGELRNLQVLDLHHNNLDGHIPES-LGNLTIL 441
L L +E +L I L N+ L ++ S L
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309
Query: 442 NSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLT 501
++ F + ++L L+ ++NK A + + +L L DLS N L+
Sbjct: 310 ELVNCKFGQFPTL------KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFL-DLSRNGLS 360
Query: 502 --GSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPL-ALKT 558
G +L L LS N + + LE+L + ++L +
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 559 LKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
L+++ LD+S + LS LE L ++ N + +F+
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-29
Identities = 76/447 (17%), Positives = 145/447 (32%), Gaps = 79/447 (17%)
Query: 77 RVTVLDLSNRSIEGILSPYVGNLSFLRF----INFANNGFSGEIPGEIGRLFRLETLILA 132
+ LDLS+ I+ I + L + ++ + N + I + RL L L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208
Query: 133 NNSFSGKIPSNL------SRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLR---DN 183
NN S + L+ R + + L R +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 184 LLAGQLAPSIGNISNLQVLSIGENRLSGRLPDS-LGQLRSLYYLSISENAFSGMFPSSIF 242
+ ++N+ S+ + S + L ++ F
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------L 322
Query: 243 NISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQN--NYTGSLPHSLSNASNLRLLD 300
+ SL+ ++ N+ + LP+LE L + +N ++ G S ++L+ LD
Sbjct: 323 KLKSLKRLTFTSNKGGNAFS---EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 301 FSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIF 360
S N + +F L L L F +NL + + L
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ--MSEFSVFLSLR--------------- 421
Query: 361 GGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVL 420
NL+ L+ + + L +L+VL
Sbjct: 422 ----------------------------NLIYLD---ISHTHTRVAFNGIFNGLSSLEVL 450
Query: 421 DLHHNNLDGHI-PESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGAL 479
+ N+ + P+ L L LDL +L P++ + +L +L++++N+L ++
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SV 509
Query: 480 PPQIL-GIVTLSILLDLSGNLLTGSIP 505
P I + +L + L N S P
Sbjct: 510 PDGIFDRLTSLQK-IWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 8e-14
Identities = 40/191 (20%), Positives = 69/191 (36%), Gaps = 6/191 (3%)
Query: 76 QRVTVLDLSNRSIE--GILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILAN 133
+ LDLS + G S + L++++ + NG + L +LE L +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQH 405
Query: 134 NSFSGKIPSN-LSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPS 192
++ + NLI + I LE L + N P
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
Query: 193 I-GNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESIS 251
I + NL L + + +L P + L SL L+++ N + ++SL+ I
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIW 524
Query: 252 LLGNRLEGSLP 262
L N + S P
Sbjct: 525 LHTNPWDCSCP 535
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 6e-56
Identities = 71/327 (21%), Positives = 125/327 (38%), Gaps = 32/327 (9%)
Query: 690 SYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECE- 748
+ ++ S ++ +IG+G +G VY+G+L E VAVKV + R ++F+ E
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANR---QNFINEKNI 58
Query: 749 -ALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVI 807
+ + H N+ + I + + +V EY GSL +L + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-------SDWV 111
Query: 808 QRLNLVIDVAFAIEYLH------HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP 861
L V + YLH H P I H DL NVL+ +D + DFGL+ L
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 862 PCSPATILETPSSSTGIKGTVGYVAPEYGMG-------GDMSATGDVYSFGILLLEMFTR 914
E +++ GT+ Y+APE G D+Y+ G++ E+F R
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 915 RRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLV 974
TD + + + +MA +V + L +R + +
Sbjct: 232 C--TDLFPGESVPEY---QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVR 286
Query: 975 AIVRIGVLCSMESPSERIQMTDVVAKL 1001
++ C + R+ ++
Sbjct: 287 SLKETIEDCWDQDAEARLTAQXAEERM 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 6e-53
Identities = 77/260 (29%), Positives = 119/260 (45%), Gaps = 28/260 (10%)
Query: 671 KHKHKSSSM-------LLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGEN 723
KH H M + D+ D + IG GSFG V+R +
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--H 59
Query: 724 EMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781
VAVK++ + A F+ E ++ +RH N++ + + + +IV E
Sbjct: 60 GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----QPPNLSIVTE 114
Query: 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNV 841
Y+ GSL LH+S + + + +RL++ DVA + YLH+ +PPIVH +LK N+
Sbjct: 115 YLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNL 170
Query: 842 LLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDV 901
L+D V DFGL+R T SS GT ++APE + DV
Sbjct: 171 LVDKKYTVKVCDFGLSRLKA--------STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 902 YSFGILLLEMFTRRRPTDNM 921
YSFG++L E+ T ++P N+
Sbjct: 223 YSFGVILWELATLQQPWGNL 242
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-52
Identities = 74/317 (23%), Positives = 129/317 (40%), Gaps = 65/317 (20%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVM-------NLKQRGATKSFVAECEALR 751
N+ IG+G FG V++G L +++ VA+K + + + F E +
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 752 NIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLN 811
N+ H N++K+ + + +V E++ CG L L ++ +L
Sbjct: 79 NLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWS-----VKLR 126
Query: 812 LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD-----HDMVAHVGDFGLARFLPPCSPA 866
L++D+A IEY+ + +PPIVH DL+ N+ L + A V DFGL++
Sbjct: 127 LMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-------- 177
Query: 867 TILETPSSSTGIKGTVGYVAPEYGMGGDMSAT--GDVYSFGILLLEMFTRRRPTDNMFND 924
++ S +G+ G ++APE + S T D YSF ++L + T P D
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY--- 231
Query: 925 GLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCS 984
+ K+ + E R I E+C + + LC
Sbjct: 232 -----SYGKIKFINMIRE-----------------EGLRPTI--PEDCPPRLRNVIELCW 267
Query: 985 MESPSERIQMTDVVAKL 1001
P +R + +V +L
Sbjct: 268 SGDPKKRPHFSYIVKEL 284
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-52
Identities = 72/311 (23%), Positives = 123/311 (39%), Gaps = 54/311 (17%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
+ ++G+G+FG V + VA+K ++ K+F+ E L + H N+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNI 63
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
+K+ C + +V EY E GSL + LH + + ++ + +
Sbjct: 64 VKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPY---YTAAHAMSWCLQCSQ 113
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLD-HDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+ YLH ++H DLKP N+LL V + DFG A + + T
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----------QTHMTN 162
Query: 878 IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937
KG+ ++APE G + S DV+S+GI+L E+ TRR+P D + +
Sbjct: 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--------GGPAFRIM 214
Query: 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDV 997
V R + I+ I + C + PS+R M ++
Sbjct: 215 WAVHN------------------GTRPPL--IKNLPKPIESLMTRCWSKDPSQRPSMEEI 254
Query: 998 VAKLCSARKIF 1008
V + + F
Sbjct: 255 VKIMTHLMRYF 265
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 4e-50
Identities = 49/231 (21%), Positives = 91/231 (39%), Gaps = 34/231 (14%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA--TKSFVAECEALRNIRHR 756
+ + + G +++G N+ + VKV+ ++ ++ F EC LR H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
N++ ++ C S ++ +M GSL + LH+ + + Q + +D+
Sbjct: 68 NVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTNF----VVDQSQAVKFALDM 120
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
A + +LH P I L +V++D DM A + + S
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------------QSP 166
Query: 877 GIKGTVGYVAPE------YGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921
G +VAPE + D++SF +LL E+ TR P ++
Sbjct: 167 GRMYAPAWVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVPFADL 214
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-49
Identities = 109/523 (20%), Positives = 186/523 (35%), Gaps = 66/523 (12%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
+ + I I + L+ + + L ++ TL
Sbjct: 5 SATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK- 59
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISN 198
+ +NL + N L I P + KL + + +N +A + N++N
Sbjct: 60 -SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLT--KLVDILMNNNQIAD--ITPLANLTN 113
Query: 199 LQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLE 258
L L++ N+++ D L L +L L +S N S S++ ++SL+ +S GN++
Sbjct: 114 LTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVT 168
Query: 259 GSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLP 318
P+ +L LE L + N + L+ +NL L + N S L
Sbjct: 169 DLKPLA---NLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDI--TPLGILT 221
Query: 319 NLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILF 378
NL LS + N L I L + + L L L N + PLS
Sbjct: 222 NLDELSLNGNQLKD--------IGTLASLTNLTDLDLANNQISNLAPLS----------- 262
Query: 379 SMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNL 438
L L L NQ++ P + L L L+L+ N L+ + NL
Sbjct: 263 ----------GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNL 308
Query: 439 TILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGN 498
L L L FN + S + + L L NNK++ + + ++ L N
Sbjct: 309 KNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWL-SAGHN 363
Query: 499 LLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKT 558
++ P + NL + QLGL++ ++N + + + +L P +
Sbjct: 364 QISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISD 419
Query: 559 LKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVP 601
S E D++ N S E S + G V
Sbjct: 420 GGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-48
Identities = 57/242 (23%), Positives = 97/242 (40%), Gaps = 23/242 (9%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G+G FG + E + +K + ++F+ E + +R + H N++K I V
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
++ + EY++ G+L + + Q QR++ D+A + YLH
Sbjct: 78 K---DKRLN--FITEYIKGGTLRGIIKSMDSQY-----PWSQRVSFAKDIASGMAYLHSM 127
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCS------PATILETPSSSTGIKG 880
I+H DL N L+ + V DFGLAR + + + G
Sbjct: 128 ---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMF----NDGLTLHEFAKMAL 936
++APE G DV+SFGI+L E+ R + + GL + F
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244
Query: 937 PE 938
P
Sbjct: 245 PP 246
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-48
Identities = 77/302 (25%), Positives = 129/302 (42%), Gaps = 57/302 (18%)
Query: 707 IGQGSFGFVYRGNL-GENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIIT 763
IG GSFG VY+G G+ VAVK++N+ ++F E LR RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
++ AIV ++ E SL LH S + + + +++ A ++YL
Sbjct: 88 YSTAPQL------AIVTQWCEGSSLYHHLHASETKF-----EMKKLIDIARQTARGMDYL 136
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
H I+H DLK +N+ L D +GDFGLA + G++
Sbjct: 137 HAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW------SGSHQFEQLSGSIL 187
Query: 884 YVAPE---YGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940
++APE S DVY+FGI+L E+ T + P N+ N +++
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------------RDQI 234
Query: 941 MEIVDPLLLLDLEARASNCGSHRTEIAKI-EECLVAIVRIGVLCSMESPSERIQMTDVVA 999
+E+V GS +++K+ C + R+ C + ER ++A
Sbjct: 235 IEMV-------------GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281
Query: 1000 KL 1001
++
Sbjct: 282 EI 283
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-48
Identities = 57/229 (24%), Positives = 88/229 (38%), Gaps = 36/229 (15%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLK----QRGATKSFVAECEALRNIRHRNLIK 760
+IG G FG VYR VAVK ++ E + ++H N+I
Sbjct: 13 EIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+ VC + +V E+ G L L + +N + +A +
Sbjct: 71 LRGVCL-----KEPNLCLVMEFARGGPLNRVLSGKRIPPD-------ILVNWAVQIARGM 118
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLD--------HDMVAHVGDFGLARFLPPCSPATILETP 872
YLH PI+H DLK SN+L+ + + + DFGLAR
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----------WHR 168
Query: 873 SSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921
++ G ++APE S DV+S+G+LL E+ T P +
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-47
Identities = 111/576 (19%), Positives = 196/576 (34%), Gaps = 66/576 (11%)
Query: 70 TCGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETL 129
+C + + ++ + L+ + + N L +L+ L
Sbjct: 1 SCSFDGR---IAFYRFCNLTQVPQ----VLNTTERLLLSFNYIRTVTASSFPFLEQLQLL 53
Query: 130 ILANNSFSGKIPSN-LSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQ 188
L + I NL + + + PD L L L L+
Sbjct: 54 ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDA 112
Query: 189 LAPS--IGNISNLQVLSIGENRLSG-RLPDSLGQLRSLYYLSISENAFSGMFPSSIFNIS 245
+ N+ L L + +N++ L S G+L SL + S N + + +
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172
Query: 246 --SLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSL 303
+L SL N L + V+ G + N+ + + +G N + +
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFS 225
Query: 304 NHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGV 363
N S ++ F +N+ D + A L S + L L +
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDP---DQNTFAGLARSS-VRHLDLSHGFVFSL 281
Query: 364 LPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLH 423
L K+L LN L YN++ A L NLQVL+L
Sbjct: 282 NSRVFETL----------------KDLKVLN---LAYNKINKIADEAFYGLDNLQVLNLS 322
Query: 424 HNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLT-----GA 478
+N L + L + +DL N + + + L L + +N LT +
Sbjct: 323 YNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPS 382
Query: 479 LPPQILGIVTLSIL---------LDLSGNLLTG-SIPAEVGNLKNLVQLGLSENRFSN-E 527
+P L L L + LS N L I + + +L L L++NRFS+
Sbjct: 383 IPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCS 442
Query: 528 IPVSLSACTTLEYLYMEGNSLTGSI-----PLALKTLKSIKELDLSRNNLSGQIPEFLEN 582
+ S +LE L++ N L + + L ++ L L+ N L+ P +
Sbjct: 443 GDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSH 502
Query: 583 LSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNK 618
L+ L L+L+ N L + + +N + N+
Sbjct: 503 LTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQ 537
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 7e-43
Identities = 122/647 (18%), Positives = 210/647 (32%), Gaps = 71/647 (10%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEI-PGEIGRLFRLETLILANNSF 136
L LS I + + L L+ + + I L L L L ++
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 137 SGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLK-LEFLSLRDNLLAG-QLAPSIG 194
P +L L + D + LK L L L N + L PS G
Sbjct: 86 YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG 145
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLR--SLYYLSISENAFSGMFPSSIFNIS------S 246
+++L+ + N++ L L+ +L + S++ N+
Sbjct: 146 KLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMV 205
Query: 247 LESISLLGNRLE-----------GSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSN--A 293
LE + + GN ++ +N ++ +
Sbjct: 206 LEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLAR 265
Query: 294 SNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEAL 353
S++R LD S F L +L L+ + N + I D F L+ L
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINK--IADEAF----YGLDNLQVL 319
Query: 354 GLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYV------KNLVNLNGFGLEYNQLTGPI 407
L N+ G + + L + + N I + K L L L N LT
Sbjct: 320 NLSYNLLGELYSSNFYGLPKVAYI-DLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT--- 375
Query: 408 PHAIGELRNLQVLDLHHNNLDGHIPESLGNLTI-LNSLDLGFNKLRG-HVPSSLGNCQNL 465
I + ++ + L N L +L + + N + L N+L + L +L
Sbjct: 376 --TIHFIPSIPDIFLSGNKL-----VTLPKINLTANLIHLSENRLENLDILYFLLRVPHL 428
Query: 466 MLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-----GNLKNLVQLGLS 520
+L ++ N+ + Q L L N+L + E+ L +L L L+
Sbjct: 429 QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLN 488
Query: 521 ENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFL 580
N ++ P S T L L + N LT L +++ LD+SRN L P+
Sbjct: 489 HNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVF 546
Query: 581 ENLSFLEYLNLSYNHLEGEVP-----------RRGVFSNKTRFYFTGNKRLCG-GLDELH 628
+LS L++++N E + Y G L L
Sbjct: 547 VSLS---VLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLS 603
Query: 629 LPVCHSAGPRKTRIALLKVVVPVTVILTIIVACLIVLYTRRRKHKHK 675
C K+ L +V VT+ L ++ + + +K
Sbjct: 604 TEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFCFICYK 650
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-30
Identities = 81/429 (18%), Positives = 158/429 (36%), Gaps = 52/429 (12%)
Query: 77 RVTVLDLSNRSIEGILSPYVGNLSF--LRFINFANNGFSGEIPGEIGRLF------RLET 128
+ +D S+ I + + L L F + A N + + G+ LE
Sbjct: 149 SLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEI 208
Query: 129 LILANNSFSGKIPSNLSRCSNLINFHA-----------RGNNLVGQIPPDI--GYSWLKL 175
L ++ N ++ I N S + + G + + + G + +
Sbjct: 209 LDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSV 268
Query: 176 EFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSG 235
L L + + + +L+VL++ N+++ ++ L +L L++S N
Sbjct: 269 RHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE 328
Query: 236 MFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASN 295
++ S+ + + + I L N + + L L+ L +R N T ++ +
Sbjct: 329 LYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPS 382
Query: 296 LRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGL 355
+ + S N KI+ + S+N L + L F+ + + L+ L L
Sbjct: 383 IPDIFLSGNKLVTLPKINL----TANLIHLSENRLEN--LDILYFLLRVPH---LQILIL 433
Query: 356 DTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELR 415
+ N F + + ++ +G N + + L L
Sbjct: 434 NQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELC-------------WDVFEGLS 480
Query: 416 NLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKL 475
+LQVL L+HN L+ P +LT L L L N+L + + NL +L +S N+L
Sbjct: 481 HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQL 538
Query: 476 TGALPPQIL 484
A P +
Sbjct: 539 L-APNPDVF 546
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 7e-47
Identities = 86/398 (21%), Positives = 163/398 (40%), Gaps = 58/398 (14%)
Query: 178 LSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMF 237
L+ + Q+ P +++ + + ++ + +L S+ L ++ + +
Sbjct: 5 LATLPAPI-NQIFP-DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASI- 59
Query: 238 PSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLR 297
I +++LE ++L GN++ P++ +L L NL + N T +L N +NLR
Sbjct: 60 -QGIEYLTNLEYLNLNGNQITDISPLS---NLVKLTNLYIGTNKITD--ISALQNLTNLR 113
Query: 298 LLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDT 357
L + ++ S L ++ L+ N+ + DL ++++T L L +
Sbjct: 114 ELYLNEDNISD--ISPLANLTKMYSLNLGANHN----LSDLSPLSNMTG---LNYLTVTE 164
Query: 358 NIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNL 417
+ V P++ NL +L L YNQ+ P + L +L
Sbjct: 165 SKVKDVTPIA---------------------NLTDLYSLSLNYNQIEDISP--LASLTSL 201
Query: 418 QVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTG 477
+ N + P + N+T LNSL +G NK+ S L N L L + N+++
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD 257
Query: 478 ALPPQILGIVTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSAC 535
I + L+ L L++ N ++ I + NL L L L+ N+ NE +
Sbjct: 258 -----INAVKDLTKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGL 310
Query: 536 TTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLS 573
T L L++ N +T P L +L + D + +
Sbjct: 311 TNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-43
Identities = 80/395 (20%), Positives = 141/395 (35%), Gaps = 57/395 (14%)
Query: 226 LSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGS 285
L+ + +FP + +++ L + + L ++ L V S
Sbjct: 5 LATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKVA-S 58
Query: 286 LPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLT 345
+ + +NL L+ + N + + L L L N I D+ + +LT
Sbjct: 59 IQ-GIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNK-----ITDISALQNLT 110
Query: 346 NCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTG 405
N L L L+ + + PL+ NL + L N
Sbjct: 111 N---LRELYLNEDNISDISPLA---------------------NLTKMYSLNLGANHNLS 146
Query: 406 PIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNL 465
+ + L L + + + + NLT L SL L +N++ S L + +L
Sbjct: 147 -DLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIED--ISPLASLTSL 201
Query: 466 MLLSVSNNKLTGALPPQILGIVTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLSENR 523
+ N++T I + ++ L L + N +T P + NL L L + N+
Sbjct: 202 HYFTAYVNQITD-----ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQ 254
Query: 524 FSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENL 583
S+ I ++ T L+ L + N ++ I L L + L L+ N L + E + L
Sbjct: 255 ISD-IN-AVKDLTKLKMLNVGSNQIS-DIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGL 310
Query: 584 SFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNK 618
+ L L LS NH+ P S F
Sbjct: 311 TNLTTLFLSQNHITDIRPLAS-LSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-37
Identities = 80/402 (19%), Positives = 144/402 (35%), Gaps = 78/402 (19%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
L S+ + L + + A + I G I L LE L L N
Sbjct: 22 AEGIRAVLQKASVTDV--VTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQ 77
Query: 136 FSGKIP-SNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIG 194
+ P SNL KL L + N + ++
Sbjct: 78 ITDISPLSNLV----------------------------KLTNLYIGTNKITD--ISALQ 107
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLG 254
N++NL+ L + E+ +S L L +Y L++ N S + N++ L +++
Sbjct: 108 NLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTE 164
Query: 255 NRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDF 314
++++ P+ +L +L +LS+ N P L++ ++L +N +
Sbjct: 165 SKVKDVTPIA---NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI--TPV 217
Query: 315 NRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSST 374
+ L L N I DL +A+L+ L L + TN I+++++
Sbjct: 218 ANMTRLNSLKIGNNK-----ITDLSPLANLSQ---LTWLEIGTN--------QISDINA- 260
Query: 375 IILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPES 434
VK+L L + NQ++ + L L L L++N L E
Sbjct: 261 ------------VKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEV 306
Query: 435 LGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLT 476
+G LT L +L L N + L + + +N +
Sbjct: 307 IGGLTNLTTLFLSQNHITD--IRPLASLSKMDSADFANQVIK 346
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 30/230 (13%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECE--ALRNIRHRNLIKII 762
+G+G +G V+RG+ VAVK+ + + KS+ E E +RH N++ I
Sbjct: 14 ECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFI 68
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
+ ++ Y E GSL D+L + + + L +V+ +A + +
Sbjct: 69 ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIASGLAH 120
Query: 823 LH-----HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
LH P I H DLK N+L+ + + D GLA + + +
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN----QLDVGNNP 176
Query: 878 IKGTVGYVAPE------YGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921
GT Y+APE D D+++FG++L E+ R +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-45
Identities = 71/322 (22%), Positives = 126/322 (39%), Gaps = 63/322 (19%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECE--ALRNIRHRNLIKII 762
IG+G FG V+RG E VAVK+ + ++ +S+ E E +RH N++ I
Sbjct: 48 ESIGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
+ + +V +Y E GSL D+L++ V + L + A + +
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAH 154
Query: 823 LH-----HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
LH P I H DLK N+L+ + + D GLA + + +
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI----APNH 210
Query: 878 IKGTVGYVAPEYGMGGDMSATG-------DVYSFGILLLEMFTR----------RRPTDN 920
GT Y+APE + ++ D+Y+ G++ E+ R + P +
Sbjct: 211 RVGTKRYMAPEV-LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 921 MFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAK-IEECLVAIVRI 979
+ ++ E K+ +K L ++ R +C + R +AK + EC A
Sbjct: 270 LVPSDPSVEEMRKVVCEQK--------LRPNIPNRWQSCEALR-VMAKIMRECWYA---- 316
Query: 980 GVLCSMESPSERIQMTDVVAKL 1001
+ + R+ + L
Sbjct: 317 -------NGAARLTALRIKKTL 331
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-45
Identities = 101/553 (18%), Positives = 185/553 (33%), Gaps = 59/553 (10%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
V D +RS I S G + ++ ++ + N + G++ L+ LIL ++ +
Sbjct: 8 GVCDGRSRSFTSIPS---GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN- 63
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISN 198
I D YS LE L L DN L+ + G +S+
Sbjct: 64 ------------------------TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS 99
Query: 199 LQVLSIGENRLSG-RLPDSLGQLRSLYYLSISENAFSGMFPSSIF-NISSLESISLLGNR 256
L+ L++ N + L +L L I F ++SL + +
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159
Query: 257 LEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNR 316
L + S+ ++ +L++ + L S++R L+ + +
Sbjct: 160 LR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV 218
Query: 317 LPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTII 376
+ + + L L L F + + + +
Sbjct: 219 DEVSSPMKKLAFRGSVLTDESFNELLKLLRYI----LELSEVEFDDCTLNGLGDFNPSES 274
Query: 377 LFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLG 436
L ++ + L+ + L + L ++ + + ++ +
Sbjct: 275 DVVSELGKVETVTIRRLH---IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQ 331
Query: 437 NLTILNSLDLGFNKL---RGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL- 492
+L L LDL N + + G +L L +S N L ++ ++TL L
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLT 390
Query: 493 -LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGS 551
LD+S N +P + + L LS V TLE L + N+L S
Sbjct: 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNNNLD-S 445
Query: 552 IPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTR 611
L L L +EL +SRN L +P+ L + +S N L + G+F T
Sbjct: 446 FSLFLPRL---QELYISRNKLK-TLPDAS-LFPVLLVMKISRNQL--KSVPDGIFDRLTS 498
Query: 612 ---FYFTGNKRLC 621
+ N C
Sbjct: 499 LQKIWLHTNPWDC 511
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-27
Identities = 56/382 (14%), Positives = 120/382 (31%), Gaps = 46/382 (12%)
Query: 245 SSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLN 304
+ S+P + +++L + N T L +NL++L +
Sbjct: 5 DASGVCDGRSRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 305 HFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVL 364
+ F L +L L S N+L + + F S L+ L L N
Sbjct: 61 RINTIEGDAFYSLGSLEHLDLSDNHLSS--LSSSWF----GPLSSLKYLNLMGN------ 108
Query: 365 PLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGL-EYNQLTGPIPHAIGELRNLQVLDLH 423
L T + NL NL + + L +L L++
Sbjct: 109 --PYQTLGVTSLF----------PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156
Query: 424 HNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQI 483
+L + +SL ++ ++ L L ++ + ++ L + + L +
Sbjct: 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL 216
Query: 484 LGIVTLSILLDLSGNLLT------GSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSA--- 534
S + L+ + + + L ++ + + + S
Sbjct: 217 PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDV 276
Query: 535 --------CTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFL 586
T+ L++ L + L+ +K + + + + F ++L L
Sbjct: 277 VSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSL 336
Query: 587 EYLNLSYNHLEGEVPRRGVFSN 608
E+L+LS N + E +
Sbjct: 337 EFLDLSENLMVEEYLKNSACKG 358
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 8e-20
Identities = 58/374 (15%), Positives = 113/374 (30%), Gaps = 48/374 (12%)
Query: 60 SMNLCQWTGVTCGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGE 119
++ + V L+L + ++ + + S
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 120 IGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLS 179
L +L IL + C+ + + + + L
Sbjct: 240 FNELLKLLRYILELSEVE------FDDCTLNGLGDFN-PSESDVVSELGKVETVTIRRLH 292
Query: 180 LRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMF-- 237
+ L L+ + ++ +++ +++ L+SL +L +SEN +
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352
Query: 238 -PSSIFNISSLESISLLGNRLEGSLPVNIGF--SLPNLENLSVRQNNYTGSLPHSLSNAS 294
+ SL+++ L N L S+ +L NL +L + +N + +P S
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPE 410
Query: 295 NLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALG 354
+R L+ S + L L S NNL + F L L+ L
Sbjct: 411 KMRFLNLSSTGIR---VVKTCIPQTLEVLDVSNNNLDS-------FSLFLPR---LQELY 457
Query: 355 LDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGEL 414
+ N + L + L+ + + NQL L
Sbjct: 458 ISRN--------KLKTLPDASLF----------PVLLVMK---ISRNQLKSVPDGIFDRL 496
Query: 415 RNLQVLDLHHNNLD 428
+LQ + LH N D
Sbjct: 497 TSLQKIWLHTNPWD 510
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 52/229 (22%), Positives = 87/229 (37%), Gaps = 33/229 (14%)
Query: 705 NMIGQGSFGFVYRGNL-GENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKI 761
+IG+G FG VY G GE VA++++++++ K+F E A R RH N++
Sbjct: 39 ELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
+ C AI+ + +L + + L+V + + ++ +
Sbjct: 95 MGACM----SPPHL-AIITSLCKGRTLYSVVRDAKIVLDVN-----KTRQIAQEIVKGMG 144
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
YLH I+H DLK NV D+ V + DFGL G
Sbjct: 145 YLHAK---GILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAG---RREDKLRIQNGW 197
Query: 882 VGYVAPEYGMGGDMSATG---------DVYSFGILLLEMFTRRRPTDNM 921
+ ++APE DV++ G + E+ R P
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-45
Identities = 54/231 (23%), Positives = 86/231 (37%), Gaps = 32/231 (13%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECE--ALRNIRHRNLIKII 762
IG+G +G V+ G + VAVKV + S+ E E +RH N++ I
Sbjct: 43 KQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFI 97
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
++ +Y E GSL D+L + + L L + +
Sbjct: 98 AADIKGTGSWTQL-YLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCH 149
Query: 823 LH-----HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
LH P I H DLK N+L+ + + D GLA + +
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDI----PPNT 205
Query: 878 IKGTVGYVAPEYGMGGDMSATG-------DVYSFGILLLEMFTRRRPTDNM 921
GT Y+ PE + ++ D+YSFG++L E+ R +
Sbjct: 206 RVGTKRYMPPEV-LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-42
Identities = 108/486 (22%), Positives = 182/486 (37%), Gaps = 83/486 (17%)
Query: 116 IPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKL 175
I L+ + +++ + ++P + ++ + PP G ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNG-EQREM 60
Query: 176 EFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSG 235
LRD L L + LS LP+ L SL S N+ +
Sbjct: 61 AVSRLRDCLD-----------RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT- 104
Query: 236 MFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASN 295
P ++ SL + L LP P LE L V N LP L N+S
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALS-DLP-------PLLEYLGVSNNQLE-KLP-ELQNSSF 154
Query: 296 LRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGL 355
L+++D N K+ + P+L ++ N L + L N L A+
Sbjct: 155 LKIIDVDNNSLK---KL-PDLPPSLEFIAAGNNQLEE--------LPELQNLPFLTAIYA 202
Query: 356 DTNIFGGVLPLSIANLSSTIILFSMGLNQIY----VKNLVNLNGFGLEYNQLTGPIPHAI 411
D N LP +L S G N + ++NL L + N L +P
Sbjct: 203 DNNSLK-KLPDLPLSLES----IVAGNNILEELPELQNLPFLTTIYADNNLLKT-LP--- 253
Query: 412 GELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVS 471
+L+ L++ N L +PE +LT L+ + F+ L P NL L+ S
Sbjct: 254 DLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNAS 305
Query: 472 NNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVS 531
+N++ +L + L ++S N L +PA L+ L+ S N + E+P
Sbjct: 306 SNEIR-SLCDLPPSLEEL----NVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPEL 355
Query: 532 LSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNL 591
L+ L++E N L P ++++ L N+ ++PE +NL + L++
Sbjct: 356 P---QNLKQLHVEYNPLR-EFPDIPESVED-----LRMNSHLAEVPELPQNL---KQLHV 403
Query: 592 SYNHLE 597
N L
Sbjct: 404 ETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-40
Identities = 96/513 (18%), Positives = 161/513 (31%), Gaps = 108/513 (21%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSF-------------LRFINFANNGFSGEIPGEIGR 122
+ T + E P G + N G S +P
Sbjct: 34 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPH 92
Query: 123 LFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRD 182
L E+L+ + NS + ++P +L+ + L P LE+L + +
Sbjct: 93 L---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP--------LLEYLGVSN 140
Query: 183 NLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF 242
N L + P + N S L+++ + N L +LPD L + N +
Sbjct: 141 NQL--EKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLE--ELPELQ 192
Query: 243 NISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFS 302
N+ L +I N L+ LP +LE++ NN LP L N L +
Sbjct: 193 NLPFLTAIYADNNSLK-KLPDLPL----SLESIVAG-NNILEELP-ELQNLPFLTTIYAD 245
Query: 303 LNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGG 362
N + + P+L L+ N L
Sbjct: 246 NNLLK---TLP-DLPPSLEALNVRDNYLTD------------------------------ 271
Query: 363 VLPLSIANLSSTIILFSMGLNQI--YVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVL 420
LP +L+ + + + + NL LN N++ +L+ L
Sbjct: 272 -LPELPQSLTF-LDVSENIFSGLSELPPNLYYLN---ASSNEIR----SLCDLPPSLEEL 322
Query: 421 DLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALP 480
++ +N L +P L L FN L VP N + L V N L P
Sbjct: 323 NVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFP 373
Query: 481 PQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEY 540
+ L + + L +P NLK L + N E P ++E
Sbjct: 374 DIPESVEDLRM-----NSHLA-EVPELPQNLKQLH---VETNPLR-EFPDIPE---SVED 420
Query: 541 LYMEGNSLTGSIPLALKTLKSIKELDLSRNNLS 573
L M + A +T +++ ++
Sbjct: 421 LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 51/241 (21%), Positives = 87/241 (36%), Gaps = 39/241 (16%)
Query: 407 IPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGN----- 461
I LQ H +NL +P N+ +++ + P G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 462 --------CQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKN 513
+ L ++N L+ +LP + + L S N LT +P +LK+
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLES----LVASCNSLT-ELPELPQSLKS 115
Query: 514 LVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLS 573
L+ + S+ P LEYL + N L +P L+ +K +D+ N+L
Sbjct: 116 LLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK 166
Query: 574 GQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNK-----RLCGGLDELH 628
++P+ + LE++ N LE E+P T Y N L L+ +
Sbjct: 167 -KLPDLPPS---LEFIAAGNNQLE-ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIV 221
Query: 629 L 629
Sbjct: 222 A 222
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-41
Identities = 60/326 (18%), Positives = 104/326 (31%), Gaps = 41/326 (12%)
Query: 284 GSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAH 343
GS H ++S L F S ++ + L R + N
Sbjct: 2 GSSHHHHHHSSGRENLYFQ---GSTALRPYHDVLSQWQRHYNADRNR-------WHSAWR 51
Query: 344 LTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQL 403
N + + + + + V L L L
Sbjct: 52 QANSNNPQIETRTGRALK-ATADLLEDATQ--------------PGRVALE---LRSVPL 93
Query: 404 TGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQ 463
P L +LQ + + L +P+++ L +L L N LR +P+S+ +
Sbjct: 94 PQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLN 150
Query: 464 NLMLLSVSNNKLTGALPPQILGIVTLSIL--------LDLSGNLLTGSIPAEVGNLKNLV 515
L LS+ LP + L L + S+PA + NL+NL
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK 209
Query: 516 QLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQ 575
L + + S + ++ LE L + G + + P +K L L +
Sbjct: 210 SLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268
Query: 576 IPEFLENLSFLEYLNLSYNHLEGEVP 601
+P + L+ LE L+L +P
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLP 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-39
Identities = 66/351 (18%), Positives = 115/351 (32%), Gaps = 47/351 (13%)
Query: 240 SIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLL 299
+ S E++ G+ + + N +N++N ++
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLS----QWQRHYNADRNRW-HSAWRQANSNNPQIE 61
Query: 300 DFSLNHFSGQVK-IDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTN 358
+ ++ P L L F S L+ + +D
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLPQ-------FPDQAFRLSHLQHMTIDAA 114
Query: 359 IFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQ 418
LP ++ L L L N L +P +I L L+
Sbjct: 115 GLM-ELPDTMQQF----------------AGLETLT---LARNPLRA-LPASIASLNRLR 153
Query: 419 VLDLHHNNLDGHIPESLGNLTI---------LNSLDLGFNKLRGHVPSSLGNCQNLMLLS 469
L + +PE L + L SL L + +R +P+S+ N QNL L
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK 212
Query: 470 VSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIP 529
+ N+ L+ AL P I + L L DL G + P G L +L L + +P
Sbjct: 213 IRNSPLS-ALGPAIHHLPKLEEL-DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270
Query: 530 VSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFL 580
+ + T LE L + G +P + L + + + +L Q+ +
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 63/364 (17%), Positives = 112/364 (30%), Gaps = 57/364 (15%)
Query: 90 GILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSN 149
G + + S + F + + + R + + + SN
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN-----SN 56
Query: 150 LINFHARGNNLVGQIPPDIGY-SWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENR 208
R + + + L LR L Q +S+LQ ++I
Sbjct: 57 NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 209 LSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIG-- 266
L LPD++ Q L L+++ N P+SI +++ L +S+ LP +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 267 ------FSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNL 320
L NL++L + SLP S++N NL+ L + S + + LP L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231
Query: 321 FRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSM 380
L L C+ L P + L
Sbjct: 232 EEL-------------------DLRGCTALRNY-----------PPIFGGRAPLKRLILK 261
Query: 381 GLNQIY-----VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHN---NLDGHIP 432
+ + + L L L +P I +L ++ + + LD H P
Sbjct: 262 DCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRP 321
Query: 433 ESLG 436
+
Sbjct: 322 VARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 42/202 (20%), Positives = 75/202 (37%), Gaps = 16/202 (7%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGR---------LFRLETL 129
L L+ + L + +L+ LR ++ E+P + L L++L
Sbjct: 130 ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 130 ILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQL 189
L +P++++ NL + R + L + P I KLE L LR
Sbjct: 189 RLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH-HLPKLEELDLRGCTALRNY 245
Query: 190 APSIGNISNLQVLSI-GENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLE 248
P G + L+ L + + L LP + +L L L + PS I + +
Sbjct: 246 PPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304
Query: 249 SISLLGNRLEGSLPVNIGFSLP 270
I + + L+ L + + P
Sbjct: 305 IILVPPH-LQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-15
Identities = 28/162 (17%), Positives = 51/162 (31%), Gaps = 3/162 (1%)
Query: 62 NLCQWTGVTCGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIG 121
L + L L I L + NL L+ + N+ S + I
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIH 226
Query: 122 RLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLR 181
L +LE L L + P + L + + + +P DI +LE L LR
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH-RLTQLEKLDLR 285
Query: 182 DNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSL 223
+ +L I + ++ + + + +
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-38
Identities = 64/427 (14%), Positives = 124/427 (29%), Gaps = 45/427 (10%)
Query: 174 KLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAF 233
+ + + D+ L LA + N++ L + N LS L L L++S N
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 234 SGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNA 293
+ ++S+L ++ L N ++ L P++E L NN + + S
Sbjct: 71 YET--LDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNIS-RVS--CSRG 119
Query: 294 SNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEAL 353
+ + + N + +D + L N + T + + A LE L
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT--VNFAELAASSDT---LEHL 174
Query: 354 GLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGE 413
L N I ++ ++ L L+ L N+L +
Sbjct: 175 NLQYN--------FIYDVKGQVVF----------AKLKTLD---LSSNKLAF-MGPEFQS 212
Query: 414 LRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNN 473
+ + L +N L I ++L L DL N +N + +V+
Sbjct: 213 AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQ 270
Query: 474 KLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSN----EIP 529
+ L Q T+ L L L + + +
Sbjct: 271 TVKK-LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLE 329
Query: 530 VSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYL 589
+ I ++ L+ + L Q+ + L+
Sbjct: 330 CERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGT 389
Query: 590 NLSYNHL 596
Sbjct: 390 LQQAVGQ 396
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-37
Identities = 60/409 (14%), Positives = 119/409 (29%), Gaps = 45/409 (11%)
Query: 193 IGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISL 252
N + ++ + ++ L L ++ L +S N S + + + + LE ++L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 253 LGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKI 312
N L +L + SL L L + N L ++ L + N+ S ++
Sbjct: 66 SSNVLYETLDLE---SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS---RV 114
Query: 313 DFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLS 372
+R + + N + + DLD S+++ L L N V +
Sbjct: 115 SCSRGQGKKNIYLANNKITM--LRDLDE----GCRSRVQYLDLKLNEIDTVNFAEL---- 164
Query: 373 STIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIP 432
+ L L+YN + + + L+ LDL N L +
Sbjct: 165 --------------AASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMG 207
Query: 433 ESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL 492
+ + + L NKL + +L QNL + N +
Sbjct: 208 PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS--KNQRV 264
Query: 493 LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGS- 551
++ + + L+ S GS
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSE 324
Query: 552 ---IPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLE 597
+ + +E+D + I + L L+
Sbjct: 325 TERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 65/506 (12%), Positives = 138/506 (27%), Gaps = 97/506 (19%)
Query: 97 GNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHAR 156
N + + ++ + + ++ L L+ N S ++L+ +
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK------- 59
Query: 157 GNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDS 216
LE L+L N+L + ++S L+ L + N +
Sbjct: 60 ------------------LELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----E 94
Query: 217 LGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLS 276
L S+ L + N S S ++I L N++ L ++ L
Sbjct: 95 LLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKIT-MLRDLDEGCRSRVQYLD 150
Query: 277 VRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIG 336
++ N + + L L+ N +
Sbjct: 151 LKLN----------------EIDTVNFAEL-------AASSDTLEHLNLQYNFIYD---- 183
Query: 337 DLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGF 396
+ +KL+ L L +N +A + ++ +
Sbjct: 184 ----VKGQVVFAKLKTLDLSSN--------KLAFMGPEF------------QSAAGVTWI 219
Query: 397 GLEYNQLTGPIPHAIGELRNLQVLDLHHNNLD-GHIPESLGNLTILNSLDLGFNKLRGHV 455
L N+L I A+ +NL+ DL N G + + + ++ ++
Sbjct: 220 SLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLT 276
Query: 456 PSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSI----LLDLSGNLLTGSIPAEVGNL 511
+ C L P ++ L LL G+ + E N
Sbjct: 277 GQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQ 335
Query: 512 KNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNN 571
++ + ++ I L + +L + + +
Sbjct: 336 ARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG 395
Query: 572 LSGQIPEFLENLSFLEYLNLSYNHLE 597
++ E S L+ L E
Sbjct: 396 Q-IELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-31
Identities = 51/317 (16%), Positives = 108/317 (34%), Gaps = 24/317 (7%)
Query: 285 SLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHL 344
++ N + ++ + + + N+ L S N L I D
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ--ISAADL---- 54
Query: 345 TNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQI-YVKNLVNLNGFGLEYNQL 403
+KLE L L +N+ L L +LS+ L + N + + ++ N +
Sbjct: 55 APFTKLELLNLSSNVLYETLDLE--SLSTLRTL-DLNNNYVQELLVGPSIETLHAANNNI 111
Query: 404 TGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRG-HVPSSLGNC 462
+ + + + + L +N + G + + LDL N++ + +
Sbjct: 112 SR-VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 463 QNLMLLSVSNNKLTGALPPQILGIVTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLS 520
L L++ N + + Q++ + L LDLS N L + E + + + L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVV----FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222
Query: 521 ENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFL 580
N+ I +L LE+ + GN K+ + +++ + +
Sbjct: 223 NNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNE 280
Query: 581 ENLSFLEYLNLSYNHLE 597
E + + E
Sbjct: 281 EECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-31
Identities = 64/502 (12%), Positives = 147/502 (29%), Gaps = 44/502 (8%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
R + +++ S++ L+ + ++ ++ + N S ++ +LE L L++N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 136 FSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGN 195
+L S L N + ++ +E L +N ++ +++ S G
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYV-QELLVGP-----SIETLHAANNNIS-RVSCSRG- 119
Query: 196 ISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF-NISSLESISLLG 254
+ + + N+++ G + YL + N + + + + +LE ++L
Sbjct: 120 -QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 255 NRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDF 314
N + + + L+ L + N + +A+ + + N ++
Sbjct: 179 NFIY-DVKGQV--VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 315 NRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSST 374
NL N +C L + ++
Sbjct: 234 RFSQNLEHFDLRGNGF---------------HCGTLRDFFSKNQ--------RVQTVAKQ 270
Query: 375 IILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELR--NLQVLDLHHNNLDGHIP 432
+ G N+ + L P + L+ +L + + +
Sbjct: 271 TVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LE 329
Query: 433 ESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTL-SI 491
N +D + R + Q + L L + L
Sbjct: 330 CERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGT 389
Query: 492 LLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGS 551
L G + E L+ L + E + +Y +
Sbjct: 390 LQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAE 449
Query: 552 IPLALKTLKSIKELDLSRNNLS 573
LK L +L L+ N +
Sbjct: 450 ENARLKKLNGEADLALASANAT 471
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 22/73 (30%), Positives = 35/73 (47%), Gaps = 3/73 (4%)
Query: 526 NEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSF 585
+EI + + + + +SL ++ ++ ++KELDLS N LS L +
Sbjct: 3 HEIKQNGN---RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 586 LEYLNLSYNHLEG 598
LE LNLS N L
Sbjct: 60 LELLNLSSNVLYE 72
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-36
Identities = 78/421 (18%), Positives = 146/421 (34%), Gaps = 48/421 (11%)
Query: 213 LPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNL 272
+ +L Y + I F +++ + ++ + + LP + S +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 273 ENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGT 332
E L++ ++ + A ++ L N F +P L L +N+L +
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 333 GAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVN 392
+ F N KL L + N + + + +L N
Sbjct: 132 --LPRGIF----HNTPKLTTLSMSNNNLERIEDDTFQATT----------------SLQN 169
Query: 393 LNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR 452
L L N+LT + + + +L ++ +N L +L + LD N +
Sbjct: 170 LQ---LSSNRLTH-VD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN 218
Query: 453 GHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNL 511
V + L +L + +N LT +L L + DLS N L I +
Sbjct: 219 -VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEV-DLSYNELE-KIMYHPFVKM 271
Query: 512 KNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNN 571
+ L +L +S NR + + TL+ L + N L + ++ L L N+
Sbjct: 272 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329
Query: 572 LSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGLDELHLPV 631
+ + L L+ L LS+N + R +F N R + C +L +
Sbjct: 330 IV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEHGL 385
Query: 632 C 632
C
Sbjct: 386 C 386
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-36
Identities = 74/410 (18%), Positives = 138/410 (33%), Gaps = 47/410 (11%)
Query: 173 LKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENA 232
+ + ++N ++++ + + L R + L++++
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 80
Query: 233 FSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSN 292
+ + +++ + + N + LP ++ ++P L L + +N+ + N
Sbjct: 81 IEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN 139
Query: 293 ASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEA 352
L L S N+ F +L L S N L + + L
Sbjct: 140 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLI---------PSLFH 190
Query: 353 LGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIG 412
+ N LS+ + + + +N + + +
Sbjct: 191 ANVSYN-----------LLST-------------LAIPIAVEELDASHNSINV-VRGPV- 224
Query: 413 ELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSN 472
L +L L HNNL L N L +DL +N+L + Q L L +SN
Sbjct: 225 -NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281
Query: 473 NKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSL 532
N+L AL I TL + LDLS N L + L L L N + L
Sbjct: 282 NRLV-ALNLYGQPIPTLKV-LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT---LKL 335
Query: 533 SACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLEN 582
S TL+ L + N + AL +++ + + +I LE+
Sbjct: 336 STHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-30
Identities = 61/338 (18%), Positives = 112/338 (33%), Gaps = 41/338 (12%)
Query: 260 SLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPN 319
+ N+ ++ + +N +++ F + +
Sbjct: 12 CIDSNL-QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 320 LFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFS 379
+ L+ + + I F ++ L + N + P N+
Sbjct: 71 VELLNLNDLQIEE--IDTYAF----AYAHTIQKLYMGFNAIRYLPPHVFQNVP------- 117
Query: 380 MGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLT 439
L L LE N L+ L L + +NNL+ ++ T
Sbjct: 118 ---------LLTVLV---LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 165
Query: 440 ILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNL 499
L +L L N+L HV L +L +VS N L+ L I + L D S N
Sbjct: 166 SLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-TLAIPI----AVEEL-DASHNS 216
Query: 500 LTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTL 559
+ + V L L L N + + L L + + N L + +
Sbjct: 217 IN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKM 271
Query: 560 KSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLE 597
+ ++ L +S N L + + + + L+ L+LS+NHL
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 72/398 (18%), Positives = 134/398 (33%), Gaps = 73/398 (18%)
Query: 81 LDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKI 140
+ + ++ + L+ + + F N+ + ++E L L + +I
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 84
Query: 141 PSN-LSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSI-GNISN 198
+ + + + N + +PP + + L L L N L+ L I N
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPK 142
Query: 199 LQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLE 258
L LS+ N L I ++ F +SL+++ L NRL
Sbjct: 143 LTTLSMSNNNLE----------------RIEDDTFQAT--------TSLQNLQLSSNRLT 178
Query: 259 GSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLP 318
+ +++ +P+L + +V N + +L+ + LD S N + +
Sbjct: 179 -HVDLSL---IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN---VVRGPVNV 226
Query: 319 NLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILF 378
L L NNL A L N L + L N + +
Sbjct: 227 ELTILKLQHNNLTD--------TAWLLNYPGLVEVDLSYN--------ELEKIMYHPF-- 268
Query: 379 SMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNL 438
+ L + N+L + + L+VLDL HN+L H+ +
Sbjct: 269 ---------VKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF 317
Query: 439 TILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLT 476
L +L L N + + L L L++S+N
Sbjct: 318 DRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-18
Identities = 48/252 (19%), Positives = 88/252 (34%), Gaps = 22/252 (8%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
T L +SN ++E I + L+ + ++N + + + + L ++ N
Sbjct: 144 TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-- 198
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISN 198
S L+ + A N++ + + L L L+ N L + N
Sbjct: 199 ---STLAIPIAVEELDASHNSIN-VVRGPVNVE---LTILKLQHNNLTD--TAWLLNYPG 249
Query: 199 LQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLE 258
L + + N L + +++ L L IS N I +L+ + L N L
Sbjct: 250 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
Query: 259 GSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLP 318
+ N LENL + N+ +L LS L+ L S N +
Sbjct: 309 -HVERNQ-PQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FR 361
Query: 319 NLFRLSFSKNNL 330
N+ R + +
Sbjct: 362 NVARPAVDDADQ 373
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 52/274 (18%), Positives = 99/274 (36%), Gaps = 23/274 (8%)
Query: 75 HQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEI-GRLFRLETLILAN 133
+ L + +I + N+ L + N S +P I +L TL ++N
Sbjct: 92 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSN 150
Query: 134 NSFSGKIPSN-LSRCSNLINFHARGNNLVGQIPPDIGYSWLK-LEFLSLRDNLLAGQLAP 191
N+ +I + ++L N N L + S + L ++ NLL+
Sbjct: 151 NNLE-RIEDDTFQATTSLQNLQLSSNRLT-----HVDLSLIPSLFHANVSYNLLS----- 199
Query: 192 SIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESIS 251
++ ++ L N ++ + L L + N + + + N L +
Sbjct: 200 TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVD 254
Query: 252 LLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVK 311
L N LE + + + LE L + N +L L++LD S NH V+
Sbjct: 255 LSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 311
Query: 312 IDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLT 345
+ + L L N++ T + + +LT
Sbjct: 312 RNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLT 345
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 47/256 (18%), Positives = 87/256 (33%), Gaps = 22/256 (8%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGR-LFRLETLILANN 134
+TVL L + + N L ++ +NN I + + L+ L L++N
Sbjct: 117 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSN 175
Query: 135 SFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIG 194
+ + LS +L + + N L + I +E L N +
Sbjct: 176 RLT-HVD--LSLIPSLFHANVSYNLL-STLAIPI-----AVEELDASHNSIN---VVRGP 223
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLG 254
L +L + N L+ L L + +S N + + LE + +
Sbjct: 224 VNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281
Query: 255 NRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDF 314
NRL +L + +P L+ L + N+ + + L L N +
Sbjct: 282 NRLV-ALNLYGQ-PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKL 335
Query: 315 NRLPNLFRLSFSKNNL 330
+ L L+ S N+
Sbjct: 336 STHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 23/144 (15%), Positives = 50/144 (34%), Gaps = 8/144 (5%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
+ +DLS +E I+ + L + +NN + + L+ L L++N
Sbjct: 248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 306
Query: 136 FSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGN 195
+ N + L N + N++V + + L+ L+L N
Sbjct: 307 LL-HVERNQPQFDRLENLYLDHNSIV-TLKLS---THHTLKNLTLSHNDW--DCNSLRAL 359
Query: 196 ISNLQVLSIGENRLSGRLPDSLGQ 219
N+ ++ + ++ L
Sbjct: 360 FRNVARPAVDDADQHCKIDYQLEH 383
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 58/248 (23%), Positives = 98/248 (39%), Gaps = 28/248 (11%)
Query: 707 IGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIIT 763
IG+GSF VY+G + VA + ++ + + F E E L+ ++H N+++
Sbjct: 34 IGRGSFKTVYKGLDTETTVE-VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 764 VCSSIDFEEVDFKAIVY-EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
S + ++ E M G+L+ +L + + + +++
Sbjct: 93 --SWESTVKGKKCIVLVTELMTSGTLKTYLK------RFKVMKIKVLRSWCRQILKGLQF 144
Query: 823 LHHHCHPPIVHGDLKPSNVLLDH-DMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
LH PPI+H DLK N+ + +GD GLA S + + GT
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----------RASFAKAVIGT 193
Query: 882 VGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940
++APE D S DVY+FG+ +LEM T P N P
Sbjct: 194 PEFMAPEMYEEKYDESV--DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 251
Query: 941 MEIVDPLL 948
++ P +
Sbjct: 252 DKVAIPEV 259
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-34
Identities = 72/416 (17%), Positives = 136/416 (32%), Gaps = 46/416 (11%)
Query: 183 NLLAGQLAPSIGNI--SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSS 240
L AGQ N + S QL +L L ++ + M +
Sbjct: 2 TLKAGQTQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TG 59
Query: 241 IFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLD 300
I ++ L + N + +L ++ NL L+ N T +L ++ + L L+
Sbjct: 60 IEKLTGLTKLICTSNNIT-TLDLS---QNTNLTYLACDSNKLT-NLD--VTPLTKLTYLN 112
Query: 301 FSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIF 360
N + K+D ++ P L L+ ++N L +D +++ ++L L N
Sbjct: 113 CDTNKLT---KLDVSQNPLLTYLNCARNTLTE-----ID----VSHNTQLTELDCHLNKK 160
Query: 361 GGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVL 420
L ++ +T+ + ++ V LN + N +T + + + L L
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTNNITK-LD--LNQNIQLTFL 217
Query: 421 DLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALP 480
D N L I + LT L D N L + L L L
Sbjct: 218 DCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL---- 267
Query: 481 PQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEY 540
+ + + L+ +V + L L + + LS L Y
Sbjct: 268 --EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITE---LDLSQNPKLVY 322
Query: 541 LYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHL 596
LY+ LT + ++ +K L ++ + + L +
Sbjct: 323 LYLNNTELT-ELDVSH--NTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-31
Identities = 77/468 (16%), Positives = 144/468 (30%), Gaps = 93/468 (19%)
Query: 126 LETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLL 185
+ + A + + + L + +++ +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-----------------DM----- 57
Query: 186 AGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNIS 245
I ++ L L N ++ L L Q +L YL+ N + + + ++
Sbjct: 58 -----TGIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL---DVTPLT 106
Query: 246 SLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNH 305
L ++ N+L L V+ P L L+ +N T + +S+ + L LD LN
Sbjct: 107 KLTYLNCDTNKLT-KLDVS---QNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNK 159
Query: 306 FSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLP 365
K+D L L S N I +LD + L L DTN
Sbjct: 160 KIT--KLDVTPQTQLTTLDCSFNK-----ITELDV----SQNKLLNRLNCDTN------- 201
Query: 366 LSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHN 425
+ ++ + + L N+LT I + L L D N
Sbjct: 202 ---------------NITKLDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVN 243
Query: 426 NLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILG 485
L + S L+ L +L L + L + L+ + + +
Sbjct: 244 PLT-ELDVS--TLSKLTTLHCIQTDL---LEIDLTHNTQLIYFQAEGCRK---IKELDVT 294
Query: 486 IVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEG 545
T LLD +T + + LV L L+ + + +S T L+ L
Sbjct: 295 HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE---LDVSHNTKLKSLSCVN 348
Query: 546 NSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSY 593
+ ++ + ++ + E L N S ++
Sbjct: 349 AHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-28
Identities = 82/495 (16%), Positives = 167/495 (33%), Gaps = 86/495 (17%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
+T LD N SI + + L+ L + +N + + + + L L +N
Sbjct: 42 ATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNK 96
Query: 136 FSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWL-KLEFLSLRDNLLAGQLAPSIG 194
+ +++ + L + N L + S L +L+ N L +
Sbjct: 97 LTN---LDVTPLTKLTYLNCDTNKLT-----KLDVSQNPLLTYLNCARNTLT---EIDVS 145
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLG 254
+ + L L N+ +L + L L S N + + + L ++
Sbjct: 146 HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDT 200
Query: 255 NRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDF 314
N + L +N L L N T + ++ + L D S+N + ++D
Sbjct: 201 NNIT-KLDLN---QNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDV 250
Query: 315 NRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSST 374
+ L L L + +L +D LT+ ++L +
Sbjct: 251 STLSKLTTLHCIQTDLLE-----ID----LTHNTQLIYFQAEGCRK-------------- 287
Query: 375 IILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPES 434
+ ++ V + L + +T + + + L L L++ L +
Sbjct: 288 -------IKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD-- 334
Query: 435 LGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSI--- 491
+ + T L SL ++ SS+G L + + +P + L +L+I
Sbjct: 335 VSHNTKLKSLSCVNAHIQD--FSSVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVS 391
Query: 492 --LLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNS-L 548
LLD GN + I G + + ++ S + P + Y + N +
Sbjct: 392 PDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDNP-------AVTYTFTSENGAI 442
Query: 549 TGSIPLALKTLKSIK 563
G++ + + IK
Sbjct: 443 VGTVTTPFEAPQPIK 457
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 67/353 (18%), Positives = 113/353 (32%), Gaps = 64/353 (18%)
Query: 247 LESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHF 306
S ++ + ++ L L +L ++ T + + + L L + N+
Sbjct: 20 FASEVAAAFEMQATDTISEE-QLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNI 76
Query: 307 SGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPL 366
+ +D ++ NL L+ N L +LD T +KL L DTN
Sbjct: 77 T---TLDLSQNTNLTYLACDSNKLT-----NLDV----TPLTKLTYLNCDTN-------- 116
Query: 367 SIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNN 426
L ++ V L N LT I + L LD H N
Sbjct: 117 --------------KLTKLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNK 159
Query: 427 LDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGI 486
+ + T L +LD FNK+ + + L L+ N +T L +
Sbjct: 160 KITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK------LDL 208
Query: 487 VTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYME 544
L LD S N LT I V L L S N + + +S + L L+
Sbjct: 209 NQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTE---LDVSTLSKLTTLHCI 262
Query: 545 GNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLE 597
L + L + ++ + + + L L+ +
Sbjct: 263 QTDLLE---IDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT 310
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-34
Identities = 74/410 (18%), Positives = 138/410 (33%), Gaps = 47/410 (11%)
Query: 173 LKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENA 232
+ + ++N ++++ + + L R + L++++
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86
Query: 233 FSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSN 292
+ + +++ + + N + LP ++ ++P L L + +N+ + N
Sbjct: 87 IEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN 145
Query: 293 ASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEA 352
L L S N+ F +L L S N L + + L
Sbjct: 146 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLI---------PSLFH 196
Query: 353 LGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIG 412
+ N LS+ + + + +N + + +
Sbjct: 197 ANVSYN-----------LLST-------------LAIPIAVEELDASHNSINV-VRGPV- 230
Query: 413 ELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSN 472
L +L L HNNL L N L +DL +N+L + Q L L +SN
Sbjct: 231 -NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287
Query: 473 NKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSL 532
N+L AL I TL + LDLS N L + L L L N + L
Sbjct: 288 NRLV-ALNLYGQPIPTLKV-LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT---LKL 341
Query: 533 SACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLEN 582
S TL+ L + N + AL +++ + + +I LE+
Sbjct: 342 STHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 72/385 (18%), Positives = 127/385 (32%), Gaps = 66/385 (17%)
Query: 213 LPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNL 272
+ +L Y + I F +++ + ++ + + LP + S +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 273 ENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGT 332
E L++ ++ + A ++ L N F +P L L +N+L +
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 137
Query: 333 GAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVN 392
L IF L
Sbjct: 138 ----------------------LPRGIFHNT------------------------PKLTT 151
Query: 393 LNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR 452
L+ + N L +LQ L L N L H+ L + L ++ +N L
Sbjct: 152 LS---MSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL- 204
Query: 453 GHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLK 512
S+L + L S+N + + + +T+ L L N LT + N
Sbjct: 205 ----STLAIPIAVEELDASHNSIN-VVRGPVNVELTI---LKLQHNNLT-DTAW-LLNYP 254
Query: 513 NLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNL 572
LV++ LS N + LE LY+ N L ++ L + + ++K LDLS N+L
Sbjct: 255 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 313
Query: 573 SGQIPEFLENLSFLEYLNLSYNHLE 597
+ LE L L +N +
Sbjct: 314 L-HVERNQPQFDRLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 4e-29
Identities = 83/528 (15%), Positives = 171/528 (32%), Gaps = 86/528 (16%)
Query: 81 LDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEI-GRLFRLETLILANNSFSGK 139
+ + ++ + L+ + + F N+ ++P + ++E L L + +
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 89
Query: 140 IPSN-LSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSI-GNIS 197
I + + + + N + +PP + + L L L N L+ L I N
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP 147
Query: 198 NLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRL 257
L LS+ N L I ++ F +SL+++ L NRL
Sbjct: 148 KLTTLSMSNNNLE----------------RIEDDTFQAT--------TSLQNLQLSSNRL 183
Query: 258 EGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRL 317
+ ++ +P+L + +V N + +L+ + LD S N + +
Sbjct: 184 T-HVDLS---LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN---VVRGPVN 231
Query: 318 PNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIIL 377
L L NNL A L N L + L N + +
Sbjct: 232 VELTILKLQHNNLTD--------TAWLLNYPGLVEVDLSYN--------ELEKIMYHPF- 274
Query: 378 FSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGN 437
+ L + N+L + + L+VLDL HN+L H+ +
Sbjct: 275 ----------VKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 322
Query: 438 LTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSG 497
L +L L N + + L L L++S+N + V + D
Sbjct: 323 FDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQ 379
Query: 498 NLLTGSIPAE-------VGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTG 550
+ + + ++ ++ + C+ + + +
Sbjct: 380 HCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHY 439
Query: 551 SIPLALKTLKSIKELDLSRNNLSGQI----PEFLENLSFLEYLNLSYN 594
L+ ++L+ N L ++ E ++ L+ L+ +
Sbjct: 440 ITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEID 487
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 6e-26
Identities = 63/325 (19%), Positives = 111/325 (34%), Gaps = 45/325 (13%)
Query: 279 QNNYTGSLPHSLSNASNLR----LLDFSLNHFSGQVKIDFN--RLPNLFRLSFSKNNLGT 332
+ N P SNL+ D ++ + V F L N ++F + +
Sbjct: 6 RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK 65
Query: 333 GAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVN 392
+ A L + ++E L L+ I + +
Sbjct: 66 --LPA----ALLDSFRQVELLNLNDL--------QIEEIDTYAF-----------AYAHT 100
Query: 393 LNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR 452
+ + +N + PH + L VL L N+L N L +L + N L
Sbjct: 101 IQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 160
Query: 453 GHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLK 512
+ +L L +S+N+LT + ++ + ++S NLL+ +
Sbjct: 161 RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFH---ANVSYNLLS-----TLAIPI 211
Query: 513 NLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNL 572
+ +L S N + V L L ++ N+LT L + E+DLS N L
Sbjct: 212 AVEELDASHNSINV---VRGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNEL 266
Query: 573 SGQIPEFLENLSFLEYLNLSYNHLE 597
+ + LE L +S N L
Sbjct: 267 EKIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 5e-20
Identities = 87/531 (16%), Positives = 173/531 (32%), Gaps = 49/531 (9%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEI-GRLFRLETLILANNSFS 137
L + +I + N+ L + N S +P I +L TL ++NN+
Sbjct: 102 QKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 160
Query: 138 GKIPSN-LSRCSNLINFHARGNNLVGQIPPDIGYSWLK-LEFLSLRDNLLAGQLAPSIGN 195
+I + ++L N N L + S + L ++ NLL+ ++
Sbjct: 161 -RIEDDTFQATTSLQNLQLSSNRLT-----HVDLSLIPSLFHANVSYNLLS-----TLAI 209
Query: 196 ISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGN 255
++ L N ++ + + L L + N + + + N L + L N
Sbjct: 210 PIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYN 264
Query: 256 RLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFN 315
LE + + + LE L + N +L L++LD S NH V+ +
Sbjct: 265 ELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQP 321
Query: 316 RLPNLFRLSFSKNNLGTGAIGDLDFIAHLT------NCSKLEALGLDTNIFGGVLPLSIA 369
+ L L N++ T + + +LT +C+ L AL F V ++
Sbjct: 322 QFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRAL------FRNVARPAVD 375
Query: 370 NLSSTIILFSMGLNQIYV----KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHN 425
+ + + + K ++ + + + A G ++ +
Sbjct: 376 DADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQS 435
Query: 426 NLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILG 485
+ L L+ N+LR V Q L + +L L +I
Sbjct: 436 LSHYITQQGGVPLQGNEQLEAEVNELRAEV-------QQLTNEQIQQEQLLQGLHAEIDT 488
Query: 486 IVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEG 545
+ L + ++ +LK L E + + + E L E
Sbjct: 489 NLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRT--EADAKQKETEDLEQEN 546
Query: 546 NSLTGSIPLA-LKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNH 595
+L + K + +E L R + + N + ++H
Sbjct: 547 IALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKKNRNPDTRRVSHHHHHH 597
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 5e-10
Identities = 55/381 (14%), Positives = 112/381 (29%), Gaps = 49/381 (12%)
Query: 77 RVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSF 136
V LD S+ SI + L + +N + + + L + L+ N
Sbjct: 212 AVEELDASHNSINVVRG---PVNVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNEL 266
Query: 137 SGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNI 196
+I +LE L + +N L L I
Sbjct: 267 E-------------------------KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 300
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNR 256
L+VL + N L + + Q L L + N+ S +L++++L N
Sbjct: 301 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTH--HTLKNLTLSHND 356
Query: 257 LEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSN-----ASNLRLLDFSLNHFSGQVK 311
+ + ++ N+ +V + + + L + S+ LD L + +
Sbjct: 357 WDCN---SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSV 413
Query: 312 IDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANL 371
++ + + N + + E L + N L + L
Sbjct: 414 VEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPL-QGNEQLEAEVNE----LRAEVQQL 468
Query: 372 SSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHN-NLDGH 430
++ I L ++ + NL + L + L + +L+
Sbjct: 469 TNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQAR 528
Query: 431 IPESLGNLTILNSLDLGFNKL 451
E+ L+ L
Sbjct: 529 RTEADAKQKETEDLEQENIAL 549
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 9e-10
Identities = 24/123 (19%), Positives = 44/123 (35%), Gaps = 4/123 (3%)
Query: 488 TLSILLDLSGNLLTGSIPA--EVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEG 545
+ D+ ++ T + E L N + + L + +E L +
Sbjct: 25 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 84
Query: 546 NSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGV 605
+ A +I++L + N + P +N+ L L L N L +P RG+
Sbjct: 85 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLP-RGI 142
Query: 606 FSN 608
F N
Sbjct: 143 FHN 145
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 6e-07
Identities = 51/355 (14%), Positives = 102/355 (28%), Gaps = 15/355 (4%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
+ +DLS +E I+ + L + +NN + + L+ L L++N
Sbjct: 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 312
Query: 136 FSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGN 195
+ N + L N + N++V + + L+ L+L N
Sbjct: 313 LL-HVERNQPQFDRLENLYLDHNSIV-TLKLS---THHTLKNLTLSHNDW--DCNSLRAL 365
Query: 196 ISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGN 255
N+ ++ + ++ QL S+ + I S +E +
Sbjct: 366 FRNVARPAVDDADQHCKIDY---QLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQG 422
Query: 256 RLEGSLPVNIGFSLPNL---ENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKI 312
R + +N SL + + Q N + A +L + + +
Sbjct: 423 RCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGL 482
Query: 313 DFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPL-SIANL 371
NL R K+ L + HL + +L
Sbjct: 483 HAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDL 542
Query: 372 SSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNN 426
I L+ K L+ ++ +V HH++
Sbjct: 543 EQENIALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKKNRNPDTRRVSHHHHHH 597
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 9e-06
Identities = 11/100 (11%), Positives = 36/100 (36%), Gaps = 4/100 (4%)
Query: 511 LKNLVQLGLSENRFSNEIPVSLSACT--TLEYLYMEGNSLTGSIPLALKTLKSIKELDLS 568
+ V + + + ++ T + + + +++ L + + ++ L+L+
Sbjct: 24 QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 83
Query: 569 RNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
+ ++ L + +N + +P VF N
Sbjct: 84 DLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLP-PHVFQN 121
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 705 NMIGQGSFGFVYRGNL---GENEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRN 757
++G+G FG V GNL + VAVK +K +++ F++E +++ H N
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
+I+++ VC + + + ++ +M+ G L +L S + + + L ++D+A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 818 FAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP--SS 874
+EYL + + +H DL N +L DM V DFGL++ I
Sbjct: 158 LGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYYRQ 205
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914
K V ++A E ++ DV++FG+ + E+ TR
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 32/234 (13%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNL----GENEMAVAVKVMNLK---QRGATKSFVAECEALR 751
+F ++G G+FG VY+G + ++ VA+K L+ A K + E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMA 72
Query: 752 NIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLN 811
++ + ++ +++ +C + V ++ + M G L D++ + D + LN
Sbjct: 73 SVDNPHVCRLLGICLT---STV---QLITQLMPFGCLLDYVREHKDNI-----GSQYLLN 121
Query: 812 LVIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
+ +A + YL VH DL NVL+ + DFGLA+ L
Sbjct: 122 WCVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY--- 174
Query: 871 TPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+ G K + ++A E + + DV+S+G+ + E+ T +P D +
Sbjct: 175 ---HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 63/224 (28%), Positives = 90/224 (40%), Gaps = 26/224 (11%)
Query: 707 IGQGSFGFVYRGNL---GENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRNLIK 760
+G GSFG V RG ++VAVK + L Q A F+ E A+ ++ HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+ V + + +V E GSL D L + + + VA +
Sbjct: 86 LYGVVLT---PPM---KMVTELAPLGSLLDRLRKHQGHF-----LLGTLSRYAVQVAEGM 134
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
YL +H DL N+LL + +GDFGL R LP + K
Sbjct: 135 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV-----MQEHRKV 186
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+ APE S D + FG+ L EMFT + P +
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 26/233 (11%)
Query: 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR 754
+ +DF ++GQG+FG V + + A+K + + + ++E L ++
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLN 60
Query: 755 HRNLIKIITVCSSIDFEEVDFKA--------IVYEYMECGSLEDWLHQSNDQLEVGNFNV 806
H+ +++ A I EY E G+L D +H N N
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQR 115
Query: 807 IQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPA 866
+ L + A+ Y+H I+H DLKP N+ +D +GDFGLA+ +
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 867 TILETPSSS------TGIKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEM 911
L++ + T GT YVA E G G D+YS GI+ EM
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI-DMYSLGIIFFEM 224
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-33
Identities = 86/523 (16%), Positives = 170/523 (32%), Gaps = 73/523 (13%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
T+L++S I + + + +LS LR + ++N LE L L++N
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAG-QLAPSIGNI 196
KI + + L+ L L N + GN+
Sbjct: 83 -KISCH---------------------------PTVNLKHLDLSFNAFDALPICKEFGNM 114
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLY-YLSISENAFSGMFPSSIFNISSLE-SISLLG 254
S L+ L + L + L L + E P + + ++ I
Sbjct: 115 SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174
Query: 255 NRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDF 314
N+ + ++ NLE +++ + LS + L+ N ++ +
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234
Query: 315 NRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSST 374
N + L + + + G L + S T
Sbjct: 235 NSFIRIL---------------------QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273
Query: 375 IILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPES 434
L + + +V+ + P + N+ + + +
Sbjct: 274 ------SLKALSIHQVVS--------DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLC 319
Query: 435 LGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL-- 492
++ LD N L V + G+ L L + N+L L + L
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQ 378
Query: 493 LDLSGNLLTGSIPAEV-GNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGS 551
LD+S N ++ K+L+ L +S N ++ I L ++ L + N + S
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-S 435
Query: 552 IPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYN 594
IP + L++++EL+++ N L + L+ L+ + L N
Sbjct: 436 IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-33
Identities = 90/469 (19%), Positives = 170/469 (36%), Gaps = 39/469 (8%)
Query: 163 QIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRS 222
+P D+ L++ N ++ I ++S L++L I NR+ +
Sbjct: 14 HVPKDLSQK---TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQE 70
Query: 223 LYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFS-LPNLENLSVRQNN 281
L YL +S N + S +L+ + L N + +LP+ F + L+ L + +
Sbjct: 71 LEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTH 126
Query: 282 YTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLS----------------F 325
S +++ + ++L + K D L + S
Sbjct: 127 LEKSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDV 184
Query: 326 SKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQI 385
S + + ++ + CS ++ + L++ N+ +T F L +
Sbjct: 185 SVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV 244
Query: 386 YVKNL--VNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNS 443
+ + +++ L+ ++ L+ L + + + + +N
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 444 LDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGS 503
+ + R + L SNN LT + G +T L L N L
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLILQMNQLK-E 362
Query: 504 IPAEVG---NLKNLVQLGLSENRFSNEIPVSL-SACTTLEYLYMEGNSLTGSIPLALKTL 559
+ +K+L QL +S+N S + S +L L M N LT +I L
Sbjct: 363 LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--P 420
Query: 560 KSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
IK LDL N + IP+ + L L+ LN++ N L+ VP G+F
Sbjct: 421 PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVP-DGIFDR 466
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-26
Identities = 68/451 (15%), Positives = 148/451 (32%), Gaps = 47/451 (10%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGF-SGEIPGEIGRLFRLETLILANNSFS 137
LDLS+ + I L+ ++ + N F + I E G + +L+ L L+
Sbjct: 72 EYLDLSHNKLVKISC---HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNIS 197
++ + G + P+ SL + I ++S
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPE---GLQDFNTESLHIVFPTNKEFHFILDVS 185
Query: 198 NLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRL 257
V ++ + + L D+ + N + + I +L
Sbjct: 186 VKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVW 245
Query: 258 EGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRL 317
++ ++ N+ ++ +S ++ L + + F +
Sbjct: 246 HTTVWYF------SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF 299
Query: 318 PNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIIL 377
N+ +F+ + + S L N + +
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPS------KISPFLHLDFSNN--------LLTDTVFENC- 344
Query: 378 FSMGLNQIYVKNLVNLNGFGLEYNQLT--GPIPHAIGELRNLQVLDLHHNNLDGHIPESL 435
+L L L+ NQL I ++++LQ LD+ N++ +
Sbjct: 345 ----------GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD 394
Query: 436 -GNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLD 494
L SL++ N L + L + +L + +NK+ ++P Q++ + L L +
Sbjct: 395 CSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQEL-N 450
Query: 495 LSGNLLTGSIPAEV-GNLKNLVQLGLSENRF 524
++ N L S+P + L +L ++ L N +
Sbjct: 451 VASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 8e-15
Identities = 75/396 (18%), Positives = 133/396 (33%), Gaps = 53/396 (13%)
Query: 79 TVLDLSNRSIEGI-LSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
LDLS + + + + GN+S L+F+ + I L + L++ ++
Sbjct: 93 KHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG 152
Query: 138 GKIP----SNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSI 193
K + + S I F N I + LE +++ L + + +
Sbjct: 153 EKEDPEGLQDFNTESLHIVFPT--NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFL 210
Query: 194 GNISNL------QVLSIGENRLSGRLPDSLGQL---RSLYYLSISENAFSGMFPSSIFNI 244
++ L L++ + + QL +++Y SIS G F+
Sbjct: 211 SILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY 270
Query: 245 S--SLESISL--LGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLD 300
S SL+++S+ + + + G I N+ + + S S LD
Sbjct: 271 SGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLD 330
Query: 301 FSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIF 360
FS N + V + L L L N L + + + L+ L + N
Sbjct: 331 FSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT-TQMKS---LQQLDISQNSV 386
Query: 361 GGVLP---------LSIANLSSTII-------------LFSMGLNQI-----YVKNLVNL 393
L N+SS I+ + + N+I V L L
Sbjct: 387 SYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEAL 446
Query: 394 NGFGLEYNQLTGPIPH-AIGELRNLQVLDLHHNNLD 428
+ NQL +P L +LQ + LH N D
Sbjct: 447 QELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 35/206 (16%), Positives = 75/206 (36%), Gaps = 28/206 (13%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
+ + + + + +S ++F+NN + + G L LETLIL N
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL- 360
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSI-GNI 196
LS+ + + L+ L + N ++
Sbjct: 361 ----KELSKIAEM--TT----------------QMKSLQQLDISQNSVSYDEKKGDCSWT 398
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNR 256
+L L++ N L+ + L + L + N P + + +L+ +++ N+
Sbjct: 399 KSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQ 455
Query: 257 LEGSLPVNIGFSLPNLENLSVRQNNY 282
L+ S+P I L +L+ + + N +
Sbjct: 456 LK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-33
Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 25/228 (10%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHR 756
D + + +G G +G VY G + + VAVK + + F+ E ++ I+H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 276
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
NL++++ VC+ E F I+ E+M G+L D+L + N Q + + L + +
Sbjct: 277 NLVQLLGVCT----REPPFY-IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQI 327
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
+ A+EYL +H +L N L+ + + V DFGL+R + +T ++
Sbjct: 328 SSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAHA 377
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
G K + + APE S DV++FG+LL E+ T P +
Sbjct: 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-33
Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 39/228 (17%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRNLIKII 762
IG+G+FG V+ G L + VAVK F+ E L+ H N++++I
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
VC+ + + IV E ++ G +L ++ V L +V D A +EY
Sbjct: 179 GVCT--QKQPI---YIVMELVQGGDFLTFL-RTEG----ARLRVKTLLQMVGDAAAGMEY 228
Query: 823 LHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE---TPSSSTG-- 877
L +H DL N L+ V + DFG++R + S
Sbjct: 229 LESK---CCIHRDLAARNCLVTEKNVLKISDFGMSRE--------EADGVYAASGGLRQV 277
Query: 878 -IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+K T APE G S+ DV+SFGILL E F+ P N+ N
Sbjct: 278 PVKWT----APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 31/226 (13%)
Query: 707 IGQGSFGFVYRGNL---GENEMAVAVKVMN----LKQRGATKSFVAECEALRNIRHRNLI 759
+G G FG V G L + E++VA+K + KQR + F+ E + H N+I
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNII 109
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
++ V + + IV EYME GSL+ +L + + Q VIQ + ++ +A
Sbjct: 110 RLEGVVT-----KSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASG 159
Query: 820 IEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
++YL VH DL N+L++ ++V V DFGL R L E ++ G
Sbjct: 160 MKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVL-----EDDPEAAYTTRGG 210
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
K + + +PE ++ DV+S+GI+L E+ + RP M N
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 50/312 (16%), Positives = 102/312 (32%), Gaps = 40/312 (12%)
Query: 285 SLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHL 344
++ N + ++ + + + N+ L S N L I D
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ--ISAADL---- 54
Query: 345 TNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLT 404
+KLE L L +N+ L L +L L L N +
Sbjct: 55 APFTKLELLNLSSNVLYETLDLE---------------------SLSTLRTLDLNNNYVQ 93
Query: 405 GPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQN 464
+ +++ L +NN+ + S G ++ L NK+ G
Sbjct: 94 -----ELLVGPSIETLHAANNNI-SRVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSR 145
Query: 465 LMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRF 524
+ L + N++ ++ L+L N + + +V L L LS N+
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL 203
Query: 525 SNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLS-GQIPEFLENL 583
+ + + + ++ + N L I AL+ ++++ DL N G + +F
Sbjct: 204 A-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
Query: 584 SFLEYLNLSYNH 595
++ +
Sbjct: 262 QRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 56/332 (16%), Positives = 108/332 (32%), Gaps = 47/332 (14%)
Query: 265 IGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLS 324
I + + V ++ +L +A N++ LD S N S D L L+
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 325 FSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQ 384
S N L L + S L L L+ N +
Sbjct: 65 LSSNVLYE--------TLDLESLSTLRTLDLNNN-----------YVQE----------- 94
Query: 385 IYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSL 444
+ ++ N ++ + + + + L +N + G + + L
Sbjct: 95 --LLVGPSIETLHAANNNISR-VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149
Query: 445 DLGFNKLRG-HVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL--LDLSGNLLT 501
DL N++ + + L L++ N + + Q++ + L LDLS N L
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV----FAKLKTLDLSSNKLA 204
Query: 502 GSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLT-GSIPLALKTLK 560
+ E + + + L N+ I +L LE+ + GN G++ +
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 561 SIKELDLSRN-NLSGQIPEFLENLSFLEYLNL 591
++ + L+GQ E + Y
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 45/253 (17%), Positives = 91/253 (35%), Gaps = 34/253 (13%)
Query: 346 NCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTG 405
N ++ + + + L + N+ L+ L N L+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSA----------------WNVKELD---LSGNPLSQ 48
Query: 406 PIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNL 465
+ L++L+L N L + L +L+ L +LDL N + L ++
Sbjct: 49 ISAADLAPFTKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSI 101
Query: 466 MLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFS 525
L +NN ++ + + L+ N +T + G + L L N
Sbjct: 102 ETLHAANNNIS-RVSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
Query: 526 N-EIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLS 584
++ TLE+L ++ N + + +K LDLS N L+ + ++ +
Sbjct: 158 TVNFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAA 214
Query: 585 FLEYLNLSYNHLE 597
+ +++L N L
Sbjct: 215 GVTWISLRNNKLV 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 62/349 (17%), Positives = 113/349 (32%), Gaps = 46/349 (13%)
Query: 174 KLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAF 233
+ + + D+ L LA + N++ L + N LS L L L++S N
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 234 SGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNA 293
+ ++S+L ++ L N ++ L P++E L NN + + S
Sbjct: 71 YE--TLDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNIS-RVS--CSRG 119
Query: 294 SNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEAL 353
+ + + N + +D + L N + T + + A LE L
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT--VNFAELAASSDT---LEHL 174
Query: 354 GLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGE 413
L N I ++ ++ L L+ L N+L +
Sbjct: 175 NLQYN--------FIYDVKGQVVF----------AKLKTLD---LSSNKLAF-MGPEFQS 212
Query: 414 LRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR-GHVPSSLGNCQNLMLLSVSN 472
+ + L +N L I ++L L DL N G + Q + ++
Sbjct: 213 AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271
Query: 473 NKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSE 521
K + + T L G +PA L+ LG
Sbjct: 272 VKKLTGQNEEECTVPT----LGHYGAYCCEDLPAPFA--DRLIALGHHH 314
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 55/377 (14%), Positives = 110/377 (29%), Gaps = 67/377 (17%)
Query: 193 IGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISL 252
N + ++ + ++ L L ++ L +S N S + + + + LE ++L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 253 LGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKI 312
N L +L + SL L L + N L ++ L + N+ S ++
Sbjct: 66 SSNVLYETLDLE---SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS---RV 114
Query: 313 DFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLS 372
+R + + N + + L S
Sbjct: 115 SCSRGQGKKNIYLANNKITM------------------------------LRDLDEGCRS 144
Query: 373 STIILFSMGLNQIYVKNLVNLNGFGLEYNQLTG-PIPHAIGELRNLQVLDLHHNNLDGHI 431
+ L+ L+ N++ L+ L+L +N + +
Sbjct: 145 ----------------RVQYLD---LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DV 184
Query: 432 PESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSI 491
+ L +LDL NKL + + + +S+ NNKL + + L
Sbjct: 185 KGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEH 241
Query: 492 LLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGS 551
DL GN KN +++ + CT +
Sbjct: 242 -FDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299
Query: 552 IPLALKTLKSIKELDLS 568
L ++
Sbjct: 300 PAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 64/389 (16%), Positives = 119/389 (30%), Gaps = 78/389 (20%)
Query: 213 LPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNL 272
+ + +++++ S + +++ + L GN L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60
Query: 273 ENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGT 332
E L++ N L + S LR LD + N+ + P++ L + NN+
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 333 GAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVN 392
+ + + N
Sbjct: 114 ----------------------VSCSRG---------------------------QGKKN 124
Query: 393 LNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDG-HIPESLGNLTILNSLDLGFNKL 451
+ L N++T G +Q LDL N +D + E + L L+L +N +
Sbjct: 125 IY---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 452 RGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNL 511
V + L L +S+NKL + P+ ++ + L N L I +
Sbjct: 182 Y-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW-ISLRNNKLV-LIEKALRFS 236
Query: 512 KNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNN 571
+NL L N F C TL + + + +K L E + +
Sbjct: 237 QNLEHFDLRGNGFH---------CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 572 L---SGQIPEFLENLSFLEYLNLSYNHLE 597
L E L + L ++H
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 45/293 (15%), Positives = 100/293 (34%), Gaps = 31/293 (10%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
R + +++ S++ L+ + ++ ++ + N S ++ +LE L L++N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 136 FSGKIP-----------------SNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFL 178
+ L ++ HA NN+ ++ G + +
Sbjct: 70 LYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI-SRVSCSRGQG---KKNI 125
Query: 179 SLRDNLLAGQLAPSIGNISNLQVLSIGENRLSG-RLPDSLGQLRSLYYLSISENAFSGMF 237
L +N + G S +Q L + N + + +L +L++ N
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DV 184
Query: 238 PSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLR 297
+ + L+++ L N+L + S + +S+R N + +L + NL
Sbjct: 185 KGQVV-FAKLKTLDLSSNKLA-FMGPEFQ-SAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 298 LLDFSLNHFSGQVKIDF----NRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTN 346
D N F DF R+ + + + K + + H
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 19/95 (20%), Positives = 41/95 (43%), Gaps = 2/95 (2%)
Query: 503 SIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSI 562
+I N ++++ + + ++ L + GN L+ L +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 563 KELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLE 597
+ L+LS N L + + E+LS L L+L+ N+++
Sbjct: 61 ELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYVQ 93
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 52/245 (21%), Positives = 93/245 (37%), Gaps = 41/245 (16%)
Query: 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR 754
+ DF +IG G FG V++ + +K + A + E +AL +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62
Query: 755 HRNLIKIITVCSSIDFEEVDFKA----------------IVYEYMECGSLEDWLHQSNDQ 798
H N++ ++ D+ I E+ + G+LE W+ + +
Sbjct: 63 HVNIVHYNGC-----WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 799 LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858
+ + L L + ++Y+H +++ DLKPSN+ L +GDFGL
Sbjct: 118 K----LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPT 918
L+ T KGT+ Y++PE D D+Y+ G++L E+
Sbjct: 171 ---------SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221
Query: 919 DNMFN 923
Sbjct: 222 FETSK 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 30/225 (13%)
Query: 707 IGQGSFGFVYRGNL----GENEMAVAVKVMNLKQRGATKS---FVAECEALRNIRHRNLI 759
+G G FG V++G ++ V +KV ++ + +S A+ ++ H +++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
+++ +C + +V +Y+ GSL D + Q L LN + +A
Sbjct: 79 RLLGLCPG---SSL---QLVTQYLPLGSLLDHVRQHRGAL-----GPQLLLNWGVQIAKG 127
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+ YL H +VH +L NVLL V DFG+A LPP + K
Sbjct: 128 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL------LYSEAK 178
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+ ++A E G + DV+S+G+ + E+ T P +
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 51/231 (22%), Positives = 100/231 (43%), Gaps = 26/231 (11%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNL----GENEMAVAVKVMNLK-QRGATKSFVAECEALRNI 753
+F ++G G+FG VY+G + ++ VA+K + A K + E + ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 754 RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLV 813
+ ++ +++ +C + V ++ + M G L D++ + D + LN
Sbjct: 75 DNPHVCRLLGICLT---STV---QLITQLMPFGCLLDYVREHKDNI-----GSQYLLNWC 123
Query: 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS 873
+ +A + YL +VH DL NVL+ + DFGLA+ L
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY------ 174
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+ G K + ++A E + + DV+S+G+ + E+ T +P D +
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 68/225 (30%), Positives = 106/225 (47%), Gaps = 29/225 (12%)
Query: 707 IGQGSFGFVYRGNL---GENEMAVAVKVMNLKQRGAT----KSFVAECEALRNIRHRNLI 759
IG G G V G L G+ ++ VA+K + G T + F++E + H N+I
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
++ V + + IV EYME GSL+ +L + Q ++Q + ++ V
Sbjct: 114 RLEGVVTR---GRLAM--IVTEYMENGSLDTFLRTHDGQF-----TIMQLVGMLRGVGAG 163
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+ YL VH DL NVL+D ++V V DFGL+R L + ++TG K
Sbjct: 164 MRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----DAAYTTTGGK 215
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+ + APE S+ DV+SFG+++ E+ RP NM N
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG-ATKSFVAECEALRNIRHRN 757
DF +G+G FG V+ ++ A+K + L R A + + E +AL + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 758 LIK----IITVCSSIDFEEVDFKAIVY---EYMECGSLEDWLHQSNDQLEVGNFNVIQRL 810
+++ + ++ + K +Y + +L+DW++ E L
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE---RERSVCL 121
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL----PPCSPA 866
++ + +A A+E+LH ++H DLKPSN+ D V VGDFGL + +
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 867 TILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
T + + TG GT Y++PE G S D++S G++L E+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 29/224 (12%)
Query: 707 IGQGSFGFVYRG--NLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIRHRNLIKI 761
+G G+FG V +G + + ++ VA+KV LK ++ T+ + E + + + + ++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
I VC + E + +V E G L +L V L+ V+ ++
Sbjct: 76 IGVCQA---EAL---MLVMEMAGGGPLHKFL-VGKR----EEIPVSNVAELLHQVSMGMK 124
Query: 822 YL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
YL + VH DL NVLL + A + DFGL++ L ++ + K
Sbjct: 125 YLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-----TARSAGKW 175
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+ + APE S+ DV+S+G+ + E + ++P M
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-32
Identities = 73/379 (19%), Positives = 120/379 (31%), Gaps = 56/379 (14%)
Query: 204 IGENRLSGRLPDSLGQ--LRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSL 261
E+R + + L++ E+ + P + + ++ + N L SL
Sbjct: 21 AEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SL 76
Query: 262 PVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLF 321
P L L V N T SLP L + L H L
Sbjct: 77 PALPP----ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLC 124
Query: 322 RLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMG 381
+L N L + L+ L + N LP + L + ++
Sbjct: 125 KLWIFGNQLTS-------LPVLPPG---LQELSVSDNQLA-SLPALPSELCK-LWAYNNQ 172
Query: 382 LNQI--YVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLT 439
L + L L+ + NQL +P EL L + +L P L
Sbjct: 173 LTSLPMLPSGLQELS---VSDNQLAS-LPTLPSELYKLWAYNNRLTSL----PALPSGLK 224
Query: 440 ILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNL 499
L + N+L +P L L VS N+LT +LP G+++L + N
Sbjct: 225 ---ELIVSGNRLT-SLPVLPSE---LKELMVSGNRLT-SLPMLPSGLLSL----SVYRNQ 272
Query: 500 LTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTL 559
LT +P + +L + + L N S E + T Y +
Sbjct: 273 LT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGY--SGPIIRFDMAGASAP 328
Query: 560 KSIKELDLSRNNLSGQIPE 578
+ + L L+ + E
Sbjct: 329 RETRALHLAAADWLVPARE 347
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 5e-29
Identities = 85/353 (24%), Positives = 125/353 (35%), Gaps = 95/353 (26%)
Query: 245 SSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLN 304
+ +++ + L +LP + ++ L + NN T SLP LR L+ S N
Sbjct: 40 NGNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPALPPE---LRTLEVSGN 91
Query: 305 HFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVL 364
+ LP +L
Sbjct: 92 QLT--------SLP-----------------------VLPPGLLELSIFSNPLT------ 114
Query: 365 PLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHH 424
+L + L L + NQLT +P LQ L +
Sbjct: 115 -----HLPALP------------SGLCKLW---IFGNQLTS-LPVLPP---GLQELSVSD 150
Query: 425 NNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQIL 484
N L +P L L N+L +P Q L SVS+N+L +LP
Sbjct: 151 NQLA-SLPALPSELC---KLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLPS 201
Query: 485 GIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYME 544
+ L N LT S+PA LK L+ +S NR + +PV S L+ L +
Sbjct: 202 ELYKL----WAYNNRLT-SLPALPSGLKELI---VSGNRLT-SLPVLPSE---LKELMVS 249
Query: 545 GNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLE 597
GN LT S+P+ L S L + RN L+ ++PE L +LS +NL N L
Sbjct: 250 GNRLT-SLPMLPSGLLS---LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-29
Identities = 78/397 (19%), Positives = 130/397 (32%), Gaps = 73/397 (18%)
Query: 102 LRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLV 161
+N +G + +P + + TL++ +N+ + +P+ L GN L
Sbjct: 42 NAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQLT 94
Query: 162 GQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLR 221
+P L+L S L S L L I N+L+ LP L+
Sbjct: 95 -SLPVLPP-GLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLPVLPPGLQ 144
Query: 222 SLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNN 281
L +S+N + P+ S L + N+L SLP+ L+ LSV N
Sbjct: 145 ELS---VSDNQLA-SLPALP---SELCKLWAYNNQLT-SLPMLPS----GLQELSVSDNQ 192
Query: 282 YTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFI 341
SLP S L + L L L S N L + + L
Sbjct: 193 LA-SLPTLPSELYKLWAYNNRLTSLPAL-------PSGLKELIVSGNRLTS--LPVL--- 239
Query: 342 AHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYN 401
S+L+ L + N LP+ + L S L+ + N
Sbjct: 240 -----PSELKELMVSGNRLTS-LPMLPSGLLS-------------------LS---VYRN 271
Query: 402 QLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGN 461
QLT +P ++ L + ++L N L ++L +T + S+
Sbjct: 272 QLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330
Query: 462 CQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGN 498
+ L L + + L A + +
Sbjct: 331 TRALHLA--AADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 77/444 (17%), Positives = 126/444 (28%), Gaps = 122/444 (27%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
VL++ + +P + + TL++ +N+ +
Sbjct: 43 AVLNVGESGLT-------------------------TLPDCLPA--HITTLVIPDNNLT- 74
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISN 198
+P+ L GN L +P L+L S L S
Sbjct: 75 SLPALP---PELRTLEVSGNQLT-SLPVLPP-GLLELSIFSNPLTHLPALP-------SG 122
Query: 199 LQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLE 258
L L I N+L+ LP L+ L +S+N + P+ S L + N+L
Sbjct: 123 LCKLWIFGNQLT-SLPVLPPGLQELS---VSDNQLA-SLPAL---PSELCKLWAYNNQLT 174
Query: 259 GSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLP 318
SLP+ L+ LSV N SLP S L + L
Sbjct: 175 -SLPMLPS----GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPAL-------PS 221
Query: 319 NLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILF 378
L L S N L + LP+ + L
Sbjct: 222 GLKELIVSGNRLTS-------------------------------LPVLPSELK------ 244
Query: 379 SMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNL 438
L + N+LT +P L L ++ N L +PESL +L
Sbjct: 245 -------------ELM---VSGNRLTS-LPMLPS---GLLSLSVYRNQLT-RLPESLIHL 283
Query: 439 TILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGN 498
+ +++L N L + + + + L + +
Sbjct: 284 SSETTVNLEGNPLSERTLQ---ALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAAD 340
Query: 499 LLTGSIPAEVGNLKNLVQLGLSEN 522
L + E G +N
Sbjct: 341 WLVPAREGEPAPADRWHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-16
Identities = 42/188 (22%), Positives = 71/188 (37%), Gaps = 30/188 (15%)
Query: 449 NKLRGHVPSSLGNCQ--NLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPA 506
++ R V + C +L+V + LT LP + +T L + N LT S+PA
Sbjct: 24 SRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPAHITT---LVIPDNNLT-SLPA 78
Query: 507 EVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELD 566
L+ L +S N+ + +PV L L + +L
Sbjct: 79 LPPELRTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLW 127
Query: 567 LSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNK-----RLC 621
+ N L+ +P L+ L++S N L +P + S + + N+ L
Sbjct: 128 IFGNQLT-SLPVLPPG---LQELSVSDNQLA-SLP--ALPSELCKLWAYNNQLTSLPMLP 180
Query: 622 GGLDELHL 629
GL EL +
Sbjct: 181 SGLQELSV 188
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 59/248 (23%), Positives = 103/248 (41%), Gaps = 29/248 (11%)
Query: 707 IGQGSFGFVYRGNL----GENEMAVAVKVMNLKQRG--ATKSFVAECEALRNIRHRNLIK 760
+G+G+FG V VAVK L+ G + F E + L+ + ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
V + + +V EY+ G L D+L + +L + + L + +
Sbjct: 89 YRGVSYGPGRQSL---RLVMEYLPSGCLRDFLQRHRARL-----DASRLLLYSSQICKGM 140
Query: 821 EYLH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
EYL C VH DL N+L++ + + DFGLA+ LP + +
Sbjct: 141 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK-----DYYVVREPGQ 191
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRP-TDNMFNDGLTLHEFAKMALP 937
+ + APE S DV+SFG++L E+FT + + + + E AL
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
Query: 938 EKVMEIVD 945
++E+++
Sbjct: 252 R-LLELLE 258
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-32
Identities = 73/218 (33%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG+G FG V G+ VAVK +K ++F+AE + +RH NL++++ V
Sbjct: 201 IGKGEFGDVMLGDY--RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
EE IV EYM GSL D+L L +DV A+EYL +
Sbjct: 257 ----EEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVA 886
VH DL NVL+ D VA V DFGL + E S+ K V + A
Sbjct: 309 N---FVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTA 354
Query: 887 PEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
PE S DV+SFGILL E+++ R P +
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-32
Identities = 68/227 (29%), Positives = 114/227 (50%), Gaps = 32/227 (14%)
Query: 707 IGQGSFGFVYRGNL----GENEMAVAVKVMN----LKQRGATKSFVAECEALRNIRHRNL 758
IG G FG VY+G L G+ E+ VA+K + KQR F+ E + H N+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR---VDFLGEAGIMGQFSHHNI 108
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
I++ V S + I+ EYME G+L+ +L + + + +V+Q + ++ +A
Sbjct: 109 IRLEGVISK---YKPMM--IITEYMENGALDKFLREKDGEF-----SVLQLVGMLRGIAA 158
Query: 819 AIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
++YL + + VH DL N+L++ ++V V DFGL+R L E +++G
Sbjct: 159 GMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVL-----EDDPEATYTTSG 209
Query: 878 IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
K + + APE ++ DV+SFGI++ E+ T RP + N
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 27/221 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIITV 764
+G G +G VY G + + VAVK + + F+ E ++ I+H NL++++ V
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL- 823
C+ E + I+ E+M G+L D+L + N Q + + L + ++ A+EYL
Sbjct: 78 CTR---EPPFY--IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLE 128
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
+ +H DL N L+ + + V DFGL+R + +T ++ G K +
Sbjct: 129 KKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAHAGAKFPIK 177
Query: 884 YVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+ APE S DV++FG+LL E+ T P +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 58/249 (23%), Positives = 97/249 (38%), Gaps = 30/249 (12%)
Query: 707 IGQGSFGFVYRGNL----GENEMAVAVKVMNLKQRGATKS---FVAECEALRNIRHRNLI 759
+G+G FG V VAVK LK E E LRN+ H N++
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
K +C+ + ++ E++ GSL+++L N N+ Q+L + +
Sbjct: 87 KYKGICTEDGGNGI---KLIMEFLPSGSLKEYL-PKNK----NKINLKQQLKYAVQICKG 138
Query: 820 IEYLH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
++YL VH DL NVL++ + +GDFGL + + E +
Sbjct: 139 MDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-----EYYTVKDDR 189
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT--RRRPTDNMFNDGLTLHEFAKMAL 936
V + APE M DV+SFG+ L E+ T + + +M +
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249
Query: 937 PEKVMEIVD 945
++ +
Sbjct: 250 TR-LVNTLK 257
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 707 IGQGSFGFVYRGNL----GENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKII 762
+G+G+FG V VAVK + + F E E L++++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
VC S + ++ EY+ GSL D+L + +++ + I+ L + +EY
Sbjct: 78 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERI-----DHIKLLQYTSQICKGMEY 129
Query: 823 LH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
L +H DL N+L++++ +GDFGL + LP E +
Sbjct: 130 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EFFKVKEPGESP 180
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ + APE S DV+SFG++L E+FT
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 73/219 (33%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG+G FG V G+ VAVK +K ++F+AE + +RH NL++++ V
Sbjct: 29 IGKGEFGDVMLGDY--RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL-HH 825
EE IV EYM GSL D+L L +DV A+EYL +
Sbjct: 85 ----EEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 826 HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYV 885
+ VH DL NVL+ D VA V DFGL + E S+ K V +
Sbjct: 137 NF----VHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWT 181
Query: 886 APEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
APE S DV+SFGILL E+++ R P +
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 707 IGQGSFGFVYRG--NLGENEMAVAVKVM--NLKQRGATKSFVAECEALRNIRHRNLIKII 762
+G G+FG V +G + + VAVK++ +AE ++ + + ++++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
+C + E +V E E G L +L Q+ + + LV V+ ++Y
Sbjct: 85 GICEA---ESW---MLVMEMAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKY 132
Query: 823 L-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
L + VH DL NVLL A + DFGL++ L + T K
Sbjct: 133 LEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-----KAQTHGKWP 183
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
V + APE S+ DV+SFG+L+ E F+ ++P M
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIITV 764
+G G FG V G + VA+K++ G+ F+ E + + N+ H L+++ V
Sbjct: 32 LGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL- 823
C+ + I+ EYM G L ++L + F Q L + DV A+EYL
Sbjct: 88 CT--KQRPI---FIITEYMANGCLLNYL-REMR----HRFQTQQLLEMCKDVCEAMEYLE 137
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP-SSSTGIKGTV 882
+H DL N L++ V V DFGL+R+ +L+ +SS G K V
Sbjct: 138 SKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRY--------VLDDEYTSSVGSKFPV 185
Query: 883 GYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+ PE M S+ D+++FG+L+ E+++ + P + N
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 31/222 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIITV 764
+G G FG V+ G VAVK + +G+ +F+AE ++ ++H+ L+++ V
Sbjct: 21 LGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL- 823
+ +E + I+ EYME GSL D+L + + + L++ +A + ++
Sbjct: 77 VT----QEPIY--IITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE 126
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP-SSSTGIKGTV 882
+ +H DL+ +N+L+ + + DFGLAR I + ++ G K +
Sbjct: 127 ERNY----IHRDLRAANILVSDTLSCKIADFGLARL--------IEDNEYTAREGAKFPI 174
Query: 883 GYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+ APE G + DV+SFGILL E+ T R P M N
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 707 IGQGSFGFVYRGNL----GENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKII 762
+G+G+FG V VAVK + + F E E L++++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
VC S + ++ EY+ GSL D+L + +++ + I+ L + +EY
Sbjct: 109 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERI-----DHIKLLQYTSQICKGMEY 160
Query: 823 LH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
L +H DL N+L++++ +GDFGL + LP E +
Sbjct: 161 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EYYKVKEPGESP 211
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ + APE S DV+SFG++L E+FT
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 37/333 (11%), Positives = 79/333 (23%), Gaps = 56/333 (16%)
Query: 666 YTRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEM 725
+ ++ + + Q + LS+ + G V+ E
Sbjct: 29 ALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLE 88
Query: 726 AVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLI---------------------KI 761
A+KV + R + A + +
Sbjct: 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEV-GNFNVIQRLNLVIDVAFAI 820
+ D V ++ LE + G+ ++ L +
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAASV-DLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
L +VHG P N+ + D +GD + +
Sbjct: 208 ANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW-----------KVGTRGPASSV 253
Query: 881 TVGYVAPEY--GMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA--- 935
V Y E+ + + + G+ + ++ P + + +
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313
Query: 936 -----------LPEKVMEIVDPLLLLDLEARAS 957
LP+ V ++ L D R
Sbjct: 314 TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL 346
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 29/222 (13%)
Query: 705 NMIGQGSFGFVYRGNL---GENEMAVAVKVMNLKQRGAT----KSFVAECEALRNIRHRN 757
+IG+G FG VY G +N + A+K ++ R ++F+ E +R + H N
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNHPN 83
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
++ +I + E + ++ YM G L ++ V ++ + VA
Sbjct: 84 VLALIGIML--PPEGLPH--VLLPYMCHGDLLQFIRSPQRNP-----TVKDLISFGLQVA 134
Query: 818 FAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
+EYL VH DL N +LD V DFGLAR + ++ + +
Sbjct: 135 RGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRP 917
+K T A E + DV+SFG+LL E+ TR P
Sbjct: 191 PVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIITV 764
IG G FG V+ G N+ VA+K +++ GA + F+ E E + + H L+++ V
Sbjct: 16 IGSGQFGLVHLGYW-LNKDKVAIKT--IRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL- 823
C + +V E+ME G L D+L ++ G F L + +DV + YL
Sbjct: 72 CLE---QAPIC--LVTEFMEHGCLSDYL-RTQR----GLFAAETLLGMCLDVCEGMAYLE 121
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
+H DL N L+ + V V DFG+ RF+ + +SSTG K V
Sbjct: 122 EACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFPVK 170
Query: 884 YVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+ +PE S+ DV+SFG+L+ E+F+ + P +N N
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-31
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 25/221 (11%)
Query: 705 NMIGQGSFGFVYRGNL---GENEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRN 757
M+G+G FG V L + + VAVK+ LK S F+ E ++ H +
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKM--LKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 758 LIKIITVCSSIDFEEVDFKA-IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
+ K++ V + ++ +M+ G L +L S N + + ++D+
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 817 AFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
A +EYL + +H DL N +L DM V DFGL+R I
Sbjct: 147 ACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDYYR 194
Query: 876 TGIKGT--VGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914
G V ++A E + DV++FG+ + E+ TR
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-31
Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 27/220 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIITV 764
+G G FG V+ VAVK M G+ ++F+AE ++ ++H L+K+ V
Sbjct: 196 LGAGQFGEVWMATY-NKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
+ + I+ E+M GSL D+L + + ++ +A + ++
Sbjct: 252 VTK------EPIYIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIAEGMAFIE 301
Query: 825 HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGY 884
+H DL+ +N+L+ +V + DFGLAR + ++ G K + +
Sbjct: 302 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIED-------NEYTAREGAKFPIKW 351
Query: 885 VAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
APE G + DV+SFGILL+E+ T R P M N
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT--KSFVAECEALRNIRHRNLIKIITV 764
+G G FG V G + + VAVK++ G+ F E + + + H L+K V
Sbjct: 16 LGSGQFGVVKLGKW-KGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL- 823
CS E + IV EY+ G L ++L +S+ Q L + DV + +L
Sbjct: 72 CSK---EYPIY--IVTEYISNGCLLNYL-RSHG----KGLEPSQLLEMCYDVCEGMAFLE 121
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP-SSSTGIKGTV 882
H +H DL N L+D D+ V DFG+ R+ +L+ SS G K V
Sbjct: 122 SHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRY--------VLDDQYVSSVGTKFPV 169
Query: 883 GYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+ APE S+ DV++FGIL+ E+F+ + P D N
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 8e-31
Identities = 67/265 (25%), Positives = 109/265 (41%), Gaps = 36/265 (13%)
Query: 671 KHKHKSSSMLLMEQQFPMVSYADLSKATNDF---------SSSNMIGQGSFGFVYRGNLG 721
+ K + L + ++ +GQG FG V+ G
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW- 205
Query: 722 ENEMAVAVKVMNLKQRGATKS--FVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIV 779
VA+K + G F+ E + ++ +RH L+++ V S IV
Sbjct: 206 NGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI------YIV 256
Query: 780 YEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPS 839
EYM GSL D+L + + Q +++ +A + Y+ VH DL+ +
Sbjct: 257 TEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAA 309
Query: 840 NVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATG 899
N+L+ ++V V DFGLAR + ++ G K + + APE + G +
Sbjct: 310 NILVGENLVCKVADFGLARLIED-------NEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 900 DVYSFGILLLEMFTR-RRPTDNMFN 923
DV+SFGILL E+ T+ R P M N
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVN 387
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 29/222 (13%)
Query: 705 NMIGQGSFGFVYRGNL---GENEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRN 757
+IG+G FG VY G L ++ AVK +N R F+ E +++ H N
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
++ ++ +C + + +V YM+ G L +++ V + + VA
Sbjct: 88 VLSLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNP-----TVKDLIGFGLQVA 138
Query: 818 FAIEYLH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
++YL VH DL N +LD V DFGLAR + ++ +
Sbjct: 139 KGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 194
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRP 917
+K A E + DV+SFG+LL E+ TR P
Sbjct: 195 PVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 64/249 (25%), Positives = 99/249 (39%), Gaps = 32/249 (12%)
Query: 707 IGQGSFGFVYRG---NLGENE-MAVAVKVMNLKQRGATKS---FVAECEALRNIRHRNLI 759
+G+G FG V + VAVK LK + + E + LR + H ++I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
K C + +V EY+ GSL D+L + + + Q L +
Sbjct: 97 KYKGCCEDAGAASL---QLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEG 146
Query: 820 IEYLH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+ YLH H +H DL NVLLD+D + +GDFGLA+ +P E
Sbjct: 147 MAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-----EYYRVREDG 197
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT--RRRPTDNMFNDGLTLHEFAKMAL 936
V + APE DV+SFG+ L E+ T + L +M +
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257
Query: 937 PEKVMEIVD 945
+ E+++
Sbjct: 258 LR-LTELLE 265
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 67/279 (24%), Positives = 113/279 (40%), Gaps = 40/279 (14%)
Query: 669 RRKHKHKSSSMLLMEQQFPMVSYADLSKATN--DFSSSNMIGQGSFGFVYRGNLGENEMA 726
+ + +H S L + S A+ + +S IG G V++ L E +
Sbjct: 24 KFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQI 82
Query: 727 VAVKVMNLKQRG--ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYME 784
A+K +NL++ S+ E L ++ + KII + D+E D +Y ME
Sbjct: 83 YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL---YDYEITDQY--IYMVME 136
Query: 785 C--GSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVL 842
C L WL + + + +R + ++ A+ +H H IVH DLKP+N L
Sbjct: 137 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFL 187
Query: 843 LDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPE--YGMGGDMSATG- 899
+ M+ + DFG+A + P + + + ++ G V Y+ PE M
Sbjct: 188 IVDGML-KLIDFGIANQMQPDTTSVVKDS------QVGAVNYMPPEAIKDMSSSRENGKS 240
Query: 900 --------DVYSFGILLLEMFTRRRPTDNMFNDGLTLHE 930
DV+S G +L M + P + N LH
Sbjct: 241 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 41/274 (14%)
Query: 671 KHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVK 730
H H SS + L + S + + +S IG G V++ L E + A+K
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGR---IYSILKQIGSGGSSKVFQV-LNEKKQIYAIK 58
Query: 731 VMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMEC--G 786
+NL++ S+ E L ++ + KII + D+E D +Y MEC
Sbjct: 59 YVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL---YDYEITDQY--IYMVMECGNI 112
Query: 787 SLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD 846
L WL + + + +R + ++ A+ +H H IVH DLKP+N L+
Sbjct: 113 DLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG 163
Query: 847 MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPE--YGMGGDMSATG----- 899
M+ + DFG+A + P + + + ++ GTV Y+ PE M
Sbjct: 164 ML-KLIDFGIANQMQPDTTSVVKDS------QVGTVNYMPPEAIKDMSSSRENGKSKSKI 216
Query: 900 ----DVYSFGILLLEMFTRRRPTDNMFNDGLTLH 929
DV+S G +L M + P + N LH
Sbjct: 217 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 2e-30
Identities = 54/255 (21%), Positives = 97/255 (38%), Gaps = 34/255 (13%)
Query: 706 MIGQGSFGFVYRG---NLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHRNLIKI 761
I G G++Y N+ V +K + A +AE + L + H ++++I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRP--VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
D IV EY+ SL+ V + + ++++ A+
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--------QKLPVAEAIAYLLEILPALS 196
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG-IKG 880
YLH +V+ DLKP N++L + + + D G + +S G + G
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTEEQLK-LIDLGAVSRI-------------NSFGYLYG 239
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940
T G+ APE G AT D+Y+ G L + + + DGL + + +
Sbjct: 240 TPGFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLPTRNGRYVDGLP-EDDPVLKTYDSY 297
Query: 941 MEIVDPLLLLDLEAR 955
++ + D R
Sbjct: 298 GRLLRRAIDPDPRQR 312
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 63/246 (25%), Positives = 103/246 (41%), Gaps = 38/246 (15%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG--ATKSFVAECEALRNIRHR 756
+S IG G V++ L E + A+K +NL++ S+ E L ++
Sbjct: 9 RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMEC--GSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
+ KII + D+E D +Y MEC L WL + + + +R +
Sbjct: 68 S-DKIIRL---YDYEITDQY--IYMVMECGNIDLNSWLKKK------KSIDPWERKSYWK 115
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
++ A+ +H H IVH DLKP+N L+ M+ + DFG+A + P + + + ++
Sbjct: 116 NMLEAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS--- 168
Query: 875 STGIKGTVGYVAPE--YGMGGDMSATG---------DVYSFGILLLEMFTRRRPTDNMFN 923
GTV Y+ PE M DV+S G +L M + P + N
Sbjct: 169 ---QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225
Query: 924 DGLTLH 929
LH
Sbjct: 226 QISKLH 231
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 34/226 (15%)
Query: 707 IGQGSFGFVYRGNL---GENEMAVAVKVMNLKQRGAT----KSFVAECEALRNIRHRNLI 759
IG+G FG V++G +AVA+K + + F+ E +R H +++
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
K+I V + V I+ E G L +L Q + ++ + ++ A
Sbjct: 80 KLIGVITE---NPV---WIIMELCTLGELRSFL-QVRK----YSLDLASLILYAYQLSTA 128
Query: 820 IEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+ YL VH D+ NVL+ + +GDFGL+R++ T ++
Sbjct: 129 LAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKG 177
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
K + ++APE ++ DV+ FG+ + E+ +P + N
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-30
Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 29/228 (12%)
Query: 705 NMIGQGSFGFVYRGNL---GENEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRN 757
+IG+G FG VY G L ++ AVK +N R F+ E +++ H N
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
++ ++ +C + + +V YM+ G L +++ V + + VA
Sbjct: 152 VLSLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNP-----TVKDLIGFGLQVA 202
Query: 818 FAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
+++L VH DL N +LD V DFGLAR + ++ +
Sbjct: 203 KGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+K A E + DV+SFG+LL E+ TR P ++
Sbjct: 259 PVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 48/235 (20%), Positives = 102/235 (43%), Gaps = 44/235 (18%)
Query: 707 IGQGSFGFVYRGNL-------GENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLI 759
+GQG+F +++G +E V +KV++ R ++SF + + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
VC +E +V E+++ GSL+ +L ++ + + N++ +L + +A A
Sbjct: 76 LNYGVCV--CGDEN---ILVQEFVKFGSLDTYLKKNKNCI-----NILWKLEVAKQLAAA 125
Query: 820 IEYL-HHHCHPPIVHGDLKPSNVLLDHD--------MVAHVGDFGLARFLPPCSPATILE 870
+ +L + +HG++ N+LL + + D G++ + P IL+
Sbjct: 126 MHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV---LPKDILQ 178
Query: 871 TPSSSTGIKGTVGYVAPE-YGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
I PE +++ D +SFG L E+ + +P + +
Sbjct: 179 ER-----IPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 4e-30
Identities = 50/227 (22%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 707 IGQGSFGFVYRG---NLGENEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRNLI 759
+G+G FG VY G N ++ VAVK + T F++E ++N+ H +++
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
K+I + + I+ E G L +L + N + V+ + + + A
Sbjct: 77 KLIGIIEE------EPTWIIMELYPYGELGHYL-ERNK----NSLKVLTLVLYSLQICKA 125
Query: 820 IEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP-SSSTG 877
+ YL +C VH D+ N+L+ +GDFGL+R+ I + ++
Sbjct: 126 MAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRY--------IEDEDYYKASV 173
Query: 878 IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+ + +++PE + DV+ F + + E+ + ++P + N
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-30
Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 27/220 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKS--FVAECEALRNIRHRNLIKIITV 764
+GQG FG V+ G VA+K + G F+ E + ++ +RH L+++ V
Sbjct: 275 LGQGCFGEVWMGTW-NGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
S IV EYM GSL D+L + + Q +++ +A + Y+
Sbjct: 331 VSEEPI------YIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVE 380
Query: 825 HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGY 884
VH DL+ +N+L+ ++V V DFGLAR + ++ G K + +
Sbjct: 381 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIED-------NEYTARQGAKFPIKW 430
Query: 885 VAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
APE + G + DV+SFGILL E+ T+ R P M N
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 8e-30
Identities = 51/222 (22%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 707 IGQGSFGFVYRGNL--GENEMAVAVKVM-NLKQRGATKSFVAECEALRNIRHRNLIKIIT 763
+G G+FG V +G + ++ VA+KV+ ++ T+ + E + + + + ++++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
VC + E + +V E G L +L +++ V L+ V+ ++YL
Sbjct: 404 VCQA---EAL---MLVMEMAGGGPLHKFLVGKREEI-----PVSNVAELLHQVSMGMKYL 452
Query: 824 -HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTV 882
+ VH +L NVLL + A + DFGL++ L ++ + K +
Sbjct: 453 EEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-----TARSAGKWPL 503
Query: 883 GYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
+ APE S+ DV+S+G+ + E + ++P M
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 59/314 (18%), Positives = 117/314 (37%), Gaps = 30/314 (9%)
Query: 285 SLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHL 344
++P + + RLLD N + +F P+L L ++N + + F
Sbjct: 25 AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA--VEPGAF---- 76
Query: 345 TNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLT 404
N L LGL +N + + + L NL + N++
Sbjct: 77 NNLFNLRTLGLRSN--------RLKLIPLGVF-----------TGLSNLTKLDISENKIV 117
Query: 405 GPIPHAIGELRNLQVLDLHHNNLDGHIPE-SLGNLTILNSLDLGFNKLRGHVPSSLGNCQ 463
+ + +L NL+ L++ N+L +I + L L L L L +L +
Sbjct: 118 ILLDYMFQDLYNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLH 176
Query: 464 NLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENR 523
L++L + + + A+ + +L++S ++ NL L ++
Sbjct: 177 GLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235
Query: 524 FSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENL 583
+ +++ L +L + N ++ L L ++E+ L L+ P L
Sbjct: 236 LTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGL 295
Query: 584 SFLEYLNLSYNHLE 597
++L LN+S N L
Sbjct: 296 NYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 77/373 (20%), Positives = 133/373 (35%), Gaps = 61/373 (16%)
Query: 156 RGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPD 215
V +P I L L N + + +L+ L + EN +S
Sbjct: 19 HRKRFV-AVPEGIPTE---TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS----- 69
Query: 216 SLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENL 275
++ AF+ + +L ++ L NRL+ +P+ + L NL L
Sbjct: 70 -----------AVEPGAFNNL--------FNLRTLGLRSNRLK-LIPLGVFTGLSNLTKL 109
Query: 276 SVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAI 335
+ +N L + + NL+ L+ N F+ L +L +L+ K NL + I
Sbjct: 110 DISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS--I 167
Query: 336 GDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNG 395
+HL L L L +I + F L L
Sbjct: 168 PTEAL-SHLHG---LIVLRLRHL--------NINAIRDY--SFK---------RLYRLKV 204
Query: 396 FGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPE-SLGNLTILNSLDLGFNKLRGH 454
+ + + NL L + H NL +P ++ +L L L+L +N +
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTI 263
Query: 455 VPSSLGNCQNLMLLSVSNNKLTGALPPQIL-GIVTLSILLDLSGNLLTGSIPAEV-GNLK 512
S L L + + +L + P G+ L + L++SGN LT ++ V ++
Sbjct: 264 EGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRV-LNVSGNQLT-TLEESVFHSVG 320
Query: 513 NLVQLGLSENRFS 525
NL L L N +
Sbjct: 321 NLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 85/402 (21%), Positives = 132/402 (32%), Gaps = 90/402 (22%)
Query: 64 CQWTG--VTCGHRH---------QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGF 112
C V C + +LDL I+ + + L + N
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 113 SGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSW 172
S PG LF L TL L +N IP +
Sbjct: 69 SAVEPGAFNNLFNLRTLGLRSNRLK-------------------------LIPLGVFTGL 103
Query: 173 LKLEFLSLRDNLLAGQLAPSI-GNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISEN 231
L L + +N + L + ++ NL+ L +G+N L IS
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV----------------YISHR 146
Query: 232 AFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLS 291
AFSG+ +SLE ++L L S+P L L L +R N +S
Sbjct: 147 AFSGL--------NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFK 197
Query: 292 NASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLE 351
L++L+ S + + + NL LS + NL + L + L
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA--VPYLAV----RHLVYLR 251
Query: 352 ALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAI 411
L L N I+ + ++ L+ L L QL P+A
Sbjct: 252 FLNLSYN--------PISTIEGSM--LH---------ELLRLQEIQLVGGQLAVVEPYAF 292
Query: 412 GELRNLQVLDLHHNNLDGHIPESL-GNLTILNSLDLGFNKLR 452
L L+VL++ N L + ES+ ++ L +L L N L
Sbjct: 293 RGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 707 IGQGSFGFVYRGN---LGENEMAVAVKVMNLKQRG---ATKSFVAECEALRNIRHRNLIK 760
+G G VY L VA+K + + R K F E + H+N++
Sbjct: 19 LGGGGMSTVYLAEDTILNIK---VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+I V EE D +V EY+E +L +++ G +V +N + I
Sbjct: 76 MIDVD-----EEDDCYYLVMEYIEGPTLSEYIESH------GPLSVDTAINFTNQILDGI 124
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
++ H IVH D+KP N+L+D + + DFG+A+ L S ++ +T + G
Sbjct: 125 KHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL---SETSLTQTNH----VLG 174
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
TV Y +PE G D+YS GI+L EM P
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 31/236 (13%)
Query: 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNI 753
S + + + S+++GQG+ V+RG + A+KV N + E E L+ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 754 RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLV 813
H+N++K+ + + K ++ E+ CGSL L + + + L ++
Sbjct: 65 NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVL 118
Query: 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLL----DHDMVAHVGDFGLARFLPPCSPATIL 869
DV + +L + IVH ++KP N++ D V + DFG AR L
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQF 172
Query: 870 ETPSSSTGIKGTVGYVAPE--------YGMGGDMSATGDVYSFGILLLEMFTRRRP 917
+ + GT Y+ P+ AT D++S G+ T P
Sbjct: 173 VS------LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 30/238 (12%)
Query: 690 SYADLSKATNDFSSSNM--------IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA-- 739
+ + T + +M IG+GSFG E+ +K +N+ + +
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 740 TKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL 799
+ E L N++H N+++ FEE IV +Y E G L ++ L
Sbjct: 67 REESRREVAVLANMKHPNIVQYRES-----FEENGSLYIVMDYCEGGDLFKRINAQKGVL 121
Query: 800 EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859
F Q L+ + + A++++H I+H D+K N+ L D +GDFG+AR
Sbjct: 122 ----FQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 860 LPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
L T + GT Y++PE + D+++ G +L E+ T +
Sbjct: 175 LN--------STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 54/240 (22%), Positives = 87/240 (36%), Gaps = 13/240 (5%)
Query: 389 NLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGH--IPESLGNLTILNSLDL 446
+ L LE N+L +L L L L N L +S T L LDL
Sbjct: 29 SATRLE---LESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85
Query: 447 GFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPA 506
FN + + S+ + L L ++ L + + I LD+S
Sbjct: 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFN 143
Query: 507 EV-GNLKNLVQLGLSENRFSNEI-PVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKE 564
+ L +L L ++ N F P + L +L + L P A +L S++
Sbjct: 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 203
Query: 565 LDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPR---RGVFSNKTRFYFTGNKRLC 621
L++S NN + L+ L+ L+ S NH+ + + S+ T N C
Sbjct: 204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 51/285 (17%), Positives = 93/285 (32%), Gaps = 36/285 (12%)
Query: 246 SLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNH 305
S I L S+P I + L + N + L L S N
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63
Query: 306 FSGQ--VKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGV 363
S + +L L S N + T ++ +LE L +
Sbjct: 64 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-------MSSNFLGLEQLEHLDFQHS----- 111
Query: 364 LPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLH 423
++ +S + +L NL + + L +L+VL +
Sbjct: 112 ---NLKQMSEFSVF----------LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 158
Query: 424 HNNLDGHIPE-SLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQ 482
N+ + L L LDL +L P++ + +L +L++S+N +L
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTF 217
Query: 483 ILGIVTLSILLDLSGNLLTGSIPAEV--GNLKNLVQLGLSENRFS 525
+ +LD S N + + + +L L L++N F+
Sbjct: 218 PYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 53/234 (22%), Positives = 95/234 (40%), Gaps = 8/234 (3%)
Query: 102 LRFINFANNGFSGEIPGEIGRLFRLETLILANN--SFSGKIPSNLSRCSNLINFHARGNN 159
+ +N G +L +L L L++N SF G + ++L N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 160 LVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSI-GNISNLQVLSIGENRLSGRLPDSLG 218
++ + + +LE L + + L S+ ++ NL L I
Sbjct: 90 VI-TMSSNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147
Query: 219 QLRSLYYLSISENAFSGMFPSSIF-NISSLESISLLGNRLEGSLPVNIGFSLPNLENLSV 277
L SL L ++ N+F F IF + +L + L +LE L SL +L+ L++
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNM 206
Query: 278 RQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLP-NLFRLSFSKNNL 330
NN+ ++L++LD+SLNH K + P +L L+ ++N+
Sbjct: 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 56/252 (22%), Positives = 95/252 (37%), Gaps = 11/252 (4%)
Query: 109 NNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNL-VGQIPPD 167
+ G + +P I L L +N + + L N L
Sbjct: 16 SKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72
Query: 168 IGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSL-GQLRSLYYL 226
+ L++L L N + ++ + + L+ L + L S+ LR+L YL
Sbjct: 73 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 131
Query: 227 SISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSL 286
IS F +SSLE + + GN + + +I L NL L + Q
Sbjct: 132 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 191
Query: 287 PHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTN 346
P + ++ S+L++L+ S N+F + L +L L +S N++ T +L
Sbjct: 192 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP---- 247
Query: 347 CSKLEALGLDTN 358
S L L L N
Sbjct: 248 -SSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 18/80 (22%), Positives = 34/80 (42%), Gaps = 5/80 (6%)
Query: 519 LSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQ--I 576
+ + +P + ++ L +E N L L + +L LS N LS +
Sbjct: 14 CNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70
Query: 577 PEFLENLSFLEYLNLSYNHL 596
+ + L+YL+LS+N +
Sbjct: 71 SQSDFGTTSLKYLDLSFNGV 90
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 45/231 (19%), Positives = 92/231 (39%), Gaps = 20/231 (8%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G+G F +V + A+K + ++ + E + R H N+++++
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA--Y 94
Query: 767 SIDFEEVDFKA-IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
+ +A ++ + + G+L + + + D+ Q L L++ + +E +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHA 152
Query: 826 HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL--PPCSPATILETPSSSTGIKGTVG 883
H DLKP+N+LL + + D G L + + T+
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA-QRCTIS 208
Query: 884 YVAPE------YGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 928
Y APE + + + + DV+S G +L M P D +F G ++
Sbjct: 209 YRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-28
Identities = 54/226 (23%), Positives = 96/226 (42%), Gaps = 34/226 (15%)
Query: 707 IGQGSFGFVYRGNL---GENEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRNLI 759
IG+G FG V++G MAVA+K K + S F+ E +R H +++
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKT--CKN-CTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
K+I V + + I+ E G L +L L++ + + ++ A
Sbjct: 455 KLIGVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASL-----ILYAYQLSTA 503
Query: 820 IEYLH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+ YL VH D+ NVL+ + +GDFGL+R++ T ++
Sbjct: 504 LAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKG 552
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR-RRPTDNMFN 923
K + ++APE ++ DV+ FG+ + E+ +P + N
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 56/223 (25%), Positives = 88/223 (39%), Gaps = 17/223 (7%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA--TKSFVAECEALRNIRHR 756
D+ IG GS+G + + + K ++ + V+E LR ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
N I+ I IV EY E G L + + E + L ++ +
Sbjct: 66 N---IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG--TKERQYLDEEFVLRVMTQL 120
Query: 817 AFAIEYLH--HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
A++ H ++H DLKP+NV LD +GDFGLAR L + +T
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKT--- 175
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT Y++PE + D++S G LL E+ P
Sbjct: 176 ---FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 68/388 (17%), Positives = 130/388 (33%), Gaps = 32/388 (8%)
Query: 225 YLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTG 284
Y+ +S N+ + + +S + L+ + + + N L +L L + N +
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ 93
Query: 285 SLPHSLSNASNLRLLDFSLNHFSGQV--KIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIA 342
+ + +NL +L + + G V F L +L L NN+ I F
Sbjct: 94 LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK--IQPASFFL 151
Query: 343 HLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQ 402
++ L L N + + N + L ++ +
Sbjct: 152 NMRR---FHVLDLTFNKVKSICEEDLLNFQGK---------HFTLLRLSSITLQDMNEYW 199
Query: 403 LTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNC 462
L + ++ LDL N + + + + ++ SS G+
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259
Query: 463 QNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLSE 521
N G + DLS + + ++ V + +L QL L++
Sbjct: 260 N---FKDPDNFTFKGLEASGV-------KTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQ 308
Query: 522 NRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPE-FL 580
N + + T L L + N L + L ++ LDLS N++ + +
Sbjct: 309 NEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSF 367
Query: 581 ENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
L L+ L L N L+ VP G+F
Sbjct: 368 LGLPNLKELALDTNQLK-SVP-DGIFDR 393
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-27
Identities = 66/382 (17%), Positives = 126/382 (32%), Gaps = 28/382 (7%)
Query: 158 NNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSI-GNISNLQVLSIGENRLSGRLPDS 216
N + ++ L+FL + + + +S+L +L + N+ +
Sbjct: 39 LNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGA 98
Query: 217 LGQLRSLYYLSISENAF-SGMFPSSIF-NISSLESISLLGNRLEGSLPVNIGFSLPNLEN 274
L +L L++++ + + F ++SLE + L N ++ P + ++
Sbjct: 99 FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHV 158
Query: 275 LSVRQNNYTGSLPHSLSNASNLRLLDFSL----------NHFSGQVKIDFNRLPNLFRLS 324
L + N L N L + + + ++ L
Sbjct: 159 LDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLD 218
Query: 325 FSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQ 384
S N +K+++L L N + N GL
Sbjct: 219 LSGNGFKESMAKRFF---DAIAGTKIQSLILS-NSYNMGSSFGHTNFKDPDNFTFKGLEA 274
Query: 385 IYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPE-SLGNLTILNS 443
VK L +++ + +L+ L L N ++ I + + LT L
Sbjct: 275 SGVKTCD------LSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLK 327
Query: 444 LDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGS 503
L+L N L N L +L +S N + AL Q + L L N L S
Sbjct: 328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-S 385
Query: 504 IPAEV-GNLKNLVQLGLSENRF 524
+P + L +L ++ L N +
Sbjct: 386 VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 38/194 (19%), Positives = 62/194 (31%), Gaps = 15/194 (7%)
Query: 443 SLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTG 502
+DL N + +S Q+L L V + ++ I+L L N
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL- 92
Query: 503 SIPAEV-GNLKNLVQLGLSENRF-SNEIPV-SLSACTTLEYLYMEGNSLTGSIPL--ALK 557
+ L NL L L++ + T+LE L + N++ I
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFL 151
Query: 558 TLKSIKELDLSRNNLSGQIPEFLENL--SFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFT 615
++ LDL+ N + E L N L LS L + + +
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL------QDMNEYWLGWEKC 205
Query: 616 GNKRLCGGLDELHL 629
GN + L L
Sbjct: 206 GNPFKNTSITTLDL 219
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 7e-09
Identities = 25/107 (23%), Positives = 40/107 (37%), Gaps = 7/107 (6%)
Query: 503 SIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPL-ALKTLKS 561
+PA ++ + LS N + S S L++L +E + I + L S
Sbjct: 27 ELPA------HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 562 IKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
+ L L N L+ LE L L+ +L+G V F
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 41/262 (15%), Positives = 90/262 (34%), Gaps = 26/262 (9%)
Query: 30 LHSNETDRLALLAIKSQLQDPLGVTSSWNN---SMNLCQWTGVTCG--HRHQRVTVLDLS 84
L N+ + + + + + MN CG ++ +T LDLS
Sbjct: 161 LTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLS 220
Query: 85 NRSIEGILS-PYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSN 143
+ ++ + ++ + + + N +F G S
Sbjct: 221 GNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS----FGHTNFKDPDNFTFKGLEASG 276
Query: 144 LS--RCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSI-GNISNLQ 200
+ S + + + + + LE L+L N + ++ + +++L
Sbjct: 277 VKTCDLSK---------SKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLL 326
Query: 201 VLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF-NISSLESISLLGNRLEG 259
L++ +N L L L L +S N F + +L+ ++L N+L+
Sbjct: 327 KLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK- 384
Query: 260 SLPVNIGFSLPNLENLSVRQNN 281
S+P I L +L+ + + N
Sbjct: 385 SVPDGIFDRLTSLQKIWLHTNP 406
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 46/221 (20%), Positives = 84/221 (38%), Gaps = 36/221 (16%)
Query: 706 MIGQGSFGFVYRGN---LGENEMAVAVKVMNLKQRGATKSFVA----ECEALRNIRHRNL 758
++G+G G VY VA+K+M+ + F E ++ +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERI---VALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPH- 95
Query: 759 IKIITVCSSIDFEEVDFKA-IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
++ + DF E+D + + + L L + G + + +V +
Sbjct: 96 --VVPI---HDFGEIDGQLYVDMRLINGVDLAAMLRRQ------GPLAPPRAVAIVRQIG 144
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
A++ H H D+KP N+L+ D A++ DFG+A + + G
Sbjct: 145 SALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIAS--------ATTDEKLTQLG 193
Query: 878 -IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT+ Y+APE + D+Y+ +L E T P
Sbjct: 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-28
Identities = 54/236 (22%), Positives = 97/236 (41%), Gaps = 31/236 (13%)
Query: 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN-LKQRGATKSFVAECEALRNI 753
S + + + S+++GQG+ V+RG + A+KV N + + E E L+ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 754 RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLV 813
H+N++K+ + + K ++ E+ CGSL L + + + L ++
Sbjct: 65 NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVL 118
Query: 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLL----DHDMVAHVGDFGLARFLPPCSPATIL 869
DV + +L + IVH ++KP N++ D V + DFG AR L
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQF 172
Query: 870 ETPSSSTGIKGTVGYVAPE--------YGMGGDMSATGDVYSFGILLLEMFTRRRP 917
+ + GT Y+ P+ AT D++S G+ T P
Sbjct: 173 VS------LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 51/234 (21%), Positives = 92/234 (39%), Gaps = 20/234 (8%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-HRNLIKIITV 764
++ +G F FVY + A+K + + ++ + E ++ + H N+++ +
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 765 CSSIDFEEVDFKAIVYEYMEC--GSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
S E +A E G L ++L + + G + L + A+++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQH 151
Query: 823 LHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL--PPCSPATILETPSSSTGIK- 879
+H PPI+H DLK N+LL + + DFG A + P + I
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 880 -GTVGYVAPE----YGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 928
T Y PE Y + D+++ G +L + R+ P F DG L
Sbjct: 211 NTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL 259
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-27
Identities = 48/326 (14%), Positives = 86/326 (26%), Gaps = 55/326 (16%)
Query: 668 RRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRG---NLGENE 724
+ S L P ++L + ++GQ GE
Sbjct: 47 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGE-- 104
Query: 725 MAVAVKVMNLKQ---RGATKSFVAECEALRNIRH----------------RNLIKIITVC 765
+ V V + A K E LR +R +L+K
Sbjct: 105 -SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163
Query: 766 SSIDFEEVDFKAIVYEY-----MECGSLEDWLHQSNDQLEV-GNFNVIQRLNLVIDVAFA 819
I + V +L+ + + RL L + V
Sbjct: 164 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 223
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+ LHH+ +VH L+P +++LD + F S
Sbjct: 224 LASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------SAVSPIGRGF 273
Query: 880 GTVGYVAPE-----YGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934
A M+ D ++ G+ + ++ P D L +
Sbjct: 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTDDAALGGSEWI 329
Query: 935 -----ALPEKVMEIVDPLLLLDLEAR 955
+P+ V +++ L E R
Sbjct: 330 FRSCKNIPQPVRALLEGFLRYPKEDR 355
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 1e-27
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 20/234 (8%)
Query: 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA-ECEALRNI 753
++ + +G G FG+V R + VA+K + + E + ++ +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 754 RHRNLIKIITVC-SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNL 812
H N++ V D + EY E G L +L+Q + L
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTL 126
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD---HDMVAHVGDFGLARFLPPCSPATIL 869
+ D++ A+ YLH + I+H DLKP N++L ++ + D G A+ L +
Sbjct: 127 LSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ---GELC 180
Query: 870 ETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFN 923
GT+ Y+APE + T D +SFG L E T RP +
Sbjct: 181 TE------FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 70/333 (21%), Positives = 111/333 (33%), Gaps = 69/333 (20%)
Query: 285 SLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHL 344
+P L + LLD N + DF L NL L N +
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI-------------- 88
Query: 345 TNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLT 404
+ I G LV L L NQL
Sbjct: 89 ------------SKISPGAF-----------------------APLVKLERLYLSKNQLK 113
Query: 405 GPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHV--PSSLGNC 462
+P + LQ L +H N + L + ++LG N L+ +
Sbjct: 114 E-LP--EKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170
Query: 463 QNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLSE 521
+ L + +++ +T +P + +L+ L L GN +T + A L NL +LGLS
Sbjct: 171 KKLSYIRIADTNIT-TIPQGLPP--SLTEL-HLDGNKIT-KVDAASLKGLNNLAKLGLSF 225
Query: 522 NRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSG------Q 575
N S SL+ L L++ N L +P L K I+ + L NN+S
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284
Query: 576 IPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
P + + ++L N ++ + F
Sbjct: 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 56/321 (17%), Positives = 110/321 (34%), Gaps = 46/321 (14%)
Query: 164 IPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSL 223
+P D+ L L++N + N+ NL L + N++S P + L L
Sbjct: 46 VPKDLPPD---TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 224 YYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYT 283
L +S+N P + +L+ + + N + + ++ L + + + N
Sbjct: 103 ERLYLSKNQLK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK 158
Query: 284 GSL--PHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFI 341
S + L + + + + I P+L L N + +
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITK--VDAASL- 212
Query: 342 AHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYN 401
+ L LGL N SI+ + + + N +L L N
Sbjct: 213 ---KGLNNLAKLGLSFN--------SISAVDNGSL-----------ANTPHLRELHLNNN 250
Query: 402 QLTGPIPHAIGELRNLQVLDLHHNNL------DGHIPESLGNLTILNSLDLGFNKLRGHV 455
+L +P + + + +QV+ LH+NN+ D P + + L N ++
Sbjct: 251 KLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309
Query: 456 --PSSLGNCQNLMLLSVSNNK 474
PS+ + + N K
Sbjct: 310 IQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 61/334 (18%), Positives = 113/334 (33%), Gaps = 62/334 (18%)
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNR 256
+ +L + N+++ L++L+ L + N S + P + + LE + L N+
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 257 LEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNR 316
L+ LP + L+ L V +N T + S+ FN
Sbjct: 112 LK-ELPEKM---PKTLQELRVHENEIT-KVRKSV-----------------------FNG 143
Query: 317 LPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTII 376
L + + N L + I + F KL + + +I +
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAF----QGMKKLSYIRIADT--------NITTIPQG-- 189
Query: 377 LFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLG 436
L +L L+ L+ N++T ++ L NL L L N++ SL
Sbjct: 190 LPP---------SLTELH---LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237
Query: 437 NLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL---- 492
N L L L NKL VP L + + + ++ + NN ++ +
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 296
Query: 493 -LDLSGNLLT-GSIPAEV-GNLKNLVQLGLSENR 523
+ L N + I + + L +
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 61/351 (17%), Positives = 117/351 (33%), Gaps = 59/351 (16%)
Query: 79 TVLDLSNRSIEGILSPYVGNL-SFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
V+ S+ +E + P +L ++ NN + G+ L L TLIL NN S
Sbjct: 34 RVVQCSDLGLEKV--P--KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 138 GKIPSN-LSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNI 196
KI + L + N L ++P + + L+ L + +N + +
Sbjct: 90 -KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKT---LQELRVHENEITKVRKSVFNGL 144
Query: 197 SNLQVLSIGENRLSGRL--PDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLG 254
+ + V+ +G N L + ++ L Y+ I++ + + P + SL + L G
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI-PQGLP--PSLTELHLDG 201
Query: 255 NRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDF 314
N++ + L NL L + N+ + SL+N +LR L + N +V
Sbjct: 202 NKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 315 NRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSST 374
+ + NN+ D + T + + L +N P+ +
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN------PVQYWEIQ-- 311
Query: 375 IILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHN 425
P + + L +
Sbjct: 312 ---------------------------------PSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 25/92 (27%), Positives = 37/92 (40%), Gaps = 4/92 (4%)
Query: 527 EIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFL 586
++P L T L ++ N +T K LK++ L L N +S P L L
Sbjct: 45 KVPKDLPPDTA--LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 587 EYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNK 618
E L LS N L+ E+P + N+
Sbjct: 103 ERLYLSKNQLK-ELP-EKMPKTLQELRVHENE 132
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 28/137 (20%), Positives = 49/137 (35%), Gaps = 8/137 (5%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
T L L I + + + L+ L + + N S G + L L L NN
Sbjct: 195 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 253
Query: 139 KIPSNLSRCSNLINFHARGNNL--VGQ---IPPDIGYSWLKLEFLSLRDN-LLAGQLAPS 192
K+P L+ + + NN+ +G PP +SL N + ++ PS
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
Query: 193 I-GNISNLQVLSIGENR 208
+ + +G +
Sbjct: 314 TFRCVYVRAAVQLGNYK 330
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-27
Identities = 50/227 (22%), Positives = 94/227 (41%), Gaps = 32/227 (14%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNL 758
F +++G G+ G + + +N VAVK + + E + LR H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNR-DVAVKRILPECFSFADR---EVQLLRESDEHPNV 80
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
I+ ++ F+ I E +L++++ Q + ++ + L+
Sbjct: 81 IRYFCT-----EKDRQFQYIAIELCA-ATLQEYVEQKD-----FAHLGLEPITLLQQTTS 129
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLL-----DHDMVAHVGDFGLARFLPPCSPATILETPS 873
+ +LH IVH DLKP N+L+ + A + DFGL + L + S
Sbjct: 130 GLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF-----S 181
Query: 874 SSTGIKGTVGYVAPEY---GMGGDMSATGDVYSFGILLLEMFTRRRP 917
+G+ GT G++APE + + T D++S G + + +
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 24/218 (11%)
Query: 706 MIGQGSFGFVYRGN---LGENEMAVAVKVMNLKQRG---ATKSFVAECEALRNIRHRNLI 759
++G G V+ + VAVKV+ F E + + H ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRD---VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
+ + + IV EY++ +L D +H G + + ++ D A
Sbjct: 76 AVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQA 128
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+ + H + I+H D+KP+N+++ V DFG+AR + S ++ +T + +
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD-SGNSVTQTAA----VI 180
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT Y++PE G + A DVYS G +L E+ T P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 64/254 (25%), Positives = 100/254 (39%), Gaps = 28/254 (11%)
Query: 667 TRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRG-NLGENEM 725
+R + + + +L+ ++ V Y + + + + +G+GSFG V+R +
Sbjct: 27 LQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 726 AVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA-IVYEYME 784
AVK + L+ V E A + ++ + I E +E
Sbjct: 86 -CAVKKVRLE-----VFRVEELVACAGLSSPRIVPLY------GAVREGPWVNIFMELLE 133
Query: 785 CGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD 844
GSL + Q G + L + +EYLH I+HGD+K NVLL
Sbjct: 134 GGSLGQLIKQM------GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLS 184
Query: 845 HD-MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYS 903
D A + DFG A L P L T I GT ++APE MG A D++S
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDY---IPGTETHMAPEVVMGKPCDAKVDIWS 241
Query: 904 FGILLLEMFTRRRP 917
++L M P
Sbjct: 242 SCCMMLHMLNGCHP 255
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 52/228 (22%), Positives = 87/228 (38%), Gaps = 31/228 (13%)
Query: 695 SKATNDFSSSNMIGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGAT--KSFVAECEALR 751
S F + +G GS+G V++ + + + AVK RG +AE +
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRL-YAVKRSMSPFRGPKDRARKLAEVGSHE 111
Query: 752 NI-RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRL 810
+ +H +++ +EE + E SL+ + Q
Sbjct: 112 KVGQHPCCVRLEQA-----WEEGGILYLQTELCG-PSLQQHCEAWG-----ASLPEAQVW 160
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
+ D A+ +LH +VH D+KP+N+ L +GDFGL L
Sbjct: 161 GYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV---------ELG 208
Query: 871 TPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRP 917
T + +G Y+APE G +A DV+S G+ +LE+
Sbjct: 209 TAGAGEVQEGDPRYMAPELLQGSYGTAA--DVFSLGLTILEVACNMEL 254
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-27
Identities = 49/333 (14%), Positives = 94/333 (28%), Gaps = 64/333 (19%)
Query: 668 RRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAV 727
+ S L P ++L + ++GQ E +
Sbjct: 42 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 101
Query: 728 AVKVMNLKQRGA------TKSFVAECEALRNIRHRNLI-------------------KII 762
V V +R K V LR I+++ K+I
Sbjct: 102 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 161
Query: 763 TVCSSIDFEEVDFKAIVYEYMEC--GSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
V V + +Y M+ + + L + + RL L + V +
Sbjct: 162 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS--THKSLVHHARLQLTLQVIRLL 219
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
LHH+ +VH L+P +++LD + F +
Sbjct: 220 ASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR------------DGARVVSSV 264
Query: 881 TVGYVAPEY-----------GMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH 929
+ G+ PE M+ + D ++ G+++ ++ P L
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP----ITKDAALG 320
Query: 930 EFAK-----MALPEKVMEIVDPLLLLDLEARAS 957
+P+ V +++ L E R
Sbjct: 321 GSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLL 353
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 43/231 (18%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRN 757
+G G+FG VY G + + + VAVK + ++ F+ E + H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 94
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVG-NFNVIQRLNLVIDV 816
+++ I V + + I+ E M G L+ +L ++ + + ++ L++ D+
Sbjct: 95 IVRCIGVSL-----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 817 AFAIEYL-HHHCHPPIVHGDLKPSNVLLD---HDMVAHVGDFGLARFLPPCSPATILETP 872
A +YL +H +H D+ N LL VA +GDFG+AR +
Sbjct: 150 ACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----------DIY 194
Query: 873 SSSTGIKGTVGYV-----APEYGMGGDMSATGDVYSFGILLLEMFTR-RRP 917
+S KG + PE M G ++ D +SFG+LL E+F+ P
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATK---SFVAECEALRNIRH 755
+F IG+G F VYR + + VA+K + + K + E + L+ + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
N +I +S F E + IV E + G L + + + + +
Sbjct: 92 PN---VIKYYAS--FIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFVQ 144
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+ A+E++H ++H D+KP+NV + V +GD GL RF S T +
Sbjct: 145 LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHS---- 195
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
+ GT Y++PE + D++S G LL EM + P
Sbjct: 196 --LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 53/227 (23%), Positives = 96/227 (42%), Gaps = 42/227 (18%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRN 757
+GQGSFG VY G E E VA+K +N A+ F+ E ++ +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL----HQSNDQLEVGNFNVIQRLNLV 813
+++++ V S + ++ E M G L+ +L + + ++ + + +
Sbjct: 90 VVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 814 IDVAFAIEYLH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP 872
++A + YL+ + VH DL N ++ D +GDFG+ R +
Sbjct: 145 GEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTR-----------DIY 189
Query: 873 SSSTGIKGTVGYV-----APEYGMGGDMSATGDVYSFGILLLEMFTR 914
+ KG G + +PE G + DV+SFG++L E+ T
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 236
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 43/296 (14%), Positives = 89/296 (30%), Gaps = 36/296 (12%)
Query: 693 DLSKATNDFSSSNMIGQGSFGFVYRG-----NLGENEMAVAVKVMNLKQRGATKSFVAEC 747
+ + +++G+G+F VY N +N+ +KV
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 748 EALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVI 807
E L+ +K + + +V E G+L + ++ + E
Sbjct: 119 ERLKPSMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLLNAINLYKNTPE-KVMPQG 172
Query: 808 QRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG-----------DFGL 856
++ + + + IE +H I+HGD+KP N +L + + D G
Sbjct: 173 LVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229
Query: 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEMFTR 914
+ + TI T T G+ E + D + + M
Sbjct: 230 SIDMKLFPKGTIF------TAKCETSGFQCVEMLSNKPWNYQI--DYFGVAATVYCMLFG 281
Query: 915 RRPTDNMFNDGLTLHE-FAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKI 969
F ++ + E +L + + R ++ K+
Sbjct: 282 TYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-26
Identities = 90/488 (18%), Positives = 166/488 (34%), Gaps = 44/488 (9%)
Query: 145 SRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPS-IGNISNLQVLS 203
NL +P D+ + LSL N ++ +L I +S L+VL
Sbjct: 28 FSNELESMVDYSNRNLT-HVPKDLPPR---TKALSLSQNSIS-ELRMPDISFLSELRVLR 82
Query: 204 IGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPV 263
+ NR+ + L YL +S N + S ++SL + L N + LPV
Sbjct: 83 LSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNI---SCCPMASLRHLDLSFNDFD-VLPV 138
Query: 264 NIGFS-LPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQ-VKIDFNRLPNLF 321
F L L L + + L +L + L + + + + ++PN
Sbjct: 139 CKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTT 197
Query: 322 RLSFSKNNLGTGAIGDLDFIAHLT------------NCSKLEALGLDTNIFGGVLPLSIA 369
L + ++ + L NC +L + +L +++
Sbjct: 198 VLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQ 257
Query: 370 NLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIG-----ELRNLQVLDLHH 424
++ +T + + + LN + +T I L++L + + +
Sbjct: 258 HIETTWKCSVKLFQFFWPRPVEYLN---IYNLTITERIDREEFTYSETALKSLMIEHVKN 314
Query: 425 NNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQIL 484
+N L + + + L+ + N T Q
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGC 373
Query: 485 GIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRF----SNEIPVSLSACTTLEY 540
+ L L N L + KN+ L + S+ + + ++
Sbjct: 374 STLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432
Query: 541 LYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEV 600
L + N LTGS+ L +K LDL N + IP+ + +L L+ LN++ N L+ V
Sbjct: 433 LNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SV 488
Query: 601 PRRGVFSN 608
P GVF
Sbjct: 489 P-DGVFDR 495
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-26
Identities = 83/468 (17%), Positives = 148/468 (31%), Gaps = 35/468 (7%)
Query: 126 LETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLL 185
+ L L+ NS S ++S S L N + + + LE+L + N L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 186 AGQLAPSIGNISNLQVLSIGENRLSGRLPDS--LGQLRSLYYLSISENAFSGMFPSSIFN 243
S +++L+ L + N LP G L L +L +S F + +
Sbjct: 113 Q---NISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPV-- 166
Query: 244 ISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNAS-------NL 296
+ L +L + + + SL + + SL N S L
Sbjct: 167 -AHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL 225
Query: 297 RLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLD 356
+ + + + L+ + ++ T + +E L +
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF-QFFWPRPVEYLNIY 284
Query: 357 TNIFGGVLPLSIANLSSTII----LFSMGLNQIYV------KNLVNLNGFGLEYNQLTGP 406
+ S T + + + +N L +
Sbjct: 285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI 344
Query: 407 IPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR--GHVPSSLGNCQN 464
+ L+ N + + L L +L L N L+ V N +
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSS 404
Query: 465 LMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRF 524
L L VS N L + ++L+LS N+LTGS+ + + L L NR
Sbjct: 405 LETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRI 462
Query: 525 SNEIPVSLSACTTLEYLYMEGNSLTGSIPL-ALKTLKSIKELDLSRNN 571
IP ++ L+ L + N L S+P L S++ + L N
Sbjct: 463 M-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 8e-20
Identities = 62/416 (14%), Positives = 138/416 (33%), Gaps = 32/416 (7%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGF-SGEIPGEIGRLFRLETLILANNSFS 137
LD+S+ ++ I ++ LR ++ + N F + E G L +L L L+ F
Sbjct: 103 EYLDVSHNRLQNISC---CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGN-- 195
+L ++L + + I S L L N
Sbjct: 160 Q---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS 216
Query: 196 ISNLQVLSIGENRLSGR-------LPDSLGQLRSLYYLSISENAFSGMFPSSIFNI---S 245
++ L L + +L+ L + +L +++ + +F
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276
Query: 246 SLESISLLGNRLEGSL----PVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDF 301
+E +++ + + +L +L V+ + S S + + +
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336
Query: 302 SLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLT----NCSKLEALGLDT 357
S++ + + L+F++N + L + L+
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVA 396
Query: 358 NIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNL 417
+ + L ++S + ++ L N LTG + + +
Sbjct: 397 LMTKNMSSLETLDVSLN--SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKV 452
Query: 418 QVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNN 473
+VLDLH+N + IP+ + +L L L++ N+L+ +L + + +N
Sbjct: 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 4e-12
Identities = 51/343 (14%), Positives = 94/343 (27%), Gaps = 44/343 (12%)
Query: 98 NLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARG 157
+L F F+ +L ++ + + L
Sbjct: 200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259
Query: 158 NNLVGQIPPDIGYSWLK-LEFLSLRDNLLAGQLAPSIGNISN-----LQVLSIGENRLSG 211
+ W + +E+L++ + + ++ S L + +
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLF 319
Query: 212 RLPDSLGQLRSLYYLSISENAFSGMFPSSIFNI-SSLESISLLGNRLEGSLPVNIGFSLP 270
+ +S + + SS ++ N +L
Sbjct: 320 SKEALYSVFAEMNIKMLSISD-TPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCSTLK 377
Query: 271 NLENLSVRQNNYTGSLP---HSLSNASNLRLLDFSLNHF-SGQVKIDFNRLPNLFRLSFS 326
L+ L +++N + N S+L LD SLN S ++ L+ S
Sbjct: 378 RLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436
Query: 327 KNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIY 386
N L L K++ L L N + S
Sbjct: 437 SNMLTGSVFRCLP--------PKVKVLDLHNN-----------RIMS----IPKD----- 468
Query: 387 VKNLVNLNGFGLEYNQLTGPIPH-AIGELRNLQVLDLHHNNLD 428
V +L L + NQL +P L +LQ + LH N D
Sbjct: 469 VTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 42/182 (23%), Positives = 73/182 (40%), Gaps = 9/182 (4%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
+ + LS I + S F+NF N F+ + L RL+TLIL N
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
Query: 138 GKIPSNLSRCSNLINFHARGN--NLVGQIPPDIGYSWL-KLEFLSLRDNLLAGQLAPSIG 194
N+ + N + D +W + L+L N+L G + +
Sbjct: 391 -NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF-NISSLESISLL 253
++VL + NR+ +P + L++L L+++ N P +F ++SL+ I L
Sbjct: 450 --PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505
Query: 254 GN 255
N
Sbjct: 506 DN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 28/211 (13%), Positives = 70/211 (33%), Gaps = 10/211 (4%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
+ + + + N+ + + + + L N
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV 364
Query: 136 FSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDN----LLAGQLAP 191
F+ + S L + N L + + + L D L +
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGL--KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDR 422
Query: 192 SIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESIS 251
+ ++ VL++ N L+G + L + L + N P + ++ +L+ ++
Sbjct: 423 TCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIMS-IPKDVTHLQALQELN 479
Query: 252 LLGNRLEGSLPVNIGFSLPNLENLSVRQNNY 282
+ N+L+ S+P + L +L+ + + N +
Sbjct: 480 VASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 40/227 (17%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKI 761
+G+G+FG V+ +++M VAVK + A + F E E L ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWL---------HQSNDQLEVGNFNVIQRLNL 812
VC+ E +V+EYM G L +L + + G + Q L +
Sbjct: 109 FGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 813 VIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILET 871
VA + YL H VH DL N L+ +V +GDFG++R +
Sbjct: 164 ASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSR-----------DI 208
Query: 872 PSSSTGIKGTVGYV-----APEYGMGGDMSATGDVYSFGILLLEMFT 913
S+ G + PE + + DV+SFG++L E+FT
Sbjct: 209 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 43/229 (18%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKI 761
+G+G+FG V+ +++M VAVK + A K F E E L N++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWL----------HQSNDQLEVGNFNVIQRLN 811
VC + D +V+EYM+ G L +L + G + Q L+
Sbjct: 83 YGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 812 LVIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
+ +A + YL H VH DL N L+ +++ +GDFG++R +
Sbjct: 138 IASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRD--------VYS 185
Query: 871 TP---SSSTG---IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
T I+ PE M + DV+SFG++L E+FT
Sbjct: 186 TDYYRVGGHTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRN 757
+G G+FG VY G + + + VAVK + ++ F+ E + H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQS-NDQLEVGNFNVIQRLNLVIDV 816
+++ I V + + I+ E M G L+ +L ++ + + ++ L++ D+
Sbjct: 136 IVRCIGVSL-----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 817 AFAIEYL-HHHCHPPIVHGDLKPSNVLLD---HDMVAHVGDFGLARFLPPCSPATILETP 872
A +YL +H +H D+ N LL VA +GDFG+AR +
Sbjct: 191 ACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----------DIY 235
Query: 873 SSSTGIKGTVGYV-----APEYGMGGDMSATGDVYSFGILLLEMFT 913
+ KG + PE M G ++ D +SFG+LL E+F+
Sbjct: 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 9/211 (4%)
Query: 388 KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLG 447
K L +L L N+++ A LR LQ L + N+L IP +L + L L +
Sbjct: 75 KGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIH 131
Query: 448 FNKLRGHVPSSLGNCQNLMLLSVSNNKLT-GALPPQILGIVTLSILLDLSGNLLTGSIPA 506
N++R +N+ + + N L P + L+ L +S LT IP
Sbjct: 132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYL-RISEAKLT-GIPK 189
Query: 507 EVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELD 566
+ L +L L N+ L + L L + N + +L L +++EL
Sbjct: 190 --DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELH 247
Query: 567 LSRNNLSGQIPEFLENLSFLEYLNLSYNHLE 597
L N LS ++P L +L L+ + L N++
Sbjct: 248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 68/333 (20%), Positives = 112/333 (33%), Gaps = 70/333 (21%)
Query: 285 SLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHL 344
++P +S + LLD N S K DF L +L+ L N +
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI-------------- 90
Query: 345 TNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLT 404
+ I L L + N L
Sbjct: 91 ------------SKIHEKAF-----------------------SPLRKLQKLYISKNHLV 115
Query: 405 GPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR-GHVPSSLGNCQ 463
IP + +L L +H N + L +N +++G N L +
Sbjct: 116 E-IPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL 172
Query: 464 NLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLSEN 522
L L +S KLT +P + TL+ L L N + +I E L +LGL N
Sbjct: 173 KLNYLRISEAKLT-GIPKDLPE--TLNEL-HLDHNKIQ-AIELEDLLRYSKLYRLGLGHN 227
Query: 523 RFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPE---- 578
+ SLS TL L+++ N L+ +P L LK ++ + L NN++ ++
Sbjct: 228 QIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFC 285
Query: 579 ---FLENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
F ++ ++L N + + F
Sbjct: 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 64/321 (19%), Positives = 113/321 (35%), Gaps = 47/321 (14%)
Query: 164 IPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSL 223
+P +I L L++N ++ + +L L + N++S + LR L
Sbjct: 48 VPKEISPD---TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 224 YYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYT 283
L IS+N P ++ SSL + + NR+ +P + L N+ + + N
Sbjct: 105 QKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 284 -GSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIA 342
+ L L S + I + L L N + I D
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLT---GIPKDLPETLNELHLDHNKIQA--IELEDL-- 213
Query: 343 HLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQ 402
SKL LGL N + S++ L L L+ L+ N+
Sbjct: 214 --LRYSKLYRLGLGHNQIRMIENGSLSFLP----------------TLRELH---LDNNK 252
Query: 403 LTGPIPHAIGELRNLQVLDLHHNNLDGHIPES-------LGNLTILNSLDLGFNKLRGHV 455
L+ +P + +L+ LQV+ LH NN+ + + N + L N +
Sbjct: 253 LSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWE 310
Query: 456 --PSSLGNCQNLMLLSVSNNK 474
P++ + + + N K
Sbjct: 311 VQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 9e-23
Identities = 57/334 (17%), Positives = 105/334 (31%), Gaps = 63/334 (18%)
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNR 256
+ +L + N +S D L+ LY L + N S + + + L+ + + N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 257 LEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNR 316
L +P N+ +L L + N +P + F+
Sbjct: 114 LV-EIPPNL---PSSLVELRIHDNRIR-KVPKGV-----------------------FSG 145
Query: 317 LPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTII 376
L N+ + N L F + KL L + + +
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAF-----DGLKLNYLRISEA--------KLTGIPKD-- 190
Query: 377 LFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLG 436
L L L+ L++N++ + L L L HN + SL
Sbjct: 191 LPE---------TLNELH---LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238
Query: 437 NLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLT----GALPPQILGIVTLSI- 491
L L L L NKL VP+ L + + L ++ + N +T P G+
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN 297
Query: 492 LLDLSGNLLT-GSIPAEV-GNLKNLVQLGLSENR 523
+ L N + + + + + + +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 63/285 (22%), Positives = 104/285 (36%), Gaps = 21/285 (7%)
Query: 79 TVLDLSNRSIEGI---LSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
V+ S+ ++ + +SP ++ NN S + L L L+L NN
Sbjct: 36 RVVQCSDLGLKAVPKEISPD------TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK 89
Query: 136 FSGKIPSN-LSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIG 194
S KI S L + N+LV +IPP++ S L L + DN +
Sbjct: 90 IS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSS---LVELRIHDNRIRKVPKGVFS 144
Query: 195 NISNLQVLSIGENRL-SGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLL 253
+ N+ + +G N L + L YL ISE +G+ P + +L + L
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGI-PKDLP--ETLNELHLD 201
Query: 254 GNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKID 313
N+++ ++ + L L + N SLS LR L N S +V
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259
Query: 314 FNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTN 358
L L + NN+ + D + + + L N
Sbjct: 260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNN 304
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 30/119 (25%), Positives = 50/119 (42%), Gaps = 8/119 (6%)
Query: 493 LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSI 552
+ S L ++P E+ + L L N S L L + N ++
Sbjct: 38 VQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIH 94
Query: 553 PLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTR 611
A L+ +++L +S+N+L +IP L S L L + N + +VP +GVFS
Sbjct: 95 EKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVP-KGVFSGLRN 148
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 23/92 (25%), Positives = 39/92 (42%), Gaps = 4/92 (4%)
Query: 527 EIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFL 586
+P +S TT L ++ N ++ K L+ + L L N +S + L L
Sbjct: 47 AVPKEISPDTT--LLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 587 EYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNK 618
+ L +S NHL E+P + S+ N+
Sbjct: 105 QKLYISKNHLV-EIP-PNLPSSLVELRIHDNR 134
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 48/232 (20%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRN 757
+G+ FG VY+G+L GE AVA+K LK A F E ++H N
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKD-KAEGPLREEFRHEAMLRARLQHPN 73
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL----------HQSNDQLEVGNFNVI 807
++ ++ V + + ++++ Y G L ++L +D+
Sbjct: 74 VVCLLGVVT-----KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 808 QRLNLVIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPA 866
++LV +A +EYL HH VH DL NVL+ + + D GL R +
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREV------ 178
Query: 867 TILETPSSSTGIKGTVGYV-----APEYGMGGDMSATGDVYSFGILLLEMFT 913
++ + APE M G S D++S+G++L E+F+
Sbjct: 179 -----YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 24/222 (10%)
Query: 706 MIGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITV 764
++G+G++G VY G +L +A+K + + ++ E ++++H+N+++ +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVR-IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
F E F I E + GSL L L+ N I + ++YLH
Sbjct: 88 -----FSENGFIKIFMEQVPGGSLSALLRSKWGPLKD-NEQTIG--FYTKQILEGLKYLH 139
Query: 825 HHCHPPIVHGDLKPSNVLLD-HDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
+ IVH D+K NVL++ + V + DFG ++ + + GT+
Sbjct: 140 DNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSK--------RLAGINPCTETFTGTLQ 188
Query: 884 YVAPEYGMGGDMSATG--DVYSFGILLLEMFTRRRPTDNMFN 923
Y+APE G D++S G ++EM T + P +
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 65/280 (23%), Positives = 116/280 (41%), Gaps = 50/280 (17%)
Query: 664 VLYTRRRKHKHKSSSMLLMEQQFPMVSYADLSKATND----FSSSN-----MIGQGSFGF 714
V Y ++K K++ ++ + ++ D ++ + F +N +G G+FG
Sbjct: 2 VDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGK 61
Query: 715 VYRGNL-----GENEMAVAVKVMNLKQRGATKS----FVAECEALRNI-RHRNLIKIITV 764
V + + VAVK M LK A ++E + + ++ +H N++ ++
Sbjct: 62 VVEATAFGLGKEDAVLKVAVK-M-LKS-TAHADEKEALMSELKIMSHLGQHENIVNLLGA 118
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNL--------VIDV 816
C+ ++ EY G L ++L + + LE I V
Sbjct: 119 CTH---GGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 817 AFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP--S 873
A + +L +C +H D+ NVLL + VA +GDFGLAR I+
Sbjct: 174 AQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARD--------IMNDSNYI 221
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ V ++APE + DV+S+GILL E+F+
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 59/286 (20%), Positives = 101/286 (35%), Gaps = 63/286 (22%)
Query: 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG-ATKSFVAECEALRNI 753
S+ DF +G+G FG V+ ++ A+K + L R A + + E +AL +
Sbjct: 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 754 R----------------------------------------------------HRNLIKI 761
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
TV + I + +L+DW+++ + + L++ I +A A+E
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC---LHIFIQIAEAVE 178
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL----PPCSPATILETPSSSTG 877
+LH ++H DLKPSN+ D V VGDFGL + + T + ++ TG
Sbjct: 179 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235
Query: 878 IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFN 923
GT Y++PE G + S D++S G++L E+
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 56/243 (23%), Positives = 91/243 (37%), Gaps = 43/243 (17%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALR-NIRHRN 757
N S ++G GS G V + VAVK M + + E + L + H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLIDF---CDIALMEIKLLTESDDHPN 70
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLE-VGNFNVIQRLNLVIDV 816
+I+ F I E +L+D + N E + ++L+ +
Sbjct: 71 VIRYYCS-----ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDH-------------DMVAHVGDFGLARFLPP- 862
A + +LH I+H DLKP N+L+ ++ + DFGL + L
Sbjct: 125 ASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 863 -CSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATG-------DVYSFGILLLEMFTR 914
S T L PS GT G+ APE + T D++S G + + ++
Sbjct: 182 QSSFRTNLNNPS------GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 915 RRP 917
+
Sbjct: 236 GKH 238
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 51/270 (18%), Positives = 98/270 (36%), Gaps = 55/270 (20%)
Query: 695 SKATNDFSSSNMIGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGAT--KSFVAECEALR 751
S+ T +F IG G FG V++ + + A+K G+ ++ + E A
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCI-YAIKRSKKPLAGSVDEQNALREVYAHA 65
Query: 752 NI-RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRL 810
+ +H ++++ + + E D I EY GSL D + ++ + F +
Sbjct: 66 VLGQHSHVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIM--SYFKEAELK 118
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV------------------- 851
+L++ V + Y+H +VH D+KPSN+ + + +
Sbjct: 119 DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175
Query: 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPE---YGMGGDMSATGDVYSFGILL 908
GD G + SS +G ++A E A D+++ + +
Sbjct: 176 GDLGHVTRI------------SSPQVEEGDSRFLANEVLQENYTHLPKA--DIFALALTV 221
Query: 909 LEMFTRRRPTDNMFNDGLTLHEFAKMALPE 938
+ +G HE + LP
Sbjct: 222 VCAAGAEPL----PRNGDQWHEIRQGRLPR 247
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 51/254 (20%), Positives = 93/254 (36%), Gaps = 46/254 (18%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLG-ENEMAVAVKVMNLKQRGATKSFVA------------ 745
ND+ + QG F + L ++ A+K + F
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 746 -----ECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL--HQSNDQ 798
E + + +I++ + + D I+YEYME S+ + D+
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-----ITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 799 LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858
+ ++ V + Y+H+ + I H D+KPSN+L+D + + DFG +
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESE 200
Query: 859 FLPPCSPATILETPSSSTGIKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEMFTRRR 916
+ ++ +GT ++ PE A D++S GI L MF
Sbjct: 201 Y----MVDKKIKG------SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
Query: 917 PTDNMFNDGLTLHE 930
P F+ ++L E
Sbjct: 251 P----FSLKISLVE 260
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 60/235 (25%), Positives = 97/235 (41%), Gaps = 46/235 (19%)
Query: 705 NMIGQGSFGFVYRGNL--GENEMAVAVKVMNLKQRGATKS----FVAECEALRNI-RHRN 757
++IG+G+FG V + + M A+K M A+K F E E L + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQS----------NDQLEVGNFNVI 807
+I ++ C + + EY G+L D+L +S +
Sbjct: 88 IINLLGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 808 QRLNLVIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPA 866
Q L+ DVA ++YL +H DL N+L+ + VA + DFGL+R
Sbjct: 143 QLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSRG------- 191
Query: 867 TILETPSSSTGIKGTVGYVAPE---YGMGGDMSATGDVYSFGILLLEMFTR-RRP 917
E T + V ++A E Y + + DV+S+G+LL E+ + P
Sbjct: 192 --QEVYVKKTMGRLPVRWMAIESLNYSV---YTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 48/233 (20%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGATKS----FVAECEALRNI-RHR 756
+G+G+FG V + VAVK++ GAT S ++E + L +I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL----------HQSNDQLEVGNFNV 806
N++ ++ C+ ++ E+ + G+L +L + + L +
Sbjct: 92 NVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 807 IQRLNLVIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSP 865
+ VA +E+L C +H DL N+LL V + DFGLAR +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDI----- 198
Query: 866 ATILETPSSSTGIKGTVGYV-----APEYGMGGDMSATGDVYSFGILLLEMFT 913
++ + APE + DV+SFG+LL E+F+
Sbjct: 199 ------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 30/219 (13%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
DF N++G+GSF VYR + VA+K+++ + + G + E + ++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL---EVGNFNVIQRLNL 812
+++++ FE+ ++ +V E G + +L E +F + ++
Sbjct: 71 PSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQI-- 121
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP 872
+ YLH H I+H DL SN+LL +M + DFGLA L P T
Sbjct: 122 ----ITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK--MPHEKHYT- 171
Query: 873 SSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
+ GT Y++PE DV+S G + +
Sbjct: 172 -----LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTL 205
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-25
Identities = 52/232 (22%), Positives = 92/232 (39%), Gaps = 22/232 (9%)
Query: 375 IILFSMGLNQIY-VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPE 433
I S + QI+ L+ +T + EL ++ + +++++ + +
Sbjct: 4 TITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-Q 59
Query: 434 SLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL- 492
+ L + L L NKL L N +NL L + NK+ + + L L
Sbjct: 60 GIQYLPNVTKLFLNGNKLT--DIKPLTNLKNLGWLFLDENKIK-----DLSSLKDLKKLK 112
Query: 493 -LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGS 551
L L N ++ I + +L L L L N+ ++ LS T L+ L +E N ++
Sbjct: 113 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-D 167
Query: 552 IPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRR 603
I L L ++ L LS+N++S L L L+ L L +
Sbjct: 168 IV-PLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINH 216
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 97.1 bits (241), Expect = 8e-21
Identities = 60/307 (19%), Positives = 114/307 (37%), Gaps = 53/307 (17%)
Query: 290 LSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSK 349
+ + + V + L ++ ++ + ++ I + I +L N
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSD-----IKSVQGIQYLPN--- 66
Query: 350 LEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPH 409
+ L L+ N + ++ + NL NL L+ N++
Sbjct: 67 VTKLFLNGN--------KLTDIKP-------------LTNLKNLGWLFLDENKIKDLSS- 104
Query: 410 AIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLS 469
+ +L+ L+ L L HN + L +L L SL LG NK+ + L L LS
Sbjct: 105 -LKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLS 159
Query: 470 VSNNKLTGALPPQILGIVTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNE 527
+ +N+++ I+ + L+ L L LS N ++ + + LKNL L L N+
Sbjct: 160 LEDNQIS-----DIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNK 212
Query: 528 IPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLE 587
S + SL ++ + D + N+ +PEF +SF+
Sbjct: 213 PINHQSNLVVPNTVKNTDGSLVTPEIIS-------DDGDYEKPNVKWHLPEFTNEVSFIF 265
Query: 588 YLNLSYN 594
Y ++
Sbjct: 266 YQPVTIG 272
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 93.6 bits (232), Expect = 8e-20
Identities = 54/333 (16%), Positives = 112/333 (33%), Gaps = 48/333 (14%)
Query: 268 SLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKID-FNRLPNLFRLSFS 326
+ ++++ + T ++ + +++ + + + + LPN+ +L +
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK---SVQGIQYLPNVTKLFLN 73
Query: 327 KNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIY 386
N + D+ + +L N L L LD N I +LSS
Sbjct: 74 GNK-----LTDIKPLTNLKN---LGWLFLDEN--------KIKDLSS------------- 104
Query: 387 VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDL 446
+K+L L LE+N ++ I + L L+ L L +N + L LT L++L L
Sbjct: 105 LKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSL 160
Query: 447 GFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL--LDLSGNLLTGSI 504
N++ L L L +S N ++ + + L L L+L
Sbjct: 161 EDNQISD--IVPLAGLTKLQNLYLSKNHIS-----DLRALAGLKNLDVLELFSQECLNKP 213
Query: 505 PAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKE 564
NL + ++ +S + T + +I +
Sbjct: 214 INHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGK 273
Query: 565 LDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLE 597
+ Q + + +S+ + +E
Sbjct: 274 AKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVE 306
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 91.7 bits (227), Expect = 4e-19
Identities = 52/280 (18%), Positives = 101/280 (36%), Gaps = 47/280 (16%)
Query: 239 SSIFNISSLESI---SLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASN 295
IF + +L + ++ N L +++ + ++ S+ + N
Sbjct: 12 KQIFPDDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIK-SVQ-GIQYLPN 66
Query: 296 LRLLDFSLNHFSGQVKID-FNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALG 354
+ L + N + I L NL L +N I DL + L L++L
Sbjct: 67 VTKLFLNGNKLT---DIKPLTNLKNLGWLFLDENK-----IKDLSSLKDLKK---LKSLS 115
Query: 355 LDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGEL 414
L+ N I++++ + +L L L N++T + L
Sbjct: 116 LEHN--------GISDING-------------LVHLPQLESLYLGNNKITDITV--LSRL 152
Query: 415 RNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNK 474
L L L N + I L LT L +L L N + +L +NL +L + + +
Sbjct: 153 TKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQE 208
Query: 475 LTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNL 514
+V + + + G+L+T I ++ G+ +
Sbjct: 209 CLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKP 248
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 89.8 bits (222), Expect = 1e-18
Identities = 52/283 (18%), Positives = 99/283 (34%), Gaps = 46/283 (16%)
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLG 254
+ ++ + ++ + +L S+ + + + + I + ++ + L G
Sbjct: 19 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNG 74
Query: 255 NRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKID- 313
N+L P+ +L NL L + +N L SL + L+ L N S I+
Sbjct: 75 NKLTDIKPLT---NLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS---DING 126
Query: 314 FNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSS 373
LP L L N I D+ ++ LT L+ L L+ N I+++
Sbjct: 127 LVHLPQLESLYLGNNK-----ITDITVLSRLTK---LDTLSLEDN--------QISDIVP 170
Query: 374 TIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPE 433
+ L L L N ++ A+ L+NL VL+L
Sbjct: 171 -------------LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPIN 215
Query: 434 SLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLT 476
NL + N++ L P + + + +V +
Sbjct: 216 HQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 44/218 (20%), Positives = 84/218 (38%), Gaps = 14/218 (6%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
L L I+ + + +L L+ ++ +NG S +I G + L +LE+L L NN +
Sbjct: 90 GWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT- 144
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISN 198
+ LSR + L N + I P G + KL+ L L N ++ L + + N
Sbjct: 145 -DITVLSRLTKLDTLSLEDNQIS-DIVPLAGLT--KLQNLYLSKNHIS-DLRA-LAGLKN 198
Query: 199 LQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLE 258
L VL + + + L + ++ + + P I + E ++ + E
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 256
Query: 259 GSLPVN-IGFSLPNLENLSVRQNNYTGSLPHSLSNASN 295
+ V+ I + + R + + S
Sbjct: 257 FTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSY 294
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-25
Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 51/235 (21%)
Query: 707 IGQGSFGFVYRGNL-------GENEMAVAVKVMNLKQRGATKS----FVAECEALRNI-R 754
+G+G+FG V + + VAVK++ AT+ V+E E ++ I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL----------HQSNDQLEVGNF 804
H+N+I ++ C+ + + ++ EY G+L ++L +++
Sbjct: 100 HKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 805 NVIQRLNLVIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863
++ +A +EYL C +H DL NVL+ + V + DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----- 205
Query: 864 SPATILETPSSSTGIKGTVGYV-----APEYGMGGDMSATGDVYSFGILLLEMFT 913
+ + K T G + APE + DV+SFG+L+ E+FT
Sbjct: 206 ------DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRNLIKII 762
+G+G F + + + + A K++ L + + E R++ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL---EVGNFNVIQRLNLVIDVAFA 819
FE+ DF +V E SL + LH+ L E + ++++ +
Sbjct: 82 GF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY--LRQI---VL---G 127
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+YLH + ++H DLK N+ L+ D+ +GDFGLA + + +
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKV------LC 176
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT Y+APE S DV+S G ++ + + P
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 54/241 (22%), Positives = 94/241 (39%), Gaps = 58/241 (24%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRN 757
+G+G FG V + VAVK++ A+ S ++E L+ + H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPH 87
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL---------------HQSNDQLEVG 802
+IK+ CS + ++ EY + GSL +L +++ L+
Sbjct: 88 VIKLYGACS--QDGPL---LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 803 NFNVIQRLNLV---IDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858
+ + +L+ ++ ++YL VH DL N+L+ + DFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 859 FLPPCSPATILETP---SSSTG---IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMF 912
+ E S G +K A E + DV+SFG+LL E+
Sbjct: 199 D--------VYEEDSYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 913 T 913
T
Sbjct: 247 T 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 51/225 (22%), Positives = 85/225 (37%), Gaps = 22/225 (9%)
Query: 376 ILFSMGLNQIY-VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPES 434
I +N I+ L N + +T + +L + L + I E
Sbjct: 3 ITQPTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EG 58
Query: 435 LGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL-- 492
+ L L L+L N++ + L N + L +S N L + I L +
Sbjct: 59 VQYLNNLIGLELKDNQIT--DLAPLKNLTKITELELSGNPLK-----NVSAIAGLQSIKT 111
Query: 493 LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSI 552
LDL+ +T P + L NL L L N+ +N P L+ T L+YL + ++ +
Sbjct: 112 LDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DL 166
Query: 553 PLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLE 597
L L + L N +S L +L L ++L N +
Sbjct: 167 T-PLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 54/276 (19%), Positives = 105/276 (38%), Gaps = 48/276 (17%)
Query: 317 LPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTII 376
L N +++ K+N + D A L + L + +
Sbjct: 18 LANAIKIAAGKSN-----VTDTVTQADLDG---ITTLSAFGT--------GVTTIEG--- 58
Query: 377 LFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLG 436
V+ L NL G L+ NQ+T P + L + L+L N L ++
Sbjct: 59 ----------VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIA 104
Query: 437 NLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL--LD 494
L + +LDL ++ + L NL +L + N++T I + L+ L L
Sbjct: 105 GLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQIT-----NISPLAGLTNLQYLS 157
Query: 495 LSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPL 554
+ ++ + + NL L L +N+ S+ P L++ L ++++ N ++ PL
Sbjct: 158 IGNAQVS-DLTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPL 213
Query: 555 ALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLN 590
A ++ + L+ ++ Q + NL +
Sbjct: 214 A--NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVK 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 55/235 (23%), Positives = 101/235 (42%), Gaps = 26/235 (11%)
Query: 368 IANLSSTIILFSMGLNQI----YVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLH 423
L++ I + + G + + +L + +T I + L NL L+L
Sbjct: 15 DPALANAIKI-AAGKSNVTDTVTQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELK 71
Query: 424 HNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQI 483
N + + L NLT + L+L N L+ S++ Q++ L +++ ++T +
Sbjct: 72 DNQIT-DLAP-LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQIT-----DV 122
Query: 484 LGIVTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYL 541
+ LS L L L N +T +I + L NL L + + S+ P L+ + L L
Sbjct: 123 TPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL 178
Query: 542 YMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHL 596
+ N ++ I L +L ++ E+ L N +S P L N S L + L+ +
Sbjct: 179 KADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 58/321 (18%), Positives = 112/321 (34%), Gaps = 70/321 (21%)
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLG 254
++N ++ G++ ++ + L + LS ++++E +
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGT-----------GVTTIEGVQ--- 60
Query: 255 NRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKID- 313
L NL L ++ N T L L N + + L+ S N +
Sbjct: 61 -------------YLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK---NVSA 102
Query: 314 FNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSS 373
L ++ L + I D+ +A L+N L+ L LD N I N+S
Sbjct: 103 IAGLQSIKTLDLTSTQ-----ITDVTPLAGLSN---LQVLYLDLN--------QITNISP 146
Query: 374 TIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPE 433
+ L NL + Q++ P + L L L N +
Sbjct: 147 -------------LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD--IS 189
Query: 434 SLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILL 493
L +L L + L N++ S L N NL +++++N +T +V +++
Sbjct: 190 PLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVK 247
Query: 494 DLSGNLLTGSIPAEVGNLKNL 514
SG + + ++ G +
Sbjct: 248 GPSGAPIAPATISDNGTYASP 268
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 53/304 (17%), Positives = 113/304 (37%), Gaps = 48/304 (15%)
Query: 174 KLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAF 233
++ + + + ++ + LS ++ + + L +L L + +N
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQI 75
Query: 234 SGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNA 293
+ + + + N++ + + L GN L+ + L +++ L + T P L+
Sbjct: 76 TDL--APLKNLTKITELELSGNPLKNVSAIA---GLQSIKTLDLTSTQITDVTP--LAGL 128
Query: 294 SNLRLLDFSLNHFSGQVKID-FNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEA 352
SNL++L LN + I L NL LS + DL +A+L+ L
Sbjct: 129 SNLQVLYLDLNQIT---NISPLAGLTNLQYLSIGNAQ-----VSDLTPLANLSK---LTT 177
Query: 353 LGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIG 412
L D N I+++S + +L NL L+ NQ++ P +
Sbjct: 178 LKADDN--------KISDISP-------------LASLPNLIEVHLKNNQISDVSP--LA 214
Query: 413 ELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSN 472
NL ++ L + + NL + N + P+++ + +++
Sbjct: 215 NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP--IAPATISDNGTYASPNLTW 272
Query: 473 NKLT 476
N +
Sbjct: 273 NLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 51/257 (19%), Positives = 91/257 (35%), Gaps = 45/257 (17%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
+T L + I V L+ L + +N + ++ + L ++ L L+ N
Sbjct: 41 DGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNP 96
Query: 136 FSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGN 195
K S ++ ++ + + + P G S L+ L L N + +
Sbjct: 97 L--KNVSAIAGLQSIKTLDL-TSTQITDVTPLAGLS--NLQVLYLDLNQI--TNISPLAG 149
Query: 196 ISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGN 255
++NLQ LSIG ++S L L L L +N IS + ++
Sbjct: 150 LTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDN-----------KISDISPLA---- 192
Query: 256 RLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFN 315
SLPNL + ++ N + P L+N SNL ++ + +
Sbjct: 193 ------------SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT---NQPVF 235
Query: 316 RLPNLFRLSFSKNNLGT 332
NL + K G
Sbjct: 236 YNNNLVVPNVVKGPSGA 252
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 27/216 (12%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
DF +G+G FG VY +++ +A+KV+ L++ G E E ++RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
N++++ F + ++ EY G++ L + F+ + + +
Sbjct: 69 PNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKL------SKFDEQRTATYITE 117
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+A A+ Y H ++H D+KP N+LL + DFG + P +
Sbjct: 118 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------ 168
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
GT+ Y+ PE G D++S G+L E
Sbjct: 169 ----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 51/220 (23%), Positives = 93/220 (42%), Gaps = 35/220 (15%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRNLIKII 762
+G+G F + + + + A K++ L + + E R++ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL---EVGNFNVIQRLNLVIDVAFA 819
FE+ DF +V E SL + LH+ L E + ++++ +
Sbjct: 108 GF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY--LRQI---VL---G 153
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS--STG 877
+YLH + ++H DLK N+ L+ D+ +GDFGL AT +E
Sbjct: 154 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL---------ATKVEYDGERKKV- 200
Query: 878 IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
+ GT Y+APE S DV+S G ++ + + P
Sbjct: 201 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-HRNLIKIITV 764
++G+G+ V AVK++ + E E L + HRN++++I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
FEE D +V+E M GS+ +H + +FN ++ +V DVA A+++LH
Sbjct: 80 -----FEEEDRFYLVFEKMRGGSILSHIH------KRRHFNELEASVVVQDVASALDFLH 128
Query: 825 HHCHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
+ I H DLKP N+L + + DF L + + + TP T G+
Sbjct: 129 NKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GS 184
Query: 882 VGYVAPEYGMGGDMSATG-----DVYSFGILL 908
Y+APE A+ D++S G++L
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 51/235 (21%)
Query: 707 IGQGSFGFVYRGNL-------GENEMAVAVKVMNLKQRGATKS----FVAECEALRNI-R 754
+G+G FG V + + VAVK++ AT+ V+E E ++ I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 145
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL----------HQSNDQLEVGNF 804
H+N+I ++ C+ + + ++ EY G+L ++L +++
Sbjct: 146 HKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 805 NVIQRLNLVIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863
++ +A +EYL C +H DL NVL+ + V + DFGLAR
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----- 251
Query: 864 SPATILETPSSSTGIKGTVGYV-----APEYGMGGDMSATGDVYSFGILLLEMFT 913
+ + K T G + APE + DV+SFG+L+ E+FT
Sbjct: 252 ------DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 51/233 (21%), Positives = 90/233 (38%), Gaps = 47/233 (20%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGATKS----FVAECEALRNI-RHR 756
+G G+FG V + M VAVK++ A + ++E + L + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL------------HQSNDQLEVGNF 804
N++ ++ C+ ++ EY G L ++L + + +
Sbjct: 88 NIVNLLGACTI---GGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 805 NVIQRLNLVIDVAFAIEYLH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863
++ L+ VA + +L +C +H DL N+LL H + + DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI--- 195
Query: 864 SPATILETPSSSTG---IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+K APE + DV+S+GI L E+F+
Sbjct: 196 --KNDSNYVVKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 59/232 (25%), Positives = 93/232 (40%), Gaps = 43/232 (18%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVA-ECEALRNIRHRNLIKII 762
+G+GS+G V E AVK++ L++ ++ V E + LR +RH+N+I+++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA---F- 818
V + EE +V EY CG E + + + + A F
Sbjct: 73 DV---LYNEEKQKMYMVMEYCVCGMQE---------M----LDSVPEKRFPVCQAHGYFC 116
Query: 819 ----AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
+EYLH IVH D+KP N+LL + G+A L P + T
Sbjct: 117 QLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ- 172
Query: 875 STGIKGTVGYVAPEYGMGGDM--SATGDVYSFGILLLEMFTRRRPTDNMFND 924
G+ + PE G D D++S G+ L + T P F
Sbjct: 173 -----GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP----FEG 215
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-24
Identities = 59/235 (25%), Positives = 97/235 (41%), Gaps = 51/235 (21%)
Query: 707 IGQGSFGFVYRG-------NLGENEMAVAVKVMNLKQRGATKS----FVAECEALRNI-R 754
+G+G+FG V + VAVK++ AT+ ++E E ++ I +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL----------HQSNDQLEVGNF 804
H+N+I ++ C+ + + ++ EY G+L ++L +
Sbjct: 134 HKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 805 NVIQRLNLVIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPC 863
+ ++ VA +EYL C +H DL NVL+ D V + DFGLAR +
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDI--- 241
Query: 864 SPATILETPSSSTGIKGTVGYV-----APEYGMGGDMSATGDVYSFGILLLEMFT 913
K T G + APE + DV+SFG+LL E+FT
Sbjct: 242 --------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 52/202 (25%), Positives = 81/202 (40%), Gaps = 6/202 (2%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPS 457
L N + L +L+VL L N++ + L LN+L+L N L
Sbjct: 82 LMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSG 141
Query: 458 SLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSG-NLLTGSIPAEV-GNLKNLV 515
+ L L + NN + ++P V + LDL L I L NL
Sbjct: 142 AFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLK 199
Query: 516 QLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQ 575
L L + +P +L+ LE L M GN P + L S+K+L + + +S
Sbjct: 200 YLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI 257
Query: 576 IPEFLENLSFLEYLNLSYNHLE 597
+ L+ L LNL++N+L
Sbjct: 258 ERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 6/209 (2%)
Query: 388 KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLG 447
++L +L L N + A L +L L+L N L + L+ L L L
Sbjct: 96 RHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155
Query: 448 FNKLRGHVPSSLGNCQNLMLLSVSN-NKLTGALPPQIL-GIVTLSILLDLSGNLLTGSIP 505
N + + +LM L + KL + G+ L L +L + +P
Sbjct: 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYL-NLGMCNIK-DMP 212
Query: 506 AEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKEL 565
+ L L +L +S N F P S ++L+ L++ + ++ A L S+ EL
Sbjct: 213 N-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271
Query: 566 DLSRNNLSGQIPEFLENLSFLEYLNLSYN 594
+L+ NNLS + L +L L+L +N
Sbjct: 272 NLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 13/214 (6%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPS 457
L+ +P I N + L+L NN+ ++ +L L L LG N +R
Sbjct: 61 CTRRGLSE-VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVG 117
Query: 458 SLGNCQNLMLLSVSNNKLTGALPPQIL-GIVTLSILLDLSGNLLTGSIPAEV-GNLKNLV 515
+ +L L + +N LT +P + L L L N + SIP+ + +L+
Sbjct: 118 AFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRE-LWLRNNPIE-SIPSYAFNRVPSLM 174
Query: 516 QLGLSENRFSNEIPV-SLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSG 574
+L L E + I + L+YL + ++ +P L L ++EL++S N+
Sbjct: 175 RLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPE 232
Query: 575 QIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
P LS L+ L + + + + R F
Sbjct: 233 IRPGSFHGLSSLKKLWVMNSQVS-LIE-RNAFDG 264
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 56/233 (24%), Positives = 88/233 (37%), Gaps = 17/233 (7%)
Query: 350 LEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYV------KNLVNLNGFGLEYNQL 403
L L N + + +L +L +G N I L +LN L N L
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVL-QLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135
Query: 404 TGPIPHAIGELRNLQVLDLHHNNLDGHIPE-SLGNLTILNSLDLG-FNKLRGHVPSSLGN 461
T A L L+ L L +N + IP + + L LDLG KL +
Sbjct: 136 TVIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 462 CQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLS 520
NL L++ + P + +V L L ++SGN I L +L +L +
Sbjct: 195 LFNLKYLNLGMCNIKD--MPNLTPLVGLEEL-EMSGNHFP-EIRPGSFHGLSSLKKLWVM 250
Query: 521 ENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPL-ALKTLKSIKELDLSRNNL 572
++ S + +L L + N+L+ S+P L+ + EL L N
Sbjct: 251 NSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 9e-17
Identities = 58/307 (18%), Positives = 102/307 (33%), Gaps = 61/307 (19%)
Query: 125 RLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNL 184
+ ++ S ++P + + +N N + I D LE L L N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIPSNTRYLNLM---ENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 185 LAGQLAPSI-GNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFN 243
+ Q+ +++L L + +N L+ I AF +
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLT----------------VIPSGAFEYL------- 146
Query: 244 ISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLP-HSLSNASNLRLLDFS 302
S L + L N +E S+P +P+L L + + + + NL+ L+
Sbjct: 147 -SKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204
Query: 303 LNHFSGQVKI-DFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFG 361
+ + + + L L L S N+ I F S L+ L + +
Sbjct: 205 MCNIK---DMPNLTPLVGLEELEMSGNHFPE--IRPGSF----HGLSSLKKLWVMNSQVS 255
Query: 362 GVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLD 421
+ + L+ +LV LN L +N L+ LR L L
Sbjct: 256 LIERNAFDGLA----------------SLVELN---LAHNNLSSLPHDLFTPLRYLVELH 296
Query: 422 LHHNNLD 428
LHHN +
Sbjct: 297 LHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-14
Identities = 60/255 (23%), Positives = 95/255 (37%), Gaps = 20/255 (7%)
Query: 64 CQWTG--VTCGHRH---------QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGF 112
C V C R L+L +I+ I + +L L + N
Sbjct: 52 CSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 113 SGEIPGEIGRLFRLETLILANNSFSGKIPSN-LSRCSNLINFHARGNNLVGQIPPDIGYS 171
G L L TL L +N + IPS S L R N + IP
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNR 169
Query: 172 WLKLEFLSLRDNLLAGQLAPSI-GNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISE 230
L L L + ++ + NL+ L++G + +P+ L L L L +S
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSG 227
Query: 231 NAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHS- 289
N F + P S +SSL+ + ++ +++ + N L +L L++ NN + SLPH
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDL 285
Query: 290 LSNASNLRLLDFSLN 304
+ L L N
Sbjct: 286 FTPLRYLVELHLHHN 300
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 6/202 (2%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPS 457
L NQ+ ++ LR+L++L L N++ + L LN+L+L N+L
Sbjct: 71 LHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNG 130
Query: 458 SLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSG-NLLTGSIPAEV-GNLKNLV 515
+ L L + NN + ++P + LDL L+ I L NL
Sbjct: 131 AFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLR 188
Query: 516 QLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQ 575
L L+ EIP +L+ L+ L + GN L+ P + + L +++L + ++ +
Sbjct: 189 YLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVI 246
Query: 576 IPEFLENLSFLEYLNLSYNHLE 597
+NL L +NL++N+L
Sbjct: 247 ERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 6/209 (2%)
Query: 388 KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLG 447
K+L +L L N + A L NL L+L N L + L+ L L L
Sbjct: 85 KHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR 144
Query: 448 FNKLRGHVPSSLGNCQNLMLLSVS-NNKLTGALPPQIL-GIVTLSILLDLSGNLLTGSIP 505
N + + +L L + +L+ + G+ L L +L+ L IP
Sbjct: 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYL-NLAMCNLR-EIP 201
Query: 506 AEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKEL 565
+ L L +L LS N S P S L+ L+M + + A L+S+ E+
Sbjct: 202 N-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260
Query: 566 DLSRNNLSGQIPEFLENLSFLEYLNLSYN 594
+L+ NNL+ + L LE ++L +N
Sbjct: 261 NLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 13/214 (6%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPS 457
L +P I N ++L+LH N + S +L L L L N +R
Sbjct: 50 CVRKNLRE-VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG 106
Query: 458 SLGNCQNLMLLSVSNNKLTGALPPQIL-GIVTLSILLDLSGNLLTGSIPAEV-GNLKNLV 515
+ NL L + +N+LT +P + L L L N + SIP+ + +L
Sbjct: 107 AFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKE-LWLRNNPIE-SIPSYAFNRIPSLR 163
Query: 516 QLGLSENRFSNEIPV-SLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSG 574
+L L E + + I + + L YL + +L IP L L + ELDLS N+LS
Sbjct: 164 RLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSA 221
Query: 575 QIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
P + L L+ L + + ++ + R F N
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQ-VIE-RNAFDN 253
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 4e-20
Identities = 55/232 (23%), Positives = 88/232 (37%), Gaps = 15/232 (6%)
Query: 350 LEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYV------KNLVNLNGFGLEYNQL 403
L L N + S +L IL + N I L NLN L N+L
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEIL-QLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124
Query: 404 TGPIPHAIGELRNLQVLDLHHNNLDGHIPESL-GNLTILNSLDLG-FNKLRGHVPSSLGN 461
T A L L+ L L +N ++ IP + L LDLG +L +
Sbjct: 125 TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
Query: 462 CQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLS 520
NL L+++ L P + ++ L L DLSGN L+ +I L +L +L +
Sbjct: 184 LSNLRYLNLAMCNLRE--IPNLTPLIKLDEL-DLSGNHLS-AIRPGSFQGLMHLQKLWMI 239
Query: 521 ENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNL 572
+++ + +L + + N+LT L ++ + L N
Sbjct: 240 QSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-16
Identities = 63/306 (20%), Positives = 111/306 (36%), Gaps = 59/306 (19%)
Query: 125 RLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNL 184
+ +I + ++P +S + L+N H N + I + LE L L N
Sbjct: 44 QFSKVICVRKNLR-EVPDGISTNTRLLNLH---ENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 185 LAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNI 244
+ + ++NL L + +NRL+ +I AF +
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT----------------TIPNGAFVYL-------- 135
Query: 245 SSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLP-HSLSNASNLRLLDFSL 303
S L+ + L N +E S+P +P+L L + + + + SNLR L+ ++
Sbjct: 136 SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAM 194
Query: 304 NHFSGQVKI-DFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGG 362
+ +I + L L L S N+L I F L+ L + +
Sbjct: 195 CNLR---EIPNLTPLIKLDELDLSGNHLSA--IRPGSF----QGLMHLQKLWMIQSQIQV 245
Query: 363 VLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDL 422
+ + NL +LV +N L +N LT L +L+ + L
Sbjct: 246 IERNAFDNLQ----------------SLVEIN---LAHNNLTLLPHDLFTPLHHLERIHL 286
Query: 423 HHNNLD 428
HHN +
Sbjct: 287 HHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 8e-15
Identities = 56/274 (20%), Positives = 98/274 (35%), Gaps = 42/274 (15%)
Query: 69 VTCGHRH---------QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGE 119
V C ++ +L+L I+ I N F
Sbjct: 48 VICVRKNLREVPDGISTNTRLLNLHENQIQIIKV----------------NSFKH----- 86
Query: 120 IGRLFRLETLILANNSFSGKIPSN-LSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFL 178
L LE L L+ N I + +NL N L IP KL+ L
Sbjct: 87 ---LRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKEL 141
Query: 179 SLRDNLLAGQLAPSI-GNISNLQVLSIGE-NRLSGRLPDSLGQLRSLYYLSISENAFSGM 236
LR+N + + I +L+ L +GE RLS + L +L YL+++ +
Sbjct: 142 WLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI 200
Query: 237 FPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNL 296
++ + L+ + L GN L ++ L +L+ L + Q+ ++ N +L
Sbjct: 201 --PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257
Query: 297 RLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNL 330
++ + N+ + F L +L R+ N
Sbjct: 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 25/105 (23%), Positives = 37/105 (35%), Gaps = 3/105 (2%)
Query: 493 LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSI 552
+ L +P + N L L EN+ S LE L + N +
Sbjct: 48 VICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIE 104
Query: 553 PLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLE 597
A L ++ L+L N L+ LS L+ L L N +E
Sbjct: 105 IGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE 149
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 50/202 (24%), Positives = 80/202 (39%), Gaps = 33/202 (16%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G G+F V+ A+K + S E L+ I+H N++ + +
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI-- 74
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
+E +V + + G L D + LE G + ++ V A++YLH +
Sbjct: 75 ---YESTTHYYLVMQLVSGGELFDRI------LERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 827 CHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
IVH DLKP N+L + + + DFGL++ +T GT G
Sbjct: 126 G---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----------GTPG 172
Query: 884 YVAPE------YGMGGDMSATG 899
YVAPE Y D + G
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIG 194
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 51/240 (21%), Positives = 88/240 (36%), Gaps = 56/240 (23%)
Query: 707 IGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGATKS----FVAECEALRNIRHRN 757
IG+G+FG V++ E VAVK++ A+ F E + + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDNPN 111
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQR-------- 809
++K++ VC+ +++EYM G L ++L + +
Sbjct: 112 IVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 810 ----------LNLVIDVAFAIEYLH-HHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858
L + VA + YL VH DL N L+ +MV + DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 859 FLPPCSPATILETPSSSTGIKGTVGYV-----APEYGMGGDMSATGDVYSFGILLLEMFT 913
S+ + PE + DV+++G++L E+F+
Sbjct: 223 -----------NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 57/200 (28%), Positives = 82/200 (41%), Gaps = 6/200 (3%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPS 457
L N+++ + RNL +L LH N L + L +L LDL N V
Sbjct: 39 LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDP 98
Query: 458 S-LGNCQNLMLLSVSNNKLTGALPPQIL-GIVTLSILLDLSGNLLTGSIPAEV-GNLKNL 514
+ L L + L L P + G+ L L L N L ++P + +L NL
Sbjct: 99 ATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL-YLQDNALQ-ALPDDTFRDLGNL 155
Query: 515 VQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSG 574
L L NR S+ + +L+ L + N + P A + L + L L NNLS
Sbjct: 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215
Query: 575 QIPEFLENLSFLEYLNLSYN 594
E L L L+YL L+ N
Sbjct: 216 LPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 45/212 (21%), Positives = 74/212 (34%), Gaps = 9/212 (4%)
Query: 399 EYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSS 458
L +P I Q + LH N + S L L L N L ++
Sbjct: 19 PQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 459 LGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQL 517
L L +S+N ++ P + L L L + + L L L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134
Query: 518 GLSENRFSNEIPV-SLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQI 576
L +N +P + L +L++ GN ++ A + L S+ L L +N ++
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 577 PEFLENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
P +L L L L N+L +P +
Sbjct: 194 PHAFRDLGRLMTLYLFANNLS-ALP-TEALAP 223
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 53/214 (24%), Positives = 87/214 (40%), Gaps = 14/214 (6%)
Query: 369 ANLSSTIILFSMGLNQIYV------KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDL 422
+ + + N+I + NL L N L A L L+ LDL
Sbjct: 28 VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87
Query: 423 HHNNLDGHIP-ESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPP 481
N + + L L++L L L+ P L L + +N L ALP
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPD 146
Query: 482 QIL-GIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLSENRFSNEIPVSLSACTTLE 539
+ L+ L L GN ++ S+P L +L +L L +NR ++ P + L
Sbjct: 147 DTFRDLGNLTHL-FLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204
Query: 540 YLYMEGNSLTGSIPL-ALKTLKSIKELDLSRNNL 572
LY+ N+L+ ++P AL L++++ L L+ N
Sbjct: 205 TLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 42/203 (20%), Positives = 76/203 (37%), Gaps = 3/203 (1%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
+ L I + + L + +N + L LE L L++N+
Sbjct: 35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 139 KIPSN-LSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNIS 197
+ L H L ++ P + L++L L+DN L + ++
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 198 NLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRL 257
NL L + NR+S + L SL L + +N + + P + ++ L ++ L N L
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 258 EGSLPVNIGFSLPNLENLSVRQN 280
+LP L L+ L + N
Sbjct: 214 S-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 54/253 (21%), Positives = 81/253 (32%), Gaps = 49/253 (19%)
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNR 256
+ Q + + NR+S S R+L L + N + + ++ ++ LE + L N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 257 LEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNR 316
S+ L L L + + L L F
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL-----------------------FRG 127
Query: 317 LPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTII 376
L L L N L + D F + L L L N I+++
Sbjct: 128 LAALQYLYLQDNALQA--LPDDTF----RDLGNLTHLFLHGN--------RISSVPERA- 172
Query: 377 LFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLG 436
F L +L+ L N++ PHA +L L L L NNL E+L
Sbjct: 173 -FR---------GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALA 222
Query: 437 NLTILNSLDLGFN 449
L L L L N
Sbjct: 223 PLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 42/197 (21%), Positives = 72/197 (36%), Gaps = 11/197 (5%)
Query: 163 QIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRS 222
+P I + + + L N ++ A S NL +L + N L+ + L
Sbjct: 25 AVPVGIPAA---SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 223 LYYLSISENAFSGMFPSSIF-NISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNN 281
L L +S+NA + F + L ++ L L+ L + L L+ L ++ N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 282 YTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFI 341
+ + NL L N S + F L +L RL +N + + F
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH--VHPHAF- 197
Query: 342 AHLTNCSKLEALGLDTN 358
+ +L L L N
Sbjct: 198 ---RDLGRLMTLYLFAN 211
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 44/206 (21%), Positives = 79/206 (38%), Gaps = 7/206 (3%)
Query: 102 LRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSN-LSRCSNLINFHARGNNL 160
+ I N S L L L +N + +I + + + L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 161 VGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSI-GNISNLQVLSIGENRLSGRLPDSLGQ 219
+ + P + +L L L L +L P + ++ LQ L + +N L D+
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 220 LRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQ 279
L +L +L + N S + + + SL+ + L NR+ + + L L L +
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFA 210
Query: 280 NNYTGSLPHS-LSNASNLRLLDFSLN 304
NN + +LP L+ L+ L + N
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 37/158 (23%), Positives = 64/158 (40%), Gaps = 6/158 (3%)
Query: 79 TVLDLS-NRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEI-GRLFRLETLILANNSF 136
LDLS N + + L L ++ G E+ + L L+ L L +N+
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 137 SGKIPSN-LSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGN 195
+P + NL + GN + +P L+ L L N +A + +
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 196 ISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAF 233
+ L L + N LS ++L LR+L YL +++N +
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 27/216 (12%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
+DF +G+G FG VY +N+ +A+KV+ L++ G E E ++RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
N++++ F + ++ E+ G L L + G F+ + + +
Sbjct: 74 PNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKH------GRFDEQRSATFMEE 122
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+A A+ Y H ++H D+KP N+L+ + + DFG + +P+ T
Sbjct: 123 LADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVH----APSLRRRT---- 171
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
+ GT+ Y+ PE G D++ G+L E
Sbjct: 172 --MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEF 205
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 37/208 (17%)
Query: 695 SKATNDFSS----SNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKS-------- 742
S +T+ F ++G+G V R AVK++++ G+ +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 743 -FVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLE 800
+ E + LR + H N+I++ +E F +V++ M+ G L D+L E
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL------TE 117
Query: 801 VGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860
+ + ++ + I LH IVH DLKP N+LLD DM + DFG + L
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 174
Query: 861 PPCSPATILETPSSSTGIKGTVGYVAPE 888
P + GT Y+APE
Sbjct: 175 DPGEKL---------REVCGTPSYLAPE 193
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 61/291 (20%), Positives = 108/291 (37%), Gaps = 67/291 (23%)
Query: 666 YTRRRKHKHKSSSMLLMEQQFPMVSYADLSKATND----FSSSN-----MIGQGSFGFVY 716
Y ++ +++ + + + Y D + D F N ++G G+FG V
Sbjct: 3 YKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVM 62
Query: 717 RGNL-----GENEMAVAVKVMNLKQRGAT----KSFVAECEALRNI-RHRNLIKIITVCS 766
+ VAVK++ A ++ ++E + + + H N++ ++ C+
Sbjct: 63 NATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQR----------------- 809
+ +++EY G L ++L ++ +
Sbjct: 120 L---SGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 174
Query: 810 LNLVIDVAFAIEYL-HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATI 868
L VA +E+L C VH DL NVL+ H V + DFGLAR I
Sbjct: 175 LCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARD--------I 222
Query: 869 LETP---SSSTG---IKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ +K APE G + DV+S+GILL E+F+
Sbjct: 223 MSDSNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 57/259 (22%), Positives = 94/259 (36%), Gaps = 34/259 (13%)
Query: 669 RRKHKHKSSSM-LLMEQQFPMVSYADLSKATNDFSS----SNMIGQGSFGFVYRGNLGEN 723
H H S L + ++ S +G G++G V
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 724 EMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781
+ A+K++ + + E L+ + H N++K+ FE+ +V E
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-----FEDKRNYYLVME 116
Query: 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNV 841
+ G L D + + FN + ++ V + YLH H IVH DLKP N+
Sbjct: 117 CYKGGELFDEI------IHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENL 167
Query: 842 LL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSAT 898
LL + D + + DFGL+ GT Y+APE +
Sbjct: 168 LLESKEKDALIKIVDFGLSAVFENQKK---------MKERLGTAYYIAPEV-LRKKYDEK 217
Query: 899 GDVYSFGILLLEMFTRRRP 917
DV+S G++L + P
Sbjct: 218 CDVWSIGVILFILLAGYPP 236
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 35/212 (16%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITV 764
+G+GSFG V + + AVKV+N T + + E E L+ + H N++K+ +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
E+ IV E G L D + ++ F+ ++ V I Y+H
Sbjct: 90 -----LEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 825 HHCHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
H IVH DLKP N+LL + D + DFGL+ + GT
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---------KDRIGT 186
Query: 882 VGYVAPE-----YGMGGDMSATGDVYSFGILL 908
Y+APE Y D+ + G V + ILL
Sbjct: 187 AYYIAPEVLRGTYDEKCDVWSAG-VILY-ILL 216
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 55/263 (20%), Positives = 93/263 (35%), Gaps = 27/263 (10%)
Query: 339 DFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGL 398
D+ + K G + N +L + N S + L + L+ + + +
Sbjct: 28 DYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSSLPDNLPPQITVLEI 87
Query: 399 EYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSS 458
N L +P +L+ LD N L +PE +L LD+ N+L +P
Sbjct: 88 TQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPASLK---HLDVDNNQLT-MLPEL 138
Query: 459 LGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLG 518
L ++ NN+LT LP + L + N LT +P +L+ L
Sbjct: 139 PAL---LEYINADNNQLT-MLPELPTSLEVL----SVRNNQLT-FLPELPESLE---ALD 186
Query: 519 LSENRFSNEIPVSLSACTTLE----YLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSG 574
+S N +P E + N +T IP + +L + L N LS
Sbjct: 187 VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244
Query: 575 QIPEFLENLSFLEYLNLSYNHLE 597
+I E L + + +
Sbjct: 245 RIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 7e-20
Identities = 67/328 (20%), Positives = 102/328 (31%), Gaps = 50/328 (15%)
Query: 158 NNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLA-PSIGNISNLQVLSIGENRLSGRLPDS 216
N + D +W K E +L ++ I+ L + LS LPD+
Sbjct: 19 YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDN 77
Query: 217 LGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLS 276
L + L I++NA P +SLE + NRL +LP +L++L
Sbjct: 78 LPP--QITVLEITQNALI-SLPELP---ASLEYLDACDNRLS-TLPELPA----SLKHLD 126
Query: 277 VRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIG 336
V N T LP + L ++ N Q+ + +L LS N L
Sbjct: 127 VDNNQLT-MLPELPAL---LEYINADNN----QLTMLPELPTSLEVLSVRNNQLTF---- 174
Query: 337 DLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGF 396
+ LEAL + TN LP + +
Sbjct: 175 ---LPELPES---LEALDVSTN-LLESLPAVPVRNHHSEET------------EIFFR-- 213
Query: 397 GLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVP 456
N++T IP I L + L N L I ESL T D ++ +
Sbjct: 214 -CRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ--PDYHGPRIYFSMS 269
Query: 457 SSLGNCQNLMLLSVSNNKLTGALPPQIL 484
N + L +
Sbjct: 270 DGQQNTLHRPLADAVTAWFPENKQSDVS 297
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 49/197 (24%), Positives = 74/197 (37%), Gaps = 31/197 (15%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG+GS+G V + A K + F E E ++++ H N+I++
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
FE+ +V E G L + + + F ++ DV A+ Y H
Sbjct: 75 ---FEDNTDIYLVMELCTGGELFERV------VHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 827 CHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
+ H DLKP N L D + DFGLA P ++ T GT
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRT------KVGTPY 173
Query: 884 YVAPE-----YGMGGDM 895
YV+P+ YG D
Sbjct: 174 YVSPQVLEGLYGPECDE 190
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 52/241 (21%), Positives = 102/241 (42%), Gaps = 32/241 (13%)
Query: 682 MEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATK 741
M + + ++ +D+ +IG G+ V + VA+K +NL++ +
Sbjct: 1 MSEDSSALPWSINR---DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM 57
Query: 742 S-FVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWL--HQSNDQ 798
+ E +A+ H N++ S + +E+ +V + + GS+ D + + +
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYY--TSFVVKDEL---WLVMKLLSGGSVLDIIKHIVAKGE 112
Query: 799 LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858
+ G + ++ +V +EYLH + +H D+K N+LL D + DFG++
Sbjct: 113 HKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS- 168
Query: 859 FLPPCSPATILETPSSSTGIK-----GTVGYVAPE---YGMGGDMSATGDVYSFGILLLE 910
A + + GT ++APE G D A D++SFGI +E
Sbjct: 169 -------AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA--DIWSFGITAIE 219
Query: 911 M 911
+
Sbjct: 220 L 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 62/313 (19%), Positives = 116/313 (37%), Gaps = 35/313 (11%)
Query: 667 TRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMA 726
+ + + + L +Q+ + +DF + +G G+ G V++ + + +
Sbjct: 8 ELDEQQRKRLEAFLTQKQKVGELK-------DDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 727 VAVKVMNLKQRGAT-KSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMEC 785
+A K+++L+ + A + E + L I + + + I E+M+
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPY----IVGFYGAFYSDGEIS-ICMEHMDG 115
Query: 786 GSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH 845
GSL+ L ++ E ++ ++ I V + YL I+H D+KPSN+L++
Sbjct: 116 GSLDQVLKKAGRIPE----QILGKV--SIAVIKGLTYLREKHK--IMHRDVKPSNILVNS 167
Query: 846 DMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFG 905
+ DFG++ L S + GT Y++PE G S D++S G
Sbjct: 168 RGEIKLCDFGVSGQL----------IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMG 217
Query: 906 ILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTE 965
+ L+EM R P + P + G
Sbjct: 218 LSLVEMAVGRYP----IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRP 273
Query: 966 IAKIEECLVAIVR 978
I E L IV
Sbjct: 274 PMAIFELLDYIVN 286
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 6e-22
Identities = 51/191 (26%), Positives = 80/191 (41%), Gaps = 32/191 (16%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA--------ECEALRNIR-HRN 757
IG+G V R AVK+M + + + E LR + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
+I +I +E F +V++ M G L D+L E + + +++ +
Sbjct: 162 IITLIDS-----YESSSFMFLVFDLMRKGELFDYL------TEKVALSEKETRSIMRSLL 210
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
A+ +LH + IVH DLKP N+LLD +M + DFG + L P
Sbjct: 211 EAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL---------RE 258
Query: 878 IKGTVGYVAPE 888
+ GT GY+APE
Sbjct: 259 LCGTPGYLAPE 269
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 6e-22
Identities = 56/280 (20%), Positives = 93/280 (33%), Gaps = 60/280 (21%)
Query: 672 HKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKV 731
H H SS ++ L + + IGQGS+G V + A+K+
Sbjct: 4 HHHHSSG-----RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKI 58
Query: 732 MNLKQ-----RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECG 786
MN + + E ++ + H N+ ++ V +E+ + +V E G
Sbjct: 59 MNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGG 113
Query: 787 SLEDWLHQSNDQLEVGNFNVIQRL----------------------------------NL 812
L D L+ D + + N+
Sbjct: 114 HLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILE 870
+ + A+ YLH+ I H D+KP N L + + DFGL++ +
Sbjct: 174 MRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230
Query: 871 TPSSSTGIKGTVGYVAPE--YGMGGDMSATGDVYSFGILL 908
T GT +VAPE D +S G+LL
Sbjct: 231 M----TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 6e-22
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 34/234 (14%)
Query: 694 LSKATNDFSS----SNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAE 746
+ +T FS ++G+GSFG V AVKV++ +KQ+ +S + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 747 CEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNV 806
+ L+ + H N++K+ FE+ + +V E G L D + + F+
Sbjct: 77 VQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEI------ISRKRFSE 125
Query: 807 IQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLARFLPPC 863
+ ++ V I Y+H + IVH DLKP N+LL D + DFGL+
Sbjct: 126 VDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 864 SPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT Y+APE + G DV+S G++L + + P
Sbjct: 183 KKM---------KDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-22
Identities = 60/267 (22%), Positives = 98/267 (36%), Gaps = 44/267 (16%)
Query: 671 KHKHKSSSMLLMEQQFPMVSYADLSKATNDFSS----SNMIGQGSFGFVYRGNLGENEMA 726
H H S L Q + + K +G G++G V
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 727 VAVKVMNLKQRGATKSFVA-------------ECEALRNIRHRNLIKIITVCSSIDFEEV 773
A+KV+ Q + E L+++ H N+IK+ V FE+
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FEDK 118
Query: 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVH 833
+ +V E+ E G L + + + F+ N++ + I YLH H IVH
Sbjct: 119 KYFYLVTEFYEGGELFEQI------INRHKFDECDAANIMKQILSGICYLHKHN---IVH 169
Query: 834 GDLKPSNVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYG 890
D+KP N+LL + + + DFGL+ F GT Y+APE
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSK---------DYKLRDRLGTAYYIAPEV- 219
Query: 891 MGGDMSATGDVYSFGILLLEMFTRRRP 917
+ + DV+S G+++ + P
Sbjct: 220 LKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 49/246 (19%), Positives = 75/246 (30%), Gaps = 21/246 (8%)
Query: 366 LSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHN 425
L++ + L + + L L LE ++TG P + E + L+
Sbjct: 73 LTVRAARIPSRILFGALRVLGISGLQELT---LENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 426 NLD-GHIPESLGNL-----TILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTG-- 477
N+ L L L L + + L L +S+N G
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 478 ----ALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSL- 532
AL P + + L + +G A L L LS N +
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 533 SACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLS 592
+ L L + L +P L + LDLS N L P E L + L+L
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR-NPSPDE-LPQVGNLSLK 304
Query: 593 YNHLEG 598
N
Sbjct: 305 GNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 63/297 (21%), Positives = 98/297 (32%), Gaps = 34/297 (11%)
Query: 217 LGQLRSLYYLSISENAFSGMFP-SSIFNISSLESISLLGNRLEGSLPVNI--GFSLPNLE 273
G RSL YL + + + + I SL+ +++ R+ + + L+
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 274 NLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDF------NRLPNLFRLSFSK 327
L++ TG+ P L A+ L +L + S + + P L LS ++
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 328 NNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYV 387
+ + + L L L N G L A
Sbjct: 159 AHSLNF---SCEQVRVFPA---LSTLDLSDNPELGERGLISALCPLKF------------ 200
Query: 388 KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESL-GNLTILNSLDL 446
L L +G LQ LDL HN+L + LNSL+L
Sbjct: 201 PTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL 260
Query: 447 GFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGS 503
F L+ VP L L +L +S N+L P + + L L GN S
Sbjct: 261 SFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN--PSPDELPQVGN-LSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 57/292 (19%), Positives = 89/292 (30%), Gaps = 28/292 (9%)
Query: 344 LTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQL 403
NC + L L + + + F+ + + +K L ++
Sbjct: 27 AFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRA------ARI 80
Query: 404 TGPIPHAIGELRN---LQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR-GHVPSSL 459
I + LQ L L + + G P L T + L + + L
Sbjct: 81 PSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWL 140
Query: 460 GNCQNLML-----LSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIP----AEVGN 510
Q + LS++ Q+ LS L DLS N G
Sbjct: 141 AELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL-DLSDNPELGERGLISALCPLK 199
Query: 511 LKNLVQLGLSENRF---SNEIPVSLSACTTLEYLYMEGNSLTGSIP-LALKTLKSIKELD 566
L L L S +A L+ L + NSL + + + L+
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259
Query: 567 LSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNK 618
LS L Q+P+ L + L L+LSYN L+ P GN
Sbjct: 260 LSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNP 307
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 42/244 (17%), Positives = 75/244 (30%), Gaps = 20/244 (8%)
Query: 102 LRFINFANNGFSGEIPGEIGRLF---RLETLILANNSFSGKIPSNLSRCS--NLINFHAR 156
L+ + I R+ L+ L L N +G P L + +L + R
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 157 GNNLVGQ---IPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRL 213
+ + + + L+ LS+ + L L + +N G
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 214 P----DSLGQLRSLYYLSISENAF---SGMFPSSIFNISSLESISLLGNRLEGSLPVNIG 266
+ +L L++ SG+ + L+ + L N L +
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 267 FSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFS 326
L +L++ +P L + L +LD S N D LP + LS
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPSPDE--LPQVGNLSLK 304
Query: 327 KNNL 330
N
Sbjct: 305 GNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 29/183 (15%), Positives = 46/183 (25%), Gaps = 32/183 (17%)
Query: 58 NNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIP 117
+ W + VL ++ V L ++ ++N GE
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 118 GEI----GRLFRLETLILANN---SFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGY 170
+ L+ L L N + SG + + L N+L
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD-AAGAPSC 249
Query: 171 SWL----------------------KLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENR 208
W KL L L N L PS + + LS+ N
Sbjct: 250 DWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNRL--DRNPSPDELPQVGNLSLKGNP 307
Query: 209 LSG 211
Sbjct: 308 FLD 310
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 49/198 (24%), Positives = 77/198 (38%), Gaps = 28/198 (14%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN-LKQRGATKSFVAECEALRNIRHRNLIKIITVC 765
+G G+FG V+ + + +K +N + + + AE E L+++ H N+IKI V
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
FE+ IV E E G L + + + + + L+ + A+ Y H
Sbjct: 89 ----FEDYHNMYIVMETCEGGELLERIVSAQARG--KALSEGYVAELMKQMMNALAYFHS 142
Query: 826 HCHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTV 882
+VH DLKP N+L + DFGLA GT
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTN------AAGTA 190
Query: 883 GYVAPE-----YGMGGDM 895
Y+APE D+
Sbjct: 191 LYMAPEVFKRDVTFKCDI 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 48/204 (23%), Positives = 78/204 (38%), Gaps = 36/204 (17%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G G+FG V+R K +N + E + + H LI +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL---EVGNFNVIQRLNLVIDVAFAIEYL 823
FE+ ++ E++ G L D + + ++ EV N+ + Q ++++
Sbjct: 117 ---FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY-MRQACE-------GLKHM 165
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPSSSTGIKGT 881
H H IVH D+KP N++ + + V DFGLA L P + T
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---------TTAT 213
Query: 882 VGYVAPE------YGMGGDMSATG 899
+ APE G DM A G
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIG 237
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 36/213 (16%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA--TKSFVAECEALRNIRHRNLIKIITV 764
+G+G+F V R + A K++N K+ A + E R ++H N++++
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
+E F +V++ + G L + + + ++ + + + +I Y H
Sbjct: 74 -----IQEESFHYLVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYCH 122
Query: 825 HHCHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
+ IVH +LKP N+LL + DFGLA + G GT
Sbjct: 123 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---------HGFAGT 170
Query: 882 VGYVAPE------YGMGGDMSATGDVYSFGILL 908
GY++PE Y D+ A G V + ILL
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACG-VILY-ILL 201
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 61/258 (23%), Positives = 96/258 (37%), Gaps = 76/258 (29%)
Query: 707 IGQGSFGFVYRGNLGENE---MAVAVKVMN----LKQRGATKSFVA-------------- 745
IG+GS+G V L NE A+KV++ ++Q G +
Sbjct: 21 IGKGSYGVVK---LAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 746 --------ECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSND 797
E L+ + H N++K++ V +D D +V+E + G +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPV--------- 125
Query: 798 QLEVGNFNVIQRLNLVIDVA---F-----AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVA 849
V L D A F IEYLH+ I+H D+KPSN+L+ D
Sbjct: 126 ------MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHI 176
Query: 850 HVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATG---DVYSFGI 906
+ DFG++ +L GT ++APE +G DV++ G+
Sbjct: 177 KIADFGVSNEFKG--SDALLSNTV------GTPAFMAPESLSETRKIFSGKALDVWAMGV 228
Query: 907 LLLEMFTRRRPTDNMFND 924
L + P F D
Sbjct: 229 TLYCFVFGQCP----FMD 242
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 53/293 (18%), Positives = 101/293 (34%), Gaps = 28/293 (9%)
Query: 140 IPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNL 199
IPS L+ + + N + I + L+ L L N + S ++ +L
Sbjct: 46 IPSGLT--EAVKSLDLSNNRI-TYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 200 QVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF-NISSLESISLLGNRLE 258
+ L + N LS L SL +L++ N + + +S+F +++ L+ + +
Sbjct: 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 259 GSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLP 318
+ L LE L + ++ P SL + N+ L + ++I +
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222
Query: 319 NLFRLSFSKNNLGTGAIGDLDFIA--HLTNCSKLEALGLDTNIFGGVLPLSIANLSSTII 376
++ L +L T +L L + + +L +
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE-----------SLFQVMK 271
Query: 377 LFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPH-AIGELRNLQVLDLHHNNLD 428
L + + L NQL +P L +LQ + LH N D
Sbjct: 272 LLN---------QISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 66/314 (21%), Positives = 108/314 (34%), Gaps = 47/314 (14%)
Query: 285 SLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHL 344
S+P L+ ++ LD S N + D R NL L + N + T L
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFS---SL 99
Query: 345 TNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLT 404
+ LE L L N ++NLSS+ F L +L L N
Sbjct: 100 GS---LEHLDLSYN--------YLSNLSSS--WFK---------PLSSLTFLNLLGNPYK 137
Query: 405 GPIPHAI-GELRNLQVLDLHHNNLDGHIPE-SLGNLTILNSLDLGFNKLRGHVPSSLGNC 462
++ L LQ+L + + + I LT L L++ + L+ + P SL +
Sbjct: 138 TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSI 197
Query: 463 QNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSEN 522
QN+ L + + L + + + L+L L +
Sbjct: 198 QNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDT----------------FHFS 240
Query: 523 RFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLEN 582
S SL T + + SL + L + + EL+ SRN L +
Sbjct: 241 ELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDR 299
Query: 583 LSFLEYLNLSYNHL 596
L+ L+ + L N
Sbjct: 300 LTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 51/257 (19%), Positives = 102/257 (39%), Gaps = 22/257 (8%)
Query: 369 ANLSSTIILFSMGLNQIYV------KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDL 422
+ L+ + + N+I + VNL L N + + L +L+ LDL
Sbjct: 48 SGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107
Query: 423 HHNNLDGHIPESL-GNLTILNSLDLGFNKLRGHVPSSL-GNCQNLMLLSVSNNKLTGALP 480
+N L ++ S L+ L L+L N + +SL + L +L V N +
Sbjct: 108 SYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166
Query: 481 PQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLSENRFSNEIPVSLSACTTLE 539
+ +T L++ + L S + +++N+ L L + + + + +++E
Sbjct: 167 RKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225
Query: 540 YLYMEGNSLTG----SIP----LALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNL 591
L + L + +L + + + ++ +L Q+ + L +S L L
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEF 284
Query: 592 SYNHLEGEVPRRGVFSN 608
S N L+ VP G+F
Sbjct: 285 SRNQLKS-VP-DGIFDR 299
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 45/284 (15%), Positives = 100/284 (35%), Gaps = 25/284 (8%)
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF-NISSLESISLLGN 255
++ L + NR++ L + +L L ++ N + F ++ SLE + L N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 256 RLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKI--- 312
L +L + L +L L++ N Y +L + + +L + + KI
Sbjct: 111 YLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 313 DFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLS 372
DF L L L ++L + L + + L L L
Sbjct: 169 DFAGLTFLEELEIDASDLQSYEPKSLK------SIQNVSHLILHMK--------QHILLL 214
Query: 373 STIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIP 432
I + + L + + +++L+ +++ + + + + +L +
Sbjct: 215 E--IFVD-VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL-FQVM 270
Query: 433 ESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLT 476
+ L ++ L L+ N+L+ +L + + N
Sbjct: 271 KLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 57/264 (21%), Positives = 99/264 (37%), Gaps = 15/264 (5%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
V LDLSN I I + + L+ + +NG + L LE L L+ N S
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113
Query: 138 GKIPSNL-SRCSNLINFHARGNNLVGQIPPDIGYSWL-KLEFLSLRDNLLAGQLAPSI-G 194
+ S+ S+L + GN + +S L KL+ L + + ++
Sbjct: 114 -NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF-NISSLESISLL 253
++ L+ L I + L P SL ++++ +L + + SS+E + L
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELR 230
Query: 254 GNRLEG----SLPVNIGFSLPN---LENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHF 306
L+ L SL N+ + + + L+ S L L+FS N
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
Query: 307 SGQVKIDFNRLPNLFRLSFSKNNL 330
F+RL +L ++ N
Sbjct: 290 KSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 41/217 (18%)
Query: 694 LSKATNDFSS----SNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEA 749
L + + F+ IG GS+ R M AVK+++ +R T+ E E
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEI 68
Query: 750 L-RNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQ 808
L R +H N+I + V +++ + +V E M+ G L D + L F+ +
Sbjct: 69 LLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGELLDKI------LRQKFFSERE 117
Query: 809 RLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL----DHDMVAHVGDFGLARFLPPCS 864
++ + +EYLH +VH DLKPSN+L + + DFG A+ L +
Sbjct: 118 ASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 865 PATILETPSSSTGIKGTVGYVAPE------YGMGGDM 895
+L TP T +VAPE Y D+
Sbjct: 175 --GLLMTPC------YTANFVAPEVLERQGYDAACDI 203
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 23/211 (10%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIK 760
F +G+GS+G VY+ E VA+K + ++ + + E ++ +++K
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+ + IV EY GS+ D + N L I + +
Sbjct: 89 YYGS-----YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ-----STLKGL 138
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
EYLH +H D+K N+LL+ + A + DFG+A + +T + + G
Sbjct: 139 EYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA--------GQLTDTMAKRNTVIG 187
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
T ++APE + D++S GI +EM
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEM 218
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-21
Identities = 46/204 (22%), Positives = 80/204 (39%), Gaps = 30/204 (14%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLI 759
S + ++G G FG V++ + +A K++ + + E + + H NLI
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
++ FE + +V EY++ G L D + + N + + + +
Sbjct: 150 QLYDA-----FESKNDIVLVMEYVDGGELFDRIIDES-----YNLTELDTILFMKQICEG 199
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPSSSTG 877
I ++H I+H DLKP N+L + + DFGLAR P +
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--------- 247
Query: 878 IKGTVGYVAPE------YGMGGDM 895
GT ++APE DM
Sbjct: 248 NFGTPEFLAPEVVNYDFVSFPTDM 271
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-21
Identities = 47/215 (21%), Positives = 83/215 (38%), Gaps = 39/215 (18%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITV 764
+G+G+F V R A ++N K+ + E R ++H N++++
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
E ++++ + G L + + + ++ + + + A+ + H
Sbjct: 79 -----ISEEGHHYLIFDLVTGGELFEDI------VAREYYSEADASHCIQQILEAVLHCH 127
Query: 825 HHCHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
+VH +LKP N+LL + DFGLA + G GT
Sbjct: 128 QMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAW------FGFAGT 176
Query: 882 VGYVAPE------YGMGGDMSATGDV--YSFGILL 908
GY++PE YG D+ A G V Y ILL
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACG-VILY---ILL 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN--------LKQRGATKSFVAECEALRNIRHRNL 758
+G G+ G V + VA+K+++ ++ + E E L+ + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
IKI F+ D+ IV E ME G L D + + +
Sbjct: 78 IKIKNF-----FDAEDY-YIVLELMEGGELFDKV------VGNKRLKEATCKLYFYQMLL 125
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
A++YLH + I+H DLKP NVLL + D + + DFG ++ L +++ T
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRT---- 175
Query: 876 TGIKGTVGYVAPEYGMGGDMSATG---DVYSFGILL 908
+ GT Y+APE + + D +S G++L
Sbjct: 176 --LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 7e-21
Identities = 55/245 (22%), Positives = 100/245 (40%), Gaps = 26/245 (10%)
Query: 667 TRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMA 726
+ +V D S IG+GS G V +
Sbjct: 16 ENLYFQSGVVTHEQFKAALRMVVDQGDPRL---LLDSYVKIGEGSTGIVCLAREKHSGRQ 72
Query: 727 VAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECG 786
VAVK+M+L+++ + E +R+ +H N++++ S + EE+ ++ E+++ G
Sbjct: 73 VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK--SYLVGEEL---WVLMEFLQGG 127
Query: 787 SLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD 846
+L D + Q +L + V A+ YLH ++H D+K ++LL D
Sbjct: 128 ALTDIVSQV--RLNEEQIATVCE-----AVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177
Query: 847 MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGI 906
+ DFG A I + + GT ++APE + D++S GI
Sbjct: 178 GRVKLSDFGFC--------AQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229
Query: 907 LLLEM 911
+++EM
Sbjct: 230 MVIEM 234
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-21
Identities = 33/189 (17%), Positives = 67/189 (35%), Gaps = 15/189 (7%)
Query: 413 ELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSN 472
+ L ++ + +LT + ++ L G + N+ L+++N
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 473 NKLTGALPPQILGIVTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPV 530
T I LS L L + G +T + L +L L +S + + I
Sbjct: 76 IHATN-----YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 531 SLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLN 590
++ + + + N I LKTL +K L++ + + +E+ L L
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLY 187
Query: 591 LSYNHLEGE 599
+ G+
Sbjct: 188 AFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 34/193 (17%), Positives = 65/193 (33%), Gaps = 37/193 (19%)
Query: 312 IDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANL 371
I ++ +L ++ + N + DL I + N ++ L ++ N
Sbjct: 38 ITEAQMNSLTYITLANIN-----VTDLTGIEYAHN---IKDLTINNI--------HATNY 81
Query: 372 SSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHI 431
+ + L NL + +T + L +L +LD+ H+ D I
Sbjct: 82 NP-------------ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128
Query: 432 PESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSI 491
+ L +NS+DL +N + L L L++ + + GI
Sbjct: 129 LTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD-----YRGIEDFPK 182
Query: 492 L--LDLSGNLLTG 502
L L + G
Sbjct: 183 LNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 9e-17
Identities = 29/217 (13%), Positives = 70/217 (32%), Gaps = 34/217 (15%)
Query: 262 PVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKID-FNRLPNL 320
N+ + + + + + ++L + + + + + N+
Sbjct: 12 QDNVNIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT---DLTGIEYAHNI 68
Query: 321 FRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSM 380
L+ + + + + I+ L+N LE L + +++ L
Sbjct: 69 KDLTINNIH-----ATNYNPISGLSN---LERLRIMGKDVTSDKIPNLSGL--------- 111
Query: 381 GLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTI 440
+L L+ + ++ I I L + +DL +N I L L
Sbjct: 112 -------TSLTLLD---ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPE 160
Query: 441 LNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTG 477
L SL++ F+ + + + L L + + G
Sbjct: 161 LKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 33/211 (15%), Positives = 75/211 (35%), Gaps = 36/211 (17%)
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLG 254
+G++ + + Q+ SL Y++++ + + + I +++ +++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINN 75
Query: 255 NRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDF 314
P++ L NLE L + + T +LS ++L LLD S + +
Sbjct: 76 IHATNYNPIS---GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 315 NRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSST 374
N LP + + S N I D+ + L L++L + + + +
Sbjct: 133 NTLPKVNSIDLSYNGA----ITDIMPLKTLPE---LKSLNIQFD--------GVHDYRG- 176
Query: 375 IILFSMGLNQIYVKNLVNLNGFGLEYNQLTG 405
+++ LN + G
Sbjct: 177 ------------IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 30/201 (14%), Positives = 64/201 (31%), Gaps = 36/201 (17%)
Query: 81 LDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKI 140
L S I ++ L +I AN + ++ G I ++ L + N +
Sbjct: 28 GLLGQSSTANI---TEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHAT--- 79
Query: 141 PSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQ 200
N + S L N LE L + + P++ +++L
Sbjct: 80 --NYNPISGLSN----------------------LERLRIMGKDVTSDKIPNLSGLTSLT 115
Query: 201 VLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGS 260
+L I + + + L + + +S N + + L+S+++ + +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDGVHDY 174
Query: 261 LPVNIGFSLPNLENLSVRQNN 281
+ P L L
Sbjct: 175 RGIE---DFPKLNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 12/93 (12%), Positives = 37/93 (39%), Gaps = 4/93 (4%)
Query: 509 GNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLS 568
+ +L + L+ ++ + ++ L + T P+ L +++ L +
Sbjct: 41 AQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNPI--SGLSNLERLRIM 96
Query: 569 RNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVP 601
+++ L L+ L L++S++ + +
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 26/158 (16%), Positives = 53/158 (33%), Gaps = 8/158 (5%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
+T + L+N ++ + + ++ + N + P I L LE L + +
Sbjct: 46 LTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVT 101
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNIS 197
NLS ++L + I I + K+ + L N + P + +
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKIN-TLPKVNSIDLSYNGAITDIMP-LKTLP 159
Query: 198 NLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSG 235
L+ L+I + + + L L G
Sbjct: 160 ELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 9e-21
Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 40/215 (18%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITV 764
+G+G+F V R + A K++N K+ + E R ++H N++++
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
+E F +V++ + G L + + + ++ + + + +I Y H
Sbjct: 97 -----IQEESFHYLVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYCH 145
Query: 825 HHCHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
+ IVH +LKP N+LL + DFGLA + G GT
Sbjct: 146 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---------HGFAGT 193
Query: 882 VGYVAPE------YGMGGDMSATGDV--YSFGILL 908
GY++PE Y D+ A G V Y ILL
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACG-VILY---ILL 224
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 35/199 (17%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-HRNLIKIITVC 765
+G+GSF + ++ A AVK+++ + T+ E AL+ H N++K+ V
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEV- 74
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
F + +V E + G L + + + +F+ + ++ + A+ ++H
Sbjct: 75 ----FHDQLHTFLVMELLNGGELFERI------KKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 826 HCHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTV 882
+VH DLKP N+L + ++ + DFG AR PP + L+TP T+
Sbjct: 125 VG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPC------FTL 173
Query: 883 GYVAPE------YGMGGDM 895
Y APE Y D+
Sbjct: 174 HYAAPELLNQNGYDESCDL 192
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 57/241 (23%), Positives = 97/241 (40%), Gaps = 42/241 (17%)
Query: 686 FPMVSYADLSKATNDFSS----SNMIGQGSFGFVYRGNLGENEMAVAVKVMN-------- 733
F ++ D S S +G G+ G V + VA+++++
Sbjct: 118 FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS 177
Query: 734 LKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLH 793
++ + E E L+ + H +IKI F+ D+ IV E ME G L D +
Sbjct: 178 AREADPALNVETEIEILKKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKV- 230
Query: 794 QSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL---DHDMVAH 850
+ + A++YLH + I+H DLKP NVLL + D +
Sbjct: 231 -----VGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 282
Query: 851 VGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATG---DVYSFGIL 907
+ DFG ++ L +++ T + GT Y+APE + + D +S G++
Sbjct: 283 ITDFGHSKIL---GETSLMRT------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
Query: 908 L 908
L
Sbjct: 334 L 334
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 48/242 (19%), Positives = 83/242 (34%), Gaps = 36/242 (14%)
Query: 667 TRRRKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSS----SNMIGQGSFGFVYRGNLGE 722
R K S+ + + + + +G G+FG V+R
Sbjct: 121 IVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA 180
Query: 723 NEMAVAVKVMNLKQRGATKSFVA-ECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYE 781
A K + + K V E + + +RH L+ + FE+ + ++YE
Sbjct: 181 TGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYE 234
Query: 782 YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNV 841
+M G L + + E + + + + V + ++H + VH DLKP N+
Sbjct: 235 FMSGGELFEKVAD-----EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENI 286
Query: 842 LLDHDMVAHV--GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPE------YGMGG 893
+ + DFGL L P + GT + APE G
Sbjct: 287 MFTTKRSNELKLIDFGLTAHLDPKQSVKV---------TTGTAEFAAPEVAEGKPVGYYT 337
Query: 894 DM 895
DM
Sbjct: 338 DM 339
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 25/215 (11%)
Query: 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRN 757
++ IGQG+ G VY VA++ MNL+Q+ + + E +R ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 758 LIKIITVCSSIDFEEVDFKA-IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
++ +D V + +V EY+ GSL D + ++ ++ G + R +
Sbjct: 79 IVNY------LDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCR-----EC 125
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
A+E+LH + ++H D+K N+LL D + DFG A I S +
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC--------AQITPEQSKRS 174
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
+ GT ++APE D++S GI+ +EM
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-20
Identities = 65/253 (25%), Positives = 103/253 (40%), Gaps = 38/253 (15%)
Query: 670 RKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAV 729
H H SS + Q ++ ++ M+G+GSFG V + + AV
Sbjct: 2 HHHHHHSSGRENLYFQ------GTFAE---RYNIVCMLGKGSFGEVLKCKDRITQQEYAV 52
Query: 730 KVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGS 787
KV+N T + + E E L+ + H N++K+ + E+ IV E G
Sbjct: 53 KVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI-----LEDSSSFYIVGELYTGGE 107
Query: 788 LEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL---D 844
L D + ++ F+ ++ V I Y+H H IVH DLKP N+LL +
Sbjct: 108 LFDEI------IKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKE 158
Query: 845 HDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSF 904
D + DFGL+ + GT Y+APE + G DV+S
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTK---------MKDRIGTAYYIAPEV-LRGTYDEKCDVWSA 208
Query: 905 GILLLEMFTRRRP 917
G++L + + P
Sbjct: 209 GVILYILLSGTPP 221
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 55/228 (24%), Positives = 85/228 (37%), Gaps = 40/228 (17%)
Query: 371 LSSTIILFSMGLNQIY-VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDG 429
L S I + QI+ L+ +T + EL ++ + +++++
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK- 59
Query: 430 HIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTL 489
+ + + L + L L NKL L N +NL L + NK+
Sbjct: 60 SV-QGIQYLPNVTKLFLNGNKLT--DIKPLANLKNLGWLFLDENKVK------------- 103
Query: 490 SILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLT 549
DLS + +LK L L L N S+ L LE LY+ N +T
Sbjct: 104 ----DLSS----------LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT 147
Query: 550 GSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLE 597
I L L + L L N +S I L L+ L+ L LS NH+
Sbjct: 148 -DIT-VLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 51/280 (18%), Positives = 102/280 (36%), Gaps = 47/280 (16%)
Query: 239 SSIFNISSLESI---SLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASN 295
IF+ + +L + ++ N L +++ + ++ S+ + N
Sbjct: 15 KQIFSDDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIK-SVQ-GIQYLPN 69
Query: 296 LRLLDFSLNHFSGQVKI-DFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALG 354
+ L + N + I L NL L +N + DL + L L++L
Sbjct: 70 VTKLFLNGNKLT---DIKPLANLKNLGWLFLDENK-----VKDLSSLKDLKK---LKSLS 118
Query: 355 LDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGEL 414
L+ N I++++ + +L L L N++T + L
Sbjct: 119 LEHN--------GISDING-------------LVHLPQLESLYLGNNKITDITV--LSRL 155
Query: 415 RNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNK 474
L L L N + I L LT L +L L N + +L +NL +L + + +
Sbjct: 156 TKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQE 211
Query: 475 LTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNL 514
+V + + + G+L+T I ++ G+ +
Sbjct: 212 CLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKP 251
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 64/312 (20%), Positives = 117/312 (37%), Gaps = 55/312 (17%)
Query: 290 LSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSK 349
+ + + V N L ++ ++ + ++ I + I +L N
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSD-----IKSVQGIQYLPN--- 69
Query: 350 LEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPH 409
+ L L+ N + ++ + NL NL L+ N++
Sbjct: 70 VTKLFLNGN--------KLTDIKP-------------LANLKNLGWLFLDENKVKDLSS- 107
Query: 410 AIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLS 469
+ +L+ L+ L L HN + I L +L L SL LG NK+ + L L LS
Sbjct: 108 -LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLS 162
Query: 470 VSNNKLTGALPPQILGIVTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNE 527
+ +N+++ I+ + L+ L L LS N ++ + + LKNL L L N+
Sbjct: 163 LEDNQIS-----DIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNK 215
Query: 528 IPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKEL-DLSRNNLSGQIPEFLENLSFL 586
S + SL T + I + D + N+ +PEF +SF+
Sbjct: 216 PINHQSNLVVPNTVKNTDGSLV--------TPEIISDDGDYEKPNVKWHLPEFTNEVSFI 267
Query: 587 EYLNLSYNHLEG 598
Y ++ +
Sbjct: 268 FYQPVTIGKAKA 279
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 56/287 (19%), Positives = 96/287 (33%), Gaps = 54/287 (18%)
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLG 254
+ ++ + ++ + +L S+ + + + +I S++ I
Sbjct: 22 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNS-----------DIKSVQGIQ--- 65
Query: 255 NRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKID- 313
LPN+ L + N T P L+N NL L N +
Sbjct: 66 -------------YLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK---DLSS 107
Query: 314 FNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSS 373
L L LS N I D++ + HL LE+L L N + LS L+
Sbjct: 108 LKDLKKLKSLSLEHNG-----ISDINGLVHLPQ---LESLYLGNNKITDITVLS--RLTK 157
Query: 374 TIILFSMGLNQIY----VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDG 429
L S+ NQI + L L L N ++ + L+NL VL+L
Sbjct: 158 LDTL-SLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLN 214
Query: 430 HIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLT 476
NL + N++ L P + + + +V +
Sbjct: 215 KPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 43/245 (17%), Positives = 92/245 (37%), Gaps = 20/245 (8%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
+ + +N I+ + + L + + N + +I + L L L L N
Sbjct: 48 IDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK 103
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNIS 197
+ S+L L + N + I + +LE L L +N + + ++
Sbjct: 104 -DL-SSLKDLKKLKSLSLEHNGIS-DINGLVHLP--QLESLYLGNNKITD--ITVLSRLT 156
Query: 198 NLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRL 257
L LS+ +N++S L L L L +S+N S + ++ + +L+ + L
Sbjct: 157 KLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQEC 212
Query: 258 EGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLD--FSLNHFSGQVKIDFN 315
+ P+N +L + + P +S+ + + + L F+ +V F
Sbjct: 213 L-NKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFTNEVSFIFY 269
Query: 316 RLPNL 320
+ +
Sbjct: 270 QPVTI 274
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 46/205 (22%), Positives = 85/205 (41%), Gaps = 39/205 (19%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA-ECEALRNIRHRNLIKIITVC 765
+G+G FG V+R ++ K + K +G + V E L RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILHLHES- 69
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL---EVGNFNVIQRLNLVIDVAFAIEY 822
FE ++ +++E++ + + ++ S +L E+ ++ V Q A+++
Sbjct: 70 ----FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-VHQVCE-------ALQF 117
Query: 823 LHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPSSSTGIKG 880
LH H I H D++P N++ + + +FG AR L P + +
Sbjct: 118 LHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---------LFT 165
Query: 881 TVGYVAPE------YGMGGDMSATG 899
Y APE DM + G
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLG 190
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 48/204 (23%), Positives = 77/204 (37%), Gaps = 11/204 (5%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESL-GNLTILNSLDLGFNKLRGHVP 456
L +N L ++ LQVLDL + I + +L+ L++L L N ++
Sbjct: 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLAL 93
Query: 457 SSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLV 515
+ +L L L +L +G + L+++ NL+ E NL NL
Sbjct: 94 GAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152
Query: 516 QLGLSENRFSNEIPV----SLSACTTLEY-LYMEGNSLTGSIPLALKTLKSIKELDLSRN 570
L LS N+ + I L L L + N + I +KEL L N
Sbjct: 153 HLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTN 210
Query: 571 NLSGQIPEFLENLSFLEYLNLSYN 594
L + L+ L+ + L N
Sbjct: 211 QLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 9/164 (5%)
Query: 389 NLVNLNGFGLEYNQLTGPIPHAI-GELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLG 447
+L +L+ L N + + L +LQ L NL +G+L L L++
Sbjct: 74 SLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 448 FNKLRG-HVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVT----LSILLDLSGNLLTG 502
N ++ +P N NL L +S+NK+ ++ L ++ L++ LDLS N +
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN- 190
Query: 503 SIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGN 546
I L +L L N+ + T+L+ +++ N
Sbjct: 191 FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 49/235 (20%), Positives = 84/235 (35%), Gaps = 28/235 (11%)
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF-NISSLESISLLGN 255
+ + L + N L S L L +S + ++S L ++ L GN
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 256 RLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSL-SNASNLRLLDFSLNHF-SGQVKID 313
++ SL + L +L+ L + N SL + + L+ L+ + N S ++
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 314 FNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSS 373
F+ L NL L S N + + DL + + + +L L N + P + +
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL--SLDLSLNPMNFIQPGAFKEI-- 200
Query: 374 TIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLD 428
L L+ NQL L +LQ + LH N D
Sbjct: 201 ------------------RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 38/164 (23%), Positives = 68/164 (41%), Gaps = 21/164 (12%)
Query: 461 NCQNLMLLSV-------------SNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAE 507
C L + S N L L +LDLS + +I
Sbjct: 13 QCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDG 70
Query: 508 V-GNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIP-LALKTLKSIKEL 565
+L +L L L+ N + + S ++L+ L +L S+ + LK++KEL
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKEL 129
Query: 566 DLSRNNL-SGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
+++ N + S ++PE+ NL+ LE+L+LS N ++ +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIY-CTDLRV 171
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 43/277 (15%), Positives = 79/277 (28%), Gaps = 61/277 (22%)
Query: 64 CQWTGVTC-GHRHQRV--------TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSG 114
C ++ LDLS + + S + L+ ++ +
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 115 EIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLK 174
G L L TLIL N +
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQ-------------------------SLALGAFSGLSS 101
Query: 175 LEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFS 234
L+ L + LA IG++ L+ L++ N ++S FS
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHN-----------LIQSF----KLPEYFS 146
Query: 235 GMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVR---QNNYTGSLPHSLS 291
+ ++LE + L N+++ S+ L + L++ N +
Sbjct: 147 NL--------TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 292 NASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKN 328
L+ L N F+RL +L ++ N
Sbjct: 198 KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 20/99 (20%), Positives = 38/99 (38%), Gaps = 16/99 (16%)
Query: 536 TTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPE-FLENLSFLEYLNLSYN 594
+ + L + N L + + ++ LDLSR + I + ++LS L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 595 HLEGEVPRRGVFSNKTRFYFTGNKRLCGGLDELHLPVCH 633
++ + G FS + L +L +
Sbjct: 87 PIQ-SLA-LGAFSGLSS------------LQKLVAVETN 111
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 4e-20
Identities = 48/253 (18%), Positives = 84/253 (33%), Gaps = 36/253 (14%)
Query: 671 KHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQG--SFGFVYRGNLGENEMAVA 728
H H L Q M S+ + +IG+G V V
Sbjct: 2 AHHHHHHMENLYFQG--MSSFLP---EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVT 56
Query: 729 VKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECG 786
V+ +NL+ E + H N++ F + +V +M G
Sbjct: 57 VRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT-----FIADNELWVVTSFMAYG 111
Query: 787 SLEDWLHQS-NDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH 845
S +D + D + I + V A++Y+HH + VH +K S++L+
Sbjct: 112 SAKDLICTHFMDGMNELAIAYILQ-----GVLKALDYIHHMGY---VHRSVKASHILISV 163
Query: 846 DMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG---YVAPE----YGMGGDMSAT 898
D ++ + + K +V +++PE G D +
Sbjct: 164 DGKVYLSGLRSNLSM----ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS- 218
Query: 899 GDVYSFGILLLEM 911
D+YS GI E+
Sbjct: 219 -DIYSVGITACEL 230
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 55/245 (22%), Positives = 93/245 (37%), Gaps = 28/245 (11%)
Query: 682 MEQQFPMVSYADLSKATND----FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR 737
M + D F+ IG+GSFG V++G + VA+K+++L++
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA 60
Query: 738 GATKS-FVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSN 796
E L + K S + ++ I+ EY+ GS D L
Sbjct: 61 EDEIEDIQQEITVLSQCDSPYVTKYY--GSYLKDTKL---WIIMEYLGGGSALDLLE--P 113
Query: 797 DQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856
L+ I R ++ ++YLH +H D+K +NVLL + DFG+
Sbjct: 114 GPLDETQIATILR-----EILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV 165
Query: 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRR 916
A + +T GT ++APE + D++S GI +E+
Sbjct: 166 A--------GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 217
Query: 917 PTDNM 921
P +
Sbjct: 218 PHSEL 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 6e-20
Identities = 57/232 (24%), Positives = 90/232 (38%), Gaps = 50/232 (21%)
Query: 707 IGQGSFGFVYRGNLGENEM---AVAVKVMNLKQRGATKSFVA-ECEALRNIRHRNLIKII 762
+G+G++G V L N + AVAVK++++K+ + E + + H N++K
Sbjct: 15 LGEGAYGEVQ---LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA---F- 818
E + + + EY G L D + + + A F
Sbjct: 72 GH-----RREGNIQYLFLEYCSGGELFDRI--------------EPDIGMPEPDAQRFFH 112
Query: 819 ----AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
+ YLH I H D+KP N+LLD + DFGLA + +L
Sbjct: 113 QLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC- 168
Query: 875 STGIKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFND 924
GT+ YVAPE + DV+S GI+L M P ++
Sbjct: 169 -----GTLPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELP----WDQ 210
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 34/230 (14%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIK 760
+ +G G+FG VY+ E A KV+ K + ++ E E L H ++K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 761 IITVCSSIDFEEVDFKA----IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
+ I+ E+ G+++ + + + L V+ R +
Sbjct: 81 ---------LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QM 126
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
A+ +LH I+H DLK NVL+ + + DFG++ A L+T
Sbjct: 127 LEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS--------AKNLKTLQKRD 175
Query: 877 GIKGTVGYVAPEYGMGGDMSATG-----DVYSFGILLLEMFTRRRPTDNM 921
GT ++APE M M T D++S GI L+EM P +
Sbjct: 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 41/218 (18%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA------ECEALRNIRHRNLIK 760
+G G F V + + A K + +Q A++ V+ E LR + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+ V +E ++ E + G L D+L + + + + + + + +
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGV 128
Query: 821 EYLHHHCHPPIVHGDLKPSNVLL----DHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
YLH I H DLKP N++L + DFGLA +
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---------K 176
Query: 877 GIKGTVGYVAPE------YGMGGDMSATGDVYSFGILL 908
I GT +VAPE G+ DM + G V ++ ILL
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITY-ILL 212
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 36/217 (16%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA------ECEALRNIRHRNLIK 760
IG+G F V R E AVK+++ + + ++ E ++H ++++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVD-VAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
++ + +V+E+M+ L + + D ++ + + + A+
Sbjct: 91 LLET-----YSSDGMLYMVFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEAL 143
Query: 821 EYLHHHCHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
Y H + I+H D+KP VLL ++ +G FG+A L E+ + G
Sbjct: 144 RYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--------ESGLVAGG 192
Query: 878 IKGTVGYVAPE------YGMGGDMSATGDVYSFGILL 908
GT ++APE YG D+ G V F ILL
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCG-VILF-ILL 227
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 43/211 (20%), Positives = 72/211 (34%), Gaps = 8/211 (3%)
Query: 388 KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPES-LGNLTILNSLDL 446
+N + L +L A +L+ +++ N++ I NL L+ + +
Sbjct: 30 RNAIELR---FVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86
Query: 447 -GFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIP 505
N L P + N NL L +SN + LP +LLD+ N+ +I
Sbjct: 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE 145
Query: 506 AEV--GNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIK 563
G V L L++N + + E + N+L
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205
Query: 564 ELDLSRNNLSGQIPEFLENLSFLEYLNLSYN 594
LD+SR + LENL L +
Sbjct: 206 ILDISRTRIHSLPSYGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 35/207 (16%), Positives = 72/207 (34%), Gaps = 14/207 (6%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPE-SLGNLTILNSLDLGFNKLRGHVP 456
+ +++T IP + RN L L I + + L +++ N + +
Sbjct: 16 CQESKVTE-IPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIE 71
Query: 457 SS-LGNCQNLMLLSVSN-NKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKN 513
+ N L + + N L + P+ + L +S + +P +
Sbjct: 72 ADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQ 129
Query: 514 LVQLGLSENRFSNEIPVSLSA--CTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNN 571
V L + +N + I + L++ N + I + + EL+LS NN
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNN 188
Query: 572 LSGQIPEF-LENLSFLEYLNLSYNHLE 597
++P S L++S +
Sbjct: 189 NLEELPNDVFHGASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 40/248 (16%), Positives = 76/248 (30%), Gaps = 29/248 (11%)
Query: 246 SLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNH 305
S +++ +P ++ N L + S +L ++ S N
Sbjct: 10 SNRVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 65
Query: 306 FSGQVKID-FNRLPNLFRLSFSKNNLGTGAIGDLDFIAH--LTNCSKLEALGLDTNIFGG 362
++ D F+ LP L + K N +L +I N L+ L +
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKAN-------NLLYINPEAFQNLPNLQYLLISNTGIKH 118
Query: 363 VLPLSIANLSSTIILFSMGLNQIYV----------KNLVNLNGFGLEYNQLTGPIPHAIG 412
+ + + ++L I+ V L L N + A
Sbjct: 119 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW---LNKNGIQEIHNSAFN 175
Query: 413 ELRNLQVLDLHHNNLDGHIPE-SLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVS 471
+ ++ +NNL+ +P + LD+ ++ L N + L S
Sbjct: 176 GTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234
Query: 472 NNKLTGAL 479
N K L
Sbjct: 235 NLKKLPTL 242
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 34/186 (18%), Positives = 57/186 (30%), Gaps = 8/186 (4%)
Query: 416 NLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKL 475
+ +V + + IP L L KLR + +L + +S N +
Sbjct: 10 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 476 TGALPPQIL-GIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLSENRFSNEIPVSLS 533
+ + + L + N L I E NL NL L +S + V
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 125
Query: 534 ACTTLEYLYMEGNSLTGSIP-LALKTLKS-IKELDLSRNNLSGQIPEFLENLSFLEYLNL 591
L ++ N +I + L L L++N + E
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185
Query: 592 SYNHLE 597
N+LE
Sbjct: 186 DNNNLE 191
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 41/219 (18%), Positives = 66/219 (30%), Gaps = 10/219 (4%)
Query: 115 EIPGEIGRLFRLETLILANNSFSGKIPSN-LSRCSNLINFHARGNNLVGQIPPDIGYSWL 173
EIP ++ R L I S +L N+++ I D+ +
Sbjct: 23 EIPSDLPR--NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79
Query: 174 KLEFLSLRDNLLAGQLAPSI-GNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENA 232
KL + + + P N+ NLQ L I + L I +N
Sbjct: 80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 139
Query: 233 FSGMFPSSIFN--ISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLP-HS 289
+ F + L N ++ + + F+ L+ L++ NN LP
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSA-FNGTQLDELNLSDNNNLEELPNDV 197
Query: 290 LSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKN 328
AS +LD S L L S
Sbjct: 198 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 236
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 50/209 (23%), Positives = 81/209 (38%), Gaps = 39/209 (18%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA------ECEALRNIRHRNLIK 760
+G G F V + A K + ++ +++ V+ E LR IRH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+ + FE ++ E + G L D+L E + + + + +
Sbjct: 73 LHDI-----FENKTDVVLILELVSGGELFDFL------AEKESLTEDEATQFLKQILDGV 121
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAH----VGDFGLARFLPPCSPATILETPSSST 876
YLH I H DLKP N++L V + + DFG+A + +
Sbjct: 122 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---------K 169
Query: 877 GIKGTVGYVAPE------YGMGGDMSATG 899
I GT +VAPE G+ DM + G
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIG 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 55/202 (27%), Positives = 83/202 (41%), Gaps = 34/202 (16%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G+G+ VYR + A+KV+ K E L + H N+IK+ +
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEI-- 116
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
FE ++V E + G L D + +E G ++ + V + A+ YLH +
Sbjct: 117 ---FETPTEISLVLELVTGGELFDRI------VEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 827 CHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
IVH DLKP N+L D + DFGL++ + + GT G
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---------QVLMKTVCGTPG 215
Query: 884 YVAPE------YGMGGDMSATG 899
Y APE YG DM + G
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVG 237
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 39/209 (18%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA------ECEALRNIRHRNLIK 760
+G G F V + + A K + +Q A++ V E LR + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+ V +E ++ E + G L D+L + + + + + + + +
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGV 128
Query: 821 EYLHHHCHPPIVHGDLKPSNVLL----DHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
YLH I H DLKP N++L + DFGLA +
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---------K 176
Query: 877 GIKGTVGYVAPE------YGMGGDMSATG 899
I GT +VAPE G+ DM + G
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIG 205
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 41/224 (18%)
Query: 705 NMIGQGSFGFVYRG-NLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKI 761
IG+G++G V++ N +E+ VA+K + L G S + E L+ ++H+N++++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEI-VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL---EVGNFNVIQRLNLVIDVAF 818
V S ++ +V+E+ + L+ + N L V +F + Q L
Sbjct: 67 HDVLHS---DKKLT--LVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF-LFQLLK------- 112
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR-FLPPCSPAT---ILETPSS 874
+ + H ++H DLKP N+L++ + + +FGLAR F P + +
Sbjct: 113 GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV------ 163
Query: 875 STGIKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRRRP 917
T+ Y P+ G + +T D++S G + E+ RP
Sbjct: 164 ------TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 57/232 (24%), Positives = 90/232 (38%), Gaps = 50/232 (21%)
Query: 707 IGQGSFGFVYRGNLGENEM---AVAVKVMNLKQRGATKSFVA-ECEALRNIRHRNLIKII 762
+G+G++G V L N + AVAVK++++K+ + E + + H N++K
Sbjct: 15 LGEGAYGEVQ---LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA---F- 818
E + + + EY G L D + + + A F
Sbjct: 72 GH-----RREGNIQYLFLEYCSGGELFDRI--------------EPDIGMPEPDAQRFFH 112
Query: 819 ----AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
+ YLH I H D+KP N+LLD + DFGLA + +L
Sbjct: 113 QLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC- 168
Query: 875 STGIKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFND 924
GT+ YVAPE + DV+S GI+L M P ++
Sbjct: 169 -----GTLPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELP----WDQ 210
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-19
Identities = 84/462 (18%), Positives = 151/462 (32%), Gaps = 81/462 (17%)
Query: 197 SNLQVLSIGENRLS-GRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNI----SSLESIS 251
++Q L I LS R + L L+ + + + + I + +L ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 252 LLGNRL--EGSLPVNIGFSLPN--LENLSVRQNNYT----GSLPHSLSNASNLRLLDFSL 303
L N L G V G P+ ++ LS++ T G L +L L+ L S
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 304 NHFSGQ-VKIDFNRL----PNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTN 358
N +++ L L +L +L A + L + L + N
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS--AASCEPLASVLRAKPDFKELTVSNN 180
Query: 359 IFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLT----GPIPHAIGEL 414
+ + + GL + L LE +T + +
Sbjct: 181 DIN----------EAGVRVLCQGLKD----SPCQLEALKLESCGVTSDNCRDLCGIVASK 226
Query: 415 RNLQVLDLHHNNLDG----HIPESLGN-LTILNSLDLGFNKLR----GHVPSSLGNCQNL 465
+L+ L L N L + L + + L +L + + G + L ++L
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL 286
Query: 466 MLLSVSNNKLTGALPPQILGIVTLSIL----------LDLSGNLLTG----SIPAEVGNL 511
LS++ N+L G L L + T + +
Sbjct: 287 KELSLAGNELGDE------GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 340
Query: 512 KNLVQLGLSENRFSNEIPVSLSA-----CTTLEYLYMEGNSLT----GSIPLALKTLKSI 562
+ L++L +S NR + L + L L++ ++ S+ L S+
Sbjct: 341 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL 400
Query: 563 KELDLSRNNLSGQ----IPEFLE-NLSFLEYLNLSYNHLEGE 599
+ELDLS N L + E + LE L L + E
Sbjct: 401 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-19
Identities = 51/225 (22%), Positives = 99/225 (44%), Gaps = 36/225 (16%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRN 757
+ + +G+G++ VY+G + VA+K + L+ GA + + E L++++H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVI--QRLNLVID 815
++ + + + E+ +V+EY++ L+ +L + + + N + Q L
Sbjct: 62 IVTLHDIIHT---EKSLT--LVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLR---- 111
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR-FLPPCSPAT---ILET 871
+ Y H ++H DLKP N+L++ + DFGLAR P +
Sbjct: 112 ---GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--- 162
Query: 872 PSSSTGIKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
T+ Y P+ +G +T D++ G + EM T R
Sbjct: 163 ---------TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-19
Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 39/209 (18%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA------ECEALRNIRHRNLIK 760
+G G F V + + A K + ++ +++ V+ E L+ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+ V +E ++ E + G L D+L E + + + + +
Sbjct: 79 LHEV-----YENKTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGV 127
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAH----VGDFGLARFLPPCSPATILETPSSST 876
YLH I H DLKP N++L V + DFGLA + +
Sbjct: 128 YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---------K 175
Query: 877 GIKGTVGYVAPE------YGMGGDMSATG 899
I GT +VAPE G+ DM + G
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIG 204
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 69/256 (26%), Positives = 111/256 (43%), Gaps = 50/256 (19%)
Query: 670 RKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAV 729
H H SS + Q M Y L K +G+G++G VY+ + + VA+
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEK----------VGEGTYGVVYKAKDSQGRI-VAL 50
Query: 730 KVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGS 787
K + L G + + E L+ + H N++ +I V S E +V+E+ME
Sbjct: 51 KRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS---ERCLT--LVFEFMEK-D 104
Query: 788 LEDWLHQSNDQL---EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD 844
L+ L ++ L ++ + + Q L + + H H I+H DLKP N+L++
Sbjct: 105 LKKVLDENKTGLQDSQIKIY-LYQLLR-------GVAHCHQHR---ILHRDLKPQNLLIN 153
Query: 845 HDMVAHVGDFGLAR-FLPPCSPAT---ILETPSSSTGIKGTVGYVAPEYGMGGDMSATG- 899
D + DFGLAR F P T + T+ Y AP+ MG +T
Sbjct: 154 SDGALKLADFGLARAFGIPVRSYTHEVV------------TLWYRAPDVLMGSKKYSTSV 201
Query: 900 DVYSFGILLLEMFTRR 915
D++S G + EM T +
Sbjct: 202 DIWSIGCIFAEMITGK 217
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 53/232 (22%), Positives = 93/232 (40%), Gaps = 25/232 (10%)
Query: 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHR 756
F ++G G++G VY+G + A+KVM++ + E L+ HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 757 NLIKIITVCSSIDFEEVDFKA-IVYEYMECGSLEDWLHQSNDQ-LEVGNFNVIQRLNLVI 814
N+ + +D + +V E+ GS+ D + + L+ I R
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR----- 136
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
++ + +LH H ++H D+K NVLL + + DFG++ A + T
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--------AQLDRTVGR 185
Query: 875 STGIKGTVGYVAPEYGMGGDMSATG-----DVYSFGILLLEMFTRRRPTDNM 921
GT ++APE + D++S GI +EM P +M
Sbjct: 186 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 57/235 (24%), Positives = 91/235 (38%), Gaps = 37/235 (15%)
Query: 672 HKHKSSSMLLMEQQFPMVSYADLSKATNDFS-SSNMIGQGSFGFVYRGNLGENEMAVAVK 730
H H SS L + Q P ++ D+ S ++G G G V A+K
Sbjct: 4 HHHHHSSGLEVLFQGPEPKKYAVTD---DYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60
Query: 731 VMNLKQRGATKSFVAECEAL-RNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLE 789
++ A + E + + +++ I+ V ++ + I+ E ME G L
Sbjct: 61 LLY-DSPKARQ----EVDHHWQASGGPHIVCILDVYENMHHGKRCL-LIIMECMEGGELF 114
Query: 790 DWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL---DHD 846
+ + DQ F + ++ D+ AI++LH H I H D+KP N+L + D
Sbjct: 115 SRIQERGDQ----AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKD 167
Query: 847 MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPE------YGMGGDM 895
V + DFG A+ + T T YVAPE Y DM
Sbjct: 168 AVLKLTDFGFAKETTQNALQTPC----------YTPYYVAPEVLGPEKYDKSCDM 212
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 51/217 (23%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIIT 763
+G G++ VY+G + VA+K + L G + + E ++ ++H N++++
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
V + E +V+E+M+ L+ ++ + + + +
Sbjct: 71 VIHT---ENKLT--LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR-FLPPCSPAT---ILETPSSSTGIK 879
H + I+H DLKP N+L++ +GDFGLAR F P + + +
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV----------- 170
Query: 880 GTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
T+ Y AP+ MG +T D++S G +L EM T +
Sbjct: 171 -TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 49/216 (22%), Positives = 87/216 (40%), Gaps = 19/216 (8%)
Query: 376 ILFSMGLNQIY-VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPES 434
I +NQ++ L N L +T + EL +Q + ++N+ +
Sbjct: 3 IQRPTPINQVFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AG 58
Query: 435 LGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL-L 493
+ T L L L N++ S L + L LSV+ N+L + GI + + L
Sbjct: 59 MQFFTNLKELHLSHNQIS--DLSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRL 111
Query: 494 DLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIP 553
L N L + + +LKNL L + N+ + + L + LE L + GN +T +
Sbjct: 112 FLDNNELR-DTDS-LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT-NTG 166
Query: 554 LALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYL 589
L LK + +DL+ + ++ L +
Sbjct: 167 -GLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTV 201
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 37/188 (19%), Positives = 74/188 (39%), Gaps = 20/188 (10%)
Query: 411 IGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSV 470
L N +L ++ + S L+ + + + + ++ + + NL L +
Sbjct: 15 DPGLANAVKQNLGKQSVT-DL-VSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHL 70
Query: 471 SNNKLTGALPPQILGIVTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEI 528
S+N+++ + + L+ L L ++ N L ++ L +L L N +
Sbjct: 71 SHNQIS-----DLSPLKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNELRD-- 120
Query: 529 PVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEY 588
SL LE L + N L SI L L ++ LDL N ++ L L + +
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNW 176
Query: 589 LNLSYNHL 596
++L+
Sbjct: 177 IDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 53/247 (21%), Positives = 96/247 (38%), Gaps = 25/247 (10%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
+L +S+ ++S LS ++ N N+ + G + L+ L L++N S
Sbjct: 21 AVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS 76
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDI-GYSWLKLEFLSLRDNLLAGQLAPSIGNI 196
+ S L + L N L ++ G L L L +N L S+ ++
Sbjct: 77 -DL-SPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELRD--TDSLIHL 127
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNR 256
NL++LSI N+L LG L L L + N + + + + I L G +
Sbjct: 128 KNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQK 183
Query: 257 LEGSLPVNIGFSLPNLENL-SVRQNNYTGSLPHSLSNASNLRLLD--FSLNHFSGQVKID 313
+ PV P L +V+ + P+ +SN + + L ++ +V
Sbjct: 184 CV-NEPVKY---QPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYK 239
Query: 314 FNRLPNL 320
F+ N+
Sbjct: 240 FSEYINV 246
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 44/284 (15%), Positives = 84/284 (29%), Gaps = 67/284 (23%)
Query: 193 IGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISL 252
++N ++G+ ++ S +L + + + NI SL +
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNS-----------NIQSLAGMQ- 60
Query: 253 LGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKI 312
NL+ L + N + L L + + L L + N +
Sbjct: 61 ---------------FFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK---NL 100
Query: 313 DFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLS 372
+ L RL N + D D + HL N LE L + N + ++
Sbjct: 101 NGIPSACLSRLFLDNNE-----LRDTDSLIHLKN---LEILSIRNN--------KLKSIV 144
Query: 373 STIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIP 432
+ L L L N++T + L+ + +DL
Sbjct: 145 M-------------LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPV 189
Query: 433 ESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLT 476
+ L I N++ + P + N + + V
Sbjct: 190 KYQPELYITNTVKDPDGRWI--SPYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 19/88 (21%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 510 NLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSR 569
L N V+ L + ++ + + ++ + +++ S+ ++ ++KEL LS
Sbjct: 17 GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSH 72
Query: 570 NNLSGQIPEFLENLSFLEYLNLSYNHLE 597
N +S + L++L+ LE L+++ N L+
Sbjct: 73 NQIS-DL-SPLKDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 20/105 (19%), Positives = 39/105 (37%), Gaps = 9/105 (8%)
Query: 493 LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSI 552
+L +T + L + + + + T L+ L++ N ++ +
Sbjct: 24 QNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSHNQIS-DL 78
Query: 553 PLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLE 597
LK L ++EL ++RN L + + L L L N L
Sbjct: 79 S-PLKDLTKLEELSVNRNRLK--NLNGIPSAC-LSRLFLDNNELR 119
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRNLIKIIT 763
IG+G+F V VA+K+++ L K F E ++ + H N++K+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
V I+ E+ + ++ EY G + D+L + G + + + A++Y
Sbjct: 82 V---IETEKTLY--LIMEYASGGEVFDYL------VAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
H IVH DLK N+LLD DM + DFG + + L+ G
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE---FTVGGKLDAFC------GAPP 178
Query: 884 YVAPE--YGMGGDMSATGDVYSFGILLLEMFTRRRPTD 919
Y APE G D DV+S G++L + + P D
Sbjct: 179 YAAPELFQGKKYDGPEV-DVWSLGVILYTLVSGSLPFD 215
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 27/218 (12%), Positives = 56/218 (25%), Gaps = 62/218 (28%)
Query: 707 IGQGSFGFVYRG---NLGENEMAVAVKVMNLKQRGATKS---FVAECEALRNIRHRNLIK 760
G ++ L VA+ ++ + ++ L I
Sbjct: 39 HGGVPPLQFWQALDTALDR---QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG--- 92
Query: 761 IITVCSSIDF-EEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
+ V +D +V E++ GSL++ + + + + + +A A
Sbjct: 93 VARV---LDVVHTRAGGLVVAEWIRGGSLQEVAD--------TSPSPVGAIRAMQSLAAA 141
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+ H + PS V + D + +P +P
Sbjct: 142 ADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---TMPDANPQD------------ 183
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
D+ G L + R P
Sbjct: 184 --------------------DIRGIGASLYALLVNRWP 201
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 59/252 (23%), Positives = 100/252 (39%), Gaps = 44/252 (17%)
Query: 682 MEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGAT 740
M +Q+ V + + + IGQG+FG V++ + + VA+K K
Sbjct: 1 MAKQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQK-VALK----KVL--- 51
Query: 741 KSFVAECE-----ALRNI------RHRNLIKIITVCSSIDFEEVDFKAIVY---EYMEC- 785
E E ALR I +H N++ +I +C + K +Y ++ E
Sbjct: 52 --MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD 109
Query: 786 -GSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD 844
L + E+ + LN + Y+H + I+H D+K +NVL+
Sbjct: 110 LAGLLSNVLVKFTLSEIKRV-MQMLLN-------GLYYIHRNK---ILHRDMKAANVLIT 158
Query: 845 HDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATG-DVYS 903
D V + DFGLAR ++ + T+ Y PE +G D++
Sbjct: 159 RDGVLKLADFGLARAFSL--AKNSQPNRYTNRVV--TLWYRPPELLLGERDYGPPIDLWG 214
Query: 904 FGILLLEMFTRR 915
G ++ EM+TR
Sbjct: 215 AGCIMAEMWTRS 226
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 56/200 (28%), Positives = 85/200 (42%), Gaps = 14/200 (7%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPS 457
+ LT +P + ++ +L L N L +L T L L+L +L
Sbjct: 17 CDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQ 71
Query: 458 SLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQ 516
G L L +S+N+L +LP + L++ LD+S N LT S+P L L +
Sbjct: 72 VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTV-LDVSFNRLT-SLPLGALRGLGELQE 128
Query: 517 LGLSENRFSNEIPVSLSACTT-LEYLYMEGNSLTGSIPL-ALKTLKSIKELDLSRNNLSG 574
L L N +P L T LE L + N+LT +P L L+++ L L N+L
Sbjct: 129 LYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT 186
Query: 575 QIPEFLENLSFLEYLNLSYN 594
IP+ L + L N
Sbjct: 187 -IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 13/177 (7%)
Query: 437 NLTILNSLDLGFNKLRGHVPSSL-GNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDL 495
+ ++ L +P L + L L S N L L T L+L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPKDTTILHL---SENLLY-TFSLATLMPYTRLTQLNL 62
Query: 496 SGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPL- 554
LT + + G L L L LS N+ + +P+ L L + N LT S+PL
Sbjct: 63 DRAELT-KLQVD-GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLG 118
Query: 555 ALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTR 611
AL+ L ++EL L N L P L LE L+L+ N+L E+P G+ +
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELP-AGLLNGLEN 173
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 44/232 (18%), Positives = 72/232 (31%), Gaps = 35/232 (15%)
Query: 243 NISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFS 302
++S ++ L +LP ++ + L + +N +L + L L+
Sbjct: 8 KVASHLEVNCDKRNL-TALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 303 LNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGG 362
LP L L S N L + + L L L + N
Sbjct: 64 RAEL--TKLQVDGTLPVLGTLDLSHNQLQSLPLL----GQTLPA---LTVLDVSFN---- 110
Query: 363 VLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDL 422
+ +L L L L+ N+L P + L+ L L
Sbjct: 111 ----RLTSLPLGA--LR---------GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155
Query: 423 HHNNLDGHIPESL-GNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNN 473
+NNL +P L L L++L L N L +P L + N
Sbjct: 156 ANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 41/180 (22%), Positives = 63/180 (35%), Gaps = 8/180 (4%)
Query: 126 LETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLL 185
L L+ N + L + L + L ++ D L L L N L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVDGTLP--VLGTLDLSHNQL 89
Query: 186 AGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF-NI 244
L + L VL + NRL+ +L L L L + N P +
Sbjct: 90 Q-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 245 SSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLN 304
LE +SL N L LP + L NL+ L +++N+ ++P + L N
Sbjct: 148 PKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 52/234 (22%), Positives = 76/234 (32%), Gaps = 41/234 (17%)
Query: 126 LETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLL 185
+ + + +P +L + H N L + +L L+L L
Sbjct: 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLL-YTFSLATLMPYTRLTQLNLDRAEL 67
Query: 186 AGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF-NI 244
G + L L + N+L LP L +L L +S N + P +
Sbjct: 68 --TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGL 123
Query: 245 SSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLN 304
L+ + L GN L+ +LP + P LE LS+ NN T LP L
Sbjct: 124 GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGL-------------- 167
Query: 305 HFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTN 358
N L NL L +N+L T G L L N
Sbjct: 168 ---------LNGLENLDTLLLQENSLYTIPKGFFGS-------HLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 51/229 (22%), Positives = 73/229 (31%), Gaps = 54/229 (23%)
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNR 256
+ +L + EN L +L L L++ + + + L ++ L N+
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPVLGTLDLSHNQ 88
Query: 257 LEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNR 316
L+ SLP +G +LP L L V N T SLP
Sbjct: 89 LQ-SLP-LLGQTLPALTVLDVSFNRLT-SLPLGA-----------------------LRG 122
Query: 317 LPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTII 376
L L L N L T G L LE L L N ++ L + +
Sbjct: 123 LGELQELYLKGNELKTLPPGLLT---PTPK---LEKLSLANN--------NLTELPAGL- 167
Query: 377 LFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHN 425
+ L NL+ L+ N L IP L LH N
Sbjct: 168 -LN---------GLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 39/182 (21%), Positives = 63/182 (34%), Gaps = 39/182 (21%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
T L+L + + G L L ++ ++N +P L L L ++ N
Sbjct: 58 TQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFN---- 110
Query: 139 KIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSI-GNIS 197
++ S +P +L+ L L+ N L L P +
Sbjct: 111 RLTS---------------------LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTP 148
Query: 198 NLQVLSIGENRLSGRLP----DSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLL 253
L+ LS+ N L+ LP + L L +L + EN+ P F L L
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLL---LQENSLY-TIPKGFFGSHLLPFAFLH 203
Query: 254 GN 255
GN
Sbjct: 204 GN 205
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-18
Identities = 55/238 (23%), Positives = 87/238 (36%), Gaps = 44/238 (18%)
Query: 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR 754
K + F M GQG+FG V G M+VA+K + R + + + L +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77
Query: 755 HRNLIK---IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLN 811
H N+++ D ++ + +V EY+ + LH+
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDI-YLNVVMEYVP----DT-LHRCCRNYYRRQ----VAPP 127
Query: 812 LVIDVAF------AIEYLHHHCHPPIVHGDLKPSNVLLD-HDMVAHVGDFGLARFLPPCS 864
++ F +I LH + H D+KP NVL++ D + DFG A+ L P
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 865 PATILETPSSSTGIKGTVGYV------APEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
P V Y+ APE G T D++S G + EM
Sbjct: 187 P---------------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 52/221 (23%), Positives = 85/221 (38%), Gaps = 51/221 (23%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA---------ECEALRNIRHRN 757
+G G+FGFV+ E V VK + K++ ++ E L + H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 758 LIKIITVCSSIDFEEVDFKAIVYE-YMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
+IK++ + FE F +V E + L ++ + L +
Sbjct: 91 IIKVLDI-----FENQGFFQLVMEKHGSGLDLFAFI--------------DRHPRLDEPL 131
Query: 817 A---F-----AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATI 868
A F A+ YL I+H D+K N+++ D + DFG A +L +
Sbjct: 132 ASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKL 185
Query: 869 LETPSSSTGIKGTVGYVAPEYGMGGD-MSATGDVYSFGILL 908
T GT+ Y APE MG +++S G+ L
Sbjct: 186 FYTFC------GTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 7e-18
Identities = 57/224 (25%), Positives = 89/224 (39%), Gaps = 28/224 (12%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
N F ++G+G FG V + A K + +K+R + E + L +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
R + V + +E D +V M G L+ ++ F + + +
Sbjct: 244 RFV-----VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG----FPEARAVFYAAE 294
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPS 873
+ +E LH IV+ DLKP N+LLD H+ D GLA +P
Sbjct: 295 ICCGLEDLHRER---IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTI------- 342
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
G GTVGY+APE + + D ++ G LL EM + P
Sbjct: 343 --KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 37/235 (15%)
Query: 695 SKATNDFSSSNMIGQGSFGFVYRG-NLGENEMAVAVKVMNL-KQRGATKSFVAECEALRN 752
S AT+ + IG G++G VY+ + VA+K + + G +R
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHF-VALKSVRVPNGGGGGGGL--PISTVRE 61
Query: 753 I---------RHRNLIKIITVCSSIDFEEVDFKAIVYEYMEC---GSLEDWLHQSNDQLE 800
+ H N+++++ VC++ + +V+E+++ L+
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAET 121
Query: 801 VGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860
+ + + Q L +++LH +C IVH DLKP N+L+ + DFGLAR
Sbjct: 122 IKDL-MRQFLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 170
Query: 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRR 915
+ T + T+ Y APE + + D++S G + EMF R+
Sbjct: 171 SY---------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 52/244 (21%), Positives = 85/244 (34%), Gaps = 51/244 (20%)
Query: 672 HKHKSSSMLLMEQQFPMVSYADLSKATNDFSS-----SNMIGQGSFGFVYRGNLGENEMA 726
H H SS + L + ++ +F++ S +G+G F V +
Sbjct: 4 HHHHSSGVDLGTENL-------YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQE 56
Query: 727 VAVKVMNLKQRGAT--KSFVAECEALRNIRHR-NLIKIITVCSSIDFEEVDFKAIVYEYM 783
A K + ++RG + E L + +I + V +E ++ EY
Sbjct: 57 YAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV-----YENTSEIILILEYA 111
Query: 784 ECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL 843
G + + + L+ + + YLH + IVH DLKP N+LL
Sbjct: 112 AGGEIFSLCLPELA----EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILL 164
Query: 844 DHD------MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPE------YGM 891
+ DFG++R + A L I GT Y+APE
Sbjct: 165 SSIYPLGDIKIV---DFGMSRKI---GHACELRE------IMGTPEYLAPEILNYDPITT 212
Query: 892 GGDM 895
DM
Sbjct: 213 ATDM 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 63/225 (28%), Positives = 92/225 (40%), Gaps = 43/225 (19%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRHRNLIKIIT 763
+G G+FG V G VAVK++N ++ E + L+ RH ++IK+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA------ 817
V I F +V EY+ G L D++ + + A
Sbjct: 79 V---ISTPTDFF--MVMEYVSGGELFDYI--------------CKHGRVEEMEARRLFQQ 119
Query: 818 --FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
A++Y H H +VH DLKP NVLLD M A + DFGL+ + S L T
Sbjct: 120 ILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTSC-- 171
Query: 876 TGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTD 919
G+ Y APE G D++S G++L + P D
Sbjct: 172 ----GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 62/283 (21%), Positives = 103/283 (36%), Gaps = 64/283 (22%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN------LKQRGATKSFVAECEALRN 752
DF ++G+GSF V A+K++ + E + +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT---RERDVMSR 86
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLN- 811
+ H +K+ + F++ + Y + G L I+++
Sbjct: 87 LDHPFFVKLY--FT---FQDDEKLYFGLSYAKNGEL---------------LKYIRKIGS 126
Query: 812 LVIDVA-F-------AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLP 861
F A+EYLH I+H DLKP N+LL+ DM H+ DFG A+ L
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDM--HIQITDFGTAKVLS 181
Query: 862 PCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921
P S + GT YV+PE + D+++ G ++ ++ P
Sbjct: 182 PESKQARANS------FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP---- 231
Query: 922 FNDGLTLHEFAKMA---------LPEKVMEIVDPLLLLDLEAR 955
F G F K+ K ++V+ LL+LD R
Sbjct: 232 FRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 274
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 48/226 (21%), Positives = 86/226 (38%), Gaps = 29/226 (12%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT-KSFVAECEAL-RNIRHR 756
ND + +G G+ G V++ + +AVK M K + + + + ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
I C D I E M + + E ++ ++ + +
Sbjct: 85 Y----IVQCFGTFITNTDVF-IAMELMGTCAEKLKKRMQGPIPE----RILGKM--TVAI 133
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
A+ YL ++H D+KPSN+LLD + DFG++ +++ +
Sbjct: 134 VKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS--------GRLVDDKAKDR 183
Query: 877 GIKGTVGYVAPE-----YGMGGDMSATGDVYSFGILLLEMFTRRRP 917
G Y+APE D DV+S GI L+E+ T + P
Sbjct: 184 SA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 57/236 (24%), Positives = 97/236 (41%), Gaps = 51/236 (21%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
+ F IG+GSFG V + + A+K MN +R ++ E + ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNL--- 812
L+ + S F++ + +V + + G L +Q+
Sbjct: 75 PFLVNLW--YS---FQDEEDMFMVVDLLLGGDL---------------RYHLQQNVHFKE 114
Query: 813 ------VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPA 866
+ ++ A++YL + I+H D+KP N+LLD H+ DF +A LP +
Sbjct: 115 ETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI 171
Query: 867 TILETPSSSTGIKGTVGYVAPE-----YGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T T + GT Y+APE G G + D +S G+ E+ RRP
Sbjct: 172 T---TMA------GTKPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRRP 216
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 50/232 (21%), Positives = 98/232 (42%), Gaps = 25/232 (10%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT-KSFVAECE-ALRNIRHR 756
+D +G+G++G V + + +AVK + K + + + ++R +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
F E D I E M+ SL+ + Q D+ + +++ ++ + +
Sbjct: 67 F----TVTFYGALFREGDVW-ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKI--AVSI 118
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
A+E+LH ++H D+KPSNVL++ + DFG++ +L ++ +
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--------VDDVAKDI 168
Query: 877 GIKGTVGYVAPE----YGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFND 924
G Y+APE S D++S GI ++E+ R P D+
Sbjct: 169 DA-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 2e-17
Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 38/220 (17%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKII 762
IG+G++G VY+ E A+K + L++ G + + E L+ ++H N++K+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFN--VIQRLNLVIDVAFAI 820
V + ++ +V+E+++ L+ L LE ++Q LN I
Sbjct: 67 DVIHT---KKRLV--LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN-------GI 113
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR-FLPPCSPAT---ILETPSSST 876
Y H ++H DLKP N+L++ + + DFGLAR F P T +
Sbjct: 114 AYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-------- 162
Query: 877 GIKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
T+ Y AP+ MG +T D++S G + EM
Sbjct: 163 ----TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-17
Identities = 61/230 (26%), Positives = 93/230 (40%), Gaps = 39/230 (16%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAE---CEALRN 752
NDFS +IG+G FG VY + A+K ++ +K + + E +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNL 812
+ VC S F D + + + M G L L Q G F+
Sbjct: 249 GDCPFI-----VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH------GVFSEADMRFY 297
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILE 870
++ +E++H+ +V+ DLKP+N+LLD HV D GLA P +
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHASV- 351
Query: 871 TPSSSTGIKGTVGYVAPE---YGMGGDMSATGDVYSFGILLLEMFTRRRP 917
GT GY+APE G+ D SA D +S G +L ++ P
Sbjct: 352 ---------GTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSP 390
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-17
Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNL--KQRGATKSFVAECEALRNIRHRNLIK---I 761
+G+G++G V VA+K + K A ++ E + L++ +H N+I I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHENIITIFNI 77
Query: 762 ITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQ--SNDQLEVGNFNVI--QRLNLVIDVA 817
S +F EV I+ E M+ D LH+ S L + Q L
Sbjct: 78 QRPDSFENFNEV---YIIQELMQT----D-LHRVISTQMLSDDHIQYFIYQTLR------ 123
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS-- 875
A++ LH ++H DLKPSN+L++ + V DFGLAR + + T S
Sbjct: 124 -AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 876 TGIKGTVGYVAPEYGMGGDMSATG--DVYSFGILLLEMFTRR 915
T Y APE M + DV+S G +L E+F RR
Sbjct: 180 VEFVATRWYRAPEV-MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 3e-17
Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 707 IGQGSFGFVY--RGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITV 764
+G+G++G VY + G+++ A+K ++ G + S E LR ++H N+I + V
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALK--QIEGTGISMSACREIALLRELKHPNVISLQKV 86
Query: 765 CSSIDFEEVDFKAIVYEYMEC--GSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEY 822
S +V ++++Y E + + S + +L+ + I Y
Sbjct: 87 FLSHADRKV---WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 823 LHHHCHPPIVHGDLKPSNVLLDHDMVAH----VGDFGLAR-FLPPCSPATILETPSSSTG 877
LH + ++H DLKP+N+L+ + + D G AR F P L+ +
Sbjct: 144 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP------LKPLADLDP 194
Query: 878 IKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
+ T Y APE +G D+++ G + E+ T
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-17
Identities = 51/239 (21%), Positives = 96/239 (40%), Gaps = 47/239 (19%)
Query: 695 SKATNDFSSSNMIGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGATKSFVAECE----- 748
+A + IG+G++G V++ +L VA+K + ++ E
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---------GEEGMPLS 57
Query: 749 ALRNI---------RHRNLIKIITVCSSIDFEEVDFKAIVYEYMEC---GSLEDWLHQSN 796
+R + H N++++ VC+ + +V+E+++ L+
Sbjct: 58 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 117
Query: 797 DQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856
+ + + Q L +++LH H +VH DLKP N+L+ + DFGL
Sbjct: 118 PTETIKDM-MFQLLR-------GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 166
Query: 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRR 915
AR + T + T+ Y APE + + D++S G + EMF R+
Sbjct: 167 ARIYSF---------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 57/248 (22%), Positives = 87/248 (35%), Gaps = 65/248 (26%)
Query: 707 IGQGSFGFVYRGNLGENEM---AVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIIT 763
IG G+FG L +++ VAVK + + ++ E R++RH N+++
Sbjct: 28 IGSGNFGVAR---LMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 764 VCSS---IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA--- 817
V + + AI+ EY G L + + D A
Sbjct: 84 VILTPTHL--------AIIMEYASGGELYER--------------ICNAGRFSEDEARFF 121
Query: 818 F-----AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAH--VGDFGLARFLPPCSPATILE 870
F + Y H I H DLK N LLD + DFG ++ S +
Sbjct: 122 FQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PK 175
Query: 871 TPSSSTGIKGTVGYVAPEYGMG----GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGL 926
+ GT Y+APE + G DV+S G+ L M P F D
Sbjct: 176 STV------GTPAYIAPEVLLRQEYDG---KIADVWSCGVTLYVMLVGAYP----FEDPE 222
Query: 927 TLHEFAKM 934
++ K
Sbjct: 223 EPRDYRKT 230
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 53/234 (22%), Positives = 89/234 (38%), Gaps = 29/234 (12%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT-KSFVAECE-ALRNIRHR 756
D IG+G++G V + + +AVK + K + + + +R+
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVG-NFNVIQRLNLVID 815
I F E D I E M S + + L+ ++ ++ +
Sbjct: 82 Y----IVQFYGALFREGDCW-ICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKI--TLA 133
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
A+ +L + I+H D+KPSN+LLD + DFG+ + L +
Sbjct: 134 TVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGI---------SGQLVDSIAK 182
Query: 876 TGIKGTVGYVAPE----YGMGGDMSATGDVYSFGILLLEMFTRRRP---TDNMF 922
T G Y+APE DV+S GI L E+ T R P +++F
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 52/234 (22%), Positives = 89/234 (38%), Gaps = 53/234 (22%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA-------ECEALRNIRHR--N 757
+G G FG VY G + + VA+K + K R + + E L+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYME-CGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
+I+++ FE D ++ E E L D++ +R L ++
Sbjct: 110 VIRLLDW-----FERPDSFVLILERPEPVQDLFDFI--------------TERGALQEEL 150
Query: 817 A---F-----AIEYLHHHCHPPIVHGDLKPSNVLLDHD-MVAHVGDFGLARFLPPCSPAT 867
A F A+ + H+ ++H D+K N+L+D + + DFG L T
Sbjct: 151 ARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD----T 203
Query: 868 ILETPSSSTGIKGTVGYVAPEYGMGGD-MSATGDVYSFGILLLEMFTRRRPTDN 920
+ GT Y PE+ + V+S GILL +M P ++
Sbjct: 204 VYTDFD------GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 48/234 (20%), Positives = 78/234 (33%), Gaps = 70/234 (29%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-------HRNLI 759
+G+G + V+ N V VK++ V + + R I+ N+I
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKP---------VKKKKIKREIKILENLRGGPNII 94
Query: 760 KII-TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
+ V + + D Q + Q L D+ F
Sbjct: 95 TLADIVKDPVSRTPA---LVFEHVNNT----D-FKQ-----------LYQTLTD-YDIRF 134
Query: 819 -------AIEYLHHHCHPPIVHGDLKPSNVLLDHD-MVAHVGDFGLARFLPPCSPATILE 870
A++Y H I+H D+KP NV++DH+ + D+GLA F P
Sbjct: 135 YMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN--- 188
Query: 871 TPSSSTGIKGTVGYV------APEYGMGGDM-SATGDVYSFGILLLEMFTRRRP 917
V PE + M + D++S G +L M R+ P
Sbjct: 189 ------------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 7e-17
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 31/227 (13%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
+ F ++G+G FG V+ + A K +N LK+R + + E + L +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
R + V + FE +V M G + H N + F + +
Sbjct: 245 RFI-----VSLAYAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPS 873
+ +E+LH I++ DLKP NVLLD D +V D GLA E +
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDD--GNVRISDLGLAV-----------ELKA 341
Query: 874 SSTGIK---GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T K GT G++APE +G + + D ++ G+ L EM R P
Sbjct: 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 48/239 (20%)
Query: 693 DLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA-----EC 747
D+ + + +G+G F VY+ VA+K + L R K + E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 748 EALRNIRHRNLIK---IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL---EV 801
+ L+ + H N+I S+I ++V+++ME LE + ++ L +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNI--------SLVFDFMET-DLEVIIKDNSLVLTPSHI 114
Query: 802 GNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR-FL 860
+ ++ L +EYLH H I+H DLKP+N+LLD + V + DFGLA+ F
Sbjct: 115 KAY-MLMTLQ-------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163
Query: 861 PPCSPAT---ILETPSSSTGIKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
P T + T Y APE G M G D+++ G +L E+ R
Sbjct: 164 SPNRAYTHQVV------------TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 65/229 (28%), Positives = 99/229 (43%), Gaps = 51/229 (22%)
Query: 707 IGQGSFGFVYRGNLGENEM---AVAVKVMNLKQRGATKSFVA----ECEALRNIRHRNLI 759
+G G+FG V +G++E+ VAVK++N +Q+ + V E + L+ RH ++I
Sbjct: 24 LGVGTFGKVK---VGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA-- 817
K+ V I F +V EY+ G L D++ + L +
Sbjct: 80 KLYQV---ISTPSDIF--MVMEYVSGGELFDYI--------------CKNGRLDEKESRR 120
Query: 818 ------FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILET 871
++Y H H +VH DLKP NVLLD M A + DFGL+ + S L T
Sbjct: 121 LFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRT 174
Query: 872 PSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTD 919
G+ Y APE G D++S G++L + P D
Sbjct: 175 SC------GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 48/203 (23%), Positives = 78/203 (38%), Gaps = 40/203 (19%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVC 765
+G G G V + + A+K++ A + E E + ++++I+ V
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDV- 123
Query: 766 SSIDFEEVDFKA----IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
+E + IV E ++ G L + DQ F + ++ + AI+
Sbjct: 124 ----YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQ 175
Query: 822 YLHHHCHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
YLH I H D+KP N+L + + + DFG A+ + L TP
Sbjct: 176 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPC----- 224
Query: 879 KGTVGYVAPE------YGMGGDM 895
T YVAPE Y DM
Sbjct: 225 -YTPYYVAPEVLGPEKYDKSCDM 246
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 54/230 (23%), Positives = 98/230 (42%), Gaps = 46/230 (20%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIK 760
++ + +IG GSFG VY+ L ++ VA+K + +R + E + +R + H N+++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 761 IITV-CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF- 818
+ SS + ++ + +V +Y+ E +++ Q L ++ +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVP----ET-VYRVARHYSRAK----QTLPVIYVKLYM 162
Query: 819 -----AIEYLHHHCHPPIVHGDLKPSNVLLDHDM-VAHVGDFGLARFLPPCSPATILETP 872
++ Y+H I H D+KP N+LLD D V + DFG A+ L P
Sbjct: 163 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV----- 214
Query: 873 SSSTGIKGTVGYV------APEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
Y+ APE G + DV+S G +L E+ +
Sbjct: 215 ----------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 37/218 (16%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITV 764
+G+GS+G V + + VA+K + K + E + L+ +RH NL+ ++ V
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 765 CSSIDFEEVDFKA---IVYEYMECGSLEDWLHQSNDQL---EVGNFNVIQRLNLVIDVAF 818
C K +V+E+++ ++ D L + L V + + Q +N
Sbjct: 93 CKK--------KKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKY-LFQIIN------- 135
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
I + H H I+H D+KP N+L+ V + DFG AR L +P +
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVY------DDE 184
Query: 879 KGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
T Y APE +G DV++ G L+ EMF
Sbjct: 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 53/226 (23%)
Query: 707 IGQGSFGFVYRG-NLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIIT 763
IG+GS+G V++ N ++ VA+K + K + E L+ ++H NL+ ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQI-VAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 764 VCSSIDFEEVDFKA---IVYEYMECGSLEDWLHQSNDQL---EVGNFNVIQRLNLVIDVA 817
V K +V+EY + ++ L + + V + Q L
Sbjct: 70 VFRR--------KRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSI-TWQTLQ------ 113
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR-FLPPCSPATILETPSSST 876
A+ + H H +H D+KP N+L+ V + DFG AR P
Sbjct: 114 -AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD--------- 160
Query: 877 GIKGTVGYV------APEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
V +PE +G DV++ G + E+ +
Sbjct: 161 ------DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 52/237 (21%), Positives = 88/237 (37%), Gaps = 55/237 (23%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA-------ECEALRNIR---- 754
++G+G FG V+ G+ + + VA+KV+ + R S ++ E L +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYME-CGSLEDWLHQSNDQLEVGNFNVIQRLNLV 813
H +I+++ FE + +V E L D++ ++ L
Sbjct: 97 HPGVIRLLDW-----FETQEGFMLVLERPLPAQDLFDYI--------------TEKGPLG 137
Query: 814 IDVA---F-----AIEYLHHHCHPPIVHGDLKPSNVLLDHDM-VAHVGDFGLARFLPPCS 864
+ F AI++ H +VH D+K N+L+D A + DFG L
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-- 192
Query: 865 PATILETPSSSTGIKGTVGYVAPEYGMGGD-MSATGDVYSFGILLLEMFTRRRPTDN 920
GT Y PE+ + V+S GILL +M P +
Sbjct: 193 --EPYTDFD------GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 52/230 (22%), Positives = 98/230 (42%), Gaps = 41/230 (17%)
Query: 699 NDFSSSNMIGQGSFGFVYRG-NLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRH 755
+ + +G+G++G VY+ + NE VA+K + L+ G + + E L+ ++H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNET-VAIKRIRLEHEEEGVPGTAIREVSLLKELQH 92
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
RN+I++ +V +++EY E L+ ++ ++ + ++ + +
Sbjct: 93 RNIIELKSVIHH---NHRLH--LIFEYAEN-DLKKYMDKN------PDVSMRVIKSFLYQ 140
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG-----DFGLAR-FLPPCSPAT-- 867
+ + + H +H DLKP N+LL + DFGLAR F P T
Sbjct: 141 LINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197
Query: 868 -ILETPSSSTGIKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
I T+ Y PE +G +T D++S + EM +
Sbjct: 198 II------------TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 56/237 (23%), Positives = 92/237 (38%), Gaps = 54/237 (22%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
+DF +IG+G+F V + + A+K+MN + +RG F E + L N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
R + ++ + F++ ++ +V EY G L ++ + I
Sbjct: 121 RWITQLH--FA---FQDENYLYLVMEYYVGGDL---------------LTLLSKFGERIP 160
Query: 816 ----------VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPC 863
+ AI+ +H VH D+KP N+LLD H+ DFG C
Sbjct: 161 AEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC--GHIRLADFGS------C 209
Query: 864 SPATILETPSSSTGIKGTVGYVAPE--YGMGGDMSATG-----DVYSFGILLLEMFT 913
T S + GT Y++PE +GG D ++ G+ EMF
Sbjct: 210 LKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 42/224 (18%)
Query: 707 IGQGSFGFVYRGNLGENEM---AVAVKVMNLKQRGATKSFVA----ECEALRNIRHRNLI 759
+G+GSFG V L + VA+K ++ +Q E L+ +RH ++I
Sbjct: 17 LGEGSFGKVK---LATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMEC--GSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
K+ V ++ + +E G L D++ +E + +
Sbjct: 73 KLYDVITT--------PTDIVMVIEYAGGELFDYI------VEKKRMTEDEGRRFFQQII 118
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
AIEY H H IVH DLKP N+LLD ++ + DFGL+ + L+T
Sbjct: 119 CAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT---DGNFLKTSC---- 168
Query: 878 IKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEMFTRRRPTD 919
G+ Y APE G DV+S GI+L M R P D
Sbjct: 169 --GSPNYAAPEVINGKLYAGPEV-DVWSCGIVLYVMLVGRLPFD 209
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 49/227 (21%), Positives = 74/227 (32%), Gaps = 43/227 (18%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVK--VMNLKQRGATKSFVAECEALRNIR---------H 755
I GS+G V G E VA+K + R +R H
Sbjct: 30 ISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 756 RNLIK---IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVI--QRL 810
N++ I ++ +V E M L +H + + L
Sbjct: 89 PNILGLRDIFVHFEEPAMHKL---YLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
+ LH +VH DL P N+LL + + DF LAR
Sbjct: 145 L-------GLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAR---------EDT 185
Query: 871 TPSSSTGIKGTVGYVAPEYGMGGDMSATG--DVYSFGILLLEMFTRR 915
++ T Y APE + T D++S G ++ EMF R+
Sbjct: 186 ADANKTHYVTHRWYRAPEL-VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 36/227 (15%)
Query: 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVK-VMNL--KQRGATKSFVAECEALRNIR 754
+ + IG G+ G V E VA+K + Q A +++ E ++ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 82
Query: 755 HRNLIKIITV----CSSIDFEEVDFKAIVYEYMECGSLEDWLHQ--SNDQLEVGNFNVIQ 808
H+N+I ++ V S +F++V IV E M+ +L + ++++ + + Q
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDV---YIVMELMDA-NLCQVIQMELDHERMS---YLLYQ 135
Query: 809 RLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATI 868
L I++LH I+H DLKPSN+++ D + DFGLAR
Sbjct: 136 MLC-------GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------T 176
Query: 869 LETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRR 915
T T T Y APE +G D++S G ++ EM
Sbjct: 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 32/217 (14%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGAT---KSFVAECEALRNIRHRN 757
FS IG GSFG VY N VA+K M+ + + + + E L+ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
I+ + +V EY GS D L L+ +
Sbjct: 116 TIQYRG-----CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTH-----GAL 164
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+ YLH H ++H D+K N+LL + +GDFG A + + + +
Sbjct: 165 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIM----APANS 209
Query: 878 IKGTVGYVAPEYGMGGDMSATG---DVYSFGILLLEM 911
GT ++APE + D DV+S GI +E+
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 6e-16
Identities = 54/249 (21%), Positives = 90/249 (36%), Gaps = 42/249 (16%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNL--KQRGATKSFVAECEALRNIRHRNLIKIITV 764
IG GS+G V + VA+K + + K + E L + H +++K++ +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQ---SNDQLEVGNFNVI--QRLNLVIDVAFA 819
D E+ D +V E + D + + L + + L
Sbjct: 121 VIPKDVEKFDELYVVLEIADS----D-FKKLFRTPVYLTELHIKTLLYNLLV-------G 168
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
++Y+H I+H DLKP+N L++ D V DFGLAR + S
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 880 GTV-------------GYV------APEYGMGGDM-SATGDVYSFGILLLEMFTRRRPTD 919
V G+V APE + + + DV+S G + E+ +
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 920 NMFNDGLTL 928
D L
Sbjct: 286 AYHADRGPL 294
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 54/230 (23%), Positives = 102/230 (44%), Gaps = 47/230 (20%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIK 760
+++ +IG GSFG V++ L E++ VA+K + +R + E + +R ++H N++
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR----ELQIMRIVKHPNVVD 96
Query: 761 IITV-CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF- 818
+ S+ D ++ F +V EY+ E +++++ Q + +++ +
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYVP----ET-VYRASRHYAKLK----QTMPMLLIKLYM 147
Query: 819 -----AIEYLHHHCHPPIVHGDLKPSNVLLDHDM-VAHVGDFGLARFLPPCSPATILETP 872
++ Y+H I H D+KP N+LLD V + DFG A+ L P
Sbjct: 148 YQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP------- 197
Query: 873 SSSTGIKGTVGYV------APEYGMGGDMSATG-DVYSFGILLLEMFTRR 915
V Y+ APE G T D++S G ++ E+ +
Sbjct: 198 --------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 56/240 (23%), Positives = 95/240 (39%), Gaps = 59/240 (24%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR----------HR 756
+G+G++G V++ VAVK + +F +A R R H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQ-------SNDQLEVGNFNVIQR 809
N++ ++ V + + +V +V++YME D LH + + V Q
Sbjct: 70 NIVNLLNVLRADNDRDV---YLVFDYMET----D-LHAVIRANILEPVHKQ---YVVYQL 118
Query: 810 LNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATIL 869
+ I+YLH ++H D+KPSN+LL+ + V DFGL+R T
Sbjct: 119 IK-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 870 ETPSSSTGIKGTV-------GYV------APEYGMGGDM-SATGDVYSFGILLLEMFTRR 915
S + + YV APE +G + D++S G +L E+ +
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 55/185 (29%), Positives = 78/185 (42%), Gaps = 13/185 (7%)
Query: 416 NLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR---GHVPSSLGNCQNLMLLSVSN 472
+ + LDL N L ++ LT L L L NKL+ + L N L L V++
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKN---LETLWVTD 94
Query: 473 NKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLSENRFSNEIPVS 531
NKL ALP + + L L N L S+P V +L L L L N + +P
Sbjct: 95 NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKG 151
Query: 532 L-SACTTLEYLYMEGNSLTGSIPL-ALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYL 589
+ T+L+ L + N L +P A L +K L L N L ++L L+ L
Sbjct: 152 VFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210
Query: 590 NLSYN 594
L N
Sbjct: 211 QLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 30/171 (17%)
Query: 461 NCQNLMLLSV-------------SNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAE 507
+C + L ++ +NKL+ +LP + +T LL L+ N L ++PA
Sbjct: 22 DCSSKKLTAIPSNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAG 79
Query: 508 V-GNLKNLVQLGLSENRFS---NEIPVSLSACTTLEYLYMEGNSLTGSIPL-ALKTLKSI 562
+ LKNL L +++N+ + L L L ++ N L S+P +L +
Sbjct: 80 IFKELKNLETLWVTDNKLQALPIGVFDQL---VNLAELRLDRNQLK-SLPPRVFDSLTKL 135
Query: 563 KELDLSRNNLSGQIPE--FLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTR 611
L L N L +P+ F + L+ L+ L L N L+ VP G F T
Sbjct: 136 TYLSLGYNELQ-SLPKGVF-DKLTSLKELRLYNNQLK-RVP-EGAFDKLTE 182
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 52/254 (20%), Positives = 86/254 (33%), Gaps = 76/254 (29%)
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFN-ISSLESISLLGN 255
++ + L + N+LS + +L L L +++N + P+ IF + +LE++ + N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL-PAGIFKELKNLETLWVTDN 95
Query: 256 RLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFN 315
+L+ +LP+ + L NL L + +N SLP + F+
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRV-----------------------FD 130
Query: 316 RLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTI 375
L L LS N L + L +F
Sbjct: 131 SLTKLTYLSLGYNELQS----------------------LPKGVF--------------- 153
Query: 376 ILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESL 435
L +L L NQL A +L L+ L L +N L +
Sbjct: 154 ------------DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAF 201
Query: 436 GNLTILNSLDLGFN 449
+L L L L N
Sbjct: 202 DSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 44/174 (25%), Positives = 71/174 (40%), Gaps = 7/174 (4%)
Query: 158 NNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSI-GNISNLQVLSIGENRLSGRLPDS 216
+N + +P + KL L L DN L L I + NL+ L + +N+L
Sbjct: 46 SNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGV 104
Query: 217 LGQLRSLYYLSISENAFSGMFPSSIF-NISSLESISLLGNRLEGSLPVNIGFSLPNLENL 275
QL +L L + N P +F +++ L +SL N L+ SLP + L +L+ L
Sbjct: 105 FDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKEL 162
Query: 276 SVRQNNYTGSLPHSL-SNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKN 328
+ N +P + L+ L N + F+ L L L +N
Sbjct: 163 RLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 53/261 (20%), Positives = 100/261 (38%), Gaps = 51/261 (19%)
Query: 670 RKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAV 729
RK+K+ + + + + + D+ +IG+G+FG V A+
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKA--EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 730 KVMN---LKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECG 786
K+++ + +R + F E + + ++++ + F++ + +V EYM G
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYA---FQDDRYLYMVMEYMPGG 154
Query: 787 SLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA-F-------AIEYLHHHCHPPIVHGDLKP 838
L N++ ++ A F A++ +H +H D+KP
Sbjct: 155 DL---------------VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKP 196
Query: 839 SNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPE--YGMGGD 894
N+LLD H+ DFG + T + GT Y++PE GGD
Sbjct: 197 DNMLLDKS--GHLKLADFGTCMKMNK------EGMVRCDTAV-GTPDYISPEVLKSQGGD 247
Query: 895 MSATGDV--YSFGILLLEMFT 913
+ +S G+ L EM
Sbjct: 248 GYYGRECDWWSVGVFLYEMLV 268
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-15
Identities = 52/235 (22%), Positives = 90/235 (38%), Gaps = 52/235 (22%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
DF +IG+G+FG V L + A+K++N + +R T F E + L N
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
+ + + + F++ + +V +Y G L ++ + +
Sbjct: 134 KWITTLH--YA---FQDDNNLYLVMDYYVGGDL---------------LTLLSKFEDRLP 173
Query: 816 ----------VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPC 863
+ AI+ +H VH D+KP N+L+D + H+ DFG C
Sbjct: 174 EEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMN--GHIRLADFGS------C 222
Query: 864 SPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATG-----DVYSFGILLLEMFT 913
T SS + GT Y++PE + D +S G+ + EM
Sbjct: 223 LKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 55/314 (17%), Positives = 100/314 (31%), Gaps = 64/314 (20%)
Query: 320 LFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFG--GVLPLSIANLSSTIIL 377
+ S + + + A L ++ + L N G LS ++S L
Sbjct: 6 IEGKSLKLDAIT--TEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN-IASKKDL 62
Query: 378 FSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNL--DG--HIPE 433
+ I+ + + L + A+ + L + L N + +
Sbjct: 63 EIAEFSDIFTGRVKDEIPEALRL------LLQALLKCPKLHTVRLSDNAFGPTAQEPLID 116
Query: 434 SLGNLTILNSLDLGFNKL-------------RGHVPSSLGNCQNLMLLSVSNNKLTGALP 480
L T L L L N L V N L + N+L
Sbjct: 117 FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG-- 174
Query: 481 PQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNE-----IPVSLSAC 535
+ + + + L + + +N E + L+ C
Sbjct: 175 ----SMKEWAKTF---------------QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215
Query: 536 TTLEYLYMEGNSLT--GSIPLA--LKTLKSIKELDLSRNNLSGQ----IPEFLENLSF-- 585
L+ L ++ N+ T GS LA LK+ +++EL L+ LS + + + L
Sbjct: 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG 275
Query: 586 LEYLNLSYNHLEGE 599
L+ L L YN +E +
Sbjct: 276 LQTLRLQYNEIELD 289
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 52/318 (16%), Positives = 101/318 (31%), Gaps = 73/318 (22%)
Query: 318 PNLFRLSFSKNNLGTG---AIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSST 374
++ + S N +GT + + + + LE G V L
Sbjct: 32 DSVKEIVLSGNTIGTEAARWLSEN-----IASKKDLEIAEFSDIFTGRVKDEIPEALRL- 85
Query: 375 IILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGEL----RNLQVLDLHHNNL--- 427
+L ++ L + L N + + L+ L LH+N L
Sbjct: 86 -LLQALLKC----PKLHTVR---LSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ 137
Query: 428 ----------DGHIPESLGNLTILNSLDLGFNKLRG----HVPSSLGNCQNLMLLSVSNN 473
+ + + N L S+ G N+L + + + L + + N
Sbjct: 138 AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQN 197
Query: 474 KLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNE----IP 529
+ GI L +L L+ + L L L +N F++ +
Sbjct: 198 GIRPE------GIEHL-LLEGLAYC-------------QELKVLDLQDNTFTHLGSSALA 237
Query: 530 VSLSACTTLEYLYMEGNSLT--GSIPL--ALKTL--KSIKELDLSRNNLSGQ----IPEF 579
++L + L L + L+ G+ + A L ++ L L N + +
Sbjct: 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297
Query: 580 L-ENLSFLEYLNLSYNHL 596
+ E + L +L L+ N
Sbjct: 298 IDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 58/369 (15%), Positives = 109/369 (29%), Gaps = 89/369 (24%)
Query: 96 VGNLSFLRFINFANNGFSGEIPGEIGRLFR----LETLILANNSFSGK----IPSNLSRC 147
+ S + + + + E + + ++ ++L+ N+ + + N++
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 148 SNL--INFHARGNNLVGQIPPDIGYSWLK-------LEFLSLRDNLL----AGQLAPSIG 194
+L F V P+ L+ L + L DN L +
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLG 254
+ L+ L + N L G I+ N L SI
Sbjct: 120 KHTPLEHLYLHNNGLG----PQAGA-------KIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 255 NRLEGSLPVNIGFSL---PNLENLSVRQNNYT-----GSLPHSLSNASNLRLLDFSLNHF 306
NRLE + L + + QN L L+ L++LD N F
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
Query: 307 SGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFG--GVL 364
+ +LG+ A+ L + L LGL+ + G
Sbjct: 229 T---------------------HLGSSALAIA-----LKSWPNLRELGLNDCLLSARGAA 262
Query: 365 PLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGE-----LRNLQV 419
+ A +++ L L L+YN++ + + +L
Sbjct: 263 AVVDA------------FSKLENIGLQTLR---LQYNEIELDAVRTLKTVIDEKMPDLLF 307
Query: 420 LDLHHNNLD 428
L+L+ N
Sbjct: 308 LELNGNRFS 316
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 46/234 (19%)
Query: 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVK-VMNLKQRGATKSFVAECEALRNIRHR 756
+++ + IG+G++G V N++ VA+K + + + + + E + L RH
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQ-------SNDQLEVGNFNVIQR 809
N+I I + + E++ IV + ME D L++ SND + + + Q
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMET----D-LYKLLKTQHLSNDHIC---YFLYQI 137
Query: 810 LNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATIL 869
L ++Y+H ++H DLKPSN+LL+ + DFGLAR P T
Sbjct: 138 LR-------GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 870 ETPSSSTGIKGTVGYV------APEYGMGGDMSATG--DVYSFGILLLEMFTRR 915
T YV APE M T D++S G +L EM + R
Sbjct: 188 LT-----------EYVATRWYRAPEI-MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 5e-15
Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 43/243 (17%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVK-VMNLKQRGA-TKSFVAECEALRNIRHRNLIKIITV 764
IG+GS+G+VY E VA+K V + + K + E L ++ +I++ +
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 765 C---SSIDFEEVDFKAIVYEYMECGSLEDWLHQ---SNDQLEVGNFNVI--QRLNLVIDV 816
+ F+E+ IV E + D L + + L + I L
Sbjct: 94 IIPDDLLKFDEL---YIVLEIADS----D-LKKLFKTPIFLTEEHIKTILYNLLL----- 140
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
++H I+H DLKP+N LL+ D V DFGLAR + I+ +
Sbjct: 141 --GENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 877 GIKGTV--------GYV------APEYGMGGDM-SATGDVYSFGILLLEMFTRRRPTDNM 921
+V APE + + + + D++S G + E+ + N
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 922 FND 924
+
Sbjct: 256 PTN 258
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 55/230 (23%), Positives = 87/230 (37%), Gaps = 44/230 (19%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN------LKQRGATKSFVAECEALRN 752
+ F +G GSFG V E+ A+K+++ LKQ T + E L+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---EKRILQA 97
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL---EVGNFNVIQR 809
+ L+K+ S D + V EY+ G + + H F Q
Sbjct: 98 VNFPFLVKLE--FSFKDNSNLYM---VMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQ- 149
Query: 810 LNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATIL 869
+ EYLH +++ DLKP N+L+D V DFG A+
Sbjct: 150 ------IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK----------- 189
Query: 870 ETPSSSTGIKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEMFTRRRP 917
+ + GT +APE G + + D ++ G+L+ EM P
Sbjct: 190 RVKGRTWTLCGTPEALAPEIILSKGYNKAV--DWWALGVLIYEMAAGYPP 237
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 6e-15
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 32/225 (14%)
Query: 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVK-VMNL--KQRGATKSFVAECEALRNIR 754
+ + IG G+ G V + VA+K + Q A +++ E ++ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 119
Query: 755 HRNLIKIITV----CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRL 810
H+N+I ++ V + +F++V +V E M+ +L + D + + Q L
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDV---YLVMELMDA-NLCQVIQMELDHERMSYL-LYQML 174
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
I++LH I+H DLKPSN+++ D + DFGLAR
Sbjct: 175 C-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAG 215
Query: 871 TPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRR 915
T T T Y APE +G D++S G ++ EM +
Sbjct: 216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 6e-15
Identities = 57/233 (24%), Positives = 94/233 (40%), Gaps = 29/233 (12%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVM---NLKQRGATKSFVAECEALRNIRH 755
N+F ++G+G+FG V A+K++ + + + E L+N RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
L + S F+ D V EY G L L + F+ + +
Sbjct: 208 PFLTALK--YS---FQTHDRLCFVMEYANGGELFFHLSRE------RVFSEDRARFYGAE 256
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+ A++YLH + +V+ DLK N++LD D + DFGL + I + +
Sbjct: 257 IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-------EGIKDGATMK 307
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP-----TDNMFN 923
T GT Y+APE D D + G+++ EM R P + +F
Sbjct: 308 T-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 48/234 (20%), Positives = 91/234 (38%), Gaps = 55/234 (23%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITV-- 764
+G G G V+ + + VA+K + L + K + E + +R + H N++K+ +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 765 -----CSSIDFEEVDFKAI--VYEYMECGSLEDWLHQ-------SNDQLEVGNFNVIQRL 810
+ + ++ V EYME D L + + Q L
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMET----D-LANVLEQGPLLEEHAR---LFMYQLL 130
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD-HDMVAHVGDFGLARFLPPCSPATIL 869
++Y+H ++H DLKP+N+ ++ D+V +GDFGLAR + P
Sbjct: 131 R-------GLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 870 ETPSSSTGIKGTVGYV------APEYGMGGDMSATG--DVYSFGILLLEMFTRR 915
+ + +P + + T D+++ G + EM T +
Sbjct: 181 LS-----------EGLVTKWYRSPRL-LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 47/232 (20%)
Query: 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN--LKQRGATKSFVAECEALRNIRH 755
+ S +G G++G V + VA+K ++ + K E L++++H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 756 RNLIKIITV----CSSIDFEEVDFKAIVYEYMECGSLEDWLHQ------SNDQLEVGNFN 805
N+I ++ V S +F + +V +M+ D L + S ++++ +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDF---YLVMPFMQT----D-LQKIMGLKFSEEKIQ---YL 131
Query: 806 VIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSP 865
V Q L ++Y+H +VH DLKP N+ ++ D + DFGLAR
Sbjct: 132 VYQMLK-------GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR------- 174
Query: 866 ATILETPSSSTGIKGTVGYVAPEYGMGGDMSATG--DVYSFGILLLEMFTRR 915
+ TG T Y APE + M D++S G ++ EM T +
Sbjct: 175 ----HADAEMTGYVVTRWYRAPEV-ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 60/237 (25%), Positives = 97/237 (40%), Gaps = 56/237 (23%)
Query: 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA------TKSFVAECEALR 751
+ + + +G G++G V + + VAVK K K E L+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLK 83
Query: 752 NIRHRNLIKIITV----CSSIDFEEVDFKAIVYEYMECGSLEDWLHQ-------SNDQLE 800
+++H N+I ++ V S +F +V +V M D L+ ++D ++
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGA----D-LNNIVKCQKLTDDHVQ 135
Query: 801 VGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860
F + Q L ++Y+H I+H DLKPSN+ ++ D + DFGLAR
Sbjct: 136 ---FLIYQILR-------GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-- 180
Query: 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATG--DVYSFGILLLEMFTRR 915
T TG T Y APE M M D++S G ++ E+ T R
Sbjct: 181 ---------HTADEMTGYVATRWYRAPEI-MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 57/230 (24%), Positives = 93/230 (40%), Gaps = 42/230 (18%)
Query: 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVK-VMN-LKQRGATKSFVAECEALRNIRH 755
+ +G G++G V G VA+K + + K E L+++RH
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 756 RNLIKIITV----CSSIDFEEVDFKAIVYEYMECGSLEDWLHQ--SNDQLEVGNFNVI-- 807
N+I ++ V + DF + +V +M D L + +++L +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDF---YLVMPFMGT----D-LGKLMKHEKLGEDRIQFLVY 135
Query: 808 QRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPAT 867
Q L + Y+H I+H DLKP N+ ++ D + DFGLAR
Sbjct: 136 QMLK-------GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--------- 176
Query: 868 ILETPSSSTGIKGTVGYVAPEYGMGGDMSATG--DVYSFGILLLEMFTRR 915
+ S TG T Y APE + M T D++S G ++ EM T +
Sbjct: 177 --QADSEMTGYVVTRWYRAPEV-ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 32/205 (15%), Positives = 62/205 (30%), Gaps = 29/205 (14%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPE-SLGNLTILNSLDLGFNKLRGHVP 456
L L HA L N+ + + + + S NL+ + +++ + ++
Sbjct: 38 LIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID 97
Query: 457 SS-LGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNL 514
L L L + N L + + +L+++ N SIP L N
Sbjct: 98 PDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE 157
Query: 515 VQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSG 574
L + N T S+ + + L++N
Sbjct: 158 -----------------------TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT 193
Query: 575 QIPE--FLENLSFLEYLNLSYNHLE 597
I + F S L++S +
Sbjct: 194 VIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 31/185 (16%), Positives = 62/185 (33%), Gaps = 13/185 (7%)
Query: 416 NLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKL 475
+ + ++ IP + +L L LR + N N+ + VS +
Sbjct: 12 QEEDFRVTCKDIQ-RIPSLPPSTQ---TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 476 TGALPPQIL-GIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLSENRFSNEIP--VS 531
L + ++ +++ I + L L LG+ P
Sbjct: 68 LQQLESHSFYNLSKVTH-IEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK 125
Query: 532 LSACTTLEYLYMEGNSLTGSIPL-ALKTLKS-IKELDLSRNNLSGQIPEFLENLSFLEYL 589
+ + L + N SIP+ A + L + L L N + + + N + L+ +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 590 NLSYN 594
L+ N
Sbjct: 185 YLNKN 189
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 38/277 (13%), Positives = 76/277 (27%), Gaps = 76/277 (27%)
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNR 256
+ Q L + E L +I +AFS + ++ I + +
Sbjct: 31 PSTQTLKLIETHLR----------------TIPSHAFSNL--------PNISRIYVSIDV 66
Query: 257 LEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNR 316
L + ++L + ++ +R +
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDA-----------------------LKE 103
Query: 317 LPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPL-SIANLSSTI 375
LP L L L DL + L + N + +P+ + L +
Sbjct: 104 LPLLKFLGIFNTGLKM--FPDLTKVYSTDI---FFILEITDNPYMTSIPVNAFQGLCN-- 156
Query: 376 ILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESL 435
+ L L N T + L + L+ N I +
Sbjct: 157 -------------ETLTLK---LYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDA 199
Query: 436 --GNLTILNSLDLGFNKLRGHVPS-SLGNCQNLMLLS 469
G + + LD+ + +PS L + + L+ +
Sbjct: 200 FGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 41/253 (16%), Positives = 72/253 (28%), Gaps = 61/253 (24%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEI-GRLFRLETLILANNSF 136
L L + I S NL + I + + ++ L ++ + + N
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT-- 90
Query: 137 SGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNI 196
NL I PD L
Sbjct: 91 ---------------------RNLT-YIDPDA--------LKEL---------------- 104
Query: 197 SNLQVLSIGENRLSGRLPD--SLGQLRSLYYLSISENAFSGMFPSSIFN--ISSLESISL 252
L+ L I L PD + + L I++N + P + F + ++ L
Sbjct: 105 PLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163
Query: 253 LGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLP-HSLSNA-SNLRLLDFSLNHFSGQV 310
N S+ F+ L+ + + +N Y + + S LLD S +
Sbjct: 164 YNNGFT-SVQGYA-FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT--- 218
Query: 311 KIDFNRLPNLFRL 323
+ L +L L
Sbjct: 219 ALPSKGLEHLKEL 231
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 9e-14
Identities = 65/232 (28%), Positives = 95/232 (40%), Gaps = 48/232 (20%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN------LKQRGATKSFVAECEALRN 752
DF +G GSFG V+ N A+KV+ LKQ T E L
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN---DERLMLSI 62
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL---EVGNFNVIQR 809
+ H +I++ + F++ ++ +Y+E G L + Q V F +
Sbjct: 63 VTHPFIIRMW--GT---FQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAE- 114
Query: 810 LNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPAT 867
V A+EYLH I++ DLKP N+LLD + H+ DFG A+
Sbjct: 115 ------VCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAK--------- 154
Query: 868 ILETPSSSTGIKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEMFTRRRP 917
P + + GT Y+APE + S D +SFGIL+ EM P
Sbjct: 155 --YVPDVTYTLCGTPDYIAPEVVSTKPYNKSI--DWWSFGILIYEMLAGYTP 202
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 44/251 (17%), Positives = 87/251 (34%), Gaps = 68/251 (27%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVK-VMNLKQRGATKSFVAECEALRNIRHRNLIKIITV- 764
+G GSFG V E+ A+K V+ + E + ++ + H N+IK++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-----NRELDIMKVLDHVNIIKLVDYF 69
Query: 765 -CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID-------- 815
+ + + + + + H + + LN++++
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK---YLNVIMEYVPDTLHK 126
Query: 816 ----------------VAF-------AIEYLHHHCHPPIVHGDLKPSNVLLD-HDMVAHV 851
++ A+ ++H I H D+KP N+L++ D +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKL 183
Query: 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYV------APEYGMGGDMSATG-DVYSF 904
DFG A+ L P P+ Y+ APE +G D++S
Sbjct: 184 CDFGSAKKLIPSEPSV---------------AYICSRFYRAPELMLGATEYTPSIDLWSI 228
Query: 905 GILLLEMFTRR 915
G + E+ +
Sbjct: 229 GCVFGELILGK 239
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 47/191 (24%), Positives = 73/191 (38%), Gaps = 22/191 (11%)
Query: 416 NLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR----GHVPSSLGNCQNLMLLSVS 471
+L L ++P+SL + T LDL N L P+ L N +L+L S
Sbjct: 19 ASNILSCSKQQLP-NVPQSLPSYT--ALLDLSHNNLSRLRAEWTPTRLTNLHSLLL---S 72
Query: 472 NNKLTGALPPQILGIVTLSIL--LDLSGNLLTGSIPAEV-GNLKNLVQLGLSENRFSNEI 528
+N L + + V + L LDLS N L ++ + +L+ L L L N
Sbjct: 73 HNHLN-FISSEAF--VPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVD 128
Query: 529 PVSLSACTTLEYLYMEGNSLTGSIP----LALKTLKSIKELDLSRNNLSGQIPEFLENLS 584
+ L+ LY+ N ++ P L + LDLS N L L+ L
Sbjct: 129 RNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLP 187
Query: 585 FLEYLNLSYNH 595
L ++
Sbjct: 188 AWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 38/156 (24%), Positives = 63/156 (40%), Gaps = 23/156 (14%)
Query: 461 NCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV--GNLKNLVQLG 518
+C L +V + LP LLDLS N L+ + AE L NL L
Sbjct: 24 SCSKQQLPNVPQS-----LPSYT-------ALLDLSHNNLS-RLRAEWTPTRLTNLHSLL 70
Query: 519 LSENRFSNEIPV-SLSACTTLEYLYMEGNSLTGSIP-LALKTLKSIKELDLSRNNLSGQI 576
LS N + I + L YL + N L ++ L++++ L L N++ +
Sbjct: 71 LSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VV 127
Query: 577 PEF-LENLSFLEYLNLSYNHLEGEVPRRGVFSNKTR 611
E+++ L+ L LS N + P + + +
Sbjct: 128 DRNAFEDMAQLQKLYLSQNQIS-RFP-VELIKDGNK 161
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 40/162 (24%), Positives = 63/162 (38%), Gaps = 11/162 (6%)
Query: 369 ANLSSTIILFSMGLNQIYV-------KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLD 421
+L S L + N + L NL+ L +N L A + NL+ LD
Sbjct: 35 QSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLD 94
Query: 422 LHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPP 481
L N+L +L L L L N + ++ + L L +S N+++ P
Sbjct: 95 LSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
Query: 482 QIL-GIVTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLS 520
+++ L L LDLS N L ++ L V+ GL
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 49/199 (24%), Positives = 68/199 (34%), Gaps = 41/199 (20%)
Query: 285 SLPHSLSNASNLRLLDFSLNHFSG-QVKIDFNRLPNLFRLSFSKNNLGT---GAIGDLDF 340
++P SL S LLD S N+ S + + RL NL L S N+L A
Sbjct: 32 NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEA------ 83
Query: 341 IAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEY 400
L L L +N + L + FS +L L L
Sbjct: 84 ---FVPVPNLRYLDLSSN--------HLHTLDEFL--FS---------DLQALEVLLLYN 121
Query: 401 NQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPE----SLGNLTILNSLDLGFNKLRGHVP 456
N + +A ++ LQ L L N + P L L LDL NKL+
Sbjct: 122 NHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPL 180
Query: 457 SSLGNCQNLML--LSVSNN 473
+ L + L + NN
Sbjct: 181 TDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 37/164 (22%), Positives = 67/164 (40%), Gaps = 13/164 (7%)
Query: 126 LETLILANNSFSGKIPSN--LSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDN 183
L L++N+ S ++ + +R +NL + N+L I + L +L L N
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSN 98
Query: 184 LLAGQLAPSI-GNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIF 242
L L + ++ L+VL + N + ++ + L L +S+N S FP +
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELI 156
Query: 243 ----NISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVR-QNN 281
+ L + L N+L+ LP+ LP + NN
Sbjct: 157 KDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNN 199
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 8e-13
Identities = 61/292 (20%), Positives = 91/292 (31%), Gaps = 32/292 (10%)
Query: 381 GLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTI 440
G N+ L +L L + + L + + +S
Sbjct: 292 GRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDS-ATDEQ 350
Query: 441 LNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNN--KLTGALPPQILGIVTLSILLDLSGN 498
L +L K + S L +C+ L L N LT L + L + +
Sbjct: 351 LFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS 409
Query: 499 LLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKT 558
L P L ++F E V + L++ LT + L+
Sbjct: 410 TLKAVDP------MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQ 461
Query: 559 LKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNK 618
L + LDLS N L +P L L LE L S N LE V N+
Sbjct: 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNR 519
Query: 619 ----------RLCGGLDELHL---PVCHSAGPRKTRIALLKVVVP-VTVILT 656
C L L+L +C G ++ +L P V+ ILT
Sbjct: 520 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML----PSVSSILT 567
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 1e-12
Identities = 50/293 (17%), Positives = 92/293 (31%), Gaps = 37/293 (12%)
Query: 185 LAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNI 244
G+ PS + +L S+ + S + ++ +
Sbjct: 290 PDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATD 348
Query: 245 SSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLN 304
L L + L + S L+ L ++ + L +L
Sbjct: 349 EQLFRCELSVEKST-VLQSELE-SCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQ 406
Query: 305 HFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVL 364
+FS +D R L L + + + L L
Sbjct: 407 YFSTLKAVDPMRAAYLDDLRSKFLL---------ENSVLKMEYADVRVLHLAHKDL---- 453
Query: 365 PLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHH 424
+ +L + + +L+ L +N+L +P A+ LR L+VL
Sbjct: 454 -TVLCHLE-------------QLLLVTHLD---LSHNRLRA-LPPALAALRCLEVLQASD 495
Query: 425 NNLDGHIPESLGNLTILNSLDLGFNKLRGH-VPSSLGNCQNLMLLSVSNNKLT 476
N L+ ++ + NL L L L N+L+ L +C L+LL++ N L
Sbjct: 496 NALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 4e-09
Identities = 34/221 (15%), Positives = 69/221 (31%), Gaps = 35/221 (15%)
Query: 6 SISYLATLVWCFSLFLLHSHSCFALHSNETDRLALLAIKSQLQ--DPLGVTSSWNNSMNL 63
S L L LL L S L+ DP+ + ++ +
Sbjct: 370 SCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRA-AYLDDLRSK 428
Query: 64 CQWTGVTCGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRL 123
+ V VL L+++ + + ++ L + ++ ++N +P + L
Sbjct: 429 FLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAAL 485
Query: 124 FRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDN 183
LE L ++N L + N +L+ L L +N
Sbjct: 486 RCLEVLQASDN--------ALENVDGVANLP-------------------RLQELLLCNN 518
Query: 184 LLAG-QLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSL 223
L + + L +L++ N L + +L +
Sbjct: 519 RLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 1e-06
Identities = 32/194 (16%), Positives = 61/194 (31%), Gaps = 11/194 (5%)
Query: 408 PHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSL----GNCQ 463
P ++ + DL +L+ +P+ + S L P +
Sbjct: 290 PDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDE 349
Query: 464 NLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENR 523
L +S K T L ++ L L + L I ++ L L +
Sbjct: 350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTII----LLMRALDPLLYEKET 404
Query: 524 FSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENL 583
+ YL + + ++ L L+ +L+ + LE L
Sbjct: 405 LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQL 462
Query: 584 SFLEYLNLSYNHLE 597
+ +L+LS+N L
Sbjct: 463 LLVTHLDLSHNRLR 476
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 59/235 (25%), Positives = 93/235 (39%), Gaps = 34/235 (14%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVM---NLKQRGATKSFVAECEALRNIRH 755
NDF ++G+G+FG V A+K++ + + V E L+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
L + + F+ D V EY G L L + F + +
Sbjct: 65 PFLTAL--KYA---FQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAE 113
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPS 873
+ A+EYLH +V+ D+K N++LD D H+ DFGL + I + +
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK-------EGISDGAT 161
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP-----TDNMFN 923
T GT Y+APE D D + G+++ EM R P + +F
Sbjct: 162 MKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 2e-12
Identities = 58/235 (24%), Positives = 96/235 (40%), Gaps = 33/235 (14%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVM---NLKQRGATKSFVAECEALRNIRH 755
DF+ ++G+GSFG V + AVK++ + Q + + E L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
+ + C F+ +D V EY+ G L + Q VG F + +
Sbjct: 401 PPFLTQLHSC----FQTMDRLYFVMEYVNGGDLMYHIQQ------VGRFKEPHAVFYAAE 450
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPS 873
+A + +L I++ DLK NV+LD + H+ DFG+ + I + +
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK-------ENIWDGVT 498
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP-----TDNMFN 923
+ T GT Y+APE + D ++FG+LL EM + P D +F
Sbjct: 499 TKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 79/498 (15%), Positives = 140/498 (28%), Gaps = 93/498 (18%)
Query: 171 SWLKLEFLSLRDNLLAGQLAPSIGNI----SNLQVLSIGENRLSGRLPDSLGQLRSLYYL 226
SW ++E R + A S + ++ + L G+ + L +
Sbjct: 36 SWYEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVE-----LKGKPHFADFNLVPDGWG 90
Query: 227 SISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNY--TG 284
M S + LE I L + I S N + L + T
Sbjct: 91 GYVYPWIEAMSSSY----TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTD 146
Query: 285 SLPHSLSNASNLRLLDFS------------------------LNHFSGQVKIDFN----- 315
L + NL+ LD LN ++ F+
Sbjct: 147 GLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERL 206
Query: 316 --RLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGL-------DTNIFGGVLP- 365
R PNL L + A+ L +LE LG +++ G+
Sbjct: 207 VTRCPNLKSLKLN------RAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVA 260
Query: 366 ----LSIANLSSTIILFSMGLNQIY--VKNLVNLNGFGLEYNQLTGP-IPHAIGELRNLQ 418
+ LS L +Y L LN L Y + + + + LQ
Sbjct: 261 LSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLN---LSYATVQSYDLVKLLCQCPKLQ 317
Query: 419 VLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSS----------LGNCQNLMLL 468
L + D + L L + ++ P+ C L +
Sbjct: 318 RLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESV 377
Query: 469 SVSNNKLTGA-----------LPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQL 517
++T A + L I+ L+ L A V + K+L +L
Sbjct: 378 LYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRL 437
Query: 518 GLSENRFSNEIPVSLSACTTLEYLYMEGNSLTG-SIPLALKTLKSIKELDLSRNNLSGQ- 575
LS + +E L + + + L S+++L++ +
Sbjct: 438 SLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKA 497
Query: 576 IPEFLENLSFLEYLNLSY 593
+ L + L +S
Sbjct: 498 LLANASKLETMRSLWMSS 515
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 68/443 (15%), Positives = 132/443 (29%), Gaps = 36/443 (8%)
Query: 59 NSMNLCQWTGVTCGHRHQRVTVLDLSNRSI-EGILSPYVGNLSFLRFINFAN-NGFSGEI 116
+ + + L + + L + + + ++ GFS +
Sbjct: 88 GWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDG 147
Query: 117 PGEIGRLFR-LETLILANNSFSGKIPSNLS----RCSNL--INFHARGNNLVGQIPPDIG 169
I R L+ L L + LS ++L +N + + +
Sbjct: 148 LAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLV 207
Query: 170 YSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIG------ENRLSGRLPDSLGQLRSL 223
L+ L L + +LA + L+ L G + L +L + L
Sbjct: 208 TRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKEL 267
Query: 224 YYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYT 283
LS +A P+ S L +++L ++ V + P L+ L V
Sbjct: 268 RCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIED 327
Query: 284 GSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPN--LFRLSFSKNNL-----GTGAIG 336
L S +LR L + V L L +S L +
Sbjct: 328 AGLEVLASTCKDLRELR--VFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMT 385
Query: 337 DLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGF 396
+ I N + L L++ L K+L L+
Sbjct: 386 NAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHC-----KDLRRLSLS 440
Query: 397 GLEYNQLTGPIPHAIGE-LRNLQVLDLHHNNL-DGHIPESLGNLTILNSLDLGFNKLRG- 453
GL LT + IG + +++L + D + L L L++
Sbjct: 441 GL----LTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK 496
Query: 454 HVPSSLGNCQNLMLLSVSNNKLT 476
+ ++ + + L +S+ ++
Sbjct: 497 ALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 47/296 (15%), Positives = 85/296 (28%), Gaps = 44/296 (14%)
Query: 314 FNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSS 373
+ + R N + + + K+ ++ L L
Sbjct: 37 WYEIERWCRRKVFIGNCYAVSPATV-----IRRFPKVRSVELKGKPHFADFNLVPDGWGG 91
Query: 374 TIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGE-LRNLQVLDLHHNNL--DGH 430
+ + ++ L + L+ +T I + +N +VL L
Sbjct: 92 YVYPWIEAMSS-SYTWLEEIR---LKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDG 147
Query: 431 IPESLGNLTILNSLDLGFNKLRGHVPSSLG----NCQNLMLLSVSNNKLTGALPPQILGI 486
+ L LDL + + L +L+ L++S
Sbjct: 148 LAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA----------SE 197
Query: 487 VTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEG- 545
V+ S L L V NL L L+ ++ L LE L G
Sbjct: 198 VSFSALERL------------VTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGY 245
Query: 546 -----NSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHL 596
+ + +AL K ++ L + + +P S L LNLSY +
Sbjct: 246 TAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATV 301
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 4e-12
Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 35/236 (14%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVM---NLKQRGATKSFVAECEAL-RNIR 754
DF M+G+GSFG V+ + A+K + + + + E L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
H L + C+ F+ + V EY+ G L + F++ +
Sbjct: 77 HPFLTHM--FCT---FQTKENLFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYAA 125
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETP 872
++ +++LH IV+ DLK N+LLD D H+ DFG+ + +L
Sbjct: 126 EIILGLQFLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK-------ENMLGDA 173
Query: 873 SSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP-----TDNMFN 923
++T GT Y+APE +G + + D +SFG+LL EM + P + +F+
Sbjct: 174 KTNT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 7e-12
Identities = 93/611 (15%), Positives = 178/611 (29%), Gaps = 167/611 (27%)
Query: 237 FPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENL------SVRQNNYTGSLPHSL 290
P SI + ++ I + + + G+L + L E + V + NY L +
Sbjct: 41 MPKSILSKEEIDHIIMSKDAVSGTLRL-FWTLLSKQEEMVQKFVEEVLRINY-KFLMSPI 98
Query: 291 SNASNLRLLDFSL-------NHFSGQV--KIDFNRLP-------NLFRLSFSKNNLGTGA 334
+ + + QV K + +RL L L +KN L G
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158
Query: 335 IGDLDFIAHLTNCSK----LEAL---GLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYV 387
+G K L+ + + + L++ N +S + M L ++
Sbjct: 159 LG----------SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEM-LQKLLY 207
Query: 388 KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLG 447
+ N + + I ELR L + N L + ++ N N+ +L
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL--VLLNVQNAKAWNAFNLS 265
Query: 448 ------------FNKLRG---------HVPSSLGNCQNLMLLSVSNNKLTGALPPQILGI 486
+ L H +L + LL + LP ++L
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT 325
Query: 487 VTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGN 546
+ + I +++ + + N + ++ +
Sbjct: 326 NPRRLSI----------IAES---IRDGL------ATWDN-------------WKHVNCD 353
Query: 547 SLTGSIPLALKTLKS--IKEL--DLS--RNNLSGQIPEFLENLSFLEYLNLSYNHLEGEV 600
LT I +L L+ +++ LS + IP L LS + + +
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA--HIPTIL--LSLI------WFDVIKSD 403
Query: 601 PRRGVFSNKTRFYFTGNKRLCGGLDELHLPVCHSAGPRKTRIALLKVVVPVTVILTIIVA 660
V NK Y K+ + + AL + IV
Sbjct: 404 VM--VVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR----------SIVD 451
Query: 661 CLIVLYTRRRKHK-------------------H-KSSSMLLMEQQFPMVSYADLS----K 696
Y + H K+ F MV + D K
Sbjct: 452 H----YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMV-FLDFRFLEQK 506
Query: 697 ATNDFSSSNMIGQ-----GSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEA-L 750
+D ++ N G F Y+ + +N+ V + F+ + E L
Sbjct: 507 IRHDSTAWNASGSILNTLQQLKF-YKPYICDNDPKYERLVNAILD------FLPKIEENL 559
Query: 751 RNIRHRNLIKI 761
++ +L++I
Sbjct: 560 ICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 5e-10
Identities = 67/408 (16%), Positives = 119/408 (29%), Gaps = 129/408 (31%)
Query: 38 LALLAIKS---QLQDPLGVTSSWNNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEGILSP 94
+AL S Q + + W + + + TVL++ + + I
Sbjct: 166 VALDVCLSYKVQCKMDFKI--FW-----------LNLKNCNSPETVLEMLQKLLYQIDPN 212
Query: 95 YVGNLSFLRFINFANNGFSGEIPGEIGRLFRLET-----LILAN-------NSFSG--KI 140
+ I + I E+ RL + + L+L N N+F+ KI
Sbjct: 213 WTSRSDHSSNIKLRIH----SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI 268
Query: 141 PSNL--SRCSNLINFHARGNNLVGQIPPDIGYSWL----KLEFLSLRDNLLAGQLAPSIG 194
L +R + +F I D L L + L +
Sbjct: 269 ---LLTTRFKQVTDF--LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVL 323
Query: 195 NISNLQVLSIGE-----------------NRLSGRLPDSLGQL-----RSLYY-LSISEN 231
+ ++ I E ++L+ + SL L R ++ LS+
Sbjct: 324 TTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV--- 380
Query: 232 AFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSV---RQNNYTGSLPH 288
FP S +I + +SL+ + S + + + L S+ + T S+P
Sbjct: 381 -----FPPSA-HIPT-ILLSLIWFDVIKSDVMVV---VNKLHKYSLVEKQPKESTISIPS 430
Query: 289 -------SLSNASNL--RLLD-------FSLNHFSGQV--------------KIDFNRLP 318
L N L ++D F + I+
Sbjct: 431 IYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERM 490
Query: 319 NLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPL 366
LFR+ F L D F+ K+ N G +L
Sbjct: 491 TLFRMVF----L------DFRFLE-----QKIRHDSTAWNASGSILNT 523
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 9e-08
Identities = 73/516 (14%), Positives = 136/516 (26%), Gaps = 187/516 (36%)
Query: 562 IKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLC 621
E ++ + F + F++ N ++ + + S +
Sbjct: 11 TGEHQYQYKDI---LSVFEDA--FVD--NFDCKDVQDMP--KSILSKEE----------- 50
Query: 622 GGLDELHLPVCHSAGPRKTRIALLKVVV---PVTVILTIIVACLIVLY---TRRRKHKHK 675
+D + + + L + ++ + L + Y K + +
Sbjct: 51 --IDHII-----MSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR 103
Query: 676 SSSMLLMEQQFPMVSYAD-LSKATND---FSSSNMIGQGSFGFVYRGNLGENEMAVAVKV 731
SM Y + + ND F+ N V R
Sbjct: 104 QPSM-------MTRMYIEQRDRLYNDNQVFAKYN---------VSR----------LQPY 137
Query: 732 MNLKQRGATKSFVAECEALRNIR-HRNLI--------K---IITVCSSIDFEEV-DFKAI 778
+ L+Q AL +R +N++ K + VC S + DFK
Sbjct: 138 LKLRQ------------ALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFK-- 183
Query: 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKP 838
++ WL+ N ++Q+L ID + H + + ++
Sbjct: 184 IF----------WLNLKNCNSPETVLEMLQKLLYQIDPNWT-SRSDHSSNIKLRIHSIQA 232
Query: 839 S-----------NVLLDHDMVAHVGDFGLAR-FLPPCSPATILETPSSSTGIKGTVGYVA 886
N LL +V + F C IL T T K +++
Sbjct: 233 ELRRLLKSKPYENCLLVLL---NVQNAKAWNAFNLSC---KILLT----TRFKQVTDFLS 282
Query: 887 PEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHE----FAKMA------L 936
T + + + LT E K L
Sbjct: 283 AA------------------------TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL 318
Query: 937 PEKVMEIVDPLL-------LLDLEARASN-----CGSHRTEIAKIEECL----------- 973
P +V+ +P + D A N C T I L
Sbjct: 319 PREVLTT-NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR 377
Query: 974 VAI----VRI--GVLCSMESPSERIQMTDVVAKLCS 1003
+++ I +L + + + VV KL
Sbjct: 378 LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 47/264 (17%), Positives = 92/264 (34%), Gaps = 53/264 (20%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR--------HRN 757
+G G F V+ N VA+K++ + T++ E + L+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 758 LIKIITVCSSIDFEEVDFK--AIVYEYMECGSLEDWLHQSNDQ---LEVGNFNVIQRLNL 812
I+ + + + + +V+E + +L + + + L Q L
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLL- 142
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAH------VGDFGLARFLPPCSPA 866
++Y+H C I+H D+KP NVL++ + D G A +
Sbjct: 143 ------GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW------- 187
Query: 867 TILETPSSSTGIKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEMFTRRR--PTDNMF 922
+ I+ T Y +PE G A D++S L+ E+ T D
Sbjct: 188 ---YDEHYTNSIQ-TREYRSPEVLLGAPWGCGA--DIWSTACLIFELITGDFLFEPDEGH 241
Query: 923 NDGLTLHEFAKMALPEKVMEIVDP 946
+ A++ +E++
Sbjct: 242 SYTKDDDHIAQI------IELLGE 259
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 28/173 (16%), Positives = 60/173 (34%), Gaps = 34/173 (19%)
Query: 707 IGQGSFGFVYRG--------NLGENEMAVAVKV----------MNLKQRGATKSFVAECE 748
+ + G +Y + G + ++K+ N QR A V + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 749 ALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQ 808
L + + + + ++ +V + SL+ L S + +
Sbjct: 110 KLYSTPLLAIPTCM----GFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHV----LSERS 160
Query: 809 RLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLAR 858
L + + A+E+LH + VHG++ N+ + D V + +G A
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 44/198 (22%), Positives = 77/198 (38%), Gaps = 33/198 (16%)
Query: 707 IGQGSFGFVYRGNLGENE-----MAVAVKV-----------MNLKQRGATKSFVAECEAL 750
IGQG FG +Y ++ +E VKV + QR A + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 751 RNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECG-SLEDWLHQSNDQLEVGNFNVIQR 809
R +++ + K D ++ ++ + G L+ + F+
Sbjct: 103 RKLKYLGVPKYWG-SGLHDKNGKSYRFMIMDRF--GSDLQKIYEANA-----KRFSRKTV 154
Query: 810 LNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD--HDMVAHVGDFGLA-RFLPPCSPA 866
L L + + +EY+H H VHGD+K SN+LL+ + ++ D+GLA R+ P
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 867 TILETPSSSTGIKGTVGY 884
P GT+ +
Sbjct: 212 AYAADPKRC--HDGTIEF 227
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 45/195 (23%), Positives = 78/195 (40%), Gaps = 30/195 (15%)
Query: 707 IGQGSFGFVYRG---NLGENEMAVAVKV-----------MNLKQRGATKSFVAECEALRN 752
IG G FG +Y N E + VKV + QR A K + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNL 812
+ + + +F+ ++ +V E + L+ + N G F L L
Sbjct: 105 LDYLGIPLFYG-SGLTEFKGRSYRFMVMERLGI-DLQK-ISGQN-----GTFKKSTVLQL 156
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD--HDMVAHVGDFGLA-RFLPPCSPATIL 869
I + +EY+H + VHGD+K +N+LL + ++ D+GL+ R+ P +
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 870 ETPSSSTGIKGTVGY 884
E P GT+ +
Sbjct: 214 ENPRKG--HNGTIEF 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 47/278 (16%), Positives = 90/278 (32%), Gaps = 84/278 (30%)
Query: 705 NMIGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQRGAT----KSFVAECEALRNI-R 754
+G+G+FG V + VAVK++ GAT ++ ++E + L +I
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGH 84
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
H N++ ++ C+ + ++ E+ + G+L +L ++ +
Sbjct: 85 HLNVVNLLGACTKPGGPLM----VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKD 140
Query: 815 DVAFA---------------------------IEYLHHHCHPPIVHGDLKPSNVLL---- 843
V + + P ++ D L+
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200
Query: 844 --------------------------DHDMVAHVGDFGLARFLPPCSPATILETPS--SS 875
V + DFGLAR I + P
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--------DIYKDPDYVRK 252
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT 913
+ + ++APE + DV+SFG+LL E+F+
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 40/196 (20%), Positives = 68/196 (34%), Gaps = 43/196 (21%)
Query: 382 LNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTIL 441
+ + + + + L+ + L L NN++ I SL + L
Sbjct: 17 RKSVVATEAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENL 72
Query: 442 NSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLT 501
L LG N ++ + + L L +S N++ LSG
Sbjct: 73 RILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-----------------SLSG---- 110
Query: 502 GSIPAEVGNLKNLVQLGLSENRFSNEIPVS-LSACTTLEYLYMEGNSLTGSIPLA----- 555
+ L NL L +S N+ +N + L+A LE L + GN L
Sbjct: 111 ------IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
Query: 556 -----LKTLKSIKELD 566
+K L ++K+LD
Sbjct: 165 YRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 33/168 (19%), Positives = 63/168 (37%), Gaps = 34/168 (20%)
Query: 443 SLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTG 502
L + + ++L + L++S N + +I +
Sbjct: 29 ELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-----KISSL---------------- 66
Query: 503 SIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSI 562
++NL L L N +I + TLE L++ N + S+ ++ L ++
Sbjct: 67 ------SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNL 117
Query: 563 KELDLSRNNLS--GQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
+ L +S N ++ G+I + L L LE L L+ N L + S
Sbjct: 118 RVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 19/84 (22%), Positives = 37/84 (44%), Gaps = 4/84 (4%)
Query: 514 LVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLS 573
V+L + +LS ++L + N++ I +L +++++ L L RN +
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK 83
Query: 574 GQIPEFLENLSFLEYLNLSYNHLE 597
+I LE L +SYN +
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA 106
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 35/158 (22%), Positives = 56/158 (35%), Gaps = 38/158 (24%)
Query: 202 LSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSL 261
L + ++ +L L++ +L++S N NI + S+S
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTN-----------NIEKISSLS---------- 67
Query: 262 PVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKID-FNRLPNL 320
+ NL LS+ +N + + + A L L S N + + +L NL
Sbjct: 68 ------GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA---SLSGIEKLVNL 117
Query: 321 FRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTN 358
L S N I + I L KLE L L N
Sbjct: 118 RVLYMSNNK-----ITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 20/89 (22%), Positives = 33/89 (37%), Gaps = 18/89 (20%)
Query: 541 LYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEV 600
L+ + + L TLK+ K L LS NN+ +I L + L L+L N ++
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK--- 83
Query: 601 PRRGVFSNKTRFYFTGNKRLCGGLDELHL 629
+ L+EL +
Sbjct: 84 ------------KIENLDAVADTLEELWI 100
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 35/115 (30%), Positives = 55/115 (47%), Gaps = 20/115 (17%)
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPS 873
+A A+++LH I++ DLKP N+LLD + H+ DFGL++ +I
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK-------ESIDHEKK 182
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP-----TDNMFN 923
+ + GTV Y+APE + + D +SFG+L+ EM T P
Sbjct: 183 AYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 27/132 (20%), Positives = 54/132 (40%), Gaps = 3/132 (2%)
Query: 416 NLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKL 475
+ + L N + P + L +DL N++ P + ++L L + NK+
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92
Query: 476 TGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLSENRFSNEIPVSLSA 534
T LP + + LL L+ N + + + +L NL L L +N+ + S
Sbjct: 93 T-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 535 CTTLEYLYMEGN 546
++ +++ N
Sbjct: 151 LRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 30/150 (20%), Positives = 59/150 (39%), Gaps = 20/150 (13%)
Query: 461 NCQNLMLLSV-------------SNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAE 507
+C+ L + N + +PP +DLS N ++ + +
Sbjct: 17 DCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPD 74
Query: 508 V-GNLKNLVQLGLSENRFSNEIPVSL-SACTTLEYLYMEGNSLTGSIPL-ALKTLKSIKE 564
L++L L L N+ + E+P SL +L+ L + N + + + A + L ++
Sbjct: 75 AFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNL 132
Query: 565 LDLSRNNLSGQIPEFLENLSFLEYLNLSYN 594
L L N L L ++ ++L+ N
Sbjct: 133 LSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 20/106 (18%), Positives = 41/106 (38%), Gaps = 10/106 (9%)
Query: 504 IPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPL-ALKTLKSI 562
+P + ++ L +N P + S L + + N ++ + A + L+S+
Sbjct: 30 LPETITEIR------LEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82
Query: 563 KELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
L L N ++ E L L+ L L+ N + + F +
Sbjct: 83 NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLR-VDAFQD 126
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 21/85 (24%), Positives = 38/85 (44%), Gaps = 2/85 (2%)
Query: 390 LVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPE-SLGNLTILNSLDLGF 448
L +LN L N++T L +LQ+L L+ N + + + +L LN L L
Sbjct: 79 LRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYD 137
Query: 449 NKLRGHVPSSLGNCQNLMLLSVSNN 473
NKL+ + + + + ++ N
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 29/134 (21%), Positives = 55/134 (41%), Gaps = 5/134 (3%)
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFN-ISSLESISLLGN 255
+ + + +N + P + + L + +S N S + F + SL S+ L GN
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL-APDAFQGLRSLNSLVLYGN 90
Query: 256 RLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPH-SLSNASNLRLLDFSLNHFSGQVKIDF 314
++ LP ++ L +L+ L + N L + + NL LL N K F
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTF 148
Query: 315 NRLPNLFRLSFSKN 328
+ L + + ++N
Sbjct: 149 SPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 30/157 (19%), Positives = 51/157 (32%), Gaps = 27/157 (17%)
Query: 294 SNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEAL 353
+ + N F+ L R+ S N + A L + L +L
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ---GLRS---LNSL 85
Query: 354 GLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPH-AIG 412
L N I L ++ F + L +L L N++ + A
Sbjct: 86 VLYGN--------KITELPKSL--F---------EGLFSLQLLLLNANKINC-LRVDAFQ 125
Query: 413 ELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFN 449
+L NL +L L+ N L + L + ++ L N
Sbjct: 126 DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 27/131 (20%), Positives = 54/131 (41%), Gaps = 5/131 (3%)
Query: 127 ETLILANNSFSGKIPSN-LSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLL 185
+ L N+ IP S L N + ++ PD L L L N +
Sbjct: 35 TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 186 AGQLAPSI-GNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNI 244
+L S+ + +LQ+L + N+++ D+ L +L LS+ +N + + +
Sbjct: 93 T-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 245 SSLESISLLGN 255
+++++ L N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 33/154 (21%), Positives = 56/154 (36%), Gaps = 12/154 (7%)
Query: 64 CQWTGVTCGHRH---------QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSG 114
C V C + + +T + L +I+ I LR I+ +NN S
Sbjct: 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE 70
Query: 115 EIPGEIGRLFRLETLILANNSFSGKIPSNL-SRCSNLINFHARGNNLVGQIPPDIGYSWL 173
P L L +L+L N + ++P +L +L N + + D
Sbjct: 71 LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLH 128
Query: 174 KLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGEN 207
L LSL DN L + + +Q + + +N
Sbjct: 129 NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-11
Identities = 38/115 (33%), Positives = 51/115 (44%), Gaps = 20/115 (17%)
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPS 873
+A A+ YLH IV+ DLKP N+LLD H+ DFGL + I +
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK-------ENIEHNST 195
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP-----TDNMFN 923
+ST GT Y+APE T D + G +L EM P T M++
Sbjct: 196 TST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 7e-11
Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 20/115 (17%)
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPS 873
++ A+ +LH I++ DLKP N++L+H HV DFGL + +I +
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCK-------ESIHDGTV 177
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP-----TDNMFN 923
+ T GT+ Y+APE M + D +S G L+ +M T P +
Sbjct: 178 THT-FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-11
Identities = 56/240 (23%), Positives = 97/240 (40%), Gaps = 43/240 (17%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVM---NLKQRGATKSFVAECEALRNI-- 753
DF+ ++G+GSFG V + AVK++ + Q + + E + +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE----KRVLA 75
Query: 754 ---RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRL 810
+ L ++ F+ +D V EY+ G L + Q G F +
Sbjct: 76 LPGKPPFLTQLH--SC---FQTMDRLYFVMEYVNGGDLMYHIQQV------GRFKEPHAV 124
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATI 868
++A + +L I++ DLK NV+LD + H+ DFG+ + I
Sbjct: 125 FYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK-------ENI 172
Query: 869 LETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP-----TDNMFN 923
+ ++ T GT Y+APE + D ++FG+LL EM + P D +F
Sbjct: 173 WDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 35/155 (22%), Positives = 63/155 (40%), Gaps = 17/155 (10%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVC 765
+G G G V + + A+K++ A + E E + ++++I+ V
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
++ IV E ++ G L + DQ F + ++ + AI+YLH
Sbjct: 81 ENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHS 135
Query: 826 HCHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLA 857
I H D+KP N+L + + + DFG A
Sbjct: 136 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 51/224 (22%), Positives = 87/224 (38%), Gaps = 28/224 (12%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVM---NLKQRGATKSFVAECEALRNIRH 755
DF +IG+GS+ V L + + A++V+ + E +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
+ + C F+ V EY+ G L + + +
Sbjct: 112 HPFLVGLHSC----FQTESRLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAE 161
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPS 873
++ A+ YLH I++ DLK NVLLD + H+ D+G+ + + +
Sbjct: 162 ISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK-------EGLRPGDT 209
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
+ST GT Y+APE G D + D ++ G+L+ EM R P
Sbjct: 210 TST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-10
Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 28/224 (12%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVM---NLKQRGATKSFVAECEALRNIRH 755
DF +IG+GS+ V L + + A+KV+ + E +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
+ + C F+ V EY+ G L + + +
Sbjct: 69 HPFLVGLHSC----FQTESRLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAE 118
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPS 873
++ A+ YLH I++ DLK NVLLD + H+ D+G+ + + +
Sbjct: 119 ISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK-------EGLRPGDT 166
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
+ST GT Y+APE G D + D ++ G+L+ EM R P
Sbjct: 167 TST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 3e-10
Identities = 67/519 (12%), Positives = 153/519 (29%), Gaps = 76/519 (14%)
Query: 143 NLSRCSNLINFHARGNNLVGQIPP---DIGYSWLKLEFLSLRDNLL--AGQLAPSIGNIS 197
L F+ N G + P +I + +L+ + R ++ +
Sbjct: 79 KLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARAD 138
Query: 198 NLQVLSIGE-NRLSGRLPDSLGQ-LRSLYYLSISENAFSGMFPSSIFNIS----SLESIS 251
+L+ L + + + + S+ R + L + E++FS + ++ SLE ++
Sbjct: 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLN 198
Query: 252 LLGNRLEG----SLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFS 307
L I + +L ++ V + L A+NL +
Sbjct: 199 FYMTEFAKISPKDL-ETIARNCRSLVSVKVG-DFEILELVGFFKAAANLEEFCGGSLNED 256
Query: 308 GQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGL-DTNIFGGVLPL 366
+ + L +L LG +G + +++ L L +
Sbjct: 257 IGMPEKYMNLVFPRKL----CRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCT 312
Query: 367 SIANLSS----------------TIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHA 410
I + + + L ++ ++ + G E ++ A
Sbjct: 313 LIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIA 372
Query: 411 IGE-LRNLQVLDLHHNNLD----GHIPESLGNLTILNSLDLGFNKLRGHVPSSLG----- 460
+ + + L+ + ++ +++ I L NL + L + +P G
Sbjct: 373 LAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLL 432
Query: 461 -NCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGL 519
C+ L + G L + N+ + L
Sbjct: 433 IGCKKLRRFA----------------------FYLRQGGLTDLGLSYIGQYSPNVRWMLL 470
Query: 520 SENRFSNE-IPVSLSACTTLEYLYMEGNSLT-GSIPLALKTLKSIKELDLSRNNLSGQIP 577
S+E + C L+ L M G + +I A+ L S++ L + S
Sbjct: 471 GYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQ 530
Query: 578 EFLE---NLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFY 613
+ ++ +E + + +
Sbjct: 531 DLMQMARPYWNIELIPSRRVPEVNQQGEIREMEHPAHIL 569
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 43/240 (17%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVM---NLKQRGATKSFVAECEALRNI-- 753
++F ++G+GSFG V + E AVKV+ + Q + + E + I
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE----KRILS 78
Query: 754 ---RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRL 810
H L ++ C F+ D V E++ G L + +S F+ +
Sbjct: 79 LARNHPFLTQLF--CC---FQTPDRLFFVMEFVNGGDLMFHIQKS------RRFDEARAR 127
Query: 811 NLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATI 868
++ A+ +LH I++ DLK NVLLDH+ H DFG+ + I
Sbjct: 128 FYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCK-------EGI 175
Query: 869 LETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP-----TDNMFN 923
+++T GT Y+APE D ++ G+LL EM P D++F
Sbjct: 176 CNGVTTAT-FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 20/104 (19%)
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPS 873
+ A+E+LH I++ D+K N+LLD + HV DFGL++ + +
Sbjct: 168 IVLALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSK-------EFVADETE 215
Query: 874 SSTGIKGTVGYVAPE----YGMGGDMSATGDVYSFGILLLEMFT 913
+ GT+ Y+AP+ G D + D +S G+L+ E+ T
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLT 257
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 48/276 (17%), Positives = 91/276 (32%), Gaps = 55/276 (19%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-----HRNLIK 760
+G G F V+ + + VA+KV+ + T++ + E L+++R N
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY-TETALDEIRLLKSVRNSDPNDPNREM 102
Query: 761 IITVCSSIDFEEVDFK--AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
++ + V+ +V+E + L W+ +SN Q + ++ V
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQG----LPLPCVKKIIQQVLQ 157
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS--- 875
++YLH C I+H D+KP N+LL + A + S+
Sbjct: 158 GLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 876 -----------------------------------TGIKGTVGYVAPEYGMGGDMSATGD 900
T T Y + E +G + D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 901 VYSFGILLLEMFTRRRPTDNMFNDGLTLHE--FAKM 934
++S + E+ T + + T E A +
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALI 311
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 57/320 (17%), Positives = 104/320 (32%), Gaps = 61/320 (19%)
Query: 318 PNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFG--GVLPLS--IANLSS 373
+ L S NNL + + +L T S + +L L N G L +A + +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPAS-VTSLNLSGNSLGFKNSDELVQILAAIPA 80
Query: 374 TIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDG---- 429
+ ++ N + K+ L L T + VLDL N+
Sbjct: 81 NVTSLNLSGNFLSYKSSDEL-VKTLAAIPFT------------ITVLDLGWNDFSSKSSS 127
Query: 430 HIPESLGNL-TILNSLDLGFNKLRGHVPSSLG-----NCQNLMLLSVSNNKLT--GALPP 481
++ NL + SL+L N L L N+ L++ N L
Sbjct: 128 EFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC--- 184
Query: 482 QILGIV------TLSILLDLSGNLLTGS-----IPAEVGNLKNLVQLGLSENRFSNE--- 527
L +++ L DLS NLL ++V L L N
Sbjct: 185 AELAKFLASIPASVTSL-DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLE 243
Query: 528 -IPVSLSACTTLEYLYMEGNSLTG-------SIPLALKTLKSIKELDLSRNNLSG----Q 575
+ + + L+ +Y++ + + ++ A ++ I +D + +
Sbjct: 244 NLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIP 303
Query: 576 IPEFLENLSF-LEYLNLSYN 594
I + LS + +L
Sbjct: 304 ISNLIRELSGKADVPSLLNQ 323
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 49/246 (19%), Positives = 75/246 (30%), Gaps = 50/246 (20%)
Query: 398 LEYNQLTGPIPHAIGEL----RNLQVLDLHHNNLDGHIPESLG-----NLTILNSLDLGF 448
+ Y P + + E + LDL NNL L + SL+L
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 449 NKLRGHVPSSLG-----NCQNLMLLSVSNNKLTGALPPQILGIVTLS----------ILL 493
N L L N+ L++S N L+ L +L
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYK------SSDELVKTLAAIPFTITVL 114
Query: 494 DLSGNLLTGS-----IPAEVGNLKNLVQLGLSENRFSNEIPVSLSAC-----TTLEYLYM 543
DL N + A ++ L L N + L + L +
Sbjct: 115 DLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNL 174
Query: 544 EGNSLT----GSIPLALKTL-KSIKELDLSRNNLSGQ----IPEFLE-NLSFLEYLNLSY 593
GN+L + L ++ S+ LDLS N L + + + + LNL
Sbjct: 175 RGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCL 234
Query: 594 NHLEGE 599
N L G
Sbjct: 235 NCLHGP 240
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 45/156 (28%), Positives = 69/156 (44%), Gaps = 7/156 (4%)
Query: 418 QVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTG 477
+ LDL L + LT L L+L +N+L+ + L L ++NN+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 478 ALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLSENRFSNEIPVSL-SAC 535
+LP + +T L L GN L S+P+ V L L +L L+ N+ IP
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 536 TTLEYLYMEGNSLTGSIPL-ALKTLKSIKELDLSRN 570
T L+ L + N L S+P A L ++ + L N
Sbjct: 155 TNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 13/158 (8%)
Query: 443 SLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTG 502
LDL L ++ L L++ N+L L + +T L L+ N L
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA- 96
Query: 503 SIPAEV-GNLKNLVQLGLSENRFSNEIPV----SLSACTTLEYLYMEGNSLTGSIPL-AL 556
S+P V +L L +L L N+ +P L T L+ L + N L SIP A
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRL---TKLKELRLNTNQLQ-SIPAGAF 151
Query: 557 KTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYN 594
L +++ L LS N L + L L+ + L N
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 44/166 (26%), Positives = 54/166 (32%), Gaps = 31/166 (18%)
Query: 299 LDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTN 358
LD + F L L L+ N L T + G D LT L LGL N
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFD---DLTE---LGTLGLANN 93
Query: 359 --------IFGGVLPLSIANLSSTIILFSMGLNQIYV------KNLVNLNGFGLEYNQLT 404
+F + L L NQ+ L L L NQL
Sbjct: 94 QLASLPLGVFDHLTQLDKLYLGG---------NQLKSLPSGVFDRLTKLKELRLNTNQLQ 144
Query: 405 GPIPH-AIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFN 449
IP A +L NLQ L L N L + L L ++ L N
Sbjct: 145 S-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 43/184 (23%), Positives = 70/184 (38%), Gaps = 33/184 (17%)
Query: 176 EFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSG 235
E L L+ LA + ++ L L++ N+L ++S F
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ----------------TLSAGVFDD 81
Query: 236 MFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSL-SNAS 294
+ + L ++ L N+L SLP+ + L L+ L + N SLP + +
Sbjct: 82 L--------TELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLT 131
Query: 295 NLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALG 354
L+ L + N F++L NL LS S N L + G D KL+ +
Sbjct: 132 KLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFD------RLGKLQTIT 185
Query: 355 LDTN 358
L N
Sbjct: 186 LFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 46/204 (22%), Positives = 69/204 (33%), Gaps = 52/204 (25%)
Query: 226 LSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGS 285
L + + + ++ ++ L ++L N+L+ +L + L L L + N S
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 286 LPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLT 345
LP + F+ L L +L N L + G D LT
Sbjct: 98 LPLGV-----------------------FDHLTQLDKLYLGGNQLKSLPSGVFD---RLT 131
Query: 346 NCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTG 405
L+ L L+TN +P F L NL L NQL
Sbjct: 132 K---LKELRLNTNQLQ-SIPAGA---------FD---------KLTNLQTLSLSTNQLQS 169
Query: 406 PIPH-AIGELRNLQVLDLHHNNLD 428
+PH A L LQ + L N D
Sbjct: 170 -VPHGAFDRLGKLQTITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 37/151 (24%), Positives = 63/151 (41%), Gaps = 14/151 (9%)
Query: 158 NNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLS---GRLP 214
+ + + KL +L+L N L A +++ L L + N+L+ +
Sbjct: 44 STGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVF 103
Query: 215 DSLGQLRSLYYLSISENAFSGMFPSSIF-NISSLESISLLGNRLEGSLPVNIGFSLPNLE 273
D L QL L + N + PS +F ++ L+ + L N+L+ S+P L NL+
Sbjct: 104 DHLTQLD---KLYLGGNQLKSL-PSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQ 158
Query: 274 NLSVRQNNYTGSLPH----SLSNASNLRLLD 300
LS+ N S+PH L + L
Sbjct: 159 TLSLSTNQLQ-SVPHGAFDRLGKLQTITLFG 188
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 47/220 (21%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHR---NLIKII 762
+IG+GSFG V + + VA+K++ ++R ++ E L ++R + N + +I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNVI 162
Query: 763 TVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVG-NFNVIQRLNLVIDVAFAIE 821
+ + F + +E + +L + + ++ Q G + ++++ + ++
Sbjct: 163 HMLENFTFRN--HICMTFELLSM-NLYELIKKNKFQ---GFSLPLVRKF--AHSILQCLD 214
Query: 822 YLHHHCHPPIVHGDLKPSNVLLDHDMVAH--VGDFGLARFLPPCSPATILETPSSSTGIK 879
LH + I+H DLKP N+LL + V DFG + + + +
Sbjct: 215 ALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--------QRVYT----- 258
Query: 880 GTVGYV------APEYGMGGDMSATGDVYSFGILLLEMFT 913
Y+ APE +G D++S G +L E+ T
Sbjct: 259 ----YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 2e-09
Identities = 25/96 (26%), Positives = 40/96 (41%), Gaps = 3/96 (3%)
Query: 407 IPHAIGELRNLQVLDLHHNNLDGHIP-ESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNL 465
H + NL L + + H+ L L L +L + + LR P + L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 466 MLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLT 501
L++S N L +L + + ++L L LSGN L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQE-LVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 22/103 (21%), Positives = 35/103 (33%), Gaps = 5/103 (4%)
Query: 522 NRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPL-ALKTLKSIKELDLSRNNLSGQIPEFL 580
+ + L L LY+E + L L+ L ++ L + ++ L P+
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 581 ENLSFLEYLNLSYNHLEGEVPRRGVFSNK--TRFYFTGNKRLC 621
L LNLS+N L E +GN C
Sbjct: 77 HFTPRLSRLNLSFNAL--ESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 20/112 (17%), Positives = 35/112 (31%), Gaps = 4/112 (3%)
Query: 462 CQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLS 520
L + + + G L+ L + + L L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTEL-YIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 521 ENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNL 572
++ P + L L + N+L S+ S++EL LS N L
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 20/96 (20%), Positives = 32/96 (33%), Gaps = 3/96 (3%)
Query: 115 EIPGEIGRLFRLETLILANNSFSGKIPSN-LSRCSNLINFHARGNNLVGQIPPDIGYSWL 173
+ + L L + N + L L N + L + PD +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 174 KLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRL 209
+L L+L N L L+ +LQ L + N L
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 31/150 (20%), Positives = 56/150 (37%), Gaps = 19/150 (12%)
Query: 461 NCQNLMLLSV-------------SNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAE 507
+C N L + +NN+ T I + ++ S N +T I
Sbjct: 17 DCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEG 75
Query: 508 V-GNLKNLVQLGLSENRFSNEIPVSL-SACTTLEYLYMEGNSLTGSIPL-ALKTLKSIKE 564
+ ++ L+ NR N + + +L+ L + N +T + + L S++
Sbjct: 76 AFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRL 133
Query: 565 LDLSRNNLSGQIPEFLENLSFLEYLNLSYN 594
L L N ++ P + L L LNL N
Sbjct: 134 LSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 19/85 (22%), Positives = 32/85 (37%), Gaps = 7/85 (8%)
Query: 390 LVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPE-SLGNLTILNSLDLGF 448
+N L N+L L +L+ L L N + + S L+ + L L
Sbjct: 80 ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYD 138
Query: 449 NKLRGHVP----SSLGNCQNLMLLS 469
N++ V +L + L LL+
Sbjct: 139 NQIT-TVAPGAFDTLHSLSTLNLLA 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 30/143 (20%), Positives = 52/143 (36%), Gaps = 16/143 (11%)
Query: 294 SNLRLLDFSLNHFSG-QVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEA 352
L + N F+ + F +LP L +++FS N + G + + +
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFE---GASG---VNE 85
Query: 353 LGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYV------KNLVNLNGFGLEYNQLTGP 406
+ L +N V L S L + N+I L ++ L NQ+T
Sbjct: 86 ILLTSNRLENVQHKMFKGLESLKTL-MLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-T 143
Query: 407 IPH-AIGELRNLQVLDLHHNNLD 428
+ A L +L L+L N +
Sbjct: 144 VAPGAFDTLHSLSTLNLLANPFN 166
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 43/160 (26%), Positives = 67/160 (41%), Gaps = 26/160 (16%)
Query: 707 IGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVC 765
IG G+FG + G NL NE VA+K+ +K R E + L +
Sbjct: 17 IGCGNFGELRLGKNLYTNEY-VAIKLEPMKSRA--PQLHLEYRFY-----KQLGSGDGIP 68
Query: 766 SSIDF-EEVDFKAIVYEYMECG-SLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
F + A+V E + G SLED + F++ L + I + +EY+
Sbjct: 69 QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYV 121
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDM-----VAHVGDFGLAR 858
H +++ D+KP N L+ V H+ DF LA+
Sbjct: 122 HSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPS 457
L+ +T L ++ + +++++ + + L + L LG NKL
Sbjct: 26 LKKKSVTD-AVTQNE-LNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKL-----H 76
Query: 458 SLG---NCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGN-LKN 513
+ NL L ++ N+L +LP + +T L L N L S+P V + L N
Sbjct: 77 DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTN 134
Query: 514 LVQLGLSENRFSNEIPV----SLSACTTLEYLYMEGNSLTGSIPL-ALKTLKSIKELDLS 568
L L L+ N+ + +P L T L L + N L S+P L +K+L L
Sbjct: 135 LTYLNLAHNQLQS-LPKGVFDKL---TNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLY 189
Query: 569 RNNLSGQIPE--FLENLSFLEYLNLSYN 594
+N L +P+ F + L+ L+Y+ L N
Sbjct: 190 QNQLKS-VPDGVF-DRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 43/198 (21%), Positives = 82/198 (41%), Gaps = 24/198 (12%)
Query: 140 IPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNL 199
P + + N V + ++ + ++ + + I + N+
Sbjct: 13 FPDDAFAETIKANLK---KKSVTDAVTQNELN--SIDQIIANNSDI--KSVQGIQYLPNV 65
Query: 200 QVLSIGENRLSGRLP--DSLGQLRSLYYLSISENAFSGMFPSSIFN-ISSLESISLLGNR 256
+ L++G N+L + L L L ++ N + P+ +F+ +++L+ + L+ N+
Sbjct: 66 RYLALGGNKLH-DISALKELTNLTYLI---LTGNQLQSL-PNGVFDKLTNLKELVLVENQ 120
Query: 257 LEGSLPVNIGFSLPNLENLSVRQNNYTGSLPH----SLSNASNLRLLDFSLNHFSGQVKI 312
L+ SLP + L NL L++ N SLP L +NL LD S N +
Sbjct: 121 LQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKL---TNLTELDLSYNQLQSLPEG 175
Query: 313 DFNRLPNLFRLSFSKNNL 330
F++L L L +N L
Sbjct: 176 VFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 40/177 (22%), Positives = 64/177 (36%), Gaps = 31/177 (17%)
Query: 461 NCQNLMLLSV-------------SNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAE 507
+ +T Q + + + + + S+
Sbjct: 4 TVSTPIKQIFPDDAFAETIKANLKKKSVT-DAVTQN--ELNSIDQIIANNSDIK-SVQG- 58
Query: 508 VGNLKNLVQLGLSENRFSNEIPV--SLSACTTLEYLYMEGNSLTGSIPL-ALKTLKSIKE 564
+ L N+ L L N+ + I L T L YL + GN L S+P L ++KE
Sbjct: 59 IQYLPNVRYLALGGNKLHD-ISALKEL---TNLTYLILTGNQLQ-SLPNGVFDKLTNLKE 113
Query: 565 LDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVF---SNKTRFYFTGNK 618
L L N L + L+ L YLNL++N L+ GVF +N T + N+
Sbjct: 114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPK--GVFDKLTNLTELDLSYNQ 168
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 55/239 (23%), Positives = 82/239 (34%), Gaps = 45/239 (18%)
Query: 238 PSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLR 297
P F + +L + + + + N+ S+ + N+R
Sbjct: 14 PDDAF--AETIKANLKKKSVT-DAVTQNELNSIDQIIAN---NSDIKSVQ-GIQYLPNVR 66
Query: 298 LLDFSLNHFSGQVKID-FNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLD 356
L N I L NL L + N L + G D LT L+ L L
Sbjct: 67 YLALGGNKLH---DISALKELTNLTYLILTGNQLQSLPNGVFD---KLT---NLKELVLV 117
Query: 357 TNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAI-GELR 415
N + +L + L NL L +NQL +P + +L
Sbjct: 118 EN--------QLQSLPDGVF-----------DKLTNLTYLNLAHNQLQS-LPKGVFDKLT 157
Query: 416 NLQVLDLHHNNLDGHIPESL-GNLTILNSLDLGFNKLRGHVPS----SLGNCQNLMLLS 469
NL LDL +N L +PE + LT L L L N+L+ VP L + Q + L
Sbjct: 158 NLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHD 214
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 22/157 (14%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG GSFG +Y G VA+K+ +K + E + + ++ + + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ-----GGVGIPT 69
Query: 767 SIDF-EEVDFKAIVYEYMECG-SLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
E D+ +V E + G SLED + + F++ L L + IEY+H
Sbjct: 70 IRWCGAEGDYNVMVMELL--GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIH 122
Query: 825 HHCHPPIVHGDLKPSNVLL---DHDMVAHVGDFGLAR 858
+H D+KP N L+ + ++ DFGLA+
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 1e-08
Identities = 29/204 (14%), Positives = 57/204 (27%), Gaps = 53/204 (25%)
Query: 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVM--------NLKQRGATKSFVAECE 748
T IG+G FG V++ VA+K++ N + + + E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 749 ALRNI---------RHRNLIKIITVC-------------------------SSIDFEEVD 774
+ + R I + +V DF + D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHG 834
IV E+ G + + ++ +++ + ++ H
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTK-------LSSLATAKSILHQLTASLAVAEASLR--FEHR 186
Query: 835 DLKPSNVLLDHDMVAHVGDFGLAR 858
DL NVLL + + +
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 35/159 (22%), Positives = 61/159 (38%), Gaps = 24/159 (15%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG+GSFG ++ G N VA+K + E + L + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTY-----KLLAGCTGIPN 70
Query: 767 SIDF-EEVDFKAIVYEYMECG-SLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
F +E +V + + G SLED L F+V + ++ +H
Sbjct: 71 VYYFGQEGLHNVLVIDLL--GPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIH 123
Query: 825 HHCHPPIVHGDLKPSNVLL-----DHDMVAHVGDFGLAR 858
+V+ D+KP N L+ + + +V DFG+ +
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 34/218 (15%), Positives = 74/218 (33%), Gaps = 24/218 (11%)
Query: 401 NQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLG 460
+L + L L + + S L+ L L+L ++ + +
Sbjct: 36 KKLGKLGRQVLPPSELLDHL--FFHYEFQNQRFSAEVLSSLRQLNLAGVRMTPVKCTVVA 93
Query: 461 -----NCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGS---IPAEV--GN 510
L +++++ +L A +L + + L L N L ++ +
Sbjct: 94 AVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHD 153
Query: 511 LKNLVQLGLSENRFSNE----IPVSLSACTTLEYLYMEGNSLT----GSIPLALKTLKSI 562
+ L LS N + + L+ T++ +L + L + L + +
Sbjct: 154 QCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQL 213
Query: 563 KELDLSRNNLSGQ----IPEFLENLSFLEYLNLSYNHL 596
+EL+++ N + LE L+L +N L
Sbjct: 214 QELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 38/245 (15%), Positives = 70/245 (28%), Gaps = 45/245 (18%)
Query: 377 LFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGEL-----RNLQVLDLHHNNLDGHI 431
+ + + L +L L ++T + + L ++L LD
Sbjct: 58 HYEFQNQRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAG 117
Query: 432 PESLGN-LTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLS 490
+L L L N L L + LL ++T
Sbjct: 118 LRTLLPVFLRARKLGLQLNSLGPEACKDLRD-----LLLHDQCQIT-------------- 158
Query: 491 ILLDLSGNLLTGS----IPAEVGNLKNLVQLGLSENRFSNE----IPVSLSACTTLEYLY 542
L LS N LT + + + ++ L L +E + L L+ L
Sbjct: 159 -TLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELN 217
Query: 543 MEGNSLTGS----IPLALKTLKSIKELDLSRNNLS-------GQIPEFLENLSFLEYLNL 591
+ N + + A + S++ L L N LS + E + +
Sbjct: 218 VAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLT 277
Query: 592 SYNHL 596
+
Sbjct: 278 EGTAV 282
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 47/356 (13%), Positives = 98/356 (27%), Gaps = 54/356 (15%)
Query: 255 NRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFS--LNHFSGQVKI 312
+ L I +L LEN + L + L L F + ++
Sbjct: 12 RAVLAQLGCPIK-NLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEV 70
Query: 313 DFNRLPNLFRLSFSKNNL---GTGAIGDLDFIAHLTNCSKLEALGLDTNIFG--GVLPLS 367
L +L +L+ + + + + L+ + L + G+ L
Sbjct: 71 ----LSSLRQLNLAGVRMTPVKCTVVAA----VLGSGRHALDEVNLASCQLDPAGLRTLL 122
Query: 368 IANLSSTIILFSMGLNQIYVK-----------NLVNLNGFGLEYNQLTGP----IPHAIG 412
L + + + N + + + + L N LT + +
Sbjct: 123 PVFLRARKLGLQL--NSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180
Query: 413 ELRNLQVLDLHHNNLD----GHIPESLGNLTILNSLDLGFNKLRG----HVPSSLGNCQN 464
++ L L H L + L L L++ +N + + +
Sbjct: 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPS 240
Query: 465 LMLLSVSNNKLTGALPPQILGIVTLS-ILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENR 523
L LL + N+L+ G L + G E + + LSE +
Sbjct: 241 LELLHLYFNELSSE------GRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQ 294
Query: 524 FSNEI--PVSLSACTTLEYLYMEGNSLT----GSIPLALKTLKSIKELDLSRNNLS 573
+ + L +E + L+ ++ L +
Sbjct: 295 RNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 25/156 (16%), Positives = 49/156 (31%), Gaps = 19/156 (12%)
Query: 493 LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSI 552
+ L+ L+ + A+ N +L L + I + + + N + +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 553 PLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLE--GEVPRRGVFSNKT 610
L+ +K L ++ N + + L L L L+ N L G++ + T
Sbjct: 58 D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 611 RFYFTGNKRLCGGLDELHLPVCHSAGPRKTRIALLK 646
N PV + R I +
Sbjct: 117 YLCILRN------------PVTNKKHYRLYVIYKVP 140
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 27/158 (17%), Positives = 51/158 (32%), Gaps = 32/158 (20%)
Query: 370 NLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDG 429
L++ +I + N V L ++ I + L +D N +
Sbjct: 3 KLTAELIEQAAQYT-----NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK 56
Query: 430 HIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTL 489
+ L L +L + N++ +L L ++NN +V L
Sbjct: 57 L--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS-----------LVEL 103
Query: 490 SILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNE 527
L L+ +LK+L L + N +N+
Sbjct: 104 GDLDPLA-------------SLKSLTYLCILRNPVTNK 128
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 21/120 (17%), Positives = 42/120 (35%), Gaps = 9/120 (7%)
Query: 239 SSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRL 298
+ N + L G ++ + N+G +L + + +N L L+
Sbjct: 13 AQYTNAVRDRELDLRGYKIP--VIENLGATLDQFDAID-FSDNEIRKLDG-FPLLRRLKT 68
Query: 299 LDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTN 358
L + N + LP+L L + N+ + +L + L + L L + N
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNS-----LVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 28/140 (20%), Positives = 46/140 (32%), Gaps = 29/140 (20%)
Query: 341 IAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEY 400
A TN + L L I NL +T+ ++
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-----VIENLGATL------------DQFDAID---FSD 51
Query: 401 NQLT--GPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR--GHVP 456
N++ P LR L+ L +++N + L L L L N L G +
Sbjct: 52 NEIRKLDGFPL----LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL- 106
Query: 457 SSLGNCQNLMLLSVSNNKLT 476
L + ++L L + N +T
Sbjct: 107 DPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 28/136 (20%), Positives = 50/136 (36%), Gaps = 14/136 (10%)
Query: 173 LKLEFLSLRDNLLAGQLAPSIGNI----SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSI 228
++ L LR + P I N+ + +N + +L D LR L L +
Sbjct: 19 VRDRELDLRGYKI-----PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLV 71
Query: 229 SENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQN---NYTGS 285
+ N + + L + L N L ++ SL +L L + +N N
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 131
Query: 286 LPHSLSNASNLRLLDF 301
+ + +R+LDF
Sbjct: 132 RLYVIYKVPQVRVLDF 147
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 26/112 (23%), Positives = 41/112 (36%), Gaps = 13/112 (11%)
Query: 77 RVTVLDLSN---RSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILAN 133
R LDL IE + + L I+F++N ++ G L RL+TL++ N
Sbjct: 20 RDRELDLRGYKIPVIENLGA----TLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNN 73
Query: 134 NSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGY--SWLKLEFLSLRDN 183
N +L N+L D+ S L +L + N
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLCILRN 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 31/140 (22%), Positives = 50/140 (35%), Gaps = 17/140 (12%)
Query: 510 NLKNLVQLGLSENRFSN-EIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLS 568
++ +L L +R + ++ LE+L LT SI L L +K+L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 569 RNNLSGQIPEFLENLSFLEYLNLSYNHLE--GEVPRRGVFSNKTRFYFTGNKRLCGGLDE 626
N +SG + E L +LNLS N ++ + N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC--------- 123
Query: 627 LHLPVCHSAGPRKTRIALLK 646
V + R+ LL
Sbjct: 124 ---EVTNLNDYRENVFKLLP 140
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 30/116 (25%), Positives = 47/116 (40%), Gaps = 7/116 (6%)
Query: 243 NISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFS 302
S ++ + L +R + LE LS N S+ + L + L+ L+ S
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLST-INVGLTSIAN-LPKLNKLKKLELS 72
Query: 303 LNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTN 358
N SG +++ + PNL L+ S N I DL I L L++L L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNK-----IKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 31/133 (23%), Positives = 48/133 (36%), Gaps = 12/133 (9%)
Query: 441 LNSLDLGFNKL-RGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL--LDLSG 497
+ L L ++ G + + L LS N LT I + L+ L L+LS
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKLELSD 73
Query: 498 NLLTGSIPAEVGNLKNLVQLGLSENRFSN-EIPVSLSACTTLEYLYMEGNSLTGSI---P 553
N ++G + NL L LS N+ + L L+ L + +T
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRE 133
Query: 554 LALKTLKSIKELD 566
K L + LD
Sbjct: 134 NVFKLLPQLTYLD 146
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 38/133 (28%), Positives = 57/133 (42%), Gaps = 10/133 (7%)
Query: 418 QVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR----GHVPSSLGNCQNLMLLSVSNN 473
Q+L LH N + P +L L L LG N+L G V SL L L N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFDSLTQLTVLDL---GTN 98
Query: 474 KLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLS 533
+LT LP + + L + N LT +P + L +L L L +N+ + +
Sbjct: 99 QLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156
Query: 534 ACTTLEYLYMEGN 546
++L + Y+ GN
Sbjct: 157 RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 40/130 (30%), Positives = 62/130 (47%), Gaps = 6/130 (4%)
Query: 443 SLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTG 502
L L N++ P + NL L + +N+L ALP + +T +LDL N LT
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 503 SIPAEV-GNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPL-ALKTLK 560
+P+ V L +L +L + N+ + E+P + T L +L ++ N L SIP A L
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLS 159
Query: 561 SIKELDLSRN 570
S+ L N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 27/154 (17%)
Query: 461 NCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLS 520
+C++ SV P GI T + +L L N +T P +L NL +L L
Sbjct: 25 DCRSKRHASV---------PA---GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLG 72
Query: 521 ENRFSNEIPVSLSA-----CTTLEYLYMEGNSLTGSIPLAL-KTLKSIKELDLSRNNLSG 574
N+ +L T L L + N LT +P A+ L +KEL + N L+
Sbjct: 73 SNQLG-----ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE 126
Query: 575 QIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSN 608
+P +E L+ L +L L N L+ +P G F
Sbjct: 127 -LPRGIERLTHLTHLALDQNQLKS-IP-HGAFDR 157
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 31/125 (24%), Positives = 56/125 (44%), Gaps = 4/125 (3%)
Query: 197 SNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFN-ISSLESISLLGN 255
+N Q+L + +N+++ P L +L L + N + P +F+ ++ L + L N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL-PVGVFDSLTQLTVLDLGTN 98
Query: 256 RLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFN 315
+L LP + L +L+ L + N T LP + ++L L N F+
Sbjct: 99 QLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156
Query: 316 RLPNL 320
RL +L
Sbjct: 157 RLSSL 161
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 28/92 (30%), Positives = 41/92 (44%), Gaps = 11/92 (11%)
Query: 389 NLVNLNGFGLEYNQLTGPIPHAI-GELRNLQVLDLHHNNLDGHIPE----SLGNLTILNS 443
+L+NL L NQL +P + L L VLDL N L +P L +L
Sbjct: 62 SLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTV-LPSAVFDRLVHLKE--- 116
Query: 444 LDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKL 475
L + NKL +P + +L L++ N+L
Sbjct: 117 LFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 42/145 (28%), Positives = 53/145 (36%), Gaps = 31/145 (21%)
Query: 299 LDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTN 358
L N + F+ L NL L N LG +G D LT L L L TN
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD---SLTQ---LTVLDLGTN 98
Query: 359 IFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQ 418
VLP ++ F LV+L + N+LT +P I L +L
Sbjct: 99 QLT-VLPSAV---------FD---------RLVHLKELFMCCNKLTE-LPRGIERLTHLT 138
Query: 419 VLDLHHNNLDGHIPE----SLGNLT 439
L L N L IP L +LT
Sbjct: 139 HLALDQNQLKS-IPHGAFDRLSSLT 162
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 37/162 (22%), Positives = 50/162 (30%), Gaps = 33/162 (20%)
Query: 413 ELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSN 472
+R L VLD +N DG I L L L L S+ N L L
Sbjct: 25 AVREL-VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGL-----ISVSNLPKLPKLKK-- 75
Query: 473 NKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVS- 531
L+LS N + G + L NL L LS N+ + +
Sbjct: 76 --------------------LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP 115
Query: 532 LSACTTLEYLYMEGNSLTGSI---PLALKTLKSIKELDLSRN 570
L L+ L + +T K L + LD
Sbjct: 116 LKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDR 157
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 26/116 (22%), Positives = 46/116 (39%), Gaps = 7/116 (6%)
Query: 243 NISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFS 302
+++ + L + + NLE LS+ N S+ +L L+ L+ S
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSL-INVGLISVS-NLPKLPKLKKLELS 79
Query: 303 LNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTN 358
N G + + +LPNL L+ S N + D+ + L L++L L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNK-----LKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 7e-07
Identities = 25/89 (28%), Positives = 42/89 (47%), Gaps = 3/89 (3%)
Query: 510 NLKNLVQLGLSENRFSN-EIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLS 568
+ +L L + ++ +I + LE+L + L S+ L L +K+L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 569 RNNLSGQIPEFLENLSFLEYLNLSYNHLE 597
N + G + E L L +LNLS N L+
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 28/121 (23%), Positives = 42/121 (34%), Gaps = 26/121 (21%)
Query: 407 IPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLM 466
I E NL+ L L + L + +L L L L+L N++ G + NL
Sbjct: 41 IEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98
Query: 467 LLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSN 526
L++S NK + +S L L L+ L L L +N
Sbjct: 99 HLNLSGNK-----------LKDISTLEPLK-------------KLECLKSLDLFNCEVTN 134
Query: 527 E 527
Sbjct: 135 L 135
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 48/236 (20%), Positives = 90/236 (38%), Gaps = 51/236 (21%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHR-----NLIK 760
+G G+FG V +N+ AVKV+ ++ + + E + L+ I++ N++K
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-EADILKKIQNDDINNNNIVK 100
Query: 761 IITVCSSIDFEEVDFKA---IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
+ + +++E + SL + + ++N F+ + +
Sbjct: 101 Y--------HGKFMYYDHMCLIFEPLGP-SLYEIITRNNYN----GFH----IEDIKLYC 143
Query: 818 F----AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS 873
A+ YL + H DLKP N+LLD ++
Sbjct: 144 IEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 874 -------SSTGIKGTVG-------YVAPE--YGMGGDMSATGDVYSFGILLLEMFT 913
+T G Y APE +G D+S+ D++SFG +L E++T
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSS--DMWSFGCVLAELYT 254
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 25/217 (11%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG GSFG +Y G + VA+K+ N+K + + E + R L + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIY-----RILQGGTGIPN 67
Query: 767 SIDF-EEVDFKAIVYEYMECG-SLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
F E D+ +V + + G SLED L + ++ L L + +E++H
Sbjct: 68 VRWFGVEGDYNVLVMDLL--GPSLED-LFNFCSR----KLSLKTVLMLADQMINRVEFVH 120
Query: 825 HHCHPPIVHGDLKPSNVLLDHDMVAH---VGDFGLA-RFLPPCSPATILETPSSSTGIKG 880
+H D+KP N L+ A+ + DFGLA ++ + I + + G
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI--PYRENKNLTG 175
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T Y + +G + S D+ S G +L+ P
Sbjct: 176 TARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 705 NMIGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHR---NLIK 760
++IG+GSFG V + + E E VA+K++ K+ ++ + E L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEW-VAIKIIKNKKAFLNQAQI-EVRLLELMNKHDTEMKYY 117
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVG-NFNVIQRLNLVIDVAFA 819
I+ + F +V+E + +L D L +N + G + N+ ++ + A
Sbjct: 118 IVHLKRHFMFRN--HLCLVFEMLSY-NLYDLLRNTNFR---GVSLNLTRKF--AQQMCTA 169
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAH--VGDFGLARFLPPCSPATILETPSSSTG 877
+ +L I+H DLKP N+LL + + + DFG +
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----------LGQRIYQY 218
Query: 878 IKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEMFT 913
I+ + Y +PE GM D++ D++S G +L+EM T
Sbjct: 219 IQ-SRFYRSPEVLLGMPYDLAI--DMWSLGCILVEMHT 253
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 2e-07
Identities = 29/212 (13%), Positives = 66/212 (31%), Gaps = 29/212 (13%)
Query: 247 LESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHF 306
I + V++ L + L+ + T +L NL+ L+
Sbjct: 146 WGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGL 205
Query: 307 SGQVKIDF--NRLPNLFRLSF---SKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFG 361
V D + LPNL +L ++ G + + L+ LG+
Sbjct: 206 PDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQ 265
Query: 362 GVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTG----PIPHAIGELRNL 417
V+ + L ++ + LT + + ++++L
Sbjct: 266 NVVVEMFLESD-------------ILPQLETMD---ISAGVLTDEGARLLLDHVDKIKHL 309
Query: 418 QVLDLHHNNLDG----HIPESLGNLTILNSLD 445
+ +++ +N L + +SL ++
Sbjct: 310 KFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.5 bits (122), Expect = 7e-07
Identities = 21/129 (16%), Positives = 51/129 (39%), Gaps = 18/129 (13%)
Query: 493 LDLSGNLLTGSIPAEVG--NLKNLVQLGL---SENRFSNEIPVSLSA------CTTLEYL 541
L++ L S+ ++ +L NL +L L E+ + L++L
Sbjct: 198 LEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWL 257
Query: 542 YMEGNSLTGSIPLAL---KTLKSIKELDLSRNNLSG----QIPEFLENLSFLEYLNLSYN 594
+ + L ++ +D+S L+ + + ++ + L+++N+ YN
Sbjct: 258 GIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317
Query: 595 HLEGEVPRR 603
+L E+ +
Sbjct: 318 YLSDEMKKE 326
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 6e-05
Identities = 28/185 (15%), Positives = 56/185 (30%), Gaps = 28/185 (15%)
Query: 405 GPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLT--ILNSLDLGFNKLRGHVPSSLGNC 462
+ + + L L + N + NL + S L + + + S L N
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 463 QNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSEN 522
+ L+L + + L NL LG+ +
Sbjct: 222 EKLVLYVGVEDYGFDG------DMNVFRPLF-------------SKDRFPNLKWLGIVDA 262
Query: 523 RFSNEIPVSLSAC---TTLEYLYMEGNSLTGS----IPLALKTLKSIKELDLSRNNLSGQ 575
N + LE + + LT + + +K +K +++ N LS +
Sbjct: 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
Query: 576 IPEFL 580
+ + L
Sbjct: 323 MKKEL 327
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 6e-04
Identities = 30/167 (17%), Positives = 56/167 (33%), Gaps = 24/167 (14%)
Query: 387 VKNLVNLNGFGLEYNQ--LTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLG--NLTILN 442
+ + LN ++ G P NL+ L++ L + E + +L L
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRP-----NLKSLEIISGGLPDSVVEDILGSDLPNLE 222
Query: 443 SLDLGF---NKLRGHVPSSL------GNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL- 492
L L + + NL L + + + + L L L
Sbjct: 223 KLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLE 282
Query: 493 -LDLSGNLLTGS----IPAEVGNLKNLVQLGLSENRFSNEIPVSLSA 534
+D+S +LT + V +K+L + + N S+E+ L
Sbjct: 283 TMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 41.9 bits (97), Expect = 8e-04
Identities = 30/242 (12%), Positives = 64/242 (26%), Gaps = 63/242 (26%)
Query: 19 LFLLHSHSCFALHSNETDRLALLAIKSQLQDPLGVTSSWNNSMNLCQWTGVTCGH-RHQR 77
+ + D +L L + + + ++ G
Sbjct: 146 WGDIDFEEQEISWIEQVDLSPVLDAMPLLNN-----------LKIKGTNNLSIGKKPRPN 194
Query: 78 VTVLDLSN--RSIEGILSPYVGNLSFLR----FINFANNGFSGEIPG-----EIGRLFRL 126
+ L++ + + +L L ++ + GF G++ R L
Sbjct: 195 LKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNL 254
Query: 127 ETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLL- 185
+ L + + + L LE + + +L
Sbjct: 255 KWLGIVDAEEQNVVVEMFLESDILPQ----------------------LETMDISAGVLT 292
Query: 186 ---AGQLAPSIGNISNLQVLSIGENRLSG----RLPDSLGQLRSL----------YYLSI 228
A L + I +L+ +++ N LS L SL + Y I
Sbjct: 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQEYDDDYSYPMI 352
Query: 229 SE 230
+E
Sbjct: 353 TE 354
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 45/126 (35%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 471 SNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPV 530
SN L LP GI L L GN T +P E+ N K+L + LS NR S
Sbjct: 18 SNKGLK-VLPK---GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQ 72
Query: 531 SLSACTTLEYLYMEGNSLTGSIPL-ALKTLKSIKELDLSRNNLSGQIPEFL-ENLSFLEY 588
S S T L L + N L IP LKS++ L L N++S +PE +LS L +
Sbjct: 73 SFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSH 130
Query: 589 LNLSYN 594
L + N
Sbjct: 131 LAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 24/78 (30%), Positives = 43/78 (55%), Gaps = 1/78 (1%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPS 457
L+ NQ T +P + ++L ++DL +N + +S N+T L +L L +N+LR P
Sbjct: 38 LDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPR 96
Query: 458 SLGNCQNLMLLSVSNNKL 475
+ ++L LLS+ N +
Sbjct: 97 TFDGLKSLRLLSLHGNDI 114
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 23/71 (32%), Positives = 34/71 (47%), Gaps = 3/71 (4%)
Query: 536 TTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNH 595
+ LY++GN T +P L K + +DLS N +S + N++ L L LSYN
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 596 LEGEVPRRGVF 606
L +P F
Sbjct: 90 LR-CIP-PRTF 98
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 28/82 (34%), Positives = 38/82 (46%), Gaps = 6/82 (7%)
Query: 443 SLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQIL-GIVTLSILLDLSGNLLT 501
L L N+ VP L N ++L L+ +SNN+++ L Q + L L LS N L
Sbjct: 35 ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLT-LILSYNRLR 91
Query: 502 GSIPAEV-GNLKNLVQLGLSEN 522
IP LK+L L L N
Sbjct: 92 -CIPPRTFDGLKSLRLLSLHGN 112
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 43/233 (18%), Positives = 88/233 (37%), Gaps = 49/233 (21%)
Query: 706 MIGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHR------NL 758
+G+G+FG V + + VA+K++ + + + E L+ I+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFLC 84
Query: 759 IKIITVCSSIDFEEVDFKA---IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
+ + + +F I +E + + ++L ++N Q + L V
Sbjct: 85 VLM--------SDWFNFHGHMCIAFELLGK-NTFEFLKENNFQ----PYP----LPHVRH 127
Query: 816 VAF----AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATI--- 868
+A+ A+ +LH + + H DLKP N+L + + + + +I
Sbjct: 128 MAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 869 ------LETPSSSTGIKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEMFT 913
+ +T + T Y PE +G DV+S G +L E +
Sbjct: 185 DFGSATFDHEHHTTIVA-TRHYRPPEVILELGWAQPC--DVWSIGCILFEYYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 46/233 (19%), Positives = 85/233 (36%), Gaps = 49/233 (21%)
Query: 706 MIGQGSFGFVYRG-NLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHR------NL 758
+G+G+FG V + VAVK++ R + E + L ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-EIQVLEHLNTTDPNSTFRC 79
Query: 759 IKIITVCSSIDFEEVDFKA---IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
+++ E + IV+E + S D++ ++ F L+ +
Sbjct: 80 VQM--------LEWFEHHGHICIVFELLGL-STYDFIKENGFL----PFR----LDHIRK 122
Query: 816 VAF----AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATI--- 868
+A+ ++ +LH + + H DLKP N+L + + R I
Sbjct: 123 MAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 869 ------LETPSSSTGIKGTVGYVAPE--YGMGGDMSATGDVYSFGILLLEMFT 913
+ ST + T Y APE +G DV+S G +L+E +
Sbjct: 180 DFGSATYDDEHHSTLVS-TRHYRAPEVILALGWSQPC--DVWSIGCILIEYYL 229
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 37/110 (33%), Positives = 48/110 (43%), Gaps = 11/110 (10%)
Query: 418 QVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR----GHVPSSLGNCQNLMLLSVSNN 473
LDL N+L LT L L LG NKL+ G V + L + L L S N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG-VFNKLTSLTYLNL---STN 86
Query: 474 KLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLKNLVQLGLSEN 522
+L +LP + +T L L+ N L S+P V L L L L +N
Sbjct: 87 QLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 38/130 (29%), Positives = 55/130 (42%), Gaps = 11/130 (8%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPS 457
LE N L EL +L L L N L LT L L+L N+L+ +P+
Sbjct: 35 LETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS-LPN 93
Query: 458 ----SLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEV-GNLK 512
L L L+++ N+L +LP + +T L L N L S+P V L
Sbjct: 94 GVFDKLT---QLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLT 148
Query: 513 NLVQLGLSEN 522
+L + L +N
Sbjct: 149 SLQYIWLHDN 158
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 26/129 (20%), Positives = 49/129 (37%), Gaps = 25/129 (19%)
Query: 461 NCQNLMLLSV-------------SNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAE 507
+C L + ++N+L + G + + L+L N LT I
Sbjct: 14 DCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPN 72
Query: 508 V-GNLKNLVQLGLSENRFSNEIPV----SLSACTTLEYLYMEGNSLTGSIPL-ALKTLKS 561
++ +L L EN+ EI L L+ L + N ++ + + + L S
Sbjct: 73 AFEGASHIQELQLGENKIK-EISNKMFLGL---HQLKTLNLYDNQIS-CVMPGSFEHLNS 127
Query: 562 IKELDLSRN 570
+ L+L+ N
Sbjct: 128 LTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 25/87 (28%), Positives = 38/87 (43%), Gaps = 7/87 (8%)
Query: 388 KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESL-GNLTILNSLDL 446
L +L L+ NQLTG P+A ++Q L L N + I + L L +L+L
Sbjct: 51 GRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI-KEISNKMFLGLHQLKTLNL 109
Query: 447 GFNKLRGHVPS----SLGNCQNLMLLS 469
N++ V L + +L L S
Sbjct: 110 YDNQISC-VMPGSFEHLNSLTSLNLAS 135
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 21/102 (20%), Positives = 34/102 (33%), Gaps = 8/102 (7%)
Query: 815 DVAFAIEYLHHH---CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSP-ATILE 870
D ++L HGDL SN+ + V+ D G + A +
Sbjct: 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVR 225
Query: 871 TPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMF 912
+ G + V G+ D + + ILL E+F
Sbjct: 226 SIREDIGEEQYVELFFDLLGIKPDW----EKIKYYILLDELF 263
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 18/100 (18%), Positives = 38/100 (38%), Gaps = 14/100 (14%)
Query: 514 LVQLGLSENRFSNEIPVSLSAC----TTLEYLYMEGNSLTG----SIPLALKTLKSIKEL 565
+ + + R ++ + +L+ TL+ L +E N ++G ++ AL++ S+ EL
Sbjct: 67 VKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIEL 126
Query: 566 DLS--RNNLSGQ----IPEFLENLSFLEYLNLSYNHLEGE 599
+ L I LE + L +
Sbjct: 127 RIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGPR 166
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 15/84 (17%), Positives = 30/84 (35%), Gaps = 1/84 (1%)
Query: 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKP 838
Y +E + +D L + N I RL + + + + H D+
Sbjct: 157 FYNQIEFDNSDDKLTAAFKSFFNQNSAAIHRLVDTSE-KLSKKIQPDLDKYVLCHSDIHA 215
Query: 839 SNVLLDHDMVAHVGDFGLARFLPP 862
NVL+ ++ ++ D+ P
Sbjct: 216 GNVLVGNEESIYIIDWDEPMLAPK 239
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 34/193 (17%), Positives = 71/193 (36%), Gaps = 14/193 (7%)
Query: 415 RNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNK 474
+ + + +D + E + + + L C L LS+ +
Sbjct: 70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 129
Query: 475 LTGALPPQILGIVTLSIL--LDLSG--NLLTGSIPAEVGNLKNLVQLGLSE-NRFSNEIP 529
L+ + + + S L L+LSG ++ + + L +L LS F+ +
Sbjct: 130 LSDPI---VNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV 186
Query: 530 VSLSA--CTTLEYLYMEG--NSLT-GSIPLALKTLKSIKELDLSR-NNLSGQIPEFLENL 583
A T+ L + G +L + ++ ++ LDLS L + L
Sbjct: 187 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL 246
Query: 584 SFLEYLNLSYNHL 596
++L++L+LS +
Sbjct: 247 NYLQHLSLSRCYD 259
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1013 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-29 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-28 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 7e-58
Identities = 76/308 (24%), Positives = 124/308 (40%), Gaps = 53/308 (17%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGA--TKSFVAECEALRNIRHR 756
+ IG GSFG VY+G + VAVK++N+ ++F E LR RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
N++ + + AIV ++ E SL LH F +I+ +++
Sbjct: 65 NILLFM------GYSTAPQLAIVTQWCEGSSLYHHLHIIE-----TKFEMIKLIDIARQT 113
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
A ++YLH I+H DLK +N+ L D+ +GDFGLA S +
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH------QFE 164
Query: 877 GIKGTVGYVAPEYGMGGDM---SATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933
+ G++ ++APE D S DVY+FGI+L E+ T + P N+ N + +
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224
Query: 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ 993
L + ++ C A+ R+ C + ER
Sbjct: 225 GYLSPDLSKVRS-------------------------NCPKAMKRLMAECLKKKRDERPL 259
Query: 994 MTDVVAKL 1001
++A +
Sbjct: 260 FPQILASI 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (480), Expect = 2e-54
Identities = 77/325 (23%), Positives = 140/325 (43%), Gaps = 58/325 (17%)
Query: 690 SYADLSKATNDFSSS---------NMIGQGSFGFVYRGNL---GENEMAVAVKVMNLKQ- 736
++ D ++A +F+ +IG G FG V G+L G+ E+ VA+K +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 737 RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSN 796
+ F++E + H N+I + V + I+ E+ME GSL+ +L Q++
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLRQND 122
Query: 797 DQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856
G F VIQ + ++ +A ++YL VH DL N+L++ ++V V DFGL
Sbjct: 123 -----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRR 916
+RFL T T +S+ G K + + APE ++ DV+S+GI++ E+ +
Sbjct: 175 SRFLE---DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
Query: 917 PTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAI 976
+ M + V+ ++ L +C A+
Sbjct: 232 RP------------YWDMT-NQDVINAIEQDYRLPPP----------------MDCPSAL 262
Query: 977 VRIGVLCSMESPSERIQMTDVVAKL 1001
++ + C + + R + +V L
Sbjct: 263 HQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-51
Identities = 62/318 (19%), Positives = 114/318 (35%), Gaps = 37/318 (11%)
Query: 694 LSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRN 752
+ +DF + +G G+ G V++ + + + +A K+++L+ + + E + L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNL 812
++ +I E+M+ GSL+ L ++ G +
Sbjct: 61 CNSPYIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKA------GRIPEQILGKV 109
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP 872
I V + YL I+H D+KPSN+L++ + DFG++ L
Sbjct: 110 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---------- 157
Query: 873 SSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP--TDNMFNDGLTLHE 930
S + GT Y++PE G S D++S G+ L+EM R P + L
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217
Query: 931 FAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSME---- 986
+ E P L S E+ + S+E
Sbjct: 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
Query: 987 -------SPSERIQMTDV 997
+P+ER + +
Sbjct: 278 VNKCLIKNPAERADLKQL 295
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-51
Identities = 66/303 (21%), Positives = 120/303 (39%), Gaps = 51/303 (16%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
+G G FG V+ G VAVK + + + +F+AE ++ ++H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRL 70
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
+++ V + + I+ EYME GSL D+L + + + L++ +A
Sbjct: 71 VRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAE 120
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+ ++ +H DL+ +N+L+ + + DFGLAR + ++ G
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED-------NEYTAREGA 170
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPE 938
K + + APE G + DV+SFGILL E+ T R + + E
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------E 224
Query: 939 KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVV 998
+ +V P + C + ++ LC E P +R +
Sbjct: 225 RGYRMVRP-----------------------DNCPEELYQLMRLCWKERPEDRPTFDYLR 261
Query: 999 AKL 1001
+ L
Sbjct: 262 SVL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 9e-51
Identities = 66/308 (21%), Positives = 117/308 (37%), Gaps = 39/308 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG+G FG V+RG E VAVK+ + ++ + AE +RH N++ I +
Sbjct: 11 IGKGRFGEVWRGKWRGEE--VAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
+ +V +Y E GSL D+L++ +E + L + A + +LH
Sbjct: 68 KDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASGLAHLHME 119
Query: 827 C-----HPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
P I H DLK N+L+ + + D GLA + + GT
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD----TIDIAPNHRVGT 175
Query: 882 VGYVAPEY------GMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM- 934
Y+APE + D+Y+ G++ E+ R + L ++
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 935 -ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ 993
++ E + + L ++ R +C E L + +I C + + R+
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSC-----------EALRVMAKIMRECWYANGAARLT 284
Query: 994 MTDVVAKL 1001
+ L
Sbjct: 285 ALRIKKTL 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-50
Identities = 60/318 (18%), Positives = 120/318 (37%), Gaps = 55/318 (17%)
Query: 697 ATNDFSSSNM-IGQGSFGFVYRG--NLGENEMAVAVKVMNLK-QRGATKSFVAECEALRN 752
++ +++ +G G+FG V +G + + ++ VA+KV+ ++ T+ + E + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNL 812
+ + ++++I VC + +V E G L +L +++ V L
Sbjct: 66 LDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKREEIPVS-----NVAEL 114
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP 872
+ V+ ++YL VH DL NVLL + A + DFGL++ L
Sbjct: 115 LHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYY 166
Query: 873 SSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932
++ + K + + APE S+ DV+S+G+ + E + + + E
Sbjct: 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK----PYKKMKGPEVM 222
Query: 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI 992
K ME EC + + C + +R
Sbjct: 223 AFIEQGKRMEC-------------------------PPECPPELYALMSDCWIYKWEDRP 257
Query: 993 QMTDVVAKLCSARKIFLS 1010
V ++ R + S
Sbjct: 258 DFLTVEQRM---RACYYS 272
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-50
Identities = 73/308 (23%), Positives = 133/308 (43%), Gaps = 52/308 (16%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNL----GENEMAVAVKVMNLKQR-GATKSFVAECEALRNI 753
+ + +IG G FG VY+G L G+ E+ VA+K + F+ E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 754 RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLV 813
H N+I++ V + I+ EYME G+L+ +L + + G F+V+Q + ++
Sbjct: 67 SHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKD-----GEFSVLQLVGML 116
Query: 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS 873
+A + + + VH DL N+L++ ++V V DFGL+R L AT
Sbjct: 117 RGIA---AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT-----Y 168
Query: 874 SSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933
+++G K + + APE ++ DV+SFGI++ E+ T +
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------- 218
Query: 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ 993
+VM+ ++ L +C AI ++ + C + + R +
Sbjct: 219 ---NHEVMKAINDGFRLPTP----------------MDCPSAIYQLMMQCWQQERARRPK 259
Query: 994 MTDVVAKL 1001
D+V+ L
Sbjct: 260 FADIVSIL 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-50
Identities = 68/311 (21%), Positives = 119/311 (38%), Gaps = 49/311 (15%)
Query: 704 SNMIGQGSFGFVYRGNLGEN---EMAVAVKVMN-LKQRGATKSFVAECEALRNIRHRNLI 759
+ +IG+G FG VY G L +N ++ AVK +N + G F+ E +++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
++ +C +V YM+ G L +++ E N V + + VA
Sbjct: 92 SLLGIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 142
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+ VH DL N +LD V DFGLAR + ++ + TG K
Sbjct: 143 ---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----FDSVHNKTGAK 195
Query: 880 GTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEK 939
V ++A E + DV+SFG+LL E+ TR P + + L +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGR 251
Query: 940 VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999
+ E C + + + C R +++V+
Sbjct: 252 RLLQ-------------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
Query: 1000 KLCSARKIFLS 1010
++ + F+
Sbjct: 287 RISAIFSTFIG 297
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-49
Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 22/245 (8%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITV 764
IG+GSF VY+G E + VA + ++ + + F E E L+ ++H N+++
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
S + +V E M G+L+ +L + + + + +++LH
Sbjct: 77 WESTVKGK-KCIVLVTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLH 129
Query: 825 HHCHPPIVHGDLKPSNVLL-DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
PPI+H DLK N+ + +GD GLA S + + GT
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----------ASFAKAVIGTPE 178
Query: 884 YVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEI 943
++APE + DVY+FG+ +LEM T P N P ++
Sbjct: 179 FMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237
Query: 944 VDPLL 948
P +
Sbjct: 238 AIPEV 242
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-49
Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 51/303 (16%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
+GQG FG V+ G VA+K + + ++F+ E + ++ +RH L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
+++ V S + IV EYM GSL D+L + + Q +++ +A
Sbjct: 75 VQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIAS 124
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+ Y+ VH DL+ +N+L+ ++V V DFGLAR + ++ G
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED-------NEYTARQGA 174
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPE 938
K + + APE + G + DV+SFGILL E+ T+ R
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------------NR 221
Query: 939 KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVV 998
+V++ V+ + EC ++ + C + P ER +
Sbjct: 222 EVLDQVERGYRMPCP----------------PECPESLHDLMCQCWRKEPEERPTFEYLQ 265
Query: 999 AKL 1001
A L
Sbjct: 266 AFL 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (443), Expect = 2e-49
Identities = 70/320 (21%), Positives = 128/320 (40%), Gaps = 51/320 (15%)
Query: 682 MEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATK 741
M+ P +Y D + + +G G +G VY G + + VAVK + + +
Sbjct: 2 MDPSSP--NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVE 58
Query: 742 SFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEV 801
F+ E ++ I+H NL++++ VC I+ E+M G+L D+L + N Q
Sbjct: 59 EFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYIITEFMTYGNLLDYLRECNRQ--- 110
Query: 802 GNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLP 861
+ + L + ++ A+EYL +H DL N L+ + + V DFGL+R +
Sbjct: 111 -EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166
Query: 862 PCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921
+T ++ G K + + APE S DV++FG+LL E+ T
Sbjct: 167 G-------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219
Query: 922 FNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGV 981
+ +V E+++ ++ E C + +
Sbjct: 220 ID-------------LSQVYELLEKDYRMERP----------------EGCPEKVYELMR 250
Query: 982 LCSMESPSERIQMTDVVAKL 1001
C +PS+R ++
Sbjct: 251 ACWQWNPSDRPSFAEIHQAF 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-49
Identities = 63/273 (23%), Positives = 102/273 (37%), Gaps = 24/273 (8%)
Query: 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRN 752
S+A D+ IG GS+G + + + K ++ + V+E LR
Sbjct: 1 SRA-EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNL 812
++H N+++ IV EY E G L + + E + L +
Sbjct: 60 LKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRV 114
Query: 813 VIDVAFAIEYLHHH--CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILE 870
+ + A++ H ++H DLKP+NV LD +GDFGLAR L
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-------- 166
Query: 871 TPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH- 929
S + GT Y++PE + D++S G LL E+ P L
Sbjct: 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 226
Query: 930 -----EFAKMALPEKVMEIVDPLLLLDLEARAS 957
+++ EI+ +L L R S
Sbjct: 227 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPS 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-48
Identities = 80/303 (26%), Positives = 115/303 (37%), Gaps = 55/303 (18%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
+ IG+G FG V G+ N+ VAVK +K ++F+AE + +RH NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKC--IKNDATAQAFLAEASVMTQLRHSNL 62
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
++++ V EE IV EYM GSL D+L + L +DV
Sbjct: 63 VQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCE 114
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
A+EYL + VH DL NVL+ D VA V DFGL + S+
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----------STQDTG 160
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPE 938
K V + APE S DV+SFGILL E+++ R + L +
Sbjct: 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKG 216
Query: 939 KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVV 998
M+ D C A+ + C + R +
Sbjct: 217 YKMDAPD-------------------------GCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
Query: 999 AKL 1001
+L
Sbjct: 252 EQL 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 4e-48
Identities = 66/301 (21%), Positives = 109/301 (36%), Gaps = 53/301 (17%)
Query: 705 NMIGQGSFGFVYRGNLGENEM--AVAVKVMNLK--QRGATKSFVAECEALRNIRHRNLIK 760
+G G+FG V +G ++ VAVK++ + +AE ++ + + +++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+I +C E + +V E E G L +L Q+ + + LV V+ +
Sbjct: 73 MIGIC------EAESWMLVMEMAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGM 120
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
+YL VH DL NVLL A + DFGL++ L + T K
Sbjct: 121 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKW 172
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKV 940
V + APE S+ DV+SFG+L+ E F+ + G+ E M +
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK----PYRGMKGSEVTAMLEKGER 228
Query: 941 MEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000
M C + + LC R V +
Sbjct: 229 MGC-------------------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELR 263
Query: 1001 L 1001
L
Sbjct: 264 L 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 9e-48
Identities = 68/303 (22%), Positives = 116/303 (38%), Gaps = 51/303 (16%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
D + +G G FG V G + VA+K++ + + F+ E + + N+ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
+++ VC + I+ EYM G L ++L + F Q L + DV
Sbjct: 62 VQLYGVC-----TKQRPIFIITEYMANGCLLNYLREMR-----HRFQTQQLLEMCKDVCE 111
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
A+EYL +H DL N L++ V V DFGL+R++ + +SS G
Sbjct: 112 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-------DEYTSSVGS 161
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPE 938
K V + PE M S+ D+++FG+L+ E+++ + F
Sbjct: 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------------NS 208
Query: 939 KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVV 998
+ E + L L + I C E ER ++
Sbjct: 209 ETAEHIAQGLRLYRP----------------HLASEKVYTIMYSCWHEKADERPTFKILL 252
Query: 999 AKL 1001
+ +
Sbjct: 253 SNI 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 66/303 (21%), Positives = 120/303 (39%), Gaps = 51/303 (16%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
++ + IG G FG V+ G + VA+K + + + + F+ E E + + H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
+++ VC E +V+E+ME G L D+L F L + +DV
Sbjct: 63 VQLYGVC-----LEQAPICLVFEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCE 112
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGI 878
+ + ++H DL N L+ + V V DFG+ RF+ + +SSTG
Sbjct: 113 G---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGT 162
Query: 879 KGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPE 938
K V + +PE S+ DV+SFG+L+ E+F+ + ++ + + +
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---- 218
Query: 939 KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVV 998
+ P + +I C E P +R + ++
Sbjct: 219 --FRLYKP-----------------------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
Query: 999 AKL 1001
+L
Sbjct: 254 RQL 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 5e-46
Identities = 61/327 (18%), Positives = 115/327 (35%), Gaps = 66/327 (20%)
Query: 699 NDFSSSNMIGQGSFGFVYRG-----NLGENEMAVAVKVMNLK-QRGATKSFVAECEALRN 752
+ ++G G+FG V + + VAVK++ K ++ ++E + +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 753 I-RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL------------ 799
+ H N++ ++ C +++EY G L ++L ++
Sbjct: 97 LGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 800 -----EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854
++ L VA +E+L VH DL NVL+ H V + DF
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDF 208
Query: 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTR 914
GLAR + S + + V ++APE G + DV+S+GILL E+F+
Sbjct: 209 GLARDIMSDSNYVV------RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262
Query: 915 RRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLV 974
+ + + +++ +D A+
Sbjct: 263 GVNP------------YPGIPVDANFYKLIQNGFKMDQPFYATE---------------- 294
Query: 975 AIVRIGVLCSMESPSERIQMTDVVAKL 1001
I I C +R ++ + L
Sbjct: 295 EIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (417), Expect = 6e-46
Identities = 64/336 (19%), Positives = 117/336 (34%), Gaps = 67/336 (19%)
Query: 690 SYADLSKATNDFSSSNMIGQGSFGFVYRGNL-----GENEMAVAVKVMNLK-QRGATKSF 743
L N+ IG+G+FG V++ E VAVK++ + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 744 VAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGN 803
E + + N++K++ VC +++EYM G L ++L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 804 ------------------FNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH 845
+ ++L + VA + YL VH DL N L+
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175
Query: 846 DMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFG 905
+MV + DFGL+R + + + ++ PE + DV+++G
Sbjct: 176 NMVVKIADFGLSRNIYSADYYK------ADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 229
Query: 906 ILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTE 965
++L E+F+ + MA E + + D +L
Sbjct: 230 VVLWEIFSYGLQP------------YYGMAHEEVIYYVRDGNIL---------------- 261
Query: 966 IAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001
A E C + + + LC + P++R + L
Sbjct: 262 -ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-46
Identities = 66/330 (20%), Positives = 120/330 (36%), Gaps = 67/330 (20%)
Query: 686 FPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKS 742
+P++ + ND ++IG+G+FG V + + ++ + + + +K+ + +
Sbjct: 4 YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 743 FVAECEALRNI-RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSN----- 796
F E E L + H N+I ++ C E + + EY G+L D+L +S
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111
Query: 797 -----DQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV 851
+ Q L+ DVA + + +H DL N+L+ + VA +
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKI 168
Query: 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEM 911
DFGL+R E T + V ++A E + DV+S+G+LL E+
Sbjct: 169 ADFGLSRG---------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219
Query: 912 FTRRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEE 971
+ G+T E + +E
Sbjct: 220 VSLGGT----PYCGMTCAELYEKLPQGYRLEK-------------------------PLN 250
Query: 972 CLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001
C + + C E P ER ++ L
Sbjct: 251 CDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-45
Identities = 57/267 (21%), Positives = 107/267 (40%), Gaps = 32/267 (11%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
DF +G+G FG VY +++ +A+KV+ L++ G E E ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
N++++ + ++ EY G++ L + + F+ + + +
Sbjct: 66 PNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYITE 114
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+A A+ Y H ++H D+KP N+LL + DFG + P T
Sbjct: 115 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-------- 163
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP-TDNMFNDGLTLHEFAKM 934
+ GT+ Y+ PE G D++S G+L E + P N + + +
Sbjct: 164 --LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 221
Query: 935 ALPEKV----MEIVDPLLLLDLEARAS 957
P+ V +++ LL + R
Sbjct: 222 TFPDFVTEGARDLISRLLKHNPSQRPM 248
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (415), Expect = 2e-45
Identities = 62/270 (22%), Positives = 94/270 (34%), Gaps = 39/270 (14%)
Query: 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRN 757
FS IG GSFG VY N VA+K M+ + + + E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
I+ +V EY + + ++ +
Sbjct: 77 TIQYRGCY-----LREHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAVTHGAL 125
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+ YLH H ++H D+K N+LL + +GDFG A + P +
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------------ANS 170
Query: 878 IKGTVGYVAPEYGMG---GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLH----- 929
GT ++APE + G DV+S GI +E+ R+ P NM H
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230
Query: 930 --EFAKMALPEKVMEIVDPLLLLDLEARAS 957
E VD L + R +
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-45
Identities = 60/269 (22%), Positives = 104/269 (38%), Gaps = 30/269 (11%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRN 757
D+ +G+G++G V E AVAVK++++K+ ++ E + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
++K E + + + EY G L D + +
Sbjct: 65 VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLM 113
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+ YLH I H D+KP N+LLD + DFGLA + +L
Sbjct: 114 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL------NK 164
Query: 878 IKGTVGYVAPEYGMGGDMSATG-DVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM-- 934
+ GT+ YVAPE + A DV+S GI+L M P D + ++ +
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224
Query: 935 ------ALPEKVMEIVDPLLLLDLEARAS 957
+ + ++ +L+ + AR +
Sbjct: 225 YLNPWKKIDSAPLALLHKILVENPSARIT 253
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-45
Identities = 58/264 (21%), Positives = 103/264 (39%), Gaps = 34/264 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G G+FG VY+ E + A KV++ K + ++ E + L + H N++K++
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 78
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
+ I+ E+ G+++ + + Q + A+ YLH +
Sbjct: 79 ----YYENNLWILIEFCAGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHDN 129
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVA 886
I+H DLK N+L D + DFG++ T GT ++A
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--------RTIQRRDSFIGTPYWMA 178
Query: 887 PEYGMGGDMSATG-----DVYSFGILLLEMFTRRRPTDNMFNDGLTLH----EFAKMALP 937
PE M DV+S GI L+EM P + + L E +A P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238
Query: 938 EKV----MEIVDPLLLLDLEARAS 957
+ + + L +++AR +
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWT 262
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 4e-45
Identities = 69/290 (23%), Positives = 118/290 (40%), Gaps = 36/290 (12%)
Query: 677 SSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ 736
S ++E+ +VS D K ++ IGQG+ G VY VA++ MNL+Q
Sbjct: 1 SDEEILEKLRSIVSVGDPKK---KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 737 RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSN 796
+ + + E +R ++ N++ + D +V EY+ GSL D + ++
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETC 112
Query: 797 DQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856
Q + + A+E+LH + ++H D+K N+LL D + DFG
Sbjct: 113 MDEG-------QIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 162
Query: 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRR 916
+ P S + + GT ++APE D++S GI+ +EM
Sbjct: 163 CAQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 917 PTDNMFNDGLTLHEFAKMA---------LPEKVMEIVDPLLLLDLEARAS 957
P N N L+ A L + ++ L +D+E R S
Sbjct: 215 PYLNE-NPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 8e-45
Identities = 76/313 (24%), Positives = 114/313 (36%), Gaps = 53/313 (16%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNL---GENEMAVAVKVMN---LKQRGATKSFVAECEALRN 752
D +G GSFG V RG ++VAVK + L Q A F+ E A+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNL 812
+ HRNLI++ V + + +V E GSL D L + G+F +
Sbjct: 68 LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRY 116
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP 872
+ VA + YL +H DL N+LL + +GDFGL R LP +
Sbjct: 117 AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-----DHY 168
Query: 873 SSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932
K + APE S D + FG+ L EMFT + N
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------- 219
Query: 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI 992
+++ +D + + E+C I + V C P +R
Sbjct: 220 ----GSQILHKID---------------KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRP 260
Query: 993 QMTDVVAKLCSAR 1005
+ L A+
Sbjct: 261 TFVALRDFLLEAQ 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 3e-44
Identities = 60/307 (19%), Positives = 118/307 (38%), Gaps = 54/307 (17%)
Query: 700 DFSSSNMIGQGSFGFVYRG-NLGENE---MAVAVKVMNL-KQRGATKSFVAECEALRNIR 754
+F ++G G+FG VY+G + E E + VA+K + A K + E + ++
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
+ ++ +++ +C + + ++ + M G L D++ + N LN +
Sbjct: 70 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCV 118
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
+A + YL +VH DL NVL+ + DFGLA+ L E
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEYH 169
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934
+ G K + ++A E + + DV+S+G+ + E+ T DG+ E + +
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----PYDGIPASEISSI 225
Query: 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQM 994
+ + C + + I V C M R +
Sbjct: 226 LEKGERLPQ-------------------------PPICTIDVYMIMVKCWMIDADSRPKF 260
Query: 995 TDVVAKL 1001
+++ +
Sbjct: 261 RELIIEF 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 5e-44
Identities = 60/322 (18%), Positives = 107/322 (33%), Gaps = 61/322 (18%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQR-GATKSFVAECEALRN 752
N S +G G+FG V + M VAVK++ ++ ++E + L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 753 I-RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL------------ 799
+ H N++ ++ C ++ EY G L ++L + D
Sbjct: 83 LGNHMNIVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 800 EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859
+ ++ L+ VA + +L +H DL N+LL H + + DFGLAR
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 860 LPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTD 919
+ S + V ++APE + DV+S+GI L E+F+
Sbjct: 195 IKNDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 920 NMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRI 979
K +++ + E + I
Sbjct: 249 PGMPV------------DSKFYKMIKEGFRMLSP----------------EHAPAEMYDI 280
Query: 980 GVLCSMESPSERIQMTDVVAKL 1001
C P +R +V +
Sbjct: 281 MKTCWDADPLKRPTFKQIVQLI 302
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 6e-43
Identities = 61/271 (22%), Positives = 109/271 (40%), Gaps = 30/271 (11%)
Query: 696 KATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRN 752
K DF ++G+GSF V A+K++ + + E + +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNL 812
+ H +K+ F++ + Y + G L ++ + +G+F+
Sbjct: 65 LDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYIRK------IGSFDETCTRFY 113
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP 872
++ A+EYLH I+H DLKP N+LL+ DM + DFG A+ L P S
Sbjct: 114 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA----- 165
Query: 873 SSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932
+ GT YV+PE + D+++ G ++ ++ P N+ L +
Sbjct: 166 -RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKII 223
Query: 933 KMA------LPEKVMEIVDPLLLLDLEARAS 957
K+ K ++V+ LL+LD R
Sbjct: 224 KLEYDFPEKFFPKARDLVEKLLVLDATKRLG 254
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 157 bits (397), Expect = 1e-42
Identities = 54/270 (20%), Positives = 101/270 (37%), Gaps = 33/270 (12%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNL 758
+ + +G G+FG V+R A K + ++ E + + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 759 IKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
+ + FE+ + ++YE+M G L + + + + + + + V
Sbjct: 86 VNLHDA-----FEDDNEMVMIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCK 135
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPSSST 876
+ ++H + VH DLKP N++ + DFGL L P S
Sbjct: 136 GLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---------QSVK 183
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP---------TDNMFNDGLT 927
GT + APE G + D++S G+L + + P N+ +
Sbjct: 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 243
Query: 928 LHEFAKMALPEKVMEIVDPLLLLDLEARAS 957
+ + A + E + + LLL D R +
Sbjct: 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMT 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-42
Identities = 57/313 (18%), Positives = 116/313 (37%), Gaps = 53/313 (16%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQ-RGATKSFVAECEALRN 752
+ S +GQGSFG VY G E E VA+K +N F+ E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLE----VGNFNVIQ 808
++++++ V + ++ E M G L+ +L + + ++ +
Sbjct: 80 FNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 809 RLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATI 868
+ + ++A + YL+ + VH DL N ++ D +GDFG+ R +
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR- 190
Query: 869 LETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 928
V +++PE G + DV+SFG++L E+ T GL+
Sbjct: 191 -----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSN 241
Query: 929 HEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESP 988
+ + + +++ D C + + +C +P
Sbjct: 242 EQVLRFVMEGGLLDKPD-------------------------NCPDMLFELMRMCWQYNP 276
Query: 989 SERIQMTDVVAKL 1001
R ++++ +
Sbjct: 277 KMRPSFLEIISSI 289
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 149 bits (376), Expect = 1e-40
Identities = 57/287 (19%), Positives = 108/287 (37%), Gaps = 27/287 (9%)
Query: 695 SKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALR 751
S ++ + ++G G V+ VAVKV+ + F E +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 752 NIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLN 811
+ H ++ + + + IV EY++ +L D +H G + +
Sbjct: 63 ALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHT------EGPMTPKRAIE 115
Query: 812 LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILET 871
++ D A+ + H + I+H D+KP+N+++ V DFG+AR + +
Sbjct: 116 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG-----NS 167
Query: 872 PSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP---------TDNMF 922
+ + + GT Y++PE G + A DVYS G +L E+ T P
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227
Query: 923 NDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKI 969
+ L + +V L + E R R ++ ++
Sbjct: 228 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 58/307 (18%), Positives = 107/307 (34%), Gaps = 54/307 (17%)
Query: 699 NDFSSSNMIGQGSFGFVYRG---NLGENEMAVAVKVM-NLKQRGATKSFVAECEALRNIR 754
IG+G FG V++G + +AVA+K N + F+ E +R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
H +++K+I V + + I+ E G L +L L++ +
Sbjct: 67 HPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLA-----SLILYAY 115
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
++ A L + VH D+ NVL+ + +GDFGL+R++ T
Sbjct: 116 QLSTA---LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYK 165
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934
++ K + ++APE ++ DV+ FG+ + E+ + +
Sbjct: 166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 225
Query: 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQM 994
L L + +C PS R +
Sbjct: 226 ERLPMPPNCPPTLYSL------------------MTKCWA-----------YDPSRRPRF 256
Query: 995 TDVVAKL 1001
T++ A+L
Sbjct: 257 TELKAQL 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 149 bits (376), Expect = 7e-40
Identities = 50/262 (19%), Positives = 94/262 (35%), Gaps = 33/262 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G G+FG V+R K +N + E + + H LI +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 94
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
FE+ ++ E++ G L D + + + + +N + ++++H H
Sbjct: 95 ---FEDKYEMVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH 146
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPSSSTGIKGTVGY 884
IVH D+KP N++ + + V DFGLA L P T +
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---------DEIVKVTTATAEF 194
Query: 885 VAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP---------TDNMFNDGLTLHEFAKMA 935
APE + D+++ G+L + + P N+ E A +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 936 LPEKVMEIVDPLLLLDLEARAS 957
+ + + + LL + R +
Sbjct: 255 VSPEAKDFIKNLLQKEPRKRLT 276
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-38
Identities = 62/319 (19%), Positives = 111/319 (34%), Gaps = 56/319 (17%)
Query: 699 NDFSSSNMIGQGSFGFVYRG-------NLGENEMAVAVKVMNLKQ-RGATKSFVAECEAL 750
+ +G+G+FG V + VAVK++ ++E E +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 751 RNI-RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQR 809
+ I +H+N+I ++ C + ++ EY G+L ++L ++N
Sbjct: 73 KMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 810 LNLVIDVAFAIEY-------LHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPP 862
+ + + + +H DL NVL+ D V + DFGLAR +
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 863 CSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMF 922
+ +T + V ++APE + DV+SFG+LL E+FT
Sbjct: 188 I------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----P 237
Query: 923 NDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVL 982
G+ + E K+ M+ C + +
Sbjct: 238 YPGVPVEELFKLLKEGHRMDK-------------------------PSNCTNELYMMMRD 272
Query: 983 CSMESPSERIQMTDVVAKL 1001
C PS+R +V L
Sbjct: 273 CWHAVPSQRPTFKQLVEDL 291
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 145 bits (367), Expect = 1e-38
Identities = 58/283 (20%), Positives = 101/283 (35%), Gaps = 39/283 (13%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK------QRGATKSFVAECEALRN 752
NDFS +IG+G FG VY + A+K ++ K + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNL 812
++ + F D + + + M G L L Q E
Sbjct: 64 GDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSE------ADMRFY 112
Query: 813 VIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETP 872
++ +E++H+ +V+ DLKP+N+LLD + D GLA +
Sbjct: 113 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF----------SK 159
Query: 873 SSSTGIKGTVGYVAPEYGMGGDM-SATGDVYSFGILLLEMFTRRRPTD--------NMFN 923
GT GY+APE G ++ D +S G +L ++ P +
Sbjct: 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 219
Query: 924 DGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEI 966
LT+ + ++ +++ LL D+ R G E+
Sbjct: 220 MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 262
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-38
Identities = 57/262 (21%), Positives = 109/262 (41%), Gaps = 34/262 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G+G FG V+R ++ K + +K E L RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHES-- 69
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
FE ++ +++E++ + + ++ S N + ++ V V A+++LH H
Sbjct: 70 ---FESMEELVMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH 121
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHV--GDFGLARFLPPCSPATILETPSSSTGIKGTVGY 884
I H D++P N++ + + +FG AR L P + + Y
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---------LFTAPEY 169
Query: 885 VAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP---------TDNMFNDGLTLHEFAKMA 935
APE +S D++S G L+ + + P +N+ N T E A
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 936 LPEKVMEIVDPLLLLDLEARAS 957
+ + M+ VD LL+ + ++R +
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMT 251
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (355), Expect = 1e-37
Identities = 52/270 (19%), Positives = 93/270 (34%), Gaps = 30/270 (11%)
Query: 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ-RGATKSFVAECEALRNIRHR 756
+ + +++G G+F V + VA+K + K G S E L I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
N++ + + +E ++ + + G L D + + G + L+ V
Sbjct: 68 NIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVEK------GFYTERDASRLIFQV 116
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
A++YLH LD D + DFGL++ P S +
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS--------- 167
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPT---------DNMFNDGLT 927
GT GYVAPE S D +S G++ + P + +
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 227
Query: 928 LHEFAKMALPEKVMEIVDPLLLLDLEARAS 957
+ + + + L+ D E R +
Sbjct: 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFT 257
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 140 bits (353), Expect = 3e-37
Identities = 64/280 (22%), Positives = 109/280 (38%), Gaps = 41/280 (14%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
DF +G GSFG V+ N A+KV+ + + + E L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
+I++ ++ ++ +Y+E G L L +S +
Sbjct: 64 PFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPN------PVAKFYAAE 112
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
V L + I++ DLKP N+LLD + + DFG A+++ P +
Sbjct: 113 VC---LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----------PDVT 158
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935
+ GT Y+APE + + D +SFGIL+ EM P F D T+ + K+
Sbjct: 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEKIL 214
Query: 936 ---------LPEKVMEIVDPLLLLDLEARASNCGSHRTEI 966
E V +++ L+ DL R N + ++
Sbjct: 215 NAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 6e-37
Identities = 61/310 (19%), Positives = 121/310 (39%), Gaps = 27/310 (8%)
Query: 694 LSKATNDFSSSNMIGQGSFGFVYRG-NLGENEMAVAVKVMNLK--QRGATKSFVAECEAL 750
L +A + IG+G++G V++ +L VA+K + ++ + G S + E L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 751 RNI---RHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVI 807
R++ H N++++ VC+ + +V+E+++
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-----PGVPTE 116
Query: 808 QRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPAT 867
+++ + +++LH H +VH DLKP N+L+ + DFGLAR
Sbjct: 117 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-- 171
Query: 868 ILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLT 927
T + T+ Y APE + + D++S G + EMF R+ +D
Sbjct: 172 -------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQ 223
Query: 928 LHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMES 987
L + + + + L + + + I+E ++ C +
Sbjct: 224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFN 280
Query: 988 PSERIQMTDV 997
P++RI
Sbjct: 281 PAKRISAYSA 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-36
Identities = 58/268 (21%), Positives = 105/268 (39%), Gaps = 31/268 (11%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEAL-RNIR 754
DF M+G+GSFG V+ + A+K + + + + E L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
H L + + + V EY+ G L + F++ +
Sbjct: 62 HPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYAA 110
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSS 874
++ +++LH IV+ DLK N+LLD D + DFG+ + +
Sbjct: 111 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML--------GDAK 159
Query: 875 STGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP-----TDNMFNDGLTLH 929
+ GT Y+APE +G + + D +SFG+LL EM + P + +F+ +
Sbjct: 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 219
Query: 930 EFAKMALPEKVMEIVDPLLLLDLEARAS 957
F L ++ +++ L + + E R
Sbjct: 220 PFYPRWLEKEAKDLLVKLFVREPEKRLG 247
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 137 bits (346), Expect = 1e-36
Identities = 56/283 (19%), Positives = 106/283 (37%), Gaps = 48/283 (16%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---------RGATKSFVAECEAL 750
++ ++G+G V R AVK++++ + ++ + E + L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 751 RNIR-HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQR 809
R + H N+I++ +E F +V++ M+ G L D+L + + +
Sbjct: 64 RKVSGHPNIIQLKD-----TYETNTFFFLVFDLMKKGELFDYLTEK------VTLSEKET 112
Query: 810 LNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATIL 869
++ + I LH IVH DLKP N+LLD DM + DFG + L P
Sbjct: 113 RKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP------- 162
Query: 870 ETPSSSTGIKGTVGYVAPEYGMGGDMSATG------DVYSFGILLLEMFTRRRP------ 917
+ GT Y+APE D++S G+++ + P
Sbjct: 163 --GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 220
Query: 918 ---TDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARAS 957
+ + + V ++V L++ + R +
Sbjct: 221 MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 54/319 (16%), Positives = 108/319 (33%), Gaps = 56/319 (17%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNL-----GENEMAVAVKVMNLKQ-RGATKSFVAECEALRN 752
+ +G+G+FG V + VAVK++ ++ ++E + L +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 753 IRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQ----------LEVG 802
I H + + ++ E+ + G+L +L ++ L
Sbjct: 73 IGHHL---NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 803 NFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPP 862
+ + VA +E+L +H DL N+LL V + DFGLAR +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 863 CSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMF 922
+ + ++APE + DV+SFG+LL E+F+
Sbjct: 187 D------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---- 236
Query: 923 NDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVL 982
+ + + E+ + + + + + +
Sbjct: 237 --------YPGVKIDEEFCRRLKEGTRMRA----------------PDYTTPEMYQTMLD 272
Query: 983 CSMESPSERIQMTDVVAKL 1001
C PS+R +++V L
Sbjct: 273 CWHGEPSQRPTFSELVEHL 291
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 1e-36
Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 19/222 (8%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVC 765
IG GSFG +Y G VA+K+ +K + E + + ++ I I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH 825
E D+ +V E + + + S F++ L L + IEY+H
Sbjct: 72 ----GAEGDYNVMVMELLGPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHS 121
Query: 826 HCHPPIVHGDLKPSNVL---LDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTV 882
+H D+KP N L + ++ DFGLA+ + + + GT
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN-LTGTA 177
Query: 883 GYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFND 924
Y + +G + S D+ S G +L+ P +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-35
Identities = 54/244 (22%), Positives = 99/244 (40%), Gaps = 18/244 (7%)
Query: 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN-LKQRGATKSFVAECEALRNIRHR 756
+++ + IG+G++G V N++ VA+K ++ + + + + E + L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
N+I I + + E++ +V M L L + + + +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLKT-------QHLSNDHICYFLYQI 118
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
++Y+H ++H DLKPSN+LL+ + DFGLAR P + T
Sbjct: 119 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-----DHTGFLT 170
Query: 877 GIKGTVGYVAPEYGMGGDM-SATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935
T Y APE + + + D++S G +L EM + R H +
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 936 LPEK 939
P +
Sbjct: 231 SPSQ 234
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-35
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 22/221 (9%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLI 759
++ + +IG GSFG VY+ L ++ VA+K + +R E + +R + H N++
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIV 76
Query: 760 KIITVC-SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAF 818
++ SS + ++ + +V +Y+ H S + VI + +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFR 133
Query: 819 AIEYLHHHCHPPIVHGDLKPSNVLLDHD-MVAHVGDFGLARFLPPCSPATILETPSSSTG 877
++ Y+H I H D+KP N+LLD D V + DFG A+ L P +
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---------NVS 181
Query: 878 IKGTVGYVAPEYGMGGDM-SATGDVYSFGILLLEMFTRRRP 917
+ Y APE G +++ DV+S G +L E+ +
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 62/299 (20%), Positives = 111/299 (37%), Gaps = 31/299 (10%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-----GATKSFVAECEALRNIRHRNLI 759
+ +G+G F VY+ VA+K + L R G ++ + E + L+ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 760 KIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFA 819
++ ++V+++ME S ++
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNS------LVLTPSHIKAYMLMTLQG 112
Query: 820 IEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIK 879
+EYLH H I+H DLKP+N+LLD + V + DFGLA+ + T
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG--------SPNRAYTHQV 161
Query: 880 GTVGYVAPEYGMGGDM-SATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPE 938
T Y APE G M D+++ G +L E+ R + F + P
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 221
Query: 939 KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDV 997
+ L + ++ + + L+ +++ + +P RI T
Sbjct: 222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQA 277
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-34
Identities = 65/308 (21%), Positives = 127/308 (41%), Gaps = 24/308 (7%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK--QRGATKSFVAECEALRNIRHR 756
+ + IGQG+FG V++ + VA+K + ++ + G + + E + L+ ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 757 NLIKIITVCSSIDFEEVDFKA---IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLV 813
N++ +I +C + K +V+++ E + + F + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV------LVKFTLSEIKRVM 123
Query: 814 IDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPS 873
+ + L++ I+H D+K +NVL+ D V + DFGLAR P+
Sbjct: 124 QML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN----SQPN 176
Query: 874 SSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRP-TDNMFNDGLTLHEF 931
T T+ Y PE +G D D++ G ++ EM+TR N L L
Sbjct: 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236
Query: 932 AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSM--ESPS 989
++ +V VD L E G R +++ + + ++ + P+
Sbjct: 237 LCGSITPEVWPNVDNYEL--YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
Query: 990 ERIQMTDV 997
+RI D
Sbjct: 295 QRIDSDDA 302
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-33
Identities = 50/270 (18%), Positives = 96/270 (35%), Gaps = 42/270 (15%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLK------QRGATKSFVAECEALRNIRHRNLIK 760
+G G F V + + A K + + + + + E L+ I+H N+I
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 761 IITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAI 820
+ V +E ++ E + G L D+L + E ++++ +
Sbjct: 78 LHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI---------L 123
Query: 821 EYLHHHCHPPIVHGDLKPSNVLLDHDMVA----HVGDFGLARFLPPCSPATILETPSSST 876
+++ I H DLKP N++L V + DFGLA + +
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---------GNEFK 174
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTD---------NMFNDGLT 927
I GT +VAPE + D++S G++ + + P N+
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 928 LHEFAKMALPEKVMEIVDPLLLLDLEARAS 957
+ + + LL+ D + R +
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMT 264
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-33
Identities = 52/269 (19%), Positives = 101/269 (37%), Gaps = 39/269 (14%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEAL-RNIRHRNLIKIITV 764
++G G G V + + A+K++ + E E R + ++++I+ V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 765 CSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLH 824
++ IV E ++ G L + DQ F + ++ + AI+YLH
Sbjct: 74 YENLYAGRKCL-LIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH 128
Query: 825 HHCHPPIVHGDLKPSNVLLDH---DMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGT 881
I H D+KP N+L + + + DFG A+ +S T T
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---------HNSLTTPCYT 176
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM------- 934
YVAPE + D++S G+++ + P + ++ ++
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236
Query: 935 ------ALPEKVMEIVDPLLLLDLEARAS 957
+ E+V ++ LL + R +
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMT 265
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 127 bits (320), Expect = 5e-33
Identities = 41/268 (15%), Positives = 85/268 (31%), Gaps = 36/268 (13%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
IG+GSFG ++ G N VA+K +R E + + I +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF- 69
Query: 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHH 826
+E +V + + + F+V + ++ +H
Sbjct: 70 ---GQEGLHNVLVIDLLGPSLEDLLDLCGR------KFSVKTVAMAAKQMLARVQSIHEK 120
Query: 827 CHPPIVHGDLKPSNVLLDHDMVAHVG-----DFGLARFLPPCSPATILETPSSSTGIKGT 881
+V+ D+KP N L+ + DFG+ +F + + GT
Sbjct: 121 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN-LSGT 176
Query: 882 VGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA------ 935
Y++ +G + S D+ + G + + P + ++ ++
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-NKQKYERIGEKKQST 235
Query: 936 --------LPEKVMEIVDPLLLLDLEAR 955
PE+ + + L +A
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 6e-33
Identities = 59/276 (21%), Positives = 96/276 (34%), Gaps = 30/276 (10%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN---LKQRGATKSFVAECEALRNIRH 755
NDF ++G+G+FG V A+K++ + + V E L+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
L + + D V EY G L L + E +
Sbjct: 65 PFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI----- 114
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+ L + +V+ D+K N++LD D + DFGL + ++
Sbjct: 115 ----VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------ATM 162
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP-----TDNMFNDGLTLHE 930
GT Y+APE D D + G+++ EM R P + +F L
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222
Query: 931 FAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEI 966
L + ++ LL D + R S E+
Sbjct: 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 6e-32
Identities = 52/303 (17%), Positives = 106/303 (34%), Gaps = 28/303 (9%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHR 756
+ IG+G++G V++ E VA+K + L G S + E L+ ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
N++++ V +V+E+ + + + + D + + +L
Sbjct: 62 NIVRLHDV-----LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------ 110
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
++ L ++H DLKP N+L++ + + +FGLAR S
Sbjct: 111 ---LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-------PVRCYSA 160
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP--TDNMFNDGLTLHEFAKM 934
+ S + D++S G + E+ RP N +D L
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQM 994
E+ + L S + K+ +++ +P +RI
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISA 277
Query: 995 TDV 997
+
Sbjct: 278 EEA 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 7e-32
Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 24/221 (10%)
Query: 700 DFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRN 757
+F IG+G++G VY+ VA+K + L G + + E L+ + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
++K++ V + +V+E++ + + + + + +
Sbjct: 63 IVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASAL-----TGIPLPLIKSYLFQLL 112
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTG 877
+ + H H ++H DLKP N+L++ + + DFGLAR + T
Sbjct: 113 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG--------VPVRTYTH 161
Query: 878 IKGTVGYVAPE-YGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T+ Y APE S D++S G + EM TRR
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (312), Expect = 2e-31
Identities = 62/305 (20%), Positives = 114/305 (37%), Gaps = 37/305 (12%)
Query: 670 RKHKHKSSSMLLMEQQFPMVSYADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAV 729
++ K+ L + + P + A L + F +G GSFG V E+ A+
Sbjct: 16 KEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAM 71
Query: 730 KVMN---LKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECG 786
K+++ + + + + E L+ + L+K+ ++ +V EY+ G
Sbjct: 72 KILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVAGG 126
Query: 787 SLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD 846
+ L + G F+ + EYLH +++ DLKP N+L+D
Sbjct: 127 EMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQ 177
Query: 847 MVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGI 906
V DFG A+ + + GT +APE + + D ++ G+
Sbjct: 178 GYIQVTDFGFAKR-----------VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 907 LLLEMFTRRRP-TDNMFNDGLTLHEFAKMALPEKV----MEIVDPLLLLDLEARASNCGS 961
L+ EM P + K+ P +++ LL +DL R N +
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKN 286
Query: 962 HRTEI 966
+I
Sbjct: 287 GVNDI 291
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-31
Identities = 49/262 (18%), Positives = 90/262 (34%), Gaps = 34/262 (12%)
Query: 706 MIGQGSFGFVYRGNLGENEMAVAVKVMNLK------QRGATKSFVAECEALRNIR--HRN 757
++G G FG VY G + + VA+K + + E L+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
+I+++ E D ++ E E G + V
Sbjct: 71 VIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVL 120
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHD-MVAHVGDFGLARFLPPCSPATILETPSSST 876
A+ + H+ ++H D+K N+L+D + + DFG L + T
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK----------DTVYT 167
Query: 877 GIKGTVGYVAPEYGMGGD-MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935
GT Y PE+ + V+S GILL +M P ++ + + F +
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-EEIIRGQVFFRQR 226
Query: 936 LPEKVMEIVDPLLLLDLEARAS 957
+ + ++ L L R +
Sbjct: 227 VSSECQHLIRWCLALRPSDRPT 248
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 120 bits (301), Expect = 1e-30
Identities = 51/302 (16%), Positives = 104/302 (34%), Gaps = 28/302 (9%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHR 756
+ IG+G++G VY+ E A+K + L++ G + + E L+ ++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 757 NLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDV 816
N++K+ V +V+E+++ + G + + ++ +
Sbjct: 61 NIVKLYDVI-----HTKKRLVLVFEHLDQDLKKLLDVCE------GGLESVTAKSFLLQL 109
Query: 817 AFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSST 876
+ + ++H DLKP N+L++ + + DFGLAR +
Sbjct: 110 L---NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI-------PVRKYTH 159
Query: 877 GIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMAL 936
I S T D++S G + EM + + F +
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219
Query: 937 P-EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMT 995
P K V L D + + ++E + ++ P++RI
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAK 276
Query: 996 DV 997
Sbjct: 277 QA 278
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (296), Expect = 2e-29
Identities = 51/250 (20%), Positives = 99/250 (39%), Gaps = 30/250 (12%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-HRN 757
+D+ +G+G + V+ N V VK++ ++ K E + L N+R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 758 LIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVA 817
+I + + A+V+E++ + + ++
Sbjct: 92 IITLADIVKDPVSRTP---ALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEIL 139
Query: 818 FAIEYLHHHCHPPIVHGDLKPSNVLLDHD-MVAHVGDFGLARFLPPCSPATILETPSSST 876
A++Y H I+H D+KP NV++DH+ + D+GLA F P +
Sbjct: 140 KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV-------- 188
Query: 877 GIKGTVGYVAPEYGMGGDM-SATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935
+ + PE + M + D++S G +L M R+ P + ++ L AK+
Sbjct: 189 -RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247
Query: 936 LPEKVMEIVD 945
E + + +D
Sbjct: 248 GTEDLYDYID 257
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 2e-29
Identities = 55/286 (19%), Positives = 104/286 (36%), Gaps = 38/286 (13%)
Query: 699 NDFSSSNMIGQGSFGFVYRG---NLGENEMAVAVKVMN----LKQRGATKSFVAECEALR 751
+F ++G G++G V+ + + A+KV+ +++ T+ E + L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 752 NIRHRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLN 811
+IR + + F+ ++ +Y+ G L L Q E + +
Sbjct: 84 HIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI- 138
Query: 812 LVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILET 871
+ L H I++ D+K N+LLD + + DFGL++
Sbjct: 139 --------VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE------- 183
Query: 872 PSSSTGIKGTVGYVAPEYGMGGDMSATG--DVYSFGILLLEMFTRRRP---------TDN 920
+ GT+ Y+AP+ GGD D +S G+L+ E+ T P
Sbjct: 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 243
Query: 921 MFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEI 966
+ L + +++ LL+ D + R EI
Sbjct: 244 ISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 289
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 4e-29
Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 26/215 (12%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMN--LKQRGATKSFVAECEALRNIRHRNLIKIITV 764
+G G++G V G VA+K + + K E L+++RH N+I ++ V
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 765 CSSID-FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYL 823
+ + ++ +V +M G+ L + + LV + + Y+
Sbjct: 86 FTPDETLDDFTDFYLVMPFM--GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYI 137
Query: 824 HHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVG 883
H H DLKP N+ ++ D + DFGLAR S TG T
Sbjct: 138 HAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA-----------DSEMTGYVVTRW 183
Query: 884 YVAPEYGMGGD-MSATGDVYSFGILLLEMFTRRRP 917
Y APE + + T D++S G ++ EM T +
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 7e-29
Identities = 49/222 (22%), Positives = 88/222 (39%), Gaps = 24/222 (10%)
Query: 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN--LKQRGATKSFVAECEALRNIRHR 756
+ + IG G+ G V + VA+K ++ + + K E ++ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 757 NLIKIITVCSSID-FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
N+I ++ V + EE +V E M+ + + + + + L+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE---------RMSYLLYQ 127
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+ I++LH +H DLKPSN+++ D + DFGLAR T
Sbjct: 128 MLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP------- 177
Query: 876 TGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T Y APE +G D++S G ++ EM +
Sbjct: 178 --YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 114 bits (286), Expect = 2e-28
Identities = 81/323 (25%), Positives = 125/323 (38%), Gaps = 20/323 (6%)
Query: 33 NETDRLALLAIKSQLQDPLGVTSSWNNSMNLCQ--WTGVTC--GHRHQRVTVLDLSNRSI 88
N D+ ALL IK L +P SSW + + C W GV C + RV LDLS ++
Sbjct: 4 NPQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 89 EGI--LSPYVGNLSFLRFINFANN-GFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLS 145
+ + NL +L F+ G IP I +L +L L + + + SG IP LS
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 146 RCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIG 205
+ L+ N L G +PP I S L ++ N ++G + S G+ S L
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 206 ENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNI 265
+L ++ +S N G + + + I L N L L
Sbjct: 182 SRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG 241
Query: 266 GFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSF 325
N +L N G+LP L+ L L+ S N+ G++ L ++
Sbjct: 242 LSKNLNGLDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAY 298
Query: 326 SKNNLGTGAIGDLDFIAHLTNCS 348
+ N G + L C+
Sbjct: 299 ANNKCLCG--------SPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 91.0 bits (224), Expect = 2e-20
Identities = 71/270 (26%), Positives = 110/270 (40%), Gaps = 31/270 (11%)
Query: 389 NLVNLNGFGLEYNQLTG--PIPHAIGELRNLQVLDLHHN-NLDGHIPESLGNLTILNSLD 445
+N L L PIP ++ L L L + NL G IP ++ LT L+ L
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 446 LGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIP 505
+ + G +P L + L+ L S N L+G LPP I + + + GN ++G+IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL-PNLVGITFDGNRISGAIP 166
Query: 506 AEVGNLKNLVQ-LGLSENRFSNEIPVSLSACTTLEYL----------------------Y 542
G+ L + +S NR + +IP + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 543 MEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPR 602
+ + K++ LDL N + G +P+ L L FL LN+S+N+L GE+P+
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 603 RGVFSNKTRFYFTGNKRLCGGLDELHLPVC 632
G + NK LCG LP C
Sbjct: 287 GGNLQRFDVSAYANNKCLCGS----PLPAC 312
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 1e-27
Identities = 48/223 (21%), Positives = 88/223 (39%), Gaps = 24/223 (10%)
Query: 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMN--LKQRGATKSFVAECEALRNIRH 755
+ + + +G G++G V + + VAVK ++ + K E L++++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 756 RNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVID 815
N+I ++ V + E + ++ L + + L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQ 129
Query: 816 VAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSS 875
+ ++Y+H H DLKPSN+ ++ D + DFGLAR
Sbjct: 130 ILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE-----------M 175
Query: 876 TGIKGTVGYVAPEYGMGGDM-SATGDVYSFGILLLEMFTRRRP 917
TG T Y APE + + T D++S G ++ E+ T R
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (276), Expect = 9e-27
Identities = 44/217 (20%), Positives = 83/217 (38%), Gaps = 15/217 (6%)
Query: 707 IGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCS 766
+G G F V+ N VA+K++ + T++ E + L+ + + K ++ +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 767 S-----IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIE 821
+ +D V+ M L + L + E +I + + ++
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 822 YLHHHCHPPIVHGDLKPSNVLLD-HDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKG 880
Y+H C I+H D+KP NVL++ D ++ +A C T
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW------YDEHYTNSIQ 191
Query: 881 TVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRP 917
T Y +PE +G D++S L+ E+ T
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 106 bits (265), Expect = 4e-25
Identities = 75/412 (18%), Positives = 137/412 (33%), Gaps = 60/412 (14%)
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLG 254
++ +G+ ++ + + L + L I S++ +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRL-----------GIKSIDGVE--- 63
Query: 255 NRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDF 314
L NL ++ N T P L N + L + + N + +
Sbjct: 64 -------------YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLAN 108
Query: 315 NRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSST 374
L ++ + + + + + + + ++
Sbjct: 109 LTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL 168
Query: 375 IILFSMGLNQIYVK------------NLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDL 422
L ++ + L NL NQ++ P I NL L L
Sbjct: 169 KPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSL 226
Query: 423 HHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQ 482
+ N L +L +LT L LDL N++ P L L L + N+++ P
Sbjct: 227 NGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 280
Query: 483 ILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLY 542
+ L+ L +L N + + NLKNL L L N S+ P +S+ T L+ L+
Sbjct: 281 ---LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 335
Query: 543 MEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYN 594
N ++ +L L +I L N +S P L NL+ + L L+
Sbjct: 336 FANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.5 bits (218), Expect = 4e-19
Identities = 77/399 (19%), Positives = 140/399 (35%), Gaps = 60/399 (15%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
+VT L I+ I V L+ L INF+NN + P + L +L +++ NN
Sbjct: 44 DQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99
Query: 136 FSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGN 195
+ P + + + + L+L
Sbjct: 100 IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS------------------ 141
Query: 196 ISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGN 255
+++ + +L L+ + G + + +++L ++ L
Sbjct: 142 -------------------NTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDI 182
Query: 256 RLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFN 315
+++ L NLE+L N + P +NL L + N
Sbjct: 183 SSNKVSDISVLAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKDI--GTLA 238
Query: 316 RLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPL-SIANLSST 374
L NL L + N + +A L+ +KL L L N + PL + L++
Sbjct: 239 SLTNLTDLDLANNQISN--------LAPLSGLTKLTELKLGANQISNISPLAGLTALTNL 290
Query: 375 IILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPES 434
+ + + + NL NL L +N ++ P + L LQ L +N + S
Sbjct: 291 ELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSS 346
Query: 435 LGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNN 473
L NLT +N L G N++ P L N + L +++
Sbjct: 347 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 79.3 bits (194), Expect = 4e-16
Identities = 78/425 (18%), Positives = 139/425 (32%), Gaps = 65/425 (15%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
L ++ +S +L + + G I G + L L + +NN
Sbjct: 22 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQ 77
Query: 136 FSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGN 195
+ P L + L++ N + P + G +
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNL-------------TGLTLFNNQI 122
Query: 196 ISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGN 255
+ ++ +++ + +L L+ + G + + +++L ++ L
Sbjct: 123 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDI 182
Query: 256 RLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFN 315
+++ L NLE+L N + P +NL L + N
Sbjct: 183 SSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKDI--GTLA 238
Query: 316 RLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTI 375
L NL L + N + +A L+ +KL L L N + PL
Sbjct: 239 SLTNLTDLDLANNQISN--------LAPLSGLTKLTELKLGANQISNISPL--------- 281
Query: 376 ILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESL 435
L L L NQ I L+NL L L+ NN+ P +
Sbjct: 282 ------------AGLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISDISP--V 325
Query: 436 GNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSIL--L 493
+LT L L NK+ SSL N N+ LS +N+++ P + L+ + L
Sbjct: 326 SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP-----LANLTRITQL 378
Query: 494 DLSGN 498
L+
Sbjct: 379 GLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.7 bits (190), Expect = 1e-15
Identities = 40/199 (20%), Positives = 75/199 (37%), Gaps = 15/199 (7%)
Query: 57 WNNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEI 116
+ Q + +T + L L+ ++ I + +L+ L ++ ANN S
Sbjct: 200 ESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA 257
Query: 117 PGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLE 176
P + L +L L L N S P + L N + L
Sbjct: 258 P--LSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDISPISNLKNLT 310
Query: 177 FLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGM 236
+L+L N ++ + +++ LQ L N++S SL L ++ +LS N S +
Sbjct: 311 YLTLYFNNISDI--SPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDL 366
Query: 237 FPSSIFNISSLESISLLGN 255
P + N++ + + L
Sbjct: 367 TP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.3 bits (189), Expect = 2e-15
Identities = 74/374 (19%), Positives = 132/374 (35%), Gaps = 36/374 (9%)
Query: 174 KLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAF 233
++ L + + + ++NL ++ N+L+ P L L L + ++ N
Sbjct: 45 QVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100
Query: 234 SGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNA 293
+ + P + + ++ L + L + ++ + L
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ--- 157
Query: 294 SNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEAL 353
L L RL S N + I+ L + LE+L
Sbjct: 158 -------QLSFGNQVTDLKPLANLTTLERLDISSNK--------VSDISVLAKLTNLESL 202
Query: 354 GLDTNIFGGVLPLSIANLSSTIILFSMGLNQI-YVKNLVNLNGFGLEYNQLTGPIPHAIG 412
N + PL I + L L I + +L NL L NQ++ P +
Sbjct: 203 IATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LS 260
Query: 413 ELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSN 472
L L L L N + P L LT L +L+L N+L P S N +NL L++
Sbjct: 261 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYF 316
Query: 473 NKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSL 532
N ++ P + + L L + N ++ + + NL N+ L N+ S+ P L
Sbjct: 317 NNISDISP--VSSLTKLQR-LFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--L 369
Query: 533 SACTTLEYLYMEGN 546
+ T + L +
Sbjct: 370 ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.7 bits (164), Expect = 2e-12
Identities = 70/327 (21%), Positives = 110/327 (33%), Gaps = 61/327 (18%)
Query: 312 IDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANL 371
+ L + L + I +D + +L N L + N + PL NL
Sbjct: 38 VSQTDLDQVTTLQADRLG-----IKSIDGVEYLNN---LTQINFSNNQLTDITPLK--NL 87
Query: 372 SSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHI 431
+ + + + L NL + +N I
Sbjct: 88 TKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDI 147
Query: 432 --------------------PESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVS 471
+ L NLT L LD+ NK+ + NL L +
Sbjct: 148 SALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA--KLTNLESLIAT 205
Query: 472 NNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVS 531
NN+++ P IL + L L+GN L + +L NL L L+ N+ SN P
Sbjct: 206 NNQISDITPLGILTNLD---ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP-- 258
Query: 532 LSACTTLEYLYMEGNSLTGSIPLALKT--------------------LKSIKELDLSRNN 571
LS T L L + N ++ PLA T LK++ L L NN
Sbjct: 259 LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318
Query: 572 LSGQIPEFLENLSFLEYLNLSYNHLEG 598
+S P + +L+ L+ L + N +
Sbjct: 319 ISDISP--VSSLTKLQRLFFANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 1e-06
Identities = 57/283 (20%), Positives = 101/283 (35%), Gaps = 21/283 (7%)
Query: 345 TNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIY-VKNLVNLNGFGLEYNQL 403
T ++ L + + + +T+ +G+ I V+ L NL NQL
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQL 78
Query: 404 TGPIPHAIGELRNLQVLDL------------HHNNLDGHIPESLGNLTILNSLDLGFNKL 451
T P + L L + + + NL G + I +L
Sbjct: 79 TDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136
Query: 452 RGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNL 511
+++ + L L+ G + + L+ L L + S + + L
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196
Query: 512 KNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNN 571
NL L + N+ S+ P+ + T L+ L + GN L L +L ++ +LDL+ N
Sbjct: 197 TNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 252
Query: 572 LSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYF 614
+S P L L+ L L L N + P G+ +
Sbjct: 253 ISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELN 293
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.7 bits (208), Expect = 3e-18
Identities = 47/217 (21%), Positives = 85/217 (39%), Gaps = 11/217 (5%)
Query: 407 IPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLM 466
+P + + +LDL +N + NL L++L L NK+ P + L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 467 LLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGL--SENRF 524
L +S N+L LP ++ + L + N +T + L ++ + L + +
Sbjct: 83 RLYLSKNQLKE-LPEKMPKTLQ---ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 138
Query: 525 SNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLS 584
S + L Y+ + ++T +IP L S+ EL L N ++ L+ L+
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLN 195
Query: 585 FLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLC 621
L L LS+N + + R N +L
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.4 bits (202), Expect = 2e-17
Identities = 51/292 (17%), Positives = 94/292 (32%), Gaps = 22/292 (7%)
Query: 64 CQWTGVTCGHRH---------QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSG 114
C V C +LDL N I I NL L + NN S
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 115 EIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLK 174
PG L +LE L L+ N L + + + + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL--NQMI 127
Query: 175 LEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFS 234
+ L +G + + L + I + ++ +P L SL L + N +
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184
Query: 235 GMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNAS 294
+ +S+ +++L + L N + + P+L L + NN +P L++
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAV-DNGSLANTPHLRELHL-NNNKLVKVPGGLADHK 242
Query: 295 NLRLLDFSLNHFSG------QVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDF 340
++++ N+ S + + +S N + I F
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF 294
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.8 bits (185), Expect = 2e-15
Identities = 51/267 (19%), Positives = 92/267 (34%), Gaps = 11/267 (4%)
Query: 237 FPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNL 296
P + + L N++ + +L NL L + N + P + + L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFK-NLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 297 RLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCS-KLEALGL 355
L S N + L L + L+ + + + L++ G+
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 356 DTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELR 415
+ F G+ LS ++ T + I +L L+ N++T ++ L
Sbjct: 142 ENGAFQGMKKLSYIRIADT------NITTIPQGLPPSLTELHLDGNKITKVDAASLKGLN 195
Query: 416 NLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKL 475
NL L L N++ SL N L L L NKL VP L + + + ++ + NN +
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254
Query: 476 TGALPPQILGIVTLSILLDLSGNLLTG 502
+ + SG L
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFS 281
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.8 bits (185), Expect = 3e-15
Identities = 60/269 (22%), Positives = 102/269 (37%), Gaps = 17/269 (6%)
Query: 350 LEALGLDTNIFGGVLPLSIANLSS--TIILFSMGLNQIY---VKNLVNLNGFGLEYNQLT 404
L L N + NL + T+IL + +++I LV L L NQL
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 405 GPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQN 464
L+ L+V + + + L + ++ L K G + +
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKK 151
Query: 465 LMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRF 524
L + +++ +T +P + +T L L GN +T A + L NL +LGLS N
Sbjct: 152 LSYIRIADTNIT-TIPQGLPPSLTE---LHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 525 SNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSG------QIPE 578
S SL+ L L++ N L +P L K I+ + L NN+S P
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 579 FLENLSFLEYLNLSYNHLEGEVPRRGVFS 607
+ + ++L N ++ + F
Sbjct: 267 YNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.2 bits (197), Expect = 8e-18
Identities = 26/166 (15%), Positives = 52/166 (31%), Gaps = 29/166 (17%)
Query: 705 NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATK----------SFVAECEALRNIR 754
++G+G V+ + VK + K F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 755 HRNLIKIITVCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVI 814
R L K+ + + A++ E ++ L ++ D++ +
Sbjct: 65 FRALQKLQGLAV-PKVYAWEGNAVLMELIDAKELYRVRVENPDEV-------------LD 110
Query: 815 DVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860
+ + +H IVHGDL NVL+ + + DF + +
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEV 152
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (200), Expect = 2e-17
Identities = 42/256 (16%), Positives = 74/256 (28%), Gaps = 31/256 (12%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEI--------------------- 116
+ L I + + L + +N +
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 117 ----PGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSW 172
P L RL TL L P + L + + N L +P D
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDL 152
Query: 173 LKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENA 232
L L L N ++ + + +L L + +NR++ P + L L L + N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 233 FSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSN 292
S + ++ + +L+ + L N L+ + SLP L+
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDC--RARPLWAWLQKFRGSSSEVPCSLPQRLAG 270
Query: 293 ASNLRLLDFSLNHFSG 308
L + N G
Sbjct: 271 ---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 45/281 (16%), Positives = 79/281 (28%), Gaps = 29/281 (10%)
Query: 318 PNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIIL 377
R+ N + +LT + + + L +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 378 FSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGN 437
++ L L+ L+ L P L LQ L L N L ++ +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 438 LTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSG 497
L L L L N++ + +L L L
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLD-------------------------RLLLHQ 186
Query: 498 NLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALK 557
N + P +L L+ L L N S +L+ L+YL + N
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RP 245
Query: 558 TLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEG 598
+++ S + + +P+ L L+ N L+G
Sbjct: 246 LWAWLQKFRGSSSEVPCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (159), Expect = 3e-12
Identities = 47/246 (19%), Positives = 80/246 (32%), Gaps = 26/246 (10%)
Query: 407 IPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLM 466
+P I Q + LH N + S L L L N L ++ L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 467 LLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSN 526
L +S+N ++ P + L L L P L L L L +N
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 527 EIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSF- 585
+ L +L++ GN ++ A + L S+ L L +N ++ P +L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 586 -----------------------LEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCG 622
L+YL L+ N + R +++ +F + ++ C
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263
Query: 623 GLDELH 628
L
Sbjct: 264 LPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (151), Expect = 4e-11
Identities = 42/260 (16%), Positives = 83/260 (31%), Gaps = 5/260 (1%)
Query: 71 CGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLI 130
C ++ + ++ + + N S L L
Sbjct: 6 CVCYNEPKVTTSCPQQGLQAVPVGIPAASQRI---FLHGNRISHVPAASFRACRNLTILW 62
Query: 131 LANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLA 190
L +N + + + + L N + + P + +L L L L
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 191 PSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESI 250
++ LQ L + +N L D+ L +L +L + N S + + + SL+ +
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 251 SLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQV 310
L NR+ P L L L + NN + +L+ L+ L + N +
Sbjct: 183 LLHQNRVAHVHPHAF-RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241
Query: 311 KIDFNRLPNLFRLSFSKNNL 330
+ L + S + +
Sbjct: 242 RARPL-WAWLQKFRGSSSEV 260
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (125), Expect = 6e-08
Identities = 32/203 (15%), Positives = 60/203 (29%), Gaps = 5/203 (2%)
Query: 57 WNNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEI 116
+ + H R+ L L ++ + L+ L+++ +N
Sbjct: 86 DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145
Query: 117 PGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLE 176
L L L L N S +L N + + P +L
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLM 204
Query: 177 FLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGM 236
L L N L+ ++ + LQ L + +N + L S +
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCS 263
Query: 237 FPSSIFNISSLESISLLGNRLEG 259
P + L+ ++ N L+G
Sbjct: 264 LPQRLAGR-DLKRLAA--NDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.0 bits (149), Expect = 5e-11
Identities = 34/213 (15%), Positives = 62/213 (29%), Gaps = 9/213 (4%)
Query: 240 SIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLL 299
+ ++S ++ L +LP ++ + L + +N +L + L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 300 DFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNI 359
+ L+ LP L + ++ ++ L + L +
Sbjct: 61 N--LDRAELTKLQVDGTLPVLG--TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 360 FGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQV 419
G + L L + L L N LT + L NL
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 420 LDLHHNNLDGHIPESLGNLTILNSLDLGFNKLR 452
L L N+ IP+ +L L N
Sbjct: 177 LLLQENS-LYTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (139), Expect = 1e-09
Identities = 46/204 (22%), Positives = 75/204 (36%), Gaps = 13/204 (6%)
Query: 391 VNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNK 450
VN + L +P + ++ +L L N L +L T L L+L +
Sbjct: 15 VNCDKRNLTA------LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 451 LRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGN 510
L + +L ++ + P + + +LD+S N LT +
Sbjct: 67 LTKLQV----DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122
Query: 511 LKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRN 570
L L +L L N P L+ LE L + N+LT L L+++ L L N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182
Query: 571 NLSGQIPEFLENLSFLEYLNLSYN 594
+L IP+ L + L N
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 9e-08
Identities = 47/211 (22%), Positives = 76/211 (36%), Gaps = 7/211 (3%)
Query: 411 IGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSV 470
+ ++ + ++ NL +P L L L N L ++L L L++
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 471 SNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPV 530
+LT L + + S+P L L L +S NR ++
Sbjct: 63 DRAELTKLQVDGTLP----VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 531 SLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLN 590
+L L+ LY++GN L P L +++L L+ NNL+ L L L+ L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 591 LSYNHLEGEVPRRGVFSNKTRFYFTGNKRLC 621
L N L + GN LC
Sbjct: 179 LQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 36/209 (17%), Positives = 64/209 (30%), Gaps = 10/209 (4%)
Query: 268 SLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSK 327
+ + ++ + N T +LP L + +L S N L +L+ +
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 328 NNLGTGAIGDLDFIAHLTN-CSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIY 386
+ L L + + ++ L + L
Sbjct: 65 AE-----LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 387 VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDL 446
++ L L L+ N+L P + L+ L L +NNL L L L++L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 447 GFNKLRGHVPSSLGNCQNLMLLSVSNNKL 475
N L +P L + N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 6e-07
Identities = 41/185 (22%), Positives = 63/185 (34%), Gaps = 8/185 (4%)
Query: 388 KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLG 447
K+ L+ L N L + L L+L L + L +L +LDL
Sbjct: 31 KDTTILH---LSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPVLGTLDLS 85
Query: 448 FNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAE 507
N+L+ +L N + LP L + L L GN L P
Sbjct: 86 HNQLQSLPLLGQTLPALTVLDVSFNRLTS--LPLGALRGLGELQELYLKGNELKTLPPGL 143
Query: 508 VGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDL 567
+ L +L L+ N + L+ L+ L ++ NSL +IP + L
Sbjct: 144 LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFL 202
Query: 568 SRNNL 572
N
Sbjct: 203 HGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 5e-05
Identities = 37/180 (20%), Positives = 59/180 (32%), Gaps = 5/180 (2%)
Query: 78 VTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFS 137
T+L LS + + + L +N + G L L TL L++N
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGTLPVLGTLDLSHNQLQ 90
Query: 138 GKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNIS 197
+ + N + +P +L+ L L+ N L +
Sbjct: 91 SLPLLG--QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148
Query: 198 NLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRL 257
L+ LS+ N L+ L L +L L + EN+ P F L L GN
Sbjct: 149 KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 9e-05
Identities = 16/65 (24%), Positives = 24/65 (36%), Gaps = 3/65 (4%)
Query: 531 SLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLN 590
+S + + + +LT ++P L K L LS N L L + L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 591 LSYNH 595
L
Sbjct: 62 LDRAE 66
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 45/290 (15%), Positives = 90/290 (31%), Gaps = 29/290 (10%)
Query: 209 LSGR--LPDSLGQL--RSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVN 264
L+G+ PD G+L + + + F+ ++ + L + +E S
Sbjct: 7 LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEVSTLHG 65
Query: 265 IGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFS--LNHFSGQVKIDFNRLPNLFR 322
I L+NLS+ + + ++L+ SNL L+ S ++ + L
Sbjct: 66 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125
Query: 323 LSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGL 382
L+ S T + ++L G N+ L
Sbjct: 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL------------------QKSDL 167
Query: 383 NQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHH-NNLDGHIPESLGNLTIL 441
+ + + ++ + L +L LQ L L ++ LG + L
Sbjct: 168 STLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227
Query: 442 NSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSI 491
+L + G + + L ++ + T P I I
Sbjct: 228 KTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 5e-06
Identities = 38/267 (14%), Positives = 82/267 (30%), Gaps = 11/267 (4%)
Query: 79 TVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSG 138
LDL+ +++ ++ + + + F + + E FR++ + L+N+
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAF-RCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60
Query: 139 K-IPSNLSRCSNLINFHARGNNLVGQIPPDIG-------YSWLKLEFLSLRDNLLAGQLA 190
+ LS+CS L N G L I + + S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 191 PSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESI 250
+ ++ E + + + L +N + + +L +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 251 SLLGNRLEGSLPVNIGFSLPNLENLSVRQNNY-TGSLPHSLSNASNLRLLDFSLNHFSGQ 309
L + + + F L L++LS+ + L L+ L G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 310 VKIDFNRLPNLFRLSFSKNNLGTGAIG 336
+++ LP+L + IG
Sbjct: 241 LQLLKEALPHLQINCSHFTTIARPTIG 267
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 1e-05
Identities = 36/221 (16%), Positives = 80/221 (36%), Gaps = 11/221 (4%)
Query: 392 NLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNL-DGHIPESLGNLTILNSLDLGFNK 450
+ F + + P+ R +Q +DL ++ + + L + L +L L +
Sbjct: 24 GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 451 LRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQI-------LGIVTLSILLDLSGNLLTGS 503
L + ++L NL+ L++S Q L + LS D + + +
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 142
Query: 504 IPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSL-TGSIPLALKTLKSI 562
+ + L G +N +++ + C L +L + + + L +
Sbjct: 143 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202
Query: 563 KELDLSR-NNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPR 602
+ L LSR ++ + L + L+ L + +G +
Sbjct: 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 7e-05
Identities = 38/253 (15%), Positives = 80/253 (31%), Gaps = 17/253 (6%)
Query: 128 TLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDN-LLA 186
TL L + + L +I F + + P +S +++ + L ++ +
Sbjct: 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQ--PLAEHFSPFRVQHMDLSNSVIEV 60
Query: 187 GQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFP-------- 238
L + S LQ LS+ RLS + ++L + +L L++S + F
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 239 SSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRL 298
S + ++ ++ ++ + + + + + L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 299 LDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTN 358
+F +L L LS S+ + L L+ L +
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET-----LLELGEIPTLKTLQVFGI 235
Query: 359 IFGGVLPLSIANL 371
+ G L L L
Sbjct: 236 VPDGTLQLLKEAL 248
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 20/100 (20%), Positives = 39/100 (39%), Gaps = 2/100 (2%)
Query: 418 QVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTG 477
Q LDL NL + L + ++ + + + + + + + +SN+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 478 ALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQL 517
+ IL + L L G L+ I + NLV+L
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 18/120 (15%), Positives = 38/120 (31%), Gaps = 4/120 (3%)
Query: 517 LGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSG-Q 575
L L+ ++ L + + + + + + ++ +DLS + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62
Query: 576 IPEFLENLSFLEYLNLSYNHLEGEVPRR-GVFSNKTRFYFTGNKRLCGGLDELHLPVCHS 634
+ L S L+ L+L L + SN R +G + L C
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 3e-09
Identities = 39/218 (17%), Positives = 66/218 (30%), Gaps = 21/218 (9%)
Query: 388 KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLG 447
L N + +T + A +L + L + E + L L L+L
Sbjct: 16 PALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELK 71
Query: 448 FNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSG---------- 497
N++ P + LS + K A+ ++
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 498 ---NLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPL 554
L I LS L+ + L L + N ++ PL
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL 191
Query: 555 ALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLS 592
A +L ++ E+ L N +S P L N S L + L+
Sbjct: 192 A--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 4e-06
Identities = 36/234 (15%), Positives = 76/234 (32%), Gaps = 25/234 (10%)
Query: 227 SISENA-FSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGS 285
SI++ + +FP +++ I+ + + ++ L + LS T +
Sbjct: 2 SITQPTAINVIFPDP--ALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVT-T 55
Query: 286 LPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLT 345
+ + +NL L+ N + + LS + + G
Sbjct: 56 IE-GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDL 114
Query: 346 N-CSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMG------------LNQIYVKNLVN 392
+ L VL L + +++ L + + + NL
Sbjct: 115 TSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSK 174
Query: 393 LNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDL 446
L + N+++ P + L NL + L +N + P L N + L + L
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 9e-06
Identities = 42/228 (18%), Positives = 73/228 (32%), Gaps = 26/228 (11%)
Query: 262 PVNIGFSLPNLEN---LSVRQNNYTGSLPHS-LSNASNLRLLDFSLNHFSGQVKIDFNRL 317
+N+ F P L N ++ ++N T ++ + L + L + G L
Sbjct: 8 AINVIFPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYL 62
Query: 318 PNLFRLSFSKN---------NLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSI 368
NL L N NL +L + + T +
Sbjct: 63 NNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 369 ANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPH----AIGELRNLQVLDLHH 424
L+ L + L+ + N+ L G G + L L L
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 425 NNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSN 472
N + P L +L L + L N++ P L N NL +++++N
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 38/230 (16%), Positives = 74/230 (32%), Gaps = 20/230 (8%)
Query: 195 NISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLG 254
++N ++ G++ ++ + + L + LS ++++E + L
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGT-----------GVTTIEGVQYLN 63
Query: 255 NRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDF 314
N + L N L L+NL+ P +A +L+ S Q+
Sbjct: 64 NLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT 123
Query: 315 NRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSST 374
+ I L + +L S A D + L+
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 375 IILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHH 424
I L +L NL L+ NQ++ P + NL ++ L +
Sbjct: 184 KISDISPL-----ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 32/227 (14%), Positives = 71/227 (31%), Gaps = 20/227 (8%)
Query: 76 QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNS 135
+ ++ ++ +L + ++ G + I G + L L L L +N
Sbjct: 19 ANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 136 FSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGN 195
+ +L+ NL + ++ L L +
Sbjct: 75 IT-----DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST------QITDVT 123
Query: 196 ISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGN 255
++ + +S + + N+S L ++ N
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 256 RLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFS 302
++ P+ SLPNL + ++ N + P L+N SNL ++ +
Sbjct: 184 KISDISPLA---SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 34/202 (16%), Positives = 68/202 (33%), Gaps = 21/202 (10%)
Query: 414 LRNLQVLDLHHNNLDGHIPES-LGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSN 472
L N + +N+ + ++ L +T L++ G + G + NL+ L + +
Sbjct: 18 LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELKD 72
Query: 473 NKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSE----------- 521
N++T P + L +T L ++ + +L +++
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 522 --NRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEF 579
N+I Y+ + S L L + L N +S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 580 LENLSFLEYLNLSYNHLEGEVP 601
L +L L ++L N + P
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 39/231 (16%), Positives = 72/231 (31%), Gaps = 24/231 (10%)
Query: 292 NASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLE 351
+N + ++ + + L + LS + ++ + +L N L
Sbjct: 17 ALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTG-----VTTIEGVQYLNN---LI 66
Query: 352 ALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAI 411
L L N + T + S + + L+ +
Sbjct: 67 GLELKDNQITDL-APLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPL 125
Query: 412 GELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVS 471
L NLQVL L N + P + S + + L N L L
Sbjct: 126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLS----IGNAQVSDLTPLANLSKLTTLKAD 181
Query: 472 NNKLTGALPPQILGIVTLSIL--LDLSGNLLTGSIPAEVGNLKNLVQLGLS 520
+NK++ I + +L L + L N ++ P + N NL + L+
Sbjct: 182 DNKISD-----ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.9 bits (121), Expect = 4e-08
Identities = 31/108 (28%), Positives = 42/108 (38%), Gaps = 6/108 (5%)
Query: 493 LDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSI 552
L L+ LT + + L + L LS NR P +L+A LE L N
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALEN 57
Query: 553 PLALKTLKSIKELDLSRNNL-SGQIPEFLENLSFLEYLNLSYNHLEGE 599
+ L ++EL L N L + L + L LNL N L E
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.3 bits (117), Expect = 1e-07
Identities = 30/118 (25%), Positives = 45/118 (38%), Gaps = 6/118 (5%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPS 457
L + LT + + +L + LDL HN L P +L L L L +
Sbjct: 5 LAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALENVD 59
Query: 458 SLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLV 515
+ N L L + NN+L + Q L +LL+L GN L L ++
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 3e-07
Identities = 34/148 (22%), Positives = 53/148 (35%), Gaps = 29/148 (19%)
Query: 418 QVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTG 477
+VL L H +L + L L ++ LDL N+LR P+ L + L +L S+N L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 478 ALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTT 537
L + L L N L S L +C
Sbjct: 58 VDGVANLPRLQE---LLLCNNRLQQSAA-----------------------IQPLVSCPR 91
Query: 538 LEYLYMEGNSLTGSIPLALKTLKSIKEL 565
L L ++GNSL + + + + +
Sbjct: 92 LVLLNLQGNSLCQEEGIQERLAEMLPSV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 9e-05
Identities = 26/128 (20%), Positives = 50/128 (39%), Gaps = 10/128 (7%)
Query: 200 QVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEG 259
+VL + L+ L QL + +L +S N + P+ +++L + +L
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNA 54
Query: 260 SLPVNIGFSLPNLENLSVRQNNYTG-SLPHSLSNASNLRLLDFSLNHFSGQVKID---FN 315
V+ +LP L+ L + N + L + L LL+ N + I
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 316 RLPNLFRL 323
LP++ +
Sbjct: 115 MLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 3e-04
Identities = 28/107 (26%), Positives = 44/107 (41%), Gaps = 5/107 (4%)
Query: 178 LSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMF 237
L L L + + + L + NRL P +L LR L L S+NA
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNAL--EN 57
Query: 238 PSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTG 284
+ N+ L+ + L NRL+ S + S P L L+++ N+
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.002
Identities = 19/108 (17%), Positives = 39/108 (36%), Gaps = 5/108 (4%)
Query: 80 VLDLSNRSIEGILSPYVGNLSFLRFINFANNGFSGEIPGEIGRLFRLETLILANNSFSGK 139
VL L+++ + + ++ L + ++ ++N P + L LE L ++N+
Sbjct: 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 140 IPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAG 187
+ N L S +L L+L+ N L
Sbjct: 59 DGVANLPRLQELLLC--NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.003
Identities = 24/129 (18%), Positives = 44/129 (34%), Gaps = 19/129 (14%)
Query: 323 LSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGL 382
L + +L + HL + L L N + P ++A L +L +
Sbjct: 3 LHLAHKDLTV--------LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN 53
Query: 383 NQIYVKNLVNLNGFG---LEYNQLTG-PIPHAIGELRNLQVLDLHHNNL------DGHIP 432
V + NL L N+L + L +L+L N+L +
Sbjct: 54 ALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 113
Query: 433 ESLGNLTIL 441
E L +++ +
Sbjct: 114 EMLPSVSSI 122
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 7e-08
Identities = 20/94 (21%), Positives = 31/94 (32%), Gaps = 9/94 (9%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPS 457
N + I +L+ L++ +N L +P L L FN L VP
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHL-AEVPE 321
Query: 458 SLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSI 491
N + L + N L P + L +
Sbjct: 322 LPQNLKQLHV---EYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 22/96 (22%), Positives = 41/96 (42%), Gaps = 10/96 (10%)
Query: 495 LSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPL 554
N + I + +L +L +S N+ E+P LE L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP- 320
Query: 555 ALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLN 590
+ +++K+L + N L + P+ E++ L +N
Sbjct: 321 --ELPQNLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 8e-07
Identities = 23/80 (28%), Positives = 36/80 (45%), Gaps = 8/80 (10%)
Query: 519 LSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPE 578
N SNEI +LE L + N L +P ++ L S N+L+ ++PE
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPE 321
Query: 579 FLENLSFLEYLNLSYNHLEG 598
+NL + L++ YN L
Sbjct: 322 LPQNL---KQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 20/92 (21%), Positives = 30/92 (32%), Gaps = 10/92 (10%)
Query: 207 NRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIG 266
N S + SL L++S N P+ LE + N L +
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-----EVP 320
Query: 267 FSLPNLENLSVRQNNYTGSLPHSLSNASNLRL 298
NL+ L V N P + +LR+
Sbjct: 321 ELPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 6e-04
Identities = 19/93 (20%), Positives = 36/93 (38%), Gaps = 10/93 (10%)
Query: 180 LRDNLLAGQLAPSIGNISNLQVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPS 239
N + ++ +L+ L++ N+L LP +L L S N + P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLAE-VPE 321
Query: 240 SIFNISSLESISLLGNRLEGSLPVNIGFSLPNL 272
+L+ + + N L P +I S+ +L
Sbjct: 322 L---PQNLKQLHVEYNPLR-EFP-DIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 7e-04
Identities = 21/92 (22%), Positives = 34/92 (36%), Gaps = 10/92 (10%)
Query: 133 NNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPS 192
N+ S +I S +L + N L+ ++P +LE L N L ++
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP----RLERLIASFNHL-AEVPEL 322
Query: 193 IGNISNLQVLSIGENRLSGRLPDSLGQLRSLY 224
N L+ L + N L PD + L
Sbjct: 323 PQN---LKQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 21/77 (27%), Positives = 33/77 (42%), Gaps = 7/77 (9%)
Query: 542 YMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVP 601
N+ + I S++EL++S N L ++P L E L S+NHL EVP
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVP 320
Query: 602 RRGVFSNKTRFYFTGNK 618
+ N + + N
Sbjct: 321 --ELPQNLKQLHVEYNP 335
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 2e-07
Identities = 19/78 (24%), Positives = 30/78 (38%), Gaps = 9/78 (11%)
Query: 535 CTTLEYLYMEGNSLTG----SIPLALKTLKSIKELDLSRNNLSGQIPEFL-----ENLSF 585
+ L L++ ++ S+ L S++ELDLS N L L +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 586 LEYLNLSYNHLEGEVPRR 603
LE L L + E+ R
Sbjct: 428 LEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 2e-07
Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 10/93 (10%)
Query: 513 NLVQLGLSENRFSNEIPVSL-SACTTLEYLYMEGNSLTG----SIPLALKTLKSIKELDL 567
++ L + S+ L + + ++ LT I AL+ ++ EL+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 568 SRNNLSGQIPEFL-----ENLSFLEYLNLSYNH 595
N L + ++ L+L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 3e-07
Identities = 16/93 (17%), Positives = 32/93 (34%), Gaps = 10/93 (10%)
Query: 391 VNLNGFGLEYNQLT-GPIPHAIGELRNLQVLDLHHNNLDG----HIPESLGNLTILNSLD 445
+++ ++ +L+ + L+ QV+ L L I +L L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 446 LGFNKLRGHVPSSLG-----NCQNLMLLSVSNN 473
L N+L + + LS+ N
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 6e-07
Identities = 17/83 (20%), Positives = 33/83 (39%), Gaps = 9/83 (10%)
Query: 510 NLKNLVQLGLSENRFSNE----IPVSLSACTTLEYLYMEGNSLTGSIPLAL-----KTLK 560
L L L++ S+ + +L A +L L + N L + L L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 561 SIKELDLSRNNLSGQIPEFLENL 583
+++L L S ++ + L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 14/67 (20%), Positives = 24/67 (35%), Gaps = 5/67 (7%)
Query: 538 LEYLYMEGNSLTGS-IPLALKTLKSIKELDLSRNNLSGQ----IPEFLENLSFLEYLNLS 592
++ L ++ L+ + L L+ + + L L+ I L L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 593 YNHLEGE 599
N L
Sbjct: 64 SNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 13/92 (14%), Positives = 34/92 (36%), Gaps = 9/92 (9%)
Query: 464 NLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTG----SIPAEVGNLKNLVQLGL 519
++ L + +L+ A ++L ++ ++ L LT I + + L +L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 520 SENRFSNEIPVSL-----SACTTLEYLYMEGN 546
N + + + ++ L ++
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 6e-05
Identities = 15/95 (15%), Positives = 29/95 (30%), Gaps = 13/95 (13%)
Query: 388 KNLVNLNGFGLEYNQLTG----PIPHAIGELRNLQVLDLHHNNLDGHIPESLG-----NL 438
+ L L ++ + + +L+ LDL +N L L
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 439 TILNSLDLGFNKLRGHVPSSLG----NCQNLMLLS 469
+L L L + L + +L ++S
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 7e-04
Identities = 17/91 (18%), Positives = 31/91 (34%), Gaps = 8/91 (8%)
Query: 430 HIPESLGNLTILNSLDLGFNKLRG----HVPSSLGNCQNLMLLSVSNNKLTGALPPQILG 485
++L L L + + ++L +L L +SNN L A Q++
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 486 IV----TLSILLDLSGNLLTGSIPAEVGNLK 512
V L L L + + + L+
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 16/94 (17%), Positives = 34/94 (36%), Gaps = 9/94 (9%)
Query: 198 NLQVLSIGENRLS-GRLPDSLGQLRSLYYLSISENAFSGM----FPSSIFNISSLESISL 252
++Q L I LS R + L L+ + + + + S++ +L ++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 253 LGNRLEGSLPVNIGFSL----PNLENLSVRQNNY 282
N L + L ++ LS++
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 13/78 (16%), Positives = 22/78 (28%), Gaps = 3/78 (3%)
Query: 295 NLRLLDFSLNHFS-GQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEAL 353
+++ LD S + L + L D+ + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSALRVNPALAEL 60
Query: 354 GLDTNIFGGVLPLSIANL 371
L +N G V +
Sbjct: 61 NLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 8/68 (11%), Positives = 20/68 (29%), Gaps = 4/68 (5%)
Query: 246 SLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTG----SLPHSLSNASNLRLLDF 301
++S+ + L + + L + + + T + +L L L+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 302 SLNHFSGQ 309
N
Sbjct: 63 RSNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 16/97 (16%), Positives = 33/97 (34%), Gaps = 9/97 (9%)
Query: 57 WNNSMNLCQWTGVTCGHRHQRVTVLDLSNRSIEGI----LSPYVGNLSFLRFINFANNGF 112
+ G + VL L++ + L+ + LR ++ +NN
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409
Query: 113 SGEIPGEIGRLFR-----LETLILANNSFSGKIPSNL 144
++ R LE L+L + +S ++ L
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 19/112 (16%), Positives = 33/112 (29%), Gaps = 12/112 (10%)
Query: 104 FINFANNGFSGEIPGEIGRLFRLETLILANNSFSGK----IPSNLSRCSNLINFHARGNN 159
+ G G L L LA+ S + + L +L N
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408
Query: 160 LVGQIPPDIG----YSWLKLEFLSLRDNLLAGQLAPSIGNIS----NLQVLS 203
L + LE L L D + ++ + + +L+V+S
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 10/48 (20%), Positives = 18/48 (37%), Gaps = 4/48 (8%)
Query: 556 LKTLKSIKELDLSRNNLSGQ----IPEFLENLSFLEYLNLSYNHLEGE 599
+ ++ L L+ ++S + L L L+LS N L
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 41/205 (20%), Positives = 78/205 (38%), Gaps = 17/205 (8%)
Query: 388 KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLG 447
L+ +T + EL ++ + +++++ + + L + L L
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLN 76
Query: 448 FNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAE 507
NKL P L N +NL L + NK+ + L + L + + G +
Sbjct: 77 GNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLP 134
Query: 508 VGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDL 567
L +++ + T L+ L +E N ++ +PLA L ++ L L
Sbjct: 135 QLESLYLGNNKITDITVLSR-------LTKLDTLSLEDNQISDIVPLA--GLTKLQNLYL 185
Query: 568 SRNNLSGQIPEFLENLSFLEYLNLS 592
S+N++S L L L+ L L
Sbjct: 186 SKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 37/213 (17%), Positives = 70/213 (32%), Gaps = 18/213 (8%)
Query: 262 PVNIGFSLPNLENLSVRQNNYTGSLPH--SLSNASNLRLLDFSLNHFSGQVKIDFNRLPN 319
P+ FS ++ N S+ + + +++ + + + I + LPN
Sbjct: 13 PIKQIFSDDAFAET-IKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQY--LPN 69
Query: 320 LFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFS 379
+ +L + N + D+ +A+L N L + L S
Sbjct: 70 VTKLFLNGNK-----LTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 380 MGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLT 439
+N + L + L L L L N + +P L LT
Sbjct: 125 SDINGLVHLP----QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLT 178
Query: 440 ILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSN 472
L +L L N + +L +NL +L + +
Sbjct: 179 KLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 10/58 (17%), Positives = 25/58 (43%), Gaps = 4/58 (6%)
Query: 541 LYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEG 598
++ S+T ++ L SI ++ + +++ ++ L + L L+ N L
Sbjct: 29 DNLKKKSVTDAVTQNE--LNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD 82
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.5 bits (111), Expect = 2e-06
Identities = 32/161 (19%), Positives = 60/161 (37%), Gaps = 5/161 (3%)
Query: 364 LPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLH 423
+PL L + L +L L+ NQLTG P+A ++Q L L
Sbjct: 27 IPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86
Query: 424 HNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQI 483
N + + L L +L+L N++ +P S + +L L++++N
Sbjct: 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146
Query: 484 LGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRF 524
L+G P++ ++++ L + F
Sbjct: 147 F--AEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 30/189 (15%), Positives = 50/189 (26%), Gaps = 39/189 (20%)
Query: 64 CQWTGVTCGHRH---------QRVTVLDLS-NRSIEGILSPYVGNLSFLR---------- 103
C+ T V C R T L L+ N G L L
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 104 --------------FINFANNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSN 149
+ N L +L+TL L +N S +P + ++
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 150 LINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRL 209
L + + N WL+ SL + ++Q+ + +
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRK--KSLNGGAARCGAPSK---VRDVQIKDLPHSEF 182
Query: 210 SGRLPDSLG 218
+S G
Sbjct: 183 KCSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.0 bits (89), Expect = 0.001
Identities = 22/175 (12%), Positives = 47/175 (26%), Gaps = 7/175 (4%)
Query: 398 LEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPS 457
L IP I + L L+ N L + L +
Sbjct: 15 CTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP 71
Query: 458 SLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQL 517
+ + + + ++ + L+L N ++ +P +L +L L
Sbjct: 72 NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131
Query: 518 GLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNL 572
+ N L + G + P ++ ++ DL +
Sbjct: 132 N-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEF 182
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (106), Expect = 6e-06
Identities = 26/149 (17%), Positives = 53/149 (35%), Gaps = 8/149 (5%)
Query: 454 HVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLS-GNLLTGSIPAEVGNLK 512
+ + + ++ L +V +I + L+ + + ++ N+
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL-----RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIP 65
Query: 513 NLVQLGLSENRFSN--EIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRN 570
L+ L LS NR ++ + L+ L + GN L L ++EL L N
Sbjct: 66 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 125
Query: 571 NLSGQIPEFLENLSFLEYLNLSYNHLEGE 599
+LS + +S + L+G
Sbjct: 126 SLSDTFRDQSTYISAIRERFPKLLRLDGH 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 4e-04
Identities = 27/133 (20%), Positives = 44/133 (33%), Gaps = 7/133 (5%)
Query: 492 LLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTG- 550
LDL G ++ V L + + + + L L + N L
Sbjct: 26 ALDLKGL----RSDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRL 80
Query: 551 -SIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNK 609
+ ++ ++K L+LS N L + LE L L N L + + +
Sbjct: 81 DDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140
Query: 610 TRFYFTGNKRLCG 622
R F RL G
Sbjct: 141 IRERFPKLLRLDG 153
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 44/208 (21%), Positives = 74/208 (35%), Gaps = 18/208 (8%)
Query: 383 NQIYV-KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTIL 441
NQI+ L L +T + +L + L + + + L L
Sbjct: 9 NQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNL 64
Query: 442 NSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLT 501
++ N+L P +L++ + L +
Sbjct: 65 TQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGL-------TLFNNQ 117
Query: 502 GSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKS 561
+ + NL NL +L LS N S+ +S T+L+ L N +T PLA L +
Sbjct: 118 ITDIDPLKNLTNLNRLELSSNTISDISALS--GLTSLQQLNFSSNQVTDLKPLA--NLTT 173
Query: 562 IKELDLSRNNLSGQIPEFLENLSFLEYL 589
++ LD+S N +S L L+ LE L
Sbjct: 174 LERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 5e-05
Identities = 37/203 (18%), Positives = 65/203 (32%), Gaps = 28/203 (13%)
Query: 261 LPVNIGFSLPNLEN---LSVRQNNYTGSLPHS-LSNASNLRLLDFSLNHFSGQVKIDFNR 316
P+N F+ L + + N T ++ + L + L+ + G
Sbjct: 6 TPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEY 60
Query: 317 LPNLFRLSFSKNNLG---------------TGAIGDLDFIAHLTNCSKLEALGLDTNIFG 361
L NL +++FS N L D + + I
Sbjct: 61 LNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD 120
Query: 362 GVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLD 421
++ NL+ + + + + L +L NQ+T P + L L+ LD
Sbjct: 121 IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLD 178
Query: 422 LHHNNLDGHIPESLGNLTILNSL 444
+ N + L LT L SL
Sbjct: 179 ISSNKVSD--ISVLAKLTNLESL 199
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 38/323 (11%), Positives = 89/323 (27%), Gaps = 31/323 (9%)
Query: 173 LKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGENRLSGR----LPDSLGQLRSLYYLSI 228
L+ ++ + + +++ + + N + L +++ + L
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 229 SENAFSGMFPSSIFNISSLESISLLGNRLE--GSLPVNIGFSLPNLENLSVRQNNYTGSL 286
S+ + + L L +L G + + ++ L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 287 PHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTN 346
+ + V P L + +N L G++ +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 347 CSKLEALGLDTNIFGGVLPLSIANLSSTIILFSM------------GLNQIYVKNLVNLN 394
+ + G+ L + L+ L + I +K+ NL
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 395 GFGLEYNQLTGPIPHAIGE------LRNLQVLDLHHNNLDGHIPESL-----GNLTILNS 443
GL L+ A+ + LQ L L +N ++ +L + L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 444 LDLGFNKLRGHVPSSLGNCQNLM 466
L+L N+ + + +
Sbjct: 307 LELNGNRF-SEEDDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 8e-04
Identities = 12/50 (24%), Positives = 20/50 (40%), Gaps = 4/50 (8%)
Query: 551 SIPLALKTLKSIKELDLSRNNLSGQ----IPEFLENLSFLEYLNLSYNHL 596
S+ L S+KE+ LS N + + + E + + LE S
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 9e-04
Identities = 11/92 (11%), Positives = 31/92 (33%), Gaps = 8/92 (8%)
Query: 392 NLNGFGLEYNQLTG----PIPHAIGELRNLQVLDLHHNNLDG----HIPESLGNLTILNS 443
++ G L+ + +T + + E +++ + L N + + E++ + L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 444 LDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKL 475
+ + L+ + KL
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.002
Identities = 45/316 (14%), Positives = 87/316 (27%), Gaps = 18/316 (5%)
Query: 295 NLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDL-DFIAHLTNCSKLEAL 353
+L+L + + ++ + S N +GT A L + IA + E
Sbjct: 9 SLKLDAITTEDEKSVFAVLLE-DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 354 GLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGE 413
+ T +P ++ L ++ N + L+ P
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 414 LRNLQVLD-----LHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLL 468
L N + + + + + N L S+ G N+L +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL-ENGSMKEWAKTFQSHR 186
Query: 469 SVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEI 528
+ K+ L L L + L ++ + N
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 529 PVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFL-----ENL 583
+ L+ C L G + + ++ L L N + L E +
Sbjct: 247 ELGLNDC----LLSARGAAAVVD-AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 584 SFLEYLNLSYNHLEGE 599
L +L L+ N E
Sbjct: 302 PDLLFLELNGNRFSEE 317
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 30/239 (12%), Positives = 61/239 (25%), Gaps = 10/239 (4%)
Query: 246 SLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNH 305
S +++ +P ++ N L + S +L ++ S N
Sbjct: 9 SNRVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 64
Query: 306 FSGQVKIDFNRLPNLFRLSFSKNNLGTGAIGDLDFIAHLTNCSKLEA---LGLDTNIFGG 362
++ D + I F L + + ++
Sbjct: 65 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 124
Query: 363 VLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDL 422
+ I +V L N + A + ++
Sbjct: 125 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLS 184
Query: 423 HHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPP 481
+NNL+ + + LD+ ++ L N + L S N K LP
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 32/208 (15%), Positives = 64/208 (30%), Gaps = 6/208 (2%)
Query: 388 KNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLG 447
+N + L +L A +L+ +++ N++ I + +
Sbjct: 29 RNAIELR---FVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85
Query: 448 ---FNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSI 504
N L + + LL + +I + + + + + N+ T
Sbjct: 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 145
Query: 505 PAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKE 564
+ VG V L L++N + + E + N+L
Sbjct: 146 NSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 205
Query: 565 LDLSRNNLSGQIPEFLENLSFLEYLNLS 592
LD+SR + LENL L +
Sbjct: 206 LDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.004
Identities = 27/246 (10%), Positives = 44/246 (17%), Gaps = 47/246 (19%)
Query: 64 CQWTGVTCGHRH---------QRVTVLDLSNRSIEGILSPYVGNLSFLRFINFA------ 108
C C + L + I L I +
Sbjct: 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 109 ---------------------NNGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRC 147
NN LI +
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 148 SNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNLLAGQLAPSIGNISNLQVLSIGEN 207
++ N+ + L L N + + ++ N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 208 RLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGF 267
L D L IS + + N+ L + S +
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK----------- 236
Query: 268 SLPNLE 273
LP LE
Sbjct: 237 KLPTLE 242
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 5e-04
Identities = 21/132 (15%), Positives = 39/132 (29%), Gaps = 6/132 (4%)
Query: 389 NLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGF 448
N V L ++ I + L +D N + + L L +L +
Sbjct: 16 NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNN 72
Query: 449 NKLRGHVPSSLGNCQNLMLLSVSNNKLTG---ALPPQILGIVTLSILLDLSGNLLTGSIP 505
N++ +L L ++NN L P L +T +L
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 506 AEVGNLKNLVQL 517
+ + + L
Sbjct: 133 YVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.002
Identities = 8/38 (21%), Positives = 14/38 (36%), Gaps = 1/38 (2%)
Query: 559 LKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHL 596
+ELDL + I L + ++ S N +
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 25/143 (17%), Positives = 48/143 (33%), Gaps = 3/143 (2%)
Query: 392 NLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIP-ESLGNLTILNSLDLGFNK 450
+G + H + NL L + + H+ L L L +L + +
Sbjct: 9 GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 451 LRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGN 510
LR P + L L++S N L +L + + ++L L+ L +
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 511 LKNLVQLGLSENRFSNEIPVSLS 533
+ G+ E + L+
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLA 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1013 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.98 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.95 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.93 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.92 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.88 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.79 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.78 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.77 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.76 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.71 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.64 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.63 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.61 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.6 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.03 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.96 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.87 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.63 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.62 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.12 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.03 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.92 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.73 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.52 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.85 Aligned_cols=268 Identities=29% Similarity=0.448 Sum_probs=210.7
Q ss_pred HHHHHCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECC--CCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
Q ss_conf 6654114898880110542389999989997399999974134--56036799999998417999630499996147745
Q 001782 694 LSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 694 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 771 (1013)
++...++|.+.+.||+|+||+||+|+++ ..||||+++... ....+.+.+|++++++++||||+++++++..
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---- 75 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---- 75 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred CCCCCCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC----
T ss_conf 1315451899889830788589999999---989999997346998999999999999984799878645679715----
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 65418899860447877777300365421578899999999999999999986169999052588998557558995598
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV 851 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl 851 (1013)
...++||||+++|+|.+++.... ..+++.++..++.|++.||+|||++ +||||||||+|||++.++.+||
T Consensus 76 --~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl 145 (276)
T d1uwha_ 76 --PQLAIVTQWCEGSSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKI 145 (276)
T ss_dssp --SSCEEEEECCCEEEHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEE
T ss_pred --CEEEEEEECCCCCCHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEE
T ss_conf --58999996589988899985235-----7899999999999999998887509---9951614789979818997887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCH
Q ss_conf 01466545899999863457898766666644236333379---998963333789799999881999999767787418
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG---GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTL 928 (1013)
Q Consensus 852 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~ 928 (1013)
+|||+|+........ .......||+.|||||++.+ ..++.++|||||||++|||+||+.||.+........
T Consensus 146 ~DFGla~~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~ 219 (276)
T d1uwha_ 146 GDFGLATVKSRWSGS------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 219 (276)
T ss_dssp CCCCCSCC------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH
T ss_pred CCCCCEEECCCCCCC------CCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf 500221333556776------31256655743179999950568999953151635999999997889989989699999
Q ss_pred HHHHHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 99988518834898401110013656420389971347899999999999865024689899999899999999766544
Q 001782 929 HEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIF 1008 (1013)
Q Consensus 929 ~~~~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1008 (1013)
........++ +... ....++.++.+++.+||+.||.+|||+.||++.|+.+++++
T Consensus 220 ~~~~~~~~~p------------~~~~-------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 220 FMVGRGYLSP------------DLSK-------------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp HHHHHTSCCC------------CGGG-------------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHCCCCCC------------CCHH-------------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 9996588898------------6000-------------36555499999999975889768929999999999999709
Q ss_pred H
Q ss_conf 2
Q 001782 1009 L 1009 (1013)
Q Consensus 1009 ~ 1009 (1013)
.
T Consensus 275 P 275 (276)
T d1uwha_ 275 P 275 (276)
T ss_dssp C
T ss_pred C
T ss_conf 8
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.82 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=207.0
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEEE
Q ss_conf 11489888011054238999998999739999997413456036799999998417999630499996147745654188
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 777 (1013)
.++|++.+.||+|+||+||+|++..+++.||+|++........+.+.+|+++++.++||||+++++++ ...+..|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEE
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----EECCEEE
T ss_conf 10538878981285829999999899989999998430172799999999999867999880585779-----8899989
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 99860447877777300365421578899999999999999999986169999052588998557558995598014665
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a 857 (1013)
+||||+++|+|.+++... .+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 94 ivmEy~~gg~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a 163 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (293)
T ss_dssp EEEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEECCCCCHHHHHHCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHH
T ss_conf 999703798089886415-------999999999999999999999987---9722677688868878996864251564
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 45899999863457898766666644236333379998963333789799999881999999767787418999885188
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1013)
+.+.... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+......
T Consensus 164 ~~~~~~~--------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----------- 224 (293)
T d1yhwa1 164 AQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----------- 224 (293)
T ss_dssp EECCSTT--------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----------
T ss_pred EEECCCC--------CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHH-----------
T ss_conf 1321366--------644444447773682664479988012031372999998048899899799999-----------
Q ss_pred HHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 34898401110013656420389971347899999999999865024689899999899999
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 938 ~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~ 999 (1013)
....+... .+. ...+...+.++.+++.+||+.||.+|||+.|+++
T Consensus 225 --~~~~~~~~---~~~------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 225 --LYLIATNG---TPE------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --HHHHHHHC---SCC------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --HHHHHHCC---CCC------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf --99998579---998------------8885537999999999986699668909999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.92 Aligned_cols=254 Identities=25% Similarity=0.333 Sum_probs=205.7
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEE
Q ss_conf 1148988801105423899999899973999999741345-603679999999841799963049999614774565418
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 776 (1013)
.++|++.+.||+|+||+||+|+++.+++.||+|++..... ...+.+.+|++++++++||||+++++++ .+.+..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----CCCCEE
T ss_conf 746089989721748099999999999799999984566412799999999999857998884696540-----467436
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 89986044787777730036542157889999999999999999998616999905258899855755899559801466
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~ 856 (1013)
++||||+++|+|.+++... ..+++.++..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 79 ~ivmEy~~gg~L~~~l~~~------~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp EEEEECCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHH
T ss_conf 7988645898089997537------9999999999999999999999975---983575468997887899879832314
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 545899999863457898766666644236333379998-9633337897999998819999997677874189998851
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDM-SATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1013)
|+.+.... ........+||+.|||||++.+..+ +.++||||+||++|||++|+.||................
T Consensus 150 a~~~~~~~------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~- 222 (271)
T d1nvra_ 150 ATVFRYNN------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK- 222 (271)
T ss_dssp CEECEETT------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-
T ss_pred HEEECCCC------CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC-
T ss_conf 22404688------65311132557474287286189999971016173799999982997888898599999998638-
Q ss_pred CCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 8834898401110013656420389971347899999999999865024689899999899999
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~ 999 (1013)
.....+ ....+.++.+++.+|++.||++|||++|+++
T Consensus 223 -----------~~~~~~----------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 223 -----------KTYLNP----------------WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -----------CTTSTT----------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------CCCCCC----------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -----------887886----------------4469999999999976799668909999961
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.24 Aligned_cols=268 Identities=23% Similarity=0.339 Sum_probs=207.3
Q ss_pred HHCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCE
Q ss_conf 41148988801105423899999899973999999741345-60367999999984179996304999961477456541
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 775 (1013)
..++|++.+.||+|+||+||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++ .+...
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEE-----EECCE
T ss_conf 7568889789712778099999998999699999987540978999999999999867999999499999-----98999
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 88998604478777773003654215788999999999999999999861-69999052588998557558995598014
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH-HCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nili~~~~~~kl~Df 854 (1013)
.++||||+++|+|.+++.+. +.+++..+..++.|++.|+.|||+ + +|+||||||+|||++.++.+||+||
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~------~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DF 149 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDF 149 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEECCCCCCHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEEEEC
T ss_conf 99999767998689987424------99999999999999999999999859---9971445779946878998999548
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH-
Q ss_conf 6654589999986345789876666664423633337999896333378979999988199999976778741899988-
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK- 933 (1013)
Q Consensus 855 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~- 933 (1013)
|+|+.+.+ ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...............
T Consensus 150 Gla~~~~~----------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 219 (322)
T d1s9ja_ 150 GVSGQLID----------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219 (322)
T ss_dssp CCCHHHHH----------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----
T ss_pred CCCCCCCC----------CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf 77625678----------86211137714119468758998948889989999999998889989988789999998875
Q ss_pred -HH---CCH--------------------HHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf -51---883--------------------489840111001365642038997134789999999999986502468989
Q 001782 934 -MA---LPE--------------------KVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPS 989 (1013)
Q Consensus 934 -~~---~~~--------------------~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 989 (1013)
.. .+. ...+.........|..++. ...+.++.+++.+|++.||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~s~~~~dli~~~L~~dP~ 287 (322)
T d1s9ja_ 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS------------GVFSLEFQDFVNKCLIKNPA 287 (322)
T ss_dssp --------------------------CCCCHHHHHHHHHTSCCCCCCB------------TTBCHHHHHHHHHHTCSSTT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC------------CCCCHHHHHHHHHHCCCCHH
T ss_conf 177545774212333221111222354134778876650268766764------------44899999999998689946
Q ss_pred CCCCHHHHHHH
Q ss_conf 99998999999
Q 001782 990 ERIQMTDVVAK 1000 (1013)
Q Consensus 990 ~RPs~~eil~~ 1000 (1013)
+||||+|+++.
T Consensus 288 ~R~ta~e~L~H 298 (322)
T d1s9ja_ 288 ERADLKQLMVH 298 (322)
T ss_dssp TSCCHHHHHTS
T ss_pred HCCCHHHHHHC
T ss_conf 79089999609
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=369.54 Aligned_cols=266 Identities=25% Similarity=0.426 Sum_probs=213.3
Q ss_pred HHHHHHHCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
Q ss_conf 66665411489888011054238999998999739999997413456036799999998417999630499996147745
Q 001782 692 ADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 692 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 771 (1013)
+.++...++|++.+.||+|+||+||+|.+..+++.||||++... ....+++.+|++++++++||||+++++++.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~----- 83 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT----- 83 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred CCCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCEE-----
T ss_conf 65174579939865982088808999999999969999997776-103999999999998679998826775274-----
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 65418899860447877777300365421578899999999999999999986169999052588998557558995598
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV 851 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl 851 (1013)
+.+..++||||+++|+|.+++..... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl 156 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKV 156 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred ECCEEEEEEECCCCCCHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEE
T ss_conf 57854787631467606777530355----4157999999999999978889878---9305760457689989992898
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHH
Q ss_conf 01466545899999863457898766666644236333379998963333789799999881999999767787418999
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 852 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~ 931 (1013)
+|||+|+....... .......|++.|+|||++.+..++.++||||+||++|||++|..|+......
T Consensus 157 ~DFG~a~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------- 222 (287)
T d1opja_ 157 ADFGLSRLMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------- 222 (287)
T ss_dssp CCCCCTTTCCSSSS-------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------
T ss_pred CCCCCEEECCCCCC-------EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-------
T ss_conf 32445465378872-------2103556654666927872799981043021789999998679988774259-------
Q ss_pred HHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 885188348984011100136564203899713478999999999998650246898999998999999997665
Q 001782 932 AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~ 1006 (1013)
....+.+.... ++.. +..++.++.+++.+||+.||.+|||+.|+++.|+.+.+
T Consensus 223 ------~~~~~~i~~~~------~~~~----------~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 223 ------SQVYELLEKDY------RMER----------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ------HHHHHHHHTTC------CCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ------HHHHHHHHCCC------CCCC----------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------99999985588------8888----------74330999999999757797689399999999999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=364.30 Aligned_cols=264 Identities=28% Similarity=0.451 Sum_probs=209.6
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCE---EEEEEEEEECCC-CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
Q ss_conf 1148988801105423899999899973---999999741345-603679999999841799963049999614774565
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEM---AVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 773 (1013)
.++|++.++||+|+||+||+|+++.++. .||||.+..... ...+++.+|++++++++||||++++|++. ..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KS 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE-----EC
T ss_conf 0042785698027882999999957997889999999784459899999999999998579988861899996-----28
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 41889986044787777730036542157889999999999999999998616999905258899855755899559801
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~D 853 (1013)
+..++||||+++|+|.+++.... +.+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~D 171 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSD 171 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CEEEEEEEECCCCCCEEEECCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECC
T ss_conf 87799997227985300210456-----7999999999999999988988527---983576150448988999199888
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHH
Q ss_conf 466545899999863457898766666644236333379998963333789799999881-9999997677874189998
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~P~~~~~~~~~~~~~~~ 932 (1013)
||+|+.+....... .........||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....
T Consensus 172 FGla~~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-------- 240 (299)
T d1jpaa_ 172 FGLSRFLEDDTSDP---TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-------- 240 (299)
T ss_dssp C--------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------
T ss_pred CCCCEECCCCCCCC---EEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH--------
T ss_conf 44315756777765---3650256668830038788836997861214453578999986799999999999--------
Q ss_pred HHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 851883489840111001365642038997134789999999999986502468989999989999999976654
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~~ 1007 (1013)
+....+.... |+. .+.+++.++.+++.+||+.||.+|||+.||++.|+.+.+.
T Consensus 241 ------~~~~~i~~~~------~~~----------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 241 ------DVINAIEQDY------RLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ------HHHHHHHTTC------CCC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------HHHHHHHCCC------CCC----------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf ------9999997378------899----------9742269999999997587976892999999999998418
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.01 Aligned_cols=248 Identities=22% Similarity=0.379 Sum_probs=204.7
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEEC---CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCC
Q ss_conf 11489888011054238999998999739999997413---456036799999998417999630499996147745654
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 774 (1013)
.++|++.+.||+|+||+||+|+++.+++.||+|++... .......+.+|+++++.++||||+++++++ .+..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE-----EECC
T ss_conf 53769988985177858999999899949999998168856768999999999999856888888599999-----9899
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 18899860447877777300365421578899999999999999999986169999052588998557558995598014
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Df 854 (1013)
..++||||+++|+|.+++... ..+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+||+||
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~------~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DF 150 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKL------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF 150 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEEECCCCCHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCC
T ss_conf 989998504798589887504------8999999999999999999999988---9465220234414668998711555
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 66545899999863457898766666644236333379998963333789799999881999999767787418999885
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1013)
|+|...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 151 G~a~~~~~~----------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---------- 210 (263)
T d2j4za1 151 GWSVHAPSS----------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---------- 210 (263)
T ss_dssp CSCSCCCCC----------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------
T ss_pred CEEEECCCC----------CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH----------
T ss_conf 633544888----------523557887634999975899893144046759999983299998889999----------
Q ss_pred HCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 188348984011100136564203899713478999999999998650246898999998999999
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
+....+. ...+ .. +...++++.+++.+|++.||++|||+.|+++.
T Consensus 211 ----~~~~~i~---~~~~----~~----------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 211 ----ETYKRIS---RVEF----TF----------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ----HHHHHHH---TTCC----CC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----HHHHHHH---CCCC----CC----------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ----9999997---1899----99----------86689999999999764797689099999719
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=362.59 Aligned_cols=255 Identities=20% Similarity=0.292 Sum_probs=206.0
Q ss_pred HHCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEE
Q ss_conf 41148988801105423899999899973999999741345603679999999841799963049999614774565418
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 776 (1013)
..++|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+.++++++||||+++++++ .+.+..
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~ 98 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEM 98 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEE-----EECCEE
T ss_conf 865758988984076819999998899989999998452431699999999999867997999299999-----989999
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEECCC
Q ss_conf 899860447877777300365421578899999999999999999986169999052588998557558--995598014
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH--DMVAHVGDF 854 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~--~~~~kl~Df 854 (1013)
++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+||
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DF 170 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF 170 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred EEEEECCCCCCHHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEEC
T ss_conf 99998579988999997623-----7899999999999999999999756---976000154673641688986999545
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 66545899999863457898766666644236333379998963333789799999881999999767787418999885
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1013)
|+|+.+.... ......||+.|||||++.+..++.++||||+||++|+|++|+.||.+.... ...
T Consensus 171 G~a~~~~~~~---------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~------ 234 (350)
T d1koaa2 171 GLTAHLDPKQ---------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETL------ 234 (350)
T ss_dssp TTCEECCTTS---------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH------
T ss_pred CHHEECCCCC---------CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHH------
T ss_conf 2104425654---------320006862421889975899872676554659999998598998997999-999------
Q ss_pred HCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 188348984011100136564203899713478999999999998650246898999998999999
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
..+........+ . .....++++.+++.+|+..||++|||++|+++.
T Consensus 235 ------~~i~~~~~~~~~-~-------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 235 ------RNVKSCDWNMDD-S-------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ------HHHHHTCCCSCC-G-------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ------HHHHHCCCCCCC-C-------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------999847889894-2-------------235899999999999756896679089998629
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=360.72 Aligned_cols=255 Identities=19% Similarity=0.251 Sum_probs=205.9
Q ss_pred HHCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEE
Q ss_conf 41148988801105423899999899973999999741345603679999999841799963049999614774565418
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 776 (1013)
..++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|++++++++||||++++++ +.+....
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~ 101 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDKYEM 101 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEE-----EECSSEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEE-----EEECCEE
T ss_conf 54035998999317782999999989997999999887264679999999999986799798919999-----9989999
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEECCC
Q ss_conf 89986044787777730036542157889999999999999999998616999905258899855755--8995598014
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD--HDMVAHVGDF 854 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~--~~~~~kl~Df 854 (1013)
|+||||+++|+|.+++.... ..+++.+++.++.|++.||.|||++ ||+||||||+|||++ .++.+||+||
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DF 173 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF 173 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred EEEEECCCCCHHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEEC
T ss_conf 99998289980888898638-----9989999999999999999999977---926513144553113467884899525
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 66545899999863457898766666644236333379998963333789799999881999999767787418999885
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1013)
|+|..+.+.. ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.... .........
T Consensus 174 Gla~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~ 243 (352)
T d1koba_ 174 GLATKLNPDE---------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRC 243 (352)
T ss_dssp TTCEECCTTS---------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHC
T ss_pred CCCEECCCCC---------CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHC
T ss_conf 6303437887---------201004764534899974799897633389899999999688998997999-999999847
Q ss_pred HCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 188348984011100136564203899713478999999999998650246898999998999999
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
. .. .+... ....+.++.+++.+|++.||.+|||+.|+++.
T Consensus 244 ~------------~~-~~~~~-------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 244 D------------WE-FDEDA-------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp C------------CC-CCSST-------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred C------------CC-CCCCC-------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8------------89-89300-------------24799999999999756996689189999609
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.28 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=198.3
Q ss_pred CCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEEEE
Q ss_conf 8988801105423899999899973999999741345--60367999999984179996304999961477456541889
Q 001782 701 FSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 701 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 778 (1013)
|+..++||+|+||+||+|.+..++..||+|++..... ...+.+.+|++++++++||||+++++++... .......++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCCCCEEEE
T ss_conf 8851697008284999999999995999999851227989999999999999857999850699998403-345888999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCEEEC-CCCCEEECCCC
Q ss_conf 9860447877777300365421578899999999999999999986169999--05258899855755-89955980146
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPP--IVHGDLKPSNVLLD-HDMVAHVGDFG 855 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dikp~Nili~-~~~~~kl~Dfg 855 (1013)
||||+++|+|.+++... ..+++..+..++.|++.|++|||++ + |+||||||+|||++ .++.+||+|||
T Consensus 90 vmE~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG 160 (270)
T ss_dssp EEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEECCCCCCHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEECCCCHHHCEEECCCCCEEEEECC
T ss_conf 99578989489997513------5546999999999999999999978---99799687674351166799988980057
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 65458999998634578987666666442363333799989633337897999998819999997677874189998851
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1013)
+|+.... .......||+.|+|||++.+ .++.++||||+||++|||++|+.||....+............
T Consensus 161 la~~~~~----------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~ 229 (270)
T d1t4ha_ 161 LATLKRA----------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV 229 (270)
T ss_dssp GGGGCCT----------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC
T ss_pred CCEECCC----------CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
T ss_conf 6542368----------76677553813008988478-999867110079999999878899987655999999997389
Q ss_pred CCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 8834898401110013656420389971347899999999999865024689899999899999
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~ 999 (1013)
.+... ....++++.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~----------------------------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 230 KPASF----------------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCGGG----------------------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCC----------------------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 98656----------------------------7557899999999976379758929999967
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.35 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=204.6
Q ss_pred CCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEEEE
Q ss_conf 14898880110542389999989997399999974134560367999999984179996304999961477456541889
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 778 (1013)
+.|++.+.||+|+||+||+|++..+++.||+|++........+.+.+|++++++++||||+++++++ .+.+..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE-----EECCEEEE
T ss_conf 3759847993077819999999999939999998728999999999999999867999988498898-----00995899
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 98604478777773003654215788999999999999999999861699990525889985575589955980146654
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~ 858 (1013)
||||+++|+|.+++.... ..+++.++..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 87 vmEy~~~g~L~~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEECCTTEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEECCCCCCHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHH
T ss_conf 996279981889998628-----9999999999999999999999988---98871407003148789998997161230
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Q ss_conf 589999986345789876666664423633337-----999896333378979999988199999976778741899988
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGM-----GGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~ 933 (1013)
.... .........||+.|+|||++. +..|+.++||||+||++|||++|+.||....... .......
T Consensus 159 ~~~~--------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~ 229 (288)
T d2jfla1 159 KNTR--------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAK 229 (288)
T ss_dssp ECHH--------HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHH
T ss_pred CCCC--------CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHC
T ss_conf 3577--------864100102562647999983202578888806657878999999820889999989999-9999970
Q ss_pred HHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 5188348984011100136564203899713478999999999998650246898999998999999
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
...+ ....+...+.++.+++.+||+.||.+|||+.|+++.
T Consensus 230 ~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 230 SEPP---------------------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SCCC---------------------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCC---------------------------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 7998---------------------------777656699999999999766996689199999629
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.68 Aligned_cols=265 Identities=23% Similarity=0.371 Sum_probs=208.5
Q ss_pred HHCCCCCCCCEEECCCEEEEEEEECCCC-----EEEEEEEEEECC-CCCHHHHHHHHHHHHCC-CCCCCCEEEEEEECCC
Q ss_conf 4114898880110542389999989997-----399999974134-56036799999998417-9996304999961477
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENE-----MAVAVKVMNLKQ-RGATKSFVAECEALRNI-RHRNLIKIITVCSSID 769 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 769 (1013)
..++|++.++||+|+||+||+|++...+ ..||+|++.... ......+.+|+.++.++ +||||+++++++.
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~--- 111 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT--- 111 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE---
T ss_conf 78993970198307881999999857885542049999996633587899999999999997158996868778886---
Q ss_pred CCCCCEEEEEEEECCCCCHHHHHHCCCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEE
Q ss_conf 45654188998604478777773003654-----------------2157889999999999999999998616999905
Q 001782 770 FEEVDFKAIVYEYMECGSLEDWLHQSNDQ-----------------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIV 832 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv 832 (1013)
..+..++||||+++|+|.++++..+.. .....+++..++.++.|++.|+.|||++ +|+
T Consensus 112 --~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~Ii 186 (325)
T d1rjba_ 112 --LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 186 (325)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred --ECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEE
T ss_conf --299589999727999599999862577751022100001222001257789999999999999999999739---905
Q ss_pred ECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 25889985575589955980146654589999986345789876666664423633337999896333378979999988
Q 001782 833 HGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMF 912 (1013)
Q Consensus 833 H~Dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 912 (1013)
||||||+||+++.++.+||+|||+|+........ .......||+.|||||++.++.++.++|||||||++|||+
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~eml 260 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred ECCCCHHCCCCCCCCEEEEEECCCCCCCCCCCCE------EEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHH
T ss_conf 0527032144345982898514222204577861------5623435787657838872799996330300039999998
Q ss_pred H-CCCCCCCCCCCCCCHHHHHHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 1-999999767787418999885188348984011100136564203899713478999999999998650246898999
Q 001782 913 T-RRRPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSER 991 (1013)
Q Consensus 913 t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 991 (1013)
+ |..||.+..... .+.+.+......+ .+..++.++.+++.+||+.||++|
T Consensus 261 t~g~~Pf~~~~~~~-------------~~~~~~~~~~~~~----------------~p~~~~~~l~~li~~cl~~dP~~R 311 (325)
T d1rjba_ 261 SLGVNPYPGIPVDA-------------NFYKLIQNGFKMD----------------QPFYATEEIYIIMQSCWAFDSRKR 311 (325)
T ss_dssp TTSCCSSTTCCCSH-------------HHHHHHHTTCCCC----------------CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HCCCCCCCCCCHHH-------------HHHHHHHCCCCCC----------------CCCCCCHHHHHHHHHHCCCCHHHC
T ss_conf 38999999989899-------------9999985699899----------------887678999999999758896689
Q ss_pred CCHHHHHHHHHHH
Q ss_conf 9989999999976
Q 001782 992 IQMTDVVAKLCSA 1004 (1013)
Q Consensus 992 Ps~~eil~~L~~~ 1004 (1013)
||++||++.|...
T Consensus 312 Pt~~ei~~~L~~~ 324 (325)
T d1rjba_ 312 PSFPNLTSFLGCQ 324 (325)
T ss_dssp CCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHCC
T ss_conf 3999999997488
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.87 Aligned_cols=259 Identities=28% Similarity=0.446 Sum_probs=206.6
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEEE
Q ss_conf 11489888011054238999998999739999997413456036799999998417999630499996147745654188
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 777 (1013)
.++|+..+.||+|+||+||+|++. ++..||||++... ....+++.+|++++++++||||++++|+|. ..+..+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~ 76 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 76 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCE
T ss_pred HHHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEEC-----CCCCEE
T ss_conf 699588889820888299999988-9999999998788-676899999999999668997565352431-----599337
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 99860447877777300365421578899999999999999999986169999052588998557558995598014665
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a 857 (1013)
+||||+++|+|.+++.... ..+++..++.++.|++.|+.|+|++ +|+||||||+||+++.++.+||+|||+|
T Consensus 77 lv~E~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT 148 (263)
T ss_dssp EEEECCTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred EEEEECCCCCHHHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHH
T ss_conf 9998369991899752013-----4788999999999999987765316---4310443153266668877686553210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 45899999863457898766666644236333379998963333789799999881999999767787418999885188
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1013)
+....... .......||+.|+|||++.+..++.++|||||||++|||+|+..|+...... .
T Consensus 149 ~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~----~-------- 209 (263)
T d1sm2a_ 149 RFVLDDQY-------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----S-------- 209 (263)
T ss_dssp -----------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH----H--------
T ss_pred EECCCCCC-------EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCH----H--------
T ss_conf 02368873-------3504300176667857860799984033210599999998789888778999----9--------
Q ss_pred HHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 3489840111001365642038997134789999999999986502468989999989999999976654
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007 (1013)
Q Consensus 938 ~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~~ 1007 (1013)
...+.+...... .++ ..++.++.+++.+||+.||.+|||++||++.|+.++++
T Consensus 210 -~~~~~i~~~~~~---~~p-------------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 210 -EVVEDISTGFRL---YKP-------------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -HHHHHHHHTCCC---CCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHHCCCC---CCC-------------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -999999806888---995-------------43679999999997657976891999999999999857
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=362.04 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=204.5
Q ss_pred HHCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCE
Q ss_conf 41148988801105423899999899973999999741345-60367999999984179996304999961477456541
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 775 (1013)
..+.|++.+.||+|+||+||+|+++.+++.||+|++..... .....+.+|+.+++.++||||+++++++ .+...
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEE-----EECCE
T ss_conf 7666699889940658399999999999899999981577312899999999999867998999198999-----98998
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEC
Q ss_conf 889986044787777730036542157889999999999999999998616999905258899855755---89955980
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLD---HDMVAHVG 852 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~---~~~~~kl~ 852 (1013)
.|+||||+++|+|.+++... +.+++.++..++.|++.|+.|||++ +|+||||||+||++. .++.+||+
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~ 152 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEK------GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMIS 152 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTC------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEECCCCCCHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEE
T ss_conf 88988526898488865303------6788789999999999998752413---05568704630011046888249983
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Q ss_conf 14665458999998634578987666666442363333799989633337897999998819999997677874189998
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 853 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~ 932 (1013)
|||+|+..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... .
T Consensus 153 DFG~a~~~~~~---------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~----- 217 (307)
T d1a06a_ 153 DFGLSKMEDPG---------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-L----- 217 (307)
T ss_dssp CC---------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H-----
T ss_pred CCCEEEECCCC---------CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-H-----
T ss_conf 15435872589---------70440032842259188737999807873451599999985979999989999-9-----
Q ss_pred HHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 85188348984011100136564203899713478999999999998650246898999998999999
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
...+........+ ......++++.+++.+|++.||++|||+.|+++.
T Consensus 218 -------~~~i~~~~~~~~~--------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 218 -------FEQILKAEYEFDS--------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -------HHHHHTTCCCCCT--------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -------HHHHHCCCCCCCC--------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -------9998616877787--------------6666789999999999760897579189998629
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.75 Aligned_cols=254 Identities=21% Similarity=0.322 Sum_probs=206.7
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCC
Q ss_conf 114898880110542389999989997399999974134---56036799999998417999630499996147745654
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 774 (1013)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++ .+.+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSS
T ss_pred CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----EECC
T ss_conf 98778988985087909999999899979999998657755777899999999999876888861799999-----9899
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 18899860447877777300365421578899999999999999999986169999052588998557558995598014
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Df 854 (1013)
..|+||||+++|+|.+++... +.+++..+..++.|++.|+.|+|++ +|+||||||+|||++.++.+||+||
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DF 152 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDF 152 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEECCCCCCHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCC
T ss_conf 889999704898777765315------9999999999999999999762165---0884767741236688853886032
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 66545899999863457898766666644236333379998963333789799999881999999767787418999885
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1013)
|+|+.+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..
T Consensus 153 G~a~~~~~~~~------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~------- 218 (288)
T d1uu3a_ 153 GTAKVLSPESK------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-LI------- 218 (288)
T ss_dssp TTCEECC----------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH-------
T ss_pred CCCEECCCCCC------CCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHH-HH-------
T ss_conf 10242256776------43335556775525844002689896662304569999980388998995999-99-------
Q ss_pred HCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 18834898401110013656420389971347899999999999865024689899999899999999
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLC 1002 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~ 1002 (1013)
...+...... -| ...+.++.+++.+|++.||.+|||++|++..-.
T Consensus 219 -----~~~i~~~~~~-~p-----------------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 219 -----FQKIIKLEYD-FP-----------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp -----HHHHHTTCCC-CC-----------------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred -----HHHHHCCCCC-CC-----------------CCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHH
T ss_conf -----9999718999-98-----------------547999999999985579768919789737789
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.04 Aligned_cols=263 Identities=25% Similarity=0.427 Sum_probs=207.5
Q ss_pred HHHHHHCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCC
Q ss_conf 66654114898880110542389999989997399999974134560367999999984179996304999961477456
Q 001782 693 DLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 693 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 772 (1013)
++....++|++.+.||+|+||+||+|.++ ++..||||++... ....+.+.+|++++++++||||+++++++..
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----- 79 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----- 79 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred CEECCHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-----
T ss_conf 70038899388679810798289999999-9999999998647-6888999999999986799988578731045-----
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEC
Q ss_conf 54188998604478777773003654215788999999999999999999861699990525889985575589955980
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~ 852 (1013)
+..++||||+++|+|.+++..... ..+++.++++++.|++.|+.|||++ +|+||||||+|||++.++.+||+
T Consensus 80 -~~~~iv~Ey~~~g~L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~ 151 (272)
T d1qpca_ 80 -EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIA 151 (272)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEEC
T ss_pred -CCEEEEEEECCCCCHHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEEC
T ss_conf -976999995789828888751478----9887889999999999999999748---95467564225156202440423
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Q ss_conf 14665458999998634578987666666442363333799989633337897999998819999997677874189998
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 853 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~ 932 (1013)
|||+|+.+..... .......|++.|+|||++.++.++.++|||||||++|||+||..|+.......
T Consensus 152 DFGla~~~~~~~~-------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~------- 217 (272)
T d1qpca_ 152 DFGLARLIEDNEY-------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------- 217 (272)
T ss_dssp CCTTCEECSSSCE-------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------
T ss_pred CCCCEEECCCCCC-------CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------
T ss_conf 4101477358864-------42035677444458289837999824564525799999996898888888999-------
Q ss_pred HHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 85188348984011100136564203899713478999999999998650246898999998999999997665
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~ 1006 (1013)
+....+.... |+.. +..++.++.+++.+||+.||++|||+.||++.|+..-.
T Consensus 218 ------~~~~~i~~~~------~~~~----------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 218 ------EVIQNLERGY------RMVR----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ------HHHHHHHTTC------CCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHHHHHHCC------CCCC----------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------9999997068------8889----------65571999999999758897689399999998611321
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.21 Aligned_cols=259 Identities=22% Similarity=0.297 Sum_probs=205.6
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCE
Q ss_conf 1148988801105423899999899973999999741345--60367999999984179996304999961477456541
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 775 (1013)
.++|++.+.||+|+||+||+|+++.+++.||+|++..... ...+.+.+|++++++++||||+++++++.+ .....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE---CCCCE
T ss_conf 333799679830889199999999999799999987465797999999999999997789998248999991---78998
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 8899860447877777300365421578899999999999999999986169--99905258899855755899559801
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHC--HPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~Dikp~Nili~~~~~~kl~D 853 (1013)
.|+||||+++|+|.+++..... ....+++..++.++.|++.|+.|||++. ..+|+||||||+|||++.++.+||+|
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred EEEEEECCCCCCHHHHHHHCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEE
T ss_conf 9999956899938999985154--57899999999999999999999997167788788586765425747888579800
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Q ss_conf 46654589999986345789876666664423633337999896333378979999988199999976778741899988
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~ 933 (1013)
||+|+.+.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..
T Consensus 158 FG~a~~~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-----~~-- 222 (269)
T d2java1 158 FGLARILNHDT--------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-----EL-- 222 (269)
T ss_dssp HHHHHHC-------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HH--
T ss_pred CCCEEECCCCC--------CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHH-----HH--
T ss_conf 10003224577--------7556677882327999983999993898875278999980188998998999-----99--
Q ss_pred HHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 518834898401110013656420389971347899999999999865024689899999899999
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~ 999 (1013)
...+........| ..++.++.+++.+||+.||.+|||+.|+++
T Consensus 223 ------~~~i~~~~~~~~~-----------------~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 223 ------AGKIREGKFRRIP-----------------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------HHHHHHTCCCCCC-----------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------HHHHHCCCCCCCC-----------------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf ------9999718998897-----------------435999999999976799557918999972
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.39 Aligned_cols=265 Identities=23% Similarity=0.372 Sum_probs=209.7
Q ss_pred HCCCCCCCC-EEECCCEEEEEEEECC--CCEEEEEEEEEECCC-CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
Q ss_conf 114898880-1105423899999899--973999999741345-603679999999841799963049999614774565
Q 001782 698 TNDFSSSNM-IGQGSFGFVYRGNLGE--NEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 698 ~~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 773 (1013)
.++|.+.+. ||+|+||+||+|.++. ++..||||++..... ...+++.+|++++++++||||++++++|..
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 80 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 80 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC------
T ss_conf 44718878487306080999999960897689999998820397899999999999986799888068656036------
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 41889986044787777730036542157889999999999999999998616999905258899855755899559801
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~D 853 (1013)
+..++||||+++|+|.+++...+ ..+++.++..++.|++.||.|||++ +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~D 152 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISD 152 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECC
T ss_pred CEEEEEEEECCCCCHHHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECC
T ss_conf 80799998078996899752125-----6999999999999999987899868---810576764660454688542033
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHH
Q ss_conf 466545899999863457898766666644236333379998963333789799999881-9999997677874189998
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~P~~~~~~~~~~~~~~~ 932 (1013)
||+|+.+...... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||......
T Consensus 153 FGla~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------- 219 (285)
T d1u59a_ 153 FGLSKALGADDSY-----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------- 219 (285)
T ss_dssp CTTCEECTTCSCE-----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------
T ss_pred CHHHHCCCCCCCC-----CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHH--------
T ss_conf 1342115543432-----113562113743358688727999954123220178999993899999997999--------
Q ss_pred HHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHCC
Q ss_conf 8518834898401110013656420389971347899999999999865024689899999899999999766544205
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIFLSN 1011 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 1011 (1013)
++...+... .|+.. +..++.++.+++.+||+.||++||++.+|++.|+.+..++.+.
T Consensus 220 ------~~~~~i~~~------~~~~~----------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 220 ------EVMAFIEQG------KRMEC----------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp ------HHHHHHHTT------CCCCC----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ------HHHHHHHCC------CCCCC----------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHC
T ss_conf ------999999818------99999----------9767899999999975779768909999999999999985411
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=359.08 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=198.6
Q ss_pred CCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCC---CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCE
Q ss_conf 1489888011054238999998999739999997413456---0367999999984179996304999961477456541
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG---ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 775 (1013)
..|+..+.||+|+||+||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++. +...
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-----ECCE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999-----8998
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 88998604478777773003654215788999999999999999999861699990525889985575589955980146
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg 855 (1013)
.++|||||++|++..++... ..+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EEEEEEECCCCCHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECC
T ss_conf 89999806999457899737------9999999999999999999999868---97666788421798799978984436
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Q ss_conf 6545899999863457898766666644236333379---9989633337897999998819999997677874189998
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG---GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~ 932 (1013)
+|..... .....||+.|||||++.+ +.|+.++||||+||++|||++|..||.+.... ..
T Consensus 161 ~a~~~~~------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~----~~-- 222 (309)
T d1u5ra_ 161 SASIMAP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SA-- 222 (309)
T ss_dssp TCBSSSS------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HH--
T ss_pred CCCCCCC------------CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH----HH--
T ss_conf 5334677------------87313476636889983467888672145455899999998788999997999----99--
Q ss_pred HHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 8518834898401110013656420389971347899999999999865024689899999899999
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~ 999 (1013)
....... ..|.... ..+++++.+++.+||+.||.+|||+.|+++
T Consensus 223 -------~~~i~~~---~~~~~~~-------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 223 -------LYHIAQN---ESPALQS-------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -------HHHHHHS---CCCCCSC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------HHHHHHC---CCCCCCC-------------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -------9999828---9998887-------------888999999999977379657918999971
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.73 Aligned_cols=202 Identities=27% Similarity=0.353 Sum_probs=179.8
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEEC---CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCC
Q ss_conf 11489888011054238999998999739999997413---456036799999998417999630499996147745654
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 774 (1013)
.++|.+.+.||+|+||.||+|+++.+++.||+|++... .....+.+.+|+.++++++||||+++++++ .+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----CCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640-----3564
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 18899860447877777300365421578899999999999999999986169999052588998557558995598014
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Df 854 (1013)
..|+||||+++|+|.+++... ..+++..+..++.|++.|+.|+|++ +|+||||||+|||++.++.+||+||
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~------~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred CCCCCEECCCCCCHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEEC
T ss_conf 211100035798605555325------6775999999999996521134315---9622464777847658998888205
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 6654589999986345789876666664423633337999896333378979999988199999976
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 855 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~ 921 (1013)
|+|+..... .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 150 G~a~~~~~~--------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 150 GLCKEGISD--------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp TTCBCSCCT--------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCCCCCC--------CCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCC
T ss_conf 652003567--------86205510088996666504898883331022306788998789999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.42 Aligned_cols=252 Identities=20% Similarity=0.284 Sum_probs=204.9
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC------CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
Q ss_conf 1148988801105423899999899973999999741345------6036799999998417999630499996147745
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR------GATKSFVAECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 771 (1013)
.++|++.+.||+|+||+||+|+++.+++.||||++..... ...+.+.+|+.++++++||||+++++++ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEE-----E
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999-----9
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----
Q ss_conf 6541889986044787777730036542157889999999999999999998616999905258899855755899----
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM---- 847 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~---- 847 (1013)
+....++||||+++|+|.+++... +.+++..+..++.|++.|+.|||++ +|+||||||+||+++.++
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~------~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSC
T ss_pred ECCEEEEEEECCCCCCCCCHHCCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCC
T ss_conf 799899999867786431001035------6421557899999999998766625---4221133301279825898666
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 55980146654589999986345789876666664423633337999896333378979999988199999976778741
Q 001782 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLT 927 (1013)
Q Consensus 848 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~ 927 (1013)
.+|++|||+|...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..
T Consensus 155 ~vkl~DfG~a~~~~~~---------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~ 224 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFG---------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ET 224 (293)
T ss_dssp CEEECCCTTCEECTTS---------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH
T ss_pred CEEECCHHHHHHCCCC---------CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHH-HH
T ss_conf 4696433442105777---------6312247777430999981899997665221409999997088998899999-99
Q ss_pred HHHHHHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 899988518834898401110013656420389971347899999999999865024689899999899999
Q 001782 928 LHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 928 ~~~~~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~ 999 (1013)
. ..+........ .......+..+.+++.+||+.||.+|||++|+++
T Consensus 225 ~------------~~i~~~~~~~~--------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 225 L------------ANVSAVNYEFE--------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp H------------HHHHTTCCCCC--------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred H------------HHHHHCCCCCC--------------CHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 9------------99981688887--------------0104788999999999986389668919999961
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.51 Aligned_cols=262 Identities=28% Similarity=0.471 Sum_probs=206.2
Q ss_pred CCCCCCCCEEECCCEEEEEEEECCCC----EEEEEEEEEECCC-CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
Q ss_conf 14898880110542389999989997----3999999741345-603679999999841799963049999614774565
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENE----MAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 773 (1013)
..|+..++||+|+||+||+|.++.++ ..||||++..... .....+.+|++++++++||||++++|++. ..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-----CC
T ss_conf 9968615981177909999999689987879999999884459689999999999998568987832367783-----38
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 41889986044787777730036542157889999999999999999998616999905258899855755899559801
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~D 853 (1013)
...++||||+.++++.+++.... ..+++.++..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~D 153 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD 153 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CCEEEEEEECCCCCCHHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECC
T ss_conf 80389997213574022210234-----5420899999999999854121212---342576564427888998499845
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Q ss_conf 46654589999986345789876666664423633337999896333378979999988199999976778741899988
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~ 933 (1013)
||+|+.+...... ........||+.|+|||++.++.++.++|||||||++|||++|..|+.......
T Consensus 154 FGla~~~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-------- 220 (283)
T d1mqba_ 154 FGLSRVLEDDPEA-----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------- 220 (283)
T ss_dssp CCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------
T ss_pred CCHHHCCCCCCCC-----CEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH--------
T ss_conf 5103003578765-----267426777734348888704999973556344898999996798865568999--------
Q ss_pred HHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 51883489840111001365642038997134789999999999986502468989999989999999976654
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~~ 1007 (1013)
+..+.+.... |+.. +..++.++.+++.+||+.||.+||++.||++.|+.+.+.
T Consensus 221 -----~~~~~i~~~~------~~~~----------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 221 -----EVMKAINDGF------RLPT----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----HHHHHHHTTC------CCCC----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----HHHHHHHCCC------CCCC----------CHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -----9999986357------8998----------504579999999997767976893999999999998669
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.70 Aligned_cols=254 Identities=27% Similarity=0.449 Sum_probs=208.1
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEEE
Q ss_conf 11489888011054238999998999739999997413456036799999998417999630499996147745654188
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 777 (1013)
.++|+..++||+|+||+||+|+++ +++.||||+++.. ....+.+.+|+.++++++||||++++|+|. .....+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~ 75 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEE-----ECCCEE
T ss_conf 699799689820788399999988-9989999998747-577899999999999668986015889985-----078169
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 99860447877777300365421578899999999999999999986169999052588998557558995598014665
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLA 857 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a 857 (1013)
+||||+++|++.+++.... ..+++..+++++.|++.|+.|||++ +|+||||||+||+++.++.+||+|||+|
T Consensus 76 iv~Ey~~~g~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a 147 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLS 147 (258)
T ss_dssp EEEECCTTEEHHHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EEEECCCCCCHHHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHH
T ss_conf 9997048993888641024-----6776899999999999999987546---8434665413588769984798861442
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHC
Q ss_conf 45899999863457898766666644236333379998963333789799999881-99999976778741899988518
Q 001782 858 RFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMAL 936 (1013)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 936 (1013)
+.+..... .......||+.|+|||++.+..++.++||||||+++|||+| |+.||......
T Consensus 148 ~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------------ 208 (258)
T d1k2pa_ 148 RYVLDDEY-------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------------ 208 (258)
T ss_dssp CBCSSSSC-------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------------
T ss_pred EECCCCCC-------EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHH------------
T ss_conf 02357872-------25246578877578078637998852103364324673975599998899999------------
Q ss_pred CHHHHHHHHHHH-CCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 834898401110-01365642038997134789999999999986502468989999989999999976
Q 001782 937 PEKVMEIVDPLL-LLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSA 1004 (1013)
Q Consensus 937 ~~~~~~~i~~~l-~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~ 1004 (1013)
+....+.... ...| ..+++++.+++.+||+.||.+|||+.|+++.|..+
T Consensus 209 --~~~~~i~~~~~~~~p-----------------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 209 --ETAEHIAQGLRLYRP-----------------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --HHHHHHHTTCCCCCC-----------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --HHHHHHHHCCCCCCC-----------------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf --999999807978996-----------------54659999999997668976893999999874188
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.95 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=202.4
Q ss_pred CCEEECCCEEEEEEEEC--CCCEEEEEEEEEECCC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEEEEEE
Q ss_conf 80110542389999989--9973999999741345--6036799999998417999630499996147745654188998
Q 001782 705 NMIGQGSFGFVYRGNLG--ENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIVY 780 (1013)
Q Consensus 705 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 780 (1013)
++||+|+||+||+|.++ .+++.||||++..... ...+++.+|++++++++||||++++++|.. +..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC------CCEEEEE
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505------9779999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCC
Q ss_conf 60447877777300365421578899999999999999999986169999052588998557558995598014665458
Q 001782 781 EYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFL 860 (1013)
Q Consensus 781 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~~~ 860 (1013)
||+++|+|.+++... ..+++.+++.++.|++.||.|||++ +|+||||||+|||++.++.+|++|||+|+.+
T Consensus 87 E~~~~g~L~~~l~~~------~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 87 EMAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp ECCTTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred ECCCCCCHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHC
T ss_conf 747889689997522------5789999999999999997668747---9556777611310235675123413453313
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHCCHH
Q ss_conf 99999863457898766666644236333379998963333789799999881-99999976778741899988518834
Q 001782 861 PPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMALPEK 939 (1013)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1013)
...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.... +
T Consensus 158 ~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--------------~ 218 (277)
T d1xbba_ 158 RADENY-----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------------E 218 (277)
T ss_dssp CTTCSE-----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------------H
T ss_pred CCCCCC-----CCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHH--------------H
T ss_conf 432344-----322445677842039166537999843443034031328965899999998999--------------9
Q ss_pred HHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 898401110013656420389971347899999999999865024689899999899999999766544
Q 001782 940 VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIF 1008 (1013)
Q Consensus 940 ~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1008 (1013)
....+... .|+.. +..++.++.+++.+||+.||++|||+++|++.|+......
T Consensus 219 ~~~~i~~~------~~~~~----------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 219 VTAMLEKG------ERMGC----------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp HHHHHHTT------CCCCC----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHCC------CCCCC----------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHHC
T ss_conf 99999828------99999----------8656799999999975889768909899999852887504
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=349.51 Aligned_cols=201 Identities=24% Similarity=0.356 Sum_probs=171.4
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHH---HHHHHHCCCCCCCCEEEEEEECCCCC
Q ss_conf 114898880110542389999989997399999974134---560367999---99998417999630499996147745
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVA---ECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~ 771 (1013)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+ ++.+++.++||||+++++++ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEE-----E
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999-----9
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 65418899860447877777300365421578899999999999999999986169999052588998557558995598
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV 851 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl 851 (1013)
..+..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl 148 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 148 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEE
T ss_pred ECCEEEEEEEECCCCCHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEE
T ss_conf 899889999914898389998732------5532789999999999999999977---9622044422167858896798
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 01466545899999863457898766666644236333379-998963333789799999881999999767
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMF 922 (1013)
Q Consensus 852 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~P~~~~~ 922 (1013)
+|||+|+.+... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||....
T Consensus 149 ~DFGla~~~~~~----------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 149 SDLGLACDFSKK----------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp CCCTTCEECSSS----------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred EEECEEEECCCC----------CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 220102333788----------64331134554216876038999844104677899999985999888899
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.81 Aligned_cols=259 Identities=22% Similarity=0.399 Sum_probs=207.1
Q ss_pred CCCCCCCCEEECCCEEEEEEEECCCCE----EEEEEEEEEC-CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
Q ss_conf 148988801105423899999899973----9999997413-45603679999999841799963049999614774565
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEM----AVAVKVMNLK-QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 773 (1013)
.+|++.++||+|+||+||+|.+..+++ +||+|.+... .....+++.+|++++++++||||++++++|..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC------
T ss_conf 99978319820899299999995899889899999996513497999999999999986799888158999961------
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 41889986044787777730036542157889999999999999999998616999905258899855755899559801
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~D 853 (1013)
...++++|++.+|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D 154 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 154 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTS-----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred CCEEEEEEECCCCCCCCCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEEC
T ss_conf 98369998426874010111334-----5799999999999999999999876---950476212031167998758602
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHH
Q ss_conf 466545899999863457898766666644236333379998963333789799999881-9999997677874189998
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~P~~~~~~~~~~~~~~~ 932 (1013)
||+|+.+...... .......||+.|+|||++.++.++.++|||||||++|||+| |..||......
T Consensus 155 FGla~~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-------- 220 (317)
T d1xkka_ 155 FGLAKLLGAEEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------- 220 (317)
T ss_dssp CSHHHHTTTTCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--------
T ss_pred CCCCEECCCCCCC------CCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------
T ss_conf 5522233544453------22365105864467088746999835654407999999997799999999989--------
Q ss_pred HHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 851883489840111001365642038997134789999999999986502468989999989999999976654
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~~ 1007 (1013)
.+...+.... |+.. +..++.++.+++.+||+.||.+|||+.|+++.|..+.+.
T Consensus 221 ------~~~~~i~~~~------~~~~----------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 221 ------EISSILEKGE------RLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ------GHHHHHHHTC------CCCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------HHHHHHHCCC------CCCC----------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ------9999997599------8999----------855689999999984789934691999999999998758
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=351.78 Aligned_cols=268 Identities=22% Similarity=0.336 Sum_probs=213.0
Q ss_pred HHCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC---CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
Q ss_conf 41148988801105423899999899973999999741345---603679999999841799963049999614774565
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR---GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 773 (1013)
..++|++.+.||+|+||+||+|++..+++.||+|++..... .....+.+|+++++.++||||+++++++... ....
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~-~~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-TPAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-CSSS
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEC-CCCC
T ss_conf 062069868996089929999999999989999998556646989999999999999856999887311435432-6887
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 41889986044787777730036542157889999999999999999998616999905258899855755899559801
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~D 853 (1013)
...|+||||+++++|.+++... +.+++.++..++.|++.|+.|||++ +|+||||||+||+++.++..+++|
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d 154 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMD 154 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECC
T ss_pred CEEEEEEECCCCCEEHHHHCCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEH
T ss_conf 6699999778898710112035------8999999999999999999999857---952763467556657543201003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Q ss_conf 46654589999986345789876666664423633337999896333378979999988199999976778741899988
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~ 933 (1013)
||.+........ .........||+.|+|||++.+..++.++||||+||++|||++|+.||........
T Consensus 155 ~~~~~~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------- 222 (277)
T d1o6ya_ 155 FGIARAIADSGN-----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------- 222 (277)
T ss_dssp CTTCEECC---------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------
T ss_pred HHHHHHHCCCCC-----CCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHH-------
T ss_conf 444322123544-----33334642576243699998399999663202652899999769799899699999-------
Q ss_pred HHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHHH
Q ss_conf 51883489840111001365642038997134789999999999986502468989999-98999999997665
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-QMTDVVAKLCSARK 1006 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~eil~~L~~~~~ 1006 (1013)
....+... ...+... ....+.++.+++.+|++.||.+|| |+.++++.|..+++
T Consensus 223 ------~~~~~~~~-~~~~~~~-------------~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 223 ------AYQHVRED-PIPPSAR-------------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp ------HHHHHHCC-CCCGGGT-------------SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ------HHHHHHCC-CCCCCHH-------------CCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHC
T ss_conf ------99998469-9997100-------------347899999999998667976777399999999999758
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.44 Aligned_cols=273 Identities=21% Similarity=0.318 Sum_probs=209.3
Q ss_pred HHHHHHCCCCCCCCEEECCCEEEEEEEECC-----CCEEEEEEEEEECCC-CCHHHHHHHHHHHHCC-CCCCCCEEEEEE
Q ss_conf 666541148988801105423899999899-----973999999741345-6036799999998417-999630499996
Q 001782 693 DLSKATNDFSSSNMIGQGSFGFVYRGNLGE-----NEMAVAVKVMNLKQR-GATKSFVAECEALRNI-RHRNLIKIITVC 765 (1013)
Q Consensus 693 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 765 (1013)
.+....++|++.+.||+|+||.||+|.+.. +++.||+|++..... ...+.+.+|...+.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEE
T ss_conf 52616799798449841678399999986777555783999999860017178999999999988614998499741154
Q ss_pred ECCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECC
Q ss_conf 1477456541889986044787777730036542----------157889999999999999999998616999905258
Q 001782 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL----------EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGD 835 (1013)
Q Consensus 766 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~D 835 (1013)
. ......++||||+++|+|.++++...... ....+++.++..++.|++.|+.|||++ +|+|||
T Consensus 87 ~----~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD 159 (299)
T d1ywna1 87 T----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 159 (299)
T ss_dssp C----STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred C----CCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCC
T ss_conf 0----479757999984589929999985366666532220233214689999999999999999988737---971786
Q ss_pred CCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 89985575589955980146654589999986345789876666664423633337999896333378979999988199
Q 001782 836 LKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRR 915 (1013)
Q Consensus 836 ikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 915 (1013)
|||+|||++.++.+||+|||+|+........ .......||+.|+|||++.+..++.++||||+||++|||++|.
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~ 233 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTS------CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCCCCEEECCCCCEEECCCCCHHHCCCCCCC------CCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCC
T ss_conf 7731065779982898457520011356652------2247516672102036864688996632213678999998688
Q ss_pred -CCCCCCCCCCCCHHHHHHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCH
Q ss_conf -9999767787418999885188348984011100136564203899713478999999999998650246898999998
Q 001782 916 -RPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQM 994 (1013)
Q Consensus 916 -~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 994 (1013)
.||........ ....+.... |+.. +..++.++.+++.+||+.||.+|||+
T Consensus 234 ~~p~~~~~~~~~-------------~~~~~~~~~------~~~~----------~~~~~~~l~~li~~cl~~dP~~Rpt~ 284 (299)
T d1ywna1 234 ASPYPGVKIDEE-------------FCRRLKEGT------RMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTF 284 (299)
T ss_dssp CCSSTTCCCSHH-------------HHHHHHHTC------CCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCCCHHHH-------------HHHHHHCCC------CCCC----------CCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 999989998999-------------999996389------8888----------86578999999999767796679199
Q ss_pred HHHHHHHHHHHHH
Q ss_conf 9999999976654
Q 001782 995 TDVVAKLCSARKI 1007 (1013)
Q Consensus 995 ~eil~~L~~~~~~ 1007 (1013)
.|++++|+.+.++
T Consensus 285 ~eil~~L~~ilq~ 297 (299)
T d1ywna1 285 SELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHC
T ss_conf 9999999799867
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=348.19 Aligned_cols=246 Identities=21% Similarity=0.258 Sum_probs=202.0
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCC
Q ss_conf 114898880110542389999989997399999974134---56036799999998417999630499996147745654
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 774 (1013)
.++|++.+.||+|+||.||+|+++.+++.||||++.... ....+.+.+|+++++.++||||+++++++ ....
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCC-----CCCC
T ss_conf 23708988961176808999999899989999998267745889999999999999974877274034444-----3222
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 18899860447877777300365421578899999999999999999986169999052588998557558995598014
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Df 854 (1013)
..++|+||+.+|+|.+++... +.+++..+..++.|++.||.|||++ +||||||||+|||++.++.+||+||
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DF 185 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCCCCCCCCCCCCHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEEC
T ss_conf 223222233466226667515------8989999999999999989999859---9861767999936077897886101
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 66545899999863457898766666644236333379998963333789799999881999999767787418999885
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1013)
|+|+.+.. ......||+.|||||++.+..++.++||||+||++|||++|+.||.+.... ..
T Consensus 186 G~a~~~~~-----------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~------- 246 (350)
T d1rdqe_ 186 GFAKRVKG-----------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QI------- 246 (350)
T ss_dssp TTCEECSS-----------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH-------
T ss_pred EEEEECCC-----------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH-HH-------
T ss_conf 03332256-----------664336763567889971799885331145007899997588998995999-99-------
Q ss_pred HCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 1883489840111001365642038997134789999999999986502468989999-----9899999
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eil~ 999 (1013)
...+..... ..| ...+.++.+++.+|++.||.+|+ ++.|+++
T Consensus 247 -----~~~i~~~~~-~~p-----------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 247 -----YEKIVSGKV-RFP-----------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----HHHHHHCCC-CCC-----------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----HHHHHCCCC-CCC-----------------CCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf -----999861798-897-----------------66899999999998340998606553454999971
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=346.43 Aligned_cols=246 Identities=26% Similarity=0.337 Sum_probs=199.2
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEEC---CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCC
Q ss_conf 11489888011054238999998999739999997413---456036799999998417999630499996147745654
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLK---QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 774 (1013)
.++|++.+.||+|+||+||+|+++.+++.||||++... .....+.+.+|+.+++.++||||+++++++ .+..
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEE-----EECC
T ss_conf 54708888972076808999999899979999998457754889999999999999863696753303568-----5288
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 18899860447877777300365421578899999999999999999986169999052588998557558995598014
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Df 854 (1013)
..|+||||+++|++.+++... ..+++..+..++.|++.|+.|+|++ +|+||||||+|||++.++.+||+||
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DF 148 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF 148 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEEECCCCCCCCCCCCC------CCCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECC
T ss_conf 005676503786322343222------2111007999999998765541247---6770556810503868998898317
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 66545899999863457898766666644236333379998963333789799999881999999767787418999885
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1013)
|+|+..... ....+||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ...
T Consensus 149 G~a~~~~~~-----------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~------ 210 (316)
T d1fota_ 149 GFAKYVPDV-----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTY------ 210 (316)
T ss_dssp SSCEECSSC-----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHH------
T ss_pred CCCEEECCC-----------CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHH-HHH------
T ss_conf 521671245-----------64345763435999983899980430465333689997598999996999-999------
Q ss_pred HCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 1883489840111001365642038997134789999999999986502468989999-----9899999
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERI-----QMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eil~ 999 (1013)
..+....... | ...+.++.+++.+|+..||.+|+ +++|+++
T Consensus 211 ------~~i~~~~~~~-p-----------------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 211 ------EKILNAELRF-P-----------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ------HHHHHCCCCC-C-----------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------HHHHCCCCCC-C-----------------CCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf ------9997089889-9-----------------77899999999999544997666431021999981
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.10 Aligned_cols=264 Identities=26% Similarity=0.419 Sum_probs=209.1
Q ss_pred CCCEEECCCEEEEEEEECCC---CEEEEEEEEEEC-CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEEEEE
Q ss_conf 88011054238999998999---739999997413-45603679999999841799963049999614774565418899
Q 001782 704 SNMIGQGSFGFVYRGNLGEN---EMAVAVKVMNLK-QRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAIV 779 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 779 (1013)
.++||+|+||+||+|++..+ ...||||++... .....+++.+|++++++++||||++++|+|.. .+...++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE----CCCCEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980----69943899
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 86044787777730036542157889999999999999999998616999905258899855755899559801466545
Q 001782 780 YEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLARF 859 (1013)
Q Consensus 780 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~~ 859 (1013)
|||+++|+|.+++.... ...++..+++++.|++.|+.|+|+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 108 ~E~~~~g~l~~~~~~~~-----~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp EECCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred EEEEECCCHHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHH
T ss_conf 98740674144210134-----5404899999999988765200336---762577668757677999889910652322
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHCCHH
Q ss_conf 89999986345789876666664423633337999896333378979999988199999976778741899988518834
Q 001782 860 LPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALPEK 939 (1013)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1013)
....... .........||+.|+|||.+....++.++||||||+++|||++|+.||.................
T Consensus 180 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~---- 251 (311)
T d1r0pa_ 180 MYDKEFD----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---- 251 (311)
T ss_dssp TTTTTCC----CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC----
T ss_pred CCCCCCC----CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC----
T ss_conf 5566555----31002565556455676887437999745746619999999978999988899999999998089----
Q ss_pred HHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf 8984011100136564203899713478999999999998650246898999998999999997665442058
Q 001782 940 VMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIFLSNR 1012 (1013)
Q Consensus 940 ~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~ 1012 (1013)
|+... ..++.++.+++.+||+.||++||++.||+++|+.+.+.+.+..
T Consensus 252 ---------------~~~~p----------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 252 ---------------RLLQP----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp ---------------CCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred ---------------CCCCC----------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHHH
T ss_conf ---------------88996----------4475999999999768897689399999999999997520121
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=351.06 Aligned_cols=271 Identities=23% Similarity=0.385 Sum_probs=211.0
Q ss_pred HHHHHHHCCCCCCCCEEECCCEEEEEEEECC-----CCEEEEEEEEEECCCC-CHHHHHHHHHHHHCCCCCCCCEEEEEE
Q ss_conf 6666541148988801105423899999899-----9739999997413456-036799999998417999630499996
Q 001782 692 ADLSKATNDFSSSNMIGQGSFGFVYRGNLGE-----NEMAVAVKVMNLKQRG-ATKSFVAECEALRNIRHRNLIKIITVC 765 (1013)
Q Consensus 692 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~ 765 (1013)
.+++...++|++.+.||+|+||+||+|++++ ++..||||++...... ..+++.+|+++++.++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEE
T ss_conf 31138988938867982078839999998887657788299999988210857999999999999966899765524666
Q ss_pred ECCCCCCCCEEEEEEEECCCCCHHHHHHCCCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 147745654188998604478777773003654------------------21578899999999999999999986169
Q 001782 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQ------------------LEVGNFNVIQRLNLVIDVAFAIEYLHHHC 827 (1013)
Q Consensus 766 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 827 (1013)
. .....++++||+++|+|.+++...... .....+++..++.++.|++.|++|+|++
T Consensus 86 ~-----~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~- 159 (301)
T d1lufa_ 86 A-----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER- 159 (301)
T ss_dssp C-----SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred C-----CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC-
T ss_conf 0-----5980389998158992999998527554210000111001210346788989999999999999985541357-
Q ss_pred CCCEEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 99905258899855755899559801466545899999863457898766666644236333379998963333789799
Q 001782 828 HPPIVHGDLKPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGIL 907 (1013)
Q Consensus 828 ~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 907 (1013)
++|||||||+|||++.++.+||+|||+|+.+.+... ........|++.|+|||++.+..++.++|||||||+
T Consensus 160 --~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvv 231 (301)
T d1lufa_ 160 --KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 231 (301)
T ss_dssp --TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred --CEEEEEECCCCEEECCCCCEEECCCHHHEECCCCCC------CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHH
T ss_conf --868548840116898999289833144211367764------111577776767679899726889805630252362
Q ss_pred HHHHHHCC-CCCCCCCCCCCCHHHHHHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 99988199-99997677874189998851883489840111001365642038997134789999999999986502468
Q 001782 908 LLEMFTRR-RPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSME 986 (1013)
Q Consensus 908 l~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 986 (1013)
+|||++|. .||...... +....+... . ++.. +..++.++.+++.+||+.
T Consensus 232 l~ell~~~~~p~~~~~~~--------------e~~~~v~~~---~---~~~~----------p~~~~~~~~~li~~cl~~ 281 (301)
T d1lufa_ 232 LWEIFSYGLQPYYGMAHE--------------EVIYYVRDG---N---ILAC----------PENCPLELYNLMRLCWSK 281 (301)
T ss_dssp HHHHHTTTCCTTTTSCHH--------------HHHHHHHTT---C---CCCC----------CTTCCHHHHHHHHHHTCS
T ss_pred HHHHHCCCCCCCCCCCHH--------------HHHHHHHCC---C---CCCC----------CCCCHHHHHHHHHHHCCC
T ss_conf 999980689999998999--------------999999739---9---7888----------732529999999997488
Q ss_pred CCCCCCCHHHHHHHHHHHHH
Q ss_conf 98999998999999997665
Q 001782 987 SPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 987 dP~~RPs~~eil~~L~~~~~ 1006 (1013)
||++|||+.||+++|+.+.+
T Consensus 282 ~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 282 LPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp SGGGSCCHHHHHHHHHHTTC
T ss_pred CHHHCCCHHHHHHHHHHHCC
T ss_conf 96579399999999998429
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.08 Aligned_cols=263 Identities=27% Similarity=0.432 Sum_probs=208.5
Q ss_pred HHHHHCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
Q ss_conf 66541148988801105423899999899973999999741345603679999999841799963049999614774565
Q 001782 694 LSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 694 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 773 (1013)
+....++|++.+.||+|+||+||+|+++.+ ..||||++... ....+.+.+|+.++++++|+||++++++|..
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------ 83 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------ 83 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred EECCHHHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC------
T ss_conf 074779979846993079809999999999-99999998804-4888999999999986666788689999823------
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 41889986044787777730036542157889999999999999999998616999905258899855755899559801
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~D 853 (1013)
+..++||||+++|+|..++..... ..+++.+++.++.|++.|+.|||++ +|+||||||+|||++.++.+||+|
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~D 156 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD 156 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred CCEEEEEEECCCCCHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECC
T ss_conf 975999994479943542000035----5305999999999999999987541---143353123079998999299844
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Q ss_conf 46654589999986345789876666664423633337999896333378979999988199999976778741899988
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK 933 (1013)
Q Consensus 854 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~ 933 (1013)
||+|+.+.+... .......||+.|+|||++..+.++.++||||||+++|||++|..|+......
T Consensus 157 fGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--------- 220 (285)
T d1fmka3 157 FGLARLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------- 220 (285)
T ss_dssp CCTTC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------
T ss_pred CCHHHHCCCCCC-------EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCH---------
T ss_conf 255542568873-------3524545566545808983799891774132358999998689999988889---------
Q ss_pred HHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 51883489840111001365642038997134789999999999986502468989999989999999976654
Q 001782 934 MALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007 (1013)
Q Consensus 934 ~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~~ 1007 (1013)
.+....+.... |+. ....+++++.+++.+||+.||++||++.+|++.|+.....
T Consensus 221 ----~~~~~~i~~~~------~~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 221 ----REVLDQVERGY------RMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp ----HHHHHHHHTTC------CCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ----HHHHHHHHHCC------CCC----------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf ----99999998268------999----------9832379999999997566975891999999987666238
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.91 Aligned_cols=258 Identities=19% Similarity=0.242 Sum_probs=201.1
Q ss_pred HCCCCCC-CCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCC-CCCCCCEEEEEEECCCCCCCCE
Q ss_conf 1148988-8011054238999998999739999997413456036799999998417-9996304999961477456541
Q 001782 698 TNDFSSS-NMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 698 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 775 (1013)
.++|.+. ++||+|+||.||+|++..+++.||||++.. ...+.+|+.++.++ +||||+++++++.+. ......
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEEC-CCCCCE
T ss_conf 14879810796545486999999889998999999897-----477999999999866999978298999503-468978
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEC
Q ss_conf 8899860447877777300365421578899999999999999999986169999052588998557558---9955980
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH---DMVAHVG 852 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~---~~~~kl~ 852 (1013)
.|+|||||++|+|.+++..... ..+++.++..++.|++.|+.|||++ +|+||||||+|||++. .+.+||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEECCCCCCHHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 9999977899849999986278----7757999999999999999999976---98644410022011355556631135
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Q ss_conf 14665458999998634578987666666442363333799989633337897999998819999997677874189998
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 853 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~ 932 (1013)
|||+|+...... ......||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+...... ...
T Consensus 157 DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~-- 224 (335)
T d2ozaa1 157 DFGFAKETTSHN---------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPG-- 224 (335)
T ss_dssp CCTTCEECCCCC---------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred CCCEEEECCCCC---------CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHH-HHH--
T ss_conf 455123336888---------64322677563792777489888888887645167788658899889887788-999--
Q ss_pred HHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 85188348984011100136564203899713478999999999998650246898999998999999
Q 001782 933 KMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
....+.......| .......++++.+++.+|++.||++|||+.|+++.
T Consensus 225 -------~~~~i~~~~~~~~-------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 225 -------MKTRIRMGQYEFP-------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----------CCCSCSSSCC-------------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------HHHHHHCCCCCCC-------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -------9999853888889-------------85434699999999999756996579099999709
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.62 Aligned_cols=254 Identities=20% Similarity=0.301 Sum_probs=205.1
Q ss_pred HHCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEE
Q ss_conf 41148988801105423899999899973999999741345603679999999841799963049999614774565418
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 776 (1013)
..++|.+.+.||+|+||+||+|.+..+++.||+|++..... ....+.+|+++++.++||||++++++ +++....
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~ 76 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHES-----FESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEE-----EEETTEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEE-----EEECCEE
T ss_conf 70105887898317783999999989996999999757866-59999999999985799798909899-----9889988
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCEEECCC
Q ss_conf 8998604478777773003654215788999999999999999999861699990525889985575589--95598014
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD--MVAHVGDF 854 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~--~~~kl~Df 854 (1013)
|+||||+++|+|.+++.... ..+++.++..++.|++.|+.|||++ +|+||||||+|||++.+ ..+|++||
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DF 148 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred EEEEECCCCCCHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCC
T ss_conf 99995389980889987538-----9999999999999999999999876---997513554443443788518997644
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 66545899999863457898766666644236333379998963333789799999881999999767787418999885
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1013)
|+++..... .......+++.|+|||...+..++.++||||+||++|+|++|..||...... ..
T Consensus 149 G~~~~~~~~---------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~------- 211 (321)
T d1tkia_ 149 GQARQLKPG---------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QI------- 211 (321)
T ss_dssp TTCEECCTT---------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HH-------
T ss_pred CHHHCCCCC---------CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHH-HH-------
T ss_conf 111003467---------7532122332223402104877784011302799999998289999998999-99-------
Q ss_pred HCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 188348984011100136564203899713478999999999998650246898999998999999
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
...+.......+. ......+.++.+++.+|+..||.+|||+.|+++.
T Consensus 212 -----~~~i~~~~~~~~~--------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 212 -----IENIMNAEYTFDE--------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -----HHHHHHTCCCCCH--------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----HHHHHHCCCCCCH--------------HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----9999838999880--------------2236789999999999866996689099999639
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.54 Aligned_cols=281 Identities=23% Similarity=0.308 Sum_probs=203.7
Q ss_pred CCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHH--HHHHHHCCCCCCCCEEEEEEECCCCCCCCEE
Q ss_conf 14898880110542389999989997399999974134560367999--9999841799963049999614774565418
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVA--ECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 776 (1013)
.+|...+.||+|+||.||+|++ +++.||||++.... ...+.. |+..+..++||||++++++|.... ......
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC-CCCEEE
T ss_conf 6899988982078819999999--99899999987200---46799999999996279986832688998379-860489
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 899860447877777300365421578899999999999999999986169-----999052588998557558995598
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHC-----HPPIVHGDLKPSNVLLDHDMVAHV 851 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~Dikp~Nili~~~~~~kl 851 (1013)
++||||+++|+|.++++.. .+++.++++++.|++.|+.|+|+.. .++|+||||||+|||++.++.+||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl 149 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred EEEEECCCCCCHHHHHHCC-------CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEE
T ss_conf 9999646698989998658-------999899999999999999998876652046898661531731357868877688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 0146654589999986345789876666664423633337999------8963333789799999881999999767787
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD------MSATGDVYSFGILLLEMFTRRRPTDNMFNDG 925 (1013)
Q Consensus 852 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~elltg~~P~~~~~~~~ 925 (1013)
+|||+++.+...... .........||+.|+|||++.+.. ++.++|||||||++|||+||..||.......
T Consensus 150 ~DFGl~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~ 225 (303)
T d1vjya_ 150 ADLGLAVRHDSATDT----IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp CCCTTCEEEETTTTE----ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred EECCCCCCCCCCCCC----EECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 763866234677762----0013552503547678221056545467776750122015999999962899887663112
Q ss_pred CCHHHHHHHHCC-HHHH-HHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 418999885188-3489-84011100136564203899713478999999999998650246898999998999999997
Q 001782 926 LTLHEFAKMALP-EKVM-EIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCS 1003 (1013)
Q Consensus 926 ~~~~~~~~~~~~-~~~~-~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~ 1003 (1013)
............ .... ......+..+...+ ....+.+..+.+++.+||+.||++|||+.||++.|+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR-----------WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-----------GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHCCCCCCHHHHHHHHHHCCCCCCCCCCC-----------CCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 41012255643099999987502468887765-----------5776899999999999760698589599999999998
Q ss_pred HHHH
Q ss_conf 6654
Q 001782 1004 ARKI 1007 (1013)
Q Consensus 1004 ~~~~ 1007 (1013)
+.+.
T Consensus 295 i~~~ 298 (303)
T d1vjya_ 295 LSQQ 298 (303)
T ss_dssp HHHH
T ss_pred HHHH
T ss_conf 8886
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.25 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=207.9
Q ss_pred HHHCCCCCCCCEEECCCEEEEEEEECCC---CEEEEEEEEEECCC-CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
Q ss_conf 5411489888011054238999998999---73999999741345-6036799999998417999630499996147745
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLGEN---EMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 771 (1013)
...++|.+.+.||+|+||.||+|++..+ +..||+|++..... ...+.+.+|++++++++||||+++++++.
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----- 78 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 78 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-----
T ss_conf 688996987799307882999999936996449999999365668799999999999998689999856988995-----
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 65418899860447877777300365421578899999999999999999986169999052588998557558995598
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV 851 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl 851 (1013)
.+..++||||+++|++.+++.... ..+++..++.++.|++.|+.|+|++ +|+||||||+||+++.++.+||
T Consensus 79 -~~~~~iv~E~~~~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl 149 (273)
T d1mp8a_ 79 -ENPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKL 149 (273)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred -CCEEEEEEEECCCCCHHHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEE
T ss_conf -374799998406980776542247-----8999999999999998775230226---7441410265532067896787
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHH
Q ss_conf 01466545899999863457898766666644236333379998963333789799999881-99999976778741899
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHE 930 (1013)
Q Consensus 852 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~P~~~~~~~~~~~~~ 930 (1013)
+|||+|+.+.... ........||+.|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 150 ~DfG~a~~~~~~~-------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----- 217 (273)
T d1mp8a_ 150 GDFGLSRYMEDST-------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----- 217 (273)
T ss_dssp CC--------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----
T ss_pred CCCHHHEECCCCC-------CEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH-----
T ss_conf 6503421336776-------2330540058310326675169988745244424789999826999988899999-----
Q ss_pred HHHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 98851883489840111001365642038997134789999999999986502468989999989999999976654
Q 001782 931 FAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKI 1007 (1013)
Q Consensus 931 ~~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~~ 1007 (1013)
+...+... .++.. +..++.++.+++.+||+.||.+|||+.||++.|+.+.+.
T Consensus 218 ---------~~~~i~~~------~~~~~----------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 218 ---------VIGRIENG------ERLPM----------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ---------HHHHHHTT------CCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------HHHHHHCC------CCCCC----------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf ---------99999818------99989----------877799999999997687976892999999999999778
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.43 Aligned_cols=238 Identities=24% Similarity=0.380 Sum_probs=193.6
Q ss_pred CCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHH-CCCCCCCCEEEEEEECCCCCCCC
Q ss_conf 14898880110542389999989997399999974134---560367999999984-17999630499996147745654
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ---RGATKSFVAECEALR-NIRHRNLIKIITVCSSIDFEEVD 774 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~ 774 (1013)
++|.+.++||+|+||+||+|++..+++.||||++.... ....+.+..|..++. .++||||+++++++ .+.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----CCCC
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897-----0498
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 18899860447877777300365421578899999999999999999986169999052588998557558995598014
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Df 854 (1013)
..|+||||+++|+|.+++... ..+++.++..++.|++.|+.|||++ +|+||||||+|||++.++.+|++||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~------~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred CEEEEEEECCCCCHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCC
T ss_conf 316777503798089986404------7899999999999999999999868---9340347654044448996301555
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH-
Q ss_conf 6654589999986345789876666664423633337999896333378979999988199999976778741899988-
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAK- 933 (1013)
Q Consensus 855 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~- 933 (1013)
|+|+..... ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..... .......
T Consensus 148 G~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~ 218 (320)
T d1xjda_ 148 GMCKENMLG--------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-LFHSIRMD 218 (320)
T ss_dssp TTCBCCCCT--------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC
T ss_pred CHHHHCCCC--------CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHCC
T ss_conf 302323566--------533454578777689999827998832320112278989873889999989999-99999718
Q ss_pred -----HHCCHHHHHHHHHHHCCCHHHHHCCC
Q ss_conf -----51883489840111001365642038
Q 001782 934 -----MALPEKVMEIVDPLLLLDLEARASNC 959 (1013)
Q Consensus 934 -----~~~~~~~~~~i~~~l~~dp~~R~~~~ 959 (1013)
..+++++.+++.+|+..+|.+|++..
T Consensus 219 ~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~ 249 (320)
T d1xjda_ 219 NPFYPRWLEKEAKDLLVKLFVREPEKRLGVR 249 (320)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 9989756799999999996544898783889
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.58 Aligned_cols=270 Identities=22% Similarity=0.317 Sum_probs=210.2
Q ss_pred HHHCCCCCCCCEEECCCEEEEEEEEC-----CCCEEEEEEEEEECCC-CCHHHHHHHHHHHHCC-CCCCCCEEEEEEECC
Q ss_conf 54114898880110542389999989-----9973999999741345-6036799999998417-999630499996147
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLG-----ENEMAVAVKVMNLKQR-GATKSFVAECEALRNI-RHRNLIKIITVCSSI 768 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 768 (1013)
...++|++.++||+|+||.||+|++. .+++.||||+++.... .....+.+|+.+++.+ +||||++++++|.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~-- 97 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT-- 97 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE--
T ss_conf 778996985498206882999999806644778869999998742487799999999999876269998878998983--
Q ss_pred CCCCCCEEEEEEEECCCCCHHHHHHCCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCC
Q ss_conf 745654188998604478777773003654------------21578899999999999999999986169999052588
Q 001782 769 DFEEVDFKAIVYEYMECGSLEDWLHQSNDQ------------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDL 836 (1013)
Q Consensus 769 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Di 836 (1013)
.....++||||+++|+|.++++..... .....+++..+..++.|++.|+.|||++ +++||||
T Consensus 98 ---~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDL 171 (311)
T d1t46a_ 98 ---IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDL 171 (311)
T ss_dssp ---SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ---ECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCC
T ss_conf ---1997899997379987999998535665444445332223345889999999999999999988757---9266624
Q ss_pred CCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCC
Q ss_conf 99855755899559801466545899999863457898766666644236333379998963333789799999881999
Q 001782 837 KPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRR 916 (1013)
Q Consensus 837 kp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 916 (1013)
||+||+++.++.+|++|||.++........ .......||+.|+|||++.++.++.++||||||+++|||+|++.
T Consensus 172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~ 245 (311)
T d1t46a_ 172 AARNILLTHGRITKICDFGLARDIKNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245 (311)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTS------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCCCCCCCCCCCCCCCCCHHEECCCCCCC------EEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 102100002575210234010233678861------58620135968767788617999974001025899999985899
Q ss_pred CCCCCCCCCCCHHHHHHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 99976778741899988518834898401110013656420389971347899999999999865024689899999899
Q 001782 917 PTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTD 996 (1013)
Q Consensus 917 P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 996 (1013)
|+......... +.+++........ +..++..+.+++.+||+.||++|||++|
T Consensus 246 p~~~~~~~~~~------------~~~~i~~~~~~~~----------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~ 297 (311)
T d1t46a_ 246 SPYPGMPVDSK------------FYKMIKEGFRMLS----------------PEHAPAEMYDIMKTCWDADPLKRPTFKQ 297 (311)
T ss_dssp CSSTTCCSSHH------------HHHHHHHTCCCCC----------------CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCHHHH------------HHHHHHCCCCCCC----------------CCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 88778998999------------9999866898898----------------5436599999999975779657929999
Q ss_pred HHHHHHHHHHH
Q ss_conf 99999976654
Q 001782 997 VVAKLCSARKI 1007 (1013)
Q Consensus 997 il~~L~~~~~~ 1007 (1013)
|++.|+++...
T Consensus 298 il~~L~~~i~~ 308 (311)
T d1t46a_ 298 IVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHCC
T ss_conf 99999876534
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.15 Aligned_cols=264 Identities=25% Similarity=0.387 Sum_probs=207.3
Q ss_pred HHCCCCCCCCEEECCCEEEEEEEECCCCE--EEEEEEEEEC-CCCCHHHHHHHHHHHHCC-CCCCCCEEEEEEECCCCCC
Q ss_conf 41148988801105423899999899973--9999997413-456036799999998417-9996304999961477456
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEM--AVAVKVMNLK-QRGATKSFVAECEALRNI-RHRNLIKIITVCSSIDFEE 772 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 772 (1013)
..++|++.++||+|+||+||+|+++.++. .||||.+... .....+.+.+|+++++++ +||||++++++|. .
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~ 82 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----H 82 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----E
T ss_pred CHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE-----C
T ss_conf 87996887798207882899999989996999999997823385799999999999986228998836788884-----1
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 5418899860447877777300365----------421578899999999999999999986169999052588998557
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSND----------QLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVL 842 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nil 842 (1013)
.+..++||||+++|+|.+++..... ......+++.++.+++.|++.|+.|+|++ +|+||||||+|||
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL 159 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL 159 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEE
T ss_conf 8736999980289869999864035555512310123457899999999999999998766308---9545550520489
Q ss_pred ECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCC-CCCCC
Q ss_conf 55899559801466545899999863457898766666644236333379998963333789799999881999-99976
Q 001782 843 LDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRR-PTDNM 921 (1013)
Q Consensus 843 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~-P~~~~ 921 (1013)
++.++.+||+|||+|+..... .......||..|+|||.+.++.++.++||||||+++|||++|.. ||...
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~~---------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp ECGGGCEEECCTTCEESSCEE---------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ECCCCCEEECCCCCCCCCCCC---------CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCC
T ss_conf 868876387434432244422---------34553013775555387526999962215313889999983689999999
Q ss_pred CCCCCCHHHHHHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 77874189998851883489840111001365642038997134789999999999986502468989999989999999
Q 001782 922 FNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKL 1001 (1013)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L 1001 (1013)
.. .++.+.+... .|+... ..++.++.+++.+||+.||++|||+.||++.|
T Consensus 231 ~~--------------~~~~~~i~~~------~~~~~~----------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 231 TC--------------AELYEKLPQG------YRLEKP----------LNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp CH--------------HHHHHHGGGT------CCCCCC----------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CH--------------HHHHHHHHHC------CCCCCC----------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 99--------------9999999826------888887----------66789999999997678966894999999999
Q ss_pred HHHHHH
Q ss_conf 976654
Q 001782 1002 CSARKI 1007 (1013)
Q Consensus 1002 ~~~~~~ 1007 (1013)
+.+.+.
T Consensus 281 ~~i~~~ 286 (309)
T d1fvra_ 281 NRMLEE 286 (309)
T ss_dssp HHHHHS
T ss_pred HHHHHC
T ss_conf 999861
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.61 Aligned_cols=254 Identities=30% Similarity=0.412 Sum_probs=205.4
Q ss_pred HHCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEE
Q ss_conf 41148988801105423899999899973999999741345603679999999841799963049999614774565418
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 776 (1013)
..++|++.+.||+|+||.||+|+++ +..||||+++.. ...+.+.+|++++++++||||++++|+|. +..+..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~ 76 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGL 76 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CC
T ss_pred CHHHEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEE----ECCCCE
T ss_conf 7899488579820798089999999--909999998857--77999999999998678989854987887----238928
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 89986044787777730036542157889999999999999999998616999905258899855755899559801466
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~ 856 (1013)
++||||+++|+|.+++..... ..+++..+++++.|++.|+.|||+. +|+||||||+||+++.++.+|++|||+
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EEEEECCCCCCHHHHHHHCCC----CCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCC
T ss_conf 999963699989999874578----8889999999999998523211337---655366656760146899776324560
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 545899999863457898766666644236333379998963333789799999881-9999997677874189998851
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 935 (1013)
++..... .....++..|+|||++.++.++.++||||||+++|||++ |+.||......
T Consensus 150 s~~~~~~-----------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~----------- 207 (262)
T d1byga_ 150 TKEASST-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------- 207 (262)
T ss_dssp -----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----------
T ss_pred CEECCCC-----------CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----------
T ss_conf 0344787-----------765566646778178727988858877757999999997899999999999-----------
Q ss_pred CCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 88348984011100136564203899713478999999999998650246898999998999999997665
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~ 1006 (1013)
++...+... .|+.. +..++.++.+++.+||+.||.+|||+.|++++|+.++.
T Consensus 208 ---~~~~~i~~~------~~~~~----------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 208 ---DVVPRVEKG------YKMDA----------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ---GHHHHHTTT------CCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHCC------CCCCC----------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ---999999808------99999----------76579999999999756697689399999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=334.87 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=202.8
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCC---------CHHHHHHHHHHHHCCC-CCCCCEEEEEEEC
Q ss_conf 11489888011054238999998999739999997413456---------0367999999984179-9963049999614
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG---------ATKSFVAECEALRNIR-HRNLIKIITVCSS 767 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 767 (1013)
.++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+.+|+.++++++ ||||+++++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 79 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 79 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEC--
T ss_conf 663888528841768499999999999899999996244641147888999999999999999850799747997621--
Q ss_pred CCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC
Q ss_conf 77456541889986044787777730036542157889999999999999999998616999905258899855755899
Q 001782 768 IDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM 847 (1013)
Q Consensus 768 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~ 847 (1013)
.+.+..|+||||+++|+|.+++... +.+++.++..++.|++.|+.|||++ +|+||||||+||+++.++
T Consensus 80 ---~~~~~~~ivmE~~~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 80 ---ETNTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDM 147 (277)
T ss_dssp ---ECSSEEEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred ---CCCCCEEEEEECCCCCHHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCC
T ss_conf ---4676059999768986689999865------9999999999999999999999875---994323462548986899
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 559801466545899999863457898766666644236333379------99896333378979999988199999976
Q 001782 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG------GDMSATGDVYSFGILLLEMFTRRRPTDNM 921 (1013)
Q Consensus 848 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~P~~~~ 921 (1013)
.+||+|||+|+.+.+.. ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.
T Consensus 148 ~~kl~DFG~a~~~~~~~---------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGE---------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp CEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CEEECCCHHEEECCCCC---------CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCC
T ss_conf 83871240316726887---------213452467888988860534456788992331856560231032288898899
Q ss_pred CCCCCCHHHHHHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 7787418999885188348984011100136564203899713478999999999998650246898999998999999
Q 001782 922 FNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
.... .. ..+...... .+..+ ....++++.+++.+|++.||++|||+.|+++.
T Consensus 219 ~~~~-~~------------~~i~~~~~~-~~~~~-------------~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 219 KQML-ML------------RMIMSGNYQ-FGSPE-------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp SHHH-HH------------HHHHHTCCC-CCTTT-------------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHHH-HH------------HHHHHCCCC-CCCCC-------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9999-99------------999818988-89854-------------34689999999999765896689199999739
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.76 Aligned_cols=277 Identities=23% Similarity=0.328 Sum_probs=204.2
Q ss_pred CCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEE
Q ss_conf 148988801105423899999899973999999741345--603679999999841799963049999614774565418
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 776 (1013)
++|++.+.||+|+||+||+|++..+++.||+|++..... ...+.+.+|++++++++||||+++++++ .+....
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCC-----CCCCCE
T ss_conf 997765177237680999999999997999999802225758999999999999867998388744533-----224320
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 89986044787777730036542157889999999999999999998616999905258899855755899559801466
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~ 856 (1013)
|+||||+.+ ++.+++..... ..+++..+..++.|++.||.|||++ +||||||||+|||++.++.+|++|||.
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred EEEEEECCC-CHHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCC
T ss_conf 378862377-44555442025----6888899999999999999986528---899213571140113467621035786
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 54589999986345789876666664423633337999-89633337897999998819999997677874189998851
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD-MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1013)
|+..... ........||+.|+|||+..... ++.++||||+||++|+|++|+.||........ ........
T Consensus 149 a~~~~~~--------~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~ 219 (298)
T d1gz8a_ 149 ARAFGVP--------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTL 219 (298)
T ss_dssp HHHHCCC--------SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred CEECCCC--------CCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHH-HHHHHHHC
T ss_conf 1343688--------64100103652154112213665777422103333134279668799898899999-99999832
Q ss_pred -CCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHH-HHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -88348984011100136564203899713478-999999999998650246898999998999999
Q 001782 936 -LPEKVMEIVDPLLLLDLEARASNCGSHRTEIA-KIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 936 -~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
.+.+ .........+..+............ .......++.+++.+|++.||++|||+.|+++.
T Consensus 220 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 220 GTPDE---VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCCCT---TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCH---HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 89833---31444222421243454322220444166789999999999763995579189999678
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.52 Aligned_cols=271 Identities=22% Similarity=0.246 Sum_probs=197.1
Q ss_pred CCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCC-----CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEEEE
Q ss_conf 88011054238999998999739999997413456-----0367999999984179996304999961477456541889
Q 001782 704 SNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG-----ATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKAI 778 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 778 (1013)
.++||+|+||+||+|++..+++.||||++...... ..+.+.+|+.+++.++||||+++++++ ......++
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~i 77 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNISL 77 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCEE
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----CCCCCEEE
T ss_conf 6385127282999999999996999999842021245679999999999999867999986898542-----25874022
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 98604478777773003654215788999999999999999999861699990525889985575589955980146654
Q 001782 779 VYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 779 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~ 858 (1013)
||||++++++..+.... ..+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 78 vmE~~~~~~~~~~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 148 (299)
T ss_dssp EEECCSEEHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred HHHHHCCHHHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCC
T ss_conf 04553450776554126------6778999999999999999886316---35503577625885377841146576100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 58999998634578987666666442363333799-98963333789799999881999999767787418999885188
Q 001782 859 FLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMALP 937 (1013)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 937 (1013)
..... .......+||+.|+|||++.+. .++.++||||+||++|||++|..||......+ ......+....
T Consensus 149 ~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~ 219 (299)
T d1ua2a_ 149 SFGSP--------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGT 219 (299)
T ss_dssp TTTSC--------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCC
T ss_pred CCCCC--------CCCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHH-HHHHHHHHCCC
T ss_conf 05787--------5543302047333639997267788805643630428999985969999999999-99999985189
Q ss_pred HHHHHHHHHHHCCCHHHHHCCCCC-CCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 348984011100136564203899-713478999999999998650246898999998999999
Q 001782 938 EKVMEIVDPLLLLDLEARASNCGS-HRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 938 ~~~~~~i~~~l~~dp~~R~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
.....+.+....... ...... ............+++.+++.+|++.||++||||.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 220 PTEEQWPDMCSLPDY---VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCTTTSSSTTSSTTC---CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCHHHCCCHHCCCHH---HHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 972545210002134---4303478988678565689999999999763894569089999679
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.73 Aligned_cols=286 Identities=21% Similarity=0.230 Sum_probs=205.4
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEE
Q ss_conf 1148988801105423899999899973999999741345-603679999999841799963049999614774565418
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 776 (1013)
..+|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|+++++.++||||+++++++....+......
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 89986044787777730036542157889999999999999999998616999905258899855755899559801466
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~ 856 (1013)
++++ ++.+|+|.+++... .+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 87 ~l~~-~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 87 YLVT-HLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp EEEE-ECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEE-EECCCCHHHHHHCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCC
T ss_conf 9999-62598656644058-------999999999999999999999978---986777876437887999778754570
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 545899999863457898766666644236333379-9989633337897999998819999997677874189998851
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1013)
|........ .........|++.|+|||++.. ..++.++||||+||++|+|++|+.||......+..........
T Consensus 156 a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~ 230 (345)
T d1pmea_ 156 ARVADPDHD-----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230 (345)
T ss_dssp CEECCGGGC-----BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEECCCCCC-----CCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCC
T ss_conf 565047776-----410101102652000387860478887410100467013377669799788888999998765206
Q ss_pred CCHHHHHHHHHHHCCCHHHHHCCCCCCCHHH-HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 8834898401110013656420389971347-8999999999998650246898999998999999
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEI-AKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
.+.......... .................. ........++.+++.+|++.||.+||||.|+++.
T Consensus 231 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 231 SPSQEDLNCIIN-LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp SCCHHHHHTCCC-HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHH-HHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 997566423433-22220244677557787778378999999999999764895679089998619
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.80 Aligned_cols=268 Identities=24% Similarity=0.370 Sum_probs=210.7
Q ss_pred HHHCCCCCCCCEEECCCEEEEEEEECCCC-------EEEEEEEEEECCC-CCHHHHHHHHHHHHCC-CCCCCCEEEEEEE
Q ss_conf 54114898880110542389999989997-------3999999741345-6036799999998417-9996304999961
Q 001782 696 KATNDFSSSNMIGQGSFGFVYRGNLGENE-------MAVAVKVMNLKQR-GATKSFVAECEALRNI-RHRNLIKIITVCS 766 (1013)
Q Consensus 696 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 766 (1013)
...++|.+.+.||+|+||.||+|+...++ ..||||+++.... .....+.+|...+.++ +||||++++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCC
T ss_conf 25899697009851678289999985787555667549999998811286889999999999998139996973465220
Q ss_pred CCCCCCCCEEEEEEEECCCCCHHHHHHCCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCC
Q ss_conf 47745654188998604478777773003654----------21578899999999999999999986169999052588
Q 001782 767 SIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQ----------LEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDL 836 (1013)
Q Consensus 767 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Di 836 (1013)
+....++||||+++|+|.+++...... .....+++.++++++.|++.|+.|||++ +||||||
T Consensus 90 -----~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDi 161 (299)
T d1fgka_ 90 -----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDL 161 (299)
T ss_dssp -----SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred -----CCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEE
T ss_conf -----18868999973699909999986067764322233457434679999999999999999876637---9786302
Q ss_pred CCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CC
Q ss_conf 99855755899559801466545899999863457898766666644236333379998963333789799999881-99
Q 001782 837 KPSNVLLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RR 915 (1013)
Q Consensus 837 kp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~ 915 (1013)
||+|||++.++.+||+|||+++...... .........|++.|+|||++.++.++.++||||||+++|||++ |.
T Consensus 162 Kp~NiLl~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~ 235 (299)
T d1fgka_ 162 AARNVLVTEDNVMKIADFGLARDIHHID------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235 (299)
T ss_dssp SGGGEEECTTCCEEECSTTCCCCGGGCC------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCEEECCCCCEEECCCHHHCCCCCCC------CCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCC
T ss_conf 2102245478976762211101135555------5431466788846632667517988825554775888887401798
Q ss_pred CCCCCCCCCCCCHHHHHHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 99997677874189998851883489840111001365642038997134789999999999986502468989999989
Q 001782 916 RPTDNMFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMT 995 (1013)
Q Consensus 916 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 995 (1013)
.||...... ...+.+.... ++... ..++.++.+++.+||+.||.+|||+.
T Consensus 236 ~p~~~~~~~--------------~~~~~i~~~~------~~~~p----------~~~~~~l~~li~~cl~~dP~~Rps~~ 285 (299)
T d1fgka_ 236 SPYPGVPVE--------------ELFKLLKEGH------RMDKP----------SNCTNELYMMMRDCWHAVPSQRPTFK 285 (299)
T ss_dssp CSSTTCCHH--------------HHHHHHHTTC------CCCCC----------SSCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCHH--------------HHHHHHHCCC------CCCCC----------CCCHHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 989999999--------------9999997288------88987----------43529999999997667976793999
Q ss_pred HHHHHHHHHHHH
Q ss_conf 999999976654
Q 001782 996 DVVAKLCSARKI 1007 (1013)
Q Consensus 996 eil~~L~~~~~~ 1007 (1013)
||++.|+.+.+.
T Consensus 286 eil~~L~~i~a~ 297 (299)
T d1fgka_ 286 QLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHC
T ss_conf 999999888604
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.11 Aligned_cols=282 Identities=20% Similarity=0.281 Sum_probs=203.2
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCC-CEEEEEEEEEECCC--CCHHHHHHHHHHHHCC---CCCCCCEEEEEEECCCCC
Q ss_conf 11489888011054238999998999-73999999741345--6036799999998417---999630499996147745
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGEN-EMAVAVKVMNLKQR--GATKSFVAECEALRNI---RHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~ 771 (1013)
.++|++.+.||+|+||+||+|++..+ ++.||||++..... .....+.+|+.+++.+ +||||+++++++.....+
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 65418899860447877777300365421578899999999999999999986169999052588998557558995598
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV 851 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl 851 (1013)
.....++++|+++++.+........ ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCEEEEEEEECCCCCHHHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEE
T ss_conf 6746999997405871444443037-----8999899999999999999999758---8983579862789858997542
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHH
Q ss_conf 01466545899999863457898766666644236333379998963333789799999881999999767787418999
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 852 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~ 931 (1013)
+|||++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......
T Consensus 158 ~dfg~~~~~~~---------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i 227 (305)
T d1blxa_ 158 ADFGLARIYSF---------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKI 227 (305)
T ss_dssp CSCCSCCCCCG---------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH
T ss_pred CCHHHHHHHCC---------CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHH-HHHHHH
T ss_conf 10001011002---------34577765485114831001798881110003289999998787998998989-999999
Q ss_pred HHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 885188348984011100136564203899713478999999999998650246898999998999999
Q 001782 932 AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
...........+-... .. +..... ..............++.+.+++.+|++.||++||||.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~-~~-~~~~~~-~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDV-AL-PRQAFH-SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHCCCCGGGSCTTC-SS-CGGGSC-CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHCCCCHHCCCCCC-CC-HHHHHC-CCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9840799611053211-11-033302-234564544044589999999999874896679189999669
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.66 Aligned_cols=260 Identities=29% Similarity=0.424 Sum_probs=204.6
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCC---CEEEEEEEEEECC---CCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
Q ss_conf 11489888011054238999998999---7399999974134---56036799999998417999630499996147745
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGEN---EMAVAVKVMNLKQ---RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFE 771 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 771 (1013)
.++|++.+.||+|+||+||+|++... ...||||++.... ....+++.+|+.++++++||||++++|++..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---- 82 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 82 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE----
T ss_conf 4891997898038883999999988999079999999983555798999999999999986899998789877740----
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 65418899860447877777300365421578899999999999999999986169999052588998557558995598
Q 001782 772 EVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHV 851 (1013)
Q Consensus 772 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl 851 (1013)
...++||||+++|++.+++.... ..+++..+..++.|++.|+.|||++ +|+||||||+||+++.++.+|+
T Consensus 83 --~~~~lv~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl 152 (273)
T d1u46a_ 83 --PPMKMVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKI 152 (273)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred --CCHHEEEEEECCCCHHHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEE
T ss_conf --10011465423861254442126-----8999999999999999999875217---8752056688815655654332
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHH
Q ss_conf 01466545899999863457898766666644236333379998963333789799999881-99999976778741899
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFT-RRRPTDNMFNDGLTLHE 930 (1013)
Q Consensus 852 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~P~~~~~~~~~~~~~ 930 (1013)
+|||+++.+........ ......|+..|+|||++.+..++.++||||||+++|||++ |+.||......+ .
T Consensus 153 ~DfGl~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-~--- 223 (273)
T d1u46a_ 153 GDFGLMRALPQNDDHYV-----MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-I--- 223 (273)
T ss_dssp CCCTTCEECCC-CCEEE-----C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-H---
T ss_pred CCCHHHHHCCCCCCCCE-----ECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH-H---
T ss_conf 56115553035887526-----54763257310799998379999421566148999999968999999969999-9---
Q ss_pred HHHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 988518834898401110013656420389971347899999999999865024689899999899999999766
Q 001782 931 FAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSAR 1005 (1013)
Q Consensus 931 ~~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~ 1005 (1013)
...+.... .|+. .+..++.++.+++.+||+.||.+|||+.||.+.|.+++
T Consensus 224 ---------~~~i~~~~------~~~~----------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 224 ---------LHKIDKEG------ERLP----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp ---------HHHHHTSC------CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---------HHHHHHCC------CCCC----------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHCC
T ss_conf ---------99998479------9999----------85445399999999976889667929999999999649
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.84 Aligned_cols=275 Identities=21% Similarity=0.364 Sum_probs=212.1
Q ss_pred HHHHHHHCCCCCCCCEEECCCEEEEEEEECC-----CCEEEEEEEEEECCC-CCHHHHHHHHHHHHCCCCCCCCEEEEEE
Q ss_conf 6666541148988801105423899999899-----973999999741345-6036799999998417999630499996
Q 001782 692 ADLSKATNDFSSSNMIGQGSFGFVYRGNLGE-----NEMAVAVKVMNLKQR-GATKSFVAECEALRNIRHRNLIKIITVC 765 (1013)
Q Consensus 692 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~ 765 (1013)
+++....++|++.+.||+|+||+||+|.+.. .+..||||+++.... .....+.+|+.++++++||||++++++|
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred CCEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf 10042689918835982078818999998786447789689999987012868999999999999976999884125478
Q ss_pred ECCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCE
Q ss_conf 1477456541889986044787777730036542----157889999999999999999998616999905258899855
Q 001782 766 SSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQL----EVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNV 841 (1013)
Q Consensus 766 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Ni 841 (1013)
. .....++||||+++|+|.+++...+... ....+++..+.+++.|++.||.|||++ +|+||||||+||
T Consensus 93 ~-----~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~Ni 164 (308)
T d1p4oa_ 93 S-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC 164 (308)
T ss_dssp C-----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred E-----CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCE
T ss_conf 4-----28810677760489988999875033211344468879999999999999999987647---965432867754
Q ss_pred EECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCC-CCCCC
Q ss_conf 75589955980146654589999986345789876666664423633337999896333378979999988199-99997
Q 001782 842 LLDHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRR-RPTDN 920 (1013)
Q Consensus 842 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~P~~~ 920 (1013)
|++.++++||+|||+|+.+..... ........|++.|+|||.+.+..++.++||||||+++|||+||. .||..
T Consensus 165 Lld~~~~~Kl~DFGla~~~~~~~~------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 165 MVAEDFTVKIGDFGMTRDIYETDY------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 238 (308)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGC------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred EECCCCEEEEEECCCCEECCCCCC------EEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
T ss_conf 035996499942454202357763------03134023163237888873699883334443789999999689999999
Q ss_pred CCCCCCCHHHHHHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 67787418999885188348984011100136564203899713478999999999998650246898999998999999
Q 001782 921 MFNDGLTLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
.... . ....+.+......| ..++..+.+++.+||+.+|.+|||+.+|+++
T Consensus 239 ~~~~-----~--------~~~~i~~~~~~~~p-----------------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 239 LSNE-----Q--------VLRFVMEGGLLDKP-----------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp SCHH-----H--------HHHHHHTTCCCCCC-----------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHH-----H--------HHHHHHHCCCCCCC-----------------CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 8999-----9--------99999808888886-----------------3353999999999757796589399999999
Q ss_pred HHHHHHHHHC
Q ss_conf 9976654420
Q 001782 1001 LCSARKIFLS 1010 (1013)
Q Consensus 1001 L~~~~~~~~~ 1010 (1013)
|++..+...+
T Consensus 289 L~~~~~~~~~ 298 (308)
T d1p4oa_ 289 IKEEMEPGFR 298 (308)
T ss_dssp HGGGSCTTHH
T ss_pred HHHHCCCCCC
T ss_conf 7876177875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.53 Aligned_cols=286 Identities=21% Similarity=0.296 Sum_probs=207.1
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECC--CCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCC---CC
Q ss_conf 114898880110542389999989997399999974134--5603679999999841799963049999614774---56
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDF---EE 772 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~ 772 (1013)
.++|++.+.||+|+||+||+|++..+++.||||++.... .....++.+|+++++.++|+|++++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEC
Q ss_conf 54188998604478777773003654215788999999999999999999861699990525889985575589955980
Q 001782 773 VDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVG 852 (1013)
Q Consensus 773 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~ 852 (1013)
....++||||++++.+..+.... ..+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+|++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~------~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred CCEEEEEEECCCCCCCCHHHHCC------CCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEE
T ss_conf 76389998535787410122203------4433089999999999999885229---98856767222036689968763
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHH
Q ss_conf 14665458999998634578987666666442363333799-98963333789799999881999999767787418999
Q 001782 853 DFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 853 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~ 931 (1013)
|||+++.+...... .........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... ......
T Consensus 160 dfg~~~~~~~~~~~----~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i 234 (318)
T d3blha1 160 DFGLARAFSLAKNS----QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALI 234 (318)
T ss_dssp CCTTCEECCC---------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH
T ss_pred ECCEEEECCCCCCC----CCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHH-HHHHHH
T ss_conf 13500223554443----2113566024978742899707999891787006786466174487998998999-999999
Q ss_pred HHHH--CCHHHHHHHHHHHCCCHHHHHCCCCCCCHH---HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 8851--883489840111001365642038997134---78999999999998650246898999998999999
Q 001782 932 AKMA--LPEKVMEIVDPLLLLDLEARASNCGSHRTE---IAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 932 ~~~~--~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
.+.. .++.. ...................... ..........+.+++.+|++.||++||||.|+++.
T Consensus 235 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 235 SQLCGSITPEV---WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHCCCCTTT---STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHCCCCCHHH---CCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 98418998255---344320344433201334455503340444599899999999873896589099999749
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.27 Aligned_cols=281 Identities=22% Similarity=0.254 Sum_probs=197.5
Q ss_pred CCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCC-CCCCCEEE
Q ss_conf 14898880110542389999989997399999974134560367999999984179996304999961477-45654188
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSID-FEEVDFKA 777 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~ 777 (1013)
.+|+..++||+|+||+||+|++..+++.||||++..... ...+|++++++++|+||+++++++.... ..+..+.+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEE
T ss_conf 776751698217683999999999997999999881606----8999999998668989873878997447657731899
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEECCCCC
Q ss_conf 9986044787777730036542157889999999999999999998616999905258899855755899-559801466
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM-VAHVGDFGL 856 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~-~~kl~Dfg~ 856 (1013)
+||||++++.+..+...... ...+++.++..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~---~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEECCCCCCHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCC
T ss_conf 99841688607888863103---68999999999999999999999866---8764578860378735897116733660
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 545899999863457898766666644236333379-9989633337897999998819999997677874189998851
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMG-GDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1013)
+..+... .......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...... .......+..
T Consensus 170 a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~ 239 (350)
T d1q5ka_ 170 AKQLVRG---------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVL 239 (350)
T ss_dssp CEECCTT---------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHH
T ss_pred HHHCCCC---------CCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHH-HHHHHHHHHH
T ss_conf 5440477---------65320025555568277640468882100024652778550287998987999-9999999974
Q ss_pred CCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 88348984011100136564203899713478999999999998650246898999998999999
Q 001782 936 LPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
.... .+.+..........+.................+.++.+++.+|++.||++||||.|+++.
T Consensus 240 g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 240 GTPT-REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCCC-HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCH-HHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8981-776543062101103554456744443156899999999999765895579299999669
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.06 Aligned_cols=279 Identities=21% Similarity=0.261 Sum_probs=204.5
Q ss_pred HHCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCC-CCCC
Q ss_conf 41148988801105423899999899973999999741345--60367999999984179996304999961477-4565
Q 001782 697 ATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSID-FEEV 773 (1013)
Q Consensus 697 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~ 773 (1013)
..++|++.+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+++++.++||||+++++++.... ....
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47718998898017781999999999998999999852225969999999999999866898754799986357655554
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 41889986044787777730036542157889999999999999999998616999905258899855755899559801
Q 001782 774 DFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGD 853 (1013)
Q Consensus 774 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~D 853 (1013)
...++||||+. .+|..+.+. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|++|
T Consensus 96 ~~~~lv~e~~~-~~l~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~D 164 (346)
T d1cm8a_ 96 TDFYLVMPFMG-TDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 164 (346)
T ss_dssp CCCEEEEECCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred CEEEEEEECCC-CCHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCC
T ss_conf 15999984055-218999874-------0226999999999999999998737---876456685111121001221134
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Q ss_conf 4665458999998634578987666666442363333799-989633337897999998819999997677874189998
Q 001782 854 FGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFA 932 (1013)
Q Consensus 854 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~ 932 (1013)
||.|+.... ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||...... .......
T Consensus 165 fg~a~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~ 232 (346)
T d1cm8a_ 165 FGLARQADS-----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIM 232 (346)
T ss_dssp CTTCEECCS-----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH
T ss_pred CCCEECCCC-----------CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHH-HHHHHHH
T ss_conf 310220687-----------6310245533358899817878996501030038999999786998889768-9999998
Q ss_pred HHH--CCHHHHHHHHHHHCCCHHHHHCCCCCCCHH-HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 851--883489840111001365642038997134-78999999999998650246898999998999999
Q 001782 933 KMA--LPEKVMEIVDPLLLLDLEARASNCGSHRTE-IAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 933 ~~~--~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
... .+.+................. ....... ..........+.+++.+|+..||.+|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 233 KVTGTPPAEFVQRLQSDEAKNYMKGL--PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHCCCCHHHHHTCSCHHHHHHHHHS--CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCCHHHHHHHCCHHHHHHHCCC--CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 50378848888653000344331157--8666556677556899999999999772995579299999639
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=326.44 Aligned_cols=270 Identities=21% Similarity=0.256 Sum_probs=206.1
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEEE
Q ss_conf 11489888011054238999998999739999997413456036799999998417999630499996147745654188
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFKA 777 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 777 (1013)
.++|++.+.||+|+||+||+|++..+++.||||++..... .+++..|+++++.++|++++..++.+ +......+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~----~~~~~~~~ 79 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYNV 79 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEE----EEETTEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEE----EECCCEEE
T ss_conf 8889996898507880999999988998999999721005--88899999999970389960179999----95198778
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEECCC
Q ss_conf 99860447877777300365421578899999999999999999986169999052588998557558---995598014
Q 001782 778 IVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH---DMVAHVGDF 854 (1013)
Q Consensus 778 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~---~~~~kl~Df 854 (1013)
+||||++ +++.+.+.... ..+++..+..++.|++.|++|||++ +|+||||||+|||++. +..+|++||
T Consensus 80 ivme~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DF 150 (299)
T d1ckia_ 80 MVMELLG-PSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF 150 (299)
T ss_dssp EEEECCC-CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred EEEEECC-CCHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECC
T ss_conf 9998738-71333244306-----8876899999999999999999979---9442667876606433577761565046
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 66545899999863457898766666644236333379998963333789799999881999999767787418999885
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1013)
|+|+.+........ ..........||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 151 G~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~---- 225 (299)
T d1ckia_ 151 GLAKKYRDARTHQH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY---- 225 (299)
T ss_dssp SSCEECBCTTTCCB-CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H----
T ss_pred CCCEECCCCCCCCC-EECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHH----
T ss_conf 75134255445541-0001357767873532999991899898321886177899998498766553057799999----
Q ss_pred HCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 188348984011100136564203899713478999999999998650246898999998999999997665
Q 001782 935 ALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARK 1006 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~ 1006 (1013)
.......+...+.. ....++.++.+++..|++.+|.+||++.++.+.|+.+..
T Consensus 226 ------~~~~~~~~~~~~~~-------------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 226 ------ERISEKKMSTPIEV-------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ------HHHHHHHHHSCHHH-------------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ------HHHHCCCCCCCHHH-------------HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------98523567898357-------------534788999999999843995579199999999999999
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=327.38 Aligned_cols=292 Identities=30% Similarity=0.511 Sum_probs=212.0
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC--EEEEEEECCCC--CEEEEEEECCCCCCCC--CCCCCCCCCCCCEE
Q ss_conf 998879999999984479999998989999985--05899968989--8169995013555456--74234787777743
Q 001782 32 SNETDRLALLAIKSQLQDPLGVTSSWNNSMNLC--QWTGVTCGHRH--QRVTVLDLSNRSIEGI--LSPYVGNLSFLRFI 105 (1013)
Q Consensus 32 ~~~~~~~~Ll~~k~~~~~~~~~~~sw~~~~~~c--~w~gv~c~~~~--~~v~~l~l~~~~l~~~--~~~~l~~l~~L~~L 105 (1013)
|.++|++||++||+++.||. .+++|..++||| .|.||+|+... .||+.|||+++++.+. +|+.+++|++|++|
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCHHHHHHHHHHHHHCCCCC-CCCCCCCCCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCCCC
T ss_conf 89899999999999779998-67788999999889488969748999479889989899888888798478467533520
Q ss_pred EECC-CCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCEECCCCC
Q ss_conf 4015-876546996547764214985168865447998400377882421356533487898323233322403202433
Q 001782 106 NFAN-NGFSGEIPGEIGRLFRLETLILANNSFSGKIPSNLSRCSNLINFHARGNNLVGQIPPDIGYSWLKLEFLSLRDNL 184 (1013)
Q Consensus 106 ~L~~-n~l~~~~p~~~~~l~~L~~L~ls~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~p~~~~~~l~~L~~L~l~~n~ 184 (1013)
+|++ |+++|.+|.+|+++++|++|+|++|++.+..+..+..+.+|++++++.|.+.+.+|..+. .++.++.+++++|.
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~-~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS-SLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG-GCTTCCEEECCSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHC-CCCCCCEEECCCCC
T ss_conf 20265433300243114542001102035643443322222011100111122455556851220-67400000023553
Q ss_pred CCCCCCCCCCCCCCC-CEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHCCCCCCCEEECCCCCCCCCCCC
Q ss_conf 454488886688875-5566316524788998324456434655433434678950001677203001237766788887
Q 001782 185 LAGQLAPSIGNISNL-QVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPV 263 (1013)
Q Consensus 185 l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~lp~ 263 (1013)
+.+.+|..+..+..+ +.++++.|++++..|..+..+..+ .++++.+...+.+|..+..+++++.+++++|.+.+.+|
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~- 238 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG- 238 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-
T ss_conf 3562031214431123231022464353324332222222-33333343322222222222221112222222222222-
Q ss_pred CCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 768899987679944033645489988889999669742572433356333488874300134576
Q 001782 264 NIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSFSKNN 329 (1013)
Q Consensus 264 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 329 (1013)
.++ .+++|+.|++++|++++.+|..+.++++|++|+|++|+++|.+| .+..+++|+.+++++|+
T Consensus 239 ~~~-~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 239 KVG-LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302 (313)
T ss_dssp GCC-CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-CSTTGGGSCGGGTCSSS
T ss_pred CCC-CCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCC-CCCCCCCCCHHHHCCCC
T ss_conf 222-45544444476570666087688479999989795883516689-86667998978868895
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=325.10 Aligned_cols=275 Identities=20% Similarity=0.245 Sum_probs=201.9
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCC-CCCCCEEEEEEECCCCCCCCEE
Q ss_conf 114898880110542389999989997399999974134560367999999984179-9963049999614774565418
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~ 776 (1013)
.++|++.++||+|+||+||+|++..+++.||+|++... ..+++.+|+++++.+. ||||+++++++.. ......
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEE---CCCCCE
T ss_conf 86718978983174819999998899979999998889---999999999999851579987679999981---687712
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEECCCC
Q ss_conf 89986044787777730036542157889999999999999999998616999905258899855755899-55980146
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDM-VAHVGDFG 855 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~-~~kl~Dfg 855 (1013)
++||||+++++|.++. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+|++|||
T Consensus 108 ~~v~e~~~~~~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG 175 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWG 175 (328)
T ss_dssp EEEEECCCSCBGGGTT---------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred EEEEEECCCCCHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCC
T ss_conf 6888631798589974---------6899999999999999999887643---344345644123774899836641565
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 65458999998634578987666666442363333799-98963333789799999881999999767787418999885
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1013)
+|+...+.. ......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||................
T Consensus 176 ~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~ 246 (328)
T d3bqca1 176 LAEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246 (328)
T ss_dssp GCEECCTTC---------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred CCEECCCCC---------CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
T ss_conf 426646887---------44432248642476102688888845232335455587604889998876018999999998
Q ss_pred HCCHHHHHHHHHHH-CCCHHHHHCCCCCCCH------HHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 18834898401110-0136564203899713------47899999999999865024689899999899999
Q 001782 935 ALPEKVMEIVDPLL-LLDLEARASNCGSHRT------EIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 935 ~~~~~~~~~i~~~l-~~dp~~R~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~ 999 (1013)
...+...+.....- ...+..........+. ..........++.+++.+|++.||++|||++|+++
T Consensus 247 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 788415555542254447430000033343311211552112448999999999986699568908999964
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.63 Aligned_cols=242 Identities=21% Similarity=0.319 Sum_probs=195.5
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC------CCHHHHHHHHHHHHCCC--CCCCCEEEEEEECCC
Q ss_conf 1148988801105423899999899973999999741345------60367999999984179--996304999961477
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR------GATKSFVAECEALRNIR--HRNLIKIITVCSSID 769 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 769 (1013)
.++|++.+.||+|+||+||+|++..+++.||||++..... ....++.+|+.++++++ ||||+++++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~---- 78 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF---- 78 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE----
T ss_conf 8837996798408783999999999997999999856884433455679999999999997435898812799998----
Q ss_pred CCCCCEEEEEEEECCC-CCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-C
Q ss_conf 4565418899860447-8777773003654215788999999999999999999861699990525889985575589-9
Q 001782 770 FEEVDFKAIVYEYMEC-GSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHD-M 847 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~-~ 847 (1013)
...+..++||||+.+ +++.+++... ..+++.++..++.|++.|+.|||++ +|+||||||+|||++.+ +
T Consensus 79 -~~~~~~~lv~e~~~~~~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~ 148 (273)
T d1xwsa_ 79 -ERPDSFVLILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG 148 (273)
T ss_dssp -ECSSEEEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred -EECCEEEEEEEECCCCCHHHHHHHCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCC
T ss_conf -30996899998336862289998615------8999999999999999999999877---9755667611147744788
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 559801466545899999863457898766666644236333379998-9633337897999998819999997677874
Q 001782 848 VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDM-SATGDVYSFGILLLEMFTRRRPTDNMFNDGL 926 (1013)
Q Consensus 848 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~P~~~~~~~~~ 926 (1013)
.+||+|||+|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 149 ~vkl~DFG~a~~~~~~----------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---- 214 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDT----------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 214 (273)
T ss_dssp EEEECCCTTCEECCSS----------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred EEEECCCCCCEECCCC----------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH----
T ss_conf 4897754653532444----------55665658774799998489978865332554034536756889988736----
Q ss_pred CHHHHHHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 18999885188348984011100136564203899713478999999999998650246898999998999999
Q 001782 927 TLHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 927 ~~~~~~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
... ....... ...+.++.+++.+|++.||++|||+.|+++.
T Consensus 215 ---~i~------------~~~~~~~------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 ---EII------------RGQVFFR------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---HHH------------HCCCCCS------------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HHH------------HCCCCCC------------------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---776------------1544778------------------7799999999999760897589399998539
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=326.10 Aligned_cols=274 Identities=20% Similarity=0.282 Sum_probs=201.0
Q ss_pred CCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECC--CCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEE
Q ss_conf 14898880110542389999989997399999974134--5603679999999841799963049999614774565418
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQ--RGATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 776 (1013)
++|++.++||+|+||+||+|+++ +++.||||++.... ....+++.+|+.++++++||||+++++++ ......
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred CCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEC-----CCCCCE
T ss_conf 99634318722778189999968-999999999812326858999999999999867998687660120-----467731
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 89986044787777730036542157889999999999999999998616999905258899855755899559801466
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~ 856 (1013)
++++|++.++.+..+.... +.+++..+..++.|++.||.|||++ +||||||||+|||++.++.+|++|||.
T Consensus 76 ~i~~e~~~~~~~~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp EEEEECCSEEHHHHHHTST------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEEEEEEHHHHHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCC
T ss_conf 5899740045678998604------7751445689999999999986057---488267877505686899787323664
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 5458999998634578987666666442363333799-989633337897999998819999997677874189998851
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG-DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1013)
|....... .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+ .........
T Consensus 147 a~~~~~~~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~ 217 (286)
T d1ob3a_ 147 ARAFGIPV--------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRIL 217 (286)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred CEECCCCC--------CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHH-HHHHHHHHH
T ss_conf 30114676--------541010243110137887178888841002111758999977979989889899-999999863
Q ss_pred CCHHHHHH--HHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 88348984--01110013656420389971347899999999999865024689899999899999
Q 001782 936 LPEKVMEI--VDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVA 999 (1013)
Q Consensus 936 ~~~~~~~~--i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~ 999 (1013)
.......+ ............. .............+..+.+++.+|++.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 218 GTPNSKNWPNVTELPKYDPNFTV---YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCC---CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCHHHCCCHHHHHHCCCCCCC---CCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 89971104212333221433333---5676466651258999999999986689668909999856
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=316.74 Aligned_cols=271 Identities=16% Similarity=0.202 Sum_probs=210.4
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCC-CCCCEEEEEEECCCCCCCCEE
Q ss_conf 1148988801105423899999899973999999741345603679999999841799-963049999614774565418
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRH-RNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~ 776 (1013)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|++.++.+.| ++++.+++++ ......
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEE-----ECCCCC
T ss_conf 980699799841788299999998899799999975025--8299999999999964899987799996-----018811
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEE
Q ss_conf 899860447877777300365421578899999999999999999986169999052588998557558-----995598
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDH-----DMVAHV 851 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~-----~~~~kl 851 (1013)
++||||+. ++|.+++.... ..+++.++..++.|++.|++|+|++ +|+||||||+||+++. ++.+||
T Consensus 77 ~~vme~~~-~~l~~~~~~~~-----~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl 147 (293)
T d1csna_ 77 VLVIDLLG-PSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV 147 (293)
T ss_dssp EEEEECCC-CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred EEEEEECC-CCHHHHHHHHC-----CCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEE
T ss_conf 79999648-88799997520-----3110689999999999999999977---966266771315234754344795687
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHH
Q ss_conf 01466545899999863457898766666644236333379998963333789799999881999999767787418999
Q 001782 852 GDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEF 931 (1013)
Q Consensus 852 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~ 931 (1013)
+|||+|+.+........ ..........||+.|||||++.+..++.++||||+|+++|||++|+.||.......... ..
T Consensus 148 ~DFG~a~~~~~~~~~~~-~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-~~ 225 (293)
T d1csna_ 148 VDFGMVKFYRDPVTKQH-IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KY 225 (293)
T ss_dssp CCCTTCEESBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HH
T ss_pred CCCCEEEECCCCCCCCC-EEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HH
T ss_conf 23660577146766541-11024676277510267989648888869998983199999986987678853021999-99
Q ss_pred HHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 88518834898401110013656420389971347899999999999865024689899999899999999766544
Q 001782 932 AKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAKLCSARKIF 1008 (1013)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1008 (1013)
..+........+.+ ....+++++.+++..|++.+|.+||++..+.+.++.+.+..
T Consensus 226 ---------~~i~~~~~~~~~~~-------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 226 ---------ERIGEKKQSTPLRE-------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp ---------HHHHHHHHHSCHHH-------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---------HHHHHCCCCCCHHH-------------HCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
T ss_conf ---------99970567999589-------------65799899999999984399300859999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.09 Aligned_cols=281 Identities=20% Similarity=0.189 Sum_probs=207.1
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCC-CCCC
Q ss_conf 1148988801105423899999899973999999741345--603679999999841799963049999614774-5654
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDF-EEVD 774 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 774 (1013)
.++|++.++||+|+||+||+|.+..+++.||||++..... ....++.+|+.+++.++||||+++++++..... +...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 18899860447877777300365421578899999999999999999986169999052588998557558995598014
Q 001782 775 FKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDF 854 (1013)
Q Consensus 775 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Df 854 (1013)
..|+||||+.++.+ +.+. ..+++..+..++.|++.|+.|||++ ||+||||||+|||++.++.+|++||
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~--------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEECCCHHHH-HHHH--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECH
T ss_conf 26999841446778-7650--------3899999999999999999886522---1124567763211365443132010
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 66545899999863457898766666644236333379998963333789799999881999999767787418999885
Q 001782 855 GLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 855 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1013)
|.++.... ........+|+.|+|||++.+..++.++||||+||++|+|++|+.||...... .........
T Consensus 164 ~~~~~~~~---------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~ 233 (355)
T d2b1pa1 164 GLARTAGT---------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQ 233 (355)
T ss_dssp CC------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred HHHHCCCC---------CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHH-HHHHHHHHH
T ss_conf 23211466---------65533221465555813314777787743335662578986598998889778-899999972
Q ss_pred HC----------CHHHHHHHHHHHCCCHH--HHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 18----------83489840111001365--64203899713478999999999998650246898999998999999
Q 001782 935 AL----------PEKVMEIVDPLLLLDLE--ARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 935 ~~----------~~~~~~~i~~~l~~dp~--~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
.. .....+........... .+.................+..+.+++.+|++.||++||||+|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 058987999876566777764175435666421264333543210133379999999999876994579089999669
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.57 Aligned_cols=279 Identities=19% Similarity=0.227 Sum_probs=203.5
Q ss_pred HCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCE
Q ss_conf 1148988801105423899999899973999999741345--60367999999984179996304999961477456541
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 775 (1013)
.++|++.++||+|+||+||+|++..+++.||||++..... ...+++.+|+++++.++|||++++++++......+...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 88998604478777773003654215788999999999999999999861699990525889985575589955980146
Q 001782 776 KAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFG 855 (1013)
Q Consensus 776 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg 855 (1013)
.+++++++.+|+|.+++.. ..+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+|++|||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred EEEEEEEECCCCHHHHCCC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 4999996258862320022-------4530999999999999999999738---87651667763345543220013210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 654589999986345789876666664423633337999-8963333789799999881999999767787418999885
Q 001782 856 LARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD-MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKM 934 (1013)
Q Consensus 856 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~ 934 (1013)
.|..... ......|+..|+|||...+.. ++.++||||+||++|+|++|+.||.+...... .....+.
T Consensus 167 ~a~~~~~-----------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~ 234 (348)
T d2gfsa1 167 LARHTDD-----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRL 234 (348)
T ss_dssp ---CCTG-----------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred HHCCCCC-----------CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHH
T ss_conf 0012575-----------444434543555835533775678551243205899999768899788988999-9999973
Q ss_pred HC--CHHHHHHHHHHHCCCHHHHHCCCCCCCHHH-HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 18--834898401110013656420389971347-8999999999998650246898999998999999
Q 001782 935 AL--PEKVMEIVDPLLLLDLEARASNCGSHRTEI-AKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 935 ~~--~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
.. +.+...........+....... ...... ........++.+++.+|++.||.+||||.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 235 VGTPGAELLKKISSESARNYIQSLTQ--MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HCCCCHHHHTTCCCHHHHHHHTTSCC--CCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCHHHHHHCCCHHHHHHHHHCCC--CCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 07997577320010244544430355--78755566267899999999999775883459389998559
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.42 Aligned_cols=278 Identities=17% Similarity=0.243 Sum_probs=204.7
Q ss_pred CCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCCEE
Q ss_conf 148988801105423899999899973999999741345--603679999999841799963049999614774565418
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR--GATKSFVAECEALRNIRHRNLIKIITVCSSIDFEEVDFK 776 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 776 (1013)
++|++.++||+|+||+||+|++..+++.||||+++.... ....++.+|+.+++.++||||+++++++ .+....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCC-----CCCCCE
T ss_conf 997862697128681999999999996999999803217868999999999999856757888213544-----444311
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 89986044787777730036542157889999999999999999998616999905258899855755899559801466
Q 001782 777 AIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVAHVGDFGL 856 (1013)
Q Consensus 777 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~ 856 (1013)
++|+|++.++++..++... +.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.
T Consensus 77 ~iv~~~~~~~~l~~~~~~~------~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEEECCSEEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEECCCCCCCCCCCCC------CCCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCH
T ss_conf 5886302332221121235------6540367899999999998774339---986001467612113378266520460
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 54589999986345789876666664423633337999-89633337897999998819999997677874189998851
Q 001782 857 ARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGD-MSATGDVYSFGILLLEMFTRRRPTDNMFNDGLTLHEFAKMA 935 (1013)
Q Consensus 857 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 935 (1013)
|+...... .......++..|+|||++.+.. ++.++||||+||++|||++|+.||....+............
T Consensus 148 a~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 219 (292)
T d1unla_ 148 ARAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp CEECCSCC--------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred HHCCCCCC--------CCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHC
T ss_conf 11046887--------5100103443101466750698888044402654188998518999988999999999998611
Q ss_pred CCHHHHHHHHHHHCCCHHHH-HCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 88348984011100136564-203899713478999999999998650246898999998999999
Q 001782 936 LPEKVMEIVDPLLLLDLEAR-ASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 936 ~~~~~~~~i~~~l~~dp~~R-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eil~~ 1000 (1013)
.+.....+-.. ...+... ....................+.+++.+|++.||.+||||.|+++.
T Consensus 220 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 220 GTPTEEQWPSM--TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCTTTCTTG--GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHHH--HHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 89973551344--32221133444544310433065689999999999864996689099999649
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.08 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=199.4
Q ss_pred HCCCCCCCCEEECCCEEEEEEEE---CCCCEEEEEEEEEECC----CCCHHHHHHHHHHHHCCCC-CCCCEEEEEEECCC
Q ss_conf 11489888011054238999998---9997399999974134----5603679999999841799-96304999961477
Q 001782 698 TNDFSSSNMIGQGSFGFVYRGNL---GENEMAVAVKVMNLKQ----RGATKSFVAECEALRNIRH-RNLIKIITVCSSID 769 (1013)
Q Consensus 698 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~ 769 (1013)
.++|++.+.||+|+||+||+|++ +.+++.||+|++.... ....+.+.+|++++++++| |||+++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~---- 98 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 98 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE----
T ss_conf 1025999898328783999999876588794899999836772101689999999999998646798399962000----
Q ss_pred CCCCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 45654188998604478777773003654215788999999999999999999861699990525889985575589955
Q 001782 770 FEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLLDHDMVA 849 (1013)
Q Consensus 770 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~ 849 (1013)
++....++++||+.+|+|.+++... ..+++..+..++.|++.|+.|+|+. +|+||||||+||+++.++.+
T Consensus 99 -~~~~~~~~v~e~~~~~~L~~~i~~~------~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~v 168 (322)
T d1vzoa_ 99 -QTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV 168 (322)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred -CCCCCEEEEEECCCCCHHHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCE
T ss_conf -2487300123123411799998730------4543788888899999999885149---98965477320124699988
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 98014665458999998634578987666666442363333799--9896333378979999988199999976778741
Q 001782 850 HVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGG--DMSATGDVYSFGILLLEMFTRRRPTDNMFNDGLT 927 (1013)
Q Consensus 850 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~P~~~~~~~~~~ 927 (1013)
||+|||+|+.+.... ........|++.|+|||.+.+. .++.++||||+||++|+|++|+.||.........
T Consensus 169 kL~DFG~a~~~~~~~-------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~ 241 (322)
T d1vzoa_ 169 VLTDFGLSKEFVADE-------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 241 (322)
T ss_dssp EESCSSEEEECCGGG-------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH
T ss_pred EEEECCCHHHHCCCC-------CCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf 874132022203444-------4322122233333106876057768871325177779999997689998888777799
Q ss_pred HHHHHHHHCCHHHHHHHHHHHCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 899988518834898401110013656420389971347899999999999865024689899999-----899999
Q 001782 928 LHEFAKMALPEKVMEIVDPLLLLDLEARASNCGSHRTEIAKIEECLVAIVRIGVLCSMESPSERIQ-----MTDVVA 999 (1013)
Q Consensus 928 ~~~~~~~~~~~~~~~~i~~~l~~dp~~R~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~eil~ 999 (1013)
..... ......+ . .+...+.++.+++.+|+++||.+||| +.|+++
T Consensus 242 ~~i~~-------------~~~~~~~----~----------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 242 AEISR-------------RILKSEP----P----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHH-------------HHHHCCC----C----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHH-------------HCCCCCC----C----------CCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf 99998-------------3356899----8----------8654799999999997445898819997450999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=294.29 Aligned_cols=280 Identities=17% Similarity=0.215 Sum_probs=192.4
Q ss_pred CCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCC-----------CCCCCEEEEEEEC
Q ss_conf 14898880110542389999989997399999974134560367999999984179-----------9963049999614
Q 001782 699 NDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-----------HRNLIKIITVCSS 767 (1013)
Q Consensus 699 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 767 (1013)
++|++.++||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 85799899750778189999999999799999983431-33689999999999840145555542276764789987631
Q ss_pred CCCCCCCEEEEEEEECCCCC-HHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECC
Q ss_conf 77456541889986044787-77773003654215788999999999999999999861-69999052588998557558
Q 001782 768 IDFEEVDFKAIVYEYMECGS-LEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHH-HCHPPIVHGDLKPSNVLLDH 845 (1013)
Q Consensus 768 ~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nili~~ 845 (1013)
......+.+++++..+. ......... ...+++..+..++.|++.|+.|||+ . +|+||||||+|||++.
T Consensus 92 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 92 ---KGPNGVHVVMVFEVLGENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEI 161 (362)
T ss_dssp ---EETTEEEEEEEECCCCEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEE
T ss_pred ---CCCCCEEEEEEECCCCCCCCCCCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEEC
T ss_conf ---256520234320003542000001223----467868999999999999988876405---8646567705705630
Q ss_pred CC------CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCC
Q ss_conf 99------559801466545899999863457898766666644236333379998963333789799999881999999
Q 001782 846 DM------VAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVAPEYGMGGDMSATGDVYSFGILLLEMFTRRRPTD 919 (1013)
Q Consensus 846 ~~------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P~~ 919 (1013)
++ .++++|||.|..... ......||+.|+|||++.+..++.++||||+||++++|++|+.||.
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDE-----------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTB-----------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCCCCCCCEEEEEECCCCCCCCC-----------CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 57656443056753144212344-----------5422366521057132146677764320123789999987889989
Q ss_pred CCCCCCC-----CHHHHHHH--HCCHHHHHH-HHHHHCCCHHHHHCCCCCC----CH-----HHHHHHHHHHHHHHHHHH
Q ss_conf 7677874-----18999885--188348984-0111001365642038997----13-----478999999999998650
Q 001782 920 NMFNDGL-----TLHEFAKM--ALPEKVMEI-VDPLLLLDLEARASNCGSH----RT-----EIAKIEECLVAIVRIGVL 982 (1013)
Q Consensus 920 ~~~~~~~-----~~~~~~~~--~~~~~~~~~-i~~~l~~dp~~R~~~~~~~----~~-----~~~~~~~~~~~l~~l~~~ 982 (1013)
....... ........ ..+...... .......+........... .. ........+.++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 310 (362)
T d1q8ya_ 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310 (362)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHH
T ss_conf 87554321026899999998379987886245322000132012202432357764442100015674358999999999
Q ss_pred CCCCCCCCCCCHHHHHHH
Q ss_conf 246898999998999999
Q 001782 983 CSMESPSERIQMTDVVAK 1000 (1013)
Q Consensus 983 cl~~dP~~RPs~~eil~~ 1000 (1013)
|++.||.+||||+|+++.
T Consensus 311 mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 311 MLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp GGCSSTTTCBCHHHHHTC
T ss_pred HCCCCHHHCCCHHHHHCC
T ss_conf 877994579089999669
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=4.2e-39 Score=232.93 Aligned_cols=192 Identities=31% Similarity=0.412 Sum_probs=138.2
Q ss_pred HHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 60245666364146655577351138999998998447856766885335657568777688724687886644674545
Q 001782 387 VKNLVNLNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLM 466 (1013)
Q Consensus 387 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 466 (1013)
+..++++..+.+++|.+++..| +...++|+.|++++|++++. ..+..+++|+.+++++|.+++.. .+..+++|+
T Consensus 193 ~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~ 266 (384)
T d2omza2 193 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLT 266 (384)
T ss_dssp GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCS
T ss_pred CCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCC--CCCCCCCCC
T ss_conf 0223532333035774478786--44457787888877777896--13432565341004467447877--535546687
Q ss_pred EEECCCCCCCCCCCCHHHCCCCHHHHHCCCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 01102332223487001100000133214798102668834357677748975588788878100004544320012263
Q 001782 467 LLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGN 546 (1013)
Q Consensus 467 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 546 (1013)
.|++++|++++. +. +.....++.++++.|.+++ ...+..+++++.|++++|.+.+.. .+..+++|++|++++|
T Consensus 267 ~L~l~~~~l~~~-~~--~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n 339 (384)
T d2omza2 267 ELKLGANQISNI-SP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANN 339 (384)
T ss_dssp EEECCSSCCCCC-GG--GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSS
T ss_pred EEECCCCCCCCC-CC--CCCCCCCCCCCCCCCCCCC--CCCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCC
T ss_conf 754567445787-73--2356522223323233333--221000024676777788778984--5366898898989899
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 2345647000044777857355662356561012464533501057863
Q 001782 547 SLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNH 595 (1013)
Q Consensus 547 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 595 (1013)
++++ ++ .+..+++|+.|++++|++++..| +..+++|+.|++++|.
T Consensus 340 ~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 340 KVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp CCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred CCCC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCCC
T ss_conf 8999-74-67089999989897995899800--0039999996397895
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.3e-41 Score=244.71 Aligned_cols=235 Identities=33% Similarity=0.529 Sum_probs=136.5
Q ss_pred CCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 66364146-65557735113899999899844785676688533565756877768872468788664467454501102
Q 001782 393 LNGFGLEY-NQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVS 471 (1013)
Q Consensus 393 L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 471 (1013)
|++|+|++ |.++|.+|..|+++++|++|++++|++.+..+..+..+..|+.+++++|.+.+.+|..+.+++.++.++++
T Consensus 78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~ 157 (313)
T d1ogqa_ 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECC
T ss_conf 35202026543330024311454200110203564344332222201110011112245555685122067400000023
Q ss_pred CCCCCCCCCCHHHCCCCHHHHHCCCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 33222348700110000013321479810266883435767774897558878887810000454432001226323456
Q 001782 472 NNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGS 551 (1013)
Q Consensus 472 ~N~l~~~~~~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 551 (1013)
+|.+.+.+|..+......++.+++++|++++..+..+..+..+ .+++++|...+.+|..+..+++|+.+++++|.+.+.
T Consensus 158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~ 236 (313)
T d1ogqa_ 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 5533562031214431123231022464353324332222222-333333433222222222222211122222222222
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf 47000044777857355662356561012464533501057863878789997447876101508867778987788886
Q 001782 552 IPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRGVFSNKTRFYFTGNKRLCGGLDELHLPV 631 (1013)
Q Consensus 552 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~ 631 (1013)
++ .+..+++|+.|+|++|++++.+|..+..+++|++|++++|+++|.+|..+.+..+..+.+.+|+.+||.|. |.
T Consensus 237 ~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl----p~ 311 (313)
T d1ogqa_ 237 LG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL----PA 311 (313)
T ss_dssp GG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS----SC
T ss_pred CC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCC----CC
T ss_conf 22-22245544444476570666087688479999989795883516689866679989788688950019898----89
Q ss_pred CC
Q ss_conf 55
Q 001782 632 CH 633 (1013)
Q Consensus 632 ~~ 633 (1013)
|+
T Consensus 312 c~ 313 (313)
T d1ogqa_ 312 CT 313 (313)
T ss_dssp CC
T ss_pred CC
T ss_conf 89
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.4e-37 Score=224.34 Aligned_cols=163 Identities=28% Similarity=0.396 Sum_probs=71.8
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 66364146655577351138999998998447856766885335657568777688724687886644674545011023
Q 001782 393 LNGFGLEYNQLTGPIPHAIGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSN 472 (1013)
Q Consensus 393 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 472 (1013)
|+.+++++|.++.. ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++. + .+..++.++.++++.
T Consensus 221 L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~-~-~~~~~~~l~~l~~~~ 294 (384)
T d2omza2 221 LDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-S-PLAGLTALTNLELNE 294 (384)
T ss_dssp CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-G-GGTTCTTCSEEECCS
T ss_pred CCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCC-C-CCCCCCCCCCCCCCC
T ss_conf 87888877777896--134325653410044674478775--35546687754567445787-7-323565222233232
Q ss_pred CCCCCCCCCHHHCCCCHHHHHCCCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 32223487001100000133214798102668834357677748975588788878100004544320012263234564
Q 001782 473 NKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSI 552 (1013)
Q Consensus 473 N~l~~~~~~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 552 (1013)
|.+++ ++ . ....+.++.+++++|++++.. .+..+++|+.|++++|++++ ++ .+..+++|++|++++|++++..
T Consensus 295 n~l~~-~~-~-~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~ 367 (384)
T d2omza2 295 NQLED-IS-P-ISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLT 367 (384)
T ss_dssp SCCSC-CG-G-GGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCG
T ss_pred CCCCC-CC-C-CCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCH
T ss_conf 33333-22-1-000024676777788778984--53668988989898998999-74-6708999998989799589980
Q ss_pred CCCCCCCCCCCEEECCCC
Q ss_conf 700004477785735566
Q 001782 553 PLALKTLKSIKELDLSRN 570 (1013)
Q Consensus 553 ~~~~~~l~~L~~L~Ls~N 570 (1013)
| +..+++|+.|+|++|
T Consensus 368 ~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 368 P--LANLTRITQLGLNDQ 383 (384)
T ss_dssp G--GTTCTTCSEEECCCE
T ss_pred H--HCCCCCCCEEECCCC
T ss_conf 0--003999999639789
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.5e-34 Score=203.76 Aligned_cols=285 Identities=21% Similarity=0.234 Sum_probs=0.0
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 20300123776678888776889998767994403364548998888999966974257243335633348887430013
Q 001782 246 SLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSF 325 (1013)
Q Consensus 246 ~L~~L~L~~n~l~~~lp~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 325 (1013)
.++.++-+++.++ .+|..++ +++++|++++|+++...+..|.++++|+.|++++|++....+..|..+++|+.|++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCEEEECCCCCC-CCCCCCC---CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECC
T ss_conf 5999985599988-5198889---99798978499189869657604656523112344344523566527985578315
Q ss_pred CCCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHCCHHHHHHHHCCCHHHHHHCCCCCCEEECCCCCCCC
Q ss_conf 45768888889813443103454111204544334896620110110347787314126776024566636414665557
Q 001782 326 SKNNLGTGAIGDLDFIAHLTNCSKLEALGLDTNIFGGVLPLSIANLSSTIILFSMGLNQIYVKNLVNLNGFGLEYNQLTG 405 (1013)
Q Consensus 326 s~N~l~~~~~~~~~~~~~l~~~~~L~~l~l~~n~~~~~~p~~~~~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 405 (1013)
++|++...+.... ..+..+.+..|.+..
T Consensus 87 ~~n~l~~l~~~~~----------------------------------------------------~~l~~L~~~~n~l~~ 114 (305)
T d1xkua_ 87 SKNQLKELPEKMP----------------------------------------------------KTLQELRVHENEITK 114 (305)
T ss_dssp CSSCCSBCCSSCC----------------------------------------------------TTCCEEECCSSCCCB
T ss_pred CCCCCCCCCCCHH----------------------------------------------------HHHHHHHCCCCCHHH
T ss_conf 6875676764001----------------------------------------------------113232102461023
Q ss_pred CCCCCCCCCCCCCEEECCCCCCC--CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHH
Q ss_conf 73511389999989984478567--6688533565756877768872468788664467454501102332223487001
Q 001782 406 PIPHAIGELRNLQVLDLHHNNLD--GHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQI 483 (1013)
Q Consensus 406 ~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 483 (1013)
..+..+.....+..++...|... ...+..+..+++|+.+++++|.+. .++..+ +++|+.|++++|..++..+..+
T Consensus 115 l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~ 191 (305)
T d1xkua_ 115 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASL 191 (305)
T ss_dssp BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGG
T ss_pred HHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCC--CCCCCEEECCCCCCCCCCHHHH
T ss_conf 4444540133110000123333346777642234565671203467745-167101--7766789897886778882676
Q ss_pred HCCCCHHHHHCCCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------
Q ss_conf 10000013321479810266883435767774897558878887810000454432001226323456470000------
Q 001782 484 LGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALK------ 557 (1013)
Q Consensus 484 ~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~------ 557 (1013)
.. .+.++.|++++|.+++..+..+..+++|++|+|++|.++ .+|.+|..+++|++|+|++|+|+......|.
T Consensus 192 ~~-~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~ 269 (305)
T d1xkua_ 192 KG-LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 269 (305)
T ss_dssp TT-CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCT
T ss_pred HC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCHHC
T ss_conf 41-341330154455332223454334433224302554002-4631103346789898989865763810026721002
Q ss_pred CCCCCCEEECCCCCCC--CCCCCCCCCCCCCCEEEC
Q ss_conf 4477785735566235--656101246453350105
Q 001782 558 TLKSIKELDLSRNNLS--GQIPEFLENLSFLEYLNL 591 (1013)
Q Consensus 558 ~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~l 591 (1013)
.+.+|+.|+|++|++. ...|..|..+.....+++
T Consensus 270 ~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~~~~ 305 (305)
T d1xkua_ 270 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305 (305)
T ss_dssp TSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC
T ss_pred CCCCCCEEECCCCCCCCCCCCHHHHCCCCCCCCCCC
T ss_conf 158889788989957667689768300245742409
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-33 Score=199.79 Aligned_cols=39 Identities=28% Similarity=0.383 Sum_probs=12.3
Q ss_pred CCCCCEEEEEECCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 998767994403364548998888999966974257243
Q 001782 269 LPNLENLSVRQNNYTGSLPHSLSNASNLRLLDFSLNHFS 307 (1013)
Q Consensus 269 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~ 307 (1013)
+++|+.+++++|++++..|..|.++++|++|++++|++.
T Consensus 176 l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~ 214 (284)
T d1ozna_ 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214 (284)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCC
T ss_conf 563413142114346628167665320002333335221
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.5e-31 Score=190.43 Aligned_cols=92 Identities=26% Similarity=0.238 Sum_probs=36.4
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 35767774897558878887810000454432001226323456470000447778573556623565610124645335
Q 001782 508 VGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLE 587 (1013)
Q Consensus 508 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 587 (1013)
+..+.+++.|++++|.+....+..+..+++|+.+++++|++++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+
T Consensus 120 ~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~ 198 (266)
T d1p9ag_ 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198 (266)
T ss_dssp TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCS
T ss_pred CCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCC
T ss_conf 222211112212434210221233322111000000015652237200134212423430139785-5686677788899
Q ss_pred EEECCCCCCCCCC
Q ss_conf 0105786387878
Q 001782 588 YLNLSYNHLEGEV 600 (1013)
Q Consensus 588 ~L~l~~N~l~~~~ 600 (1013)
.|++++|+|.|.+
T Consensus 199 ~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 199 FAFLHGNPWLCNC 211 (266)
T ss_dssp EEECCSCCBCCSG
T ss_pred EEEECCCCCCCCC
T ss_conf 9983699987886
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=1.9e-26 Score=161.86 Aligned_cols=142 Identities=26% Similarity=0.356 Sum_probs=59.1
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCHH
Q ss_conf 38999998998447856766885335657568777688724687886644674545011023322234870011000001
Q 001782 411 IGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLS 490 (1013)
Q Consensus 411 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 490 (1013)
+..++.++.+++++|.... .+. ...++..+.+..|.+.. .+... ..+...++..+.+.+. +. .....
T Consensus 200 ~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~-~~~~~---~~l~~~~~~~~~~~~l-~~----l~~~~ 266 (353)
T d1jl5a_ 200 LQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTD-LPELP---QSLTFLDVSENIFSGL-SE----LPPNL 266 (353)
T ss_dssp CTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSEE-SC----CCTTC
T ss_pred CCCCCCCCCCCCCCCCCCC-CCC---CCCCCCCCCCCCCCCCC-CCCCC---CCCCCCCCCCCCCCCC-CC----CCCHH
T ss_conf 3455533312225422234-553---23343332223333344-43334---4322222222333222-34----53000
Q ss_pred HHHCCCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 33214798102668834357677748975588788878100004544320012263234564700004477785735566
Q 001782 491 ILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRN 570 (1013)
Q Consensus 491 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 570 (1013)
...++..+.+.+ + ...+++|++|++++|++. .+|.. +++|+.|+|++|+|+ .+|.. +.+|+.|++++|
T Consensus 267 ~~~~~~~~~~~~-~---~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N 334 (353)
T d1jl5a_ 267 YYLNASSNEIRS-L---CDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYN 334 (353)
T ss_dssp CEEECCSSCCSE-E---CCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSS
T ss_pred CCCCCCCCCCCC-C---CCCCCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCC
T ss_conf 123333575323-4---566898898979799168-35665---487998989999687-54532---288898987699
Q ss_pred CCCCCCCC
Q ss_conf 23565610
Q 001782 571 NLSGQIPE 578 (1013)
Q Consensus 571 ~l~~~~~~ 578 (1013)
+|+ .+|.
T Consensus 335 ~L~-~lp~ 341 (353)
T d1jl5a_ 335 PLR-EFPD 341 (353)
T ss_dssp CCS-SCCC
T ss_pred CCC-CCCC
T ss_conf 189-7776
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.95 E-value=3e-25 Score=155.09 Aligned_cols=56 Identities=30% Similarity=0.422 Sum_probs=23.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 5443200122632345647000044777857355662356561012464533501057863878
Q 001782 535 CTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYLNLSYNHLEG 598 (1013)
Q Consensus 535 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 598 (1013)
+++|++|++++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|++++|+++.
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~ 338 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE 338 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS
T ss_pred CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCCC
T ss_conf 898898979799168-35665---487998989999687-54532---2888989876991897
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1e-30 Score=185.83 Aligned_cols=88 Identities=20% Similarity=0.131 Sum_probs=37.0
Q ss_pred CCCCCCEEECCCCCCCC-----CCCCCCCCCCCCCEEECCCCCCCCCC----CCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 24566636414665557-----73511389999989984478567668----8533565756877768872468788664
Q 001782 389 NLVNLNGFGLEYNQLTG-----PIPHAIGELRNLQVLDLHHNNLDGHI----PESLGNLTILNSLDLGFNKLRGHVPSSL 459 (1013)
Q Consensus 389 ~l~~L~~L~L~~n~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 459 (1013)
....++.+.+.+|.+.. .....+.....++.+++++|.+.... ...+...+.++.+++++|.++......+
T Consensus 224 ~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l 303 (460)
T d1z7xw1 224 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 303 (460)
T ss_dssp HCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHH
T ss_pred CCCCCCCCCHHHCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf 22221001002112233442011000111111100001345433212334332211123433344444333224564211
Q ss_pred -----CCCCCCCEEECCCCCCC
Q ss_conf -----46745450110233222
Q 001782 460 -----GNCQNLMLLSVSNNKLT 476 (1013)
Q Consensus 460 -----~~l~~L~~L~Ls~N~l~ 476 (1013)
.....|+.+++++|.++
T Consensus 304 ~~~l~~~~~~L~~l~l~~~~l~ 325 (460)
T d1z7xw1 304 CETLLEPGCQLESLWVKSCSFT 325 (460)
T ss_dssp HHHHTSTTCCCCEEECTTSCCB
T ss_pred HCCCCCCCCCCCCCCCCCCCHH
T ss_conf 1012333444333323334102
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=5.6e-27 Score=164.84 Aligned_cols=163 Identities=18% Similarity=0.175 Sum_probs=117.3
Q ss_pred CCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCC------------------CHHHHHHHHHHHHCCCCCCCCEEEE
Q ss_conf 9888011054238999998999739999997413456------------------0367999999984179996304999
Q 001782 702 SSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRG------------------ATKSFVAECEALRNIRHRNLIKIIT 763 (1013)
Q Consensus 702 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~l~~ 763 (1013)
.+.++||+|+||+||+|.+. +++.||||+++..... .......|...+.++.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred HHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 22778024856599999979-99999999986044346665565630008889999997789999999816999144998
Q ss_pred EEECCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 96147745654188998604478777773003654215788999999999999999999861699990525889985575
Q 001782 764 VCSSIDFEEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHCHPPIVHGDLKPSNVLL 843 (1013)
Q Consensus 764 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dikp~Nili 843 (1013)
+ ...+++|||++++.+.+ ++......++.|++.++.|||++ +|+||||||+|||+
T Consensus 82 ~---------~~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv 136 (191)
T d1zara2 82 W---------EGNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 136 (191)
T ss_dssp E---------ETTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred E---------CCCEEEEEEECCCCCCC-------------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEE
T ss_conf 6---------28889999504565420-------------01578999999999999998268---88983689036114
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 5899559801466545899999863457898766666644236------3333799989633337897999
Q 001782 844 DHDMVAHVGDFGLARFLPPCSPATILETPSSSTGIKGTVGYVA------PEYGMGGDMSATGDVYSFGILL 908 (1013)
Q Consensus 844 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DiwslG~il 908 (1013)
+++ .++++|||.|....+... ..|.. .+. ....|+.++|+||..--+
T Consensus 137 ~~~-~~~liDFG~a~~~~~~~~----------------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVGEEGW----------------REILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ETT-EEEECCCTTCEETTSTTH----------------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECC-CEEEEECCCCCCCCCCCC----------------HHHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHH
T ss_conf 289-899987788430899870----------------99998779999999-757899844689999987
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.8e-30 Score=183.32 Aligned_cols=87 Identities=22% Similarity=0.148 Sum_probs=34.4
Q ss_pred CCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCCCC-----CCCCCCCEEECCCCCCCCCCCC---
Q ss_conf 45666364146655577----35113899999899844785676688533-----5657568777688724687886---
Q 001782 390 LVNLNGFGLEYNQLTGP----IPHAIGELRNLQVLDLHHNNLDGHIPESL-----GNLTILNSLDLGFNKLRGHVPS--- 457 (1013)
Q Consensus 390 l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~~~--- 457 (1013)
...++.+++++|.+... ....+...+.++.+++++|.+.+.....+ .....|+.+++++|.++.....
T Consensus 254 ~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~ 333 (460)
T d1z7xw1 254 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 333 (460)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHCC
T ss_conf 11100001345433212334332211123433344444333224564211101233344433332333410233443213
Q ss_pred -CCCCCCCCCEEECCCCCCC
Q ss_conf -6446745450110233222
Q 001782 458 -SLGNCQNLMLLSVSNNKLT 476 (1013)
Q Consensus 458 -~~~~l~~L~~L~Ls~N~l~ 476 (1013)
.+...++|++|++++|.++
T Consensus 334 ~~~~~~~~L~~L~Ls~N~i~ 353 (460)
T d1z7xw1 334 SVLAQNRFLLELQISNNRLE 353 (460)
T ss_dssp HHHHHCSSCCEEECCSSBCH
T ss_pred CCCCCCCCHHHHHEEEECCC
T ss_conf 32211011113201210135
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.2e-24 Score=151.73 Aligned_cols=136 Identities=17% Similarity=0.104 Sum_probs=54.1
Q ss_pred CCCCCCCCCCCCCEEEECCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCCHHCCCC-CCCEEECCCCCCCCCCCCCC
Q ss_conf 488886688875556631652478899-8324456434655433434678950001677-20300123776678888776
Q 001782 188 QLAPSIGNISNLQVLSIGENRLSGRLP-DSLGQLRSLYYLSISENAFSGMFPSSIFNIS-SLESISLLGNRLEGSLPVNI 265 (1013)
Q Consensus 188 ~~~~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~lp~~~ 265 (1013)
..+..|.++++|+++++++|.+....+ ..+..+..+..+..+++.+....+..+.+++ .++.|++++|+++ .++...
T Consensus 94 ~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~ 172 (242)
T d1xwdc1 94 INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCA 172 (242)
T ss_dssp ECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTT
T ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCC
T ss_conf 2222122222222223421111255433322211112222222121112222222222331001220012333-322222
Q ss_pred CCCCCCCCEE-EEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 8899987679-94403364548998888999966974257243335633348887430013
Q 001782 266 GFSLPNLENL-SVRQNNYTGSLPHSLSNASNLRLLDFSLNHFSGQVKIDFNRLPNLFRLSF 325 (1013)
Q Consensus 266 ~~~l~~L~~L-~l~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 325 (1013)
+ ..++++.+ .+++|+++...+..|.++++|+.|++++|+++......|..+++|+.+++
T Consensus 173 ~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 173 F-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp T-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred C-CCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCCCCC
T ss_conf 2-20111012123543246424788668999998989799289459779737713414767
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=8.2e-23 Score=141.43 Aligned_cols=12 Identities=25% Similarity=0.169 Sum_probs=3.7
Q ss_pred CCCCEEECCCCC
Q ss_conf 756877768872
Q 001782 439 TILNSLDLGFNK 450 (1013)
Q Consensus 439 ~~L~~L~Ls~N~ 450 (1013)
++|++|++++|+
T Consensus 195 ~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 195 PNLIEVHLKNNQ 206 (227)
T ss_dssp TTCCEEECTTSC
T ss_pred CCCCEEECCCCC
T ss_conf 999989795996
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=2.1e-22 Score=139.18 Aligned_cols=78 Identities=27% Similarity=0.368 Sum_probs=29.1
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 57677748975588788878100004544320012263234564700004477785735566235656101246453350
Q 001782 509 GNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEY 588 (1013)
Q Consensus 509 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 588 (1013)
...++|+.|++++|.+.+.. .+..+++|++|+|++|++++. + .+..+++|+.|+|++|++++..| +..+++|+.
T Consensus 148 ~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~ 221 (227)
T d1h6ua2 148 AGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221 (227)
T ss_dssp GGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCE
T ss_pred CCCCCCCCCCCCCCCCCCCH--HHCCCCCCEECCCCCCCCCCC-H-HHCCCCCCCEEECCCCCCCCCCC--CCCCCCCCE
T ss_conf 10211100233333333100--105646335644588841778-5-34479999989795996899802--036999898
Q ss_pred EECC
Q ss_conf 1057
Q 001782 589 LNLS 592 (1013)
Q Consensus 589 L~l~ 592 (1013)
|+++
T Consensus 222 L~ls 225 (227)
T d1h6ua2 222 VTLT 225 (227)
T ss_dssp EEEE
T ss_pred EEEE
T ss_conf 9712
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.88 E-value=6.7e-23 Score=141.94 Aligned_cols=176 Identities=18% Similarity=0.180 Sum_probs=0.0
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCHHHHHCCC
Q ss_conf 899844785676688533565756877768872468-7886644674545011023322234870011000001332147
Q 001782 418 QVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRG-HVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLS 496 (1013)
Q Consensus 418 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~ls 496 (1013)
+.++.++++++ .+|..+. +++++|+|++|+|+. ..+..|.++++|+.|++++|.+. .++...+...+.++.|+++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~-~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECC
T ss_pred CEEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCC-CCCCCCCCCCCCCCEEEEC
T ss_conf 99997089967-0298989--787889848987755302002578762721301363221-2121222112222101003
Q ss_pred CCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 98102668834357677748975588788878100004544320012263234564700004477785735566235656
Q 001782 497 GNLLTGSIPAEVGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQI 576 (1013)
Q Consensus 497 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 576 (1013)
+|+++...+..|.++++|+.|+|++|+|+.+.+..|..+++|++|+|++|.+. .......-...++.+.+..|.++...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~-~~~~~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN-CNCHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC-CSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHCCCCCCEEECC
T ss_conf 55344349799807974655245774535359778568753342000364434-35302777642354035689827689
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 1012464533501057863878789
Q 001782 577 PEFLENLSFLEYLNLSYNHLEGEVP 601 (1013)
Q Consensus 577 ~~~~~~l~~L~~L~l~~N~l~~~~~ 601 (1013)
|..+. .++.++++.|.+.|..+
T Consensus 166 p~~l~---~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 166 PSKVR---DVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp STTTT---TSBGGGSCTTTCCCCCC
T ss_pred CHHHC---CCEEEECCHHHCCCCCC
T ss_conf 84336---98861448755758998
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=6.6e-22 Score=136.37 Aligned_cols=76 Identities=32% Similarity=0.449 Sum_probs=25.7
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 76777489755887888781000045443200122632345647000044777857355662356561012464533501
Q 001782 510 NLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIPEFLENLSFLEYL 589 (1013)
Q Consensus 510 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 589 (1013)
.++.++.++++.|.+.+ +..+..+++|+.+++++|++.+.. .+..+++|+.|+|++|+++. ++ .+..+++|+.|
T Consensus 132 ~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L 205 (210)
T d1h6ta2 132 HLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVL 205 (210)
T ss_dssp GCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEE
T ss_pred CCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEE
T ss_conf 11112221122233345--431000133210013464302564--53678989999897998998-72-11699998999
Q ss_pred EC
Q ss_conf 05
Q 001782 590 NL 591 (1013)
Q Consensus 590 ~l 591 (1013)
++
T Consensus 206 ~L 207 (210)
T d1h6ta2 206 EL 207 (210)
T ss_dssp EE
T ss_pred EC
T ss_conf 71
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=3.8e-21 Score=132.10 Aligned_cols=14 Identities=43% Similarity=0.465 Sum_probs=4.5
Q ss_pred CCCCCEEECCCCCC
Q ss_conf 57568777688724
Q 001782 438 LTILNSLDLGFNKL 451 (1013)
Q Consensus 438 l~~L~~L~Ls~N~l 451 (1013)
+++|+.|++++|++
T Consensus 177 l~~L~~L~Ls~N~i 190 (210)
T d1h6ta2 177 LTKLQNLYLSKNHI 190 (210)
T ss_dssp CTTCCEEECCSSCC
T ss_pred CCCCCEEECCCCCC
T ss_conf 89899998979989
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=2.5e-21 Score=133.12 Aligned_cols=62 Identities=39% Similarity=0.530 Sum_probs=24.3
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 357677748975588788878100004544320012263234564700004477785735566235
Q 001782 508 VGNLKNLVQLGLSENRFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLS 573 (1013)
Q Consensus 508 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 573 (1013)
+..+++|+.|++++|.+.. ++ .+..+++|+.|++++|++++.. .+..+++|+.|++++|+++
T Consensus 124 ~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 124 LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp GTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred CCHHHHHHHHHHHHHHHCC-CC-CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCEEECCCCCCC
T ss_conf 0012236776431111002-34-3332111111223455556770--1167998999978799799
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.1e-20 Score=129.41 Aligned_cols=60 Identities=22% Similarity=0.233 Sum_probs=26.5
Q ss_pred CCCCCEEECCCC-CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 677748975588-788878100004544320012263-234564700004477785735566
Q 001782 511 LKNLVQLGLSEN-RFSNEIPVSLSACTTLEYLYMEGN-SLTGSIPLALKTLKSIKELDLSRN 570 (1013)
Q Consensus 511 l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N 570 (1013)
+++|+.|++++| .+++.....+..+++|++|+++++ .+++.....+..+++|+.|+++++
T Consensus 174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECC
T ss_conf 22212355322347783033332135768779899999787378999726999898964488
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.78 E-value=1.1e-20 Score=129.41 Aligned_cols=15 Identities=27% Similarity=0.410 Sum_probs=7.2
Q ss_pred CCCCCEEECCCCCCC
Q ss_conf 477785735566235
Q 001782 559 LKSIKELDLSRNNLS 573 (1013)
Q Consensus 559 l~~L~~L~Ls~N~l~ 573 (1013)
.+.|+.|+|++|++.
T Consensus 301 ~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 301 MPDLLFLELNGNRFS 315 (344)
T ss_dssp CTTCCEEECTTSBSC
T ss_pred CCCCCEEECCCCCCC
T ss_conf 899998978798089
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.77 E-value=2.7e-20 Score=127.33 Aligned_cols=12 Identities=33% Similarity=0.390 Sum_probs=4.4
Q ss_pred CCCEEECCCCCC
Q ss_conf 335010578638
Q 001782 585 FLEYLNLSYNHL 596 (1013)
Q Consensus 585 ~L~~L~l~~N~l 596 (1013)
+|+.|++++|++
T Consensus 303 ~L~~L~l~~N~~ 314 (344)
T d2ca6a1 303 DLLFLELNGNRF 314 (344)
T ss_dssp TCCEEECTTSBS
T ss_pred CCCEEECCCCCC
T ss_conf 999897879808
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.8e-21 Score=132.87 Aligned_cols=10 Identities=30% Similarity=0.178 Sum_probs=3.2
Q ss_pred CCCCCEEECC
Q ss_conf 7454501102
Q 001782 462 CQNLMLLSVS 471 (1013)
Q Consensus 462 l~~L~~L~Ls 471 (1013)
+++|+.|+++
T Consensus 224 ~~~L~~L~l~ 233 (284)
T d2astb2 224 IPTLKTLQVF 233 (284)
T ss_dssp CTTCCEEECT
T ss_pred CCCCCEEEEE
T ss_conf 9998989644
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=7.4e-18 Score=113.62 Aligned_cols=14 Identities=21% Similarity=0.491 Sum_probs=4.7
Q ss_pred CCCCCEEECCCCCC
Q ss_conf 57568777688724
Q 001782 438 LTILNSLDLGFNKL 451 (1013)
Q Consensus 438 l~~L~~L~Ls~N~l 451 (1013)
+++|+.|++++|.|
T Consensus 40 l~~L~~L~Ls~N~i 53 (162)
T d1a9na_ 40 LDQFDAIDFSDNEI 53 (162)
T ss_dssp TTCCSEEECCSSCC
T ss_pred CCCCCEEECCCCCC
T ss_conf 14599898979978
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=1.9e-16 Score=105.76 Aligned_cols=134 Identities=20% Similarity=0.113 Sum_probs=94.7
Q ss_pred HHCCCCCEECCCCCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 3214798102668834357677748975588-788878100004544320012263234564700004477785735566
Q 001782 492 LLDLSGNLLTGSIPAEVGNLKNLVQLGLSEN-RFSNEIPVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRN 570 (1013)
Q Consensus 492 ~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 570 (1013)
.++.+++.++ ..|..+..+++|+.|++++| .++.+.+..|..+++|+.|+|++|+|+...+.+|..+++|+.|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCC
T ss_conf 6985289976-586002576565743168986644369212256666672162021247742011124554333322678
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC--CCCCCCCEEEECCCCCCCCCCCC
Q ss_conf 2356561012464533501057863878789997--44787610150886777898778
Q 001782 571 NLSGQIPEFLENLSFLEYLNLSYNHLEGEVPRRG--VFSNKTRFYFTGNKRLCGGLDEL 627 (1013)
Q Consensus 571 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~--~~~~~~~~~~~~n~~~c~~~~~~ 627 (1013)
+|+...+..+..+ +|+.|++++|+|.|.+...+ .+.......+..+...|.+|..+
T Consensus 91 ~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l 148 (156)
T d2ifga3 91 ALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPL 148 (156)
T ss_dssp CCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCS
T ss_pred CCCCCCHHHHCCC-CCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCEECCCHHH
T ss_conf 7851574563353-212433579863388117999999985657667578577968688
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.63 E-value=6.5e-16 Score=102.68 Aligned_cols=118 Identities=25% Similarity=0.345 Sum_probs=0.0
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEEEEE
Q ss_conf 55663165247889983244564346554334346789500016772030012377667888877688999876799440
Q 001782 200 QVLSIGENRLSGRLPDSLGQLRSLYYLSISENAFSGMFPSSIFNISSLESISLLGNRLEGSLPVNIGFSLPNLENLSVRQ 279 (1013)
Q Consensus 200 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~lp~~~~~~l~~L~~L~l~~ 279 (1013)
++|++++|+++ .++. ++++++|++|++++|+++ .+|..+..+++|+.|++++|+++ .+|. +. .+++|+.|++++
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~-~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VA-NLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GT-TCSSCCEEECCS
T ss_pred CEEECCCCCCC-CCCC-CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCCC-CC-CCCCCCEEECCC
T ss_conf 98986899898-8710-105898898979787168-65215655431354532432112-3574-12-335557688889
Q ss_pred CCCCCCCC-CCCCCCCCCCEEECCCCCCCCCC---CCCCCCCCCCCCC
Q ss_conf 33645489-98888999966974257243335---6333488874300
Q 001782 280 NNYTGSLP-HSLSNASNLRLLDFSLNHFSGQV---KIDFNRLPNLFRL 323 (1013)
Q Consensus 280 n~l~~~~~-~~l~~l~~L~~L~l~~N~l~~~~---~~~~~~l~~L~~L 323 (1013)
|+++.... ..+..+++|+.|++++|+++... ......+|+++.|
T Consensus 75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred CCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHHHHHCCCCCEE
T ss_conf 865888882565379999999897996886826799999989673138
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.61 E-value=1.1e-17 Score=112.66 Aligned_cols=42 Identities=29% Similarity=0.450 Sum_probs=19.9
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 53356575687776887246878866446745450110233222
Q 001782 433 ESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKLT 476 (1013)
Q Consensus 433 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 476 (1013)
..+..+++|++|+|++|+|+ .++ .+..+++|+.|++++|.++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~ 83 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK 83 (198)
T ss_dssp HHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC
T ss_pred HHHHCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCC
T ss_conf 67762604615199446899-864-4247825357341353432
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.60 E-value=1.4e-17 Score=112.13 Aligned_cols=62 Identities=26% Similarity=0.343 Sum_probs=21.5
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 38999998998447856766885335657568777688724687886644674545011023322
Q 001782 411 IGELRNLQVLDLHHNNLDGHIPESLGNLTILNSLDLGFNKLRGHVPSSLGNCQNLMLLSVSNNKL 475 (1013)
Q Consensus 411 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 475 (1013)
+..+++|+.|++++|+|+.+ + .+..+++|+.|++++|.|+ .++..+..+++|+.|++++|++
T Consensus 44 l~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i 105 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQI 105 (198)
T ss_dssp HHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEEC
T ss_pred HHCCCCCCEEECCCCCCCCC-C-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCC
T ss_conf 76260461519944689986-4-4247825357341353432-1000033221233333333222
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.03 E-value=2.3e-09 Score=65.93 Aligned_cols=149 Identities=15% Similarity=0.133 Sum_probs=97.3
Q ss_pred HHHHHHHCCCCCCCCEEECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCC-CCCCCEEEEEEECCCC
Q ss_conf 666654114898880110542389999989997399999974134560367999999984179-9963049999614774
Q 001782 692 ADLSKATNDFSSSNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR-HRNLIKIITVCSSIDF 770 (1013)
Q Consensus 692 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 770 (1013)
.++.+....|+..+..+-+..+.||+... ++..+++|+...........+.+|...+..+. +--+.+++.+.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~----- 79 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE----- 79 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEE--CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEE-----
T ss_conf 99997513527997678998771899990--89869999848876532556999999999876069987289997-----
Q ss_pred CCCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------
Q ss_conf 565418899860447877777300365421578899999999999999999986169-----------------------
Q 001782 771 EEVDFKAIVYEYMECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHC----------------------- 827 (1013)
Q Consensus 771 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------- 827 (1013)
+.++..++||++.+|.++.+..... .. ...++.+++..+..||+..
T Consensus 80 ~~~~~~~lv~~~l~G~~~~~~~~~~--------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T d1j7la_ 80 RHDGWSNLLMSEADGVLCSEEYEDE--------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp EETTEEEEEEECCSSEEHHHHTTTC--------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred ECCCCEEEEEEECCCCCCCCCCCCC--------CC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 5089649999860433435433440--------26---999999899999998556842143576446565557789987
Q ss_pred ---------------------------------CCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf ---------------------------------9990525889985575589955980146654
Q 001782 828 ---------------------------------HPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 828 ---------------------------------~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~ 858 (1013)
.+.++|+|+.|.||++++++.+-++||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf 7655554303323200579999999984498678178986004764236499659996023144
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.96 E-value=3.3e-11 Score=76.26 Aligned_cols=81 Identities=27% Similarity=0.294 Sum_probs=37.5
Q ss_pred CCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-------CCC
Q ss_conf 7677748975588788878--1000045443200122632345647000044777857355662356561-------012
Q 001782 510 NLKNLVQLGLSENRFSNEI--PVSLSACTTLEYLYMEGNSLTGSIPLALKTLKSIKELDLSRNNLSGQIP-------EFL 580 (1013)
Q Consensus 510 ~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-------~~~ 580 (1013)
.++.|+.|+|++|+|+... +..+..+++|+.|+|++|.|+...+..+.....|+.|++++|++..... ..+
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~ 142 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR 142 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHH
T ss_pred HCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHH
T ss_conf 48787886377766667731588986588561000435721342344222033104266489976767666156999999
Q ss_pred CCCCCCCEEE
Q ss_conf 4645335010
Q 001782 581 ENLSFLEYLN 590 (1013)
Q Consensus 581 ~~l~~L~~L~ 590 (1013)
..+|+|+.||
T Consensus 143 ~~~P~L~~LD 152 (162)
T d1koha1 143 ERFPKLLRLD 152 (162)
T ss_dssp TTSTTCCEET
T ss_pred HHCCCCCEEC
T ss_conf 9889978799
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.87 E-value=2.2e-10 Score=71.70 Aligned_cols=15 Identities=40% Similarity=0.412 Sum_probs=5.4
Q ss_pred CCCCCEEECCCCCCC
Q ss_conf 677748975588788
Q 001782 511 LKNLVQLGLSENRFS 525 (1013)
Q Consensus 511 l~~L~~L~Ls~N~l~ 525 (1013)
+++|+.|+|++|.++
T Consensus 90 l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 90 APNLKILNLSGNELK 104 (162)
T ss_dssp STTCCCCCCTTSCCC
T ss_pred CCCCCCCCCCCCCCC
T ss_conf 885610004357213
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.63 E-value=9.7e-08 Score=56.81 Aligned_cols=130 Identities=16% Similarity=0.082 Sum_probs=79.4
Q ss_pred CEEECCC-EEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCC--CCCCCEEEEEEECCCCCCCCEEEEEEEE
Q ss_conf 0110542-389999989997399999974134560367999999984179--9963049999614774565418899860
Q 001782 706 MIGQGSF-GFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIR--HRNLIKIITVCSSIDFEEVDFKAIVYEY 782 (1013)
Q Consensus 706 ~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~ 782 (1013)
.+..|.. +.||+.... ++..+++|...... ...+..|...++.+. .--+.+++.++. ..+..++||++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEEC
T ss_pred ECCCCCCCCEEEEEEEC-CCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECC-----CCCCEEEEEEE
T ss_conf 76786547758999938-98789999589667---76899999999999865999886132224-----56615999874
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------
Q ss_conf 447877777300365421578899999999999999999986169-----------------------------------
Q 001782 783 MECGSLEDWLHQSNDQLEVGNFNVIQRLNLVIDVAFAIEYLHHHC----------------------------------- 827 (1013)
Q Consensus 783 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------- 827 (1013)
++|.++.+.. ... ...+.+++..+..||...
T Consensus 88 i~G~~~~~~~-----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (255)
T d1nd4a_ 88 VPGQDLLSSH-----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 153 (255)
T ss_dssp CSSEETTTSC-----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EECCCCCCCC-----------CCH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHH
T ss_conf 4135543221-----------268---99999999999987368854488755412468899999987541101134011
Q ss_pred --------------------CCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf --------------------9990525889985575589955980146654
Q 001782 828 --------------------HPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 828 --------------------~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~ 858 (1013)
.+.++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 213799999999871876579567867888763577379658999853326
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.62 E-value=2.5e-07 Score=54.47 Aligned_cols=77 Identities=17% Similarity=0.169 Sum_probs=51.7
Q ss_pred CCCEEECCCEEEEEEEECCCCEEEEEEEEEECCC-------CCHHHHHHHHHHHHCCC-C--CCCCEEEEEEECCCCCCC
Q ss_conf 8801105423899999899973999999741345-------60367999999984179-9--963049999614774565
Q 001782 704 SNMIGQGSFGFVYRGNLGENEMAVAVKVMNLKQR-------GATKSFVAECEALRNIR-H--RNLIKIITVCSSIDFEEV 773 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~~ 773 (1013)
.+.+|.|....||++.+..+++.+++|...+..+ ....+...|.+.++.+. + ..+++++.+..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~------- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT------- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEECC-------
T ss_conf 9980798527689999579984899961771303467778887789999999999865057988552899859-------
Q ss_pred CEEEEEEEECCCCC
Q ss_conf 41889986044787
Q 001782 774 DFKAIVYEYMECGS 787 (1013)
Q Consensus 774 ~~~~lv~e~~~~gs 787 (1013)
+..++|||++++..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEECCCCCC
T ss_conf 88779871357765
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.12 E-value=1.5e-05 Score=44.50 Aligned_cols=144 Identities=15% Similarity=0.125 Sum_probs=75.0
Q ss_pred CCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCCC--CCEEEEEEECCCCCCCCEEEEEEEECCCCCH
Q ss_conf 42389999989997399999974134560367999999984179996--3049999614774565418899860447877
Q 001782 711 SFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHRN--LIKIITVCSSIDFEEVDFKAIVYEYMECGSL 788 (1013)
Q Consensus 711 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL 788 (1013)
.--.||++... +|..|++|+.+.. ....+.+..|...+..+.... ++..+.......+......+.++++.+|..+
T Consensus 34 ~EN~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 34 YENRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSSEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCCEEEEEECC-CCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 12026999838-9997999984787-788999999999999998559987875206898056653479999865277688
Q ss_pred H-----HH------H---HC---CCCCCCCCCCCH----------------------HHHHHHHHHHHHHHHHHH-HCCC
Q ss_conf 7-----77------3---00---365421578899----------------------999999999999999986-1699
Q 001782 789 E-----DW------L---HQ---SNDQLEVGNFNV----------------------IQRLNLVIDVAFAIEYLH-HHCH 828 (1013)
Q Consensus 789 ~-----~~------l---~~---~~~~~~~~~l~~----------------------~~~~~i~~qi~~~l~~LH-~~~~ 828 (1013)
. ++ + +. ..........+. ......+.++...+...- ....
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 990525889985575589955980146654
Q 001782 829 PPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 829 ~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~ 858 (1013)
.+++|+|+.+.|||++++ ..++||+.+.
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCC
T ss_conf 120247888042878389--3588652014
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.03 E-value=7.6e-07 Score=51.78 Aligned_cols=122 Identities=13% Similarity=0.176 Sum_probs=0.0
Q ss_pred HHHHHCCCCCCEEECCC-CCCCCC----CCCCCCCCCCCCEEECCCCCCC----CCCCCCCCCCCCCCEEECCCCCCC--
Q ss_conf 67760245666364146-655577----3511389999989984478567----668853356575687776887246--
Q 001782 384 QIYVKNLVNLNGFGLEY-NQLTGP----IPHAIGELRNLQVLDLHHNNLD----GHIPESLGNLTILNSLDLGFNKLR-- 452 (1013)
Q Consensus 384 ~~~~~~l~~L~~L~L~~-n~l~~~----~p~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~-- 452 (1013)
+....+.++|+.|+|++ +.+... +...+...+.|+.|++++|.+. ..+.+.+...+.|+.|+|++|.++
T Consensus 8 ~~l~~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~ 87 (167)
T d1pgva_ 8 NRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPE 87 (167)
T ss_dssp HHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHH
T ss_pred HHHHHCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHH
T ss_conf 99982899981978279999898999999999763776454012015621567988753100023433003301021459
Q ss_pred --CCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCHHHHHCCCCCEECCCCCCCCCCCCCCCEEECCCCC
Q ss_conf --87886644674545011023322234870011000001332147981026688343576777489755887
Q 001782 453 --GHVPSSLGNCQNLMLLSVSNNKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQLGLSENR 523 (1013)
Q Consensus 453 --~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 523 (1013)
..+..++...++|+.|++++|++. .+...... .+...+..-+.|+.|+++.+.
T Consensus 88 g~~~l~~aL~~n~sL~~L~l~~n~~~-~~g~~~~~-----------------~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 88 LLARLLRSTLVTQSIVEFKADNQRQS-VLGNQVEM-----------------DMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHHHHTTTTCCCSEEECCCCSSC-CCCHHHHH-----------------HHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHHHHHCCCCCEEECCCCCCC-CCCHHHHH-----------------HHHHHHHHCCCCCEEECCCCC
T ss_conf 99999999984893898778877688-86579999-----------------999999729985386486888
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.92 E-value=5.9e-05 Score=41.18 Aligned_cols=74 Identities=19% Similarity=0.199 Sum_probs=48.3
Q ss_pred CCCEEECCCEEEEEEEECC-------CCEEEEEEEEEECCCCCHHHHHHHHHHHHCCC-CCCCCEEEEEEECCCCCCCCE
Q ss_conf 8801105423899999899-------97399999974134560367999999984179-996304999961477456541
Q 001782 704 SNMIGQGSFGFVYRGNLGE-------NEMAVAVKVMNLKQRGATKSFVAECEALRNIR-HRNLIKIITVCSSIDFEEVDF 775 (1013)
Q Consensus 704 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 775 (1013)
.+.++.|-.-.+|++.... ....|.+++.. ... ......+|..+++.+. +.-..++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~--------- 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFS--------- 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET---------
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-CCC-HHHHHHHHHHHHHHHHHCCCCCEEEEECC---------
T ss_conf 9991785334348999688775445789817999659-961-16589999999999975799980899818---------
Q ss_pred EEEEEEECCCCCH
Q ss_conf 8899860447877
Q 001782 776 KAIVYEYMECGSL 788 (1013)
Q Consensus 776 ~~lv~e~~~~gsL 788 (1013)
-..|+||++|.++
T Consensus 116 ~g~I~efi~g~~l 128 (395)
T d1nw1a_ 116 GGRLEEYIPSRPL 128 (395)
T ss_dssp TEEEECCCCEEEC
T ss_pred CCEEEEEECCCCC
T ss_conf 9569997345548
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.73 E-value=0.00058 Score=35.59 Aligned_cols=166 Identities=10% Similarity=0.005 Sum_probs=79.9
Q ss_pred CCHHHHHHHHCCCCCCCCEE-----ECCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHCCCCC--CCCEE
Q ss_conf 50666665411489888011-----054238999998999739999997413456036799999998417999--63049
Q 001782 689 VSYADLSKATNDFSSSNMIG-----QGSFGFVYRGNLGENEMAVAVKVMNLKQRGATKSFVAECEALRNIRHR--NLIKI 761 (1013)
Q Consensus 689 ~~~~~~~~~~~~y~~~~~lg-----~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l 761 (1013)
++.+++.....+|.+++... .|.--+.|..+... ..+++|++.... ..+.+..|.+.+..+... .+...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~--g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS--CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECC--CCEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 899999999986799985685237888526738999789--728999807899--9889999999987543025554556
Q ss_pred EEEEEC-CCCCCCCEEEEEEEECCCCCHHH--------------HHHC----CCCCCCCCC-----------------CC
Q ss_conf 999614-77456541889986044787777--------------7300----365421578-----------------89
Q 001782 762 ITVCSS-IDFEEVDFKAIVYEYMECGSLED--------------WLHQ----SNDQLEVGN-----------------FN 805 (1013)
Q Consensus 762 ~~~~~~-~~~~~~~~~~lv~e~~~~gsL~~--------------~l~~----~~~~~~~~~-----------------l~ 805 (1013)
+..... ...........++.+..+..... .++. ......... ..
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred CEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHC
T ss_conf 41048976213412550245311465533320467888889987645444320245310111012002456777765311
Q ss_pred HHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 99999999999999999861-699990525889985575589955980146654
Q 001782 806 VIQRLNLVIDVAFAIEYLHH-HCHPPIVHGDLKPSNVLLDHDMVAHVGDFGLAR 858 (1013)
Q Consensus 806 ~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~ 858 (1013)
.......+......+...+. ....|+||+|+.++||+++.+...-+.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 412799999998764204855454503337863656402045412674222123
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.52 E-value=2.1e-06 Score=49.30 Aligned_cols=125 Identities=16% Similarity=0.147 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCEEECCC-CCCC----CCCCCCCCCCCCCCEEECCCCCCC----CCCCCCCCCCCCCCEEECCC
Q ss_conf 55577351138999998998447-8567----668853356575687776887246----87886644674545011023
Q 001782 402 QLTGPIPHAIGELRNLQVLDLHH-NNLD----GHIPESLGNLTILNSLDLGFNKLR----GHVPSSLGNCQNLMLLSVSN 472 (1013)
Q Consensus 402 ~l~~~~p~~~~~l~~L~~L~L~~-N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~----~~~~~~~~~l~~L~~L~Ls~ 472 (1013)
.+...+.....+.+.|+.|++++ +.++ ..+...+...++|+.|++++|.++ ..+...+...++++.+++++
T Consensus 4 ~i~~~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~ 83 (166)
T d1io0a_ 4 DVEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVES 83 (166)
T ss_dssp CHHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCS
T ss_pred CHHHHHHHHHHCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCC
T ss_conf 39999999995599986887689999898999999988841982574301589611778999998775212210121025
Q ss_pred CCCCCCCCCHHHCCCCHHHHHCCCCCEECCCCCCCCCCCCCCCE--EECCCCCCCC----CCCCCCCCCCCCCCCCCCCC
Q ss_conf 32223487001100000133214798102668834357677748--9755887888----78100004544320012263
Q 001782 473 NKLTGALPPQILGIVTLSILLDLSGNLLTGSIPAEVGNLKNLVQ--LGLSENRFSN----EIPVSLSACTTLEYLYMEGN 546 (1013)
Q Consensus 473 N~l~~~~~~~~~~~~~~l~~L~ls~N~l~~~~~~~~~~l~~L~~--L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N 546 (1013)
|.+....-..+.. .+...+.|+. |++++|.+.. .+...+...++|+.|+++.+
T Consensus 84 ~~~~~~g~~~l~~---------------------~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 84 NFISGSGILALVE---------------------ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp SCCCHHHHHHHHH---------------------GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred CCCCCHHHHHHHH---------------------HHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCC
T ss_conf 4322014788999---------------------9984865247732167786767999999999984998478858189
Q ss_pred C
Q ss_conf 2
Q 001782 547 S 547 (1013)
Q Consensus 547 ~ 547 (1013)
.
T Consensus 143 ~ 143 (166)
T d1io0a_ 143 Q 143 (166)
T ss_dssp S
T ss_pred C
T ss_conf 8
|